PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Keller, T; Egenberger, B; Gorboulev, V; Bernhard, F; Uzelac, Z; Gorbunov, D; Wirth, C; Koppatz, S; Dotsch, V; Hunte, C; Sitte, HH; Koepsell, H				Keller, Thorsten; Egenberger, Brigitte; Gorboulev, Valentin; Bernhard, Frank; Uzelac, Zeljko; Gorbunov, Dmitry; Wirth, Christophe; Koppatz, Stefan; Doetsch, Volker; Hunte, Carola; Sitte, Harald H.; Koepsell, Hermann			The Large Extracellular Loop of Organic Cation Transporter 1 Influences Substrate Affinity and Is Pivotal for Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; D-GLUCOSE COTRANSPORTER; CELL-FREE EXPRESSION; AMINO-ACIDS; PLASMA-MEMBRANE; FUNCTIONAL RECONSTITUTION; ANION TRANSPORTER; BINDING REGION; ROCT1; PROTEIN	Polyspecific organic anion transporters (OATs) and organic cation transporters (OCTs) of the SLC22 transporter family play a pivotal role in absorption, distribution, and excretion of drugs. Polymorphisms in these transporters influence therapeutic effects. On the basis of functional characterizations, homology modeling, and mutagenesis, hypotheses for how OCTs bind and translocate structurally different cations were raised, assuming functionally competent monomers. However, homo-oligomerization has been described for OATs and OCTs. In the present study, evidence is provided that the large extracellular loops (EL) of rat Oct1 (rOct1) and rat Oat1 (rOat1) mediate homo-but not hetero-oligomerization. Replacement of the cysteine residues in the EL of rOct1 by serine residues (rOct1(6 Delta C-l)) or breaking disulfide bonds with dithiothreitol prevented oligomerization. rOct1 chimera containing the EL of rOat1 (rOct1(rOat1-l)) showed oligomerization but reduced transporter amount in the plasma membrane. For rOct1(6 Delta C-l) and rOct1(rOat1-l), similar K-m values for 1-methyl-4-phenylpyridinium(+) (MPP+) and tetraethylammonium(+) (TEA(+)) were obtained that were higher compared with rOct1 wild type. The increased K-m of rOct1(rOat1-l) indicates an allosteric effect of EL on the cation binding region. The similar substrate affinity of the oligomerizing and non-oligomerizing loop mutants suggests that oligomerization does not influence transport function. Independent transport function of rOct1 monomers was also demonstrated by showing that K-m values for MPP+ and TEA(+) were not changed after treatment with dithiothreitol and that a tandem protein with two rOct1 monomers showed about 50% activity with unchanged K-m values for MPP+ and TEA(+) when one monomer was blocked. The data help to understand how OCTs work and how mutations in patients may affect their functions.	[Keller, Thorsten; Egenberger, Brigitte; Gorboulev, Valentin; Gorbunov, Dmitry; Koppatz, Stefan; Koepsell, Hermann] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Bernhard, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Uzelac, Zeljko; Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Wirth, Christophe; Hunte, Carola] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Hunte, Carola] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	University of Wurzburg; Goethe University Frankfurt; Medical University of Vienna; University of Freiburg; University of Freiburg	Koepsell, H (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	Hermann@Koepsell.de	Sitte, Harald/N-2681-2013; Gorbunov, Dmitry/F-2295-2014; Sitte, Harald/O-7025-2019; Hunte, Carola/E-4071-2015	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Hunte, Carola/0000-0002-0826-3986; Wirth, Christophe/0000-0001-8864-6508; Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783; Keller, Thorsten/0000-0002-2897-5761	Deutsche Forschungsgemeinschaft [SFB 487/A4, SFB 746/P21]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Austrian Science Fund/FWF [SFB3506]; Austrian Science Fund (FWF) [F 3506] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 487/A4 (to H. K.) and SFB 746/P21 (to C. H.), by the Excellence Initiative of the German Federal and State Governments (EXC 294) (to C. H.), and the Austrian Science Fund/FWF (SFB3506 to H. H. S.).	Arndt P, 2001, AM J PHYSIOL-RENAL, V281, pF454, DOI 10.1152/ajprenal.2001.281.3.F454; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Brosig B, 1998, PROTEIN SCI, V7, P1052; Busch AE, 1996, FEBS LETT, V395, P153, DOI 10.1016/0014-5793(96)01030-7; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Duan P, 2011, MOL PHARMACOL, V79, P569, DOI 10.1124/mol.110.070185; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821; Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; GRUNDEMANN D, 1994, ANAL BIOCHEM, V216, P459, DOI 10.1006/abio.1994.1069; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Keller T, 2005, BIOCHEMISTRY-US, V44, P12253, DOI 10.1021/bi050676c; Keller T, 2008, BIOCHEMISTRY-US, V47, P4552, DOI 10.1021/bi800060w; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Perry JL, 2006, J BIOL CHEM, V281, P38071, DOI 10.1074/jbc.M608834200; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Rizwan AN, 2007, PHARM RES-DORDR, V24, P450, DOI 10.1007/s11095-006-9181-4; Schmid JA, 2003, CURR OPIN ONCOL, V15, P55, DOI 10.1097/00001622-200301000-00008; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Sturm A, 2007, AM J PHYSIOL-RENAL, V293, pF767, DOI 10.1152/ajprenal.00106.2007; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Valentin M, 2000, BBA-BIOMEMBRANES, V1468, P367, DOI 10.1016/S0005-2736(00)00277-7; VEYHL M, 1993, J BIOL CHEM, V268, P25041; Veyhl M, 2003, J MEMBRANE BIOL, V196, P71, DOI 10.1007/s00232-003-0626-y; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	37	52	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37874	37886		10.1074/jbc.M111.289330	http://dx.doi.org/10.1074/jbc.M111.289330			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896487	Green Published, hybrid			2022-12-25	WOS:000296542400082
J	Xu, LS; Xiao, HL; Xu, MH; Zhou, C; Yi, L; Liang, H				Xu, Lunshan; Xiao, Hualiang; Xu, Minhui; Zhou, Chun; Yi, Liang; Liang, Hong			Glioma-derived T Cell Immunoglobulin- and Mucin Domain-containing Molecule-4 (TIM4) Contributes to Tumor Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-INITIATING CELLS; TGF-BETA; IMMUNE CELLS; PHOSPHATIDYLSERINE; MICROENVIRONMENT; PROLIFERATION; GLIOBLASTOMA; INFLAMMATION; PROGRESSION; RESPONSES	Tumor tolerance plays a critical role in tumor growth and escape from immune surveillance. The mechanism of tumor tolerance development is not fully understood. Regulatory T cells (Tregs) play a critical role in tumor tolerance. TIM4 (T cell immunoglobulin-and mucin domain-containing molecule-4) is involved in immune regulation. We investigated the role of TIM4 in the induction of Tregs in tumors. Surgically removed glioma tissue and peripheral blood samples were obtained from 25 glioma patients. Immune cells were isolated from the tissue and blood samples. Confocal microscopy was employed to detect macrophages phagocytosing apoptotic T cells. The generation of tumor-specific Tregs and the immune suppression function of Tregs were observed in cell culture models. High levels of TIM4 were detected in glioma-derived macrophages. Phosphatidylserine (PS) was detected in glioma-derived T cells; naive T cells expressed low levels of PS that could be up-regulated by hypoxia. Glioma-derived macrophages phagocytosed PS-expressing T cells, gaining the tolerogenic properties, which could induce tumor-specific Tregs; the latter could suppress tumor-specific CD8(+) T cells. We conclude that macrophage-derived TIM4 plays an important role in the induction of Tregs in gliomas, which may play an important role in tumor tolerance.	[Xu, Minhui] Third Mil Med Univ, PLA, Daping Hosp, Dept Neurosurg, Chongqing 400042, Peoples R China; [Xiao, Hualiang] Third Mil Med Univ, Dept Pathol, Daping Hosp, Chongqing 400042, Peoples R China	Army Medical University; Army Medical University	Xu, MH (corresponding author), Third Mil Med Univ, PLA, Daping Hosp, Dept Neurosurg, Chongqing 400042, Peoples R China.	xuminhui8@163.com			National Natural Science Foundation of China [30872649/C1608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China Grant 30872649/C1608.	Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dorfman DM, 2010, HUM PATHOL, V41, P1486, DOI 10.1016/j.humpath.2010.04.005; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kren L, 2010, J NEUROIMMUNOL, V220, P131, DOI 10.1016/j.jneuroim.2010.01.014; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Piersma SJ, 2008, HUM IMMUNOL, V69, P241, DOI 10.1016/j.humimm.2008.02.005; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Yang SB, 2011, J LEUKOCYTE BIOL, V89, P85, DOI 10.1189/jlb.0910506; Zhao PQ, 2010, CELL MOL IMMUNOL, V7, P152, DOI 10.1038/cmi.2009.118	29	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36694	36699		10.1074/jbc.M111.292540	http://dx.doi.org/10.1074/jbc.M111.292540			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21896488	hybrid, Green Published			2022-12-25	WOS:000296538300052
J	Alegre, KO; Reverter, D				Alegre, Kamela O.; Reverter, David			Swapping Small Ubiquitin-like Modifier (SUMO) Isoform Specificity of SUMO Proteases SENP6 and SENP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PML; SUMOYLATION; PRECURSORS; MATURATION; PROTEINS; DISTINCT; RNF4	SUMO proteases can regulate the amounts of SUMO-conjugated proteins in the cell by cleaving off the isopeptidic bond between SUMO and the target protein. Of the six members that constitute the human SENP/ULP protease family, SENP6 and SENP7 are the most divergent members in their conserved catalytic domain. The SENP6 and SENP7 subclass displays a clear proteolytic cleavage preference for SUMO2/3 isoforms. To investigate the structural determinants for such isoform specificity, we have identified a unique sequence insertion in the SENP6 and SENP7 subclass that is essential for their proteolytic activity and that forms a more extensive interface with SUMO during the proteolytic reaction. Furthermore, we have identified a region in the SUMO surface determinant for the SUMO2/3 isoform specificity of SENP6 and SENP7. Double point amino acid mutagenesis on the SUMO surface allows us to swap the specificity of SENP6 and SENP7 between the two SUMO isoforms. Structure-based comparisons combined with biochemical and mutagenesis analysis have revealed Loop 1 insertion in SENP6 and SENP7 as a platform to discriminate between SUMO1 and SUMO2/3 isoforms in this subclass of the SUMO protease family.	[Alegre, Kamela O.; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	david.reverter@uab.cat	Reverter, David/H-5360-2015	Reverter, David/0000-0002-5347-0992; Alegre, Kamela/0000-0002-2666-4767	Ministerio de Educacion y Ciencia [BFU2008-0364]; European Community [MIRG-CT-2007-200346]	Ministerio de Educacion y Ciencia(Spanish Government); European Community(European Commission)	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2008-0364 and European Community Grant MIRG-CT-2007-200346.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Fu CH, 2005, ONCOGENE, V24, P5401, DOI 10.1038/sj.onc.1208714; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KNIPSCHEER P, 2003, CURR OPIN STRUC BIOL, V6, P665; Kolli N, 2010, BIOCHEM J, V430, P335, DOI 10.1042/BJ20100504; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Shen LN, 2009, BIOCHEM J, V421, P223, DOI 10.1042/BJ20090246; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Xu Z, 2005, BIOCHEM J, V386, P325, DOI 10.1042/BJ20041210; Xu Z, 2006, BIOCHEM J, V398, P345, DOI 10.1042/BJ20060526; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	36	20	21	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36142	36151		10.1074/jbc.M111.268847	http://dx.doi.org/10.1074/jbc.M111.268847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878624	hybrid, Green Published			2022-12-25	WOS:000295927100086
J	Velours, J; Stines-Chaumeil, C; Habersetzer, J; Chaignepain, S; Dautant, A; Brethes, D				Velours, Jean; Stines-Chaumeil, Claire; Habersetzer, Johan; Chaignepain, Stephane; Dautant, Alain; Brethes, Daniel			Evidence of the Proximity of ATP Synthase Subunits 6 (a) in the Inner Mitochondrial Membrane and in the Supramolecular Forms of Saccharomyces cerevisiae ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; F1F0-ATP SYNTHASE; CRYOELECTRON TOMOGRAPHY; YEAST MITOCHONDRIA; SPANNING SEGMENT; CROSS-LINKING; GXXXG MOTIF; IN-VIVO; COMPLEX; CRISTAE	The involvement of subunit 6 (a) in the interface between yeast ATP synthase monomers has been highlighted. Based on the formation of a disulfide bond and using the unique cysteine 23 as target, we show that two subunits 6 are close in the inner mitochondrial membrane and in the solubilized supramolecular forms of the yeast ATP synthase. In a null mutant devoid of supernumerary subunits e and g that are involved in the stabilization of ATP synthase dimers, ATP synthase monomers are close enough in the inner mitochondrial membrane to make a disulfide bridge between their subunits 6, and this proximity is maintained in detergent extract containing this enzyme. The cross-linking of cysteine 23 located in the N-terminal part of the first transmembrane helix of subunit 6 suggests that this membrane-spanning segment is in contact with its counterpart belonging to the ATP synthase monomer that faces it and participates in the monomer-monomer interface.	[Velours, Jean; Stines-Chaumeil, Claire; Habersetzer, Johan; Chaignepain, Stephane; Dautant, Alain; Brethes, Daniel] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Velours, Jean; Stines-Chaumeil, Claire; Habersetzer, Johan; Chaignepain, Stephane; Dautant, Alain; Brethes, Daniel] Univ Bordeaux, UMR 5095, F-33077 Bordeaux, France; [Chaignepain, Stephane] CNRS, UMR 5248, F-33600 Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Velours, J (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	jean.velours@ibgc.cnrs.fr; daniel.brethes@ibgc.cnrs.fr			CNRS; Universite Victor Segalen, Bordeaux; Conseil Regional d'Aquitaine; Agence Nationale de la Recherche [ANR-06-PCV-0016]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Victor Segalen, Bordeaux; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the CNRS, the Universite Victor Segalen, Bordeaux, the Conseil Regional d'Aquitaine, and the Agence Nationale de la Recherche (ANR-06-PCV-0016).	ANSORGE W, 1983, ELECTROPHORESIS, V82, P235; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Belogrudov GI, 1996, J BIOL CHEM, V271, P20340, DOI 10.1074/jbc.271.34.20340; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728; Cano-Estrada A, 2010, BBA-BIOENERGETICS, V1797, P1439, DOI 10.1016/j.bbabio.2010.02.024; Chateaubodeau G A, 1976, Biochimie, V58, P601, DOI 10.1016/S0300-9084(76)80230-1; Couoh-Cardel SJ, 2010, J BIOL CHEM, V285, P36447, DOI 10.1074/jbc.M110.144907; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dudkina NV, 2006, FEBS LETT, V580, P3427, DOI 10.1016/j.febslet.2006.04.097; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P272, DOI 10.1016/j.bbabio.2009.11.004; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x; Fronzes R, 2006, BIOCHEMISTRY-US, V45, P6715, DOI 10.1021/bi0601407; Gavin PD, 2005, J BIOENERG BIOMEMBR, V37, P55, DOI 10.1007/s10863-005-4128-8; Gavin PD, 2004, J CELL SCI, V117, P2333, DOI 10.1242/jcs.01074; GrandierVazeille X, 1996, ANAL BIOCHEM, V242, P248, DOI 10.1006/abio.1996.0460; Guerin B, 1979, Methods Enzymol, V55, P149; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Krause F, 2005, BIOCHEM BIOPH RES CO, V329, P583, DOI 10.1016/j.bbrc.2005.02.010; Lau WCY, 2008, J MOL BIOL, V382, P1256, DOI 10.1016/j.jmb.2008.08.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHON T, 1988, EUR J BIOCHEM, V172, P621, DOI 10.1111/j.1432-1033.1988.tb13934.x; Minauro-Sanmiguel F, 2005, P NATL ACAD SCI USA, V102, P12356, DOI 10.1073/pnas.0503893102; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Nicastro D, 2000, J STRUCT BIOL, V129, P48, DOI 10.1006/jsbi.1999.4204; PAUL MF, 1989, EUR J BIOCHEM, V185, P163, DOI 10.1111/j.1432-1033.1989.tb15098.x; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Paumard P, 2002, BIOCHEMISTRY-US, V41, P10390, DOI 10.1021/bi025923g; Paumard P, 2000, BIOCHEMISTRY-US, V39, P4199, DOI 10.1021/bi992438l; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Soubannier V, 2002, J BIOL CHEM, V277, P10739, DOI 10.1074/jbc.M111882200; Spannagel C, 1998, BIOCHEMISTRY-US, V37, P615, DOI 10.1021/bi9714971; Spannagel C, 1998, BBA-BIOMEMBRANES, V1414, P260, DOI 10.1016/S0005-2736(98)00174-6; Stephens AN, 2003, J BIOL CHEM, V278, P17867, DOI 10.1074/jbc.M300967200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Thomas D, 2008, BIOL CELL, V100, P591, DOI 10.1042/BC20080022; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Weimann T, 2008, BIOCHEMISTRY-US, V47, P3556, DOI 10.1021/bi702000g; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2008, MOL CELL PROTEOMICS, V7, P995, DOI 10.1074/mcp.M700465-MCP200; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	54	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35477	35484		10.1074/jbc.M111.275776	http://dx.doi.org/10.1074/jbc.M111.275776			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868388	Green Published, hybrid			2022-12-25	WOS:000295927100019
J	Ketroussi, F; Giuliani, M; Bahri, R; Azzarone, B; Charpentier, B; Durrbach, A				Ketroussi, Farah; Giuliani, Massimo; Bahri, Rajia; Azzarone, Bruno; Charpentier, Bernard; Durrbach, Antoine			Lymphocyte Cell-Cycle Inhibition by HLA-G Is Mediated by Phosphatase SHP-2 and Acts on the mTOR Pathway	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; T-CELLS; G EXPRESSION; G MOLECULE; PROLIFERATIVE RESPONSE; ALLOGRAFT ACCEPTANCE; DENDRITIC CELLS; RECEPTOR; ANTIGEN; CD4(+)	Human leukocyte antigen G (HLA-G) is involved in regulating T-cell responses through its interaction with inhibitory receptors belonging to the immunoglobulin-like transcript family (ILT). In this context, we investigated the pathways involved in the control of cell-cycle entry of T cells following HLA-G interaction with its inhibitory receptor. We show that HLA-G acts through its interaction with the LILRB1 receptor expressed on T lymphocytes. Both HLA-G and LILRB1 antibodies block the inhibitory effect of HLA-G and restore T-cell proliferation. The interaction of HLA-G with T lymphocytes is associated with phosphorylation of SHP-2 phosphatase, but not SHP-1. In addition, in activated T cells, their incubation with HLA-G is not associated with a decrease in the TCR or CD28 downstream pathways, but is associated with dephosphorylation of the mTOR molecule and p70S6K. In contrast, Akt, which acts upstream of mTOR, is not affected by HLA-G. The inhibition of SHP-2 by NSC-87877(5 mu M), a chemical inhibitor of SHP-2, or the use of siRNA, abrogates dephosphorylation of mTOR and impairs the overexpression of p27(kip) in the presence of HLA-G. Together, these results indicate that HLA-G is associated with activation of phosphatase SHP-2, which inhibits the mTOR pathway and favors the inhibition of the cell-cycle entry of human-activated T cells.	[Ketroussi, Farah; Giuliani, Massimo; Bahri, Rajia; Azzarone, Bruno; Charpentier, Bernard; Durrbach, Antoine] INSERM U1014, Villejuif, France; [Charpentier, Bernard; Durrbach, Antoine] Univ Paris 11, Dept Nephrol, Hop Kremlin Bicetre, IFRNT, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Ketroussi, F (corresponding author), INSERM U1014, Villejuif, France.	antoine.durrbach@vjf.inserm.fr	Azzarone, Bruno/AAH-9251-2019; Bahri, Rajia/ABE-1725-2021	Azzarone, Bruno/0000-0002-5962-3849; 	Association pour Utilisation du Rein Artificiel (AURA)	Association pour Utilisation du Rein Artificiel (AURA)	This work was supported by the Association pour Utilisation du Rein Artificiel (AURA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge DRJ, 2000, J REPROD IMMUNOL, V48, P17, DOI 10.1016/S0165-0378(00)00070-X; Bellon T, 2002, J IMMUNOL, V168, P3351, DOI 10.4049/jimmunol.168.7.3351; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Chiang YJ, 2001, CELL TRANSPLANT, V10, P343, DOI 10.3727/000000001783986729; Christophi GP, 2008, LAB INVEST, V88, P243, DOI 10.1038/labinvest.3700720; Colonna M, 1997, IMMUNOL REV, V155, P127, DOI 10.1111/j.1600-065X.1997.tb00945.x; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Creput C, 2003, J HEPATOL, V39, P587, DOI 10.1016/S0168-8278(03)00354-4; Crisa L, 1997, J EXP MED, V186, P289, DOI 10.1084/jem.186.2.289; Dorling A, 2000, EUR J IMMUNOL, V30, P586, DOI 10.1002/1521-4141(200002)30:2<586::AID-IMMU586>3.0.CO;2-Y; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; Le Friec G, 2003, HUM IMMUNOL, V64, P752, DOI 10.1016/S0198-8859(03)00091-0; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Le Rond S, 2004, EUR J IMMUNOL, V34, P649, DOI 10.1002/eji.200324266; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2003, HUM IMMUNOL, V64, P1025, DOI 10.1016/j.humimm.2003.08.348; Lila N, 2000, LANCET, V355, P2138, DOI 10.1016/S0140-6736(00)02386-2; Lila N, 2002, CIRCULATION, V105, P1949, DOI 10.1161/01.CIR.0000015075.89984.46; Lila N, 2001, P NATL ACAD SCI USA, V98, P12150, DOI 10.1073/pnas.201407398; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; NAJI A, 2007, BLOOD; Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X; Puppo Francesco, 2002, ScientificWorldJournal, V2, P421; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0; Riteau B, 2001, INT IMMUNOL, V13, P193, DOI 10.1093/intimm/13.2.193; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; SUMIMOTO R, 1990, TRANSPLANTATION, V50, P678, DOI 10.1097/00007890-199010000-00029	37	23	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22776	10.1371/journal.pone.0022776	http://dx.doi.org/10.1371/journal.pone.0022776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887223	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000005
J	Alhamidi, M; Buvang, EK; Fagerheim, T; Brox, V; Lindal, S; Van Ghelue, M; Nilssen, O				Alhamidi, Maisoon; Buvang, Elisabeth Kjeldsen; Fagerheim, Toril; Brox, Vigdis; Lindal, Sigurd; Van Ghelue, Marijke; Nilssen, Oivind			Fukutin-Related Protein Resides in the Golgi Cisternae of Skeletal Muscle Fibres and Forms Disulfide-Linked Homodimers via an N-Terminal Interaction	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; ALPHA-DYSTROGLYCAN; SUBCELLULAR-LOCALIZATION; ABNORMAL GLYCOSYLATION; MENTAL-RETARDATION; BETA-DYSTROGLYCAN; MUTATIONS; GENE; GLYCOSYLTRANSFERASES; ORGANIZATION	Limb-Girdle Muscular Dystrophy type 2I (LGMD2I) is an inheritable autosomal, recessive disorder caused by mutations in the FuKutin-Related Protein (FKRP) gene (FKRP) located on chromosome 19 (19q13.3). Mutations in FKRP are also associated with Congenital Muscular Dystrophy (MDC1C), Walker-Warburg Syndrome (WWS) and Muscle Eye Brain disease (MEB). These four disorders share in common an incomplete/aberrant O-glycosylation of the membrane/extracellular matrix (ECM) protein alpha-dystroglycan. However, further knowledge on the FKRP structure and biological function is lacking, and its intracellular location is controversial. Based on immunogold electron microscopy of human skeletal muscle sections we demonstrate that FKRP co-localises with the middle-to-trans-Golgi marker MG160, between the myofibrils in human rectus femoris muscle fibres. Chemical cross-linking experiments followed by pairwise yeast 2-hybrid experiments, and co-immune precipitation, demonstrate that FKRP can exist as homodimers as well as in large multimeric protein complexes when expressed in cell culture. The FKRP homodimer is kept together by a disulfide bridge provided by the most N-terminal cysteine, Cys6. FKRP contains N-glycan of high mannose and/or hybrid type; however, FKRP N-glycosylation is not required for FKRP homodimer or multimer formation. We propose a model for FKRP which is consistent with that of a Golgi resident type II transmembrane protein.	[Alhamidi, Maisoon; Fagerheim, Toril; Brox, Vigdis; Van Ghelue, Marijke; Nilssen, Oivind] Univ Hosp N Norway, Dept Med Genet, Div Child & Adolescent Hlth, Tromso, Norway; [Alhamidi, Maisoon; Buvang, Elisabeth Kjeldsen; Van Ghelue, Marijke; Nilssen, Oivind] Univ Tromso, Dept Clin Med Med Genet, Tromso, Norway; [Lindal, Sigurd] Univ Hosp N Norway, Dept Pathol, Tromso, Norway; [Lindal, Sigurd] Univ Tromso, Inst Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Alhamidi, M (corresponding author), Univ Hosp N Norway, Dept Med Genet, Div Child & Adolescent Hlth, Tromso, Norway.	oivind.nilssen@uit.no			Helse Nord RHF [1911 / SFP802-08]	Helse Nord RHF	This work was supported by Helse Nord RHF, http://www.helse-nord.no/, (AM, MVG, ON) Grant ID 1911 / SFP802-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartel P. L., 1993, CELLULAR INTERACTION, P153; Beedle AM, 2007, J BIOL CHEM, V282, P16713, DOI 10.1074/jbc.C700061200; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cullen MJ, 1998, J HISTOCHEM CYTOCHEM, V46, P945, DOI 10.1177/002215549804600808; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Graffenried CL, 2004, CURR OPIN CELL BIOL, V16, P356, DOI 10.1016/j.ceb.2004.06.007; Dolatshad NF, 2005, EXP CELL RES, V309, P370, DOI 10.1016/j.yexcr.2005.06.017; El-Battari A, 2003, GLYCOBIOLOGY, V13, P941, DOI 10.1093/glycob/cwg117; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Esapa CT, 2005, HUM MOL GENET, V14, P295, DOI 10.1093/hmg/ddi026; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gleeson PA, 1998, HISTOCHEM CELL BIOL, V109, P517, DOI 10.1007/s004180050252; GRIFFITHS G, FINE STRUCTURE IMMUN; Harnett W, 2010, TRENDS PARASITOL, V26, P114, DOI 10.1016/j.pt.2009.12.003; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kellokumpu S, 1997, J BIOL CHEM, V272, P2770, DOI 10.1074/jbc.272.5.2770; Keramaris-Vrantsis E, 2007, MUSCLE NERVE, V36, P455, DOI 10.1002/mus.20833; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Louhichi N, 2004, NEUROGENETICS, V5, P27, DOI 10.1007/s10048-003-0165-9; Lu PJ, 2010, BBA-MOL BASIS DIS, V1802, P253, DOI 10.1016/j.bbadis.2009.10.016; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Martin-Rendon E, 2003, TRENDS PHARMACOL SCI, V24, P178, DOI 10.1016/S0165-6147(03)00050-6; Matsumoto H, 2004, J BIOCHEM, V135, P709, DOI 10.1093/jb/mvh086; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Ralston E, 1999, J NEUROSCI, V19, P10694, DOI 10.1523/JNEUROSCI.19-24-10694.1999; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Torelli S, 2005, NEUROMUSCULAR DISORD, V15, P836, DOI 10.1016/j.nmd.2005.09.004; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wakayama Y, 2001, MICROSC RES TECHNIQ, V55, P154, DOI 10.1002/jemt.1166; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	46	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22968	10.1371/journal.pone.0022968	http://dx.doi.org/10.1371/journal.pone.0022968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886772	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500005
J	Cermelli, S; Ruggieri, A; Marrero, JA; Ioannou, GN; Beretta, L				Cermelli, Silvia; Ruggieri, Anna; Marrero, Jorge A.; Ioannou, George N.; Beretta, Laura			Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							IN-VIVO; VIRUS; EXPRESSION; MIR-122; TRANSLATION; BIOMARKERS; STEATOSIS; INFECTION	MicroRNAs miR-122, miR-34a, miR-16 and miR-21 are commonly deregulated in liver fibrosis and hepatocellular carcinoma. This study examined whether circulating levels of these miRNAs correlate with hepatic histological disease severity in patients with chronic hepatitis C infection (CHC) or non-alcoholic fatty-liver disease (NAFLD) and can potentially serve as circulating markers for disease stage assessment. We first used an in vitro model of hepatitis C virus (HCV) infection to measure the extracellular levels of these four miRNAs. Whereas miR-21 extracellular levels were unchanged, extracellular levels of miR-122, miR-34a and to a lesser extent miR-16, steadily increased during the course of HCV infection, independently of viral replication and production. Similarly, in CHC patients, serum levels of miR-122, miR-34a and miR-16 were significantly higher than in control individuals, while miR-21 levels were unchanged. There was no correlation between the serum levels of any of these microRNAs and HCV viral loads. In contrast, miR-122 and miR-34a levels positively correlated with disease severity. Identical results were obtained in an independent cohort of CHC patients. We extended the study to patients with NAFLD. As observed in CHC patients, serum levels of miR-122, miR-34a and miR-16 were significantly higher in NAFLD patients than in controls, while miR-21 levels were unchanged. Again, miR-122 and miR-34a levels positively correlated with disease severity from simple steatosis to steatohepatitis. In both CHC and NAFLD patient groups, serum levels of miR-122 and miR-34a correlated with liver enzymes levels, fibrosis stage and inflammation activity. miR-122 levels also correlated with serum lipids in NAFLD patients. Conclusion: Serum levels of miR-34a and miR-122 may represent novel, noninvasive biomarkers of diagnosis and histological disease severity in patients with CHC or NAFLD.	[Cermelli, Silvia; Ruggieri, Anna; Beretta, Laura] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Ruggieri, Anna] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Marrero, Jorge A.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Div Gastroenterol, Seattle, WA USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Cermelli, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	lberetta@fhcrc.org	ruggieri, anna/C-9950-2015	Ruggieri, Anna/0000-0003-2987-3844; Laura, Beretta/0000-0002-2054-684X	National Institutes of Health [DK066840]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK066840 from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BIHRER V, 2011, AM J GASTROENTEROL; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuguchi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015304; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Negro F, 2009, LIVER INT, V29, P26, DOI 10.1111/j.1478-3231.2008.01950.x; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; QU KZ, 2011, J CLIN GAST IN PRESS; Ramcharran D, 2011, J VIRAL HEPATITIS, V18, pe144, DOI 10.1111/j.1365-2893.2010.01394.x; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Sanyal AJ., 2011, HEPATOLOGY, DOI 10.1002/hep.24376; Sanyal AJ, 2011, LIVER INT, V31, P23, DOI 10.1111/j.1478-3231.2010.02397.x; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	37	410	433	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23937	10.1371/journal.pone.0023937	http://dx.doi.org/10.1371/journal.pone.0023937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886843	gold, Green Submitted, Green Published			2022-12-25	WOS:000294253500040
J	Miyajima, F; Roberts, P; Swale, A; Price, V; Jones, M; Horan, M; Beeching, N; Brazier, J; Parry, C; Pendleton, N; Pirmohamed, M				Miyajima, Fabio; Roberts, Paul; Swale, Andrew; Price, Valerie; Jones, Maureen; Horan, Michael; Beeching, Nicholas; Brazier, Jonathan; Parry, Christopher; Pendleton, Neil; Pirmohamed, Munir			Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom	PLOS ONE			English	Article							TERM-CARE FACILITIES; INCREASED SPORULATION; TOXIN PRODUCTION; COLONIZATION; DIARRHEA; INFECTION; RESIDENTS; RISK; TRANSMISSION; EPIDEMIC	Background: Community-associated Clostridium difficile infection (CDI) appears to be an increasing problem. Reported carriage rates by C.difficile are debatable with suggestions that primary asymptomatic carriage is associated with decreased risk of subsequent diarrhoea. However, knowledge of potential reservoirs and intestinal carriage rates in the community, particularly in the elderly, the most susceptible group, is limited. We have determined the presence of C.difficile in the faeces of a healthy elderly cohort living outside of long-term care facilities (LCFs) in the United Kingdom. Methods: Faecal samples from 149 community-based healthy elderly volunteers (median age 81 years) were screened for C.difficile using direct (Brazier's CCEY) and enrichment (Cooked Meat broth) culture methods and a glutamate dehydrogenase (GDH) immunoassay. Isolates were PCR-ribotyped and analysed for toxin production and the presence of toxin genes. Results: Of 149 faecal samples submitted, six (4%) were found to contain C.difficile. One particular sample was positive by both the GDH immunoassay and direct culture, and concurrently produced two distinct strain types: one toxigenic and the other non-toxigenic. The other five samples were only positive by enrichment culture method. Overall, four C.difficile isolates were non-toxigenic (PCR-ribotypes 009, 026 (n = 2) and 039), while three were toxigenic (PCR-ribotypes 003, 005 and 106). All individuals who had a positive culture were symptom-free and none of them had a history of CDI and/or antibiotics use in the 3 month period preceding recruitment. Conclusions: To our knowledge, this is the first study of the presence of C.difficile in healthy elderly community-dwelling individuals residing outside of LCFs. The observed carriage rate is lower than that reported for individuals in LCFs and interestingly no individual carried the common epidemic strain PCR-ribotype 027 (NAP1/BI). Further follow-up of asymptomatic carriers in the community, is required to evaluate host susceptibility to CDI and identify dynamic changes in the host and microbial environment that are associated with pathogenicity.	[Miyajima, Fabio; Roberts, Paul; Swale, Andrew; Price, Valerie; Beeching, Nicholas; Parry, Christopher; Pirmohamed, Munir] Royal Liverpool & Broadgreen Univ Hosp Natl Hlth, NIHR, Biomed Res Ctr, Liverpool, Merseyside, England; [Miyajima, Fabio; Swale, Andrew; Pirmohamed, Munir] Univ Liverpool, Dept Pharmacol, Wolfson Ctr Personalised Med, Liverpool L69 3BX, Merseyside, England; [Roberts, Paul; Price, Valerie] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Directorate Infect & Immun, Liverpool, Merseyside, England; [Jones, Maureen; Horan, Michael; Pendleton, Neil] Univ Manchester, Sch Community Based Med, Neurodegenerat Res Grp, Manchester, Lancs, England; [Beeching, Nicholas] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [Brazier, Jonathan] Univ Wales Hosp, Publ Hlth Lab, Anaerobe Reference Unit, Cardiff CF4 4XW, S Glam, Wales; [Parry, Christopher] Univ Liverpool, Inst Global Hlth, Div Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Parry, Christopher] Mahidol Oxford Trop Med Res Unit, Wellcome Trust Major Overseas Programme, Bangkok, Thailand	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Manchester; Liverpool School of Tropical Medicine; University of Liverpool; Cardiff University; University of Liverpool; Mahidol Oxford Tropical Medicine Research Unit (MORU)	Miyajima, F (corresponding author), Royal Liverpool & Broadgreen Univ Hosp Natl Hlth, NIHR, Biomed Res Ctr, Liverpool, Merseyside, England.	munirp@liv.ac.uk	Miyajima, Fabio/K-6587-2012; Pirmohamed, Munir/H-6004-2011; Pendleton, Neil/F-2333-2015; Beeching, Nicholas J/L-5363-2017	Miyajima, Fabio/0000-0002-1347-4825; Pirmohamed, Munir/0000-0002-7534-7266; Pendleton, Neil/0000-0003-0794-2386; Beeching, Nicholas/0000-0002-7019-8791	Liverpool Biomedical Research Centre (Royal Liverpool University Hospital/NHS Trust and the Wolfson Centre for Personalised Medicine/University of Liverpool); National Institute for Health Research; Northwest Development Agency	Liverpool Biomedical Research Centre (Royal Liverpool University Hospital/NHS Trust and the Wolfson Centre for Personalised Medicine/University of Liverpool); National Institute for Health Research(National Institute for Health Research (NIHR)); Northwest Development Agency	This work was supported by the Liverpool Biomedical Research Centre (Royal Liverpool University Hospital/NHS Trust and the Wolfson Centre for Personalised Medicine/University of Liverpool), the National Institute for Health Research and The Northwest Development Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Brazier JS, 1999, J HOSP INFECT, V43, P317, DOI 10.1016/S0195-6701(99)90431-0; BRAZIER JS, 1993, CLIN INFECT DIS, V16, pS228, DOI 10.1093/clinids/16.Supplement_4.S228; CAMPBELL RR, 1988, AGE AGEING, V17, P333, DOI 10.1093/ageing/17.5.333; DENEVE C, 2009, INT J ANTIMICROBIAL, V33; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; DONTA ST, 1982, J PEDIATR-US, V100, P431, DOI 10.1016/S0022-3476(82)80454-X; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; GERDING DN, 1986, ARCH INTERN MED, V146, P95, DOI 10.1001/archinte.146.1.95; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; Kaur S, 2007, MICROBIOL IMMUNOL, V51, P1209, DOI 10.1111/j.1348-0421.2007.tb04016.x; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Martinsen TC, 2005, BASIC CLIN PHARMACOL, V96, P94, DOI 10.1111/j.1742-7843.2005.pto960202.x; Matsuki S, 2005, INT MICROBIOL, V8, P43; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Rabbitt PMA, 2004, AGING NEUROPSYCHOL C, V11, P245, DOI 10.1080/13825580490511116; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; Ryan J, 2010, IRISH J MED SCI, V179, P245, DOI 10.1007/s11845-009-0361-1; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; SIMOR AE, 1993, CLIN INFECT DIS, V17, P672, DOI 10.1093/clinids/17.4.672; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; TATAROWICZ W, 2010, 3 INT CLOSTR DIFF S, V44; US Department of Health and Human Services, 2009, COMMON TERMINOLOGY C; WALKER KJ, 1993, J AM GERIATR SOC, V41, P940, DOI 10.1111/j.1532-5415.1993.tb06759.x; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	33	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22804	10.1371/journal.pone.0022804	http://dx.doi.org/10.1371/journal.pone.0022804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886769	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000294253500003
J	Oballah, P; Flach, B; Eller, LA; Eller, MA; Ouma, B; de Souza, M; Kibuuka, HN; Wabwire-Mangen, F; Brown, BK; Michael, NL; Robb, ML; Montefiori, D; Polonis, VR				Oballah, Peter; Flach, Britta; Eller, Leigh A.; Eller, Michael A.; Ouma, Benson; de Souza, Mark; Kibuuka, Hannah N.; Wabwire-Mangen, Fred; Brown, Bruce K.; Michael, Nelson L.; Robb, Merlin L.; Montefiori, David; Polonis, Victoria R.			B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODY-RESPONSES; MEDIATED CYTOTOXICITY; DISEASE PROGRESSION; EFFECTOR FUNCTION; RHESUS MACAQUES; DIFFERENT RATES; MEMORY; PANEL; NAIVE	To better understand the nature of B cell dysfunctions in subjects infected with HIV-1 subtype A, a rural cohort of 50 treatment-naive Ugandan patients chronically infected with HIV-1 subtype A was studied, and the relationship between B cell depletion and HIV disease was assessed. B cell absolute counts were found to be significantly lower in HIV-1+ patients, when compared to community matched negative controls (p<0.0001). HIV-1-infected patients displayed variable functional and binding antibody titers that showed no correlation with viral load or CD4+ T cell count. However, B cell absolute counts were found to correlate inversely with neutralizing antibody (NAb) titers against subtype A (p = 0.05) and subtype CRF02_AG (p = 0.02) viruses. A positive correlation was observed between subtype A gp120 binding antibody titers and NAb breadth (p = 0.02) and mean titer against the 10 viruses (p = 0.0002). In addition, HIV-1 subtype A sera showed preferential neutralization of the 5 subtype A or CRF02_AG pseudoviruses, as compared with 5 pseudoviruses from subtypes B, C or D (p<0.001). These data demonstrate that in patients with chronic HIV-1 subtype A infection, significant B cell depletion can be observed, the degree of which does not appear to be associated with a decrease in functional antibodies. These findings also highlight the potential importance of subtype in the specificity of cross-clade neutralization in HIV-1 infection.	[Oballah, Peter; Flach, Britta; Ouma, Benson; Kibuuka, Hannah N.; Wabwire-Mangen, Fred] Makerere Univ, Walter Reed Project, Kampala, Uganda; [Flach, Britta; Eller, Leigh A.; Eller, Michael A.; de Souza, Mark; Brown, Bruce K.; Michael, Nelson L.; Robb, Merlin L.; Polonis, Victoria R.] Mil HIV Res Program, Rockville, MD USA; [Flach, Britta; Eller, Leigh A.; Eller, Michael A.; de Souza, Mark; Brown, Bruce K.; Robb, Merlin L.] Henry M Jackson Fdn, Rockville, MD USA; [de Souza, Mark] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Michael, Nelson L.; Polonis, Victoria R.] Walter Reed Army Inst Res, Rockville, MD USA; [Montefiori, David] Duke Univ, Durham, NC USA	Makerere University; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Makerere University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Duke University	Oballah, P (corresponding author), Makerere Univ, Walter Reed Project, Kampala, Uganda.	vpolonis@hivresearch.org	Eller, Michael A./I-2156-2019	Eller, Michael A./0000-0003-3905-4877	Bill and Melinda Gates Foundation through Duke University [210810/2]	Bill and Melinda Gates Foundation through Duke University	The funding for this study was provided by the Bill and Melinda Gates Foundation through Duke University to Makere University (contract number 210810/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 1994, J ACQ IMMUN DEF SYND, V7, P428; Ahmad R, 2001, J CLIN IMMUNOL, V21, P227, DOI 10.1023/A:1011087132180; Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Banks ND, 2002, AIDS RES HUM RETROV, V18, P1197, DOI 10.1089/08892220260387940; Beniguel Lydie, 2004, Clin Dev Immunol, V11, P121, DOI 10.1080/10446670410001722104; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Blish CA, 2009, J VIROL, V83, P7783, DOI 10.1128/JVI.00673-09; Brown BK, 2008, VIROLOGY, V375, P529, DOI 10.1016/j.virol.2008.02.022; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Cecilia D, 1999, J INFECT DIS, V179, P1365, DOI 10.1086/314773; CHIRMULE N, 1992, BLOOD, V79, P1245; Chong Y, 2004, AIDS RES HUM RETROV, V20, P621, DOI 10.1089/0889222041217455; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Chuenchitra T, 2003, AIDS RES HUM RETROV, V19, P293, DOI 10.1089/088922203764969492; Chung A, 2008, CURR HIV RES, V6, P515, DOI 10.2174/157016208786501472; Conge AM, 1998, AIDS, V12, P1437, DOI 10.1097/00002030-199812000-00005; Cox JH, 1999, METH MOLEC MED, V17, P373, DOI 10.1385/0-89603-369-4:373; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Eller MA, 2009, JAIDS-J ACQ IMM DEF, V51, P380, DOI 10.1097/QAI.0b013e3181aa256e; Epeldegui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011448; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Forthal DN, 2001, AIDS RES HUM RETROV, V17, P553, DOI 10.1089/08892220151126661; Gaidano G, 2000, SEMIN ONCOL, V27, P431; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hidajat R, 2009, J VIROL, V83, P791, DOI 10.1128/JVI.01672-08; Hoelscher M, 2002, AIDS, V16, P2055, DOI 10.1097/00002030-200210180-00011; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; KATZ IR, 1986, CLIN IMMUNOL IMMUNOP, V39, P359, DOI 10.1016/0090-1229(86)90164-9; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; KOUP RA, 1991, AIDS, V5, P1309, DOI 10.1097/00002030-199111000-00004; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Letvin NL, 2002, ANNU REV IMMUNOL, V20, P73, DOI 10.1146/annurev.immunol.20.081501.094854; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; LJUNGGREN K, 1988, CLIN EXP IMMUNOL, V73, P343; Malaspina A, 2003, J IMMUNOL, V170, P5965, DOI 10.4049/jimmunol.170.12.5965; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROOK AH, 1987, J IMMUNOL, V138, P1064; SAWYER LA, 1990, AIDS RES HUM RETROV, V6, P341, DOI 10.1089/aid.1990.6.341; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; SHEN X, CURR HIV AIDS REP, V8, P23; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Titanji K, 2005, AIDS, V19, P1947, DOI 10.1097/01.aids.0000191231.54170.89; Titanji K, 2003, CLIN EXP IMMUNOL, V132, P297, DOI 10.1046/j.1365-2249.2003.02145.x; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; TYLER DS, 1990, J IMMUNOL, V144, P3375; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Widney D, 1999, CLIN IMMUNOL, V93, P114, DOI 10.1006/clim.1999.4782; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10; Yates A, 2007, PLOS MED, V4, P948, DOI 10.1371/journal.pmed.0040177; Zhang YJ, 1997, J INFECT DIS, V176, P1180, DOI 10.1086/514111	83	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22653	10.1371/journal.pone.0022653	http://dx.doi.org/10.1371/journal.pone.0022653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886768	gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500002
J	Wang, W; Hale, C; Goulding, D; Haslam, SM; Tissot, B; Lindsay, C; Michell, S; Titball, R; Yu, J; Toribio, AL; Rossi, R; Dell, A; Bradley, A; Dougan, G				Wang, Wei; Hale, Christine; Goulding, Dave; Haslam, Stuart M.; Tissot, Berangere; Lindsay, Christopher; Michell, Stephen; Titball, Rick; Yu, Jun; Toribio, Ana Luisa; Rossi, Raffaella; Dell, Anne; Bradley, Allan; Dougan, Gordon			Mannosidase 2, alpha 1 Deficiency Is Associated with Ricin Resistance in Embryonic Stem (ES) Cells	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; GLYCANS; GLYCOPROTEINS; TRANSPORT; PIGGYBAC; LIBRARY	Host gene products required for mediating the action of toxins are potential targets for reversing or controlling their pathogenic impact following exposure. To identify such targets libraries of insertional gene-trap mutations generated with a PiggyBac transposon in Blm-deficient embryonic stem cells were exposed to the plant toxin, ricin. Resistant clones were isolated and genetically characterised and one was found to be a homozygous mutant of the mannosidase 2, alpha 1 (Man2 alpha 1) locus with a matching defect in the homologous allele. The causality of the molecular lesion was confirmed by removal of the transposon following expression of PB-transposase. Comparative glycomic and lectin binding analysis of the Man2 alpha 1 (-/-) ricin resistant cells revealed an increase in the levels of hybrid glycan structures and a reduction in terminal beta-galactose moieties, potential target receptors for ricin. Furthermore, naive ES cells treated with inhibitors of the N-linked glycosylation pathway at the mannosidase 2, alpha 1 step exhibited either full or partial resistance to ricin. Therefore, we conclusively identified mannosidase 2, alpha 1 deficiency to be associated with ricin resistance.	[Wang, Wei; Hale, Christine; Goulding, Dave; Toribio, Ana Luisa; Rossi, Raffaella; Bradley, Allan; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Haslam, Stuart M.; Tissot, Berangere; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England; [Lindsay, Christopher] Dept Biomed Sci, Cellular Tox Team, Salisbury, Wilts, England; [Michell, Stephen; Titball, Rick] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Yu, Jun] Univ Strathclyde, Royal Coll, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	Wellcome Trust Sanger Institute; Imperial College London; University of Exeter; University of Strathclyde	Wang, W (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	cbh@sanger.ac.uk		Toribio, Ana/0000-0002-0101-4258; Bradley, Allan/0000-0002-2349-8839	Biotechnology and Biological Sciences Research Council (BBSRC) [BBF0083091]; Wellcome Trust [077187, 076962]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Biotechnology and Biological Sciences Research Council (BBSRC, www.bbsrc.ac.uk) grant number BBF0083091 (awarded to AD, SMH) and the Wellcome Trust (www.wellcome.ac.uk) grant numbers 077187 and 076962 (awarded to AB and GD respectively). Ricin was supplied by the Biomedical Sciences Department, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ. The funding providers had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Crispin M, 2009, J BIOL CHEM, V284, P21684, DOI 10.1074/jbc.M109.006254; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; FONG WP, 1991, LIFE SCI, V49, P1859, DOI 10.1016/0024-3205(91)90286-K; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Hato M, 2006, MOL CELL PROTEOMICS, V5, P2146, DOI 10.1074/mcp.M600213-MCP200; Hughes R C, 1979, Nature, V281, P526, DOI 10.1038/281526a0; HUGHES RC, 1986, J CELL PHYSIOL, V128, P402, DOI 10.1002/jcp.1041280309; HUGHES RC, 1985, BIOCHEM J, V226, P487, DOI 10.1042/bj2260487; HUGHES RC, 1983, BIOCHEM J, V211, P575, DOI 10.1042/bj2110575; MEAGER A, 1975, NATURE, V257, P137, DOI 10.1038/257137a0; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Parry S, 2007, GLYCOBIOLOGY, V17, P646, DOI 10.1093/glycob/cwm024; POWELL LD, 2001, CURR PROTOC IMMUNOL, pCH8; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Ripper D, 2008, BIOL CELL, V100, P109, DOI 10.1042/BC20070106; Roberts LM, 2004, MINI-REV MED CHEM, V4, P505, DOI 10.2174/1389557043403846; Sandvig K, 1999, FEBS LETT, V452, P67, DOI 10.1016/S0014-5793(99)00529-3; SORIANO P, 1991, J VIROL, V65, P2314, DOI 10.1128/JVI.65.5.2314-2319.1991; SUTTONSMITH M, 2006, CELL BIOL LAB HDB, P425; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; TOKUYASU, 1997, CELLS LAB MANUAL; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Wang W, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r48; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; Wu JH, 2006, BIOCHIMIE, V88, P201, DOI 10.1016/j.biochi.2005.07.007; WU JH, 1993, MOL IMMUNOL, V30, P333, DOI 10.1016/0161-5890(93)90062-G; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646	33	49	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22993	10.1371/journal.pone.0022993	http://dx.doi.org/10.1371/journal.pone.0022993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886775	gold, Green Accepted, Green Published			2022-12-25	WOS:000294253500007
J	Wang, Q; Byrnes, LJ; Shui, B; Rohrig, UF; Singh, A; Chudakov, DM; Lukyanov, S; Zipfel, WR; Kotlikoff, MI; Sondermann, H				Wang, Qi; Byrnes, Laura J.; Shui, Bo; Roehrig, Ute F.; Singh, Avtar; Chudakov, Dmitriy M.; Lukyanov, Sergey; Zipfel, Warren R.; Kotlikoff, Michael I.; Sondermann, Holger			Molecular Mechanism of a Green-Shifted, pH-Dependent Red Fluorescent Protein mKate Variant	PLOS ONE			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURES; PROTON PATHWAYS; CHROMOPHORE; SENSORS; GFP; PHOTOCONVERSION; APPROXIMATION; EXCITATION; CONVERSION	Fluorescent proteins that can switch between distinct colors have contributed significantly to modern biomedical imaging technologies and molecular cell biology. Here we report the identification and biochemical analysis of a green-shifted red fluorescent protein variant GmKate, produced by the introduction of two mutations into mKate. Although the mutations decrease the overall brightness of the protein, GmKate is subject to pH-dependent, reversible green-to-red color conversion. At physiological pH, GmKate absorbs blue light (445 nm) and emits green fluorescence (525 nm). At pH above 9.0, GmKate absorbs 598 nm light and emits 646 nm, far-red fluorescence, similar to its sequence homolog mNeptune. Based on optical spectra and crystal structures of GmKate in its green and red states, the reversible color transition is attributed to the different protonation states of the cis-chromophore, an interpretation that was confirmed by quantum chemical calculations. Crystal structures reveal potential hydrogen bond networks around the chromophore that may facilitate the protonation switch, and indicate a molecular basis for the unusual bathochromic shift observed at high pH. This study provides mechanistic insights into the color tuning of mKate variants, which may aid the development of green-to-red color-convertible fluorescent sensors, and suggests GmKate as a prototype of genetically encoded pH sensors for biological studies.	[Wang, Qi; Byrnes, Laura J.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Shui, Bo; Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Roehrig, Ute F.] Ludwig Inst Canc Res, Mol Modeling Grp, Lausanne, Switzerland; [Roehrig, Ute F.] Swiss Inst Bioinformat, Lausanne, Switzerland; [Singh, Avtar; Zipfel, Warren R.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Chudakov, Dmitriy M.; Lukyanov, Sergey] Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Chudakov, Dmitriy M.; Lukyanov, Sergey] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia	Cornell University; Cornell University; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; Cornell University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Privolzhsky Research Medical University	Wang, Q (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	qwang@berkeley.edy; mik7@cornell.edu; hs293@cornell.edu	Lukyanov, Sergey/F-9140-2014; Chudakov, Dmitriy M/G-7741-2014; Wang, Qi/H-9399-2012; Zipfel, Warren/B-4059-2016	Chudakov, Dmitriy M/0000-0003-0430-790X; Wang, Qi/0000-0002-9703-1676; Singh, Avtar/0000-0001-5509-8330; Roehrig, Ute/0000-0002-4676-4087; Zipfel, Warren/0000-0003-2640-329X	National Science Foundation [DMR-0225180]; National Institutes of Health (NIH)/National Institute of General Medical Sciences [RR-01646]; Ministry of Education and Science of the Russian Federation [11.G34.31.0017, 16.512.11.2139]; National Institutes of Health [R01GM086736]; PEW Scholar award in Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086736] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Scholar award in Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is based upon research conducted at CHESS/MacCHESS, which is supported by the National Science Foundation (award DMR-0225180) and the National Institutes of Health (NIH)/National Institute of General Medical Sciences (award RR-01646). This work was supported by grants 11.G34.31.0017 and 16.512.11.2139 from the Ministry of Education and Science of the Russian Federation (D. M. C. and S. L.), grant R01GM086736 from the National Institutes of Health (M. I. K.), and a PEW Scholar award in Biomedical Sciences (H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Bizzarri R, 2006, BIOPHYS J, V90, P3300, DOI 10.1529/biophysj.105.074708; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Burrone J, 2006, NAT PROTOC, V1, P2970, DOI 10.1038/nprot.2006.449; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Chudakov DM, 2003, J BIOL CHEM, V278, P7215, DOI 10.1074/jbc.M211988200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filippi C, 2009, J CHEM THEORY COMPUT, V5, P2074, DOI 10.1021/ct900227j; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; Hasegawa J, 2010, J PHYS CHEM B, V114, P2971, DOI 10.1021/jp9099573; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Henderson JN, 2009, J AM CHEM SOC, V131, P13212, DOI 10.1021/ja904665x; Henderson JN, 2009, J AM CHEM SOC, V131, P4176, DOI 10.1021/ja808851n; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kremers GJ, 2009, NAT METHODS, V6, P355, DOI [10.1038/NMETH.1319, 10.1038/nmeth.1319]; Laino T, 2005, J CHEM THEORY COMPUT, V1, P1176, DOI 10.1021/ct050123f; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McAnaney TB, 2002, BIOCHEMISTRY-US, V41, P15489, DOI 10.1021/bi026610o; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P8701, DOI 10.1021/bi050132a; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakatsuji H., 1997, COMPUTATIONAL CHEM R, V2, P62, DOI DOI 10.1016/J.CPLETT.2005.12.040; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; RIDLEY J, 1973, THEOR CHIM ACTA, V32, P111, DOI 10.1007/BF00528484; Sanchez-Garcia E, 2010, J COMPUT CHEM, V31, P1603, DOI 10.1002/jcc.21443; Sanchez-Garcia E, 2009, J PHYS CHEM B, V113, P16622, DOI 10.1021/jp9069042; Schafer LV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000034; Schafer LV, 2007, ANGEW CHEM INT EDIT, V46, P530, DOI 10.1002/anie.200602315; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shinobu A, 2010, J AM CHEM SOC, V132, P11093, DOI 10.1021/ja1010652; Silva-Junior MR, 2010, J CHEM THEORY COMPUT, V6, P1546, DOI 10.1021/ct100030j; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; Subach FV, 2009, P NATL ACAD SCI USA, V106, P21097, DOI 10.1073/pnas.0909204106; Sun Q, 2010, PHYS CHEM CHEM PHYS, V12, P2450, DOI 10.1039/b918523b; Taguchi N, 2009, J PHYS CHEM B, V113, P1153, DOI 10.1021/jp808151c; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tretyakova YA, 2007, J AM CHEM SOC, V129, P7748, DOI 10.1021/ja071992c; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2009, CHEM BIOL, V16, P1140, DOI 10.1016/j.chembiol.2009.10.010; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Zhang L, 2010, Bioorg Khim, V36, P187; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	64	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23513	10.1371/journal.pone.0023513	http://dx.doi.org/10.1371/journal.pone.0023513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887263	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800015
J	Haywood-Watson, RJ; Holcomb, JB; Gonzalez, EA; Peng, ZL; Pati, S; Park, PW; Wang, WW; Zaske, AM; Menge, T; Kozar, RA				Haywood-Watson, Ricky J.; Holcomb, John B.; Gonzalez, Ernest A.; Peng, Zhanglong; Pati, Shibani; Park, Pyong Woo; Wang, WeiWei; Zaske, Ana Maria; Menge, Tyler; Kozar, Rosemary A.			Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation	PLOS ONE			English	Article							FRESH-FROZEN PLASMA; HEPARAN-SULFATE PROTEOGLYCAN; ENDOTHELIAL GLYCOCALYX; INFLAMMATORY RESPONSE; BLOOD; TRAUMA; MODEL; TRANSFUSIONS; COAGULATION; FRACTALKINE	The early use of fresh frozen plasma as a resuscitative agent after hemorrhagic shock has been associated with improved survival, but the mechanism of protection is unknown. Hemorrhagic shock causes endothelial cell dysfunction and we hypothesized that fresh frozen plasma would restore endothelial integrity and reduce syndecan-1 shedding after hemorrhagic shock. A prospective, observational study in severely injured patients in hemorrhagic shock demonstrated significantly elevated levels of syndecan-1 (554+/-93 ng/ml) after injury, which decreased with resuscitation (187+/-36 ng/ml) but was elevated compared to normal donors (27+/-1 ng/ml). Three pro-inflammatory cytokines, interferon-gamma, fractalkine, and interleukin-1 beta, negatively correlated while one anti-inflammatory cytokine, IL-10, positively correlated with shed syndecan-1. These cytokines all play an important role in maintaining endothelial integrity. An in vitro model of endothelial injury then specifically examined endothelial permeability after treatment with fresh frozen plasma orlactated Ringers. Shock or endothelial injury disrupted junctional integrity and increased permeability, which was improved with fresh frozen plasma, but not lactated Ringers. Changes in endothelial cell permeability correlated with syndecan-1 shedding. These data suggest that plasma based resuscitation preserved endothelial syndecan-1 and maintained endothelial integrity, and may help to explain the protective effects of fresh frozen plasma after hemorrhagic shock.	[Haywood-Watson, Ricky J.; Holcomb, John B.; Peng, Zhanglong; Pati, Shibani; Menge, Tyler; Kozar, Rosemary A.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA; [Holcomb, John B.; Pati, Shibani; Zaske, Ana Maria] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury & Res CeTIR, Houston, TX USA; [Gonzalez, Ernest A.] Univ Texas SW Austin, Dept Surg, Austin, TX USA; [Park, Pyong Woo] Harvard Univ, Childrens Hosp, Sch Med, Div Resp Dis, Boston, MA 02115 USA; [Wang, WeiWei] Univ Texas Hlth Sci Ctr Houston, Ctr Clin & Translat Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston	Haywood-Watson, RJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX USA.	Rosemary.A.Kozar@uth.tmc.edu		Park, Pyong Woo/0000-0002-7979-4979; holcomb, john/0000-0001-8312-9157	National Institutes of Health [T-32 GM008792, P-50 GM38529]; Department of Defense [W81XWH-08-C-0712]; NIH CTSA [UL1 RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107482, P50GM038529, T32GM008792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the National Institutes of Health T-32 GM008792 and P-50 GM38529 and the Department of Defense W81XWH-08-C-0712. Statistical support was provided by the Biostatistics/Epidemiology/Research Design (BERD) component of the Center for Clinical and Translational Sciences (CCTS) for this project. CCTS is mainly funded by NIH CTSA grant (UL1 RR024148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Childs EW, 2010, SHOCK, V34, P229, DOI 10.1097/SHK.0b013e3181d75b50; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; GONZALEZ EA, 2009, SHOCK, V31, P56; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; Kadl A, 2005, ANTIOXID REDOX SIGN, V7, P1744, DOI 10.1089/ars.2005.7.1744; KELLUM JA, 2009, ARCH INTERN MED, V167, P1655; Kliment CR, 2009, J BIOL CHEM, V284, P3537, DOI 10.1074/jbc.M807001200; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; London NR, 2009, ANGIOGENESIS, V12, P149, DOI 10.1007/s10456-009-9130-z; Lozano FS, 2005, WORLD J SURG, V29, P1248, DOI 10.1007/s00268-005-7877-y; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Maroszynska I, 2000, Ann Transplant, V5, P5; Matheson PJ, 2009, ARCH SURG-CHICAGO, V144, P625, DOI 10.1001/archsurg.2009.125; Matsuo Mitsunori, 2008, Kurume Medical Journal, V55, P19, DOI 10.2739/kurumemedj.55.19; Mees ST, 2007, LANGENBECK ARCH SURG, V392, P629, DOI 10.1007/s00423-007-0152-y; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Peng Z, 2010, SHOCK, V33, P61; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Robinson EK, 2008, JPEN-PARENTER ENTER, V32, P433, DOI 10.1177/0148607108319806; Sadir R, 1998, J BIOL CHEM, V273, P10919, DOI 10.1074/jbc.273.18.10919; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Spinella PC, 2008, J TRAUMA, V64, pS69, DOI 10.1097/TA.0b013e318160ba2f; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Takahashi T, 2001, CIRC RES, V88, P422; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tharakan B, 2010, CLIN EXP PHARMACOL P, V37, P939, DOI 10.1111/j.1440-1681.2010.05414.x; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F	46	128	135	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23530	10.1371/journal.pone.0023530	http://dx.doi.org/10.1371/journal.pone.0023530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886795	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100017
J	Asmal, M; Hellmann, I; Liu, WM; Keele, BF; Perelson, AS; Bhattacharya, T; Gnanakaran, S; Daniels, M; Haynes, BF; Korber, BT; Hahn, BH; Shaw, GM; Letvin, NL				Asmal, Mohammed; Hellmann, Ina; Liu, Weimin; Keele, Brandon F.; Perelson, Alan S.; Bhattacharya, Tanmoy; Gnanakaran, S.; Daniels, Marcus; Haynes, Barton F.; Korber, Bette T.; Hahn, Beatrice H.; Shaw, George M.; Letvin, Norman L.			A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DYNAMICS IN-VIVO; QUALITY-CONTROL; SELECTIVE TRANSMISSION; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN; SEQUENCE; PROTEIN; GP120; POPULATION	Mucosal transmission of the human immunodeficiency virus (HIV) results in a bottleneck in viral genetic diversity. Gnanakaran and colleagues used a computational strategy to identify signature amino acids at particular positions in Envelope that were associated either with transmitted sequences sampled very early in infection, or sequences sampled during chronic infection. Among the strongest signatures observed was an enrichment for the stable presence of histidine at position 12 at transmission and in early infection, and a recurrent loss of histidine at position 12 in chronic infection. This amino acid lies within the leader peptide of Envelope, a region of the protein that has been shown to influence envelope glycoprotein expression and virion infectivity. We show a strong association between a positively charged amino acid like histidine at position 12 in transmitted/founder viruses with more efficient trafficking of the nascent envelope polypeptide to the endoplasmic reticulum and higher steady-state glycoprotein expression compared to viruses that have a non-basic position 12 residue, a substitution that was enriched among viruses sampled from chronically infected individuals. When expressed in the context of other viral proteins, transmitted envelopes with a basic amino acid position 12 were incorporated at higher density into the virus and exhibited higher infectious titers than did non-signature envelopes. These results support the potential utility of using a computational approach to examine large viral sequence data sets for functional signatures and indicate the importance of Envelope expression levels for efficient HIV transmission.	[Asmal, Mohammed; Hellmann, Ina; Letvin, Norman L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Sch Med, Boston, MA 02215 USA; [Liu, Weimin; Keele, Brandon F.; Hahn, Beatrice H.; Shaw, George M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Perelson, Alan S.; Bhattacharya, Tanmoy; Gnanakaran, S.; Daniels, Marcus; Korber, Bette T.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bhattacharya, Tanmoy; Korber, Bette T.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Duke University	Asmal, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Sch Med, Boston, MA 02215 USA.	masmal@bidmc.harvard.edu	Perelson, Alan S/Z-1959-2019; Bhattacharya, Tanmoy/J-8956-2013	Perelson, Alan S/0000-0002-2455-0002; Bhattacharya, Tanmoy/0000-0002-1060-652X; Gnanakaran, S/0000-0002-9368-3044; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887	NIH [AI28433-19, RR06555-18, AI-067854]; Center for HIV/AIDS Vaccine Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R37AI028433, P30AI060354, R01AI028433, U19AI067854, T32AI007387, R01AI094604] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011095] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for HIV/AIDS Vaccine Immunology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the NIH AI28433-19, RR06555-18 and AI-067854, and the Center for HIV/AIDS Vaccine Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Bachrach E, 2005, VIROLOGY, V332, P418, DOI 10.1016/j.virol.2004.11.031; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; CRISE B, 1992, J VIROL, V66, P2296, DOI 10.1128/JVI.66.4.2296-2301.1992; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; Enose Y, 1997, ARCH VIROL, V142, P37, DOI 10.1007/s007050050057; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frater AJ, 2006, J VIROL, V80, P7226, DOI 10.1128/JVI.02014-05; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; JABBAR MA, 1990, J VIROL, V64, P6297, DOI 10.1128/JVI.64.12.6297-6304.1990; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; LI Y, 1994, VIROLOGY, V204, P266, DOI 10.1006/viro.1994.1531; Li Y, 2000, VIROLOGY, V272, P417, DOI 10.1006/viro.2000.0357; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; MAC ARTHUR ROBERT H., 1967; Maggioni C, 2005, CURR TOP MICROBIOL, V285, P175; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pfeiffer T, 2006, FEBS LETT, V580, P3775, DOI 10.1016/j.febslet.2006.05.070; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rizzotto L, 2006, MOL MED, V12, P137, DOI 10.2119/2005-00040.Rizzotto; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Stepanyuk GA, 2008, PROTEIN EXPRES PURIF, V61, P142, DOI 10.1016/j.pep.2008.05.013; Wang BZ, 2007, J VIROL, V81, P10869, DOI 10.1128/JVI.00542-07; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	49	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23673	10.1371/journal.pone.0023673	http://dx.doi.org/10.1371/journal.pone.0023673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876761	Green Submitted, Green Published, gold			2022-12-25	WOS:000294126900033
J	Evans, CL; Abu-Yousif, AO; Park, YJ; Klein, OJ; Celli, JP; Rizvi, I; Zheng, X; Hasan, T				Evans, Conor L.; Abu-Yousif, Adnan O.; Park, Yong Jin; Klein, Oliver J.; Celli, Jonathan P.; Rizvi, Imran; Zheng, Xiang; Hasan, Tayyaba			Killing Hypoxic Cell Populations in a 3D Tumor Model with EtNBS-PDT	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; OVARIAN-CANCER; IN-VITRO; 3-DIMENSIONAL MODEL; OXYGEN-CONSUMPTION; DRUG-RESISTANCE; MURINE SARCOMAS; SOLID TUMORS; BENZOPHENOTHIAZINE; EFFICACY	An outstanding problem in cancer therapy is the battle against treatment-resistant disease. This is especially true for ovarian cancer, where the majority of patients eventually succumb to treatment-resistant metastatic carcinomatosis. Limited perfusion and diffusion, acidosis, and hypoxia play major roles in the development of resistance to the majority of front-line therapeutic regimens. To overcome these limitations and eliminate otherwise spared cancer cells, we utilized the cationic photosensitizer EtNBS to treat hypoxic regions deep inside in vitro 3D models of metastatic ovarian cancer. Unlike standard regimens that fail to penetrate beyond similar to 150 mu m, EtNBS was found to not only penetrate throughout the entirety of large (>200 mu m) avascular nodules, but also concentrate into the nodules' acidic and hypoxic cores. Photodynamic therapy with EtNBS was observed to be highly effective against these hypoxic regions even at low therapeutic doses, and was capable of destroying both normoxic and hypoxic regions at higher treatment levels. Imaging studies utilizing multiphoton and confocal microscopies, as well as time-lapse optical coherence tomography (TL-OCT), revealed an inside-out pattern of cell death, with apoptosis being the primary mechanism of cell killing. Critically, EtNBS-based photodynamic therapy was found to be effective against the model tumor nodules even under severe hypoxia. The inherent ability of EtNBS photodynamic therapy to impart cytotoxicity across a wide range of tumoral oxygenation levels indicates its potential to eliminate treatment-resistant cell populations.	[Evans, Conor L.; Abu-Yousif, Adnan O.; Klein, Oliver J.; Celli, Jonathan P.; Rizvi, Imran; Zheng, Xiang; Hasan, Tayyaba] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA; [Park, Yong Jin] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Evans, CL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	thasan@partners.org	Rizvi, Imran/A-3889-2019; Rizvi, Imran/E-5049-2013	Rizvi, Imran/0000-0001-9673-4700; Rizvi, Imran/0000-0001-9673-4700; Hasan, Tayyaba/0000-0003-0871-6057	F32 fellowship [F32 CA138153]; Wellman graduate fellowship; HST-KAIST; National Institutes of Health [NIH RC1 CA146337, DP2 OD007096]; NATIONAL CANCER INSTITUTE [F32CA138153, RC1CA146337] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007096] Funding Source: NIH RePORTER	F32 fellowship; Wellman graduate fellowship; HST-KAIST; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CLE was supported by a F32 fellowship (F32 CA138153). IR was supported by the Wellman graduate fellowship. YJP was supported by the HST-KAIST summer internship program. Funding for this work came from National Institutes of Health grant NIH RC1 CA146337 to TH and an NIH New Innovator Award DP2 OD007096 to CLE. Information on the New Innovator Award Program is at http://nihroadmap.nih.gov/newinnovator/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, CLIN EXP METASTAS, V22, P391, DOI 10.1007/s10585-005-1262-y; Alderden RA, 2007, J AM CHEM SOC, V129, P13400, DOI 10.1021/ja076281t; Berek J. S., 2003, CANC MED, P1831; BREDELGEISSLER A, 1992, J CELL PHYSIOL, V153, P44, DOI 10.1002/jcp.1041530108; Busch TM, 2004, CLIN CANCER RES, V10, P4630, DOI 10.1158/1078-0432.CCR-04-0359; Celli JP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3483903; Celli JP, 2010, CHEM REV, V110, P2795, DOI 10.1021/cr900300p; CINCOTTA L, 1993, CANCER RES, V53, P2571; CINCOTTA L, 1994, CANCER RES, V54, P1249; Cincotta L, 1996, PHOTOCHEM PHOTOBIOL, V63, P229, DOI 10.1111/j.1751-1097.1996.tb03019.x; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; del Carmen MG, 2005, JNCI-J NATL CANCER I, V97, P1516, DOI 10.1093/jnci/dji314; Duska LR, 1999, J NATL CANCER I, V91, P1557, DOI 10.1093/jnci/91.18.1557; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Evans C. L., 2010, P SPIE, V7551; Evans CL, 2009, OPT EXPRESS, V17, P8892, DOI 10.1364/OE.17.008892; Frimberger AE, 1998, CLIN CANCER RES, V4, P2207; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Georgakoudi I, 1998, PHOTOCHEM PHOTOBIOL, V68, P115, DOI 10.1111/j.1751-1097.1998.tb03261.x; Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037; Greijer AE, 2005, CELL ONCOL, V27, P43; Hendren SK, 2001, ANN SURG ONCOL, V8, P65, DOI 10.1245/aso.2001.8.1.65; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Jain RK, 1998, J CONTROL RELEASE, V53, P49, DOI 10.1016/S0168-3659(97)00237-X; Koch S, 2003, BRIT J CANCER, V89, P2133, DOI 10.1038/sj.bjc.6601375; Molpus KL, 1996, CANCER RES, V56, P1075; PASS HI, 1993, JNCI-J NATL CANCER I, V85, P443, DOI 10.1093/jnci/85.6.443; Rahmanzadeh R, 2010, CANCER RES, V70, P9234, DOI 10.1158/0008-5472.CAN-10-1190; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Rizvi I, 2010, CANCER RES, V70, P9319, DOI 10.1158/0008-5472.CAN-10-1783; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Tannock IF, 2002, CLIN CANCER RES, V8, P878; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Verma S, 2009, PHOTOCHEM PHOTOBIOL, V85, P111, DOI 10.1111/j.1751-1097.2008.00403.x; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Zhong H, 1999, CANCER RES, V59, P5830	38	68	69	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23434	10.1371/journal.pone.0023434	http://dx.doi.org/10.1371/journal.pone.0023434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876751	gold, Green Published, Green Submitted			2022-12-25	WOS:000294126900023
J	Bernardo, BC; Belluoccio, D; Rowley, L; Little, CB; Hansen, U; Bateman, JF				Bernardo, Bianca C.; Belluoccio, Daniele; Rowley, Lynn; Little, Christopher B.; Hansen, Uwe; Bateman, John F.			Cartilage Intermediate Layer Protein 2 (CILP-2) Is Expressed in Articular and Meniscal Cartilage and Down-regulated in Experimental Osteoarthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CARTILAGE; AGE-RELATED-CHANGES; CELL-ADHESION; NUCLEOTIDE PYROPHOSPHOHYDROLASE; KNEE OSTEOARTHRITIS; SKELETAL-MUSCLES; CANDIDATE GENES; MICROARRAY DATA; TYPE-1 REPEATS; THROMBOSPONDIN	Using transcriptome profiling to determine differential gene expression between the permanent mouse articular cartilage and the transient growth plate cartilage, we identified a highly expressed gene, Cilp2, which is expressed differentially by articular chondrocytes. CILP-2 is highly homologous to CILP-1 (cartilage intermediate layer protein 1), which is expressed in the intermediate zone of articular cartilage and has been linked to cartilage degenerative diseases. We demonstrated that Cilp2 has a restricted mRNA distribution at the surface of the mouse articular cartilage during development, becoming localized to the intermediate zone of articular cartilage and meniscal cartilage with maturity. Although the extracellular CILP-2 protein localization is broadly similar to CILP-1, CILP-2 appears to be more localized in the deeper intermediate zone of the articular cartilage extracellular matrix at maturity. CILP-2 was shown to be proteolytically processed, N-glycosylated, and present in human articular cartilage. In surgically induced osteoarthritis in mice, Cilp1 and Cilp2 gene expression was dysregulated. However, whereas Cilp1 expression was increased, Cilp2 gene expression was down-regulated demonstrating a differential response to mechanically induced joint destabilization. CILP-2 protein was reduced in the mouse osteoarthritic cartilage. Ultrastructural analysis also suggested that CILP-2 may be associated with collagen VI microfibrils and thus may mediate interactions between matrix components in the territorial and inter-territorial articular cartilage matrix. mRNA expression analysis indicated that whereas Cilp1 and Cilp2 are expressed most abundantly in cartilaginous tissues, expression can be detected in muscle and heart.	[Bernardo, Bianca C.; Belluoccio, Daniele; Rowley, Lynn; Bateman, John F.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bernardo, Bianca C.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Little, Christopher B.] Royal N Shore Hosp, Univ Sydney, Raymond Purves Bone & Joint Res Labs, Kolling Inst Med Res, St Leonards, NSW 2065, Australia; [Hansen, Uwe] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Munster	Bateman, JF (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	john.bateman@mcri.edu.au	Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Bateman, John/0000-0001-8542-0730; Bernardo, Bianca Christine/0000-0002-4534-0549	National Health and Medical Research Council of Australia [607399]; Murdoch Childrens Research Institute; Victorian Government; Sonderforschungsbereich [SFB 492, TP A2]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government; Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported in part by National Health and Medical Research Council of Australia Grant 607399), the Murdoch Childrens Research Institute, the Victorian Government's Operational Infrastructure Support Program, and Sonderforschungsbereich Grant SFB 492, TP A2.	Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Alman BA, 2008, CLIN GENET, V73, P24, DOI 10.1111/j.1399-0004.2007.00933.x; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Belluoccio D, 2006, PROTEOMICS, V6, P6549, DOI 10.1002/pmic.200600191; Bock HC, 2001, OSTEOARTHR CARTILAGE, V9, P654, DOI 10.1053/joca.2001.0420; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Gantt SM, 1997, J BIOL CHEM, V272, P19205, DOI 10.1074/jbc.272.31.19205; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; GUO NH, 1992, J BIOL CHEM, V267, P19349; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; Johnson K, 2003, ARTHRITIS RHEUM-US, V48, P1302, DOI 10.1002/art.10927; Kassner A, 2003, MATRIX BIOL, V22, P131, DOI 10.1016/S0945-053X(03)00008-8; LIGHT N, 1984, BIOCHEM J, V219, P1017, DOI 10.1042/bj2191017; Listrat A, 1999, TISSUE CELL, V31, P17, DOI 10.1054/tice.1998.0015; Listrat A, 2000, HISTOCHEM J, V32, P349, DOI 10.1023/A:1004013613793; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; Lorenzo P, 1998, J BIOL CHEM, V273, P23469, DOI 10.1074/jbc.273.36.23469; Magnetto S, 1998, CELL BIOCHEM FUNCT, V16, P211, DOI 10.1002/(SICI)1099-0844(199809)16:3<211::AID-CBF788>3.3.CO;2-Q; Masuda I, 2001, J BONE MINER RES, V16, P868, DOI 10.1359/jbmr.2001.16.5.868; Mori M, 2006, BIOCHEM BIOPH RES CO, V341, P121, DOI 10.1016/j.bbrc.2005.12.159; Mundlos S., 2002, CONNECTIVE TISSUE IT, P993; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Pacifici M, 1995, MATRIX BIOL, V14, P689, DOI 10.1016/S0945-053X(05)80011-3; Passerieux E, 2006, J STRUCT BIOL, V154, P206, DOI 10.1016/j.jsb.2006.01.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Seki S, 2005, NAT GENET, V37, P607, DOI 10.1038/ng1557; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tsuruha J, 2001, ARTHRITIS RHEUM, V44, P838, DOI 10.1002/1529-0131(200104)44:4<838::AID-ANR140>3.3.CO;2-3; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2004, ARTHRITIS RHEUM-US, V50, P2497, DOI 10.1002/art.20443; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654	43	47	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37758	37767		10.1074/jbc.M111.248039	http://dx.doi.org/10.1074/jbc.M111.248039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880736	Green Published, hybrid			2022-12-25	WOS:000296542400071
J	Estela, A; Pla-Martin, D; Sanchez-Piris, M; Sesaki, H; Palau, F				Estela, Anna; Pla-Martin, David; Sanchez-Piris, Maribel; Sesaki, Hiromi; Palau, Francesc			Charcot-Marie-Tooth-related Gene GDAP1 Complements Cell Cycle Delay at G(2)/M Phase in Saccharomyces cerevisiae fis1 Gene-defective Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-ASSOCIATED PROTEIN-1; DOMINANT OPTIC ATROPHY; MITOCHONDRIAL FISSION; GLUTATHIONE TRANSFERASE; ORGANELLE INHERITANCE; 4A DISEASE; MUTATIONS; GTPASE; YEAST; SYSTEM	Mutations in the GDAP1 gene are responsible of the Charcot-Marie-Tooth CMT4A, ARCMT2K, and CMT2K variants. GDAP1 is a mitochondrial outer membrane protein that has been related to the fission pathway of the mitochondrial network dynamics. As mitochondrial dynamics is a conserved process, we reasoned that expressing GDAP1 in Saccharomyces cerevisiae strains defective for genes involved in mitochondrial fission or fusion could increase our knowledge of GDAP1 function. We discovered a consistent relation between Fis1p and the cell cycle because fis1 Delta cells showed G(2)/M delay during cell cycle progression. The fis1 Delta phenotype, which includes cell cycle delay, was fully rescued by GDAP1. By contrast, clinical missense mutations rescued the fis1 Delta phenotype except for the cell cycle delay. In addition, both Fis1p and human GDAP1 interacted with beta-tubulins Tub2p and TUBB, respectively. A defect in the fis1 gene may induce abnormal location of mitochondria during budding mitosis, causing the cell cycle delay at G(2)/M due to its anomalous interaction with microtubules from the mitotic spindle. In the case of neurons harboring defects in GDAP1, the interaction between mitochondria and the microtubule cytoskeleton would be altered, which might affect mitochondrial axonal transport and movement within the cell and may explain the pathophysiology of the GDAP1-related Charcot-Marie-Tooth disease.	[Estela, Anna; Pla-Martin, David; Sanchez-Piris, Maribel; Palau, Francesc] CSIC, Inst Biomed Valencia, Genet & Mol Med Unit, Valencia 46010, Spain; [Estela, Anna; Pla-Martin, David; Palau, Francesc] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia 46010, Spain; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Johns Hopkins University	Palau, F (corresponding author), CSIC, Inst Biomed Valencia, Genet & Mol Med Unit, C Jaume Roig 11, Valencia 46010, Spain.	fpalau@ibv.csic.es	Pla Martin, David/GXV-8888-2022; Palau, Francesc/A-9391-2014	Palau, Francesc/0000-0002-8635-5421; Pla Martin, David/0000-0002-5189-0723	National Institutes of Health [GM089853]; Spanish Ministry of Science and Innovation [SAF2006-01147, SAF2009-07063]; Instituto de Salud Carlos III; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM089853. This work was also supported by Grants SAF2006-01147 and SAF2009-07063 and a predoctoral FPI fellowship (to D. P.-M.) from the Spanish Ministry of Science and Innovation, a "Sara Borrell" postdoctoral contract from the Instituto de Salud Carlos III (to A. E.), the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), an initiative from the Instituto de Salud Carlos III, and the INGENIO 2010 Program.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Baxter RV, 2002, NAT GENET, V30, P21, DOI 10.1038/ng796; Burke D., 2000, METHODS YEAST GENETI; Cerveny KL, 2007, DEV CELL, V12, P363, DOI 10.1016/j.devcel.2007.01.017; Cheng WC, 2008, CELL DEATH DIFFER, V15, P1838, DOI 10.1038/cdd.2008.117; Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178; Cuesta A, 2002, NAT GENET, V30, P22, DOI 10.1038/ng798; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Lawson VH, 2005, NEUROLOGY, V65, P197, DOI 10.1212/01.wnl.0000168898.76071.70; Lee Choogon, 2007, Methods Mol Biol, V362, P385; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Marco A, 2004, MOL BIOL EVOL, V21, P176, DOI 10.1093/molbev/msh013; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Niu W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000120; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Pedrola L, 2005, HUM MOL GENET, V14, P1087, DOI 10.1093/hmg/ddi121; Pedrola L, 2008, J CELL MOL MED, V12, P679, DOI 10.1111/j.1582-4934.2007.00158.x; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Shield AJ, 2006, BIOCHEM BIOPH RES CO, V347, P859, DOI 10.1016/j.bbrc.2006.06.189; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; YANG XO, 1992, SCIENCE, V257, P680, DOI 10.1126/science.1496382; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	38	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36777	36786		10.1074/jbc.M111.260042	http://dx.doi.org/10.1074/jbc.M111.260042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890626	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000296538300059
J	Park, S; Kim, W; Tian, G; Gygi, SP; Finley, D				Park, Soyeon; Kim, Woong; Tian, Geng; Gygi, Steven P.; Finley, Daniel			Structural Defects in the Regulatory Particle-Core Particle Interface of the Proteasome Induce a Novel Proteasome Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; UBIQUITIN LIGASE HUL5; REG-GAMMA-PROTEASOME; 20S PROTEASOME; TRANSCRIPTION FACTOR; ASSEMBLY PATHWAY; AAA SUBUNITS; PROTEIN; YEAST; COMPLEX	Proteasomes consist of a 19-subunit regulatory particle (RP) and 28-subunit core particle (CP), an alpha(7)alpha(7)alpha(7)alpha(7) structure. The RP recognizes substrates and translocates them into the CP for degradation. At the RP-CP interface, a heterohexameric Rpt ring joins to a heteroheptameric CP alpha ring. Rpt C termini insert individually into the alpha ring pockets to form a salt bridge with a pocket lysine residue. We report that substitutions of alpha pocket lysine residues produce an unexpected block to CP assembly, arising from a late stage defect in beta ring assembly. Substitutions alpha 5(K66A) and alpha 6(K62A) resulted in abundant incorporation of immature CP beta subunits, associated with a complete beta ring, into proteasome holoenzymes. Incorporation of immature CP into the proteasome depended on a proteasome-associated protein, Ecm29. Using ump1 mutants, we identified Ecm29 as a potent negative regulator of RP assembly and confirmed our previous findings that proper RP assembly requires the CP. Ecm29 was enriched on proteasomes of pocket lysine mutants, as well as those of rpt4-Delta 1 and rpt6-Delta 1 mutants, in which the C-terminal residue, thought to contact the pocket lysine, is deleted. In both rpt6-Delta 1 and Delta 6(K62A) proteasomes, Ecm29 suppressed opening of the CP substrate translocation channel, which is gated through interactions between Rpt C termini and the alpha pockets. The ubiquitin ligase Hul5 was recruited to these proteasomes together with Ecm29. Proteasome remodeling through the addition of Ecm29 and Hul5 suggests a new layer of the proteasome stress response and may be a common response to structurally aberrant proteasomes or deficient proteasome function.	[Park, Soyeon; Kim, Woong; Tian, Geng; Gygi, Steven P.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Tian, Geng/G-7374-2011		National Institutes of Health [GM43601, GM67945]; Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, R37GM043601, R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43601 (to D.F.) and GM67945 (to S.P.G.). This work was also supported by a fellowship from the Charles A. King Trust Postdoctoral Fellowship Program (to S.P.).	Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dohmen R. Jurgen, 2005, V301, P243; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P3; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tian G., 2011, NAT STRUCT IN PRESS; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; van Deventer S, 2010, CELL, V142, P517, DOI 10.1016/j.cell.2010.08.002; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	69	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36652	36666		10.1074/jbc.M111.285924	http://dx.doi.org/10.1074/jbc.M111.285924			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878652	Green Published, hybrid			2022-12-25	WOS:000296538300048
J	Dukhande, VV; Rogers, DM; Roma-Mateo, C; Donderis, J; Marina, A; Taylor, AO; Sanz, P; Gentry, MS				Dukhande, Vikas V.; Rogers, Devin M.; Roma-Mateo, Carlos; Donderis, Jordi; Marina, Alberto; Taylor, Adam O.; Sanz, Pascual; Gentry, Matthew S.			Laforin, a Dual Specificity Phosphatase Involved in Lafora Disease, Is Present Mainly as Monomeric Form with Full Phosphatase Activity	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PROGRESSIVE MYOCLONUS EPILEPSY; CARBOHYDRATE-BINDING DOMAIN; ALKALINE-PHOSPHATASE; GLYCOGEN-SYNTHESIS; ESCHERICHIA-COLI; DIMERIZATION; METABOLISM; MECHANISM; MALIN	Lafora Disease (LD) is a fatal neurodegenerative epileptic disorder that presents as a neurological deterioration with the accumulation of insoluble, intracellular, hyperphosphorylated carbohydrates called Lafora bodies (LBs). LD is caused by mutations in either the gene encoding laforin or malin. Laforin contains a dual specificity phosphatase domain and a carbohydrate-binding module, and is a member of the recently described family of glucan phosphatases. In the current study, we investigated the functional and physiological relevance of laforin dimerization. We purified recombinant human laforin and subjected the monomer and dimer fractions to denaturing gel electrophoresis, mass spectrometry, phosphatase assays, protein-protein interaction assays, and glucan binding assays. Our results demonstrate that laforin prevalently exists as a monomer with a small dimer fraction both in vitro and in vivo. Of mechanistic importance, laforin monomer and dimer possess equal phosphatase activity, and they both associate with malin and bind glucans to a similar extent. However, we found differences between the two states' ability to interact simultaneously with malin and carbohydrates. Furthermore, we tested other members of the glucan phosphatase family. Cumulatively, our data suggest that laforin monomer is the dominant form of the protein and that it contains phosphatase activity.	[Dukhande, Vikas V.; Rogers, Devin M.; Taylor, Adam O.; Gentry, Matthew S.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40526 USA; [Dukhande, Vikas V.; Rogers, Devin M.; Taylor, Adam O.; Gentry, Matthew S.] Univ Kentucky, Coll Med, Struct Biol Ctr, Lexington, KY USA; [Roma-Mateo, Carlos; Donderis, Jordi; Marina, Alberto; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Roma-Mateo, Carlos; Donderis, Jordi; Marina, Alberto; Sanz, Pascual] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Valencia, Spain	University of Kentucky; University of Kentucky; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Dukhande, VV (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40526 USA.	sanz@ibv.csic.es; matthew.gentry@uky.edu	Marina, Alberto/H-6264-2011; Romá-Mateo, Carlos/B-6640-2016; Sanz, Pascual/K-2751-2014	Marina, Alberto/0000-0002-1334-5273; Romá-Mateo, Carlos/0000-0002-7981-7157; Sanz, Pascual/0000-0002-2399-4103	National Center for Research Resources of the National Institutes of Health (NIH) [P20RR0202171]; University of Kentucky College of Medicine; NIH [R00NS061803, R01NS070899]; Spanish Ministry of Education and Science [SAF2008-01907]; Generalitat Valenciana [Prometeo 2009/051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899, R00NS061803] Funding Source: NIH RePORTER	National Center for Research Resources of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Kentucky College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Center of Biomedical Research Excellence (COBRE) grant from the National Center for Research Resources of the National Institutes of Health (NIH, grant P20RR0202171), University of Kentucky College of Medicine startup funds, and NIH grants R00NS061803, R01NS070899 to MSG; as well as a grant from the Spanish Ministry of Education and Science (SAF2008-01907) and a grant from Generalitat Valenciana (Prometeo 2009/051) to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOVIC SF, 1991, J CLIN NEUROPHYSIOL, V8, P261, DOI 10.1097/00004691-199107010-00003; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Castanheira P, 2010, PROTEIN EXPRES PURIF, V71, P195, DOI 10.1016/j.pep.2010.02.004; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; DUKHANDE VV, 2010, UCSD NATURE MOL PAGE; Fordham-Skelton AP, 2002, PLANT J, V29, P705, DOI 10.1046/j.1365-313X.2002.01250.x; Ganesh S, 2000, HUM MOL GENET, V9, P2251, DOI 10.1093/oxfordjournals.hmg.a018916; Garyali P, 2009, HUM MOL GENET, V18, P688, DOI 10.1093/hmg/ddn398; Gatzeva-Topalova PZ, 2005, STRUCTURE, V13, P929, DOI 10.1016/j.str.2005.03.018; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Girard JM, 2006, BIOCHIMIE, V88, P1961, DOI 10.1016/j.biochi.2006.08.002; JANEWAY R, 1967, ARCH NEUROL-CHICAGO, V16, P565, DOI 10.1001/archneur.1967.00470240003001; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Kerk D, 2006, PLANT J, V46, P400, DOI 10.1111/j.1365-313X.2006.02704.x; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Lee S, 2007, MOL CELL BIOL, V27, P1795, DOI 10.1128/MCB.00535-06; Liu RH, 2008, MOL CELL BIOL, V28, P7236, DOI 10.1128/MCB.01334-08; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Minassian BA, 2001, PEDIATR NEUROL, V25, P21, DOI 10.1016/S0887-8994(00)00276-9; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; Roma-Mateo C, 2011, BIOCHEM J, V439, P265, DOI 10.1042/BJ20110150; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHLESINGER MJ, 1965, J BIOL CHEM, V240, P4284; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; SOWADSKI JM, 1985, J MOL BIOL, V186, P417, DOI 10.1016/0022-2836(85)90115-9; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Tabernero L, 1999, BIOCHEMISTRY-US, V38, P11651, DOI 10.1021/bi990381x; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2011, CELL METAB, V13, P274, DOI 10.1016/j.cmet.2011.01.017; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; TENHAM MWV, 1975, HDB CLIN NEUROLOGY, P382; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Walchli S, 2005, BIOCHEM BIOPH RES CO, V331, P497, DOI 10.1016/j.bbrc.2005.03.196; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang Y, 2008, CANCER RES, V68, P4039, DOI 10.1158/0008-5472.CAN-07-6314; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012; ZHANG ZY, 1995, J BIOL CHEM, V270, P11199, DOI 10.1074/jbc.270.19.11199	56	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24040	10.1371/journal.pone.0024040	http://dx.doi.org/10.1371/journal.pone.0024040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887368	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298800029
J	Thompson, J; MacMillan, M; Boegler, K; Wood, C; Elder, JH; VandeWoude, S				Thompson, Jesse; MacMillan, Martha; Boegler, Karen; Wood, Charles; Elder, John H.; VandeWoude, Sue			Pathogenicity and Rapid Growth Kinetics of Feline Immunodeficiency Virus Are Linked to 3 ' Elements	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; DOMESTIC CATS; PERSISTENT INFECTION; NUCLEOTIDE-SEQUENCE; GENETIC DIVERSITY; DISEASE; FIV; INTEGRASE; MACAQUES; RECEPTOR	Chimeric viruses constructed between a highly pathogenic Feline Immunodeficiency Virus isolate (FIV-C36) and a less pathogenic but neurotropic strain (FIV-PPR) have been used to map viral genetic determinants of in vivo pathogenicity. Chimeric virus FIV-PCenv, which contains FIV-C36 genome from the 3' region of pol to upstream of the 3'LTR on an FIV-PPR backbone, was previously shown to be replication-competent in vivo, inducing altered CD4(+) T-cell and neutrophil profiles intermediate between parental strains following a delay in viral replication during initial infection. Examination of FIV-PCenv proviral sequences recovered at week 11 post-infection revealed two changes compared to initial viral inoculum; the most significant being arginine to histidine in the integrase region of Pol at residue 813 (R813H). Pooled plasma from the initial in vivo study was used to inoculate a second cohort of cats to determine whether similar virulence and kinetics could be established following primary infection. Viral replication kinetics and immunocyte profiles were monitored in blood, bone marrow, and saliva over a one-year period. Passaged FIV-PCenv again displayed intermediate phenotype between parental strains, but unlike primary experiments, the onset of acute viremia was not delayed. CD4/8 alterations were noted in all groups of animals, though significant changes from controls were delayed in FIV-PPR infected animals compared to FIV-C36 and FIV-PCenv. In vivo passage of FIV-PCenv increased replication-competence relative to the initial molecularly-cloned chimera in association with one adaptive nucleotide change in the 5' end of the genome relative to primary tissue culture inoculum, while mutations in the 3' end of the genome were not detected. The results are consistent with the interpretation that 3' elements contribute to heightened virulence of FIV-C36, and that integrase residue 813 plays an important role in facilitating successful in vivo replication.	[Thompson, Jesse; MacMillan, Martha; Boegler, Karen; VandeWoude, Sue] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Elder, John H.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Thompson, Jesse; Wood, Charles] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE USA	Colorado State University; Scripps Research Institute; University of Nebraska System; University of Nebraska Lincoln	Thompson, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jthompson12@unl.edu	Wood, Charles/AAH-4536-2021	Wood, Charles/0000-0002-4256-1530; VandeWoude, Sue/0000-0001-9227-1622	National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI048411, AI25825]; Virginia Schmidt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048411, R01AI025825] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Virginia Schmidt; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health, National Institute of Allergy and Infectious Diseases R01 to JHE and SV AI048411, and R01 to JHE AI25825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jeanette Hayes-Klug, Kelly Anderson, and Erin McNulty for assistance in animal care and sample collection, and Virginia Schmidt for assistance in laboratory assay development and support.	Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; de Parseval A, 2005, NAT STRUCT MOL BIOL, V12, P60, DOI 10.1038/nsmb872; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Parseval A, 1999, J VIROL, V73, P608, DOI 10.1128/JVI.73.1.608-617.1999; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; De Rozieres S, 2008, J VIROL, V82, P7953, DOI 10.1128/JVI.00337-08; DIEHL LJ, 1995, J VIROL, V69, P6149, DOI 10.1128/JVI.69.10.6149-6157.1995; Duarte A, 2006, VET MICROBIOL, V114, P25, DOI 10.1016/j.vetmic.2005.11.056; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; ENGLISH RV, 1994, J INFECT DIS, V170, P543, DOI 10.1093/infdis/170.3.543; Ikeda Y, 1996, J GEN VIROL, V77, P1623, DOI 10.1099/0022-1317-77-8-1623; Johnston JB, 2002, J VIROL, V76, P2622, DOI 10.1128/JVI.76.6.2622-2633.2002; KAKINUMA S, 1995, J VIROL, V69, P3639, DOI 10.1128/JVI.69.6.3639-3646.1995; Kann R, 2006, J S AFR VET ASSOC, V77, P108; Kann RKC, 2006, AUST VET J, V84, P112, DOI 10.1111/j.1751-0813.2006.tb13392.x; Koh Y, 2011, J VIROL, V85, P3677, DOI 10.1128/JVI.02541-10; KOHMOTO M, 1994, J GEN VIROL, V75, P1935, DOI 10.1099/0022-1317-75-8-1935; Kozyrev IL, 2001, VIROLOGY, V282, P6, DOI 10.1006/viro.2000.0839; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; LI JT, 1995, J VIROL, V69, P7061, DOI 10.1128/JVI.69.11.7061-7067.1995; LUCIW PA, 1995, P NATL ACAD SCI USA, V92, P7490, DOI 10.1073/pnas.92.16.7490; Nakamura K, 2003, ARCH VIROL, V148, P783, DOI 10.1007/s00705-002-0954-8; NOWAK MA, 1990, AIDS, V4, P1095, DOI 10.1097/00002030-199011000-00007; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; PEDERSEN NC, 1989, VET IMMUNOL IMMUNOP, V21, P111, DOI 10.1016/0165-2427(89)90134-7; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Slaughter MR, 2002, LAB ANIM-UK, V36, P403, DOI 10.1258/002367702320389062; SODORA DL, 1994, J VIROL, V68, P2230, DOI 10.1128/JVI.68.4.2230-2238.1994; SPARGER EE, 1994, VIROLOGY, V205, P546, DOI 10.1006/viro.1994.1677; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; Tomonaga K, 1996, J GEN VIROL, V77, P1611, DOI 10.1099/0022-1317-77-8-1611; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Watanabe T, 2011, MICROBES INFECT, V13, P160, DOI 10.1016/j.micinf.2010.10.006; Willett BJ, 1997, J VIROL, V71, P6407, DOI 10.1128/JVI.71.9.6407-6415.1997; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463	40	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24020	10.1371/journal.pone.0024020	http://dx.doi.org/10.1371/journal.pone.0024020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887365	Green Published, gold			2022-12-25	WOS:000294298800027
J	Fischer, I; Alliod, C; Martinier, N; Newcombe, J; Brana, C; Pouly, S				Fischer, Iris; Alliod, Chantal; Martinier, Nicolas; Newcombe, Jia; Brana, Corinne; Pouly, Sandrine			Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; S1P RECEPTORS; REACTIVE ASTROCYTES; NERVOUS-SYSTEM; SPINAL-CORD; PROTEASOMAL DEGRADATION; EPITHELIAL-CELLS; MAST-CELLS; IN-VIVO; SPHINGOSINE-1-PHOSPHATE	Background: Reactive astrocytes are implicated in the development and maintenance of neuroinflammation in the demyelinating disease multiple sclerosis (MS). The sphingosine kinase 1 (SphK1)/sphingosine1-phosphate (S1P) receptor signaling pathway is involved in modulation of the inflammatory response in many cell types, but the role of S1P receptor subtype 3 (S1P(3)) signaling and SphK1 in activated rat astrocytes has not been defined. Methodology/Principal Findings: Using immunohistochemistry we observed the upregulation of S1P(3) and SphK1 expression on reactive astrocytes and SphK1 on macrophages in MS lesions. Increased mRNA and protein expression of S1P(3) and SphK1, as measured by qPCR and Western blotting respectively, was observed after treatment of rat primary astrocyte cultures with the pro-inflammatory stimulus lipopolysaccharide (LPS). Activation of SphK by LPS stimulation was confirmed by SphK activity assay and was blocked by the use of the SphK inhibitor SKI (2-(p-hydroxyanilino)-4-(p-chlorphenyl) thiazole. Treatment of astrocytes with a selective S1P(3) agonist led to increased phosphorylation of extracellular signal-regulated kinase (ERK)-1/2), which was further elevated with a LPS pre-challenge, suggesting that S1P(3) upregulation can lead to increased functionality. Moreover, astrocyte migration in a scratch assay was induced by S1P and LPS and this LPS-induced migration was sensitive to inhibition of SphK1, and independent of cell proliferation. In addition, S1P induced secretion of the potentially neuroprotective chemokine CXCL1, which was increased when astrocytes were pre-challenged with LPS. A more prominent role of S1P(3) signaling compared to S1P(1) signaling was demonstrated by the use of selective S1P(3) or S1P(1) agonists. Conclusion/Significance: In summary, our data demonstrate that the SphK1/S1P(3) signaling axis is upregulated when astrocytes are activated by LPS. This signaling pathway appears to play a role in the establishment and maintenance of astrocyte activation. Upregulation of the pathway in MS may be detrimental, e. g. through enhancing astrogliosis, or beneficial through increased remyelination via CXCL1.	[Fischer, Iris; Alliod, Chantal; Martinier, Nicolas; Brana, Corinne; Pouly, Sandrine] Merck Serono Int, Geneva Res Ctr, TA Neurodegenerat Dis, Geneva, Switzerland; [Newcombe, Jia] UCL Inst Neurol, London, England	Merck KGaA; EMD Serono Inc.; University of London; University College London	Fischer, I (corresponding author), Merck Serono Int, Geneva Res Ctr, TA Neurodegenerat Dis, Geneva, Switzerland.	sandrine.pouly@merckgroup.com		Newcombe, Jia/0000-0001-9609-7975	Merck Serono	Merck Serono(Merck & Company)	Merck Serono funded the study, and employed several of the authors. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Durafourt BA, 2011, J NEUROIMMUNOL, V230, P10, DOI 10.1016/j.jneuroim.2010.08.006; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Gonzalez-Cabrera PJ, 2007, J BIOL CHEM, V282, P7254, DOI 10.1074/jbc.M610581200; Hammad SM, 2008, PROSTAG OTH LIPID M, V85, P107, DOI 10.1016/j.prostaglandins.2007.11.002; He F, 2007, INT J BIOCHEM CELL B, V39, P661, DOI 10.1016/j.biocel.2006.10.022; Herr DR, 2007, CURR DRUG TARGETS, V8, P155, DOI 10.2174/138945007779315669; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Jolly PS, 2005, BLOOD, V105, P4736, DOI 10.1182/blood-2004-12-4686; Kanno T, 2010, NEUROSCIENCE, V171, P973, DOI 10.1016/j.neuroscience.2010.10.021; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kawata T, 2005, BIOCHEM BIOPH RES CO, V331, P640, DOI 10.1016/j.bbrc.2005.03.223; Kopp A, 2010, ENDOCRINOLOGY, V151, P1097, DOI 10.1210/en.2009-1140; Kulakowska A, 2010, NEUROSCI LETT, V477, P149, DOI 10.1016/j.neulet.2010.04.052; Lee DH, 2010, BIOCHEM BIOPH RES CO, V393, P476, DOI 10.1016/j.bbrc.2010.02.027; Lin CI, 2007, BIOCHEM BIOPH RES CO, V355, P895, DOI 10.1016/j.bbrc.2007.02.043; Liu K, 2008, AM J RESP CELL MOL, V39, P305, DOI 10.1165/rcmb.2007-0458OC; LONG JS, 2010, MOL CELL BIOL; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Olivera A, 1998, Methods Mol Biol, V105, P233; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Ozaki Harunobu, 2003, J Atheroscler Thromb, V10, P125; Pan SF, 2006, CHEM BIOL, V13, P1227, DOI 10.1016/j.chembiol.2006.09.017; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Pebay A, 2001, EUR J NEUROSCI, V13, P2067, DOI 10.1046/j.0953-816x.2001.01585.x; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Ramos CDL, 2003, CYTOKINE, V21, P214, DOI 10.1016/S1043-4666(03)00050-4; Rao TS, 2003, BRAIN RES, V990, P182, DOI 10.1016/S0006-8993(03)03527-3; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robinson S, 1998, J NEUROSCI, V18, P10457; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; TAKUWA N, 2009, CARDIOVASC RES; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Verzijl D, 2010, MOL CELLS, V29, P99, DOI 10.1007/s10059-010-0041-z; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Weigert A, 2009, IMMUNOBIOLOGY, V214, P748, DOI 10.1016/j.imbio.2009.06.003; Wu Q, 2000, J NEUROSCI, V20, P2609; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180; YAMASAKI Y, 1995, STROKE, V26, P318, DOI 10.1161/01.STR.26.2.318	71	84	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23905	10.1371/journal.pone.0023905	http://dx.doi.org/10.1371/journal.pone.0023905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887342	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000072
J	Jones, RW; Ospina-Giraldo, M				Jones, Richard W.; Ospina-Giraldo, Manuel			Novel Cellulose-Binding-Domain Protein in Phytophthora Is Cell Wall Localized	PLOS ONE			English	Article							ENDOGLUCANASE-ENCODING GENE; PARASITICA VAR.-NICOTIANAE; TRICHODERMA; EXPRESSION; IDENTIFICATION; SWOLLENIN; ELICITOR; MODULES; CLONING	Cellulose binding domains (CBD) in the carbohydrate binding module family 1 (CBM1) are structurally conserved regions generally linked to catalytic regions of cellulolytic enzymes. While widespread amongst saprophytic fungi that subsist on plant cell wall polysaccharides, they are absent amongst most plant pathogenic fungal cellulases. A genome wide survey for CBM1 was performed on the highly destructive plant pathogen Phytophthora infestans, a fungal-like Stramenopile, to determine if it harbored cellulolytic enzymes with CBM1. Only five genes were found to encode CBM1, and none were associated with catalytic domains. Surveys of other genomes indicated that the CBM1-containing proteins, lacking other domains, represent a unique group of proteins largely confined to the Stramenopiles. Immunolocalization of one of these proteins, CBD1, indicated that it is embedded in the hyphal cell wall. Proteins with CBM1 domains can have plant host elicitor activity, but tests with Agrobacterium-mediated in planta expression and synthetic peptide infiltration failed to identify plant hypersensitive elicitation with CBD1. A structural basis for differential elicitor activity is proposed.	[Jones, Richard W.] ARS, Genet Improvement Fruit & Vegetables Lab, USDA, Beltsville, MD USA; [Ospina-Giraldo, Manuel] Lafayette Coll, Dept Biol, Easton, PA 18042 USA	United States Department of Agriculture (USDA); Lafayette College	Jones, RW (corresponding author), ARS, Genet Improvement Fruit & Vegetables Lab, USDA, Beltsville, MD USA.	Richard.Jones@ars.usda.gov			United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding for this study was obtained from ongoing budgeted federal funding of the United States Department of Agriculture Agriculture Research Service program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Costanzo S, 2007, CURR GENET, V52, P115, DOI 10.1007/s00294-007-0144-z; Costanzo S, 2006, FUNGAL GENET BIOL, V43, P707, DOI 10.1016/j.fgb.2006.04.006; FARKAS V, 1979, MICROBIOL REV, V43, P117, DOI 10.1128/MMBR.43.2.117-144.1979; Gaulin E, 2002, J CELL SCI, V115, P4565, DOI 10.1242/jcs.00138; Gaulin E, 2006, PLANT CELL, V18, P1766, DOI 10.1105/tpc.105.038687; Gaulin E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001723; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; HOFFREN AM, 1995, PROTEIN ENG, V8, P443, DOI 10.1093/protein/8.5.443; JONES RW, 1988, J GEN MICROBIOL, V134, P2067; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Liu QY, 1996, J PHYCOL, V32, P995, DOI 10.1111/j.0022-3646.1996.00995.x; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Metcalf T, 2003, MICROBIOL-SGM, V149, P305, DOI 10.1099/mic.0.25984-0; Picard K, 2000, APPL ENVIRON MICROB, V66, P4305, DOI 10.1128/AEM.66.10.4305-4314.2000; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; Wang Haiyin, 1996, Phytopathology, V86, pS91; WANG HY, 1995, GENE, V158, P125, DOI 10.1016/0378-1119(95)00094-M; WANG HY, 1995, APPL ENVIRON MICROB, V61, P2004, DOI 10.1128/AEM.61.5.2004-2006.1995; Wang YZ, 2001, EUR J BIOCHEM, V268, P4334, DOI 10.1046/j.1432-1327.2001.02354.x; Wei YD, 2002, MICROBIOL-SGM, V148, P2149, DOI 10.1099/00221287-148-7-2149; Westerink N, 2002, MOL PLANT MICROBE IN, V15, P1219, DOI 10.1094/MPMI.2002.15.12.1219	32	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23555	10.1371/journal.pone.0023555	http://dx.doi.org/10.1371/journal.pone.0023555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887271	Green Published, gold			2022-12-25	WOS:000295832000027
J	Kraev, I; Henneberger, C; Rossetti, C; Conboy, L; Kohler, LB; Fantin, M; Jennings, A; Venero, C; Popov, V; Rusakov, D; Stewart, MG; Bock, E; Berezin, V; Sandi, C				Kraev, Igor; Henneberger, Christian; Rossetti, Clara; Conboy, Lisa; Kohler, Lene B.; Fantin, Martina; Jennings, Alistair; Venero, Cesar; Popov, Victor; Rusakov, Dmitri; Stewart, Michael G.; Bock, Elisabeth; Berezin, Vladimir; Sandi, Carmen			A Peptide Mimetic Targeting Trans-Homophilic NCAM Binding Sites Promotes Spatial Learning and Neural Plasticity in the Hippocampus	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; POLYSIALIC ACID; DENTATE GYRUS; DENDRITIC SPINES; UP-REGULATION; COGNITIVE IMPAIRMENT; RECEPTOR TRAFFICKING; SYNAPTIC PLASTICITY	The key roles played by the neural cell adhesion molecule ( NCAM) in plasticity and cognition underscore this membrane protein as a relevant target to develop cognitive-enhancing drugs. However, NCAM is a structurally and functionally complex molecule with multiple domains engaged in a variety of actions, which raise the question as to which NCAM fragment should be targeted. Synthetic NCAM mimetic peptides that mimic NCAM sequences relevant to specific interactions allow identification of the most promising targets within NCAM. Recently, a decapeptide ligand of NCAM-plannexin, which mimics a homophilic trans-binding site in Ig2 and binds to Ig3-was developed as a tool for studying NCAM's trans-interactions. In this study, we investigated plannexin's ability to affect neural plasticity and memory formation. We found that plannexin facilitates neurite outgrowth in primary hippocampal neuronal cultures and improves spatial learning in rats, both under basal conditions and under conditions involving a deficit in a key plasticity-promoting posttranslational modification of NCAM, its polysialylation. We also found that plannexin enhances excitatory synaptic transmission in hippocampal area CA1, where it also increases the number of mushroom spines and the synaptic expression of the AMPAR subunits GluA1 and GluA2. Altogether, these findings provide compelling evidence that plannexin is an important facilitator of synaptic functional, structural and molecular plasticity in the hippocampal CA1 region, highlighting the fragment in NCAM's Ig3 module where plannexin binds as a novel target for the development of cognition-enhancing drugs.	[Kraev, Igor; Popov, Victor; Stewart, Michael G.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Henneberger, Christian; Jennings, Alistair; Rusakov, Dmitri] UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Rossetti, Clara; Conboy, Lisa; Fantin, Martina; Sandi, Carmen] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland; [Kohler, Lene B.; Bock, Elisabeth; Berezin, Vladimir] Univ Copenhagen, Panum Inst, Prot Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Venero, Cesar] UNED, Dept Psychobiol, Madrid, Spain	Open University - UK; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Copenhagen; Universidad Nacional de Educacion a Distancia (UNED)	Kraev, I (corresponding author), Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England.	m.g.stewart@open.ac.uk; carmen.sandi@epfl.ch	Henneberger, Christian/C-1557-2008; Venero, César/G-2789-2011; Rusakov, Dmitri A/E-1987-2011; Rusakov, Dmitri/AAH-4529-2021; Venero, César/AAP-7263-2021; Kraev, Igor V/J-2528-2015	Henneberger, Christian/0000-0002-5391-7387; Rusakov, Dmitri A/0000-0001-9539-9947; Rusakov, Dmitri/0000-0001-9539-9947; Venero, César/0000-0003-4879-3495; Kraev, Igor V/0000-0003-1822-278X; Sandi, Carmen/0000-0001-7713-8321	EU; Swiss Society for Neuroscience [310000-120791, CRSIK0-122697, CRSIK0-122691]; Swiss Federal Institute for Technology; MRC [G0802216, G0900613] Funding Source: UKRI; Medical Research Council [G0802216, G0900613] Funding Source: researchfish	EU(European Commission); Swiss Society for Neuroscience; Swiss Federal Institute for Technology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the EU 7th Framework Program (MemStick), the Swiss Society for Neuroscience (310000-120791; Sinergia CRSIK0-122697 and CRSIK0-122691) and by the Swiss Federal Institute for Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonurm-Helm A, 2008, EUR J NEUROSCI, V28, P1618, DOI 10.1111/j.1460-9568.2008.06471.x; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Belluardo N, 1997, J COMP NEUROL, V379, P226; Berezin V, 2004, J MOL NEUROSCI, V22, P33, DOI 10.1385/JMN:22:1-2:33; Bisaz R, 2011, HIPPOCAMPUS, V21, P56, DOI 10.1002/hipo.20723; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bush DEA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00154; Calandreau L, 2010, GENES BRAIN BEHAV, V9, P958, DOI 10.1111/j.1601-183X.2010.00635.x; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; CHENG B, 1995, J NEUROCHEM, V65, P2525; Chernyshova Y, 2011, J NEUROSCI, V31, P3522, DOI 10.1523/JNEUROSCI.3109-10.2011; Conboy L, 2010, ADV EXP MED BIOL, V663, P271, DOI 10.1007/978-1-4419-1170-4_18; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; El Maarouf A, 2010, ADV EXP MED BIOL, V663, P137, DOI 10.1007/978-1-4419-1170-4_9; Fiala JC, 1998, J NEUROSCI, V18, P8900; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kohler LB, 2010, EUR J CELL BIOL, V89, P817, DOI 10.1016/j.ejcb.2010.07.007; Kohler LB, 2010, J NEUROSCI RES, V88, P2165, DOI 10.1002/jnr.22380; Liu Y, 2010, NAT NEUROSCI, V13, P223, DOI 10.1038/nn.2474; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; Markram K, 2007, NEUROBIOL LEARN MEM, V87, P573, DOI 10.1016/j.nlm.2006.11.007; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Medvedev NI, 2010, NEUROSCIENCE, V165, P1170, DOI 10.1016/j.neuroscience.2009.11.047; Medvedev NI, 2008, EUR J NEUROSCI, V27, P315, DOI 10.1111/j.1460-9568.2007.06005.x; Merino JJ, 2000, EUR J NEUROSCI, V12, P3283, DOI 10.1046/j.1460-9568.2000.00191.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Murphy KJ, 1999, NEUROBIOL LEARN MEM, V72, P28, DOI 10.1006/nlme.1998.3894; Murphy KJ, 2001, J NEUROCHEM, V78, P704, DOI 10.1046/j.1471-4159.2001.00411.x; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; Ni Dhuill CM, 1999, J NEUROSCI RES, V55, P99, DOI 10.1002/(SICI)1097-4547(19990101)55:1<99::AID-JNR11>3.0.CO;2-S; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Popov VI, 2004, NEUROSCIENCE, V128, P251, DOI 10.1016/j.neuroscience.2004.06.029; Popov VI, 2008, EUR J NEUROSCI, V27, P301, DOI 10.1111/j.1460-9568.2007.06004.x; Potschka H, 2008, NEUROSCIENCE, V152, P1093, DOI 10.1016/j.neuroscience.2007.09.027; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rizhova L, 2007, NEUROSCIENCE, V149, P931, DOI 10.1016/j.neuroscience.2007.08.008; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Savtchouk I, 2011, J NEUROSCI, V31, P501, DOI 10.1523/JNEUROSCI.2608-10.2011; Schousboe A., 1989, DISSECTION TISSUE CU, P203; Scott R, 2006, J NEUROSCI, V26, P7071, DOI 10.1523/JNEUROSCI.0946-06.2006; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Sorra KE, 1998, J NEUROSCI, V18, P658; Stewart MG, 2005, EUR J NEUROSCI, V21, P3368, DOI 10.1111/j.1460-9568.2005.04174.x; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Vaithianathan T, 2004, J BIOL CHEM, V279, P47975, DOI 10.1074/jbc.M407138200; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Williams JM, 2007, J NEUROSCI, V27, P14171, DOI 10.1523/JNEUROSCI.2348-07.2007; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x	73	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23433	10.1371/journal.pone.0023433	http://dx.doi.org/10.1371/journal.pone.0023433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887252	Green Published, Green Accepted, gold			2022-12-25	WOS:000295832000019
J	Krakauer, DC; Page, K; Flack, J				Krakauer, David C.; Page, Karen; Flack, Jessica			The Immuno-Dynamics of Conflict Intervention in Social Systems	PLOS ONE			English	Article							COOPERATION; PRIMATES; ROBUSTNESS; PUNISHMENT; RESOLUTION; SOCIETIES; EVOLUTION; COST	We present statistical evidence and dynamical models for the management of conflict and a division of labor (task specialization) in a primate society. Two broad intervention strategy classes are observed- a dyadic strategy - pacifying interventions, and a triadic strategy - policing interventions. These strategies, their respective degrees of specialization, and their consequences for conflict dynamics can be captured through empirically-grounded mathematical models inspired by immuno-dynamics. The spread of aggression, analogous to the proliferation of pathogens, is an epidemiological problem. We show analytically and computationally that policing is an efficient strategy as it requires only a small proportion of a population to police to reduce conflict contagion. Policing, but not pacifying, is capable of effectively eliminating conflict. These results suggest that despite implementation differences there might be universal features of conflict management mechanisms for reducing contagion-like dynamics that apply across biological and social levels. Our analyses further suggest that it can be profitable to conceive of conflict management strategies at the behavioral level as mechanisms of social immunity.	[Krakauer, David C.; Flack, Jessica] Santa Fe Inst, Santa Fe, NM 87501 USA; [Page, Karen] UCL, Dept Math, London, England; [Flack, Jessica] Yerkes Natl Primate Res Ctr, Atlanta, GA USA	The Santa Fe Institute; University of London; University College London	Krakauer, DC (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	krakauer@santafe.edu		Page, Karen/0000-0003-4189-4664	National Science Foundation [0904863]; National Institute for Mathematical and Biological Synthesis	National Science Foundation(National Science Foundation (NSF)); National Institute for Mathematical and Biological Synthesis	DK and JF acknowledge support from National Science Foundation grant 0904863 on network conflict theory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KP thanks the National Institute for Mathematical and Biological Synthesis for a sabbatical fellowship during which part of the work was completed.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F., 2000, NATURAL CONFLICT RES; Bergstrom CT, 2006, TRENDS ECOL EVOL, V21, P22, DOI 10.1016/j.tree.2005.11.008; Boehm C., 2010, SOCIAL PSYCHOL POWER; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Buss L., 1987, EVOLUTION INDIVIDUAL; Caldecott J., 1986, CONTRIBUTIONS PRIMAT, V21; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; DeDeo S, 2011, J R SOC INTERFACE, V8, P1260, DOI 10.1098/rsif.2010.0687; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; Durkheim E, 1893, DIVISION LABOR SOC F; El Mouden C, 2010, EVOLUTION, V64, P2139, DOI 10.1111/j.1558-5646.2010.00963.x; Flack JC, 2006, AM NAT, V168, pE87, DOI 10.1086/506526; Flack J.C., 2004, MACAQUE SOC, P157; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Flack JC, 2005, AM NAT, V165, pE126, DOI 10.1086/429277; Flack JC, 2007, P NATL ACAD SCI USA, V104, P1581, DOI 10.1073/pnas.0603565104; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; Frank S, 2009, EVOLUTIONAR IN PRESS; Frank SA, 2003, EVOLUTION, V57, P693; Karzem AJN, 2005, ANIMAL COMMUNICATION; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; Lachmann M, 2001, P NATL ACAD SCI USA, V98, P13189, DOI 10.1073/pnas.231216498; Levin S, 2009, SPRINGER SER GAME TH, P143, DOI 10.1007/978-3-540-85436-4_8; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Michod RE, 2003, PNAS, V103, P9113; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Snolnoki A, 2011, PHYS REV E, V83; Thierry Bernard, 2000, P106; Thiery B, 2004, MACAQUE SOC MODEL ST; Wahl LW, 2002, J THEOR BIOL, V250, P135; Wodarz D, 2000, VIROLOGY, V274, P94, DOI 10.1006/viro.2000.0399; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	41	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22709	10.1371/journal.pone.0022709	http://dx.doi.org/10.1371/journal.pone.0022709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887221	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000004
J	Shang, HQ; Li, Q; Feng, GH; Cui, ZB				Shang, Hanqiao; Li, Qing; Feng, Guohui; Cui, Zongbin			Identification and Characterization of Alternative Promoters, Transcripts and Protein Isoforms of Zebrafish R2 Gene	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE R2; CELL-CYCLE REGULATION; DNA-DAMAGING AGENTS; SMALL-SUBUNIT; MESSENGER-RNA; IN-VITRO; S-PHASE; MAMMALIAN-CELLS; EXPRESSION; P53R2	Ribonucleotide reductase (RNR) is the rate-limiting enzyme in the de novo synthesis of deoxyribonucleoside triphosphates. Expression of RNR subunits is closely associated with DNA replication and repair. Mammalian RNR M2 subunit (R2) functions exclusively in DNA replication of normal cells due to its S phase-specific expression and late mitotic degradation. Herein, we demonstrate the control of R2 expression through alternative promoters, splicing and polyadenylation sites in zebrafish. Three functional R2 promoters were identified to generate six transcript variants with distinct 5' termini. The proximal promoter contains a conserved E2F binding site and two CCAAT boxes, which are crucial for the transcription of R2 gene during cell cycle. Activity of the distal promoter can be induced by DNA damage to generate four transcript variants through alternative splicing. In addition, two novel splice variants were found to encode distinct N-truncated R2 isoforms containing residues for enzymatic activity but no KEN box essential for its proteolysis. These two N-truncated R2 isoforms remained in the cytoplasm and were able to interact with RNR M1 subunit (R1). Thus, our results suggest that multilayered mechanisms control the differential expression and function of zebrafish R2 gene during cell cycle and under genotoxic stress.	[Shang, Hanqiao; Li, Qing; Feng, Guohui; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Shang, Hanqiao; Feng, Guohui] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shang, HQ (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn			National Natural Science Foundation of China [30671602, 30871442]; National Basic Research Program of China [2012CB944500]; National High-tech RD (863) Program [2007AA10Z164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-tech RD (863) Program(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (#30671602 and #30871442 to Z. Cui), the National Basic Research Program of China (#2012CB944500) and the National High-tech R&D (863) Program (#2007AA10Z164 to Z. Cui). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bracchi-Ricard V, 2005, J MOL BIOL, V347, P749, DOI 10.1016/j.jmb.2005.01.051; CARLSON J, 1984, P NATL ACAD SCI-BIOL, V81, P4294, DOI 10.1073/pnas.81.14.4294; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chaboute ME, 1998, PLANT MOL BIOL, V38, P797, DOI 10.1023/A:1006083318906; Chaboute ME, 2000, PLANT CELL, V12, P1987, DOI 10.1105/tpc.12.10.1987; Chaboute ME, 2002, J BIOL CHEM, V277, P17845, DOI 10.1074/jbc.M200959200; Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105; Chen YP, 2005, EXP PARASITOL, V111, P250, DOI 10.1016/j.exppara.2005.08.001; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; DeGregori J, 2006, CURR MOL MED, V6, P739; Domkin V, 2002, J BIOL CHEM, V277, P18574, DOI 10.1074/jbc.M201553200; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1989, MOL CELL BIOL, V9, P5373, DOI 10.1128/MCB.9.12.5373; FILATOV D, 1995, J BIOL CHEM, V270, P25239, DOI 10.1074/jbc.270.42.25239; Fu Y, 2008, FEMS MICROBIOL REV, V32, P908, DOI 10.1111/j.1574-6976.2008.00126.x; Gammon DB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000984; Gaudet P, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.2.e5; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hakansson P, 2006, J BIOL CHEM, V281, P1778, DOI 10.1074/jbc.M511716200; Harris P, 1996, MOL GEN GENET, V252, P284; Hartmann B, 2009, CURR OPIN CELL BIOL, V21, P377, DOI 10.1016/j.ceb.2009.02.006; Herbst A, 2000, MOL BIOL REP, V27, P203, DOI 10.1023/A:1011008018565; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; IMBRA RJ, 1987, MOL CELL BIOL, V7, P1358, DOI 10.1128/MCB.7.4.1358; Jayachandran G, 2004, INSECT MOL BIOL, V13, P231, DOI 10.1111/j.0962-1075.2004.00480.x; Kauppi B, 1996, J MOL BIOL, V262, P706, DOI 10.1006/jmbi.1996.0546; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Kotova I, 2001, EUR J BIOCHEM, V268, P4527, DOI 10.1046/j.1432-1327.2001.02378.x; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Lincker F, 2004, NUCLEIC ACIDS RES, V32, P1430, DOI 10.1093/nar/gkh310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mathews CZ, 1996, MOL MAR BIOL BIOTECH, V5, P284; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Mo SJ, 2010, DEV BIOL, V344, P210, DOI 10.1016/j.ydbio.2010.04.033; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nestoras K, 2010, GENE DEV, V24, P1145, DOI 10.1101/gad.561910; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Park JB, 2000, BIOCHEM BIOPH RES CO, V267, P651, DOI 10.1006/bbrc.1999.1980; PARKER NJ, 1991, NUCLEIC ACIDS RES, V19, P3741, DOI 10.1093/nar/19.13.3741; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Roa H, 2009, PLANT PHYSIOL, V151, P461, DOI 10.1104/pp.109.140053; Rova U, 1999, J BIOL CHEM, V274, P23746, DOI 10.1074/jbc.274.34.23746; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; SEPPLORENZINO L, 1991, EUR J BIOCHEM, V200, P579, DOI 10.1111/j.1432-1033.1991.tb16221.x; Shang H, 2010, GENE; Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048; Sommerhalter M, 2004, BIOCHEMISTRY-US, V43, P7736, DOI 10.1021/bi049510m; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; STANDART N, 1990, GENE DEV, V4, P2157, DOI 10.1101/gad.4.12a.2157; Stern HM, 2003, NAT REV CANCER, V3, P533, DOI 10.1038/nrc1126; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Tyagi R, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-2; Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wang X, 2009, CANCER LETT, V276, P1, DOI 10.1016/j.canlet.2008.07.019; Wu CM, 2009, BIOCHEM BIOPH RES CO, V386, P140, DOI 10.1016/j.bbrc.2009.05.138; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhao HC, 2000, CANCER RES, V60, P6276; Zhou BS, 2003, CANCER RES, V63, P6583	74	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24089	10.1371/journal.pone.0024089	http://dx.doi.org/10.1371/journal.pone.0024089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887375	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000093
J	Dhurandhar, EJ; Dubuisson, O; Mashtalir, N; Krishnapuram, R; Hegde, V; Dhurandhar, NV				Dhurandhar, Emily J.; Dubuisson, Olga; Mashtalir, Nazar; Krishnapuram, Rashmi; Hegde, Vijay; Dhurandhar, Nikhil V.			E4orf1: A Novel Ligand That Improves Glucose Disposal in Cell Culture	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HUMAN ADENOVIRUS TYPE-36; INSULIN-RESISTANCE; PHOSPHATIDYLINOSITOL 3-KINASE; GLYCOGEN-SYNTHESIS; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; PI 3-KINASE; RAS; ADIPONECTIN	Reducing dietary fat intake and excess adiposity, the cornerstones of behavioral treatment of insulin resistance(IR), are marginally successful over the long term. Ad36, a human adenovirus, offers a template to improve IR, independent of dietary fat intake or adiposity. Ad36 increases cellular glucose uptake via a Ras-mediated activation of phosphatidyl inositol 3-kinase(PI3K), and improves hyperglycemia in mice, despite a high-fat diet and without reducing adiposity. Ex-vivo studies suggest that Ad36 improves hyperglycemia in mice by increasing glucose uptake by adipose tissue and skeletal muscle, and by reducing hepatic glucose output. It is impractical to use Ad36 for therapeutic action. Instead, we investigated if the E4orf1 protein of Ad36, mediates its anti-hyperglycemic action. Such a candidate protein may offer an attractive template for therapeutic development. Experiment-1 determined that Ad36 'requires' E4orf1 protein to up-regulate cellular glucose uptake. Ad36 significantly increased glucose uptake in 3T3-L1 preadipocytes, which was abrogated by knocking down E4orf1 with siRNA. Experiment-2 identified E4orf1 as 'sufficient' to up-regulate glucose uptake. 3T3-L1 cells that inducibly express E4orf1, increased glucose uptake in an induction-dependent manner, compared to null vector control cells. E4orf1 up-regulated PI3K pathway and increased abundance of Ras-the obligatory molecule in Ad36-induced glucose uptake. Experiment-3: Signaling studies of cells transiently transfected with E4orf1 or a null vector, revealed that E4orf1 may activate Ras/PI3K pathway by binding to Drosophila discs-large(Dlg1) protein. E4orf1 activated total Ras and, particularly the H-Ras isoform. By mutating the PDZ domain binding motif(PBM) of E4orf1, Experiment-4 showed that E4orf1 requires its PBM to increase Ras activation or glucose uptake. Experiment-5: In-vitro, a transient transfection by E4orf1 significantly increased glucose uptake in preadipocytes, adipocytes, or myoblasts, and reduced glucose output by hepatocytes. Thus, the highly attractive anti-hyperglycemic effect of Ad36 is mirrored by E4orf1 protein, which may offer a novel ligand to develop anti-hyperglycemic drugs.	[Dhurandhar, Emily J.; Dubuisson, Olga; Mashtalir, Nazar; Krishnapuram, Rashmi; Hegde, Vijay; Dhurandhar, Nikhil V.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dhurandhar, EJ (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA USA.	Nikhil.Dhurandhar@PBRC.edu			National Institutes of Health [R-01 DK066164]; Mathile Institute for the Advancement of Human Nutrition; COBRE (NIH) [P20-RR021945]; NORC (NIH) [1P30-DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066164, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathile Institute for the Advancement of Human Nutrition; COBRE (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by grants by the National Institutes of Health (R-01 DK066164) and by The Mathile Institute for the Advancement of Human Nutrition, awarded to NVD. This work used Genomics core facilities at the Pennington Biomedical Research Center, which are supported in part by COBRE (NIH P20-RR021945) and NORC (NIH 1P30-DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson R. L, 2009, INT J PEDIATR OBES, P1, DOI DOI 10.1080/17477160903111789; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Crompton AM, 2007, CURR CANCER DRUG TAR, V7, P133; Dhurandhar NV, 2001, INT J OBESITY, V25, P990, DOI 10.1038/sj.ijo.0801668; Dhurandhar NV, 2002, J NUTR, V132, P3155, DOI 10.1093/jn/131.10.3155; Dhurandhar NV, 2000, INT J OBESITY, V24, P989, DOI 10.1038/sj.ijo.0801319; Dorrestijn J, 1996, DIABETOLOGIA, V39, P558, DOI 10.1007/s001250050478; Dorrestijn J, 1997, EXP CLIN ENDOCR DIAB, V105, P254, DOI 10.1055/s-0029-1211762; Frese KK, 2006, EMBO J, V25, P1406, DOI 10.1038/sj.emboj.7601030; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; Gabbert C, 2010, PEDIATRICS, V126, P721, DOI 10.1542/peds.2009-3362; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21391; Heiker JT, 2010, BIOL CHEM, V391, P1005, DOI 10.1515/BC.2010.104; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Houseknecht KL, 1996, J BIOL CHEM, V271, P11347, DOI 10.1074/jbc.271.19.11347; Katagiri H, 1997, AM J PHYSIOL-ENDOC M, V272, pE326, DOI 10.1152/ajpendo.1997.272.2.E326; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; KRISHNAPURAM R, AM J PHYSL ENDOCRINO; Libertini S, 2007, ENDOCRINOLOGY, V148, P5186, DOI 10.1210/en.2007-0752; Lin E, 2007, DIABETES, V56, P735, DOI 10.2337/db06-1161; Na HN, 2010, INT J OBESITY, V34, P89, DOI 10.1038/ijo.2009.207; Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170; Pan Q, 2007, MOL CELL BIOCHEM, V304, P315, DOI 10.1007/s11010-007-9514-6; Pasarica M, 2008, ARCH VIROL, V153, P2097, DOI 10.1007/s00705-008-0219-2; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Semple RK, 2008, DIABETES CARE, V31, P977, DOI 10.2337/dc07-2194; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Sesti G, 2001, DIABETES-METAB RES, V17, P363, DOI 10.1002/dmrr.225; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Trovato GM, 2009, INT J OBESITY, V33, P1402, DOI 10.1038/ijo.2009.196; Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313	46	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23394	10.1371/journal.pone.0023394	http://dx.doi.org/10.1371/journal.pone.0023394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886789	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500014
J	Park, JH; Magan, N				Park, Jeong Hyeon; Magan, Natisha			Reverse Transcriptase-Coupled Quantitative Real Time PCR Analysis of Cell-Free Transcription on the Chromatin-Assembled p21 Promoter	PLOS ONE			English	Article							RNA-POLYMERASE-II; IN-VITRO; P53; ACTIVATION; DROSOPHILA; INITIATION; BINDING; SYSTEM	Background: Cell-free eukaryotic transcription assays have contributed tremendously to the current understanding of the molecular mechanisms that govern transcription at eukaryotic promoters. Currently, the conventional G-less cassette transcription assay is one of the simplest and fastest methods for measuring transcription in vitro. This method requires several components, including the radioisotope labelling of RNA product during the transcription reaction followed by visualization of transcripts using autoradiography. Methodology/Principal Findings: To further simplify and expedite the conventional G-less cassette transcription assay, we have developed a method to incorporate a reverse transcriptase-coupled quantitative real time PCR (RT-qPCR). By using DNA template depletion steps that include DNA template immobilization, Trizol extraction and DNase I treatment, we have successfully enriched p21 promoter-driven transcripts over DNA templates. The quantification results of RNA transcripts using the RT-qPCR assay were comparable to the results of the conventional G-less cassette transcription assay both in naked DNA and chromatin-assembled templates. Conclusions: We first report a proof-of-concept demonstration that incorporating RT-qPCR in cell-free transcription assays can be a simpler and faster alternative method to the conventional radioisotope-mediated transcription assays. This method will be useful for developing high throughput in vitro transcription assays and provide quantitative data for RNA transcripts generated in a defined cell-free transcription reaction.	[Park, Jeong Hyeon; Magan, Natisha] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Park, JH (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	J.Park@massey.ac.nz		Park, Jeong Hyeon/0000-0003-2294-6342	Massey University	Massey University	This work was supported by 2011 Massey University Research Fund to JHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; BULGER M, 1995, P NATL ACAD SCI USA, V92, P11726, DOI 10.1073/pnas.92.25.11726; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; CAREY MF, 2010, COLD SPRING HARB PRO; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Guermah M, 2009, METHODS, V48, P353, DOI 10.1016/j.ymeth.2009.02.022; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; WEIL PA, 1979, CELL, V18, P469	16	5	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23617	10.1371/journal.pone.0023617	http://dx.doi.org/10.1371/journal.pone.0023617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886803	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500019
J	Ramos-Sevillano, E; Moscoso, M; Garcia, P; Garcia, E; Yuste, J				Ramos-Sevillano, Elisa; Moscoso, Miriam; Garcia, Pedro; Garcia, Ernesto; Yuste, Jose			Nasopharyngeal Colonization and Invasive Disease Are Enhanced by the Cell Wall Hydrolases LytB and LytC of Streptococcus pneumoniae	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; IMPAIRED OPSONIZATION; VIRULENCE FACTORS; GENOME SEQUENCE; COMPLEMENT; PEPTIDOGLYCAN; CHOLINE; PHAGOCYTOSIS; AUTOLYSIN; BINDING	Background\ Streptococcus pneumoniae is a common colonizer of the human nasopharynx and one of the major pathogens causing invasive disease worldwide. Dissection of the molecular pathways responsible for colonization, invasion, and evasion of the immune system will provide new targets for antimicrobial or vaccine therapies for this common pathogen. Methodology/Principal Findings: We have constructed mutants lacking the pneumococcal cell wall hydrolases (CWHs) LytB and LytC to investigate the role of these proteins in different phases of the pneumococcal pathogenesis. Our results show that LytB and LytC are involved in the attachment of S. pneumoniae to human nasopharyngeal cells both in vitro and in vivo. The interaction of both proteins with phagocytic cells demonstrated that LytB and LytC act in concert avoiding pneumococcal phagocytosis mediated by neutrophils and alveolar macrophages. Furthermore, C3b deposition was increased on the lytC mutant confirming that LytC is involved in complement evasion. As a result, the lytC mutant showed a reduced ability to successfully cause pneumococcal pneumonia and sepsis. Bacterial mutants lacking both LytB and LytC showed a dramatically impaired attachment to nasopharyngeal cells as well as a marked degree of attenuation in a mouse model of colonization. In addition, C3b deposition and phagocytosis was more efficient for the double lytB lytC mutant and its virulence was greatly impaired in both systemic and pulmonary models of infection. Conclusions/Significance: This study confirms that the CWHs LytB and LytC of S. pneumoniae are essential virulence factors involved in the colonization of the nasopharynx and in the progress of invasive disease by avoiding host immunity.	[Ramos-Sevillano, Elisa] CSIC, Ctr Invest Biol, Madrid, Spain; CIBER Enfermed Respiratorias CIBERES, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ramos-Sevillano, E (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	jyuste@isciii.es	Sevillano, Elisa Ramos/J-4824-2016; YUSTE, JOSE/ABG-9851-2020; García, Pedro/L-2808-2017	Sevillano, Elisa Ramos/0000-0003-0803-2755; García, Pedro/0000-0001-6717-8717; Moscoso, Miriam/0000-0001-8977-3269; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; YUSTE, JOSE/0000-0001-7996-0837	Direccion General de Investigacion Cientifica y Tecnica [SAF2009-10824]; Ministerio de Ciencia e Innovacion	Direccion General de Investigacion Cientifica y Tecnica(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Partial support for these investigations was provided by grant SAF2009-10824 from Direccion General de Investigacion Cientifica y Tecnica. Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES) is an initiative of the ISCIII. E.R-S. was supported by an FPU fellowship from the Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; AUSTRIAN R, 1953, J EXP MED, V98, P21, DOI 10.1084/jem.98.1.21; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Cabanes D, 2004, MOL MICROBIOL, V51, P1601, DOI 10.1111/j.1365-2958.2003.03945.x; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; De las Rivas B, 2002, J BACTERIOL, V184, P4988, DOI 10.1128/JB.184.18.4988-5000.2002; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Fleck RA, 2005, CLIN DIAGN LAB IMMUN, V12, P19, DOI 10.1128/CDLI.12.1.19-27.2005; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Garcia P, 1999, MOL MICROBIOL, V31, P1275, DOI 10.1046/j.1365-2958.1999.01238.x; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.t01-1-03106.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Hendriksen WT, 2008, INFECT IMMUN, V76, P1230, DOI 10.1128/IAI.01004-07; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kharat AS, 2006, MOL MICROBIOL, V60, P93, DOI 10.1111/j.1365-2958.2006.05082.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Marti-Lliteras P, 2009, INFECT IMMUN, V77, P4232, DOI 10.1128/IAI.00305-09; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Moscoso M, 2005, APPL ENVIRON MICROB, V71, P8706, DOI 10.1128/AEM.71.12.8706-8713.2005; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Moscoso M, 2009, INT MICROBIOL, V12, P77, DOI 10.2436/20.1501.01.84; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Quin LR, 2007, INFECT IMMUN, V75, P4082, DOI 10.1128/IAI.00474-07; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Stegenga ME, 2009, CRIT CARE MED, V37, P614, DOI 10.1097/CCM.0b013e31819599b6; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang LR, 2008, MICROBIOL-SGM, V154, P1900, DOI 10.1099/mic.0.2007/015172-0; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08; Yuste J, 2010, MICROBES INFECT, V12, P626, DOI 10.1016/j.micinf.2010.04.004; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09	50	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23626	10.1371/journal.pone.0023626	http://dx.doi.org/10.1371/journal.pone.0023626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886805	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500021
J	Wu, D; Li, GX; Qin, CF; Ren, XF				Wu, Dan; Li, Guangxing; Qin, Chengfeng; Ren, Xiaofeng			Phage Displayed Peptides to Avian H5N1 Virus Distinguished the Virus from Other Viruses	PLOS ONE			English	Article							INFLUENZA-VIRUS; LIBRARY; ANTIBODY; ASSAY	The purpose of the current study was to identify potential ligands and develop a novel diagnostic test to highly pathogenic avian influenza A virus (HPAI), subtype H5N1 viruses using phage display technology. The H5N1 viruses were used as an immobilized target in a biopanning process using a 12-mer phage display random peptide library. After five rounds of panning, three phages expressing peptides HAWDPIPARDPF, AAWHLIVALAPN or ATSHLHVRLPSK had a specific binding activity to H5N1 viruses were isolated. Putative binding motifs to H5N1 viruses were identified by DNA sequencing. In terms of the minimum quantity of viruses, the phage-based ELISA was better than antiserum-based ELISA and a manual, semi-quantitative endpoint RT-PCR for detecting H5N1 viruses. More importantly, the selected phages bearing the specific peptides to H5N1 viruses were capable of differentiating this virus from other avian viruses in enzyme-linked immunosorbent assays.	[Wu, Dan; Ren, Xiaofeng] NE Agr Univ, Dept Vet Prevent Med, Coll Vet Med, Harbin, Peoples R China; [Li, Guangxing] NE Agr Univ, Dept Basic Vet Med, Coll Vet Med, Harbin, Peoples R China; [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Northeast Agricultural University - China; Northeast Agricultural University - China; Beijing Institute of Microbiology & Epidemiology	Wu, D (corresponding author), NE Agr Univ, Dept Vet Prevent Med, Coll Vet Med, Harbin, Peoples R China.	rxfemail@yahoo.com.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807	National 973 Plan of China [2010CB534002]; National Natural Science Foundation of China [30972195]; Heilongjiang Provincial University [1155-NCET-005]; Heilongjiang Provincial Science and Technology Department, China [ZJN0702-01]	National 973 Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Provincial University; Heilongjiang Provincial Science and Technology Department, China	This work was supported, in part, by the National 973 Plan of China (2010CB534002). We also acknowledge National Natural Science Foundation of China (30972195), the Program for New Century Excellent Talents in Heilongjiang Provincial University (1155-NCET-005) and Heilongjiang Provincial Science and Technology Department, China (ZJN0702-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN H, 2008, CHIN ANIMAL HUSBANDR, V35, P120; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Fouchier R, 2005, NATURE, V435, P419, DOI 10.1038/435419a; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Guo JianShun, 2004, Chinese Journal of Veterinary Science, V24, P534; Hayden MS, 1997, CURR OPIN IMMUNOL, V9, P201, DOI 10.1016/S0952-7915(97)80136-7; Kang SK, 2008, J BIOTECHNOL, V135, P210, DOI 10.1016/j.jbiotec.2008.01.021; Kang XP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-113; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Latzka J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019383; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YinJu, 2008, Chinese Journal of Veterinary Science, V28, P511; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019848; Matsubara T, 2009, J MED CHEM, V52, P4247, DOI 10.1021/jm801570y; Ren XF, 2011, VIROLOGY, V410, P299, DOI 10.1016/j.virol.2010.11.014; Ren XF, 2010, J CLIN MICROBIOL, V48, P1875, DOI 10.1128/JCM.01707-09; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; WANG J, 2011, CHIN ANIMAL HUSBANDR, V38, P178; WANG Q, 2011, HUNAN ANIMAL SCI VET, V1, P20; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, EP PAND AL RESP EPR; Yingst SL, 2006, EMERG INFECT DIS, V12, P1295, DOI 10.3201/eid1708.060264; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; ZENG Q, 2010, HUNAN ANIMAL SCI VET, V1, P3; Zhao JQ, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-74	28	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23058	10.1371/journal.pone.0023058	http://dx.doi.org/10.1371/journal.pone.0023058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887228	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800007
J	Hamer, GL; Chaves, LF; Anderson, TK; Kitron, UD; Brawn, JD; Ruiz, MO; Loss, SR; Walker, ED; Goldberg, TL				Hamer, Gabriel L.; Chaves, Luis F.; Anderson, Tavis K.; Kitron, Uriel D.; Brawn, Jeffrey D.; Ruiz, Marilyn O.; Loss, Scott R.; Walker, Edward D.; Goldberg, Tony L.			Fine-Scale Variation in Vector Host Use and Force of Infection Drive Localized Patterns of West Nile Virus Transmission	PLOS ONE			English	Article							POPULATION-DYNAMICS; ECOLOGICAL TRAPS; MOSQUITO; DISEASE; BIODIVERSITY; DIVERSITY; DESIGN; PREVALENCE; RESERVOIRS; CULICIDAE	The influence of host diversity on multi-host pathogen transmission and persistence can be confounded by the large number of species and biological interactions that can characterize many transmission systems. For vector-borne pathogens, the composition of host communities has been hypothesized to affect transmission; however, the specific characteristics of host communities that affect transmission remain largely unknown. We tested the hypothesis that vector host use and force of infection (i.e., the summed number of infectious mosquitoes resulting from feeding upon each vertebrate host within a community of hosts), and not simply host diversity or richness, determine local infection rates of West Nile virus (WNV) in mosquito vectors. In suburban Chicago, Illinois, USA, we estimated community force of infection for West Nile virus using data on Culex pipiens mosquito host selection and WNV vertebrate reservoir competence for each host species in multiple residential and semi-natural study sites. We found host community force of infection interacted with avian diversity to influence WNV infection in Culex mosquitoes across the study area. Two avian species, the American robin (Turdus migratorius) and the house sparrow (Passer domesticus), produced 95.8% of the infectious Cx. pipiens mosquitoes and showed a significant positive association with WNV infection in Culex spp. mosquitoes. Therefore, indices of community structure, such as species diversity or richness, may not be reliable indicators of transmission risk at fine spatial scales in vector-borne disease systems. Rather, robust assessment of local transmission risk should incorporate heterogeneity in vector host feeding and variation in vertebrate reservoir competence at the spatial scale of vector-host interaction.	[Hamer, Gabriel L.; Anderson, Tavis K.; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Chaves, Luis F.; Kitron, Uriel D.] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; [Chaves, Luis F.] Univ Nacl, Programa Invest Enfermedades Trop, Escuela Med Vet, Heredia, Costa Rica; [Chaves, Luis F.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Chaves, Luis F.] Hokkaido Univ, Global Ctr Excellence Program Integrated Field &, Sapporo, Hokkaido, Japan; [Brawn, Jeffrey D.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Ruiz, Marilyn O.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Loss, Scott R.] Univ Minnesota, St Paul, MN 55108 USA; [Hamer, Gabriel L.; Walker, Edward D.] Michigan State Univ, Dept Microbiol & Mol Genet, Lansing, MI USA	University of Wisconsin System; University of Wisconsin Madison; Emory University; Universidad Nacional Costa Rica; Hokkaido University; Hokkaido University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Michigan State University	Hamer, GL (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	ghamer@msu.edu	Loss, Scott R/B-1504-2014; Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Kitron, Uriel/0000-0003-0493-2043; Loss, Scott/0000-0002-8753-2995; Anderson, Tavis/0000-0002-3138-5535	National Science Foundation [EF-0840403]; Michigan Agricultural Experiment Station; Agricultural Research Service [NE-507]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [10F00392] Funding Source: KAKEN	National Science Foundation(National Science Foundation (NSF)); Michigan Agricultural Experiment Station; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by the National Science Foundation Ecology of Infectious Diseases Program, award no. EF-0840403, and the Michigan Agricultural Experiment Station and the Agricultural Research Service, multi-state project NE-507. LFC is funded by Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; ANDERSON R M, 1991; Anderson RA, 1999, ECOL LETT, V2, P98, DOI 10.1046/j.1461-0248.1999.22055.x; Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Begon Michael, 2008, P12; Biggerstaff B.J., 2006, POOLEDINFRATE VERSIO; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Burnham KP, 2002, MULTIMODEL INFERENCE; Celli A, 1933, HIST MALARIA ROMAN C; Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003; Chaves LF, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00088.1; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; CORBET PS, 1966, ARCTIC, V19, P153; Darbro JM, 2007, AM J TROP MED HYG, V77, P488, DOI 10.4269/ajtmh.2007.77.488; Darbro JM, 2007, BEHAV ECOL, V18, P750, DOI 10.1093/beheco/arm043; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Eisen L, 2007, EMERG INFECT DIS, V13, P1816, DOI 10.3201/eid1312.070211; Ezenwa VO, 2007, VECTOR-BORNE ZOONOT, V7, P173, DOI 10.1089/vbz.2006.0584; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; Griffing SM, 2007, VECTOR-BORNE ZOONOT, V7, P437, DOI 10.1089/vbz.2006.0560; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Koenig WD, 2010, OECOLOGIA, V163, P903, DOI 10.1007/s00442-010-1627-z; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Loss SR, 2009, OECOLOGIA, V159, P415, DOI 10.1007/s00442-008-1224-6; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manly B.F.J., 2002, RESOURCE SELECTION A; McKenzie VJ, 2010, ECOHEALTH, V7, P439, DOI 10.1007/s10393-010-0360-8; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Platt KB, 2008, VECTOR-BORNE ZOONOT, V8, P225, DOI 10.1089/vbz.2007.0182; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; R Core Team, 2022, R LANG ENV STAT COMP; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; SERVICE MW, 1991, REV SAUDE PUBL, V25, P165, DOI 10.1590/S0034-89101991000300002; Simpson JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007861; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	57	97	100	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23767	10.1371/journal.pone.0023767	http://dx.doi.org/10.1371/journal.pone.0023767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886821	Green Published, gold, Green Submitted			2022-12-25	WOS:000294128100030
J	Santini, V; Girelli, D; Sanna, A; Martinelli, N; Duca, L; Campostrini, N; Cortelezzi, A; Corbella, M; Bosi, A; Reda, G; Olivieri, O; Cappellini, MD				Santini, Valeria; Girelli, Domenico; Sanna, Alessandro; Martinelli, Nicola; Duca, Lorena; Campostrini, Natascia; Cortelezzi, Agostino; Corbella, Michela; Bosi, Alberto; Reda, Gianluigi; Olivieri, Oliviero; Cappellini, Maria Domenica			Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes	PLOS ONE			English	Article							IRON OVERLOAD; URINARY; QUANTIFICATION; CLASSIFICATION; INFLAMMATION; EXPRESSION; EXCRETION; CRITERIA; ANEMIA; HEART	Iron overload may represent an additional clinical problem in patients with Myelodysplastic Syndromes (MDS), with recent data suggesting prognostic implications. Beyond red blood cells transfusions, dysregulation of hepcidin, the key iron hormone, may play a role, but studies until now have been hampered by technical problems. Using a recently validated assay, we measured serum hepcidin in 113 patients with different MDS subtypes. Mean hepcidin levels were consistently heterogeneous across different MDS subtypes, with the lowest levels in refractory anemia with ringed sideroblasts (RARS, 1.43 nM) and the highest in refractory anemia with excess blasts (RAEB, 11.3 nM) or in chronic myelomonocytic leukemia (CMML, 10.04 nM) (P = 0.003 by ANOVA). MDS subtypes remained significant predictors of hepcidin in multivariate analyses adjusted for ferritin and transfusion history. Consistently with current knowledge on hepcidin action/regulation, RARS patients had the highest levels of toxic non-transferrin-bound-iron, while RAEB and CMML patients had substantial elevation of C-Reactive Protein as compared to other MDS subtypes, and showed lost of homeostatic regulation by iron. Growth differentiation factor 15 did not appear as a primary hepcidin regulator in this series. If confirmed, these results may help to calibrate future treatments with chelating agents and/or hepcidin modulators in MDS patients.	[Santini, Valeria; Sanna, Alessandro; Bosi, Alberto] Univ Florence, Hematol Unit, AOU Careggi, Florence, Italy; [Girelli, Domenico; Martinelli, Nicola; Campostrini, Natascia; Corbella, Michela; Olivieri, Oliviero] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy; [Duca, Lorena; Cappellini, Maria Domenica] Univ Milan, Dept Internal Med, Ca Granda Fdn IRCCS, Milan, Italy; [Cortelezzi, Agostino; Reda, Gianluigi] Univ Milan, Hematol Unit 1, Ca Granda Fdn IRCCS, Milan, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Santini, V (corresponding author), Univ Florence, Hematol Unit, AOU Careggi, Florence, Italy.	domenico.girelli@univr.it	Nava, Isabella/AAA-7747-2020; Duca, Lorena/AAV-5773-2021; SANTINI, VALERIA/AAL-3135-2020; Martinelli, Nicola/J-5622-2016; CAPPELLINI, MARIA DOMENICA/B-4475-2017; Reda, Gianluigi/J-8127-2015	Nava, Isabella/0000-0003-4106-0088; SANTINI, VALERIA/0000-0002-5439-2172; GIRELLI, Domenico/0000-0001-9684-1899; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Martinelli, Nicola/0000-0001-6465-5119; olivieri, oliviero/0000-0001-8209-9056; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864; Duca, Lorena/0000-0002-2008-3187; BOSI, ALBERTO/0000-0002-5486-4838; Reda, Gianluigi/0000-0003-4687-7089	Telethon Foundation (Rome, Italy) [GGP06213]; Cariverona Foundation (Verona, Italy)	Telethon Foundation (Rome, Italy)(Fondazione Telethon); Cariverona Foundation (Verona, Italy)(Fondazione Cariverona)	This work was supported by Telethon Foundation (Rome, Italy) Grants GGP06213 and the Cariverona Foundation (Verona, Italy) to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand P, 2011, BIOL BLOOD MARROW TR, V17, P852, DOI 10.1016/j.bbmt.2010.09.006; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Bennett JM, 2008, AM J HEMATOL, V83, P858, DOI 10.1002/ajh.21269; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bozzini C, 2008, BLOOD CELL MOL DIS, V40, P347, DOI 10.1016/j.bcmd.2007.10.001; Breda L, 2007, BLOOD, V110, p225B, DOI 10.1182/blood.V110.11.4612.4612; BUJA LM, 1971, AM J MED, V51, P209, DOI 10.1016/0002-9343(71)90240-3; Campostrini N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/329646; Castagna A, 2010, J PROTEOMICS, V73, P527, DOI 10.1016/j.jprot.2009.08.003; Cazzola Mario, 2008, Hematology Am Soc Hematol Educ Program, P166, DOI 10.1182/asheducation-2008.1.166; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cortelezzi A, 2000, Hematol J, V1, P153, DOI 10.1038/sj.thj.6200028; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fenaux P, 2009, BLOOD REV, V23, pS15, DOI 10.1016/S0268-960X(09)70005-0; FINCH CA, 1982, NEW ENGL J MED, V306, P1520, DOI 10.1056/NEJM198206243062504; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gattermann N, 2007, LEUKEMIA RES, V31, pS10, DOI 10.1016/S0145-2126(07)70461-7; Girelli D, 2010, HAEMATOLOGICA, V96, P500, DOI DOI 10.3324/HAEMAT0L.2010.033449.EPUB; Gosriwatana I, 1999, ANAL BIOCHEM, V273, P212, DOI 10.1006/abio.1999.4216; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kempf T, 2009, CIRC-CARDIOVASC GENE, V2, P286, DOI 10.1161/CIRCGENETICS.108.824870; Kroot JJC, 2009, HAEMATOL-HEMATOL J, V94, P1748, DOI 10.3324/haematol.2009.010322; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Malcovati L, 2006, HAEMATOLOGICA, V91, P1588; Mariani R, 2008, BRIT J HAEMATOL, V143, DOI 10.1111/j.1365-2141.2008.07397.x; Murphy PT, 2009, BRIT J HAEMATOL, V144, P451, DOI 10.1111/j.1365-2141.2008.07455.x; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, HAEMATOLOGICA, V91, P727; Piperno A, 1998, HAEMATOLOGICA, V83, P447; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Porter JB, 2005, ANN NY ACAD SCI, V1054, P155, DOI 10.1196/annals.1345.018; Pullarkat V, 2009, BLOOD, V114, P5251, DOI 10.1182/blood-2009-07-234062; Ramirez JM, 2009, BRIT J HAEMATOL, V144, P251, DOI 10.1111/j.1365-2141.2008.07441.x; Rose C, 2010, LEUKEMIA RES, V34, P864, DOI 10.1016/j.leukres.2009.12.004; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; TRAGLIA M, 2011, J MED GENET IN PRESS; Valenti L, 2009, CLIN J AM SOC NEPHRO, V4, P1331, DOI 10.2215/CJN.01370209; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Winder A, 2008, BRIT J HAEMATOL, V142, P669, DOI 10.1111/j.1365-2141.2008.07225.x; Zaidi SHE, 2010, J AM COLL CARDIOL, V55, P135, DOI 10.1016/j.jacc.2009.08.041	49	82	115	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23109	10.1371/journal.pone.0023109	http://dx.doi.org/10.1371/journal.pone.0023109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886780	Green Published, gold, Green Submitted			2022-12-25	WOS:000294128100007
J	Villarreal-Silva, M; Centeno-Cruz, F; Suarez-Sanchez, R; Garrido, E; Cisneros, B				Villarreal-Silva, Marcela; Centeno-Cruz, Federico; Suarez-Sanchez, Rocio; Garrido, Efrain; Cisneros, Bulmaro			Knockdown of Dystrophin Dp71 Impairs PC12 Cells Cycle: Localization in the Spindle and Cytokinesis Structures Implies a Role for Dp71 in Cell Division	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; NUCLEAR-ENVELOPE; DEPENDENT TRANSCRIPTION; PHEOCHROMOCYTOMA CELLS; NONMUSCLE TISSUES; SKELETAL-MUSCLE; MAJOR PRODUCT; LAMIN-A; GENE; DUCHENNE	The function of dystrophin Dp71 in neuronal cells remains to be established. Previously, we revealed the involvement of this protein in both nerve growth factor (NGF)-induced neuronal differentiation and cell adhesion by isolation and characterization of PC12 neuronal cells with depleted levels of Dp71. In this work, a novel phenotype of Dp71-knockdown cells was characterized, which is their delayed growth rate. Cell cycle analyses revealed an altered behavior of Dp71-depleted cells, which consists of a delay in G0/G1 transition and an increase in apoptosis during nocodazole-induced mitotic arrest. Dp71 associates with lamin B1 and beta-dystroglycan, proteins involved in aspects of the cell division cycle; therefore, we compared the distribution of Dp71 with that of lamin B1 and beta-dystroglycan in PC12 cells at mitosis and cytokinesis by means of immunofluorescence and confocal microscopy analysis. All of these three proteins exhibited a similar immunostaining pattern, localized at mitotic spindle, cleavage furrow, and midbody. It is noteworthy that a drastic decreased staining in mitotic spindle, cleavage furrow, and midbody was observed for both lamin B1 and beta-dystroglycan in Dp71-depleted cells. Furthermore, we demonstrated the interaction of Dp71 with lamin B1 in PC12 cells by immunoprecipitation and pull-down assays, and importantly, we revealed that knockdown of Dp71 expression caused a marked reduction in lamin B1 levels and altered localization of the nuclear envelope protein emerin. Our data indicate that Dp71 is a component of the mitotic spindle and cytokinesis multi-protein apparatuses that might modulate the cell division cycle by affecting lamin B1 and beta-dystroglycan levels.	[Villarreal-Silva, Marcela; Centeno-Cruz, Federico; Suarez-Sanchez, Rocio; Garrido, Efrain; Cisneros, Bulmaro] Ctr Invest & Estudios Avanzados IPN CINVESTAV IPN, Dept Genet & Mol Biol, Mexico City, DF, Mexico; [Centeno-Cruz, Federico] Inst Nacl Med Genom, Lab Enfermedades Complejas, Mexico City, DF, Mexico; [Suarez-Sanchez, Rocio] Inst Nacl Rehabil, Dept Genet, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Medicina Genomica	Villarreal-Silva, M (corresponding author), Ctr Invest & Estudios Avanzados IPN CINVESTAV IPN, Dept Genet & Mol Biol, Mexico City, DF, Mexico.	bcisnero@cinvestav.mx		Centeno Cruz, Federico/0000-0002-3512-4519	CONACYT-Mexico [54858, 183964]	CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACYT-Mexico, grant 54858 (to Dr. Cisneros) and grant 183964 for PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta R, 2004, EXP CELL RES, V296, P265, DOI 10.1016/j.yexcr.2004.01.015; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blake DJ, 1999, J CELL BIOL, V147, P645, DOI 10.1083/jcb.147.3.645; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cerna J, 2006, J MOL BIOL, V362, P954, DOI 10.1016/j.jmb.2006.07.075; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; DIAZBARRIGA F, 1989, TOXICOL IN VITRO, V3, P277, DOI 10.1016/0887-2333(89)90034-9; Eaton MJ, 2004, MOL CELL ENDOCRINOL, V228, P39, DOI 10.1016/j.mce.2003.02.001; Endo K, 2010, FEBS LETT, V584, P2387, DOI 10.1016/j.febslet.2010.04.029; Enriquez-Aragon JA, 2005, NEUROREPORT, V16, P235; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; FUJITA K, 1989, ENVIRON HEALTH PERSP, V80, P127, DOI 10.2307/3430738; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gojo I, 2002, CLIN CANCER RES, V8, P3527; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Higginson JR, 2008, INT J BIOCHEM CELL B, V40, P892, DOI 10.1016/j.biocel.2007.10.019; Holder E, 1996, HUM GENET, V97, P232, DOI 10.1007/BF02265272; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kutay U, 2008, CURR OPIN CELL BIOL, V20, P669, DOI 10.1016/j.ceb.2008.09.010; LEDERFEIN D, 1993, HUM MOL GENET, V2, P1883, DOI 10.1093/hmg/2.11.1883; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Long BH, 1998, CANCER RES, V58, P1111; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; Martin C, 2010, CHROMOSOME RES, V18, P525, DOI 10.1007/s10577-010-9137-8; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Rivier F, 1999, HISTOCHEM J, V31, P425, DOI 10.1023/A:1003805905456; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; SUNADA Y, 1995, CURR OPIN NEUROL, V8, P379, DOI 10.1097/00019052-199510000-00010; Tanaka K, 2009, CANCER SCI, V100, P1158, DOI 10.1111/j.1349-7006.2009.01178.x; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Villarreal-Silva M, 2010, NEUROCHEM RES, V35, P366, DOI 10.1007/s11064-009-0064-z	45	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23504	10.1371/journal.pone.0023504	http://dx.doi.org/10.1371/journal.pone.0023504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886794	gold, Green Submitted, Green Published			2022-12-25	WOS:000294128100016
J	Gao, W; Xu, LJ; Guan, R; Liu, XX; Han, YX; Wu, Q; Xiao, Y; Qi, F; Zhu, ZY; Lin, S; Zhang, B				Gao, Wei; Xu, Linjie; Guan, Rui; Liu, Xinxing; Han, Yuxiang; Wu, Qian; Xiao, Yi; Qi, Fei; Zhu, Zuoyan; Lin, Shuo; Zhang, Bo			Wdr18 Is Required for Kupffer's Vesicle Formation and Regulation of Body Asymmetry in Zebrafish	PLOS ONE			English	Article							PROTEIN-KINASE-C; LATERALITY ORGAN; BETA-SUBUNIT; NO TAIL; GENE; CELLS; EMBRYO; BRAIN; IDENTIFICATION; SPECIFICATION	Correct specification of the left-right (L-R) axis is important for organ morphogenesis. Conserved mechanisms involving cilia rotation inside node-like structures and asymmetric Nodal signaling in the lateral plate mesoderm (LPM), which are important symmetry-breaking events, have been intensively studied. In zebrafish, the clustering and migration of dorsal forerunner cells (DFCs) is critical for the formation of the Kuppfer's vesicle (KV). However, molecular events underlying DFC clustering and migration are less understood. The WD-repeat proteins function in a variety of biological processes, including cytoskeleton assembly, intracellular trafficking, mRNA splicing, transcriptional regulation and cell migration. However, little is known about the function of WD-repeat proteins in L-R asymmetry determination. Here, we report the identification and functional analyses of zebrafish wdr18, a novel gene that encodes a WD-repeat protein that is highly conserved among vertebrate species. wdr18 was identified from a Tol2 transposon-mediated enhancer trap screen. Follow-up analysis of wdr18 mRNA expression showed that it was detected in DFCs or the KV progenitor cells and later in the KV at early somitogenesis stages. Morpholino knockdown of wdr18 resulted in laterality defects in the visceral organs, which were preceded by the mis-expression of Nodal-related genes, including spaw and pitx2. Examination of morphants at earlier stages revealed that the KV had fewer and shorter cilia which are immotile and a smaller cavity. We further investigated the organization of DFCs in wdr18 morphant embryos using ntl and sox17 as specific markers and found that the clustering and migration of DFC was altered, leading to a disorganized KV. Finally, through a combination of wdr18 and itgb1b morpholino injections, we provided evidence that wdr18 and itgb1b genetically interact in the laterality determination process. Thus, we reveal a new and essential role for WD-repeat proteins in the determination and regulation of L-R asymmetry and propose a potential mechanism for wdr18 in the regulation of DFC clustering and migration and KV formation.	[Gao, Wei; Xu, Linjie; Guan, Rui; Liu, Xinxing; Han, Yuxiang; Wu, Qian; Xiao, Yi; Qi, Fei; Zhu, Zuoyan; Lin, Shuo; Zhang, Bo] Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Peking University; University of California System; University of California Los Angeles	Gao, W (corresponding author), Peking Univ, Coll Life Sci, Ctr Dev Biol & Genet, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China.	shuolin@ucla.edu; bzhang@pku.edu.cn	Zhang, Bo/K-7162-2012		NSFC [30730056]; 973 program [2007CB914502]	NSFC(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This work was partially supported by grants from NSFC (30730056) and 973 program (2007CB914502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aamar E, 2010, DEV DYNAM, V239, P2980, DOI 10.1002/dvdy.22431; Ablooglu AJ, 2010, DEVELOPMENT, V137, P3449, DOI 10.1242/dev.045310; Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Cooper MS, 1996, DEV BIOL, V180, P184, DOI 10.1006/dbio.1996.0294; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Furtado MB, 2008, GENE DEV, V22, P3037, DOI 10.1101/gad.1682108; Gao CL, 2010, DEV DYNAM, V239, P2190, DOI 10.1002/dvdy.22355; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 2007, BIOESSAYS, V29, P271, DOI 10.1002/bies.20545; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Monsoro-Burq AH, 2001, MOL CELL, V7, P789, DOI 10.1016/S1097-2765(01)00223-4; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Oteiza P, 2010, DEVELOPMENT, V137, P3459, DOI 10.1242/dev.049981; Rietzler M, 1998, J BIOL CHEM, V273, P27459, DOI 10.1074/jbc.273.42.27459; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Takahashi M, 2002, J NEUROSCI, V22, P3929, DOI 10.1523/JNEUROSCI.22-10-03929.2002; THISSE C, 1993, DEVELOPMENT, V119, P1203; Yamauchi H, 2009, DEV BIOL, V332, P177, DOI 10.1016/j.ydbio.2009.05.568; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016	37	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23386	10.1371/journal.pone.0023386	http://dx.doi.org/10.1371/journal.pone.0023386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876750	gold, Green Published, Green Submitted			2022-12-25	WOS:000294126900022
J	Iguchi, A; Shirai, H; Seto, K; Ooka, T; Ogura, Y; Hayashi, T; Osawa, K; Osawa, R				Iguchi, Atsushi; Shirai, Hiroki; Seto, Kazuko; Ooka, Tadasuke; Ogura, Yoshitoshi; Hayashi, Tetsuya; Osawa, Kayo; Osawa, Ro			Wide Distribution of O157-Antigen Biosynthesis Gene Clusters in Escherichia coli	PLOS ONE			English	Article							PCR-BASED DETECTION; SALMONELLA-TYPHIMURIUM; CHAIN-LENGTH; SEQUENCE; STRAINS; O157; IDENTIFICATION; PREVALENCE; VIRULENCE; DNA	Most Escherichia coli O157-serogroup strains are classified as enterohemorrhagic E. coli (EHEC), which is known as an important food-borne pathogen for humans. They usually produce Shiga toxin (Stx) 1 and/or Stx2, and express H7-flagella antigen (or nonmotile). However, O157 strains that do not produce Stxs and express H antigens different from H7 are sometimes isolated from clinical and other sources. Multilocus sequence analysis revealed that these 21 O157:non-H7 strains tested in this study belong to multiple evolutionary lineages different from that of EHEC O157:H7 strains, suggesting a wide distribution of the gene set encoding the O157-antigen biosynthesis in multiple lineages. To gain insight into the gene organization and the sequence similarity of the O157-antigen biosynthesis gene clusters, we conducted genomic comparisons of the chromosomal regions (about 59 kb in each strain) covering the O-antigen gene cluster and its flanking regions between six O157:H7/non-H7 strains. Gene organization of the O157-antigen gene cluster was identical among O157:H7/non-H7 strains, but was divided into two distinct types at the nucleotide sequence level. Interestingly, distribution of the two types did not clearly follow the evolutionary lineages of the strains, suggesting that horizontal gene transfer of both types of O157-antigen gene clusters has occurred independently among E. coli strains. Additionally, detailed sequence comparison revealed that some positions of the repetitive extragenic palindromic (REP) sequences in the regions flanking the O-antigen gene clusters were coincident with possible recombination points. From these results, we conclude that the horizontal transfer of the O157-antigen gene clusters induced the emergence of multiple O157 lineages within E. coli and speculate that REP sequences may involve one of the driving forces for exchange and evolution of O-antigen loci.	[Iguchi, Atsushi] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Shirai, Hiroki; Osawa, Kayo] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Kobe, Hyogo 657, Japan; [Seto, Kazuko] Osaka Prefectural Inst Publ Hlth, Div Bacteriol, Osaka 537, Japan; [Ooka, Tadasuke; Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Microbiol, Miyazaki, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioenvironm Sci, Miyazaki, Japan; [Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Kobe, Hyogo, Japan	University of Miyazaki; Kobe University; Osaka Prefectural Institute of Public Health; University of Miyazaki; University of Miyazaki; Kobe University	Iguchi, A (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	iguchi@med.miyazaki-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020	, Atsushi/0000-0003-3826-7520	Japanese Ministry of Education, Culture, Sports, Science and Technology [21790424]; University of Miyazaki, Japan	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki, Japan	This work was supported by a Grant-in-Aid for Young Scientists (B) (no. 21790424), the Special Coordination Fund for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and a Grant-in-Aid for Scientific Research on Priority Areas from the University of Miyazaki, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellier S, 1997, GENETICS, V145, P551; Bertrand R, 2007, WATER RES, V41, P1280, DOI 10.1016/j.watres.2006.11.027; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; CHART H, 1993, J INFECTION, V27, P237, DOI 10.1016/0163-4453(93)91952-L; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; ENGELHORN N, 1995, NUCLEIC ACIDS RES, V23, P2959, DOI 10.1093/nar/23.15.2959; Feng PCH, 2010, FEMS MICROBIOL LETT, V308, P62, DOI 10.1111/j.1574-6968.2010.01990.x; FRANKE J, 1994, J CLIN MICROBIOL, V32, P2460, DOI 10.1128/JCM.32.10.2460-2463.1994; GILSON E, 1990, NUCLEIC ACIDS RES, V18, P3941, DOI 10.1093/nar/18.13.3941; GUNZBURG ST, 1995, J CLIN MICROBIOL, V33, P1375, DOI 10.1128/JCM.33.5.1375-1377.1995; Guo HJ, 2005, APPL ENVIRON MICROB, V71, P7995, DOI 10.1128/AEM.71.12.7995-8001.2005; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HIGGINS CF, 1982, NATURE, V298, P760, DOI 10.1038/298760a0; Iguchi A, 2007, CURR MICROBIOL, V54, P14, DOI 10.1007/s00284-006-0139-x; KARCH H, 1993, J CLIN MICROBIOL, V31, P1200, DOI 10.1128/JCM.31.5.1200-1205.1993; Kobayashi H, 2001, APPL ENVIRON MICROB, V67, P484, DOI 10.1128/AEM.67.1.484-489.2001; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Makino S, 1999, MICROBIOL IMMUNOL, V43, P381, DOI 10.1111/j.1348-0421.1999.tb02419.x; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEWBURY SF, 1987, CELL, V48, P297, DOI 10.1016/0092-8674(87)90433-8; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Shimizu T, 1999, MICROB PATHOGENESIS, V26, P235, DOI 10.1006/mpat.1998.0253; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054, DOI 10.1128/JCM.33.5.1054-1059.1995; Stephan R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-10; STERN MJ, 1988, MOL MICROBIOL, V2, P141, DOI 10.1111/j.1365-2958.1988.tb00015.x; STERN MJ, 1984, CELL, V37, P1015, DOI 10.1016/0092-8674(84)90436-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANAKA T, 1989, MOL BIOL EVOL, V6, P447; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; WILLSHAW GA, 1994, J CLIN MICROBIOL, V32, P897, DOI 10.1128/JCM.32.4.897-902.1994; YANG Y, 1988, P NATL ACAD SCI USA, V85, P8850, DOI 10.1073/pnas.85.23.8850; Yatsuyanagi J, 2002, J CLIN MICROBIOL, V40, P294, DOI 10.1128/JCM.40.1.294-297.2002; Zhang WL, 2002, J CLIN MICROBIOL, V40, P4486, DOI 10.1128/JCM.40.12.4486-4492.2002	40	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23250	10.1371/journal.pone.0023250	http://dx.doi.org/10.1371/journal.pone.0023250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876740	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900012
J	Geraldo, MV; Yamashita, AS; Kimura, ET				Geraldo, M. V.; Yamashita, A. S.; Kimura, E. T.			MicroRNA miR-146b-5p regulates signal transduction of TGF-beta by repressing SMAD4 in thyroid cancer	ONCOGENE			English	Article						microRNA; TGF-beta; papillary thyroid carcinoma	GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; PCCL3 CELLS; ACTIVIN-A; THYROTROPIN; ONCOGENE; DIFFERENTIATION; METASTASIS	MicroRNAs (miRNA) are small non-coding RNAs involved in post-transcriptional gene regulation that have crucial roles in several types of tumors, including papillary thyroid carcinoma (PTC). miR-146b-5p is overexpressed in PTCs and is regarded as a relevant diagnostic marker for this type of cancer. A computational search revealed that miR-146b-5p putatively binds to the 3' untranslated region (UTR) of SMAD4, an important member of the transforming growth factor beta (TGF-beta) signaling pathway. The TGF-beta pathway is a negative regulator of thyroid follicular cell growth, and the mechanism by which thyroid cancer cells evade its inhibitory signal remains unclear. We questioned whether the modulation of the TGF-beta pathway by miR-146b-5p can contribute to thyroid tumorigenesis. Luciferase reporter assay confirmed the direct binding of miR-146b-5p on the SMAD4 3'UTR. Specific inhibition of miR-146b-5p with a locked nucleic acid-modified anti-miR-146b oligonucleotide significantly increased SMAD4 levels in the human papillary carcinoma cell lines, TPC-1 and BCPAP. Moreover, suppression of miR-146b-5p increased the cellular response to the TGF-beta anti-proliferative signal, significantly decreasing the proliferation rate. The overexpression of miR-146b-5p in normal rat follicular PCCL3 cells decreased SMAD4 levels and disrupted TGF-beta signal transduction. MiR-146b-5p overexpression in PCCL3 cells also significantly increased cell proliferation in the absence of thyroid-stimulating hormone and conferred resistance to TGF-beta-mediated cell-cycle arrest. Additionally, the activation of thyroid most common oncogenes RET/PTC3 and BRAF in PCCL3 cells upregulated miR-146b-5p expression. Our results confirm the oncogenic role of miR-146b-5p in thyroid follicular cells and contribute to knowledge regarding the modulation of TGF-beta signal transduction by miRNAs in PTCs. Oncogene (2012) 31, 1910-1922; doi:10.1038/onc.2011.381; published online 29 August 2011	[Geraldo, M. V.; Yamashita, A. S.; Kimura, E. T.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade de Sao Paulo	Kimura, ET (corresponding author), Univ Sao Paulo, Dept Cell & Dev Biol, Inst Biomed Sci, Av Prof Lineu Prestes 1524,Room 414, BR-05508000 So Paulo, Brazil.	etkimura@usp.br	Yamashita, Alex Shimura/B-3772-2013; Geraldo, Murilo V/C-6427-2016; Kimura, Edna/D-7334-2012; Geraldo, Murilo V/F-7211-2013	Kimura, Edna/0000-0001-8403-4459; Geraldo, Murilo V/0000-0002-9418-6103	Fundaco de Amparo A Pesquisa do Estado de So Paulo (FAPESP); Conselho Nacional de Desenvolvimento CientUfico e Tecnoloegico (CNPq)	Fundaco de Amparo A Pesquisa do Estado de So Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento CientUfico e Tecnoloegico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	We thank Dr Konstantin D Taganov for donation of pcDNA3.1-miR-146b plasmid, Dr Joan MassaguO for donation of p3TP-Lux plasmid, Dr Nancy Carrasco for donation of anti-NIS antibody, Dr Massimo Santoro for BCPAP, and Dr James A Fagin for PCCL3, PCCL3-rtTA, PTC3-5, TPC-1, and ARO cell lines used in this study. This work was supported by Fundaco de Amparo A Pesquisa do Estado de So Paulo (FAPESP) and Conselho Nacional de Desenvolvimento CientUfico e Tecnoloegico (CNPq).	Adeniran AJ, 2006, AM J SURG PATHOL, V30, P216, DOI 10.1097/01.pas.0000176432.73455.1b; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Cahill S, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-70; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cerutti JM, 2003, J ENDOCRINOL INVEST, V26, P516, DOI 10.1007/BF03345213; Chou CK, 2010, THYROID, V20, P489, DOI 10.1089/thy.2009.0027; Costamagna E, 2004, J BIOL CHEM, V279, P3439, DOI 10.1074/jbc.M307138200; D'Inzeo S, 2010, J MOL ENDOCRINOL, V45, P229, DOI 10.1677/JME-10-0044; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Ellenrieder V, 2008, ANTICANCER RES, V28, P1531; Ermak G, 2003, ANAL BIOCHEM, V318, P152, DOI 10.1016/S0003-2697(03)00166-0; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Fagin JA, 2002, MOL ENDOCRINOL, V16, P903, DOI 10.1210/me.16.5.903; Franzen A, 1999, ENDOCRINOLOGY, V140, P4300, DOI 10.1210/en.140.9.4300; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Garcia-Jimenez C, 2007, ARQ BRAS ENDOCRINOL, V51, P654, DOI 10.1590/S0004-27302007000500003; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JHIANG SM, 1992, ONCOGENE, V7, P1331; Kawaguchi A, 1997, THYROID, V7, P789, DOI 10.1089/thy.1997.7.789; Kimura ET, 2003, CANCER RES, V63, P1454; Kimura ET, 1999, THYROID, V9, P119, DOI 10.1089/thy.1999.9.119; Lazzereschi D, 2005, ONCOGENE, V24, P5344, DOI 10.1038/sj.onc.1208603; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuo SE, 2010, ARQ BRAS ENDOCRINOL, V54, P406, DOI 10.1590/S0004-27302010000400010; Matsuo SE, 2006, J ENDOCRINOL, V190, P141, DOI 10.1677/joe.1.06713; MORRIS JC, 1988, ENDOCRINOLOGY, V123, P1385, DOI 10.1210/endo-123-3-1385; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nicolussi A, 2003, MOL CELL ENDOCRINOL, V207, P1, DOI 10.1016/S0303-7207(03)00238-7; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; Nikiforova MN, 2009, ENDOCR PATHOL, V20, P85, DOI 10.1007/s12022-009-9069-z; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Paire A, 1997, J BIOL CHEM, V272, P18245, DOI 10.1074/jbc.272.29.18245; Pallante P, 2010, ENDOCR-RELAT CANCER, V17, pF91, DOI 10.1677/ERC-09-0217; Palona I, 2006, ENDOCRINOLOGY, V147, P5699, DOI 10.1210/en.2006-0400; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Saavedra HI, 2000, ONCOGENE, V19, P3948, DOI 10.1038/sj.onc.1203723; Santoro M, 2002, ANN NY ACAD SCI, V963, P116, DOI 10.1111/j.1749-6632.2002.tb04102.x; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TATON M, 1993, MOL CELL ENDOCRINOL, V95, P13, DOI 10.1016/0303-7207(93)90024-E; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yang G, 2010, INT J BIOL SCI, V6, P1; Zhong H, 2010, INT J HEMATOL, V92, P129, DOI 10.1007/s12185-010-0626-5	53	154	156	0	32	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1910	1922		10.1038/onc.2011.381	http://dx.doi.org/10.1038/onc.2011.381			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21874046				2022-12-25	WOS:000302809900004
J	Baker, JM; De Lisio, M; Parise, G				Baker, J. M.; De Lisio, Michael; Parise, Gianni			Endurance exercise training promotes medullary hematopoiesis	FASEB JOURNAL			English	Article						bone marrow; blood; mesenchymal; cytokine; skeletal muscle	COLONY-STIMULATING FACTOR; MESENCHYMAL STEM-CELLS; BONE-MARROW ADIPOCYTES; HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; MESSENGER-RNA; GM-CSF; ERYTHROPOIETIN; PROGENITORS; EXPRESSION	Endurance exercise is a poorly defined yet powerful mediator of hematopoiesis. The purpose of this study was to directly investigate the effects of endurance exercise training on hematopoiesis and to identify potential mechanisms responsible for any observed changes. Four-week-old male C57Bl/6 mice were trained on a treadmill at progressive speeds over a 10-wk period. Tissues were harvested 2 d following the final training session. Flow cytometry, the cobblestone area-forming cell assay, and the methycellulose colony-forming unit assay were used to assess medullary and mobilized hematopoietic stem and progenitor cells. Quantitative real-time PCR and Western blots were used to measure hematopoietic cytokine production. Histochemistry was also used to assess adaptations to exercise in the bone marrow niche. Depending on the cell type, endurance training increased medullary and mobilized hematopoietic stem and progenitor cell content from 50 to 800%. Training also reduced marrow cavity fat by 78%. Skeletal muscle hematopoietic cytokine expression was also increased at least 60% by training. Sedentary mice served as controls for the above experiments. In conclusion, endurance exercise training greatly promotes hematopoiesis and does so through improvements in medullary niche architecture as well as increased skeletal muscle hematopoietic cytokine production.-Baker, J. M., De Lisio, M., Parise, G. Endurance exercise training promotes medullary hematopoiesis. FASEB J. 25, 4348-4357 (2011). www.fasebj.org	[Baker, J. M.; De Lisio, Michael; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca			Canadian Institutes of Health Research (CIHR) [96344]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Authorship contribution was as follows: J.B. designed and performed experiments, analyzed data, and wrote the manuscript; M. D. designed and performed experiments and analyzed data; G. P. designed experiments, supervised the project, and edited the manuscript. The authors declare no competing financial interests. This study was supported by Canadian Institutes of Health Research (CIHR) grant 96344 (to G.P.). M.D. was supported by a CIHR Canadian Graduate Scholarship.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Bonsignore MR, 2010, J APPL PHYSIOL, V109, P60, DOI 10.1152/japplphysiol.01344.2009; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CARRINGTON PA, 1991, BLOOD, V77, P34; CONVERTINO V A, 1991, Medicine and Science in Sports and Exercise, V23, P1338; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; D'Andrea Alan D, 2002, Hematology Am Soc Hematol Educ Program, P58; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Donnelly S, 2001, AM J KIDNEY DIS, V38, P415, DOI 10.1053/ajkd.2001.26111; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Iwamoto J, 2001, J Orthop Sci, V6, P128; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malm C, 1999, J APPL PHYSIOL, V86, P461, DOI 10.1152/jappl.1999.86.2.461; Margeli A, 2005, J CLIN ENDOCR METAB, V90, P3914, DOI 10.1210/jc.2004-2346; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; Menuki K, 2008, BONE, V43, P613, DOI 10.1016/j.bone.2008.04.022; Miharada K, 2008, J CELL PHYSIOL, V215, P526, DOI 10.1002/jcp.21334; Morici G, 2005, AM J PHYSIOL-REG I, V289, pR1496, DOI 10.1152/ajpregu.00338.2005; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; NIENHUIS AW, 1987, J CLIN INVEST, V80, P573, DOI 10.1172/JCI113106; Pedersen B K, 1999, J Sci Med Sport, V2, P234, DOI 10.1016/S1440-2440(99)80176-5; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; PIROSO E, 1991, AM J HEMATOL, V36, P105, DOI 10.1002/ajh.2830360208; ROZMAN C, 1993, MED CLIN-BARCELONA, V101, P441; Rundqvist H, 2009, EUR J ENDOCRINOL, V161, P427, DOI 10.1530/EJE-09-0342; Schodel J, 2009, AM J PATHOL, V174, P1663, DOI 10.2353/ajpath.2009.080687; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shin JW, 2008, WORLD J GASTROENTERO, V14, P2323, DOI 10.3748/wjg.14.2323; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Spivak JL, 2005, NAT REV CANCER, V5, P543, DOI 10.1038/nrc1648; Steensberg A, 2007, FASEB J, V21, P2683, DOI 10.1096/fj.06-7477com; Sugita S, 2007, OBESITY, V15, P1988, DOI 10.1038/oby.2007.237; SUKI W, 1960, AM J PHYSIOL, V199, P629, DOI 10.1152/ajplegacy.1960.199.4.629; Sun XJ, 2008, TISSUE ENG PT A, V14, P391, DOI 10.1089/tea.2006.0429; TAN CC, 1992, AM J PHYSIOL, V263, pF474, DOI 10.1152/ajprenal.1992.263.3.F474; TAVASSOLI M, 1974, BLOOD, V43, P33, DOI 10.1182/blood.V43.1.33.33; Trudel G, 2009, J APPL PHYSIOL, V107, P540, DOI 10.1152/japplphysiol.91530.2008; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilber RL, 2001, SPORTS MED, V31, P249, DOI 10.2165/00007256-200131040-00002; Wingard JR, 2010, INFECT DIS CLIN N AM, V24, P257, DOI 10.1016/j.idc.2010.01.010; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	51	50	51	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4348	4357		10.1096/fj.11-189043	http://dx.doi.org/10.1096/fj.11-189043			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21868472	Bronze			2022-12-25	WOS:000298138100026
J	Kobayashi, H; Ogura, Y; Sawada, M; Nakayama, R; Takano, K; Minato, Y; Takemoto, Y; Tashiro, E; Watanabe, H; Imoto, M				Kobayashi, Hiroki; Ogura, Yusuke; Sawada, Masato; Nakayama, Ryoji; Takano, Kei; Minato, Yusuke; Takemoto, Yasushi; Tashiro, Etsu; Watanabe, Hidenori; Imoto, Masaya			Involvement of 14-3-3 Proteins in the Second Epidermal Growth Factor-induced Wave of Rac1 Activation in the Process of Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; RHO; CDC42; COMPLEXES; MOTILITY; GTPASES; 14-3-3-PROTEINS; PHOSPHORYLATION; LAMELLIPODIA; ADHESION	Immense previous efforts have elucidated the core machinery in cell migration, actin remodeling regulated by Rho family small GTPases including RhoA, Cdc42, and Rac1; however, the spatiotemporal regulation of these molecules remains largely unknown. Here, we report that EGF induces biphasic Rac1 activation in the process of cell migration, and UTKO1, a cell migration inhibitor, inhibits the second EGF-induced wave of Rac1 activation but not the first wave. To address the regulation mechanism and role of the second wave of Rac1 activation, we identified 14-3-3 xi as a target protein of UTKO1 and also showed that UTKO1 abrogated the binding of 14-3-3 xi to Tiam1 that was responsible for the second wave of Rac1 activation, suggesting that the interaction of 14-3-3 xi with Tiam1 is involved in this event. To our knowledge, this is the first report to use a chemical genetic approach to demonstrate the mechanism of temporal activation of Rac1.	[Kobayashi, Hiroki; Sawada, Masato; Nakayama, Ryoji; Takano, Kei; Minato, Yusuke; Takemoto, Yasushi; Tashiro, Etsu; Imoto, Masaya] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Ogura, Yusuke; Watanabe, Hidenori] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Keio University; University of Tokyo	Imoto, M (corresponding author), Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	imoto@bio.keio.ac.jp	Tashiro, Etsu/C-4903-2014; Imoto, Masaya/F-7957-2014	Sawada, Masato/0000-0002-8694-8526; Tashiro, Etsu/0000-0003-4533-623X; Kobayashi, Hiroki/0000-0002-3785-2317; Takano, Kei/0000-0002-4219-6123	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23102010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology.	AITKEN A, 1995, BIOCHEM SOC T, V23, P605, DOI 10.1042/bst0230605; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CHINKERS M, 1979, J CELL BIOL, V83, P260, DOI 10.1083/jcb.83.1.260; Deakin NO, 2009, J CELL SCI, V122, P1654, DOI 10.1242/jcs.049130; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jones GE, 1998, CELL ADHES COMMUN, V6, P237, DOI 10.3109/15419069809004479; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee SH, 2007, CANCER RES, V67, P11045, DOI 10.1158/0008-5472.CAN-07-0986; Marcoux N, 2003, ONCOGENE, V22, P6100, DOI 10.1038/sj.onc.1206712; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sawada M, 2011, BIOORG MED CHEM LETT, V21, P1385, DOI 10.1016/j.bmcl.2011.01.028; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takemoto Y, 2005, CHEM BIOL, V12, P1337, DOI 10.1016/j.chembiol.2005.09.017; Takenawa T, 2001, J CELL SCI, V114, P1801; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Veluthakal R, 2009, BIOCHEM PHARMACOL, V77, P101, DOI 10.1016/j.bcp.2008.09.021; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770	39	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39259	39268		10.1074/jbc.M111.255489	http://dx.doi.org/10.1074/jbc.M111.255489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21868386	hybrid, Green Published			2022-12-25	WOS:000296759800044
J	Wang, L; Li, L; Zhang, HL; Luo, X; Dai, JQ; Zhou, SL; Gu, J; Zhu, JD; Atadja, P; Lu, C; Li, E; Zhao, KH				Wang, Li; Li, Ling; Zhang, Hailong; Luo, Xiao; Dai, Jingquan; Zhou, Shaolian; Gu, Justin; Zhu, Jidong; Atadja, Peter; Lu, Chris; Li, En; Zhao, Kehao			Structure of Human SMYD2 Protein Reveals the Basis of p53 Tumor Suppressor Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE; IDENTIFICATION; PROLIFERATION; SPECIFICITY; MECHANISM; DOMAINS; SET	SMYD2 belongs to a subfamily of histone lysine methyltransferase and was recently identified to methylate tumor suppressor p53 and Rb. Here we report that SMYD2 prefers to methylate p53 Lys-370 over histone substrates in vitro. Consistently, the level of endogenous p53 Lys-370 monomethylation is significantly elevated when SMYD2 is overexpressed in vivo. We have solved the high resolution crystal structures of the full-length SMYD2 protein in binary complex with its cofactor S-adenosylmethionine and in ternary complex with cofactor product S-adenosylhomocysteine and p53 substrate peptide (residues 368375), respectively. p53 peptide binds to a deep pocket of the interface between catalytic SET(1-282) and C-terminal domain (CTD) with an unprecedented U-shaped conformation. Subtle conformational change exists around the p53 binding site between the binary and ternary structures, in particular the tetratricopeptide repeat motif of the CTD. In addition, a unique EDEE motif between the loop of anti-parallel beta 7 and beta 8 sheets of the SET core not only interacts with p53 substrate but also forms a hydrogen bond network with residues from CTD. These observations suggest that the tetratricopeptide repeat and EDEE motif may play an important role in determining p53 substrate binding specificity. This is further verified by the findings that deletion of the CTD domain drastically reduces the methylation activity of SMYD2 to p53 protein. Meanwhile, mutation of EDEE residues impairs both the binding and the enzymatic activity of SMYD2 to p53 Lys-370. These data together reveal the molecular basis of SMYD2 in specifically recognizing and regulating functions of p53 tumor suppressor through Lys-370 monomethylation.	[Wang, Li; Li, Ling; Zhang, Hailong; Luo, Xiao; Dai, Jingquan; Zhou, Shaolian; Gu, Justin; Zhu, Jidong; Atadja, Peter; Lu, Chris; Li, En; Zhao, Kehao] Novartis Inst BioMed Res, Shanghai 201203, Peoples R China	Novartis	Zhao, KH (corresponding author), Novartis Inst BioMed Res, Bldg 8,Lane 898,Halei Rd, Shanghai 201203, Peoples R China.	Kehao.zhao@novartis.com		Zhao, Kehao/0000-0003-2485-058X	Novartis	Novartis(Novartis)	This work was supported by a Novartis postdoctoral fellowship.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Campagna-Slater V, 2011, J CHEM INF MODEL, V51, P612, DOI 10.1021/ci100479z; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Del Rizzo PA, 2010, J BIOL CHEM, V285, P31849, DOI 10.1074/jbc.M110.114587; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Luger K, 1999, METHOD ENZYMOL, V304, P3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CY, 2010, P NATL ACAD SCI USA, V107, P20750, DOI 10.1073/pnas.1013493107; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Scoumanne A, 2008, HISTOL HISTOPATHOL, V23, P1143, DOI 10.14670/HH-23.1143; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; West LE, 2010, J BIOL CHEM, V285, P37725, DOI 10.1074/jbc.M110.139527; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xu S., 2011, J MOL CELL IN PRESS; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019	40	53	56	7	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38725	38737		10.1074/jbc.M111.262410	http://dx.doi.org/10.1074/jbc.M111.262410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880715	Green Published, hybrid			2022-12-25	WOS:000296594200084
J	Nemet, I; Monnier, VM				Nemet, Ina; Monnier, Vincent M.			Vitamin C Degradation Products and Pathways in the Human Lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DICARBONYL COMPOUNDS; L-ASCORBIC-ACID; MAILLARD REACTION; PHYSIOLOGICAL CONDITIONS; ARGININE RESIDUES; CROSS-LINKS; EYE LENS; PROTEINS; LYSINE; CATARACTOGENESIS	Vitamin C and its degradation products participate in chemical modifications of proteins in vivo through non-enzymatic glycation (Maillard reaction) and formation of different products called advanced glycation end products. Vitamin C levels are particularly high in selected tissues, such as lens, brain and adrenal gland, and its degradation products can inflict substantial protein damage via formation of advanced glycation end products. However, the pathways of in vivo vitamin C degradation are poorly understood. Here we have determined the levels of vitamin C oxidation and degradation products dehydroascorbic acid, 2,3-dike-togulonic acid, 3-deoxythreosone, xylosone, and threosone in the human lens using o-phenylenediamine to trap both free and protein-bound adducts. In the protein-free fraction and water-soluble proteins (WSP), all five listed degradation products were identified. Dehydroascorbic acid, 2,3-diketogulonic acid, and 3-deoxythreosone were the major products in the protein-free fraction, whereas in the WSP, 3-deoxythreosone was the most abundant measured dicarbonyl. In addition, 3-deoxythreosone in WSP showed positive linear correlation with age (p < 0.05). In water-insoluble proteins, only 3-deoxythreosone and threosone were detected, whereby the level of 3-deoxythreosone was similar to 20 times higher than the level of threosone. The identification of 3-deoxythreosone as the major degradation product bound to human lens proteins provides in vivo evidence for the non-oxidative pathway of dehydroascorbate degradation in to erythrulose as a major pathway for vitamin C degradation in vivo.	[Nemet, Ina; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Nemet, Ina] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb 10000, Croatia	Case Western Reserve University; Case Western Reserve University; Rudjer Boskovic Institute	Monnier, VM (corresponding author), 2103 Cornell Rd,WRB 5127, Cleveland, OH 44106 USA.	vmm3@cwru.edu	Nemet, Ina/ABG-2855-2021	Nemet, Ina/0000-0002-0657-7121	NEI, National Institutes of Health [EY07099]; Ministry of Science, Education, and Sports of Croatia [098-0982933-2936]; Juvenile Diabetes Research International; NATIONAL EYE INSTITUTE [R01EY007099] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ministry of Science, Education, and Sports of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Juvenile Diabetes Research International; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by NEI, National Institutes of Health, Grant EY07099. This work was also supported by Ministry of Science, Education, and Sports of Croatia Grant 098-0982933-2936.; Recipient of a fellowship from the Juvenile Diabetes Research International.	Argirov OK, 2004, J BIOL CHEM, V279, P6487, DOI 10.1074/jbc.M309090200; Atalay A, 1998, BIOCHIMIE, V80, P283, DOI 10.1016/S0300-9084(98)80068-0; Cheng RZ, 2006, BBA-MOL BASIS DIS, V1762, P533, DOI 10.1016/j.bbadis.2006.01.009; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Fan XJ, 2009, J BIOL CHEM, V284, P34618, DOI 10.1074/jbc.M109.032094; Glomb MA, 2001, J AGR FOOD CHEM, V49, P5543, DOI 10.1021/jf010148h; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; Gobert J, 2009, J AGR FOOD CHEM, V57, P8591, DOI 10.1021/jf9019085; LO TWC, 1994, J BIOL CHEM, V269, P32299; Mittelmaier S, 2010, J CHROMATOGR B, V878, P877, DOI 10.1016/j.jchromb.2010.02.004; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nishikawa Y, 2001, BIOSCI BIOTECH BIOCH, V65, P1707, DOI 10.1271/bbb.65.1707; OTSUKA M, 1986, AGR BIOL CHEM TOKYO, V50, P531, DOI 10.1080/00021369.1986.10867421; PATTHY L, 1975, J BIOL CHEM, V250, P557; Reihl O, 2004, CARBOHYD RES, V339, P483, DOI 10.1016/j.carres.2003.12.004; Salomon L. L., 1952, J AM CHEM SOC, P5161; Sell DR, 2005, ANN NY ACAD SCI, V1043, P118, DOI 10.1196/annals.1333.015; SHIN DB, 1990, CARBOHYD RES, V208, P246; Simpson GLW, 2000, BBA-MOL BASIS DIS, V1501, P12, DOI 10.1016/S0925-4439(00)00009-0; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P2465, DOI 10.1271/bbb.70229; VARMA SD, 1988, OPHTHALMIC RES, V20, P164, DOI 10.1159/000266579; VUORINEN T, 1990, CARBOHYD RES, V207, P185, DOI 10.1016/0008-6215(90)84048-Y; WELLS WW, 1994, J BIOENERG BIOMEMBR, V26, P369, DOI 10.1007/BF00762777; Xing KY, 2010, INVEST OPHTH VIS SCI, V51, P6598, DOI 10.1167/iovs.10-5672; Xue MZ, 2011, SEMIN CELL DEV BIOL, V22, P293, DOI 10.1016/j.semcdb.2011.02.013	29	54	56	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37128	37136		10.1074/jbc.M111.245100	http://dx.doi.org/10.1074/jbc.M111.245100			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21885436	hybrid, Green Published			2022-12-25	WOS:000296542400013
J	Brammer, LA; Smith, JM; Wade, H; Meyers, CF				Brammer, Leighanne A.; Smith, Jessica M.; Wade, Herschel; Meyers, Caren Freel			1-Deoxy-D-xylulose 5-Phosphate Synthase Catalyzes a Novel Random Sequential Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; 2-C-METHYL-D-ERYTHRITOL 4-PHOSPHATE PATHWAY; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; THIAMIN DIPHOSPHATE; ENZYME; SUBSTRATE; CLONING; IDENTIFICATION	Emerging resistance of human pathogens to anti-infective agents make it necessary to develop new agents to treat infection. The methylerythritol phosphate pathway has been identified as an anti-infective target, as this essential isoprenoid biosynthetic pathway is widespread in human pathogens but absent in humans. The first enzyme of the pathway, 1-deoxy-D-xylulose 5-phosphate (DXP) synthase, catalyzes the formation of DXP via condensation of D-glyceraldehyde 3-phosphate (D-GAP) and pyruvate in a thiamine diphosphate-dependent manner. Structural analysis has revealed a unique domain arrangement suggesting opportunities for the selective targeting of DXP synthase; however, reports on the kinetic mechanism are conflicting. Here, we present the results of tryptophan fluorescence binding and kinetic analyses of DXP synthase and propose a new model for substrate binding and mechanism. Our results are consistent with a random sequential kinetic mechanism, which is unprecedented in this enzyme class.	[Brammer, Leighanne A.; Smith, Jessica M.; Meyers, Caren Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Wade, Herschel] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Meyers, CF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	cmeyers@jhmi.edu		Basta, Leighanne/0000-0002-4121-5505; Freel Meyers, Caren/0000-0003-1458-0897	National Institutes of Health [GM084998, 5T32GM007445-34]; Johns Hopkins Malaria Research Institute Pilot; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084998, T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute Pilot; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM084998 (to L.A.B. and C.F.M.) and 5T32GM007445-34 (to J.M.S.). This work was also supported by a grant from The Johns Hopkins Malaria Research Institute Pilot (to L.A.B. and C.F.M.).	Altincicek B, 2000, FEMS MICROBIOL LETT, V190, P329, DOI 10.1111/j.1574-6968.2000.tb09307.x; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; Bailey AM, 2002, GLYCOBIOLOGY, V12, P813, DOI 10.1093/glycob/cwf100; Brammer LA, 2009, ORG LETT, V11, P4748, DOI 10.1021/ol901961q; Brandt GS, 2009, BIOCHEMISTRY-US, V48, P3247, DOI 10.1021/bi801950k; BUBB WA, 1995, BIOORG CHEM, V23, P119, DOI 10.1006/bioo.1995.1010; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cane DE, 2001, BIOORGAN MED CHEM, V9, P1467, DOI 10.1016/S0968-0896(01)00050-5; Copeland R. A., 2005, EVALUATION ENZYME IN, P42; Eoh H, 2009, TUBERCULOSIS, V89, P1, DOI 10.1016/j.tube.2008.07.004; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Fang MH, 2010, BIOCHEMISTRY-US, V49, P2672, DOI 10.1021/bi901432d; FLOURNOY DS, 1989, BIOCHEMISTRY-US, V28, P9594, DOI 10.1021/bi00451a007; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; GISH G, 1988, J AM CHEM SOC, V110, P6230, DOI 10.1021/ja00226a044; Hahn FM, 2001, J BACTERIOL, V183, P1, DOI 10.1128/JB.183.1.1-11.2001; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Matsue Y, 2010, J ANTIBIOT, V63, P583, DOI 10.1038/ja.2010.100; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2006, BIOORG CHEM, V34, P362, DOI 10.1016/j.bioorg.2006.09.001; OBRIEN TA, 1980, BIOCHIM BIOPHYS ACTA, V613, P10, DOI 10.1016/0005-2744(80)90186-2; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Querol J, 2001, BIOCHEM BIOPH RES CO, V289, P155, DOI 10.1006/bbrc.2001.5957; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Segel I. H., 1975, ENZYME KINETICS, P273; Sisquella X, 2010, FASEB J, V24, P4203, DOI 10.1096/fj.10-155507; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Steinmetz A, 2010, BIOCHEMISTRY-US, V49, P5188, DOI 10.1021/bi100555q; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200	38	44	44	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36522	36531		10.1074/jbc.M111.259747	http://dx.doi.org/10.1074/jbc.M111.259747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878632	Green Published, hybrid			2022-12-25	WOS:000296538300037
J	Bruck, I; Kanter, DM; Kaplan, DL				Bruck, Irina; Kanter, Diane M.; Kaplan, Daniel L.			Enabling Association of the GINS Protein Tetramer with the Mini Chromosome Maintenance (Mcm)2-7 Protein Complex by Phosphorylated Sld2 Protein and Single-stranded Origin DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; CYCLIN-DEPENDENT KINASE; BUDDING YEAST; MCM2-7 HELICASE; SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; S-PHASE; CDC45; INITIATION; PROGRESSION	The Cdc45-Mcm2-7-GINS (CMG) complex is the replication fork helicase in eukaryotes. Synthetic lethal with Dpb11-1 (Sld2) is required for the initiation of DNA replication, and the S phase cyclin-dependent kinase (S-CDK) phosphorylates Sld2 in vivo. We purified components of the replication initiation machinery and studied their interactions in vitro. We found that unphosphorylated or CDK-phosphorylated Sld2 binds to the mini chromosome maintenance (Mcm) 2-7 complex with similar efficiency. Sld2 interaction with Mcm2-7 blocks the interaction between GINS and Mcm2-7. The interaction between CDK-phosphorylated Sld2 and Mcm2-7 is substantially inhibited by origin single-stranded DNA (ssDNA). Furthermore, origin ssDNA allows GINS to bind to Mcm2-7 in the presence of CDK-phosphorylated Sld2. However, unphosphorylated Sld2 blocks the interaction between GINS and Mcm2-7 even in the presence of origin ssDNA. We identified a mutant of Sld2 that does not bind to DNA. When this mutant is expressed in yeast cells, cell growth is severely inhibited with very slow progression into S phase. We propose a model wherein Sld2 blocks the interaction between GINS and Mcm2-7 in vivo. Once origin ssDNA is extruded from the Mcm2-7 ring and CDK phosphorylates Sld2, the origin ssDNA binds to CDK-phosphorylated Sld2. This event may allow the interaction between GINS and Mcm2-7 in vivo. Thus, CDK phosphorylation of Sld2 may be important to release Sld2 from Mcm2-7, thereby allowing GINS to bind Mcm2-7. Furthermore, origin ssDNA may stimulate the formation of the CMG complex by alleviating inhibitory interactions between Sld2 with Mcm2-7.	[Kaplan, Daniel L.] Vanderbilt Univ, Stn B, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Kaplan, DL (corresponding author), Vanderbilt Univ, Stn B, Dept Biol Sci, Box 35-1634, Nashville, TN 37235 USA.	daniel.kaplan@vanderbilt.edu		Kaplan, Daniel/0000-0003-2760-7745	American Cancer Society [RSG-08-124-01-CCG]; National Science Foundation [1121534]; Vanderbilt University; Vanderbilt Ingram Cancer Center	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Vanderbilt University; Vanderbilt Ingram Cancer Center	This work was supported by American Cancer Society Research Scholar Grant RSG-08-124-01-CCG (to D.L.K. and I.B.), National Science Foundation Grant 1121534 (to D.L.K. and I.B.), a Vanderbilt University Discovery grant (to D.L.K.), and a Vanderbilt Ingram Cancer Center grant (to D.L.K.).	Araki H, 2010, CURR OPIN CELL BIOL, V22, P766, DOI 10.1016/j.ceb.2010.07.015; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Diffley JFX, 2010, COLD SH Q B, V75, P135, DOI 10.1101/sqb.2010.75.062; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Masai H, 2011, J BIOCHEM, V149, P629, DOI 10.1093/jb/mvr031; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; SANCHEZDIAZ A, 2004, SCI STKE, pPL8, DOI DOI 10.1126/STKE.2232004PL8; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	42	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36414	36426		10.1074/jbc.M111.282822	http://dx.doi.org/10.1074/jbc.M111.282822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868389	Green Published, hybrid			2022-12-25	WOS:000296538300027
J	Coppe, JP; Rodier, F; Patil, CK; Freund, A; Desprez, PY; Campisi, J				Coppe, Jean-Philippe; Rodier, Francis; Patil, Christopher K.; Freund, Adam; Desprez, Pierre-Yves; Campisi, Judith			Tumor Suppressor and Aging Biomarker p16(INK4a) Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; REPLICATIVE SENESCENCE; FIBROBLAST SENESCENCE; TRIGGERS SENESCENCE; DEPENDENT KINASES; HUMAN-CELLS; EXPRESSION; GROWTH; P53; INHIBITORS	Cellular senescence suppresses cancer by preventing the proliferation of cells that experience potentially oncogenic stimuli. Senescent cells often express p16(INK4a), a cyclin-dependent kinase inhibitor, tumor suppressor, and biomarker of aging, which renders the senescence growth arrest irreversible. Senescent cells also acquire a complex phenotype that includes the secretion of many cytokines, growth factors, and proteases, termed a senescence-associated secretory phenotype (SASP). The SASP is proposed to underlie age-related pathologies, including, ironically, late life cancer. Here, we show that ectopic expression of p16(INK4a) and another cyclin-dependent kinase inhibitor, p21(CIP1/WAF1), induces senescence without a SASP, even though they induced other features of senescence, including a stable growth arrest. Additionally, human fibroblasts induced to senesce by ionizing radiation or oncogenic RAS developed a SASP regardless of whether they expressed p16(INK4a). Cells induced to senesce by ectopic p16(INK4a) expression lacked paracrine activity on epithelial cells, consistent with the absence of a functional SASP. Nonetheless, expression of p16(INK4a) by cells undergoing replicative senescence limited the accumulation of DNA damage and premature cytokine secretion, suggesting an indirect role for p16(INK4a) in suppressing the SASP. These findings suggest that p16(INK4a)-positive cells may not always harbor a SASP in vivo and, furthermore, that the SASP is not a consequence of p16(INK4a) activation or senescence per se, but rather is a damage response that is separable from the growth arrest.	[Coppe, Jean-Philippe; Rodier, Francis; Patil, Christopher K.; Freund, Adam; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Coppe, Jean-Philippe; Rodier, Francis; Patil, Christopher K.; Freund, Adam; Desprez, Pierre-Yves; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Rodier, Francis] Univ Montreal, Inst Canc Montreal, Dept Radiol Radiooncol & Nucl Med, CRCHUM, Montreal, PQ H2L 4M1, Canada; [Desprez, Pierre-Yves] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA	Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Universite de Montreal; California Pacific Medical Center; California Pacific Medical Center Research Institute	Campisi, J (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	jcampisi@buckinstitute.org		Rodier, Francis/0000-0003-2523-309X	National Institutes of Health [AG09909, AG017242, CA126540]; NATIONAL CANCER INSTITUTE [U54CA126540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG009909, R01AG009909, R37AG009909, P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG09909, AG017242, and CA126540 (to J. C.).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204; Chang BD, 1999, CANCER RES, V59, P3761; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donehower LA, 1996, SEMIN CANCER BIOL, V7, P269, DOI 10.1006/scbi.1996.0035; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen GP, 1999, LAB INVEST, V79, P1137; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stein GH, 1999, MOL CELL BIOL, V19, P2109; te Poele RH, 2002, CANCER RES, V62, P1876; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zindy F, 1997, CELL GROWTH DIFFER, V8, P1139	62	279	288	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36396	36403		10.1074/jbc.M111.257071	http://dx.doi.org/10.1074/jbc.M111.257071			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880712	Green Published, hybrid			2022-12-25	WOS:000296538300025
J	Shang, Y; Li, YP; Lin, HF; Yang, ZH				Shang, Yue; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao			Enhancing Biomedical Text Summarization Using Semantic Relation Extraction	PLOS ONE			English	Article								Automatic text summarization for a biomedical concept can help researchers to get the key points of a certain topic from large amount of biomedical literature efficiently. In this paper, we present a method for generating text summary for a given biomedical concept, e.g., H1N1 disease, from multiple documents based on semantic relation extraction. Our approach includes three stages: 1) We extract semantic relations in each sentence using the semantic knowledge representation tool SemRep. 2) We develop a relation-level retrieval method to select the relations most relevant to each query concept and visualize them in a graphic representation. 3) For relations in the relevant set, we extract informative sentences that can interpret them from the document collection to generate text summary using an information retrieval based method. Our major focus in this work is to investigate the contribution of semantic relation extraction to the task of biomedical text summarization. The experimental results on summarization for a set of diseases show that the introduction of semantic knowledge improves the performance and our results are better than the MEAD system, a well-known tool for text summarization.	[Shang, Yue; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Shang, Y (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	shangyue@mail.dlut.edu.cn			Natural Science Foundation of China [60673039, 61070098]; National High Tech Research and Development Plan of China [2006AA01Z151]; Doctoral Program Foundation of Institutions of Higher Education of China [20090041110002]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This research was supported by grants from the Natural Science Foundation of China (No. 60673039 and 61070098), the National High Tech Research and Development Plan of China (No. 2006AA01Z151), Doctoral Program Foundation of Institutions of Higher Education of China(20090041110002), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	[Anonymous], UMLS SEM NETW; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Carbonell J., 1998, Proceedings of the 21st Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P335, DOI 10.1145/290941.291025; Clarke C. L. A., 2008, P 31 ANN INT ACM SIG, P659, DOI DOI 10.1145/1390334.1390446; CUTTING D, 1992, THIRD CONFERENCE ON APPLIED NATURAL LANGUAGE PROCESSING, P133; EDMUNDSON HP, 1969, J ACM, V16, P264, DOI 10.1145/321510.321519; Erkan G, 2004, J ARTIF INTELL RES, V22, P457, DOI 10.1613/jair.1523; Fiszman M., 2004, P HLT NAACL WORKSH C, P76, DOI DOI 10.3115/1596431.1596442; Hersh W, 2006, 15 TEXT RETR C; Jones K. S., 2000, Information Processing & Management, V36, P809, DOI 10.1016/S0306-4573(00)00016-9; Lin C.-Y., 2004, TEXT SUMMARIZATION B, P74, DOI DOI 10.3115/V1/D14-1020; Lin CY, 2006, P N AM CHAPT ASS COM, P71; Ling Xu, 2006, Pac Symp Biocomput, P40; Ling X, 2007, INFORM PROCESS MANAG, V43, P1777, DOI 10.1016/j.ipm.2007.01.018; LUHN HP, 1958, IBM J RES DEV, V2, P159, DOI 10.1147/rd.22.0159; McKeown K., 1995, SIGIR Forum, P74; Mihalcea R., 2004, P 2004 C EMP METH NA, P404, DOI DOI 10.3115/1219044.1219064; Reeve LH, 2007, INFORM PROCESS MANAG, V43, P1765, DOI 10.1016/j.ipm.2007.01.026; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Rindflesch TC, 2005, INT SER I S, V8, P399; Teufel S., 1997, Intelligent Scalable Text Summarization. Proceedings of a Workshop, P58; Wan Xiaojun, 2008, P C EMP METH NAT LAN, P755; Workman TE, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-6; Workman TE, 2010, J MED LIBR ASSOC, V98, P273, DOI 10.3163/1536-5050.98.4.003; Zhan JM, 2009, EXPERT SYST APPL, V36, P2107, DOI 10.1016/j.eswa.2007.12.039	26	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23862	10.1371/journal.pone.0023862	http://dx.doi.org/10.1371/journal.pone.0023862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	812MY	21887336	gold, Green Published			2022-12-25	WOS:000294298800021
J	Belforte, N; Sande, PH; de Zavalia, N; Fernandez, DC; Silberman, DM; Chianelli, MS; Rosenstein, RE				Belforte, Nicolas; Sande, Pablo H.; de Zavalia, Nuria; Fernandez, Diego C.; Silberman, Dafne M.; Chianelli, Monica S.; Rosenstein, Ruth E.			Ischemic Tolerance Protects the Rat Retina from Glaucomatous Damage	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; INTRAOCULAR-PRESSURE; OXIDATIVE STRESS; OPTIC NEUROPATHY; NEURONAL DEATH; REPERFUSION; MECHANISMS; INJURY; MODEL; NEUROPROTECTION	Glaucoma is a leading cause of acquired blindness which may involve an ischemic-like insult to retinal ganglion cells and optic nerve head. We investigated the effect of a weekly application of brief ischemia pulses (ischemic conditioning) on the rat retinal damage induced by experimental glaucoma. Glaucoma was induced by weekly injections of chondroitin sulfate (CS) in the rat eye anterior chamber. Retinal ischemia was induced by increasing intraocular pressure to 120 mmHg for 5 min; this maneuver started after 6 weekly injections of vehicle or CS and was weekly repeated in one eye, while the contralateral eye was submitted to a sham procedure. Glaucoma was evaluated in terms of: i) intraocular pressure (IOP), ii) retinal function (electroretinogram (ERG)), iii) visual pathway function (visual evoked potentials, (VEPs)) iv) histology of the retina and optic nerve head. Retinal thiobarbituric acid substances levels were assessed as an index of lipid peroxidation. Ischemic conditioning significantly preserved ERG, VEPs, as well as retinal and optic nerve head structure from glaucomatous damage, without changes in IOP. Moreover, ischemia pulses abrogated the increase in lipid peroxidation induced by experimental glaucoma. These results indicate that induction of ischemic tolerance could constitute a fertile avenue for the development of new therapeutic strategies in glaucoma treatment.	[Belforte, Nicolas; Sande, Pablo H.; de Zavalia, Nuria; Fernandez, Diego C.; Silberman, Dafne M.; Chianelli, Monica S.; Rosenstein, Ruth E.] Univ Buenos Aires CEFyBO, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, CONICET,Sch Med, Buenos Aires, DF, Argentina; [Belforte, Nicolas; Fernandez, Diego C.] Univ Moron, Sch Med, Histol Lab, Moron, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Belforte, N (corresponding author), Univ Buenos Aires CEFyBO, Lab Retinal Neurochem & Expt Ophthalmol, Dept Human Biochem, CONICET,Sch Med, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar		Fernandez, Diego Carlos/0000-0002-4363-1318; Belforte, Nicolas/0000-0001-5857-8006	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); University of Buenos Aires; CONICET, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); University of Buenos Aires(University of Buenos Aires); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), the University of Buenos Aires, and CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belforte N, 2010, INVEST OPHTH VIS SCI, V51, P5768, DOI 10.1167/iovs.10-5660; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; Casson RJ, 2003, INVEST OPHTH VIS SCI, V44, P1348, DOI 10.1167/iovs.02-0368; Chauhan BC, 2002, INVEST OPHTH VIS SCI, V43, P2969; Chung HS, 1999, SURV OPHTHALMOL, V43, pS43, DOI 10.1016/S0039-6257(99)00050-8; Delaney Y, 2006, OPTOMETRY VISION SCI, V83, P406, DOI 10.1097/01.opx.0000225877.13217.01; Dijk F, 2007, EXP EYE RES, V84, P858, DOI 10.1016/j.exer.2007.01.006; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 1994, SURV OPHTHALMOL, V38, pS3; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Galassi F, 2003, ARCH OPHTHALMOL-CHIC, V121, P1711, DOI 10.1001/archopht.121.12.1711; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Grippo TM, 2006, INVEST OPHTH VIS SCI, V47, P5331, DOI 10.1167/iovs.06-0527; Gugleta K, 2009, Praxis (Bern 1994), V98, P201, DOI 10.1024/1661-8157.98.4.201; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; Li B, 2000, EXP EYE RES, V70, P755, DOI 10.1006/exer.2000.0843; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moreno MC, 2005, FASEB J, V19, P1161, DOI 10.1096/fj.04-3313fje; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; Na HS, 1996, AM HEART J, V132, P78, DOI 10.1016/S0002-8703(96)90393-2; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; PAPST N, 1984, GRAEF ARCH CLIN EXP, V222, P29, DOI 10.1007/BF02133774; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Roth S, 2004, BRAIN RES BULL, V62, P461, DOI 10.1016/j.brainresbull.2003.07.006; Roth S, 1998, INVEST OPHTH VIS SCI, V39, P777; Sakamoto K, 2001, EUR J PHARMACOL, V418, P89, DOI 10.1016/S0014-2999(01)00938-4; Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Viswanathan S, 2000, INVEST OPHTH VIS SCI, V41, P2797; Yamamoto T, 1998, PROG RETIN EYE RES, V17, P127, DOI 10.1016/S1350-9462(97)00009-8; Yu SY, 2005, J SURG RES, V128, P28, DOI 10.1016/j.jss.2005.04.025; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zink JM, 2003, BRIT J OPHTHALMOL, V87, P1487, DOI 10.1136/bjo.87.12.1487	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23763	10.1371/journal.pone.0023763	http://dx.doi.org/10.1371/journal.pone.0023763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887313	Green Published, gold			2022-12-25	WOS:000295832000054
J	Tsai, YW; Yang, YR; Wang, PS; Wang, RY				Tsai, Yi-Wei; Yang, Yea-Ru; Wang, Paulus S.; Wang, Ray-Yau			Intermittent Hypoxia after Transient Focal Ischemia Induces Hippocampal Neurogenesis and c-Fos Expression and Reverses Spatial Memory Deficits in Rats	PLOS ONE			English	Article							LONG-TERM-MEMORY; ADULT NEUROGENESIS; COGNITIVE DEFICITS; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; BRAIN; PHOSPHORYLATION; TRANSCRIPTION; PLASTICITY; MILD	Background: Memory impairment is a frequent complication of brain ischemia. Neurogenesis is implicated in learning and memory and is regulated by the transcription factor c-Fos. Preconditioning intermittent hypoxia (IH) attenuates ischemia-related memory impairments, but it is not known whether post-ischemia IH intervention has a similar effect. We investigated the effects of post-ischemia IH on hippocampal neurogenesis and c-Fos expression as well as spatial learning and memory in rats. Methodology/Principal Findings: Focal cerebral ischemia was induced in some rats by middle cerebral artery occlusion (MCAO), while other rats received sham MCAO surgery. Beginning a week later, half of the rats of each group received IH interventions (12% oxygen concentration, 4 hrs/d, for 7 d) and half received sham IH sessions. An additional group of rats received MCAO, IH, and injections of the neurogenesis-impairing agent 3'-AZT. Spatial learning and memory was measured in the Morris water maze, and hippocampal neurogenesis and c-Fos expression were examined. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) and phosphorylated mitogen-activated protein kinase (pMAPK) were considered as possible mediators of IH-induced changes in neurogenesis and c-Fos expression. IH intervention following MCAO resulted in recovered spatial memory, increased hippocampal neurogenesis, and increased expression of c-Fos in newborn hippocampal cells. These effects were blocked by 3'-AZT. IH intervention following MCAO also was associated with increased hippocampal pMAPK and HIF-1 alpha expression. Conclusions/Significance: IH intervention following MCAO rescued ischemia-induced spatial learning and memory impairments, likely by inducing hippocampal neurogenesis and c-Fos expression through mediators including pMAPK and HIF-1 alpha	[Tsai, Yi-Wei; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Tsai, Yi-Wei; Yang, Yea-Ru; Wang, Ray-Yau] Natl Yang Ming Univ, Inst Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Wang, Paulus S.] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan; [Wang, Paulus S.] Natl Yang Ming Univ, Inst Physiol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Tsai, YW (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	rywang@ym.edu.tw			Aim for Top University, Ministry of Education, Republic of China; National Science Council of Republic of China [NSC 98-2314-B-010-004-MY3]	Aim for Top University, Ministry of Education, Republic of China; National Science Council of Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the Aim for Top University, Ministry of Education, Republic of China and the National Science Council of Republic of China (grant no. NSC 98-2314-B-010-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Countryman RA, 2005, HIPPOCAMPUS, V15, P56, DOI 10.1002/hipo.20030; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Hattori K, 2000, STROKE, V31, P1939, DOI 10.1161/01.STR.31.8.1939; HIRAKAWA M, 1994, STROKE, V25, P2471, DOI 10.1161/01.STR.25.12.2471; Jenkins TA, 2006, NEUROSCIENCE, V137, P747, DOI 10.1016/j.neuroscience.2005.09.034; Li WL, 2009, J NEUROSCI RES, V87, P112, DOI 10.1002/jnr.21829; Lin AMY, 2003, ANN NY ACAD SCI, V993, P168, DOI 10.1111/j.1749-6632.2003.tb07527.x; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Pourie G, 2006, NEUROSCIENCE, V140, P1369, DOI 10.1016/j.neuroscience.2006.02.083; Rybnikova E, 2005, BEHAV BRAIN RES, V160, P107, DOI 10.1016/j.bbr.2004.11.023; Rybnikova E, 2009, NEUROSCI RES, V65, P360, DOI 10.1016/j.neures.2009.08.013; Shao Guo, 2006, Neurosignals, V15, P314, DOI 10.1159/000121368; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tsai YW, 2008, CHINESE J PHYSIOL, V51, P324; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Zhu LL, 2005, BRAIN RES, V1055, P1, DOI 10.1016/j.brainres.2005.04.075	24	68	81	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24001	10.1371/journal.pone.0024001	http://dx.doi.org/10.1371/journal.pone.0024001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887361	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000085
J	Cooper, CDO; Lawrie, CH; Liggins, AP; Collins, GP; Hatton, CSR; Pulford, K; Banham, AH				Cooper, Christopher D. O.; Lawrie, Charles H.; Liggins, Amanda P.; Collins, Graham P.; Hatton, Christian S. R.; Pulford, Karen; Banham, Alison H.			Identification and Characterization of Peripheral T-Cell Lymphoma-Associated SEREX Antigens	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; TUMOR-ASSOCIATED ANTIGENS; GENE-EXPRESSION ANALYSIS; RNA-POLYMERASE-II; CHROMOSOMAL INSTABILITY; PROTEIN; ALK; KINASE; ELONGATION; AUTOPHAGY	Peripheral T-cell lymphomas (PTCL) are generally less common and pursue a more aggressive clinical course than B-cell lymphomas, with the T-cell phenotype itself being a poor prognostic factor in adult non-Hodgkin lymphoma (NHL). With notable exceptions such as ALK(+) anaplastic large cell lymphoma (ALCL, ALK+), the molecular abnormalities in PTCL remain poorly characterised. We had previously identified circulating antibodies to ALK in patients with ALCL, ALK(+). Thus, as a strategy to identify potential antigens associated with the pathogenesis of PTCL, not otherwise specified (PTCL, NOS), we screened a testis cDNA library with sera from four PTCL, NOS patients using the SEREX (serological analysis of recombinant cDNA expression libraries) technique. We identified nine PTCL, NOS-associated antigens whose immunological reactivity was further investigated using sera from 52 B- and T-cell lymphoma patients and 17 normal controls. The centrosomal protein CEP250 was specifically recognised by patients sera and showed increased protein expression in cell lines derived from T-cell versus B-cell malignancies. TCEB3, BECN1, and two previously uncharacterised proteins, c14orf93 and ZBTB44, were preferentially recognised by patients' sera. Transcripts for all nine genes were identified in 39 cancer cell lines and the five genes encoding preferentially lymphoma-recognised antigens were widely expressed in normal tissues and mononuclear cell subsets. In summary, this study identifies novel molecules that are immunologically recognised in vivo by patients with PTCL, NOS. Future studies are needed to determine whether these tumor antigens play a role in the pathogenesis of PTCL.	[Cooper, Christopher D. O.; Lawrie, Charles H.; Liggins, Amanda P.; Pulford, Karen; Banham, Alison H.] Univ Oxford, John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Cooper, Christopher D. O.] Univ Oxford, Struct Genom Consortium, Oxford OX3 9DU, England; [Lawrie, Charles H.] Biodonostia Inst, San Sebastian, Spain; [Collins, Graham P.; Hatton, Christian S. R.] John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; Instituto de Investigacion Sanitaria Biodonostia; University of Oxford	Cooper, CDO (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England.	charles.lawrie@ndcls.ox.ac.uk; alison.banham@ndcls.ox.ac.uk	Cooper, Christopher/E-8392-2013; Cooper, Chris/G-9982-2014; Banham, Alison H/B-2966-2009	Cooper, Chris/0000-0002-9197-8041; Collins, Graham/0000-0002-8803-4234; Lawrie, Charles/0000-0002-8882-1131; Banham, Alison/0000-0002-3197-273X	Leukaemia and Lymphoma Research and the Julian Starmer-Smith Memorial Fund	Leukaemia and Lymphoma Research and the Julian Starmer-Smith Memorial Fund	This work was supported by grants from Leukaemia and Lymphoma Research and the Julian Starmer-Smith Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Tahar K, 2010, BLOOD, V115, P3314, DOI 10.1182/blood-2009-11-251892; Ait-Taharl K, 2006, INT J CANCER, V118, P688, DOI 10.1002/ijc.21410; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Chan WC, 1997, BLOOD, V89, P3909; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; COIFFIER B, 1990, ANN ONCOL, V1, P45, DOI 10.1093/oxfordjournals.annonc.a057673; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cuadros M, 2007, J CLIN ONCOL, V25, P3321, DOI 10.1200/JCO.2006.09.4474; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Eichmuller S, 2003, INT J CANCER, V104, P482, DOI 10.1002/ijc.10967; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Forgber M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008376; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Hartmann TB, 2004, BRIT J DERMATOL, V150, P252, DOI 10.1111/j.1365-2133.2004.05651.x; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; JAFFE E, 2001, WHO CLASSIFICATION T, P190; Kramer A, 2003, LEUKEMIA, V17, P2207, DOI 10.1038/sj.leu.2403142; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee M, 2007, CANCER IMMUNOL IMMUN, V56, P783, DOI 10.1007/s00262-006-0239-2; Lepretre S, 2000, CANCER GENET CYTOGEN, V117, P71, DOI 10.1016/S0165-4608(99)00151-X; Li CY, 2006, J IMMUNOL, V177, P5163, DOI 10.4049/jimmunol.177.8.5163; Liggins AP, 2005, METH MOLEC MED, V115, P109; Liggins AP, 2004, INT J CANCER, V110, P563, DOI 10.1002/ijc.20170; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Martinez-Delgado B, 2006, HEMATOL ONCOL, V24, P113, DOI 10.1002/hon.781; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Miyata K, 2007, CELL DEATH DIFFER, V14, P716, DOI 10.1038/sj.cdd.4402067; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Piccaluga PP, 2007, CANCER RES, V67, P10703, DOI 10.1158/0008-5472.CAN-07-1708; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pulford K, 2000, BLOOD, V96, P1605, DOI 10.1182/blood.V96.4.1605.h8001605_1605_1607; Pulford K, 1997, BLOOD, V89, P1394, DOI 10.1182/blood.V89.4.1394; PULFORD K, 2004, J CELL PHYS IN PRESS; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RODRIGUEZ J, 2008, CRIT REV ONCOL HEMAT; Rodriguez J, 2007, EUR J HAEMATOL, V79, P32, DOI 10.1111/j.1600-0609.2007.00856.x; Sambrook J., 2002, MOL CLONING LAB MANU; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Shiota M, 1996, LEUKEMIA LYMPHOMA, V23, P25, DOI 10.3109/10428199609054798; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Swerdlow E., 2008, WHO CLASSIFICATION T; van de Wetering CI, 2007, CANCER RES, V67, P8081, DOI 10.1158/0008-5472.CAN-07-1666; Went P, 2006, J CLIN ONCOL, V24, P2472, DOI 10.1200/JCO.2005.03.6327; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017; ZYSS D, 2009, TRENDS CELL BIOL	51	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23916	10.1371/journal.pone.0023916	http://dx.doi.org/10.1371/journal.pone.0023916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887344	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000294251800038
J	Grami, B; Rasconi, S; Niquil, N; Jobard, M; Saint-Beat, B; Sime-Ngando, T				Grami, Boutheina; Rasconi, Serena; Niquil, Nathalie; Jobard, Marlene; Saint-Beat, Blanche; Sime-Ngando, Telesphore			Functional Effects of Parasites on Food Web Properties during the Spring Diatom Bloom in Lake Pavin: A Linear Inverse Modeling Analysis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ASTERIONELLA-FORMOSA; BACTERIAL PRODUCTION; CONVERSION FACTORS; SEASONAL DYNAMICS; CELL-VOLUME; ENERGY-FLOW; ECOSYSTEM; WATER; STABILITY	This study is the first assessment of the quantitative impact of parasitic chytrids on a planktonic food web. We used a carbon-based food web model of Lake Pavin (Massif Central, France) to investigate the effects of chytrids during the spring diatom bloom by developing models with and without chytrids. Linear inverse modelling procedures were employed to estimate undetermined flows in the lake. The Monte Carlo Markov chain linear inverse modelling procedure provided estimates of the ranges of model-derived fluxes. Model results support recent theories on the probable impact of parasites on food web function. In the lake, during spring, when 'inedible' algae (unexploited by planktonic herbivores) were the dominant primary producers, the epidemic growth of chytrids significantly reduced the sedimentation loss of algal carbon to the detritus pool through the production of grazer-exploitable zoospores. We also review some theories about the potential influence of parasites on ecological network properties and argue that parasitism contributes to longer carbon path lengths, higher levels of activity and specialization, and lower recycling. Considering the "structural asymmetry" hypothesis as a stabilizing pattern, chytrids should contribute to the stability of aquatic food webs.	[Grami, Boutheina; Rasconi, Serena; Niquil, Nathalie; Saint-Beat, Blanche] Univ La Rochelle, CNRS, UMR Littoral Environm & Soc LIENSs 6250, La Rochelle, France; [Rasconi, Serena; Jobard, Marlene; Sime-Ngando, Telesphore] Clermont Univ, LMGE, Lab Microorganismes Genome & Environm, UMR CNRS 6023, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Grami, B (corresponding author), Univ La Rochelle, CNRS, UMR Littoral Environm & Soc LIENSs 6250, La Rochelle, France.	nniquil@univ-lr.fr	Niquil, Nathalie/N-2561-2013; Sime-Ngando, Télesphore/M-4134-2019; Niquil, Nathalie/C-8233-2009	Sime-Ngando, Télesphore/0000-0002-7240-5803; Niquil, Nathalie/0000-0002-0772-754X; Saint-Beat, Blanche/0000-0002-2401-2052; GRAMI, Boutheina/0000-0001-5537-4817; Rasconi, Serena/0000-0001-6667-8904	French ANR (Agence Nationale de la Recherche); DREP; CNRS; Region Poitou-Charentes	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); DREP; CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This study was supported by a grant from the French ANR (Agence Nationale de la Recherche) Programme Blanc 'DREP: Diversite et Roles des Eumycetes dans le Pelagos'; Coordinator TSN. B. G. and S. R. were supported by grants from DREP (T.S.-N., N.N.). B. S. B. was supported by a PhD fellowship from the CNRS and Region Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD C, 1992, MICROBIAL ECOL, V24, P109, DOI 10.1007/BF00174449; AMBLARD C, 1990, J PLANKTON RES, V12, P645, DOI 10.1093/plankt/12.3.645; AMBLARD C, 1978, THESIS U CLERMONT FD; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; Arias-Gonzalez JE, 2006, MAR ECOL PROG SER, V320, P43, DOI 10.3354/meps320043; Arnous MB, 2010, AQUAT SCI, V72, P245, DOI 10.1007/s00027-010-0127-x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; Baird D, 1996, WATER SA, V22, P307; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Baird D, 1998, ESTUAR COAST SHELF S, V47, P329, DOI 10.1006/ecss.1998.0360; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Bettarel Y, 2003, MICROB ECOL, V45, P119, DOI 10.1007/s00248-002-1016-1; Bettarel Y, 2002, ANN LIMNOL-INT J LIM, V38, P263, DOI 10.1051/limn/2002021; BJORNSEN PK, 1986, APPL ENVIRON MICROB, V51, P1199; BORSHEIM KY, 1987, MAR ECOL PROG SER, V36, P171, DOI 10.3354/meps036171; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CANTER HM, 1979, NEW PHYTOL, V82, P187, DOI 10.1111/j.1469-8137.1979.tb07574.x; CANTER HM, 1969, OSTERR BOT Z, V116, P351, DOI 10.1007/BF01379634; CANTER HM, 1950, ANN BOT-LONDON, V14, P263, DOI 10.1093/oxfordjournals.aob.a083246; CANTER HM, 1951, ANN BOT-LONDON, V15, P359; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491, DOI 10.1128/AEM.46.2.491-498.1983; Carrias JF, 1998, FRESHWATER BIOL, V39, P91, DOI 10.1046/j.1365-2427.1998.00263.x; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; DEANGELIS DL, 1980, ECOLOGY, V61, P764, DOI 10.2307/1936746; DEVAUX J, 1980, HYDROBIOLOGIA, V62, P67; DEVAUX J, 1976, ANN STN BIOL BESSE E, V10, P1; Dobson AR, 2006, SFI S SCI C, P119; DUSSART B., 1967, COPEPODES EAUX CONTI, P500; Elton C. S., 1958, ECOLOGY INVASIONS AN; Feller R.J., 1988, P181; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; GLEASON FH, 2009, NEWSLETTER MYCOL SOC, V59, P1; Gradinger R, 1999, DEEP-SEA RES PT II, V46, P1457, DOI 10.1016/S0967-0645(99)00030-2; Grami B, 2008, ESTUAR COAST SHELF S, V79, P101, DOI 10.1016/j.ecss.2008.03.009; Hosack GR, 2009, ECOL MODEL, V220, P1054, DOI 10.1016/j.ecolmodel.2009.01.033; HUBERPESTALOZZI G, 1946, NEW PHYTOL, V47, P238; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; HUXHAM M, 1995, J ANIM ECOL, V64, P168, DOI 10.2307/5752; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Jobard M, 2010, J MICROBIOL METH, V83, P236, DOI 10.1016/j.mimet.2010.09.006; Johnson GA, 2009, ECOL MODEL, V220, P3448, DOI 10.1016/j.ecolmodel.2009.08.003; Jordan F, 2003, ECOL MODEL, V161, P117, DOI 10.1016/S0304-3800(02)00296-X; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2007, P R SOC B, V274, P1561, DOI 10.1098/rspb.2007.0425; Kagami M, 2006, LIMNOL OCEANOGR, V51, P2775, DOI 10.4319/lo.2006.51.6.2775; Kagami M, 2011, HYDROBIOLOGIA, V659, P49, DOI 10.1007/s10750-010-0274-z; KANKAALA P, 1986, J PLANKTON RES, V8, P1027, DOI 10.1093/plankt/8.6.1027; Kay J. J, 1989, NETWORK ANAL MARINE; Kones JK, 2006, J MARINE SYST, V60, P153, DOI 10.1016/j.jmarsys.2005.12.002; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; KUDOH S, 1990, J PHYCOL, V26, P239, DOI 10.1111/j.0022-3646.1990.00239.x; KURIS AM, 2008, NATURE, V24, P15; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty Kevin D., 2006, P119; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Legendre L., 1991, PARTICLE ANAL OCEANO, P261, DOI [DOI 10.1007/978-3-642-75121-9_11, 10.1007/978-3-642-75121-9_11]; Lepere C, 2010, ISME J, V4, P1509, DOI 10.1038/ismej.2010.83; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; Marquis E, 2007, ESTUAR COAST SHELF S, V73, P223, DOI 10.1016/j.ecss.2007.01.003; May R. M., 1973, STABILITY COMPLEXITY; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCauley E., 1984, IBP HDB, P228; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; MULLIN MM, 1966, LIMNOL OCEANOGR, V11, P307, DOI 10.4319/lo.1966.11.2.0307; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Niquil N, 1998, MAR ECOL PROG SER, V165, P17, DOI 10.3354/meps165017; NIQUIL N, 2012, TREATISE COASTAL EST, V9, pCH9; Niquil N, 2006, FRESHWATER BIOL, V51, P1570, DOI 10.1111/j.1365-2427.2006.01595.x; Niquil N, 2011, HYDROBIOLOGIA, V659, P65, DOI 10.1007/s10750-010-0308-6; Not F, 2002, AQUAT MICROB ECOL, V28, P157, DOI 10.3354/ame028157; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; PACE ML, 1981, LIMNOL OCEANOGR, V26, P822, DOI 10.4319/lo.1981.26.5.0822; PASCUAL M, 2006, ECOLOGICAL NETWORKS; Petit M, 1999, FRESHWATER BIOL, V42, P513, DOI 10.1046/j.1365-2427.1999.00500.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pimm SL, 1991, BALANCE NATURE ECOLO; PREPAS E, 1978, LIMNOL OCEANOGR, V23, P557, DOI 10.4319/lo.1978.23.3.0557; PUTT M, 1989, LIMNOL OCEANOGR, V34, P1097, DOI 10.4319/lo.1989.34.6.1097; RASCONI S, 2010, THESIS BLAISE PASCAL; Rasconi S, 2009, APPL ENVIRON MICROB, V75, P2545, DOI 10.1128/AEM.02211-08; RIEMANN F, 1990, MAR BIOL, V104, P453, DOI 10.1007/BF01314349; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; RUTLEDGE RW, 1976, J THEOR BIOL, V57, P355, DOI 10.1016/0022-5193(76)90007-2; Sigee D. C., 2005, FRESHWATER MICROBIOL; SIMENGANDO T, 1991, EUR J PROTISTOL, V27, P249, DOI 10.1016/S0932-4739(11)80062-3; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SONDERGAARD M, 1991, MAR ECOL PROG SER, V79, P139, DOI 10.3354/meps079139; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; SUBERKROPP KF, 1973, ARCH MIKROBIOL, V89, P205, DOI 10.1007/BF00422201; Thompson RM, 2005, J ANIM ECOL, V74, P77, DOI 10.1111/j.1365-2656.2004.00899.x; Tsui C.K.M., 2003, FUNGAL DIVERSITY RES, V10; Tukey JW, 1977, EXPLORATORY DATA ANA; Ulanowicz R. E., 1991, Environmental Software, V6, P131, DOI 10.1016/0266-9838(91)90024-K; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; ULANOWICZ RE, 1979, AM NAT, V114, P871, DOI 10.1086/283534; ULANOWICZ RE, 1980, J THEOR BIOL, V85, P223, DOI 10.1016/0022-5193(80)90019-3; Ulanowicz RE, 2003, COMPUT BIOL CHEM, V27, P523, DOI 10.1016/S1476-9271(03)00050-1; ULANOWICZ RE, 1988, ECOL MODEL, V43, P45, DOI 10.1016/0304-3800(88)90072-5; ULANOWICZ RE, 1991, COMPARATIVE ANALYSES OF ECOSYSTEMS, P140; ULANOWICZ RE, 1990, INT J SYST SCI, V21, P429, DOI 10.1080/00207729008910372; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Donk E., 1989, P171; VANDONK E, 1983, FRESHWATER BIOL, V13, P241; VEZINA AF, 1988, MAR ECOL PROG SER, V42, P269, DOI 10.3354/meps042269; Weinbauer MG, 2002, AQUAT MICROB ECOL, V27, P103, DOI 10.3354/ame027103; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Yoshimizu Chikage, 2001, Limnology, V2, P37, DOI 10.1007/s102010170014	118	52	53	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23273	10.1371/journal.pone.0023273	http://dx.doi.org/10.1371/journal.pone.0023273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887240	Green Published, gold			2022-12-25	WOS:000294251800009
J	Kuete, V; Wabo, HK; Eyong, KO; Feussi, MT; Wiench, B; Krusche, B; Tane, P; Folefoc, GN; Efferth, T				Kuete, Victor; Wabo, Hippolyte K.; Eyong, Kenneth O.; Feussi, Michel T.; Wiench, Benjamin; Krusche, Benjamin; Tane, Pierre; Folefoc, Gabriel N.; Efferth, Thomas			Anticancer Activities of Six Selected Natural Compounds of Some Cameroonian Medicinal Plants	PLOS ONE			English	Article							ANTHRAQUINONE COUPLED PIGMENT; ANTIMICROBIAL ACTIVITY; CONSTITUENTS; NEWBOULDIAQUINONE; EXTRACTS	Background: Natural products are well recognized as sources of drugs in several human ailments. In the present work, we carried out a preliminary screening of six natural compounds, xanthone V-1 (1); 2-acetylfuro-1,4-naphthoquinone (2); physcion (3); bisvismiaquinone (4); vismiaquinone (5); 1,8-dihydroxy-3-geranyloxy-6-methylanthraquinone (6) against MiaPaCa-2 pancreatic and CCRF-CEM leukemia cells and their multidrug-resistant subline, CEM/ADR5000. Compounds 1 and 2 were then tested in several other cancer cells and their possible mode of action were investigated. Methodology/Findings: The tested compounds were previously isolated from the Cameroonian medicinal plants Vismia laurentii (1, 3, 4, 5 and 6) and Newbouldia laevis (2). The preliminary cytotoxicity results allowed the selection of xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone, which were then tested on a panel of cancer cell lines. The study was also extended to the analysis of cell cycle distribution, apoptosis induction, caspase 3/7 activation and the anti-angiogenic properties of xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone. IC50 values around or below 4 mu g/ml were obtained on 64.29% and 78.57% of the tested cancer cell lines for xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone, respectively. The most sensitive cell lines (IC50 <1 mu g/ml) were breast MCF-7 (to xanthone V-1), cervix HeLa and Caski (to xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone), leukemia PF-382 and melanoma colo-38 (to 2-acetylfuro-1,4-naphthoquinone). The two compounds showed respectively, 65.8% and 59.6% inhibition of the growth of blood capillaries on the chorioallantoic membrane of quail eggs in the anti-angiogenic assay. Upon treatment with two fold IC50 and after 72 h, the two compounds induced cell cycle arrest in S-phase, and also significant apoptosis in CCRF-CEM leukemia cells. Caspase 3/7 was activated by xanthone V-1. Conclusions/Significance: The overall results of the present study provided evidence for the cytotoxicity of compounds xanthone V-1 and 2-acetylfuro-1,4-naphthoquinone, and bring supportive data for future investigations that will lead to their use in cancer therapy.	[Kuete, Victor] Univ Dschang, Fac Sci, Dept Biochem, Dschang, Cameroon; [Kuete, Victor; Wiench, Benjamin; Krusche, Benjamin; Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharm & Biochem, Mainz, Germany; [Wabo, Hippolyte K.; Feussi, Michel T.; Tane, Pierre] Univ Dschang, Fac Sci, Dept Chem, Dschang, Cameroon; [Eyong, Kenneth O.; Folefoc, Gabriel N.] Univ Yaounde I, Dept Organ Chem, Fac Sci, Yaounde, Cameroon	Johannes Gutenberg University of Mainz; University of Yaounde I	Kuete, V (corresponding author), Univ Dschang, Fac Sci, Dept Biochem, Dschang, Cameroon.	efferth@uni-mainz.de	Victor, Kuete/O-2742-2018	Victor, Kuete/0000-0002-1070-1236; Efferth, Thomas/0000-0002-3096-3292	University of Mainz	University of Mainz	VK received a six-month funding stay at the University of Mainz paid by the University of Mainz, and a three-month stay as DAAD fellow at the University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu G, 2010, NAT PROD COMMUN, V5, P747; Boik J., 2001, NATURAL COMPOUNDS CA; Boonsri S, 2006, PHYTOCHEMISTRY, V67, P723, DOI 10.1016/j.phytochem.2006.01.007; Brahemi G, 2010, J MED CHEM, V53, P2757, DOI 10.1021/jm901757t; CORDELL GA, 1991, J ETHNOPHARMACOL, V32, P117, DOI 10.1016/0378-8741(91)90110-Y; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; DARCY PF, 1967, BRIT J PHARM CHEMOTH, V29, P378, DOI 10.1111/j.1476-5381.1967.tb01969.x; Eyong KO, 2006, PHYTOCHEMISTRY, V67, P605, DOI 10.1016/j.phytochem.2005.12.019; Eyong KO, 2005, CHEM PHARM BULL, V53, P616, DOI 10.1248/cpb.53.616; Guo SY, 2011, MOLECULES, V16, P1201, DOI 10.3390/molecules16021201; Hussein AA, 2003, J NAT PROD, V66, P858, DOI 10.1021/np020566w; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joshi SC, 2010, FOOD CHEM TOXICOL, V48, P37, DOI 10.1016/j.fct.2009.09.011; Kuete V, 2007, PHARMAZIE, V62, P552, DOI 10.1691/ph.2007.7.6757; Kuete V, 2007, J ETHNOPHARMACOL, V109, P372, DOI 10.1016/j.jep.2006.07.044; Kuete V, 2011, J ETHNOPHARMACOL, V134, P803, DOI 10.1016/j.jep.2011.01.035; Kuo YC, 1997, LIFE SCI, V61, P2335, DOI 10.1016/S0024-3205(97)00937-5; Lenta BN, 2007, MOLECULES, V12, P1548, DOI 10.3390/12081548; Ma XX, 2010, PEST MANAG SCI, V66, P718, DOI 10.1002/ps.1933; Marchesan M, 1998, PHYTOTHER RES, V12, pS33, DOI 10.1002/(SICI)1099-1573(1998)12:1+&lt;S33::AID-PTR242&gt;3.0.CO;2-B; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Popoca J, 1998, J ETHNOPHARMACOL, V59, P173, DOI 10.1016/S0378-8741(97)00110-4; Shao Li-Jun, 2010, Zhong Yao Cai, V33, P1091; Tsaffack M, 2009, CHEM PHARM BULL, V57, P1113, DOI 10.1248/cpb.57.1113; Wabo HK, 2007, CHEM PHARM BULL, V55, P1640, DOI 10.1248/cpb.55.1640; Wang Junxian, 2010, Zhongguo Zhong Yao Za Zhi, V35, P1435; WITTMANN J, 1987, J EXP ZOOL, P325	27	76	76	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e21762	10.1371/journal.pone.0021762	http://dx.doi.org/10.1371/journal.pone.0021762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886765	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100001
J	Liot, C; Seguin, L; Siret, A; Crouin, C; Schmidt, S; Bertoglio, J				Liot, Caroline; Seguin, Laetitia; Siret, Aurelie; Crouin, Catherine; Schmidt, Susanne; Bertoglio, Jacques			APC(cdh1) Mediates Degradation of the Oncogenic Rho-GEF Ect2 after Mitosis	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; CYTOKINESIS REGULATOR ECT2; AURORA-B; SIGNALING PATHWAYS; DESTRUCTION BOX; ACTIVATION; EXPRESSION; MGCRACGAP; GTPASE; PHOSPHORYLATION	Background: Besides regulation of actin cytoskeleton-dependent functions, Rho GTPase pathways are essential to cell cycle progression and cell division. Rho, Rac and Cdc42 regulate G1 to S phase progression and are involved in cytokinesis. RhoA GDP/GTP cycling is required for normal cytokinesis and recent reports have shown that the exchange factor Ect2 and the GTPase activating protein MgcRacGAP regulate RhoA activity during mitosis. We previously showed that the transcription factors E2F1 and CUX1 regulate expression of MgcRacGAP and Ect2 as cells enter S-phase. Methodology/Principal Findings: We now report that Ect2 is subject to proteasomal degradation after mitosis, following ubiquitination by the APC/C complex and its co-activator Cdh1. A proper nuclear localization of Ect2 is necessary for its degradation. APC-Cdh1 assembles K11-linked poly-ubiquitin chains on Ect2, depending upon a stretch of similar to 25 amino acid residues that contain a bi-partite NLS, a conventional D-box and two TEK-like boxes. Site-directed mutagenesis of target sequences generated stabilized Ect2 proteins. Furthermore, such degradation-resistant mutants of Ect2 were found to activate RhoA and subsequent signalling pathways and are able to transform NIH3T3 cells. Conclusions/Significance: Our results identify Ect2 as a bona fide cell cycle-regulated protein and suggest that its ubiquitination-dependent degradation may play an important role in RhoA regulation at the time of mitosis. Our findings raise the possibility that the overexpression of Ect2 that has been reported in some human tumors might result not only from deregulated transcription, but also from impaired degradation.	[Liot, Caroline; Seguin, Laetitia; Siret, Aurelie; Crouin, Catherine; Bertoglio, Jacques] Inst Gustave Roussy, Inserm U749, Villejuif, France; [Schmidt, Susanne] CNRS UMR 5237, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Liot, C (corresponding author), Inst Gustave Roussy, Inserm U749, Villejuif, France.	jacques.bertoglio@igr.fr		Seguin, Laetitia/0000-0002-9610-7093; SEGUIN, Laetitia/0000-0003-2950-4766	Inserm; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche [BLAN06 2_135169]; Ministry of Research and Education; Association pour la Recherche contre le Cancer	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministry of Research and Education; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was funded in part by Inserm, and grants from Ligue Nationale Contre le Cancer (equipe labellisee) and Agence Nationale de la Recherche grant BLAN06 2_135169. CL was supported by Ministry of Research and Education and by Association pour la Recherche contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Bouquier N, 2009, CHEM BIOL, V16, P391, DOI 10.1016/j.chembiol.2009.02.006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Eguchi T, 2007, ONCOGENE, V26, P509, DOI 10.1038/sj.onc.1209810; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hahn MA, 2005, ONCOGENE, V24, P6241, DOI 10.1038/sj.onc.1208778; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; HORI T, 1987, BLOOD, V70, P1069; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Manchinelly SAS, 2010, J BIOL CHEM, V285, P26923, DOI 10.1074/jbc.M110.103804; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mzali R, 2005, FASEB J, V19, P1911, DOI 10.1096/fj.05-4030fje; Naoe H, 2010, MOL CELL BIOL, V30, P3994, DOI 10.1128/MCB.01358-09; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Seguin L, 2009, MOL CELL BIOL, V29, P570, DOI 10.1128/MCB.01275-08; Solski PA, 2004, J BIOL CHEM, V279, P25226, DOI 10.1074/jbc.M313792200; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Su L, 2009, EXP CELL RES, V315, P1347, DOI 10.1016/j.yexcr.2009.02.014; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Toure A, 2008, FEBS LETT, V582, P1182, DOI 10.1016/j.febslet.2007.12.036; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200	50	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23676	10.1371/journal.pone.0023676	http://dx.doi.org/10.1371/journal.pone.0023676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886810	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100024
J	Howard, MK; Sabarth, N; Savidis-Dacho, H; Portsmouth, D; Kistner, O; Kreil, TR; Ehrlich, HJ; Barrett, PN				Howard, M. Keith; Sabarth, Nicolas; Savidis-Dacho, Helga; Portsmouth, Daniel; Kistner, Otfried; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel			H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model	PLOS ONE			English	Article							PANDEMIC INFLUENZA VACCINE; CELL-CULTURE; MONOCLONAL-ANTIBODIES; THERAPEUTIC-EFFICACY; EGG-ADAPTATION; H1N1 VACCINE; WILD-TYPE; INFECTION; MICE; HEMAGGLUTININ	Background: Vero cell culture-derived whole-virus H5N1 vaccines have been extensively tested in clinical trials and consistently demonstrated to be safe and immunogenic; however, clinical efficacy is difficult to evaluate in the absence of wide-spread human disease. A lethal mouse model has been utilized which allows investigation of the protective efficacy of active vaccination or passive transfer of vaccine induced sera following lethal H5N1 challenge. Methods: We used passive transfer of immune sera to investigate antibody-mediated protection elicited by a Vero cell-derived, non-adjuvanted inactivated whole-virus H5N1 vaccine. Mice were injected intravenously with H5N1 vaccine-induced rodent or human immune sera and subsequently challenged with a lethal dose of wild-type H5N1 virus. Results: Passive transfer of H5N1 vaccine-induced mouse, guinea pig and human immune sera provided dose-dependent protection of recipient mice against lethal challenge with wild-type H5N1 virus. Protective dose fifty values for serum H5N1 neutralizing antibody titers were calculated to be <= 1:11 for all immune sera, independently of source species. Conclusions: These data underpin the confidence that the Vero cell culture-derived, whole-virus H5N1 vaccine will be effective in a pandemic situation and support the use of neutralizing serum antibody titers as a correlate of protection for H5N1 vaccines.	[Howard, M. Keith; Sabarth, Nicolas; Savidis-Dacho, Helga; Portsmouth, Daniel; Kistner, Otfried; Kreil, Thomas R.; Barrett, P. Noel] Baxter BioSci, Vaccine Res & Dev, Orth, Austria; [Ehrlich, Hartmut J.] Baxter BioSci, Global Res & Dev, Vienna, Austria		Howard, MK (corresponding author), Baxter BioSci, Vaccine Res & Dev, Orth, Austria.	keith_howard@baxter.com	Sabarth, Nicolas/GQQ-0093-2022; Sabarth, Nicolas/GQP-7376-2022	Sabarth, Nicolas/0000-0003-3844-6297; 	Baxter Bioscience	Baxter Bioscience	This study was funded by Baxter Bioscience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Ascione A, 2009, ANTIVIR RES, V83, P238, DOI 10.1016/j.antiviral.2009.05.005; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Barrett PN, 2010, CURR OPIN MOL THER, V12, P21; Beasley DWC, 2004, VACCINE, V22, P3722, DOI 10.1016/j.vaccine.2004.03.027; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ehrlich HJ, 2009, J INFECT DIS, V200, P1113, DOI 10.1086/605608; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; FDA, 2007, GUID IND CLIN DAT NE; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Govorkova E A, 1999, Dev Biol Stand, V98, P39; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; HARDY CT, 1995, VIROLOGY, V211, P302, DOI 10.1006/viro.1995.1405; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; Howard MK, 2008, BIOL CHEM, V389, P569, DOI 10.1515/BC.2008.060; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Keitel W, 2010, VACCINE, V28, P840, DOI 10.1016/j.vaccine.2009.10.019; Kistner O, 1999, Dev Biol Stand, V98, P101; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Koudstaal W, 2009, J INFECT DIS, V200, P1870, DOI 10.1086/648378; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Leroux-Roels I, 2009, EXPERT REV VACCINES, V8, P401, DOI 10.1586/ERV.09.15; Lu JH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-43; Medina RA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1026; Nicholson KG, 2011, LANCET INFECT DIS, V11, P91, DOI 10.1016/S1473-3099(10)70296-6; *NIH, 2010, GUID SURV BLEED MIC; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Planitzer CB, 2007, J INFECT DIS, V196, P435, DOI 10.1086/519392; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005672; Prabhu N, 2009, ANTIVIR THER, V14, P911, DOI 10.3851/IMP1413; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROBERTSON JS, 1993, J GEN VIROL, V74, P2047, DOI 10.1099/0022-1317-74-10-2047; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Stephenson I, 2006, LANCET, V368, P965, DOI 10.1016/S0140-6736(06)69340-9; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Takada A, 2007, VACCINE, V25, P993, DOI 10.1016/j.vaccine.2006.09.076; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	49	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23791	10.1371/journal.pone.0023791	http://dx.doi.org/10.1371/journal.pone.0023791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876771	gold, Green Submitted, Green Published			2022-12-25	WOS:000294126900043
J	Wang, YJ; Jung, TP				Wang, Yijun; Jung, Tzyy-Ping			A Collaborative Brain-Computer Interface for Improving Human Performance	PLOS ONE			English	Article							SINGLE-TRIAL EEG; EVOKED-POTENTIALS; BCI; CLASSIFICATION; COMMUNICATION	Electroencephalogram (EEG) based brain-computer interfaces (BCI) have been studied since the 1970s. Currently, the main focus of BCI research lies on the clinical use, which aims to provide a new communication channel to patients with motor disabilities to improve their quality of life. However, the BCI technology can also be used to improve human performance for normal healthy users. Although this application has been proposed for a long time, little progress has been made in real-world practices due to technical limits of EEG. To overcome the bottleneck of low single-user BCI performance, this study proposes a collaborative paradigm to improve overall BCI performance by integrating information from multiple users. To test the feasibility of a collaborative BCI, this study quantitatively compares the classification accuracies of collaborative and single-user BCI applied to the EEG data collected from 20 subjects in a movement-planning experiment. This study also explores three different methods for fusing and analyzing EEG data from multiple subjects: (1) Event-related potentials (ERP) averaging, (2) Feature concatenating, and (3) Voting. In a demonstration system using the Voting method, the classification accuracy of predicting movement directions (reaching left vs. reaching right) was enhanced substantially from 66% to 80%, 88%, 93%, and 95% as the numbers of subjects increased from 1 to 5, 10, 15, and 20, respectively. Furthermore, the decision of reaching direction could be made around 100-250 ms earlier than the subject's actual motor response by decoding the ERP activities arising mainly from the posterior parietal cortex (PPC), which are related to the processing of visuomotor transmission. Taken together, these results suggest that a collaborative BCI can effectively fuse brain activities of a group of people to improve the overall performance of natural human behavior.	[Wang, Yijun; Jung, Tzyy-Ping] Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, San Diego, CA 92103 USA	University of California System; University of California San Diego	Wang, YJ (corresponding author), Univ Calif San Diego, Swartz Ctr Computat Neurosci, Inst Neural Computat, San Diego, CA 92103 USA.	yijun@sccn.ucsd.edu; jung@sccn.ucsd.edu	Kheir, Michael/ABA-5760-2021; Wang, Yijun/F-3547-2012; Wang, Yijun/GXW-1763-2022	Kheir, Michael/0000-0001-6469-6746	Abraxis Bioscience Inc.; Army Research Laboratory [W911NF-10-2-0022]	Abraxis Bioscience Inc.; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	This work is supported by a gift fund from Abraxis Bioscience Inc. Research is also sponsored in part by the Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-10-2-0022. The views and the conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U.S. Government. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigdely-Shamlo N, 2008, IEEE T NEUR SYS REH, V16, P432, DOI 10.1109/TNSRE.2008.2003381; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; DAVILA CE, 1992, IEEE T BIO-MED ENG, V39, P338, DOI 10.1109/10.126606; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Duda R.O., 2000, PATTERN CLASSIFICATI; Fabiani M., 1987, ADV PSYCHOPHYSIOL, V2, P1, DOI DOI 10.1016/0013-4694(88)90149-6; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Jung TP, 1997, IEEE T BIO-MED ENG, V44, P60, DOI 10.1109/10.553713; Katzenbach JR, 1993, WISDOM TEAMS CREATIN; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lin CT, 2010, NEUROIMAGE, V52, P633, DOI 10.1016/j.neuroimage.2010.04.250; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Luck S.J., 2005, INTRO EVENT RELATED; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; NIJHOLT A, 2009, LECT NOTES COMPUTER, P225; Parra LC, 2003, IEEE T NEUR SYS REH, V11, P173, DOI 10.1109/TNSRE.2003.814446; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Roco M. C., 2003, CONVERGING TECHNOLOG; SANTAMARIA J, 1987, J CLIN NEUROPHYSIOL, V4, P327, DOI 10.1097/00004691-198710000-00002; Schalk G, 2000, CLIN NEUROPHYSIOL, V111, P2138, DOI 10.1016/S1388-2457(00)00457-0; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; SUMMERER L, 2009, INT REV NEUROBIOL, P213; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Vidaurre C, 2007, IEEE T BIO-MED ENG, V54, P550, DOI 10.1109/TBME.2006.888836; Wang YJ, 2008, IEEE ENG MED BIOL, V27, P64, DOI 10.1109/MEMB.2008.923958; Wang YJ, 2009, LECT NOTES ARTIF INT, V5638, P437, DOI 10.1007/978-3-642-02812-0_52; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	39	365	379	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20422	10.1371/journal.pone.0020422	http://dx.doi.org/10.1371/journal.pone.0020422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21887260	Green Published, gold			2022-12-25	WOS:000291097600065
J	Catty, P; Boutigny, S; Miras, R; Joyard, J; Rolland, N; Seigneurin-Berny, D				Catty, Patrice; Boutigny, Sylvain; Miras, Roger; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne			Biochemical Characterization of AtHMA6/PAA1, a Chloroplast Envelope Cu(I)-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; METAL TRANSPORT; SACCHAROMYCES-CEREVISIAE; ARCHAEOGLOBUS-FULGIDUS; FUNCTIONAL EXPRESSION; COPPER HOMEOSTASIS; ENTEROCOCCUS-HIRAE; COFACTOR DELIVERY; P-1B-TYPE ATPASE; ARABIDOPSIS	Copper is an essential plant micronutrient playing key roles in cellular processes, among them photosynthesis. In Arabidopsis thaliana, copper delivery to chloroplasts, mainly studied by genetic approaches, is thought to involve two P-IB-type ATPases: AtHMA1 and AtHMA6/PAA1. The lack of biochemical characterization of AtHMA1 and PAA1, and more generally of plant P-IB-type ATPases, is due to the difficulty of getting high amounts of these membrane proteins in an active form, either from their native environment or after expression in heterologous systems. In this study, we report the first biochemical characterization of PAA1, a plant copper-transporting ATPase. PAA1 produced in Lactococcus lactis is active, forming an aspartyl phosphate intermediate in the presence of ATP and the adequate metal ion. PAA1 can also be phosphorylated using inorganic phosphate in the absence of transition metal. Both phosphorylation types allowed us to demonstrate that PAA1 is activated by monovalent copper ions (and to a lower extent by silver ions) with an apparent affinity in the micromolar range. In agreement with these biochemical data, we also demonstrate that when expressed in yeast, PAA1 induces increased sensitivities to copper and silver. These data provide the first enzymatic characterization of a P-IB-1-type plant ATPase and clearly identify PAA1 as a high affinity Cu(I) transporter of the chloroplast envelope.	[Catty, Patrice; Miras, Roger] CNRS, Lab Chim & Biol Metaux, UMR5249, F-38054 Grenoble, France; [Catty, Patrice; Miras, Roger] Commissariat Energie Atom & Energies Alternat CEA, Direct Sci Vivant, IRTSV, Lab Chim & Biol Metaux, F-38054 Grenoble, France; [Boutigny, Sylvain; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne] Commissariat Energie Atom & Energies Alternat CEA, Direct Sci Vivant, IRTSV, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble, France; [Catty, Patrice; Miras, Roger] Univ Grenoble 1, Lab Chim & Biol Metaux, F-38054 Grenoble, France; [Boutigny, Sylvain; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne] INRA, Physiol Cellulaire Vegetale Lab, UMR1200, F-38054 Grenoble, France; [Boutigny, Sylvain; Joyard, Jacques; Rolland, Norbert; Seigneurin-Berny, Daphne] Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Seigneurin-Berny, D (corresponding author), CNRS UJF INRA CEA Grenoble, Physiol Cellulaire Vegetale Lab, IRTSV, UMR5168, 17 Rue Martyrs, F-38054 Grenoble, France.	daphne.berny@cea.fr	ROLLAND, Norbert/B-4405-2012; SEIGNEURIN-BERNY, Daphne/C-8412-2017	ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	CEA; CEA-PM project; CNRS; INRA; University of Grenoble	CEA(French Atomic Energy Commission); CEA-PM project; CNRS(Centre National de la Recherche Scientifique (CNRS)); INRA; University of Grenoble	This work was supported by the CEA (funding of the CEA-PM project), a Ph. D. fellowship from the CNRS (to S. B.), the INRA, and the University of Grenoble.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; Bissig KD, 2001, FEBS LETT, V507, P367, DOI 10.1016/S0014-5793(01)03009-5; Blair D., 1961, TALANTA LONDON, V7, P163; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Frelet-Barrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008746; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; GUIMARAESMOTTA H, 1980, ARCH BIOCHEM BIOPHYS, V203, P395, DOI 10.1016/0003-9861(80)90192-7; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hung YH, 2007, BIOCHEM J, V401, P569, DOI 10.1042/BJ20060924; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; KUO CL, 1983, MOL CELL BIOL, V3, P1730, DOI 10.1128/MCB.3.10.1730; Lowe J, 2004, J BIOL CHEM, V279, P25986, DOI 10.1074/jbc.M308736200; Lutsenko S, 2008, ARCH BIOCHEM BIOPHYS, V476, P22, DOI 10.1016/j.abb.2008.05.005; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Pilon M, 2006, CURR OPIN PLANT BIOL, V9, P256, DOI 10.1016/j.pbi.2006.03.007; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; SIKORSKI RS, 1989, GENETICS, V122, P19; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Wu CC, 2004, BIOCHEM BIOPH RES CO, V324, P1034, DOI 10.1016/j.bbrc.2004.09.160; Wu CC, 2006, J BIOL CHEM, V281, P29533, DOI 10.1074/jbc.M604658200; Yoshimizu T, 1998, BIOSCI BIOTECH BIOCH, V62, P1258, DOI 10.1271/bbb.62.1258; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	55	40	44	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36188	36197		10.1074/jbc.M111.241034	http://dx.doi.org/10.1074/jbc.M111.241034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878617	Green Published, hybrid			2022-12-25	WOS:000296538300004
J	Jin, ZG; Mei, WY; Strack, S; Jia, JH; Yang, J				Jin, Zhigang; Mei, Wenyan; Strack, Stefan; Jia, Jianhang; Yang, Jing			The Antagonistic Action of B56-containing Protein Phosphatase 2As and Casein Kinase 2 Controls the Phosphorylation and Gli Turnover Function of Daz Interacting Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; ZINC-FINGER PROTEIN; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTOR; CUBITUS-INTERRUPTUS; REPRESSOR FUNCTIONS; REGULATORY SUBUNIT; DEGRADATION; LOCALIZATION; ZEBRAFISH	The Hedgehog (Hh) pathway is evolutionarily conserved and plays critical roles during embryonic development and adult tissue homeostasis. Defective Hh signaling has been linked to a wide range of birth defects and cancers. Hh family proteins regulate the expression of their downstream target genes through the control of proteolytic processing and the transcriptional activation function of Gli transcription factors. Although Hh-dependent regulation of Gli has been studied extensively, other Gli regulatory mechanisms remain relatively unappreciated. Here we report our identification of a novel signaling cascade that controls the stability of Gli proteins. This cascade consists of Daz interacting protein 1 (Dzip1), casein kinase 2 (CK2), and B56 containing protein phosphatase 2As (PP2As). We provide evidence that Dzip1 is involved in a novel Gli turnover pathway. We show that CK2 directly phosphorylates Dzip1 at four serine residues, Ser-664/665/706/714. B56-containing PP2As, through binding to a domain located between amino acid residue 474 and 550 of Dzip1, dephosphorylate Dzip1 on these CK2 sites. Our mutagenesis analysis further demonstrates that the unphosphorylatable form of Dzip1 is more potent in promoting Gli turnover. Consistently, we found that the stability of Gli proteins was decreased upon CK2 inhibition and increased by inhibition of B56-containing PP2As. Thus, reversible phosphorylation of Dzip1, which is controlled by the antagonistic action of CK2 and B56-containing PP2As, has an important impact on the stability of Gli transcription factors and Hh signaling.	[Jin, Zhigang; Mei, Wenyan; Yang, Jing] Ohio State Univ, Res Inst, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Strack, Stefan] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Jia, Jianhang] Univ Kentucky, Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Iowa; University of Kentucky	Yang, J (corresponding author), Ohio State Univ, Res Inst, Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr, Columbus, OH 43205 USA.	Jing.Yang@nationwidechildrens.org	Jin, Zhigang/T-7125-2019	Jin, Zhigang/0000-0001-7557-2968; Jia, Jianhang/0000-0002-9313-3843; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [R01GM093217, 1R01GM079684]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217, R01GM079684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM093217 (to J. Y.) and 1R01GM079684 (to J. J.).	AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Hannus M, 2002, DEVELOPMENT, V129, P3493; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jin ZG, 2010, J BIOL CHEM, V285, P34493, DOI 10.1074/jbc.M110.169581; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Krauss S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007471; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sive H., 2000, EARLY DEV XENOPUS LA, P91; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Stubbs JL, 2006, DEVELOPMENT, V133, P2507, DOI 10.1242/dev.02417; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vokes SA, 2004, CURR BIOL, V14, pR668, DOI 10.1016/j.cub.2004.08.015; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Yang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000363; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	46	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36171	36179		10.1074/jbc.M111.274761	http://dx.doi.org/10.1074/jbc.M111.274761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878643	Green Published, hybrid			2022-12-25	WOS:000296538300002
J	Pircher, H; Straganz, GD; Ehehalt, D; Morrow, G; Tanguay, RM; Jansen-Durr, P				Pircher, Haymo; Straganz, Grit D.; Ehehalt, Daniela; Morrow, Genevieve; Tanguay, Robert M.; Jansen-Duerr, Pidder			Identification of Human Fumarylacetoacetate Hydrolase Domain-containing Protein 1 (FAHD1) as a Novel Mitochondrial Acylpyruvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY TYROSINEMIA; FUMARYLHYDROLASE; PURIFICATION; DEFICIENT; LIVER; ACID	The human fumarylacetoacetate hydrolase (FAH) domain-containing protein 1 (FAHD1) is part of the FAH protein superfamily, but its enzymatic function is unknown. In the quest for a putative enzymatic function of FAHD1, we found that FAHD1 exhibits acylpyruvase activity, demonstrated by the hydrolysis of acetylpyruvate and fumarylpyruvate in vitro, whereas several structurally related compounds were not hydrolyzed as efficiently. Conserved amino acids Asp-102 and Arg-106 of FAHD1 were found important for its catalytic activity, and Mg2+ was required for maximal enzyme activity. FAHD1 was found expressed in all tested murine tissues, with highest expression in liver and kidney. FAHD1 was also found in several human cell lines, where it localized to mitochondria. In summary, the current work identified mammalian FAHD1 as a novel mitochondrial enzyme with acylpyruvate hydrolase activity.	[Pircher, Haymo; Ehehalt, Daniela; Jansen-Duerr, Pidder] Austrian Acad Sci, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Straganz, Grit D.] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria; [Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Lab Cell & Dev Genet, Dept Mol Biol Med Biochem & Pathol, IBIS, Quebec City, PQ G1V 0A6, Canada; [Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, PROTEO, Quebec City, PQ G1V 0A6, Canada	Austrian Academy of Sciences; Graz University of Technology; Laval University; Laval University	Jansen-Durr, P (corresponding author), Austrian Acad Sci, Inst Biomed Aging Res, Rennweg 10, A-6020 Innsbruck, Austria.	p.jansen-duerr@oeaw.ac.at	Jansen-Dürr, Pidder/ABG-2466-2020	Jansen-Dürr, Pidder/0000-0001-7771-3429	Austrian Science Fund (FWF) [NFN S93, P18828]; European Union; Canadian Institutes of Health Research [MOP-86566]; MiMage project	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MiMage project	This work was supported by the Austrian Science Fund (FWF) through Grant NFN S93 and by the European Union through the MiMage project.; Supported by the Austrian Science Fund (FWF) through Grant P18828.; Supported by the Canadian Institutes of Health Research (Grant MOP-86566) and the MiMage project.	Brecker L, 1999, NEW J CHEM, V23, P437, DOI 10.1039/a807247g; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; DAVEY JF, 1975, J BIOL CHEM, V250, P3826; HSIANG HH, 1972, BIOCHEMISTRY-US, V11, P2098, DOI 10.1021/bi00761a016; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Krebs HA, 1937, BIOCHEM J, V31, P772, DOI 10.1042/bj0310772; KVITTINGEN EA, 1981, CLIN CHIM ACTA, V115, P311, DOI 10.1016/0009-8981(81)90244-8; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; MAHURAN DJ, 1977, CAN J BIOCHEM CELL B, V55, P1; Manjasetty BA, 2004, BIOL CHEM, V385, P935, DOI 10.1515/BC.2004.122; MEISTER A, 1948, J BIOL CHEM, V175, P573; MITCHELL GA, 2001, METABOLIC MOL BASES, P1777; Muck C, 2010, J GERONTOL A-BIOL, V65, P1165, DOI 10.1093/gerona/glq129; PHANEUF D, 1991, AM J HUM GENET, V48, P525; Pollard JR, 1998, EUR J BIOCHEM, V251, P98, DOI 10.1046/j.1432-1327.1998.2510098.x; Tame JRH, 2002, BIOCHEMISTRY-US, V41, P2982, DOI 10.1021/bi015717t; Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	18	23	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36500	36508		10.1074/jbc.M111.264770	http://dx.doi.org/10.1074/jbc.M111.264770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878618	Green Published, hybrid			2022-12-25	WOS:000296538300035
J	Teng, YW; Mehedint, MG; Garrow, TA; Zeisel, SH				Teng, Ya-Wen; Mehedint, Mihai G.; Garrow, Timothy A.; Zeisel, Steven H.			Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; DIETARY REQUIREMENTS; RAT-LIVER; ADENOSYLMETHIONINE; DEFICIENT; ADENOSYLHOMOCYSTEINE; PURIFICATION; METHIONINE; TISSUES; CANCER	Betaine-homocysteine S-methyltransferase (BHMT) uses betaine to catalyze the conversion of homocysteine (Hcy) to methionine. There are common genetic polymorphisms in the BHMT gene in humans that can alter its enzymatic activity. We generated the first Bhmt(-/-) mouse to model the functional effects of mutations that result in reduced BHMT activity. Deletion of Bhmt resulted in a 6-fold increase (p < 0.01) in hepatic and an 8-fold increase (p < 0.01) in plasma total Hcy concentrations. Deletion of Bhmt resulted in a 43% reduction in hepatic S-adenosylmethionine (AdoMet) (p < 0.01) and a 3-fold increase in hepatic S-adenosylhomocysteine (AdoHcy) (p < 0.01) concentrations, resulting in a 75% reduction in methylation potential (AdoMet: AdoHcy) (p < 0.01). Bhmt(-/-) mice accumulated betaine in most tissues, including a 21-fold increase in the liver concentration compared with wild type (WT) (p < 0.01). These mice had lower concentrations of choline, phosphocholine, glycerophosphocholine, phosphatidylcholine, and sphingomyelin in several tissues. At 5 weeks of age, Bhmt(-/-) mice had 36% lower total hepatic phospholipid concentrations and a 6-fold increase in hepatic triacyglycerol concentrations compared with WT (p < 0.01), which was due to a decrease in the secretion of very low density lipoproteins. At 1 year of age, 64% of Bhmt(-/-) mice had visible hepatic tumors. Histopathological analysis revealed that Bhmt(-/-) mice developed hepatocellular carcinoma or carcinoma precursors. These results indicate that BHMT has an important role in Hcy, choline, and one-carbon homeostasis. A lack of Bhmt also affects susceptibility to fatty liver and hepatocellular carcinoma. We suggest that functional polymorphisms in BHMT that significantly reduce activity may have similar effects in humans.	[Teng, Ya-Wen; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Mehedint, Mihai G.; Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC 28081 USA; [Garrow, Timothy A.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of Illinois System; University of Illinois Urbana-Champaign	Zeisel, SH (corresponding author), 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu			National Institutes of Health [DK55865, DK36530, DK52501]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052501, R29DK052501, R01DK055865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55865 and DK36530 (to S. H. Z.) and DK52501 (to T. A. G.).	BARAK AJ, 1993, ALCOHOL CLIN EXP RES, V17, P552, DOI 10.1111/j.1530-0277.1993.tb00798.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLUMENSTEIN J, 1963, CAN J BIOCHEM PHYS, V41, P201, DOI 10.1139/y63-025; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collinsova M, 2006, J NUTR, V136, P1493, DOI 10.1093/jn/136.6.1493; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; da Costa KA, 2004, AM J CLIN NUTR, V80, P163; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; DACOSTA KA, 1993, J BIOL CHEM, V268, P2100; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Feng QP, 2011, MOL GENET METAB, V102, P126, DOI 10.1016/j.ymgme.2010.10.010; Feo F, 2006, BBA-REV CANCER, V1765, P126, DOI 10.1016/j.bbcan.2005.08.007; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; GROSSMAN EB, 1989, AM J PHYSIOL, V256, pF107; HORNE DW, 1988, CLIN CHEM, V34, P2357; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Kharbanda KK, 2007, J HEPATOL, V46, P314, DOI 10.1016/j.jhep.2006.08.024; Kim SK, 2003, BIOCHEM PHARMACOL, V65, P1565, DOI 10.1016/S0006-2952(03)00115-1; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Kwon DY, 2009, J NUTR, V139, P63, DOI 10.3945/jn.108.094771; Lillie RD, 1965, HISTOPATHOLOGIC TECH; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; NEWBERNE PM, 1986, ANNU REV NUTR, V6, P407, DOI 10.1146/annurev.nu.06.070186.002203; Newell P, 2008, J HEPATOL, V48, P858, DOI 10.1016/j.jhep.2008.01.008; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16864; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; RUSHMORE TH, 1984, CANCER LETT, V24, P251, DOI 10.1016/0304-3835(84)90020-X; Schwahn BC, 2003, FASEB J, V17, P512, DOI 10.1096/fj.02-0456fje; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051; Stabler SP, 2009, FREE RADICAL BIO MED, V47, P1147, DOI 10.1016/j.freeradbiomed.2009.07.019; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; SVANBORG A, 1961, ACTA MED SCAND, V169, P43; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; WAGNER C, 1985, BIOCHEM BIOPH RES CO, V127, P746, DOI 10.1016/S0006-291X(85)80006-1; Watkins SM, 2001, LIPIDS, V36, P247, DOI 10.1007/s11745-001-0714-8; Weisberg IS, 2003, ATHEROSCLEROSIS, V167, P205, DOI 10.1016/S0021-9150(03)00010-8; Xu XR, 2009, FASEB J, V23, P4022, DOI 10.1096/fj.09-136507; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhou L, 2006, WORLD J GASTROENTERO, V12, P1175, DOI 10.3748/wjg.v12.i8.1175	52	134	140	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36258	36267		10.1074/jbc.M111.265348	http://dx.doi.org/10.1074/jbc.M111.265348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878621	hybrid, Green Published			2022-12-25	WOS:000296538300010
J	Zhang, W; Peng, G; Lin, SY; Zhang, PM				Zhang, Wei; Peng, Guang; Lin, Shiaw-Yih; Zhang, Pumin			DNA Damage Response Is Suppressed by the High Cyclin-dependent Kinase 1 Activity in Mitotic Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SPINDLE CHECKPOINT; END RESECTION; PROTEIN; PHOSPHORYLATION; EXIT; REPAIR; BRIT1/MCPH1; ACTIVATION; MECHANISM	DNA damage response (DDR) is vital for genomic stability, and its deficiency is linked to tumorigenesis. Extensive studies in interphase (G(1)-S-G(2)) mammalian cells have revealed the mechanisms of DDR in great detail; however, how mitotic cells respond to DNA damage remains less defined. We report here that a full DDR is suppressed in mitotic mammalian cells until telophase/cytokinesis. Although early DDR markers such as the phosphorylations of ataxia telangiectasia mutated (ATM) and histone H2A.x(H2AX) can be readily detected, the ionizing radiation-induced foci (IRIF) formation of late DDR markers such as breast cancer type 1 susceptibility protein (BRCA1) and p53-binding protein 1 (53BP1) are absent until the telophase/cytokinesis stage. We further showed that the IR-induced ubiquitination cascade around DNA damage sites did not occur in mitotic cells, which explains, at least in part, why BRCA1 and 53BP1 cannot be recruited to the damaged sites. These observations indicate that DDR is suppressed in mitotic cells after the step of gamma H2AX formation. Not surprisingly, we found that the absence of a full DDR in mitotic cells was associated with the high cyclin-dependent kinase 1 (CDK1) activities. More 53BP1 IRIF could be detected when the irradiated mitotic cells were treated with a CDK1 inhibitor. Further, the activation of CDK5 in interphase cells impedes the formation of 53BP1 IRIF. Together, these results suggest that the DDR is suppressed by the high CDK1 activity in mitotic mammalian cells.	[Zhang, Wei; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Peng, Guang; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Zhang, PM (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, 1 Baylor Plaza, Houston, TX 77030 USA.	pzhang@bcm.edu			National Institutes of Health [CA116097, CA122623]; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA116097 and CA122623 (to P. Z.).	Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bloecher A, 2000, NAT CELL BIOL, V2, P556, DOI 10.1038/35019601; Cerqueira A, 2009, J CELL BIOL, V187, P773, DOI 10.1083/jcb.200903033; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krishnan R, 2000, GENETICS, V156, P489; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pereira G, 2000, MOL CELL, V6, P1, DOI 10.1016/S1097-2765(05)00017-1; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; Wang YC, 2000, CURR BIOL, V10, P1379, DOI 10.1016/S0960-9822(00)00779-X; Wohlbold L, 2009, DNA REPAIR, V8, P1018, DOI 10.1016/j.dnarep.2009.04.009; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200	44	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35899	35905		10.1074/jbc.M111.267690	http://dx.doi.org/10.1074/jbc.M111.267690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878640	Green Published, hybrid			2022-12-25	WOS:000295927100063
J	Risner-Janiczek, JR; Ungless, MA; Li, M				Risner-Janiczek, Jessica R.; Ungless, Mark A.; Li, Meng			Electrophysiological Properties of Embryonic Stem Cell-Derived Neurons	PLOS ONE			English	Article							FUNCTIONAL-INTEGRATION; LINEAGE SELECTION; CURRENTS	In vitro generation of functional neurons from embryonic stem (ES) cells and induced pluripotent stem cells offers exciting opportunities for dissecting gene function, disease modelling, and therapeutic drug screening. To realize the potential of stem cells in these biomedical applications, a complete understanding of the cell models of interest is required. While rapid advances have been made in developing the technologies for directed induction of defined neuronal subtypes, most published works focus on the molecular characterization of the derived neural cultures. To characterize the functional properties of these neural cultures, we utilized an ES cell model that gave rise to neurons expressing the green fluorescent protein (GFP) and conducted targeted whole-cell electrophysiological recordings from ES cell-derived neurons. Current-clamp recordings revealed that most neurons could fire single overshooting action potentials; in some cases multiple action potentials could be evoked by depolarization, or occurred spontaneously. Voltage-clamp recordings revealed that neurons exhibited neuronal-like currents, including an outward current typical of a delayed rectifier potassium conductance and a fast-activating, fast-inactivating inward current, typical of a sodium conductance. Taken together, these results indicate that ES cell-derived GFP(+) neurons in culture display functional neuronal properties even at early stages of differentiation.	[Risner-Janiczek, Jessica R.; Ungless, Mark A.; Li, Meng] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, Fac Med, MRC, London, England	Imperial College London	Risner-Janiczek, JR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, Fac Med, MRC, London, England.	j.risner@imperial.ac.uk	Li, Meng/I-6941-2013	Ungless, Mark/0000-0002-1730-3353	EU [222934]; U.K. Medical Research Council (MRC) [U120085816, U120005004]; MRC [MC_U120085816, G117/560, MC_U120085817] Funding Source: UKRI; Medical Research Council [G117/560, MC_U120085817, MC_U120085816] Funding Source: researchfish	EU(European Commission); U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by EU framework 7 to ML (NeuroStemCell, grant No. 222934; http://www.neurostemcell.org/), and the U.K. Medical Research Council (MRC) to MAU (U120085816) and ML (U120005004; http://www.mrc.ac.uk/index.htm). ML was an MRC Senior Non-Clinical Research Fellow, and MAU is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Benninger F, 2003, J NEUROSCI, V23, P7075, DOI 10.1523/JNEUROSCI.23-18-07075.2003; Bishop MW, 2010, J NEUROPHYSIOL, V104, P3009, DOI 10.1152/jn.00466.2010; CAIAZZO M, 2011, NATURE          0703, DOI DOI 10.1038/NATURE10284; Chabbert C, 2001, J NEUROPHYSIOL, V85, P1017, DOI 10.1152/jn.2001.85.3.1017; Chu HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013118; GRIFFITHS DS, 2005, THESIS U EDINBURGH S; Harkany T, 2004, J NEUROCHEM, V88, P1229, DOI 10.1046/j.1471-4159.2003.02243.x; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; Lang RJ, 2004, EUR J NEUROSCI, V20, P3209, DOI 10.1111/j.1460-9568.2004.03782.x; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; OCONNELL KMS, 2010, NATURE, V107, P12351; Parmar M, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-86; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; QIAO GF, 2009, CHARACTERIZATION PER; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; Risner JR, 2006, J NEUROPHYSIOL, V96, P2364, DOI 10.1152/jn.00523.2006; Ruschenschmidt T, 2005, EPILEPSIA, V46, P174, DOI 10.1111/j.1528-1167.2005.01028.x; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Washio H, 1999, NEUROSCI RES, V34, P91, DOI 10.1016/S0168-0102(99)00039-5; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24169	10.1371/journal.pone.0024169	http://dx.doi.org/10.1371/journal.pone.0024169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887381	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298800035
J	Tsai, YH; Wei, JR; Lin, CS; Chen, PH; Huang, S; Lin, YC; Wei, CF; Lu, CC; Lai, HC				Tsai, Yu-Huan; Wei, Jun-Rong; Lin, Chuan-Sheng; Chen, Po-Han; Huang, Stella; Lin, Yu-Ching; Wei, Chia-Fong; Lu, Chia-Chen; Lai, Hsin-Chih			RssAB Signaling Coordinates Early Development of Surface Multicellularity in Serratia marcescens	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA PA14; SWARMING MOTILITY; BIOFILM FORMATION; ESCHERICHIA-COLI; TRANSDUCTION SYSTEM; EXPRESSION; RESISTANCE; OMPR; DIFFERENTIATION; LOCALIZATION	Bacteria can coordinate several multicellular behaviors in response to environmental changes. Among these, swarming and biofilm formation have attracted significant attention for their correlation with bacterial pathogenicity. However, little is known about when and where the signaling occurs to trigger either swarming or biofilm formation. We have previously identified an RssAB two-component system involved in the regulation of swarming motility and biofilm formation in Serratia marcescens. Here we monitored the RssAB signaling status within single cells by tracing the location of the translational fusion protein EGFP-RssB following development of swarming or biofilm formation. RssAB signaling is specifically activated before surface migration in swarming development and during the early stage of biofilm formation. The activation results in the release of RssB from its cognate inner membrane sensor kinase, RssA, to the cytoplasm where the downstream gene promoters are located. Such dynamic localization of RssB requires phosphorylation of this regulator. By revealing the temporal activation of RssAB signaling following development of surface multicellular behavior, our findings contribute to an improved understanding of how bacteria coordinate their lifestyle on a surface.	[Tsai, Yu-Huan; Chen, Po-Han; Huang, Stella] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Wei, Jun-Rong] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lin, Chuan-Sheng] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan; [Lin, Yu-Ching; Wei, Chia-Fong; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lin, Yu-Ching; Wei, Chia-Fong; Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan	National Taiwan University; Harvard University; Harvard T.H. Chan School of Public Health; Chang Gung University; Chang Gung University; Chang Gung University; Fu Jen Catholic University	Tsai, YH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	hclai@mail.cgu.edu.tw	CHEN, PO-HAN/ABB-6690-2021	CHEN, PO-HAN/0000-0002-9471-4471; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council [NSC98-2320-B-182-007-MY3]; Chang Gung Memorial Hospital [CMRPD190501]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council (NSC98-2320-B-182-007-MY3) and Chang Gung Memorial Hospital (CMRPD190501), which are greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor E, 2006, MOL MICROBIOL, V59, P1767, DOI 10.1111/j.1365-2958.2006.05048.x; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Cos P, 2010, CURR PHARM DESIGN, V16, P2279, DOI 10.2174/138161210791792868; Eberl L, 1996, J BACTERIOL, V178, P554, DOI 10.1128/jb.178.2.554-559.1996; Eberl L, 1999, J BACTERIOL, V181, P1703, DOI 10.1128/JB.181.6.1703-1712.1999; Elkins JG, 1999, APPL ENVIRON MICROB, V65, P4594; Gooderham WJ, 2008, J BACTERIOL, V190, P5624, DOI 10.1128/JB.00594-08; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kearns DB, 2003, MOL MICROBIOL, V49, P581, DOI 10.1046/j.1365-2958.2003.03584.x; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kim DJ, 2003, J BACTERIOL, V185, P5290, DOI 10.1128/JB.185.17.5290-5294.2003; Kolter R, 2010, INT MICROBIOL, V13, P1, DOI 10.2436/20.1501.01.105; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Lai HC, 2005, J BACTERIOL, V187, P3407, DOI 10.1128/JB.187.10.3407-3414.2005; Lai S, 2009, ENVIRON MICROBIOL, V11, P126, DOI 10.1111/j.1462-2920.2008.01747.x; Lin CS, 2010, INFECT IMMUN, V78, P4870, DOI 10.1128/IAI.00661-10; Lopian L, 2003, P NATL ACAD SCI USA, V100, P7099, DOI 10.1073/pnas.1037608100; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; Oh YJ, 2007, ULTRAMICROSCOPY, V107, P869, DOI 10.1016/j.ultramic.2007.01.021; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Pincet F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000977; Pratt JT, 2009, J BACTERIOL, V191, P6632, DOI 10.1128/JB.00708-09; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Rather PN, 2005, ENVIRON MICROBIOL, V7, P1065, DOI 10.1111/j.1462-2920.2005.00806.x; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Soo PC, 2008, J BACTERIOL, V190, P2496, DOI 10.1128/JB.01670-07; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Wei JR, 2005, J BACTERIOL, V187, P5683, DOI 10.1128/JB.187.16.5683-5690.2005	38	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24154	10.1371/journal.pone.0024154	http://dx.doi.org/10.1371/journal.pone.0024154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887380	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298800034
J	Adachi, I; Hampton, RR				Adachi, Ikuma; Hampton, Robert R.			Rhesus Monkeys See Who They Hear: Spontaneous Cross-Modal Memory for Familiar Conspecifics	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; MACACA-MULATTA; FACE RECOGNITION; SOCIAL RELATIONSHIPS; VOCAL RECOGNITION; CONTACT CALLS; DISCRIMINATION; INDIVIDUALS; CATEGORIZATION; ORIENTATION	Rhesus monkeys gather much of their knowledge of the social world through visual input and may preferentially represent this knowledge in the visual modality. Recognition of familiar faces is clearly advantageous, and the flexibility and utility of primate social memory would be greatly enhanced if visual memories could be accessed cross-modally either by visual or auditory stimulation. Such cross-modal access to visual memory would facilitate flexible retrieval of the knowledge necessary for adaptive social behavior. We tested whether rhesus monkeys have cross-modal access to visual memory for familiar conspecifics using a delayed matching-to-sample procedure. Monkeys learned visual matching of video clips of familiar individuals to photographs of those individuals, and generalized performance to novel videos. In crossmodal probe trials, coo-calls were played during the memory interval. The calls were either from the monkey just seen in the sample video clip or from a different familiar monkey. Even though the monkeys were trained exclusively in visual matching, the calls influenced choice by causing an increase in the proportion of errors to the picture of the monkey whose voice was heard on incongruent trials. This result demonstrates spontaneous cross-modal recognition. It also shows that viewing videos of familiar monkeys activates naturally formed memories of real monkeys, validating the use of video stimuli in studies of social cognition in monkeys.	[Adachi, Ikuma; Hampton, Robert R.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA		Adachi, I (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA USA.	adachi@pri.kyoto-u.ac.jp		Hampton, Robert/0000-0002-6686-2290; Adachi, Ikuma/0000-0003-2856-8792	Japan Society for the Promotion of Science; MEXT [22700270]; James S. McDonnell Foundation; Center for Behavioral Neuroscience under National Science Foundation [IBN-9876754]; National Institutes of Health [RR-00165, R01MH082819]; National Science Foundation [0000017475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082819] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23220006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); James S. McDonnell Foundation; Center for Behavioral Neuroscience under National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Postdoctoral Fellowship for Research Abroad awarded to IA by the Japan Society for the Promotion of Science and by a Grant-in-Aid for Young Scientists (B) # 22700270 from MEXT to IA. This study was also supported by a grant from the James S. McDonnell Foundation, by the Center for Behavioral Neuroscience under the STC Program of the National Science Foundation under Agreement No. IBN-9876754, and by Yerkes Center base grant No. RR-00165 awarded by the Animal Resources Program of the National Institutes of Health. Additional support was provided by grant R01MH082819 from the National Institutes of Health and grant 0000017475 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adachi I, 2006, PRIMATES, V47, P350, DOI 10.1007/s10329-006-0182-z; Adachi I, 2009, DEVELOPMENTAL SCI, V12, P446, DOI 10.1111/j.1467-7687.2008.00780.x; Adachi I, 2009, CURR BIOL, V19, P1270, DOI 10.1016/j.cub.2009.05.067; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bovet D, 2003, J COMP PSYCHOL, V117, P400, DOI 10.1037/0735-7036.117.4.400; Bovet D, 2009, FOLIA PRIMATOL, V80, P220, DOI 10.1159/000235688; BRUCE C, 1982, NEUROPSYCHOLOGIA, V20, P515, DOI 10.1016/0028-3932(82)90025-2; Byrne R., 1988, MACHIAVELLIAN INTELL; CHENEY D, 1986, SCIENCE, V234, P1361, DOI 10.1126/science.3538419; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Dahl CD, 2010, P ROY SOC B-BIOL SCI, V277, P2973, DOI 10.1098/rspb.2010.0438; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; DASSER V, 1988, ANIM BEHAV, V36, P225, DOI 10.1016/S0003-3472(88)80265-3; GOUZOULES S, 1984, ANIM BEHAV, V32, P182, DOI 10.1016/S0003-3472(84)80336-X; Humphrey N. K., 1976, GROWING POINTS ETHOL, P303; ITAKURA S, 1992, PSYCHOL REC, V42, P157, DOI 10.1007/BF03399594; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Koba R, 2006, ANIM COGN, V9, P183, DOI 10.1007/s10071-006-0020-0; Kummer H., 1982, Life Sciences Research Report, P113; Martin-Malivel J, 2001, ANIM LEARN BEHAV, V29, P10, DOI 10.3758/BF03192812; Martin-Malivel J, 2001, BEHAV BRAIN RES, V122, P209, DOI 10.1016/S0166-4328(01)00179-6; Martin-Malivel J, 2007, BEHAV NEUROSCI, V121, P1145, DOI 10.1037/0735-7044.121.6.1145; Matsuzawa T, 1991, CHIMPANZEE KARA MITA; MITANI JC, 1985, ANIM BEHAV, V33, P272, DOI 10.1016/S0003-3472(85)80141-X; Morrongiello BA, 2003, J EXP CHILD PSYCHOL, V84, P1, DOI 10.1016/S0022-0965(02)00162-5; Owren MJ, 2003, J COMP PSYCHOL, V117, P380, DOI 10.1037/0735-7036.117.4.380; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 2008, ANIM COGN, V11, P467, DOI 10.1007/s10071-008-0137-4; Parr LA, 2006, PERCEPTION, V35, P1473, DOI 10.1068/p5455; Paxton R, 2010, J COMP PSYCHOL, V124, P395, DOI 10.1037/a0019751; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; ROSENFELD SA, 1979, NEUROPSYCHOLOGIA, V17, P503, DOI 10.1016/0028-3932(79)90057-5; Schell A, 2011, ANIM COGN, V14, P503, DOI 10.1007/s10071-011-0383-8; Seyfarth RM, 2009, P NATL ACAD SCI USA, V106, P669, DOI 10.1073/pnas.0811894106; Sliwa J, 2011, P NATL ACAD SCI USA, V108, P1735, DOI 10.1073/pnas.1008169108; SNOWDON CT, 1980, ANIM BEHAV, V28, P717, DOI 10.1016/S0003-3472(80)80131-X; Tomasello Michael, 1994, Yearbook of Physical Anthropology, V37, P273; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; WASSERMAN EA, 1988, J EXP PSYCHOL ANIM B, V14, P235, DOI 10.1037/0097-7403.14.3.235; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004	48	25	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23345	10.1371/journal.pone.0023345	http://dx.doi.org/10.1371/journal.pone.0023345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887244	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000014
J	Douce, RW; Aleman, W; Chicaiza-Ayala, W; Madrid, C; Sovero, M; Delgado, F; Rodas, M; Ampuero, J; Chauca, G; Perez, J; Garcia, J; Kochel, T; Halsey, ES; Laguna-Torres, VA				Douce, Richard W.; Aleman, Washington; Chicaiza-Ayala, Wilson; Madrid, Cesar; Sovero, Merly; Delgado, Franklin; Rodas, Mireya; Ampuero, Julia; Chauca, Gloria; Perez, Juan; Garcia, Josefina; Kochel, Tadeusz; Halsey, Eric S.; Alberto Laguna-Torres, V.			Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006-2010	PLOS ONE			English	Article							SOUTH-AMERICA; TRANSMISSION; SEASONALITY; VIRUSES	Background: Tropical countries are thought to play an important role in the global behavior of respiratory infections such as influenza. The tropical country of Ecuador has almost no documentation of the causes of acute respiratory infections. The objectives of this study were to identify the viral agents associated with influenza like illness (ILI) in Ecuador, describe what strains of influenza were circulating in the region along with their epidemiologic characteristics, and perform molecular characterization of those strains. Methodology/Findings: This is a prospective surveillance study of the causes of ILI based on viral culture of oropharyngeal specimens and case report forms obtained in hospitals from two cities of Ecuador over 4 years. Out of 1,702 cases of ILI, nine viral agents were detected in 597 patients. During the time of the study, seven genetic variants of influenza circulated in Ecuador, causing six periods of increased activity. There appeared to be more heterogeneity in the cause of ILI in the tropical city of Guayaquil when compared with the Andean city of Quito. Conclusions/Significance: This was the most extensive documentation of the viral causes of ILI in Ecuador to date. Influenza was a common cause of ILI in Ecuador, causing more than one outbreak per year. There was no well defined influenza season although there were periods of time when no influenza was detected alternating with epidemics of different variant strains.	[Douce, Richard W.; Chicaiza-Ayala, Wilson] Hosp Vozandes, Quito, Ecuador; [Aleman, Washington; Rodas, Mireya] Hosp Alcivar & Vernaza, Guayaquil, Ecuador; [Madrid, Cesar; Delgado, Franklin] Hosp Naval, Guayaquil, Ecuador; [Sovero, Merly; Ampuero, Julia; Chauca, Gloria; Perez, Juan; Garcia, Josefina; Kochel, Tadeusz; Halsey, Eric S.; Alberto Laguna-Torres, V.] US Naval Med Res Unit Six, Lima, Peru		Douce, RW (corresponding author), Hosp Vozandes, Quito, Ecuador.	rdouce@hcjb.org.ec	Halsey, Eric/AAC-8110-2022	Halsey, Eric/0000-0001-6291-8923; , Merly Sovero/0000-0002-4373-0295; Douce, Richard/0000-0002-8675-7658; LAGUNA-TORRES, VICTOR ALBERTO/0000-0002-9507-6301; Ampuero, Julia/0000-0001-5486-1656; Chicaiza-Ayala, Wilson/0000-0001-8639-698X	United States Department of Defense [847705.82000.25GB.B0016]; sentinel centers in Ecuador	United States Department of Defense(United States Department of Defense); sentinel centers in Ecuador	This study was funded by the United States Department of Defense Global Emerging Infections Systems Research Program, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to all personnel working at sentinel centers in Ecuador for supporting this surveillance study. We thank Dr. Brett Forshey who provided the map and the professional staff of the Virology Department of NAMRU-6 for invaluable laboratory and technical support in the execution of the study. We would also like to thank Dr. Juan Martin Moreira and members of the department of epidemiology as well as Dr. Nancy Vasconez and the members of the department of the national program of immunization of the Ecuadorian Ministry of Health for their comments and insight as to the behavior of acute respiratory infections in Ecuador.	Aguilera JF, EUROFLU CASE DEFINIT; Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Chow BDW, 2009, CLIN LAB MED, V29, P695, DOI 10.1016/j.cll.2009.07.010; Estrella B, 2005, ENVIRON HEALTH PERSP, V113, P607, DOI 10.1289/ehp.7494; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Forshey BM, 2010, INFLUENZA OTHER RESP, V4, P235, DOI 10.1111/j.1750-2659.2010.00139.x; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P327, DOI 10.1111/j.1750-2659.2009.00107.x; Garcia J, 2009, INFLUENZA OTHER RESP, V3, P69, DOI 10.1111/j.1750-2659.2009.00072.x; Gonzalez V, 2001, INCIDENCIA ENFERMEDA; Gordon A, 2009, EMERG INFECT DIS, V15, P2005; Hall CB, 2010, MANDELL DOUGLAS BENN, P2207; Hanley BP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-98; Laguna-Torres VA, 2011, INFLUENZA OTHER RESP, V5, P123, DOI 10.1111/j.1750-2659.2010.00182.x; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lee VJ, 2009, PLOS ONE, V4, P8; Lieberman D, 2006, J CLIN MICROBIOL, V44, P525, DOI 10.1128/JCM.44.2.525-528.2006; Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09; Little P, 2008, NICE CLIN GUIDEL, P1; Michiels B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-4; Moura FEA, 2010, CURR OPIN INFECT DIS, V23, P415, DOI 10.1097/QCO.0b013e32833cc955; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Naumova EN, 2007, ENV HLTH, V6, P1; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Paredes G, 2010, MED INTENSIVA, V34, P310, DOI 10.1016/j.medin.2010.03.011; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Schiffer JT, 2010, MANDELL DOUGLAS BENN; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Tamerius J, 2010, ENVIRON HEALTH PERSP; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002768; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; World Health Organization, 2008, PRIM HLTH CAR MOR NE, P1	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22206	10.1371/journal.pone.0022206	http://dx.doi.org/10.1371/journal.pone.0022206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887216	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000001
J	Li, CW; Yang, XB; Ding, YH; Zhang, LY; Fang, HX; Tang, SH; Jiang, ZG				Li, Chunwang; Yang, Xiaobo; Ding, Yuhua; Zhang, Linyuan; Fang, Hongxia; Tang, Songhua; Jiang, Zhigang			Do Pere David's Deer Lose Memories of Their Ancestral Predators?	PLOS ONE			English	Article							HUMAN DISTURBANCE; PRACTICAL GUIDE; EFFECT SIZE; BEHAVIOR; VIGILANCE; PREY; HYPOTHESIS; SELECTION	Whether prey retains antipredator behavior after a long period of predator relaxation is an important question in predator-prey evolution. Pere David's deer have been raised in enclosures for more than 1200 years and this isolation provides an opportunity to study whether Pere David's deer still respond to the cues of their ancestral predators or to novel predators. We played back the sounds of crows (familiar sound) and domestic dogs (familiar non-predators), of tigers and wolves (ancestral predators), and of lions (potential naive predator) to Pere David's deer in paddocks, and blank sounds to the control group, and videoed the behavior of the deer during the experiment. We also showed life-size photo models of dog, leopard, bear, tiger, wolf, and lion to the deer and video taped their responses after seeing these models. Pere David's deer stared at and approached the hidden loudspeaker when they heard the roars of tiger or lion. The deer listened to tiger roars longer, approached to tiger roars more and spent more time staring at the tiger model. The stags were also found to forage less in the trials of tiger roars than that of other sound playbacks. Additionally, it took longer for the deer to restore their normal behavior after they heard tiger roars, which was longer than that after the trial of other sound playbacks. Moreover, the deer were only found to walk away after hearing the sounds of tiger and wolf. Therefore, the tiger was probably the main predator for Pere David's deer in ancient time. Our study implies that Pere David's deer still retain the memories of the acoustic and visual cues of their ancestral predators in spite of the long term isolation from natural habitat.	[Li, Chunwang; Yang, Xiaobo; Fang, Hongxia; Tang, Songhua; Jiang, Zhigang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Yang, Xiaobo; Jiang, Zhigang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Ding, Yuhua] Dafeng Milu Natl Nat Reserve, Dafeng, Jiangsu, Peoples R China; [Zhang, Linyuan] Beijing Milu Ecol Res Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	jiangzg@ioz.ac.cn	Jiang, Zhigang/E-4598-2014	Jiang, Zhigang/0000-0003-2154-8588	National Nature Science Foundation [31070469, 31070348]; Chinese Academy of Sciences [KSCX2-EW-Z-4]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	The project was supported by National Nature Science Foundation (No. 31070469, 31070348) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Beck BB, 1983, BIOL MANAGEMENT EXTI; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Blumstein DT, 2009, ANIM BEHAV, V78, P873, DOI 10.1016/j.anbehav.2009.07.010; Blumstein DT, 2006, ETHOLOGY, V112, P209, DOI 10.1111/j.1439-0310.2006.01209.x; Blumstein DT, 2004, ETHOLOGY, V110, P919, DOI 10.1111/j.1439-0310.2004.01033.x; Blumstein DT, 2002, BEHAV ECOL, V13, P657, DOI 10.1093/beheco/13.5.657; Brown JS, 1999, EVOL ECOL RES, V1, P49; Burger J, 1997, APPL ANIM BEHAV SCI, V54, P345, DOI 10.1016/S0168-1591(96)01195-1; Byers J.A., 1997, AM PRONGHORN SOCIAL; CAO KQ, 1990, MI DEER ELAPHURUS DA; COSS RG, 1993, BEHAVIOUR, V124, P137, DOI 10.1163/156853993X00542; Coss RG, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P180; Davies NB, 1993, INTRO BEHAV ECOLOGY, P77; DICKMAN CR, 1992, ECOLOGY, V73, P313, DOI 10.2307/1938742; Ding Y, 2000, CHINESE MILU RES; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Fernandez-Juricic E, 2001, ENVIRON CONSERV, V28, P263, DOI 10.1017/S0376892901000273; Griesser M, 2008, CURR BIOL, V18, P69, DOI 10.1016/j.cub.2007.11.069; Hofling A, 2009, THESIS LINKOPINGS U; Huang X, 2003, THESIS BEIJING FORES; Jiang ZG, 2000, WILDLIFE SOC B, V28, P681; Jiang Zhigang, 2000, Acta Theriologica Sinica, V20, P1; Kramer DL, 1997, ANIM BEHAV, V54, P289, DOI 10.1006/anbe.1996.0360; Kunzl C, 2003, HORM BEHAV, V43, P187, DOI 10.1016/S0018-506X(02)00017-X; Li C, 2007, ZOO BIOL, V26, P461, DOI 10.1002/zoo.20132; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; Li CW, 2011, APPL ANIM BEHAV SCI, V129, P146, DOI 10.1016/j.applanim.2010.11.013; Lima SL, 1999, ANIM BEHAV, V58, P537, DOI 10.1006/anbe.1999.1182; Lingle S, 2001, ETHOLOGY, V107, P125, DOI 10.1046/j.1439-0310.2001.00647.x; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; OHTAISHI N, 1990, MAMMAL REV, V20, P125, DOI 10.1111/j.1365-2907.1990.tb00108.x; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Orrock JL, 2010, ETHOLOGY, V116, P338, DOI 10.1111/j.1439-0310.2010.01740.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sih Andrew, 1998, P221; Sokal R. R., 2012, BIOMETRY; Stankowich T, 2007, P ROY SOC B-BIOL SCI, V274, P175, DOI 10.1098/rspb.2006.3716; Wang L, 2002, CHINESE SOCIAL SCI, V135, P36; Yang Daode, 2005, Shengwu Duoyangxing, V13, P451, DOI 10.1360/biodiv.050031; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Yorzinski JL, 2007, ETHOLOGY, V113, P1219, DOI 10.1111/j.1439-0310.2007.01435.x; Zeng Y, 2007, CONSERV GENET, V8, P1051, DOI 10.1007/s10592-006-9256-0; Zhang JX, 2003, PHYSIOL BEHAV, V79, P549, DOI 10.1016/S0031-9384(03)00123-9; Zhang L, 1999, P 3 NATL S CONS SUST, P265	48	23	27	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23623	10.1371/journal.pone.0023623	http://dx.doi.org/10.1371/journal.pone.0023623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887286	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000040
J	Karmali, PP; Brunquell, C; Tram, H; Ireland, SK; Ruoslahti, E; Biliran, H				Karmali, Priya Prakash; Brunquell, Chris; Tram, Hau; Ireland, Shubha Kale; Ruoslahti, Erkki; Biliran, Hector			Metastasis of Tumor Cells Is Enhanced by Downregulation of Bit1	PLOS ONE			English	Article							CANCER METASTASIS; KINASE; INVASION; ACTIVATION; INTEGRINS; SURVIVAL; ADHESION; PROTEIN; PHOSPHATASES; PREDICTION	Background: Resistance to anoikis, which is defined as apoptosis induced by loss of integrin-mediated cell attachment to the extracellular matrix, is a determinant of tumor progression and metastasis. We have previously identified the mitochondrial Bit1 (Bcl-2 inhibitor of transcription) protein as a novel anoikis effector whose apoptotic function is independent from caspases and is uniquely controlled by integrins. In this report, we examined the possibility that Bit1 is suppressed during tumor progression and that Bit1 downregulation may play a role in tumor metastasis. Methodology/Principal Findings: Using a human breast tumor tissue array, we found that Bit1 expression is suppressed in a significant fraction of advanced stages of breast cancer. Targeted disruption of Bit1 via shRNA technology in lowly aggressive MCF7 cells conferred enhanced anoikis resistance, adhesive and migratory potential, which correlated with an increase in active Extracellular kinase regulated (Erk) levels and a decrease in Erk-directed phosphatase activity. These pro-metastasis phenotypes were also observed following downregulation of endogenous Bit1 in Hela and B16F1 cancer cell lines. The enhanced migratory and adhesive potential of Bit1 knockdown cells is in part dependent on their high level of Erk activation since down-regulating Erk in these cells attenuated their enhanced motility and adhesive properties. The Bit1 knockdown pools also showed a statistically highly significant increase in experimental lung metastasis, with no differences in tumor growth relative to control clones in vivo using a BALB/c nude mouse model system. Importantly, the pulmonary metastases of Bit1 knockdown cells exhibited increased phospho-Erk staining. Conclusions/Significance: These findings indicate that downregulation of Bit1 conferred cancer cells with enhanced anoikis resistance, adhesive and migratory properties in vitro and specifically potentiated tumor metastasis in vivo. These results underscore the therapeutic importance of restoring Bit1 expression in cancer cells to circumvent metastasis at least in part through inhibition of the Erk pathway.	[Karmali, Priya Prakash] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Brunquell, Chris; Ruoslahti, Erkki] Sanford Burnham Med Res Inst, Santa Barbara, CA USA; [Tram, Hau; Ireland, Shubha Kale; Biliran, Hector] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Xavier University of Louisiana	Karmali, PP (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	hbiliran@xula.edu			National Institute of Health-National Institute of General Medical Sciences SCORE2 (NIH-NIGMS SC2); Louisiana Cancer Research Consortium (LCRC)	National Institute of Health-National Institute of General Medical Sciences SCORE2 (NIH-NIGMS SC2); Louisiana Cancer Research Consortium (LCRC)	Funding was provided by the National Institute of Health-National Institute of General Medical Sciences SCORE2 (NIH-NIGMS SC2 grant) and Louisiana Cancer Research Consortium (LCRC) start up funds to H. Biliran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Biliran H, 2008, J BIOL CHEM, V283, P28029, DOI 10.1074/jbc.M803139200; Blaschke F, 2002, BIOCHEM BIOPH RES CO, V296, P890, DOI 10.1016/S0006-291X(02)02033-8; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; FIDLER IJ, 1990, CANCER RES, V50, P6130; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Griffiths GS, 2011, J BIOL CHEM, V286, P14713, DOI 10.1074/jbc.M111.228387; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Laakko T, 2003, J BIOL CHEM, V278, P31621, DOI 10.1074/jbc.M304700200; LESTER BR, 1992, CANCER METAST REV, V11, P31, DOI 10.1007/BF00047601; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mitsushima M, 2007, EXP CELL RES, V313, P1830, DOI 10.1016/j.yexcr.2007.03.001; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Ward Y, 2001, MOL CELL BIOL, V21, P5958, DOI 10.1128/MCB.21.17.5958-5969.2001; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004	27	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23840	10.1371/journal.pone.0023840	http://dx.doi.org/10.1371/journal.pone.0023840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886829	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500033
J	Hildebrandt, H; Hoffmann, NA; Illing, RB				Hildebrandt, Heika; Hoffmann, Nadine A.; Illing, Robert-Benjamin			Synaptic Reorganization in the Adult Rat's Ventral Cochlear Nucleus following Its Total Sensory Deafferentation	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; GAP-43 IMMUNOREACTIVITY; INDUCED SYNAPTOGENESIS; OLIVOCOCHLEAR NEURONS; BUSHY CELLS; SYNAPSES; PLASTICITY; CAT; EXPRESSION; CORTEX	Ablation of a cochlea causes total sensory deafferentation of the cochlear nucleus in the brainstem, providing a model to investigate nervous degeneration and formation of new synaptic contacts in the adult brain. In a quantitative electron microscopical study on the plasticity of the central auditory system of the Wistar rat, we first determined what fraction of the total number of synaptic contact zones (SCZs) in the anteroventral cochlear nucleus (AVCN) is attributable to primary sensory innervation and how many synapses remain after total unilateral cochlear ablation. Second, we attempted to identify the potential for a deafferentation-dependent synaptogenesis. SCZs were ultrastructurally identified before and after deafferentation in tissue treated for ethanolic phosphotungstic acid (EPTA) staining. This was combined with pre-embedding immunocytochemistry for gephyrin identifying inhibitory SCZs, the growth-associated protein GAP-43, glutamate, and choline acetyltransferase. A stereological analysis of EPTA stained sections revealed 1.11+/-0.09 (S. E. M.) x 10(9) SCZs per mm(3) of AVCN tissue. Within 7 days of deafferentation, this number was down by 46%. Excitatory and inhibitory synapses were differentially affected on the side of deafferentation. Excitatory synapses were quickly reduced and then began to increase in number again, necessarily being complemented from sources other than cochlear neurons, while inhibitory synapses were reduced more slowly and continuously. The result was a transient rise of the relative fraction of inhibitory synapses with a decline below original levels thereafter. Synaptogenesis was inferred by the emergence of morphologically immature SCZs that were consistently associated with GAP-43 immunoreactivity. SCZs of this type were estimated to make up a fraction of close to 30% of the total synaptic population present by ten weeks after sensory deafferentation. In conclusion, there appears to be a substantial potential for network reorganization and synaptogenesis in the auditory brainstem after loss of hearing, even in the adult brain.	[Hildebrandt, Heika; Hoffmann, Nadine A.; Illing, Robert-Benjamin] Univ Freiburg, Neurobiol Res Lab, Dept Otorhinolaryngol, Freiburg, Germany	University of Freiburg	Hildebrandt, H (corresponding author), Univ Freiburg, Neurobiol Res Lab, Dept Otorhinolaryngol, Freiburg, Germany.	robert.illing@uniklinik-freiburg.de						AGHAJANIAN G. K., 1967, BRAIN RES, V6, P716, DOI 10.1016/0006-8993(67)90128-X; Babalian AL, 2005, EXP BRAIN RES, V167, P451, DOI 10.1007/s00221-005-0178-8; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Benson CG, 1997, SYNAPSE, V25, P243; BENSON TE, 1990, J COMP NEUROL, V295, P52, DOI 10.1002/cne.902950106; BLOOM FE, 1966, SCIENCE, V154, P1575, DOI 10.1126/science.154.3756.1575; CANT NB, 1978, NEUROSCIENCE, V3, P1003, DOI 10.1016/0306-4522(78)90120-3; CASPARY DM, 1983, EXP NEUROL, V82, P491, DOI 10.1016/0014-4886(83)90419-3; Doucet JR, 2009, JARO-J ASSOC RES OTO, V10, P269, DOI 10.1007/s10162-008-0155-6; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; DUNNMEYNELL AA, 1992, J COMP NEUROL, V315, P160, DOI 10.1002/cne.903150204; Dyson S E, 1984, Brain Res, V315, P125; DYSON SE, 1976, CELL TISSUE RES, V167, P363; EVANS EF, 1973, EXP BRAIN RES, V17, P428; Feig SL, 2005, NEUROSCIENCE, V136, P1147, DOI 10.1016/j.neuroscience.2005.08.033; Fuentes-Santamaria V, 2007, NEUROSCIENCE, V148, P1033, DOI 10.1016/j.neuroscience.2007.07.026; GENTSCHEV T, 1973, BRAIN RES, V62, P37, DOI 10.1016/0006-8993(73)90618-5; Gerrikagoitia I, 2009, ANAT REC, V292, P1968, DOI 10.1002/ar.20999; Ghosh A, 2010, NAT NEUROSCI, V13, P97, DOI 10.1038/nn.2448; GRAY EG, 1959, J ANAT, V93, P420; Haenggeli CA, 2005, J COMP NEUROL, V484, P191, DOI 10.1002/cne.20466; Harris JL, 2011, HIPPOCAMPUS, V21, P81, DOI 10.1002/hipo.20725; Held H., 1893, ARCH ANAT PHYSL ANAT, P201; Horvath M, 2000, J COMP NEUROL, V422, P95; Illing RB, 2005, HEARING RES, V206, P185, DOI 10.1016/j.heares.2005.01.016; Illing RB, 1997, J COMP NEUROL, V382, P116, DOI 10.1002/(SICI)1096-9861(19970526)382:1<116::AID-CNE8>3.0.CO;2-4; KANE EC, 1974, ANAT REC, V179, P67, DOI 10.1002/ar.1091790106; KEITHLEY EM, 1979, J COMP NEUROL, V188, P429, DOI 10.1002/cne.901880306; Kneussel M, 2007, BIOL CELL, V99, P297, DOI 10.1042/BC20060120; Knobloch M, 2011, EUR J NEUROSCI, V33, P1013, DOI 10.1111/j.1460-9568.2010.07598.x; KOERBER KC, 1966, EXP NEUROL, V16, P119, DOI 10.1016/0014-4886(66)90091-4; Korshunova I, 2010, ADV EXP MED BIOL, V663, P169, DOI 10.1007/978-1-4419-1170-4_11; Kraus KS, 2004, J COMP NEUROL, V475, P374, DOI 10.1002/cne.20180; KRAUS KS, 2011, NEUROSCIENC IN PRESS; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; MARKUS EJ, 1987, DEV BRAIN RES, V35, P239, DOI 10.1016/0165-3806(87)90048-4; MARTIN MR, 1985, HEARING RES, V20, P215, DOI 10.1016/0378-5955(85)90026-7; Meidinger MA, 2006, EUR J NEUROSCI, V23, P3187, DOI 10.1111/j.1460-9568.2006.04853.x; Meltzer NE, 2006, ANAT REC PART A, V288A, P397, DOI 10.1002/ar.a.20300; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Michler SA, 2003, AUDIOL NEURO-OTOL, V8, P190, DOI 10.1159/000071060; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; MUGNAINI E, 1980, J COMP NEUROL, V191, P581, DOI 10.1002/cne.901910406; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; Nicol MJ, 2002, J PHYSIOL-LONDON, V539, P713, DOI 10.1113/jphysiol.2001.012972; ROBAIN O, 1981, BRAIN RES, V206, P1, DOI 10.1016/0006-8993(81)90095-0; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; ROUILLER EM, 1986, J COMP NEUROL, V249, P261, DOI 10.1002/cne.902490210; RYUGO DK, 1991, J COMP NEUROL, V305, P35, DOI 10.1002/cne.903050105; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SNYDER RL, 1988, J COMP NEUROL, V278, P209, DOI 10.1002/cne.902780205; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tierney TS, 1997, J COMP NEUROL, V378, P295, DOI 10.1002/(SICI)1096-9861(19970210)378:2<295::AID-CNE11>3.0.CO;2-R; Torres AC, 1999, NEUROSCIENCE, V92, P1475, DOI 10.1016/S0306-4522(99)00078-0; VRENSEN G, 1973, BRAIN RES, V58, P25, DOI 10.1016/0006-8993(73)90821-4; Wenthold R. J., 1984, HEARING SCI RECENT A, P341; WHITE JS, 1983, J COMP NEUROL, V219, P203, DOI 10.1002/cne.902190206; WICKESBERG RE, 1989, BRAIN RES, V486, P39, DOI 10.1016/0006-8993(89)91275-4; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; WOODWARD DJ, 1971, BRAIN RES, V34, P73, DOI 10.1016/0006-8993(71)90352-0; Zhu QZ, 1999, EXP NEUROL, V155, P228, DOI 10.1006/exnr.1998.6989	61	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23686	10.1371/journal.pone.0023686	http://dx.doi.org/10.1371/journal.pone.0023686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887295	gold, Green Published, Green Submitted			2022-12-25	WOS:000294251800019
J	Ammoun, S; Schmid, MC; Zhou, L; Ristic, N; Ercolano, E; Hilton, DA; Perks, CM; Hanemann, CO				Ammoun, S.; Schmid, M. C.; Zhou, L.; Ristic, N.; Ercolano, E.; Hilton, D. A.; Perks, C. M.; Hanemann, C. O.			Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival	ONCOGENE			English	Article						human schwannoma; IGFBP-1; PTEN/AKT; Src/FAK; proliferation; adhesion	CELL-PROLIFERATION; SIGNALING PATHWAY; BREAST-CANCER; KINASE; PTEN; ACTIVATION; INTEGRIN; MERLIN; PHOSPHORYLATION; AKT	Merlin is a tumour suppressor involved in the development of a variety of tumours including mesotheliomas. Neurofibromatosis type 2 (NF2), a dominantly inherited tumour disease, is also caused by loss of merlin. NF2 patients suffer from multiple genetically well-defined tumours, schwannomas are most frequent among those. Using our in vitro model for human schwannoma, we found that schwannoma cells display enhanced proliferation because of the overexpression/activation of platelet-derived growth factor receptor and ErbB2/3, increased cell-matrix adhesion because of the overexpression of integrins, and decreased apoptosis. Mechanisms underlying schwannomas basal proliferation and cell-matrix adhesion are not understood. Here, we investigated insulin-like growth factor-binding protein-1 (IGFBP-1), which is expressed and released from central nervous system tumours and strongly overexpressed in schwannoma at the mRNA level. IGFBP-1 acts via beta 1-integrin and focal-adhesion-kinase (FAK), which are strongly overexpressed and basally activated in schwannoma. Using short hairpin RNA knockdown, small inhibitors and recombinant IGFBP-1, we demonstrate that schwannoma cells, in contrast to Schwann cells, release IGFBP-1 that activates the Src/FAK pathway, via integrin beta 1, potentiating schwannoma's proliferation and cell-matrix adhesion. We show that FAK localizes to the nucleus and Src triggers IGFBP-1 production. Further, we observed downregulation of the tumour-suppressor phosphatase and tensin homolog in schwannoma cells leading to increased activity of antiapoptotic AKT. Thus, IGFBP-1/integrin beta 1/Src/FAK pathway has a crucial role in merlin-related tumourigenesis and therefore represents an important therapeutic target in the treatment of merlin-deficient tumours. Oncogene (2012) 31, 1710-1722; doi:10.1038/onc.2011.357; published online 5 September 2011	[Ammoun, S.; Schmid, M. C.; Zhou, L.; Ristic, N.; Ercolano, E.; Hanemann, C. O.] Peninsula Coll Med & Dent, Plymouth PL6 8BU, Devon, England; [Hilton, D. A.] Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England; [Perks, C. M.] Univ Bristol, Dept Clin Sci N Bristol, IGFs & Metab Endocrinol, Bristol, Avon, England	University of Plymouth; Derriford Hospital; University of Bristol	Hanemann, CO (corresponding author), Peninsula Coll Med & Dent, John Bull Bldg,Tamar Sci Pk,Res Way, Plymouth PL6 8BU, Devon, England.	oliver.hanemann@pms.ac.uk	Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025; Perks, Claire/0000-0003-1562-891X	CTF; Northcott Devon Medical Foundation; Peninsula College of Medicine and Dentistry, Plymouth, UK; Action Medical Research [1792] Funding Source: researchfish	CTF; Northcott Devon Medical Foundation; Peninsula College of Medicine and Dentistry, Plymouth, UK; Action Medical Research	This work was supported by the CTF, Northcott Devon Medical Foundation and by Peninsula College of Medicine and Dentistry, Plymouth, UK. Pfizer supplied inhibitor.	Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Ammoun S, 2010, NEURO-ONCOLOGY, V12, P834, DOI 10.1093/neuonc/noq012; Ammoun S, 2010, NEUROBIOL DIS, V37, P141, DOI 10.1016/j.nbd.2009.09.017; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chaves J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0b013e32834258a1; Feron M, 2009, AM J PATHOL, V174, P1459, DOI 10.2353/ajpath.2009.080460; Flaiz C, 2007, J NEUROPATH EXP NEUR, V66, P608, DOI 10.1097/nen.0b013e318093e555; Fraenzer JT, 2003, INT J ONCOL, V23, P1493; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hanemann CO, 2006, NEUROPATH APPL NEURO, V32, P605, DOI 10.1111/j.1365-2990.2006.00769.x; Hilton DA, 2009, HISTOPATHOLOGY, V55, P744, DOI 10.1111/j.1365-2559.2009.03440.x; Hiromura M, 2004, J BIOL CHEM, V279, P53407, DOI 10.1074/jbc.M403775200; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; JONES JI, 1993, J BIOL CHEM, V268, P1125; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; JONES JI, 1991, P NATL ACAD SCI USA, V88, P7481, DOI 10.1073/pnas.88.17.7481; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lin CH, 2003, J NEUROSCI, V23, P1574; Liu WJ, 2008, ANTICANCER RES, V28, P3613; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Nagashima T, 2008, ENDOCRINOLOGY, V149, P1227, DOI 10.1210/en.2007-1217; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Park CH, 2008, BRAIN RES, V1234, P148, DOI 10.1016/j.brainres.2008.07.082; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Rosenbaum C, 2000, NEUROBIOL DIS, V7, P483, DOI 10.1006/nbdi.2000.0307; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Utermark T, 2005, BRAIN PATHOL, V15, P17; Utermark T, 2003, BRAIN PATHOL, V13, P352; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yee D, 2002, SEMIN ONCOL, V29, P86, DOI 10.1053/sonc.2002.34060; Zhang H, 2006, CLIN CANCER RES, V12, P6323, DOI 10.1158/1078-0432.CCR-06-1707; Zumkeller W, 2001, J CLIN PATHOL-MOL PA, V54, P227, DOI 10.1136/mp.54.4.227	46	38	39	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	13					1710	1722		10.1038/onc.2011.357	http://dx.doi.org/10.1038/onc.2011.357			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	918EF	21892205				2022-12-25	WOS:000302231400009
J	Zaika, E; Wei, JX; Yin, DP; Andl, C; Moll, U; El-Rifai, W; Zaika, AI				Zaika, Elena; Wei, Jinxiong; Yin, Dengping; Andl, Claudia; Moll, Ute; El-Rifai, Wael; Zaika, Alexander I.			p73 protein regulates DNA damage repair	FASEB JOURNAL			English	Article						p53; p63; bile acids	KINASE C-ABL; APOPTOTIC RESPONSE; BILE-ACIDS; P53; EXPRESSION; DELTA-NP73; REFLUX; CANCER; P63; ADENOCARCINOMAS	Although the p53 tumor suppressor is relatively well characterized, much less is known about the functions of other members of the p53 family, p73 and p63. Here, we present evidence that in specific pathological conditions caused by exposure of normal cells to bile acids in acidic conditions, p73 protein plays the predominant role in the DNA damage response. These pathological conditions frequently occur during gastric reflux in the human esophagus and are associated with progression to esophageal adenocarcinoma. We found that despite strong DNA damage induced by bile acid exposure, only p73 (but not p53 and p63) is selectively activated in a c-Abl kinase-dependent manner. The activated p73 protein induces DNA damage repair. Using a human DNA repair PCR array, we identified multiple DNA repair genes affected by p73. Two glycosylases involved in base excision repair, SMUG1 and MUTYH, were characterized and found to be transcriptionally regulated by p73 in DNA damage conditions. Using a surgical procedure in mice, which recapitulates bile acid exposure, we found that p73 deficiency is associated with increased DNA damage. These findings were further investigated with organotypic and traditional cell cultures. Collectively our studies demonstrate that p73 plays an important role in the regulation of DNA damage repair.-Zaika, E., Wei, J., Yin, D., Andl, C., Moll, U., El-Rifai, W., Zaika, A. I. p73 protein regulates DNA damage repair. FASEB J. 25, 4406-4414 (2011). www.fasebj.org	[Zaika, Elena; Wei, Jinxiong; Yin, Dengping; Andl, Claudia; El-Rifai, Wael; Zaika, Alexander I.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [El-Rifai, Wael; Zaika, Alexander I.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Moll, Ute] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zaika, AI (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg & Canc Biol, 1255 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	alexander.zaika@vanderbilt.edu			U.S. National Cancer Institute [NIH R01CA138833, NIH R01CA108956, NIH R01CA106176]; NATIONAL CANCER INSTITUTE [R01CA108956, R01CA106176, R01CA138833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075379] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002115] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. National Cancer Institute, grants NIH R01CA138833, NIH R01CA108956, and NIH R01CA106176. The authors thank Dr. P. Williams for valuable discussion of the manuscript.	Agami R, 1999, NATURE, V399, P809; ALTORKI N, 1993, CANCER-AM CANCER SOC, V72, P649, DOI 10.1002/1097-0142(19930801)72:3<649::AID-CNCR2820720305>3.0.CO;2-L; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Belyi VA, 2009, P NATL ACAD SCI USA, V106, P17609, DOI 10.1073/pnas.0910634106; Bernal C, 2008, BIOL RES, V41, P303, DOI [10.4067/S0716-97602008000300007, /S0716-97602008000300007]; Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329; Cai YYC, 2000, CARCINOGENESIS, V21, P683, DOI 10.1093/carcin/21.4.683; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Chen XX, 2000, CARCINOGENESIS, V21, P257, DOI 10.1093/carcin/21.2.257; Christmann M, 2005, ONCOGENE, V24, P8304, DOI 10.1038/sj.onc.1208994; Concin N, 2005, CLIN CANCER RES, V11, P8372, DOI 10.1158/1078-0432.CCR-05-0899; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Dvorak K, 2007, GUT, V56, P763, DOI 10.1136/gut.2006.103697; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Gong JG, 1999, NATURE, V399, P806; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kauer WKH, 1997, SURGERY, V122, P874, DOI 10.1016/S0039-6060(97)90327-5; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Li Y, 2007, DIS ESOPHAGUS, V20, P372, DOI 10.1111/j.1442-2050.2007.00713.x; Lin KW, 2004, NEOPLASIA, V6, P546, DOI 10.1593/neo.04205; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Maley CC, 2005, SEMIN CANCER BIOL, V15, P474, DOI 10.1016/j.semcancer.2005.06.004; Masuda N, 2003, CANCER SCI, V94, P612, DOI 10.1111/j.1349-7006.2003.tb01491.x; Melhado Rachel E, 2010, Cancers (Basel), V2, P1379, DOI 10.3390/cancers2031379; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Poulsen MLM, 2008, CURR GENOMICS, V9, P420, DOI 10.2174/138920208785699562; Qiao DH, 2001, CARCINOGENESIS, V22, P957, DOI 10.1093/carcin/22.6.957; Roman S, 2007, AM J PHYSIOL-GASTR L, V293, pG45, DOI 10.1152/ajpgi.00583.2006; Souza R. F., 2002, SURG ONCOL CLIN N AM, V11, pviii; Souza Rhonda F, 2002, Surg Oncol Clin N Am, V11, P257, DOI 10.1016/S1055-3207(02)00003-0; Speit G, 1998, MUTAT RES-GEN TOX EN, V412, P187, DOI 10.1016/S1383-5718(97)00199-X; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; STONER GD, 1991, CANCER RES, V51, P365; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Theisen J, 2005, ANN SURG, V241, P63, DOI 10.1097/01.sla.0000150072.55037.e3; Tomkova K, 2006, ONCOGENE, V25, P6032, DOI 10.1038/sj.onc.1209610; Vilgelm A, 2008, ONCOGENE, V27, P2170, DOI 10.1038/sj.onc.1210862; Vilgelm AE, 2010, ONCOGENE, V29, P5861, DOI 10.1038/onc.2010.319; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Vilgelm AE, 2010, MOL CANCER THER, V9, P693, DOI 10.1158/1535-7163.MCT-09-0912; Wang WG, 2006, P NATL ACAD SCI USA, V103, P11003, DOI 10.1073/pnas.0604507103; Wei A, 2008, GASTROENTEROLOGY, V134, P1412, DOI 10.1053/j.gastro.2008.01.072; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011572; Yokozaki H, 1999, INT J CANCER, V83, P192, DOI 10.1002/(SICI)1097-0215(19991008)83:2<192::AID-IJC8>3.0.CO;2-E; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang HY, 2009, CANCER RES, V69, P9083, DOI 10.1158/0008-5472.CAN-09-2518	50	30	31	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4406	4414		10.1096/fj.11-192815	http://dx.doi.org/10.1096/fj.11-192815			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21891782	Green Published			2022-12-25	WOS:000298138100031
J	Ohara-Nemoto, Y; Shimoyama, Y; Kimura, S; Kon, A; Haraga, H; Ono, T; Nemoto, TK				Ohara-Nemoto, Yuko; Shimoyama, Yu; Kimura, Shigenobu; Kon, Asako; Haraga, Hiroshi; Ono, Toshio; Nemoto, Takayuki K.			Asp- and Glu-specific Novel Dipeptidyl Peptidase 11 of Porphyromonas gingivalis Ensures Utilization of Proteinaceous Energy Sources	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPEPTIDYL AMINOPEPTIDASE; STAPHYLOCOCCUS-EPIDERMIDIS; GLUTAMYL ENDOPEPTIDASE; BACILLUS-SPHAERICUS; PERIODONTAL-DISEASE; GENOME SEQUENCE; ORAL BACTERIA; STRAIN W83; BACTEROIDES; PURIFICATION	Porphyromonas gingivalis and Porphyromonas endodontalis, asaccharolytic black-pigmented anaerobes, are predominant pathogens of human chronic and periapical periodontitis, respectively. They incorporate di- and tripeptides from the environment as carbon and energy sources. In the present study we cloned a novel dipeptidyl peptidase (DPP) gene of P. endodontalis ATCC 35406, designated as DPP11. The DPP11 gene encoded 717 amino acids with a molecular mass of 81,090 Da and was present as a 75-kDa form with an N terminus of Asp(22). A homology search revealed the presence of a P. gingivalis orthologue, PGN0607, that has been categorized as an isoform of authentic DPP7. P. gingivalis DPP11 was exclusively cell-associated as a truncated 60-kDa form, and the gene ablation retarded cell growth. DPP11 specifically removed dipeptides from oligopeptides with the penultimate N-terminal Asp and Glu and has a P2-position preference to hydrophobic residues. Optimum pH was 7.0, and the k(cat)/K-m value was higher for Asp than Glu. Those activities were lost by substitution of Ser(652) in P. endodontalis and Ser(655) in P. gingivalis DPP11 to Ala, and they were consistently decreased with increasing NaCl concentration. Arg(670) is a unique amino acid completely conserved in all DPP11 members distributed in the genera Porphyromonas, Bacteroides, and Parabacteroides, whereas this residue is converted to Gly in all authentic DPP7 members. Substitution analysis suggested that Arg(670) interacts with an acidic residue of the substrate. Considered to preferentially utilize acidic amino acids, DPP11 ensures efficient degradation of oligopeptide substrates in these Gram-negative anaerobic rods.	[Ohara-Nemoto, Yuko; Ono, Toshio; Nemoto, Takayuki K.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, Nagasaki 8528588, Japan; [Shimoyama, Yu; Kimura, Shigenobu; Kon, Asako; Haraga, Hiroshi] Iwate Med Univ, Div Mol Microbiol, Dept Microbiol, Yahaba, Iwate 0283691, Japan	Nagasaki University; Iwate Medical University	Ohara-Nemoto, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Mol Biol, Course Med & Dent Sci, Nagasaki 8528588, Japan.	ynemoto@nagasaki-u.ac.jp		Nemoto, Takayuki K./0000-0002-5007-6260	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan ( to Y. O.-N., T. K. N., and S. K.).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Banbula A, 2001, J BIOL CHEM, V276, P6299, DOI 10.1074/jbc.M008789200; Banbula A, 2000, INFECT IMMUN, V68, P1176, DOI 10.1128/IAI.68.3.1176-1182.2000; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; CARMONA C, 1987, NUCLEIC ACIDS RES, V15, P6757, DOI 10.1093/nar/15.16.6757; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Citron D. M., 2007, MANUAL CLIN MICROBIO, V1, P911; Conrads G, 2005, INT J SYST EVOL MICR, V55, P607, DOI 10.1099/ijs.0.63234-0; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Dubois V, 2010, BBA-PROTEINS PROTEOM, V1804, P781, DOI 10.1016/j.bbapap.2009.11.022; ELLIS S, 1967, J BIOL CHEM, V242, P4623; Finegold SM, 2004, J CLIN MICROBIOL, V42, P5298, DOI 10.1128/JCM.42.11.5298-5301.2004; FUJIMURA S, 1992, ORAL MICROBIOL IMMUN, V7, P212, DOI 10.1111/j.1399-302X.1992.tb00027.x; Grenier D, 2001, ORAL MICROBIOL IMMUN, V16, P212, DOI 10.1034/j.1399-302X.2001.160403.x; GUINAND M, 1979, J BACTERIOL, V138, P126, DOI 10.1128/JB.138.1.126-132.1979; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Ikeda Y, 2004, CAN J MICROBIOL, V50, P493, DOI [10.1139/w04-055, 10.1139/W04-055]; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Iwai T, 2005, J VASC SURG, V42, P107, DOI 10.1016/j.jvs.2005.03.016; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; KASTELEIN P, 1981, A VAN LEEUW J MICROB, V47, P1, DOI 10.1007/BF00399062; Kiyama M, 1998, BBA-GENE STRUCT EXPR, V1396, P39, DOI 10.1016/S0167-4781(97)00225-X; Kon A, 2002, DENT J IWATE MED U, V27, P187; KRIEGER TJ, 1994, FEBS LETT, V352, P385, DOI 10.1016/0014-5793(94)00988-0; Kshirsagar AV, 2007, BLOOD PURIFICAT, V25, P125, DOI 10.1159/000096411; LOESCHE WJ, 1985, J PERIODONTOL, V56, P447, DOI 10.1902/jop.1985.56.8.447; Maes MB, 2005, BIOCHEM J, V386, P315, DOI 10.1042/BJ20041156; MAYRAND D, 1988, MICROBIOL REV, V52, P134, DOI 10.1128/MMBR.52.1.134-152.1988; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; McDonald J. K., 1971, PROTEASES MAMMALIAN, P311; MCDONALD JK, 1968, J BIOL CHEM, V243, P2028; McNicholas K, 2009, CLIN CHEM LAB MED, V47, P262, DOI 10.1515/CCLM.2009.061; MOORE WEC, 1982, INFECT IMMUN, V38, P1137, DOI 10.1128/IAI.38.3.1137-1148.1982; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nemoto TK, 2008, FEBS J, V275, P573, DOI 10.1111/j.1742-4658.2007.06224.x; Oda H, 2009, J PERIODONTAL RES, V44, P362, DOI 10.1111/j.1600-0765.2008.01117.x; Ohara-Nemoto Y, 2008, BIOL CHEM, V389, P1209, DOI 10.1515/BC.2008.137; OYA H, 1974, ARCH ORAL BIOL, V19, P489, DOI 10.1016/0003-9969(74)90158-7; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; PIKE R, 1994, J BIOL CHEM, V269, P406; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; SUIDO H, 1986, J DENT RES, V65, P1335, DOI 10.1177/00220345860650111101; SUNDQVIST G, 1989, J ENDODONT, V15, P13, DOI 10.1016/S0099-2399(89)80092-5; Takahashi N, 2002, ORAL MICROBIOL IMMUN, V17, P50, DOI 10.1046/j.0902-0055.2001.00089.x; Takahashi N, 2001, J DENT RES, V80, P1425, DOI 10.1177/00220345010800050801; Takahashi N, 2000, J BACTERIOL, V182, P4704, DOI 10.1128/JB.182.17.4704-4710.2000; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; VACHERON MJ, 1979, EUR J BIOCHEM, V100, P189, DOI 10.1111/j.1432-1033.1979.tb02048.x; VANSTEENBERGEN TJM, 1984, INT J SYST BACTERIOL, V34, P118, DOI 10.1099/00207713-34-2-118; VANSTEENBERGEN TJM, 1986, FEMS MICROBIOL LETT, V33, P219, DOI 10.1016/0378-1097(86)90241-7; VANWINKELHOFF AJ, 1987, J DENT RES, V66, P1663, DOI 10.1177/00220345870660111201; VIMR ER, 1983, J BACTERIOL, V153, P1259, DOI 10.1128/JB.153.3.1259-1265.1983; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; WHITE D, 1981, J PERIODONTAL RES, V16, P259, DOI 10.1111/j.1600-0765.1981.tb00974.x	60	32	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38115	38127		10.1074/jbc.M111.278572	http://dx.doi.org/10.1074/jbc.M111.278572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896480	Green Published, hybrid			2022-12-25	WOS:000296594200025
J	Nakata, M; Kimura, KR; Sumitomo, T; Wada, S; Sugauchi, A; Oiki, E; Higashino, M; Kreikemeyer, B; Podbielski, A; Okahashi, N; Hamada, S; Isoda, R; Terao, Y; Kawabata, S				Nakata, Masanobu; Kimura, Keiji Richard; Sumitomo, Tomoko; Wada, Satoshi; Sugauchi, Akinari; Oiki, Eiji; Higashino, Miharu; Kreikemeyer, Bernd; Podbielski, Andreas; Okahashi, Nobuo; Hamada, Shigeyuki; Isoda, Ryutaro; Terao, Yutaka; Kawabata, Shigetada			Assembly Mechanism of FCT Region Type 1 Pili in Serotype M6 Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; GROUP-A STREPTOCOCCI; CORYNEBACTERIUM-DIPHTHERIAE; ISOPEPTIDE BONDS; CELL-WALL; STABILIZING ISOPEPTIDE; ESCHERICHIA-COLI; SURFACE PROTEIN; GENE; EXPRESSION	The human pathogen Streptococcus pyogenes produces diverse pili depending on the serotype. We investigated the assembly mechanism of FCT type 1 pili in a serotype M6 strain. The pili were found to be assembled from two precursor proteins, the backbone protein T6 and ancillary protein FctX, and anchored to the cell wall in a manner that requires both a housekeeping sortase enzyme (SrtA) and pilus-associated sortase enzyme (SrtB). SrtB is primarily required for efficient formation of the T6 and FctX complex and subsequent polymerization of T6, whereas proper anchoring of the pili to the cell wall is mainly mediated by SrtA. Because motifs essential for polymerization of pilus backbone proteins in other Gram-positive bacteria are not present in T6, we sought to identify the functional residues involved in this process. Our results showed that T6 encompasses the novel VAKS pilin motif conserved in streptococcal T6 homologues and that the lysine residue (Lys-175) within the motif and cell wall sorting signal of T6 are prerequisites for isopeptide linkage of T6 molecules. Because Lys-175 and the cell wall sorting signal of FctX are indispensable for substantial incorporation of FctX into the T6 pilus shaft, FctX is suggested to be located at the pilus tip, which was also implied by immunogold electron microscopy findings. Thus, the elaborate assembly of FCT type 1 pili is potentially organized by sortase-mediated cross-linking between sorting signals and the amino group of Lys-175 positioned in the VAKS motif of T6, thereby displaying T6 and FctX in a temporospatial manner.	[Nakata, Masanobu; Kimura, Keiji Richard; Sumitomo, Tomoko; Wada, Satoshi; Sugauchi, Akinari; Higashino, Miharu; Isoda, Ryutaro; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Oiki, Eiji] Osaka Univ, Grad Sch Med, Ctr Med Res & Educ, Suita, Osaka 5650871, Japan; [Kreikemeyer, Bernd; Podbielski, Andreas] Univ Rostock, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Dept Oral Frontier Biol, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Minist Publ Hlth, Res Collaborat Ctr Emerging & Reemerging Infect R, Dept Med Sci, Muang Nonthaburi 11000, Thailand	Osaka University; Osaka University; University of Rostock; Osaka University; Ministry of Public Health - Thailand	Kawabata, S (corresponding author), Osaka Univ, Dept Oral & Mol Microbiol, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	okahashi, nobuo/A-4032-2010	okahashi, nobuo/0000-0002-8045-7021; Nakata, Masanobu/0000-0003-1686-5415; Kreikemeyer, Bernd/0000-0001-9527-5098; Terao, Yutaka/0000-0002-4450-5583	Japan Society for the Promotion of Science [20390465]; Ministry of Education, Culture, Sports, Science and Technology [18073011, 2189048, 19791343, 20791336, 21791786]; Deutsche Forschungsgemeinschaft (German Research Foundation) [Po391/12-1, Kr1765/2-1]; Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research); Grants-in-Aid for Scientific Research [23592700, 23593027] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research (B) 20390465 from the Japan Society for the Promotion of Science and Grant-in-aid for Scientific Research on Priority Areas 18073011; Grant-in-aid for Scientific Research for Young Scientists (A) 2189048; and Grants-in-aid for Scientific Research for Young Scientists (B) 19791343, 20791336, and 21791786 from the Ministry of Education, Culture, Sports, Science and Technology.; Supported by Deutsche Forschungsgemeinschaft (German Research Foundation) Grants Po391/12-1 and Kr1765/2-1 and the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) in the framework of ERANet PathoGenoMics I and II and SysMO Systems Biology of Microorganisms I and II.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Griffith F, 1934, J HYG-CAMBRIDGE, V34, P542, DOI 10.1017/S0022172400043308; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, BIOPOLYMERS, V91, P1126, DOI 10.1002/bip.21170; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kreikemeyer B, 2011, INT J MED MICROBIOL, V301, P240, DOI 10.1016/j.ijmm.2010.09.003; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murakami J, 2002, EPIDEMIOL INFECT, V128, P397, DOI 10.1017/S0950268802006854; Nakata M, 2005, MOL MICROBIOL, V57, P786, DOI 10.1111/j.1365-2958.2005.04730.x; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; Okahashi N, 2011, MICROB PATHOGENESIS, V50, P148, DOI 10.1016/j.micpath.2011.01.005; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Okura M, 2011, J BACTERIOL, V193, P822, DOI 10.1128/JB.01555-09; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Podbielski A, 1999, MOL MICROBIOL, V31, P1051, DOI 10.1046/j.1365-2958.1999.01241.x; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; SCHNEEWIND O, 1990, J BACTERIOL, V172, P3310, DOI 10.1128/jb.172.6.3310-3317.1990; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; Zahner D, 2008, J BACTERIOL, V190, P527, DOI 10.1128/JB.01520-07	46	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37566	37577		10.1074/jbc.M111.239780	http://dx.doi.org/10.1074/jbc.M111.239780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880740	Green Published, hybrid			2022-12-25	WOS:000296542400055
J	Ueno, N; Taketomi, Y; Yamamoto, K; Hirabayashi, T; Kamei, D; Kita, Y; Shimizu, T; Shinzawa, K; Tsujimoto, Y; Ikeda, K; Taguchi, R; Murakamia, M				Ueno, Noriko; Taketomi, Yoshitaka; Yamamoto, Kei; Hirabayashi, Tetsuya; Kamei, Daisuke; Kita, Yoshihiro; Shimizu, Takao; Shinzawa, Koei; Tsujimoto, Yoshihide; Ikeda, Kazutaka; Taguchi, Ryo; Murakamia, Makoto			Analysis of Two Major Intracellular Phospholipases A(2) (PLA(2)) in Mast Cells Reveals Crucial Contribution of Cytosolic PLA(2)alpha, Not Ca2+-independent PLA(2)beta, to Lipid Mobilization in Proximal Mast Cells and Distal Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; SMOOTH-MUSCLE-CELLS; TRANSCELLULAR BIOSYNTHESIS; PROSTAGLANDIN D-2; CYSTEINYL LEUKOTRIENES; EICOSANOID GENERATION; ALLERGIC INFLAMMATION; BROMOENOL LACTONE; EXPRESS GROUP; MICE LACKING	Mast cells release a variety of mediators, including arachidonic acid (AA) metabolites, to regulate allergy, inflammation, and host defense, and their differentiation and maturation within extravascular microenvironments depend on the stromal cytokine stem cell factor. Mouse mast cells express two major intracellular phospholipases A(2) (PLA(2)s), namely group IVA cytosolic PLA(2) (cPLA(2)alpha) and group VIA Ca2+-independent PLA2 (iPLA(2)beta), and the role of cPLA(2)alpha in eicosanoid synthesis by mast cells has been well documented. Lipidomic analyses of mouse bone marrow-derived mast cells (BMMCs) lacking cPLA(2)alpha (Pla2g4a(-/-)) or iPLA(2)beta (Pla2g6(-/-)) revealed that phospholipids with AA were selectively hydrolyzed by cPLA(2)alpha, not by iPLA(2)beta, during Fc epsilon RI-mediated activation and even during fibroblast-dependent maturation. Neither Fc epsilon RI-dependent effector functions nor maturation-driven phospholipid remodeling was impaired in Pla2g6(-/-) BMMCs. Although BMMCs did not produce prostaglandin E-2 (PGE(2)), the AA released by cPLA(2)alpha from BMMCs during maturation was converted to PGE(2) by microsomal PGE synthase-1 (mPGES-1) in cocultured fibroblasts, and accordingly, Pla2g4a(-/-) BMMCs promoted microenvironmental PGE(2) synthesis less efficiently than wild-type BMMCs both in vitro and in vivo. Mice deficient in mPGES-1 (Ptges(-/-)) had an augmented local anaphylactic response. These results suggest that cPLA(2)alpha in mast cells is functionally coupled, through the AA transfer mechanism, with stromal mPGES-1 to provide anti-anaphylactic PGE(2). Although iPLA(2)beta is partially responsible for PGE(2) production by macrophages and dendritic cells, it is dispensable for mast cell maturation and function.	[Ueno, Noriko; Taketomi, Yoshitaka; Yamamoto, Kei; Hirabayashi, Tetsuya; Murakamia, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, Tokyo 1568506, Japan; [Taketomi, Yoshitaka; Kamei, Daisuke] Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; [Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Shinzawa, Koei; Tsujimoto, Yoshihide] Osaka Univ, Sch Med, Lab Mol Genet, Dept Med Genet, Suita, Osaka 5650871, Japan; [Ikeda, Kazutaka; Taguchi, Ryo; Murakamia, Makoto] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Ikeda, Kazutaka] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Taguchi, Ryo] Chubu Univ, Coll Life & Hlth Sci, Aichi 4878501, Japan	Tokyo Metropolitan Institute of Medical Science; Showa University; University of Tokyo; University of Tokyo; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST); Keio University; Chubu University	Murakamia, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	murakami-mk@igakuken.or.jp	Shimizu, Takao/AAV-7052-2021	Hirabayashi, Tetsuya/0000-0001-8099-5367	Ministry of Education, Science, Culture, Sports and Technology of Japan; Japan Science and Technology Agency; Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency; Toray Foundation; Mitsubishi Science Foundation; Terumo Life Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [22116005] Funding Source: KAKEN	Ministry of Education, Science, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency; Toray Foundation; Mitsubishi Science Foundation; Terumo Life Science Foundation(Terumo Life Science Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in aid for scientific research from the Ministry of Education, Science, Culture, Sports and Technology of Japan.; Supported by Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency.; Supported by Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency, The Toray Foundation, The Mitsubishi Science Foundation, The Terumo Life Science Foundation, and The Uehara Memorial Foundation.	Abonia JP, 2005, BLOOD, V105, P4308, DOI 10.1182/blood-2004-09-3578; Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Austen KF, 2008, NAT IMMUNOL, V9, P113, DOI 10.1038/ni0208-113; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P20958, DOI 10.1074/jbc.M600075200; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DAYTON ET, 1988, P NATL ACAD SCI USA, V85, P569, DOI 10.1073/pnas.85.2.569; Diaz BL, 2002, J IMMUNOL, V168, P1397, DOI 10.4049/jimmunol.168.3.1397; Dietrich HH, 2010, AM J PHYSIOL-HEART C, V298, pH2208, DOI 10.1152/ajpheart.00839.2009; Fabre JE, 2002, J CLIN INVEST, V109, P1373, DOI 10.1172/JCI200214869; Fensome-Green A, 2007, CELL CALCIUM, V41, P145, DOI 10.1016/j.ceca.2006.06.002; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Gurish MF, 2001, J EXP MED, V194, P1243, DOI 10.1084/jem.194.9.1243; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; HU ZQ, 1995, J IMMUNOL, V155, P2134; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200; Kendall JC, 1997, J ALLERGY CLIN IMMUN, V99, P113; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; LEVISCHAFFER F, 1995, J INVEST DERMATOL, V104, P999, DOI 10.1111/1523-1747.ep12606237; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Lundequist A, 2010, J IMMUNOL, V184, P433, DOI 10.4049/jimmunol.0902835; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; MURAKAMI M, 1995, J EXP MED, V182, P197, DOI 10.1084/jem.182.1.197; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; Nakatani N, 2000, BIOCHEM J, V352, P311, DOI 10.1042/0264-6021:3520311; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Nikolic DM, 2007, J BIOL CHEM, V282, P33405, DOI 10.1074/jbc.M704133200; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; Ogasawara T, 1997, J IMMUNOL, V158, P393; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Reddy ST, 1996, J BIOL CHEM, V271, P186, DOI 10.1074/jbc.271.1.186; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; Sala A, 2010, PHARMACOL REP, V62, P503, DOI 10.1016/S1734-1140(10)70306-6; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Sharma J, 2010, BIOCHEMISTRY-US, V49, P5473, DOI 10.1021/bi100752u; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smith RS, 1997, AM J PATHOL, V151, P317; Smith TJ, 1999, ENDOCRINOLOGY, V140, P3518, DOI 10.1210/en.140.8.3518; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Taketomi Y, 2007, J IMMUNOL, V178, P7042, DOI 10.4049/jimmunol.178.11.7042; Trautmann A, 1998, J IMMUNOL, V160, P5053; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wijewickrama GT, 2006, J BIOL CHEM, V281, P10935, DOI 10.1074/jbc.M512657200; Wong G. W., 1999, SIGNAL TRANSDUCTION, P39; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yamashita A, 2005, J BIOCHEM, V137, P557, DOI 10.1093/jb/mvi067; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	85	23	23	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37249	37263		10.1074/jbc.M111.290312	http://dx.doi.org/10.1074/jbc.M111.290312			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880721	hybrid, Green Published			2022-12-25	WOS:000296542400025
J	Verma, V; Testero, SA; Amini, K; Wei, W; Liu, J; Balachandran, N; Monoharan, T; Stynes, S; Kotra, LP; Golemi-Kotra, D				Verma, Vidhu; Testero, Sebastian A.; Amini, Kaveh; Wei, William; Liu, Jerome; Balachandran, Naresh; Monoharan, Tharseekan; Stynes, Siobhan; Kotra, Lakshmi P.; Golemi-Kotra, Dasantila			Hydrolytic Mechanism of OXA-58 Enzyme, a Carbapenem-hydrolyzing Class D beta-Lactamase from Acinetobacterbaumannii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; CLASS-A; RESISTANCE; BAUMANNII; INHIBITION; INSIGHTS; DESIGN; LYSINE; ACID	Carbapenem-hydrolyzing class D beta-lactamases (CHDLs) represent an emerging antibiotic resistance mechanism encountered among the most opportunistic Gram-negative bacterial pathogens. We report here the substrate kinetics and mechanistic characterization of a prominent CHDL, the OXA-58 enzyme, from Acinetobacter baumannii. OXA-58 uses a carbamylated lysine to activate the nucleophilic serine used for beta-lactam hydrolysis. The deacylating water molecule approaches the acyl-enzyme species, anchored at this serine (Ser-83), from the alpha-face. Our data show that OXA-58 retains the catalytic machinery found in class D beta-lactamases, of which OXA-10 is representative. Comparison of the homology model of OXA-58 and the recently solved crystal structures of OXA-24 and OXA-48 with the OXA-10 crystal structure suggests that these CHDLs have evolved the ability to hydrolyze imipenem, an important carbapenem in clinical use, by subtle structural changes in the active site. These changes may contribute to tighter binding of imipenem to the active site and removal of steric hindrances from the path of the deacylating water molecule.	[Verma, Vidhu; Amini, Kaveh; Liu, Jerome; Balachandran, Naresh; Monoharan, Tharseekan; Stynes, Siobhan; Golemi-Kotra, Dasantila] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada; [Testero, Sebastian A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Wei, William; Kotra, Lakshmi P.] Univ Hlth Network, Ctr Mol Design & Preformulat, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada	York University - Canada; University of Notre Dame; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Golemi-Kotra, D (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada.	dgkotra@yorku.ca	/N-6611-2013; Testero, Sebastian A./AAF-6532-2019	/0000-0003-1299-6987; Testero, Sebastian A./0000-0002-0185-5751; Amini, Kaveh/0000-0001-8587-2120; Kotra, Lakshmi P./0000-0002-7071-4637				Afzal-Shah M, 2001, ANTIMICROB AGENTS CH, V45, P583, DOI 10.1128/AAC.45.2.583-588.2001; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bonfiglio G, 2002, EXPERT OPIN INV DRUG, V11, P529; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chen Y, 2009, PROTEIN SCI, V18, P662, DOI 10.1002/pro.60; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Dubus A, 1996, PROTEINS, V25, P473, DOI 10.1002/prot.7; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi D, 2000, J ANTIBIOT, V53, P1022, DOI 10.7164/antibiotics.53.1022; Golemi D, 2000, J AM CHEM SOC, V122, P6132, DOI 10.1021/ja0013881; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Heritier C, 2005, J ANTIMICROB CHEMOTH, V55, P115, DOI 10.1093/jac/dkh500; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; KITZ RJ, 1967, BIOCHEM PHARMACOL, V16, P2201, DOI 10.1016/0006-2952(67)90019-6; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; Li J, 2005, PROTEINS, V61, P246, DOI 10.1002/prot.20596; Livermore DM, 1998, J ANTIMICROB CHEMOTH, V41, P25, DOI 10.1093/jac/41.suppl_4.25; Marque S, 2005, J CLIN MICROBIOL, V43, P4885, DOI 10.1128/JCM.43.9.4885-4888.2005; Maveyraud L, 1996, J AM CHEM SOC, V118, P7435, DOI 10.1021/ja9609718; Maveyraud L, 2002, J AM CHEM SOC, V124, P2461, DOI 10.1021/ja016736t; Maveyraud L, 2000, STRUCTURE, V8, P1289, DOI 10.1016/S0969-2126(00)00534-7; MIYASHITA K, 1995, J AM CHEM SOC, V117, P11055, DOI 10.1021/ja00150a003; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; Nagase T, 2001, BIOORG CHEM, V29, P140, DOI 10.1006/bioo.2001.1205; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; Paton R, 1993, Int J Antimicrob Agents, V2, P81, DOI 10.1016/0924-8579(93)90045-7; Pernot L, 2001, J MOL BIOL, V310, P859, DOI 10.1006/jmbi.2001.4805; Poduch E, 2006, J MED CHEM, V49, P4937, DOI 10.1021/jm060202r; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P6136, DOI 10.1021/bi900448u; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Testero A., 2010, BURGER MED CHEM DRUG, P259; Testero SA, 2009, ORG LETT, V11, P2515, DOI 10.1021/ol900668k; Vercheval L, 2010, BIOCHEM J, V432, P495, DOI 10.1042/BJ20101122; Walsh TR, 2008, CURR OPIN INFECT DIS, V21, P367, DOI 10.1097/QCO.0b013e328303670b; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Zarrilli Raffaele, 2009, J Infect Dev Ctries, V3, P335, DOI 10.3855/jidc.240	48	30	34	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37292	37303		10.1074/jbc.M111.280115	http://dx.doi.org/10.1074/jbc.M111.280115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880707	Green Published, hybrid			2022-12-25	WOS:000296542400029
J	Chouabe, C; Eyraud, V; Da Silva, P; Rahioui, I; Royer, C; Soulage, C; Bonvallet, R; Huss, M; Gressent, F				Chouabe, Christophe; Eyraud, Vanessa; Da Silva, Pedro; Rahioui, Isabelle; Royer, Corinne; Soulage, Christophe; Bonvallet, Robert; Huss, Markus; Gressent, Frederic			New Mode of Action for a Knottin Protein Bioinsecticide PEA ALBUMIN 1 SUBUNIT b (PA1b) IS THE FIRST PEPTIDIC INHIBITOR OF V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASES; BIOLOGICAL-ACTIVITY; WEEVIL SITOPHILUS; PLASMA-MEMBRANE; BINDING-SITE; PEA-SEEDS; CELLS; ENTOMOTOXIN; PURIFICATION; CYCLOTIDES	PA1b (for pea albumin 1 subunit b) is a plant bioinsecticide lethal to several pests that are important in agriculture or human health. PA1b belongs to the inhibitory cystine knot family or knottin family. Originating from a plant (the garden pea) commonly eaten by humans without any known toxic or allergic effects, PA1b is a candidate for transgenic applications and is one of the most promising biopesticides for pest control. Using whole-cell patch-clamp techniques on Sf9 PA1b-sensitive lepidopteran insect cells, we discovered that PA1b reversibly blocked ramp membrane currents in a dose-dependent manner (EC50 = 0.52 mu M). PA1b had the same effect as bafilomycin, a specific inhibitor of the vacuolar proton pump (V-type H+-ATPase), and the PA1b-sensitive current depended on the internal proton concentration. Biochemical assays on purified V-ATPase from the lepidopteran model Manduca sexta showed that PA1b inhibited the V1V0-type H+-ATPase holoenzyme activity (IC50 similar to 70 nM) by interacting with the membrane-bound V-0 part of the V-ATPase. V-ATPase is a complex protein that has been studied increasingly because of its numerous physiological roles. In the midgut of insects, V-ATPase activity is essential for energizing nutrient absorption, and the results reported in this work explain the entomotoxic properties of PA1b. Targeting V-ATPase is a promising means of combating insect pests, and PA1b represents the first peptidic V-ATPase inhibitor. The search for V-ATPase inhibitors is currently of great importance because it has been demonstrated that V-ATPase plays a role in so many physiological processes.	[Eyraud, Vanessa; Da Silva, Pedro; Rahioui, Isabelle; Royer, Corinne; Gressent, Frederic] Univ Lyon, INSA Lyon Inst Natl Sci Appl, INRA, BF2I,UMR203, F-69621 Villeurbanne, France; [Chouabe, Christophe; Bonvallet, Robert] Univ Lyon, UMR CNRS 5534, Ctr Genet & Physiol Mol & Cellulaires, F-69622 Villeurbanne, France; [Soulage, Christophe] Univ Lyon 1, INSA Lyon, CarMeN, INSERM U1060, F-69621 Villeurbanne, France; [Huss, Markus] Univ Osnabruck, Abt Tierphysiol, Fachbereich Biol Chem, D-49069 Osnabruck, Germany	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University Osnabruck	Gressent, F (corresponding author), Univ Lyon, INSA Lyon Inst Natl Sci Appl, INRA, BF2I,UMR203, F-69621 Villeurbanne, France.	frederic.gressent@lyon.inra.fr	SOULAGE, Christophe O/J-2759-2014	SOULAGE, Christophe O/0000-0002-8800-2144; GRESSENT, Frederic/0000-0002-7029-8709	Region Centre	Region Centre(Region Centre-Val de Loire)	This work was supported by the IFR41 (Lyon) and the Region Centre.	Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chouabe C, 1997, J MOL CELL CARDIOL, V29, P193, DOI 10.1006/jmcc.1996.0264; Craik DJ, 2007, CURR OPIN DRUG DISC, V10, P176; Da Silva P, 2010, J BIOL CHEM, V285, P32689, DOI 10.1074/jbc.M110.147199; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; Delobel B., 1998, French Patent, Patent No. [9805877, 98 05877]; Dun XP, 2008, PEPTIDES, V29, P891, DOI 10.1016/j.peptides.2008.01.013; Dun XP, 2007, FEBS J, V274, P751, DOI 10.1111/j.1742-4658.2006.05619.x; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Grenier AM, 1997, HEREDITY, V79, P15, DOI 10.1038/hdy.1997.118; Gressent F, 2003, EUR J BIOCHEM, V270, P2429, DOI 10.1046/j.1432-1033.2003.03611.x; Gressent F, 2007, J INSECT SCI, V7; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Jouvensal L, 2003, BIOCHEMISTRY-US, V42, P11915, DOI 10.1021/bi034803l; Ma BY, 2011, CELL SIGNAL, V23, P1244, DOI 10.1016/j.cellsig.2011.03.003; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Perez-Sayans M, 2009, CANCER TREAT REV, V35, P707, DOI 10.1016/j.ctrv.2009.08.003; Petit J., 2009, Bureau IP, Patent No. [WO/2009/056689, 2009056689]; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Rahioui I, 2007, BIOCHIMIE, V89, P1539, DOI 10.1016/j.biochi.2007.07.021; Rosengren KJ, 2002, BIOCHEMISTRY-US, V41, P3294, DOI 10.1021/bi011932y; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007	36	30	32	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36291	36296		10.1074/jbc.M111.281055	http://dx.doi.org/10.1074/jbc.M111.281055			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890633	Green Published, hybrid			2022-12-25	WOS:000296538300013
J	Hidalgo, AA; Deeb, KK; Pike, JW; Johnson, CS; Trump, DL				Hidalgo, Alejandro A.; Deeb, Kristin K.; Pike, J. Wesley; Johnson, Candace S.; Trump, Donald L.			Dexamethasone Enhances 1 alpha,25-Dihydroxyvitamin D-3 Effects by Increasing Vitamin D Receptor Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOCORTICOID-RECEPTOR; ENDOTHELIAL-CELLS; BINDING-SITES; IN-VIVO; GENE; CALCITRIOL; DNA; PROMOTER; CALCIUM; SEQUENCES	Calcitriol, the active form of vitamin D, in combination with the glucocorticoid dexamethasone (Dex) has been shown to increase the antitumor effects of calcitriol in squamous cell carcinoma. In this study we found that pretreatment with Dex potentiates calcitriol effects by inhibiting cell growth and increasing vitamin D receptor (VDR) and VDR-mediated transcription. Treatment with actinomycin D inhibits Vdr mRNA synthesis, indicating that Dex regulates VDR expression at transcriptional level. Real time PCR shows that treatment with Dex increases Vdr transcripts in a time-and a dose-dependent manner, indicating that Dex directly regulates expression of Vdr. RU486, an inhibitor of glucocorticoids, inhibits Dex-induced Vdr expression. In addition, the silencing of glucocorticoid receptor (GR) abolishes the induction of Vdr by Dex, indicating that Dex increases Vdr transcripts in a GR-dependent manner. A fragment located 5.2 kb upstream of Vdr transcription start site containing two putative glucocorticoid response elements (GREs) was evaluated using a luciferase-based reporter assay. Treatment with 100 nM Dex induces transcription of luciferase driven by the fragment. Deletion of the GRE distal to transcription start site was sufficient to abolish Dex induction of luciferase. Also, chromatin immunoprecipitation reveals recruitment of GR to distal GRE with Dex treatment. We conclude that Dex increases VDR and vitamin D effects by increasing Vdr de novo transcription in a GR-dependent manner.	[Trump, Donald L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Hidalgo, Alejandro A.; Johnson, Candace S.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Hidalgo, Alejandro A.; Deeb, Kristin K.; Johnson, Candace S.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; University of Wisconsin System; University of Wisconsin Madison	Trump, DL (corresponding author), Roswell Pk Canc Inst, Dept Med, Elm & Carlton Sts, Buffalo, NY 14263 USA.	donald.trump@roswellpark.org	Deeb, Kristin K/H-5619-2016		National Institutes of Health [CA67267, CA85142, CA95045]; Department of Defense [PCRP050202]; Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile; NATIONAL CANCER INSTITUTE [R01CA085142, R01CA095045, R01CA067267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA67267, CA85142, and CA95045.; Supported by predoctoral fellowships from Department of Defense (PCRP050202) and Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile.	Alheim K, 2003, J MOL ENDOCRINOL, V30, P359, DOI 10.1677/jme.0.0300359; Arriagada G, 2007, J STEROID BIOCHEM, V103, P425, DOI 10.1016/j.jsbmb.2006.12.021; Bagamasbad P, 2011, GEN COMP ENDOCR, V170, P3, DOI 10.1016/j.ygcen.2010.03.013; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Bernardi RJ, 2001, CLIN CANCER RES, V7, P4164; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; Chung I, 2007, J STEROID BIOCHEM, V103, P768, DOI 10.1016/j.jsbmb.2006.12.042; Chung I, 2007, J BIOL CHEM, V282, P8704, DOI 10.1074/jbc.M608894200; Chung I, 2006, CANCER RES, V66, P8565, DOI 10.1158/0008-5472.CAN-06-0905; CUNNINGHAM D, 1985, BRIT MED J, V291, P1153, DOI 10.1136/bmj.291.6503.1153; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dhawan P, 2010, J CELL BIOCHEM, V110, P1314, DOI 10.1002/jcb.22645; Feldman D, 2000, ENDOCRINOLOGY, V141, P5, DOI 10.1210/en.141.1.5; Flynn G, 2006, ONCOLOGY-BASEL, V70, P447, DOI 10.1159/000098872; Halsall JA, 2007, J STEROID BIOCHEM, V103, P352, DOI 10.1016/j.jsbmb.2006.12.046; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARDIN J, 1994, BLOOD, V84, P3063; Hidalgo AA, 2007, J STEROID BIOCHEM, V103, P731, DOI 10.1016/j.jsbmb.2006.12.072; Hidalgo AA, 2010, J STEROID BIOCHEM, V121, P372, DOI 10.1016/j.jsbmb.2010.03.081; HSIEH JC, 1991, P NATL ACAD SCI USA, V88, P9315, DOI 10.1073/pnas.88.20.9315; Inaba H, 2010, CANCER, V117, P1313; Jakubowiak AJ, 2009, J CLIN ONCOL, V27, P5015, DOI 10.1200/JCO.2008.19.5370; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Jehan F, 2000, ARCH BIOCHEM BIOPHYS, V377, P273, DOI 10.1006/abbi.2000.1788; Johnson CS, 2006, ANTICANCER RES, V26, P2543; JURUTKA PW, 1993, J BIOL CHEM, V268, P6791; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; Kim MH, 2009, LIFE SCI, V85, P146, DOI 10.1016/j.lfs.2009.05.013; Kim MH, 2009, EXP PHYSIOL, V94, P138, DOI 10.1113/expphysiol.2008.044339; KIMBERG DV, 1971, J CLIN INVEST, V50, P1309, DOI 10.1172/JCI106610; KOEFFLER HP, 1985, CANCER TREAT REP, V69, P1399; Krishnan AV, 2003, J CELL BIOCHEM, V88, P363, DOI 10.1002/jcb.10334; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Merkulov VM, 2009, J STEROID BIOCHEM, V115, P1, DOI 10.1016/j.jsbmb.2009.02.003; MIKSICEK R, 1986, CELL, V46, P283, DOI 10.1016/0092-8674(86)90745-2; Morris KL, 2005, OBES RES, V13, P670, DOI 10.1038/oby.2005.75; Muzikar KA, 2009, P NATL ACAD SCI USA, V106, P16598, DOI 10.1073/pnas.0909192106; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Peehl DM, 2004, J STEROID BIOCHEM, V92, P307, DOI 10.1016/j.jsbmb.2004.10.006; Pike JW, 2010, J STEROID BIOCHEM, V121, P130, DOI 10.1016/j.jsbmb.2010.02.036; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; RENKAWITZ R, 1984, CELL, V37, P503, DOI 10.1016/0092-8674(84)90380-5; ROLLA D, 1993, PERITON DIALYSIS INT, V13, P118; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; SHULTZ TD, 1982, P NATL ACAD SCI-BIOL, V79, P3542, DOI 10.1073/pnas.79.11.3542; Slater E P, 1985, Trans Assoc Am Physicians, V98, P66; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Sun X, 2008, INT J OBESITY, V32, P1305, DOI 10.1038/ijo.2008.59; Thorne JL, 2011, NUCLEIC ACIDS RES, V39, P2045, DOI 10.1093/nar/gkq875; Trump DL, 2006, CANCER-AM CANCER SOC, V106, P2136, DOI 10.1002/cncr.21890; Verlinden L, 1998, MOL CELL ENDOCRINOL, V142, P57, DOI 10.1016/S0303-7207(98)00117-8; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wallace AD, 2010, STEROIDS, V75, P1016, DOI 10.1016/j.steroids.2010.06.015; Yu WD, 1998, J NATL CANCER I, V90, P134, DOI 10.1093/jnci/90.2.134; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	59	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36228	36237		10.1074/jbc.M111.244061	http://dx.doi.org/10.1074/jbc.M111.244061			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868377	Green Published, hybrid			2022-12-25	WOS:000296538300007
J	Laine, V; Frokjaer-Jensen, C; Couchoux, H; Jospin, M				Laine, Viviane; Frokjaer-Jensen, Christian; Couchoux, Harold; Jospin, Maelle			The alpha 1 Subunit EGL-19, the alpha 2/delta Subunit UNC-36, and the beta Subunit CCB-1 Underlie Voltage-dependent Calcium Currents in Caenorhabditis elegans Striated Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; C-ELEGANS; CA2+ CURRENT; PHARYNGEAL MUSCLE; ACTION-POTENTIALS; CHANNEL; CONTRACTION; EXPRESSION; MUTATIONS; ABSENCE	Voltage-gated calcium channels, which play key roles in many physiological processes, are composed of a pore-forming alpha 1 subunit associated with up to three auxiliary subunits. In vertebrates, the role of auxiliary subunits has mostly been studied in heterologous systems, mainly because of the severe phenotypes of knock-out animals. The genetic model Caenorhabditis elegans has all main types of voltage-gated calcium channels and strong loss-of-function mutations in all pore-forming and auxiliary subunits; it is therefore a useful model to investigate the roles of auxiliary subunits in their native context. By recording calcium currents from channel and auxiliary subunit mutants, we molecularly dissected the voltage-dependent calcium currents in striated muscle of C. elegans. We show that EGL-19 is the only alpha 1 subunit that carries calcium currents in muscle cells. We then demonstrate that the alpha 2/delta subunit UNC-36 modulates the voltage dependence, the activation kinetics, and the conductance of calcium currents, whereas another alpha 2/delta subunit TAG-180 has no effect. Finally, we characterize mutants of the two beta subunits, CCB-1 and CCB-2. CCB-1 is necessary for viability, and voltage-dependent calcium currents are abolished in the absence of CCB-1 whereas CCB-2 does not affect currents. Altogether these results show that EGL-19, UNC-36, and CCB-1 underlie voltage-dependent calcium currents in C. elegans striated muscle.	[Laine, Viviane; Couchoux, Harold; Jospin, Maelle] Univ Lyon 1, CNRS, UMR 5534, F-69622 Villeurbanne, France; [Frokjaer-Jensen, Christian] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian] Univ Copenhagen, Dept Biomed Sci, DK-1165 Copenhagen, Denmark; [Frokjaer-Jensen, Christian] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-1165 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Jospin, M (corresponding author), Univ Lyon 1, CNRS, UMR 5534, Batiment Dubois,43 Bd 11 Novembre, F-69622 Villeurbanne, France.	jospin@univ-lyon1.fr	Jospin, Maelle/G-9063-2017; Frøkjær-Jensen, Christian/ABB-4637-2020; Tuluc, Petronel/C-2527-2011	Jospin, Maelle/0000-0002-1694-4394; Frokjaer-Jensen, Christian/0000-0002-3178-0906	Centre National de la Recherche Scientifique; Universite Lyon 1; Lundbeck Foundation	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Lyon 1; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Centre National de la Recherche Scientifique, the Universite Lyon 1, and a postdoctoral fellowship (to C. F. J.) from the Lundbeck Foundation.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; BRENNER S, 1974, GENETICS, V77, P71; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dayal A, 2010, CELL CALCIUM, V47, P500, DOI 10.1016/j.ceca.2010.04.003; Dempster J, 1993, COOPERATIVE LEARNING, P133; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Fuller-Bicer GA, 2009, AM J PHYSIOL-HEART C, V297, pH117, DOI 10.1152/ajpheart.00122.2009; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Huang SLB, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-24; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Jospin M, 2007, CURR BIOL, V17, P1595, DOI 10.1016/j.cub.2007.08.036; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Ly CV, 2008, J CELL BIOL, V181, P157, DOI 10.1083/jcb.200712152; Mathews EA, 2003, J NEUROSCI, V23, P6537; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Obermair GJ, 2005, J BIOL CHEM, V280, P2229, DOI 10.1074/jbc.M411501200; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Saheki Y, 2009, NAT NEUROSCI, V12, P1257, DOI 10.1038/nn.2383; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; Strube C, 2008, PFLUG ARCH EUR J PHY, V455, P921, DOI 10.1007/s00424-007-0345-9; Tam T, 2000, DEV BIOL, V226, P104, DOI 10.1006/dbio.2000.9854; Tuluc P, 2007, P NATL ACAD SCI USA, V104, P11091, DOI 10.1073/pnas.0700577104; Vinogradova Irina, 2006, Invertebrate Neuroscience, V6, P57, DOI 10.1007/s10158-006-0018-y; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1; Xu XF, 2011, J BIOL CHEM, V286, P9677, DOI 10.1074/jbc.M110.187864; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236; Zhou WB, 2006, CELL CALCIUM, V39, P227, DOI 10.1016/j.ceca.2005.10.015	47	17	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36180	36187		10.1074/jbc.M111.256149	http://dx.doi.org/10.1074/jbc.M111.256149			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878625	Green Published, hybrid			2022-12-25	WOS:000296538300003
J	Xiao, L; Chen, YH; Ji, M; Volle, DJ; Lewis, RE; Tsai, MY; Dong, JX				Xiao, Ling; Chen, Yuanhong; Ji, Ming; Volle, Deanna J.; Lewis, Robert E.; Tsai, Ming-Ying; Dong, Jixin			KIBRA Protein Phosphorylation Is Regulated by Mitotic Kinase Aurora and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DOMAIN-CONTAINING PROTEIN; ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; HIPPO PATHWAY; GROWTH-CONTROL; HEPATOCELLULAR-CARCINOMA; CONTACT INHIBITION; NEGATIVE REGULATOR	Recent genetic studies in Drosophila identified Kibra as a novel regulator of the Hippo pathway, which controls tissue growth and tumorigenesis by inhibiting cell proliferation and promoting apoptosis. The cellular function and regulation of human KIBRA remain largely unclear. Here, we show that KIBRA is a phosphoprotein and that phosphorylation of KIBRA is regulated in a cell cycle-dependent manner with the highest level of phosphorylated KIBRA detected in mitosis. We further demonstrate that the mitotic kinases Aurora-A and -B phosphorylate KIBRA both in vitro and in vivo. We identified the highly conserved Ser(539) as the primary phosphorylation site for Aurora kinases. Moreover, we found that wild-type, but not catalytically inactive, protein phosphatase 1 (PP1) associates with KIBRA. PP1 dephosphorylated Aurora-phosphorylated KIBRA. KIBRA depletion impaired the interaction between Aurora-A and PP1. We also show that KIBRA associates with neurofibromatosis type 2/Merlin in a Ser(539) phosphorylation-dependent manner. Phosphorylation of KIBRA on Ser(539) plays a role in mitotic progression. Our results suggest that KIBRA is a physiological substrate of Aurora kinases and reveal a new avenue between KIBRA/Hippo signaling and the mitotic machinery.	[Xiao, Ling; Chen, Yuanhong; Ji, Ming; Volle, Deanna J.; Lewis, Robert E.; Tsai, Ming-Ying; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu	Lewis, Robert E./H-3404-2019		National Institutes of Health [5P20-RR018759]; National Center for Research Resources; Nebraska Cancer and Smoking Disease Research Program; NATIONAL CANCER INSTITUTE [R01CA090400] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Cancer and Smoking Disease Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P20-RR018759 from the National Center for Research Resources. This work was also supported by a grant from the Nebraska Cancer and Smoking Disease Research Program (to J. D.).	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cohen PTW, 2002, J CELL SCI, V115, P241; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hill VK, 2011, EPIGENETICS-US, V6, P326, DOI 10.4161/epi.6.3.14404; Hilton HN, 2008, BBA-MOL CELL RES, V1783, P383, DOI 10.1016/j.bbamcr.2007.12.007; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lachenmayer Anja, 2010, Gastroenterology, V139, P692, DOI 10.1053/j.gastro.2010.06.036; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Morisaki T, 2002, FEBS LETT, V529, P319, DOI 10.1016/S0014-5793(02)03360-4; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oh HJ, 2010, CURR BIOL, V20, P416, DOI 10.1016/j.cub.2009.12.054; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	84	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36304	36315		10.1074/jbc.M111.246850	http://dx.doi.org/10.1074/jbc.M111.246850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878642	hybrid, Green Published			2022-12-25	WOS:000296538300015
J	Zhao, XY; Zhao, KW; Jiang, Y; Zhao, M; Chen, GQ				Zhao, Xu-Yun; Zhao, Ke-Wen; Jiang, Yi; Zhao, Meng; Chen, Guo-Qiang			Synergistic Induction of Galectin-1 by CCAAT/Enhancer Binding Protein alpha and Hypoxia-inducible Factor 1 alpha and Its Role in Differentiation of Acute Myeloid Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; INDUCED ACTIVATION; OXYGEN-TENSION; DEATH-RECEPTOR; STROMAL CELLS; C/EBP-ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; IDENTIFICATION	Galectin-1 is a member of the galectin family and has a high affinity for galactose and N-acetylglucosamine moieties of glycoproteins. It mediates multiple signal transduction pathways to modulate cellular proliferation, survival, differentiation, and migration. However, the mechanisms for the regulation of its expression remain greatly elusive. We reported previously that galectin-1 is a direct target of the hypoxia-inducible factor 1 (HIF-1), a key heterodimeric transcriptional factor for the cellular response to hypoxia. Here we show that CCAAT/enhancer binding protein alpha (C/EBP alpha), a critical transcriptional factor for hematopoietic cell differentiation, can directly activate galectin-1 through binding to the -48 to -42 bp region of its promoter. Based on the physical interaction of C/EBP alpha and HIF-1 1 alpha, the synergistic transcriptional activity of C/EBP alpha and HIF-1 alpha on the promoter of the galectin-1 gene is also found by chromatin immunoprecipitation (ChIP), ChIP followed by ChIP (ChIP-reChIP), and luciferase assay. Moreover, knockdown or chemical inhibition of galectin-1 partially blocks the differentiation induced by HIF-1 alpha or C/EBP alpha, which can be rescued by recombinant galectin-1. These discoveries would shed new insights on the mechanisms for galectin-1 expression regulation and HIF-1 alpha- and C/EBP alpha-induced leukemic cell differentiation.	[Zhao, Xu-Yun; Zhao, Ke-Wen; Jiang, Yi; Zhao, Meng; Chen, Guo-Qiang] SJTU SM, Minist Educ China, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, Shanghai 200025, Peoples R China; [Zhao, Xu-Yun; Zhao, Ke-Wen; Jiang, Yi; Zhao, Meng; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Chem Biol Div, Shanghai Univ E Inst, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China	Ministry of Education, China; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, GQ (corresponding author), SJTU SM, Minist Educ China, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, 280 Chong Qing S Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn			National Key Program (973) for Basic Research of China [NO2009CB918404]; National Natural Science Foundation [30971274, 81000214]; Shanghai Municipal Education Commission [11ZR1419800, 11ZZ106]; Science and Technology Committee of Shanghai	National Key Program (973) for Basic Research of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee)	This work was supported in part by National Key Program (973) for Basic Research of China Grant NO2009CB918404 (to G.-Q. C.), by National Natural Science Foundation Grants 30971274 (to Y. J.) and 81000214 (to M. Z.), by Program for Innovative Research Team of Shanghai Municipal Education Commission Grant 11ZR1419800 (to K.-W. Z.) from Science and Technology Committee of Shanghai, and by Shanghai Municipal Education Commission Grant 11ZZ106 (to K.-W. Z.).	Brandt B, 2008, HISTOCHEM CELL BIOL, V129, P599, DOI 10.1007/s00418-008-0395-x; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Hittelet A, 2003, INT J CANCER, V103, P370, DOI 10.1002/ijc.10843; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; Janardhan HP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143jc2; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Kim JS, 2006, TOXICOLOGY, V223, P36, DOI 10.1016/j.tox.2006.03.004; Kovacs-Solyom F, 2010, IMMUNOL LETT, V127, P108, DOI 10.1016/j.imlet.2009.10.003; Lange F, 2009, HISTOCHEM CELL BIOL, V132, P211, DOI 10.1007/s00418-009-0597-x; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; Lutomski D, 1997, GLYCOBIOLOGY, V7, P1193, DOI 10.1093/glycob/7.8.1193; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Nagy N, 2002, GUT, V50, P392, DOI 10.1136/gut.50.3.392; Nguyen-Khac F, 2006, ONCOGENE, V25, P4840, DOI 10.1038/sj.onc.1209503; Pace KE, 2003, METHOD ENZYMOL, V363, P499; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; PUCHE AC, 1995, J COMP NEUROL, V357, P513, DOI 10.1002/cne.903570403; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Satelli A, 2011, INT J CANCER, V129, P799, DOI 10.1002/ijc.25750; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; Smitha T, 2011, J Oral Maxillofac Pathol, V15, P26, DOI 10.4103/0973-029X.80034; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Vas V, 2005, STEM CELLS, V23, P279, DOI 10.1634/stemcells.2004-0084; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhang J, 2008, HAEMATOL-HEMATOL J, V93, P1480, DOI 10.3324/haematol.13096; Zhang Jing, 2009, Pathophysiology, V16, P297, DOI 10.1016/j.pathophys.2009.02.005; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006552; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	43	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36808	36819		10.1074/jbc.M111.247262	http://dx.doi.org/10.1074/jbc.M111.247262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880716	Green Published, hybrid			2022-12-25	WOS:000296538300061
J	Cai, LQ; Phong, BL; Fisher, AL; Wang, Z				Cai, Liquan; Phong, Binh L.; Fisher, Alfred L.; Wang, Zhou			Regulation of Fertility, Survival, and Cuticle Collagen Function by the Caenorhabditis elegans eaf-1 and ell-1 Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR; TRANSCRIPTION FACTOR; MLL; EXPRESSION; IDENTIFICATION; U19/EAF2; SUPPRESSION; MUTATIONS; HOMOLOG	EAF2, an androgen-regulated protein, interacts with members of the ELL (eleven-nineteen lysine-rich leukemia) transcription factor family and also acts as a tumor suppressor. Although these proteins control transcriptional elongation and perhaps modulate the effects of other transcription factors, the mechanisms of their actions remain largely unknown. To gain new insights into the biology of the EAF2 and ELL family proteins, we used Caenorhabditis elegans as a model to explore the in vivo roles of their worm orthologs. Through the use of transgenic worms, RNAi, and an eaf-1 mutant, we found that both genes are expressed in multiple cell types throughout the worm life cycle and that they play important roles in fertility, survival, and body size regulation. ELL-1 and EAF-1 likely contribute to these activities in part through modulating cuticle synthesis, given that we observed a disrupted cuticle structure in ell-1 RNAi-treated or eaf-1 mutant worms. Consistent with disruption of cuticle structure, loss of either ELL-1 or EAF-1 suppressed the rol phenotype of specific collagen mutants, possibly through the control of dpy-3, dpy-13, and sqt-3 collagen gene expression. Furthermore, we also noted the regulation of collagen expression by ELL overexpression in PC3 human prostate cancer cells. Together, these results reveal important roles for the eaf-1 and ell-1 genes in the regulation of extracellular matrix components.	[Fisher, Alfred L.] Univ Pittsburgh, Dept Med, Div Geriatr Med, Pittsburgh, PA 15260 USA; [Cai, Liquan; Phong, Binh L.; Wang, Zhou] Univ Pittsburgh, Dept Urol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, AL (corresponding author), Univ Pittsburgh, Dept Med, Div Geriatr Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA.	afisher@pitt.edu; wangz2@upmc.edu	Fisher, Alfred/H-3031-2012	Cai, Liquan/0000-0001-9192-2673; Fisher, Alfred/0000-0001-6451-2644	National Institutes of Health [T32 DK007774, R37 DK51193, R01 CA120386, P50 CA090386, K08 AG028977]; NATIONAL CANCER INSTITUTE [P50CA090386, R01CA120386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051193, T32DK007774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG028977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 DK007774 (to L. C.); Grants R37 DK51193, R01 CA120386, and P50 CA090386 (to Z. W.); and Grant K08 AG028977 (to A. L. F.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Banks CAS, 2007, J BIOL CHEM, V282, P5761, DOI 10.1074/jbc.M610393200; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Eissenberg JC, 2002, P NATL ACAD SCI USA, V99, P9894, DOI 10.1073/pnas.152193699; Ferguson AA, 2009, PLASMID, V62, P140, DOI 10.1016/j.plasmid.2009.06.001; Gerber M, 2001, EMBO J, V20, P6104, DOI 10.1093/emboj/20.21.6104; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Hahn J, 2007, PROSTATE, V67, P146, DOI 10.1002/pros.20481; Hochbaum Daniel, 2010, J Vis Exp, DOI 10.3791/2090; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; KRAMER JM, 1993, GENETICS, V135, P1035; KRAMER JM, 1994, ANNU REV GENET, V28, P95; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Liu LQ, 2010, PROSTATE, V70, P797, DOI 10.1002/pros.21113; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Nystrom J, 2002, GENETICS, V161, P83; O'Malley KJ, 2009, PROSTATE, V69, P1716, DOI 10.1002/pros.21034; PETERS K, 1991, GENETICS, V129, P95; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shilatifard A, 1998, J BIOL CHEM, V273, P11212, DOI 10.1074/jbc.273.18.11212; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Suzuki Y, 2002, GENETICS, V162, P1631; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Thein MC, 2003, DEV DYNAM, V226, P523, DOI 10.1002/dvdy.10259; Thirman MJ, 1997, P NATL ACAD SCI USA, V94, P1408, DOI 10.1073/pnas.94.4.1408; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Wiederschain D, 2003, MOL CELL BIOL, V23, P4230, DOI 10.1128/MCB.23.12.4230-4246.2003; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang Y, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-119; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	42	22	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35915	35921		10.1074/jbc.M111.270454	http://dx.doi.org/10.1074/jbc.M111.270454			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21880729	Green Published, hybrid			2022-12-25	WOS:000295927100065
J	Riboldi, E; Daniele, R; Parola, C; Inforzato, A; Arnold, PL; Bosisio, D; Fremont, DH; Bastone, A; Colonna, M; Sozzani, S				Riboldi, Elena; Daniele, Roberta; Parola, Carmen; Inforzato, Antonio; Arnold, Phoebe L.; Bosisio, Daniela; Fremont, Daved H.; Bastone, Antonio; Colonna, Marco; Sozzani, Silvano			Human C-type Lectin Domain Family 4, Member C (CLEC4C/BDCA-2/CD303) Is a Receptor for Asialo-galactosyl-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMACYTOID DENDRITIC CELLS; INHIBITS TLR9-MEDIATED ACTIVATION; ANTIGEN; RECOGNITION; INTERFERON	Plasmacytoid dendritic cells are specialized in the production of type I interferon (type I IFN), which promotes antiviral and antitumor responses, as well as autoimmune disorders. Activation of type I IFN secretion depends on the pattern recognition receptors TLR7 and TLR9, which sense microbial RNA and DNA, respectively. Type I IFN production is modulated by several receptors, including the type II C-type lectin domain family 4, member C (CLEC4C). The natural ligand of CLEC4C is unknown. To identify it, here we probed a glycan array with a soluble form of the CLEC4C ectodomain. We found that CLEC4C recognizes complex type sugars with terminal galactose. Importantly, soluble CLEC4C bound peripheral blood leukocytes and tumor cells that express glycans with galactose residues at the non-reducing ends. The positive and negative modulation of galactose residues on cell membranes was paralleled by the regulation of type I IFN secretion by plasmacytoid dendritic cells in co-culture experiments in vitro. These results suggest that the modulation in the expression of non-sialylated oligosaccharides by invading pathogens or transformed cells may affect type I IFN response and immune surveillance.	[Inforzato, Antonio; Sozzani, Silvano] Ist Clin Humanitas IRCCS, I-20089 Rozzano, MI, Italy; [Riboldi, Elena; Daniele, Roberta; Parola, Carmen; Bosisio, Daniela] Univ Brescia, Dipartimento Sci Biomed & Biotecnol, I-25123 Brescia, Italy; [Arnold, Phoebe L.; Fremont, Daved H.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bastone, Antonio] Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy	IRCCS Humanitas Research Hospital; University of Brescia; Washington University (WUSTL); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Sozzani, S (corresponding author), Ist Clin Humanitas IRCCS, Via Manzoni 113, I-20089 Rozzano, MI, Italy.	sozzani@med.unibs.it	Inforzato, Antonio/K-6954-2012; Inforzato, Antonio/ABG-4513-2020; Sozzani, Silvano/C-1447-2009	Inforzato, Antonio/0000-0001-8110-0027; Fremont, Daved/0000-0002-8544-2689; Colonna, Marco/0000-0001-5222-4987; Sozzani, Silvano/0000-0002-3144-8743; BOSISIO, Daniela/0000-0001-6276-5365	Associazione Italiana per la Ricerca sul Cancro; Consorzio Interuniversitario per le Biotecnologie; Consiglio Nazionale delle Ricerche; Fondazione Humanitas per la Ricerca	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Consorzio Interuniversitario per le Biotecnologie; Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); Fondazione Humanitas per la Ricerca	This work was supported by Associazione Italiana per la Ricerca sul Cancro.; Supported by Consorzio Interuniversitario per le Biotecnologie and Consiglio Nazionale delle Ricerche.; Supported by Fondazione Humanitas per la Ricerca.	Aarnoudse CA, 2006, CURR OPIN IMMUNOL, V18, P105, DOI 10.1016/j.coi.2005.11.001; Arce I, 2001, EUR J IMMUNOL, V31, P2733, DOI 10.1002/1521-4141(200109)31:9<2733::AID-IMMU2733>3.0.CO;2-X; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bochner BS, 2005, J BIOL CHEM, V280, P4307, DOI 10.1074/jbc.M412378200; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hartmann E, 2003, CANCER RES, V63, P6478; Kogelberg H, 2001, CURR OPIN STRUC BIOL, V11, P635, DOI 10.1016/S0959-440X(00)00259-1; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Riboldi E, 2009, IMMUNOBIOLOGY, V214, P868, DOI 10.1016/j.imbio.2009.06.016; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; VERMI W, 2011, J LEUKOCYTE IN PRESS; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031	25	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35329	35333		10.1074/jbc.C111.290494	http://dx.doi.org/10.1074/jbc.C111.290494			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21880719	hybrid, Green Published			2022-12-25	WOS:000295927100003
J	Yang, X; Guo, ZY; Sun, F; Li, W; Alfano, A; Shimelis, H; Chen, MY; Brodie, AMH; Chen, HG; Xiao, Z; Veenstra, TD; Qiu, Y				Yang, Xi; Guo, Zhiyong; Sun, Feng; Li, Wei; Alfano, Alan; Shimelis, Hermela; Chen, Mingyuan; Brodie, Angela M. H.; Chen, Hegang; Xiao, Zhen; Veenstra, Timothy D.; Qiu, Yun			Novel Membrane-associated Androgen Receptor Splice Variant Potentiates Proliferative and Survival Responses in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; RESISTANT GROWTH; PALMITOYLATION; PROGRESSION; THERAPY	Progression from the androgen-sensitive to androgen-insensitive (or castration-resistant) stage is the major obstacle for sustained effectiveness of hormonal therapy for prostate cancer. The androgen receptor (AR) and its splice variants play important roles in regulating the transcription program essential for castration resistance. Here, we report the identification of a novel AR splice variant, designated as AR8, which is up-regulated in castration-resistant prostate cancer cells. AR8 is structurally different from other known AR splice variants because it lacks a DNA binding domain and therefore, unlikely functions as a transcription factor on its own. Immunofluorescence staining revealed that AR8 was primarily localized on the plasma membrane, possibly through palmitoylation of two cysteine residues within its unique C-terminal sequence. Mutation of these putative palmitoylation sites in AR8 led to loss of its plasma membrane localization. In addition, we demonstrated that overexpression of AR8 in prostate cancer cells promoted association of Src and AR with the EGF receptor in response to EGF treatment and enhanced tyrosine phosphorylation of AR. Conversely, specific knockdown of AR8 expression in prostate cancer cells compromised EGF-induced Src activation and AR phosphorylation. This effect was accompanied with attenuation of proliferation and increased apoptosis in prostate cancer cells cultured in androgen-depleted medium. We also showed that AR8 was required for optimal transcriptional activity of AR in response to treatment of both androgen and EGF. Taken together, our results demonstrate that the membrane-associated AR8 isoform may contribute to castration resistance by potentiating AR-mediated proliferative and survival responses to hormones and growth factors.	[Yang, Xi; Guo, Zhiyong; Sun, Feng; Li, Wei; Alfano, Alan; Shimelis, Hermela; Chen, Mingyuan; Brodie, Angela M. H.; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Xiao, Zhen; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, SAIC Frederick, NIH, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21202 USA.	yqiu@som.umaryland.edu	Chen, Ming/GVU-8412-2022	Shimelis, Hermela/0000-0003-1284-8909	National Institutes of Health [CA106504]; NCI [HHSN261200800001E]; Department of Defense [W81XWH-08-1-0174]; NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA106504 (to Y. Q.) and Grant HHSN261200800001E through the NCI. This work was also supported by Department of Defense Grant W81XWH-08-1-0174 (to Y. Q.).	Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Culig Z, 2002, ENDOCR-RELAT CANCER, V9, P155, DOI 10.1677/erc.0.0090155; Dai BJ, 2010, CANCER RES, V70, P5587, DOI 10.1158/0008-5472.CAN-09-4610; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Scher HI, 2004, ENDOCR-RELAT CANCER, V11, P459, DOI 10.1677/erc.1.00525; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	22	76	79	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36152	36160		10.1074/jbc.M111.265124	http://dx.doi.org/10.1074/jbc.M111.265124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878636	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000295927100087
J	Luo, HB; Ma, L; Xi, HF; Duan, W; Li, SH; Loescher, W; Wang, JF; Wang, LJ				Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Duan, Wei; Li, Shao-Hua; Loescher, Wayne; Wang, Jun-Fang; Wang, Li-Jun			Photosynthetic Responses to Heat Treatments at Different Temperatures and following Recovery in Grapevine (Vitis amurensis L.) Leaves	PLOS ONE			English	Article							PHOTOSYSTEM-II; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; FLUORESCENCE TRANSIENT; ELECTRON-TRANSPORT; ACTIVATION STATE; LEAF TEMPERATURE; CO2 FIXATION; RUBISCO; STRESS; INHIBITION	Background: The electron transport chain, Rubisco and stomatal conductance are important in photosynthesis. Little is known about their combined responses to heat treatment at different temperatures and following recovery in grapevines (Vitis spp.) which are often grown in climates with high temperatures. Methodology/Findings: The electron transport function of photosystem II, the activation state of Rubisco and the influence of stomatal behavior were investigated in grapevine leaves during heat treatments and following recovery. High temperature treatments included 35, 40 and 45 degrees C, with 25 degrees C as the control and recovery temperature. Heat treatment at 35 degrees C did not significantly (P>0.05) inhibit net photosynthetic rate (P-n). However, with treatments at 40 and 45 degrees C, P-n was decreased, accompanied by an increase in substomatal CO2 concentration (C-i), decreases in stomatal conductance (g(s)) and the activation state of Rubisco, and inhibition of the donor side and the reaction center of PSII. The acceptor side of PSII was inhibited at 45 degrees C but not at 40 degrees C. When grape leaves recovered following heat treatment, P-n, g(s) and the activation state of Rubisco also increased, and the donor side and the reaction center of PSII recovered. The increase in P-n during the recovery period following the second 45 degrees C stress was slower than that following the 40 degrees C stress, and these increases corresponded to the donor side of PSII and the activation state of Rubisco. Conclusions: Heat treatment at 35 degrees C did not significantly (P>0.05) influence photosynthesis. The decrease of P-n in grape leaves exposed to more severe heat stress (40 or 45 degrees C) was mainly attributed to three factors: the activation state of Rubisco, the donor side and the reaction center of PSII. However, the increase of P-n in grape leaves following heat stress was also associated with a stomatal response. The acceptor side of PSII in grape leaves was responsive but less sensitive to heat stress.	[Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Duan, Wei; Wang, Jun-Fang; Wang, Li-Jun] Chinese Acad Sci, Inst Bot, Beijing Key Lab Viticulture & Enol, Beijing, Peoples R China; [Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Duan, Wei; Wang, Jun-Fang; Wang, Li-Jun] Chinese Acad Sci, Inst Bot, Key Lab Plant Resource Sci, Beijing, Peoples R China; [Luo, Hai-Bo; Ma, Ling; Xi, Hui-Feng; Wang, Jun-Fang] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Li, Shao-Hua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Loescher, Wayne] Michigan State Univ, Coll Agr & Nat Resources, E Lansing, MI 48824 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Michigan State University	Luo, HB (corresponding author), Chinese Acad Sci, Inst Bot, Beijing Key Lab Viticulture & Enol, Beijing, Peoples R China.	ljwang@ibcas.ac.cn			National Natural Science Foundation of China [30771758]; Chinese Academy of Sciences [KSCX2-EW-J-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (No. 30771758) and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX2-EW-J-1). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; BUKHOV NG, 1990, PHOTOSYNTH RES, V23, P81, DOI 10.1007/BF00030066; Bukhov NG, 2002, RUSS J PLANT PHYSL+, V49, P332, DOI 10.1023/A:1015536817680; Cen YP, 2005, PLANT PHYSIOL, V139, P979, DOI 10.1104/pp.105.066233; Chen LS, 2003, J AM SOC HORTIC SCI, V128, P754, DOI 10.21273/JASHS.128.5.0754; Cheng LL, 2000, J EXP BOT, V51, P1687, DOI 10.1093/jexbot/51.351.1687; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Crafts-Brandner SJ, 2000, PLANTA, V212, P67, DOI 10.1007/s004250000364; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; ENAMI I, 1994, BBA-BIOENERGETICS, V1185, P75, DOI 10.1016/0005-2728(94)90195-3; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; FERRINI F, 1995, AM J ENOL VITICULT, V46, P375; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; HAVAUX M, 1993, PLANT CELL ENVIRON, V16, P461, DOI 10.1111/j.1365-3040.1993.tb00893.x; Hendrickson L, 2003, FUNCT PLANT BIOL, V30, P631, DOI 10.1071/FP02114; Hendrickson L, 2004, PLANT CELL ENVIRON, V27, P795, DOI 10.1111/j.1365-3040.2004.01184.x; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kadir S, 2007, J AM SOC HORTIC SCI, V132, P764, DOI 10.21273/JASHS.132.6.764; Kadir S, 2006, J AM SOC HORTIC SCI, V131, P476, DOI 10.21273/JASHS.131.4.476; KOBZA J, 1987, PLANT PHYSIOL, V83, P69, DOI 10.1104/pp.83.1.69; Kouril R, 2004, PHOTOSYNTH RES, V81, P49, DOI 10.1023/B:PRES.0000028391.70533.eb; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; LAKSO AN, 1978, AM J ENOL VITICULT, V29, P145; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Lin ZH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-43; Makino A, 2007, PLANT CELL PHYSIOL, V48, P1472, DOI 10.1093/pcp/pcm118; MATSUI S, 1986, AM J ENOL VITICULT, V37, P67; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; NASH D, 1985, BIOCHIM BIOPHYS ACTA, V807, P127, DOI 10.1016/0005-2728(85)90115-X; Pospisil P, 1999, PHOTOSYNTH RES, V62, P55, DOI 10.1023/A:1006369009170; Quinn P. J., 1985, Photosynthetic mechanisms and the environment, P1; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Schrader SM, 2004, PLANT CELL ENVIRON, V27, P725, DOI 10.1111/j.1365-3040.2004.01172.x; Schultz H. R., 2000, Australian Journal of Grape and Wine Research, V6, P2, DOI 10.1111/j.1755-0238.2000.tb00156.x; SCHULTZ HR, 2007, COST ACT 858 WORKSH; SEPULVEDA G, 1986, AM J ENOL VITICULT, V37, P44; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Srivastava A, 1997, BBA-BIOENERGETICS, V1320, P95, DOI 10.1016/S0005-2728(97)00017-0; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Strasser RJ., 1999, CROP IMPROVEMENT FOO, P72; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; van Leeuwen C, 2004, AM J ENOL VITICULT, V55, P207; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; WEIS E, 1981, PLANTA, V151, P33, DOI 10.1007/BF00384234; Wise RR, 2004, PLANT CELL ENVIRON, V27, P717, DOI 10.1111/j.1365-3040.2004.01171.x	50	67	83	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23033	10.1371/journal.pone.0023033	http://dx.doi.org/10.1371/journal.pone.0023033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887227	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298800003
J	Kou, XJ; Li, Q; Liu, SR				Kou, Xiaojun; Li, Qin; Liu, Shirong			Quantifying Species' Range Shifts in Relation to Climate Change: A Case Study of Abies spp. in China	PLOS ONE			English	Article							GLOBAL LAND AREAS; DISTRIBUTION MODELS; EXTINCTION RISK; DISTRIBUTIONS; TRANSFERABILITY; CLASSIFICATION; UNCERTAINTIES; PERFORMANCE; PROJECTIONS; PREVALENCE	Predicting species range shifts in response to climatic change is a central aspect of global change studies. An ever growing number of species have been modeled using a variety of species distribution models (SDMs). However, quantitative studies of the characteristics of range shifts are rare, predictions of range changes are hard to interpret, analyze and summarize, and comparisons between the various models are difficult to make when the number of species modeled is large. Maxent was used to model the distribution of 12 Abies spp. in China under current and possible future climate conditions. Two fuzzy set defined indices, range increment index (I) and range overlapping index (O), were used to quantify range shifts of the chosen species. Correlation analyses were used to test the relationships between these indices and species distribution characteristics. Our results show that Abies spp. range increments (I) were highly correlated with longitude, latitude, and mean roughness of their current distributions. Species overlapping (O) was moderately, or not, correlated with these parameters. Neither range increments nor overlapping showed any correlation with species prevalence. These fuzzy sets defined indices provide ideal measures of species range shifts because they are stable and threshold-free. They are reliable indices that allow large numbers of species to be described, modeled, and compared on a variety of taxonomic levels.	[Kou, Xiaojun] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Li, Qin] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Shirong] Chinese Acad Forestry, Inst Forest Environm & Ecol, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Forestry	Kou, XJ (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	xj_kou@bnu.edu.cn			Special Research Program for Public-Welfare Forestry [200804001]; NSFC [30590383]	Special Research Program for Public-Welfare Forestry; NSFC(National Natural Science Foundation of China (NSFC))	This research was carried out with the support of the Special Research Program for Public-Welfare Forestry (Grant No. 200804001) and NSFC's Major Project (Grant No. 30590383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dunn AM, 2008, EMU, V108, P42, DOI 10.1071/MU07034; *ED COMM FLOR CHIN, 1978, FLOR CHIN, V7; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Harrison JA, 1997, ATLAS SO AFRICAN BIR; Harrison SP, 2010, J VEG SCI, V21, P300, DOI 10.1111/j.1654-1103.2009.01144.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hou X., 2001, VEGETATION ATLAS CHI; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kou XJ, 2011, ECOL INFORM, V6, P196, DOI 10.1016/j.ecoinf.2011.01.004; Kurtto Arto, 1999, Acta Botanica Fennica, V162, P67; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Patterson BD, 2003, DIGITAL DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Platts PJ, 2010, DIVERS DISTRIB, V16, P628, DOI 10.1111/j.1472-4642.2010.00668.x; Poyry J, 2008, GLOBAL ECOL BIOGEOGR, V17, P403, DOI 10.1111/j.1466-8238.2007.00373.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Robertson MP, 2010, DIVERS DISTRIB, V16, P363, DOI 10.1111/j.1472-4642.2010.00639.x; Robertson MP, 2004, DIVERS DISTRIB, V10, P461, DOI 10.1111/j.1366-9516.2004.00108.x; Svenning JC, 2009, ECOGRAPHY, V32, P3, DOI 10.1111/j.1600-0587.2009.06024.x; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, NATURE, V430, DOI 10.1038/nature02716; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wu, 1980, VEGETATION CHINA; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	45	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23115	10.1371/journal.pone.0023115	http://dx.doi.org/10.1371/journal.pone.0023115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887231	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000006
J	Owen, KA; Abshire, MY; Tilghman, RW; Casanova, JE; Bouton, AH				Owen, Katherine A.; Abshire, Michelle Y.; Tilghman, Robert W.; Casanova, James E.; Bouton, Amy H.			FAK Regulates Intestinal Epithelial Cell Survival and Proliferation during Mucosal Wound Healing	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CYCLIN D1; CANCER-CELLS; SRC; APOPTOSIS; P53; PROGRESSION; EXPRESSION; ACTIVATION; MEDIATORS	Background: Following damage to the intestinal epithelium, restoration of epithelial barrier integrity is triggered by a robust proliferative response. In other tissues, focal adhesion kinase (FAK) regulates many of the cellular processes that are critical for epithelial homeostasis and restitution, including cell migration, proliferation and survival. However, few studies to date have determined how FAK contributes to mucosal wound healing in vivo. Methodology and Principal Findings: To examine the role of FAK in intestinal epithelial homeostasis and during injury, we generated intestinal epithelium (IE)-specific conditional FAK knockout mice. Colitis was induced with dextran-sulfate-sodium (DSS) and intestinal tissues were analyzed by immunohistochemistry and immunoblotting. While intestinal development occurred normally in mice lacking FAK, FAK-deficient animals were profoundly susceptible to colitis. The loss of epithelial FAK resulted in elevated p53 expression and an increased sensitivity to apoptosis, coincident with a failure to upregulate epithelial cell proliferation. FAK has been reported to function as a mechanosensor, inducing cyclin D1 expression and promoting cell cycle progression under conditions in which tissue/matrix stiffness is increased. Collagen deposition, a hallmark of inflammatory injury resulting in increased tissue rigidity, was observed in control and FAK knockout mice during colitis. Despite this fibrotic response, the colonic epithelium in FAK-deficient mice exhibited significantly reduced cyclin D1 expression, suggesting that proliferation is uncoupled from fibrosis in the absence of FAK. In support of this hypothesis, proliferation of Caco-2 cells increased proportionally with matrix stiffness in vitro only under conditions of normal FAK expression; FAK depleted cells exhibited reduced proliferation concomitant with attenuated cyclin D1 expression. Conclusions: In the colon, FAK functions as a regulator of epithelial cell survival and proliferation under conditions of mucosal injury and a mechanosensor of tissue compliance, inducing repair-driven proliferation in the colonic epithelium through upregulation of cyclin D1.	[Owen, Katherine A.; Casanova, James E.] Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA USA; [Abshire, Michelle Y.; Tilghman, Robert W.; Casanova, James E.; Bouton, Amy H.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA	University of Virginia; University of Virginia	Owen, KA (corresponding author), Univ Virginia Hlth Syst, Dept Cell Biol, Charlottesville, VA USA.	jec9e@virginia.edu; ahb8y@virginia.edu			National Institutes of Health [AI050733, DK58536, 5F32DK839022, NCI-CA40042]; University of Virginia Digestive Health Research Center; Coulter Foundation; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050733, T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Digestive Health Research Center; Coulter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health (AI050733 to AHB, DK58536 to JEC, 5F32DK839022 to KAO and NCI-CA40042 to J. Thomas Parsons, University of Virginia), the University of Virginia Digestive Health Research Center pilot grant program (to AHB and JEC) and the Coulter Foundation Translational Partners Award (to RWT). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cance WG, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.120pe22; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; Hao HF, 2009, WORLD J GASTROENTERO, V15, P5916, DOI 10.3748/wjg.15.5916; HARPER J, 1987, BIOCHEM BIOPH RES CO, V147, P550, DOI 10.1016/0006-291X(87)90966-1; HARPER PH, 1987, DIS COLON RECTUM, V30, P174, DOI 10.1007/BF02554332; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jones RG, 2006, J CELL BIOL, V175, P505, DOI 10.1083/jcb.200602160; KANNER SB, 1989, ONCOGENE, V4, P295; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MATTHES H, 1992, GASTROENTEROLOGY, V102, P431, DOI 10.1016/0016-5085(92)90087-F; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; Sanders MA, 2008, BIOL CHEM, V389, P47, DOI 10.1515/BC.2008.008; Sasaki Makoto, 2005, J Inflamm (Lond), V2, P13, DOI 10.1186/1476-9255-2-13; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Seno H, 2009, P NATL ACAD SCI USA, V106, P256, DOI 10.1073/pnas.0803343106; Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23123	10.1371/journal.pone.0023123	http://dx.doi.org/10.1371/journal.pone.0023123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887232	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000007
J	Wang, KS; Chen, G; Shen, HL; Li, TT; Chen, F; Wang, QW; Wang, ZQ; Han, ZG; Zhang, X				Wang, Ke-Sheng; Chen, Gang; Shen, Hai-Lian; Li, Ting-Ting; Chen, Fei; Wang, Qin-Wan; Wang, Zhi-Qin; Han, Ze-Guang; Zhang, Xin			Insulin Receptor Tyrosine Kinase Substrate Enhances Low Levels of MDM2-Mediated p53 Ubiquitination	PLOS ONE			English	Article							BINDING-SITE; HOMOLOGY DOMAIN; CELL-MIGRATION; MDM2; HDM2; TRANSLATION; INDUCTION; REGULATOR; MEMBRANE; IRSP53	The tumor suppressor p53 controls multiple cellular functions including DNA repair, cell cycle arrest and apoptosis. MDM2-mediated p53 ubiquitination affects both degradation and cytoplasmic localization of p53. Several cofactors are known to modulate MDM2-mediated p53 ubiquitination and proteasomal degradation. Here we show that IRTKS, a novel IRSp53-like protein inhibited p53-induced apoptosis and depressed its transcription activity. IRTKS bound directly to p53 and increased p53 ubiquitination and cytoplasmic localization. Further studies revealed that IRTKS interacted with MDM2 and promoted low levels of MDM2-mediated p53 ubiquitination in vitro and in vivo. In unstressed cells with low levels of MDM2, IRTKS was found to stabilize the interaction of p53 and MDM2. In stressed cells, IRTKS dissociated from p53, and high levels of MDM2 induced by p53 activation mediate IRTKS poly-ubiquitination and subsequent proteasomal degradation. These data suggest that IRTKS is a novel regulator of p53, modulating low level of MDM2-mediated p53 ubiquitination in unstressed cells.	[Wang, Ke-Sheng; Chen, Gang; Shen, Hai-Lian; Li, Ting-Ting; Chen, Fei; Wang, Qin-Wan; Wang, Zhi-Qin; Han, Ze-Guang; Zhang, Xin] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China; [Chen, Gang; Li, Ting-Ting] E China Univ Sci & Technol, Sch Bioengn, Shanghai 200237, Peoples R China; [Han, Ze-Guang] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai 200030, Peoples R China	East China University of Science & Technology; Shanghai Jiao Tong University	Wang, KS (corresponding author), Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China.	zhang68@hotmail.com		Han, Ze-Guang/0000-0002-1018-1752	Chinese High-Tech Research and Development Program [2006AA02A305]; China National Key Projects for Infectious Disease [2008ZX10002-020, 2008ZX10002-021]; Shanghai Commission for Science and Technology [10JC1411900]	Chinese High-Tech Research and Development Program; China National Key Projects for Infectious Disease; Shanghai Commission for Science and Technology	The work was supported by Chinese High-Tech Research and Development Program grants (2006AA02A305), the China National Key Projects for Infectious Disease (2008ZX10002-020 and 2008ZX10002-021), and Shanghai Commission for Science and Technology (10JC1411900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2006, ONCOGENE, V25, P4534, DOI 10.1038/sj.onc.1209490; Argentini M, 2001, ONCOGENE, V20, P1267, DOI 10.1038/sj.onc.1204241; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Coutts AS, 2009, DNA REPAIR, V8, P483, DOI 10.1016/j.dnarep.2009.01.008; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Lee JH, 2010, ONCOGENE, V29, P1431, DOI 10.1038/onc.2009.438; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; [李婷婷 LI Tingting], 2009, [医学分子生物学杂志, Journal of Medical Molecular Biology], V6, P214; Lohrum MAE, 2000, CURR BIOL, V10, P539, DOI 10.1016/S0960-9822(00)00472-3; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wu H, 2011, NAT MED, V17, P347, DOI 10.1038/nm.2283; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; ZHAN QM, 1994, ONCOGENE, V9, P3743; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23571	10.1371/journal.pone.0023571	http://dx.doi.org/10.1371/journal.pone.0023571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887275	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000030
J	Zhao, XB; Valen, E; Parker, BJ; Sandelin, A				Zhao, Xiaobei; Valen, Eivind; Parker, Brian J.; Sandelin, Albin			Systematic Clustering of Transcription Start Site Landscapes	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DNA METHYLATION; PROMOTERS; IDENTIFICATION; ELEMENTS; DIFFERENTIATION; ARCHITECTURE; PLURIPOTENT; VERTEBRATE; INITIATION	Genome-wide, high-throughput methods for transcription start site (TSS) detection have shown that most promoters have an array of neighboring TSSs where some are used more than others, forming a distribution of initiation propensities. TSS distributions (TSSDs) vary widely between promoters and earlier studies have shown that the TSSDs have biological implications in both regulation and function. However, no systematic study has been made to explore how many types of TSSDs and by extension core promoters exist and to understand which biological features distinguish them. In this study, we developed a new non-parametric dissimilarity measure and clustering approach to explore the similarities and stabilities of clusters of TSSDs. Previous studies have used arbitrary thresholds to arrive at two general classes: broad and sharp. We demonstrated that in addition to the previous broad/sharp dichotomy an additional category of promoters exists. Unlike typical TATA-driven sharp TSSDs where the TSS position can vary a few nucleotides, in this category virtually all TSSs originate from the same genomic position. These promoters lack epigenetic signatures of typical mRNA promoters and a substantial subset of them are mapping upstream of ribosomal protein pseudogenes. We present evidence that these are likely mapping errors, which have confounded earlier analyses, due to the high similarity of ribosomal gene promoters in combination with known G addition bias in the CAGE libraries. Thus, previous two-class separations of promoter based on TSS distributions are motivated, but the ultra-sharp TSS distributions will confound downstream analyses if not removed.	[Zhao, Xiaobei] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; Univ Copenhagen, Biotech Res & Innovat Ctr, Bioinformat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Zhao, XB (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	albin@binf.ku.dk	Sandelin, Albin/G-2881-2011; Valen, Eivind/A-8617-2011; Zhao, Xiaobei/G-3567-2014	Sandelin, Albin/0000-0002-7109-7378; Zhao, Xiaobei/0000-0002-5277-0846; Parker, Brian/0000-0002-5193-6867; Valen, Eivind/0000-0003-1840-6108	Novo Nordisk Foundation; European Research Council under the EU [204135]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council under the EU(European Research Council (ERC))	This work was supported by a grant from the Novo Nordisk Foundation, http://www.novonordiskfonden.dk/. The European Research Council (http://erc.europa.eu/) has provided financial support to Dr. Sandelin under the EU 7th Framework Programme (FP7/2007-2013)/ERC grant agreement 204135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; Bajic VB, 2006, PLOS GENET, V2, P614, DOI 10.1371/journal.pgen.0020054; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumann M, 2010, MOL BIOTECHNOL, V45, P241, DOI 10.1007/s12033-010-9265-6; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, CAP ANAL GENE EXPRES; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cha SH, 2002, PATTERN RECOGN, V35, P1355, DOI 10.1016/S0031-3203(01)00118-2; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Frith MC, 2006, GENOME RES, V16, P713, DOI 10.1101/gr.5031006; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Islam S, 2011, GENOME RES; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kobor MS, 2009, TRENDS BIOCHEM SCI, V34, P158, DOI 10.1016/j.tibs.2008.12.006; Kratz A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-257; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Mark S.A., 1984, CLUSTER ANAL QUANTIT; MARUYAMA K, 1994, GENE, V138, P171; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/nmeth.1470, 10.1038/NMETH.1470]; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rubner Y, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P59, DOI 10.1109/ICCV.1998.710701; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZL, 2002, GENOME RES, V12, P1466, DOI 10.1101/gr.331902	65	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23409	10.1371/journal.pone.0023409	http://dx.doi.org/10.1371/journal.pone.0023409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887249	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000017
J	Lanyi, A; Barath, M; Peterfi, Z; Bogel, G; Orient, A; Simon, T; Petrovszki, E; Kis-Toth, K; Sirokmany, G; Rajnavolgyi, E; Terhorst, C; Buday, L; Geiszt, M				Lanyi, Arpad; Barath, Monika; Peterfi, Zalan; Bogel, Gabor; Orient, Anna; Simon, Tuende; Petrovszki, Eniko; Kis-Toth, Katalin; Sirokmany, Gabor; Rajnavoelgyi, Eva; Terhorst, Cox; Buday, Laszlo; Geiszt, Miklos			The Homolog of the Five SH3-Domain Protein (HOFI/SH3PXD2B) Regulates Lamellipodia Formation and Cell Spreading	PLOS ONE			English	Article							CANCER-CELLS; PX DOMAIN; ACTIN CYTOSKELETON; PODOSOME FORMATION; CONTACT SITES; SRC SUBSTRATE; CORTACTIN; PHOSPHORYLATION; MIGRATION; INVASION	Motility of normal and transformed cells within and across tissues requires specialized subcellular structures, e. g. membrane ruffles, lamellipodia and podosomes, which are generated by dynamic rearrangements of the actin cytoskeleton. Because the formation of these sub-cellular structures is complex and relatively poorly understood, we evaluated the role of the adapter protein SH3PXD2B [HOFI, fad49, Tks4], which plays a role in the development of the eye, skeleton and adipose tissue. Surprisingly, we find that SH3PXD2B is requisite for the development of EGF-induced membrane ruffles and lamellipodia, as well as for efficient cellular attachment and spreading of HeLa cells. Furthermore, SH3PXD2B is present in a complex with the non-receptor protein tyrosine kinase Src, phosphorylated by Src, which is consistent with SH3PXD2B accumulating in Src-induced podosomes. Furthermore, SH3PXD2B closely follows the subcellular relocalization of cortactin to Src-induced podosomes, EGF-induced membrane ruffles and lamellipodia. Because SH3PXD2B also forms a complex with the C-terminal region of cortactin, we propose that SH3PXD2B is a scaffold protein that plays a key role in regulating the actin cytoskeleton via Src and cortactin.	[Lanyi, Arpad; Barath, Monika; Simon, Tuende; Petrovszki, Eniko; Kis-Toth, Katalin; Rajnavoelgyi, Eva] Univ Debrecen Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary; [Lanyi, Arpad; Barath, Monika; Simon, Tuende; Petrovszki, Eniko; Kis-Toth, Katalin; Rajnavoelgyi, Eva] Univ Debrecen Med & Hlth Sci Ctr, Res Ctr Mol Med, Debrecen, Hungary; [Peterfi, Zalan; Orient, Anna; Sirokmany, Gabor; Geiszt, Miklos] Semmelweis Univ, Fac Med, Dept Physiol, Budapest, Hungary; [Bogel, Gabor; Buday, Laszlo] Semmelweis Univ, Fac Med, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Immunol, Boston, MA 02215 USA; [Buday, Laszlo] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, Budapest, Hungary; [Peterfi, Zalan; Geiszt, Miklos] Semmelweis Univ, Peroxidase Enzyme Res Grp, Budapest, Hungary	University of Debrecen; University of Debrecen; Semmelweis University; Semmelweis University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Semmelweis University	Lanyi, A (corresponding author), Univ Debrecen Med & Hlth Sci Ctr, Dept Immunol, Debrecen, Hungary.	alanyi@dote.hu; geiszt@eok.sote.hu	Rajnavölgyi, Éva/D-4384-2013	Peterfi, Zalan/0000-0002-7432-2438	Hungarian Research Fund [OTKA 042573, NF72669, OTKA 63700, OTKA 81676, OTKA 61555, 83867]; Jedlik Anyos program [1/010/2005, A1-0069/2006]; National Office for Research and Technology [OMFB-01680/2009]; Wellcome Trust; Mihaly Polanyi grant [KFKT-1-2006-0006]; Hungarian Academy of Sciences; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund	Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Jedlik Anyos program; National Office for Research and Technology(National Office for Research and Technology); Wellcome Trust(Wellcome TrustEuropean Commission); Mihaly Polanyi grant; Hungarian Academy of Sciences(Hungarian Academy of Sciences); TAMOP; European Social Fund(European Social Fund (ESF))	This work was supported by grants from the Hungarian Research Fund OTKA 042573 and NF72669 (MG), OTKA 63700 (AL), OTKA 81676 (AL), and OTKA 61555 and 83867 (LB); by grants from the Jedlik Anyos program 1/010/2005 (MG) and A1-0069/2006 (AL); and by grants from the National Office for Research and Technology OMFB-01680/2009 (MG), the Wellcome Trust (MG), the Mihaly Polanyi grant KFKT-1-2006-0006, and the "Lendulet" grant from the Hungarian Academy of Sciences (LB). The work was also supported by the TAMOP 4.2.1./B-09/1/KONV-2010-0007 project (AL). The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Adam Z, 2000, CLIN EXP METASTAS, V18, P295, DOI 10.1023/A:1011043412634; Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; BUSCHMAN MD, 2009, MOL BIOL CELL; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Campbell DH, 1999, CANCER RES, V59, P5376; Chuma M, 2004, J HEPATOL, V41, P629, DOI 10.1016/j.jhep.2004.06.018; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gianni D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000370; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Illes A, 2006, IMMUNOL LETT, V104, P124, DOI 10.1016/j.imlet.2005.11.011; Illes A, 2006, CELL SIGNAL, V18, P830, DOI 10.1016/j.cellsig.2005.07.012; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Li YS, 2001, CANCER RES, V61, P6906; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mao M, 2009, MAMM GENOME, V20, P462, DOI 10.1007/s00335-009-9210-9; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Patel AS, 1998, ONCOGENE, V16, P3227, DOI 10.1038/sj.onc.1201850; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Rethi B, 2006, BLOOD, V107, P2821, DOI 10.1182/blood-2005-06-2265; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tsai WC, 2007, J HISTOCHEM CYTOCHEM, V55, P955, DOI 10.1369/jhc.7A7235.2007; Turner CE, 2000, J CELL SCI, V113, P4139; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; vanDamme H, 1997, J BIOL CHEM, V272, P7374, DOI 10.1074/jbc.272.11.7374; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; WHITE MK, 1988, MOL CELL BIOL, V8, P138, DOI 10.1128/MCB.8.1.138; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Wunderlich L, 1999, CELL SIGNAL, V11, P253, DOI 10.1016/S0898-6568(98)00054-0; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200	56	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23653	10.1371/journal.pone.0023653	http://dx.doi.org/10.1371/journal.pone.0023653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886807	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500023
J	Sun, J; Steindler, L; Thrash, JC; Halsey, KH; Smith, DP; Carter, AE; Landry, ZC; Giovannoni, SJ				Sun, Jing; Steindler, Laura; Thrash, J. Cameron; Halsey, Kimberly H.; Smith, Daniel P.; Carter, Amy E.; Landry, Zachary C.; Giovannoni, Stephen J.			One Carbon Metabolism in SAR11 Pelagic Marine Bacteria	PLOS ONE			English	Article							METHYLOBACTERIUM-EXTORQUENS AM1; MULTIPLE SEQUENCE ALIGNMENT; GLYCINE BETAINE; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; FORMALDEHYDE DEHYDROGENASE; METHYLOTROPHIC BACTERIA; METHANOL DEHYDROGENASE; UTILIZATION PATHWAY; CRYSTAL-STRUCTURE	The SAR11 Alphaproteobacteria are the most abundant heterotrophs in the oceans and are believed to play a major role in mineralizing marine dissolved organic carbon. Their genomes are among the smallest known for free-living heterotrophic cells, raising questions about how they successfully utilize complex organic matter with a limited metabolic repertoire. Here we show that conserved genes in SAR11 subgroup Ia (Candidatus Pelagibacter ubique) genomes encode pathways for the oxidation of a variety of one-carbon compounds and methyl functional groups from methylated compounds. These pathways were predicted to produce energy by tetrahydrofolate (THF)-mediated oxidation, but not to support the net assimilation of biomass from C1 compounds. Measurements of cellular ATP content and the oxidation of C-14-labeled compounds to (CO2)-C-14 indicated that methanol, formaldehyde, methylamine, and methyl groups from glycine betaine (GBT), trimethylamine (TMA), trimethylamine N-oxide (TMAO), and dimethylsulfoniopropionate (DMSP) were oxidized by axenic cultures of the SAR11 strain Ca. P. ubique HTCC1062. Analyses of metagenomic data showed that genes for C1 metabolism occur at a high frequency in natural SAR11 populations. In short term incubations, natural communities of Sargasso Sea microbial plankton expressed a potential for the oxidation of C-14-labeled formate, formaldehyde, methanol and TMAO that was similar to cultured SAR11 cells and, like cultured SAR11 cells, incorporated a much larger percentage of pyruvate and glucose (27-35%) than of C1 compounds (2-6%) into biomass. Collectively, these genomic, cellular and environmental data show a surprising capacity for demethylation and C1 oxidation in SAR11 cultures and in natural microbial communities dominated by SAR11, and support the conclusion that C1 oxidation might be a significant conduit by which dissolved organic carbon is recycled to CO2 in the upper ocean.	[Sun, Jing; Steindler, Laura; Thrash, J. Cameron; Smith, Daniel P.; Carter, Amy E.; Landry, Zachary C.; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Halsey, Kimberly H.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Sun, J (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	steve.giovannoni@oregonstate.edu	Smith, Daniel/L-6827-2019	Smith, Daniel/0000-0002-2479-2044; Halsey, Kimberly/0000-0002-1407-0777; Thrash, Cameron/0000-0003-0896-9986	Marine Microbiology Initiative of the Gordon and Betty Moore Foundation; National Science Foundation [MCB-0237728, DBI-1003269]; Division Of Ocean Sciences [0802004] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1003269] Funding Source: National Science Foundation	Marine Microbiology Initiative of the Gordon and Betty Moore Foundation; National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by a grant from the Marine Microbiology Initiative of the Gordon and Betty Moore Foundation to SJG, National Science Foundation Microbial Observatory grant MCB-0237728 to SJG, and is based upon work supported by the National Science Foundation award no. DBI-1003269 to JCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Antoine E, 1999, EUR J BIOCHEM, V264, P880, DOI 10.1046/j.1432-1327.1999.00685.x; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Arfman N, 1997, EUR J BIOCHEM, V244, P426, DOI 10.1111/j.1432-1033.1997.00426.x; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Barra L, 2006, J BACTERIOL, V188, P7195, DOI 10.1128/JB.00208-06; BARRETT EL, 1985, ANNU REV MICROBIOL, V39, P131, DOI 10.1146/annurev.mi.39.100185.001023; BENBASSAT A, 1980, J GEN MICROBIOL, V116, P213; BICKNELL B, 1980, J GEN MICROBIOL, V117, P89; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Bystrykh Leonid V., 1993, P245; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Chen Y, 2010, APPL ENVIRON MICROB, V76, P4102, DOI 10.1128/AEM.00469-10; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; CHLUMSKY LJ, 1995, J BIOL CHEM, V270, P18252, DOI 10.1074/jbc.270.31.18252; CRAFT TR, 1987, MUTAT RES, V176, P147, DOI 10.1016/0027-5107(87)90262-4; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; DEVRIES GE, 1992, J BACTERIOL, V174, P5346, DOI 10.1128/JB.174.16.5346-5353.1992; DIAZ MR, 1992, FEMS MICROBIOL LETT, V96, P61, DOI 10.1016/0378-1097(92)90457-Y; Dixon JL, 2011, ISME J, V5, P704, DOI 10.1038/ismej.2010.169; Dworkin M, 2006, CAPNOPHILIC BIRD PAT, V3rd; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gabaldon T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni SJ, 2008, ENVIRON MICROBIOL, V10, P1771, DOI 10.1111/j.1462-2920.2008.01598.x; Goenrich M, 2002, J BIOL CHEM, V277, P3069, DOI 10.1074/jbc.C100579200; Goode JG, 2000, J GEOPHYS RES-ATMOS, V105, P22147, DOI 10.1029/2000JD900287; GRAFSTROM RC, 1983, SCIENCE, V220, P216, DOI 10.1126/science.6828890; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; Heikes BG, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001895; HENDERSON JF, 1979, BIOCHEM EDUC, V7, P51; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; JONES DP, 1978, J BIOL CHEM, V253, P6031; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karl DM, 2008, NAT GEOSCI, V1, P473, DOI 10.1038/ngeo234; Kiene RP, 1998, APPL ENVIRON MICROB, V64, P1045; King GM, 2007, NAT REV MICROBIOL, V5, P107, DOI 10.1038/nrmicro1595; Latypova E, 2010, MOL MICROBIOL, V75, P426, DOI 10.1111/j.1365-2958.2009.06989.x; Lin CN, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-84; Liu XQ, 2009, MICROBIOL-SGM, V155, P2078, DOI 10.1099/mic.0.027201-0; MANIAN SS, 1984, APPL ENVIRON MICROB, V48, P276, DOI 10.1128/AEM.48.2.276-279.1984; Mcdowell L. R., 2000, VITAMINS ANIMAL HUMA, DOI DOI 10.1002/9780470376911; Meskys R, 2001, EUR J BIOCHEM, V268, P3390, DOI 10.1046/j.1432-1327.2001.02239.x; MOPPER K, 1991, NATURE, V353, P60, DOI 10.1038/353060a0; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; RAS J, 1995, J BACTERIOL, V177, P247, DOI 10.1128/jb.177.1.247-251.1995; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Robbertse B, 2006, FUNGAL GENET BIOL, V43, P715, DOI 10.1016/j.fgb.2006.05.001; Robbertse B, 2011, PLOS CURR-TREE LIFE, DOI 10.1371/currents.RRN1213; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Scott DA, 2008, J BIOL CHEM, V283, P155, DOI 10.1074/jbc.M708014200; Scrutton NS, 2005, BIOCHEM SOC T, V33, P776, DOI 10.1042/BST0330776; Serra AL, 2002, J BACTERIOL, V184, P4301, DOI 10.1128/JB.184.15.4301-4303.2002; Singh HB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017933; SINGH RK, 1984, J BIOSCIENCE, V6, P181, DOI 10.1007/BF02702639; Sorokin DY, 2010, MICROBIOL-SGM, V156, P819, DOI 10.1099/mic.0.033712-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Studer A, 2002, J BACTERIOL, V184, P3476, DOI 10.1128/JB.184.13.3476-3484.2002; Teplyakov A, 2004, J BACTERIOL, V186, P7134, DOI 10.1128/JB.186.21.7134-7140.2004; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Tripp HJ, 2009, ENVIRON MICROBIOL, V11, P230, DOI 10.1111/j.1462-2920.2008.01758.x; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Vandecasteele J.-P, 2008, PETROLEUM MICROBIOLO; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Wang W, 2002, APPL MICROBIOL BIOT, V60, P139, DOI 10.1007/s00253-002-1093-6; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Wilson SM, 2008, MICROBIOL-SGM, V154, P296, DOI 10.1099/mic.0.2007/011346-0; ZIMMERMAN PR, 1978, GEOPHYS RES LETT, V5, P679, DOI 10.1029/GL005i008p00679	82	110	110	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23973	10.1371/journal.pone.0023973	http://dx.doi.org/10.1371/journal.pone.0023973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886845	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500041
J	Wang, SC; Chang, Y; Guo, JJ; Zeng, QN; Ellis, BE; Chen, JG				Wang, Shucai; Chang, Ying; Guo, Jianjun; Zeng, Qingning; Ellis, Brian E.; Chen, Jin-Gui			Arabidopsis Ovate Family Proteins, a Novel Transcriptional Repressor Family, Control Multiple Aspects of Plant Growth and Development	PLOS ONE			English	Article							AUX/IAA PROTEINS; CELL-DIVISION; BETA-SUBUNIT; GENES; ROLES; LEAF; SUPPRESSES; EXPRESSION	Background: The Arabidopsis genome contains 18 genes that are predicted to encode Ovate Family Proteins (AtOFPs), a protein family characterized by a conserved OVATE domain, an approximately 70-amino acid domain that was originally found in tomato OVATE protein. Among AtOFP family members, AtOFP1 has been shown to suppress cell elongation, in part, by suppressing the expression of AtGA20ox1, AtOFP4 has been shown to regulate secondary cell wall formation by interact with KNOTTED1-LIKE HOMEODOMAIN PROTEIN 7 (KNAT7), and AtOFP5 has been shown to regulate the activity of a BEL1-LIKEHOMEODOMAIN 1(BLH1)-KNAT3 complex during early embryo sac development, but little is known about the function of other AtOFPs. Methodology/Principal Findings: We demonstrated here that AtOFP proteins could function as effective transcriptional repressors in the Arabidopsis protoplast transient expression system. The analysis of loss-of-function alleles of AtOFPs suggested AtOFP genes may have overlapping function in regulating plant growth and development, because none of the single mutants identified, including T-DNA insertion mutants in AtOFP1, AtOFP4, AtOFP8, AtOFP10, AtOFP15 and AtOFP16, displayed any apparent morphological defects. Further, Atofp1 Atofp4 and Atofp15 Atofp16 double mutants still did not differ significantly from wild-type. On the other hand, plants overexpressing AtOFP genes displayed a number of abnormal phenotypes, which could be categorized into three distinct classes, suggesting that AtOFP genes may also have diverse functions in regulating plant growth and development. Further analysis suggested that AtOFP1 regulates cotyledon development in a postembryonic manner, and global transcript profiling revealed that it suppress the expression of many other genes. Conclusions/Significance: Our results showed that AtOFPs function as transcriptional repressors and they regulate multiple aspects of plant growth and development. These results provided the first overview of a previously unknown transcriptional repressor family, and revealed their possible roles in plant growth and development.	[Wang, Shucai] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China; [Wang, Shucai] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Chang, Ying] NE Agr Univ, Dept Bot, Haerbin, Peoples R China; [Wang, Shucai; Chang, Ying; Guo, Jianjun; Zeng, Qingning; Chen, Jin-Gui] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Zeng, Qingning; Ellis, Brian E.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Chen, Jin-Gui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA	Northeast Normal University - China; Northeast Normal University - China; Northeast Agricultural University - China; University of British Columbia; University of British Columbia; United States Department of Energy (DOE); Oak Ridge National Laboratory	Wang, SC (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China.	wangshucai@yahoo.com	guo, jianjun/G-6852-2013; Zeng, Qingning/M-2245-2013; Chen, Jin-Gui/A-4773-2011; Chen, Jin-Gui/AFV-6337-2022	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Wang, Shucai/0000-0001-7619-2385	Northeast Normal University; National Natural Science Foundation of China [30870144]; Oak Ridge National Laboratory; U.S. Department of Energy [DE-AC05-00OR22725]	Northeast Normal University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oak Ridge National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by a startup grant from Northeast Normal University (www.nenu.edu.cn) (S. W.), grant from the National Natural Science Foundation of China (www.nsfc.gov.cn, grant No 30870144) (Y.C.), and the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (www.ornl.gov/ornlhome/ldrd) (J.-G.C.). Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Sakamoto T, 2001, GENE DEV, V15, P581, DOI 10.1101/gad.867901; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; TSUKAYA H, 1994, PLANTA, V195, P309, DOI 10.1007/BF00199692; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x	22	78	109	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23896	10.1371/journal.pone.0023896	http://dx.doi.org/10.1371/journal.pone.0023896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886836	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500036
J	Ploski, JE; Monsey, MS; Nguyen, T; DiLeone, RJ; Schafe, GE				Ploski, Jonathan E.; Monsey, Melissa S.; Tam Nguyen; DiLeone, Ralph J.; Schafe, Glenn E.			The Neuronal PAS Domain Protein 4 (Npas4) Is Required for New and Reactivated Fear Memories	PLOS ONE			English	Article							LONG-TERM-MEMORY; ACTIVITY-DEPENDENT REGULATION; ELEMENT-BINDING PROTEIN; NEUROTROPHIC FACTOR; RNA INTERFERENCE; LATERAL AMYGDALA; CREB; HIPPOCAMPUS; MICE; TRANSCRIPTION	The Neuronal PAS domain protein 4 (Npas4) is a neuronal activity-dependent immediate early gene that has recently been identified as a transcription factor which regulates the transcription of genes that control inhibitory synapse development and synaptic plasticity. The role Npas4 in learning and memory, however, is currently unknown. Here, we systematically examine the role of Npas4 in auditory Pavlovian fear conditioning, an amygdala-dependent form of emotional learning. In our first series of experiments, we show that Npas4 mRNA and protein are regulated in the rat lateral nucleus of the amygdala (LA) in a learning-dependent manner. Further, knockdown of Npas4 protein in the LA via adeno-associated viral (AAV) mediated gene delivery of RNAi was observed to impair fear memory formation, while innate fear and the expression of fear memory were not affected. In our second series of experiments, we show that Npas4 protein is regulated in the LA by retrieval of an auditory fear memory and that knockdown of Npas4 in the LA impairs retention of a reactivated, but not a non-reactivated, fear memory. Collectively, our findings provide the first comprehensive look at the functional role of Npas4 in learning and memory.	[Ploski, Jonathan E.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Monsey, Melissa S.; Tam Nguyen; Schafe, Glenn E.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [DiLeone, Ralph J.; Schafe, Glenn E.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [DiLeone, Ralph J.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	University of Texas System; University of Texas Dallas; Yale University; Yale University; Yale University	Ploski, JE (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	glenn.schafe@yale.edu		DiLeone, Ralph/0000-0002-4770-2590	National Institutes of Health [MH 073949, MH079560-01A2]; Yale University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073949, F32MH079560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Institutes of Health (MH 073949 to G. E. S.; MH079560-01A2 to J.E.P.) and by Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Coba MP, 2008, J BIOL CHEM, V283, P34101, DOI 10.1074/jbc.M804951200; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jeyaseelan K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e58; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Marty S, 2000, J NEUROSCI, V20, P8087; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ploski JE, 2010, J NEUROCHEM, V112, P636, DOI 10.1111/j.1471-4159.2009.06491.x; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	29	68	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23760	10.1371/journal.pone.0023760	http://dx.doi.org/10.1371/journal.pone.0023760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887312	gold, Green Submitted, Green Published			2022-12-25	WOS:000294251800029
J	Schauble, S; Heiland, I; Voytsekh, O; Mittag, M; Schuster, S				Schaeuble, Sascha; Heiland, Ines; Voytsekh, Olga; Mittag, Maria; Schuster, Stefan			Predicting the Physiological Role of Circadian Metabolic Regulation in the Green Alga Chlamydomonas reinhardtii	PLOS ONE			English	Article							RNA-BINDING PROTEIN; CONSTRAINT-BASED ANALYSIS; ELEMENTARY MODE ANALYSIS; FLUX BALANCE MODELS; ESCHERICHIA-COLI; PATHWAY ANALYSIS; MESSENGER-RNAS; RECONSTRUCTION; ASSIMILATION; NETWORKS	Although the number of reconstructed metabolic networks is steadily growing, experimental data integration into these networks is still challenging. Based on elementary flux mode analysis, we combine sequence information with metabolic pathway analysis and include, as a novel aspect, circadian regulation. While minimizing the need of assumptions, we are able to predict changes in the metabolic state and can hypothesise on the physiological role of circadian control in nitrogen metabolism of the green alga Chlamydomonas reinhardtii.	[Schaeuble, Sascha; Heiland, Ines; Schuster, Stefan] Univ Jena, Dept Bioinformat, Jena, Germany; [Voytsekh, Olga; Mittag, Maria] Univ Jena, Inst Gen Bot & Plant Physiol, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schauble, S (corresponding author), Univ Jena, Dept Bioinformat, Jena, Germany.	heiland.ines@uni-jena.de	Heiland, Ines/B-9212-2014; Schäuble, Sascha/AAF-7809-2021	Heiland, Ines/0000-0002-9124-5112; 	German Federal Ministry of Education and Research (BMBF) [0315260A]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (BMBF project 0315260A; http://www.bmbf.de/; http://www.forsys.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACUA V, 2010, BIOSYSTEMS, V99, P210; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Behre J, 2008, J THEOR BIOL, V252, P433, DOI 10.1016/j.jtbi.2007.09.043; Carlson R, 2002, BIOTECHNOL BIOENG, V79, P121, DOI 10.1002/bit.10305; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Daniel-Vedele F, 1998, CURR OPIN PLANT BIOL, V1, P235, DOI 10.1016/S1369-5266(98)80110-6; Diniz SC, 2006, BIOTECHNOL BIOENG, V93, P698, DOI 10.1002/bit.20760; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Feist AM, 2010, CURR OPIN MICROBIOL; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Gonzalez-Ballester D, 2004, PLANT MOL BIOL, V56, P863, DOI 10.1007/s11103-004-5292-7; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; Hadicke O, 2010, J BIOTECHNOL, V147, P88, DOI 10.1016/j.jbiotec.2010.03.006; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Iliev D, 2006, PLANT PHYSIOL, V142, P797, DOI 10.1104/pp.106.085944; Kaleta C, 2009, GENOME RES, V19, P1872, DOI 10.1101/gr.090639.108; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kenanov D, 2010, FEBS J, V277, P1023, DOI 10.1111/j.1742-4658.2009.07546.x; Kiaulehn S, 2007, J BIOL RHYTHM, V22, P275, DOI 10.1177/0748730407301053; Kromer JO, 2006, METAB ENG, V8, P353, DOI 10.1016/j.ymben.2006.02.001; Kucho K, 2005, PLANT MOL BIOL, V57, P889, DOI 10.1007/s11103-005-3248-1; May P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-209; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michal G, 1999, BIOCH PATHWAYS ATLAS; Mittag M, 1996, P NATL ACAD SCI USA, V93, P14401, DOI 10.1073/pnas.93.25.14401; Piques M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.68; QUESADA A, 1993, MOL GEN GENET, V240, P387, DOI 10.1007/BF00280390; Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 2005, FEBS J, V272, P5278, DOI 10.1111/j.1742-4658.2005.04924.x; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Schwartz JM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r123; Schwarz R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-313; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Trinh CT, 2009, APPL ENVIRON MICROB, V75, P6696, DOI 10.1128/AEM.00670-09; Trinh CT, 2009, APPL MICROBIOL BIOT, V81, P813, DOI 10.1007/s00253-008-1770-1; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Waltenberger H, 2001, MOL GENET GENOMICS, V265, P180; Wlaschin AP, 2006, METAB ENG, V8, P338, DOI 10.1016/j.ymben.2006.01.007; Zhao B, 2004, EUKARYOT CELL, V3, P815, DOI 10.1128/EC.3.3.815-825.2004; [No title captured], DOI DOI 10.1142/S0218339094000131	47	2	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23026	10.1371/journal.pone.0023026	http://dx.doi.org/10.1371/journal.pone.0023026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887226	Green Submitted, gold, Green Published			2022-12-25	WOS:000294251800006
J	Tummala, H; Fleming, S; Hocking, PM; Wehner, D; Naseem, Z; Ali, M; Inglehearn, CF; Zhelev, N; Lester, DH				Tummala, Hemanth; Fleming, Stewart; Hocking, Paul M.; Wehner, Daniel; Naseem, Zahid; Ali, Manir; Inglehearn, Christopher F.; Zhelev, Nikolai; Lester, Douglas H.			The D153del Mutation in GNB3 Gene Causes Tissue Specific Signalling Patterns and an Abnormal Renal Morphology in Rge Chickens	PLOS ONE			English	Article							PROTEIN BETA-3 SUBUNIT; HETEROTRIMERIC G-PROTEINS; GAMMA-SUBUNITS; SPLICE VARIANT; RETINAL DEGENERATION; COUPLED RECEPTORS; GOLGI MEMBRANES; 825T ALLELE; CYCLIC-GMP; KINASE	Background: The GNB3 gene is expressed in cone but not rod photoreceptors of vertebrates, where it acts as the beta transducin subunit in the colour visual transduction process. A naturally occurring mutation 'D153del' in the GNB3 gene causes the recessively inherited blinding phenotype retinopathy globe enlarged (rge) disease in chickens. GNB3 is however also expressed in most other vertebrate tissues suggesting that the D153del mutation may exert pathological effects that outlie from eye. Principal Findings: Recombinant studies in COS-7 cells that were transfected with normal and mutant recombinant GNB3 constructs and subjected to cycloheximide chase showed that the mutant GNB3d protein had a much shorter half life compared to normal GNB3. GNB3 codes for the G beta 3 protein subunit that, together with different G gamma and G alpha subunits, activates and regulates phosphorylation cascades in different tissues. As expected, the relative levels of cGMP and cAMP secondary messengers and their activated kinases such as MAPK, AKT and GRK2 were also found to be altered significantly in a tissue specific manner in rge chickens. Histochemical analysis on kidney tissue sections, from rge homozygous affected chickens, showed the chickens had enlargement of the glomerular capsule, causing glomerulomegaly and tubulointerstitial inflammation whereas other tissues (brain, heart, liver, pancreas) were unaffected. Significance: These findings confirm that the D153del mutation in GNB3 gene targets GNB3 protein to early degradation. Lack of GNB3 signalling causes reduced phosphorylation activity of ERK2 and AKT leading to severe pathological phenotypes such as blindness and renal abnormalities in rge chickens.	[Tummala, Hemanth; Wehner, Daniel; Naseem, Zahid; Zhelev, Nikolai; Lester, Douglas H.] Univ Abertay Dundee, Sch Contemporary Sci, Dundee, Scotland; [Hocking, Paul M.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Hocking, Paul M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Ali, Manir; Inglehearn, Christopher F.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Fleming, Stewart] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Ctr Oncol & Mol Med,Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland	University of Abertay Dundee; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Saint James's University Hospital; University of Leeds; University of Dundee	Tummala, H (corresponding author), Univ Abertay Dundee, Sch Contemporary Sci, Dundee, Scotland.	D.Lester@abertay.ac.uk	Zhelev, Nikolai Z/A-8589-2012; Tummala, Hemanth/ABC-8367-2020; Ali, Manir/ABE-5251-2020	Zhelev, Nikolai Z/0000-0002-5189-3975; Tummala, Hemanth/0000-0002-1413-745X; Ali, Manir/0000-0003-3204-3788; Wehner, Daniel/0000-0003-2880-4759	MRC [G0501050]; Medical Research Council [G0501050] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by MRC research grant no. G0501050 between September 2006 and August 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Baltrons MA, 2008, NEUROCHEM RES, V33, P2427, DOI 10.1007/s11064-008-9681-1; Bommakanti RK, 2000, J BIOL CHEM, V275, P38870, DOI 10.1074/jbc.M007403200; Boote C, 2008, J STRUCT BIOL, V161, P1, DOI 10.1016/j.jsb.2007.08.015; Boote C, 2009, J STRUCT BIOL, V166, P195, DOI 10.1016/j.jsb.2009.01.009; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Bullido MJ, 2004, NEUROBIOL AGING, V25, P853, DOI 10.1016/j.neurobiolaging.2003.10.006; Davis RJ, 2008, INVEST OPHTH VIS SCI, V49, P5067, DOI 10.1167/iovs.07-1422; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Downs MA, 2006, VISION RES, V46, P4442, DOI 10.1016/j.visres.2006.07.021; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; Gao JX, 2005, FEBS LETT, V579, P122, DOI 10.1016/j.febslet.2004.11.057; Gao Y Q, 1998, Mol Vis, V4, P16; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Inglehearn C, 2003, MOL VIS, V9, P295; Ionita MA, 2007, EXP EYE RES, V84, P1, DOI 10.1016/j.exer.2005.12.012; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kacimi R, 2003, HYPERTENSION, V41, P968, DOI 10.1161/01.HYP.0000062465.60601.CC; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kihara AH, 2008, NEUROSCIENCE, V151, P995, DOI 10.1016/j.neuroscience.2007.09.088; Kleppisch Thomas, 2009, V191, P549, DOI 10.1007/978-3-540-68964-5_24; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; Lee HJ, 2004, PHARMACOGENOMICS J, V4, P29, DOI 10.1038/sj.tpj.6500217; Montiani-Ferreira F, 2005, MOL VIS, V11, P11; Mustafa SB, 2008, J CELL PHYSIOL, V215, P101, DOI 10.1002/jcp.21291; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Poon LSW, 2009, CELL SIGNAL, V21, P737, DOI 10.1016/j.cellsig.2009.01.018; PREMONT RT, 1995, FASEB J, V9, P175, DOI 10.1096/fasebj.9.2.7781920; RITCHEY ER, 2010, NEUROSCIENCE; Rosskopf D, 2003, BBA-GENE STRUCT EXPR, V1626, P33, DOI 10.1016/S0167-4781(03)00035-6; Rosskopf D, 2003, CELL SIGNAL, V15, P479, DOI 10.1016/S0898-6568(02)00140-7; Rosskopf D, 2003, BIOCHEM J, V371, P223, DOI 10.1042/BJ20021208; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; SANGHERA JS, 1992, MOL BIOL CELL, V3, P775, DOI 10.1091/mbc.3.7.775; Schrader EK, 2009, NAT CHEM BIOL, V5, P954, DOI 10.1038/nchembio1209-954c; Siffert W, 2000, NEPHROL DIAL TRANSPL, V15, P1298, DOI 10.1093/ndt/15.9.1298; Siffert W, 1998, KIDNEY INT, V53, P1466, DOI 10.1046/j.1523-1755.1998.00934.x; Siffert W, 1999, J AM SOC NEPHROL, V10, P1921; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Thompson Miles D., 2008, V448, P77, DOI 10.1007/978-1-59745-205-2_6; Traverso V, 2002, INVEST OPHTH VIS SCI, V43, P1655; Tummala H, 2006, INVEST OPHTH VIS SCI, V47, P4714, DOI 10.1167/iovs.06-0292; Vanhoutte P M, 2006, Bull Mem Acad R Med Belg, V161, P529; Vanhoutte P. M., 2006, B MEM ACAD R MED BEL, V161, P536; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e21156	10.1371/journal.pone.0021156	http://dx.doi.org/10.1371/journal.pone.0021156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887213	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800001
J	Golob, JL; Kumar, RM; Guenther, MG; Pabon, LM; Pratt, GA; Loring, JF; Laurent, LC; Young, RA; Murry, CE				Golob, Jonathan L.; Kumar, Roshan M.; Guenther, Matthew G.; Pabon, Lil M.; Pratt, Gabriel A.; Loring, Jeanne F.; Laurent, Louise C.; Young, Richard A.; Murry, Charles E.			Evidence That Gene Activation and Silencing during Stem Cell Differentiation Requires a Transcriptionally Paused Intermediate State	PLOS ONE			English	Article							RNA-POLYMERASE-II; CHROMATIN IMMUNOPRECIPITATION; INITIATION; PROMOTERS; TRANSPLANTATION; ELONGATION; EXPRESSION; RELEASE; EMBRYO; HEART	A surprising portion of both mammalian and Drosophila genomes are transcriptionally paused, undergoing initiation without elongation. We tested the hypothesis that transcriptional pausing is an obligate transition state between definitive activation and silencing as human embryonic stem cells (hESCs) change state from pluripotency to mesoderm. Chromatin immunoprecipitation for trimethyl lysine 4 on histone H3 (ChIP-Chip) was used to analyze transcriptional initiation, and 3' transcript arrays were used to determine transcript elongation. Pluripotent and mesodermal cells had equivalent fractions of the genome in active and paused transcriptional states (similar to 48% each), with similar to 4% definitively silenced (neither initiation nor elongation). Differentiation to mesoderm changed the transcriptional state of 12% of the genome, with roughly equal numbers of genes moving toward activation or silencing. Interestingly, almost all loci (98-99%) changing transcriptional state do so either by entering or exiting the paused state. A majority of these transitions involve either loss of initiation, as genes specifying alternate lineages are archived, or gain of initiation, in anticipation of future full-length expression. The addition of chromatin dynamics permitted much earlier predictions of final cell fate compared to sole use of conventional transcript arrays. These findings indicate that the paused state may be the major transition state for genes changing expression during differentiation, and implicate control of transcriptional elongation as a key checkpoint in lineage specification.	[Golob, Jonathan L.; Pabon, Lil M.; Pratt, Gabriel A.; Murry, Charles E.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Golob, Jonathan L.; Pabon, Lil M.; Pratt, Gabriel A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Kumar, Roshan M.; Guenther, Matthew G.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Loring, Jeanne F.; Laurent, Louise C.] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute; University of California System; University of California San Diego	Golob, JL (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	murry@u.washington.edu	Young, Richard A/F-6495-2012; Loring, Jeanne F/A-1620-2011	Young, Richard A/0000-0001-8855-8647; Loring, Jeanne F/0000-0001-6226-9767; Laurent, Louise/0000-0002-2095-7534	NIGMS [P01GM081619]; NHLBI [P01 HL 094374, U01 HL100405, R01 HL084642]; Experimental Pathology of Cardiovascular Disease Training Grant [T32 HL07312-31]; ARCS Foundation; Poncin Foundation; NIH/NICHD WRHR [K12 HD001259]; CIRM [RT1-01108, TR1-01250]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, R01HL084642, T32HL007312, P01HL094374] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Experimental Pathology of Cardiovascular Disease Training Grant; ARCS Foundation; Poncin Foundation; NIH/NICHD WRHR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants NIGMS P01GM081619, NHLBI P01 HL 094374, U01 HL100405 and R01 HL084642. JLG was supported by the Experimental Pathology of Cardiovascular Disease Training Grant (T32 HL07312-31), the ARCS Foundation and the Poncin Foundation. LCL is supported by an NIH/NICHD WRHR Career Development Award (K12 HD001259). JFL is supported by CIRM (RT1-01108, TR1-01250). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barnes M, 2005, NUCLEIC ACIDS RES, V33, P5914, DOI 10.1093/nar/gki890; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Golob JL, 2008, DEV DYNAM, V237, P1389, DOI 10.1002/dvdy.21545; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Morkin E, 2000, MICROSC RES TECHNIQ, V50, P522, DOI 10.1002/1097-0029(20000915)50:6<522::AID-JEMT9>3.0.CO;2-U; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Tulloch NL, 2011, CIRC RES; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e22416	10.1371/journal.pone.0022416	http://dx.doi.org/10.1371/journal.pone.0022416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886766	Green Submitted, gold, Green Published			2022-12-25	WOS:000294128100002
J	von Leupoldt, A; Brassen, S; Baumann, HJ; Klose, H; Buchel, C				von Leupoldt, Andreas; Brassen, Stefanie; Baumann, Hans Joerg; Klose, Hans; Buechel, Christian			Structural Brain Changes Related to Disease Duration in Patients with Asthma	PLOS ONE			English	Article							GRAY-MATTER; SYMPTOM PERCEPTION; CHRONIC PAIN; DYSPNEA; CHILDREN; INTENSITY; CIRCUITRY; IMPACT; LOADS	Dyspnea is the impairing, cardinal symptom patients with asthma repeatedly experience over the course of the disease. However, its accurate perception is also crucial for timely initiation of treatment. Reduced perception of dyspnea is associated with negative treatment outcome, but the underlying brain mechanisms of perceived dyspnea in patients with asthma remain poorly understood. We examined whether increasing disease duration in fourteen patients with mild-to-moderate asthma is related to structural brain changes in the insular cortex and brainstem periaqueductal grey (PAG). In addition, the association between structural brain changes and perceived dyspnea were studied. By using magnetic resonance imaging in combination with voxel-based morphometry, gray matter volumes of the insular cortex and the PAG were analysed and correlated with asthma duration and perceived affective unpleasantness of resistive load induced dyspnea. Whereas no associations were observed for the insular cortex, longer duration of asthma was associated with increased gray matter volume in the PAG. Moreover, increased PAG gray matter volume was related to reduced ratings of dyspnea unpleasantness. Our results demonstrate that increasing disease duration is associated with increased gray matter volume in the brainstem PAG in patients with mild-to-moderate asthma. This structural brain change might contribute to the reduced perception of dyspnea in some patients with asthma and negatively impact the treatment outcome.	[von Leupoldt, Andreas] Univ Hamburg, Dept Psychol, Hamburg, Germany; [von Leupoldt, Andreas; Brassen, Stefanie; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany; [Baumann, Hans Joerg; Klose, Hans] Univ Med Ctr Hamburg Eppendorf, Dept Pneumol, Hamburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	von Leupoldt, A (corresponding author), Univ Hamburg, Dept Psychol, Hamburg, Germany.	andreas.vonleupoldt@uni-hamburg.de	Brassen, Stefanie/H-5386-2012	Brassen, Stefanie/0000-0002-8884-7593	Deutsche Forschungsgemeinschaft (DFG) [LE 1843/5-1, LE 1843/9-1, BR 2877/2-1]; Federal Ministry of Education and Research Germany (BMBF) [01GO0510]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG LE 1843/5-1 and LE 1843/9-1) to AvL and SB (BR 2877/2-1) and a grant from the Federal Ministry of Education and Research Germany (BMBF, 01GO0510) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Banzett RB, 2000, AM J RESP CRIT CARE, V162, P1178, DOI 10.1164/ajrccm.162.3.9909112; BARNES PJ, 1994, NEW ENGL J MED, V330, P1383, DOI 10.1056/NEJM199405123301910; Barnes SJ, 2010, NEUROSCIENTIST, V16, P186, DOI 10.1177/1073858409343961; BERNHARDT V, 2010, FASEB J, V24; Carrieri-Kohlman V, 2001, NURS RES, V50, P136, DOI 10.1097/00006199-200105000-00002; Chen CY, 2001, J ALLERGY CLIN IMMUN, V108, P557; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; Davenport PW, 2000, AM J RESP CRIT CARE, V161, P1830, DOI 10.1164/ajrccm.161.6.9903077; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Evans KC, 2010, BIOL PSYCHOL, V84, P13, DOI 10.1016/j.biopsycho.2010.02.005; Fauroux B, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-61; Feldman JM, 2007, PEDIATR PULM, V42, P339, DOI 10.1002/ppul.20584; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gaser C., 2009, NEUROIMAGE, V1, pS121, DOI [10.1016/S1053-8119(09)71151-6, DOI 10.1016/S1053-8119(09)71151-6]; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; *GINA, 2009, NIH PUBL; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; KENDRICK AH, 1993, BRIT MED J, V307, P422, DOI 10.1136/bmj.307.6901.422; Kifle Y, 1997, AM J RESP CRIT CARE, V156, P1530, DOI 10.1164/ajrccm.156.5.9703011; KIKUCHI Y, 1994, NEW ENGL J MED, V330, P1329, DOI 10.1056/NEJM199405123301901; Lansing RW, 2009, RESP PHYSIOL NEUROBI, V167, P53, DOI 10.1016/j.resp.2008.07.012; Magadle R, 2002, CHEST, V121, P329, DOI 10.1378/chest.121.2.329; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; Meek PM, 1999, AM J RESP CRIT CARE, V159, P321; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; PATE KM, 2010, FASEB J, V24; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rosenkranz MA, 2009, NEUROIMAGE, V47, P972, DOI 10.1016/j.neuroimage.2009.05.042; Rosi E, 2006, LUNG, V184, P251, DOI 10.1007/s00408-005-2590-z; RUBINFELD AR, 1976, LANCET, V1, P882; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Serrano J, 2006, EUR RESPIR J, V28, P296, DOI 10.1183/09031936.06.00008105; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; von Leupoidt A, 2009, AM J RESP CRIT CARE, V180, P232, DOI 10.1164/rccm.200902-0300OC; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; von Leupoldt A, 2007, RESP MED, V101, P1079, DOI 10.1016/j.rmed.2006.10.026; Von Leupoldt A, 2006, PSYCHOPHYSIOLOGY, V43, P641, DOI 10.1111/j.1469-8986.2006.00453.x; von Leupoldt A, 2011, PSYCHOPHYSIOLOGY, V48, P808, DOI 10.1111/j.1469-8986.2010.01141.x; von Leupoldt A, 2010, PSYCHOPHYSIOLOGY, V47, P579, DOI 10.1111/j.1469-8986.2009.00956.x; Wan L, 2009, CHEST, V135, P455, DOI 10.1378/chest.08-1226; Webster KE, 2002, AM J RESP CRIT CARE, V166, P47, DOI 10.1164/rccm.2012006; Yorke J, 2010, THORAX, V65, P21, DOI 10.1136/thx.2009.118521	55	26	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23739	10.1371/journal.pone.0023739	http://dx.doi.org/10.1371/journal.pone.0023739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886820	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100029
J	Caputi, AA; Aguilera, PA; Pereira, AC				Caputi, Angel A.; Aguilera, Pedro A.; Pereira, Ana Carolina			Active Electric Imaging: Body-Object Interplay and Object's "Electric Texture"	PLOS ONE			English	Article							ORGAN DISCHARGES; SENSORY ACQUISITION; GYMNOTIFORM FISHES; GYMNOTUS-CARAPO; WAVE-FORM; IMAGES; ELECTROLOCATION; SIGNAL; ELECTRORECEPTION; RESPONSES	This article deals with the role of fish's body and object's geometry on determining the image spatial shape in pulse Gymnotiforms. This problem was explored by measuring local electric fields along a line on the skin in the presence and absence of objects. We depicted object's electric images at different regions of the electrosensory mosaic, paying particular attention to the perioral region where a fovea has been described. When sensory surface curvature increases relative to the object's curvature, the image details depending on object's shape are blurred and finally disappear. The remaining effect of the object on the stimulus profile depends on the strength of its global polarization. This depends on the length of the object's axis aligned with the field, in turn depending on fish body geometry. Thus, fish's body and self-generated electric field geometries are embodied in this "global effect'' of the object. The presence of edges or local changes in impedance at the nearest surface of closely located objects adds peaks to the image profiles ("local effect" or "object's electric texture"). It is concluded that two cues for object recognition may be used by active electroreceptive animals: global effects (informing on object's dimension along the field lines, conductance, and position) and local effects (informing on object's surface). Since the field has fish's centered coordinates, and electrosensory fovea is used for exploration of surfaces, fish fine movements are essential to perform electric perception. We conclude that fish may explore adjacent objects combining active movements and electrogenesis to represent them using electrosensory information.	[Caputi, Angel A.; Aguilera, Pedro A.; Pereira, Ana Carolina] Inst Invest Biol Clemente Estable, Dept Integrat & Computat Neurosci, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Caputi, AA (corresponding author), Inst Invest Biol Clemente Estable, Dept Integrat & Computat Neurosci, Montevideo, Uruguay.	caputiangel@gmail.com			European Commission Information, Society and Media, Future and Emerging Technologies (FET) [231845]; Agencia Nacional de Investigacion e Innovacion (ANII Uruguay); Fondo Clemente Estable [655]; PEDECIBA (Uruguay)	European Commission Information, Society and Media, Future and Emerging Technologies (FET)(European CommissionEuropean Commission Joint Research Centre); Agencia Nacional de Investigacion e Innovacion (ANII Uruguay); Fondo Clemente Estable; PEDECIBA (Uruguay)	This work was partially funded by the European Commission Information, Society and Media, Future and Emerging Technologies (FET) Grant # 231845; Agencia Nacional de Investigacion e Innovacion (ANII Uruguay), Fondo Clemente Estable # 655 and PEDECIBA (Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; Aguilera PA, 2001, J EXP BIOL, V204, P185; Assad C, 1999, J EXP BIOL, V202, P1185; ASSAD C, 1997, ELECT FIELD MAPS BOU; Babineau D, 2006, J EXP BIOL, V209, P3636, DOI 10.1242/jeb.02403; Bacelo J, 2008, J COMP NEUROL, V511, P342, DOI 10.1002/cne.21843; BASTIAN J, 1993, J COMP PHYSIOL A, V173, P257, DOI 10.1007/BF00212690; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bullock T.H., 1986, ELECTRORECEPTION; Bullock TH, 2005, ELECTRORECEPTION; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; Caputi AA, 1998, J EXP BIOL, V201, P2115; Caputi AA, 2003, J EXP BIOL, V206, P999, DOI 10.1242/jeb.00199; Caputi AA, 2002, J PHYSIOLOGY-PARIS, V96, P493, DOI 10.1016/S0928-4257(03)00005-6; Caputi AA, 2008, J PHYSIOL-PARIS, V102, P256, DOI 10.1016/j.jphysparis.2008.10.005; Pereira AC, 2010, INTERDISCIP SCI, V2, P291, DOI 10.1007/s12539-010-0049-2; Castello ME, 2000, J EXP BIOL, V203, P3279; Chen L, 2005, J COMP PHYSIOL A, V191, P331, DOI 10.1007/s00359-004-0587-3; Engelmann J, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-21; Gibson JJ., 1966, SENSES CONSIDERED PE; Gomez L, 2004, J EXP BIOL, V207, P2443, DOI 10.1242/jeb.01053; HEILIGENBERG W, 1973, J COMP PHYSIOL, V87, P137, DOI 10.1007/BF01352158; Hollmann M, 2008, J ZOOL, V276, P149, DOI 10.1111/j.1469-7998.2008.00465.x; Kalmijn A.J., 1974, P147; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LISSMANN HW, 1958, J EXP BIOL, V35, P451; Migliaro A, 2005, PLOS COMPUT BIOL, V1, P123, DOI 10.1371/journal.pcbi.0010016; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Nelson ME, 2002, BRAIN BEHAV EVOLUT, V59, P199, DOI 10.1159/000064907; Nelson ME, 1999, J EXP BIOL, V202, P1195; Nunez P.L, 1981, ELECT FIELDS BRAIN N; Pereira A.C., 2009, THESIS UDELAR MONTEV; Pereira AC, 2005, J EXP BIOL, V208, P961, DOI 10.1242/jeb.01481; Pusch R, 2008, J EXP BIOL, V211, P921, DOI 10.1242/jeb.014175; Rasnow B, 1996, J COMP PHYSIOL A, V178, P383; Rasnow B, 1996, J COMP PHYSIOL A, V178, P397; Rother D, 2003, BIOSYSTEMS, V71, P169, DOI 10.1016/S0303-2647(03)00124-2; Sicardi EA, 2000, PHYSICA A, V283, P86, DOI 10.1016/S0378-4371(00)00132-1; Snyder JB, 2007, PLOS BIOL, V5, P2671, DOI 10.1371/journal.pbio.0050301; Stoddard PK, 1999, J COMP PHYSIOL A, V184, P609, DOI 10.1007/s003590050359; von der Emde G, 2002, J PHYSIOLOGY-PARIS, V96, P431, DOI 10.1016/S0928-4257(03)00021-4; von der Emde G, 1998, NATURE, V395, P890, DOI 10.1038/27655; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576; VONDEREMDE G, 2010, FRONT BEHAV NEUROSCI, V28, P4	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22793	10.1371/journal.pone.0022793	http://dx.doi.org/10.1371/journal.pone.0022793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876730	gold, Green Submitted, Green Published			2022-12-25	WOS:000294126900002
J	Demattei, MV; Hedhili, S; Sinzelle, L; Bressac, C; Casteret, S; Moire, N; Cambefort, J; Thomas, X; Pollet, N; Gantet, P; Bigot, Y				Demattei, Marie-Veronique; Hedhili, Sabah; Sinzelle, Ludivine; Bressac, Christophe; Casteret, Sophie; Moire, Nathalie; Cambefort, Jeanne; Thomas, Xavier; Pollet, Nicolas; Gantet, Pascal; Bigot, Yves			Nuclear Importation of Mariner Transposases among Eukaryotes: Motif Requirements and Homo-Protein Interactions	PLOS ONE			English	Article							INVERTED TERMINAL REPEATS; LOCALIZATION SIGNALS; N-TERMINUS; IN-VITRO; TRANSPOSITION; ELEMENT; EVOLUTION; IDENTIFICATION; AGGRESOMES; ORIGIN	Mariner-like elements (MLEs) are widespread transposable elements in animal genomes. They have been divided into at least five sub-families with differing host ranges. We investigated whether the ability of transposases encoded by Mos1, Himar1 and Mcmar1 to be actively imported into nuclei varies between host belonging to different eukaryotic taxa. Our findings demonstrate that nuclear importation could restrict the host range of some MLEs in certain eukaryotic lineages, depending on their expression level. We then focused on the nuclear localization signal (NLS) in these proteins, and showed that the first 175 N-terminal residues in the three transposases were required for nuclear importation. We found that two components are involved in the nuclear importation of the Mos1 transposase: an SV40 NLS-like motif (position: aa 168 to 174), and a dimerization sub-domain located within the first 80 residues. Sequence analyses revealed that the dimerization moiety is conserved among MLE transposases, but the Himar1 and Mcmar1 transposases do not contain any conserved NLS motif. This suggests that other NLS-like motifs must intervene in these proteins. Finally, we showed that the over-expression of the Mos1 transposase prevents its nuclear importation in HeLa cells, due to the assembly of transposase aggregates in the cytoplasm.	[Demattei, Marie-Veronique; Casteret, Sophie; Cambefort, Jeanne; Thomas, Xavier] UFR Sci & Tech, CNRS, GICC, UMR 6239, Tours, France; [Casteret, Sophie; Bigot, Yves] UMR INRA CNRS 6175, PRC, Nouzilly, France; [Bressac, Christophe] UFR Sci & Tech, CNRS, IRBI, UMR 6035, Tours, France; [Moire, Nathalie] UFR Pharm, INRA, UMR 0483, Tours, France; [Sinzelle, Ludivine; Pollet, Nicolas] Univ Evry Val dEssonne, CNRS, UPS3201, Evry, France; [Hedhili, Sabah; Gantet, Pascal] CIRAD, UMR Dev & Ameliorat Plantes 1098, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CIRAD	Demattei, MV (corresponding author), UFR Sci & Tech, CNRS, GICC, UMR 6239, Tours, France.	bigot@univ-tours.fr	Bressac, Christophe/AAF-9183-2021; Pollet, Nicolas/A-4746-2013	Pollet, Nicolas/0000-0002-9975-9644; bressac, christophe/0000-0001-7609-8970	C.N.R.S.; Groupement de Recherche CNRS [2157]; European Project SyntheGeneDelivery [18716]; Ministere de l'Education Nationale, de la Recherche et de la Technologie; University of Tours; Region Centre and Ludivine Sinzelle; Genopole	C.N.R.S.(Centre National de la Recherche Scientifique (CNRS)); Groupement de Recherche CNRS; European Project SyntheGeneDelivery; Ministere de l'Education Nationale, de la Recherche et de la Technologie; University of Tours; Region Centre and Ludivine Sinzelle(Region Centre-Val de Loire); Genopole	This work was funded by grants from the C.N.R.S., the Groupement de Recherche CNRS 2157, the European Project SyntheGeneDelivery (N<SUP>o</SUP> 18716), the Ministere de l'Education Nationale, de la Recherche et de la Technologie and the University of Tours. Sabah Hedhili holds a doctoral fellowship from the Region Centre and Ludivine Sinzelle a doctoral fellowship from the Genopole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge-Gouillou C, 2005, J MOL BIOL, V351, P117, DOI 10.1016/j.jmb.2005.05.019; Auge-Gouillou C, 2001, MOL GENET GENOMICS, V265, P51, DOI 10.1007/s004380000385; Beall EL, 2002, GENETICS, V162, P217; Benjamin B, 2007, GENETICA, V130, P105, DOI 10.1007/s10709-006-0025-2; Bigot Y, 2005, J MOL BIOL, V351, P108, DOI 10.1016/j.jmb.2005.05.006; BOEHM U, 1995, PLANT J, V7, P441, DOI 10.1046/j.1365-313X.1995.7030441.x; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Butler MG, 2006, GENETICA, V127, P351, DOI 10.1007/s10709-006-6250-x; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Casse N, 2006, MOL PHYLOGENET EVOL, V40, P609, DOI 10.1016/j.ympev.2006.02.005; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; Chatterjee S, 1997, EXP CELL RES, V236, P346, DOI 10.1006/excr.1997.3746; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Clark KJ, 2009, NUCLEIC ACIDS RES, V37, P1239, DOI 10.1093/nar/gkn1025; Claudianos C, 2002, MOL BIOL EVOL, V19, P2101, DOI 10.1093/oxfordjournals.molbev.a004035; Coy MR, 2005, INSECT MOL BIOL, V14, P537, DOI 10.1111/j.1365-2583.2005.00584.x; Feng WQ, 1999, J CELL SCI, V112, P339; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Germon S, 2009, GENETICA, V137, P265, DOI 10.1007/s10709-009-9375-x; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Halaimia-Toumi N, 2004, J MOL EVOL, V59, P747, DOI 10.1007/s00239-004-2665-0; Hedhili Sabah, 2010, BMC Res Notes, V3, P301, DOI 10.1186/1756-0500-3-301; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Jarvik T, 1998, GENETICS, V149, P1569; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Keravala A, 2006, HUM GENE THER, V17, P1006, DOI 10.1089/hum.2006.17.1006; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; Lohe AR, 1996, MOL BIOL EVOL, V13, P549, DOI 10.1093/oxfordjournals.molbev.a025615; MCBRIDE KM, 2003, SCI STKE, V195, pRE13; Michel K, 2003, J CELL BIOCHEM, V89, P778, DOI 10.1002/jcb.10554; Mikitani K, 2000, J BIOL CHEM, V275, P37725, DOI 10.1074/jbc.M005271200; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Mortada H, 2010, J MOL EVOL, V71, P180, DOI 10.1007/s00239-010-9376-5; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Ono A, 2002, PLANT MOL BIOL, V50, P599, DOI 10.1023/A:1019970206057; Renault S, 2010, BIOCHEMISTRY-US, V49, P3534, DOI 10.1021/bi901957p; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; ROBERTSON HM, 1995, J INSECT PHYSIOL, V41, P99, DOI 10.1016/0022-1910(94)00082-R; SCHENBORN E, 1997, PROMEGA NOTES, V63, P13; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; Sinzelle L, 2006, J MOL EVOL, V62, P53, DOI 10.1007/s00239-005-0013-7; Sinzelle L, 2008, P NATL ACAD SCI USA, V105, P4715, DOI 10.1073/pnas.0707746105; Thomas X, 2010, GENETICA, V138, P519, DOI 10.1007/s10709-009-9414-7; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Yuan YW, 2011, P NATL ACAD SCI USA, V108, P7884, DOI 10.1073/pnas.1104208108; Zhang L, 2001, NUCLEIC ACIDS RES, V29, P3566, DOI 10.1093/nar/29.17.3566	55	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23693	10.1371/journal.pone.0023693	http://dx.doi.org/10.1371/journal.pone.0023693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876763	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900035
J	Neel, NF; Sai, J; Ham, AJL; Sobolik-Delmaire, T; Mernaugh, RL; Richmond, A				Neel, Nicole F.; Sai, Jiqing; Ham, Amy-Joan L.; Sobolik-Delmaire, Tammy; Mernaugh, Raymond L.; Richmond, Ann			IQGAP1 Is a Novel CXCR2-Interacting Protein and Essential Component of the "Chemosynapse"	PLOS ONE			English	Article							INFLUENCES ZYXIN LOCALIZATION; ACTIN-FILAMENT; CELL-MIGRATION; INTERLEUKIN-8 RECEPTOR; ENA/VASP PROTEINS; BINDING PROTEIN; SIGNALING RGS; CANCER CELLS; CDC42; REGULATORS	Background: Chemotaxis is essential for a number of physiological processes including leukocyte recruitment. Chemokines initiate intracellular signaling pathways necessary for chemotaxis through binding seven transmembrane G protein-couple receptors. Little is known about the proteins that interact with the intracellular domains of chemokine receptors to initiate cellular signaling upon ligand binding. CXCR2 is a major chemokine receptor expressed on several cell types, including endothelial cells and neutrophils. We hypothesize that multiple proteins interact with the intracellular domains of CXCR2 upon ligand stimulation and these interactions comprise a "chemosynapse", and play important roles in transducing CXCR2 mediated signaling processes. Methodology/Principal Findings: In an effort to define the complex of proteins that assemble upon CXCR2 activation to relay signals from activated chemokine receptors, a proteomics approach was employed to identify proteins that co-associate with CXCR2 with or without ligand stimulation. The components of the CXCR2 "chemosynapse" are involved in processes ranging from intracellular trafficking to cytoskeletal modification. IQ motif containing GTPase activating protein 1 (IQGAP1) was among the novel proteins identified to interact directly with CXCR2. Herein, we demonstrate that CXCR2 co-localizes with IQGAP1 at the leading edge of polarized human neutrophils and CXCR2 expressing differentiated HL-60 cells. Moreover, amino acids 1-160 of IQGAP1 directly interact with the carboxyl-terminal domain of CXCR2 and stimulation with CXCL8 enhances IQGAP1 association with Cdc42. Conclusions: Our studies indicate that IQGAP1 is a novel essential component of the CXCR2 "chemosynapse".	[Neel, Nicole F.; Sai, Jiqing; Sobolik-Delmaire, Tammy; Richmond, Ann] Dept Vet Affairs, Nashville, TN USA; [Neel, Nicole F.; Sai, Jiqing; Sobolik-Delmaire, Tammy; Richmond, Ann] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Ham, Amy-Joan L.; Mernaugh, Raymond L.] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Neel, NF (corresponding author), Dept Vet Affairs, Nashville, TN USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health (NIH) [R01CA34590, P50CA64845]; Vanderbilt-Ingram Cancer Center; Department of Veterans Affairs; Vanderbilt Multidisciplinary Basic Research Training in Cancer [T32CA09592]; Vanderbilt Vascular Biology Training [T32HL07751]; NIH [DK-20593, DK-58404, HD-15052, DK-59637, EY-08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA163069, P30CA068485, R01CA034590, T32CA009592] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, U2CDK059637, P60DK020593, P30DK020593, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center; Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Multidisciplinary Basic Research Training in Cancer; Vanderbilt Vascular Biology Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in whole or in part by National Institutes of Health (NIH) Grants - R01CA34590 (A. R.) and P50CA64845 in support of the Vanderbilt-Ingram Cancer Center. This work was also supported by a Senior Research Career Scientist Award from the Department of Veterans Affairs (A. R.), Ingram Professorship (A.R.), the Vanderbilt Multidisciplinary Basic Research Training in Cancer Grant T32CA09592 (N.F.N.), and the Vanderbilt Vascular Biology Training Grant T32HL07751 (T.S.). The authors acknowledge the VUMC cell imaging shared resource used in confocal studies (supported by NIH grants DK-20593, DK-58404, HD-15052, DK-59637 and EY-08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Benzing T, 2000, J BIOL CHEM, V275, P28167; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brunger AT, 2003, FEBS LETT, V555, P126, DOI 10.1016/S0014-5793(03)01107-4; Chen TY, 2003, BIOCHEM BIOPH RES CO, V303, P1114, DOI 10.1016/S0006-291X(03)00482-0; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Ichimura T, 2002, BIOCHEMISTRY-US, V41, P5566, DOI 10.1021/bi015946f; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lee AH, 2002, CELL MICROBIOL, V4, P739, DOI 10.1046/j.1462-5822.2002.00225.x; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Neel NF, 2009, J CELL SCI, V122, P1882, DOI 10.1242/jcs.039057; Niu JX, 2002, BIOCHEM J, V365, P677, DOI 10.1042/BJ20020390; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sai JQ, 2004, J CELL SCI, V117, P5489, DOI 10.1242/jcs.01398; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Seroussi E, 1998, GENE, V212, P13, DOI 10.1016/S0378-1119(98)00098-5; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Takahashi K, 2006, J CELL PHYSIOL, V208, P213, DOI 10.1002/jcp.20657; Vroon A, 2007, EUR J PHARMACOL, V560, P9, DOI 10.1016/j.ejphar.2007.01.007; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	49	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23813	10.1371/journal.pone.0023813	http://dx.doi.org/10.1371/journal.pone.0023813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876773	gold, Green Published, Green Submitted			2022-12-25	WOS:000294126900045
J	Sundvik, M; Kudo, H; Toivonen, P; Rozov, S; Chen, YC; Panula, P				Sundvik, Maria; Kudo, Hisaaki; Toivonen, Pauliina; Rozov, Stanislav; Chen, Yu-Chia; Panula, Pertti			The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish	FASEB JOURNAL			English	Article						locomotor activity; sleep disorders; dorsal telencephalon; tracing	H-3 RECEPTOR; HISTIDINE-DECARBOXYLASE; LARVAL ZEBRAFISH; CSF HISTAMINE; SLEEP; NARCOLEPSY; BRAIN; ACTIVATION; OREXINS; IDENTIFICATION	The histaminergic and hypocretin/orexin (hcrt) neurotransmitter systems play crucial roles in alertness/wakefulness in rodents. We elucidated the role of histamine in wakefulness and the interaction of the histamine and hcrt systems in larval zebrafish. Translation inhibition of histidine decarboxylase (hdc) with morpholino oligonucleotides (MOs) led to a behaviorally measurable decline in light-associated activity, which was partially rescued by hdc mRNA injections and mimicked by histamine receptor H1 (Hrh1) antagonist pyrilamine treatment. Histamine-immunoreactive fibers targeted the dorsal telencephalon, an area that expresses histamine receptors hrh1 and hrh3 and contains predominantly glutamatergic neurons. Tract tracing with DiI revealed that projections from dorsal telencephalon innervate the hcrt and histaminergic neurons. Translation inhibition of hdc decreased the number of hcrt neurons in a Hrh1-dependent manner. The reduction was rescued by overexpression of hdc mRNA. hdc mRNA injection alone led to an up-regulation of hcrt neuron numbers. These results suggest that histamine is essential for the development of a functional and intact hcrt system and that histamine has a bidirectional effect on the development of the hcrt neurons. In summary, our findings provide evidence that these two systems are linked both functionally and developmentally, which may have important implications in sleep disorders and narcolepsy.-Sundvik, M., Kudo, H., Toivonen, P., Rozov, S., Chen, Y.-C., Panula, P. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J. 25, 4338-4347 (2011). www.fasebj.org	[Panula, Pertti] Univ Helsinki, Fac Med, Ctr Neurosci, FIN-00290 Helsinki, Finland; [Sundvik, Maria; Kudo, Hisaaki; Toivonen, Pauliina; Rozov, Stanislav; Chen, Yu-Chia; Panula, Pertti] Univ Helsinki, Inst Biomed, FIN-00290 Helsinki, Finland; [Toivonen, Pauliina] Univ Helsinki, Dept Biosci, FIN-00290 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Panula, P (corresponding author), Univ Helsinki, Fac Med, Ctr Neurosci, POB 63,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	pertti.panula@helsinki.fi		Panula, Pertti/0000-0002-1189-5132; Rozov, Stanislav/0000-0002-0352-5502	Academy of Finland [116177, 207352]; Finnish Technology Development Fund (TEKES); Sigrid Juselius Foundation; Helsinki Biomedical Graduate School	Academy of Finland(Academy of Finland); Finnish Technology Development Fund (TEKES); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Biomedical Graduate School	The authors thank Dr. Shin-ichi Higashijima (National Institutes of Natural Sciences, Okazaki Institute for Integrative Bioscience, Okazaki, Japan) for kindly providing the gad1, gad2, skc17a6a, slc17a6b, and slc17a7 constructs; Henri Koivula and Susanna Norrbacka for excellent fish care; Anna Lehtonen for technical assistance; and Dr. Saara Nuutinen and Dr. Piotr Podlasz for constructive discussions and comments on the manuscript. This study was funded by the Academy of Finland (grants 116177 and 207352), the Finnish Technology Development Fund (TEKES), and the Sigrid Juselius Foundation. M.S. was supported by the Helsinki Biomedical Graduate School. The authors declare no conflicts of interest.	Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; AUVINEN S, 1988, J COMP NEUROL, V276, P289, DOI 10.1002/cne.902760211; Bayer L, 2001, EUR J NEUROSCI, V14, P1571, DOI 10.1046/j.0953-816x.2001.01777.x; Burgess HA, 2009, GENES BRAIN BEHAV, V8, P500, DOI 10.1111/j.1601-183X.2009.00499.x; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Burgess HA, 2010, CURR BIOL, V20, P381, DOI 10.1016/j.cub.2010.01.022; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Emran Farida, 2008, J Vis Exp, DOI 10.3791/923; Eriksson KS, 1998, EUR J NEUROSCI, V10, P3799, DOI 10.1046/j.1460-9568.1998.00394.x; Eriksson KS, 2001, J NEUROSCI, V21, P9273, DOI 10.1523/JNEUROSCI.21-23-09273.2001; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Guo RX, 2009, BRIT J PHARMACOL, V157, P104, DOI 10.1111/j.1476-5381.2009.00205.x; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jin CY, 2009, BRIT J PHARMACOL, V157, P118, DOI 10.1111/j.1476-5381.2009.00149.x; Kanbayashi T, 2009, SLEEP, V32, P181, DOI 10.1093/sleep/32.2.181; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kudo H, 2009, ENDOCRINOLOGY, V150, P1393, DOI 10.1210/en.2008-1301; Lin JS, 1996, J NEUROSCI, V16, P1523; Lin L, 2002, PEPTIDES, V23, P2203, DOI 10.1016/S0196-9781(02)00251-6; MONTI JM, 1986, J NEURAL TRANSM, V66, P1, DOI 10.1007/BF01262953; MONTI JM, 1991, EUR J PHARMACOL, V205, P283, DOI 10.1016/0014-2999(91)90911-9; Moree WJ, 2009, J MED CHEM, V52, P5307, DOI 10.1021/jm900933k; Mueller T, 2008, J COMP NEUROL, V507, P1245, DOI 10.1002/cne.21604; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Nishino S, 2009, SLEEP, V32, P175, DOI 10.1093/sleep/32.2.175; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1990, NEUROSCIENCE, V34, P127, DOI 10.1016/0306-4522(90)90307-P; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Passani MB, 2004, TRENDS PHARMACOL SCI, V25, P618, DOI 10.1016/j.tips.2004.10.003; Vargas JP, 2009, BRAIN RES BULL, V79, P436, DOI 10.1016/j.brainresbull.2009.05.008; Peitsaro N, 2003, J NEUROCHEM, V86, P432, DOI 10.1046/j.1471-4159.2003.01850.x; Peitsaro N, 2007, BIOCHEM PHARMACOL, V73, P1205, DOI 10.1016/j.bcp.2007.01.014; Perala N, 2010, DEV DYNAM, V239, P2722, DOI 10.1002/dvdy.22397; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Scammell TE, 2009, SLEEP, V32, P133, DOI 10.1093/sleep/32.2.133; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; WATANABE T, 1984, BRAIN RES, V295, P13, DOI 10.1016/0006-8993(84)90811-4; Yamanaka A, 2002, BIOCHEM BIOPH RES CO, V290, P1237, DOI 10.1006/bbrc.2001.6318; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277	57	59	62	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4338	4347		10.1096/fj.11-188268	http://dx.doi.org/10.1096/fj.11-188268			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21885652				2022-12-25	WOS:000298138100025
J	Oh, JE; Kim, RH; Shin, KH; Park, NH; Kang, MK				Oh, Ju-Eun; Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.			Delta Np63 alpha Protein Triggers Epithelial-Mesenchymal Transition and Confers Stem Cell Properties in Normal Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ORAL KERATINOCYTES; IN-VITRO; P53 HOMOLOG; P63; DIFFERENTIATION; PROLIFERATION; SENESCENCE; INDUCTION; SKIN; OVEREXPRESSION	p63 is a p53 family protein required for morphogenesis and postnatal regeneration of epithelial tissues. Here we demonstrate that Delta Np63 alpha, a p63 isoform lacking the N-terminal trans-activation domain, induces epithelial-mesenchymal transition (EMT) in primary human keratinocytes in a TGF-beta-dependent manner. Rapidly proliferating normal human epidermal keratinocytes (NHEK) were infected with retroviral vector expressing Delta Np63 alpha or empty vector and serially subcultured until replicative senescence. No phenotypic changes were observed until the culture reached senescence. Then the Delta Np63 alpha-transduced cells underwent morphological changes resembling mesenchymal cells and acquired the EMT phenotype. Treatment with exogenous TGF-beta accelerated EMT in presenescent Delta Np63 alpha-transduced cells, whereas the inhibition of TGF-beta signaling reversed the EMT phenotype. TGF-beta treatment alone led to growth arrest in control NHEK with no evidence of EMT, indicating that Delta Np63 alpha altered the cellular response to TGF-beta treatment. Delta Np63 alpha-transduced cells acquiring EMT gained the ability to be differentiated to osteo-/odontogenic and adipogenic pathways, resembling mesenchymal stem cells. Furthermore, these cells expressed enhanced levels of Nanog and Lin28, which are transcription factors associated with pluripotency. These data indicate that EMT required Delta Np63 alpha transduction and intact TGF-beta signaling in NHEK.	[Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Kim, Reuben H.; Shin, Ki-Hyuk; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Rm 43-009,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu			National Institutes of Health, NIDCR [R01DE18295, K02DE18959]; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health, NIDCR, Grants R01DE18295 and K02DE18959. This work was also supported by the Jack A. Weichman Endowed Fund.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang MK, 2000, EXP CELL RES, V258, P288, DOI 10.1006/excr.2000.4943; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kang MK, 2002, MECH AGEING DEV, V123, P585, DOI 10.1016/S0047-6374(01)00407-9; Kang Mo K, 2007, Methods Mol Biol, V371, P151; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim RH, 2007, EXP CELL RES, V313, P462, DOI 10.1016/j.yexcr.2006.10.025; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lindley LE, 2010, BIOCHEM BIOPH RES CO, V399, P659, DOI 10.1016/j.bbrc.2010.07.138; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Lo Muzio L, 2005, HUM PATHOL, V36, P187, DOI 10.1016/j.humpath.2004.12.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massion PP, 2003, CANCER RES, V63, P7113; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; Noszczyk BH, 2001, PLAST RECONSTR SURG, V108, P1242, DOI 10.1097/00006534-200110000-00022; PARK NH, 1991, CARCINOGENESIS, V12, P1627, DOI 10.1093/carcin/12.9.1627; Paula-Silva FWG, 2009, J DENT RES, V88, P339, DOI 10.1177/0022034509334070; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang JM, 2010, BIOCHEM BIOPH RES CO, V400, P334, DOI 10.1016/j.bbrc.2010.08.058; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu YH, 2010, ENDOCRINOLOGY, V151, P5497, DOI 10.1210/en.2010-0486	54	49	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38757	38767		10.1074/jbc.M111.244939	http://dx.doi.org/10.1074/jbc.M111.244939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880709	Green Published, hybrid			2022-12-25	WOS:000296594200087
J	Holley, RJ; Deligny, A; Wei, W; Watson, HA; Ninonuevo, MR; Dagalv, A; Leary, JA; Bigger, BW; Kjellen, L; Merry, CLR				Holley, Rebecca J.; Deligny, Audrey; Wei, Wei; Watson, H. Angharad; Ninonuevo, Milady R.; Dagalv, Anders; Leary, Julie A.; Bigger, Brian W.; Kjellen, Lena; Merry, Catherine L. R.			Mucopolysaccharidosis Type I, Unique Structure of Accumulated Heparan Sulfate and Increased N-Sulfotransferase Activity in Mice Lacking alpha-L-iduronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROGENITOR CELLS; BINDING-SITES; BIOSYNTHESIS; EXPRESSION; QUANTIFICATION; PROTEOGLYCANS; DOMAINS; NDST1; FGF	Mucopolysaccharide (MPS) diseases are characterized by accumulation of glycosaminoglycans (GAGs) due to deficiencies in lysosomal enzymes responsible for GAG breakdown. Using a murine model of MPSI Hurler (MPSIH), we have quantified the heparan sulfate (HS) accumulation resulting from alpha-L-iduronidase (Idua) deficiency. HS levels were significantly increased in liver and brain tissue from 12-week-old Idua(-/-) mice by 87- and 20-fold, respectively. In addition, HS chains were shown to contain significantly increased N-, 2-O-, and 6-O-sulfation. Disaccharide compositional analyses also uncovered an HS disaccharide uniquely enriched in MPSIH, representing the terminal iduronic acid residue capping the non-reducing end of the HS chain, where no further degradation can occur in the absence of Idua. Critically, we identified that excess HS, some of which is colocalized to the Golgi secretory pathway, acts as a positive regulator of HS-sulfation, increasing the N-sulfotransferase activity of HS-modifying N-deacetylase/N-sulfotransferase enzymes. This mechanism may have severe implications during disease progression but, now identified, could help direct improved therapeutic strategies.	[Holley, Rebecca J.; Merry, Catherine L. R.] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England; [Deligny, Audrey; Dagalv, Anders; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Wei, Wei; Ninonuevo, Milady R.; Leary, Julie A.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Wei, Wei; Ninonuevo, Milady R.; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Watson, H. Angharad; Bigger, Brian W.] Univ Manchester, Sch Biomed, Manchester M13 9PT, Lancs, England	University of Manchester; Uppsala University; University of California System; University of California Davis; University of California System; University of California Davis; University of Manchester	Merry, CLR (corresponding author), Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.	Catherine.merry@manchester.ac.uk	Merry, Catherine/B-5713-2013; Bigger, Brian/I-3553-2012	Bigger, Brian/0000-0002-9708-1112; Watson, Angharad/0000-0003-4356-6891; merry, catherine/0000-0002-3490-2809	Human Frontier Science Program; Medical Research Council; Swedish Research Council; Swedish Cancer Society; Polysackaridforskning AB; National Institutes of Health [NIH GM47356]; UK Society for Mucopolysaccharide Diseases; National MPS Society; Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047356] Funding Source: NIH RePORTER; Medical Research Council [G0701165] Funding Source: researchfish; MRC [G0701165] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Polysackaridforskning AB(HOGANAS ABStatisticon AB); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Society for Mucopolysaccharide Diseases; National MPS Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); University of Manchester; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by funding from The Human Frontier Science Program (to R. J. H. and C. L. R. M.), The Medical Research Council (to C. L. R. M.), The Swedish Research Council (to A. Deligny, A. Dagalv, and L. K.), The Swedish Cancer Society (to A. Deligny, A. Dagalv, and L. K.), Polysackaridforskning AB (to A. Deligny, A. Dagalv, and L. K.), National Institutes of Health Grant NIH GM47356 (to W. W., M. R. N., and J. A. L.), The UK Society for Mucopolysaccharide Diseases (to H. A. W. and B. W. B.), and The National MPS Society (to H. A. W. and B. W. B.).; The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, the Wellcome Trust, and the University of Manchester Strategic Fund.	Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blackhall FH, 2001, BRIT J CANCER, V85, P1094, DOI 10.1054/bjoc.2001.2054; Braunlin E, 2006, PEDIATR RES, V59, P27, DOI 10.1203/01.pdr.0000190579.24054.39; Byers S, 1998, MOL GENET METAB, V65, P282, DOI 10.1006/mgme.1998.2761; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deakin JA, 2008, GLYCOBIOLOGY, V18, P483, DOI 10.1093/glycob/cwn028; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dusing Stacey C, 2005, Pediatr Phys Ther, V17, P264, DOI 10.1097/01.pep.0000186510.37581.19; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Fuller M, 2005, MOL GENET METAB, V84, P18, DOI 10.1016/j.ymgme.2004.09.004; Fuller M, 2004, PEDIATR RES, V56, P733, DOI 10.1203/01.PDR.0000141987.69757.DD; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; Kjellen L, 2003, BIOCHEM SOC T, V31, P340, DOI 10.1042/BST0310340; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; KRIVIT W, 1995, CELL TRANSPLANT, V4, P385, DOI 10.1016/0963-6897(95)00021-O; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; LINHARDT RJ, 1988, BIOCHEM J, V254, P781, DOI 10.1042/bj2540781; LINKER A, 1972, BIOCHEMISTRY-US, V11, P563, DOI 10.1021/bi00754a013; LYON M, 1994, J BIOL CHEM, V269, P11208; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Muenzer J, 2009, PEDIATRICS, V123, P19, DOI 10.1542/peds.2008-0416; Pan CD, 2005, BLOOD, V106, P1956, DOI 10.1182/blood-2005-02-0657; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Saad OM, 2004, J AM SOC MASS SPECTR, V15, P1274, DOI 10.1016/j.jasms.2004.05.008; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005	42	48	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37515	37524		10.1074/jbc.M111.287474	http://dx.doi.org/10.1074/jbc.M111.287474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21873421	hybrid, Green Published			2022-12-25	WOS:000296542400050
J	Lehman, JA; Waning, DL; Batuello, CN; Cipriano, R; Kadakia, MP; Mayo, LD				Lehman, Jason A.; Waning, David L.; Batuello, Christopher N.; Cipriano, Rocky; Kadakia, Madhavi P.; Mayo, Lindsey D.			Induction of Apoptotic Genes by a p73-Phosphatase and Tensin Homolog (p73-PTEN) Protein Complex in Response to Genotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-SURVIVAL; PTEN; P73; P53; MDM2; EXPRESSION; CANCER; P63; MICE	The p53 family member, p73, has been characterized as a tumor suppressor and functions in a similar manner as p53 to induce cellular death. The phosphatase and tensin homolog (PTEN) can function as a dual specificity lipid/protein phosphatase. However, recent data have described multiple roles for nuclear PTEN independent of its lipid phosphatase activity. PTEN can directly or indirectly activate p53 to promote apoptosis. We examined whether PTEN would interact and regulate p73 independent of p53. Co-localization in the nucleus and complex formation of p73/PTEN were observed after DNA damage. Furthermore, we also demonstrate that p73 alpha/PTEN proteins directly bind one another. Both overexpressed and endogenous p73-PTEN interactions were determined to be the strongest in the nuclear fraction after DNA damage, which suggested formation of a transcriptional complex. We employed chromatin immunoprecipitation (ChIP) and found that p73 and PTEN were associated with the PUMA promoter after genotoxic stress in TP53-null cells. We found that another p73 target, BAX, had an increased expression in the presence of p73 and PTEN. In addition, in virus-transduced cell lines stably expressing p73, PTEN, or both p73/PTEN, we found that the p73/PTEN cells were more sensitive to genotoxic stress and cellular death as measured by increased poly(ADP-ribose) polymerase cleavage and PUMA/Bax induction. Conversely, knockdown of PTEN dramatically reduced Bax and PUMA levels. Thus, a p73-PTEN protein complex is engaged to induce apoptosis independent of p53 in response to DNA damage.	[Lehman, Jason A.; Waning, David L.; Batuello, Christopher N.; Mayo, Lindsey D.] Case Western Reserve Univ, Herman B Wells Ctr Pediat Res, Dept Pediat, Cleveland, OH 44106 USA; [Batuello, Christopher N.; Mayo, Lindsey D.] Case Western Reserve Univ, Dept Biochem & Mol Biol, Cleveland, OH 44106 USA; [Cipriano, Rocky] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kadakia, Madhavi P.] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA; [Mayo, Lindsey D.] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University Bloomington	Mayo, LD (corresponding author), 980 W Walnut St,R3-C518, Indianapolis, IN 46202 USA.	ldmayo@iupui.edu			National Institutes of Health, NCI [CA109262]; NRSA [T32 CA 111198]; NATIONAL CANCER INSTITUTE [R01CA109262, T32CA111198, R21CA205437] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109262 from NCI ( to L.D.M.) and NRSA T32 CA 111198 ( to J.A.L.).	Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Cipriano R, 2010, CELL CYCLE, V9, P1373, DOI 10.4161/cc.9.7.11193; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2009, ADV ENZYME REGUL, V49, P190, DOI 10.1016/j.advenzreg.2008.12.002; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Sayan BS, 2010, P NATL ACAD SCI USA, V107, P12877, DOI 10.1073/pnas.0911828107; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Vella V, 2009, INT J CANCER, V124, P2539, DOI 10.1002/ijc.24221; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Waning DL, 2010, PHARMACEUTICALS, V3, P1576, DOI 10.3390/ph3051576; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241	53	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36631	36640		10.1074/jbc.M110.217620	http://dx.doi.org/10.1074/jbc.M110.217620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873427	hybrid, Green Published			2022-12-25	WOS:000296538300046
J	Li, D; Liu, XG; Lin, L; Hou, J; Li, N; Wang, CM; Wang, P; Zhang, Q; Zhang, P; Zhou, WP; Wang, ZX; Ding, GS; Zhuang, SM; Zheng, LM; Tao, WZ; Cao, XT				Li, Dong; Liu, Xingguang; Lin, Li; Hou, Jin; Li, Nan; Wang, Chunmei; Wang, Pin; Zhang, Qian; Zhang, Peng; Zhou, Weiping; Wang, Zhengxin; Ding, Guoshan; Zhuang, Shi-Mei; Zheng, Limin; Tao, Wenzhao; Cao, Xuetao			MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES TUMORIGENICITY; CANCER CELLS; LIVER-CANCER; EXPRESSION; IDENTIFICATION; APOPTOSIS; TARGET; DELIVERY; MTOR; PROGRESSION	In our in-depth analysis carried out by the Illumina Solexa massive parallel signature sequencing, microRNA-99a (miR-99a) was found to be the sixth abundant microRNA in the miR-Nome of normal human liver but was markedly down-regulated in hepatocellular carcinoma (HCC). Compelling evidence has suggested the important roles of microRNAs in HCC development. However, the biological function of miR-99a deregulation in HCC remains unknown. In this study, we found that miR-99a was remarkably decreased in HCC tissues and cell lines. Importantly, lower miR-99a expression in HCC tissues significantly correlated with shorter survival of HCC patients, and miR-99a was identified to be an independent predictor for the prognosis of HCC patients. Furthermore, restoration of miR-99a dramatically suppressed HCC cell growth in vitro by inducing the G(1) phase cell cycle arrest. Intratumoral injection of cholesterol-conjugated miR-99a mimics significantly inhibited tumor growth and reduced the alpha-fetoprotein level in HCC-bearing nude mice. Insulin-like growth factor 1 receptor (IGF-1R) and mammalian target of rapamycin (mTOR) were further characterized as the direct targets of miR-99a. Furthermore, protein levels of IGF-1R and mTOR were found to be inversely correlated with miR-99a expression in HCC tissues. miR-99a mimics inhibited IGF-1R and mTOR pathways and subsequently sup-pressed expression of cell cycle-related proteins, including cyclin D1 in HCC cells. Conclusively, miR-99a expression was frequently down-regulated in HCC tissues and correlates with the prognosis of HCC patients, thus proposing miR-99a as a prospective prognosis predictor of HCC. miR-99a suppresses HCC growth by inducing cell cycle arrest, suggesting miR-99a as potential tumor suppressor for HCC therapeutics.	[Li, Dong; Lin, Li; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Dong; Liu, Xingguang; Hou, Jin; Li, Nan; Wang, Chunmei; Wang, Pin; Zhang, Qian; Zhang, Peng; Tao, Wenzhao; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Li, Dong; Liu, Xingguang; Hou, Jin; Li, Nan; Wang, Chunmei; Wang, Pin; Zhang, Qian; Zhang, Peng; Tao, Wenzhao; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Zhou, Weiping] Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 3, Shanghai 200433, Peoples R China; [Wang, Zhengxin; Ding, Guoshan] Shanghai Changzheng Hosp, Dept Organ Transplantat, Shanghai 200433, Peoples R China; [Zhuang, Shi-Mei; Zheng, Limin] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Zhejiang University; Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Sun Yat Sen University	Cao, XT (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China.	caoxt@immunol.org	Hou, Jin/GRY-4960-2022; Zhou, Weiping/AGI-5344-2022; zheng, limin/HGB-2510-2022	Zheng, Limin/0000-0002-8281-1450; Zhuang, Shi-Mei/0000-0002-2512-3942	National 125 Key Project [2012ZX10002-014]; National Key Basic Research Program of China [2012CB518903]; National High Biotechnology Development Program of China [2009ZX09503-003]; National Natural Science Foundation of China [31170826]; Shanghai Committee of Science and Technology [10DZ1910300]	National 125 Key Project; National Key Basic Research Program of China(National Basic Research Program of China); National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National 125 Key Project Grant 2012ZX10002-014, National Key Basic Research Program of China Grant 2012CB518903, National High Biotechnology Development Program of China Grant 2009ZX09503-003, National Natural Science Foundation of China Grant 31170826, and Shanghai Committee of Science and Technology Grant 10DZ1910300.	Alexander IE, 2008, GENE THER, V15, P831, DOI 10.1038/gt.2008.64; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arbuthnot P, 2009, CURR GENE THER, V9, P91, DOI 10.2174/156652309787909517; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Grewe M, 1999, CANCER RES, V59, P3581; Grimberg A, 2003, CANCER BIOL THER, V2, P630; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nishina K, 2008, MOL THER, V16, P734, DOI 10.1038/mt.2008.14; Permuth-Wey J, 2011, J NEURO-ONCOL, V105, P639, DOI 10.1007/s11060-011-0634-1; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhou LD, 2010, MED ONCOL, V27, P255, DOI 10.1007/s12032-009-9201-4	53	192	204	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36677	36685		10.1074/jbc.M111.270561	http://dx.doi.org/10.1074/jbc.M111.270561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878637	Green Published, hybrid			2022-12-25	WOS:000296538300050
J	Li, SC; Kanno, S; Watanabe, R; Ogiwara, H; Kohno, T; WatanabeO, G; Yasui, A; Lieber, MR				Li, Sicong; Kanno, Shin-ichiro; Watanabe, Reiko; Ogiwara, Hideaki; Kohno, Takashi; WatanabeO, Go; Yasui, Akira; Lieber, Michael R.			Polynucleotide Kinase and Aprataxin-like Forkhead-associated Protein (PALF) Acts as Both a Single-stranded DNA Endonuclease and a Single-Stranded DNA 3 ' Exonuclease and Can Participate in DNA End Joining in a Biochemical System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZING-RADIATION; APLF C2ORF13; ARTEMIS; BREAKS; RESPONSES; SITES; PK	Polynucleotide kinase and aprataxin-like forkhead-associated protein (PALF, also called aprataxin- and PNK-like factor (APLF)) has been shown to have nuclease activity and to use its forkhead-associated domain to bind to x-ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4). Because XRCC4 is a key component of the ligase IV complex that is central to the nonhomologous DNA end joining (NHEJ) pathway, this raises the possibility that PALF might play a role in NHEJ. For this reason, we further studied the nucleolytic properties of PALF, and we searched for any modulation of PALF by NHEJ components. We verified that PALF has 3' exonuclease activity. However, PALF also possesses single-stranded DNA endonuclease activity. This single-stranded DNA endonuclease activity can act at all single-stranded sites except those within four nucleotides 3' of a double-stranded DNA junction, suggesting that PALF minimally requires approximately four nucleotides of single-strandedness. Ku, DNA-dependent protein kinase catalytic subunit, and XRCC4-DNA ligase IV do not modulate PALF nuclease activity on single-stranded DNA or overhangs of duplex substrates. PALF does not open DNA hair-pins. However, in a reconstituted end joining assay that includes Ku, XRCC4-DNA ligase IV, and PALF, PALF is able to resect 3' overhanging nucleotides and permit XRCC4-DNA ligase IV to complete the joining process in a manner that is as efficient as Artemis. Reduction of PALF in vivo reduces the joining of incompatible DNA ends. Hence, PALF can function in concert with other NHEJ proteins.	[Li, Sicong; WatanabeO, Go; Lieber, Michael R.] Norris Comprehens Canc Ctr, Dept Pathol Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Li, Sicong; WatanabeO, Go; Lieber, Michael R.] Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Sicong; WatanabeO, Go; Lieber, Michael R.] Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Kanno, Shin-ichiro; Watanabe, Reiko; Yasui, Akira] Tohoku Univ, Div Dynam Proteome, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Ogiwara, Hideaki; Kohno, Takashi] Natl Canc Ctr, Res Inst 1 1, Div Genome Biol, Tokyo 1040045, Japan	Tohoku University; National Cancer Center - Japan	Lieber, MR (corresponding author), Norris Comprehens Canc Ctr, Dept Pathol Biochem & Mol Biol, Los Angeles, CA 90089 USA.	lieber@usc.edu	Kanno, Shin-ichiro/AAE-4549-2019	Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345; Ogiwara, Hideaki/0000-0003-0860-1807	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA100504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant (to M. R. L.).	Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; Tsai AG, 2009, J BIOL CHEM, V284, P7157, DOI 10.1074/jbc.M806866200	20	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36368	36377		10.1074/jbc.M111.287797	http://dx.doi.org/10.1074/jbc.M111.287797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21885877	Green Published, hybrid			2022-12-25	WOS:000296538300022
J	Kulkarni, SS; Karlsson, HKR; Szekeres, F; Chibalin, AV; Krook, A; Zierath, JR				Kulkarni, Sameer S.; Karlsson, Hakan K. R.; Szekeres, Ferenc; Chibalin, Alexander V.; Krook, Anna; Zierath, Juleen R.			Suppression of 5 '-Nucleotidase Enzymes Promotes AMP-activated Protein Kinase (AMPK) Phosphorylation and Metabolism in Human and Mouse Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; GLUCOSE-UPTAKE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; LIPID-METABOLISM; IN-VIVO; INSULIN; CELL; DEAMINASE; GENE; DIFFERENTIATION	The 5'-nucleotidase (NT5) family of enzyme dephosphorylates non-cyclic nucleoside monophosphates to produce nucleosides and inorganic phosphates. We hypothesized that gene silencing of NT5 enzymes to increase the intracellular availability of AMP would increase AMP-activated protein kinase (AMPK) activity and metabolism. We determined the role of cytosolic NT5 in metabolic responses linked to the development of insulin resistance in obesity and type 2 diabetes. Using siRNA to silence NT5C2 expression in cultured human myotubes, we observed a 2-fold increase in the AMP/ATP ratio, a 2.4-fold increase in AMPK phosphorylation (Thr(172)), and a 2.8-fold increase in acetyl-CoA carboxylase phosphorylation (Ser(79)) (p<0.05). siRNA silencing of NT5C2 expression increased palmitate oxidation by 2-fold in the absence and by 8-fold in the presence of 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside. This was paralleled by an increase in glucose transport and a decrease in glucose oxidation, incorporation into glycogen, and lactate release from NT5C2-depleted myotubes. Gene silencing of NT5C1A by shRNA injection and electroporation in mouse tibialis anterior muscle reduced protein content (60%; p<0.05) and increased phosphorylation of AMPK (60%; p<0.05) and acetyl-CoA carboxylase (50%; p<0.05) and glucose uptake (20%; p<0.05). Endogenous expression of NT5C enzymes inhibited basal lipid oxidation and glucose transport in skeletal muscle. Reduction of 5'-nucleotidase expression or activity may promote metabolic flexibility in type 2 diabetes.	[Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Zierath, JR (corresponding author), Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, Von Eulers Vag 4,4th Floor, S-17177 Stockholm, Sweden.	juleen.zierath@ki.se	Krook, Anna/K-1192-2015; Szekeres, Ferenc L M/E-4586-2018	Krook, Anna/0000-0002-0891-0258; Karlsson, Hakan/0000-0003-0818-5460; Chibalin, Alexander/0000-0002-6339-6271; Zierath, Juleen/0000-0001-6891-7497	European Research Council [ERC-2008-AdG23285]; Swedish Research Council; Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation; Stockholm County Council; Novo Nordisk Research Foundation; Commission of the European Communities [LSHM-CT-2004-005272 EXGENESIS]; Karolinska Institutet	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Strategic Research Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Commission of the European Communities(European Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by the European Research Council Ideas Program (ICEBERG, ERC-2008-AdG23285), the Swedish Research Council, the Swedish Diabetes Association, the Strategic Research Foundation, the Knut and Alice Wallenberg Foundation, the Stockholm County Council, the Novo Nordisk Research Foundation, the Commission of the European Communities (Contract LSHM-CT-2004-005272 EXGENESIS), and the Strategic Research Programme in Diabetes at Karolinska Institutet.	Al-Khalili L, 2004, ACTA PHYSIOL SCAND, V180, P395, DOI 10.1111/j.1365-201X.2004.01259.x; Al-Khalili L, 2003, CELL MOL LIFE SCI, V60, P991, DOI 10.1007/s00018-003-3001-3; Allegrini S, 1997, BIOCHEM J, V328, P483, DOI 10.1042/bj3280483; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; BELSHAM GJ, 1980, BIOCHEM J, V192, P457, DOI 10.1042/bj1920457; Bergeron R, 2001, DIABETES, V50, P1076, DOI 10.2337/diabetes.50.5.1076; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Bouzakri K, 2008, DIABETES, V57, P1508, DOI 10.2337/db07-0583; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Careddu MG, 2008, BBA-MOL CELL RES, V1783, P1529, DOI 10.1016/j.bbamcr.2008.03.018; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Fiedler M, 2001, DIABETOLOGIA, V44, P2180, DOI 10.1007/s001250100027; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Halseth AE, 2002, BIOCHEM BIOPH RES CO, V294, P798, DOI 10.1016/S0006-291X(02)00557-0; Hancock CR, 2006, J APPL PHYSIOL, V100, P406, DOI 10.1152/japplphysiol.00885.2005; Hanisch F, 2006, BIOL CHEM, V387, P53, DOI 10.1515/BC.2006.008; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Jaswal JS, 2010, AM J PHYSIOL-HEART C, V299, pH1135, DOI 10.1152/ajpheart.00186.2010; Kappock TJ, 2000, CURR OPIN CHEM BIOL, V4, P567, DOI 10.1016/S1367-5931(00)00133-2; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rampazzo C, 1999, EUR J BIOCHEM, V261, P689, DOI 10.1046/j.1432-1327.1999.00320.x; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Rune A, 2009, DIABETOLOGIA, V52, P2182, DOI 10.1007/s00125-009-1465-x; Sabina RL, 2000, PHARMACOL THERAPEUT, V87, P279, DOI 10.1016/S0163-7258(00)00040-1; Safranow K, 2009, SCAND J CLIN LAB INV, V69, P102, DOI 10.1080/00365510802430964; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Viana R, 2007, J BIOL CHEM, V282, P16117, DOI 10.1074/jbc.M611804200; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Witczak CA, 2010, AM J PHYSIOL-ENDOC M, V298, pE1150, DOI 10.1152/ajpendo.00659.2009; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	47	55	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34567	34574		10.1074/jbc.M111.268292	http://dx.doi.org/10.1074/jbc.M111.268292			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21873433	Green Published, hybrid			2022-12-25	WOS:000295406300011
J	Teng, ACT; Al-montashiri, NAM; Cheng, BLM; Lou, P; Ozmizrak, P; Chen, HH; Stewart, AFR				Teng, Allen C. T.; Al-montashiri, Naif A. M.; Cheng, Brian L. M.; Lou, Philip; Ozmizrak, Pinar; Chen, Hsiao-Huei; Stewart, Alexandre F. R.			Identification of a Phosphorylation-Dependent Nuclear Localization Motif in Interferon Regulatory Factor 2 Binding Protein 2	PLOS ONE			English	Article							SELECTIVELY MODULATES APOPTOSIS; BREAST-CANCER CELLS; SIGNAL; ACTIVATION; IMPORT; TRANSLOCATION; RECOGNITION; EXPRESSION; RECEPTORS; DYNAMICS	Background: Interferon regulatory factor 2 binding protein 2 (IRF2BP2) is a muscle-enriched transcription factor required to activate vascular endothelial growth factor-A (VEGFA) expression in muscle. IRF2BP2 is found in the nucleus of cardiac and skeletal muscle cells. During the process of skeletal muscle differentiation, some IRF2BP2 becomes relocated to the cytoplasm, although the functional significance of this relocation and the mechanisms that control nucleocytoplasmic localization of IRF2BP2 are not yet known. Methodology/Principal Findings: Here, by fusing IRF2BP2 to green fluorescent protein and testing a series of deletion and site-directed mutagenesis constructs, we mapped the nuclear localization signal (NLS) to an evolutionarily conserved sequence (354)ARKRKPSP(361) in IRF2BP2. This sequence corresponds to a classical nuclear localization motif bearing positively charged arginine and lysine residues. Substitution of arginine and lysine with negatively charged aspartic acid residues blocked nuclear localization. However, these residues were not sufficient because nuclear targeting of IRF2BP2 also required phosphorylation of serine 360 (S360). Many large-scale phosphopeptide proteomic studies had reported previously that serine 360 of IRF2BP2 is phosphorylated in numerous human cell types. Alanine substitution at this site abolished IRF2BP2 nuclear localization in C(2)C(12) myoblasts and CV1 cells. In contrast, substituting serine 360 with aspartic acid forced nuclear retention and prevented cytoplasmic redistribution in differentiated C(2)C(12) muscle cells. As for the effects of these mutations on VEGFA promoter activity, the S360A mutation interfered with VEGFA activation, as expected. Surprisingly, the S360D mutation also interfered with VEGFA activation, suggesting that this mutation, while enforcing nuclear entry, may disrupt an essential activation function of IRF2BP2. Conclusions/Significance: Nuclear localization of IRF2BP2 depends on phosphorylation near a conserved NLS. Changes in phosphorylation status likely control nucleocytoplasmic localization of IRF2BP2 during muscle differentiation.	[Teng, Allen C. T.; Al-montashiri, Naif A. M.; Stewart, Alexandre F. R.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Stewart, Alexandre F. R.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Teng, Allen C. T.; Al-montashiri, Naif A. M.; Cheng, Brian L. M.; Lou, Philip; Ozmizrak, Pinar; Chen, Hsiao-Huei; Stewart, Alexandre F. R.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Chen, Hsiao-Huei] Ottawa Hosp, Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute	Teng, ACT (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	astewart@ottawaheart.ca	Almontashiri, Naif/GQH-2893-2022; Stewart, Alexandre F.R./A-5677-2011; Almontashiri, Naif/AAR-3806-2020	Almontashiri, Naif/0000-0003-3607-395X; Chen, Hsiao-Huei/0000-0003-2914-6057; Ozmizrak, Pinar/0000-0002-2689-5346; Stewart, Alexandre/0000-0003-2673-9164	Canadian Institutes of Health Research [AFRS MOP77682, HHC MOP179197]; Heart and Stroke Foundation of Ontario [HHC NA6301]; Ontario Graduate Scholarship in Science and Technology; Taiba University, Saudi Arabia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Graduate Scholarship in Science and Technology; Taiba University, Saudi Arabia	This work was supported by operating grants from the Canadian Institutes of Health Research (AFRS MOP77682, HHC MOP179197), by a grant in aid from the Heart and Stroke Foundation of Ontario (HHC NA6301), by an Ontario Graduate Scholarship in Science and Technology (A. T.) and by a scholarship from Taiba University, Saudi Arabia (N.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; deSouza N, 2007, J CELL BIOL, V179, P923, DOI 10.1083/jcb.200708200; Fontes MRM, 2005, BBA-PROTEINS PROTEOM, V1750, P9, DOI 10.1016/j.bbapap.2005.03.014; Germain H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001250; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Heger S, 2007, J CLIN INVEST, V117, P2145, DOI 10.1172/JCI31752; Koeppel M, 2009, NUCLEIC ACIDS RES, V37, P322, DOI 10.1093/nar/gkn940; Kuwahara H, 2008, J BIOCHEM, V143, P349, DOI 10.1093/jb/mvm236; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Raijmakers R, 2010, ANAL CHEM, V82, P824, DOI 10.1021/ac901764g; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Teng ACT, 2010, FASEB J, V24, P4825, DOI 10.1096/fj.10-167049; Tinnikov AA, 2009, CANCER RES, V69, P1375, DOI 10.1158/0008-5472.CAN-08-2896; Tsai CF, 2008, J PROTEOME RES, V7, P4058, DOI 10.1021/pr800364d; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Yeung KT, 2011, MOL CELL BIOL, V31, P2287, DOI 10.1128/MCB.01381-10; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Zanta MA, 1999, P NATL ACAD SCI USA, V96, P91, DOI 10.1073/pnas.96.1.91; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang F, 2000, P NATL ACAD SCI USA, V97, P12577, DOI 10.1073/pnas.230435597	33	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24100	10.1371/journal.pone.0024100	http://dx.doi.org/10.1371/journal.pone.0024100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887377	Green Published, gold			2022-12-25	WOS:000294298800032
J	Liao, Q; Yuan, XY; Xiao, H; Liu, CN; Lv, ZY; Zhao, Y; Wu, ZD				Liao, Qi; Yuan, Xiongying; Xiao, Hui; Liu, Changning; Lv, Zhiyue; Zhao, Yi; Wu, Zhongdao			Identifying Schistosoma japonicum Excretory/Secretory Proteins and Their Interactions with Host Immune System	PLOS ONE			English	Article							DYNEIN LIGHT-CHAINS; HUMAN BLOOD FLUKE; VACCINE CANDIDATES; SIGNAL PEPTIDES; PREDICTION; MANSONI; BIOLOGY; IDENTIFICATION; SEQUENCE; GENOMICS	Schistosoma japonicum is a major infectious agent of schistosomiasis. It has been reported that large number of proteins excreted and secreted by S. japonicum during its life cycle are important for its infection and survival in definitive hosts. These proteins can be used as ideal candidates for vaccines or drug targets. In this work, we analyzed the protein sequences of S. japonicum and found that compared with other proteins in S. japonicum, excretory/secretory (ES) proteins are generally longer, more likely to be stable and enzyme, more likely to contain immune-related binding peptides and more likely to be involved in regulation and metabolism processes. Based on the sequence difference between ES and non-ES proteins, we trained a support vector machine (SVM) with much higher accuracy than existing approaches. Using this SVM, we identified 191 new ES proteins in S. japonicum, and further predicted 7 potential interactions between these ES proteins and human immune proteins. Our results are useful to understand the pathogenesis of schistosomiasis and can serve as a new resource for vaccine or drug targets discovery for anti-schistosome.	[Liao, Qi; Lv, Zhiyue; Wu, Zhongdao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Qi; Lv, Zhiyue; Wu, Zhongdao] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Qi; Yuan, Xiongying; Xiao, Hui; Liu, Changning; Zhao, Yi] Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc, Bioinformat Res Grp, Beijing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Liao, Q (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China.	biozy@ict.ac.cn; wuzhd@mail.sysu.edu.cn	Lv, Zhiyue/AAI-1135-2021; Zhao, Yi/A-2962-2011	Zhao, Yi/0000-0001-6046-8420	National '973' project of China [2007CB513102]; National Science Foundation of China [30972574, 30771888, 81000743, 30800966]	National '973' project of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National '973' project of China (grant no. 2007CB513102), and the National Science Foundation of China (NO: 30972574, 30771888, 81000743 and 30800966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SOFTB PROTCOMP 9 0; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deng JS, 2003, INFECT IMMUN, V71, P6402, DOI 10.1128/IAI.71.11.6402-6410.2003; El Ridi R, 2009, VACCINE, V27, P666, DOI 10.1016/j.vaccine.2008.11.039; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gobert GN, 2007, PARASITOLOGY, V134, P453, DOI 10.1017/S0031182006001648; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Han ZG, 2009, ANNU REV GENOM HUM G, V10, P211, DOI 10.1146/annurev-genom-082908-150036; He YX, 1993, CHIN MED J ENGL, V106, P576; Hoffmann KF, 1997, J BIOL CHEM, V272, P14509, DOI 10.1074/jbc.272.23.14509; Hoffmann KF, 1996, J BIOL CHEM, V271, P26117, DOI 10.1074/jbc.271.42.26117; Huang HH, 2011, BIOCHEMISTRY-US, V50, P5870, DOI 10.1021/bi200107n; Jenkins SJ, 2005, PARASITE IMMUNOL, V27, P385, DOI 10.1111/j.1365-3024.2005.00789.x; Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kariuki TM, 2008, PARASITE IMMUNOL, V30, P554, DOI 10.1111/j.1365-3024.2008.01054.x; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Khoontawad J, 2010, PARASITE IMMUNOL, V32, P314, DOI 10.1111/j.1365-3024.2009.01189.x; Kim DM, 2009, PARASITOL RES, V106, P269, DOI 10.1007/s00436-009-1662-z; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumagai T, 2009, MOL BIOCHEM PARASIT, V164, P26, DOI 10.1016/j.molbiopara.2008.11.002; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Kwatia MA, 2000, J PARASITOL, V86, P908, DOI 10.1645/0022-3395(2000)086[0908:MAECOS]2.0.CO;2; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu F, 2009, MOL CELL PROTEOMICS, V8, P1236, DOI 10.1074/mcp.M800538-MCP200; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Lv ZY, 2009, PARASITOL RES, V104, P733, DOI 10.1007/s00436-008-1249-0; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Ortutay C, 2006, CELL IMMUNOL, V244, P87, DOI 10.1016/j.cellimm.2007.01.012; Pearson MS, 2005, FEMS IMMUNOL MED MIC, V45, P201, DOI 10.1016/j.femsim.2005.03.009; Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riveau G, 1998, MEM I OSWALDO CRUZ, V93, P87, DOI 10.1590/S0074-02761998000700012; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Soler AP, 2001, HUM PATHOL, V32, P149, DOI 10.1053/hupa.2001.21562; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wilkins MR, 1999, METH MOL B, V112, P531; Yu FD, 2008, GENOMICS, V91, P152, DOI 10.1016/j.ygeno.2007.10.006; Zahoor Z, CELL STRESS CHAPERON; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	58	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23786	10.1371/journal.pone.0023786	http://dx.doi.org/10.1371/journal.pone.0023786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887319	gold, Green Submitted, Green Published			2022-12-25	WOS:000295832000060
J	Pattanayek, R; Williams, DR; Rossi, G; Weigand, S; Mori, T; Johnson, CH; Stewart, PL; Egli, M				Pattanayek, Rekha; Williams, Dewight R.; Rossi, Gian; Weigand, Steven; Mori, Tetsuya; Johnson, Carl H.; Stewart, Phoebe L.; Egli, Martin			Combined SAXS/EM Based Models of the S. elongatus Post-Translational Circadian Oscillator and its Interactions with the Output His-Kinase SasA	PLOS ONE			English	Article							CLOCK PROTEIN KAIA; CRYSTAL-STRUCTURE; HISTIDINE KINASE; BIOLOGICAL MACROMOLECULES; SYNECHOCOCCUS-ELONGATUS; TERMINAL DOMAIN; ATPASE ACTIVITY; PHOSPHORYLATION; SYSTEM; DYNAMICS	The circadian clock in the cyanobacterium Synechococcus elongatus is composed of a post-translational oscillator (PTO) that can be reconstituted in vitro from three different proteins in the presence of ATP and a transcription-translation feedback loop (TTFL). The homo-hexameric KaiC kinase, phosphatase and ATPase alternates between hypo- and hyper-phosphorylated states over the 24-h cycle, with KaiA enhancing phosphorylation, and KaiB antagonizing KaiA and promoting KaiC subunit exchange. SasA is a His kinase that relays output signals from the PTO formed by the three Kai proteins to the TTFL. Although the crystal structures for all three Kai proteins are known, atomic resolution structures of Kai and Kai/SasA protein complexes have remained elusive. Here, we present models of the KaiAC and KaiBC complexes derived from solution small angle X-ray scattering (SAXS), which are consistent with previous EM based models. We also present a combined SAXS/EM model of the KaiC/SasA complex, which has two N-terminal SasA sensory domains occupying positions on the C-terminal KaiC ring reminiscent of the orientations adopted by KaiB dimers. Using EM we demonstrate that KaiB and SasA compete for similar binding sites on KaiC. We also propose an EM based model of the ternary KaiABC complex that is consistent with the sequestering of KaiA by KaiB on KaiC during the PTO dephosphorylation phase. This work provides the first 3D-catalogue of protein-protein interactions in the KaiABC PTO and the output pathway mediated by SasA.	[Pattanayek, Rekha; Rossi, Gian; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Williams, Dewight R.; Johnson, Carl H.; Stewart, Phoebe L.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Weigand, Steven] Northwestern Univ, DND CAT Synchrotron Res Ctr, Adv Photon Source, Argonne Natl Lab, Argonne, IL USA; [Mori, Tetsuya; Johnson, Carl H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Vanderbilt University	Pattanayek, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	martin.egli@vanderbilt.edu	Johnson, Carl H/I-4655-2014; Weigand, Steven/G-6181-2015	Weigand, Steven/0000-0003-3137-0672; Mori, Tetsuya/0000-0001-6036-5261	US National Institutes of Health [R01 GM73845, R01 GM81646, R01 GM67152, F32 GM71276]; E. I. DuPont de Nemours Co.; Dow Chemical Company; National Science Foundation; State of Illinois; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081646, R01GM073845, F32GM071276, R37GM067152, R01GM067152] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); E. I. DuPont de Nemours Co.; Dow Chemical Company; National Science Foundation(National Science Foundation (NSF)); State of Illinois; U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding by the US National Institutes of Health (http://www.nih.gov/) for this research is gratefully acknowledged: R01 GM73845 to ME, R01 GM81646 to PLS, R01 GM67152 to CHJ and F32 GM71276 to DRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Yao Xu for providing constructs, reagents and rhythm data, Dr. Ximing Qin for providing purified proteins, Prof. Andy LiWang, University of California at Merced, for the N-KaiA plasmid, and Dr. David Friedman of the Vanderbilt Proteomics Facility for help with mass spectrometric characterization of all proteins. We also thank Drs. Michal Hammel and John Tainer for granting us access to the SIBYLS software suite. Dr. P. Thiyagarajan provided much appreciated advice on the use of SAXS for the study of Kai clock proteins and their complexes during the early stages of the project. The DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT, sector 5) Synchrotron Research Center at the Advanced Photon Source (APS, Argonne, IL) is supported by E. I. DuPont de Nemours & Co., The Dow Chemical Company, the National Science Foundation, and the State of Illinois. Vanderbilt University is a member institution of Life Sciences Collaborative Access Team (LS-CAT, sector 21) at the APS. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. W-31-109-Eng-38.	Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO VERSION; Ditty JL, 2009, BACTERIAL CIRCADIAN; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Egli M, 2008, MODELS, MYSTERIES AND MAGIC OF MOLECULES, P283, DOI 10.1007/978-1-4020-5941-4_13; Egli Martin, 2009, P121, DOI 10.1007/978-3-540-88431-6_7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; Guinier A., 1955, SMALL ANGLE SCATTERI; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Johnson CH, 2008, SCIENCE, V322, P697, DOI 10.1126/science.1150451; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2008, GENES CELLS, V13, P387, DOI 10.1111/j.1365-2443.2008.01174.x; Murayama Y, 2011, EMBO J, V30, P68, DOI 10.1038/emboj.2010.298; Mutoh R, 2010, GENES CELLS, V15, P269, DOI 10.1111/j.1365-2443.2009.01377.x; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nowak E, 2006, STRUCTURE, V14, P275, DOI 10.1016/j.str.2005.10.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Pattanayek R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007529; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V11, P623, DOI 10.1038/nsmb781; Vakonakis I, 2004, J MOL BIOL, V342, P9, DOI 10.1016/j.jmb.2004.07.010; Vakonakis I, 2004, P NATL ACAD SCI USA, V101, P10925, DOI 10.1073/pnas.0403037101; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weigand S., 2009, ADV XRAY ANAL, V52, P58; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Xu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007509; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200	62	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23697	10.1371/journal.pone.0023697	http://dx.doi.org/10.1371/journal.pone.0023697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887298	gold, Green Published			2022-12-25	WOS:000295832000048
J	Raberto, M; Rapallo, F; Scalas, E				Raberto, Marco; Rapallo, Fabio; Scalas, Enrico			Semi-Markov Graph Dynamics	PLOS ONE			English	Article							WAITING-TIMES; NETWORKS	In this paper, we outline a model of graph (or network) dynamics based on two ingredients. The first ingredient is a Markov chain on the space of possible graphs. The second ingredient is a semi-Markov counting process of renewal type. The model consists in subordinating the Markov chain to the semi-Markov counting process. In simple words, this means that the chain transitions occur at random time instants called epochs. The model is quite rich and its possible connections with algebraic geometry are briefly discussed. Moreover, for the sake of simplicity, we focus on the space of undirected graphs with a fixed number of nodes. However, in an example, we present an interbank market model where it is meaningful to use directed graphs or even weighted graphs.	[Raberto, Marco] Univ Genoa, Dipartimento Ingn Biofis & Elettron, Genoa, Italy; [Rapallo, Fabio; Scalas, Enrico] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci & Tecnol Avanzate, Alessandria, Italy; [Scalas, Enrico] Basque Ctr Appl Math, Bizkaia Technology Pk, Derio, Spain	University of Genoa; University of Eastern Piedmont Amedeo Avogadro; Basque Center for Applied Mathematics (BCAM)	Raberto, M (corresponding author), Univ Genoa, Dipartimento Ingn Biofis & Elettron, Genoa, Italy.	enrico.scalas@mfn.unipmn.it	Raberto, Marco/F-7990-2012; Rapallo, Fabio/AAD-8204-2021	Rapallo, Fabio/0000-0001-6451-5140; Scalas, Enrico/0000-0002-1516-9285	INdAM (Istituto Italiano di Alta Matematica); Erasmus Teaching Staff program; Universitat Jaume I, Castellon de La Plana, Spain	INdAM (Istituto Italiano di Alta Matematica); Erasmus Teaching Staff program; Universitat Jaume I, Castellon de La Plana, Spain	This study was funded in part by the INdAM (Istituto Italiano di Alta Matematica http://www.altamatematica.it/en), by the Erasmus Teaching Staff program, and the Research Promotion Plan 2010 of Universitat Jaume I, Castellon de La Plana, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi A.-L., 2010, BURSTS HIDDEN PATTER; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2003, LINKED EVERHTHING CO; Beghin L, 2009, ELECTRON J PROBAB, V14, P1790, DOI 10.1214/EJP.v14-675; Biggs N., 1993, ALGEBRAIC GRAPH THEO; Billingsley P., 1995, PROBABILITY MEASURE; Chung FRK, 1997, CBMS REGIONAL C S MA; Cinlar E., 1975, INTRO STOCHASTIC PRO; Drton M., 2009, LECT ALGEBRAIC STAT; Durrett Richard, 2007, RANDOM GRAPH DYNAMIC; Flomenbom O, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041101; Flomenbom O, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098105; Fulger D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021122; Garibaldi U., 2010, FINITARY PROBABILIST, DOI DOI 10.1017/CBO9780511777585; Gentleman R, 2010, GRAPH PACKAGE; Germano G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066102; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Howard R.A, 1971, DYNAMIC PROBABILISTI, V2; Janssen J., 2007, SEMIMARKOV RISK MODE; Laskin N, 2003, COMMUN NONLINEAR SCI, V8, P201, DOI 10.1016/S1007-5704(03)00037-6; Mainardi F, 2004, VIETN J MATH, V32, P53; Meerschaert MM, 2010, ELECT J PRO IN PRESS; MILGRAM S, 1967, PSYCHOL TODAY, V2, P60, DOI DOI 10.1145/335305.335325; Rapallo F, 2006, J SYMB COMPUT, V41, P164, DOI 10.1016/j.jsc.2005.04.002; Rapallo F, 2010, ANN I STAT MATH, V62, P785, DOI 10.1007/s10463-010-0289-2; Saa A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031110; Scalas E, 2004, QUANT FINANC, V4, P695, DOI 10.1080/14697680500040413; Scalas E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011107; Scalas E, 2006, PHYSICA A, V366, P463, DOI 10.1016/j.physa.2005.09.047; Schrijver A, 2003, LECT NOTES COMPUT SC, V2880, P13; SIMON HA, 1955, BIOMETRIKA, V42, P425; Team RDC, 2010, R LANG ENV STAT COMP; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	34	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23370	10.1371/journal.pone.0023370	http://dx.doi.org/10.1371/journal.pone.0023370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887245	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295832000015
J	Van Parys, A; Boyen, F; Leyman, B; Verbrugghe, E; Haesebrouck, F; Pasmans, F				Van Parys, Alexander; Boyen, Filip; Leyman, Bregje; Verbrugghe, Elin; Haesebrouck, Freddy; Pasmans, Frank			Tissue-Specific Salmonella Typhimurium Gene Expression during Persistence in Pigs	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; VIRULENCE; IDENTIFICATION; PROTEIN; COLONIZATION; REGULATOR; TRANSPORT; MUTANT; ROLES	Salmonellosis caused by Salmonella Typhimurium is one of the most important bacterial zoonotic diseases. The bacterium persists in pigs resulting in asymptomatic 'carrier pigs', generating a major source for Salmonella contamination of pork. Until now, very little is known concerning the mechanisms used by Salmonella Typhimurium during persistence in pigs. Using in vivo expression technology (IVET), a promoter-trap method based on Delta purA attenuation of the parent strain, we identified 37 Salmonella Typhimurium genes that were expressed 3 weeks post oral inoculation in the tonsils, ileum and ileocaecal lymph nodes of pigs. Several genes were expressed in all three analyzed organs, while other genes were only expressed in one or two organs. Subsequently, the identified IVET transformants were pooled and reintroduced in pigs to detect tissue-specific gene expression patterns. We found that efp and rpoZ were specifically expressed in the ileocaecal lymph nodes during Salmonella peristence in pigs. Furthermore, we compared the persistence ability of substitution mutants for the IVET-identified genes sifB and STM4067 to that of the wild type in a mixed infection model. The Delta STM4067::kanR was significantly attenuated in the ileum contents, caecum and caecum contents and faeces of pigs 3 weeks post inoculation, while deletion of the SPI-2 effector gene sifB did not affect Salmonella Typhimurium persistence. Although our list of identified genes is not exhaustive, we found that efp and rpoZ were specifically expressed in the ileocaecal lymph nodes of pigs and we identified STM4067 as a factor involved in Salmonella persistence in pigs. To our knowledge, our study is the first to identify Salmonella Typhimurium genes expressed during persistence in pigs.	[Van Parys, Alexander; Boyen, Filip; Leyman, Bregje; Verbrugghe, Elin; Haesebrouck, Freddy; Pasmans, Frank] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium	Ghent University	Van Parys, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	alexander.vanparys@ugent.be	Boyen, Filip/AAF-6109-2020; Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014	Boyen, Filip/0000-0002-4777-6880; Haesebrouck, Freddy/0000-0002-1709-933X; Van Parys, Alexander/0000-0002-0636-1208	Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT Vlaanderen), Brussels, Belgium [IWT Landbouw 040791]; Research Foundation-Flanders (FWO)	Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT Vlaanderen), Brussels, Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (FWO)(FWO)	This work was supported by the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT Vlaanderen; http://www.iwt.be), Brussels, Belgium (grant IWT Landbouw 040791) and the Research Foundation-Flanders (FWO; http://www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Barchiesi J, 2009, FEMS MICROBIOL LETT, V291, P73, DOI 10.1111/j.1574-6968.2008.01437.x; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bearson SMD, 2006, APPL ENVIRON MICROB, V72, P2829, DOI 10.1128/AEM.72.4.2829-2836.2006; Botteldoorn N, 2003, J APPL MICROBIOL, V95, P891, DOI 10.1046/j.1365-2672.2003.02042.x; Boyen F, 2009, LAB ANIM-UK, V43, P46, DOI 10.1258/la.2007.007084; Boyen F, 2008, VET MICROBIOL, V130, P1, DOI 10.1016/j.vetmic.2007.12.017; Boyen F, 2006, VET MICROBIOL, V115, P284, DOI 10.1016/j.vetmic.2006.02.006; Boyen F, 2009, VET MICROBIOL, V135, P187, DOI 10.1016/j.vetmic.2008.12.025; Boyen F, 2007, VET MICROBIOL, V128, P364; Boyen F, 2006, MICROBES INFECT, V8, P2899, DOI 10.1016/j.micinf.2006.09.008; Caldara M, 2007, J MOL BIOL, V373, P251, DOI 10.1016/j.jmb.2007.08.013; Carnell SC, 2007, MICROBIOL-SGM, V153, P1940, DOI 10.1099/mic.0.2006/006726-0; Chanana V, 2006, FEMS IMMUNOL MED MIC, V47, P278, DOI 10.1111/j.1574-695X.2006.00090.x; Chung TW, 2003, J MICROBIOL BIOTECHN, V13, P564; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dougherty M, 2003, J BACTERIOL, V185, P332, DOI 10.1128/JB.185.1.332-339.2003; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Gantois I, 2008, APPL ENVIRON MICROB, V74, P6616, DOI 10.1128/AEM.01087-08; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hensel M, 1998, ELECTROPHORESIS, V19, P608, DOI 10.1002/elps.1150190425; Huang Y, 2007, APPL ENVIRON MICROB, V73, P7522, DOI 10.1128/AEM.01481-07; Hwang ET, 2008, SENSORS-BASEL, V8, P1297, DOI 10.3390/s8021297; Ikeda JS, 2001, INFECT IMMUN, V69, P3021, DOI 10.1128/IAI.69.5.3021-3030.2001; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; Kim CH, 2003, MOL CELLS, V15, P226; Kobayashi H, 2005, J FOOD PROTECT, V68, P932, DOI 10.4315/0362-028X-68.5.932; Kwon YM, 2000, J MICROBIOL METH, V41, P195, DOI 10.1016/S0167-7012(00)00159-7; Larsen K, 2005, BBA-GENE STRUCT EXPR, V1727, P220, DOI 10.1016/j.bbaexp.2005.01.005; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Ojima Y, 2009, BIOTECHNOL LETT, V31, P139, DOI 10.1007/s10529-008-9835-x; Pang ZH, 2005, J BACTERIOL, V187, P7773, DOI 10.1128/JB.187.22.7773-7783.2005; Prieto AI, 2009, J BACTERIOL, V191, P3615, DOI 10.1128/JB.01592-08; QI SY, 1995, MOL MICROBIOL, V17, P523, DOI 10.1111/j.1365-2958.1995.mmi_17030523.x; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Schneider K, 2000, FEBS LETT, V483, P165, DOI 10.1016/S0014-5793(00)02105-0; Slominski B, 2007, MICROBIOL-SGM, V153, P1884, DOI 10.1099/mic.0.2006/000802-0; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Spory A, 2002, J BACTERIOL, V184, P3549, DOI 10.1128/JB.184.13.3549-3559.2002; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; Teixido L, 2010, INT MICROBIOL, V13, P33, DOI 10.2436/20.1501.01.109; Van Parys A, 2010, VET MICROBIOL, V144, P93, DOI 10.1016/j.vetmic.2009.12.021; Vinella D, 1996, J BACTERIOL, V178, P3818, DOI 10.1128/jb.178.13.3818-3828.1996; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	59	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24120	10.1371/journal.pone.0024120	http://dx.doi.org/10.1371/journal.pone.0024120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887378	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000094
J	Tsuge, M; Fujimoto, Y; Hiraga, N; Zhang, YZ; Ohnishi, M; Kohno, T; Abe, H; Miki, D; Imamura, M; Takahashi, S; Ochi, H; Hayes, CN; Miya, F; Tsunoda, T; Chayama, K				Tsuge, Masataka; Fujimoto, Yoshifumi; Hiraga, Nobuhiko; Zhang, Yizhou; Ohnishi, Mayu; Kohno, Tomohiko; Abe, Hiromi; Miki, Daiki; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C. Nelson; Miya, Fuyuki; Tsunoda, Tatsuhiko; Chayama, Kazuaki			Hepatitis C Virus Infection Suppresses the Interferon Response in the Liver of the Human Hepatocyte Chimeric Mouse	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; CORE PROTEIN; PEGYLATED-INTERFERON; B-VIRUS; HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; COMBINATION THERAPY; CYTIDINE DEAMINASE; GENETIC-VARIATION; TRANSGENIC MICE	Background and Aims: Recent studies indicate that hepatitis C virus (HCV) can modulate the expression of various genes including those involved in interferon signaling, and up-regulation of interferon-stimulated genes by HCV was reported to be strongly associated with treatment outcome. To expand our understanding of the molecular mechanism underlying treatment resistance, we analyzed the direct effects of interferon and/or HCV infection under immunodeficient conditions using cDNA microarray analysis of human hepatocyte chimeric mice. Methods: Human serum containing HCV genotype 1b was injected into human hepatocyte chimeric mice. IFN-alpha was administered 8 weeks after inoculation, and 6 hours later human hepatocytes in the mouse livers were collected for microarray analysis. Results: HCV infection induced a more than 3-fold change in the expression of 181 genes, especially genes related to Organismal Injury and Abnormalities, such as fibrosis or injury of the liver (P = 5.90E-16 similar to 3.66E-03). IFN administration induced more than 3-fold up-regulation in the expression of 152 genes. Marked induction was observed in the anti-fibrotic chemokines such as CXCL9, suggesting that IFN treatment might lead not only to HCV eradication but also prevention and repair of liver fibrosis. HCV infection appeared to suppress interferon signaling via significant reduction in interferon-induced gene expression in several genes of the IFN signaling pathway, including Mx1, STAT1, and several members of the CXCL and IFI families (P = 6.0E-12). Genes associated with Antimicrobial Response and Inflammatory Response were also significantly repressed (P = 5.22x10(-10) similar to 1.95x10(-2)). Conclusions: These results provide molecular insights into possible mechanisms used by HCV to evade innate immune responses, as well as novel therapeutic targets and a potential new indication for interferon therapy.	[Tsuge, Masataka; Fujimoto, Yoshifumi; Hiraga, Nobuhiko; Zhang, Yizhou; Ohnishi, Mayu; Kohno, Tomohiko; Abe, Hiromi; Miki, Daiki; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C. Nelson; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Programs Biomed Res,Div Frontier Med Sci, Hiroshima, Japan; [Tsuge, Masataka] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Tsuge, Masataka; Hiraga, Nobuhiko; Zhang, Yizhou; Ohnishi, Mayu; Kohno, Tomohiko; Abe, Hiromi; Miki, Daiki; Imamura, Michio; Takahashi, Shoichi; Ochi, Hidenori; Hayes, C. Nelson; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Fujimoto, Yoshifumi] Hiroshima Gen Hosp, Dept Internal Med 4, Hatsukaichi, Japan; [Miki, Daiki; Ochi, Hidenori; Chayama, Kazuaki] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Liver Dis, Hiroshima, Japan; [Miya, Fuyuki; Tsunoda, Tatsuhiko] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Yokohama, Kanagawa, Japan	Hiroshima University; Hiroshima University; Hiroshima University; RIKEN; RIKEN	Tsuge, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Programs Biomed Res,Div Frontier Med Sci, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Hayes, C. Nelson N/G-4596-2019; Tsuge, Masataka/G-5246-2019; Chayama, Kazuaki/B-2493-2016; Abe-Chayama, Hiromi/M-8256-2019; Miki, Daiki/L-5069-2018	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tsuge, Masataka/0000-0001-7591-8287; Miki, Daiki/0000-0002-6505-9826; Miya, Fuyuki/0000-0001-6758-2015; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Education, Sports, Culture and Technology; Ministry of Health, Labor and Welfare; Grants-in-Aid for Scientific Research [22659147] Funding Source: KAKEN	Ministry of Education, Sports, Culture and Technology; Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Ministry of Education, Sports, Culture and Technology and Ministry of Health, Labor and Welfare (Grants-in-Aid for scientific research and development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2004, J HEPATOL, V40, P831, DOI 10.1016/j.jhep.2004.01.019; Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2007, INTERVIROLOGY, V50, P361, DOI 10.1159/000107707; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Caillot F, 2009, WORLD J GASTROENTERO, V15, P300, DOI 10.3748/wjg.15.300; Caillot F, 2009, AM J PATHOL, V175, P46, DOI 10.2353/ajpath.2009.080850; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; DONG BH, 1995, J BIOL CHEM, V270, P4133, DOI 10.1074/jbc.270.8.4133; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hiraga N, 2007, FEBS LETT, V581, P1983, DOI 10.1016/j.febslet.2007.04.021; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hoofnagle JH, 2003, HEPATOLOGY, V38, P66, DOI 10.1053/jhep.2003.50258; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Joyce MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000291; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kimura T, 2008, J GEN VIROL, V89, P2108, DOI 10.1099/vir.0.83658-0; Kitamura S, 2010, ANTIVIR THER, V15, P1087, DOI 10.3851/IMP1674; Komohara Y, 2006, J MOL HISTOL, V37, P327, DOI 10.1007/s10735-006-9059-0; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Lee SH, 2005, J IMMUNOL, V175, P8226, DOI 10.4049/jimmunol.175.12.8226; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 2001, CANCER RES, V61, P4365; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Noguchi C, 2007, J GEN VIROL, V88, P432, DOI 10.1099/vir.0.82319-0; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SEZAKI H, 2008, DIG DIS SCI; Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Toh PPC, 2010, EXP DERMATOL, V19, P987, DOI 10.1111/j.1600-0625.2010.01124.x; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Walters KA, 2006, PLOS PATHOG, V2, P591, DOI 10.1371/journal.ppat.0020059; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	62	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23856	10.1371/journal.pone.0023856	http://dx.doi.org/10.1371/journal.pone.0023856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886832	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500034
J	You, XJ; Xu, C; Lu, JQ; Zhu, XY; Gao, L; Cui, XR; Li, Y; Gu, H; Ni, X				You, Xing-Ji; Xu, Chen; Lu, Jian-Qiang; Zhu, Xiao-Yan; Gao, Lu; Cui, Xiao-Rui; Li, Yuan; Gu, Hang; Ni, Xin			Expression of Cystathionine beta-synthase and Cystathionine gamma-lyase in Human Pregnant Myometrium and Their Roles in the Control of Uterine Contractility	PLOS ONE			English	Article							SMOOTH-MUSCLE RELAXANT; HYDROGEN-SULFIDE; L-CYSTEINE; IN-VITRO; H2S; MEDIATOR; PRETERM; TISSUES; CELLS; LABOR	Background: Human uterus undergoes distinct molecular and functional changes during pregnancy and parturition. Hydrogen sulfide (H2S) has recently been shown to play a key role in the control of smooth muscle tension. The role of endogenous H2S produced locally in the control of uterine contractility during labour is unknown. Methodology/Principal Findings: Human myometrium biopsies were obtained from pregnant women undergoing cesarean section at term. Immunohistochemistry analysis showed that cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthetase (CBS), the principle enzymes responsible for H2S generation, were mainly localized to smooth muscle cells of human pregnant myometrium. The mRNA and protein expression of CBS as well as H2S production rate were down-regulated in labouring tissues compared to nonlabouring tissues. Cumulative administration of L-cysteine (10(-7) - 10(-2) mol/L), a precursor of H2S, caused a dose-dependent decrease in the amplitude of spontaneous contractions in nonlabouring and labouring myometrium strips. L-cysteine at high concentration (10(-3) mol/L) increased the frequency of spontaneous contractions and induced tonic contraction. These effects of L-cysteine were blocked by the inhibitors of CBS and CSE. Pre-treatment of myometrium strips with glibenclamide, an inhibitor of ATP-sensitive potassium (K-ATP) channels, abolished the inhibitory effect of L-cysteine on spontaneous contraction amplitude. The effects of L-cysteine on the amplitude of spontaneous contractions and baseline muscle tone were less potent in labouring tissues than that in nonlabouring strips. Conclusion/Significance: H2S generated by CSE and CBS locally exerts dual effects on the contractility of pregnant myometrium. Expression of H2S synthetic enzymes is down-regulated during labour, suggesting that H2S is one of the factors involved in the transition of pregnant uterus from quiescence to contractile state after onset of parturition.	[You, Xing-Ji; Xu, Chen; Zhu, Xiao-Yan; Gao, Lu; Ni, Xin] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Cui, Xiao-Rui; Li, Yuan; Gu, Hang] Second Mil Med Univ, Changhai Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Lu, Jian-Qiang] Shanghai Univ Sports, Dept Biomech, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Shanghai University of Sport	You, XJ (corresponding author), Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China.	nxljq2003@yahoo.com.cn	Xingji, You/GQY-5030-2022		National Natural Science Foundation of China [30811120433, 30971090]; Science and Technology Commission of Shanghai Municipals [09XD1405600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipals	This work is supported by National Natural Science Foundation of China No. 30811120433 and No. 30971090 and Science and Technology Commission of Shanghai Municipals (09XD1405600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle S, 2007, MOL HUM REPROD, V13, P69, DOI 10.1093/molehr/gal093; AWATA S, 1995, BIOCHEM MOL BIOL INT, V35, P1331; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Bhatia M, 2005, IUBMB LIFE, V57, P603, DOI 10.1080/15216540500217875; Bianca RDD, 2009, P NATL ACAD SCI USA, V106, P4513, DOI 10.1073/pnas.0807974105; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Havelock OC, 2005, BIOL REPROD, V72, P707, DOI 10.1095/biolreprod.104.032979; Hay A, 2010, MOL HUM REPROD, V16, P752, DOI 10.1093/molehr/gaq046; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Kubo S, 2007, J PHARMACOL SCI, V104, P392, DOI 10.1254/jphs.SC0070199; Lim JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1261, DOI 10.1152/ajpcell.00195.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowicka E, 2007, PHARMACOL REP, V59, P4; Mazloum-Ardakani M, 2010, J IRAN CHEM SOC, V7, P251, DOI 10.1007/BF03245886; Moore PK, 2003, TRENDS PHARMACOL SCI, V24, P609, DOI 10.1016/j.tips.2003.10.007; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Raoof JB, 2007, ELECTROANAL, V19, P1822, DOI 10.1002/elan.200703932; Sidhu R, 2001, PHARMACOL TOXICOL, V88, P198, DOI 10.1034/j.1600-0773.2001.d01-104.x; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Tapley DW, 1999, BIOL BULL, V196, P52, DOI 10.2307/1543166; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9	33	42	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23788	10.1371/journal.pone.0023788	http://dx.doi.org/10.1371/journal.pone.0023788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886822	Green Submitted, Green Published, gold			2022-12-25	WOS:000294253500030
J	Elhaik-Goldman, S; Kafka, D; Yossef, R; Hadad, U; Elkabets, M; Vallon-Eberhard, A; Hulihel, L; Jung, S; Ghadially, H; Braiman, A; Apte, RN; Mandelboim, O; Dagan, R; Mizrachi-Nebenzahl, Y; Porgador, A				Elhaik-Goldman, Shirin; Kafka, Daniel; Yossef, Rami; Hadad, Uzi; Elkabets, Moshe; Vallon-Eberhard, Alexandra; Hulihel, Luai; Jung, Steffen; Ghadially, Hormas; Braiman, Alex; Apte, Ron N.; Mandelboim, Ofer; Dagan, Ron; Mizrachi-Nebenzahl, Yaffa; Porgador, Angel			The Natural Cytotoxicity Receptor 1 Contribution to Early Clearance of Streptococcus pneumoniae and to Natural Killer-Macrophage Cross Talk	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INNATE IMMUNE-RESPONSE; HUMAN NK CELLS; PNEUMOCOCCAL PNEUMONIA; INTERFERON-GAMMA; DENDRITIC CELLS; INFLUENZA INFECTION; T-CELLS; NKP46; DEFENSE	Natural killer (NK) cells serve as a crucial first line of defense against tumors, viral and bacterial infections. We studied the involvement of a principal activating natural killer cell receptor, natural cytotoxicity receptor 1 (NCR1), in the innate immune response to S. pneumoniae infection. Our results demonstrate that the presence of the NCR1 receptor is imperative for the early clearance of S. pneumoniae. We tied the ends in vivo by showing that deficiency in NCR1 resulted in reduced lung NK cell activation and lung IFN gamma production at the early stages of S. pneumoniae infection. NCR1 did not mediate direct recognition of S. pneumoniae. Therefore, we studied the involvement of lung macrophages and dendritic cells (DC) as the mediators of NK-expressed NCR1 involvement in response to S. pneumoniae. In vitro, wild type BM-derived macrophages and DC expressed ligands to NCR1 and co-incubation of S. pneumoniae-infected macrophages/DC with NCR1-deficient NK cells resulted in significantly lesser IFN gamma levels compared to NCR1-expressing NK cells. In vivo, ablation of lung macrophages and DC was detrimental to the early clearance of S. pneumoniae. NCR1-expressing mice had more potent alveolar macrophages as compared to NCR1-deficient mice. This result correlated with the higher fraction of NCR1-ligand(high) lung macrophages, in NCR1-expressing mice, that had better phagocytic activity compared to NCR1-ligand(dull) macrophages. Overall, our results point to the essential contribution of NK-expressed NCR1 in early response to S. pneumoniae infection and to NCR1-mediated interaction of NK and S. pneumoniae infected-macrophages and -DC.	[Elhaik-Goldman, Shirin; Kafka, Daniel; Yossef, Rami; Hadad, Uzi; Elkabets, Moshe; Hulihel, Luai; Braiman, Alex; Apte, Ron N.; Mizrachi-Nebenzahl, Yaffa; Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Elhaik-Goldman, Shirin; Kafka, Daniel; Yossef, Rami; Hadad, Uzi; Elkabets, Moshe; Hulihel, Luai; Braiman, Alex; Apte, Ron N.; Mizrachi-Nebenzahl, Yaffa; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Elhaik-Goldman, Shirin; Kafka, Daniel; Dagan, Ron; Mizrachi-Nebenzahl, Yaffa] Ben Gurion Univ Negev, Pediat Infect Dis Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Vallon-Eberhard, Alexandra; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ghadially, Hormas; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Weizmann Institute of Science; Hebrew University of Jerusalem	Elhaik-Goldman, S (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	angel@bgu.ac.il	Braiman, Alex/F-2179-2012; Yossef, Rami/K-5740-2019; Jung, Steffen/K-1409-2012; Yoseph, Rami/L-6823-2019; Mizrachi Nebenzahl, Yaffa/F-1657-2012; elkabets, moshe/R-6822-2019; Braiman, Alex/ABC-3482-2021	Braiman, Alex/0000-0003-2802-1148; Jung, Steffen/0000-0003-4290-5716; Braiman, Alex/0000-0003-2802-1148; Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449	Croatia-Israel research grant; Israeli Ministry of Health [4476, 5540, 3000003867]	Croatia-Israel research grant; Israeli Ministry of Health	This work was supported by a joint Croatia-Israel research grant (AP). This work was also supported by the Israeli Ministry of Health, 4476, 5540 and 3000003867 (YMN). The Israel Academy of Science, 613/04 (YMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O; Blue CE, 2003, INFECT IMMUN, V71, P4925, DOI 10.1128/IAI.71.9.4925-4935.2003; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Cundell D, 1995, CLIN INFECT DIS, V21, pS204, DOI 10.1093/clind/21.Supplement_3.S204; DAGAN RGD, 2004, PNEUMOCOCCAL INFECT, P1204; DUNN PL, 1991, INFECT IMMUN, V59, P2892, DOI 10.1128/IAI.59.9.2892-2900.1991; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Gaforio JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1282, DOI 10.1128/CDLI.9.6.1282-1294.2002; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Le-Barillec K, 2005, J IMMUNOL, V175, P1735, DOI 10.4049/jimmunol.175.3.1735; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Rijneveld AW, 2002, J INFECT DIS, V185, P91, DOI 10.1086/338122; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; Schultz MJ, 2001, EUR CYTOKINE NETW, V12, P39; Scott MJ, 2003, AM SURGEON, V69, P679; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; vanderPoll T, 1997, AM J RESP CRIT CARE, V155, P603, DOI 10.1164/ajrccm.155.2.9032201; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Weiss L, 2004, BONE MARROW TRANSPL, V33, P1137, DOI 10.1038/sj.bmt.1704475; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731	39	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23472	10.1371/journal.pone.0023472	http://dx.doi.org/10.1371/journal.pone.0023472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887255	gold, Green Published, Green Submitted			2022-12-25	WOS:000294251800011
J	Charytan, DM; Helfand, AM; MacDonald, BA; Cinelli, A; Kalluri, R; Zeisberg, EM				Charytan, David M.; Helfand, Alexander M.; MacDonald, Brian A.; Cinelli, Angeles; Kalluri, Raghu; Zeisberg, Elisabeth M.			Circulating Endoglin Concentration Is Not Elevated in Chronic Kidney Disease	PLOS ONE			English	Article							BETA-BINDING-PROTEIN; GLOMERULAR-FILTRATION-RATE; EXPERIMENTAL RENAL-FAILURE; GROWTH-FACTOR VEGF; SOLUBLE ENDOGLIN; HEART DEVELOPMENT; MASS REDUCTION; UP-REGULATION; EXPRESSION; FIBROSIS	Background: Soluble endoglin, a TGF-beta receptor, plays a key role in cardiovascular physiology. Whether circulating concentrations of soluble endoglin are elevated in CKD or underlie the high risk of cardiovascular death associated with chronic kidney disease (CKD) is unknown. Methods: Individuals with and without CKD were recruited at a single center. Estimated glomerular filtration rate (eGFR) was estimated using the modified MDRD study equation and the serum creatinine at the time of recruitment, and patients were assigned to specific CKD stage according to usual guidelines. Serum endoglin concentration was measured by ELISA and univariate and multivariable regression was used to analyze the association between eGFR or CKD stage and the concentration of soluble endoglin. Results: Serum endoglin was measured in 216 patients including 118 with stage 3 or higher CKD and 9 individuals with end stage renal disease (ESRD). Serum endoglin concentration did not vary significantly with CKD stage (increase of 0.16 ng/mL per 1 stage increase in CKD, P = 0.09) or eGFR (decrease -0.06 ng/mL per 10 mL/min/1.73 m(2) increase in GFR, P = 0.12), and was not higher in individuals with ESRD than in individuals with preserved renal function (4.2 +/- 1.1 and 4.3 +/- 1.2 ng/mL, respectively). Endoglin concentration was also not significantly associated with urinary albumin excretion. Conclusions: Renal function is not associated with the circulating concentration of soluble endoglin. Elevations in soluble endoglin concentration are unlikely to contribute to the progression of CKD or the predisposition of individuals with CKD to develop cardiovascular disease.	[Charytan, David M.; Helfand, Alexander M.; Cinelli, Angeles] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [MacDonald, Brian A.; Kalluri, Raghu; Zeisberg, Elisabeth M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Charytan, DM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA.	dcharytan@partners.org	Zeisberg, Elisabeth/ABG-4970-2021; Kalluri, Raghu/E-2677-2015	charytan, david/0000-0002-7695-3583; Kalluri, Raghu/0000-0002-2190-547X	American Heart Association Scientist Development [SDG0735602T]; Satellite Health Care; Paul Teschan Research Fund; National Institutes of Health [KO8CA129204, DK 55001]; NATIONAL CANCER INSTITUTE [K08CA129204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055001] Funding Source: NIH RePORTER	American Heart Association Scientist Development(American Heart Association); Satellite Health Care; Paul Teschan Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Charytan was funded by an American Heart Association Scientist Development Grant, a Norman S. Coplon Grant from Satellite Health Care, and the Paul Teschan Research Fund. Dr. Zeisberg was funded by an American Heart Association Scientist Development Grant (SDG0735602T) and a Mentored Clinical Scientist Development Award (KO8CA129204) from the National Institutes of Health. Dr. Kalluri was funded by NIH DK 55001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Amann K, 2003, KIDNEY INT, V63, P1708, DOI 10.1046/j.1523-1755.2003.00927.x; Amann K, 1998, NEPHROL DIAL TRANSPL, V13, P1958, DOI 10.1093/ndt/13.8.1958; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Cui SY, 2005, J AM SOC NEPHROL, V16, P3247, DOI 10.1681/ASN.2005030278; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Finn AV, 2010, JACC-CARDIOVASC IMAG, V3, P41, DOI 10.1016/j.jcmg.2009.11.001; Ikemoto T, 2011, HEART VESSELS; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Kappers MHW, 2009, J HYPERTENS, V27, P2297, DOI 10.1097/HJH.0b013e3283309b59; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li DY, 2001, HYPERTENSION, V38, P1062, DOI 10.1161/hy1101.092971; Ly J, 2004, CURR OPIN NEPHROL HY, V13, P299, DOI 10.1097/00041552-200405000-00006; Matsumoto Y, 2007, J AM SOC NEPHROL, V18, P1525, DOI 10.1681/ASN.2006070696; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mohsenin V, 2011, RESP MED, V105, P801, DOI 10.1016/j.rmed.2011.01.001; Onoue K, 2009, CIRCULATION, V120, P2470, DOI 10.1161/CIRCULATIONAHA.109.867929; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Prieto M, 2005, J PHYSIOL BIOCHEM, V61, P457, DOI 10.1007/BF03168452; Prieto M, 2005, KIDNEY BLOOD PRESS R, V28, P32, DOI 10.1159/000081439; Rodriguez-Pena A, 2001, NEPHROL DIAL TRANSPL, V16, P34, DOI 10.1093/ndt/16.suppl_1.34; Rodriguez-Pena A, 2002, HYPERTENSION, V40, P713, DOI 10.1161/01.HYP.0000037429.73954.27; RoyChaudhury P, 1997, EXP NEPHROL, V5, P55; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sun XF, 2009, NEPHROLOGY, V14, P506, DOI 10.1111/j.1440-1797.2009.01098.x; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Toporsian M, 2005, CIRC RES, V96, P684, DOI 10.1161/01.res.0000159936.38601.22; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vincent EB, 1998, DEV DYNAM, V213, P237, DOI 10.1002/(SICI)1097-0177(199811)213:3<237::AID-AJA1>3.0.CO;2-M	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23718	10.1371/journal.pone.0023718	http://dx.doi.org/10.1371/journal.pone.0023718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886815	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100027
J	Butikofer, L; Zurlinden, A; Bolliger, MF; Kunz, B; Sonderegger, P				Buetikofer, Lukas; Zurlinden, Andreas; Bolliger, Marc F.; Kunz, Beat; Sonderegger, Peter			Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia	FASEB JOURNAL			English	Article						proteolysis; muscle atrophy; neurotrypsin-overexpressing mice; neurotrypsin-deficient mice	ACETYLCHOLINE-RECEPTOR DISTRIBUTION; SKELETAL-MUSCLE FIBERS; WHOLE VASTUS LATERALIS; MOTOR UNITS; AGE-CHANGES; FAST-TWITCH; ENZYME-ACTIVITY; SOLEUS MUSCLE; TOTAL NUMBER; RAT	Etiology and pathogenesis of sarcopenia, the progressive decline in skeletal muscle mass and strength that occurs with aging, are still poorly understood. We recently found that overexpression of the neural serine protease neurotrypsin in motoneurons resulted in the degeneration of their neuromuscular junctions (NMJ) within days. Therefore, we wondered whether neurotrypsin-dependent NMJ degeneration also affected the structure and function of the skeletal muscles. Using histological and functional analyses of neurotrypsin-overexpressing and neurotrypsin-deficient mice, we found that overexpression of neurotrypsin in motoneurons installed the full sarcopenia phenotype in young adult mice. Characteristic muscular alterations included a reduced number of muscle fibers, increased heterogeneity of fiber thickness, more centralized nuclei, fiber-type grouping, and an increased proportion of type I fibers. As in age-dependent sarcopenia, excessive fragmentation of the NMJ accompanied the muscular alterations. These results suggested the destabilization of the NMJ through proteolytic cleavage of agrin at the onset of a pathogenic pathway ending in sarcopenia. Studies of neurotrypsin-deficient and agrin-overexpressing mice revealed that old-age sarcopenia also develops without neurotrypsin and is not prevented by elevated levels of agrin. Our results define neurotrypsin-and age-dependent sarcopenia as the common final outcome of 2 etiologically distinct entities.-Butikofer, L., Zurlinden, A., Bolliger, M. F., Kunz, B., Sonderegger, P. Destabilization of the neuromuscular junction by proteolytic cleavage of agrin results in precocious sarcopenia. FASEB J. 25, 4378-4393 (2011). www.fasebj.org	[Buetikofer, Lukas; Zurlinden, Andreas; Bolliger, Marc F.; Kunz, Beat; Sonderegger, Peter] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Sonderegger, P (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	peter.sonderegger@bioc.uzh.ch		Butikofer, Lukas/0000-0002-0801-746X	Swiss National Science Foundation; National Center of Competence in Research, Neural Plasticity and Repair, of the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research, Neural Plasticity and Repair, of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	The authors thank Urs Ziegler for help with microscopy and image analysis and Monika Dilkin for mouse care and husbandry. The authors thank Pico Caroni (Friedrich Miescher Institute, Basel, Switzerland) for providing the mouse line expressing synaptophysin-GFP in neurons and Silvia Arber (Friedrich Miescher Institute) and Thomas M. Jessell (Columbia University, New York, NY, USA) for providing the Hb9-Cre mouse line. The work was supported by grants of the Swiss National Science Foundation and the National Center of Competence in Research, Neural Plasticity and Repair, of the Swiss National Science Foundation. P. S. is a cofounder and minor shareholder (<0.5%) of Neurotune AG.	Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; ALNAQEEB MA, 1987, J ANAT, V153, P31; ANIANSSON A, 1992, J APPL PHYSIOL, V73, P812, DOI 10.1152/jappl.1992.73.3.812; ANSVED T, 1989, J NEUROL SCI, V93, P105, DOI 10.1016/0022-510X(89)90165-2; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; Blondet B, 2002, BRAIN RES, V930, P53, DOI 10.1016/S0006-8993(01)03405-9; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; CACCIA MR, 1979, MUSCLE NERVE, V2, P202, DOI 10.1002/mus.880020308; CARDASIS CA, 1987, MUSCLE NERVE, V10, P200, DOI 10.1002/mus.880100303; CARLSON BM, 1995, J GERONTOL A-BIOL, V50, P96; Carter EE, 2010, EXP GERONTOL, V45, P662, DOI 10.1016/j.exger.2010.04.001; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; COURTNEY J, 1981, J PHYSIOL-LONDON, V320, P435, DOI 10.1113/jphysiol.1981.sp013960; COVAULT J, 1985, P NATL ACAD SCI USA, V82, P4544, DOI 10.1073/pnas.82.13.4544; Dalton BH, 2008, MUSCLE NERVE, V38, P1108, DOI 10.1002/mus.20984; DAW CK, 1988, J APPL PHYSIOL, V64, P2428, DOI 10.1152/jappl.1988.64.6.2428; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; Edstrom E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040; EDSTROM L, 1987, J PHYSIOL-LONDON, V392, P129, DOI 10.1113/jphysiol.1987.sp016773; FIATARONE MA, 1993, J GERONTOL, V48, P77, DOI 10.1093/geronj/48.Special_Issue.77; Gallegly JC, 2004, J APPL PHYSIOL, V97, P1082, DOI 10.1152/japplphysiol.00006.2004; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Hamada K, 2004, FASEB J, V18, P264, DOI 10.1096/fj.03-1286fje; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; HASHIZUME K, 1988, J COMP NEUROL, V269, P425, DOI 10.1002/cne.902690309; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Hepple RT, 2004, J GERONTOL A-BIOL, V59, P108; Hepple Russell T, 2006, Sci Aging Knowledge Environ, V2006, ppe3, DOI 10.1126/sageke.2006.3.pe3; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; ISHIHARA A, 1987, BRAIN RES, V435, P355, DOI 10.1016/0006-8993(87)91624-6; ISHIHARA A, 1988, BRAIN RES, V446, P195, DOI 10.1016/0006-8993(88)91315-7; JAKOBSSON F, 1990, ACTA NEUROPATHOL, V80, P459, DOI 10.1007/BF00294604; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; JENNEKENS FG, 1971, J NEUROL SCI, V14, P245, DOI 10.1016/0022-510X(71)90215-2; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Kano Y, 2002, J GERONTOL A-BIOL, V57, pB422, DOI 10.1093/gerona/57.12.B422; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Larkin LM, 2003, MECH AGEING DEV, V124, P653, DOI 10.1016/S0047-6374(02)00190-2; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; LEXELL J, 1987, ACTA NEUROPATHOL, V75, P109, DOI 10.1007/BF00687070; LEXELL J, 1991, J ANAT, V174, P239; LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LEXELL J, 1986, J NEUROL SCI, V72, P211, DOI 10.1016/0022-510X(86)90009-2; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; Marques MJ, 2007, ANAT REC, V290, P846, DOI 10.1002/ar.20525; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Minatel E, 2001, MUSCLE NERVE, V24, P410, DOI 10.1002/1097-4598(200103)24:3<410::AID-MUS1014>3.0.CO;2-0; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Monemi M, 1999, J MUSCLE RES CELL M, V20, P351, DOI 10.1023/A:1005421604314; Narita S, 1999, NEUROREPORT, V10, P3233, DOI 10.1097/00001756-199910190-00020; ODA K, 1984, J NEUROL SCI, V66, P327, DOI 10.1016/0022-510X(84)90021-2; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; ROBBINS N, 1985, J NEUROCYTOL, V14, P1019, DOI 10.1007/BF01224810; Roubenoff R, 2000, J GERONTOL A-BIOL, V55, pM716, DOI 10.1093/gerona/55.12.M716; Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62; Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SCELSI R, 1980, ACTA NEUROPATHOL, V51, P99, DOI 10.1007/BF00690450; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; WEINDRUCH R, 1995, J GERONTOL A-BIOL, V50, P157; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	75	88	92	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4378	4393		10.1096/fj.11-191262	http://dx.doi.org/10.1096/fj.11-191262			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21885656				2022-12-25	WOS:000298138100029
J	Sagi, SA; Lessard, CB; Winden, KD; Maruyama, H; Koo, JC; Weggen, S; Kukar, TL; Golde, TE; Koo, EH				Sagi, Sarah A.; Lessard, Christian B.; Winden, Kellen D.; Maruyama, Hiroko; Koo, Jeremy C.; Weggen, Sascha; Kukar, Thomas L.; Golde, Todd E.; Koo, Edward H.			Substrate Sequence Influences gamma-Secretase Modulator Activity, Role of the Transmembrane Domain of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BETA-LIKE PEPTIDE; ALZHEIMERS-DISEASE; A-BETA; INTRAMEMBRANE PROTEOLYSIS; INTRACELLULAR DOMAIN; TRANSGENIC MICE; MOUSE MODEL; A-BETA-42; GENERATION	A subset of non-steroidal anti-inflammatory drugs modulates the gamma cleavage site in the amyloid precursor protein (APP) to selectively reduce production of A beta 42. It is unclear precisely how these gamma-secretase modulators (GSMs) act to preferentially spare A beta 40 production as well as Notch processing and signaling. In an effort to determine the substrate requirements in NSAID/GSM activity, we determined the effects of sulindac sulfide and flurbiprofen on gamma-cleavage of artificial constructs containing several gamma-secretase substrates. Using FLAG-tagged constructs that expressed extracellularly truncated APP, Notch-1, or CD44, we found that these substrates have different sensitivities to sulindac sulfide. gamma-Secretase cleavage of APP was altered by sulindac sulfide, but CD44 and Notch-1 were either insensitive or only minimally altered by this compound. Using chimeric APP constructs, we observed that the transmembrane domain (TMD) of APP played a pivotal role in determining drug sensitivity. Substituting the APP TMD with that of APLP2 retained the sensitivity to gamma-cleavage modulation, but replacing TMDs from Notch-1 or ErbB4 rendered the resultant molecules insensitive to drug treatment. Specifically, the GXXXG motif within APP appeared to be critical to GSM activity. Consequently, the modulatory effects on gamma-cleavage appears to be substrate-dependent. We hypothesize that the substrate present in the gamma-secretase complex influences the conformation of the complex so that the binding site of GSMs is either stabilized or less favorable to influence the cleavage of the respective substrates.	[Sagi, Sarah A.; Lessard, Christian B.; Winden, Kellen D.; Maruyama, Hiroko; Koo, Jeremy C.; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kukar, Thomas L.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Golde, Todd E.] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Coll Med, Gainesville, FL 32610 USA; [Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA	University of California System; University of California San Diego; Heinrich Heine University Dusseldorf; Emory University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	edkoo@ucsd.edu	Kukar, Thomas/AAW-2612-2021	Kukar, Thomas/0000-0002-3750-6262	National Institutes of Health [AG 20206, AG005131-22]; American Federation for Aging Research/Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [R00AG032362, P50AG005131, P01AG020206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging Research/Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG 20206 (to T. E. G. and E. H. K.) and AG005131-22 (to S. A. S.). This work was also supported by an American Federation for Aging Research/Ellison Medical Foundation fellowship (to S. A. S.).	Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Beher D, 2008, CURR TOP MED CHEM, V8, P34, DOI 10.2174/156802608783334051; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Sagi SA, 2003, J BIOL CHEM, V278, P31825, DOI 10.1074/jbc.M303588200; Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Tomita T., 2010, 40 ANN M SOC NEUR SA; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; van Groen T, 2005, BRAIN RES REV, V48, P370, DOI 10.1016/j.brainresrev.2004.12.026; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Zettl H, 2010, TRENDS PHARMACOL SCI, V31, P402, DOI 10.1016/j.tips.2010.05.007; Zhang JM, 2002, J BIOL CHEM, V277, P15069, DOI 10.1074/jbc.M105375200	47	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39794	39803		10.1074/jbc.M111.277228	http://dx.doi.org/10.1074/jbc.M111.277228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21868380	Green Published, hybrid			2022-12-25	WOS:000296925700013
J	Corcoran, K; Jabbour, M; Bhagwandin, C; Deymier, MJ; Theisen, DL; Lybarger, L				Corcoran, Kathleen; Jabbour, Maurice; Bhagwandin, Candida; Deymier, Martin J.; Theisen, Debra L.; Lybarger, Lonnie			Ubiquitin-mediated Regulation of CD86 Protein Expression by the Ubiquitin Ligase Membrane-associated RING-CH-1 (MARCH1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; DENDRITIC CELL SUBSETS; DOWN-REGULATION; INVARIANT CHAIN; PLASMA-MEMBRANE; HERPESVIRUS K3; VIRAL PROTEIN; MOLECULES; SURFACE	The activation of naive T cells requires antigen presentation by dendritic cells (DCs), and the process of antigen presentation is regulated over the course of DC maturation. One key aspect of this regulation is the cell surface up-regulation upon DC maturation of peptide center dot MHC-II complexes and the costimulatory molecule CD86. It is now clear that these critical induction events involve changes in ubiquitin-dependent trafficking of MHC-II and CD86 by the E3 ligase membrane-associated RING-CH-1 (MARCH1). Although ubiquitin-dependent trafficking of MHC-II has been well characterized, much less is known regarding the post-transcriptional regulation of CD86 expression. Here, we examined the physical and functional interaction between CD86 and MARCH1. We observed that CD86 is rapidly endocytosed in the presence of MARCH1 followed by lysosome-dependent degradation. Furthermore, we found that the association between CD86 and MARCH1 was conferred primarily by the transmembrane domains of the respective proteins. In contrast to MHC-II, which has a single, conserved ubiquitin acceptor site in the cytosolic domain, we found that multiple lysine residues in the cytosolic tail of CD86 could support ubiquitination consistent with the relative lack of sequence conservation across species within the CD86 cytosolic domain. These findings suggest that MARCH1 recruits multiple substrates via transmembrane domain-mediated interactions to permit substrate ubiquitination in the face of diverse cytosolic domain sequences.	[Corcoran, Kathleen; Bhagwandin, Candida; Lybarger, Lonnie] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Jabbour, Maurice; Lybarger, Lonnie] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA; [Deymier, Martin J.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Lybarger, Lonnie] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Lybarger, L (corresponding author), Univ Arizona, Dept Cellular & Mol Med, 1501 N Campbell Ave,LSN 444, Tucson, AZ 85724 USA.	lybarger@email.arizona.edu			National Institutes of Health [AI060723, AI080756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060723, R56AI080756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060723 and AI080756.	BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Boname JM, 2010, TRAFFIC, V11, P210, DOI 10.1111/j.1600-0854.2009.01011.x; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Corcoran K, 2009, J BIOL CHEM, V284, P17475, DOI 10.1074/jbc.M808258200; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nathan JA, 2009, EXP CELL RES, V315, P1593, DOI 10.1016/j.yexcr.2008.10.026; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Salek-Ardakani S, 2009, J IMMUNOL, V182, P2909, DOI 10.4049/jimmunol.0803545; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429; zum Bueschenfelde COM, 2004, J IMMUNOL, V173, P6119, DOI 10.4049/jimmunol.173.10.6119	66	49	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37168	37180		10.1074/jbc.M110.204040	http://dx.doi.org/10.1074/jbc.M110.204040			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896490	Green Published, hybrid			2022-12-25	WOS:000296542400017
J	Battchikova, N; Wei, LZ; Du, LY; Bersanini, L; Aro, EM; Ma, WM				Battchikova, Natalia; Wei, Lanzhen; Du, Lingyu; Bersanini, Luca; Aro, Eva-Mari; Ma, Weimin			Identification of Novel Ssl0352 Protein (NdhS), Essential for Efficient Operation of Cyclic Electron Transport around Photosystem I, in NADPH:plastoquinone Oxidoreductase (NDH-1) Complexes of Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDINE-NUCLEOTIDE DEHYDROGENASE; DISTINCT NAD(P)H DEHYDROGENASES; RESPIRATORY COMPLEX; NADPH DEHYDROGENASE; INTERSYSTEM CHAIN; THERMOSYNECHOCOCCUS-ELONGATUS; SUBUNIT COMPOSITION; SP PCC-6803; CYANOBACTERIUM; LOCALIZATION	Cyanobacterial NADPH:plastoquinone oxidoreductase, or type I NAD(P)H dehydrogenase, or the NDH-1 complex is involved in plastoquinone reduction and cyclic electron transfer (CET) around photosystem I. CET, in turn, produces extra ATP for cell metabolism particularly under stressful conditions. Despite significant achievements in the study of cyanobacterial NDH-1 complexes during the past few years, the entire subunit composition still remains elusive. To identify missing subunits, we screened a transposon-tagged library of Synechocystis 6803 cells grown under high light. Two NDH-1-mediated CET (NDH-CET)-defective mutants were tagged in the same ssl0352 gene encoding a short unknown protein. To clarify the function of Ssl0352, the ssl0352 deletion mutant and another mutant with Ssl0352 fused to yellow fluorescent protein (YFP) and the His(6) tag were constructed. Immunoblotting, mass spectrometry, and confocal microscopy analyses revealed that the Ssl0352 protein resides in the thylakoid membrane and associates with the NDH-1L and NDH-1M complexes. We conclude that Ssl0352 is a novel subunit of cyanobacterial NDH-1 complexes and designate it NdhS. Deletion of the ssl0352 gene considerably impaired the NDH-CET activity and also retarded cell growth under high light conditions, indicating that NdhS is essential for efficient operation of NDH-CET. However, the assembly of the NDH-1L and NDH-1M complexes and their content in the cells were not affected in the mutant. NdhS contains a Src homology 3-like domain and might be involved in interaction of the NDH-1 complex with an electron donor.	[Battchikova, Natalia; Bersanini, Luca; Aro, Eva-Mari] Univ Turku, Dept Biochem & Food Chem, FI-20520 Turku, Finland; [Wei, Lanzhen; Du, Lingyu; Ma, Weimin] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	University of Turku; Shanghai Normal University	Aro, EM (corresponding author), Univ Turku, Dept Biochem & Food Chem, Tykistokatu 6A,Biocity 6th Floor, FI-20520 Turku, Finland.	evaaro@utu.fi; wma@shnu.edu.cn	Aro, Eva-Mari/Q-8664-2017; Ma, Weimin/A-8158-2015	Aro, Eva-Mari/0000-0002-2922-1435; Ma, Weimin/0000-0003-4964-415X	Academy of Finland [118637]; European Union [212508]; HARVEST Marie Curie Research Training Network [PITN-GA-2009-238017]; National Basic Research Program of China [2009CB118500]; National Natural Science Foundation of China [30770175]; Chinese Ministry of Education [209045]	Academy of Finland(Academy of Finland); European Union(European Commission); HARVEST Marie Curie Research Training Network; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported in part by Academy of Finland Project 118637, European Union Project Solar-H2 (FP7 Contract 212508), HARVEST Marie Curie Research Training Network Grant PITN-GA-2009-238017, National Basic Research Program of China Grant 2009CB118500, National Natural Science Foundation of China Grant 30770175, and Key Project of Chinese Ministry of Education Grant 209045.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2010, J PROTEOME RES, V9, P5896, DOI 10.1021/pr100651w; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; Endo T, 1999, FEBS LETT, V457, P5, DOI 10.1016/S0014-5793(99)00989-8; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Jansen T, 2002, J PLANT PHYSIOL, V159, P1205, DOI 10.1078/0176-1617-00829; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kishan KVR, 2005, CURR PROTEIN PEPT SC, V6, P143, DOI 10.2174/1389203053545444; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma W., 2009, FRONT BIOL CHINA, V4, P137, DOI [10.1007/s11515-009-0005-x, DOI 10.1007/S11515-009-0005-X]; Ma WM, 2008, PLANT PHYSIOL BIOCH, V46, P775, DOI 10.1016/j.plaphy.2008.04.019; Ma WM, 2006, PLANT CELL PHYSIOL, V47, P1432, DOI 10.1093/pcp/pcl008; Ma WM, 2005, PHYSIOL PLANTARUM, V125, P135, DOI 10.1111/j.1399-3054.2005.00555.x; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Mano J, 1995, PLANT CELL PHYSIOL, V36, P1589; Matsuo M, 1998, PLANT CELL PHYSIOL, V39, P263, DOI 10.1093/oxfordjournals.pcp.a029366; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Mi HL, 2001, PHOTOSYNTH RES, V70, P167, DOI 10.1023/A:1017946524199; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Ohkawa H, 2002, FUNCT PLANT BIOL, V29, P195, DOI 10.1071/PP01180; Ohkawa H, 2001, J BACTERIOL, V183, P4938, DOI 10.1128/JB.183.16.4938-4939.2001; Ozaki H, 2007, PLANT CELL PHYSIOL, V48, P451, DOI 10.1093/pcp/pcm015; Peng LW, 2011, BBA-BIOENERGETICS, V1807, P945, DOI 10.1016/j.bbabio.2010.10.015; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Sirpio S, 2009, J BIOL CHEM, V284, P905, DOI 10.1074/jbc.M805404200; SUMIMOTO H, 1994, P NATL ACAD SCI USA, V91, P5345, DOI 10.1073/pnas.91.12.5345; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WILLIAMS JGK, 1983, GENE, V24, P37, DOI 10.1016/0378-1119(83)90129-4; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Xu M, 2008, PLANT CELL PHYSIOL, V49, P994, DOI 10.1093/pcp/pcn074; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	60	66	70	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36992	37001		10.1074/jbc.M111.263780	http://dx.doi.org/10.1074/jbc.M111.263780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880717	Green Published, hybrid			2022-12-25	WOS:000296538300077
J	Drosatos, K; Drosatos-Tampakaki, Z; Khan, R; Homma, S; Schulze, PC; Zannis, VI; Goldberg, IJ				Drosatos, Konstantinos; Drosatos-Tampakaki, Zoi; Khan, Raffay; Homma, Shunichi; Schulze, P. Christian; Zannis, Vassilis I.; Goldberg, Ira J.			Inhibition of c-Jun-N-terminal Kinase Increases Cardiac Peroxisome Proliferator-activated Receptor alpha Expression and Fatty Acid Oxidation and Prevents Lipopolysaccharide-induced Heart Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR HORMONE-RECEPTORS; HIGH-DOSE METHYLPREDNISOLONE; LIPOPROTEIN-LIPASE ACTIVITY; TUMOR-NECROSIS-FACTOR; SEVERE SEPSIS; GENE-EXPRESSION; MESSENGER-RNA; RAT-HEART; BACTERIAL LIPOPOLYSACCHARIDE; MITOCHONDRIAL DYSFUNCTION	Septic shock results from bacterial infection and is associated with multi-organ failure, high mortality, and cardiac dysfunction. Sepsis causes both myocardial inflammation and energy depletion. We hypothesized that reduced cardiac energy production is a primary cause of ventricular dysfunction in sepsis. The JNK pathway is activated in sepsis and has also been implicated in impaired fatty acid oxidation in several tissues. Therefore, we tested whether JNK activation inhibits cardiac fatty acid oxidation and whether blocking JNK would restore fatty acid oxidation during LPS treatment. LPS treatment of C57BL/6 mice and adenovirus-mediated activation of the JNK pathway in cardiomyocytes inhibited peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation. Surprisingly, none of the adaptive responses that have been described in other types of heart failure, such as increased glucose utilization, reduced alpha MHC:beta MHC ratio or induction of certain microRNAs, occurred in LPS-treated mice. Treatment of C57BL/6 mice with a general JNK inhibitor (SP600125) increased fatty acid oxidation in mice and a cardiomyocyte-derived cell line. JNK inhibition also prevented LPS-mediated reduction in fatty acid oxidation and cardiac dysfunction. Inflammation was not alleviated in LPS-treated mice that received the JNK inhibitor. We conclude that activation of JNK signaling reduces fatty acid oxidation and prevents the peroxisome proliferator-activated receptor alpha down-regulation that occurs with LPS.	[Goldberg, Ira J.] Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, New York, NY 10032 USA; [Homma, Shunichi; Schulze, P. Christian] Columbia Univ, Div Cardiol, Coll Phys & Surg, New York, NY 10032 USA; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Biochem, Boston, MA 02118 USA	Columbia University; Columbia University; Boston University; Boston University	Goldberg, IJ (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, Div Prevent Med & Nutr, 630 W 168th St, New York, NY 10032 USA.	ijg3@columbia.edu	Schulze, Christian/AGJ-7744-2022; Drosatos, Konstantinos/H-9153-2013	Schulze, Christian/0000-0001-9442-7141; Drosatos, Konstantinos/0000-0003-0903-834X; Zannis, Vassilis/0000-0002-1295-7155	National Heart, Lung, and Blood Institute [HL45095, 73029, HL48739, T32 HL007343]; American Heart Association [10POST4440032]; American Diabetes Association [ADA 07-07-MN-22]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007343, R01HL048739, R37HL045095, R01HL045095, T32HL007343, R01HL073029] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Heart, Lung, and Blood Institute Grants HL45095 and 73029 (to I. J. G.), HL48739 (V. I. Z.), and T32 HL007343 (to R. K.). This work was also supported by American Heart Association Postdoctoral Grant 10POST4440032 (to K. D.), by an American Diabetes Association mentored postdoctoral grant ADA 07-07-MN-22 (to I. J. G. and K. D.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; ASTIZ M, 1988, CIRC SHOCK, V26, P311; BAGBY GJ, 1980, AM J PHYSIOL, V238, pH325, DOI 10.1152/ajpheart.1980.238.3.H325; BALLARD FB, 1960, J CLIN INVEST, V39, P717, DOI 10.1172/JCI104088; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; BOLUYT MO, 1994, CIRC RES, V75, P23, DOI 10.1161/01.RES.75.1.23; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BRONSVELD W, 1985, CARDIOVASC RES, V19, P455, DOI 10.1093/cvr/19.8.455; Carlson DL, 2005, CRIT CARE MED, V33, P1021, DOI 10.1097/01.CCM.0000163398.79679.66; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Chang L, 2003, EUR J PHARMACOL, V473, P171, DOI 10.1016/S0014-2999(03)01972-1; Chen HW, 2003, SHOCK, V20, P274, DOI 10.1097/00024382-200309000-00013; CHRISTE ME, 1994, J MOL CELL CARDIOL, V26, P1371, DOI 10.1006/jmcc.1994.1155; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; Drosatos K, 2007, J BIOL CHEM, V282, P19556, DOI 10.1074/jbc.M700986200; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Escames G, 2007, FEBS J, V274, P2135, DOI 10.1111/j.1742-4658.2007.05755.x; Fairchild KD, 2011, AM J PHYSIOL-REG I, V300, pR330, DOI 10.1152/ajpregu.00487.2010; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Feingold K, 2004, AM J PHYSIOL-ENDOC M, V286, pE201, DOI 10.1152/ajpendo.00205.2003; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; FEINGOLD KR, 1994, ARTERIOSCLER THROMB, V14, P1866, DOI 10.1161/01.ATV.14.11.1866; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; HEARSE DJ, 1979, AM J CARDIOL, V44, P1115, DOI 10.1016/0002-9149(79)90177-2; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTCHKISS RS, 1991, AM J PHYSIOL, V260, pC50, DOI 10.1152/ajpcell.1991.260.1.C50; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Kapelko VI, 1996, MOL CELL BIOCHEM, V164, P131; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Levy B, 2003, INTENS CARE MED, V29, P292, DOI 10.1007/s00134-002-1611-0; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LING PR, 1994, METABOLISM, V43, P279, DOI 10.1016/0026-0495(94)90093-0; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Maitra U, 2009, MOL IMMUNOL, V47, P420, DOI 10.1016/j.molimm.2009.08.023; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Memon RA, 1999, BBA-MOL CELL BIOL L, V1440, P118, DOI 10.1016/S1388-1981(99)00120-1; Memon RA, 1998, AM J PHYSIOL-ENDOC M, V275, pE64, DOI 10.1152/ajpendo.1998.275.1.E64; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; PASQUE MK, 1983, ARCH SURG-CHICAGO, V118, P1437; Patel D, 2000, J CRIT CARE, V15, P64, DOI 10.1053/jcrc.2000.7902; Peng TQ, 2009, CARDIOVASC RES, V81, P733, DOI 10.1093/cvr/cvn336; Ramana KV, 2006, CIRCULATION, V114, P1838, DOI 10.1161/CIRCULATIONAHA.106.630830; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Rozo AV, 2008, DIABETOLOGIA, V51, P1493, DOI 10.1007/s00125-008-1036-6; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Sanghera JS, 1996, J IMMUNOL, V156, P4457; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Schwartz Andrei, 2002, Eur J Intern Med, V13, P434, DOI 10.1016/S0953-6205(02)00130-9; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Supinski GS, 2009, AM J PHYSIOL-REG I, V297, pR1095, DOI 10.1152/ajpregu.90902.2008; Supinski GS, 2006, AM J RESP CRIT CARE, V173, P1240, DOI 10.1164/rccm.200410-1346OC; TAEGTMEYER H, 1988, HYPERTENSION, V11, P416, DOI 10.1161/01.HYP.11.5.416; TAKEYAMA D, 1995, CARDIOVASC RES, V29, P763, DOI 10.1016/S0008-6363(96)88610-X; Takuma S, 2001, AM J PHYSIOL-HEART C, V280, pH2364, DOI 10.1152/ajpheart.2001.280.5.H2364; Tang CS, 1996, AM J PHYSIOL-REG I, V270, pR254, DOI 10.1152/ajpregu.1996.270.1.R254; Tessier JP, 2003, CARDIOVASC RES, V60, P119, DOI 10.1016/S0008-6363(03)00320-1; Tsuiki H, 2003, CANCER RES, V63, P250; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Tuunanen H, 2006, CIRCULATION, V114, P2130, DOI 10.1161/CIRCULATIONAHA.106.645184; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang CY, 2002, CIRCULATION, V105, P1609, DOI 10.1161/01.CIR.0000013022.11250.30; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200; Yu XX, 2008, AM J PHYSIOL-ENDOC M, V295, pE436, DOI 10.1152/ajpendo.00629.2007	90	74	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36331	36339		10.1074/jbc.M111.272146	http://dx.doi.org/10.1074/jbc.M111.272146			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873422	hybrid, Green Published			2022-12-25	WOS:000296538300018
J	Gao, LL; Coope, H; Grant, S; Ma, A; Ley, SC; Harhaj, EW				Gao, Linlin; Coope, Helen; Grant, Susan; Ma, Averil; Ley, Steven C.; Harhaj, Edward W.			ABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR CYLD; TOLL-LIKE RECEPTOR; RIG-I; INNATE IMMUNITY; REGULATORY FACTOR-3; NEGATIVE REGULATOR; INTERFERON; RNA; ACTIVATION	Upon virus infection, the innate immune response provides the first line of protection and rapidly induces type I interferons (IFN alpha/beta), which mediate potent antiviral effects. To maintain homeostasis and prevent autoimmunity, IFN production is tightly regulated; however, the mechanisms of negative regulation are poorly understood. Herein, we demonstrate that the A20 binding inhibitor of NF-kappa B 1 (ABIN1) is a novel negative regulator of antiviral signaling. Overexpression of ABIN1 inhibited IFN-beta promoter activation in response to virus infection or poly(I:C) transfection, whereas siRNA-mediated knockdown of ABIN1 enhanced IFN-beta production upon virus infection. ABIN1 interacted with the A20 regulatory molecule TAX1BP1 and was essential for the recruitment of TAX1BP1 and A20 to the noncanonical I kappa B kinases TBK1 and IKKi in response to poly(I:C) transfection. ABIN1 and TAX1BP1 together disrupted the interactions between the E3 ubiquitin ligase TRAF3 and TBK1/IKKi to attenuate lysine 63-linked polyubiquitination of TBK1/IKKi. Finally, an intact ubiquitin binding domain of ABIN1 was essential for ABIN1 to interact with TBK1/IKKi and inhibit IFN-beta production upon poly(I:C) transfection or virus infection. Together, these results suggest that ABIN1 requires its ubiquitin binding domain and cooperates with TAX1BP1 and A20 to restrict antiviral signaling.	[Gao, Linlin; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol,Grad Program Canc Biol, Miami, FL 33136 USA; [Coope, Helen; Grant, Susan; Ley, Steven C.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Miami; MRC National Institute for Medical Research; University of California System; University of California San Francisco	Harhaj, EW (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Microbiol & Immunol,Grad Program Canc Biol, 1550 NW 10 Ave, Miami, FL 33136 USA.	eharhaj@med.miami.edu	Gao, Linlin/S-8070-2019	Gao, Linlin/0000-0001-7332-3538	National Institutes of Health [PO1CA128115, RO1GM083143]; United Kingdom Medical Research Council; Association for International Cancer Research [AICR 03-297]; NATIONAL CANCER INSTITUTE [P01CA128115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER; Medical Research Council [MC_U117584209, U117532003] Funding Source: researchfish; MRC [MC_U117584209] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Association for International Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1CA128115 and RO1GM083143 (to E.W.H.).; Supported by the United Kingdom Medical Research Council.; Supported by Association for International Cancer Research Grant AICR 03-297.	Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Kaisho T, 2009, INT IMMUNOL, V21, P313, DOI 10.1093/intimm/dxp016; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2011, NAT IMMUNOL, V12, P834, DOI 10.1038/ni.2066; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200	44	58	59	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36592	36602		10.1074/jbc.M111.283762	http://dx.doi.org/10.1074/jbc.M111.283762			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21885437	Green Published, hybrid			2022-12-25	WOS:000296538300043
J	Kurita, S; Ogita, H; Takai, Y				Kurita, Souichi; Ogita, Hisakazu; Takai, Yoshimi			Cooperative Role of Nectin-Nectin and Nectin-Afadin Interactions in Formation of Nectin-based Cell-Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; SMALL G-PROTEINS; ADHERENS JUNCTIONS; GROWTH-FACTOR; E-CADHERIN; CONTACT INHIBITION; TRANS-INTERACTIONS; LEADING EDGES; NIH3T3 CELLS; ACTIVATION	The nectin cell adhesion molecules interact in trans with each other through their extracellular regions and with afadin through their cytoplasmic tails, forming adherens junctions in cooperation with cadherins. In a single cell, Necl-5 (nectin-like molecule-5) localizes at the leading edge and regulates directional cell movement in response to a chemoattractant. In such a single cell, afadin also localizes at the leading edge without interacting with nectins or Necl-5. It remains unknown how the nectin-nectin and nectin-afadin interactions are initiated when moving cells contact each other to initiate the formation of adherens junctions. We show here that the Necl-5-nectin interaction induced by cell-cell contact enhances the nectin-afadin interaction. This interaction then enhances the nectin-nectin interaction, which further enhances the nectin-afadin interaction in a positive feedback manner. Thus, the Necl-5-nectin, nectin-nectin, and nectin-afadin interactions cooperatively increase the clustering of the nectin-afadin complex at the cell-cell contact sites, promoting the formation of the nectin-based cell-cell adhesion.	[Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Ogita, Hisakazu/0000-0001-6750-1668	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Grants-in-Aid for Scientific Research [23590335] Funding Source: KAKEN	Global COE Program "Global Center for Education and Research in Integrative Membrane Biology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, by grants-in-aid from the Japan Society for the Promotion of Science, and by the Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency.	ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; FISHER HW, 1967, SCIENCE, V155, P581, DOI 10.1126/science.155.3762.581; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; KOIKE S, 1990, EMBO J, V9, P3217, DOI 10.1002/j.1460-2075.1990.tb07520.x; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Miyata M, 2009, J CELL SCI, V122, P4319, DOI 10.1242/jcs.048439; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 2001, J VIROL, V75, P4734, DOI 10.1128/JVI.75.10.4734-4743.2001; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Woodard AS, 1998, J CELL SCI, V111, P469; Zhadanov AB, 1999, CURR BIOL, V9, P880, DOI 10.1016/S0960-9822(99)80392-3	33	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36297	36303		10.1074/jbc.M111.261768	http://dx.doi.org/10.1074/jbc.M111.261768			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880730	hybrid, Green Published			2022-12-25	WOS:000296538300014
J	Wissing, S; Montano, M; Garcia-Perez, JL; Moran, JV; Greene, WC				Wissing, Silke; Montano, Mauricio; Luis Garcia-Perez, Jose; Moran, John V.; Greene, Warner C.			Endogenous APOBEC3B Restricts LINE-1 Retrotransposition in Transformed Cells and Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN L1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; POTENT INHIBITOR; MOUSE; RNA; DNA; PROTEINS; TRANSLATION; EXPRESSION; ELEMENT	Members of the APOBEC3 (A3) family of cytidine deaminase enzymes act as host defense mechanisms limiting both infections by exogenous retroviruses and mobilization of endogenous retrotransposons. Previous studies revealed that the overexpression of some A3 proteins could restrict engineered human Long INterspersed Element-1 (LINE-1 or L1) retrotransposition in HeLa cells. However, whether endogenous A3 proteins play a role in restricting L1 retrotransposition remains largely unexplored. Here, we show that HeLa cells express endogenous A3B and A3C, whereas human embryonic stem cells (hESCs) express A3B, A3C, A3DE, A3F, and A3G. To study the relative contribution of endogenous A3 proteins in restricting L1 retrotransposition, we first generated small hairpin RNAs (shRNAs) to suppress endogenous A3 mRNA expression, and then assessed L1 mobility using a cell-based L1 retrotransposition assay. We demonstrate that in both HeLa and hESCs, shRNA-based knockdown of A3B promotes a similar to 2-3.7-fold increase in the retrotransposition efficiency of an engineered human L1. Knockdown of the other A3s produced no significant increase in L1 activity. Thus, A3B appears to restrict engineered L1 retrotransposition in a broad range of cell types, including pluripotent cells.	[Wissing, Silke; Montano, Mauricio; Greene, Warner C.] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Luis Garcia-Perez, Jose] Univ Granada, Ctr Biomed Res, Andalusian Stem Cell Bank, Granada 18100, Spain; [Luis Garcia-Perez, Jose; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Luis Garcia-Perez, Jose] Univ Granada, GENYO Pfizer, Dept Human DNA Variabil, Granada 18007, Spain; [Luis Garcia-Perez, Jose] Andalusian Govt Ctr Genom & Oncol, Granada 18007, Spain	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Pfizer; University of Granada	Greene, WC (corresponding author), 1650 Owens St, San Francisco, CA 94158 USA.	wgreene@gladstone.ucsf.edu		Garcia-Perez, Jose Luis/0000-0002-8132-9849	National Institutes of Health [GM082970, GM060518]; California Institute for Regenerative Medicine (CIRM) [RS1-00210-1, TRI-01227, TG2/01160]; German Academy of Sciences [BMBF-LPD 9901/8-144]; Instituto de Salud Carlos III-Consejeria de Salud Junta de Andalucia [FEDER/EMER07/056]; Marie Curie IRG action [FP7-PEOPLE-2007-4-3-IRG]; Miguel Servet [FEDER/CP07/00065]; ISCIII; Innovacion y Ciencia [P09-CTS-4980]; Junta de Andalucia (Spain) [PI-002]; Spanish Ministry of Health [PI08171]; Consejeria de Economia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082970, R01GM060518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); German Academy of Sciences; Instituto de Salud Carlos III-Consejeria de Salud Junta de Andalucia; Marie Curie IRG action(European Commission); Miguel Servet; ISCIII(Instituto de Salud Carlos III); Innovacion y Ciencia; Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Consejeria de Economia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082970 and GM060518 (to J.V.M.), California Institute for Regenerative Medicine (CIRM) Grants RS1-00210-1 and TRI-01227 (to W.C.G.), and CIRM scholarship TG2/01160 and a German Academy of Sciences Leopoldina Fellowship BMBF-LPD 9901/8-144 (to S.W.). J.V.M. is an inventor on a patent entitled, "Compositions and Methods of Use of Human Retrotransposons," application number 60/006,831, issued November, 2000. J.V.M. has not received money from the patent and the issuance of the patent does not influence the results or interpretations in the paper.; Supported by Instituto de Salud Carlos III-Consejeria de Salud Junta de Andalucia (FEDER/EMER07/056), Marie Curie IRG action FP7-PEOPLE-2007-4-3-IRG, Miguel Servet Contract FEDER/CP07/00065, ISCIII, Consejeria de Economia, Innovacion y Ciencia P09-CTS-4980, Proyectos en Salud PI-002 from Junta de Andalucia (Spain), and Spanish Ministry of Health Grant Fondo Europeo Desarrollo Regional/Fondo de Investigacion Sanitaria PI08171.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; An WF, 2006, P NATL ACAD SCI USA, V103, P18662, DOI 10.1073/pnas.0605300103; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; GRIMALDI G, 1983, NUCLEIC ACIDS RES, V11, P321, DOI 10.1093/nar/11.2.321; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Hulme AE, 2007, GENE, V390, P199, DOI 10.1016/j.gene.2006.08.032; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MARTIN SL, 1993, MOL CELL BIOL, V13, P5383, DOI 10.1128/MCB.13.9.5383; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MCMILLAN JP, 1993, P NATL ACAD SCI USA, V90, P11533, DOI 10.1073/pnas.90.24.11533; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Turelli P, 2004, J BIOL CHEM, V279, P43371, DOI 10.1074/jbc.C400334200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	78	72	72	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36427	36437		10.1074/jbc.M111.251058	http://dx.doi.org/10.1074/jbc.M111.251058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878639	hybrid, Green Published			2022-12-25	WOS:000296538300028
J	Yamaguchi, H; Yu, T; Noshita, T; Kidachi, Y; Kamiie, K; Yoshida, K; Akitaya, T; Umetsu, H; Ryoyama, K				Yamaguchi, Hideaki; Yu, Tao; Noshita, Toshiro; Kidachi, Yumi; Kamiie, Katsuyoshi; Yoshida, Kenji; Akitaya, Tatsuo; Umetsu, Hironori; Ryoyama, Kazuo			Ligand-receptor Interaction between Triterpenoids and the 11 beta-Hydroxysteroid dehydrogenase type 2 (11 beta HSD2) Enzyme Predicts Their Toxic Effects against Tumorigenic r/m HM-SFME-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYO CELLS; GLYCYRRHETINIC ACID; SELECTIVE TOXICITY; DOWN-REGULATION; INHIBITION; CANCER; EXPRESSION; SERUM; GROWTH; RAS	The present study deals with in silico prediction and in vitro evaluation of the selective cytotoxic effects of triterpenoids on tumorigenic human c-Ha-ras and mouse c-myc cotransfected highly metastatic serum-free mouse embryo-1 (r/mHM-SFME-1) cells. Ligand fitting of five different triterpenoids to 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta HSD2) was analyzed with a molecular modeling method, and glycyrrhetinic acid (GA) was the best-fitted triterpenoid to the ligand binding site in 11 beta HSD2. Analysis of antiproliferative effects revealed that GA, oleanolic acid, and ursolic acid had selective toxicity against the tumor cells and that GA was the most potent triterpenoid in its selectivity. The toxic activity of the tested triterpenoids against the tumor cells showed good correlations with the partition coefficient (logP) and polar surface area values. Time-lapse microscopy, fluorescence staining, and confocal laser scanning microscopic observation revealed that GA induced morphologic changes typical of apoptosis such as cell shrinkage and blebbing and also disrupted the cytoskeletal proteins. Furthermore, GA exhibited a strong inhibitory effect on 11 beta HSD2 activity in the tumor cells. Our current results suggest that analysis of the ligand-receptor interaction between triterpenoids and 11 beta HSD2 can be utilized to predict their antitumor effects and that GA can be used as a possible chemopreventive and therapeutic antitumor agent. To the best of our knowledge, this is the first report on in silico prediction of the toxic effects of triterpenoids on tumor cells by 11 beta HSD2 inhibition.	[Yamaguchi, Hideaki; Yoshida, Kenji; Akitaya, Tatsuo] Meijo Univ, Fac Pharm, Dept Pharm, Nagoya, Aichi 4688503, Japan; [Yu, Tao] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka 5650871, Japan; [Noshita, Toshiro] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Dept Life Sci, Shobara 7270023, Japan; [Kidachi, Yumi; Kamiie, Katsuyoshi; Ryoyama, Kazuo] Aomori Univ, Dept Pharm, Fac Pharm, Aomori 0300943, Japan; [Umetsu, Hironori] Gifu Shotoku Gakuen Univ, Jr Coll, Dept Life Sci, Food Chem Lab, Gifu 0558288, Japan	Meijo University; Osaka University	Yamaguchi, H (corresponding author), Meijo Univ, Fac Pharm, Dept Pharm, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	hyamagu@meijo-u.ac.jp	Noshita, Toshiro/I-5180-2018	Noshita, Toshiro/0000-0001-7066-9314	Promotion and Mutual Aid Corporation for Private Schools of Japan	Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan)	This work was supported in part by a grant-in-aid from the Promotion and Mutual Aid Corporation for Private Schools of Japan.	AGARWAL AK, 1995, ENDOCR RES, V21, P389, DOI 10.3109/07435809509030455; ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Brown RW, 1996, BIOCHEM J, V313, P997, DOI 10.1042/bj3130997; CARMICHAEL J, 1987, CANCER RES, V47, P943; Chapman KE, 2006, MOL CELL ENDOCRINOL, V248, P3, DOI 10.1016/j.mce.2005.11.036; Cohen PG, 2005, MED HYPOTHESES, V64, P989, DOI 10.1016/j.mehy.2004.11.004; Couzin J, 2002, SCIENCE, V298, P522, DOI 10.1126/science.298.5593.522; Edwards CRW, 1996, STEROIDS, V61, P263, DOI 10.1016/0039-128X(96)00033-5; Ekins S, 2004, DRUG DISCOV TODAY, V9, P276, DOI 10.1016/S1359-6446(03)03008-3; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Ham R G, 1979, Methods Enzymol, V58, P44; Hirakawa H, 2009, PROTEIN ENG DES SEL, V22, P385, DOI 10.1093/protein/gzp014; Horigome H, 1999, AM J PHYSIOL-ENDOC M, V277, pE624, DOI 10.1152/ajpendo.1999.277.4.E624; JIAO D, 1994, CANCER RES, V54, P4327; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Kurogi Y, 2001, CURR MED CHEM, V8, P1035, DOI 10.2174/0929867013372481; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; LOO D, 1989, J CELL PHYSIOL, V139, P484, DOI 10.1002/jcp.1041390306; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; Mark PJ, 2009, BIOL REPROD, V80, P1209, DOI 10.1095/biolreprod.108.073650; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; MATHER JP, 1979, EXP CELL RES, V124, P215, DOI 10.1016/0014-4827(79)90271-4; Mazzocchi G, 1998, FASEB J, V12, P1533, DOI 10.1096/fasebj.12.14.1533; Nigawara T, 2006, ENDOCRINOLOGY, V147, P769, DOI 10.1210/en.2005-0544; NOMURA T, 1993, IN VITRO CELL DEV-AN, V29A, P614; Noshita T, 2009, EUR J MED CHEM, V44, P4931, DOI 10.1016/j.ejmech.2009.08.005; Rabbitt E, 2003, ONCOGENE, V22, P1663, DOI 10.1038/sj.onc.1206293; Rabbitt EH, 2002, FASEB J, V16, P36, DOI 10.1096/fj.01-0582com; RAWSON C, 1990, EXP CELL RES, V186, P177, DOI 10.1016/0014-4827(90)90224-X; RAWSON C, 1991, ONCOGENE, V6, P487; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Stewart PM, 2009, J CLIN INVEST, V119, P760, DOI 10.1172/JCI38936; Tommasi S, 2007, INT J CANCER, V120, P2078, DOI 10.1002/ijc.22557; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; WALKER BR, 1992, ENDOCRINOLOGY, V131, P970, DOI 10.1210/en.131.2.970; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Yamaguchi H, 2011, BIOCHIMIE, V93, P1172, DOI 10.1016/j.biochi.2011.04.011; Yamaguchi H, 2008, J HEALTH SCI, V54, P654, DOI 10.1248/jhs.54.654; Yamaguchi H, 2010, EUR J MED CHEM, V45, P2943, DOI 10.1016/j.ejmech.2010.03.021; Yamaguchi H, 2010, BIOL PHARM BULL, V33, P321, DOI 10.1248/bpb.33.321; Yu T, 2010, TOXICOL LETT, V192, P425, DOI 10.1016/j.toxlet.2009.11.021; Zafir A, 2009, STRESS, V12, P167, DOI 10.1080/10253890802234168; Zbankova S, 2004, CANCER LETT, V210, P95, DOI 10.1016/j.canlet.2003.12.019; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398	49	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36888	36897		10.1074/jbc.M111.265900	http://dx.doi.org/10.1074/jbc.M111.265900			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880714	hybrid, Green Published			2022-12-25	WOS:000296538300068
J	Rilov, G; Schiel, DR				Rilov, Gil; Schiel, David R.			Community Regulation: The Relative Importance of Recruitment and Predation Intensity of an Intertidal Community Dominant in a Seascape Context	PLOS ONE			English	Article							SUPPLY-SIDE ECOLOGY; TOP-DOWN CONTROL; INTERACTION STRENGTH; BOTTOM-UP; SETTLEMENT RATE; SPECIES INTERACTIONS; TROPHIC LINKAGES; MARINE PREDATOR; REEF FISH; PREY	Predicting the strength and context-dependency of species interactions across multiple scales is a core area in ecology. This is especially challenging in the marine environment, where populations of most predators and prey are generally open, because of their pelagic larval phase, and recruitment of both is highly variable. In this study we use a comparative-experimental approach on small and large spatial scales to test the relationship between predation intensity and prey recruitment and their relative importance in shaping populations of a dominant rocky intertidal space occupier, mussels, in the context of seascape (availability of nearby subtidal reef habitat). Predation intensity on transplanted mussels was tested inside and outside cages and recruitment was measured with standard larval settlement collectors. We found that on intertidal rocky benches with contiguous subtidal reefs in New Zealand, mussel larval recruitment is usually low but predation on recruits by subtidal consumers (fish, crabs) is intense during high tide. On nearby intertidal rocky benches with adjacent sandy subtidal habitats, larval recruitment is usually greater but subtidal predators are typically rare and predation is weaker. Multiple regression analysis showed that predation intensity accounts for most of the variability in the abundance of adult mussels compared to recruitment. This seascape-dependent, predation-recruitment relationship could scale up to explain regional community variability. We argue that community ecology models should include seascape context-dependency and its effects on recruitment and species interactions for better predictions of coastal community dynamics and structure.	[Rilov, Gil; Schiel, David R.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand	University of Canterbury	Rilov, G (corresponding author), IOLR, Natl Inst Oceanog, Haifa, Israel.	rilovg@ocean.org.il		Rilov, Gil/0000-0002-1334-4887	Andrew W Mellon Foundation [E4710]; New Zealand Foundation for Research, Science and Technology, Coasts and Oceans OBI [CO1X0501]	Andrew W Mellon Foundation; New Zealand Foundation for Research, Science and Technology, Coasts and Oceans OBI(New Zealand Foundation for Research, Science and Technology)	This research was supported by the Andrew W Mellon Foundation (grant E4710), including a post-doctoral fellowship to G. Rilov, and the New Zealand Foundation for Research, Science and Technology, Coasts and Oceans OBI, contract CO1X0501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Anderson TM, 2010, ECOLOGY, V91, P1519, DOI 10.1890/09-0739.1; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; CONNELL JH, 1961, ECOL MONOGR, V31, P61, DOI 10.2307/1950746; Connolly SR, 1999, ECOL MONOGR, V69, P277, DOI 10.1890/0012-9615(1999)069[0277:TOMCCP]2.0.CO;2; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; ESTES JA, 1978, ECOLOGY, V59, P822, DOI 10.2307/1938786; FAIRWEATHER PG, 1988, BIOL BULL, V175, P349, DOI 10.2307/1541725; Francis MP, 1996, NEW ZEAL J MAR FRESH, V30, P35, DOI 10.1080/00288330.1996.9516695; GAINES S, 1985, P NATL ACAD SCI USA, V82, P3707, DOI 10.1073/pnas.82.11.3707; GAINES SD, 1987, SCIENCE, V235, P479, DOI 10.1126/science.235.4787.479; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; HAMNER WM, 1988, B MAR SCI, V42, P459; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Jenkins SR, 2008, J ANIM ECOL, V77, P573, DOI 10.1111/j.1365-2656.2008.01366.x; JONES GP, 1984, J EXP MAR BIOL ECOL, V75, P277, DOI 10.1016/0022-0981(84)90170-9; Jones PL, 2008, J EXP MAR BIOL ECOL, V361, P98, DOI 10.1016/j.jembe.2008.05.004; Kollmann J, 2003, PLANT ECOL, V164, P249, DOI 10.1023/A:1021225728493; Langlois TJ, 2005, ECOLOGY, V86, P1508, DOI 10.1890/04-0234; LEWIN R, 1986, SCIENCE, V234, P25, DOI 10.1126/science.234.4772.25; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Menge BA, 1997, P NATL ACAD SCI USA, V94, P14530, DOI 10.1073/pnas.94.26.14530; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; Menge BA, 2004, ECOL MONOGR, V74, P663, DOI 10.1890/03-4060; Menge BA, 2003, P NATL ACAD SCI USA, V100, P12229, DOI 10.1073/pnas.1534875100; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE BA, 1995, TRENDS ECOL EVOL, V10, P431, DOI 10.1016/S0169-5347(00)89172-7; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; Pineda J, 2002, MAR BIOL, V140, P789, DOI 10.1007/s00227-001-0751-z; PINEDA J, 1994, MAR ECOL PROG SER, V107, P125, DOI 10.3354/meps107125; Pineda J, 1997, MAR BIOL, V129, P541, DOI 10.1007/s002270050195; Rilov G, 2006, ECOLOGY, V87, P731, DOI 10.1890/04-1853; Rilov G, 2008, J EXP MAR BIOL ECOL, V361, P59, DOI 10.1016/j.jembe.2008.04.008; Rilov G, 2006, MAR ECOL PROG SER, V327, P83, DOI 10.3354/meps327083; ROBLES C, 1995, ECOLOGY, V76, P565, DOI 10.2307/1941214; Schiel D.R, 2001, SCIENCE CONSERV, V182, P5; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Wassmann P, 2011, PROG OCEANOGR, V90, P1, DOI 10.1016/j.pocean.2011.02.002; White JW, 2007, ECOL LETT, V10, P1054, DOI 10.1111/j.1461-0248.2007.01098.x; Wieters EA, 2008, AM NAT, V171, P405, DOI 10.1086/527492; Witman JD, 2003, ECOL MONOGR, V73, P441, DOI 10.1890/01-4073	51	18	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23958	10.1371/journal.pone.0023958	http://dx.doi.org/10.1371/journal.pone.0023958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887351	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298800023
J	Fujii, T; Tsunesumi, S; Yamaguchi, K; Watanabe, S; Furukawa, Y				Fujii, Tomoaki; Tsunesumi, Shin-ichiro; Yamaguchi, Kiyoshi; Watanabe, Sumiko; Furukawa, Yoichi			Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; EXPRESSION; GENES; HEART; ORGANIZATION; CHROMATIN; GENETICS; ENCODES; PROTEIN; CANCER	Modifications of histone tails are involved in the regulation of a wide range of biological processes including cell cycle, cell survival, cell division, and cell differentiation. Among the modifications, histone methylation plays a critical role in cardiac and skeletal muscle differentiation. In our earlier studies, we found that SMYD3 has methyltransferase activity to histone H3 lysine 4, and that its up-regulation is involved in the tumorigenesis of human colon, liver, and breast. To clarify the role of Smyd3 in development, we have studied its expression patterns in zebrafish embryos and the effect of its suppression on development using Smyd3-specific antisense morpholino-oligonucleotides. We here show that transcripts of smyd3 were expressed in zebrafish embryos at all developmental stages examined and that knockdown of smyd3 in embryos resulted in pericardial edema and defects in the trunk structure. In addition, these phenotypes were associated with abnormal expression of three heart-chamber markers including cmlc2, amhc and vmhc, and abnormal expression of myogenic regulatory factors including myod and myog. These data suggest that Smyd3 plays an important role in the development of heart and skeletal muscle.	[Fujii, Tomoaki; Tsunesumi, Shin-ichiro; Yamaguchi, Kiyoshi; Furukawa, Yoichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Genome Res, Tokyo, Japan; [Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol Dev Biol, Tokyo, Japan	University of Tokyo; University of Tokyo	Fujii, T (corresponding author), Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Clin Genome Res, Tokyo, Japan.	furukawa@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology Japan [17015009]; Grants-in-Aid for Scientific Research [23790126] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid (#17015009) for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Liew HP, 2008, DEV BIOL, V324, P226, DOI 10.1016/j.ydbio.2008.09.020; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Roy S, 2004, CURR BIOL, V14, P1772, DOI 10.1016/j.cub.2004.09.046; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Schoenebeck JJ, 2007, SEMIN CELL DEV BIOL, V18, P27, DOI 10.1016/j.semcdb.2006.12.010; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2004, NAT CELL BIOL, V6, P685, DOI 10.1038/ncb0804-685; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Xu YF, 2000, DEV DYNAM, V219, P201, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1043>3.3.CO;2-9; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593; Zhou ZM, 2005, ANN CLIN LAB SCI, V35, P270	33	48	54	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23491	10.1371/journal.pone.0023491	http://dx.doi.org/10.1371/journal.pone.0023491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887258	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000022
J	Hsu, CJ; Baumgart, T				Hsu, Chih-Jung; Baumgart, Tobias			Spatial Association of Signaling Proteins and F-Actin Effects on Cluster Assembly Analyzed via Photoactivation Localization Microscopy in T Cells	PLOS ONE			English	Article							RECEPTOR MICROCLUSTERS; FLUORESCENCE MICROSCOPY; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; TYROSINE KINASE; ACTIVATION; SLP-76; MOLECULES; COMPLEX; DOMAIN	Recognition of antigens by T cell receptors (TCRs) triggers cellular signaling cascades initiated by recruitment to the plasma membrane of numerous effector molecules to form signaling microclusters (MCs). Here we show that the method of high-resolution photoactivation localization microscopy (PALM) imaging can be used to analyze the spatial correlation between kinase ZAP70 and adaptor SLP76 MCs at the cell periphery and the effects of F-actin on MC assembly. We first determined the photophysical rate constants of Dronpa and tdEos fluorescence probes, which allowed us to optimize our dual-color PALM imaging method. We next analyzed the degrees of spatial association through determination of Mander's colocalization coefficients from PALM images, which revealed increasing spatial segregation of ZAP70 and SLP76 MCs at the cell periphery after initiation of signaling. We showed that this spatial segregation at the cell periphery occurred in parallel with the reduction of MC phosphorylation levels. Furthermore, we used Ripley's K function to analyze spatial randomness, and determined average radii of clusters as a function of activation time. The average radii of SLP76 and LAT MCs were found to decrease, whereas ZAP70 MC radii remained relatively constant. Finally, effects of F-actin depolymerization on MC morphology were studied by determining radial distributions of cluster circularity. Our data suggest that MC morphology is affected by actin polymerization. The quantitative analysis of sub-diffraction PALM images may provide a starting point for a molecular interpretation of cluster-cluster interactions and of the regulation of T cell signaling MCs by the cytoskeleton.	[Hsu, Chih-Jung; Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Baumgart, Tobias] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hsu, CJ (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	baumgart@sas.upenn.edu			National Institutes of Health [1R21AI073409]; Nano/Bio Interface Center through the National Science Foundation NSEC [DMR08-32802]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nano/Bio Interface Center through the National Science Foundation NSEC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the National Institutes of Health grant 1R21AI073409 and by the Nano/Bio Interface Center through the National Science Foundation NSEC DMR08-32802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; BENKRID K, 2008, IAENG INT J COMPUTER, V35; BENSON DM, 1985, J CELL BIOL, V100, P1309, DOI 10.1083/jcb.100.4.1309; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Choudhuri K, 2010, FEBS LETT, V584, P4823, DOI 10.1016/j.febslet.2010.10.015; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Fang N, 1996, J IMMUNOL, V157, P3769; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Hashimoto-Tane A, 2010, MOL CELL BIOL, V30, P3421, DOI 10.1128/MCB.00160-10; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Owen DM, 2010, J BIOPHOTONICS, V3, P446, DOI 10.1002/jbio.200900089; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Petrescu AD, 2003, J BIOL CHEM, V278, P51813, DOI 10.1074/jbc.M303858200; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Purbhoo MA, 2010, SCI SIGNAL, V3, P10; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Sylvain NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001178; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Yokosuka T, 2009, IMMUNOL REV, V229, P27, DOI 10.1111/j.1600-065X.2009.00779.x; Yudushkin IA, 2010, P NATL ACAD SCI USA, V107, P22128, DOI 10.1073/pnas.1016388108; Zhang J, 2006, MICRON, V37, P14, DOI 10.1016/j.micron.2005.03.014; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	55	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23586	10.1371/journal.pone.0023586	http://dx.doi.org/10.1371/journal.pone.0023586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887278	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000033
J	Hudoklin, S; Jezernik, K; Neumuller, J; Pavelka, M; Romih, R				Hudoklin, Samo; Jezernik, Kristijan; Neumueller, Josef; Pavelka, Margit; Romih, Rok			Urothelial Plaque Formation in Post-Golgi Compartments	PLOS ONE			English	Article							RAT URINARY-BLADDER; ASYMMETRIC UNIT MEMBRANE; APICAL PLASMA-MEMBRANE; TRANSITIONAL EPITHELIAL-CELLS; UMBRELLA CELLS; SUPERFICIAL CELLS; LUMINAL MEMBRANE; PERMEABILITY BARRIER; FUSIFORM VESICLES; STRUCTURAL BASIS	Urothelial plaques are specialized membrane domains in urothelial superficial (umbrella) cells, composed of highly ordered uroplakin particles. We investigated membrane compartments involved in the formation of urothelial plaques in mouse umbrella cells. The Golgi apparatus did not contain uroplakins organized into plaques. In the post-Golgi region, three distinct membrane compartments containing uroplakins were characterized: i) Small rounded vesicles, located close to the Golgi apparatus, were labelled weakly with anti-uroplakin antibodies and they possessed no plaques; we termed them "uroplakin-positive transporting vesicles" (UPTVs). ii) Spherical-to-flattened vesicles, termed "immature fusiform vesicles" (iFVs), were uroplakin-positive in their central regions and contained small urothelial plaques. iii) Flattened "mature fusiform vesicles" (mFVs) contained large plaques, which were densely labelled with anti-uroplakin antibodies. Endoytotic marker horseradish peroxidase was not found in these post-Golgi compartments. We propose a detailed model of de novo urothelial plaque formation in post-Golgi compartments: UPTVs carrying individual 16-nm particles detach from the Golgi apparatus and subsequently fuse into iFV. Concentration of 16-nm particles into plaques and removal of uroplakin-negative membranes takes place in iFVs. With additional fusions and buddings, iFVs mature into mFVs, each carrying two urothelial plaques toward the apical surface of the umbrella cell.	[Hudoklin, Samo; Jezernik, Kristijan; Romih, Rok] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Neumueller, Josef; Pavelka, Margit] Med Univ Vienna, Dept Cell Biol & Ultrastruct Res, Ctr Anat & Cell Biol, Vienna, Austria	University of Ljubljana; Medical University of Vienna	Hudoklin, S (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.	samo.hudoklin@mf.uni-lj.si			Ministry of Education and Sport, Government of Republic of Slovenia, Slovenia [3311-04-831450]; Slovenian Research Agency [BI-AT/07-08-019]	Ministry of Education and Sport, Government of Republic of Slovenia, Slovenia; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Ministry of Education and Sport, Government of Republic of Slovenia, Slovenia (grant no. 3311-04-831450), and by Slovenian Research Agency (project: BI-AT/07-08-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AMANO O, 1988, TOHOKU J EXP MED, V156, P417, DOI 10.1620/tjem.156.417; AMANO O, 1991, ANAT RECORD, V229, P9, DOI 10.1002/ar.1092290103; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Balestreire EM, 2007, MOL BIOL CELL, V18, P1312, DOI 10.1091/mbc.E06-09-0842; Born M, 2003, EUR J CELL BIOL, V82, P343, DOI 10.1078/0171-9335-00326; CHANG A, 1994, AM J PHYSIOL-CELL PH, V267, pC1483, DOI 10.1152/ajpcell.1994.267.5.C1483; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; Guo XM, 2009, TRAFFIC, V10, P1350, DOI 10.1111/j.1600-0854.2009.00950.x; HICKS RM, 1969, NATURE, V224, P1304, DOI 10.1038/2241304a0; HICKS RM, 1966, J CELL BIOL, V30, P623, DOI 10.1083/jcb.30.3.623; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu CCA, 2008, BIOCHEM J, V414, P195, DOI 10.1042/BJ20080550; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Hudoklin S, 2009, CELL TISSUE RES, V336, P453, DOI 10.1007/s00441-009-0779-9; Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; KOSS LG, 1969, LAB INVEST, V21, P154; Kreft ME, 2010, BIOL CELL, V102, P593, DOI 10.1042/BC20100024; Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1; Kreft ME, 2009, ANN NY ACAD SCI, V1152, P18, DOI 10.1111/j.1749-6632.2008.04004.x; LEWIS SA, 1984, J MEMBRANE BIOL, V82, P123, DOI 10.1007/BF01868937; LEWIS SA, 1982, NATURE, V297, P685, DOI 10.1038/297685a0; Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867; Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013; LIN JH, 1994, J BIOL CHEM, V269, P1775; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Min GW, 2003, J CELL SCI, V116, P4087, DOI 10.1242/jcs.00811; MINSKY BD, 1978, J CELL BIOL, V77, P685, DOI 10.1083/jcb.77.3.685; MONAGHAN P, 1985, CANCER RES, V45, P5088; NOACK W, 1975, ACTA ANAT, V93, P171; PORTER KR, 1967, PROTOPLASMA, V63, P262, DOI 10.1007/BF01248042; ROMIH R, 1994, CELL BIOL INT, V18, P663, DOI 10.1006/cbir.1994.1093; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; SARIKAS SN, 1986, CELL TISSUE RES, V246, P109; SEVERS NJ, 1978, J ULTRA MOL STRUCT R, V64, P124, DOI 10.1016/S0022-5320(78)80031-8; SEVERS NJ, 1979, J ULTRA MOL STRUCT R, V69, P279, DOI 10.1016/S0022-5320(79)90117-5; STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Tu LY, 2006, J CELL SCI, V119, P5077, DOI 10.1242/jcs.03285; Tu LY, 2002, MOL BIOL CELL, V13, P4221, DOI 10.1091/mbc.E02-04-0211; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; VERGARA J, 1969, J MOL BIOL, V46, P593, DOI 10.1016/0022-2836(69)90200-9; WALZ T, 1995, J MOL BIOL, V248, P887, DOI 10.1006/jmbi.1995.0269; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; WU XR, 1995, J BIOL CHEM, V270, P29752; WU XR, 1990, J BIOL CHEM, V265, P19170; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; YU J, 1990, J CELL BIOL, V111, P1207, DOI 10.1083/jcb.111.3.1207	55	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23636	10.1371/journal.pone.0023636	http://dx.doi.org/10.1371/journal.pone.0023636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887288	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000041
J	Nestorovich, EM; Karginov, VA; Popoff, MR; Bezrukov, SM; Barth, H				Nestorovich, Ekaterina M.; Karginov, Vladimir A.; Popoff, Michel R.; Bezrukov, Sergey M.; Barth, Holger			Tailored beta-Cyclodextrin Blocks the Translocation Pores of Binary Exotoxins from C. Botulinum and C. Perfringens and Protects Cells from Intoxication	PLOS ONE			English	Article							LIPID BILAYER-MEMBRANES; ANTHRAX TOXIN CHANNELS; SYMMETRICAL TETRAALKYLAMMONIUM IONS; FLUORESCENCE-ACTIVATED CYTOMETRY; VOLTAGE-DEPENDENT BLOCK; CURRENT NOISE-ANALYSIS; CLOSTRIDIUM-BOTULINUM; C2 TOXIN; IOTA-TOXIN; ADP-RIBOSYLTRANSFERASE	Background: Clostridium botulinum C2 toxin and Clostridium perfringens iota toxin are binary exotoxins, which ADP-ribosylate actin in the cytosol of mammalian cells and thereby destroy the cytoskeleton. C2 and iota toxin consists of two individual proteins, an enzymatic active (A-) component and a separate receptor binding and translocation (B-) component. The latter forms a complex with the A-component on the surface of target cells and after receptor-mediated endocytosis, it mediates the translocation of the A-component from acidified endosomal vesicles into the cytosol. To this end, the B-components form heptameric pores in endosomal membranes, which serve as translocation channels for the A-components. Methodology/Principal Findings: Here we demonstrate that a 7-fold symmetrical positively charged beta-cyclodextrin derivative, per-6-S-(3-aminomethyl) benzylthio-beta-cyclodextrin, protects cultured cells from intoxication with C2 and iota toxins in a concentration-dependent manner starting at low micromolar concentrations. We discovered that the compound inhibited the pH-dependent membrane translocation of the A-components of both toxins in intact cells. Consistently, the compound strongly blocked transmembrane channels formed by the B-components of C2 and iota toxin in planar lipid bilayers in vitro. With C2 toxin, we consecutively ruled out all other possible inhibitory mechanisms showing that the compound did not interfere with the binding of the toxin to the cells or with the enzyme activity of the A-component. Conclusions/Significance: The described beta-cyclodextrin derivative was previously identified as one of the most potent inhibitors of the binary lethal toxin of Bacillus anthracis both in vitro and in vivo, implying that it might represent a broad-spectrum inhibitor of binary pore-forming exotoxins from pathogenic bacteria.	[Nestorovich, Ekaterina M.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; [Nestorovich, Ekaterina M.; Bezrukov, Sergey M.] NIH, Program Phys Biol, Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA; [Karginov, Vladimir A.] Innovat Biol Inc, Herndon, VA USA; [Popoff, Michel R.] Inst Pasteur, Dept Host Pathogen Interact, Paris, France; [Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, Ulm, Germany	Catholic University of America; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ulm University	Nestorovich, EM (corresponding author), Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA.	holger.barth@uni-ulm.de	Popoff, Michel/O-7719-2016; Barth, Holger/E-7920-2013	Popoff, Michel/0000-0001-9305-8989; 	Deutsche Forschungsgemeinschaft DFG [BA 2087/2-1]; Catholic University of America; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH; NIAID (National Institute of Allergy and Infectious Diseases); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Catholic University of America; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	HB was financially supported by the Deutsche Forschungsgemeinschaft DFG (http://www.dfg.de/) (grant BA 2087/2-1). EMN was supported by startup funds from The Catholic University of America. EMN and SMB were supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (http://www.nih.gov/) and NIAID (National Institute of Allergy and Infectious Diseases; http://www.niaid.nih.gov) Intramural Biodefense Research Grant for institutes other than NIAID (National Institute of Allergy and Infectious Diseases; http://www.niaid.nih.gov). VAK is an employee and shareholder of Innovative Biologics, Inc.; VAK provided the substance (beta-cyclodextrin derivative) for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1989, J CELL BIOL, V109, P1385, DOI 10.1083/jcb.109.4.1385; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Anderson DS, 2008, J GEN PHYSIOL, V132, P351, DOI 10.1085/jgp.200809984; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Backer MV, 2007, ANTIMICROB AGENTS CH, V51, P245, DOI 10.1128/AAC.00983-06; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Barth H, 2011, EUR J CELL BIOL, V90, P944, DOI 10.1016/j.ejcb.2010.11.007; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P905, DOI 10.1085/jgp.96.5.905; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; Delcour AH, 2002, J MOL MICROB BIOTECH, V4, P1; Diaz-Moscoso A, 2011, CHEMMEDCHEM, V6, P181, DOI 10.1002/cmdc.201000419; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Fujii N, 1996, BIOCHEM BIOPH RES CO, V220, P353, DOI 10.1006/bbrc.1996.0409; Gibert M, 2007, FEBS LETT, V581, P1287, DOI 10.1016/j.febslet.2007.02.041; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Hale ML, 2004, INFECT IMMUN, V72, P2186, DOI 10.1128/IAI.72.4.2186-2193.2004; Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200; Haug G, 2003, BIOCHEMISTRY-US, V42, P15284, DOI 10.1021/bi0354278; Haug G, 2003, J BIOL CHEM, V278, P32266, DOI 10.1074/jbc.M303980200; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; Kaiser E, 2006, BIOCHEMISTRY-US, V45, P13361, DOI 10.1021/bi061459u; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; Karginov VA, 2005, P NATL ACAD SCI USA, V102, P15075, DOI 10.1073/pnas.0507488102; Karginov VA, 2007, BIOORGAN MED CHEM, V15, P5424, DOI 10.1016/j.bmc.2007.05.058; Karginov VA, 2006, ANTIMICROB AGENTS CH, V50, P3740, DOI 10.1128/AAC.00693-06; KASIANOWICZ JJ, 1995, BIOPHYS J, V69, P94, DOI 10.1016/S0006-3495(95)79879-4; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Knapp O, 2002, J BIOL CHEM, V277, P6143, DOI 10.1074/jbc.M103939200; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPPLA SH, 1984, ADV CYCLIC NUCL PROT, V17, P189; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Li W. W., 2011, J AM CHEM SOC; MIYAKE M, 1987, MICROB PATHOGENESIS, V3, P279, DOI 10.1016/0882-4010(87)90061-1; Moayeri M, 2008, ANTIMICROB AGENTS CH, V52, P2239, DOI 10.1128/AAC.00009-08; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Nagahama M, 2009, INFECT IMMUN, V77, P5139, DOI 10.1128/IAI.00638-09; Nestorovich EM, 2010, BIOPHYS J, V99, P134, DOI 10.1016/j.bpj.2010.03.070; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; OHISHI I, 1980, INFECT IMMUN, V30, P668; OHISHI I, 1983, INFECT IMMUN, V40, P336, DOI 10.1128/IAI.40.1.336-339.1983; OHISHI I, 1984, INFECT IMMUN, V43, P54, DOI 10.1128/IAI.43.1.54-58.1984; OHISHI I, 1983, INFECT IMMUN, V40, P691, DOI 10.1128/IAI.40.2.691-695.1983; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; Pust S, 2010, CELL MICROBIOL, V12, P1809, DOI 10.1111/j.1462-5822.2010.01512.x; Ragle BE, 2010, ANTIMICROB AGENTS CH, V54, P298, DOI 10.1128/AAC.00973-09; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHMID A, 1994, J BIOL CHEM, V269, P16706; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sterthoff C, 2010, INFECT IMMUN, V78, P1468, DOI 10.1128/IAI.01351-09; STILES BG, 1986, INFECT IMMUN, V54, P683, DOI 10.1128/IAI.54.3.683-688.1986; Stiles BG, 2002, TOXICON, V40, P1135, DOI 10.1016/S0041-0101(02)00113-7; Stiles BG, 2000, INFECT IMMUN, V68, P3475, DOI 10.1128/IAI.68.6.3475-3484.2000; THOREN KL, 2011, MOL MICROBIOL; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WEIGT C, 1989, FEBS LETT, V246, P181, DOI 10.1016/0014-5793(89)80279-0; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237	78	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23927	10.1371/journal.pone.0023927	http://dx.doi.org/10.1371/journal.pone.0023927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887348	Green Published, gold			2022-12-25	WOS:000294251800041
J	Babiychuk, EB; Atanassoff, AP; Monastyrskaya, K; Brandenberger, C; Studer, D; Allemann, C; Draeger, A				Babiychuk, Eduard B.; Atanassoff, Alexander P.; Monastyrskaya, Katia; Brandenberger, Christina; Studer, Daniel; Allemann, Catherine; Draeger, Annette			The Targeting of Plasmalemmal Ceramide to Mitochondria during Apoptosis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SIMPLE SPHINGOLIPIDS; MOLECULAR MACHINERY; OUTER-MEMBRANE; CELL-DEATH; CALCIUM; ER; TRAFFICKING; DYNAMICS; SPHINGOMYELIN	Ceramide is a key lipid mediator of cellular processes such as differentiation, proliferation, growth arrest and apoptosis. During apoptosis, ceramide is produced within the plasma membrane. Although recent data suggest that the generation of intracellular ceramide increases mitochondrial permeability, the source of mitochondrial ceramide remains unknown. Here, we determine whether a stress-mediated plasmalemmal pool of ceramide might become available to the mitochondria of apoptotic cells. We have previously established annexin A1-a member of a family of Ca(2+) and membrane-binding proteins-to be a marker of ceramide platforms. Using fluorescently tagged annexin A1, we show that, upon its generation within the plasma membrane, ceramide self-associates into platforms that subsequently invaginate and fuse with mitochondria. An accumulation of ceramide within the mitochondria of apoptotic cells was also confirmed using a ceramide-specific antibody. Electron microscopic tomography confirmed that upon the formation of ceramide platforms, the invaginated regions of the plasma membrane extend deep into the cytoplasm forming direct physical contacts with mitochondrial outer membranes. Ceramide might thus be directly transferred from the plasma membrane to the mitochondrial outer membrane. It is conceivable that this "kiss-of-death'' increases the permeability of the mitochondrial outer membrane thereby triggering apoptosis.	[Babiychuk, Eduard B.; Atanassoff, Alexander P.; Monastyrskaya, Katia; Brandenberger, Christina; Studer, Daniel; Allemann, Catherine; Draeger, Annette] Univ Bern, Inst Anat, Bern, Switzerland	University of Bern	Babiychuk, EB (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	draeger@ana.unibe.ch	Studer, Daniel/F-8581-2012; Babiychuk, Eduard/AAV-7223-2021	Monastyrskaya, Katia/0000-0003-2042-1139; Babiychuk, Eduard/0000-0003-1786-0085	Swiss National Science Foundation [320030_128064/1, 3100A0-121980/1, 320000-111778]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by grants from the Swiss National Science Foundation http://www.snf.ch/D/Seiten/default.aspx to AD (320030_128064/1), EB (3100A0-121980/1) and KM (320000-111778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2008, TRAFFIC, V9, P1757, DOI 10.1111/j.1600-0854.2008.00800.x; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Cowart LA, 2002, J LIPID RES, V43, P2042, DOI 10.1194/jlr.M200241-JLR200; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dolman NJ, 2005, J BIOL CHEM, V280, P15794, DOI 10.1074/jbc.M412694200; Fine M, 2011, J GEN PHYSIOL, V137, P137, DOI 10.1085/jgp.201010469; Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; George NM, 2010, J BIOL CHEM, V285, P1384, DOI 10.1074/jbc.M109.049924; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hilgemann DW, 2011, J GEN PHYSIOL, V137, P155, DOI 10.1085/jgp.201010470; Jayadev S, 2000, AM J PHYSIOL-CELL PH, V279, pC1640; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lariccia V, 2011, J GEN PHYSIOL, V137, P111, DOI 10.1085/jgp.201010468; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rensing KH, 2002, PROTOPLASMA, V220, P39, DOI 10.1007/s00709-002-0033-8; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; VANCE JE, 1991, J BIOL CHEM, V266, P89; VERDURMEN WP, 2010, J CONTROL RELEASE; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	54	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23706	10.1371/journal.pone.0023706	http://dx.doi.org/10.1371/journal.pone.0023706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886813	gold, Green Submitted, Green Published			2022-12-25	WOS:000294128100026
J	Han, J; Seaman, WE; Di, XM; Wang, W; Willingham, M; Torti, FM; Torti, SV				Han, Jian; Seaman, William E.; Di, Xiumin; Wang, Wei; Willingham, Mark; Torti, Frank M.; Torti, Suzy V.			Iron Uptake Mediated by Binding of H-Ferritin to the TIM-2 Receptor in Mouse Cells	PLOS ONE			English	Article							HUMAN ERYTHROID PRECURSORS; SERUM FERRITIN; HEAVY-CHAIN; IN-VIVO; T-CELL; PROTEIN; METABOLISM; EXPRESSION; MECHANISM; SITES	Ferritin binds specifically and saturably to a variety of cell types, and recently several ferritin receptors have been cloned. TIM-2 is a specific receptor for H ferritin (HFt) in the mouse. TIM-2 is a member of the T cell immunoglobulin and mucin domain containing (TIM) protein family and plays an important role in immunity. The expression of TIM-2 outside of the immune system indicates that this receptor may have broader roles. We tested whether ferritin binding to TIM-2 can serve as an iron delivery mechanism. TIM-2 was transfected into normal (TCMK-1) mouse kidney cells, where it was appropriately expressed on the cell surface. HFt was labeled with Fe-55 and Fe-55-HFt was incubated with TIM-2 positive cells or controls. Fe-55-HFt uptake was observed only in TIM-2 positive cells. HFt uptake was also seen in A20 B cells, which express endogenous TIM-2. TIM-2 levels were not increased by iron chelation. Uptake of Fe-55-HFt was specific and temperature-dependent. HFt taken up by TIM-2 positive cells transited through the endosome and eventually entered a lysosomal compartment, distinguishing the HFt pathway from that of transferrin, the classical vehicle for cellular iron delivery. Iron delivered following binding of HFt to TIM-2 entered the cytosol and became metabolically available, resulting in increased levels of endogenous intracellular ferritin. We conclude that TIM-2 can function as an iron uptake pathway.	[Han, Jian] N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC USA; [Seaman, William E.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Seaman, William E.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Di, Xiumin; Wang, Wei; Torti, Frank M.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Willingham, Mark] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [Willingham, Mark; Torti, Frank M.; Torti, Suzy V.] Wake Forest Sch Med, Ctr Comprehens Canc, Winston Salem, NC USA; [Torti, Suzy V.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA	University of North Carolina; North Carolina A&T State University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Han, J (corresponding author), N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC USA.	storti@wfubmc.edu			National Institutes of Health [R01 AI061164, R01 DK071892, R37 DK42412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412, R01DK071892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institutes of Health (R01 AI061164 [WES], R01 DK071892 [SVT], and R37 DK42412 [FMT]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PC, 1988, HEPATOLOGY, V8, P719, DOI 10.1002/hep.1840080402; Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; ANDERSON GJ, 1989, BRIT J HAEMATOL, V73, P260, DOI 10.1111/j.1365-2141.1989.tb00262.x; ARAD I, 1988, AM J PERINAT, V5, P40, DOI 10.1055/s-2007-999651; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Barabanova YA, 2004, IMMUNOLOGY, V111, P165, DOI 10.1111/j.0019-2805.2003.01772.x; Bresgen N, 2007, J CELL PHYSIOL, V212, P157, DOI 10.1002/jcp.21009; BROXMEYER HE, 1989, BLOOD, V73, P74; CAZZOLA M, 1985, TUMORI, V71, P547, DOI 10.1177/030089168507100606; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; CLEGG GA, 1980, PROG BIOPHYS MOL BIO, V36, P53; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; COHEN LA, 2010, BLOOD; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; dos Santos CO, 2008, J BIOL CHEM, V283, P26956, DOI 10.1074/jbc.M802421200; FARGION S, 1988, BLOOD, V71, P753; FARGION S, 1991, CURR STUD HEMATOL BL, V58, P164; FISH WW, 1980, METHOD ENZYMOL, V158, P357; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Hulet SW, 2002, DEV NEUROSCI-BASEL, V24, P208, DOI 10.1159/000065704; Hulet SW, 1999, J NEUROCHEM, V72, P868, DOI 10.1046/j.1471-4159.1999.720868.x; Jiang Y, 2006, J BIOL CHEM, V281, P9058, DOI 10.1074/jbc.M507874200; Knickelbein JE, 2006, J IMMUNOL, V177, P4966, DOI 10.4049/jimmunol.177.8.4966; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Leimberg MJ, 2008, J CELL BIOCHEM, V103, P1211, DOI 10.1002/jcb.21499; LEVI S, 1988, J BIOL CHEM, V263, P18086; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; MACK U, 1983, J BIOL CHEM, V258, P4672; MATZNER Y, 1979, BRIT J HAEMATOL, V42, P345, DOI 10.1111/j.1365-2141.1979.tb01142.x; Meyron-Holtz EG, 1999, BLOOD, V94, P3205, DOI 10.1182/blood.V94.9.3205.421k25_3205_3211; MOSS D, 1992, J LAB CLIN MED, V120, P239; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; RAMM GA, 1994, J CLIN INVEST, V94, P9, DOI 10.1172/JCI117353; Recalcati S, 2008, J AUTOIMMUN, V30, P84, DOI 10.1016/j.jaut.2007.11.003; Rennert PD, 2006, J IMMUNOL, V177, P4311, DOI 10.4049/jimmunol.177.7.4311; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rucker P, 1997, PROTEIN ENG, V10, P967, DOI 10.1093/protein/10.8.967; Ruddell RG, 2009, HEPATOLOGY, V49, P887, DOI 10.1002/hep.22716; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; SANTAMBROGIO P, 1987, BRIT J HAEMATOL, V65, P235, DOI 10.1111/j.1365-2141.1987.tb02271.x; SIBILLE JC, 1988, HEPATOLOGY, V8, P296, DOI 10.1002/hep.1840080218; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; TAKAMI M, 1986, BIOCHIM BIOPHYS ACTA, V884, P31, DOI 10.1016/0304-4165(86)90223-0; Todorich B, 2008, J NEUROCHEM, V107, P1495, DOI 10.1111/j.1471-4159.2008.05678.x; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Torti S V, 1994, Adv Inorg Biochem, V10, P119; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Watanabe N, 2007, HEPATOLOGY, V45, P1240, DOI 10.1002/hep.21539; Yuan XM, 2004, FREE RADICAL RES, V38, P1133, DOI 10.1080/10715760400011692	57	50	51	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23800	10.1371/journal.pone.0023800	http://dx.doi.org/10.1371/journal.pone.0023800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886823	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100032
J	Brachtl, G; Sahakyan, K; Denk, U; Girbl, T; Alinger, B; Hofbauer, SW; Neureiter, D; Hofbauer, JP; Egle, A; Greil, R; Hartmann, TN				Brachtl, Gabriele; Sahakyan, Karine; Denk, Ursula; Girbl, Tamara; Alinger, Beate; Hofbauer, Sebastian W.; Neureiter, Daniel; Hofbauer, Josefina Pinon; Egle, Alexander; Greil, Richard; Hartmann, Tanja Nicole			Differential Bone Marrow Homing Capacity of VLA-4 and CD38 High Expressing Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							B-CELLS; PROGNOSTIC PARAMETER; ADHESION MOLECULE-1; CXCR4 EXPRESSION; SURVIVAL; ACTIVATION; SIGNALS; RELEVANCE; MIGRATION; NETWORK	Background: VLA-4 and CD38 predict a poor clinical outcome in chronic lymphocytic leukemia (CLL). We used CLL samples with discordant VLA-4/CD38 risk to address their individual roles in human bone marrow infiltration (BM), CLL cell homing to murine BM, and in supportive CLL cell-stromal cell interactions. Methods: VLA-4, CD38, and Ki-67 expression was measured in CLL cells from peripheral blood (PB) and bone marrow (BM) aspirates. CLL BM infiltration rates, routinely determined by Pathology, were correlated to VLA-4 and CD38 expression. Short-term homing capacity of CLL cells was evaluated by adoptive transfer experiments. CLL cell viability and adhesion in stromal cell co-culture was determined. Results: About 20% of CLL samples in our cohort displayed discordant VLA-4 and CD38 risk, with either high VLA-4 and low CD38 risk or vice versa. Using particularly such samples, we observed that VLA-4, and not CD38, was responsible for recirculation of CLL cells to murine BM. Human BM infiltration was also significantly higher in patients with high VLA-4 risk but not high CD38 risk. However, both molecules acted as independent prognostic markers. While both VLA-4 and CD38 expression were increased in BM-derived CLL cells, and VLA-4+ and CD38+ subpopulations showed enriched Ki-67 expression, VLA-4 did not contribute to CLL cell protection by stromal cells in vitro. Conclusions: Our data argue for a prominent role of VLA-4 but not CD38 expression in the homing of CLL cells to BM niches and in human BM infiltration, but only a limited role in their protection by stromal cells.	[Brachtl, Gabriele; Sahakyan, Karine; Denk, Ursula; Girbl, Tamara; Hofbauer, Sebastian W.; Hofbauer, Josefina Pinon; Egle, Alexander; Greil, Richard; Hartmann, Tanja Nicole] Private Med Univ Hosp, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Alinger, Beate; Neureiter, Daniel] Paracelsus Med Univ, Inst Pathol, Salzburg, Austria	Paracelsus Private Medical University	Brachtl, G (corresponding author), Private Med Univ Hosp, Lab Immunol & Mol Canc Res, Salzburg, Austria.	t.hartmann@salk.at	Hofbauer, Josefina Pinon/S-6826-2019; Egle, Alexander/AAC-3787-2020; Greil, Richard F/C-7673-2017; Hartmann, Tanja Nicole/C-9345-2017; Hartmann, Tanja Nicole/AAA-6735-2020; Hartmann, Tanja Nicole/C-9345-2017	Egle, Alexander/0000-0003-0648-4416; Greil, Richard F/0000-0002-4462-3694; Hartmann, Tanja Nicole/0000-0002-0377-7179; Hartmann, Tanja Nicole/0000-0002-0377-7179; Brachtl, Gabriele/0000-0002-2688-2940; Girbl, Tamara/0000-0001-7632-478X; Pinon Hofbauer, Josefina/0000-0002-8558-9031; Hartmann, Tanja Nicole/0000-0002-2633-7301	Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH [P021]; Austrian National Bank [13420]; Austrian Science Foundation [P021, P19481-B12, L488-B13]; province of Salzburg; Austrian Academy of Sciences	Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; Austrian National Bank; Austrian Science Foundation(Austrian Science Fund (FWF)); province of Salzburg; Austrian Academy of Sciences	This work was supported by the Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH, SFB program P021 to RG, grants from the Austrian National Bank (no. 13420 to TNH), the Austrian Science Foundation (FWF no. P19481-B12, L488-B13 to AE, SFB program P021 to RG), and the province of Salzburg. GB was a recipient of a DOC-FFORTE-fellowship of the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caligaris-Cappio F, 2008, J CLIN ONCOL, V26, P4497, DOI 10.1200/JCO.2007.15.4393; Coscia M, 2011, LEUKEMIA, V25, P828, DOI 10.1038/leu.2011.12; Dal-Bo M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-76; Damle RN, 2007, BLOOD, V110, P3352, DOI 10.1182/blood-2007-04-083832; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Deaglio S, 2005, BLOOD, V105, P3042, DOI 10.1182/blood-2004-10-3873; Deaglio S, 2003, BLOOD, V102, P2146, DOI 10.1182/blood-2003-03-0989; Deaglio S, 2007, BLOOD, V110, P4012, DOI 10.1182/blood-2007-06-094029; Deaglio S, 2007, BLOOD, V109, P5390, DOI 10.1182/blood-2006-12-061812; Deaglio S, 2006, BLOOD, V108, P1135, DOI 10.1182/blood-2006-01-013003; Gallay N, 2007, CANCER RES, V67, P8624, DOI 10.1158/0008-5472.CAN-07-0402; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Glodek AM, 2003, J EXP MED, V197, P461, DOI 10.1084/jem.20021477; Goichberg P, 2006, BLOOD, V107, P870, DOI 10.1182/blood-2005-03-0941; Hartmann TN, 2009, CANCER RES, V69, P3121, DOI 10.1158/0008-5472.CAN-08-4136; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Patten PEM, 2008, BLOOD, V111, P5173, DOI 10.1182/blood-2007-08-108605; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; ROZMAN C, 1984, BLOOD, V64, P642; Schweighofer Carmen Diana, 2008, Curr Hematol Malig Rep, V3, P54, DOI 10.1007/s11899-008-0009-7; Shanafelt TD, 2008, BRIT J HAEMATOL, V140, P537, DOI 10.1111/j.1365-2141.2007.06965.x; Shiozawa Y, 2008, LEUKEMIA, V22, P941, DOI 10.1038/leu.2008.48; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Vaisitti T, 2010, LEUKEMIA, V24, P958, DOI 10.1038/leu.2010.36; Zucchetto A, 2009, CANCER RES, V69, P4001, DOI 10.1158/0008-5472.CAN-08-4173	27	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23758	10.1371/journal.pone.0023758	http://dx.doi.org/10.1371/journal.pone.0023758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876768	gold, Green Submitted, Green Published			2022-12-25	WOS:000294126900040
J	Kavanagh, DH; Savage, DA; Patterson, CC; McKnight, AJ; Crean, JK; Maxwell, AP; McKay, GJ				Kavanagh, David H.; Savage, David A.; Patterson, Christopher C.; McKnight, Amy Jayne; Crean, John K.; Maxwell, Alexander P.; McKay, Gareth J.		Warren 3 Uk GoKinD Study Grp	Association Analysis of Canonical Wnt Signalling Genes in Diabetic Nephropathy	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; EXPRESSION; FIBROSIS; MATRIX	Aims/Hypothesis: Several studies have provided compelling evidence implicating the Wnt signalling pathway in the pathogenesis of diabetic nephropathy. Gene expression profiles associated with renal fibrosis have been attenuated through Wnt pathway modulation in model systems implicating Wnt pathway members as potential therapeutic targets for the treatment of diabetic nephropathy. We assessed tag and potentially functional single nucleotide polymorphisms (SNPs; n = 31) in four key Wnt pathway genes (CTNNB1, AXIN2, LRP5 and LRP6) for association with diabetic nephropathy using a case-control design. Methods: SNPs were genotyped using Sequenom or Taqman technologies in 1351 individuals with type 1 diabetes (651 cases with nephropathy and 700 controls without nephropathy). Cases and controls were white and recruited from the UK and Ireland. Association analyses were performed using PLINK, to compare allele and haplotype frequencies in cases and controls. Adjustment for multiple testing was performed by permutation testing. Results: Following logistic regression analysis adjusted by collection centre, duration of T1D, and average HbA1c as covariates, a single SNP in LRP6 (rs1337791) was significantly associated with DN (OR = 0.74; CI: 0.57-0.97; P = 0.028), although this was not maintained following correction for multiple testing. Three additional SNPs (rs2075241 in LRP6; rs3736228 and rs491347 both in LRP5) were marginally associated with diabetic nephropathy, but none of the associations were replicated in an independent dataset. Haplotype and subgroup analysis (according to duration of diabetes, and end-stage renal disease) also failed to reveal an association with diabetic nephropathy. Conclusions/Interpretation: Our results suggest that analysed common variants in CTNNB1, AXIN2, LRP5 and LRP6 are not strongly associated with diabetic nephropathy in type 1 diabetes among white individuals. Our findings, however, cannot entirely exclude these genes or other members of the Wnt pathway, from involvement in the pathogenesis of diabetic nephropathy as our study had limited power to detect variants with small effect size.	[Kavanagh, David H.; McKnight, Amy Jayne; Maxwell, Alexander P.; McKay, Gareth J.] Queens Univ Belfast, Nephrol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Savage, David A.] Belfast City Hosp, Histocompatibil & Immunogenet Lab, Blood Transfus Serv, Belfast BT9 7AD, Antrim, North Ireland; [Patterson, Christopher C.] Queens Univ Belfast, Epidemiol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Crean, John K.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	Queens University Belfast; Belfast City Hospital; Queens University Belfast; University College Dublin	Kavanagh, DH (corresponding author), Queens Univ Belfast, Nephrol Res Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland.	g.j.mckay@qub.ac.uk	McKay, Gareth/AAZ-2601-2020; McKnight, Amy Jayne/ABF-4492-2020; Savage, David A./AAP-6101-2020; McKnight, AJ/B-2450-2009	McKay, Gareth/0000-0001-8197-6280; McKnight, Amy Jayne/0000-0002-7482-709X; Maxwell, Alexander P./0000-0002-6110-7253; /0000-0002-4337-6177	Northern Ireland Kidney Research Fund (NIKRF); Northern Ireland Research and Development Office; Diabetes UK; Juvenile Diabetes Research Foundation; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Public Health Agency [STL/3714/07] Funding Source: researchfish	Northern Ireland Kidney Research Fund (NIKRF); Northern Ireland Research and Development Office; Diabetes UK(Diabetes UK); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Public Health Agency	David H. Kavanagh is supported by a Northern Ireland Kidney Research Fund (NIKRF) PhD studentship. We thank the NIKRF and Northern Ireland Research and Development Office for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Warren 3/UK GoKinD Study Group was jointly funded by Diabetes UK and the Juvenile Diabetes Research Foundation and includes the following individuals: Belfast: Professor A. P. Maxwell, Dr A. J. McKnight, Dr D. A. Savage; Edinburgh: Dr J. Walker; London: Dr S. Thomas, Professor G. C. Viberti; Manchester: Professor A. J. M. Boulton; Newcastle: Professor S. Marshall; Plymouth: Professor A. G. Demaine and Dr B. A. Millward; Swansea: Professor S. C. Bain.	Gradl D, 1999, MOL CELL BIOL, V19, P5576; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hughes TA, 2005, J BIOL CHEM, V280, P8581, DOI 10.1074/jbc.M410806200; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Kavanagh D, 2011, DIABETOLOGIA, V54, P334, DOI 10.1007/s00125-010-1978-3; Lin CL, 2010, J AM SOC NEPHROL, V21, P124, DOI 10.1681/ASN.2008101059; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Ullmann U, 2008, MOL HUM REPROD, V14, P169, DOI 10.1093/molehr/gan001; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23904	10.1371/journal.pone.0023904	http://dx.doi.org/10.1371/journal.pone.0023904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876774	gold, Green Submitted, Green Published			2022-12-25	WOS:000294126900046
J	Kerschgens, J; Renaud, S; Schutz, F; Grasso, L; Egener-Kuhn, T; Delaloye, JF; Lehr, HA; Vogel, H; Mermod, N				Kerschgens, Jan; Renaud, Stephanie; Schuetz, Frederic; Grasso, Luigino; Egener-Kuhn, Tanja; Delaloye, Jean-Francois; Lehr, Hans-Anton; Vogel, Horst; Mermod, Nicolas			Protein-Binding Microarray Analysis of Tumor Suppressor AP2 alpha Target Gene Specificity	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; CELL-CYCLE ARREST; DNA-BINDING; CANCER-CELLS; HUMAN TISSUE; HUMAN GENOME; APOPTOSIS INDUCTION; KALLIKREIN GENE-5; CARCINOMA-CELLS; E-CADHERIN	Cheap and massively parallel methods to assess the DNA-binding specificity of transcription factors are actively sought, given their prominent regulatory role in cellular processes and diseases. Here we evaluated the use of protein-binding microarrays (PBM) to probe the association of the tumor suppressor AP2 alpha with 6000 human genomic DNA regulatory sequences. We show that the PBM provides accurate relative binding affinities when compared to quantitative surface plasmon resonance assays. A PBM-based study of human healthy and breast tumor tissue extracts allowed the identification of previously unknown AP2 alpha target genes and it revealed genes whose direct or indirect interactions with AP2 alpha are affected in the diseased tissues. AP2 alpha binding and regulation was confirmed experimentally in human carcinoma cells for novel target genes involved in tumor progression and resistance to chemotherapeutics, providing a molecular interpretation of AP2 alpha role in cancer chemoresistance. Overall, we conclude that this approach provides quantitative and accurate assays of the specificity and activity of tumor suppressor and oncogenic proteins in clinical samples, interfacing genomic and proteomic assays.	[Kerschgens, Jan; Renaud, Stephanie; Egener-Kuhn, Tanja; Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland; [Schuetz, Frederic] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Grasso, Luigino; Vogel, Horst] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, Lausanne, Switzerland; [Egener-Kuhn, Tanja] Ecole Polytech Fed Lausanne, Natl Competence Ctr Biomed Imaging, Lausanne, Switzerland; [Delaloye, Jean-Francois; Lehr, Hans-Anton] CHU Vaudois, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kerschgens, J (corresponding author), Univ Lausanne, Inst Biotechnol, Lausanne, Switzerland.	nicolas.mermod@unil.ch	Vogel, Horst/AAJ-5490-2021		University of Lausanne; Cancer Swiss Research Foundation	University of Lausanne; Cancer Swiss Research Foundation	Work in Dr. Mermod's lab is supported by a priority grant from the University of Lausanne and by an OncoSuisse grant of the Cancer Swiss Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babini E, 2004, BIOCHEMISTRY-US, V43, P16076, DOI 10.1021/bi048388o; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; BAUER R, 1994, NUCLEIC ACIDS RES, V22, P1413, DOI 10.1093/nar/22.8.1413; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Berger Michael F., 2006, V338, P245; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Collavin L, 1998, GENOMICS, V48, P265, DOI 10.1006/geno.1997.5172; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dong Y, 2003, CLIN CANCER RES, V9, P1710; Dong Y, 2008, BIOL CHEM, V389, P99, DOI 10.1515/BC.2008.013; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Egener T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni079; Esnault G, 2009, MOL CELL BIOL, V29, P2409, DOI 10.1128/MCB.00779-08; FOHR UG, 1993, EUR J BIOCHEM, V215, P719, DOI 10.1111/j.1432-1033.1993.tb18084.x; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Johnson W, 1997, J BIOL CHEM, V272, P15405, DOI 10.1074/jbc.272.24.15405; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kerschgens J, 2009, TRENDS MOL MED, V15, P352, DOI 10.1016/j.molmed.2009.06.004; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; Masternak K, 2000, GENE DEV, V14, P1156; McPherson LA, 2002, J BIOL CHEM, V277, P45028, DOI 10.1074/jbc.M208924200; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; NYBORG JK, 1990, J BIOL CHEM, V265, P8230; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Orso F, 2008, FASEB J, V22, P2702, DOI 10.1096/fj.08-106492; Pellikainen JM, 2007, INT J CANCER, V120, P2061, DOI 10.1002/ijc.22648; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; Planque C, 2005, BIOCHEM BIOPH RES CO, V329, P1260, DOI 10.1016/j.bbrc.2005.02.100; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; *R DEV COR TEAM T, 2004, R LANG ENV STAT COMP; Rozen S, 2000, Methods Mol Biol, V132, P365; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Sgorbissa A, 1999, J CELL SCI, V112, P4475; Shinoda Y, 2007, CANCER SCI, V98, P1078, DOI 10.1111/j.1349-7006.2007.00495.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Thomadaki H, 2009, THROMB HAEMOSTASIS, V101, P373, DOI 10.1160/TH08-01-0025; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486; Wajapeyee N, 2005, CANCER RES, V65, P8628, DOI 10.1158/0008-5472.CAN-05-1059; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WILLIAMS T, 1991, SCIENCE, V251, P1067, DOI 10.1126/science.1998122; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497; Yousef GM, 2003, CLIN BIOCHEM, V36, P443, DOI 10.1016/S0009-9120(03)00055-9; Yousef GM, 2002, UROLOGY, V60, P714, DOI 10.1016/S0090-4295(02)01811-3; Yousef GM, 2002, PROSTATE, V51, P126, DOI 10.1002/pros.10067	73	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22895	10.1371/journal.pone.0022895	http://dx.doi.org/10.1371/journal.pone.0022895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876733	gold, Green Published, Green Submitted			2022-12-25	WOS:000294126900005
J	Ludwig, K; Habbach, S; Krieglstein, J; Klumpp, S; Konig, S				Ludwig, Katrin; Habbach, Schaehdi; Krieglstein, Josef; Klumpp, Susanne; Koenig, Simone			MALDI-TOF High Mass Calibration up to 200 kDa Using Human Recombinant 16 kDa Protein Histidine Phosphatase Aggregates	PLOS ONE			English	Article							SUBSTRATE	Background: Protein histidine phosphatase (PHP) is an enzyme which removes phosphate groups from histidine residues. It was described for vertebrates in the year 2002. The recombinant human 16 kDa protein forms multimeric complexes in physiological buffer and in the gas phase. High-mass calibration in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has remained a problem due to the lack of suitable standards. Large proteins can hardly be freed of their substructural microheterogeneity by classical purification procedures so that their use as calibrants is limited. A small adduct-forming protein of validated quality is a valuable alternative for that purpose. Methodology/Principal Findings: Three major PHP clusters of similar to 113, 209 and similar to 600 kDa were observed in gel filtration analysis. Re-chromatography of the monomer peak showed the same cluster distribution. The tendency to associate was detected also in MALDI-TOF MS measuring regular adducts up to 200 kDa. Conclusions/Significance: PHP forms multimers consisting of up to more than 35 protein molecules. In MALDI-TOF MS it generates adduct ions every 16 kDa. The protein can be produced with high quality so that its use as calibration compound for high mass ranges above 100 kDa, where standards are difficult to obtain, is feasible.	[Koenig, Simone] Univ Munster, Core Unit, Interdisciplinary Ctr Clin Res, Fac Med, Munster, Germany; [Ludwig, Katrin; Habbach, Schaehdi; Krieglstein, Josef; Klumpp, Susanne] Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany	University of Munster; University of Munster	Ludwig, K (corresponding author), Univ Munster, Inst Pharmaceut & Med Chem, Munster, Germany.	koenigs@uni-muenster.de	König, Simone/B-6504-2008	König, Simone/0000-0003-0672-7246	Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Muenster; Institute of Pharmaceutical and Medical Chemistry, Muenster, Germany	Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Muenster; Institute of Pharmaceutical and Medical Chemistry, Muenster, Germany	This work was supported by the Interdisciplinary Center for Clinical Research of the Medical Faculty of the University of Muenster and the Institute of Pharmaceutical and Medical Chemistry, Muenster, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumer Nicole, 2007, V365, P247; Ek P, 2002, EUR J BIOCHEM, V269, P5016, DOI 10.1046/j.1432-1033.2002.03206.x; Klumpp S, 2002, J CEREBR BLOOD F MET, V22, P1420, DOI 10.1097/01.wcb.0000045041.03034.99; Klumpp S, 2003, BIOCHEM BIOPH RES CO, V306, P110, DOI 10.1016/S0006-291X(03)00920-3; Konig S, 1998, ANAL CHEM, V70, P4453, DOI 10.1021/ac980169j; LUDWIG K, 2008, THESIS MUNSTER; LUDWIG K, 2010, BIOMACROMOL MASS SPE, V2, P89; MA NT, 2009, THESIS MUNSTER; Maurer A, 2005, BIOCHEM BIOPH RES CO, V334, P1115, DOI 10.1016/j.bbrc.2005.06.200; MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P1158, DOI 10.1002/rcm.1290091215; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105	11	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23612	10.1371/journal.pone.0023612	http://dx.doi.org/10.1371/journal.pone.0023612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876758	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900030
J	Xiao, TZ; Bhatia, N; Urrutia, R; Lomberk, GA; Simpson, A; Longley, BJ				Xiao, Tony Z.; Bhatia, Neehar; Urrutia, Raul; Lomberk, Gwen A.; Simpson, Andrew; Longley, B. Jack			MAGE I Transcription Factors Regulate KAP1 and KRAB Domain Zinc Finger Transcription Factor Mediated Gene Repression	PLOS ONE			English	Article							TUMOR-ANTIGENS; CELL-LINES; PROTEIN; CANCER; FAMILY; RESISTANCE; COMPLEXES; MELANOMA; KS1	Class I MAGE proteins (MAGE I) are normally expressed only in developing germ cells but are aberrantly expressed in many cancers. They have been shown to promote tumor survival, aggressive growth, and chemoresistance but the underlying mechanisms and MAGE I functions have not been fully elucidated. KRAB domain zinc finger transcription factors (KZNFs) are the largest group of vertebrate transcription factors and regulate neoplastic transformation, tumor suppression, cellular proliferation, and apoptosis. KZNFs bind the KAP1 protein and direct KAP1 to specific DNA sequences where it suppresses gene expression by inducing localized heterochromatin characterized by histone 3 lysine 9 trimethylation (H3me3K9). Discovery that MAGE I proteins also bind to KAP1 prompted us to investigate whether MAGE I can affect KZNF and KAP1 mediated gene regulation. We found that expression of MAGE I proteins, MAGE-A3 or MAGE-C2, relieved repression of a reporter gene by ZNF382, a KZNF with tumor suppressor activity. ChIP of MAGE I (-) HEK293T cells showed KAP1 and H3me3K9 are normally bound to the ID1 gene, a target of ZNF382, but that binding is greatly reduced in the presence of MAGE I proteins. MAGE I expression relieved KAP1 mediated ID1 repression, causing increased expression of ID1 mRNA and ID1 chromatin relaxation characterized by loss of H3me3K9. MAGE I binding to KAP1 also induced ZNF382 poly-ubiquitination and degradation, consistent with loss of ZNF382 leading to decreased KAP1 binding to ID1. In contrast, MAGE I expression caused increased KAP1 binding to Ki67, another KAP1 target gene, with increased H3me3K9 and decreased Ki67 mRNA expression. Since KZNFs are required to direct KAP1 to specific genes, these results show that MAGE I proteins can differentially regulate members of the KZNF family and KAP1 mediated gene repression.	[Xiao, Tony Z.; Bhatia, Neehar; Longley, B. Jack] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Urrutia, Raul; Lomberk, Gwen A.] Mayo Clin, Dept Mol Neurosci, Dept Biochem & Mol Biol, Rochester, MN USA; [Urrutia, Raul; Lomberk, Gwen A.] Mayo Clin, Gastroenterol Res Unit, Rochester, MN USA; [Simpson, Andrew] Ludwig Inst Canc Res, New York, NY USA; [Longley, B. Jack] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Mayo Clinic; Ludwig Institute for Cancer Research; University of Wisconsin System; University of Wisconsin Madison	Xiao, TZ (corresponding author), Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	Txiao@dermatology.wisc.edu; bjlongley@dermatology.wisc.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	University of Wisconsin Department of Dermatology; Ludwig Institute for Cancer Research; Paul P. Carbone Comprehensive Cancer Center; National Institutes of Health [1T32AR055893-01A1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR055893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	University of Wisconsin Department of Dermatology; Ludwig Institute for Cancer Research; Paul P. Carbone Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the University of Wisconsin Department of Dermatology and the Ludwig Institute for Cancer Research. This work was partially supported by the Paul P. Carbone Comprehensive Cancer Center. TZX is a recipient of a National Institutes of Health T32 training award (1T32AR055893-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATIA BYN, 2011, ARCH BIOCH BIOPHYSIC; Brichard VG, 2007, VACCINE, V25, pB61, DOI 10.1016/j.vaccine.2007.06.038; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Chomez P, 2001, CANCER RES, V61, P5544; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Park JH, 2002, MOL CELLS, V14, P122; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548	23	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23747	10.1371/journal.pone.0023747	http://dx.doi.org/10.1371/journal.pone.0023747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876767	Green Submitted, gold, Green Published			2022-12-25	WOS:000294126900039
J	Kurasawa, Y; Kozaki, K; Pimkhaokham, A; Muramatsu, T; Ono, H; Ishihara, T; Uzawa, N; Imoto, I; Amagasa, T; Inazawa, J				Kurasawa, Y.; Kozaki, K.; Pimkhaokham, A.; Muramatsu, T.; Ono, H.; Ishihara, T.; Uzawa, N.; Imoto, I.; Amagasa, T.; Inazawa, J.			Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells	ONCOGENE			English	Article						EMT; DNA hypermethylation; WNT7A; WNT10A; oral squamous cell carcinoma	MIR-200 FAMILY; E-CADHERIN; TRANSITION; METHYLATION; ZEB1; ASSOCIATION; STATISTICS; EXPRESSION; GENES	The epithelial-mesenchymal transition (EMT) has a crucial role in normal and disease processes including tumor progression. In this study, we first classified epithelial-like and mesenchymal-like oral squamous cell carcinoma (OSCC) cell lines based on expression profiles of typical EMT-related genes using a panel of 18 OSCC cell lines. Then, we performed methylation-based and expression-based analyses of components of the Wnt signaling pathway, and identified WNT7A and WNT10A as genes silenced by mesenchymal-specific DNA hypermethylation in OSCCs. A significant association was revealed between some clinicopathological findings and the DNA methylation status of WNT7A (normal vs tumor, P = 0.007; T1-2 vs T3-4, P = 0.040; I-III vs IV, P = 0.016) and WNT10A (N0-N1 vs N2-N3, P = 0.046) in the advanced stages of OSCC. Moreover, we found that E-cadherin expression in cancer cells may be positively regulated by WNT7A, whose expression is negatively regulated by mesenchymal-specific DNA hypermethylation or ZEB1 in mesenchymal-like OSCC cells. Our findings indicate that epithelial-specific gene silencing through mesenchymal-specific DNA hypermethylation may stabilize the phenotypic plasticity of cancer cells during EMT/MET. Oncogene (2012) 31, 1963-1974; doi:10.1038/onc.2011.373; published online 29 August 2011	[Kurasawa, Y.; Kozaki, K.; Pimkhaokham, A.; Muramatsu, T.; Ono, H.; Ishihara, T.; Imoto, I.; Inazawa, J.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Yushima Bunkyo Ku, Tokyo 1138510, Japan; [Kurasawa, Y.; Kozaki, K.; Pimkhaokham, A.; Muramatsu, T.; Ono, H.; Ishihara, T.; Imoto, I.; Inazawa, J.] Tokyo Med & Dent Univ, Sch Biomed Sci, Yushima Bunkyo Ku, Tokyo 1138510, Japan; [Kurasawa, Y.; Uzawa, N.; Amagasa, T.] Tokyo Med & Dent Univ, Dept Maxillofacial Surg, Yushima Bunkyo Ku, Tokyo 1138510, Japan; [Kozaki, K.; Inazawa, J.] Tokyo Med & Dent Univ, Dept Genome Med, Hard Tissue Genome Res Ctr, Yushima Bunkyo Ku, Tokyo 1138510, Japan; [Pimkhaokham, A.] Chulalongkorn Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Bangkok, Thailand; [Inazawa, J.] Tokyo Med & Dent Univ, Program Int Res, Ctr Mol Sci Tooth & Bone Dis, GCOE, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Chulalongkorn University; Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Yushima Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp	Pimkhaokham, Atiphan/AAQ-4177-2021; Imoto, Issei/AAD-5799-2020; imoto, Issei/D-8065-2012; Kozaki, Ken-ichi/M-6281-2014	Kozaki, Ken-ichi/0000-0003-3286-819X; Pimkhaokham, Atiphan/0000-0002-0170-243X	Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation; New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [23390077, 22134002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation(Core Research for Evolutional Science and Technology (CREST)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ayako Takahashi and Rumi Mori for technical assistance. This study was supported in part by Grant-in-Aid for Scientific Research (A), (B) and (C), and Scientific Research on Priority Areas and Innovative Areas, and the Global Center of Excellence Program for International Research Center for Molecular Science in Tooth and Bone Diseases from the Ministry of Education, Culture, Sports, Science and Technology, Japan; a Health and Labour Sciences Research Grant by the Ministry of Health, Labour and Welfare, Japan; a grant from Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation; and a grant from the New Energy and Industrial Technology Development Organization.	Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nomura K, 2005, CANC STAT JAPAN 2005, P36; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Papageorgis P, 2010, CANCER RES, V70, P968, DOI 10.1158/0008-5472.CAN-09-1872; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sato N, 2003, CANCER RES, V63, P3735; Scully C, 2000, ORAL ONCOL, V36, P256, DOI 10.1016/S1368-8375(00)00007-5; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Suzuki E, 2007, ONCOGENE, V26, P7921, DOI 10.1038/sj.onc.1210589; Taki M, 2003, CANCER SCI, V94, P593, DOI 10.1111/j.1349-7006.2003.tb01488.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	30	8	8	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1963	1974		10.1038/onc.2011.373	http://dx.doi.org/10.1038/onc.2011.373			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21874048				2022-12-25	WOS:000302809900008
J	Taniguchi, H; Jacinto, FV; Villanueva, A; Fernandez, AF; Yamamoto, H; Carmona, FJ; Puertas, S; Marquez, VE; Shinomura, Y; Imai, K; Esteller, M				Taniguchi, H.; Jacinto, F. V.; Villanueva, A.; Fernandez, A. F.; Yamamoto, H.; Carmona, F. J.; Puertas, S.; Marquez, V. E.; Shinomura, Y.; Imai, K.; Esteller, M.			Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer	ONCOGENE			English	Article						epigenetics; histone methyltransferase; EZH2; KLF2	TRANSCRIPTION FACTORS; CELL-GROWTH; POLYCOMB; REPRESSION; PROGRESSION; EXPRESSION; COMPLEX; TARGET	The Kruppel-like factor (KLF) proteins are multitasked transcriptional regulators with an expanding tumor suppressor function. KLF2 is one of the prominent members of the family because of its diminished expression in malignancies and its growth-inhibitory, pro-apoptotic and anti-angiogenic roles. In this study, we show that epigenetic silencing of KLF2 occurs in cancer cells through direct transcriptional repression mediated by the Polycomb group protein Enhancer of Zeste Homolog 2 (EZH2). Binding of EZH2 to the 5'-end of KLF2 is also associated with a gain of trimethylated lysine 27 histone H3 and a depletion of phosphorylated serine 2 of RNA polymerase. Upon depletion of EZH2 by RNA interference, short hairpin RNA or use of the small molecule 3-Deazaneplanocin A, the expression of KLF2 was restored. The transfection of KLF2 in cells with EZH2-associated silencing showed a significant anti-tumoral effect, both in culture and in xenografted nude mice. In this last setting, KLF2 transfection was also associated with decreased dissemination and lower mortality rate. In EZH2-depleted cells, which characteristically have lower tumorigenicity, the induction of KLF2 depletion 'rescued' partially the oncogenic phenotype, suggesting that KLF2 repression has an important role in EZH2 oncogenesis. Most importantly, the translation of the described results to human primary samples demonstrated that patients with prostate or breast tumors with low levels of KLF2 and high expression of EZH2 had a shorter overall survival. Oncogene (2012) 31, 1988-1994; doi:10.1038/onc.2011.387; published online 5 September 2011	[Taniguchi, H.; Jacinto, F. V.; Fernandez, A. F.; Carmona, F. J.; Esteller, M.] Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Taniguchi, H.; Yamamoto, H.; Shinomura, Y.] Sapporo Med Univ, Sch Med, Dept Internal Med 1, Sapporo, Hokkaido, Japan; [Taniguchi, H.] Sapporo Med Univ, Sch Med, Tumor Med Examinat & Treatment Ctr, Sapporo, Hokkaido, Japan; [Jacinto, F. V.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Villanueva, A.; Puertas, S.] Bellvitge Biomed Res Inst IDIBELL, ICO, Barcelona, Spain; [Marquez, V. E.] NCI, Biol Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Imai, K.] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Esteller, M.] ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Sapporo Medical University; Sapporo Medical University; Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tokyo; University of Barcelona; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, 3rd Floor,Avda Gran Via LHosp 199-203, Barcelona 08908, Catalonia, Spain.	mesteller@idibell.cat	Marquez, Victor/AAP-3549-2021; Esteller, Manel/L-5956-2014; Taniguchi, Hiroaki/AGB-3012-2022; Fernandez, Agustin F./N-7302-2014	Esteller, Manel/0000-0003-4490-6093; Taniguchi, Hiroaki/0000-0003-0494-5290; Fernandez, Agustin F./0000-0002-3792-4085; Carmona Sanz, F Javier/0000-0001-7904-8493	Lilly Foundation; Dr Josef Steiner Cancer Research Foundation; NIH, National Cancer Institute and Center for Cancer Research;  [SAF2007-00027-65134];  [Consolider CSD2006-49]; ICREA Funding Source: Custom	Lilly Foundation; Dr Josef Steiner Cancer Research Foundation; NIH, National Cancer Institute and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ICREA(ICREA)	We thank O Dominguez for help with the microarray procedures and analysis, F Setien for technical assistance and Miki Kojiya for the flow cytometry analysis. This work was supported by Grants SAF2007-00027-65134, Consolider CSD2006-49, and Lilly Foundation and Dr Josef Steiner Cancer Research Foundation to ME, and the Intramural Research Program of the NIH, National Cancer Institute and Center for Cancer Research to VEM. HT is supported by the Uehara Memorial Foundation and Pancreas Research Foundation of Japan. ME is an ICREA Research Professor.	Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Bureau C, 2009, CURR GENOMICS, V10, P353, DOI 10.2174/138920209788921010; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kannan-Thulasiraman P, 2010, J BIOL CHEM, V285, P19106, DOI 10.1074/jbc.M109.099770; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Pasini D, 2004, CELL CYCLE, V3, P396; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201	26	80	86	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1988	1994		10.1038/onc.2011.387	http://dx.doi.org/10.1038/onc.2011.387			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21892211	Green Published, hybrid			2022-12-25	WOS:000302809900010
J	Fujikawa, A; Fukada, M; Makioka, Y; Suzuki, R; Chow, JPH; Matsumoto, M; Noda, M				Fujikawa, Akihiro; Fukada, Masahide; Makioka, Yoshikazu; Suzuki, Ryoko; Chow, Jeremy Pak Hong; Matsumoto, Masahito; Noda, Masaharu			Consensus Substrate Sequence for Protein-tyrosine Phosphatase Receptor Type Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA RPTP-BETA; PHOSPHORYLATION SITES; TRAPPING SYSTEM; CELL-ADHESION; GROWTH-FACTOR; PAXILLIN; GIT1; MICE; ACTIVATION; IDENTIFICATION	Protein-tyrosine phosphatase receptor type Z (Ptprz) has multiple substrate proteins, including G protein-coupled receptor kinase-interactor 1 (Git1), membrane-associated guanylate kinase, WW and PDZ domain-containing 1 (Magi1), and GTPase-activating protein for Rho GTPase (p190RhoGAP). We have identified a dephosphorylation site at Tyr-1105 of p190RhoGAP; however, the structural determinants employed for substrate recognition of Ptprz have not been fully defined. In the present study, we revealed that Ptprz selectively dephosphorylates Git1 at Tyr-554, and Magi1 at Tyr-373 and Tyr-858 by in vitro and cell-based assays. Of note, the dephosphorylation of the Magi1 Tyr-858 site required PDZ domain-mediated interaction between Magi1 and Ptprz in the cellular context. Alignment of the primary sequences surrounding the target phosphotyrosine residue in these three substrates showed considerable similarity, suggesting a consensus motif for recognition by Ptprz. We then estimated the contribution of surrounding individual amino acid side chains to the catalytic efficiency by using fluorescent peptides based on the Git1 Tyr-554 sequence in vitro. The typical substrate motif for the catalytic domain of Ptprz was deduced to be Glu/Asp-Glu/Asp-Glu/Asp-Xaa-Ile/Val-Tyr(P)-Xaa (Xaa is not an acidic residue). Intriguingly, a G854D substitution of the Magi1 Tyr-858 site matching better to the motif sequence turned this site to be susceptible to dephosphorylation by Ptprz independent of the PDZ domain-mediated interaction in cells. Furthermore, we found by database screening that the substrate motif is present in several proteins, including paxillin at Tyr-118, its major phosphorylation site. Expectedly, we verified that Ptprz efficiently dephosphorylates paxillin at this site in cells. Our study thus provides key insights into the molecular basis for the substrate recognition of Ptprz.	[Fujikawa, Akihiro; Fukada, Masahide; Suzuki, Ryoko; Chow, Jeremy Pak Hong; Matsumoto, Masahito; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Chow, Jeremy Pak Hong; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; [Makioka, Yoshikazu] Tokyo Inst Technol, Chem Resources Lab, Synthet Organ Div, Midori Ku, Kanagawa 2268503, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokyo Institute of Technology	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Noda, Masaharu/D-7146-2016; Matsumoto, Masahito/ABB-3002-2021	Fujikawa, Akihiro/0000-0002-3950-0550; Noda, Masaharu/0000-0002-3796-524X; 	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)	Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT).	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Gee SH, 1998, J NEUROSCI, V18, P128; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Kawachi H, 1999, MOL BRAIN RES, V72, P47, DOI 10.1016/S0169-328X(99)00204-1; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lou XJ, 2001, MOL BIOL CELL, V12, P615, DOI 10.1091/mbc.12.3.615; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Menon P, 2010, BRAIN RES, V1317, P218, DOI 10.1016/j.brainres.2009.11.084; Mitra S, 2005, BIOORG MED CHEM LETT, V15, P5142, DOI 10.1016/j.bmcl.2005.08.054; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakamura K, 2000, J BIOL CHEM, V275, P27155; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; SABE H, 1992, MOL CELL BIOL, V12, P4706, DOI 10.1128/MCB.12.10.4706; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Schmalzigaug R, 2009, NEUROSCI LETT, V458, P79, DOI 10.1016/j.neulet.2009.04.037; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Shintani T, 2008, J BIOCHEM, V144, P259, DOI 10.1093/jb/mvn064; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsubouchi A, 2002, J CELL BIOL, V159, P673, DOI 10.1083/jcb.200202117; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Webb DJ, 2006, J CELL SCI, V119, P2847, DOI 10.1242/jcs03044; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	35	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37137	37146		10.1074/jbc.M111.270140	http://dx.doi.org/10.1074/jbc.M111.270140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890632	Green Published, hybrid			2022-12-25	WOS:000296542400014
J	Kim, SS; Seo, SR				Kim, Seon Sook; Seo, Su Ryeon			The Regulator of Calcineurin 1 (RCAN1/DSCR1) Activates the cAMP Response Element-binding Protein (CREB) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; DOWN-SYNDROME; TRANSCRIPTION FACTORS; GENE-TRANSCRIPTION; NERVOUS-SYSTEM; C-FOS; BRAIN; MEMORY; DSCR1; OVEREXPRESSION	cAMP response element-binding protein (CREB) is one of the best known transcription factors in the development and function of the nervous system. In this report, we found that the regulator of calcineurin 1 (RCAN1), which is overexpressed in the brain of patients with Down syndrome, increased the phosphorylation of CREB and cAMP response element-mediated gene transcription in response to the activation of the intracellular cAMP pathway. Furthermore, we found that the increased activation of CREB signaling by RCAN1 depended on the ability of RCAN1 to inhibit calcineurin activity. Our data provide the first evidence that RCAN1 acts as an important regulatory component in the control of CREB signaling.	[Kim, Seon Sook; Seo, Su Ryeon] Kangwon Natl Univ, Dept Mol Biosci, Coll Biomed Sci, Chunchon 200701, South Korea	Kangwon National University	Seo, SR (corresponding author), Kangwon Natl Univ, Dept Mol Biosci, Coll Biomed Sci, Chunchon 200701, South Korea.	suryeonseo@kangwon.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2009-0065231, 2010-0023815]; Brain Korea 21 program	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science, and Technology Grants 2009-0065231 and 2010-0023815 and by the Brain Korea 21 program.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Dodge KL, 2003, BIOCHEM BIOPH RES CO, V311, P1111, DOI 10.1016/j.bbrc.2003.09.040; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hahm SH, 2003, MOL PHARMACOL, V64, P1503, DOI 10.1124/mol.64.6.1503; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; KING MM, 1984, J BIOL CHEM, V259, P8080; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Lee EJ, 2007, MOL CELL NEUROSCI, V35, P585, DOI 10.1016/j.mcn.2007.05.003; Lee M, 2006, MOL CELLS, V22, P1; Liu F, 2005, J BIOL CHEM, V280, P37755, DOI 10.1074/jbc.M507475200; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yuan Q, 2003, J NEUROSCI, V23, P4760	42	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37841	37848		10.1074/jbc.M111.232165	http://dx.doi.org/10.1074/jbc.M111.232165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890628	Green Published, hybrid			2022-12-25	WOS:000296542400078
J	Tretter, V; Kerschner, B; Milenkovic, I; Ramsden, SL; Ramerstorfer, J; Saiepour, L; Maric, HM; Moss, SJ; Schindelin, H; Harvey, RJ; Sieghart, W; Harvey, K				Tretter, Verena; Kerschner, Bernd; Milenkovic, Ivan; Ramsden, Sarah L.; Ramerstorfer, Joachim; Saiepour, Leila; Maric, Hans-Michael; Moss, Stephen J.; Schindelin, Hermann; Harvey, Robert J.; Sieghart, Werner; Harvey, Kirsten			Molecular Basis of the gamma-Aminobutyric Acid A Receptor alpha 3 Subunit Interaction with the Clustering Protein Gephyrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE RECEPTOR; GABA(A) RECEPTORS; GABAERGIC SYNAPSES; KNOCKOUT MICE; A RECEPTORS; RAT-BRAIN; COLLYBISTIN; SUBTYPES; BINDING; LOCALIZATION	The multifunctional scaffolding protein gephyrin is a key player in the formation of the postsynaptic scaffold at inhibitory synapses, clustering both inhibitory glycine receptors (GlyRs) and selected GABA(A) receptor (GABA(A)R) subtypes. We report a direct interaction between the GABA(A)R alpha 3 subunit and gephyrin, mapping reciprocal binding sites using mutagenesis, overlay, and yeast two-hybrid assays. This analysis reveals that critical determinants of this interaction are located in the motif FNIVGTTYPI in the GABA(A)R alpha 3 M3-M4 domain and the motif SMDKAFITVL at the N terminus of the gephyrin E domain. GABA(A)R alpha 3 gephyrin binding-site mutants were unable to co-localize with endogenous gephyrin in transfected hippocampal neurons, despite being able to traffic to the cell membrane and form functional benzodiazepine-responsive GABA(A)Rs in recombinant systems. Interestingly, motifs responsible for interactions with GABA(A)R alpha 2, GABA(A)R alpha 3, and collybistin on gephyrin overlap. Curiously, two key residues (Asp-327 and Phe-330) in the GABA(A)R alpha 2 and alpha 3 binding sites on gephyrin also contribute to GlyR beta subunit-E domain interactions. However, isothermal titration calorimetry reveals a 27-fold difference in the interaction strength between GABA(A)R alpha 3 and GlyR beta subunits with gephyrin with dissociation constants of 5.3 mu M and 0.2 mu M, respectively. Taken together, these observations suggest that clustering of GABA(A)R alpha 2, alpha 3, and GlyRs by gephyrin is mediated by distinct mechanisms at mixed glycinergic/GABAergic synapses.	[Tretter, Verena; Kerschner, Bernd; Milenkovic, Ivan; Ramerstorfer, Joachim; Sieghart, Werner] Med Univ Vienna, Dept Biochem & Mol Biol, Ctr Brain Res, A-1090 Vienna, Austria; [Ramsden, Sarah L.; Saiepour, Leila; Harvey, Robert J.; Harvey, Kirsten] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Maric, Hans-Michael; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; [Moss, Stephen J.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Medical University of Vienna; University of London; University College London; University of London School of Pharmacy; University of Wurzburg; Tufts University; University of London; University College London	Tretter, V (corresponding author), Med Univ Vienna, Dept Biochem & Mol Biol, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	eva.tretter@meduniwien.ac.at; kirsten.harvey@pharmacy.ac.uk	Schindelin, Hermann/Q-2697-2019; Maric, Hans Michael/AAQ-8205-2020; Sieghart, Werner/A-4877-2013; Harvey, Robert/D-3994-2016	Maric, Hans Michael/0000-0002-2719-4752; Sieghart, Werner/0000-0002-0443-0302; Harvey, Robert/0000-0001-5956-6664; Milenkovic, Ivan/0000-0002-2990-0243	Medical Research Council [G0501258]; EC [HEALTH-F4-2008-202088]; Institute of Neurological Disorders and Stroke [NS047478, NS48045, NS051195, NS054900, NS056359, NS065725]; Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine [FZ 82, SFB487 C7]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS054900, R01NS081986, R01NS056359, R01NS051195, R01NS047478, R03NS065725, R01NS048045] Funding Source: NIH RePORTER; MRC [G0501258, G0800498] Funding Source: UKRI; Medical Research Council [G0800498] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC(European CommissionEuropean Commission Joint Research Centre); Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council New Investigator Award G0501258 (to K. H.), the EC-FP7 integrated project "Neurocypres," grant agreement (to W. S.), HEALTH-F4-2008-202088 grant, the Institute of Neurological Disorders and Stroke grants (NS047478, NS48045, NS051195, NS054900, NS056359, and NS065725, to S. J. M.), and the Deutsche Forschungsgemeinschaft Rudolf Virchow Center for Experimental Biomedicine Grants FZ 82 and SFB487 C7 (to H. S.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Corteen NL, 2011, EUR J NEUROSCI, V34, P250, DOI 10.1111/j.1460-9568.2011.07740.x; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fiorelli R, 2008, BEHAV PHARMACOL, V19, P582, DOI 10.1097/FBP.0b013e32830dc0c7; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Gross A, 2011, EUR J NEUROSCI, V33, P868, DOI 10.1111/j.1460-9568.2010.07552.x; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li XY, 2003, J MED CHEM, V46, P5567, DOI 10.1021/jm034164c; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	35	75	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37702	37711		10.1074/jbc.M111.291336	http://dx.doi.org/10.1074/jbc.M111.291336			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880742	Green Published, hybrid			2022-12-25	WOS:000296542400066
J	Lin, P; Correa, D; Lin, Y; Caplan, AI				Lin, Paul; Correa, Diego; Lin, Yuan; Caplan, Arnold I.			Polybrene Inhibits Human Mesenchymal Stem Cell Proliferation during Lentiviral Transduction	PLOS ONE			English	Article							GENE-TRANSFER; IN-VITRO; MARROW; EXPRESSION; CONSUMPTION; HYPOXIA	Human mesenchymal stem cells (hMSCs) can be engineered to express specific genes, either for their use in cell-based therapies or to track them in vivo over long periods of time. To obtain long-term expression of these genes, a lentivirus-or retrovirus-mediated cell transduction is often used. However, given that the efficiency with these viruses is typically low in primary cells, additives such as polybrene are always used for efficient viral transduction. Unfortunately, as presented here, exposure to polybrene alone at commonly used concentratons (1-8 mu g/mL) negatively impacts hMSC proliferation in a dose-dependent manner as measured by CyQUANT, EdU incorporation, and cell cycle analysis. This inhibition of proliferation was observable in culture even 3 weeks after exposure. Culturing the cells in the presence of FGF-2, a potent mitogen, did not abrogate this negative effect of polybrene. In fact, the normally sharp increase in hMSC proliferation that occurs during the first days of exposure to FGF-2 was absent at 4 mu g/mL or higher concentrations of polybrene. Similarly, the effect of stimulating cell proliferation under simulated hypoxic conditions was also decreased when cells were exposed to polybrene, though overall proliferation rates were higher. The negative influence of polybrene was, however, reduced when the cells were exposed to polybrene for a shorter period of time (6 hr vs 24 hr). Thus, careful evaluation should be done when using polybrene to aid in lentiviral transduction of human MSCs or other primary cells, especially when cell number is critical.	[Lin, Paul] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lin, Paul; Correa, Diego; Caplan, Arnold I.] Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA; [Lin, Yuan] Stanford Univ, Stanford Canc Ctr, Stanford, CA 94305 USA	Case Western Reserve University; Case Western Reserve University; Stanford Cancer Institute; Stanford University	Lin, P (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	pxl57@case.edu		Caplan, Arnold/0000-0002-8677-6621; Lin, Paul/0000-0002-0524-267X	L. David and E. Virginia Baldwin Foundation; National Institutes of Health [T32 GM007250]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	L. David and E. Virginia Baldwin Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the L. David and E. Virginia Baldwin Foundation. PL was supported in part by National Institutes of Health T32 GM007250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balyasnikova IV, 2010, J TISSUE ENG REGEN M, V4, P247, DOI 10.1002/term.228; Caplan A I, 1995, Connect Tissue Res, V31, pS9, DOI 10.3109/03008209509116826; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; COELEN RJ, 1983, ARCH VIROL, V75, P307, DOI 10.1007/BF01314897; Davis HE, 2002, BIOPHYS CHEM, V97, P159, DOI 10.1016/S0301-4622(02)00057-1; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; de la Garza-Rodea AS, 2011, CELL TRANSPLANT, V20, P217, DOI 10.3727/096368910X522117; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; LENNON DP, 2006, CULTURE CELLS TISSUE, P23; Mamchaoui K, 2000, AM J PHYSIOL-LUNG C, V278, pL858, DOI 10.1152/ajplung.2000.278.4.L858; METZEN E, 1995, RESP PHYSIOL, V100, P101, DOI 10.1016/0034-5687(94)00125-J; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Palsson B., 2004, TISSUE ENG, P74; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ray P, 2004, CANCER RES, V64, P1323, DOI 10.1158/0008-5472.CAN-03-1816; Seitz B, 1998, GRAEF ARCH CLIN EXP, V236, P602, DOI 10.1007/s004170050129; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com; Zielske SP, 2009, INT J RADIAT ONCOL, V75, P843, DOI 10.1016/j.ijrobp.2008.06.1953	27	53	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23891	10.1371/journal.pone.0023891	http://dx.doi.org/10.1371/journal.pone.0023891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887340	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298800022
J	Kasai, A; Kinjo, T; Ishihara, R; Sakai, I; Ishimaru, Y; Yoshioka, Y; Yamamuro, A; Ishige, K; Ito, Y; Maeda, S				Kasai, Atsushi; Kinjo, Toshihiko; Ishihara, Rie; Sakai, Ikumi; Ishimaru, Yuki; Yoshioka, Yasuhiro; Yamamuro, Akiko; Ishige, Kumiko; Ito, Yoshihisa; Maeda, Sadaaki			Apelin Deficiency Accelerates the Progression of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MOTOR-NEURON DEGENERATION; VASCULAR DEVELOPMENT; PROLONGS SURVIVAL; APJ RECEPTOR; SPINAL-CORD; G-PROTEIN; ALS; MICE; MICROGLIA	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the selective loss of motor neurons. Recent studies have implicated that chronic hypoxia and insufficient vascular endothelial growth factor (VEGF)-dependent neuroprotection may lead to the degeneration of motor neurons in ALS. Expression of apelin, an endogenous ligand for the G protein-coupled receptor APJ, is regulated by hypoxia. In addition, recent reports suggest that apelin protects neurons against glutamate-induced excitotoxicity. Here, we examined whether apelin is an endogenous neuroprotective factor using SOD1(G93A) mouse model of ALS. In mouse CNS tissues, the highest expressions of both apelin and APJ mRNAs were detected in spinal cord. APJ immunoreactivity was observed in neuronal cell bodies located in gray matter of spinal cord. Although apelin mRNA expression in the spinal cord of wild-type mice was not changed from 4 to 18 weeks age, that of SOD1(G93A) mice was reduced along with the paralytic phenotype. In addition, double mutant apelin-deficient and SOD1(G93A) displayed the disease phenotypes earlier than SOD1(G93A) littermates. Immunohistochemical observation revealed that the number of motor neurons was decreased and microglia were activated in the spinal cord of the double mutant mice, indicating that apelin deficiency pathologically accelerated the progression of ALS. Furthermore, we showed that apelin enhanced the protective effect of VEGF on H2O2-induced neuronal death in primary neurons. These results suggest that apelin/APJ system in the spinal cord has a neuroprotective effect against the pathogenesis of ALS.	[Kasai, Atsushi; Kinjo, Toshihiko; Ishihara, Rie; Sakai, Ikumi; Ishimaru, Yuki; Yoshioka, Yasuhiro; Yamamuro, Akiko; Maeda, Sadaaki] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacotherapeut, Osaka, Japan; [Ishige, Kumiko; Ito, Yoshihisa] Nihon Univ, Dept Pharm, Sch Pharm, Pharmacol Lab, Chiba, Japan; [Kasai, Atsushi] Univ Calif Los Angeles, Dept Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA	Setsunan University; Nihon University; University of California System; University of California Los Angeles	Kasai, A (corresponding author), Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacotherapeut, Osaka, Japan.	akasai@mednet.ucla.edu	Kasai, Atsushi/C-8073-2011	Kasai, Atsushi/0000-0002-1612-3078; Yoshioka, Yasuhiro/0000-0002-6827-9701; Ishimaru, Yuki/0000-0002-6767-7628	Naito Foundation [2008-116]; Japan Science Society [21-404];  [21590110]	Naito Foundation(Naito Memorial Foundation); Japan Science Society; 	This work was supported in part by Grant-in-Aid for Scientific Research (C) 21590110 (to S.M.) (http://www.jsps.go.jp/english/e-grants/grants.html), the Naito Foundation 2008-116 (to A.K.) (http://www.naito-f.or.jp/grant), and the Sasagawa Scientific Research Grant 21-404 from The Japan Science Society (to A.K.) (https://www.jss.or.jp/sasagawa). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Chian RJ, 2009, BRAIN RES, V1287, P1, DOI 10.1016/j.brainres.2009.06.066; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Ilzecka J, 2004, CLIN NEUROL NEUROSUR, V106, P289, DOI 10.1016/j.clineuro.2003.12.007; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ishiyama T, 1997, EXP NEUROL, V148, P247, DOI 10.1006/exnr.1997.6643; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kidoya H, 2008, EMBO J, V27, P522, DOI 10.1038/sj.emboj.7601982; Kunduzova O, 2008, FASEB J, V22, P4146, DOI 10.1096/fj.07-104018; Lu L, 2007, J NEUROSCI, V27, P7929, DOI 10.1523/JNEUROSCI.1877-07.2007; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Mitsumoto Hiroshi, 2007, Brain and Nerve (Tokyo), V59, P383; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; O'Donnell LA, 2007, J NEUROCHEM, V102, P1905, DOI 10.1111/j.1471-4159.2007.04645.x; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Yoshioka Y, 2010, J PHARMACOL SCI, V113, P153, DOI 10.1254/jphs.10060FP; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	36	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23968	10.1371/journal.pone.0023968	http://dx.doi.org/10.1371/journal.pone.0023968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887354	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000079
J	Lin, CH; Tsai, IL; Su, CH; Tseng, DY; Hwang, PP				Lin, Chia-Hao; Tsai, I-Lun; Su, Che-Hsien; Tseng, Deng-Yu; Hwang, Pung-Pung			Reverse Effect of Mammalian Hypocalcemic Cortisol in Fish: Cortisol Stimulates Ca2+ Uptake via Glucocorticoid Receptor-Mediated Vitamin D-3 Metabolism	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-MOSSAMBICUS; EPITHELIAL CALCIUM-CHANNEL; RAINBOW-TROUT; ION REGULATION; CORTICOSTEROID RECEPTORS; ONCORHYNCHUS-MYKISS; EXPRESSION; GILL; TELEOST; STRESS	Cortisol was reported to downregulate body-fluid Ca2+ levels in mammals but was proposed to show hypercalcemic effects in teleostean fish. Fish, unlike terrestrial vertebrates, obtain Ca2+ from the environment mainly via the gills and skin rather than by dietary means, and have to regulate the Ca2+ uptake functions to cope with fluctuating Ca2+ levels in aquatic environments. Cortisol was previously found to regulate Ca2+ uptake in fish; however, the molecular mechanism behind this is largely unclear. Zebrafish were used as a model to explore this issue. Acclimation to low-Ca2+ fresh water stimulated Ca2+ influx and expression of epithelial calcium channel (ecac), 11 beta-hydroxylase and the glucocorticoid receptor (gr). Exogenous cortisol increased Ca2+ influx and the expressions of ecac and hydroxysteroid 11-beta dehydrogenase 2 (hsd11b2), but downregulated 11 beta-hydroxylase and the gr with no effects on other Ca2+ transporters or the mineralocorticoid receptor (mr). Morpholino knockdown of the GR, but not the MR, was found to impair zebrafish Ca2+ uptake function by inhibiting the ecac expression. To further explore the regulatory mechanism of cortisol in Ca2+ uptake, the involvement of vitamin D-3 was analyzed. Cortisol stimulated expressions of vitamin D-25hydroxylase (cyp27a1), cyp27a1 like (cyp27a1l), 1 alpha-OHase (cyp27b1) at 3 dpf through GR, the first time to demonstrate the relationship between cortisol and vitamin D-3 in fish. In conclusion, cortisol stimulates ecac expression to enhance Ca2+ uptake functions, and this control pathway is suggested to be mediated by the GR. Lastly, cortisol also could mediate vitamin D-3 signaling to stimulate Ca2+ uptake in zebrafish.	[Lin, Chia-Hao; Hwang, Pung-Pung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Chia-Hao; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Tsai, I-Lun] Natl Pingtung Univ Sci & Technol, Dept Aquaculture, Pingtung, Taiwan; [Su, Che-Hsien; Hwang, Pung-Pung] Natl Taiwan Univ, Inst Fishery Sci, Taipei 10764, Taiwan; [Tseng, Deng-Yu] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Pingtung University Science & Technology; National Taiwan University; National University Tainan	Lin, CH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	pphwang@gate.sinica.edu.tw	Lin, Chia-Hao/AHC-6514-2022; Hwang, Pung-Pung/AAH-1538-2022; hwang, pp/A-3641-2011; Hwang, Pung-Pung/AEQ-4633-2022		National Science Council; Academia Sinica, Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Taiwan, ROC(Academia Sinica - Taiwan)	This study was financially supported by grants to P. P. Hwang from the National Science Council, and Academia Sinica, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink W, 2007, J ENDOCRINOL, V193, P473, DOI 10.1677/JOE-06-0164; Baker ME, 2003, ENDOCRINOLOGY, V144, P4223, DOI 10.1210/en.2003-0843; BIKLE DD, 1993, J CLIN ENDOCR METAB, V76, P456, DOI 10.1210/jc.76.2.456; Bury NR, 2007, GEN COMP ENDOCR, V153, P47, DOI 10.1016/j.ygcen.2007.03.009; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen YY, 2003, J EXP ZOOL PART A, V295A, P127, DOI 10.1002/jez.a.10195; CHESNEY RW, 1978, LANCET, V2, P1123; Cole MA, 2000, PSYCHONEUROENDOCRINO, V25, P151, DOI 10.1016/S0306-4530(99)00045-1; Colombe L, 2000, STEROIDS, V65, P319, DOI 10.1016/S0039-128X(00)00090-8; COSMAN F, 1994, J BONE MINER RES, V9, P1097; DELUCA HF, 1988, FASEB J, V2, P224, DOI 10.1096/fasebj.2.3.3280376; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; FLIK G, 1989, J ENDOCRINOL, V120, P75, DOI 10.1677/joe.0.1200075; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Greenwood AK, 2003, ENDOCRINOLOGY, V144, P4226, DOI 10.1210/en.2003-0566; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Huybers S, 2007, AM J PHYSIOL-GASTR L, V292, pG92, DOI 10.1152/ajpgi.00317.2006; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054; Jiang JQ, 2003, J MOL ENDOCRINOL, V31, P305, DOI 10.1677/jme.0.0310305; Kelly SP, 2008, IN VITRO CELL DEV-AN, V44, P96, DOI 10.1007/s11626-007-9077-6; Kiilerich P, 2007, J ENDOCRINOL, V194, P417, DOI 10.1677/JOE-07-0185; Kim MH, 2009, EXP PHYSIOL, V94, P138, DOI 10.1113/expphysiol.2008.044339; Kusakabe M, 2003, ENDOCRINOLOGY, V144, P2534, DOI 10.1210/en.2002-220446; Liao BK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-354; Lin GR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P397, DOI 10.1086/316682; Lock EJ, 2007, J ENDOCRINOL, V193, P459, DOI 10.1677/JOE-06-0198; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; Mathew LK, 2007, J BIOL CHEM, V282, P35202, DOI 10.1074/jbc.M706640200; MAULE AG, 1991, GEN COMP ENDOCR, V84, P83, DOI 10.1016/0016-6480(91)90067-G; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; McGowan JE, 2000, J NEUROSCI, V20, P7424; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MORRIS HA, 1990, CALCIFIED TISSUE INT, V46, P305, DOI 10.1007/BF02563820; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; Patschan D, 2001, BONE, V29, P498, DOI 10.1016/S8756-3282(01)00610-X; PERRY SF, 1992, FISH PHYSIOL BIOCHEM, V10, P327, DOI 10.1007/BF00004482; POTTINGER TG, 1990, GEN COMP ENDOCR, V80, P264, DOI 10.1016/0016-6480(90)90171-H; PRUMMEL MF, 1991, J CLIN ENDOCR METAB, V72, P382, DOI 10.1210/jcem-72-2-382; Qiu AD, 2004, GENE, V342, P113, DOI 10.1016/j.gene.2004.07.041; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; SEEMAN E, 1980, J CLIN INVEST, V66, P664, DOI 10.1172/JCI109902; Shahsavarani A, 2006, AM J PHYSIOL-REG I, V291, pR1490, DOI 10.1152/ajpregu.00026.2006; SHRIMPTON JM, 1994, AM J PHYSIOL, V267, pR432, DOI 10.1152/ajpregu.1994.267.2.R432; SHULTZ TD, 1982, P NATL ACAD SCI-BIOL, V79, P3542, DOI 10.1073/pnas.79.11.3542; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; SUNDELL K, 1993, GEN COMP ENDOCR, V91, P344, DOI 10.1006/gcen.1993.1135; SWARUP K, 1991, COMP BIOCHEM PHYS A, V100, P445, DOI 10.1016/0300-9629(91)90497-Z; Takahashi H, 2006, LIFE SCI, V78, P2329, DOI 10.1016/j.lfs.2005.09.050; Trapp T, 1996, TRENDS PHARMACOL SCI, V17, P145, DOI 10.1016/0165-6147(96)81590-2; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; WEISBART M, 1987, GEN COMP ENDOCR, V68, P440, DOI 10.1016/0016-6480(87)90083-9	61	53	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23689	10.1371/journal.pone.0023689	http://dx.doi.org/10.1371/journal.pone.0023689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887296	gold, Green Submitted, Green Published			2022-12-25	WOS:000295832000047
J	Ratzka, A; Baron, O; Grothe, C				Ratzka, Andreas; Baron, Olga; Grothe, Claudia			FGF-2 Deficiency Does Not Influence FGF Ligand and Receptor Expression during Development of the Nigrostriatal System	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR HOMOLOGOUS FACTORS; SUBSTANTIA-NIGRA; DOPAMINERGIC-NEURONS; FACTOR-2 ISOFORMS; GENE-EXPRESSION; CEREBRAL-CORTEX; FACTOR (FGF)-2; FACTOR FAMILY	Secreted proteins of the fibroblast growth factor (FGF) family play important roles during development of various organ systems. A detailed knowledge of their temporal and spatial expression profiles, especially of closely related FGF family members, are essential to further identification of specific functions in distinct tissues. In the central nervous system dopaminergic neurons of the substantia nigra and their axonal projections into the striatum progressively degenerate in Parkinson's disease. In contrast, FGF-2 deficient mice display increased numbers of dopaminergic neurons. In this study, we determined the expression profiles of all 22 FGF-ligands and 10 FGF-receptor isoforms, in order to clarify, if FGF-2 deficiency leads to compensatory up-regulation of other FGFs in the nigrostriatal system. Three tissues, ventral mesencephalon (VM), striatum (STR) and as reference tissue spinal cord (SC) of wild-type and FGF-2 deficient mice at four developmental stages E14.5, P0, P28, and adult were comparatively analyzed by quantitative RT-PCR. As no differences between the genotypes were observed, a compensatory up-regulation can be excluded. Moreover, this analysis revealed that the majority of FGFligands (18/22) and FGF-receptors (9/10) are expressed during normal development of the nigrostriatal system and identified dynamic changes for some family members. By comparing relative expression level changes to SC reference tissue, general alterations in all 3 tissues, such as increased expression of FGF-1, -2, -22, FgfR-2c, -3c and decreased expression of FGF-13 during postnatal development were identified. Further, specific changes affecting only one tissue, such as increased FGF-16 (STR) or decreased FGF-17 (VM) expression, or two tissues, such as decreased expression of FGF-8 (VM, STR) and FGF-15 (SC, VM) were found. Moreover, 3 developmentally down-regulated FGFs (FGF-8b, FGF-15, FGF-17a) were functionally characterized by plasmid-based over-expression in dissociated E11.5 VM cell cultures, however, such a continuous exposure had no influence on the yield of dopaminergic neurons in vitro.	[Ratzka, Andreas; Baron, Olga; Grothe, Claudia] Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany; [Baron, Olga; Grothe, Claudia] Ctr Syst Neurosci ZSN, Hannover, Germany	Hannover Medical School	Ratzka, A (corresponding author), Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany.	grothe.claudia@mh-hannover.de	Ratzka, Andreas/H-7917-2012; Baron, Olga/HII-8390-2022	Baron, Olga/0000-0002-0536-8678	Deutsche Forschungsgemeinschaft (DFG) [GR 857/23-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp) to C. G. (GR 857/23-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; BEAN AJ, 1992, NEUROREPORT, V3, P993, DOI 10.1097/00001756-199211000-00012; BEAN AJ, 1991, P NATL ACAD SCI USA, V88, P10237, DOI 10.1073/pnas.88.22.10237; Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Dono R, 1998, EMBO J, V17, P4213, DOI 10.1093/emboj/17.15.4213; Dono R, 2003, AM J PHYSIOL-REG I, V284, pR867, DOI 10.1152/ajpregu.00533.2002; Dunham-Ems SM, 2009, MOL BIOL CELL, V20, P2401, DOI 10.1091/mbc.E08-06-0600; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Gimeno L, 2003, GENE EXPR PATTERNS, V3, P473, DOI 10.1016/S1567-133X(03)00059-0; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Grothe C, 2004, NEUROBIOL DIS, V17, P163, DOI 10.1016/j.nbd.2004.07.007; Grothe C, 2000, NEUROSCIENCE, V100, P73, DOI 10.1016/S0306-4522(00)00247-5; Grothe C, 2007, BRAIN RES REV, V54, P80, DOI 10.1016/j.brainresrev.2006.12.001; Guo QX, 2010, DEV BIOL, V338, P183, DOI 10.1016/j.ydbio.2009.11.034; Haastert-Talini K, 2011, J NEUROTRAUM, V28, P661, DOI 10.1089/neu.2010.1637; Irmady K, 2011, GLIA, V59, P708, DOI 10.1002/glia.21141; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Munoz-Sanjuan I, 2000, J BIOL CHEM, V275, P2589, DOI 10.1074/jbc.275.4.2589; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohmachi S, 2000, BIOCHEM BIOPH RES CO, V277, P355, DOI 10.1006/bbrc.2000.3675; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Powles N, 2004, DEV DYNAM, V230, P44, DOI 10.1002/dvdy.20028; Quarto N, 2005, GENE, V356, P49, DOI 10.1016/j.gene.2005.05.014; Raballo R, 2000, J NEUROSCI, V20, P5012; RATZKA A, 2011, CELL TRANSP IN PRESS; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Reuss B, 2003, J NEUROSCI, V23, P6404; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Theil T, 2008, DEV DYNAM, V237, P3417, DOI 10.1002/dvdy.21765; Timmer M, 2006, NEUROBIOL DIS, V21, P587, DOI 10.1016/j.nbd.2005.09.003; Timmer M, 2007, J NEUROSCI, V27, P459, DOI 10.1523/JNEUROSCI.4493-06.2007; TOOYAMA I, 1993, NEUROLOGY, V43, P372, DOI 10.1212/WNL.43.2.372; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Umemori H, 2009, DEV GROWTH DIFFER, V51, P263, DOI 10.1111/j.1440-169X.2008.01079.x; van der Walt JM, 2004, AM J HUM GENET, V74, P1121, DOI 10.1086/421052; Yamauchi K, 2009, J NEUROSCI, V29, P4044, DOI 10.1523/JNEUROSCI.4794-08.2009; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	58	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23564	10.1371/journal.pone.0023564	http://dx.doi.org/10.1371/journal.pone.0023564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876757	Green Submitted, gold, Green Published			2022-12-25	WOS:000294126900029
J	Ryan, KS				Ryan, Katherine S.			Biosynthetic Gene Cluster for the Cladoniamides, Bis-Indoles with a Rearranged Scaffold	PLOS ONE			English	Article							LECHEVALIERIA-AEROCOLONIGENES ATCC-39243; ALPHA/BETA-HYDROLASE FOLD; PSEUDOMONAS-FLUORESCENS; HETEROLOGOUS EXPRESSION; CHROMOPYRROLIC ACID; BIOLOGICAL-ACTIVITY; TANDEM ACTION; REBECCAMYCIN; INDOLOCARBAZOLE; ENZYMES	The cladoniamides are bis-indole alkaloids isolated from Streptomyces uncialis, a lichen-associated actinomycete strain. The cladoniamides have an unusual, indenotryptoline structure rarely observed among bis-indole alkaloids. I report here the isolation, sequencing, and annotation of the cladoniamide biosynthetic gene cluster and compare it to the recently published gene cluster for BE-54017, a closely related indenotryptoline natural product. The cladoniamide gene cluster differs from the BE-54017 gene cluster in gene organization and in the absence of one N-methyltransferase gene but otherwise contains close homologs to all genes in the BE-54017 cluster. Both gene clusters encode enzymes needed for the construction of an indolocarbazole core, as well as flavin-dependent enzymes putatively involved in generating the indenotryptoline scaffold from an indolocarbazole. These two bis-indolic gene clusters exemplify the diversity of biosynthetic routes that begin from the oxidative dimerization of two molecules of L-tryptophan, highlight enzymes for further study, and provide new opportunities for combinatorial engineering.	Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia	Ryan, KS (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	ksryan@chem.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfattah MS, 2006, ANGEW CHEM INT EDIT, V45, P5685, DOI 10.1002/anie.200600511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BUSH JA, 1987, J ANTIBIOT, V40, P668, DOI 10.7164/antibiotics.40.668; Chang FY, 2011, J AM CHEM SOC, V133, P9996, DOI 10.1021/ja2022653; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Daum M, 2009, CHEMBIOCHEM, V10, P1073, DOI 10.1002/cbic.200800823; Davies J, 2005, ORG LETT, V7, P5233, DOI 10.1021/ol052081f; De Schrijver A, 1999, MICROBIOL-UK, V145, P1287, DOI 10.1099/13500872-145-6-1287; Fujimori DG, 2007, P NATL ACAD SCI USA, V104, P16498, DOI 10.1073/pnas.0708242104; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; Ishida K, 2006, J AM CHEM SOC, V128, P14619, DOI 10.1021/ja064550u; Ishikawa J, 1999, FEMS MICROBIOL LETT, V174, P251, DOI 10.1111/j.1574-6968.1999.tb13576.x; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SY, 2007, APPL MICROBIOL BIOT, V75, P1119, DOI 10.1007/s00253-007-0924-x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Medema MH, 2010, GENOME BIOL EVOL, V2, P212, DOI 10.1093/gbe/evq013; Nicolaou KC, 2007, ANGEW CHEM INT EDIT, V46, P4704, DOI 10.1002/anie.200700917; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; OMURA S, 1977, J ANTIBIOT, V30, P275, DOI 10.7164/antibiotics.30.275; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Palfey BA, 2003, J BIOL CHEM, V278, P22210, DOI 10.1074/jbc.M301830200; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Pickens LB, 2009, J AM CHEM SOC, V131, P17677, DOI 10.1021/ja907852c; Prudhomme M, 2003, EUR J MED CHEM, V38, P123, DOI 10.1016/S0223-5234(03)00011-4; Rafanan ER, 2000, ORG LETT, V2, P3225; Ramos A, 2008, MICROBIOL-SGM, V154, P781, DOI 10.1099/mic.0.2007/014035-0; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sanchez C, 2005, P NATL ACAD SCI USA, V102, P461, DOI 10.1073/pnas.0407809102; Sanchez C, 2006, NAT PROD REP, V23, P1007, DOI 10.1039/b601930g; Singh S, 2008, J BIOL CHEM, V283, P22628, DOI 10.1074/jbc.M800503200; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Williams DE, 2008, ORG LETT, V10, P3501, DOI 10.1021/ol801274c; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zehner S, 2005, CHEM BIOL, V12, P445, DOI 10.1016/j.chembiol.2005.02.005; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504; Zhang W, 2008, J AM CHEM SOC, V130, P6068, DOI 10.1021/ja800951e	46	28	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23694	10.1371/journal.pone.0023694	http://dx.doi.org/10.1371/journal.pone.0023694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876764	gold, Green Submitted, Green Published			2022-12-25	WOS:000294126900036
J	Fernandez, A; Squatrito, M; Northcott, P; Awan, A; Holland, EC; Taylor, MD; Nahle, Z; Kenney, AM				Fernandez-L, A.; Squatrito, M.; Northcott, P.; Awan, A.; Holland, E. C.; Taylor, M. D.; Nahle, Z.; Kenney, A. M.			Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation	ONCOGENE			English	Article						medulloblastoma; sonic hedgehog; cerebellum; YAP; IGF; DNA damage	CELL-CYCLE PROGRESSION; SONIC HEDGEHOG; CHECKPOINT ACTIVATION; NEURONAL SURVIVAL; DNA-DAMAGE; N-MYC; GROWTH; PROLIFERATION; PATHWAY; INHIBITION	Radiation therapy remains the standard of care for many cancers, including the malignant pediatric brain tumor medulloblastoma. Radiation leads to long-term side effects, whereas radioresistance contributes to tumor recurrence. Radio-resistant medulloblastoma cells occupy the perivascular niche. They express Yes-associated protein (YAP), a Sonic hedgehog (Shh) target markedly elevated in Shh-driven medulloblastomas. Here we report that YAP accelerates tumor growth and confers radioresistance, promoting ongoing proliferation after radiation. YAP activity enables cells to enter mitosis with un-repaired DNA through driving insulin-like growth factor 2 (IGF2) expression and Akt activation, resulting in ATM/Chk2 inactivation and abrogation of cell cycle checkpoints. Our results establish a central role for YAP in counteracting radiation-based therapies and driving genomic instability, and indicate the YAP/IGF2/Akt axis as a therapeutic target in medulloblastoma. Oncogene (2012) 31, 1923-1937; doi:10.1038/onc.2011.379; published online 29 August 2011	[Awan, A.; Nahle, Z.; Kenney, A. M.] Vanderbilt Univ, Dept Neurosurg, Nashville, TN 37232 USA; [Awan, A.; Nahle, Z.; Kenney, A. M.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Fernandez-L, A.; Squatrito, M.; Holland, E. C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Northcott, P.; Taylor, M. D.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Arthur & Sonia Labatt Brain Tumor Res Ctr,Div Neu, Toronto, ON M5G 1X8, Canada	Vanderbilt University; Vanderbilt University; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kenney, AM (corresponding author), Vanderbilt Univ, Dept Neurosurg, T-4224 MCN, Nashville, TN 37232 USA.	anna.kenney@vanderbilt.edu	Squatrito, Massimo/F-4149-2016; Northcott, Paul A/N-4022-2018	Squatrito, Massimo/0000-0002-4593-3790; Northcott, Paul A/0000-0002-1220-5252; Awan, Aashir/0000-0002-8726-2921; Taylor, Michael/0000-0001-7009-3466	Spanish Ministry of Education; Charles H Revson Foundation; Childhood Brain Tumor Foundation; Alex's Lemonade Stand Foundation; National Brain Tumor Society; James S McDonnell Foundation; NIH [NINDS R01NS061070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061070] Funding Source: NIH RePORTER	Spanish Ministry of Education(Spanish Government); Charles H Revson Foundation; Childhood Brain Tumor Foundation; Alex's Lemonade Stand Foundation; National Brain Tumor Society; James S McDonnell Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Martine Roussel and her group at St Jude Children's Research Hospital for training and advice on MBC culture and intracranial implantation. AF-L received support from the Spanish Ministry of Education, the Charles H Revson Foundation and the Childhood Brain Tumor Foundation. This work was supported by grants to AMK from the Alex's Lemonade Stand Foundation, National Brain Tumor Society, James S McDonnell Foundation and the NIH (NINDS R01NS061070).	Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Bhatia B, 2011, ONCOGENE, V30, P410, DOI 10.1038/onc.2010.454; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Chrysis DC, 2001, CLIN ENDOCRINOL, V54, P253, DOI 10.1046/j.1365-2265.2001.01198.x; Corcoran RB, 2008, CANCER RES, V68, P8788, DOI 10.1158/0008-5472.CAN-08-2135; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Eberhart CG, 2008, CANCER CELL, V14, P105, DOI 10.1016/j.ccr.2008.07.011; Fernandez A, 2010, CELL CYCLE, V9, P2292, DOI 10.4161/cc.9.12.11919; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Frappart PO, 2009, P NATL ACAD SCI USA, V106, P1880, DOI 10.1073/pnas.0806882106; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Leonard JM, 2008, J CELL BIOL, V183, P385, DOI 10.1083/jcb.200804042; Mueller S, 2009, NEUROTHERAPEUTICS, V6, P570, DOI 10.1016/j.nurt.2009.04.006; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Parathath SR, 2008, DEVELOPMENT, V135, P3291, DOI 10.1242/dev.022871; Pazzaglia S, 2006, ONCOGENE, V25, P1165, DOI 10.1038/sj.onc.1209032; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Tanori M, 2008, CARCINOGENESIS, V29, P1911, DOI 10.1093/carcin/bgn174; Tanori M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-53; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xu NH, 2010, J CELL BIOL, V190, P297, DOI 10.1083/jcb.201003004; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	52	116	119	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1923	1937		10.1038/onc.2011.379	http://dx.doi.org/10.1038/onc.2011.379			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21874045	Green Accepted			2022-12-25	WOS:000302809900005
J	Muthu, P; Wang, L; Yuan, CC; Kazmierczak, K; Huang, WR; Hernandez, OM; Kawai, M; Irving, TC; Szczesna-Cordary, D				Muthu, Priya; Wang, Li; Yuan, Chen-Ching; Kazmierczak, Katarzyna; Huang, Wenrui; Hernandez, Olga M.; Kawai, Masataka; Irving, Thomas C.; Szczesna-Cordary, Danuta			Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction	FASEB JOURNAL			English	Article						cross-bridge kinetics; FHC-linked ELC mutation; myofilament lattice spacing; transgenic mice	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; N-TERMINAL EXTENSION; ACTIN-BINDING SITE; MOLECULAR MOTORS; SKELETAL-MUSCLE; CROSS-BRIDGES; SUDDEN-DEATH; HUMAN HEART; LEVER-ARM; MUTATIONS	The myosin essential light chain (ELC) is a structural component of the actomyosin cross-bridge, but its function is poorly understood, especially the role of the cardiac specific N-terminal extension in modulating actomyosin interaction. Here, we generated transgenic (Tg) mice expressing the A57G (alanine to glycine) mutation in the cardiac ELC known to cause familial hypertrophic cardiomyopathy (FHC). The function of the ELC N-terminal extension was investigated with the Tg-Delta 43 mouse model, whose myocardium expresses a truncated ELC. Low-angle X-ray diffraction studies on papillary muscle fibers in rigor revealed a decreased interfilament spacing (similar to 1.5 nm) and no alterations in cross-bridge mass distribution in Tg-A57G mice compared to Tg-WT, expressing the full-length nonmutated ELC. The truncation mutation showed a 1.3-fold increase in I(1,1)/I(1,0), indicating a shift of cross-bridge mass from the thick filament backbone toward the thin filaments. Mechanical studies demonstrated increased stiffness in Tg-A57G muscle fibers compared to Tg-WT or Tg-Delta 43. The equilibrium constant for the cross-bridge force generation step was smallest in Tg-Delta 43. These results support an important role for the N-terminal ELC extension in prepositioning the cross-bridge for optimal force production. Subtle changes in the ELC sequence were sufficient to alter cross-bridge properties and lead to pathological phenotypes.-Muthu, P., Wang, L., Yuan, C.-C., Kazmierczak, K., Huang, W., Hernandez, O. M., Kawai, M., Irving, T. C., Szczesna-Cordary, D. Structural and functional aspects of the myosin essential light chain in cardiac muscle contraction. FASEB J. 25, 4394-4405 (2011). www.fasebj.org	[Muthu, Priya; Kazmierczak, Katarzyna; Huang, Wenrui; Hernandez, Olga M.; Szczesna-Cordary, Danuta] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Wang, Li; Kawai, Masataka] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Yuan, Chen-Ching; Irving, Thomas C.] IIT, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Yuan, Chen-Ching; Irving, Thomas C.] IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	University of Miami; University of Iowa; Illinois Institute of Technology; Illinois Institute of Technology	Szczesna-Cordary, D (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6113,R-189, Miami, FL 33136 USA.	dszczesna@med.miami.edu		Kawai, Masataka/0000-0002-3219-3527	U.S. National Institutes of Health (NIH) [HL071778, HL090786, HL070041]; American Heart Association [10POST3420009]; U.S. DOE [AC02-06CH11357]; NIH [RR-08630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071778, R01HL108343, R01HL090786, R01HL070041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); U.S. DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) grants HL071778 and HL090786 (D.S.C.) and HL070041 (M.K.); and American Heart Association grant 10POST3420009 (P.M.). The authors thank Hsiao Man Hsu for help with X-ray experiments. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract DE-AC02-06CH11357. BioCAT is an NIH-supported research center (RR-08630). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Center for Research Resources or the NIH.	Aydt EM, 2007, J STRUCT BIOL, V159, P158, DOI 10.1016/j.jsb.2007.04.002; Bai F, 2011, BIOPHYS J, V100, P1014, DOI 10.1016/j.bpj.2011.01.001; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Farman GP, 2009, J STRUCT BIOL, V168, P240, DOI 10.1016/j.jsb.2009.07.020; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Geeves MA, 2002, NATURE, V415, P129, DOI 10.1038/415129a; HENRY GD, 1985, BIOCHIM BIOPHYS ACTA, V830, P233, DOI 10.1016/0167-4838(85)90279-1; Huxley AF, 1998, NATURE, V396, P317, DOI 10.1038/24503; Irving T, 2001, J MUSCLE RES CELL M, V22, P675, DOI 10.1023/A:1016336024366; Irving TC, 2000, AM J PHYSIOL-HEART C, V279, pH2568, DOI 10.1152/ajpheart.2000.279.5.H2568; IRVING TC, 1989, J MUSCLE RES CELL M, V10, P385, DOI 10.1007/BF01758435; Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; KAWAI M, 1993, CIRC RES, V73, P35, DOI 10.1161/01.RES.73.1.35; Kazmierczak K, 2009, J MOL BIOL, V387, P706, DOI 10.1016/j.jmb.2009.02.006; Knowles AC, 2008, BIOPHYS J, V95, P3882, DOI 10.1529/biophysj.108.131508; Lee WH, 2001, AM HEART J, V141, P184, DOI 10.1067/mhj.2001.112487; Lowey S, 2007, J MOL BIOL, V371, P902, DOI 10.1016/j.jmb.2007.05.080; Lu XY, 2010, J MUSCLE RES CELL M, V31, P93, DOI 10.1007/s10974-010-9213-x; Maron Barry J, 2002, Card Electrophysiol Rev, V6, P100, DOI 10.1023/A:1017903709361; Miller MS, 2011, BIOPHYS J, V100, P1737, DOI 10.1016/j.bpj.2011.02.028; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; Miyanishi T, 2002, BIOCHEMISTRY-US, V41, P5429, DOI 10.1021/bi0118355; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; Morano I, 1999, J MOL MED-JMM, V77, P544, DOI 10.1007/s001099900031; MORANO I, 1995, CIRC RES, V76, P720, DOI 10.1161/01.RES.76.5.720; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Olson TM, 2002, CIRCULATION, V105, P2337, DOI 10.1161/01.CIR.0000018444.47798.94; Pant K, 2009, FASEB J, V23, P3571, DOI 10.1096/fj.08-126672; PARKER VP, 1985, MOL CELL BIOL, V5, P3058, DOI 10.1128/MCB.5.11.3058; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Seebohm B, 2009, BIOPHYS J, V97, P806, DOI 10.1016/j.bpj.2009.05.023; Seidman CE, 1998, BASIC RES CARDIOL, V93, P13; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Squire J., 1981, STRUCTURAL BASIS MUS, P543; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P4800, DOI 10.1021/bi00262a043; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; Timson DJ, 1999, J BIOL CHEM, V274, P18271, DOI 10.1074/jbc.274.26.18271; TRAYER IP, 1987, EUR J BIOCHEM, V164, P259, DOI 10.1111/j.1432-1033.1987.tb11019.x; Wang Y, 2006, J MOL BIOL, V361, P286, DOI 10.1016/j.jmb.2006.06.018; WINSTANLEY MA, 1977, FEBS LETT, V77, P239, DOI 10.1016/0014-5793(77)80242-1; Zhao Y, 1996, AM J PHYSIOL-HEART C, V271, pH1394, DOI 10.1152/ajpheart.1996.271.4.H1394	48	37	38	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4394	4405		10.1096/fj.11-191973	http://dx.doi.org/10.1096/fj.11-191973			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21885653	Green Published			2022-12-25	WOS:000298138100030
J	Hossain, MA; Rosengren, KJ; Samuel, CS; Shabanpoor, F; Chan, LJ; Bathgate, RAD; Wade, JD				Hossain, Mohammed Akhter; Rosengren, K. Johan; Samuel, Chrishan S.; Shabanpoor, Fazel; Chan, Linda J.; Bathgate, Ross A. D.; Wade, John D.			The Minimal Active Structure of Human Relaxin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING SITE; SOLID-PHASE SYNTHESIS; IN-VIVO; A-CHAIN; CHIMERIC PEPTIDE; HORMONE RELAXIN; ACTIVATION; COLLAGEN; INSULIN; FIBROBLASTS	H2 relaxin is a peptide hormone associated with a number of therapeutically relevant physiological effects, including regulation of collagen metabolism and multiple vascular control pathways. It is currently in phase III clinical trials for the treatment of acute heart failure due to its ability to induce vasodilation and influence renal function. It comprises 53 amino acids and is characterized by two separate polypeptide chains (A-B) that are cross-linked by three disulfide bonds. This size and complex structure represents a considerable challenge for the chemical synthesis of H2 relaxin, a major limiting factor for the exploration of modifications and derivatizations of this peptide, to optimize effect and drug-like characteristics. To address this issue, we describe the solid phase peptide synthesis and structural and functional evaluation of 24 analogues of H2 relaxin with truncations at the termini of its peptide chains. We show that it is possible to significantly truncate both the N and C termini of the B-chain while still retaining potent biological activity. This suggests that these regions are not critical for interactions with the H2 relaxin receptor, RXFP1. In contrast, truncations do reduce the activity of H2 relaxin for the related receptor RXFP2 by improving RXFP1 selectivity. In addition to new mechanistic insights into the function of H2 relaxin, this study identifies a critical active core with 38 amino acids. This minimized core shows similar antifibrotic activity as native H2 relaxin when tested in human BJ3 cells and thus represents an attractive receptor-selective lead for the development of novel relaxin therapeutics.	[Hossain, Mohammed Akhter; Samuel, Chrishan S.; Shabanpoor, Fazel; Chan, Linda J.; Bathgate, Ross A. D.; Wade, John D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Chan, Linda J.; Wade, John D.] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia; [Samuel, Chrishan S.; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Queensland	Hossain, MA (corresponding author), Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia.	akhter.hossain@florey.edu.au; john.wade@florey.edu.au	Rosengren, K. Johan/P-4450-2016; Bathgate, Ross/ABE-6471-2020	Rosengren, K. Johan/0000-0002-5007-8434; Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Wade, John/0000-0002-1352-6568	National Health and Medical Research Council (NHMRC, Australia) [350284, 508995]; Victorian Government	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by National Health and Medical Research Council (NHMRC, Australia) Project Grants 350284 and 508995 (to J. D. W. and R. A. D. B.). Studies at the FNI were supported by the Victorian Government's Operational Infrastructure support program.	Atherton E., 1998, SOLID PHASE PEPTIDE; Baccari MC, 2004, CURR PROTEIN PEPT SC, V5, P9, DOI 10.2174/1389203043486928; BULLESBACH EE, 1992, J BIOL CHEM, V267, P22957; Bullesbach EE, 2000, J BIOL CHEM, V275, P35276, DOI 10.1074/jbc.M005728200; BULLESBACH EE, 1987, J BIOL CHEM, V262, P12496; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 2005, J BIOL CHEM, V280, P14586, DOI 10.1074/jbc.M414443200; BULLESBACH EE, 1986, BIOCHEMISTRY-US, V25, P5998; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; Bullesbach EE, 2001, J PEPT RES, V57, P77, DOI 10.1034/j.1399-3011.2001.00832.x; BULLESBACH EE, 1988, INT J PEPT PROT RES, V32, P361; Chan LJ, 2011, PROTEIN PEPTIDE LETT, V18, P220; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Haugaard-Jonsson LM, 2008, J BIOL CHEM, V283, P23811, DOI 10.1074/jbc.M800489200; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2010, CURR PROTEIN PEPT SC, V11, P719; Hossain MA, 2009, ORG BIOMOL CHEM, V7, P1547, DOI 10.1039/b821882j; Hossain MA, 2009, BIOCONJUGATE CHEM, V20, P1390, DOI 10.1021/bc900181a; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Keller R., 2004, COMPUTER AIDED RESON, V1; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Masterson R, 2004, NEPHROL DIAL TRANSPL, V19, P544, DOI 10.1093/ndt/gfg598; Park JI, 2008, J BIOL CHEM, V283, P32099, DOI 10.1074/jbc.M806817200; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Rosengren KJ, 2009, ANN NY ACAD SCI, V1160, P20, DOI 10.1111/j.1749-6632.2009.03833.x; Samuel CS, 2005, CLIN MED RES, V3, P241, DOI 10.3121/cmr.3.4.241; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Samuel CS, 1996, ENDOCRINOLOGY, V137, P3884, DOI 10.1210/en.137.9.3884; SCHWABE C, 1977, SCIENCE, V197, P914, DOI 10.1126/science.887933; Scott DJ, 2009, ANN NY ACAD SCI, V1160, P74, DOI 10.1111/j.1749-6632.2009.03950.x; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Shabanpoor F, 2008, BIOCONJUGATE CHEM, V19, P1456, DOI 10.1021/bc800127p; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Svendsen AM, 2008, ENDOCRINOLOGY, V149, P1113, DOI 10.1210/en.2007-0412; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Tozzi CA, 2005, PULM PHARMACOL THER, V18, P346, DOI 10.1016/j.pupt.2005.01.003; UNEMORI EN, 1990, J BIOL CHEM, V265, P10681; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC	51	41	49	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37555	37565		10.1074/jbc.M111.282194	http://dx.doi.org/10.1074/jbc.M111.282194			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878627	Green Published, hybrid			2022-12-25	WOS:000296542400054
J	Stempin, CC; Chi, LY; Giraldo-Vela, JP; High, AA; Hacker, H; Redecke, V				Stempin, Cinthia C.; Chi, Liying; Giraldo-Vela, Juan P.; High, Anthony A.; Haecker, Hans; Redecke, Vanessa			The E3 Ubiquitin Ligase Mind Bomb-2 (MIB2) Protein Controls B-cell CLL/Lymphoma 10 (BCL10)-dependent NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE PRODUCTION; SIGNALING PATHWAY; MALT LYMPHOMA; BCL10 PLAYS; KINASE; TRAF6; TAK1; RECEPTORS; COMPLEX; ANTIGEN	B-cell CLL/lymphoma 10 (BCL10) is crucial for the activation of NF-kappa B in numerous immune receptor signaling pathways, including the T-cell receptor (TCR) and B-cell receptor signaling pathways. However, the molecular mechanisms that lead to signal transduction from BCL10 to downstream NF-kappa B effector kinases, such as TAK1 and components of the IKK complex, are not entirely understood. Here we used a proteomic approach and identified the E3 ligase MIB2 as a novel component of the activated BCL10 complex. In vitro translation and pulldown assays suggest direct interaction between BCL10 and MIB2. Overexpression experiments show that MIB2 controls BCL10-mediated activation of NF-kappa B by promoting autoubiquitination and ubiquitination of IKK gamma/NEMO, as well as recruitment and activation of TAK1. Knockdown of MIB2 inhibited BCL10-dependent NF-kappa B activation. Together, our results identify MIB2 as a novel component of the activated BCL10 signaling complex and a missing link in the BCL10-dependent NF-kappa B signaling pathway.	[Stempin, Cinthia C.; Chi, Liying; Giraldo-Vela, Juan P.; Haecker, Hans; Redecke, Vanessa] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [High, Anthony A.] St Jude Childrens Res Hosp, Hartwell Ctr, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Redecke, V (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	vanessa.redecke@stjude.org	Haecker, Hans/F-6826-2013	Haecker, Hans/0000-0001-5971-0451	National Institutes of Health [AI083443]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083443 (to H. H.). This work was also supported by the American Lebanese Syrian Associated Charities.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Chen YH, 2007, J IMMUNOL, V178, P49, DOI 10.4049/jimmunol.178.1.49; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Langel FD, 2008, J BIOL CHEM, V283, P32419, DOI 10.1074/jbc.M800670200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Yamamoto M, 2006, J IMMUNOL, V177, P7520, DOI 10.4049/jimmunol.177.11.7520; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	47	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37147	37157		10.1074/jbc.M111.263384	http://dx.doi.org/10.1074/jbc.M111.263384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896478	hybrid, Green Published			2022-12-25	WOS:000296542400015
J	Cascales, L; Henriques, ST; Kerr, MC; Huang, YH; Sweet, MJ; Daly, NL; Craik, DJ				Cascales, Laura; Henriques, Sonia T.; Kerr, Markus C.; Huang, Yen-Hua; Sweet, Matthew J.; Daly, Norelle L.; Craik, David J.			Identification and Characterization of a New Family of Cell-penetrating Peptides CYCLIC CELL-PENETRATING PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOTIDE KALATA B1; CYSTINE-KNOT MINIPROTEINS; PLASMA-MEMBRANE; PHOSPHATIDIC-ACID; HEPARAN-SULFATE; DRUG DESIGN; HIV-1 TAT; MOMORDICA-COCHINCHINENSIS; MACROCYCLIC PEPTIDES; BIOLOGICAL-ACTIVITY	Cell-penetrating peptides can translocate across the plasma membrane of living cells and thus are potentially useful agents in drug delivery applications. Disulfide-rich cyclic peptides also have promise in drug design because of their exceptional stability, but to date only one cyclic peptide has been reported to penetrate cells, the Momordica cochinchinensis trypsin inhibitor II (MCoTI-II). MCoTI-II belongs to the cyclotide family of plant-derived cyclic peptides that are characterized by a cyclic cystine knot motif. Previous studies in fixed cells showed that MCoTI-II could penetrate cells but kalata B1, a prototypic cyclotide from a separate subfamily of cyclotides, was bound to the plasma membrane and did not translocate into cells. Here, we show by live cell imaging that both MCoTI-II and kalata B1 can enter cells. Kalata B1 has the same cyclic cystine knot structural motif as MCoTI-II but differs significantly in sequence, and the mechanism by which these two peptides enter cells also differs. MCoTI-II appears to enter via macropinocytosis, presumably mediated by interaction of positively charged residues with phosphoinositides in the cell membrane, whereas kalata B1 interacts directly with the membrane by targeting phosphatidylethanolamine phospholipids, probably leading to membrane bending and vesicle formation. We also show that another plant-derived cyclic peptide, SFTI-1, can penetrate cells. SFTI-1 includes just 14 amino acids and, with the exception of its cyclic backbone, is structurally very different from the cyclotides, which are twice the size. Intriguingly, SFTI-1 does not interact with any of the phospholipids tested, and its mechanism of penetration appears to be distinct from MCoTI-II and kalata B1. The ability of diverse disulfide-rich cyclic peptides to penetrate cells enhances their potential in drug design, and we propose a new classification for them, i.e. cyclic cell-penetrating peptides.	[Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Henriques, Sonia T.] Univ Lisbon, Sch Med, Inst Mol Med, P-1649028 Lisbon, Portugal	University of Queensland; Universidade de Lisboa	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Sweet, Matthew J/F-2229-2011; Huang, Yen-Hua/J-9056-2014; Henriques, Sonia Troeira/J-3500-2016; Kerr, Markus C/A-9864-2014; Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013	Sweet, Matthew J/0000-0002-0406-8139; Huang, Yen-Hua/0000-0001-6937-2660; Henriques, Sonia Troeira/0000-0001-9564-9651; Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602	Australian Research Council [DP880105];  [PIOF-GA-2008-220318];  [FT100100657];  [APP1003470.]	Australian Research Council(Australian Research Council); ; ; 	This work was supported in part by Australian Research Council Grant DP880105.; Marie Curie International Outgoing Fellow supported by Grant PIOF-GA-2008-220318.; Australian Research Council Future Fellow supported by Grant FT100100657 and an honorary National Health and Medical Research Council Senior Research Fellow supported by Grant APP1003470.	Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Avrutina O, 2008, CHEMBIOCHEM, V9, P33, DOI 10.1002/cbic.200700452; Balla T, 2009, PHYSIOLOGY, V24, P231, DOI 10.1152/physiol.00014.2009; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Cadmel B, 2008, J PROTEOME RES, V7, P5295, DOI 10.1021/pr800540h; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen B, 2006, J NAT PROD, V69, P23, DOI 10.1021/np050317i; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2010, CELL MOL LIFE SCI, V67, P9, DOI 10.1007/s00018-009-0159-3; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Devaux PF, 2000, BIOCHIMIE, V82, P497, DOI 10.1016/S0300-9084(00)00209-1; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Henriques ST, 2005, FEBS LETT, V579, P4498, DOI 10.1016/j.febslet.2005.06.085; Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Kozlov MM, 2010, NATURE, V463, P439, DOI 10.1038/463439a; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Plan MRR, 2007, CHEMBIOCHEM, V8, P1001, DOI 10.1002/cbic.200700097; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Satoh A, 2000, FEBS LETT, V477, P249, DOI 10.1016/S0014-5793(00)01746-4; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Thongyoo P, 2007, CHEMBIOCHEM, V8, P1107, DOI 10.1002/cbic.200700187; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Yu Y, 2010, J AM CHEM SOC, V132, P195, DOI 10.1021/ja9059014; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zaro JL, 2005, EXP CELL RES, V307, P164, DOI 10.1016/j.yexcr.2005.02.024; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	133	142	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36932	36943		10.1074/jbc.M111.264424	http://dx.doi.org/10.1074/jbc.M111.264424			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873420	Green Published, hybrid			2022-12-25	WOS:000296538300072
J	Hradsky, J; Raghuram, V; Reddy, PP; Navarro, G; Hupe, M; Casado, V; McCormick, PJ; Sharma, Y; Kreutz, MR; Mikhaylova, M				Hradsky, Johannes; Raghuram, Vijeta; Reddy, Parameshwar Pasham; Navarro, Gemma; Hupe, Mike; Casado, Vicent; McCormick, Peter J.; Sharma, Yogendra; Kreutz, Michael R.; Mikhaylova, Marina			Post-translational Membrane Insertion of Tail-anchored Transmembrane EF-hand Ca2+ Sensor Calneurons Requires the TRC40/Asna1 Protein Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CALCIUM; OLIGOMERIZATION; RECOGNITION; CURVATURE; DYNAMICS; SIGNAL; SPHINGOLIPIDS; HIPPOCALCIN; INTEGRATION	Calneuron-1 and -2 are neuronal EF-hand-type calcium sensor proteins that are prominently targeted to trans-Golgi network membranes and impose a calcium threshold at the Golgi for phosphatidylinositol 4-OH kinase III beta activation and the regulated local synthesis of phospholipids that are crucial for TGN-to-plasma membrane trafficking. /In this study, we show that calneurons are nonclassical type II tail-anchored proteins that are post-translationally inserted into the endoplasmic reticulum membrane via an association of a 23-amino acid-long transmembrane domain (TMD) with the TRC40/Asna1 chaperone complex. Following trafficking to the Golgi, calneurons are probably retained in the TGN because of the length of the TMD and phosphatidylinositol 4-phosphate lipid binding. Both calneurons rapidly self-associate in vitro and in vivo via their TMD and EF-hand containing theNterminus. Although dimerization and potentially multimerization precludes TRC40/Asna1 binding and thereby membrane insertion, we found no evidence for a cytosolic pool of calneurons and could demonstrate that self-association of calneurons is restricted to membrane-inserted protein. The dimerization properties and the fact that they, unlike every other EF-hand calmodulin-like Ca2+ sensor, are always associated with membranes of the secretory pathway, including vesicles and plasma membrane, suggests a high degree of spatial segregation for physiological target interactions.	[Hradsky, Johannes; Raghuram, Vijeta; Reddy, Parameshwar Pasham; Hupe, Mike; Kreutz, Michael R.; Mikhaylova, Marina] Leibniz Inst Neurobiol, Res Grp Neuroplast, D-39118 Magdeburg, Germany; [Hradsky, Johannes; Kreutz, Michael R.] German Ctr Neurodegenerat Dis, D-39118 Magdeburg, Germany; [Raghuram, Vijeta; Sharma, Yogendra] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Navarro, Gemma; Casado, Vicent; McCormick, Peter J.] Univ Barcelona, Fac Biol, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08028 Barcelona, Spain; [Navarro, Gemma; Casado, Vicent; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain	Leibniz Institut fur Neurobiologie (LIN); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); CIBERNED; University of Barcelona; University of Barcelona	Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Res Grp Neuroplast, D-39118 Magdeburg, Germany.	kreutz@lin-magdeburg.de; mikhaylova@lin-magdeburg.de	Navarro, Gemma/AAO-7866-2021; Casadó, Vicent/K-1660-2014; McCormick, Peter/E-7387-2012; Mikhaylova, Marina/AAM-4368-2020	Navarro, Gemma/0000-0003-4654-0873; Casadó, Vicent/0000-0002-1764-3825; McCormick, Peter/0000-0002-2225-5181; Mikhaylova, Marina/0000-0001-7646-1346; Raghuram, Vijeta/0000-0002-9081-001X; Hupe, Mike/0000-0002-7735-2958	Deutsche Forschungsgemeinschaft; DZNE Magdeburg; Schram Foundation; Deutscher Akademischer Austauschdienst-Department of Science and Technology; Bundesministerium fur Bildung und Forschung, Department of Biotechnology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DZNE Magdeburg; Schram Foundation; Deutscher Akademischer Austauschdienst-Department of Science and Technology(Deutscher Akademischer Austausch Dienst (DAAD)); Bundesministerium fur Bildung und Forschung, Department of Biotechnology(Federal Ministry of Education & Research (BMBF))	This work was supported by research grants from the Deutsche Forschungsgemeinschaft, DZNE Magdeburg, and the Schram Foundation (to M. R. K.), a Deutscher Akademischer Austauschdienst-Department of Science and Technology scholar exchange grant, and a Bundesministerium fur Bildung und Forschung, Department of Biotechnology international cooperation grant (to Y. S. and M. R. K.).	Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Ceppi P, 2005, P NATL ACAD SCI USA, V102, P16269, DOI 10.1073/pnas.0508157102; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Dolman NJ, 2006, CELL CALCIUM, V40, P505, DOI 10.1016/j.ceca.2006.08.012; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mccue HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017853; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mccue HV, 2009, BIOCHEM BIOPH RES CO, V380, P825, DOI 10.1016/j.bbrc.2009.01.177; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Micaroni M, 2010, CURR MOL MED, V10, P763, DOI 10.2174/156652410793384204; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mikhaylova M, 2011, J NEUROCHEM, V118, P695, DOI 10.1111/j.1471-4159.2011.07372.x; Mikhaylova M, 2010, BIOCHEM SOC T, V38, P177, DOI 10.1042/BST0380177; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; Navarro G, 2009, J BIOL CHEM, V284, P28058, DOI 10.1074/jbc.M109.034231; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Callaghan DW, 2005, BIOCHEM J, V391, P231, DOI 10.1042/BJ20051001; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Osawa M, 2001, J BIOL CHEM, V276, P41005, DOI 10.1074/jbc.M105842200; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Renthal R, 2010, CELL MOL LIFE SCI, V67, P1077, DOI 10.1007/s00018-009-0234-9; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Shih PY, 2009, BIOCHEM BIOPH RES CO, V388, P549, DOI 10.1016/j.bbrc.2009.08.046; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	54	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36762	36776		10.1074/jbc.M111.280339	http://dx.doi.org/10.1074/jbc.M111.280339			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878631	Green Published, hybrid			2022-12-25	WOS:000296538300058
J	Sen, S; Bunda, S; Shi, JY; Wang, A; Mitts, TF; Hinek, A				Sen, Sanjana; Bunda, Severa; Shi, Junyan; Wang, Andrew; Mitts, Thomas F.; Hinek, Aleksander			Retinoblastoma Protein Modulates the Inverse Relationship between Cellular Proliferation and Elastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; CYCLIN-DEPENDENT KINASES; WILLIAMS-BEUREN-SYNDROME; ELASTIN-BINDING PROTEIN; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-I; COSTELLO-SYNDROME; SP1-MEDIATED TRANSCRIPTION; IMPAIRED ELASTOGENESIS; PHOSPHORYLATION SITES	The mechanism that leads to the inverse relationship between heightened cellular proliferation and the cessation of elastic fibers production, observed during formation of the arterial occlusions and dermal scars, is not fully understood. Because the retinoblastoma protein (Rb), responsible for cell cycle initiation, has also been implicated in insulin-like growth factor-I-mediated signaling stimulating elastin gene activation, we explored whether differential phosphorylation of Rb by various cyclin.cyclin-dependent kinase complexes would be responsible for promoting either elastogenic or pro-proliferative signals. We first tested cultures of dermal fibroblasts derived from Costello syndrome patients, in which heightened proliferation driven by mutated oncogenic H-Ras coincides with inhibition of elastogenesis. We found that Costello syndrome fibroblasts display elevated level of Rb phosphorylation on serine 780 (Ser(P)-780-Rb) and that pharmacological inhibition of Ras with radicicol, Mek/Erk with PD98059, or cyclin-dependent kinase 4 with PD0332991 not only leads to down-regulation of Ser(P)-780-Rb levels but also enhances Rb phosphorylation on threonine-821 (Thr(P)-821-Rb), which coincides with the recovery of elastin production. Then we demonstrated that treatment of normal skin fibroblasts with the pro-proliferativePDGFBB also up-regulates Ser(P)-780-Rb levels, but treatment with the pro-elastogenic insulin-like growth factor-I activates cyclinE-cdk2 complex to phosphorylate Rb on Thr-821. Importantly, we have established that elevation of Thr(P)-821-Rb promotes Rb binding to the Sp1 transcription factor and that successive binding of the Rb-Sp1 complex to the retinoblastoma control element within the elastin gene promoter stimulates tropoelastin transcription. In summary, we provide novel insight into the role of Rb in mediating the inverse relationship between elastogenesis and cellular proliferation.	[Sen, Sanjana; Bunda, Severa; Shi, Junyan; Wang, Andrew; Hinek, Aleksander] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Sen, Sanjana; Bunda, Severa; Hinek, Aleksander] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Mitts, Thomas F.] Human Matrix Sci LLC, Visalia, CA 93291 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hinek, A (corresponding author), Univ Toronto, Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.on.ca	Hinek, Aleksander/V-8790-2019		Canadian Institute of Health Research [PG 13920]; Heart and Stroke Foundation [NA 4381]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institute of Health Research Grant PG 13920 and by Heart and Stroke Foundation of Ontario Grant NA 4381 (to A.H.).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x; Banchio C, 2007, J BIOL CHEM, V282, P14827, DOI 10.1074/jbc.M700527200; Barnett CP, 2011, EUR J HUM GENET, V19, P624, DOI 10.1038/ejhg.2010.259; Barrientes S, 2000, ONCOGENE, V19, P562, DOI 10.1038/sj.onc.1203332; Bayat A, 2005, BRIT J PLAST SURG, V58, P28, DOI 10.1016/j.bjps.2004.04.024; Brooks EE, 1997, J BIOL CHEM, V272, P29207, DOI 10.1074/jbc.272.46.29207; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; CHEN LI, 1994, MOL CELL BIOL, V14, P4380, DOI 10.1128/MCB.14.7.4380; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Dridi SM, 2005, J VASC RES, V42, P190, DOI 10.1159/000085141; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Fry DW, 2004, MOL CANCER THER, V3, P1427; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hennekam RCM, 2003, AM J MED GENET C, V117C, P42, DOI 10.1002/ajmg.c.10019; Hinek A, 1999, ACTA NEUROPATHOL, V97, P399, DOI 10.1007/s004010051004; Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hwang M, 2009, CURR MED CHEM, V16, P3081, DOI 10.2174/092986709788802999; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Ikeda M, 2009, BIOCHEM BIOPH RES CO, V390, P1221, DOI 10.1016/j.bbrc.2009.10.125; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; Jung S, 1999, GLIA, V25, P179, DOI 10.1002/(SICI)1098-1136(19990115)25:2<179::AID-GLIA8>3.0.CO;2-B; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Kerr B., 2009, V17, P83; Ki SW, 1998, J ANTIBIOT, V51, P936, DOI 10.7164/antibiotics.51.936; Kielty CM, 2002, J CELL SCI, V115, P2817; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Liu Q, 1999, MOL CELL BIOL, V19, P6229; Madrigal-Matute J, 2010, CARDIOVASC RES, V86, P330, DOI 10.1093/cvr/cvq046; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Mitts TF, 2010, J INVEST DERMATOL, V130, P2396, DOI 10.1038/jid.2010.155; MIYAJIMA M, 1995, NEUROREPORT, V6, P1130, DOI 10.1097/00001756-199505300-00014; Morris CA, 2000, ANNU REV GENOM HUM G, V1, P461; Ohnishi K, 1998, LAB INVEST, V78, P1077; OIKAWA T, 1993, EUR J PHARMACOL, V241, P221, DOI 10.1016/0014-2999(93)90206-W; Poznic M, 2009, J BIOSCIENCES, V34, P305, DOI 10.1007/s12038-009-0034-2; Rauen KA, 2007, CLIN GENET, V71, P101, DOI 10.1111/j.1399-0004.2007.00743.x; Ritz-Timme S, 2003, BRIT J DERMATOL, V149, P951, DOI 10.1111/j.1365-2133.2003.05618.x; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Schmitz NMR, 2006, AM J PATHOL, V169, P1074, DOI 10.2353/ajpath.2006.051137; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Slemp AE, 2006, CURR OPIN PEDIATR, V18, P396, DOI 10.1097/01.mop.0000236389.41462.ef; Smith E, 1997, J CELL BIOCHEM, V66, P141, DOI 10.1002/(SICI)1097-4644(19970801)66:2<141::AID-JCB2>3.0.CO;2-Q; SMITH E, 1995, CANCER RES, V55, P5019; Soga S, 1998, J BIOL CHEM, V273, P822, DOI 10.1074/jbc.273.2.822; Takaki T, 2004, BIOCHEM BIOPH RES CO, V316, P252, DOI 10.1016/j.bbrc.2004.02.044; Tamrakar S, 2000, FRONT BIOSCI-LANDMRK, V5, pD121, DOI 10.2741/Tamrakar; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; TSAI LH, 1993, ONCOGENE, V8, P1593; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; Urban Z, 2002, AM J HUM GENET, V71, P30, DOI 10.1086/341035; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Waldburg N, 2004, EUR RESPIR J, V23, P783, DOI 10.1183/09031936.04.00073704; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Xiao L, 2006, MINI-REV MED CHEM, V6, P1137, DOI 10.2174/138955706778560166; Yoon JH, 2005, INT J ARTIF ORGANS, V28, P44, DOI 10.1177/039139880502800108; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	77	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36580	36591		10.1074/jbc.M111.269944	http://dx.doi.org/10.1074/jbc.M111.269944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880723	Green Published, hybrid			2022-12-25	WOS:000296538300042
J	Henderson, JN; Kuriata, AM; Fromme, R; Salvucci, ME; Wachter, RM				Henderson, J. Nathan; Kuriata, Agnieszka M.; Fromme, Raimund; Salvucci, Michael E.; Wachter, Rebekka M.			Atomic Resolution X-ray Structure of the Substrate Recognition Domain of Higher Plant Ribulose-bisphosphate Carboxylase/Oxygenase (Rubisco) Activase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; INTRINSIC FLUORESCENCE; ARGININE RESIDUES; AAA+ PROTEINS; LARGE SUBUNIT; PHOTOSYNTHESIS; ATP; ARABIDOPSIS; SUBSTITUTION; ENHANCEMENT	The rapid release of tight-binding inhibitors from dead-end ribulose-bisphosphate carboxylase/oxygenase (Rubisco) complexes requires the activity of Rubisco activase, an AAA + ATPase that utilizes chemo-mechanical energy to catalyze the reactivation of Rubisco. Activase is thought to play a central role in coordinating the rate of CO2 fixation with the light reactions of photosynthesis. Here, we present a 1.9 angstrom crystal structure of the C-domain core of creosote activase. The fold consists of a canonical four-helix bundle, from which a paddle-like extension protrudes that entails a nine-turn helix lined by an irregularly structured peptide strand. The residues Lys-313 and Val-316 involved in the species-specific recognition of Rubisco are located near the tip of the paddle. An ionic bond between Lys-313 and Glu-309 appears to stabilize the glycine-rich end of the helix. Structural superpositions onto the distant homolog FtsH imply that the paddles extend away from the hexameric toroid in a fan-like fashion, such that the hydrophobic sides of each blade bearing Trp-302 are facing inward and the polar sides bearing Lys-313 and Val-316 are facing outward. Therefore, we speculate that upon binding, the activase paddles embrace the Rubisco cylinder by placing their hydrophobic patches near the partner protein. This model suggests that conformational adjustments at the remote end of the paddle may relate to selectivity in recognition, rather than specific ionic contacts involving Lys-313. Additionally, the superpositions predict that the catalytically critical Arg-293 does not interact with the bound nucleotide. Hypothetical ring-ring stacking and peptide threading models for Rubisco reactivation are briefly discussed.	[Henderson, J. Nathan; Kuriata, Agnieszka M.; Fromme, Raimund; Wachter, Rebekka M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Salvucci, Michael E.] ARS, Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85139 USA	Arizona State University; Arizona State University-Tempe; United States Department of Agriculture (USDA)	Wachter, RM (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	rwachter@asu.edu	Fromme, Raimund/AAG-6578-2019; Fromme, Raimund/W-5838-2019	Fromme, Raimund/0000-0003-4835-1080	United States Department of Energy Office of Basic Energy Sciences [DE-FG02-09-ER16123, DE-FG02-08ER-20268]	United States Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy Office of Basic Energy Sciences Photosynthetic Systems Grants DE-FG02-09-ER16123 (to R. M. W.) and DE-FG02-08ER-20268 (to M. E. S.).	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Barta C, 2010, ARCH BIOCHEM BIOPHYS, V499, P17, DOI 10.1016/j.abb.2010.04.022; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Esau BD, 1996, ARCH BIOCHEM BIOPHYS, V326, P100, DOI 10.1006/abbi.1996.0052; Feller U, 1998, PLANT PHYSIOL, V116, P539, DOI 10.1104/pp.116.2.539; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Salvucci ME, 2004, PLANT PHYSIOL, V134, P1460, DOI 10.1104/pp.103.038323; Salvucci ME, 2006, J EXP BOT, V57, P3793, DOI 10.1093/jxb/erl140; Sharkey TD, 2001, PHOTOSYNTH RES, V67, P147, DOI 10.1023/A:1010633823747; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; vandeLoo FJ, 1996, BIOCHEMISTRY-US, V35, P8143, DOI 10.1021/bi9604901; Wang DF, 2006, PHOTOSYNTH RES, V88, P185, DOI 10.1007/s11120-006-9051-2; WANG ZY, 1992, PLANT PHYSIOL, V99, P1348, DOI 10.1104/pp.99.4.1348; WANG ZY, 1992, PLANT PHYSIOL, V100, P1858, DOI 10.1104/pp.100.4.1858; WANG ZY, 1993, BIOCHIM BIOPHYS ACTA, V1202, P47, DOI 10.1016/0167-4838(93)90061-U; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999	39	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35683	35688		10.1074/jbc.C111.289595	http://dx.doi.org/10.1074/jbc.C111.289595			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21880724	hybrid, Green Published			2022-12-25	WOS:000295927100040
J	Milenkovic, T; Memisevic, V; Bonato, A; Przulj, N				Milenkovic, Tijana; Memisevic, Vesna; Bonato, Anthony; Przulj, Natasa			Dominating Biological Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; INTERACTION DATABASE; SUBGRAPH CENTRALITY; CANCER PROTEINS; YEAST; INTERACTOME; RESOURCE; STRATEGY; GENES; ALGORITHMS	Proteins are essential macromolecules of life that carry out most cellular processes. Since proteins aggregate to perform function, and since protein-protein interaction (PPI) networks model these aggregations, one would expect to uncover new biology from PPI network topology. Hence, using PPI networks to predict protein function and role of protein pathways in disease has received attention. A debate remains open about whether network properties of "biologically central (BC)" genes (i.e., their protein products), such as those involved in aging, cancer, infectious diseases, or signaling and drug-targeted pathways, exhibit some topological centrality compared to the rest of the proteins in the human PPI network. To help resolve this debate, we design new network-based approaches and apply them to get new insight into biological function and disease. We hypothesize that BC genes have a topologically central (TC) role in the human PPI network. We propose two different concepts of topological centrality. We design a new centrality measure to capture complex wirings of proteins in the network that identifies as TC those proteins that reside in dense extended network neighborhoods. Also, we use the notion of domination and find dominating sets (DSs) in the PPI network, i.e., sets of proteins such that every protein is either in the DS or is a neighbor of the DS. Clearly, a DS has a TC role, as it enables efficient communication between different network parts. We find statistically significant enrichment in BC genes of TC nodes and outperform the existing methods indicating that genes involved in key biological processes occupy topologically complex and dense regions of the network and correspond to its "spine" that connects all other network parts and can thus pass cellular signals efficiently throughout the network. To our knowledge, this is the first study that explores domination in the context of PPI networks.	[Milenkovic, Tijana] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Memisevic, Vesna] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Bonato, Anthony] Ryerson Univ, Dept Math, Toronto, ON, Canada; [Przulj, Natasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	University of Notre Dame; University of California System; University of California Irvine; Toronto Metropolitan University; Imperial College London	Milenkovic, T (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.	natasha@imperial.ac.uk	Przulj, Natasa/AAO-2850-2020	Przulj, Natasa/0000-0002-1290-853X	National Science Foundation Faculty [IIS-0644424]; National Science Foundation Cyber-Enabled Discovery and Innovation [OIA-1028394]; Serbian Ministry of Education and Science [III44006]; Natural Sciences and Engineering Research Council; Mathematics of Information Technology and Complex Systems	National Science Foundation Faculty; National Science Foundation Cyber-Enabled Discovery and Innovation(National Science Foundation (NSF)); Serbian Ministry of Education and Science(Ministry of Education, Science & Technological Development, Serbia); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mathematics of Information Technology and Complex Systems	This work was supported by the National Science Foundation Faculty Early Career Development (CAREER) Program IIS-0644424, the National Science Foundation Cyber-Enabled Discovery and Innovation OIA-1028394, and the Serbian Ministry of Education and Science Project III44006 grants, as well as grants from Natural Sciences and Engineering Research Council and Mathematics of Information Technology and Complex Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ANAL BIOL NETWORKS; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cooper C, 2005, INTERNET MATH, V2, P275, DOI 10.1080/15427951.2005.10129105; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Duckworth W, 2006, COMB PROBAB COMPUT, V15, P513, DOI 10.1017/S0963548305007431; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2007, CHEM PHYS LETT, V439, P247, DOI 10.1016/j.cplett.2007.03.098; Ferrarini L, 2005, BIOINFORMATICS, V21, P338, DOI 10.1093/bioinformatics/bti004; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao B, 2005, INT J COMMUN SYST, V18, P743, DOI 10.1002/dac.726; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Ho HA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-84; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Houmaidi M, 2003, J OPTICAL NETWORKING, V2; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Memisevic V, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-135; Milenkovic T, 2010, J ROYAL SOC INTERFAC, V44, P353; Milenkovic T, 2008, CANCER INFORM, V6, P257; Milenkovic T, 2010, CANCER INFORM, V9, P121, DOI 10.4137/CIN.S4744; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Promislow DEL, 2004, P ROY SOC B-BIOL SCI, V271, P1225, DOI 10.1098/rspb.2004.2732; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Rai M, 2009, J NETWORKS, V4; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ratmann O, 2009, HFSP J, V3, P290, DOI 10.2976/1.3167215; Reguly T, 2006, J BIOL, V5, P10; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R., 2007, MOL SYSTEMS BIOL, V3; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stojmenovic I, 2002, IEEE T PARALL DISTR, V13, P14, DOI 10.1109/71.980024; Sun JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S5; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu J, 1999, P 3 ACM INT WORKSH D, V18, P7; Yidirim MA, 2007, NATURE BIOTECHNOLOGY, V25; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	71	71	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23016	10.1371/journal.pone.0023016	http://dx.doi.org/10.1371/journal.pone.0023016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887225	Green Published, gold			2022-12-25	WOS:000294298800002
J	Tang, X; Zhuang, JJ; Chen, J; Yu, L; Hu, LH; Jiang, HL; Shen, X				Tang, Xuan; Zhuang, Jingjing; Chen, Jing; Yu, Liang; Hu, Lihong; Jiang, Hualiang; Shen, Xu			Arctigenin Efficiently Enhanced Sedentary Mice Treadmill Endurance	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; COACTIVATOR 1-ALPHA PGC-1-ALPHA; SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; MITOCHONDRIAL BIOGENESIS; INSULIN SENSITIVITY; METABOLIC SYNDROME; ENERGY-METABOLISM; UPSTREAM KINASE; EXERCISE	Physical inactivity is considered as one of the potential risk factors for the development of type 2 diabetes and other metabolic diseases, while endurance exercise training could enhance fat oxidation that is associated with insulin sensitivity improvement in obesity. AMP-activated protein kinase (AMPK) as an energy sensor plays pivotal roles in the regulation of energy homeostasis, and its activation could improve glucose uptake, promote mitochondrial biogenesis and increase glycolysis. Recent research has even suggested that AMPK activation contributed to endurance enhancement without exercise. Here we report that the natural product arctigenin from the traditional herb Arctium lappa L. (Compositae) strongly increased AMPK phosphorylation and subsequently up-regulated its downstream pathway in both H9C2 and C2C12 cells. It was discovered that arctigenin phosphorylated AMPK via calmodulin-dependent protein kinase kinase (CaMKK) and serine/threonine kinase 11(LKB1)-dependent pathways. Mice treadmill based in vivo assay further indicated that administration of arctigenin improved efficiently mice endurance as reflected by the increased fatigue time and distance, and potently enhanced mitochondrial biogenesis and fatty acid oxidation (FAO) related genes expression in muscle tissues. Our results thus suggested that arctigenin might be used as a potential lead compound for the discovery of the agents with mimic exercise training effects to treat metabolic diseases.	[Tang, Xuan; Chen, Jing; Yu, Liang; Hu, Lihong; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Zhuang, Jingjing; Shen, Xu] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology	Tang, X (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	jingchen@mail.shcnc.ac.cn; simmhulh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn			State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National Natural Science Foundation of China [30925040, 30890044, 10979072]; Science Foundation of Shanghai [08431902900]; Foundation of Chinese Academy of Sciences [KSCX2-YW-R-168, SCX1-YW-02-2]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the State Key Program of Basic Research of China (grants 2010CB912501, 2007CB914304, 2009CB918502), the National Natural Science Foundation of China (grants 30925040, 30890044, 10979072); Science Foundation of Shanghai (08431902900), and Foundation of Chinese Academy of Sciences (grants KSCX2-YW-R-168, SCX1-YW-02-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Awale S, 2006, CANCER RES, V66, P1751, DOI 10.1158/0008-5472.CAN-05-3143; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; CANNON B, 1989, ANN NY ACAD SCI, V29, P171; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Charter NW, 2006, J BIOMOL SCREEN, V11, P390, DOI 10.1177/1087057106286829; *COMM CHIN PHARM, 2005, PHARM PEOPL REP CHIN, V1, P48; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Goodpaster BH, 2003, DIABETES, V52, P2191, DOI 10.2337/diabetes.52.9.2191; Goodyear LJ, 2008, NEW ENGL J MED, V359, P1842, DOI 10.1056/NEJMcibr0806723; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi K, 2010, BIOL PHARM BULL, V33, P1199, DOI 10.1248/bpb.33.1199; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P395, DOI 10.1016/S0006-291X(02)00883-5; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jang YP, 2002, J NEUROSCI RES, V68, P233, DOI 10.1002/jnr.10204; Jang YP, 2001, PLANTA MED, V67, P470, DOI 10.1055/s-2001-15804; Kim JY, 2010, J CELL PHYSIOL, V224, P33, DOI 10.1002/jcp.22085; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee JY, 2010, ARCH PHARM RES, V33, P947, DOI 10.1007/s12272-010-0619-1; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu QO, 2010, BBA-GENE REGUL MECH, V1799, P854, DOI 10.1016/j.bbagrm.2010.06.004; Liu Q, 2010, J STEROID BIOCHEM, V120, P155, DOI 10.1016/j.jsbmb.2010.03.090; Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Palomer X, 2009, CARDIOVASC RES, V81, P703, DOI 10.1093/cvr/cvn327; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Pulinilkunnil T, 2011, J BIOL CHEM, V286, P8798, DOI 10.1074/jbc.M111.218719; PUSKA P, 2003, PHYS ACTIVITY; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Schmitt B, 2003, PHYSIOL GENOMICS, V15, P148, DOI 10.1152/physiolgenomics.00089.2003; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; SUN S, 2010, PLANTA MED; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; UGUCCIONI G, 2010, AM J PHYSL ENDOCRINO; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yan Z, 2009, APPL PHYSIOL NUTR ME, V34, P424, DOI 10.1139/H09-030; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	62	34	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24224	10.1371/journal.pone.0024224	http://dx.doi.org/10.1371/journal.pone.0024224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887385	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298800038
J	Autio, J; Kawaguchi, H; Saito, S; Aoki, I; Obata, T; Masamoto, K; Kanno, I				Autio, Joonas; Kawaguchi, Hiroshi; Saito, Shigeyoshi; Aoki, Ichio; Obata, Takayuki; Masamoto, Kazuto; Kanno, Iwao			Spatial Frequency-Based Analysis of Mean Red Blood Cell Speed in Single Microvessels: Investigation of Microvascular Perfusion in Rat Cerebral Cortex	PLOS ONE			English	Article							PRENATAL X-IRRADIATION; AUTOMATED-METHOD; FLOW; BRAIN; CAPILLARIES; MICROSCOPY; VELOCITY; ANESTHESIA; ISOFLURANE; RADIATION	Background: Our previous study has shown that prenatal exposure to X-ray irradiation causes cerebral hypo-perfusion during the postnatal development of central nervous system (CNS). However, the source of the hypo-perfusion and its impact on the CNS development remains unclear. The present study developed an automatic analysis method to determine the mean red blood cell (RBC) speed through single microvessels imaged with two-photon microscopy in the cerebral cortex of rats prenatally exposed to X-ray irradiation (1.5 Gy). Methodology/Principal Findings: We obtained a mean RBC speed (0.9 +/- 0.6 mm/sec) that ranged from 0.2 to 4.4 mm/sec from 121 vessels in the radiation-exposed rats, which was about 40% lower than that of normal rats that were not exposed. These results were then compared with the conventional method for monitoring microvascular perfusion using the arteriovenous transit time (AVTT) determined by tracking fluorescent markers. A significant increase in the AVTT was observed in the exposed rats (1.9 +/- 0.6 sec) as compared to the age-matched non-exposed rats (1.2 +/- 0.3 sec). The results indicate that parenchyma capillary blood velocity in the exposed rats was approximately 37% lower than in non-exposed rats. Conclusions/Significance: The algorithm presented is simple and robust relative to monitoring individual RBC speeds, which is superior in terms of noise tolerance and computation time. The demonstrative results show that the method developed in this study for determining the mean RBC speed in the spatial frequency domain was consistent with the conventional transit time method.	[Autio, Joonas; Kawaguchi, Hiroshi; Saito, Shigeyoshi; Aoki, Ichio; Obata, Takayuki; Masamoto, Kazuto; Kanno, Iwao] Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Biophys, Chiba 260, Japan; [Masamoto, Kazuto] Univ Electrocommun, Ctr Frontier Sci & Engn, Tokyo, Japan	National Institutes for Quantum Science & Technology; University of Electro-Communications - Japan	Autio, J (corresponding author), Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst, Kuopio, Finland.	kanno@nirs.go.jp	Aoki, Ichio/ABF-7336-2020; Aoki, Ichio/G-2529-2011; Autio, Joonas/ABF-8326-2021; Obata, Takayuki/AAR-9820-2020; Kawaguchi, Hiroshi/F-8515-2012; Autio, Joonas A/C-5391-2017	Aoki, Ichio/0000-0002-4429-5053; Autio, Joonas/0000-0002-2232-9259; Obata, Takayuki/0000-0001-7678-5033; Kawaguchi, Hiroshi/0000-0002-1496-2812; Autio, Joonas A/0000-0002-2232-9259	Scandinavia-Japan Sasakawa Foundation; Special Coordination Funds for Promoting Science and Technology; Japan Society for the Promotion of Science in Japan; Grants-in-Aid for Scientific Research [22700441] Funding Source: KAKEN	Scandinavia-Japan Sasakawa Foundation; Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was partly supported by the Scandinavia-Japan Sasakawa Foundation (JA), the Special Coordination Funds for Promoting Science and Technology (KM), and KAKENHI from Japan Society for the Promotion of Science in Japan (TO and HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER DG, 1989, CANCER INVEST, V7, P287, DOI 10.3109/07357908909039849; Beck J, 2007, NEUROSURGERY, V61, P826, DOI 10.1227/01.NEU.0000298912.86506.B1; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Drew PJ, 2010, J COMPUT NEUROSCI, V29, P5, DOI 10.1007/s10827-009-0159-1; Duncan DD, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3494565; Dunn AK, 2000, APPL OPTICS, V39, P1194, DOI 10.1364/AO.39.001194; ELLIS CG, 1992, MICROVASC RES, V44, P214, DOI 10.1016/0026-2862(92)90081-Y; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hirase H, 2004, NEUROSCIENCE, V128, P209, DOI 10.1016/j.neuroscience.2004.07.002; Hudetz A G, 1994, Adv Pharmacol, V31, P577, DOI 10.1016/S1054-3589(08)60643-2; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202, DOI 10.1152/ajpheart.1995.268.6.H2202; Hutchinson EB, 2006, NEUROIMAGE, V32, P520, DOI 10.1016/j.neuroimage.2006.03.033; Japee SA, 2005, MICROCIRCULATION, V12, P507, DOI 10.1080/10739680591003341; Kimler BF, 1998, INT J RADIAT BIOL, V73, P423, DOI 10.1080/095530098142266; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; MA YP, 1974, MICROVASC RES, V8, P1, DOI 10.1016/0026-2862(74)90059-4; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; Malone MH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-40; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Masamoto K, 2010, ADV EXP MED BIOL, V662, P57, DOI 10.1007/978-1-4419-1241-1_7; MIKI T, 1995, NEUROSCI RES, V23, P241, DOI 10.1016/0168-0102(95)00947-7; Miki T, 2007, INT J DEV NEUROSCI, V25, P293, DOI 10.1016/j.ijdevneu.2007.05.003; Pena LA, 2000, CANCER RES, V60, P321; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; RUBIN P, 1994, RADIOTHER ONCOL, V31, P51, DOI 10.1016/0167-8140(94)90413-8; Saito S, 2011, RADIAT RES, V175, P1, DOI 10.1667/RR2134.1; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schiszler I, 2000, AM J PHYSIOL-HEART C, V279, pH1291, DOI 10.1152/ajpheart.2000.279.3.H1291; Schulte ML, 2003, BRAIN RES, V963, P81, DOI 10.1016/S0006-8993(02)03848-9; Seylaz J, 1999, J CEREBR BLOOD F MET, V19, P863, DOI 10.1097/00004647-199908000-00005; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; Tomita M, 2008, MICROCIRCULATION, V15, P163, DOI 10.1080/10739680701567089; Tomita Y, 2002, J CEREBR BLOOD F MET, V22, P663, DOI 10.1097/00004647-200206000-00004; Tomita Y, 2011, BRAIN RES, V1372, P59, DOI 10.1016/j.brainres.2010.11.014; Unekawa M, 2010, BRAIN RES, V1320, P69, DOI 10.1016/j.brainres.2010.01.032; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Ying JP, 2000, APPL OPTICS, V39, P509, DOI 10.1364/AO.39.000509; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	46	19	19	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24056	10.1371/journal.pone.0024056	http://dx.doi.org/10.1371/journal.pone.0024056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887370	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000089
J	Hardy, BL; Moncel, MH				Hardy, Bruce L.; Moncel, Marie-Helene			Neanderthal Use of Fish, Mammals, Birds, Starchy Plants and Wood 125-250,000 Years Ago	PLOS ONE			English	Article							MIDDLE PALEOLITHIC SITE; STONE TOOL FUNCTION; FEATHER FRAGMENTS; PAYRE ARDECHE; RESIDUE; IDENTIFICATION; DIET; BEHAVIOR; FRANCE; CAVE	Neanderthals are most often portrayed as big game hunters who derived the vast majority of their diet from large terrestrial herbivores while birds, fish and plants are seen as relatively unimportant or beyond the capabilities of Neanderthals. Although evidence for exploitation of other resources (small mammals, birds, fish, shellfish, and plants) has been found at certain Neanderthal sites, these are typically dismissed as unusual exceptions. The general view suggests that Neanderthal diet may broaden with time, but that this only occurs sometime after 50,000 years ago. We present evidence, in the form of lithic residue and use-wear analyses, for an example of a broad-based subsistence for Neanderthals at the site of Payre, Ardeche,France (beginning of MIS 5/end of MIS 6 to beginning of MIS 7/end of MIS 8; approximately 125-250,000 years ago). In addition to large terrestrial herbivores, Neanderthals at Payre also exploited starchy plants, birds, and fish. These results demonstrate a varied subsistence already in place with early Neanderthals and suggest that our ideas of Neanderthal subsistence are biased by our dependence on the zooarchaeological record and a deep-seated intellectual emphasis on big game hunting.	[Hardy, Bruce L.] Kenyon Coll, Dept Anthropol, Gambier, OH 43022 USA; [Moncel, Marie-Helene] Museum Natl Hist Nat, Inst Paleontol Humaine, Dept Prehist, F-75231 Paris, France	Kenyon College; Museum National d'Histoire Naturelle (MNHN)	Hardy, BL (corresponding author), Kenyon Coll, Dept Anthropol, Gambier, OH 43022 USA.	hardyb@kenyon.edu			French Ministry of Culture; Kenyon College Labalme Fund	French Ministry of Culture; Kenyon College Labalme Fund	Thanks to the French Ministry of Culture for support of the excavations at Payre and to the Kenyon College Labalme Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan GE, 2009, J ARCHAEOL SCI, V36, P895, DOI 10.1016/j.jas.2008.11.017; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; Bar-Yosef O, 2004, INT J OSTEOARCHAEOL, V14, P333, DOI 10.1002/oa.765; BEYRIES S, 1988, FUNCTIONAL VARIABILI, P213; Bicho N, 2008, QUATERNARY SCI REV, V27, P2166, DOI 10.1016/j.quascirev.2008.08.011; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Bocherens H, 2011, VERTEBR PALEOBIOL PA, P73, DOI 10.1007/978-94-007-0415-2_8; Bocherens H, 2009, VERTEBR PALEOBIOL PA, P241, DOI 10.1007/978-1-4020-9699-0_19; Braun DR, 2010, P NATL ACAD SCI USA, V107, P10002, DOI 10.1073/pnas.1002181107; BROM TG, 1986, BIJDR DIERKD, V56, P181, DOI 10.1163/26660644-05602001; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Brunner H., 1974, IDENTIFICATION MAMMA, DOI [10.1017/S0030605300014253, DOI 10.1017/S0030605300014253]; Cassoli PF, 1997, INT J OSTEOARCHAEOL, V7, P303, DOI 10.1002/(SICI)1099-1212(199707/08)7:4<303::AID-OA380>3.0.CO;2-R; Catling D, 1982, IDENTIFICATION VEGET, DOI 10.1007/978-94-011-8070-2_1; Condemi S., 1997, B SOC PREHISTORIQUE, V94, P168; Daujeard C, 2012, QUATERN INT, V252, P32, DOI 10.1016/j.quaint.2011.01.047; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; Derevianko AnatolyP., 2005, INDO PACIFIC PREHIST, V25, P57; Dove CJ, 2005, ARCTIC, V58, P38; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Fernandes P, 2008, J ARCHAEOL SCI, V35, P2357, DOI 10.1016/j.jas.2008.02.012; FINLAYSON C, 2004, NEANDERTHALS MOSERN; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Fullagar R., 2006, ANCIENT STARCH RES, P177; FULLAGAR RLK, 1991, J ARCHAEOL SCI, V18, P1, DOI 10.1016/0305-4403(91)90076-2; Genten F., 2009, ATLAS FISH HISTOLOGY, DOI DOI 10.1201/B10183; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hardy BL, 1998, J ARCHAEOL SCI, V25, P177, DOI 10.1006/jasc.1997.0234; Hardy BL, 2001, P NATL ACAD SCI USA, V98, P10972, DOI 10.1073/pnas.191384498; Hardy BL., 1994, THESIS INDIANA U; Hardy BL, 2008, J HUM EVOL, V54, P648, DOI 10.1016/j.jhevol.2007.10.003; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Haslam M, 2004, J ARCHAEOL SCI, V31, P1715, DOI 10.1016/j.jas.2004.05.006; Haslam M, 2006, J ARCHAEOL SCI, V33, P114, DOI 10.1016/j.jas.2005.07.004; Haslam M, 2006, J SOC ARCHAEOL, V6, P402, DOI 10.1177/1469605306067851; HATHER J, EUROPE SW ASIA; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Hoadley B., 1990, IDENTIFYING WOOD; Hogberg A, 2009, J ARCHAEOL SCI, V36, P1725, DOI 10.1016/j.jas.2009.03.030; IZQUIERDO R, 2005, MUNIBE, V57, P183; Kalai C., 2001, TRABAJOS PREHIST, V58, P143; KALAI C, 1998, THESIS MUSEUM NATL H; Kardulias PN, 1996, J ARCHAEOL SCI, V23, P657; Katzenberg M.A., 2000, BIOL ANTHR HUMAN SKE, P305, DOI DOI 10.1002/9780470245842.CH13; Kuhn SL, 2006, CURR ANTHROPOL, V47, P953, DOI 10.1086/507197; Lombard M, 2004, S AFR ARCHAEOL BULL, V59, P37, DOI 10.2307/3889241; Lombard M, 2007, J ARCHAEOL SCI, V34, P155, DOI 10.1016/j.jas.2006.04.008; Mansur-Franchomme M.E., 1986, MICROSCOPIE MATERIEL; Moncel M.-H., 2008, MEMOIRE SOC PREHISTO, VXLVI, P336; Moncel MH, 2007, ANTHROPOL-INT J HUM, V45, P19; Moncel MH, 2009, J ARCHAEOL SCI, V36, P1892, DOI 10.1016/j.jas.2009.04.018; Moncel MH, 1996, CR ACAD SCI II A, V322, P251; Moncel MH, 2002, B SOC PREHISTORIQUE, V99, P249, DOI DOI 10.3406/bspf.2002.12656; Odell G.H., 1980, J FIELD ARCHAEOL, V7, P87, DOI DOI 10.1179/009346980791505545; Patou-Mathis M, 2004, INT J OSTEOARCHAEOL, V14, P244, DOI 10.1002/oa.759; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Pearson J.A., 2007, FARMING ARCHAEOLOGY, V2, P1; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Richards MP, 2008, ANTIQUITY, V82, P553, DOI 10.1017/S0003598X00097210; Rigaud JP, 1995, ANTIQUITY, V69, P902, DOI 10.1017/S0003598X00082454; Rivals F, 2009, J ARCHAEOL SCI, V36, P1070, DOI 10.1016/j.jas.2008.12.009; Rots V, 2004, J ARCHAEOL SCI, V31, P1287, DOI 10.1016/j.jas.2004.02.009; Speth JohnD., 2010, INTERD CONTRIB ARCH; STINER MC, 1999, SCI, V28, P190; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; TEERINK BJ, 1990, HAIR W EUROPEAN MAMM; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Valladas H, 2008, QUAT GEOCHRONOL, V3, P377, DOI 10.1016/j.quageo.2008.01.001; Van Gijn A.L., 1989, ANALECTA PRAEHISTORI, V22; Wadley L, 2004, J ARCHAEOL SCI, V31, P1491, DOI 10.1016/j.jas.2004.03.010; Warren R., 2009, THESIS KENYON COLL G; Williamson B.S, 1996, SO AFRICAN FIELD ARC, V5, P36; [No title captured]	75	172	174	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23768	10.1371/journal.pone.0023768	http://dx.doi.org/10.1371/journal.pone.0023768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	832TW	21887315	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000056
J	Schumann, J; Leichtle, A; Thiery, J; Fuhrmann, H				Schumann, Julia; Leichtle, Alexander; Thiery, Joachim; Fuhrmann, Herbert			Fatty Acid and Peptide Profiles in Plasma Membrane and Membrane Rafts of PUFA Supplemented RAW264.7 Macrophages	PLOS ONE			English	Article							CHANGES LIPID-COMPOSITION; DOCOSAHEXAENOIC ACID; SIGNAL-TRANSDUCTION; CELL-MEMBRANES; PROTEINS; CHOLESTEROL; INHIBITION; DOMAINS; OMEGA-3-FATTY-ACIDS; LOCALIZATION	The eukaryotic cell membrane possesses numerous complex functions, which are essential for life. At this, the composition and the structure of the lipid bilayer are of particular importance. Polyunsaturated fatty acids may modulate the physical properties of biological membranes via alteration of membrane lipid composition affecting numerous physiological processes, e.g. in the immune system. In this systematic study we present fatty acid and peptide profiles of cell membrane and membrane rafts of murine macrophages that have been supplemented with saturated fatty acids as well as PUFAs from the n-3, the n-6 and the n-9 family. Using fatty acid composition analysis and mass spectrometry-based peptidome profiling we found that PUFAs from both the n-3 and the n-6 family have an impact on lipid and protein composition of plasma membrane and membrane rafts in a similar manner. In addition, we found a relation between the number of bis-allyl-methylene positions of the PUFA added and the unsaturation index of plasma membrane as well as membrane rafts of supplemented cells. With regard to the proposed significance of lipid microdomains for disease development and treatment our study will help to achieve a targeted dietary modulation of immune cell lipid bilayers.	[Schumann, Julia; Fuhrmann, Herbert] Univ Leipzig, Inst Physiol Chem, Fac Vet Med, Leipzig, Germany; [Leichtle, Alexander; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Fac Med, Leipzig, Germany	Leipzig University; Leipzig University	Schumann, J (corresponding author), Univ Leipzig, Inst Physiol Chem, Fac Vet Med, Leipzig, Germany.	julia.schumann@vmf.uni-leipzig.de	Leichtle, Alexander Benedikt/C-7262-2011	Leichtle, Alexander Benedikt/0000-0002-6528-9904	Deutsche Forschungsgemeinschaft (DFG) [SCHU 2586/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was granted by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de), grant number SCHU 2586/1-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Armstrong VT, 2003, ARCH BIOCHEM BIOPHYS, V414, P74, DOI 10.1016/S0003-9861(03)00159-0; Benatti P, 2004, J AM COLL NUTR, V23, P281, DOI 10.1080/07315724.2004.10719371; Biondo PD, 2008, J NUTR BIOCHEM, V19, P787, DOI 10.1016/j.jnutbio.2008.02.003; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Chen WQ, 2007, INVEST OPHTH VIS SCI, V48, P18, DOI 10.1167/iovs.06-0619; Dhungana S, 2009, MOL CELL PROTEOMICS, V8, P201, DOI 10.1074/mcp.M800286-MCP200; Epand RM, 1998, BBA-REV BIOMEMBRANES, V1376, P353, DOI 10.1016/S0304-4157(98)00015-X; Fiedler GM, 2009, CLIN CANCER RES, V15, P3812, DOI 10.1158/1078-0432.CCR-08-2701; Gaus K, 2005, J LIPID RES, V46, P1526, DOI 10.1194/jlr.M500103-JLR200; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Hartlova A, 2010, MICROBIOL IMMUNOL, V54, P237, DOI 10.1111/j.1348-0421.2010.00198.x; Huster D, 1997, BIOPHYS J, V73, P855, DOI 10.1016/S0006-3495(97)78118-9; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kafrawy O, 1998, CANCER LETT, V132, P23, DOI 10.1016/S0304-3835(98)00163-3; Kanayama M, 2007, J BIOL CHEM, V282, P24166, DOI 10.1074/jbc.M703212200; KELLEY EE, 1995, ARCH BIOCHEM BIOPHYS, V319, P102, DOI 10.1006/abbi.1995.1271; Kim MH, 2008, AMINO ACIDS, V34, P497, DOI 10.1007/s00726-006-0461-4; Kim W, 2008, J IMMUNOL, V181, P6236, DOI 10.4049/jimmunol.181.9.6236; Koenig BW, 1997, BIOPHYS J, V73, P1954, DOI 10.1016/S0006-3495(97)78226-2; LEAF DA, 1995, AM J CLIN NUTR, V62, P68, DOI 10.1093/ajcn/62.1.68; Li QR, 2006, EUR J NUTR, V45, P144, DOI 10.1007/s00394-005-0574-7; Li QR, 2005, J LIPID RES, V46, P1904, DOI 10.1194/jlr.M500033-JLR200; Ma DWL, 2004, J NUTR BIOCHEM, V15, P700, DOI 10.1016/j.jnutbio.2004.08.002; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Schmitz G, 2008, CURR OPIN CLIN NUTR, V11, P106, DOI 10.1097/MCO.0b013e3282f44c2c; Seidel A, 2005, J VET MED A, V52, P219, DOI 10.1111/j.1439-0442.2005.00711.x; Siddiqui RA, 2007, NUTR CLIN PRACT, V22, P74, DOI 10.1177/011542650702200174; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smaby JM, 1997, BIOPHYS J, V73, P1492, DOI 10.1016/S0006-3495(97)78181-5; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; VAN LF, 2002, CURR MOL MED, V2, P557; Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Williams EE, 1998, BBA-BIOMEMBRANES, V1371, P351, DOI 10.1016/S0005-2736(98)00039-X; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; YANAGIDA M, 2008, GLYCOSCIENCE GLYCOTE, V20, P1; Ye S, 2010, PROSTAG LEUKOTR ESS, V83, P37, DOI 10.1016/j.plefa.2010.02.002; Yi T, 2008, J CELL PHYSIOL, V217, P409, DOI 10.1002/jcp.21511; Zeyda M, 2002, J BIOL CHEM, V277, P28418, DOI 10.1074/jbc.M203343200; Zhang N, 2008, ANAL CHIM ACTA, V627, P82, DOI 10.1016/j.aca.2008.05.058; Zhang T, 2010, J MOL BIOL, V402, P761, DOI 10.1016/j.jmb.2010.08.014; 2010, SCHRIFTENREIHE DVG, V19, P53	53	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24066	10.1371/journal.pone.0024066	http://dx.doi.org/10.1371/journal.pone.0024066			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887374	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000092
J	Tanner, RM; Lynch, AI; Brophy, VH; Eckfeldt, JH; Davis, BR; Ford, CE; Boerwinkle, E; Arnett, DK				Tanner, Rikki M.; Lynch, Amy I.; Brophy, Victoria H.; Eckfeldt, John H.; Davis, Barry R.; Ford, Charles E.; Boerwinkle, Eric; Arnett, Donna K.			Pharmacogenetic Associations of MMP9 and MMP12 Variants with Cardiovascular Disease in Patients with Hypertension	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; HEART-FAILURE; MATRIX-METALLOPROTEINASE-9 ACTIVITY; GENETIC POLYMORPHISMS; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATIONS; ACE-INHIBITORS; SUSCEPTIBILITY; ATHEROSCLEROSIS; RISK	Objectives: MMP-9 and -12 function in tissue remodeling and may play roles in cardiovascular disease (CVD). We assessed associations of four MMP polymorphisms and three antihypertensive drugs with cardiovascular outcomes. Methods: Hypertensives (n = 42,418) from a double-blind, randomized, clinical trial were randomized to chlorthalidone, amlodipine, lisinopril, or doxazosin treatment (mean follow up, 4.9 years). The primary outcome was coronary heart disease (CHD). Secondary outcomes included combined CHD, all CVD outcomes combined, stroke, heart failure (HF), and mortality. Genotype-treatment interactions were tested. Results: There were 38,698 participants genotyped for at least one of the polymorphisms included here. For MMP9 R668Q (rs2274756), lower hazard ratios (HRs) were found for AA subjects for most outcomes when treated with chlorthalidone versus amlodipine (eg., CCHD: GG = 1.00, GA = 1.01, AA = 0.64; P = 0.038). For MMP9 R279Q (rs17576), modest pharmacogenetic findings were observed for combined CHD and the composite CVD outcome. For MMP12 N122S (rs652438), lower HRs were observed for CHD in subjects carrying at least one G allele and being treated with chlorthalidone versus lisinopril (CHD: AA = 1.07, AG = 0.80, GG = 0.49; P = 0.005). In the lisinopril-amlodipine comparison, higher HRs were observed for participants having at least one G allele at the MMP12 N122S locus (CHD: AA = 0.94, AG = 1.19, GG = 1.93; P = 0.041). For MMP12 -82A>G (rs2276109), no pharmacogenetic effect was found for the primary outcome, although lower HRs were observed for AA homozygotes in the chlorthalidone-amlodipine comparison for HF (P = 0.015). Conclusions: We observed interactions between antihypertensive drugs and MMP9 and MMP12 for CHD and composite CVD. The data suggest that these genes may provide useful clinical information with respect to treatment decisions.	[Tanner, Rikki M.; Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Lynch, Amy I.; Eckfeldt, John H.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Brophy, Victoria H.] Roche Mol Syst, Dept Human Genet, Pleasanton, CA USA; [Davis, Barry R.; Ford, Charles E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Houston, Ctr Human Genet, Houston, TX USA	University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; Roche Holding; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Tanner, RM (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA.	arnett@uab.edu	Brophy, Victoria/V-8964-2019; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Heart, Lung, and Blood Institute [HL63082]; National Institutes of Health [N01-HC-35130]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063082, R01HL083498] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants HL63082 (Genetics of Hypertension Associated Treatments, (GenHAT)) from the National Heart, Lung, and Blood Institute http://www.nhlbi.nih.gov) and N01-HC-35130 (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, (ALLHAT)) from the National Institutes of Health (http://www.nih.gov). The National Heart, Lung, and Blood Institute had a contributing role in the analysis and interpretation of the ALLHAT data and in the review and approval of this GenHAT article.	Alderman MH, 2003, HYPERTENSION, V42, P239, DOI 10.1161/01.HYP.0000086521.95630.5A; Armstrong C, 2007, STROKE, V38, P2895, DOI 10.1161/STROKEAHA.107.491696; Arnett D. K., 2002, Pharmacogenomics Journal, V2, P309; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Bots ML, 1997, STROKE, V28, P2442, DOI 10.1161/01.STR.28.12.2442; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Canavesi M, 2004, J CARDIOVASC PHARM, V44, P416, DOI 10.1097/01.fjc.0000139448.56713.3d; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; *DRUGBANK, AML; *DRUGBANK, CHLORTH; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Han YJ, 2009, FERTIL STERIL, V91, P2324, DOI 10.1016/j.fertnstert.2008.03.047; Hirose Y, 2008, AM J HUM GENET, V82, P1122, DOI 10.1016/j.ajhg.2008.03.013; Hlatky MA, 2007, AM HEART J, V154, P1043, DOI 10.1016/j.ahj.2007.06.042; HUTCHINSON KR, 2009, J MOL CELL CARDIOL; Jguirim-Souissi I, 2007, AM J CARDIOL, V100, P23, DOI 10.1016/j.amjcard.2007.01.069; Jin Y, 2007, J MOL CELL CARDIOL, V43, P664, DOI 10.1016/j.yjmcc.2007.09.002; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Jormsjo S, 2000, CIRC RES, V86, P998, DOI 10.1161/01.RES.86.9.998; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kerkela E, 2001, BONE, V29, P487, DOI 10.1016/S8756-3282(01)00595-6; KURE M, 2011, MOL GENET METAB; Lavigne MC, 2004, BIOCHEM BIOPH RES CO, V324, P534, DOI 10.1016/j.bbrc.2004.09.080; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Liebetrau M, 2005, NEUROSCI LETT, V376, P205, DOI 10.1016/j.neulet.2004.11.061; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Martinez MLL, 2006, J CARDIOVASC PHARM, V47, P117, DOI 10.1097/01.fjc.0000196241.96759.71; Matsuno H, 2004, J CARDIOVASC PHARM, V44, P57, DOI 10.1097/00005344-200407000-00008; Morgan AR, 2004, STROKE, V35, P1310, DOI 10.1161/01.STR.0000126822.01756.99; *NAT LIB MED, CHLORTH TABL DAIL ME; Natividad A, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-40; Reinhardt D, 2002, HEART, V88, P525, DOI 10.1136/heart.88.5.525; Sakata Y, 2004, CIRCULATION, V109, P2143, DOI 10.1161/01.CIR.0000125741.88712.77; Seeland U, 2002, J MOL CELL CARDIOL, V34, P151, DOI 10.1006/jmcc.2001.1497; Shin AS, 2005, BREAST CANCER RES, V7, pR506, DOI 10.1186/bcr1033; Su L, 2006, CARCINOGENESIS, V27, P1024, DOI 10.1093/carcin/bgi283; Takai S, 2007, EUR J PHARMACOL, V568, P231, DOI 10.1016/j.ejphar.2007.04.036; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Yamada S, 2008, AM J PATHOL, V172, P1419, DOI 10.2353/ajpath.2008.070604; Yamamoto D, 2008, EUR J PHARMACOL, V588, P277, DOI 10.1016/j.ejphar.2008.04.031; Yamamoto D, 2007, J MOL CELL CARDIOL, V43, P670, DOI 10.1016/j.yjmcc.2007.08.002; Yamamoto D, 2007, BIOCHEM BIOPH RES CO, V354, P981, DOI 10.1016/j.bbrc.2007.01.088; Yasmin, 2006, ARTERIOSCL THROM VAS, V26, P1799, DOI 10.1161/01.ATV.0000227717.46157.32; Ye S, 2006, CARDIOVASC RES, V69, P636, DOI 10.1016/j.cardiores.2005.07.015; Ye S, 2000, MATRIX BIOL, V19, P623, DOI 10.1016/S0945-053X(00)00102-5; Zervoudaki A, 2004, AM J HYPERTENS, V17, P273, DOI 10.1016/j.amjhyper.2003.11.007; Zervoudaki A, 2003, J HUM HYPERTENS, V17, P119, DOI 10.1038/sj.jhh.1001518; Zhou S, 2007, J HUM HYPERTENS, V21, P861, DOI 10.1038/sj.jhh.1002244	50	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23609	10.1371/journal.pone.0023609	http://dx.doi.org/10.1371/journal.pone.0023609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887284	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000038
J	Daneshvar, K; Khan, A; Goodliffe, JM				Daneshvar, Kaveh; Khan, Abid; Goodliffe, Julie M.			Myc Localizes to Histone Locus Bodies during Replication in Drosophila	PLOS ONE			English	Article							CAJAL BODY; RIBOSOME BIOGENESIS; PROTEIN; GROWTH; COILIN; TRANSACTIVATION; MELANOGASTER; ACTIVATION; POLYCOMB; DMYC	Myc is an important protein at the center of multiple pathways required for growth and proliferation in animals. The absence of Myc is lethal in flies and mice, and its over-production is a potent inducer of over-proliferation and cancer. Myc protein is localized to the nucleus where it executes its many functions, however the specific sub-nuclear localization of Myc has rarely been reported. The work we describe here began with an observation of unexpected, punctate spots of Myc protein in certain regions of Drosophila embryos. We investigated the identity of these puncta and demonstrate that Myc is co-localized with coilin, a marker for sub-nuclear organelles known as Cajal Bodies (CBs), in embryos, larvae and ovaries. Using antibodies specific for U7 snRNP component Lsm11, we show that the majority of Myc and coilin co-localization occurs in Histone Locus Bodies (HLBs), the sites of histone mRNA transcription and processing. Furthermore, Myc localizes to HLBs only during replication in mitotic and endocycling cells, suggesting that its role there relates to replication-dependent canonical histone gene transcription. These results provide evidence that sub-nuclear localization of Myc is cell-cycle dependent and potentially important for histone mRNA production and processing.	[Daneshvar, Kaveh; Khan, Abid; Goodliffe, Julie M.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Daneshvar, K (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	jmgoodli@uncc.edu	Khan, Abid/Y-8454-2019; Daneshvar, Kaveh/M-9443-2014	Daneshvar, Kaveh/0000-0002-7863-0489; Khan, Abid/0000-0003-0968-8705	NIH (NCI) [1R15CA135481-01]; NSF; NATIONAL CANCER INSTITUTE [R15CA135481] Funding Source: NIH RePORTER	NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been funded by the NIH (NCI, www.cancer.gov) to JMG, under grant number 1R15CA135481-01, and also by an NSF ADVANCE grant to UNC Charlotte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADING H, 1989, ONCOGENE, V4, P33; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Campos-Ortega JA, 1997, EMBRYONIC DEV DROSOP, Vxvii; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; CRANNA NJ, FLY AUSTIN, V5; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edgar BA, 2001, NOVART FDN SYMP, V237, P3, DOI 10.1002/0470846666.ch2; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Goodliffe JM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-40; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Khan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005076; Kim H, 2007, BIOCHEM BIOPH RES CO, V362, P842, DOI 10.1016/j.bbrc.2007.08.064; Kupsco JM, 2006, RNA, V12, P2103, DOI 10.1261/rna.186706; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Marinho J, 2011, DEVELOPMENT, V138, P349, DOI 10.1242/dev.054411; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; Quinn LM, 2004, DEVELOPMENT, V131, P1411, DOI 10.1242/dev.01019; Shpargel KB, 2003, J CELL SCI, V116, P303, DOI 10.1242/jcs.00211; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; White AE, 2011, J CELL BIOL, V193, P677, DOI 10.1083/jcb.201012077; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23928	10.1371/journal.pone.0023928	http://dx.doi.org/10.1371/journal.pone.0023928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886841	gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500039
J	Islam, AMMK; Richter, WF; Jacobs, LA; Lopez-Bigas, N; Benevolenskaya, EV				Islam, Abul B. M. M. K.; Richter, William F.; Jacobs, Laura A.; Lopez-Bigas, Nuria; Benevolenskaya, Elizaveta V.			Co-Regulation of Histone-Modifying Enzymes in Cancer	PLOS ONE			English	Article							METASTATIC PROSTATE-CANCER; POLYCOMB GROUP; BINDING; GENOME; GENE; DIFFERENTIATION; EZH2; METHYLTRANSFERASE; METHYLATION; LEUKEMIA	Cancer is characterized by aberrant patterns of expression of multiple genes. These major shifts in gene expression are believed to be due to not only genetic but also epigenetic changes. The epigenetic changes are communicated through chemical modifications, including histone modifications. However, it is unclear whether the binding of histone-modifying proteins to genomic regions and the placing of histone modifications efficiently discriminates corresponding genes from the rest of the genes in the human genome. We performed gene expression analysis of histone demethylases (HDMs) and histone methyltransferases (HMTs), their target genes and genes with relevant histone modifications in normal and tumor tissues. Surprisingly, this analysis revealed the existence of correlations in the expression levels of different HDMs and HMTs. The observed HDM/HMT gene expression signature was specific to particular normal and cancer cell types and highly correlated with target gene expression and the expression of genes with histone modifications. Notably, we observed that trimethylation at lysine 4 and lysine 27 separated preferentially expressed and underexpressed genes, which was strikingly different in cancer cells compared to normal cells. We conclude that changes in coordinated regulation of enzymes executing histone modifications may underlie global epigenetic changes occurring in cancer.	[Islam, Abul B. M. M. K.; Richter, William F.; Jacobs, Laura A.; Benevolenskaya, Elizaveta V.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA; [Islam, Abul B. M. M. K.; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt Hlth & Sci, Res Unit Biomed Informat, PRBB, Barcelona, Spain	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pompeu Fabra University	Islam, AMMK (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60680 USA.	evb@uic.edu	Gasull, Martina/J-4076-2019; Lopez-Bigas, Nuria/F-6193-2011	Lopez-Bigas, Nuria/0000-0003-4925-8988; Islam, Abul/0000-0002-7274-0855; Richter, William/0000-0003-4469-6428	American Cancer Society [115347-RSG-08-271-01-GMC]; Spanish Ministry of Science and Education [SAF2009-06954]; AGAUR of the Catalonian Government, Spain;  [R01CA138631]; NATIONAL CANCER INSTITUTE [R01CA138631] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Spanish Ministry of Science and Education(Spanish Government); AGAUR of the Catalonian Government, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by R01CA138631 (E.V.B.) and grant number 115347-RSG-08-271-01-GMC from the American Cancer Society (E.V.B.). N.L.-B. acknowledges funding from the Spanish Ministry of Science and Education, grant number SAF2009-06954. A. B. M. M. K. I. is supported by a fellowship from AGAUR of the Catalonian Government, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benevolenskaya EV, 2007, BIOCHEM CELL BIOL, V85, P435, DOI 10.1139/O07-057; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Berezovska OP, 2006, CELL CYCLE, V5, P1886; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chik CL, 2007, ENDOCRINOLOGY, V148, P1465, DOI 10.1210/en.2006-1454; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Gildea JJ, 2000, GENETICS, V156, P645; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Islam ABMMK, 2011, CELL CYCLE, V10, P413, DOI 10.4161/cc.10.3.14705; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	41	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e24023	10.1371/journal.pone.0024023	http://dx.doi.org/10.1371/journal.pone.0024023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886846	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500043
J	Ma, MJ; Wang, HB; Li, H; Yang, JH; Yan, Y; Xie, LP; Qi, YC; Li, JL; Chen, MJ; Liu, W; Cao, WC				Ma, Mai-Juan; Wang, Hai-Bing; Li, Hao; Yang, Jun-Hai; Yan, Yan; Xie, Lan-Pin; Qi, Ying-Cheng; Li, Jun-Lian; Chen, Mei-Juan; Liu, Wei; Cao, Wu-Chun			Genetic Variants in MARCO Are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Han Population	PLOS ONE			English	Article							SCAVENGER RECEPTOR MARCO; GENOME-WIDE ASSOCIATION; HOST-DEFENSE; IDENTIFIES VARIANTS; IN-VITRO; MACROPHAGES; INVOLVEMENT; CLEARANCE; REGION; ROLES	Background: Susceptibility to tuberculosis is not only determined by Mycobacterium tuberculosis infection, but also by the genetic component of the host. Macrophage receptor with a collagenous structure (MARCO) is essential components required for toll like receptor-signaling in macrophage response to Mycobacterium tuberculosis, which may contribute to tuberculosis risk. Principal Findings: To specifically investigated whether single nucleotide polymorphisms (SNPs) in MARCO gene are associated with pulmonary tuberculosis in Chinese Han population. By selecting tagging SNPs in MARCO gene, 17 tag SNPs were identified and genotyped in 923 pulmonary tuberculosis patients and 1033 healthy control subjects using a hospital based case-control association study. Single-point and haplotype analysis revealed an association in intron and exon region of MARCO gene. One SNP (rs17009726) was associated with susceptibility to pulmonary tuberculosis, where the carriers of the G allele had a 1.65 fold (95% CI = 1.32-2.05, p(corrected) = 9.27E-5) increased risk of pulmonary tuberculosis. Haplotype analysis revealed that haplotype GC containing G allele of 17009726 and haplotype TGCC (rs17795618T/A, rs1371562G/T, rs6761637T/C, rs2011839C/T) were also associated with susceptibility to pulmonary tuberculosis (p(corrected) = 0.0001 and 0.029, respectively). Conclusions: Our study suggested that genetic variants in MARCO gene were associated with pulmonary tuberculosis susceptibility in Chinese Han population, and the findings emphasize the importance of MARCO mediated immune responses in the pathogenesis of tuberculosis.	[Ma, Mai-Juan; Li, Hao; Liu, Wei; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Hai-Bing] Shijiazhuang Fifth Hosp, Dept TB, Shijiazhuang, Hebei, Peoples R China; [Yang, Jun-Hai; Yan, Yan] Beijing Elect Hosp, Phys Examinat Dept, Beijing, Peoples R China; [Qi, Ying-Cheng; Li, Jun-Lian; Chen, Mei-Juan] Xinjiang Uygur Autonomous Reg Chest Hosp, Urumqi, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Ma, MJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	liu_weis@sohu.com; caowc@nic.bmi.ac.cn		Ma, Mai-Juan/0000-0002-8105-462X	National Science Fund for Distinguished Young Scholars [30725032]; Academy of Military Medical Sciences [2008ZD006]; China Special Grant for the Prevention and Control of Infection Diseases [2008ZX10003-010]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Academy of Military Medical Sciences; China Special Grant for the Prevention and Control of Infection Diseases	This study was supported by the grants of National Science Fund for Distinguished Young Scholars (30725032), Innovation Research Funds of Academy of Military Medical Sciences (2008ZD006) and China Special Grant for the Prevention and Control of Infection Diseases (2008ZX10003-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredouani M, 2004, J EXP MED, V200, P267, DOI 10.1084/jem.20040731; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ito S, 1999, ARCH HISTOL CYTOL, V62, P83, DOI 10.1679/aohc.62.83; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Mukhopadhyay S, 2004, J LEUKOCYTE BIOL, V76, P577, DOI 10.1189/jlb.0104014; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; Rieder H L, 2003, Pneumologie, V57, P402; Seta N, 2001, ARTHRITIS RHEUM, V44, P931, DOI 10.1002/1529-0131(200104)44:4<931::AID-ANR150>3.3.CO;2-K; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; van der Laan LJW, 1999, J IMMUNOL, V162, P939; vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	23	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e24069	10.1371/journal.pone.0024069	http://dx.doi.org/10.1371/journal.pone.0024069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886847	gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500044
J	Zuo, WL; Li, S; Huang, JH; Yang, DL; Zhang, G; Chen, SL; Ruan, YC; Ye, KN; Cheng, CHK; Zhou, WL				Zuo, Wu-Lin; Li, Sheng; Huang, Jie-Hong; Yang, Deng-Liang; Zhang, Geng; Chen, Si-Liang; Ruan, Ye-Chun; Ye, Ke-Nan; Cheng, Christopher H. K.; Zhou, Wen-Liang			Sodium Coupled Bicarbonate Influx Regulates Intracellular and Apical pH in Cultured Rat Caput Epididymal Epithelium	PLOS ONE			English	Article							MALE REPRODUCTIVE-TRACT; SEMINIFEROUS TUBULES; ANION-EXCHANGER; CELLS; COTRANSPORTER; ACIDIFICATION; IMMUNOLOCALIZATION; TRANSPORT; FLUID; INHIBITION	Background: The epithelium lining the epididymis provides an optimal acidic fluid microenvironment in the epididymal tract that enable spermatozoa to complete the maturation process. The present study aims to investigate the functional role of Na+/HCO3- cotransporter in the pH regulation in rat epididymis. Method/Principal Findings: Immunofluorescence staining of pan cytokeratin in the primary culture of rat caput epididymal epithelium showed that the system was a suitable model for investigating the function of epididymal epithelium. Intracellular and apical pH were measured using the fluorescent pH sensitive probe carboxy-seminaphthorhodafluor-4F acetoxymethyl ester (SNARF-4F) and sparklet pH electrode respectively to explore the functional role of rat epididymal epithelium. In the HEPES buffered Krebs-Henseleit(KH) solution, the intracellular pH (pHi) recovery from NH4Cl induced acidification in the cultured caput epididymal epithelium was completely inhibited by amiloride, the inhibitor of Na+/H+ exchanger (NHE). Immediately changing of the KH solution from HEPES buffered to HCO3- buffered would cause another pHi recovery. The pHi recovery in HCO3- buffered KH solution was inhibited by 4, 4diisothiocyanatostilbene-2, 2-disulfonic acid (DIDS), the inhibitor of HCO3- transporter or by removal of extracellular Na+. The extracellular pH measurement showed that the apical pH would increase when adding DIDS to the apical side of epididymal epithelial monolayer, however adding DIDS to the basolateral side had no effect on apical pH. Conclusions: The present study shows that sodium coupled bicarbonate influx regulates intracellular and apical pH in cultured caput epididymal epithelium.	[Zuo, Wu-Lin; Li, Sheng; Huang, Jie-Hong; Yang, Deng-Liang; Zhang, Geng; Chen, Si-Liang; Ruan, Ye-Chun; Ye, Ke-Nan; Zhou, Wen-Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Cheng, Christopher H. K.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong	Zuo, WL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	chkcheng@cuhk.edu.hk; lsszwl@yahoo.com.cn	Ruan, Ye Chun/T-7531-2019; Li, Sheng/A-1964-2014; RUAN, Ye Chun/T-5919-2017; CHENG, Ki Christopher/R-9641-2018	Ruan, Ye Chun/0000-0002-4266-6789; RUAN, Ye Chun/0000-0002-4266-6789; CHENG, Ki Christopher/0000-0001-8970-9048	National Natural Science Foundation of China [30770817, 31071019]; National 973 project foundation of China [2010CB945401, 2009CB522102]; Research Grants Council of Hong Kong [CUHK 462810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 project foundation of China(National Basic Research Program of China); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	Supported by the National Natural Science Foundation of China (No. 30770817 and 31071019), National 973 project foundation (No. 2010CB945401 and 2009CB522102) of China and the Research Grants Council of Hong Kong for the provision of a General Research Fund (CUHK 462810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2004, ACTA PHYSIOL SCAND, V181, P505, DOI 10.1111/j.1365-201X.2004.01324.x; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF426, DOI 10.1152/ajprenal.2001.280.3.F426; Bernardo AA, 2006, SEMIN NEPHROL, V26, P352, DOI 10.1016/j.semnephrol.2006.07.008; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Brown D, 1997, J EXP BIOL, V200, P257; CHAN HC, 1995, BIOL REPROD, V52, P645, DOI 10.1095/biolreprod52.3.645; Chew SBC, 2000, BIOL REPROD, V62, P755, DOI 10.1095/biolreprod62.3.755; Da Silva N, 2007, ASIAN J ANDROL, V9, P476, DOI 10.1111/j.1745-7262.2007.00299.x; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Du JY, 2006, BIOL REPROD, V75, P407, DOI 10.1095/biolreprod.106.052316; Du JY, 2009, BIOL REPROD, V80, P13, DOI 10.1095/biolreprod.108.068346; Erdogan S, 2005, DEV BIOL, V286, P352, DOI 10.1016/j.ydbio.2005.08.009; Hansen LA, 1999, EXP PHYSIOL, V84, P521, DOI 10.1111/j.1469-445X.1999.01788.x; Herak-Kramberger CM, 2001, BIOL REPROD, V64, P1699, DOI 10.1095/biolreprod64.6.1699; Hilvo M, 2007, CURR TOP MED CHEM, V7, P893, DOI 10.2174/156802607780636672; Huang Y, 1999, BIOL REPROD, V60, P1509, DOI 10.1095/biolreprod60.6.1509; Jensen LJ, 1999, BIOL REPROD, V60, P573, DOI 10.1095/biolreprod60.3.573; Jensen LJ, 1999, BIOL REPROD, V61, P973, DOI 10.1095/biolreprod61.4.973; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; Kaunisto K, 2001, PFLUG ARCH EUR J PHY, V442, P230, DOI 10.1007/s004240100530; KIERSZENBAUM AL, 1981, P NATL ACAD SCI-BIOL, V78, P1675, DOI 10.1073/pnas.78.3.1675; Kim YB, 2003, BIOCHEM BIOPH RES CO, V304, P593, DOI 10.1016/S0006-291X(03)00632-6; Klein M, 2000, J GEN PHYSIOL, V115, P599, DOI 10.1085/jgp.115.5.599; LEUNG AYH, 1994, PFLUG ARCH EUR J PHY, V426, P396, DOI 10.1007/BF00388302; Leung GPH, 2001, BIOL REPROD, V64, P482, DOI 10.1095/biolreprod64.2.482; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; Liu CJ, 2008, MOL CELL BIOCHEM, V308, P117, DOI 10.1007/s11010-007-9619-y; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; Pushkin A, 2000, J ANDROL, V21, P708; ROBAIRE B, 2002, EPIDIDYMIS MOL CLIN, P81; Romero M F, 2001, JOP, V2, P182; Schwab A, 2005, J PHYSIOL-LONDON, V568, P445, DOI 10.1113/jphysiol.2005.092957; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Wang XF, 2002, BIOL REPROD, V66, P1846, DOI 10.1095/biolreprod66.6.1846; Wong P.Y.D., 2002, EPIDIDYMIS MOL CLIN, P119, DOI [10.1007/978-1-4615-0679-9_7, DOI 10.1007/978-1-4615-0679-9_7, DOI 10.1007/978-1-46150679-9_7]; WONG PYD, 1976, JPN J PHYSIOL, V26, P321; WONG PYD, 1976, BRIT J PHARMACOL, V58, P529, DOI 10.1111/j.1476-5381.1976.tb08620.x; WONG PYD, 1990, EPITHELIAL SECRETION, P333; Zhang WK, 2010, NAT CELL BIOL, V12, P507, DOI 10.1038/ncb2053; Zuo WL, 2010, FERTIL STERIL, V93, P2744, DOI 10.1016/j.fertnstert.2010.02.042	43	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e22283	10.1371/journal.pone.0022283	http://dx.doi.org/10.1371/journal.pone.0022283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887217	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800004
J	Lee, BR; Kamitani, T				Lee, Byung Rho; Kamitani, Tetsu			Improved Immunodetection of Endogenous alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; MUTATION; PHOSPHORYLATION; MEMBRANE	alpha-Synuclein is a key molecule in understanding the pathogenesis of neurodegenerative alpha-synucleinopathies such as Parkinson's disease. Despite extensive research, however, its precise function remains unclear partly because of a difficulty in immunoblotting detection of endogenous alpha-synuclein. This difficulty has largely restricted the progress for alpha-synucleinopathy research. Here, we report that alpha-synuclein monomers tend to easily detach from blotted membranes, resulting in no or very poor detection. To prevent this detachment, a mild fixation of blotted membranes with paraformaldehyde was applied to the immunoblotting method. Amazingly, this fixation led to clear and strong detection of endogenous alpha-synuclein, which has been undetectable by a conventional immunoblotting method. Specifically, we were able to detect endogenous alpha-synuclein in various human cell lines, including SH-SY5Y, HEK293, HL60, HeLa, K562, A375, and Daoy, and a mouse cell line B16 as well as in several mouse tissues such as the spleen and kidney. Moreover, it should be noted that we could clearly detect endogenous alpha-synuclein phosphorylated at Ser-129 in several human cell lines. Thus, in some tissues and cultured cells, endogenous alpha-synuclein becomes easily detectable by simply fixing the blotted membranes. This improved immunoblotting method will allow us to detect previously undetectable endogenous alpha-synuclein, thereby facilitating alpha-synuclein research.	[Lee, Byung Rho; Kamitani, Tetsu] Georgia Hlth Sci Univ, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA	University System of Georgia; Augusta University	Lee, BR (corresponding author), Georgia Hlth Sci Univ, Dept Med, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA.	tkamitani@georgiahealth.edu	Kamitani, Tetsu/GSI-7613-2022	Kamitani, Tetsu/0000-0002-3257-9630; Lee, Byung Rho/0000-0002-2729-1616	National Institutes of Health [R01AG024497]; NATIONAL INSTITUTE ON AGING [R01AG024497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by National Institutes of Health Grant R01AG024497 (to Tetsu Kamitani). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LAURITZEN E, 1988, J ACQ IMMUN DEF SYND, V1, P333; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Suzuki Y, 2008, ANAL BIOCHEM, V378, P218, DOI 10.1016/j.ab.2008.04.008; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	16	97	100	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23939	10.1371/journal.pone.0023939	http://dx.doi.org/10.1371/journal.pone.0023939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886844	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100043
J	Shi, Y; Solomon, LR; Pereda-Lopez, A; Giranda, VL; Luo, Y; Johnson, EF; Shoemaker, AR; Leverson, J; Liu, XS				Shi, Yan; Solomon, Larry R.; Pereda-Lopez, Ana; Giranda, Vincent L.; Luo, Yan; Johnson, Eric F.; Shoemaker, Alexander R.; Leverson, Joel; Liu, Xuesong			Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; DEUBIQUITINATING ENZYME USP2A; PROSTATE-CANCER; P53 PATHWAY; B KINASE; CELLS; AMPLIFICATION; EXPRESSION	The ubiquitin/proteasome pathway plays critical roles in virtually all aspects of cell biology. Enzymes of the ubiquitin pathway add (ligases) or remove (deubiquitinases) ubiquitin tags to or from their target proteins in a selective fashion. USP2a is a member of a subfamily of deubiquitinases, called ubiquitin-specific cysteine proteases (USPs). Although USP2a has been reported to be a bona fide oncogene that regulates the stability of MDM2, MDMX, and FAS, it is likely that there are other unidentified substrates for USP2a. In this study, we show that USP2a mediates mitotic progression by regulating the stability of Aurora-A. Through cell-based screening of a USP siRNA library, we discovered that knockdown of USP2a reduced the protein levels of Aurora-A. USP2a interacts with Aurora-A directly in vitro and in vivo. In addition, Aurora-A is a substrate for USP2a in vitro and in vivo. Our study provides a novel mechanism for the role of USP2a in mediating the stability of Aurora-A.	[Shi, Yan; Solomon, Larry R.; Pereda-Lopez, Ana; Giranda, Vincent L.; Luo, Yan; Johnson, Eric F.; Shoemaker, Alexander R.; Leverson, Joel; Liu, Xuesong] Abbott Labs, Dept Canc Res, Abbott Pk, IL 60064 USA	Abbott Laboratories	Liu, XS (corresponding author), Abbott Labs, Dept Canc Res, 100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.	xuesong.liu@abbott.com						Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; da Silva SD, 2009, ORAL ONCOL, V45, pE134, DOI 10.1016/j.oraloncology.2009.02.004; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lin HJ, 2000, MOL CELL BIOL, V20, P6568, DOI 10.1128/MCB.20.17.6568-6578.2000; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Liu XS, 2008, NEOPLASIA, V10, P828, DOI 10.1593/neo.08408; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wong BR, 2003, DRUG DISCOV TODAY, V8, P746, DOI 10.1016/S1359-6446(03)02780-6; Yang H, 2005, FEBS LETT, V579, P3385, DOI 10.1016/j.febslet.2005.04.080	28	48	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38960	38968		10.1074/jbc.M111.231498	http://dx.doi.org/10.1074/jbc.M111.231498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21890637	Green Published, hybrid			2022-12-25	WOS:000296759800015
J	Biedzka-Sarek, M; Metso, J; Kateifides, A; Meri, T; Jokiranta, TS; Muszynski, A; Radziejewska-Lebrecht, J; Zannis, V; Skurnik, M; Jauhiainen, M				Biedzka-Sarek, Marta; Metso, Jari; Kateifides, Andreas; Meri, Taru; Jokiranta, T. Sakari; Muszynski, Artur; Radziejewska-Lebrecht, Joanna; Zannis, Vassilis; Skurnik, Mikael; Jauhiainen, Matti			Apolipoprotein A-I Exerts Bactericidal Activity against Yersinia enterocolitica Serotype O:3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; HUMAN-SERUM; APOA-I; FACTOR-H; COMPLEMENT; BINDING; HDL; LIPOPOLYSACCHARIDE; PSEUDOTUBERCULOSIS; INHIBITION	Apolipoprotein A-I (apoA-I), the main protein component of high density lipoprotein (HDL), is well recognized for its anti-atherogenic, antioxidant, and antiinflammatory properties. Here, we report a novel role for apoA-I as a host defense molecule that contributes to the complement-mediated killing of an important gastrointestinal pathogen, Gram-negative bacterium Yersinia enterocolitica. We specifically show that the C-terminal domain of apoA-I is the effector site providing the bactericidal activity. Although the presence of the lipopolysaccharide O-antigen on the bacterial surface is absolutely required for apoA-I to kill the bacteria, apoA-I does not interact with the bacteria directly. To the contrary, exposure of the bacteria by serum proteins triggers apoA-I deposition on the bacterial surface. As our data show that both purified lipid-free and HDL-associated apoA-I displays anti-bacterial potential, apoA-I mimetic peptides may be a promising therapeutic agent for the treatment of certain Gram-negative infections.	[Biedzka-Sarek, Marta; Metso, Jari; Jauhiainen, Matti] Natl Inst Hlth & Welf, Publ Hlth Genom Res Unit, Dept Chron Dis Prevent, Helsinki 00290, Finland; [Biedzka-Sarek, Marta; Metso, Jari; Jauhiainen, Matti] Inst Mol Med Finland FIMM, Helsinki 00290, Finland; [Kateifides, Andreas; Zannis, Vassilis] Boston Univ, Med Ctr, Dept Mol Genet, Boston, MA 02118 USA; [Meri, Taru; Jokiranta, T. Sakari; Skurnik, Mikael] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki 00014, Finland; [Meri, Taru; Skurnik, Mikael] Univ Helsinki, Cent Hosp, Dept Lab Diagnost, FIN-00290 Helsinki, Finland; [Muszynski, Artur] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Radziejewska-Lebrecht, Joanna] Univ Silesia, Inst Microbiol, PL-40032 Katowice, Poland	Finland National Institute for Health & Welfare; Boston University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University System of Georgia; University of Georgia; University of Silesia in Katowice	Biedzka-Sarek, M (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Res Unit, POB 104, FIN-00251 Helsinki, Finland.	marta.biedzka-sarek@thl.fi	Skurnik, Mikael/I-8477-2019	Skurnik, Mikael/0000-0001-8791-9260; Muszynski, Artur/0000-0003-3497-9977; Zannis, Vassilis/0000-0002-1295-7155	National Institutes of Health [HL48739]; Finnish Cultural Foundation; Paulo Foundation; Aarne Koskelon Foundation; Orion Farmos; Alfred Kordelin Foundation; Research Council for Biosciences and Environment, Academy of Finland [114075]; Finnish Foundation for Cardiovascular Research; Research Council for Health, Academy of Finland [132629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paulo Foundation; Aarne Koskelon Foundation; Orion Farmos; Alfred Kordelin Foundation; Research Council for Biosciences and Environment, Academy of Finland(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES)); Finnish Foundation for Cardiovascular Research; Research Council for Health, Academy of Finland(Academy of Finland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL48739 (to V. Z.). This work was also supported by the Finnish Cultural Foundation (to M. B.-S.), the Paulo Foundation (to M. B.-S.), the Aarne Koskelon Foundation (to M. B.-S.), Orion Farmos (to M. B.-S.), the Alfred Kordelin Foundation (to M. B.-S.), the Research Council for Biosciences and Environment, Academy of Finland Grant 114075 (to M. S.), the Finnish Foundation for Cardiovascular Research (to M. J.), and the Research Council for Health, Academy of Finland, Grant 132629 (to M. J.).	Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Barlage S, 2001, J LIPID RES, V42, P281; Biedzka-Sarek M, 2005, INFECT IMMUN, V73, P2232, DOI 10.1128/IAI.73.4.2232-2244.2005; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P5016, DOI 10.1128/IAI.00314-08; Biedzka-Sarek M, 2008, INFECT IMMUN, V76, P4100, DOI 10.1128/IAI.00313-08; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; CHINA B, 1994, INFECT IMMUN, V62, P1275, DOI 10.1128/IAI.62.4.1275-1281.1994; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Chroni A, 2007, BIOCHEMISTRY-US, V46, P5697, DOI 10.1021/bi602354t; Collins LA, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-42; HAMILTON KK, 1991, J CLIN INVEST, V88, P1833, DOI 10.1172/JCI115504; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Henning MF, 2011, INNATE IMMUN-LONDON, V17, P327, DOI 10.1177/1753425910370709; HOFFMAN J, 1980, CARBOHYD RES, V78, P212, DOI 10.1016/S0008-6215(00)83675-7; HUBSCH AP, 1995, J LAB CLIN MED, V126, P548; Kirjavainen V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000140; Koukos G, 2007, BIOCHEM J, V406, P167, DOI 10.1042/BJ20070296; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lahtinen P, 2003, GENUS YERSINIA ENTER, P289; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; LINT TF, 1977, J IMMUNOL, V119, P883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDERITZ O, 1981, PHARMACOL THERAPEUT, V15, P383, DOI 10.1016/0163-7258(81)90051-6; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; MENDALL MA, 1994, BRIT HEART J, V71, P437; Muszynski A., 2004, THESIS U SILESIA KAT; Naktin J, 1999, CLIN LAB MED, V19, P523; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; PACKMAN CH, 1985, BIOCHIM BIOPHYS ACTA, V812, P107, DOI 10.1016/0005-2736(85)90527-9; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; PODACK ER, 1978, J IMMUNOL, V120, P1841; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; ROSENFELD SI, 1983, J CLIN INVEST, V71, P795, DOI 10.1172/JCI110833; SAMMALKORPI K, 1988, METABOLISM, V37, P859, DOI 10.1016/0026-0495(88)90120-5; SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; TOMSHICH SV, 1987, KHIM PRIR SOEDIN+, P657; ULEVITCH RJ, 1978, J CLIN INVEST, V62, P1313, DOI 10.1172/JCI109252; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38211	38219		10.1074/jbc.M111.249482	http://dx.doi.org/10.1074/jbc.M111.249482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896489	hybrid, Green Published			2022-12-25	WOS:000296594200035
J	Zhang, SS; Roche, K; Nasheuer, HP; Lowndes, NF				Zhang, Suisheng; Roche, Kevin; Nasheuer, Heinz-Peter; Lowndes, Noel Francis			Modification of Histones by Sugar beta-N-Acetylglucosamine (GlcNAc) Occurs on Multiple Residues, Including Histone H3 Serine 10, and Is Cell Cycle-regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; O-GLCNAC; TRANSCRIPTIONAL ACTIVATION; NUCLEOCYTOPLASMIC PROTEINS; CHROMOSOME CONDENSATION; CHROMATIN-STRUCTURE; INSULIN-RESISTANCE; GENE-REGULATION; PHOSPHORYLATION; GLCNACYLATION	The monosaccharide, beta-N-acetylglucosamine (GlcNAc), can be added to the hydroxyl group of either serines or threonines to generate an O-linked beta-N-acetylglucosamine (O-GlcNAc) residue (Love, D. C., and Hanover, J. A. (2005) Sci. STKE 2005 312, 1-14; Hart, G. W., Housley, M. P., and Slawson, C. (2007) Nature 446, 1017-1022). This post-translational protein modification, termed O-GlcNAcylation, is reversible, analogous to phosphorylation, and has been implicated in many cellular processes. Here, we present evidence that in human cells all four core histones of the nucleosome are substrates for this glycosylation in the relative abundance H3, H4/H2B, and H2A. Increasing the intracellular level of UDP-GlcNAc, the nucleotide sugar donor substrate for O-GlcNAcylation enhanced histone O-GlcNAcylation and partially suppressed phosphorylation of histone H3 at serine 10 (H3S10ph). Expression of recombinant H3.3 harboring an S10A mutation abrogated histone H3 O-GlcNAcylation relative to its wild-type version, consistent with H3S10 being a site of histone O-GlcNAcylation (H3S10glc). Moreover, O-GlcNAcylated histones were lost from H3S10ph immunoprecipitates, whereas immunoprecipitation of either H3K4me3 or H3K9me3 (active or inactive histone marks, respectively) resulted in co-immunoprecipitation of O-GlcNAcylated histones. We also examined histone O-GlcNAcylation during cell cycle progression. Histone O-GlcNAcylation is high in G(1) cells, declines throughout the S phase, increases again during late S/early G(2), and persists through late G(2) and mitosis. Thus, O-GlcNAcylation is a novel histone post-translational modification regulating chromatin conformation during transcription and cell cycle progression.	[Zhang, Suisheng; Roche, Kevin; Lowndes, Noel Francis] Natl Univ Ireland Galway, Genome Stabil Lab, Ctr Chromosome Biol, Sch Nat Sci, Galway, Ireland; [Nasheuer, Heinz-Peter] Natl Univ Ireland Galway, Cell Cycle Control Lab, Ctr Chromosome Biol, Sch Nat Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Lowndes, NF (corresponding author), Natl Univ Ireland Galway, Genome Stabil Lab, Ctr Chromosome Biol, Sch Nat Sci, Univ Rd, Galway, Ireland.	noel.lowndes@nuigalway.ie	Lowndes, Noel F/B-9084-2008; Nasheuer, Heinz P./B-9025-2008	Lowndes, Noel F/0000-0002-3216-4427; Nasheuer, Heinz Peter/0000-0002-9218-9079	Science Foundation Ireland (SFI) [07/IN1/B958]; Health Research Board (HRB) [RP/2005/265]; EMBARK Initiative; SFI CSET Systems Biology Ireland	Science Foundation Ireland (SFI)(Science Foundation Ireland); Health Research Board (HRB); EMBARK Initiative; SFI CSET Systems Biology Ireland(Science Foundation Ireland)	This work was supported by a Science Foundation Ireland (SFI) Principal Investigator award (07/IN1/B958) and a Health Research Board (HRB) Project Grant (RP/2005/265) (to N. F. L.).; Recipient of an EMBARK Initiative Postdoctoral Fellowship.; Supported by SFI CSET Systems Biology Ireland.	Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; BODE AM, 2005, SCI STKE, pRE4; BOOTSMA D, 1964, EXP CELL RES, V33, P301, DOI 10.1016/S0014-4827(64)81035-1; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartzog GA, 2007, GENE DEV, V21, P3209, DOI 10.1101/gad.1628707; He ZW, 2003, J BIOL CHEM, V278, P10588, DOI 10.1074/jbc.M208581200; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Hurtado-Guerrero R, 2008, CURR OPIN STRUC BIOL, V18, P551, DOI 10.1016/j.sbi.2008.09.005; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Johansen KM, 2006, CHROMOSOME RES, V14, P393, DOI 10.1007/s10577-006-1063-4; Kabra Dhiraj G, 2009, Biochim Biophys Acta, V1792, P574, DOI 10.1016/j.bbadis.2009.03.003; Kaleem A, 2008, J CELL BIOCHEM, V103, P835, DOI 10.1002/jcb.21454; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Mellor J, 2008, CURR OPIN GENET DEV, V18, P116, DOI 10.1016/j.gde.2007.12.005; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Pretlow T G 2nd, 1979, Cell Biophys, V1, P195, DOI 10.1007/BF02781351; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Teng HJ, 2009, J BIOL CHEM, V284, P26368, DOI 10.1074/jbc.M109.021360; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara N. E., 2002, CURR PROTOCOLS MOL S, V57, P1761; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	63	94	98	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37483	37495		10.1074/jbc.M111.284885	http://dx.doi.org/10.1074/jbc.M111.284885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896475	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000296542400047
J	Griffiths, KL; Pathan, AA; Minassian, AM; Sander, CR; Beveridge, NER; Hill, AVS; Fletcher, HA; McShane, H				Griffiths, Kristin L.; Pathan, Ansar A.; Minassian, Angela M.; Sander, Clare R.; Beveridge, Natalie E. R.; Hill, Adrian V. S.; Fletcher, Helen A.; McShane, Helen			Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNE SUPPRESSION; P2X(7) RECEPTOR; BCG VACCINATION; BOOSTING BCG; CD39; INTERLEUKIN-1-BETA; DIFFERENTIATION; IMMUNOGENICITY; EXPRESSION	Vaccination with Bacille Calmette-Guerin (BCG) has traditionally been used for protection against disease caused by the bacterium Mycobacterium tuberculosis (M.tb). The efficacy of BCG, especially against pulmonary tuberculosis (TB) is variable. The best protection is conferred in temperate climates and there is close to zero protection in many tropical areas with a high prevalence of both tuberculous and non-tuberculous mycobacterial species. Although interferon (IFN)-gamma is known to be important in protection against TB disease, data is emerging on a possible role for interleukin (IL)-17 as a key cytokine in both murine and bovine TB vaccine studies, as well as in humans. Modified Vaccinia virus Ankara expressing Antigen 85A (MVA85A) is a novel TB vaccine designed to enhance responses induced by BCG. Antigen-specific IFN-gamma production has already been shown to peak one week post-MVA85A vaccination, and an inverse relationship between IL-17-producing cells and regulatory T cells expressing the ectonucleosidease CD39, which metabolises pro-inflammatory extracellular ATP has previously been described. This paper explores this relationship and finds that consumption of extracellular ATP by peripheral blood mononuclear cells from MVA85A-vaccinated subjects drops two weeks post-vaccination, corresponding to a drop in the percentage of a regulatory T cell subset expressing the ectonucleosidase CD39. Also at this time point, we report a peak in co-production of IL-17 and IFN-gamma by CD4(+) T cells. These results suggest a relationship between extracellular ATP and effector responses and unveil a possible pathway that could be targeted during vaccine design.	[Griffiths, Kristin L.; Pathan, Ansar A.; Minassian, Angela M.; Sander, Clare R.; Beveridge, Natalie E. R.; Hill, Adrian V. S.; Fletcher, Helen A.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	Griffiths, KL (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	Helen.Mcshane@ndm.ox.ac.uk	Fletcher, Helen/D-1470-2011	Beveridge, Natalie/0000-0002-1160-2600; McShane, Helen/0000-0002-2126-5142; Minassian, Angela/0000-0001-7832-9824; /0000-0002-6008-2955; Fletcher, Helen/0000-0002-0435-1006	KLG's Wellcome Trust [WT086338RP]; HM's Wellcome Trust [WT076943MA]	KLG's Wellcome Trust; HM's Wellcome Trust	Funding was provided by KLG's Wellcome Trust studentship (www.wellcome.ac.uk; WT086338RP) and HM's Wellcome Trust Senior Fellowship (www.wellcome.ac.uk; WT076943MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Babu S, 2010, J INFECT DIS, V201, P20, DOI 10.1086/648735; Beveridge NER, 2008, TUBERCULOSIS, V88, P631, DOI 10.1016/j.tube.2008.06.005; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fletcher HA, 2008, VACCINE, V26, P5269, DOI 10.1016/j.vaccine.2008.07.040; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Freches D, 2011, CLIN VACCINE IMMUNOL, V18, P95, DOI 10.1128/CVI.00352-10; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Minassian A, MVA85A CANDIDA UNPUB; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; World Health Organization, 2010, GLOB TUB CONTR; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	35	30	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23463	10.1371/journal.pone.0023463	http://dx.doi.org/10.1371/journal.pone.0023463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887254	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000294298800010
J	Hodges, JL; Newell-Litwa, K; Asmussen, H; Vicente-Manzanares, M; Horwitz, AR				Hodges, Jennifer L.; Newell-Litwa, Karen; Asmussen, Hannelore; Vicente-Manzanares, Miguel; Horwitz, Alan Rick			Myosin IIB Activity and Phosphorylation Status Determines Dendritic Spine and Post-Synaptic Density Morphology	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; RAT FOREBRAIN; RHO-KINASE; ACTIN; ADHESION; DYNAMICS; EXPRESSION; PROTEOME; COMPLEX; SITES	Dendritic spines in hippocampal neurons mature from a filopodia-like precursor into a mushroom-shape with an enlarged post-synaptic density (PSD) and serve as the primary post-synaptic location of the excitatory neurotransmission that underlies learning and memory. Using myosin II regulatory mutants, inhibitors, and knockdowns, we show that non-muscle myosin IIB (MIIB) activity determines where spines form and whether they persist as filopodia-like spine precursors or mature into a mushroom-shape. MIIB also determines PSD size, morphology, and placement in the spine. Local inactivation of MIIB leads to the formation of filopodia-like spine protrusions from the dendritic shaft. However, di-phosphorylation of the regulatory light chain on residues Thr18 and Ser19 by Rho kinase is required for spine maturation. Inhibition of MIIB activity or a mono-phosphomimetic mutant of RLC similarly prevented maturation even in the presence of NMDA receptor activation. Expression of an actin cross-linking, non-contractile mutant, MIIB R709C, showed that maturation into a mushroom-shape requires contractile activity. Loss of MIIB also leads to an elongated PSD morphology that is no longer restricted to the spine tip; whereas increased MIIB activity, specifically through RLC-T18, S19 di-phosphorylation, increases PSD area. These observations support a model whereby myosin II inactivation forms filopodia-like protrusions that only mature once NMDA receptor activation increases RLC di-phosphorylation to stimulate MIIB contractility, resulting in mushroom-shaped spines with an enlarged PSD.	[Hodges, Jennifer L.; Newell-Litwa, Karen; Asmussen, Hannelore; Horwitz, Alan Rick] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Vicente-Manzanares, Miguel] Univ Autonoma Madrid, Sch Med, Hosp Princesa, Ramon & Cajal Program, Madrid, Spain	University of Virginia; Autonomous University of Madrid; Hospital de La Princesa	Hodges, JL (corresponding author), Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA.	jlh3ke@virginia.edu	Bustelo, Xose R./A-9526-2010; Vicente-Manzanares, Miguel/H-1010-2018; Litwa, Karen/J-3815-2019	Bustelo, Xose R./0000-0001-9398-6072; Vicente-Manzanares, Miguel/0000-0001-5943-3220; Litwa, Karen/0000-0002-6180-3486	National Institutes of Health (NIH) [GM23244, T32-GM008136]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R37GM023244, R01GM023244] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant (GM23244) and by the Cell and Molecular Biology Training Grant from the NIH (T32-GM008136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Bockers TM, 2001, J BIOL CHEM, V276, P40104, DOI 10.1074/jbc.M102454200; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; El-Hussein AE, 2000, SCIENCE, V290, P1364; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Frost NA, 2010, CURR OPIN NEUROBIOL, V20, P578, DOI 10.1016/j.conb.2010.06.009; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Goslin K., 1998, RAT HIPPOCAMPAL NEUR, P339; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iizuka K, 1999, BRIT J PHARMACOL, V128, P925, DOI 10.1038/sj.bjp.0702864; IKEBE M, 1985, J BIOL CHEM, V260, P27; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lynch G, 2007, NEUROPHARMACOLOGY, V52, P12, DOI 10.1016/j.neuropharm.2006.07.027; Ma XF, 2004, MOL BIOL CELL, V15, P2568, DOI 10.1091/mbc.E03-11-0836; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; POTIER MC, 1995, GENOMICS, V29, P562, DOI 10.1006/geno.1995.9965; Racz B, 2008, J NEUROSCI, V28, P5654, DOI 10.1523/JNEUROSCI.0756-08.2008; Rao A, 1998, J NEUROSCI, V18, P1217; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Rubio MD, 2011, J NEUROSCI, V31, P1448, DOI 10.1523/JNEUROSCI.3294-10.2011; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares Miguel, 2009, Open Neurosci J, V3, P87; Vicente-Manzanares M, 2010, BIOCHEM BIOPH RES CO, V402, P537, DOI 10.1016/j.bbrc.2010.10.071; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	62	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24149	10.1371/journal.pone.0024149	http://dx.doi.org/10.1371/journal.pone.0024149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887379	Green Submitted, gold, Green Published			2022-12-25	WOS:000294298800033
J	Thrall, PH; Laine, AL; Broadhurst, LM; Bagnall, DJ; Brockwell, J				Thrall, Peter H.; Laine, Anna-Liisa; Broadhurst, Linda M.; Bagnall, David J.; Brockwell, John			Symbiotic Effectiveness of Rhizobial Mutualists Varies in Interactions with Native Australian Legume Genera	PLOS ONE			English	Article							ROOT-NODULE BACTERIA; MICROBIAL COMMUNITIES; MOLECULAR DIVERSITY; MYCORRHIZAL FUNGI; NITROGEN-FIXATION; SHRUBBY LEGUMES; RIBOSOMAL-RNA; TRADE-OFFS; SOIL; ACACIA	Background and Objectives: Interactions between plants and beneficial soil organisms (e.g. rhizobial bacteria, mycorrhizal fungi) are models for investigating the ecological impacts of such associations in plant communities, and the evolution and maintenance of variation in mutualisms (e.g. host specificity and the level of benefits provided). With relatively few exceptions, variation in symbiotic effectiveness across wild host species is largely unexplored. Methods: We evaluated these associations using representatives of several legume genera which commonly co-occur in natural ecosystems in south-eastern Australia and an extensive set of rhizobial strains isolated from these hosts. These strains had been previously assigned to specific phylotypes on the basis of molecular analyses. In the first of two inoculation experiments, the growth responses of each host species was evaluated with rhizobial strains isolated from that species. The second experiment assessed performance across genera and the extent of host specificity using a subset of these strains. Results: While host growth responses to their own (sympatric) isolates varied considerably, rhizobial phylotype was a significant predictor of symbiotic performance, indicating that bacterial species designations on the basis of molecular markers have ecological importance. Hosts responded in qualitatively different ways to sympatric and allopatric strains of rhizobia, ranging from species with a clear preference for their own strains, to those that were broad generalists, through to species that grew significantly better with allopatric strains. Conclusion: Theory has focused on trade-offs between the provision of benefits and symbiont competitive ability that might explain the persistence of less beneficial strains. However, differences in performance among co-occurring host species could also drive such patterns. Our results thus highlight the likely importance of plant community structure in maintaining variation in symbiotic effectiveness.	[Thrall, Peter H.; Laine, Anna-Liisa; Broadhurst, Linda M.; Bagnall, David J.; Brockwell, John] Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Canberra, ACT, Australia; [Laine, Anna-Liisa] Univ Helsinki, Metapopulat Res Grp, Dept Biosci, Helsinki, Finland	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Helsinki	Thrall, PH (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Plant Ind, Canberra, ACT, Australia.	Peter.Thrall@csiro.au	Broadhurst, Linda/J-6907-2012; Laine, Anna-Liisa/B-1398-2016; Thrall, Peter/J-6672-2013	Broadhurst, Linda/0000-0002-9853-3328; Laine, Anna-Liisa/0000-0002-0703-5850; 	National Action Plan for Salinity and Water Quality [202749]	National Action Plan for Salinity and Water Quality	The work described in this study was funded by the National Action Plan for Salinity and Water Quality (project #202749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett AE, 2009, OECOLOGIA, V160, P807, DOI 10.1007/s00442-009-1345-6; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bever JD, 2011, P NATL ACAD IN PRESS; Bissett A, 2010, MOL ECOL, V19, P4315, DOI 10.1111/j.1365-294X.2010.04804.x; Brockwell J, 2010, RANGELAND J, V32, P395, DOI 10.1071/RJ09080; Burdon JJ, 1999, J APPL ECOL, V36, P398, DOI 10.1046/j.1365-2664.1999.00409.x; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI 10.1016/j.femsle.2004.07.013; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Elliott GN, 2009, ENVIRON MICROBIOL, V11, P762, DOI 10.1111/j.1462-2920.2008.01799.x; Finan TM, 2002, J BACTERIOL, V184, P2855, DOI 10.1128/JB.184.11.2855-2856.2002; Foster KR, 2006, P ROY SOC B-BIOL SCI, V273, P2233, DOI 10.1098/rspb.2006.3571; Han TX, 2008, SYST APPL MICROBIOL, V31, P287, DOI 10.1016/j.syapm.2008.04.004; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Heath KD, 2010, EVOLUTION, V64, P1446, DOI 10.1111/j.1558-5646.2009.00913.x; HERRERA MA, 1993, APPL ENVIRON MICROB, V59, P129, DOI 10.1128/AEM.59.1.129-133.1993; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Lafay B, 1998, APPL ENVIRON MICROB, V64, P3989; Lafay B, 2001, APPL ENVIRON MICROB, V67, P396, DOI 10.1128/AEM.67.1.396-402.2001; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; LAWRIE AC, 1983, APPL ENVIRON MICROB, V45, P1822, DOI 10.1128/AEM.45.6.1822-1828.1983; Littell R. C., 1996, SAS SYSTEM MIXED MOD; MacLean AM, 2007, PLANT PHYSIOL, V144, P615, DOI 10.1104/pp.107.101634; Marco DE, 2009, J THEOR BIOL, V259, P423, DOI 10.1016/j.jtbi.2009.03.033; Marsudi NDS, 1999, SOIL BIOL BIOCHEM, V31, P1229, DOI 10.1016/S0038-0717(99)00032-2; McKNIGHT T., 1949, QUEENSLAND JOUR AGRIC SCI, V6, P61; Murray B. R., 2001, Ecological Management & Restoration, V2, P213, DOI 10.1046/j.1442-8903.2001.00086.x; Ngom A, 2004, J GEN APPL MICROBIOL, V50, P17, DOI 10.2323/jgam.50.17; Palys T, 2000, INT J SYST EVOL MICR, V50, P1021, DOI 10.1099/00207713-50-3-1021; Palys T, 1997, INT J SYST BACTERIOL, V47, P1145, DOI 10.1099/00207713-47-4-1145; Parker MA, 1999, APPL ENVIRON MICROB, V65, P4914; Parker MA, 2004, J BIOGEOGR, V31, P425, DOI 10.1046/j.0305-0270.2003.01030.x; Parker MA, 2002, MICROBIOL-SGM, V148, P2557, DOI 10.1099/00221287-148-8-2557; Portier P, 2006, APPL ENVIRON MICROB, V72, P7123, DOI 10.1128/AEM.00018-06; Rangin C, 2008, APPL ENVIRON MICROB, V74, P5653, DOI 10.1128/AEM.01107-08; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Rodriguez-Echeverria S, 2005, APPL SOIL ECOL, V29, P203, DOI 10.1016/j.apsoil.2004.11.004; SAS Institute, 1999, SAS STAT SOFTW US GU; Simms EL, 2002, INTEGR COMP BIOL, V42, P369, DOI 10.1093/icb/42.2.369; Somasegaran P., 1994, HDB RHIZOBIA METHODS; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sprent J.I., 2009, LEGUME NODULATION; Sprent J.I., 2001, NODULATION LEGUMES; Thompson JN, 2002, INTEGR COMP BIOL, V42, P381, DOI 10.1093/icb/42.2.381; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2007, J ECOL, V95, P1110, DOI 10.1111/j.1365-2745.2007.01278.x; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Thrall PH, 2009, AUSTRAL ECOL, V34, P950, DOI 10.1111/j.1442-9993.2009.01998.x; Thrall PH, 2005, J APPL ECOL, V42, P740, DOI 10.1111/j.1365-2664.2005.01058.x; Thrall PH, 2000, J APPL ECOL, V37, P52, DOI 10.1046/j.1365-2664.2000.00470.x; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vincent JM, 1970, IBP HDB; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wall DH, 2010, NAT GEOSCI, V3, P297, DOI 10.1038/ngeo860; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Yates RJ, 2004, SOIL BIOL BIOCHEM, V36, P1319, DOI 10.1016/j.soilbio.2004.04.013	66	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23545	10.1371/journal.pone.0023545	http://dx.doi.org/10.1371/journal.pone.0023545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887270	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298800014
J	Jain, M; Venkatraman, G; Moniaux, N; Kaur, S; Kumar, S; Chakraborty, S; Varshney, GC; Batra, SK				Jain, Maneesh; Venkatraman, Ganesh; Moniaux, Nicolas; Kaur, Sukhwinder; Kumar, Sushil; Chakraborty, Subhankar; Varshney, Grish C.; Batra, Surinder K.			Monoclonal Antibodies Recognizing the Non-Tandem Repeat Regions of the Human Mucin MUC4 in Pancreatic Cancer	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; MOLECULAR-CLONING; GENE-EXPRESSION; CARCINOMA; CELLS; ADENOCARCINOMA; GLYCOPROTEIN; DIAGNOSIS; COMPLEX; GROWTH	The MUC4 mucin is a high molecular weight, membrane-bound, and highly glycosylated protein. It is a multi-domain protein that is putatively cleaved into a large mucin-like subunit (MUC4 alpha) and a C-terminal growth-factor like subunit (MUC4 beta). MUC4 plays critical roles in physiological and pathological conditions and is aberrantly overexpressed in several cancers, including those of the pancreas, cervix, breast and lung. It is also a potential biomarker for the diagnosis, prognosis and progression of several malignancies. Further, MUC4 plays diverse functional roles in cancer initiation and progression as evident from its involvement in oncogenic transformation, proliferation, inhibition of apoptosis, motility and invasion, and resistance to chemotherapy in human cancer cells. We have previously generated a monoclonal antibody 8G7, which is directed against the TR region of MUC4, and has been extensively used to study the expression of MUC4 in several malignancies. Here, we describe the generation of anti-MUC4 antibodies directed against the non-TR regions of MUC4. Recombinant glutathione-S-transferase (GST)-fused MUC4 alpha fragments, both upstream (MUC4 alpha-N-Ter) and downstream (MUC4 alpha-C-Ter) of the TR domain, were used as immunogens to immunize BALB/c mice. Following cell fusion, hybridomas were screened using the aforementioned recombinant proteins ad lysates from human pancreatic cell lines. Three anti MUC4 alpha-N-Ter and one anti-MUC4 alpha-C-Ter antibodies were characterized by several inmmunoassays including enzyme-linked immunosorbent assay (ELISA), immunoblotting, immunofluorescene, flow cytometry and immunoprecipitation using MUC4 expressing human pancreatic cancer cell lines. The antibodies also reacted with the MUC4 in human pancreatic tumor sections in immunohistochemical analysis. The new domain-specific anti-MUC4 antibodies will serve as important reagents to study the structure-function relationship of MUC4 domains and for the development of MUC4-based diagnostics and therapeutics.	[Jain, Maneesh; Venkatraman, Ganesh; Moniaux, Nicolas; Kaur, Sukhwinder; Kumar, Sushil; Chakraborty, Subhankar; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Varshney, Grish C.] Inst Microbial Technol, Chandigarh, India	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Jain, M (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	mjan@unmc.edu; sbatra@unmc.edu	Venkatraman, Ganesh/AAB-1467-2020; Moniaux, Nicolas/Y-3243-2018	Venkatraman, Ganesh/0000-0003-0179-9785; Moniaux, Nicolas/0000-0001-9718-1386	United States Department of Defense [BC074639, BC083295, BC09742, PC074289]; National Institutes of Health [R21 CA156037, RO1 CA78590, UO1 CA111294, RO1 CA131944, RO1 CA133774, RO1 CA138791, RO3 CA 139285, P50 CA127297]; NATIONAL CANCER INSTITUTE [R01CA133774, R01CA078590, P50CA127297, R01CA138791, U01CA111294, R21CA156037, R01CA131944, R03CA139285] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors on this work are supported, in part, by grants from the United States Department of Defense (BC074639, BC083295, BC09742, and PC074289) and the National Institutes of Health (R21 CA156037, RO1 CA78590, UO1 CA111294, RO1 CA131944, RO1 CA133774, RO1 CA138791, RO3 CA 139285 and P50 CA127297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafna S, 2009, BRIT J CANCER, V101, P1155, DOI 10.1038/sj.bjc.6605285; Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; Choudhury A, 2000, J BIOCHEM-TOKYO, V128, P233, DOI 10.1093/oxfordjournals.jbchem.a022746; Copin MC, 2000, INT J CANCER, V86, P162, DOI 10.1002/(SICI)1097-0215(20000415)86:2<162::AID-IJC3>3.3.CO;2-I; Corrales RM, 2003, CURR EYE RES, V27, P323, DOI 10.1076/ceyr.27.5.323.17221; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; Inatomi T, 1996, INVEST OPHTH VIS SCI, V37, P1684; Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9; Lin JZ, 2001, AM J PHYSIOL-LUNG C, V280, pL1157, DOI 10.1152/ajplung.2001.280.6.L1157; Liu B, 2002, J HISTOCHEM CYTOCHEM, V50, P811, DOI 10.1177/002215540205000607; Moniaux N, 2000, EUR J BIOCHEM, V267, P4536, DOI 10.1046/j.1432-1327.2000.01504.x; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; MUNRO EG, 2009, INT J GYNECOL PATHOL; Nollet S, 1998, BIOCHEM J, V332, P739, DOI 10.1042/bj3320739; OGATA S, 1992, CANCER RES, V52, P5971; Ponnusamy MP, 2008, BRIT J CANCER, V99, P520, DOI 10.1038/sj.bjc.6604517; PONNUSAMY MP, 2010, ONCOGENE; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Senapati S, 2008, BRIT J CANCER, V99, P949, DOI 10.1038/sj.bjc.6604632; SHENG ZQ, 1992, J BIOL CHEM, V267, P16341; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; TSUTSUMIDA H, 2006, LUNG CANC; WU K, 1994, J BIOL CHEM, V269, P11950	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23344	10.1371/journal.pone.0023344	http://dx.doi.org/10.1371/journal.pone.0023344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886786	Green Submitted, Green Published, gold			2022-12-25	WOS:000294253500012
J	Malhotra, S; Bustamante, MF; Miralles, F; Rio, J; de Villa, MCR; Vegas, E; Nonell, L; Deisenhammer, F; Fissolo, N; Nurtdinov, RN; Montalban, X; Comabella, M				Malhotra, Sunny; Bustamante, Marta F.; Miralles, Francisco; Rio, Jordi; Carmen Ruiz de Villa, Mari; Vegas, Esteban; Nonell, Lara; Deisenhammer, Florian; Fissolo, Nicolas; Nurtdinov, Ramil N.; Montalban, Xavier; Comabella, Manuel			Search for Specific Biomarkers of IFN beta Bioactivity in Patients with Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-INDUCIBLE GENE; NEUTRALIZING ANTIBODIES; DISEASE-ACTIVITY; EXPRESSION; THERAPY; PROTEIN; MONOCYTES; ISG15; MXA; BIOAVAILABILITY	Myxovirus A (MxA), a protein encoded by the MX1 gene with antiviral activity, has proven to be a sensitive measure of IFN beta bioactivity in multiple sclerosis (MS). However, the use of MxA as a biomarker of IFN beta bioactivity has been criticized for the lack of evidence of its role on disease pathogenesis and the clinical response to IFN beta. Here, we aimed to identify specific biomarkers of IFN beta bioactivity in order to compare their gene expression induction by type I IFNs with the MxA, and to investigate their potential role in MS pathogenesis. Gene expression microarrays were performed in PBMC from MS patients who developed neutralizing antibodies (NAB) to IFN beta at 12 and/or 24 months of treatment and patients who remained NAB negative. Nine genes followed patterns in gene expression over time similar to the MX1, which was considered the gold standard gene, and were selected for further experiments: IFI6, IFI27, IFI44L, IFIT1, HERC5, LY6E, RSAD2, SIGLEC1, and USP18. In vitro experiments in PBMC from healthy controls revealed specific induction of selected biomarkers by IFN beta but not IFN gamma, and several markers, in particular USP18 and HERC5, were shown to be significantly induced at lower IFN beta concentrations and more selective than the MX1 as biomarkers of IFN beta bioactivity. In addition, USP18 expression was deficient in MS patients compared with healthy controls (p = 0.0004). We propose specific biomarkers that may be considered in addition to the MxA to evaluate IFN beta bioactivity, and to further explore their implication in MS pathogenesis.	[Malhotra, Sunny; Bustamante, Marta F.; Miralles, Francisco; Rio, Jordi; Nonell, Lara; Fissolo, Nicolas; Nurtdinov, Ramil N.; Montalban, Xavier; Comabella, Manuel] Hosp Univ Vall Hebron HUVH, Unitat Neuroimmunol Clin, CEM Cat, Ctr Esclerosi Multiple Catalunya, Barcelona, Spain; [Carmen Ruiz de Villa, Mari; Vegas, Esteban] Univ Barcelona, Fac Biol, Dept Estadist, Barcelona, Spain; [Deisenhammer, Florian] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria	Hospital Universitari Vall d'Hebron; University of Barcelona; Medical University of Innsbruck	Malhotra, S (corresponding author), Hosp Univ Vall Hebron HUVH, Unitat Neuroimmunol Clin, CEM Cat, Ctr Esclerosi Multiple Catalunya, Barcelona, Spain.	mcomabel@ir.vhebron.net	Pérez-Miralles, Francisco Carlos/G-5067-2017; Vegas, Esteban/G-4231-2015; Malhotra, Sunny/ABI-1270-2020; Nurtdinov, Ramil N/H-4713-2015; Fissolo, Nicolas/J-3067-2012; Montalban, Xavier/J-5938-2016	Pérez-Miralles, Francisco Carlos/0000-0003-3767-3738; Vegas, Esteban/0000-0002-6869-4075; Nurtdinov, Ramil N/0000-0002-9753-6287; Fissolo, Nicolas/0000-0002-7701-9346; Montalban, Xavier/0000-0002-0098-9918; Malhotra Sareen, Sunny/0000-0003-1112-7739; Comabella Lopez, Manuel/0000-0002-2373-6657; Rio, Jordi/0000-0003-4546-7627	"Fondo de Investigacion Sanitaria" (FIS); Ministry of Science and Innovation, Spain; Ajuts per donar Suport als Grups de Recerca de Catalunya [SGR 2005-1081]; "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR); Generalitat de Catalunya, Spain; Merck-Serono (Ayudas a la Investigacion - Fundacion Salud 2000); European Community [212877]; INSERM [U563]	"Fondo de Investigacion Sanitaria" (FIS)(Instituto de Salud Carlos III); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ajuts per donar Suport als Grups de Recerca de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya, Spain(Generalitat de Catalunya); Merck-Serono (Ayudas a la Investigacion - Fundacion Salud 2000); European Community(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The authors thank the "Red Espanola de Esclerosis Multiple (REEM)" sponsored by the "Fondo de Investigacion Sanitaria" (FIS), Ministry of Science and Innovation, Spain, and the "Ajuts per donar Suport als Grups de Recerca de Catalunya (SGR 2005-1081)", sponsored by the "Agencia de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR), Generalitat de Catalunya, Spain. This work was supported by a grant from Merck-Serono (Ayudas a la Investigacion - Fundacion Salud 2000). SM is early stage researcher funded by the European Community's Seventh Framework Programme ([FP7/2007-2013] under grant agreement n<SUP>o</SUP> 212877 (UEPHA*MS). RN is an experienced researcher also funded by the European Community's Seventh Framework Programme ([FP7/2007-2013] under grant agreement n<SUP>o</SUP> 212877 (UEPHA*MS), and has a contract with INSERM U563, University of Toulouse, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotto A, 2003, NEUROLOGY, V60, P634, DOI 10.1212/01.WNL.0000046662.03894.C5; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; Deisenhammer F, 1999, NEUROLOGY, V52, P1239, DOI 10.1212/WNL.52.6.1239; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gilli F, 2006, MULT SCLER J, V12, P47, DOI 10.1191/135248506ms1245oa; Gneiss C, 2006, MULT SCLER J, V12, P731, DOI 10.1177/1352458506070941; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kosugi A, 1998, J BIOL CHEM, V273, P12301, DOI 10.1074/jbc.273.20.12301; Li HT, 2010, MOL CELL BIOCHEM, V337, P101, DOI 10.1007/s11010-009-0289-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pachner Andrew, 2003, Mol Diagn, V7, P17, DOI 10.2165/00066982-200307010-00004; Pachner AR, 2009, NEUROLOGY, V73, P1493, DOI 10.1212/WNL.0b013e3181bf98db; Pachner AR, 2003, NEUROLOGY, V61, pS24, DOI 10.1212/01.WNL.0000092361.04511.D0; Pflugh DL, 2002, J IMMUNOL, V169, P5130, DOI 10.4049/jimmunol.169.9.5130; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sellebjerg F, 2009, EUR J NEUROL, V16, P1291, DOI 10.1111/j.1468-1331.2009.02716.x; Serrano-Fernandez P, 2010, AUTOIMMUNITY, V43, P172, DOI 10.3109/08916930903219040; Smith JB, 1996, ARCH BIOCHEM BIOPHYS, V330, P290, DOI 10.1006/abbi.1996.0256; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; Takeuchi T, 2006, BIOCHEM BIOPH RES CO, V348, P473, DOI 10.1016/j.bbrc.2006.07.076; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; WATHELET MG, 1987, EUR J BIOCHEM, V169, P313, DOI 10.1111/j.1432-1033.1987.tb13614.x; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382	38	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23634	10.1371/journal.pone.0023634	http://dx.doi.org/10.1371/journal.pone.0023634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886806	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500022
J	Ray, S; Taylor, M; Burlingame, M; Tatulian, SA; Teter, K				Ray, Supriyo; Taylor, Michael; Burlingame, Mansfield; Tatulian, Suren A.; Teter, Ken			Modulation of Toxin Stability by 4-Phenylbutyric Acid and Negatively Charged Phospholipids	PLOS ONE			English	Article							RICIN-A-CHAIN; CHOLERA-TOXIN; ENDOPLASMIC-RETICULUM; SHIGA TOXIN; THERMAL-STABILITY; A(1) DOMAIN; ESCHERICHIA-COLI; C-TERMINUS; MEMBRANE; SUBUNIT	AB toxins such as ricin and cholera toxin (CT) consist of an enzymatic A domain and a receptor-binding B domain. After endocytosis of the surface-bound toxin, both ricin and CT are transported by vesicle carriers to the endoplasmic reticulum (ER). The A subunit then dissociates from its holotoxin, unfolds, and crosses the ER membrane to reach its cytosolic target. Since protein unfolding at physiological temperature and neutral pH allows the dissociated A chain to attain a translocation-competent state for export to the cytosol, the underlying regulatory mechanisms of toxin unfolding are of paramount biological interest. Here we report a biophysical analysis of the effects of anionic phospholipid membranes and two chemical chaperones, 4-phenylbutyric acid (PBA) and glycerol, on the thermal stabilities and the toxic potencies of ricin toxin A chain (RTA) and CT A1 chain (CTA1). Phospholipid vesicles that mimic the ER membrane dramatically decreased the thermal stability of RTA but not CTA1. PBA and glycerol both inhibited the thermal disordering of RTA, but only glycerol could reverse the destabilizing effect of anionic phospholipids. In contrast, PBA was able to increase the thermal stability of CTA1 in the presence of anionic phospholipids. PBA inhibits cellular intoxication by CT but not ricin, which is explained by its ability to stabilize CTA1 and its inability to reverse the destabilizing effect of membranes on RTA. Our data highlight the toxin-specific intracellular events underlying ER-to-cytosol translocation of the toxin A chain and identify a potential means to supplement the long-term stabilization of toxin vaccines.	[Ray, Supriyo; Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Ray, Supriyo; Taylor, Michael; Burlingame, Mansfield; Teter, Ken] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Burlingame, Mansfield] Lake Brantley High Sch, Altamonte Springs, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Ray, S (corresponding author), Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA.	kteter@mail.ucf.edu	Ray, Supriyo/L-1020-2019	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grant R01 AI073783 to K. Teter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Brandau DT, 2003, J PHARM SCI-US, V92, P218, DOI 10.1002/jps.10296; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Compton JR, 2011, PROTEINS, V79, P1048, DOI 10.1002/prot.22933; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Guerra L, 2009, BBA-MOL CELL RES, V1793, P489, DOI 10.1016/j.bbamcr.2008.11.017; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Hazes B, 1996, J MOL BIOL, V258, P661, DOI 10.1006/jmbi.1996.0277; Jackson LS, 2006, J AGR FOOD CHEM, V54, P7300, DOI 10.1021/jf061199n; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; LaPointe P, 2005, J BIOL CHEM, V280, P23310, DOI 10.1074/JBC.m414193200; LENCER WI, 1995, AM J PHYSIOL-GASTR L, V269, pG548, DOI 10.1152/ajpgi.1995.269.4.G548; Lord JM, 2011, TOXINS, V3, P787, DOI 10.3390/toxins3070787; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Maestri NE, 1996, NEW ENGL J MED, V335, P855, DOI 10.1056/NEJM199609193351204; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2011, METHODS MOL BIOL, V739, P49, DOI 10.1007/978-1-61779-102-4_5; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; Menikh A, 1997, BIOCHEMISTRY-US, V36, P15865, DOI 10.1021/bi970944+; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; OHARE M, 1987, FEBS LETT, V216, P73, DOI 10.1016/0014-5793(87)80759-7; Olson MA, 2004, PROTEIN ENG DES SEL, V17, P391, DOI 10.1093/protein/gzh043; ORLANDI PA, 1993, J BIOL CHEM, V268, P12010; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Pande AH, 2006, BIOCHEMISTRY-US, V45, P13734, DOI 10.1021/bi061175+; Peek LJ, 2007, J PHARM SCI-US, V96, P44, DOI 10.1002/jps.20675; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; PIATAK M, 1988, J BIOL CHEM, V263, P4837; PRESLEY JF, 1993, J CELL BIOL, V122, P1231, DOI 10.1083/jcb.122.6.1231; Quinones B, 2009, APPL ENVIRON MICROB, V75, P1410, DOI 10.1128/AEM.02230-08; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Saleh MT, 1996, BIOCHEMISTRY-US, V35, P9325, DOI 10.1021/bi960177z; SANDVIG K, 1984, BIOCHEM J, V219, P935, DOI 10.1042/bj2190935; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; SIMPSON JC, 1995, EUR J BIOCHEM, V232, P458; Smallshaw JE, 2005, VACCINE, V23, P4775, DOI 10.1016/j.vaccine.2005.04.037; Smallshaw JE, 2010, VACCINE, V28, P2428, DOI 10.1016/j.vaccine.2009.12.081; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Sreerama N., 2000, CIRCULAR DICHROISM P, P601; Suhan ML, 1998, INFECT IMMUN, V66, P5252, DOI 10.1128/IAI.66.11.5252-5259.1998; Taylor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018825; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vitetta ES, 2006, P NATL ACAD SCI USA, V103, P2268, DOI 10.1073/pnas.0510893103; WAWRZYNCZAK EJ, 1988, BIOPHYS CHEM, V31, P301, DOI 10.1016/0301-4622(88)80036-X; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; Wu MM, 2000, METHOD ENZYMOL, V327, P546, DOI 10.1016/S0076-6879(00)27301-1; YOSHIDA T, 1990, EXP CELL RES, V190, P11, DOI 10.1016/0014-4827(90)90137-Y	57	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23692	10.1371/journal.pone.0023692	http://dx.doi.org/10.1371/journal.pone.0023692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887297	Green Published, gold			2022-12-25	WOS:000294251800020
J	Hagglund, AC; Dahl, L; Carlsson, L				Hagglund, Anna-Carin; Dahl, Lina; Carlsson, Leif			Lhx2 Is Required for Patterning and Expansion of a Distinct Progenitor Cell Population Committed to Eye Development	PLOS ONE			English	Article							LENS INDUCTION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; VERTEBRATE EYE; OPTIC VESICLE; HOMEOBOX GENE; RETINA; FOREBRAIN; MOUSE; FIELD	Progenitor cells committed to eye development become specified in the prospective forebrain and develop subsequently into the optic vesicle and the optic cup. The optic vesicle induces formation of the lens placode in surface ectoderm from which the lens develops. Numerous transcription factors are involved in this process, including the eye-field transcription factors. However, many of these transcription factors also regulate the patterning of the anterior neural plate and their specific role in eye development is difficult to discern since eye-committed progenitor cells are poorly defined. By using a specific part of the Lhx2 promoter to regulate Cre recombinase expression in transgenic mice we have been able to define a distinct progenitor cell population in the forebrain solely committed to eye development. Conditional inactivation of Lhx2 in these progenitor cells causes an arrest in eye development at the stage when the optic vesicle induces lens placode formation in the surface ectoderm. The eye-committed progenitor cell population is present in the Lhx2(-/-) embryonic forebrain suggesting that commitment to eye development is Lhx2-independent. However, re-expression of Lhx2 in Lhx2(-/-) progenitor cells only promotes development of retinal pigment epithelium cells, indicating that Lhx2 promotes the acquisition of the oligopotent fate of these progenitor cells. This approach also allowed us to identify genes that distinguish Lhx2 function in eye development from that in the forebrain. Thus, we have defined a distinct progenitor cell population in the forebrain committed to eye development and identified genes linked to Lhx2's function in the expansion and patterning of these progenitor cells.	[Hagglund, Anna-Carin; Dahl, Lina; Carlsson, Leif] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University	Hagglund, AC (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	leif.carlsson@ucmm.umu.se			Swedish Research council; Swedish Cancer Society	Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work has been supported by the Swedish Research council and the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Harlow E., 1999, USING ANTIBODIES LAB; Hernandez MC, 1997, J NEUROSCI, V17, P3038; Hill Robert E., 1992, Current Opinion in Cell Biology, V4, P967, DOI 10.1016/0955-0674(92)90126-W; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; KAUFMAN M, 1994, ADAS MOUSE DEV; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lavado A, 2008, DEVELOPMENT, V135, P441, DOI 10.1242/dev.010082; Li HS, 1997, DEVELOPMENT, V124, P603; Li X, 2002, SCIENCE, V297, P1180; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Murali D, 2005, DEVELOPMENT, V132, P913, DOI 10.1242/dev.01673; Nagy A., 2003, MANIPULATING MOUSE E; NORNES HO, 1990, DEVELOPMENT, V109, P797; Ogino H, 2000, DEV GROWTH DIFFER, V42, P437; Porter FD, 1997, DEVELOPMENT, V124, P2935; Richter K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-75; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Tetreault N, 2009, DEV BIOL, V327, P541, DOI 10.1016/j.ydbio.2008.12.022; Tornqvist G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000904; Torres MA, 1996, DEVELOPMENT, V122, P3381; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wawersik S, 1999, DEV BIOL, V207, P176, DOI 10.1006/dbio.1998.9153; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Yun S, 2009, DEVELOPMENT, V136, P3895, DOI 10.1242/dev.041202; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	50	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23387	10.1371/journal.pone.0023387	http://dx.doi.org/10.1371/journal.pone.0023387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886788	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100012
J	Gehring, AJ; Koh, S; Chia, A; Paramasivam, K; Chew, VSP; Ho, ZZ; Lee, KH; Maini, MK; Madhavan, K; Lim, SG; Bertoletti, A				Gehring, Adam J.; Koh, Sarene; Chia, Adeline; Paramasivam, Komathi; Chew, Valerie Suk Peng; Ho, Zi Zong; Lee, Kang Hoe; Maini, Mala K.; Madhavan, Krishnakumar; Lim, Seng Gee; Bertoletti, Antonio			Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection	PLOS ONE			English	Article							VIRAL CLEARANCE; HBV INFECTION; KILLER-CELLS; IN-VIVO; LYMPHOCYTES; IL-15; LIVER; DISEASE; RECRUITMENT; EXPRESSION	T cell functional plasticity helps tailor antiviral immunity during different phases of infections. We tested whether, during different phases of HBV infection, virus-specific T cells can acquire specific proinflammatory functions that could drive granulocyte/mononuclear cell liver infiltration. Multifunctional analysis of HBV-specific T cells during acute and chronic HBV infection revealed that HBV-specific T cells had the capacity to produce the neutrophil chemokine CXCL-8 but not IL-17. CXCL-8 producing T cells were detectable in the liver of chronic HBV patients with active hepatitis; while in acute HBV patients CXCL-8 production by T cells was temporally limited to the acute phase of disease, concomitant with the peak of liver inflammation. Characterization of the conditions necessary for the development of CXCL-8 producing T cells showed a requirement for IL-7 and IL-15 during T cell expansion. These data show that functional plasticity of virus-specific T cells spontaneously occurs during HBV infection and that an environment rich IL-7 and IL-15 can license T cells with the ability to produce CXCL-8 and potentially influence liver pathology.	[Gehring, Adam J.; Koh, Sarene; Chia, Adeline; Paramasivam, Komathi; Ho, Zi Zong; Bertoletti, Antonio] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Koh, Sarene] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Chew, Valerie Suk Peng] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Lee, Kang Hoe] Gleneagles Hosp, Asian Ctr Liver Dis & Transplantat, Singapore, Singapore; [Maini, Mala K.] UCL, Div Infect & Immun, London, England; [Madhavan, Krishnakumar] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Lim, Seng Gee] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of London; University College London; National University of Singapore; National University of Singapore	Gehring, AJ (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	adam_gehring@sics.a-star.edu.sg	Madhavan, Krishnakumar/B-4633-2011; Bertoletti, Antonio/AAD-4830-2022	Madhavan, Krishnakumar/0000-0002-6267-9368; Bertoletti, Antonio/0000-0002-2942-0485; Maini, Mala/0000-0001-6384-1462; Gehring, Adam/0000-0003-1150-5840	Agency for Science Technology and Research (A*STAR); Medical Research Council [G0901374, G0801213] Funding Source: researchfish; MRC [G0901374, G0801213] Funding Source: UKRI	Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Work was funded by the Agency for Science Technology and Research (A*STAR; http://www.a-star.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Badolato R, 1997, BLOOD, V90, P2804, DOI 10.1182/blood.V90.7.2804.2804_2804_2809; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Britschgi M, 2001, J CLIN INVEST, V107, P1433, DOI 10.1172/JCI12118; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Curtis MM, 2010, CELL HOST MICROBE, V8, P163, DOI 10.1016/j.chom.2010.07.006; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Golden-Mason L, 2004, CLIN EXP IMMUNOL, V138, P94, DOI 10.1111/j.1365-2249.2004.02586.x; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; JIYUAN Z, 2010, HEPATOLOGY, V51, P81; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Keller M, 2005, J IMMUNOL, V175, P7678, DOI 10.4049/jimmunol.175.11.7678; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Penna A, 1996, J CLIN INVEST, V98, P1185, DOI 10.1172/JCI118902; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schaerli P, 2004, J IMMUNOL, V173, P2151, DOI 10.4049/jimmunol.173.3.2151; Sitia G, 2002, P NATL ACAD SCI USA, V99, P13717, DOI 10.1073/pnas.172521999; Suzuki A, 2006, J HEPATOL, V45, P410, DOI 10.1016/j.jhep.2006.04.008; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	35	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23330	10.1371/journal.pone.0023330	http://dx.doi.org/10.1371/journal.pone.0023330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876747	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900019
J	Swithers, KS; Fournier, GP; Green, AG; Gogarten, JP; Lapierre, P				Swithers, Kristen S.; Fournier, Gregory P.; Green, Anna G.; Gogarten, J. Peter; Lapierre, Pascal			Reassessment of the Lineage Fusion Hypothesis for the Origin of Double Membrane Bacteria	PLOS ONE			English	Article							GENE; PROTEIN; PHOTOSYNTHESIS; PROKARYOTES; LIFE; TREE; ROOT	In 2009, James Lake introduced a new hypothesis in which reticulate phylogeny reconstruction is used to elucidate the origin of Gram-negative bacteria (Nature 460: 967-971). The presented data supported the Gram-negative bacteria originating from an ancient endosymbiosis between the Actinobacteria and Clostridia. His conclusion was based on a presence-absence analysis of protein families that divided all prokaryotes into five groups: Actinobacteria, Double Membrane bacteria (DM), Clostridia, Archaea and Bacilli. Of these five groups, the DM are by far the largest and most diverse group compared to the other groupings. While the fusion hypothesis for the origin of double membrane bacteria is enticing, we show that the signal supporting an ancient symbiosis is lost when the DM group is broken down into smaller subgroups. We conclude that the signal detected in James Lake's analysis in part results from a systematic artifact due to group size and diversity combined with low levels of horizontal gene transfer.	[Swithers, Kristen S.; Green, Anna G.; Gogarten, J. Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Lapierre, Pascal] Univ Connecticut, Univ Connecticut Biotechnol Ctr, Storrs, CT USA; [Fournier, Gregory P.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	University of Connecticut; University of Connecticut; Massachusetts Institute of Technology (MIT)	Swithers, KS (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	pascal.lap@gmail.com	Green, Anna/AAE-7645-2019	Green, Anna/0000-0001-7548-3682; Gogarten, Johann Peter/0000-0001-6459-6518	National Aeronautic and Space Administration [NNX08AQ10G]; National Science Foundation [DEB 0830024]; Direct For Biological Sciences [0830024] Funding Source: National Science Foundation	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported through grants from the National Aeronautic and Space Administration Exobiology Programs (NNX08AQ10G) and the National Science Foundation Assembling the Tree of Life Programs (DEB 0830024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Boussau B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-272; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GOGARTEN JP, 1994, J MOL EVOL, V39, P541; Gribaldo S, 1999, J BACTERIOL, V181, P434, DOI 10.1128/JB.181.2.434-443.1999; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Lake JA, 2008, MOL BIOL EVOL, V25, P1677, DOI 10.1093/molbev/msn117; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Margulis L., 1995, SYMBIOSIS CELL EVOLU; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Servin JA, 2008, MOL BIOL EVOL, V25, P1, DOI 10.1093/molbev/msm249; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; SUTCLIFFE IC, 2010, ENV MICROBIOL; Valas RE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-30; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106; PATHOGENS GENES GENO	18	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23774	10.1371/journal.pone.0023774	http://dx.doi.org/10.1371/journal.pone.0023774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876769	Green Published, Green Submitted, gold			2022-12-25	WOS:000294126900041
J	Chu, IM; Michalowski, AM; Hoenerhoff, M; Szauter, KM; Luger, D; Sato, M; Flanders, K; Oshima, A; Csiszar, K; Green, JE				Chu, I. M.; Michalowski, A. M.; Hoenerhoff, M.; Szauter, K. M.; Luger, D.; Sato, M.; Flanders, K.; Oshima, A.; Csiszar, K.; Green, J. E.			GATA3 inhibits lysyl oxidase-mediated metastases of human basal triple-negative breast cancer cells	ONCOGENE			English	Article						GATA3; basal triple-negative breast cancer; lysyl oxidase; differentiation; gene expression profiling	GENE-EXPRESSION; MESENCHYMAL TRANSITION; ENZYME-ACTIVITY; MAMMARY-GLAND; DIFFERENTIATION; GROWTH; MORPHOGENESIS; PROPEPTIDE; MIGRATION; SUBTYPES	Discovery of mechanisms that impede the aggressive and metastatic phenotype of human basal triple-negative-type breast cancers (BTNBCs) could provide novel targets for therapy for this form of breast cancer that has a relatively poor prognosis. Previous studies have demonstrated that expression of GATA3, the master transcriptional regulator of mammary luminal differentiation, can reduce the tumorigenicity and metastatic propensity of the human BTNBC MDA-MB-231 cell line (MB231), although the mechanism for reduced metastases was not elucidated. We demonstrate through gene expression profiling that GATA3 expression in 231 cells resulted in the dramatic reduction in the expression of lysyl oxidase (LOX), a metastasis-promoting, matrix-remodeling protein, in part, through methylation of the LOX promoter. Suppression of LOX expression by GATA3 was further confirmed in the BTNBC Hs578T cell line. Conversely, reduction of GATA3 expression by small interfering RNA in luminal BT474 cells increased LOX expression. Reconstitution of LOX expression in 231-GATA3 cells restored metastatic propensity. A strong inverse association between LOX and GATA3 expression was confirmed in a panel of 51 human breast cancer cell lines. Similarly, human breast cancer microarray data demonstrated that high LOX/low GATA3 expression is associated with the BTNBC subtype of breast cancer and poor patient prognosis. Expression of GATA3 reprograms BTNBCs to a less aggressive phenotype and inhibits a major mechanism of metastasis through inhibition of LOX. Induction of GATA3 in BTNBC cells or novel approaches that inhibit LOX expression or activity could be important strategies for treating BTNBCs. Oncogene (2012) 31, 2017-2027; doi: 10.1038/onc.2011.382; published online 5 September 2011	[Green, J. E.] NCI, Transgen Oncogenesis & Genom Sect, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Hoenerhoff, M.] NIEHS, Cellular & Mol Pathol Branch, Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Szauter, K. M.; Csiszar, K.] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Hawaii System	Green, JE (corresponding author), NCI, Transgen Oncogenesis & Genom Sect, Lab Canc Biol & Genet, Bldg 37,Room 4054,37 Convent Dr, Bethesda, MD 20892 USA.	jegreen@nih.gov			Center for Cancer Research, NCI, NIH; Department of Defense [W81XWH-10-2-0030]; NATIONAL CANCER INSTITUTE [ZIABC005740] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank Drs Lalage Wakefield and Li Yang for helpful scientific discussions. We also thank Lara El-Touny, Dalit Barkan, Zi-Yao Liu, TingHu Qiu, Anthony Vieira, Christina Bennett, Christine Tomlinson, Steven Austin, Christian Mustroph and Wei-Chu Lai for technical assistance; Paul Meltzer for sharing unpublished data; the LRBGE Fluorescence Imaging Core and Chand Khanna for the use of fluorescence microscopy equipment; and Julie Foley and Norris Flagler for technical assistance with image analysis. This research was supported in part by the Intramural Research Program, Center for Cancer Research, NCI, NIH. IMC acknowledges support from the Department of Defense Breast Cancer Research Program (W81XWH-10-2-0030).	Abourbih DA, 2010, MELANOMA RES, V20, P97, DOI 10.1097/CMR.0b013e328336edfe; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Chu I, 2005, CANCER RES, V65, P18; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Grimsby JL, 2010, J CELL BIOCHEM, V111, P1231, DOI 10.1002/jcb.22845; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25	34	39	39	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	16					2017	2027		10.1038/onc.2011.382	http://dx.doi.org/10.1038/onc.2011.382			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21892208	Green Accepted			2022-12-25	WOS:000303008600003
J	Mamo, A; Cavallone, L; Tuzmen, S; Chabot, C; Ferrario, C; Hassan, S; Edgren, H; Kallioniemi, O; Aleynikova, O; Przybytkowski, E; Malcolm, K; Mousses, S; Tonin, PN; Basik, M				Mamo, A.; Cavallone, L.; Tuzmen, S.; Chabot, C.; Ferrario, C.; Hassan, S.; Edgren, H.; Kallioniemi, O.; Aleynikova, O.; Przybytkowski, E.; Malcolm, K.; Mousses, S.; Tonin, P. N.; Basik, M.			An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer	ONCOGENE			English	Article						ARID1A; nonsense-mediated mRNA decay; tumor-suppressor gene; breast cancer	CHROMATIN REMODELING COMPLEXES; SWI/SNF-RELATED COMPLEXES; DNA-BINDING PROPERTIES; CELL-CYCLE ARREST; TRANSCRIPTIONAL ACTIVATORS; SACCHAROMYCES-CEREVISIAE; FAMILY PROTEINS; IN-VIVO; MUTATIONS; EXPRESSION	Tumor-suppressor genes (TSGs) have been classically defined as genes whose loss of function in tumor cells contributes to the formation and/or maintenance of the tumor phenotype. TSGs containing nonsense mutations may not be expressed because of nonsense-mediated RNA decay (NMD). We combined inhibition of the NMD process, which clears transcripts that contain nonsense mutations, with the application of high-density single-nucleotide polymorphism arrays analysis to discriminate allelic content in order to identify candidate TSGs in five breast cancer cell lines. We identified ARID1A as a target of NMD in the T47D breast cancer cell line, likely as a consequence of a mutation in exon-9, which introduces a premature stop codon at position Q944. ARID1A encodes a human homolog of yeast SWI1, which is an integral member of the hSWI/SNF complex, an ATP-dependent, chromatin-remodeling, multiple-subunit enzyme. Although we did not find any somatic mutations in 11 breast tumors, which show DNA copy-number loss at the 1p36 locus adjacent to ARID1A, we show that low ARID1A RNA or nuclear protein expression is associated with more aggressive breast cancer phenotypes, such as high tumor grade, in two independent cohorts of over 200 human breast cancer cases each. We also found that low ARID1A nuclear expression becomes more prevalent during the later stages of breast tumor progression. Finally, we found that ARID1A re-expression in the T47D cell line results in significant inhibition of colony formation in soft agar. These results suggest that ARID1A may be a candidate TSG in breast cancer. Oncogene (2012) 31, 2090-2100; doi: 10.1038/onc.2011.386; published online 5 September 2011	[Mamo, A.; Chabot, C.; Ferrario, C.; Hassan, S.; Przybytkowski, E.; Malcolm, K.; Basik, M.] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Cavallone, L.; Tonin, P. N.] McGill Univ, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Tuzmen, S.; Mousses, S.] Translat Genom Res Inst, Pharmaceut Genom Div, Scottsdale, AZ USA; [Edgren, H.; Kallioniemi, O.] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Edgren, H.; Kallioniemi, O.] VTT Tech Res Ctr Finland, Turku, Finland; [Edgren, H.; Kallioniemi, O.] Univ Turku, Turku, Finland; [Aleynikova, O.] McGill Univ, Jewish Gen Hosp, Dept Pathol, Montreal, PQ H3T 1E2, Canada; [Tonin, P. N.] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Tonin, P. N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; Translational Genomics Research Institute; University of Helsinki; VTT Technical Research Center Finland; University of Turku; McGill University; McGill University; McGill University	Basik, M (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst, Dept Oncol, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	markbasik@gmail.com	Kallioniemi, Olli P/H-5111-2011; Tuzmen, Sukru/I-5663-2013; Tüzmen, Şükrü/AAH-9916-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Tuzmen, Sukru/0000-0003-4822-396X; Tüzmen, Şükrü/0000-0003-4822-396X; Hassan, Saima/0000-0003-0232-2807	Quebec Breast Cancer Foundation; McGill Integrated Cancer Research Training Program; Fonds de Recherche en Sante du Quebec (FRSQ) through the Reseau de Cancer-Axe cancer du sein et de l'ovaire	Quebec Breast Cancer Foundation; McGill Integrated Cancer Research Training Program; Fonds de Recherche en Sante du Quebec (FRSQ) through the Reseau de Cancer-Axe cancer du sein et de l'ovaire	This study was supported by a grant from the Quebec Breast Cancer Foundation to Mark Basik and Patricia N Tonin. EP is supported by the McGill Integrated Cancer Research Training Program. The tumor bank was supported by the Fonds de Recherche en Sante du Quebec (FRSQ) through the Reseau de Cancer-Axe cancer du sein et de l'ovaire to MB.	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Biegel Jaclyn A, 2004, Curr Oncol Rep, V6, P445, DOI 10.1007/s11912-004-0075-5; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dallas PB, 2000, MOL CELL BIOL, V20, P3137, DOI 10.1128/MCB.20.9.3137-3146.2000; Dworkin AM, 2009, SEMIN CANCER BIOL, V19, P165, DOI 10.1016/j.semcancer.2009.02.007; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Grand F, 1999, CANCER RES, V59, P3870; Hassan S, 2008, CLIN CANCER RES, V14, P446, DOI 10.1158/1078-0432.CCR-07-1189; Hassan S, 2009, AM J PATHOL, V175, P66, DOI 10.2353/ajpath.2009.080948; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Medina PP, 2008, EPIGENETICS-US, V3, P64, DOI 10.4161/epi.3.2.6153; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Nagl NG, 2005, CANCER RES, V65, P9236, DOI 10.1158/0008-5472.CAN-05-1225; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Orlando FA, 2009, ANN SURG ONCOL, V16, P2270, DOI 10.1245/s10434-009-0500-y; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Patsialou A, 2005, NUCLEIC ACIDS RES, V33, P66, DOI 10.1093/nar/gki145; Presneau N, 2003, CURR MOL MED, V3, P605, DOI 10.2174/1566524033479500; Roberts CWM, 2009, CANCER BIOL THER, V8, P412, DOI 10.4161/cbt.8.5.8019; Rodriguez-Nieto S, 2009, CARCINOGENESIS, V30, P547, DOI 10.1093/carcin/bgp035; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Staden R, 2000, Methods Mol Biol, V132, P115; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Takeuchi T, 1997, GENE, V204, P71, DOI 10.1016/S0378-1119(97)00525-8; Takeuchi T, 1998, GENE, V213, P189, DOI 10.1016/S0378-1119(98)00194-2; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang XM, 2004, BIOCHEM J, V383, P319, DOI 10.1042/BJ20040524; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilsker D, 2004, NUCLEIC ACIDS RES, V32, P1345, DOI 10.1093/nar/gkh277; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Yuge M, 2000, CANCER GENET CYTOGEN, V122, P37, DOI 10.1016/S0165-4608(00)00274-0; Zhang B, 2007, ONCOGENE, V26, P7153, DOI 10.1038/sj.onc.1210509	49	94	99	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	16					2090	2100		10.1038/onc.2011.386	http://dx.doi.org/10.1038/onc.2011.386			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21892209				2022-12-25	WOS:000303008600009
J	Abdulkhalek, S; Amith, SR; Franchuk, SL; Jayanth, P; Guo, M; Finlay, T; Gilmour, A; Guzzo, C; Gee, K; Beyaert, R; Szewczuk, MR				Abdulkhalek, Samar; Amith, Schammim Ray; Franchuk, Susan L.; Jayanth, Preethi; Guo, Merry; Finlay, Trisha; Gilmour, Alanna; Guzzo, Christina; Gee, Katrina; Beyaert, Rudi; Szewczuk, Myron R.			Neu1 Sialidase and Matrix Metalloproteinase-9 Cross-talk Is Essential for Toll-like Receptor Activation and Cellular Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GROWTH-FACTOR RECEPTOR; PLASMA-MEMBRANE; MATRIX METALLOPROTEINASES; LYSOSOMAL SIALIDASE; EXOGENOUS ANTIGENS; GENE-EXPRESSION; DENDRITIC CELLS; T-LYMPHOCYTES; CLASS-I	The signaling pathways of mammalian Toll-like receptors (TLRs) are well characterized, but the precise mechanism(s) by which TLRs are activated upon ligand binding remains poorly defined. Recently, we reported a novel membrane sialidase-controlling mechanism that depends on ligand binding to its TLR to induce mammalian neuraminidase-1 (Neu1) activity, to influence receptor desialylation, and subsequently to induce TLR receptor activation and the production of nitric oxide and pro-inflammatory cytokines in dendritic and macrophage cells. The alpha-2,3-sialyl residue of TLR was identified as the specific target for hydrolysis by Neu1. Here, we report a membrane signaling paradigm initiated by endotoxin lipopolysaccharide (LPS) binding to TLR4 to potentiate G protein-coupled receptor (GPCR) signaling via membrane G alpha(i) subunit proteins and matrix metalloproteinase-9 (MMP9) activation to induce Neu1. Central to this process is that a Neu1-MMP9 complex is bound to TLR4 on the cell surface of naive macrophage cells. Specific inhibition of MMP9 and GPCR G alpha(i)-signaling proteins blocks LPS-induced Neu1 activity and NF kappa B activation. Silencing MMP9 mRNA using lentivirus MMP9 shRNA transduction or siRNA transfection of macrophage cells and MMP9 knock-out primary macrophage cells significantly reduced Neu1 activity and NF kappa B activation associated with LPS-treated cells. These findings uncover a molecular organizational signaling platform of a novel Neu1 and MMP9 cross-talk in alliance with TLR4 on the cell surface that is essential for ligand activation of TLRs and subsequent cellular signaling.	[Abdulkhalek, Samar; Amith, Schammim Ray; Franchuk, Susan L.; Jayanth, Preethi; Guo, Merry; Finlay, Trisha; Gilmour, Alanna; Guzzo, Christina; Gee, Katrina; Szewczuk, Myron R.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Beyaert, Rudi] Univ Ghent, Dept Mol Biol, B-9052 Zwijnaarde, Belgium; [Beyaert, Rudi] Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signal Transduct Inflammat, B-9052 Ghent, Belgium	Queens University - Canada; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Szewczuk, MR (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	szewczuk@queensu.ca	Beyaert, Rudi/B-2589-2009; Abdulkhalek, Samar/GWC-6242-2022; Gee, Katrina/H-3093-2016	Gee, Katrina/0000-0002-7535-2882; Beyaert, Rudi/0000-0002-5704-582X; Guzzo, Christina/0000-0002-3042-0976	Natural Sciences and Engineering Research Council of Canada (NSERC); Ghent University [IAP6/18, 3G010505, 01G06B6]; R.S. McLaughlin Scholarship; Ontario Graduate Scholarship; Queen's University Research Award; Robert J. Wilson Fellowship; Ontario Graduate Scholarship in Science and Technology; Queen's Graduate Award; Franklin Bracken Scholarship; Ontario HIV Treatment Network Studentship; Canadian Institutes of Health	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ghent University(Ghent University); R.S. McLaughlin Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Queen's University Research Award; Robert J. Wilson Fellowship; Ontario Graduate Scholarship in Science and Technology; Queen's Graduate Award; Franklin Bracken Scholarship; Ontario HIV Treatment Network Studentship; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant (to M.R.S.) from the Natural Sciences and Engineering Research Council of Canada (NSERC). Research work on the TLR transfected cell lines was supported by "Interuniversitaire Attractiepolen" Grant IAP6/18, "Fonds voor Wetenschappelijk Onderzoek-Vlaanderen" Grant 3G010505, and "Geconcerteerde Onderzoeksacties" of Ghent University Grant 01G06B6 (to R.B.).; Recipient of the R.S. McLaughlin Scholarship and the Ontario Graduate Scholarship.; Recipient of the Queen's University Research Award, the Robert J. Wilson Fellowship, and the Ontario Graduate Scholarship.; Recipient of the Ontario Graduate Scholarship in Science and Technology.; Recipient of the Queen's Graduate Award and the Robert J. Wilson Fellowship. Present address: Dept. of Pathology and Molecular Medicine MDCL 4077, McMaster University, MDCL 2319, 1200 Main St. W., Hamilton, Ontario L8N 3Z5, Canada.; Recipient of the NSERC Undergraduate Student Research Award.; Recipient of the Franklin Bracken Scholarship.; Recipient of the Ontario HIV Treatment Network Studentship and the Canadian Institutes of Health Vanier Scholarship.	Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Amith SR, 2009, GLYCOCONJUGATE J, V26, P1197, DOI 10.1007/s10719-009-9239-8; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Chen XP, 1997, J IMMUNOL, V158, P3070; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P329, DOI 10.1007/s10719-010-9281-6; Fischer Oliver M., 2006, V327, P85; Gebbia JA, 2004, J INFECT DIS, V189, P113, DOI 10.1086/380414; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Gouwy M, 2009, J LEUKOCYTE BIOL, V86, P671, DOI 10.1189/jlb.1008638; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Izumi H, 2000, FEBS LETT, V481, P31, DOI 10.1016/S0014-5793(00)01902-5; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kai HST, 2002, J BIOL CHEM, V277, P48696, DOI 10.1074/jbc.M209177200; Kato K, 2006, BIOCHEM J, V394, P647, DOI 10.1042/BJ20050737; Kim SH, 2011, J BIOL CHEM, V286, P8875, DOI 10.1074/jbc.M110.187815; KOVACSOVICSBANKOWSKI M, 1994, EUR J IMMUNOL, V24, P2421; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lattin JE, 2009, MOL IMMUNOL, V47, P340, DOI 10.1016/j.molimm.2009.09.012; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Lee MH, 2004, J CELL SCI, V117, P4015, DOI 10.1242/jcs.01223; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Lukong KE, 2000, HUM MOL GENET, V9, P1075, DOI 10.1093/hmg/9.7.1075; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Murasawa S, 1998, CIRC RES, V82, P1338, DOI 10.1161/01.RES.82.12.1338; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Serezani CH, 2011, J CLIN INVEST, V121, P671, DOI 10.1172/JCI43302; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Shen ZH, 1997, J IMMUNOL, V158, P2723; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; Solomon KR, 1998, J CLIN INVEST, V102, P2019, DOI 10.1172/JCI4317; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Woronowicz A, 2004, GLYCOBIOLOGY, V14, P987, DOI 10.1093/glycob/cwh123; Woronowicz A, 2007, GLYCOBIOLOGY, V17, P10, DOI 10.1093/glycob/cwl049; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005	58	61	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36532	36549		10.1074/jbc.M111.237578	http://dx.doi.org/10.1074/jbc.M111.237578			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873432	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000296538300038
J	Fenili, D; Weng, YQ; Aubert, I; Nitz, M; McLaurin, J				Fenili, Daniela; Weng, Ying-Qi; Aubert, Isabelle; Nitz, Mark; McLaurin, JoAnne			Sodium/myo-Inositol Transporters: Substrate Transport Requirements and Regional Brain Expression in the TgCRND8 Mouse Model of Amyloid Pathology	PLOS ONE			English	Article							SCYLLO-INOSITOL; ALZHEIMERS-DISEASE; COTRANSPORTER; IDENTIFICATION; MYOINOSITOL; CELLS; SMIT2; LOCALIZATION; AGGREGATION; DEPOSITION	Inositol stereoisomers, myo- and scyllo-inositol, are known to enter the brain and are significantly elevated following oral administration. Elevations in brain inositol levels occur across a concentration gradient as a result of active transport from the periphery. There are two sodium/myo-inositol transporters (SMIT1, SMIT2) that may be responsible for regulating brain inositol levels. The goals of this study were to determine the effects of aging and Alzheimer's disease (AD)-like amyloid pathology on transporter expression, to compare regional expression and to analyze substrate requirements of the inositol transporters. QPCR was used to examine expression of the two transporters in the cortex, hippocampus and cerebellum of TgCRND8 mice, a mouse model of amyloid pathology, in comparison to non-transgenic littermates. In addition, we examined the structural features of inositol required for active transport, utilizing a cell-based competitive uptake assay. Disease pathology did not alter transporter expression in the cortex or hippocampus (p>0.005), with only minimal effects of aging observed in the cerebellum (SMIT1: F(2,26) = 12.62; p = 0.0002; SMIT2: F(2,26) = 8.71; p = 0.0015). Overall, brain SMIT1 levels were higher than SMIT2, however, regional differences were observed. For SMIT1, at 4 and 6 months cerebellar SMIT1 levels were significantly higher than cortical and hippocampal levels (p<0.05). For SMIT2, at all three ages both cortical and cerebellar SMIT2 levels were significantly higher than hippocampal levels (p<0.05) and at 4 and 6 months of age, cerebellar SMIT2 levels were also significantly higher than cortical levels (p<0.05). Inositol transporter levels are stably expressed as a function of age, and expression is unaltered with disease pathology in the TgCRND8 mouse. Given the fact that scyllo-inositol is currently in clinical trials for the treatment of AD, the stable expression of inositol transporters regardless of disease pathology is an important finding.	[Fenili, Daniela; Aubert, Isabelle; McLaurin, JoAnne] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Weng, Ying-Qi; Aubert, Isabelle] Univ Toronto, Sunnybrook Res Inst, Toronto, ON, Canada; [Nitz, Mark] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Fenili, D (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	j.mclaurin@utoronto.ca	Aubert, Isabelle/AAG-4001-2019	Aubert, Isabelle/0000-0001-5163-9961	Canadian Institutes of Health Research [37857, 55042, 93603]; Natural Science and Engineering Research Council of Canada [227923-05, 312961-05]; Ontario Alzheimer's Society; Scottish Rite Charitable Foundation of Canada; Ontario Graduate Scholarship program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Alzheimer's Society; Scottish Rite Charitable Foundation of Canada; Ontario Graduate Scholarship program(Ontario Graduate Scholarship)	The authors acknowledge support from the Canadian Institutes of Health Research (#37857, #55042, #93603), the Natural Science and Engineering Research Council of Canada (#227923-05, #312961-05), the Ontario Alzheimer's Society, the Scottish Rite Charitable Foundation of Canada, and the Ontario Graduate Scholarship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouameur R, 2007, AM J PHYSIOL-GASTR L, V293, pG1300, DOI 10.1152/ajpgi.00422.2007; BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N; Bissonnette P, 2004, J PHYSIOL-LONDON, V558, P759, DOI 10.1113/jphysiol.2004.064311; Bourgeois F, 2005, J PHYSIOL-LONDON, V563, P333, DOI 10.1113/jphysiol.2004.076679; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Choi JK, 2010, NEUROPHARMACOLOGY, V59, P353, DOI 10.1016/j.neuropharm.2010.03.011; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Fenili D, 2007, J MOL MED, V85, P603, DOI 10.1007/s00109-007-0156-7; HAGER K, 1995, J MEMBRANE BIOL, V143, P103; Hakvoort A, 1998, BRAIN RES, V795, P247, DOI 10.1016/S0006-8993(98)00284-4; Hawkes CA, 2010, EUR J NEUROSCI, V31, P203, DOI 10.1111/j.1460-9568.2009.07052.x; Inoue K, 1996, NEUROREPORT, V7, P1195, DOI 10.1097/00001756-199604260-00020; Kaiser LG, 2005, NMR BIOMED, V18, P51, DOI 10.1002/nbm.927; Klaus F, 2008, J PHYSIOL-LONDON, V586, P1539, DOI 10.1113/jphysiol.2007.146191; KWON HM, 1992, J BIOL CHEM, V267, P6297; Lin XB, 2009, ARCH BIOCHEM BIOPHYS, V481, P197, DOI 10.1016/j.abb.2008.11.008; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; McLaurin J, 2006, NAT MED, V12, P801, DOI 10.1038/nm1423; MICHAELIS T, 1993, NMR BIOMED, V6, P105, DOI 10.1002/nbm.1940060116; Ostlund RE, 1996, J BIOL CHEM, V271, P10073, DOI 10.1074/jbc.271.17.10073; PALMANO KP, 1977, BIOCHEM J, V167, P229, DOI 10.1042/bj1670229; Roll P, 2002, GENE, V285, P141, DOI 10.1016/S0378-1119(02)00416-X; RUBIN LJ, 1993, J MOL CELL CARDIOL, V25, P721, DOI 10.1006/jmcc.1993.1084; Seaquist ER, 1998, MAGNET RESON MED, V39, P313, DOI 10.1002/mrm.1910390220; Sun YD, 2008, BIOORGAN MED CHEM, V16, P7177, DOI 10.1016/j.bmc.2008.06.045; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558	27	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24032	10.1371/journal.pone.0024032	http://dx.doi.org/10.1371/journal.pone.0024032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887366	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298800028
J	Goldstein, E; Cowling, BJ; Aiello, AE; Takahashi, S; King, G; Lu, Y; Lipsitch, M				Goldstein, Edward; Cowling, Benjamin J.; Aiello, Allison E.; Takahashi, Saki; King, Gary; Lu, Ying; Lipsitch, Marc			Estimating Incidence Curves of Several Infections Using Symptom Surveillance Data	PLOS ONE			English	Article							INFLUENZA; DECONVOLUTION; ALGORITHM; EPIDEMIC; PROFILE; EM	We introduce a method for estimating incidence curves of several co-circulating infectious pathogens, where each infection has its own probabilities of particular symptom profiles. Our deconvolution method utilizes weekly surveillance data on symptoms from a defined population as well as additional data on symptoms from a sample of virologically confirmed infectious episodes. We illustrate this method by numerical simulations and by using data from a survey conducted on the University of Michigan campus. Last, we describe the data needs to make such estimates accurate.	[Goldstein, Edward; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Cowling, Benjamin J.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Aiello, Allison E.] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Takahashi, Saki] Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA; [King, Gary] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Lu, Ying] NYU, Dept Humanities & Social Sci Profess, Steinhardt Sch Culture Educ & Human Dev, New York, NY USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Michigan System; University of Michigan; Harvard University; Harvard University; New York University; Harvard University; Harvard T.H. Chan School of Public Health	Goldstein, E (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA 02115 USA.	egoldste@hsph.harvard.edu	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Takahashi, Saki/0000-0001-5413-5507; Goldstein, Edward/0000-0002-6795-0559; Lipsitch, Marc/0000-0003-1504-9213	United States National Institutes of Health Models of Infectious Disease [1 U54 GM088558]; Centers for Disease Control and Prevention [U01C1000441]; Hong Kong University Grants Committee [AoE/M-12/06]; Harvard College; RocheRpar; Pfizer/Wyeth; AIR Worldwide; Novartis Vaccines and Diagnostics; MedImmune Inc.; Avian/Pandemic Flu Registry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	United States National Institutes of Health Models of Infectious Disease; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Hong Kong University Grants Committee; Harvard College; RocheRpar; Pfizer/Wyeth(WyethPfizer); AIR Worldwide; Novartis Vaccines and Diagnostics; MedImmune Inc.(AstraZenecaMedimmune); Avian/Pandemic Flu Registry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the United States National Institutes of Health Models of Infectious Disease Agent Study program through cooperative agreement 1 U54 GM088558 (ML, EG, BC); by the Centers for Disease Control and Prevention grant U01C1000441 (AA); by the Area of Excellence Scheme of the Hong Kong University Grants Committee, grant no. AoE/M-12/06 (BC); and by the Harvard College Research Program (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML discloses consulting income from the Avian/Pandemic Flu Registry (Outcome Sciences, funded in part by RocheRpar; until 2008, and from Pfizer/Wyeth, AIR Worldwide, and Novartis Vaccines and Diagnostics. BC has received study funding from MedImmune Inc., a manufacturer of influenza vaccines. All other authors declare no competing interests exist.	Aiello AE, 2009, IOM COMM RESP PROT H; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CDC FluView, CDC FLUVIEW; Cheng CKY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-339; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Egan JR, 2011, EPIDEMIOLOGY, V22, P188, DOI 10.1097/EDE.0b013e31820937c6; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Goldstein E, 2009, P NATL ACAD SCI USA, V106, P21825, DOI 10.1073/pnas.0902958106; King G, 2008, STAT SCI, V23, P78, DOI 10.1214/07-STS247; Lam EY, 2000, J OPT SOC AM A, V17, P1177, DOI 10.1364/JOSAA.17.001177; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; McLachlan GJ, 2008, EM ALGORITHM EXTENSI, pxxvii; MENG XL, 1991, J AM STAT ASSOC, V86, P899, DOI 10.2307/2290503; Pappas DE, 2008, PEDIATR INFECT DIS J, V27, P8, DOI 10.1097/INF.0b013e31814847d9; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; van Noort S P, 2007, Euro Surveill, V12, pE5; Wang TE, 2010, EPIDEMIOLOGY, V21, P726, DOI 10.1097/EDE.0b013e3181e94274; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	23	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23380	10.1371/journal.pone.0023380	http://dx.doi.org/10.1371/journal.pone.0023380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887246	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000016
J	Moran, EM; Heydrich, R; Ng, CT; Saber, TP; McCormick, J; Sieper, J; Appel, H; Fearon, U; Veale, DJ				Moran, Ellen M.; Heydrich, Rene; Ng, Chin Teck; Saber, Tajvur P.; McCormick, Jennifer; Sieper, Joachim; Appel, Heiner; Fearon, Ursula; Veale, Douglas J.			IL-17A Expression Is Localised to Both Mononuclear and Polymorphonuclear Synovial Cell Infiltrates	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MAST-CELLS; INFLAMMATORY ARTHRITIS; T-CELLS; NEUTROPHIL APOPTOSIS; IN-VITRO; HYPOXIA; TISSUE; INTERLEUKIN-17	Introduction: This study examines the expression of IL-17A-secreting cells within the inflamed synovium and the relationship to in vivo joint hypoxia measurements. Methods: IL-17A expression was quantified in synovial tissue (ST), serum and synovial fluid (SF) by immunohistochemistry and MSD-plex assays. IL-6 SF and serum levels were measured by MSD-plex assays. Dual immunofluorescence for IL-17A was quantified in ST CD15+ cells (neutrophils), Tryptase+ (mast cells) and CD4+ (T cells). Synovial tissue oxygen (tpO(2)) levels were measured under direct visualisation at arthroscopy. Synovial infiltration was assessed using immunohistochemistry for cell specific markers. Peripheral blood mononuclear and polymorphonuclear cells were isolated and exposed to normoxic or 3% hypoxic conditions. IL-17A and IL-6 were quantified as above in culture supernatants. Results: IL-17A expression was localised to mononuclear and polymorphonuclear (PMN) cells in inflamed ST. Dual immunoflourescent staining co-localised IL-17A expression with CD15+ neutrophils Tryptase+ mast cells and CD4+ T cells. % IL-17A positivity was highest on CD15+ neutrophils, followed by mast cells and then CD4+ T-cells. The number of IL-17A-secreting PMN cells significantly correlated with sublining CD68 expression (r = 0.618, p < 0.01). IL-17A SF levels correlated with IL-6 SF levels (r = 0.675, p < 0.01). Patients categorized according to tp0(2) < or >20mmHg, showed those with low tp0(2) <20mmHg had significantly higher IL-17A+ mononuclear cells with no difference observed for PMNs. Exposure of mononuclear and polymorphonuclear cells to 3% hypoxia, significantly induced IL-6 in mononuclear cells, but had no effect on IL-17A expression in mononuclear and polymorphonuclear cells. Conclusion: This study demonstrates IL-17A expression is localised to several immune cell subtypes within the inflamed synovial tissue, further supporting the concept that IL-17A is a key mediator in inflammatory arthritis. The association of hypoxia with II-17A expression appears to be indirect, probably through hypoxia-induced pro-inflammatory pathways and leukocyte influx within the joint microenvironment.	[Moran, Ellen M.; Ng, Chin Teck; Saber, Tajvur P.; McCormick, Jennifer; Fearon, Ursula; Veale, Douglas J.] St Vincents Univ Hosp, Dept Rheumatol, Dublin 4, Ireland; [Heydrich, Rene; Sieper, Joachim; Appel, Heiner] Charite, Berlin, Germany	University College Dublin; Saint Vincent's University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Moran, EM (corresponding author), St Vincents Univ Hosp, Dept Rheumatol, Dublin 4, Ireland.	ursula.fearon@ucd.ie	Ng, Chin Teck/GRO-7239-2022; Moran, Ellen/H-7722-2019; Ng, Chin Teck/G-6276-2011	Ng, Chin Teck/0000-0002-6396-1701; Moran, Ellen/0000-0002-0743-0770; Ng, Chin Teck/0000-0002-6396-1701; Veale, Douglas/0000-0003-2802-4971; Fearon, Ursula/0000-0001-8084-0429; Saber, Tajvur/0000-0002-2599-2400	Health Research Board Ireland	Health Research Board Ireland	Health Research Board Ireland (www.hrb.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Berse B, 1999, CLIN EXP IMMUNOL, V115, P176; BINIECKA M, 2009, ANN RHEUM DIS; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Brennan FM, 2002, ARTHRITIS RES THER, V4, pS177, DOI 10.1186/ar556; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Combe Bernard, 2009, Best Pract Res Clin Rheumatol, V23, P59, DOI 10.1016/j.berh.2008.11.006; Corr M, 2002, J IMMUNOL, V169, P6604, DOI 10.4049/jimmunol.169.11.6604; Cross A, 2006, J LEUKOCYTE BIOL, V80, P521, DOI 10.1189/jlb.0306178; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Distler JHW, 2004, ARTHRITIS RHEUM-US, V50, P10, DOI 10.1002/art.11425; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; Eklund KK, 2007, IMMUNOL REV, V217, P38, DOI 10.1111/j.1600-065X.2007.00504.x; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; FANTONE JC, 1985, HUM PATHOL, V16, P973, DOI 10.1016/S0046-8177(85)80273-2; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; GULLICK NJ, PLOS ONE, V5; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; HANNAH S, 1995, FEBS LETT, V372, P233, DOI 10.1016/0014-5793(95)00986-J; Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447; Hollander AP, 2001, ARTHRITIS RHEUM-US, V44, P1540, DOI 10.1002/1529-0131(200107)44:7<1540::AID-ART277>3.0.CO;2-7; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Jin Y, 2009, STROKE; Joosten LAB, 2003, ARTHRITIS RHEUM, V48, P339, DOI 10.1002/art.10814; Kennedy A, 2011, ARTHRITIS RHEUM-US, V63, P923, DOI 10.1002/art.30221; Kennedy A, 2010, ARTHRITIS RHEUM-US, V62, P711, DOI 10.1002/art.27287; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LIN AM, J IMMUNOLOGY, V187, P490; Lundy SK, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2107; Makino Y, 2003, J IMMUNOL, V171, P6534, DOI 10.4049/jimmunol.171.12.6534; Maxova H, 2008, PHYSIOL RES, V57, P903, DOI 10.33549/physiolres.931278; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; MORAN EM, 2009, ARTHRITIS RHEUM S10, V60, P1157; Mrabet-Dahbi S, 2009, EXP DERMATOL, V18, P437, DOI 10.1111/j.1600-0625.2009.00878.x; Mu Rong, 2008, Zhonghua Yi Xue Za Zhi, V88, P1202; NG CT, 2009, ANN RHEUM DIS; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; OLIVER KM, 2009, ANTIOXID REDOX SIGNA; Page G, 2004, AM J PATHOL, V164, P409, DOI 10.1016/S0002-9440(10)63131-8; Paleolog EM, 2009, INT J EXP PATHOL, V90, P249, DOI 10.1111/j.1365-2613.2009.00640.x; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Sandler C, 2007, INFLAMM RES, V56, P230, DOI 10.1007/s00011-007-6135-1; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Sivakumar B, 2008, J HAND SURG-AM, V33A, P49, DOI 10.1016/j.jhsa.2007.09.002; STRBIAN D, 2009, ANN MED, P1; Theoharides TC, 2008, ANN NY ACAD SCI, V1144, P74, DOI 10.1196/annals.1418.029; VEALE D, 1994, BRIT J RHEUMATOL, V33, P133; Veale DJ, 1996, DRUG AGING, V9, P87, DOI 10.2165/00002512-199609020-00003; Wang DD, 2009, J NEUROIMMUNOL, V212, P17, DOI 10.1016/j.jneuroim.2009.04.007; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Yin YH, 2009, MICROBIOL IMMUNOL, V53, P281, DOI 10.1111/j.1348-0421.2009.00120.x; YUE C, 2009, RHEUMATOL INT; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	62	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24048	10.1371/journal.pone.0024048	http://dx.doi.org/10.1371/journal.pone.0024048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887369	gold, Green Submitted, Green Published			2022-12-25	WOS:000295832000088
J	Wang, ZF; Liu, XL; Zhao, ZD; Xu, CF; Zhang, K; Chen, CW; Sun, L; Gao, GF; Ye, X; Liu, WJ				Wang, Zengfu; Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Zhang, Ke; Chen, Caiwei; Sun, Lei; Gao, George F.; Ye, Xin; Liu, Wenjun			Cyclophilin E Functions as a Negative Regulator to Influenza Virus Replication by Impairing the Formation of the Viral Ribonucleoprotein Complex	PLOS ONE			English	Article							A VIRUS; RNA-BINDING; NS1 PROTEIN; MESSENGER-RNA; AMINO-ACIDS; NUCLEOPROTEIN; IDENTIFICATION; INTERACTS; CELLS; LOCALIZATION	Background: The nucleoprotein (NP) of influenza A virus is a multifunctional protein that plays a critical role in the replication and transcription of the viral genome. Therefore, examining host factors that interact with NP may shed light on the mechanism of host restriction barriers and the tissue tropism of influenza A virus. Here, Cyclophilin E (CypE), a member of the peptidyl-propyl cis-trans isomerase (PPIase) family, was found to bind to NP and inhibit viral replication and transcription. Methodology/Principal Findings: In the present study, CypE was found to interact with NP but not with the other components of the viral ribonucleoprotein complex (vRNP): PB1, PB2, and PA. Mutagenesis data revealed that the CypE domain comprised of residues 137-186 is responsible for its binding to NP. Functional analysis results indicated that CypE is a negative regulator in the influenza virus life cycle. Furthermore, knock-down of CypE resulted in increased levels of three types of viral RNA, suggesting that CypE negatively affects viral replication and transcription. Moreover, up-regulation of CypE inhibited the activity of influenza viral polymerase. We determined that the molecular mechanism by which CypE negatively regulates influenza virus replication and transcription is by interfering with NP self-association and the NP-PB1 and NP-PB2 interactions. Conclusions/Significance: CypE is a host restriction factor that inhibits the functions of NP, as well as viral replication and transcription, by impairing the formation of the vRNP. The data presented here will help us to better understand the molecular mechanisms of host restriction barriers, host adaptation, and tissue tropism of influenza A virus.	[Wang, Zengfu; Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Zhang, Ke; Chen, Caiwei; Sun, Lei; Gao, George F.; Ye, Xin; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, Ctr Mol Virol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Wang, Zengfu; Zhao, Zhendong; Xu, Chongfeng; Zhang, Ke; Chen, Caiwei; Gao, George F.; Ye, Xin; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Gao, George F.; Ye, Xin; Liu, Wenjun] Chinese Acad Sci, Inst Microbiol, China Japan Joint Lab Mol Immunol & Mol Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, ZF (corresponding author), Chinese Acad Sci, Inst Microbiol, Ctr Mol Virol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	liuwj@im.ac.cn	Liu, Xiaoling/HGD-3566-2022; Gao, George Fu/ABD-5229-2021; SUN, LEI/B-3288-2018	SUN, LEI/0000-0003-0141-2093	National Basic Research Program (973) of China [2011CB504705]; Chinese Academy of Sciences [KSCX2-YW-N-054, KSCX2-YW-R-158]; National Natural Science Foundation of China [30972185, 30901073]; National Key Technologies Research and Development Program of China [2010BAD04B01]; National Natural Science Foundation of China (NSFC) [81021003]	National Basic Research Program (973) of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (973) of China (2011CB504705), Chinese Academy of Sciences Innovation projects (KSCX2-YW-N-054, KSCX2-YW-R-158), the National Natural Science Foundation of China (30972185, 30901073), and the National Key Technologies Research and Development Program of China (2010BAD04B01). Wenjun Liu, George F Gao, and Xin Ye are the principal investigators of the Innovative Research Group of the National Natural Science Foundation of China (NSFC, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBO C, 1995, J VIROL, V69, P3799, DOI 10.1128/JVI.69.6.3799-3806.1995; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Boivin S, 2011, J BIOL CHEM, DOI [10.1074/jbc.M111.226225, DOI 10.1074/JBC.M111.226225]; Boivin S, 2011, J BIOL CHEM; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; DUESBERG PH, 1969, J MOL BIOL, V42, P485, DOI 10.1016/0022-2836(69)90237-X; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gabriel G, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1158; Goodman AG, 2007, J VIROL, V81, P2221, DOI 10.1128/JVI.02151-06; KINGSBURY DW, 1969, J VIROL, V4, P219, DOI 10.1128/JVI.4.3.219-225.1969; KINGSBURY DW, 1987, VIROLOGY, V156, P396, DOI 10.1016/0042-6822(87)90419-3; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; Kuchipudi Suresh V, 2009, J Mol Genet Med, V3, P143; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; Liang YH, 2008, J VIROL, V82, P229, DOI 10.1128/JVI.01541-07; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Medcalf L, 1999, J VIROL, V73, P7349, DOI 10.1128/JVI.73.9.7349-7356.1999; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang T, 2005, BIOCHEM BIOPH RES CO, V333, P845, DOI 10.1016/j.bbrc.2005.06.006; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Xu CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-372; YAMANAKA K, 1990, J BIOL CHEM, V265, P11151; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	48	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22625	10.1371/journal.pone.0022625	http://dx.doi.org/10.1371/journal.pone.0022625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887220	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000003
J	Young, HA; Lanzatella, CL; Sarath, G; Tobias, CM				Young, Hugh A.; Lanzatella, Christina L.; Sarath, Gautam; Tobias, Christian M.			Chloroplast Genome Variation in Upland and Lowland Switchgrass	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; NUCLEAR-DNA CONTENT; TRANSFER-RNA GENES; PANICUM-VIRGATUM; HORDEUM-VULGARE; ORYZA-SATIVA; MARKERS; GENETICS; RECOMBINATION; SUBSTITUTION	Switchgrass (Panicum virgatum L.) exists at multiple ploidies and two phenotypically distinct ecotypes. To facilitate interploidal comparisons and to understand the extent of sequence variation within existing breeding pools, two complete switchgrass chloroplast genomes were sequenced from individuals representative of the upland and lowland ecotypes. The results demonstrated a very high degree of conservation in gene content and order with other sequenced plastid genomes. The lowland ecotype reference sequence (Kanlow Lin1) was 139,677 base pairs while the upland sequence (Summer Lin2) was 139,619 base pairs. Alignments between the lowland reference sequence and short-read sequence data from existing sequence datasets identified as either upland or lowland confirmed known polymorphisms and indicated the presence of other differences. Insertions and deletions principally occurred near stretches of homopolymer simple sequence repeats in intergenic regions while most Single Nucleotide Polymorphisms (SNPs) occurred in intergenic regions and introns within the single copy portions of the genome. The polymorphism rate between upland and lowland switchgrass ecotypes was found to be similar to rates reported between chloroplast genomes of indica and japonica subspecies of rice which were believed to have diverged 0.2-0.4 million years ago.	[Young, Hugh A.; Lanzatella, Christina L.; Tobias, Christian M.] ARS, Genom & Gene Discovery Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA; [Sarath, Gautam] ARS, USDA, Cent E Reg Biomass Ctr, Lincoln, NE USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Young, HA (corresponding author), ARS, Genom & Gene Discovery Res Unit, USDA, Western Reg Res Ctr, Albany, CA USA.	christian.tobias@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X	United States Department of Agriculture, Agriculture Research Service (USDA-ARS) Current Research Information System (CRIS) [5325-21000-017, 5440-21000-028-00]; USDA/Department of Energy Office of Science Feedstock [DE-AI02-09ER64829]	United States Department of Agriculture, Agriculture Research Service (USDA-ARS) Current Research Information System (CRIS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA/Department of Energy Office of Science Feedstock(United States Department of Agriculture (USDA))	This work supported by the United States Department of Agriculture, Agriculture Research Service (USDA-ARS) Current Research Information System (CRIS) 5325-21000-017, USDA-ARS CRIS 5440-21000-028-00, and by a Joint USDA/Department of Energy Office of Science Feedstock genomics grant DE-AI02-09ER64829. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angioi SA, 2009, PLANT BIOLOGY, V11, P598, DOI 10.1111/j.1438-8677.2008.00143.x; Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; BRUNKEN J N, 1975, Southwestern Naturalist, V19, P379, DOI 10.2307/3670396; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chen DH, 1999, PLANT MOL BIOL REP, V17, P53, DOI 10.1023/A:1007585532036; Costich DE, 2010, PLANT GENOME-US, V3, P130, DOI 10.3835/plantgenome2010.04.0010; CUMMINGS MP, 1994, MOL BIOL EVOL, V11, P1; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; de Cesare M, 2010, MOL BREEDING, V26, P539, DOI 10.1007/s11032-010-9451-z; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Du PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-135; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Henry R. J., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, DOI 10.1079/9780851999043.0000; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Hultquist SJ, 1996, CROP SCI, V36, P1049, DOI 10.2135/cropsci1996.0011183X003600040039x; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kusumi J, 2005, J MOL EVOL, V60, P417, DOI 10.1007/s00239-004-0086-8; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MACHE R, 1973, NATURE-NEW BIOL, V242, P158, DOI 10.1038/newbio242158a0; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martinez-Reyna JM, 2008, CROP SCI, V48, P1312, DOI 10.2135/cropsci2007.12.0695; McGrath S, 2007, HEREDITY, V99, P531, DOI 10.1038/sj.hdy.6801030; MCMILLAN C, 1959, AM J BOT, V46, P590, DOI 10.2307/2439303; Missaoui AM, 2006, GENET RESOUR CROP EV, V53, P1291, DOI 10.1007/s10722-005-3878-9; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Nei M, 2000, MOL EVOLUTION PHYLOG; Ogihara Y, 2000, PLANT MOL BIOL REP, V18, P243, DOI 10.1007/BF02823995; PETERSEN K, 2011, PLANT MOL BIOL; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1999, P ROY SOC B-BIOL SCI, V266, P633, DOI 10.1098/rspb.1999.0683; Quesada-Vargas T, 2005, PLANT PHYSIOL, V138, P1746, DOI 10.1104/pp.105.063040; QUIGLEY F, 1985, CURR GENET, V9, P495, DOI 10.1007/BF00434054; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; Sarath G, 2008, J IND MICROBIOL BIOT, V35, P343, DOI 10.1007/s10295-007-0296-3; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SHIMADA H, 1990, MOL GEN GENET, V221, P395, DOI 10.1007/BF00259404; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Vogel KP, 2008, CROP SCI, V48, P2159, DOI 10.2135/cropsci2008.02.0117; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zalapa JE, 2011, THEOR APPL GENET, V122, P805, DOI 10.1007/s00122-010-1488-1; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	69	65	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23980	10.1371/journal.pone.0023980	http://dx.doi.org/10.1371/journal.pone.0023980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887356	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000081
J	Garaud, JC; Schickel, JN; Blaison, G; Knapp, AM; Dembele, D; Ruer-Laventie, J; Korganow, AS; Martin, T; Soulas-Sprauel, P; Pasquali, JL				Garaud, Jean-Claude; Schickel, Jean-Nicolas; Blaison, Gilles; Knapp, Anne-Marie; Dembele, Doulaye; Ruer-Laventie, Julie; Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis			B Cell Signature during Inactive Systemic Lupus Is Heterogeneous: Toward a Biological Dissection of Lupus	PLOS ONE			English	Article							CD27(HIGH) PLASMA-CELLS; FALSE DISCOVERY RATE; DISEASE-ACTIVITY; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; TYROSINE KINASES; MESSENGER-RNA; ER STRESS; ERYTHEMATOSUS; PROTEIN	Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biological heterogeneity. B lymphocytes appear central to the development of SLE which is characterized by the production of a large variety of autoantibodies and hypergammaglobulinemia. In mice, immature B cells from spontaneous lupus prone animals are able to produce autoantibodies when transferred into immunodeficient mice, strongly suggesting the existence of intrinsic B cell defects during lupus. In order to approach these defects in humans, we compared the peripheral B cell transcriptomas of quiescent lupus patients to normal B cell transcriptomas. When the statistical analysis is performed on the entire group of patients, the differences between patients and controls appear quite weak with only 14 mRNA genes having a false discovery rate ranging between 11 and 17%, with 6 underexpressed genes (PMEPA1, TLR10, TRAF3IP2, LDOC1L, CD1C and EGR1). However, unforced hierarchical clustering of the microarrays reveals a subgroup of lupus patients distinct from both the controls and the other lupus patients. This subgroup has no detectable clinical or immunological phenotypic peculiarity compared to the other patients, but is characterized by 1/an IL-4 signature and 2/the abnormal expression of a large set of genes with an extremely low false discovery rate, mainly pointing to the biological function of the endoplasmic reticulum, and more precisely to genes implicated in the Unfolded Protein Response, suggesting that B cells entered an incomplete BLIMP1 dependent plasmacytic differentiation which was undetectable by immunophenotyping. Thus, this microarray analysis of B cells during quiescent lupus suggests that, despite a similar lupus phenotype, different biological roads can lead to human lupus.	[Garaud, Jean-Claude; Schickel, Jean-Nicolas; Knapp, Anne-Marie; Ruer-Laventie, Julie; Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis] CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France; [Blaison, Gilles] Hop Civil Colmar, Colmar, France; [Dembele, Doulaye] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis] Hop Univ Strasbourg, Strasbourg, France; [Knapp, Anne-Marie; Korganow, Anne-Sophie; Martin, Thierry; Soulas-Sprauel, Pauline; Pasquali, Jean-Louis] Univ Strasbourg, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Garaud, JC (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9021, F-67084 Strasbourg, France.	jean-louis.pasquali@chru-strasbourg.fr	Dembélé, Doulaye/O-6513-2017	Dembélé, Doulaye/0000-0003-3879-6940; Martin, Thierry/0000-0002-2776-2641; Korganow, Anne-Sophie/0000-0002-1664-6311; Soulas-Sprauel, Pauline/0000-0002-2058-4811	French Ministry of Health; Groupement d'Interet Scientifique (GIS) for rare diseases	French Ministry of Health; Groupement d'Interet Scientifique (GIS) for rare diseases	Grants: French Ministry of Health (Projet Hospitalier de Recherche Clinique), and the Groupement d'Interet Scientifique (GIS) for rare diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Breitling R, 2006, BBA-GENE STRUCT EXPR, V1759, P319, DOI 10.1016/j.bbaexp.2006.06.003; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Dorner T, 2004, LUPUS, V13, P283, DOI 10.1191/0961203304lu1014oa; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gao Y, 2009, J BIOL CHEM, V284, P7114, DOI 10.1074/jbc.M804801200; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grammer AC, 2003, ARTHRITIS RES THER, V5, pS22, DOI 10.1186/ar1009; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; HOCHBERG MC, 1997, ARTHRITIS RHEUM, V40, P2, DOI DOI 10.1002/1529-0131(199709)40:9; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ickstadt K., 2006, RNEWS, V6, P45; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Korganow AS, 2010, J AUTOIMMUN, V34, P426, DOI 10.1016/j.jaut.2009.11.002; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lipsky PE, 2001, NAT IMMUNOL, V2, P764, DOI 10.1038/ni0901-764; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Luciano F, 2001, ONCOGENE, V20, P4935, DOI 10.1038/sj.onc.1204661; Lyons PA, 2010, ANN RHEUM DIS, V69, P1208, DOI 10.1136/ard.2009.108043; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Maltzman JS, 1996, J EXP MED, V183, P1747, DOI 10.1084/jem.183.4.1747; Maltzman JS, 1996, MOL CELL BIOL, V16, P2283; Mora-Lopez F, 2008, EUR J IMMUNOL, V38, P2316, DOI 10.1002/eji.200737861; Nagy G, 2000, IMMUNOL LETT, V74, P207, DOI 10.1016/S0165-2478(00)00265-0; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Reininger L, 1996, J EXP MED, V184, P853, DOI 10.1084/jem.184.3.853; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; SIMON JL, 1995, M D COMPUT, V12, P115; Tao J, 2009, J EUR ACAD DERMATOL, V23, P433, DOI 10.1111/j.1468-3083.2009.03095.x; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wong CK, 2000, LUPUS, V9, P589, DOI 10.1191/096120300678828703; Xu Y, 2009, ACTA BIOCH BIOPH SIN, V41, P488, DOI 10.1093/abbs/gmp034; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Youinou P, 2007, AUTOIMMUN REV, V7, P149, DOI 10.1016/j.autrev.2007.02.016; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Yu HH, 2010, LUPUS, V19, P1219, DOI 10.1177/0961203310371152; Zhu XC, 2004, J IMMUNOL, V173, P7141, DOI 10.4049/jimmunol.173.12.7141	51	38	39	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23900	10.1371/journal.pone.0023900	http://dx.doi.org/10.1371/journal.pone.0023900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886837	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500037
J	Mangino, G; Percario, ZA; Fiorucci, G; Vaccari, G; Acconcia, F; Chiarabelli, C; Leone, S; Noto, A; Horenkamp, FA; Manrique, S; Romeo, G; Polticelli, F; Geyer, M; Affabris, E				Mangino, Giorgio; Percario, Zulema A.; Fiorucci, Gianna; Vaccari, Gabriele; Acconcia, Filippo; Chiarabelli, Cristiano; Leone, Stefano; Noto, Alessia; Horenkamp, Florian A.; Manrique, Santiago; Romeo, Giovanna; Polticelli, Fabio; Geyer, Matthias; Affabris, Elisabetta			HIV-1 Nef Induces Proinflammatory State in Macrophages through Its Acidic Cluster Domain: Involvement of TNF Alpha Receptor Associated Factor 2	PLOS ONE			English	Article							NF-KAPPA-B; VIRUS TYPE-1 NEF; HUMAN MONOCYTES/MACROPHAGES; HUMAN MONOCYTE/MACROPHAGES; REGULATORY FACTOR-3; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; PROTEIN; KINASE	Background: HIV-1 Nef is a virulence factor that plays multiple roles during HIV replication. Recently, it has been described that Nef intersects the CD40 signalling in macrophages, leading to modification in the pattern of secreted factors that appear able to recruit, activate and render T lymphocytes susceptible to HIV infection. The engagement of CD40 by CD40L induces the activation of different signalling cascades that require the recruitment of specific tumor necrosis factor receptor-associated factors (i.e. TRAFs). We hypothesized that TRAFs might be involved in the rapid activation of NF-kappa B, MAPKs and IRF-3 that were previously described in Nef-treated macrophages to induce the synthesis and secretion of proinflammatory cytokines, chemokines and IFN beta to activate STAT1, -2 and -3. Methodology/Principal Findings: Searching for possible TRAF binding sites on Nef, we found a TRAF2 consensus binding site in the AQEEEE sequence encompassing the conserved four-glutamate acidic cluster. Here we show that all the signalling effects we observed in Nef treated macrophages depend on the integrity of the acidic cluster. In addition, Nef was able to interact in vitro with TRAF2, but not TRAF6, and this interaction involved the acidic cluster. Finally silencing experiments in THP-1 monocytic cells indicate that both TRAF2 and, surprisingly, TRAF6 are required for the Nef-induced tyrosine phosphorylation of STAT1 and STAT2. Conclusions: Results reported here revealed TRAF2 as a new possible cellular interactor of Nef and highlighted that in monocytes/macrophages this viral protein is able to manipulate both the TRAF/NF-kappa B and TRAF/IRF-3 signalling axes, thereby inducing the synthesis of proinflammatory cytokines and chemokines as well as IFN beta.	[Mangino, Giorgio; Percario, Zulema A.; Acconcia, Filippo; Chiarabelli, Cristiano; Leone, Stefano; Noto, Alessia; Polticelli, Fabio; Affabris, Elisabetta] Univ Roma Tre, Dept Biol, Rome, Italy; [Mangino, Giorgio; Romeo, Giovanna] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Rome, Italy; [Fiorucci, Gianna] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Vaccari, Gabriele] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Horenkamp, Florian A.; Manrique, Santiago; Geyer, Matthias] MPI Mol Physiol, Abt Phys Biochem, Dortmund, Germany	Roma Tre University; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Istituto Superiore di Sanita (ISS); Max Planck Society	Mangino, G (corresponding author), Univ Roma Tre, Dept Biol, Rome, Italy.	affabris@uniroma3.it	Polticelli, Fabio/A-4573-2009; Manrique, Santiago/B-2461-2012; Mangino, Giorgio/C-7310-2009; Acconcia, Filippo/AAB-6247-2022; Vaccari, Gabriele/A-9597-2010; Acconcia, Filippo/K-4960-2016; Romeo, Giovanna/AAB-2613-2019; Fiorucci, Gianna/B-3064-2013; romeo, giovanna/P-8348-2015	Polticelli, Fabio/0000-0002-7657-2019; Mangino, Giorgio/0000-0002-8950-9780; Acconcia, Filippo/0000-0002-4651-2509; Vaccari, Gabriele/0000-0003-0215-3521; romeo, giovanna/0000-0002-7638-1001; AFFABRIS, Elisabetta/0000-0001-5142-8144; Leone, Stefano/0000-0001-6339-6397; Geyer, Matthias/0000-0002-7718-5002	Italian National Research Program on AIDS of Istituto Superiore di Sanita, Rome, Italy [N.40.G1]; PRIN-MIUR (Progetti Rilevante Interesse Nazionale - Ministero dell'Universita' e della Ricerca Scientifica), Italy [prot.20072J9RWM_002]; Deutsche Forschungsgemeinschaft [GE-976/6]	Italian National Research Program on AIDS of Istituto Superiore di Sanita, Rome, Italy; PRIN-MIUR (Progetti Rilevante Interesse Nazionale - Ministero dell'Universita' e della Ricerca Scientifica), Italy(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Italian National Research Program on AIDS of Istituto Superiore di Sanita (Affabris N.40.G1), Rome, Italy, and from PRIN-MIUR (Progetti Rilevante Interesse Nazionale - Ministero dell'Universita' e della Ricerca Scientifica) 2007 (Affabris prot.20072J9RWM_002), Italy. Dr. Geyer is supported by a grant from the Deutsche Forschungsgemeinschaft (GE-976/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LW, 1983, INFECT IMMUN, V41, P837, DOI 10.1128/IAI.41.2.837-840.1983; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; Arold S, 2000, PROTEIN SCI, V9, P1137, DOI 10.1110/ps.9.6.1137; Baugh LL, 2008, J VIROL, V82, P9657, DOI 10.1128/JVI.00107-08; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Brink N, 2000, INFLAMM RES, V49, P290, DOI 10.1007/PL00000209; Brinkmann MM, 2003, J VIROL, V77, P9346, DOI 10.1128/JVI.77.17.9346-9358.2003; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; COGSWELL JP, 1994, J IMMUNOL, V153, P712; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Dow SW, 1999, J VIROL, V73, P6852, DOI 10.1128/JVI.73.8.6852-6861.1999; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Garcia MI, 2007, J VIROL, V81, P2663, DOI 10.1128/JVI.01733-06; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1986, J VIROL, V58, P67, DOI 10.1128/JVI.58.1.67-74.1986; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gulizia RJ, 1997, J VIROL, V71, P4161, DOI 10.1128/JVI.71.5.4161-4164.1997; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Horenkamp FA, 2011, TRAFFIC, V12, P867, DOI 10.1111/j.1600-0854.2011.01205.x; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Keller C, 2003, J PHYSIOL-LONDON, V550, P927, DOI 10.1113/jphysiol.2003.044883; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 1999, J VIROL, V73, P5497, DOI 10.1128/JVI.73.7.5497-5508.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KUPRASH DV, 1995, ONCOGENE, V11, P97; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Li H, 2002, AM J PHYSIOL-RENAL, V282, pF1020, DOI 10.1152/ajprenal.00291.2001; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Muroi M, 2008, J LEUKOCYTE BIOL, V83, P702, DOI 10.1189/jlb.0907629; NARAYAN O, 1980, J GEN VIROL, V50, P69, DOI 10.1099/0022-1317-50-1-69; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Oudijk EJD, 2005, THORAX, V60, P538, DOI 10.1136/thx.2004.034009; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Sandberg M, 1997, J VIROL, V71, P4649, DOI 10.1128/JVI.71.6.4649-4656.1997; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; WIDMER U, 1993, J IMMUNOL, V150, P4996; WOLFS TFW, 1992, VIROLOGY, V189, P103, DOI 10.1016/0042-6822(92)90685-I; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	64	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22982	10.1371/journal.pone.0022982	http://dx.doi.org/10.1371/journal.pone.0022982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886773	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500006
J	Pang, RD; Wang, Z; Klosinski, LP; Guo, YM; Herman, DH; Celikel, T; Dong, HW; Holschneider, DP				Pang, Raina D.; Wang, Zhuo; Klosinski, Lauren P.; Guo, Yumei; Herman, David H.; Celikel, Tansu; Dong, Hong Wei; Holschneider, Daniel P.			Mapping Functional Brain Activation Using [C-14]-Iodoantipyrine in Male Serotonin Transporter Knockout Mice	PLOS ONE			English	Article							ANXIETY-RELATED TRAITS; CEREBRAL BLOOD-FLOW; DEFICIENT MICE; 5-HTTLPR GENOTYPE; INDICATOR FRACTIONATION; VENTRAL HIPPOCAMPUS; GENETIC-VARIATION; FEAR EXTINCTION; OUT MICE; AMYGDALA	Background: Serotonin transporter knockout mice have been a powerful tool in understanding the role played by the serotonin transporter in modulating physiological function and behavior. However, little work has examined brain function in this mouse model. We tested the hypothesis that male knockout mice show exaggerated limbic activation during exposure to an emotional stressor, similar to human subjects with genetically reduced transcription of the serotonin transporter. Methodology/Principal Findings: Functional brain mapping using [C-14]-iodoantipyrine was performed during recall of a fear conditioned tone. Regional cerebral blood flow was analyzed by statistical parametric mapping from autoradiographs of the three-dimensionally reconstructed brains. During recall, knockout mice compared to wild-type mice showed increased freezing, increased regional cerebral blood flow of the amygdala, insula, and barrel field somatosensory cortex, decreased regional cerebral blood flow of the ventral hippocampus, and conditioning-dependent alterations in regional cerebral blood flow in the medial prefrontal cortex (prelimbic, infralimbic, and cingulate). Anxiety tests relying on sensorimotor exploration showed a small (open field) or paradoxical effect (marble burying) of loss of the serotonin transporter on anxiety behavior, which may reflect known abnormalities in the knockout animal's sensory system. Experiments evaluating whisker function showed that knockout mice displayed impaired whisker sensation in the spontaneous gap crossing task and appetitive gap cross training. Conclusions: This study is the first to demonstrate altered functional activation in the serotonin transporter knockout mice of critical nodes of the fear conditioning circuit. Alterations in whisker sensation and functional activation of barrel field somatosensory cortex extend earlier reports of barrel field abnormalities, which may confound behavioral measures relying on sensorimotor exploration.	[Pang, Raina D.; Klosinski, Lauren P.; Herman, David H.; Celikel, Tansu; Holschneider, Daniel P.] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Wang, Zhuo; Guo, Yumei; Holschneider, Daniel P.] Univ So Calif, Dept Psychiat & Behav Sci, Los Angeles, CA USA; [Holschneider, Daniel P.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Celikel, Tansu; Holschneider, Daniel P.] Univ So Calif, Dept Cell & Neurobiol, Los Angeles, CA USA; [Dong, Hong Wei] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pang, RD (corresponding author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.	holschne@usc.edu	Celikel, Tansu/P-4235-2018	Holschneider, Daniel/0000-0002-4297-8280; Wang, Zhuo/0000-0003-1531-8065	NARSAD: The Brain & Behavior Research Fund	NARSAD: The Brain & Behavior Research Fund	NARSAD: The Brain & Behavior Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baganz NL, 2008, P NATL ACAD SCI USA, V105, P18976, DOI 10.1073/pnas.0800466105; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Bilder RM, 2009, NEUROSCIENCE, V164, P30, DOI 10.1016/j.neuroscience.2009.01.027; Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022; Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chubakov A R, 1993, Neurosci Behav Physiol, V23, P271, DOI 10.1007/BF01182928; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Dong H.W., 2008, ALLEN REFERENCE ATLA; Dubois A, 2008, NEUROIMAGE, V40, P482, DOI 10.1016/j.neuroimage.2007.11.054; Esaki T, 2005, P NATL ACAD SCI USA, V102, P5582, DOI 10.1073/pnas.0501509102; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Gorton LM, 2010, BEHAV BRAIN RES, V213, P253, DOI 10.1016/j.bbr.2010.05.009; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; GYERTYAN I, 1995, BEHAV PHARMACOL, V6, P24; Hansen N, 2011, NEUROSCI LETT, V495, P93, DOI 10.1016/j.neulet.2011.03.035; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Hohoff C, 2009, J NEURAL TRANSM, V116, P679, DOI 10.1007/s00702-009-0215-z; Hoistad M, 2008, NEUROIMAGE, V40, P1016, DOI 10.1016/j.neuroimage.2007.12.043; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Holschneider DP, 2008, METHODS, V45, P255, DOI 10.1016/j.ymeth.2008.04.006; Holschneider DP, 2010, GASTROENTEROLOGY, V138, pS765; Holschneider DP, 2004, NEUROSCI BIOBEHAV R, V28, P449, DOI 10.1016/j.neubiorev.2004.06.007; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; Kalueff AV, 2006, NEUROREPORT, V17, P1347, DOI 10.1097/01.wnr.0000230514.08962.76; Karg K., 2011, ARCH GEN PSYCHIAT; Katsuragi S, 1999, BIOL PSYCHIAT, V45, P368, DOI 10.1016/S0006-3223(98)00090-0; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Lee JH, 2005, INT J CONTROL AUTOM, V3, P32; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Linder AE, 2008, AM J PHYSIOL-HEART C, V294, pH1745, DOI 10.1152/ajpheart.91415.2007; Line SJ, 2011, EUR NEUROPSYCHOPHARM, V21, P108, DOI 10.1016/j.euroneuro.2010.08.005; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Lukoyanov NV, 2006, BEHAV BRAIN RES, V173, P229, DOI 10.1016/j.bbr.2006.06.026; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Matsumoto M, 2004, BRAIN RES, V1022, P221, DOI 10.1016/j.brainres.2004.06.078; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Petrovic P, 2004, J COGNITIVE NEUROSCI, V16, P1289, DOI 10.1162/0898929041920469; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Vogel C, 2003, J NEUROSCI, V23, P708, DOI 10.1523/JNEUROSCI.23-02-00708.2003; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303; Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9	70	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23869	10.1371/journal.pone.0023869	http://dx.doi.org/10.1371/journal.pone.0023869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886833	gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500035
J	Tao, HR; Okamoto, M; Nishikawa, M; Yoshikawa, H; Myoui, A				Tao, Huiren; Okamoto, Mina; Nishikawa, Masataka; Yoshikawa, Hideki; Myoui, Akira			P38 Mitogen-Activated Protein Kinase Inhibitor, FR167653, Inhibits Parathyroid Hormone Related Protein-Induced Osteoclastogenesis and Bone Resorption	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CALCIUM-SENSING RECEPTOR; BREAST-CANCER CELLS; FACTOR-ALPHA; ANTIINFLAMMATORY COMPOUND; DIFFERENTIATION FACTOR; SUPPRESSIVE AGENT; SIGNALING PATHWAY; DUAL INHIBITOR; TNF-ALPHA	p38 mitogen-activated protein kinase (MAPK) acts downstream in the signaling pathway that includes receptor activator of NF-kappa B (RANK), a powerful inducer of osteoclast formation and activation. We investigated the role of p38 MAPK in parathyroid hormone related protein (PTHrP)-induced osteoclastogenesis in vitro and PTHrP-induced bone resorption in vivo. The ability of FR167653 to inhibit osteoclast formation was evaluated by counting the number of tartrate-resistant acid phosphatase positive multinucleated cells (TRAP-positive MNCs) in in vitro osteoclastgenesis assays. Its mechanisms were evaluated by detecting the expression level of c-Fos and nuclear factor of activated T cells c1 (NFATc1) in bone marrow macrophages(BMMs) stimulated with sRANKL and M-CSF, and by detecting the expression level of osteoprotegerin (OPG) and RANKL in bone marrow stromal cells stimulated with PTHrP in the presence of FR167653. The function of FR167653 on bone resorption was assessed by measuring the bone resorption area radiographically and by counting osteoclast number per unit bone tissue area in calvaria in a mouse model of bone resorption by injecting PTHrP subcutaneously onto calvaria. Whole blood ionized calcium levels were also recorded. FR167653 inhibited PTHrP-induced osteoclast formation and PTHrP-induced c-Fos and NFATc1 expression in bone marrow macrophages, but not the expression levels of RANKL and OPG in primary bone marrow stromal cells treated by PTHrP. Furthermore, bone resorption area and osteoclast number in vivo were significantly decreased by the treatment of FR167653. Systemic hypercalcemia was also partially inhibited. Inhibition of p38 MAPK by FR167653 blocks PTHrP-induced osteoclastogenesis in vitro and PTHrP-induced bone resorption in vivo, suggesting that the p38 MAPK signaling pathway plays a fundamental role in PTHrP-induced osteoclastic bone resorption.	[Tao, Huiren; Okamoto, Mina; Nishikawa, Masataka; Yoshikawa, Hideki; Myoui, Akira] Osaka Univ, Grad Sch Med, Dept Orthoped, Osaka, Japan; [Tao, Huiren] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China	Osaka University; Air Force Military Medical University	Tao, HR (corresponding author), Osaka Univ, Grad Sch Med, Dept Orthoped, Osaka, Japan.	myoi@hp-mctr.med.osaka-u.ac.jp	Myoui, Akira/E-8296-2010		Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandarajah AP, 2009, TRENDS ENDOCRIN MET, V20, P88, DOI 10.1016/j.tem.2008.10.007; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; BOYCE BF, 1989, ENDOCRINOLOGY, V125, P1142, DOI 10.1210/endo-125-3-1142; Brandstrom H, 1998, BIOCHEM BIOPH RES CO, V247, P338, DOI 10.1006/bbrc.1998.8783; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cau J, 2009, J VASC SURG, V49, P728, DOI 10.1016/j.jvs.2008.09.056; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Furuichi K, 2002, NEPHROL DIAL TRANSPL, V17, P399, DOI 10.1093/ndt/17.3.399; Gardiner SM, 1999, J CARDIOVASC PHARM, V34, P64, DOI 10.1097/00005344-199907000-00011; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Hou ZS, 2003, HEPATOL RES, V26, P40, DOI 10.1016/S1386-6346(02)00334-0; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; Jimi E, 2011, ORAL DIS, V17, P462, DOI 10.1111/j.1601-0825.2010.01781.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Morgan R, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-51; Morony S, 1999, J BONE MINER RES, V14, P1478, DOI 10.1359/jbmr.1999.14.9.1478; Mundy GR, 1998, NEW ENGL J MED, V339, P398, DOI 10.1056/NEJM199808063390609; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Nishikori T, 2002, EUR J PHARMACOL, V451, P327, DOI 10.1016/S0014-2999(02)02238-0; Startchik I, 2002, J BIOL CHEM, V277, P24265, DOI 10.1074/jbc.M110947200; Takahashi S, 2001, J PHARMACOL EXP THER, V296, P48; Tfelt-Hansen J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329, DOI 10.1152/ajpendo.00489.2002; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Wada T, 2000, J AM SOC NEPHROL, V11, P1534, DOI 10.1681/ASN.V1181534; WYSOLMERSKI JJ, 1994, ANNU REV MED, V45, P189, DOI 10.1146/annurev.med.45.1.189; Yamamoto N, 1997, EUR J PHARMACOL, V327, P169, DOI 10.1016/S0014-2999(97)89657-4; Yamamoto N, 1996, EUR J PHARMACOL, V314, P137, DOI 10.1016/S0014-2999(96)00537-7; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yoshinari D, 2001, CRIT CARE MED, V29, P628, DOI 10.1097/00003246-200103000-00029	37	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23199	10.1371/journal.pone.0023199	http://dx.doi.org/10.1371/journal.pone.0023199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886782	gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500011
J	Wang, JF; Reis, BY; Hu, MG; Christakos, G; Yang, WZ; Sun, Q; Li, ZJ; Li, XZ; Lai, SJ; Chen, HY; Wang, DC				Wang, Jin-Feng; Reis, Ben Y.; Hu, Mao-Gui; Christakos, George; Yang, Wei-Zhong; Sun, Qiao; Li, Zhong-Jie; Li, Xiao-Zhou; Lai, Sheng-Jie; Chen, Hong-Yan; Wang, Dao-Chen			Area Disease Estimation Based on Sentinel Hospital Records	PLOS ONE			English	Article							SELECTION BIAS; UNCERTAINTY	Background: Population health attributes (such as disease incidence and prevalence) are often estimated using sentinel hospital records, which are subject to multiple sources of uncertainty. When applied to these health attributes, commonly used biased estimation techniques can lead to false conclusions and ineffective disease intervention and control. Although some estimators can account for measurement error (in the form of white noise, usually after de-trending), most mainstream health statistics techniques cannot generate unbiased and minimum error variance estimates when the available data are biased. Methods and Findings: A new technique, called the Biased Sample Hospital-based Area Disease Estimation (B-SHADE), is introduced that generates space-time population disease estimates using biased hospital records. The effectiveness of the technique is empirically evaluated in terms of hospital records of disease incidence (for hand-foot-mouth disease and fever syndrome cases) in Shanghai (China) during a two-year period. The B-SHADE technique uses a weighted summation of sentinel hospital records to derive unbiased and minimum error variance estimates of area incidence. The calculation of these weights is the outcome of a process that combines: the available space-time information; a rigorous assessment of both, the horizontal relationships between hospital records and the vertical links between each hospital's records and the overall disease situation in the region. In this way, the representativeness of the sentinel hospital records was improved, the possible biases of these records were corrected, and the generated area incidence estimates were best linear unbiased estimates (BLUE). Using the same hospital records, the performance of the B-SHADE technique was compared against two mainstream estimators. Conclusions: The B-SHADE technique involves a hospital network-based model that blends the optimal estimation features of the Block Kriging method and the sample bias correction efficiency of the ratio estimator method. In this way, B-SHADE can overcome the limitations of both methods: Block Kriging's inadequacy concerning the correction of sample bias and spatial clustering; and the ratio estimator's limitation as regards error minimization. The generality of the B-SHADE technique is further demonstrated by the fact that it reduces to Block Kriging in the case of unbiased samples; to ratio estimator if there is no correlation between hospitals; and to simple statistic if the hospital records are neither biased nor space-time correlated. In addition to the theoretical advantages of the B-SHADE technique over the two other methods above, two real world case studies (hand-foot-mouth disease and fever syndrome cases) demonstrated its empirical superiority, as well.	[Wang, Jin-Feng; Hu, Mao-Gui; Li, Xiao-Zhou] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Reis, Ben Y.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Yang, Wei-Zhong; Li, Zhong-Jie; Lai, Sheng-Jie] Chinese Ctr Dis Control & Prevent CDC, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Sun, Qiao] Shanghai Pudong New Area Ctr Dis Control & Preven, Shanghai, Peoples R China; [Chen, Hong-Yan] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Wang, Dao-Chen] MGS, Manchester, Lancs, England	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Harvard University; Boston Children's Hospital; Harvard Medical School; California State University System; San Diego State University; Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention; University of Liverpool	Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	wangjf@igsnrr.ac.cn	Yang, Wei/HIA-0360-2022; Hu, Maogui/N-7105-2013	Hu, Maogui/0000-0002-7671-7863; Lai, Shengjie/0000-0001-9781-8148; Christakos, George/0000-0002-1865-5764; Wang, Jinfeng/0000-0002-6687-9420	MOST, China [2009ZX10602-01-04, 2008BAI56B02, 2007DFC20180, 2007AA12Z233, 2006BAK01A13]; NSFC [41023010]; CAS, China [KZCX2-YW-308]	MOST, China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); CAS, China(Chinese Academy of Sciences)	This study was supported by MOST, China (2009ZX10602-01-04, 2008BAI56B02, 2007DFC20180, 2007AA12Z233; 2006BAK01A13), NSFC (41023010) and CAS, China (KZCX2-YW-308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler D, 2010, NATURE, V467, P1015, DOI 10.1038/4671015a; Christakos G., 1992, RANDOM FIELD MODELS; Christakos G., 2011, HDB REGIONAL SCI; Christakos G., 1998, SPATIOTEMPORAL ENV H; Christakos G, 2011, INTEGRATIVE PROBLEM-SOLVING IN A TIME OF DECADENCE, P1, DOI 10.1007/978-90-481-9890-0; COCHRAN W. G, 1977, SAMPLING TECHNIQUES, V3rd; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Haining R., 2003, SPATIAL DATA ANAL TH; Harris P, 2011, STOCH ENV RES RISK A, V25, P123, DOI 10.1007/s00477-010-0444-6; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hoffman J, 2010, NATURE, V467, P1043, DOI 10.1038/4671043a; Isaaks E.H., 1989, ISA; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mikler AR, 2007, STOCH ENV RES RISK A, V21, P533, DOI 10.1007/s00477-007-0137-y; Orton TG, 2007, STOCH ENV RES RISK A, V21, P773, DOI 10.1007/s00477-006-0089-7; Panlilio AL, 2004, INFECT CONT HOSP EP, V25, P556, DOI 10.1086/502439; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Reis BY, 2007, PLOS MED, V4, P1019, DOI 10.1371/journal.pmed.0040210; Reis BY, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3677; ROSENBERG W, 1995, BMJ-BRIT MED J, V310, P1122, DOI 10.1136/bmj.310.6987.1122; Saito H, 2005, STOCH ENV RES RISK A, V19, P71, DOI 10.1007/s00477-004-0207-3; SNOW J, 1855, MODEL COMMUNICATION; Torner A, 2010, AM J EPIDEMIOL, V171, P602, DOI 10.1093/aje/kwp432; Wang JF, 2010, INT J GEOGR INF SCI, V24, P523, DOI 10.1080/13658810902873512; YU HL, 2010, STOCH ENV RES RISK A, V25, P485, DOI DOI 10.1007/S00477-010-0417-9	25	26	33	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23428	10.1371/journal.pone.0023428	http://dx.doi.org/10.1371/journal.pone.0023428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886791	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500015
J	Kleinstiver, BP; Berube-Janzen, W; Fernandes, AD; Edgell, DR				Kleinstiver, Benjamin P.; Berube-Janzen, Wesley; Fernandes, Andrew D.; Edgell, David R.			Divalent Metal Ion Differentially Regulates the Sequential Nicking Reactions of the GIY-YIG Homing Endonuclease I-BmoI	PLOS ONE			English	Article							INTRON-ENCODED ENDONUCLEASE; NUCLEOTIDE EXCISION-REPAIR; MOBILE TD-INTRON; RESTRICTION-ENDONUCLEASE; NUCLEASE SUPERFAMILY; DISTANCE DETERMINATION; CLEAVAGE SPECIFICITY; TN10 TRANSPOSITION; REMOTE CLEAVAGE; DNA CLEAVAGE	Homing endonucleases are site-specific DNA endonucleases that function as mobile genetic elements by introducing double-strand breaks or nicks at defined locations. Of the major families of homing endonucleases, the modular GIY-YIG endonucleases are least understood in terms of mechanism. The GIY-YIG homing endonuclease I-BmoI generates a double-strand break by sequential nicking reactions during which the single active site of the GIY-YIG nuclease domain must undergo a substantial reorganization. Here, we show that divalent metal ion plays a significant role in regulating the two independent nicking reactions by I-BmoI. Rate constant determination for each nicking reaction revealed that limiting divalent metal ion has a greater impact on the second strand than the first strand nicking reaction. We also show that substrate mutations within the I-BmoI cleavage site can modulate the first strand nicking reaction over a 314-fold range. Additionally, in-gel DNA footprinting with mutant substrates and modeling of an I-BmoI-substrate complex suggest that amino acid contacts to a critical GC-2 base pair are required to induce a bottom-strand distortion that likely directs conformational changes for reaction progress. Collectively, our data implies mechanistic roles for divalent metal ion and substrate bases, suggesting that divalent metal ion facilitates the re-positioning of the GIY-YIG nuclease domain between sequential nicking reactions.	[Kleinstiver, Benjamin P.; Berube-Janzen, Wesley; Fernandes, Andrew D.; Edgell, David R.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Fernandes, Andrew D.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Kleinstiver, BP (corresponding author), Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada.	dedgell@uwo.ca	Kleinstiver, Benjamin/K-4498-2014; Edgell, David/AAJ-1971-2020	Kleinstiver, Benjamin/0000-0002-5469-0655; 	Natural Sciences and Engineering Research Council of Canada [311610-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Discovery Grant (311610-2010) to D.R.E. from the Natural Sciences and Engineering Research Council of Canada. B.P.K. is supported by an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2002, J MOL BIOL, V319, P53, DOI 10.1016/S0022-2836(02)00297-8; Andersson CE, 2010, J MOL BIOL, V397, P1003, DOI 10.1016/j.jmb.2010.01.076; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Belfort Marlene, 2002, P761; BELLPEDERSEN D, 1990, NUCLEIC ACIDS RES, V18, P3763, DOI 10.1093/nar/18.13.3763; BELLPEDERSEN D, 1989, GENE, V82, P119, DOI 10.1016/0378-1119(89)90036-X; BELLPEDERSEN D, 1991, P NATL ACAD SCI USA, V88, P7719, DOI 10.1073/pnas.88.17.7719; BRUKNER I, 1994, J MOL BIOL, V236, P26, DOI 10.1006/jmbi.1994.1115; BRYK M, 1995, J MOL BIOL, V247, P197, DOI 10.1006/jmbi.1994.0133; Carter JM, 2007, J MOL BIOL, V374, P306, DOI 10.1016/j.jmb.2007.09.027; Chan SH, 2011, NUCLEIC ACIDS RES, V39, P1, DOI 10.1093/nar/gkq742; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; Dean AB, 2002, P NATL ACAD SCI USA, V99, P8554, DOI 10.1073/pnas.082253699; Derbyshire V, 1997, J MOL BIOL, V265, P494, DOI 10.1006/jmbi.1996.0754; DUGUID J, 1993, BIOPHYS J, V65, P1916, DOI 10.1016/S0006-3495(93)81263-3; DUJON B, 1989, GENE, V82, P115, DOI 10.1016/0378-1119(89)90035-8; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Durrenberger F, 1996, NUCLEIC ACIDS RES, V24, P3323, DOI 10.1093/nar/24.17.3323; Edgell DR, 2004, J MOL BIOL, V343, P1231, DOI 10.1016/j.jmb.2004.09.005; Edgell DR, 2003, CURR BIOL, V13, P973, DOI 10.1016/S0960-9822(03)00340-3; Edgell DR, 2001, P NATL ACAD SCI USA, V98, P7898, DOI 10.1073/pnas.141222498; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Gasiunas G, 2008, NUCLEIC ACIDS RES, V36, P938, DOI 10.1093/nar/gkm1090; Gimble FS, 2000, FEMS MICROBIOL LETT, V185, P99; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Ibryashkina EM, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-48; Ibryashkina EM, 2009, J MOL BIOL, V387, P10, DOI 10.1016/j.jmb.2009.01.048; Jakubauskas A, 2008, BIOCHEMISTRY-US, V47, P8546, DOI 10.1021/bi800660u; Junop MS, 1996, EMBO J, V15, P2547, DOI 10.1002/j.1460-2075.1996.tb00612.x; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Kaminska KH, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-48; Karakas E, 2007, EMBO J, V26, P613, DOI 10.1038/sj.emboj.7601497; Kleinstiver BP, 2010, NUCLEIC ACIDS RES, V38, P2411, DOI 10.1093/nar/gkp1223; Kowalski JC, 1999, NUCLEIC ACIDS RES, V27, P2115, DOI 10.1093/nar/27.10.2115; Liu QQ, 2008, J MOL BIOL, V379, P1094, DOI 10.1016/j.jmb.2008.04.047; Liu QQ, 2006, NUCLEIC ACIDS RES, V34, P1755, DOI 10.1093/nar/gkl079; Mak ANS, 2010, STRUCTURE, V18, P1321, DOI 10.1016/j.str.2010.07.006; Miller WE, 2002, MATH GEOL, V34, P275, DOI 10.1023/A:1014842906442; MUELLER JE, 1995, EMBO J, V14, P5724, DOI 10.1002/j.1460-2075.1995.tb00259.x; Perona JJ, 2002, METHODS, V28, P353, DOI 10.1016/S1046-2023(02)00242-6; Pommer AJ, 2001, J MOL BIOL, V314, P735, DOI 10.1006/jmbi.2001.5189; Pyatkov KI, 2004, P NATL ACAD SCI USA, V101, P14719, DOI 10.1073/pnas.0406281101; QUIRK SM, 1989, CELL, V56, P455, DOI 10.1016/0092-8674(89)90248-1; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Rouzina I, 1998, BIOPHYS J, V74, P3152, DOI 10.1016/S0006-3495(98)78021-X; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Sokolowska M, 2011, NUCLEIC ACIDS RES, V39, P1554, DOI 10.1093/nar/gkq821; Sreedhara A, 2002, BIOMETALS, V15, P211, DOI 10.1023/A:1016070614042; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Van Roey P, 2002, NAT STRUCT BIOL, V9, P806, DOI 10.1038/nsb853; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; VERMOTE CLM, 1992, BIOCHEMISTRY-US, V31, P6082, DOI 10.1021/bi00141a018; Wah DA, 1998, P NATL ACAD SCI USA, V95, P10564, DOI 10.1073/pnas.95.18.10564; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhao L, 2007, EMBO J, V26, P2432, DOI 10.1038/sj.emboj.7601672	62	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23804	10.1371/journal.pone.0023804	http://dx.doi.org/10.1371/journal.pone.0023804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887323	Green Submitted, Green Published, gold			2022-12-25	WOS:000294251800032
J	Manabe, T; Pham, TPT; Can, VV; Takasaki, J; Dinh, TTH; Nguyen, TMC; Shimbo, T; Bui, TTH; Izumi, S; Hanh, TT; Chau, NQ; Kudo, K				Manabe, Toshie; Pham Thi Phuong Thuy; Vu Van Can; Takasaki, Jin; Dinh Thi Thanh Huyen; Nguyen Thi My Chau; Shimbo, Takuro; Bui Thi Thu Ha; Izumi, Shinyu; Tran Thuy Hanh; Ngo Quy Chau; Kudo, Koichiro			Impact of Educational Intervention Concerning Awareness and Behaviors Relating to Avian Influenza (H5N1) in a High-Risk Population in Vietnam	PLOS ONE			English	Article							A H5N1; INFECTION	Background: Early initiation of treatment is essential for treatment of avian influenza A/H5N1 viral infection in humans, as the disease can lead to rapid development of severe pneumonia which can result in death. Contact with infected poultry is known to be a significant risk factor for contraction of H5N1 infection. However, handling and encountering poultry are a part of most peoples' daily lives, especially in rural communities in Vietnam where epidemic outbreaks among poultry have been continuously reported. Enhancing proper knowledge relating to H5N1 and to the importance of early initiation of treatment are crucial. The aim of this study was to develop an effective educational program to enhance awareness of H5N1 and motivate people to access to health care earlier when H5N1 infection is suspected or likely. Methodology and Principal Findings: A study was conducted in two agricultural communities (intervention and control groups) in the Ninh Binh province in Vietnam, where epidemic outbreaks of avian influenza have recently occurred in birds. A unique educational intervention was developed and provided to the intervention group, and no intervention was provided to the control group. A knowledge, attitude and practice (KAP) survey was conducted in both groups with a face-to-face interview by trained local healthcare workers at time points before and after the educational intervention. KAP scores were compared between the different time points and between the groups. How educational intervention influenced awareness relating to H5N1 and accessibility of healthcare in the population was analyzed. The study indicated an increased awareness of H5N1 and increased reliance on local health care workers. Conclusions: The novel educational program which was developed for this study impacted awareness of H5N1, and resulted in more people seeking early access to healthcare, and also resulted in earlier medical intervention for patients with H5N1 avian influenza infection in Vietnam.	[Manabe, Toshie; Takasaki, Jin; Izumi, Shinyu; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Pham Thi Phuong Thuy; Dinh Thi Thanh Huyen] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Res Inst, Tokyo, Japan; [Nguyen Thi My Chau; Tran Thuy Hanh; Ngo Quy Chau] Bach Mai Hosp, Hanoi, Vietnam; [Vu Van Can; Bui Thi Thu Ha] Hlth Dept Ninh Binh Prov, Ninh Binh City, Vietnam	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Manabe, T (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	manabe@dcc.go.jp		Ngo, Quy Chau/0000-0002-6787-2757	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HUM INF AV INFL AH5N; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; WHO, 2010, CUM NUMB CONF HUM CA; *WORLD ORG AN HLTH, 2010, OIE DAIL UPD AV INFL; Xiang NJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-34	10	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23711	10.1371/journal.pone.0023711	http://dx.doi.org/10.1371/journal.pone.0023711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887303	gold, Green Published, Green Submitted			2022-12-25	WOS:000294251800025
J	Kasang, C; Kalluvya, S; Majinge, C; Stich, A; Bodem, J; Kongola, G; Jacobs, GB; Mlewa, M; Mildner, M; Hensel, I; Horn, A; Preiser, W; van Zyl, G; Klinker, H; Koutsilieri, E; Rethwilm, A; Scheller, C; Weissbrich, B				Kasang, Christa; Kalluvya, Samuel; Majinge, Charles; Stich, August; Bodem, Jochen; Kongola, Gilbert; Jacobs, Graeme B.; Mlewa, Mathias; Mildner, Miriam; Hensel, Irina; Horn, Anne; Preiser, Wolfgang; van Zyl, Gert; Klinker, Hartwig; Koutsilieri, Eleni; Rethwilm, Axel; Scheller, Carsten; Weissbrich, Benedikt			HIV Drug Resistance (HIVDR) in Antiretroviral Therapy-Naive Patients in Tanzania Not Eligible for WHO Threshold HIVDR Survey Is Dramatically High	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; TRANSMITTED HIV; SOUTH-AFRICA; SURVEILLANCE; MUTATIONS; PHARMACOKINETICS; POPULATIONS; PERFORMANCE; DIVERSITY	Background: The World Health Organization (WHO) has recommended guidelines for a HIV drug resistance (HIVDR) survey for resource-limited countries. Eligibility criteria for patients include age below 25 years in order to focus on the prevalence of transmitted HIVDR (tHIVDR) in newly-infected individuals. Most of the participating sites across Africa have so far reported tHIVDR prevalences of below 5%. In this study we investigated whether the rate of HIVDR in patients <25 years is representative for HIVDR in the rest of the therapy-naive population. Methods and Findings: HIVDR was determined in 88 sequentially enrolled ART-naive patients from Mwanza, Tanzania (mean age 35.4 years). Twenty patients were aged <25 years and 68 patients were aged 25-63 years. The frequency of HIVDR in the study population was 14.8% (95%; CI 0.072-0.223) and independent of NVP-resistance induced by prevention of mother-to-child transmission programs. Patients >25 years had a significantly higher HIVDR frequency than younger patients (19.1%; 95% CI 0.095-0.28) versus 0%, P = 0.0344). In 2 out of the 16 patients with HIVDR we found traces of antiretrovirals (ARVs) in plasma. Conclusions: ART-naive patients aged over 25 years exhibited significantly higher HIVDR than younger patients. Detection of traces of ARVs in individuals with HIVDR suggests that besides transmission, undisclosed misuse of ARVs may constitute a significant factor in the generation of the observed high HIVDR rate. The current WHO tHIVDR survey that is solely focused on the transmission of HIVDR and that excludes patients over 25 years of age may therefore result in substantial underestimation of the prevalence of HIVDR in the therapy-naive population. Similar studies should be performed also in other areas to test whether the so far reported optimistic picture of low HIVDR prevalence in young individuals is really representative for the rest of the ART-naive HIV-infected population.	[Kasang, Christa; Bodem, Jochen; Jacobs, Graeme B.; Mildner, Miriam; Hensel, Irina; Horn, Anne; Koutsilieri, Eleni; Rethwilm, Axel; Scheller, Carsten; Weissbrich, Benedikt] Univ Wurzburg, Inst Virol & Immunobiol, D-8700 Wurzburg, Germany; [Kalluvya, Samuel; Majinge, Charles; Mlewa, Mathias] Bugando Med Ctr, Mwanza, Tanzania; [Kalluvya, Samuel; Kongola, Gilbert] BUCHS, Mwanza, Tanzania; [Stich, August] Med Mission Inst, Wurzburg, Germany; [Preiser, Wolfgang; van Zyl, Gert] Univ Stellenbosch, Div Med Virol, Dept Pathol, Natl Hlth Lab Serv, Cape Town, South Africa; [Klinker, Hartwig] Univ Wurzburg, Dept Internal Med, Div Infect Dis, D-8700 Wurzburg, Germany	University of Wurzburg; Stellenbosch University; University of Cape Town; University of Wurzburg	Kasang, C (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, Versbacher Str 7, D-8700 Wurzburg, Germany.	scheller@vim.uni-wuerzburg.de	Klinker, Hartwig/AAC-1134-2021; Bodem, Jochen/H-9122-2019; Preiser, Wolfgang/J-4875-2016; van Zyl, Gert/I-7357-2019; Kasang, Christa/AAW-5048-2021	Bodem, Jochen/0000-0003-1908-4091; Preiser, Wolfgang/0000-0002-0254-7910; van Zyl, Gert/0000-0003-3021-5101; Kasang, Christa/0000-0003-0241-0321; Jacobs, Graeme/0000-0002-3259-1496	Deutsche Forschungsgemeinschaft [DFG IRTG 1522]; German Leprosy and Tuberculosis Relief Association; Evangelisches Studienwerk e.V. Villigst; Deutscher Akademischer Austauschdienst; Bayerische Staatsregierung; Gesellschaft fur AIDS-Forschung e.V. (Gottingen); University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Leprosy and Tuberculosis Relief Association; Evangelisches Studienwerk e.V. Villigst; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Bayerische Staatsregierung; Gesellschaft fur AIDS-Forschung e.V. (Gottingen); University of Wuerzburg	The study was funded by Deutsche Forschungsgemeinschaft (www.dfg.de; DFG IRTG 1522), German Leprosy and Tuberculosis Relief Association (www.dahw.de), Evangelisches Studienwerk e.V. Villigst (www.evstudienwerk.de), Deutscher Akademischer Austauschdienst (www.daad.de), Bayerische Staatsregierung (www.bayern.de), and Gesellschaft fur AIDS-Forschung e.V. (Gottingen, no URL). Publication costs were covered by Deutsche Forschungsgemeinschaft (www.dfg.de) and the University of Wuerzburg (www.uni-wuerzburg.de) by the funding programme "Open Access Publishing.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Deeks SG, 2008, PLOS MED, V5, P1014, DOI 10.1371/journal.pmed.0050164; FAghokeng A, 2009, ANTIVIR THER, V14, P401; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Haas DW, 2009, J INFECT DIS, V199, P872, DOI 10.1086/597125; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P1009, DOI 10.1089/aid.2008.0028; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; *JOINT UN PROGR HI, 2007, FIN RES REQ ACH UN A, V3; Kamoto K, 2008, ANTIVIR THER, V13, P83; Langmann P, 2008, EUR J MED RES, V13, P52; Langmann P, 2002, EUR J MED RES, V7, P309; Maphalala G, 2008, ANTIVIR THER, V13, P95; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Nyombi Balthazar M, 2008, AIDS Res Ther, V5, P13, DOI 10.1186/1742-6405-5-13; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith PF, 2001, CLIN PHARMACOKINET, V40, P893, DOI 10.2165/00003088-200140120-00002; Somi GR, 2008, ANTIVIR THER, V13, P77; *STANDF U, STANDF U DRUG RES DA; *WHO, WHO HIVDR STAT REP; *WHO, 2010, WHO PROGR REP; NATL GUIDELINES MANA	30	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23091	10.1371/journal.pone.0023091	http://dx.doi.org/10.1371/journal.pone.0023091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886779	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100006
J	Chow, C; Wong, N; Pagano, M; Lun, SWM; Nakayama, KI; Nakayama, K; Lo, KW				Chow, C.; Wong, N.; Pagano, M.; Lun, S. W-M; Nakayama, K-I; Nakayama, K.; Lo, K-W			Regulation of APC/C-Cdc20 activity by RASSF1A-APC/C-Cdc20 circuitry	ONCOGENE			English	Article						RASSF1A; APC/C-Cdc20; Aurora; ubiquitination; mitotic checkpoint	TUMOR-SUPPRESSOR RASSF1A; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; UBIQUITIN-MEDIATED DEGRADATION; SPINDLE ASSEMBLY CHECKPOINT; KINASE AURORA-A; CYCLIN-A; CELL-CYCLE; PSEUDOSUBSTRATE INHIBITOR; MITOTIC CHECKPOINT; D-BOX	RASSF1A is a key tumor-suppressor gene that is often inactivated in a wide variety of solid tumors. Studies have illustrated that RASSF1A plays vital roles in the regulation of cell-cycle progression and functions as a guardian of mitosis. Nevertheless, the precise mechanism of RASSF1A-dependent regulation of mitosis remains largely unclear. APC/C-Cdc20 is the master switch and regulator of mitosis. The activity of APC/C-Cdc20 is tightly controlled by phosphorylation and specific inhibitors to ensure the sequential ubiquitination of downstream targets. Here, we report on the novel finding of a regulated circuitry that controls the timely expression and hence activity of APC/C-Cdc20 during mitosis. Our study showed that RASSF1A and APC/C-Cdc20 form a molecular relay that regulates the APC/C-Cdc20 activity at early mitosis. We found that RASSF1A inhibits APC/C-Cdc20 function through its D-box motifs. Paradoxically, RASSF1A was also demonstrated to be ubiquitinated by APC/C-Cdc20 in vitro and degraded at prometaphase despite of active spindle checkpoint presence. The first two unique D-boxes at the N-terminal of RASSF1A served as specific degron recognized by APC/C-Cdc20. Importantly, we found that Aurora A and Aurora B directly phosphorylate RASSF1A, a critical step by which RASSF1A switches from being an inhibitor to a substrate of APC/C-Cdc20 during the course of mitotic progression. As a result of RASSF1A degradation, APC/C-Cdc20 can then partially activate the ubiquitination of Cyclin A in the presence of spindle checkpoint. This circuitry is essential for the timely degradation of Cyclin A. To conclude, our results propose a new model for RASSF1A-APC/C-Cdc20 interaction in ensuring the sequential progression of mitosis. Oncogene (2012) 31, 1975-1987; doi:10.1038/onc.2011.372; published online 29 August 2011	[Chow, C.; Wong, N.; Lun, S. W-M; Lo, K-W] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China; [Wong, N.; Lo, K-W] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Pagano, M.] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY USA; [Nakayama, K-I] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan; [Nakayama, K.] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Dept Dev Genet,Aoba Ku, Sendai, Miyagi 980, Japan	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; New York University; Kyushu University; Tohoku University	Lo, KW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk		pagano, michele/0000-0003-3210-2442	Michael and Betty Kadoorie Cancer Genetics Research Program II (MBKCGRPII); Li Ka Shing Institute of Health Science; Hong Kong Research Grant Council [440606]; NATIONAL CANCER INSTITUTE [R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	Michael and Betty Kadoorie Cancer Genetics Research Program II (MBKCGRPII); Li Ka Shing Institute of Health Science; Hong Kong Research Grant Council(Hong Kong Research Grants Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Michael and Betty Kadoorie Cancer Genetics Research Program II (MBKCGRPII), Li Ka Shing Institute of Health Science and Hong Kong Research Grant Council (440606).	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Heron NM, 2006, BIOORG MED CHEM LETT, V16, P1320, DOI 10.1016/j.bmcl.2005.11.053; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jiang LY, 2011, J BIOL CHEM, V286, P6971, DOI 10.1074/jbc.M110.186494; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Liu L, 2007, CELL CYCLE, V6, P1663, DOI 10.4161/cc.6.13.4435; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Mortlock A, 2005, CURR TOP MED CHEM, V5, P805, DOI 10.2174/1568026054637719; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Song MS, 2008, ONCOGENE, V27, P3176, DOI 10.1038/sj.onc.1210971; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Song SJ, 2009, CANCER RES, V69, P8540, DOI 10.1158/0008-5472.CAN-09-1554; van Zon W, 2010, BIOCHEM SOC T, V38, P72, DOI 10.1042/BST0380072; Wang X, 2008, ONCOGENE, V27, P4456, DOI 10.1038/onc.2008.87; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	37	23	23	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1975	1987		10.1038/onc.2011.372	http://dx.doi.org/10.1038/onc.2011.372			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21874044	hybrid, Green Published			2022-12-25	WOS:000302809900009
J	Rishavy, MA; Hallgren, KW; Berkner, KL				Rishavy, Mark A.; Hallgren, Kevin W.; Berkner, Kathleen L.			The Vitamin K-dependent Carboxylase Generates gamma-Carboxylated Glutamates by Using CO2 to Facilitate Glutamate Deprotonation in a Concerted Mechanism That Drives Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTORS; CARBON-HYDROGEN BOND; FACTOR-IX; COMBINED DEFICIENCY; POSTTRANSLATIONAL MODIFICATION; PROTEIN CARBOXYLATION; CARBOXYGLUTAMIC ACID; MAMMALIAN-CELLS; MUTATION; BASE	The gamma-glutamyl carboxylase converts Glu to carboxylated Glu (Gla) to activate a large number of vitamin K-dependent proteins with diverse functions, and this broad physiological impact makes it critical to understand the mechanism of carboxylation. Gla formation is thought to occur in two independent steps (i.e. Glu deprotonation to form a carbanion that then reacts with CO2), based on previous studies showing unresponsiveness of Glu deprotonation to CO2. However, our recent studies on the kinetic properties of a variant enzyme (H160A) showing impaired Glu deprotonation prompted a reevaluation of this model. Glu deprotonation monitored by tritium release from the glutamyl gamma-carbon was dependent upon CO2, and a proportional increase in both tritium release and Gla formation occurred over a range of CO2 concentrations. This discrepancy with the earlier studies using microsomes is probably due to the known accessibility of microsomal carboxylase to water, which reprotonates the carbanion. In contrast, tritium incorporation experiments with purified carboxylase showed very little carbanion reprotonation and consequently revealed the dependence of Glu deprotonation on CO2. Cyanide stimulated Glu deprotonation and carbanion reprotonation to the same extent in wild type enzyme but not in the H160A variant. Glu deprotonation that depends upon CO2 but that also occurs when water or cyanide are present strongly suggests a concerted mechanism facilitated by His-160 in which an electrophile accepts the negative charge on the developing carbanion. This revised mechanism provides important insight into how the carboxylase catalyzes the reaction by avoiding the formation of a high energy discrete carbanion.	[Rishavy, Mark A.; Hallgren, Kevin W.; Berkner, Kathleen L.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Berkner, KL (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	berknek@ccf.org		Berkner, Kathleen/0000-0001-8054-8081	National Institutes of Health [RO1 HL055666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL055666 (to K. L. B.).	ANTON DL, 1983, J BIOL CHEM, V258, P4084; Bandyopadhyay PK, 2002, P NATL ACAD SCI USA, V99, P1264, DOI 10.1073/pnas.022637099; Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; BERKNER KL, 1993, METHOD ENZYMOL, V222, P450; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; Czerwiec E, 2002, EUR J BIOCHEM, V269, P6162, DOI 10.1046/j.1432-1033.2002.03335.x; Darghouth D, 2006, BLOOD, V108, P1925, DOI 10.1182/blood-2005-12-010660; DECOTTIGNIESLEMARECHAL P, 1984, J BIOL CHEM, V259, P5010; DECOTTIGNIESLEMARECHAL P, 1979, BIOCHEM BIOPH RES CO, V90, P700; DEMETZ M, 1982, FEBS LETT, V137, P253, DOI 10.1016/0014-5793(82)80361-X; DEMETZ M, 1981, FEBS LETT, V123, P215, DOI 10.1016/0014-5793(81)80290-6; DOWD P, 1995, SCIENCE, V269, P1684, DOI 10.1126/science.7569894; DOWD P, 1991, P NATL ACAD SCI USA, V88, P10583, DOI 10.1073/pnas.88.23.10583; DUBOIS J, 1983, J BIOL CHEM, V258, P7897; Finnan J. L., 1980, VITAMIN K METABOLISM, P509; FRIEDMAN PA, 1979, P NATL ACAD SCI USA, V76, P3126, DOI 10.1073/pnas.76.7.3126; Hallgren KW, 2002, BIOCHEMISTRY-US, V41, P15045, DOI 10.1021/bi026016e; HAUSCHKA PV, 1979, BIOCHEMISTRY-US, V18, P4992, DOI 10.1021/bi00589a029; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Kulman JD, 2006, P NATL ACAD SCI USA, V103, P15794, DOI 10.1073/pnas.0607543103; LARSON AE, 1981, J BIOL CHEM, V256, P1032; Li QL, 2009, J INVEST DERMATOL, V129, P553, DOI 10.1038/jid.2008.271; Li T, 2000, J BIOL CHEM, V275, P18291, DOI 10.1074/jbc.M001790200; Lingenfelter SE, 1996, BIOCHEMISTRY-US, V35, P8234, DOI 10.1021/bi9523318; MCTIGUE JJ, 1983, J BIOL CHEM, V258, P2129; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; Mutucumarana VP, 2003, J BIOL CHEM, V278, P46488, DOI 10.1074/jbc.M307707200; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rishavy MA, 2005, J BIOL CHEM, V280, P34870, DOI 10.1074/jbc.M504345200; Rishavy MA, 2004, P NATL ACAD SCI USA, V101, P13732, DOI 10.1073/pnas.0404989101; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rishavy MA, 2006, BIOCHEMISTRY-US, V45, P13239, DOI 10.1021/bi0609523; Rost S, 2004, BRIT J HAEMATOL, V126, P546, DOI 10.1111/j.1365-2141.2004.05071.x; Schultz J, 2004, TRENDS BIOCHEM SCI, V29, P4, DOI 10.1016/j.tibs.2003.11.002; Spronk HMH, 2000, BLOOD, V96, P3650; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; UOTILA L, 1988, ARCH BIOCHEM BIOPHYS, V264, P135, DOI 10.1016/0003-9861(88)90578-4; Vanakker OM, 2007, J INVEST DERMATOL, V127, P581, DOI 10.1038/sj.jid.5700610; Walker CS, 2001, J BIOL CHEM, V276, P7769, DOI 10.1074/jbc.M009576200; Wang CP, 2003, J THROMB HAEMOST, V1, P118, DOI 10.1046/j.1538-7836.2003.00069.x; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	45	5	5	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2011	286	52					44821	44832		10.1074/jbc.M111.249177	http://dx.doi.org/10.1074/jbc.M111.249177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870CA	21896484	hybrid, Green Published			2022-12-25	WOS:000298645500051
J	Dash, B; Chang, YC; Lukas, RJ				Dash, Bhagirathi; Chang, Yongchang; Lukas, Ronald J.			Reporter Mutation Studies Show That Nicotinic Acetylcholine Receptor (nAChR) alpha 5 Subunits and/or Variants Modulate Function of alpha 6*-nAChR*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ION CHANNELS; IN-VIVO; GENE; ALPHA-4-BETA-2; ACTIVATION; EXPRESSION; SUBTYPES; RELEASE; NEURONS	To further the understanding of functional alpha 6 alpha 5*-nicotinic acetylcholine receptors (nAChR; the asterisk (*) indicates known or possible presence of other subunits), we have heterologously expressed in oocytes different, mouse or human, nAChR subunit combinations. Coexpression with wild-type alpha 5 subunits or chimeric alpha 5/beta 3 subunits (in which the human alpha 5 subunit N-terminal, extracellular domain is linked to the remaining domains of the human beta 3 subunit) almost completely abolishes the very small amount of function seen for alpha 6 beta 4*-nAChR and does not induce function of alpha 6 beta 2*-nAChR. Coexpression with human alpha 5(V9)'(S) subunits bearing a valine 290 to serine mutation in the 9' position of the second transmembrane domain does not rescue the function of alpha 6 beta 4*-nAChR or induce function of alpha 6 beta 2*-nAChR. However, coexpression with mutant chimeric alpha 5/beta 3(V9)'(S) subunits has a gain-of-function effect (higher functional expression and agonist sensitivity and spontaneous opening inhibited by mecamylamine) on alpha 6 beta 4*-nAChR. Moreover, N143D + M145V mutations in the alpha 6 subunit N-terminal domain enable alpha 5/beta 3(V9)'(S) subunits to have a gain-of-function effect on alpha 6 beta 2*-nAChR. nAChR containing chimeric alpha 6/alpha 3 subunits plus either beta 2 or beta 4 subunits have some function that is modulated in the presence of alpha 5 or alpha 5/beta 3 subunits. Coexpression with alpha 5/beta 3(V9)'(S) subunits has a gain-of-function effect more pronounced than that in the presence of alpha 5(V9)'(S) subunits. Gain-of-function effects are dependent, sometimes subtly, on the nature and apparently the extracellular, cytoplasmic, and/or transmembrane domain topology of partner subunits. These studies yield insight into assembly of functional alpha 6 alpha 5*-nAChR and provide tools for development of alpha 6*-nAChR-selective ligands that could be important in the treatment of nicotine dependence, and perhaps other neurological diseases.	[Dash, Bhagirathi; Chang, Yongchang; Lukas, Ronald J.] Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ 85013 USA	Barrow Neurological Institute	Lukas, RJ (corresponding author), 350 W Thomas Rd, Phoenix, AZ 85013 USA.	rlukas@chw.edu		Dash, Bhagirathi/0000-0002-5314-5372	National Institutes of Health [R01 DA015389]; Philip Morris USA Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc.; Philip Morris International; Men's and Women's Boards of the Barrow Neurological Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA015389 and the External Research Program by Philip Morris USA Inc. and Philip Morris International, and endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation. Portions of this work have been presented in abstract form (Dash, B., Bhakta, M., Chang, Y., and Lukas, R.J. (2010) Soc. Neurosci. Abst. 36, 39.19).	BOULTER J, 1990, J BIOL CHEM, V265, P4472; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; COUTURIER S, 1990, J BIOL CHEM, V265, P17560; Cui CH, 2003, J NEUROSCI, V23, P11045; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Flora A, 2000, J NEUROCHEM, V75, P18, DOI 10.1046/j.1471-4159.2000.0750018.x; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lester HA, 2000, ANNU REV NEUROSCI, V23, P89, DOI 10.1146/annurev.neuro.23.1.89; Lukas RJ, 2001, EUR J NEUROSCI, V13, P1849, DOI 10.1046/j.0953-816x.2001.01560.x; Lukas RJ, 1999, PHARMACOL REV, V51, P397; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; Miko A, 2004, J BIOL CHEM, V279, P22833, DOI 10.1074/jbc.M402577200; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; TREININ M, 1995, NEURON, V14, P871, DOI 10.1016/0896-6273(95)90231-7; WADA E, 1990, BRAIN RES, V526, P45, DOI 10.1016/0006-8993(90)90248-A; Wang N, 2002, J PHYSIOL-LONDON, V542, P347, DOI 10.1113/jphysiol.2001.013456; Wang NS, 2004, J NEUROL SCI, V222, P87, DOI 10.1016/j.jns.2004.04.009; Winzer-Serhan UH, 2005, J COMP NEUROL, V481, P19, DOI 10.1002/cne.20357; Yu CR, 1998, J PHYSIOL-LONDON, V509, P667, DOI 10.1111/j.1469-7793.1998.667bm.x	30	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37905	37918		10.1074/jbc.M111.264044	http://dx.doi.org/10.1074/jbc.M111.264044			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21873428	hybrid, Green Published			2022-12-25	WOS:000296594200004
J	Fasken, MB; Leung, SW; Banerjee, A; Kodani, MO; Chavez, R; Bowman, EA; Purohit, MK; Rubinson, ME; Rubinson, EH; Corbett, AH				Fasken, Milo B.; Leung, Sara W.; Banerjee, Ayan; Kodani, Maja O.; Chavez, Ramiro; Bowman, Elizabeth A.; Purohit, Meghan K.; Rubinson, Max E.; Rubinson, Emily H.; Corbett, Anita H.			Air1 Zinc Knuckles 4 and 5 and a Conserved IWRXY Motif Are Critical for the Function and Integrity of the Trf4/5-Air1/2-Mtr4 Polyadenylation (TRAMP) RNA Quality Control Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXOSOME; YEAST EXOSOME; RIBOSOMAL-RNA; BIDIRECTIONAL PROMOTERS; POLY(A) POLYMERASE; DEGRADATION; PROTEIN; SURVEILLANCE	In Saccharomyces cerevisiae, non-coding RNAs, including cryptic unstable transcripts (CUTs), are subject to degradation by the exosome. The Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) complex in S. cerevisiae is a nuclear exosome cofactor that recruits the exosome to degrade RNAs. Trf4/5 are poly(A) polymerases, Mtr4 is an RNA helicase, and Air1/2 are putative RNA-binding proteins that contain five CCHC zinc knuckles (ZnKs). One central question is how the TRAMP complex, especially the Air1/2 protein, recognizes its RNA substrates. To characterize the function of the Air1/2 protein, we used random mutagenesis of the AIR1/2 gene to identify residues critical for Air protein function. We identified air1-C178R and air2-C167R alleles encoding air1/2 mutant proteins with a substitution in the second cysteine of ZnK5. Mutagenesis of the second cysteine in AIR1/2 ZnK1-5 reveals that Air1/2 ZnK4 and -5 are critical for Air protein function in vivo. In addition, we find that the level of CUT, NEL025c, in air1 ZnK1-5 mutants is stabilized, particularly in air1 ZnK4, suggesting a role for Air1 ZnK4 in the degradation of CUTs. We also find that Air1/2 ZnK4 and -5 are critical for Trf4 interaction and that the Air1-Trf4 interaction and Air1 level are critical for TRAMP complex integrity. We identify a conserved IWRXY motif in the Air1 ZnK4-5 linker that is important for Trf4 interaction. We also find that hZC-CHC7, a putative human orthologue of Air1 that contains the IWRXY motif, localizes to the nucleolus in human cells and interacts with both mammalian Trf4 orthologues, PAPD5 and PAPD7 (PAP-associated domain containing 5 and 7), suggesting that hZCCHC7 is the Air component of a human TRAMP complex.	[Fasken, Milo B.; Leung, Sara W.; Banerjee, Ayan; Kodani, Maja O.; Chavez, Ramiro; Purohit, Meghan K.; Rubinson, Max E.; Rubinson, Emily H.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Bowman, Elizabeth A.] Emory Univ, Sch Med, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA	Emory University; Emory University	Fasken, MB (corresponding author), 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	mfasken@emory.edu	Fasken, Milo/K-2177-2019; Corbett, Anita/AAH-6106-2021	Fasken, Milo/0000-0003-4317-7909; Corbett, Anita/0000-0002-0461-6895	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to A. H. C.).	Adams A, 1997, METHODS YEAST GENETI; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; An Q, 2009, HAEMATOL-HEMATOL J, V94, P1164, DOI 10.3324/haematol.2008.002808; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hamill S, 2010, P NATL ACAD SCI USA, V107, P15045, DOI 10.1073/pnas.1003505107; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Hystad ME, 2007, J IMMUNOL, V179, P3662, DOI 10.4049/jimmunol.179.6.3662; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Keller C, 2010, RNA, V16, P1124, DOI 10.1261/rna.2053710; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Liang S, 1996, MOL CELL BIOL, V16, P5139; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Nakamura R, 2008, MOL CELL BIOL, V28, P6620, DOI 10.1128/MCB.00448-08; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; SADOFF BU, 1995, GENETICS, V141, P465; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanudo M, 2011, BIOMOL NMR ASSIGN, V5, P19, DOI 10.1007/s12104-010-9257-2; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; SIKORSKI RS, 1989, GENETICS, V122, P19; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Wang ZH, 2002, GENETICS, V160, P381; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zhou AD, 2008, J GENET GENOMICS, V35, P467, DOI 10.1016/S1673-8527(08)60064-8	66	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37429	37445		10.1074/jbc.M111.271494	http://dx.doi.org/10.1074/jbc.M111.271494			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878619	Green Published, hybrid			2022-12-25	WOS:000296542400043
J	Lin, L; Bankaitis, E; Heimbach, L; Li, N; Abrink, M; Pejler, G; An, LJ; Diaz, LA; Werb, Z; Liu, Z				Lin, Lan; Bankaitis, Eric; Heimbach, Lisa; Li, Ning; Abrink, Magnus; Pejler, Gunnar; An, Lijia; Diaz, Luis A.; Werb, Zena; Liu, Zhi			Dual Targets for Mouse Mast Cell Protease-4 in Mediating Tissue Damage in Experimental Bullous Pemphigoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGELATINASE-B; IV COLLAGENASE; DEFICIENT MICE; ANTIGEN BPAG2; KEY ROLE; ACTIVATION; CHYMASE; INFLAMMATION; CLONING; PROTEIN	Mouse mast cell protease-4 (mMCP-4) has been linked to autoimmune and inflammatory diseases, although the exact mechanisms underlying its role in these pathological conditions remain unclear. Here, we have found that mMCP-4 is critical in a mouse model of the autoimmune skin blistering disease bullous pemphigoid (BP). Mice lacking mMCP-4 were resistant to experimental BP. Complement activation, mast cell (MC) degranulation, and the early phase of neutrophil (PMN) recruitment occurred comparably in mMCP-4(-/-) and WT mice. However, without mMCP-4, activation of matrix metalloproteinase (MMP)-9 was impaired in cultured mMCP-4(-/-) MCs and in the skin of pathogenic IgG-injected mMCP-4(-/-) mice. MMP-9 activation was not fully restored by local reconstitution with WT or mMCP-4(-/-) PMNs. Local reconstitution with mMCP-4(-/-) MCs, but not with mMCP-4(-/-) MCs, restored blistering, MMP-9 activation, and PMN recruitment in mMCP-4(-/-) mice. mMCP-4 also degraded the hemidesmosomal transmembrane protein BP180 both in the skin and in vitro. These results demonstrate that mMCP-4 plays two different roles in the pathogenesis of experimental BP, by both activating MMP-9 and by cleaving BP180, leading to injury of the hemidesmosomes and extracellular matrix of the basement membrane zone.	[Lin, Lan; Bankaitis, Eric; Heimbach, Lisa; Li, Ning; Diaz, Luis A.; Liu, Zhi] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA; [Lin, Lan; An, Lijia] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian 116024, Liaoning, Peoples R China; [Heimbach, Lisa; Liu, Zhi] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Abrink, Magnus] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, S-75123 Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of North Carolina; University of North Carolina Chapel Hill; Dalian University of Technology; University of North Carolina; University of North Carolina Chapel Hill; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of California System; University of California San Francisco	Liu, Z (corresponding author), Univ N Carolina, Dept Dermatol, 116 Manning Dr,Rm 422, Chapel Hill, NC 27599 USA.	zhiliu@med.unc.edu	Åbrink, Magnus/AAK-8346-2020	Diaz, Luis/0000-0002-7079-8914; Abrink, Magnus/0000-0002-1335-3927	National Institutes of Health, USPHS [AI40768, AI61430, AR052109, AR053313, AR32599, AR32081, CA057621]; Swedish Medical Research Council; China Scholarship Council; National Institutes of Health [AI007273]; NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI040768, R01AI040768, R01AI061430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR053313, R37AR032081, R01AR032081, R01AR032599, K01AR052109] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); China Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI40768 and AI61430 (to Z. L.), AR052109 and AR053313 (to N. L.), AR32599 and AR32081 (to L. A. D.), and CA057621 (to Z. W.) from the USPHS. This work was also supported by grants from the Swedish Medical Research Council (to M. A. and G. P).; Supported in part by a predoctoral fellowship from the China Scholarship Council.; Supported in part by National Institutes of Health Predoctoral Fellowship AI007273.	Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Chen RY, 2001, J CLIN INVEST, V108, P1151, DOI 10.1172/jci11494; Clark Robert A, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0723s19; Davis GE, 2001, J CELL SCI, V114, P917; DESRIVIERES S, 1993, J CELL PHYSIOL, V157, P587, DOI 10.1002/jcp.1041570319; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Fang KC, 1997, J BIOL CHEM, V272, P25628, DOI 10.1074/jbc.272.41.25628; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; FRIDMAN R, 1995, CANCER RES, V55, P2548; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Heimbach L, 2011, J BIOL CHEM, V286, P15003, DOI 10.1074/jbc.M111.221036; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jippo T, 1997, AM J PATHOL, V150, P1373; JORDON RE, 1967, J AMER MED ASSOC, V200, P751, DOI 10.1001/jama.200.9.751; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEVER WF, 1953, MEDICINE, V32, P1; LI KH, 1993, J BIOL CHEM, V268, P8825; LI KH, 1992, J INVEST DERMATOL, V99, P258, DOI 10.1111/1523-1747.ep12616611; Lijnen HR, 1998, ARTERIOSCL THROM VAS, V18, P1035, DOI 10.1161/01.ATV.18.7.1035; Liu Z, 2005, J CLIN INVEST, V115, P879, DOI 10.1172/JCI200523977; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 1998, J EXP MED, V188, P475, DOI 10.1084/jem.188.3.475; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; LIU Z, 1992, J BIOL CHEM, V267, P15829; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Metcalf J. A., 1985, LAB MANUAL NEUTROPHI, P2; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; PEJLER G, 1993, J BIOL CHEM, V268, P11817; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; Ryan JJ, 1998, J IMMUNOL, V161, P6915; Scandiuzzi L, 2010, J IMMUNOL, V185, P624, DOI 10.4049/jimmunol.0902129; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Twining SS, 1996, INVEST OPHTH VIS SCI, V37, P511; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; WERSHIL BK, 1987, J IMMUNOL, V139, P2605; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Woessner J.F., 2000, PROTEIN PROFILE SER; Younan G, 2010, J IMMUNOL, V185, P7681, DOI 10.4049/jimmunol.1002803	59	42	45	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37358	37367		10.1074/jbc.M111.272401	http://dx.doi.org/10.1074/jbc.M111.272401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880713	Green Published, hybrid			2022-12-25	WOS:000296542400036
J	Uren, PJ; Burns, SC; Ruan, JH; Singh, KK; Smith, AD; Penalva, LOF				Uren, Philip J.; Burns, Suzanne C.; Ruan, Jianhua; Singh, Kusum K.; Smith, Andrew D.; Penalva, Luiz O. F.			Genomic Analyses of the RNA-binding Protein Hu Antigen R (HuR) Identify a Complex Network of Target Genes and Novel Characteristics of Its Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; EXPRESSION; STABILITY; MICROARRAYS; PROMOTERS; MICRORNAS; SOFTWARE; CELLS; ELAV	The ubiquitously expressed RNA-binding protein Hu antigen R (HuR) or ELAVL1 is implicated in a variety of biological processes as well as being linked with a number of diseases, including cancer. Despite a great deal of prior investigation into HuR, there is still much to learn about its function. We take an important step in this direction by conducting cross-linking and immunoprecipitation and RNA sequencing experiments followed by an extensive computational analysis to determine the characteristics of the HuR binding site and impact on the transcriptome. We reveal that HuR targets predominantly uracil-rich single-stranded stretches of varying size, with a strong conservation of structure and sequence composition. Despite the fact that HuR sites are observed in intronic regions, our data do not support a role for HuR in regulating splicing. HuR sites in 3'-UTRs overlap extensively with predicted microRNA target sites, suggesting interplay between the functions of HuR and microRNAs. Network analysis showed that identified targets containing HuR binding sites in the 3' UTR are highly interconnected.	[Uren, Philip J.; Smith, Andrew D.] Univ So Calif, Los Angeles, CA 90089 USA; [Burns, Suzanne C.; Singh, Kusum K.; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Ruan, Jianhua] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX 78701 USA	University of Southern California; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA)	Smith, AD (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	andrewds@usc.edu; penalva@uthscsa.edu	Ruan, Jianhua/I-2529-2012; Smith, Andrew D./G-4104-2013; Uren, Philip J./H-5275-2019	Smith, Andrew D./0000-0002-3337-1970; Penalva, Luiz/0000-0003-4491-6769; Ruan, Jianhua/0000-0002-5622-3137	National Institutes of Health [5R21HG004664-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21HG004664-02 (to L. O. F. P.).	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghosh M, 2009, J CLIN INVEST, V119, P3530, DOI 10.1172/JCI38263; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nohata N, 2011, ONCOTARGET, V2, P29; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Srikantan S., 2011, FRONT BIOME IN PRESS; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yi J, 2010, NUCLEIC ACIDS RES, V38, P1547, DOI 10.1093/nar/gkp1114; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160	40	56	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37063	37066		10.1074/jbc.C111.266882	http://dx.doi.org/10.1074/jbc.C111.266882			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890634	hybrid, Green Published			2022-12-25	WOS:000296542400006
J	Uittenbogaard, JP; Zomer, B; Hoogerhout, P; Metz, B				Uittenbogaard, Joost P.; Zomer, Bert; Hoogerhout, Peter; Metz, Bernard			Reactions of beta-Propiolactone with Nucleobase Analogues, Nucleosides, and Peptides IMPLICATIONS FOR THE INACTIVATION OF VIRUSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMALDEHYDE-INDUCED MODIFICATIONS; SELECTIVE INACTIVATION; GAMMA-BUTYROLACTONE; MOLECULAR-MECHANISM; ONCOGENE ACTIVATION; VIRAL GENOME; HEPATITIS-A; VACCINES; DNA; DERIVATIVES	beta-Propiolactone is often applied for inactivation of viruses and preparation of viral vaccines. However, the exact nature of the reactions of beta-propiolactone with viral components is largely unknown. The purpose of the current study was to elucidate the chemical modifications occurring on nucleotides and amino acid residues caused by beta-propiolactone. Therefore, a set of nucleobase analogues was treated with beta-propiolactone, and reaction products were identified and quantified. NMR revealed at least one modification in either deoxyguanosine, deoxyadenosine, or cytidine after treatment with beta-propiolactone. However, no reaction products were found from thymidine and uracil. The most reactive sides of the nucleobase analogues and nucleosides were identified by NMR. Furthermore, a series of synthetic peptides was used to determine the conversion of reactive amino acid residues by liquid chromatography-mass spectrometry. beta-Propiolactone was shown to react with nine different amino acid residues. The most reactive residues are cysteine, methionine, and histidine and, to a lesser degree, aspartic acid, glutamic acid, tyrosine, lysine, serine, and threonine. Remarkably, cystine residues (disulfide groups) do not react with beta-propiolactone. In addition, no reaction was observed for beta-propiolactone with asparagine, glutamine, and tryptophan residues. beta-Propiolactone modifies proteins to a larger extent than expected from current literature. In conclusion, the study determined the reactivity of beta-propiolactone with nucleobase analogues, nucleosides, and amino acid residues and elucidated the chemical structures of the reaction products. The study provides detailed knowledge on the chemistry of beta-propiolactone inactivation of viruses.	[Uittenbogaard, Joost P.; Zomer, Bert; Hoogerhout, Peter; Metz, Bernard] Natl Inst Publ Hlth & Environm, Unit Vaccinol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Metz, B (corresponding author), Natl Inst Publ Hlth & Environm, Unit Vaccinol, POB 1, NL-3720 BA Bilthoven, Netherlands.	bernard.metz@rivm.nl			World Health Organization; Bill and Melinda Gates Foundation	World Health Organization(World Health Organization); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the World Health Organization using a grant from the Bill and Melinda Gates Foundation.	Ada G., 1997, NEW GENERATION VACCI, V2, P13; ANDRE FE, 1995, J INFECT DIS, V171, pS33, DOI 10.1093/infdis/171.Supplement_1.S33; ATASSI MZ, 1969, IMMUNOCHEMISTRY, V6, P801, DOI 10.1016/0019-2791(69)90286-9; BARTLETT PD, 1951, J AM CHEM SOC, V73, P4273, DOI 10.1021/ja01153a072; BARTLETT PD, 1950, J AM CHEM SOC, V72, P4867, DOI 10.1021/ja01167a006; BAUGH CM, 1966, BIOCHIM BIOPHYS ACTA, V114, P213, DOI 10.1016/0005-2787(66)90029-3; BLACKBURN GM, 1977, J CHEM SOC PERK T 2, P1492, DOI 10.1039/p29770001492; BROWN A, 1974, J VIROL, V14, P840, DOI 10.1128/JVI.14.4.840-845.1974; BRUSICK DJ, 1977, MUTAT RES, V39, P241, DOI 10.1016/0165-1110(77)90007-0; BUDOWSKY EI, 1991, VACCINE, V9, P319, DOI 10.1016/0264-410X(91)90057-D; BUDOWSKY EI, 1991, VACCINE, V9, P398, DOI 10.1016/0264-410X(91)90125-P; CAMPBELL TM, 1982, VET MICROBIOL, V7, P535, DOI 10.1016/0378-1135(82)90047-5; CARLSON RM, 1990, ENVIRON HEALTH PERSP, V87, P227, DOI 10.2307/3431029; CHEN R, 1981, CARCINOGENESIS, V2, P73, DOI 10.1093/carcin/2.2.73; COLBURN NH, 1969, VOX SANG, V17, P64; COLBURN NH, 1965, BIOCHEM PHARMACOL, V14, P1113, DOI 10.1016/0006-2952(65)90040-7; DAVIS RE, 1969, J AM CHEM SOC, V91, P91, DOI 10.1021/ja01029a020; Delrue I, 2009, VET RES, V40, DOI 10.1051/vetres/2009047; DETERMANN H, 1971, Z KLIN CHEM KLIN BIO, V9, P398; DIJKSTRA J, 1975, CHEM-BIOL INTERACT, V10, P115, DOI 10.1016/0009-2797(75)90105-2; FROSNER GG, 1983, EUR J CLIN MICROBIOL, V2, P355, DOI 10.1007/BF02019469; Fu Z. F., 1997, NEW GENERATION VACCI, P607; GARTE SJ, 1989, ENVIRON HEALTH PERSP, V81, P29, DOI 10.2307/3430800; GRESHAM TL, 1948, J AM CHEM SOC, V70, P999, DOI 10.1021/ja01183a031; GRESHAM TL, 1951, J AM CHEM SOC, V73, P3168, DOI 10.1021/ja01151a050; GRESHAM TL, 1948, J AM CHEM SOC, V70, P1004, DOI 10.1021/ja01183a034; GRESHAM TL, 1948, J AM CHEM SOC, V70, P1003, DOI 10.1021/ja01183a033; GRESHAM TL, 1949, J AM CHEM SOC, V71, P661, DOI 10.1021/ja01170a078; HEMMINKI K, 1981, CHEM-BIOL INTERACT, V34, P323, DOI 10.1016/0009-2797(81)90104-6; HO TL, 1975, CHEM REV, V75, P1, DOI 10.1021/cr60293a001; HOCHWALT AE, 1988, MOL CARCINOGEN, V1, P4, DOI 10.1002/mc.2940010104; HOCHWALT AE, 1988, CANCER RES, V48, P556; HOFFMAN RK, 1966, APPL MICROBIOL, V14, P989, DOI 10.1128/AEM.14.6.989-992.1966; Horowitz B, 1991, Biotechnology, V19, P417; IARC, 1999, IARC MON EV CARC RIS, V71, P1103; JONES JB, 1971, CAN J CHEMISTRY, V49, P3012, DOI 10.1139/v71-502; Jones RL, 2001, VACCINE, V19, P4635, DOI 10.1016/S0264-410X(01)00238-9; Kalbfuss B, 2007, BIOTECHNOL BIOENG, V97, P73, DOI 10.1002/bit.21139; Katritzky A.R., 2010, HDB HETEROCYCLIC CHE; LOGRIPPO GA, 1960, ANN NY ACAD SCI, V83, P578, DOI 10.1111/j.1749-6632.1960.tb40931.x; LONG FA, 1950, J AM CHEM SOC, V72, P3267, DOI 10.1021/ja01163a133; LoPachin RM, 2005, TOXICOL SCI, V86, P214, DOI 10.1093/toxsci/kfi197; LYLE TA, 1980, CHEM-BIOL INTERACT, V29, P197, DOI 10.1016/0009-2797(80)90033-2; Manso JA, 2005, CHEM RES TOXICOL, V18, P1161, DOI 10.1021/tx050031d; MATE U, 1977, CHEM-BIOL INTERACT, V18, P327, DOI 10.1016/0009-2797(77)90018-7; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Metz B, 2003, VACCINE, V22, P156, DOI 10.1016/j.vaccine.2003.08.003; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; PERRIN P, 1995, BIOLOGICALS, V23, P207, DOI 10.1006/biol.1995.0034; POLLEY JR, 1957, CAN J MICROBIOL, V3, P863, DOI 10.1139/m57-095; POLLEY JR, 1957, CAN J MICROBIOL, V3, P871, DOI 10.1139/m57-096; RACE E, 1995, VACCINE, V13, P1567, DOI 10.1016/0264-410X(95)00086-G; RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126; Rappuoli R., 1997, NEW GENERATION VACCI, P417; ROBERTS JJ, 1963, BIOCHEM PHARMACOL, V12, P1441, DOI 10.1016/0006-2952(63)90216-8; Roos G, 2006, CHEMBIOCHEM, V7, P981, DOI 10.1002/cbic.200500507; SACK GH, 1978, J ORG CHEM, V43, P3932, DOI 10.1021/jo00414a028; SALK JE, 1954, AM J PUBLIC HEALTH, V44, P563; Scheidler A, 1998, BIOLOGICALS, V26, P135, DOI 10.1006/biol.1998.0125; SEARLE CE, 1961, BRIT J CANCER, V15, P804, DOI 10.1038/bjc.1961.91; SEARLE CE, 1961, BIOCHIM BIOPHYS ACTA, V52, P579, DOI 10.1016/0006-3002(61)90419-X; SEGAL A, 1976, CHEM-BIOL INTERACT, V15, P319, DOI 10.1016/0009-2797(76)90137-X; SWAIN CG, 1953, J AM CHEM SOC, V75, P141, DOI 10.1021/ja01097a041; TAUBMAN MA, 1968, BIOCHEM J, V106, P829, DOI 10.1042/bj1060829; TIDKE R, 1987, VACCINE, V5, P229, DOI 10.1016/0264-410X(87)90106-X; WATTENBERG LW, 1987, CANCER RES, V47, P4351; WOODWORTH BA, 1986, CANCER LETT, V31, P293, DOI 10.1016/0304-3835(86)90150-3; Zhang YL, 2000, J MOL STRUC-THEOCHEM, V496, P139, DOI 10.1016/S0166-1280(99)00186-4	69	36	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36198	36214		10.1074/jbc.M111.279232	http://dx.doi.org/10.1074/jbc.M111.279232			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868382	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000296538300005
J	Zhang, WJ; Chen, HY; Wang, Y; Yong, WD; Zhu, WQ; Liu, YL; Wagner, GR; Payne, RM; Field, LJ; Xin, HB; Cai, CL; Shou, WN				Zhang, Wenjun; Chen, Hanying; Wang, Yong; Yong, Weidong; Zhu, Wuqiang; Liu, Yunlong; Wagner, Gregory R.; Payne, R. Mark; Field, Loren J.; Xin, Hongbo; Cai, Chen-Leng; Shou, Weinian			Tbx20 Transcription Factor Is a Downstream Mediator for Bone Morphogenetic Protein-10 in Regulating Cardiac Ventricular Wall Development and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; HEART DEVELOPMENT; CHROMATIN IMMUNOPRECIPITATION; P19 CELLS; EXPRESSION; DIFFERENTIATION; INDUCTION; PATHWAY; CARDIOGENESIS; MYOCARDIUM	Bone morphogenetic protein 10 (BMP10) belongs to the TGF beta-superfamily. Previously, we had demonstrated that BMP10 is a key regulator for ventricular chamber formation, growth, and maturation. Ablation of BMP10 leads to hypoplastic ventricular wall formation, and elevated levels of BMP10 are associated with abnormal ventricular trabeculation/compaction and wall maturation. However, the molecular mechanism(s) by which BMP10 regulates ventricle wall growth and maturation is still largely unknown. In this study, we sought to identify the specific transcriptional network that is potentially mediated by BMP10. We analyzed and compared the gene expression profiles between alpha-myosin heavy chain (alpha MHC)-BMP10 transgenic hearts and nontransgenic littermate controls using Affymetrix mouse exon arrays. T-box 20 (Tbx20), a cardiac transcription factor, was significantly up-regulated in alpha MHC-BMP10 transgenic hearts, which was validated by quantitative RT-PCR and in situ hybridization. Ablation of BMP10 reduced Tbx20 expression specifically in the BMP10-expressing region of the developing ventricle. In vitro promoter analysis demonstrated that BMP10 was able to induce Tbx20 promoter activity through a conserved Smad binding site in the Tbx20 promoter proximal region. Furthermore, overexpression of Tbx20 in myocardium led to dilated cardiomyopathy that exhibited ventricular hypertrabeculation and an abnormal muscular septum, which phenocopied genetically modified mice with elevated BMP10 levels. Taken together, our findings demonstrate that the BMP10-Tbx20 signaling cascade is important for ventricular wall development and maturation.	[Zhang, Wenjun; Chen, Hanying; Wang, Yong; Yong, Weidong; Zhu, Wuqiang; Wagner, Gregory R.; Payne, R. Mark; Field, Loren J.; Shou, Weinian] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, Indianapolis, IN 46202 USA; [Zhang, Wenjun; Chen, Hanying; Wang, Yong; Yong, Weidong; Zhu, Wuqiang; Wagner, Gregory R.; Payne, R. Mark; Field, Loren J.; Shou, Weinian] Indiana Univ, Sch Med, Dept Bioinformat, Indianapolis, IN 46202 USA; [Xin, Hongbo] Nanchang Univ, Sch Med, Ctr Translat Res, Nanchang 330031, Jiangxi, Peoples R China; [Cai, Chen-Leng] Mt Sinai Med Ctr, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Cai, Chen-Leng] Mt Sinai Med Ctr, Child Hlth & Dev Inst, Black Family Stem Cell Inst, Ctr Mol Cardiol, New York, NY 10029 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Nanchang University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Shou, WN (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, 1044 W Walnut St,R4-302D, Indianapolis, IN 46202 USA.	wshou@iupui.edu		Wang, Yong/0000-0001-6602-0491	National Institutes of Health [HL81092, HL70259, HL85098]; Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, P01HL085098, R01HL070259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Riley Children's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81092 (to W. S.), HL70259 (to W. S.), and HL85098 (to L. J. F., R. M. P, and W. S.). This work was also supported by the Riley Children's Foundation (to W. S., R. M. P., and L. J. F.) and a postdoctoral fellowship supported by Riley Children's Foundation (to W. Z.).	Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Carson CT, 2000, MECH DEVELOP, V96, P137, DOI 10.1016/S0925-4773(00)00376-2; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen HY, 2009, PEDIATR CARDIOL, V30, P626, DOI 10.1007/s00246-009-9406-5; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0; Franco D, 2001, EUR J MORPHOL, V39, P3, DOI 10.1076/ejom.39.1.3.7982; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Harada K, 2008, J BIOL CHEM, V283, P26705, DOI 10.1074/jbc.M801485200; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Simon HG, 1999, CELL TISSUE RES, V296, P57, DOI 10.1007/s004410051266; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Teichmann U, 2004, DEV GENES EVOL, V214, P96, DOI 10.1007/s00427-003-0380-2; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Yamagishi T, 2004, DEV DYNAM, V230, P576, DOI 10.1002/dvdy.20076; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	40	36	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36820	36829		10.1074/jbc.M111.279679	http://dx.doi.org/10.1074/jbc.M111.279679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890625	hybrid, Green Published			2022-12-25	WOS:000296538300062
J	Naumann, TA; Wicklow, DT; Price, NPJ				Naumann, Todd A.; Wicklow, Donald T.; Price, Neil P. J.			Identification of a Chitinase-modifying Protein from Fusarium verticillioides TRUNCATION OF A HOST RESISTANCE PROTEIN BY A FUNGALYSIN METALLOPROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-IV CHITINASE; INTRAMOLECULAR CHAPERONES; ASPERGILLUS-FUMIGATUS; ARABIDOPSIS-THALIANA; CLADOSPORIUM-FULVUM; MOLECULAR-CLONING; MAIZE SEED; GENE; BINDING; EXPRESSION	Chitinase-modifying proteins (cmps) are proteases secreted by fungal pathogens that truncate the plant class IV chitinases ChitA and ChitB during maize ear rot. cmp activity has been characterized for Bipolaris zeicola and Stenocarpella maydis, but the identities of the proteases are not known. Here, we report that cmps are secreted by multiple species from the genus Fusarium, that cmp from Fusarium verticillioides (Fv-cmp) is a fungalysin metalloprotease, and that it cleaves within a sequence that is conserved in class IV chitinases. Protein extracts from Fusarium cultures were found to truncate ChitA and ChitB in vitro. Based on this activity, Fv-cmp was purified from F. verticillioides. N-terminal sequencing of truncated ChitA and MALDI-TOF-MS analysis of reaction products showed that Fv-cmp is an endoprotease that cleaves a peptide bond on the C-terminal side of the lectin domain. The N-terminal sequence of purified Fv-cmp was determined and compared with a set of predicted proteins, resulting in its identification as a zinc metalloprotease of the fungalysin family. Recombinant Fv-cmp also truncated ChitA, confirming its identity, but had reduced activity, suggesting that the recombinant protease did not mature efficiently from its propeptide-containing precursor. This is the first report of a fungalysin that targets a nonstructural host protein and the first to implicate this class of virulence-related proteases in plant disease.	[Naumann, Todd A.] NCAUR, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL 61604 USA; [Price, Neil P. J.] NCAUR, Renewable Prod Technol Res Unit, Peoria, IL 61604 USA		Naumann, TA (corresponding author), NCAUR, Bacterial Foodborne Pathogens & Mycol Res Unit, 1815 N Univ St, Peoria, IL 61604 USA.	todd.naumann@ars.usda.gov						Aboitiz N, 2004, CHEMBIOCHEM, V5, P1245, DOI 10.1002/cbic.200400025; Agrios G. N., 2005, PLANT PATHOL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brouta F, 2002, INFECT IMMUN, V70, P5676, DOI 10.1128/IAI.70.10.5676-5683.2002; Brown DW, 2005, FUNGAL GENET BIOL, V42, P848, DOI 10.1016/j.fgb.2005.06.001; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; DEJONG AJ, 1992, PLANT CELL, V4, P425, DOI 10.2307/3869444; Desai K, 2002, BBA-MOL CELL BIOL L, V1585, P188, DOI 10.1016/S1388-1981(02)00340-2; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Gerhardt LBD, 1997, FEBS LETT, V419, P69, DOI 10.1016/S0014-5793(97)01332-X; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HUYNH QK, 1992, J BIOL CHEM, V267, P6635; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Lange J, 1996, PLANT PHYSIOL, V111, P1135, DOI 10.1104/pp.111.4.1135; Lilly WW, 2008, MYCOL RES, V112, P389, DOI 10.1016/j.mycres.2007.11.013; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; Markaryan A, 1996, J BACTERIOL, V178, P2211, DOI 10.1128/jb.178.8.2211-2215.1996; Naumann TA, 2011, MOL PLANT PATHOL, V12, P365, DOI 10.1111/j.1364-3703.2010.00677.x; Naumann TA, 2010, PHYTOPATHOLOGY, V100, P645, DOI 10.1094/PHYTO-100-7-0645; Naumann TA, 2009, PHYSIOL MOL PLANT P, V74, P134, DOI 10.1016/j.pmpp.2009.10.004; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Shinya T, 2007, BIOCHEM BIOPH RES CO, V353, P311, DOI 10.1016/j.bbrc.2006.12.009; SIRAKOVA TD, 1994, INFECT IMMUN, V62, P4208, DOI 10.1128/IAI.62.10.4208-4218.1994; Soanes DM, 2007, PLANT CELL, V19, P3318, DOI 10.1105/tpc.107.056663; Stepien L, 2010, WORLD MYCOTOXIN J, V3, P107, DOI 10.3920/WMJ2009.1193; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Wiweger M, 2003, J EXP BOT, V54, P2691, DOI 10.1093/jxb/erg299; Xu J, 2006, CAN J MICROBIOL, V52, P550, DOI 10.1139/W06-004	43	54	56	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35358	35366		10.1074/jbc.M111.279646	http://dx.doi.org/10.1074/jbc.M111.279646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878653	hybrid, Green Published			2022-12-25	WOS:000295927100007
J	Phung, B; Sun, JM; Schepsky, A; Steingrimsson, E; Ronnstrand, L				Bengt Phung; Sun, Jianmin; Schepsky, Alexander; Steingrimsson, Eirikur; Ronnstrand, Lars			C-KIT Signaling Depends on Microphthalmia-Associated Transcription Factor for Effects on Cell Proliferation	PLOS ONE			English	Article							FACTOR RECEPTOR/C-KIT; MELANOMA PROLIFERATION; TYROSINE KINASE; MITF; ACTIVATION; BINDING; LIGAND; MOUSE; MELANOGENESIS; RESIDUE-719	The development of melanocytes is regulated by the tyrosine kinase receptor c-KIT and the basic-helix-loop-helix-leucine zipper transcription factor Mitf. These essential melanocyte survival regulators are also well known oncogenic factors in malignant melanoma. Despite their importance, not much is known about the regulatory mechanisms and signaling pathways involved. In this study, we therefore sought to identify the signaling pathways and mechanisms involved in c-KIT mediated regulation of Mitf. We report that c-KIT stimulation leads to the activation of Mitf specifically through the c-KIT phosphorylation sites Y721 (PI3 kinase binding site), Y568 and Y570 (Src binding site). Our study not only confirms the involvement of Ras-Erk signaling pathway in the activation of Mitf, but also establishes that Src kinase binding to Y568 and Y570 of c-KIT is required. Using specific inhibitors we observe and verify that c-KIT induced activation of Mitf is dependent on PI3-, Akt-, Src-, p38- or Mek kinases. Moreover, the proliferative effect of c-KIT is dependent on Mitf in HEK293T cells. In contrast, c-KIT Y568F and Y721F mutants are less effective in driving cell proliferation, compared to wild type c-KIT. Our results reveal novel mechanisms by which c-KIT signaling regulates Mitf, with implications for understanding both melanocyte development and melanoma.	[Bengt Phung; Sun, Jianmin; Ronnstrand, Lars] Lund Univ, Wallenberg Lab, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden; [Schepsky, Alexander; Steingrimsson, Eirikur] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Reykjavik, Iceland	Lund University; Skane University Hospital; University of Iceland	Phung, B (corresponding author), Lund Univ, Wallenberg Lab, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden.	bengt.phung@med.lu.se	Sun, Jianmin/AAX-5094-2021	Sun, Jianmin/0000-0003-2327-4285; Phung, Bengt/0000-0002-9923-0847; Ronnstrand, Lars/0000-0003-1275-5809; Steingrimsson, Eirikur/0000-0001-5826-7486	Swedish Cancer Society; Icelandic Research Fund; Swedish Research Council; Gunnar Nilsson Cancer Society; Alfred Osterlund Foundation; Skane University Hospital; Skane University Hospital Cancer Foundation; Royal Physiographical Society (Lund); Swedish Foundation for International Cooperation in Research and Higher Education (STINT)	Swedish Cancer Society(Swedish Cancer Society); Icelandic Research Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Society; Alfred Osterlund Foundation; Skane University Hospital; Skane University Hospital Cancer Foundation; Royal Physiographical Society (Lund); Swedish Foundation for International Cooperation in Research and Higher Education (STINT)	This work was supported through grants from the Swedish Cancer Society, the Icelandic Research Fund, the Swedish Research Council, Gunnar Nilsson Cancer Society, Alfred Osterlund Foundation, Skane University Hospital Funds, Skane University Hospital Cancer Foundation, the Royal Physiographical Society (Lund), the Swedish Foundation for International Cooperation in Research and Higher Education (STINT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; Bauer GL, 2009, GENETICS, V183, P581, DOI 10.1534/genetics.109.103945; Bismuth K, 2008, GENETICS, V178, P259, DOI 10.1534/genetics.107.081893; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Fritsche-Polanz R, 2001, BRIT J HAEMATOL, V113, P357, DOI 10.1046/j.1365-2141.2001.02783.x; Hachiya A, 2009, J PATHOL, V218, P30, DOI 10.1002/path.2503; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Hou L, 2008, CELL RES, V18, P1163, DOI 10.1038/cr.2008.303; Kasamatsu S, 2008, J INVEST DERMATOL, V128, P1763, DOI 10.1038/jid.2008.9; Khaled M, 2003, J INVEST DERMATOL, V121, P831, DOI 10.1046/j.1523-1747.2003.12420.x; Kim DS, J PHARM PHARM, V62, P181; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Kitamura Y, 2002, INT ARCH ALLERGY IMM, V127, P106, DOI 10.1159/000048178; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Lee JH, 2010, INT J MOL MED, V26, P101, DOI 10.3892/ijmm_00000440; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; LEV S, 1992, P NATL ACAD SCI USA, V89, P678, DOI 10.1073/pnas.89.2.678; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Lu SY, 2010, MOL BIOL CELL, V21, P1763, DOI 10.1091/mbc.E09-07-0584; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mizutani Y, 2010, ARCH DERMATOL RES, V302, P283, DOI 10.1007/s00403-009-1007-x; Molina DM, 2005, J BIOL CHEM, V280, P42051, DOI 10.1074/jbc.M510590200; Nechushtan H, 2002, MOL IMMUNOL, V38, P1177, DOI 10.1016/S0161-5890(02)00059-7; Oka M, 2004, J INVEST DERMATOL, V123, P930, DOI 10.1111/j.0022-202X.2004.23454.x; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Price DJ, 1999, BIOCHEM BIOPH RES CO, V259, P611, DOI 10.1006/bbrc.1999.0840; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Saha B, 2006, PIGM CELL RES, V19, P595, DOI 10.1111/j.1600-0749.2006.00348.x; SERVE H, 1994, J BIOL CHEM, V269, P6026; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Tachibana M, 1999, J INVEST DERM SYMP P, V4, P126, DOI 10.1038/sj.jidsp.5640195; Taylor ML, 2001, BLOOD, V98; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Vincent S, 1998, DEVELOPMENT, V125, P4585; Wang ZQ, 2009, AM J HUM GENET, V84, P672, DOI 10.1016/j.ajhg.2009.03.019; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Wellbrock C, 2002, J BIOL CHEM, V277, P6443, DOI 10.1074/jbc.M110684200; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; Wu M, 2000, GENE DEV, V14, P301; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803	59	34	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24064	10.1371/journal.pone.0024064	http://dx.doi.org/10.1371/journal.pone.0024064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887372	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000091
J	Khajuria, C; Buschman, LL; Chen, MS; Siegfried, BD; Zhu, KY				Khajuria, Chitvan; Buschman, Lawrent L.; Chen, Ming-Shun; Siegfried, Blair D.; Zhu, Kun Yan			Identification of a Novel Aminopeptidase P-Like Gene (OnAPP) Possibly Involved in Bt Toxicity and Resistance in a Major Corn Pest (Ostrinia nubilalis)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXIN; BORER LEPIDOPTERA; DELTA-ENDOTOXIN; HELICOVERPA-ARMIGERA; INSECT RESISTANCE; MOLECULAR-CLONING; CANDIDATE GENES; FAT-BODY; MIDGUT; BINDING	Studies to understand the Bacillus thuringiensis (Bt) resistance mechanism in European corn borer (ECB, Ostrinia nubilalis) suggest that resistance may be due to changes in the midgut-specific Bt toxin receptor. In this study, we identified 10 aminopeptidase-like genes, which have previously been identified as putative Bt toxin receptors in other insects and examined their expression in relation to Cry1Ab toxicity and resistance. Expression analysis for the 10 aminopeptidase-like genes revealed that most of these genes were expressed predominantly in the larval midgut, but there was no difference in the expression of these genes in Cry1Ab resistant and susceptible strains. This suggested that altered expression of these genes was unlikely to be responsible for resistance in these ECB strains. However, we found that there were changes in two amino acid residues of the aminopeptidase-P like gene (OnAPP) involving Glu(305) to Lys(305) and Arg(307) to Leu(307) in the two Cry1Ab-resistant strains as compared with three Cry1Ab-susceptible strains. The mature OnAPP contains 682 amino acid residues and has a putative signal peptide at the N-terminus, a predicted glycosylphosphatidyl-inositol (GPI)-anchor signal at the C-terminal, three predicted N-glycosylation sites at residues N178, N278 and N417, and an O-glycosylation site at residue T653. We used a feeding based-RNA interference assay to examine the role of the OnAPP gene in Cry1Ab toxicity and resistance. Bioassays of Cry1Ab in larvae fed diet containing OnAPP dsRNA resulted in a 38% reduction in the transcript level of OnAPP and a 25% reduction in the susceptibility to Cry1Ab as compared with larvae fed GFP dsRNA or water. These results strongly suggest that the OnAPP gene could be involved in binding the Cry1Ab toxin in the ECB larval midgut and that mutations in this gene may be associated with Bt resistance in these two ECB strains.	[Khajuria, Chitvan; Buschman, Lawrent L.; Chen, Ming-Shun; Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Chen, Ming-Shun] Kansas State Univ, USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS 66506 USA; [Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA	Kansas State University; Kansas State University; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Khajuria, C (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	kzhu@ksu.edu	Khajuria, Chitvan/E-7690-2012	Zhu, Kun Yan/0000-0001-9372-8030	Kansas Agricultural Experiment Station; Arthropod Genomics Center; Kansas State University	Kansas Agricultural Experiment Station; Arthropod Genomics Center; Kansas State University	This study was supported by the Kansas Agricultural Experiment Station and the Arthropod Genomics Center funded by K-State Targeted Excellence program at Kansas State University. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AP, 2006, J ECON ENTOMOL, V99, P494, DOI 10.1603/0022-0493-99.2.494; Angelucci C, 2008, INSECT BIOCHEM MOLEC, V38, P685, DOI 10.1016/j.ibmb.2008.03.010; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bolin PC, 1999, J ECON ENTOMOL, V92, P1021, DOI 10.1093/jee/92.5.1021; Bozic N, 2003, COMP BIOCHEM PHYS B, V134, P231, DOI 10.1016/S1096-4959(02)00257-9; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Budatha M, 2007, BIOTECHNOL LETT, V29, P1651, DOI 10.1007/s10529-007-9453-z; Budatha M, 2007, BIOCHEM J, V405, P287, DOI 10.1042/BJ20070054; Chaufaux J, 2001, J ECON ENTOMOL, V94, P1564, DOI 10.1603/0022-0493-94.6.1564; Coates BS, 2008, INSECT MOL BIOL, V17, P607, DOI 10.1111/j.1365-2583.2008.00833.x; Coates BS, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2101; Crava CM, 2010, INSECT BIOCHEM MOLEC, V40, P506, DOI 10.1016/j.ibmb.2010.04.010; Crespo ALB, 2009, PEST MANAG SCI, V65, P1071, DOI 10.1002/ps.1793; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Emmerling M, 2001, INSECT BIOCHEM MOLEC, V31, P899, DOI 10.1016/S0965-1748(01)00036-4; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; HECKEL DG, 1994, BIOCONTROL SCI TECHN, V4, P405, DOI 10.1080/09583159409355351; Hua G, 1998, COMP BIOCHEM PHYS B, V121, P213, DOI 10.1016/S0305-0491(98)10091-3; HUARONG L, 2005, INSECT BIOCHEM MOLEC, V35, P847; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; Khajuria C, 2011, J INSECT PHYSIOL, V57, P345, DOI 10.1016/j.jinsphys.2010.12.005; Khajuria C, 2010, INSECT BIOCHEM MOLEC, V40, P621, DOI 10.1016/j.ibmb.2010.06.003; Khajuria C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-286; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Kulkarni G, 2002, J BIOCHEM, V131, P445, DOI 10.1093/oxfordjournals.jbchem.a003120; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HR, 2005, J ECON ENTOMOL, V98, P1333, DOI 10.1603/0022-0493-98.4.1333; Li HR, 2004, INSECT BIOCHEM MOLEC, V34, P753, DOI 10.1016/j.ibmb.2004.03.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcon PCRG, 1999, J ECON ENTOMOL, V92, P279, DOI 10.1093/jee/92.2.279; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; RYAN JW, 1994, J PHARMACOL EXP THER, V269, P941; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Siegfried Blair D., 2007, American Entomologist, V53, P208; Siqueira HAA, 2004, PEST MANAG SCI, V60, P1189, DOI 10.1002/ps.935; Siqueira HAA, 2004, J ECON ENTOMOL, V97, P1049, DOI 10.1603/0022-0493(2004)097[1049:COCONL]2.0.CO;2; Siqueira HAA, 2006, APPL ENVIRON MICROB, V72, P5318, DOI 10.1128/AEM.00219-06; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Turner AJ, 1997, ADV EXP MED BIOL, V421, P7; Valaitis AP, 2001, ARCH INSECT BIOCHEM, V46, P186, DOI 10.1002/arch.1028; Wang P, 2005, INSECT BIOCHEM MOLEC, V35, P611, DOI 10.1016/j.ibmb.2005.02.002; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; YARON A, 1968, BIOCHEM BIOPH RES CO, V32, P658, DOI 10.1016/0006-291X(68)90289-1; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675	59	27	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23983	10.1371/journal.pone.0023983	http://dx.doi.org/10.1371/journal.pone.0023983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887358	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000083
J	Pakay, JL; Diesch, J; Gilan, O; Yip, YY; Sayan, E; Kolch, W; Mariadason, JM; Hannan, RD; Tulchinsky, E; Dhillon, AS				Pakay, J. L.; Diesch, J.; Gilan, O.; Yip, Y-Y; Sayan, E.; Kolch, W.; Mariadason, J. M.; Hannan, R. D.; Tulchinsky, E.; Dhillon, A. S.			A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells	ONCOGENE			English	Article						Fra-1; turnover; TBP-1; cancer; ERK; RAS	TAT-BINDING PROTEIN-1; UBIQUITIN-INDEPENDENT DEGRADATION; C-FOS; 26S PROTEASOME; IN-VITRO; RAS; TRANSCRIPTION; GROWTH; AP-1; TRANSFORMATION	Fos-related antigen-1 (Fra-1) is a member of the Activator Protein-1 (AP-1) transcription factor superfamily that is overexpressed in a variety of cancers, including colon, breast, lung, bladder and brain. High Fra-1 levels are associated with enhanced cell proliferation, survival, migration and invasion. Despite its frequent overexpression, the molecular mechanisms that regulate the accumulation of Fra-1 proteins in tumour cells are not well understood. Here, we show that turnover of Fra-1, which does not require ubiquitylation, is cooperatively regulated by two distinct mechanisms-association with the 19S proteasomal subunit, TBP-1, and by a C-terminal degron, which acts independently of TBP-1, but is regulated by RAS-ERK (extracellular signal-regulated kinase) signalling. TBP-1 depletion stabilized Fra-1 and further increased its levels in tumour cells expressing RAS-ERK pathway oncogenes. These effects correlated with increased AP-1 transcriptional activity. We suggest that during Fra-1 degradation, association with TBP-1 provides a mechanism for ubiquitin-independent proteasomal recognition, while the C terminus of the protein regulates its subsequent proteolytic processing. Oncogene (2012) 31, 1817-1824; doi: 10.1038/onc.2011.375; published online 29 August 2011	[Diesch, J.; Gilan, O.; Hannan, R. D.; Dhillon, A. S.] Univ Melbourne, Div Res, Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; [Pakay, J. L.; Diesch, J.; Gilan, O.; Yip, Y-Y; Hannan, R. D.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Sayan, E.; Tulchinsky, E.] Univ Leicester, Leicester LE1 9HN, Leics, England; [Kolch, W.] Univ Coll Dublin, Dublin 2, Ireland; [Mariadason, J. M.] Austin Hlth, Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Hannan, R. D.] Monash Univ, Clayton, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Leicester; University College Dublin; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Monash University	Dhillon, AS (corresponding author), Univ Melbourne, Div Res, Peter MacCallum Canc Ctr, St Andrews Pl, Melbourne, Vic 3002, Australia.	et32@leicester.ac.uk; Amardeep.Dhillon@petermac.org	Kolch, Walter/ABF-2102-2021; SAYAN, A. EMRE/H-7330-2012; Tulchinsky, Eugene/ABD-7070-2021; Mariadason, John/N-2003-2013; Admin, SBI/HGB-2738-2022; Diesch, Jeannine/J-8558-2017	SAYAN, A. EMRE/0000-0002-5291-1485; Diesch, Jeannine/0000-0002-4667-3468; Dhillon, Amardeep/0000-0002-6065-663X; Hannan, Ross/0000-0002-2166-4493; Kolch, Walter/0000-0001-5777-5016; Mariadason, John/0000-0001-9123-7684	National Health and Medical Research Council of Australia; Association for International Cancer Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research	We thank Drs Nishida, Satoh, Greer and Gillespie for generously providing reagents used in this study, and Dr Willie Bienvenut for assistance with the mass spectrometry experiments. This work was supported by grants from the National Health and Medical Research Council of Australia (to ASD and RDH) and the Association for International Cancer Research (to ET).	Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; Chen CS, 2007, FEBS LETT, V581, P1124, DOI 10.1016/j.febslet.2007.02.018; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cohn MA, 2001, NUCLEIC ACIDS RES, V29, P3335, DOI 10.1093/nar/29.16.3335; Corn PG, 2003, NAT GENET, V35, P229, DOI 10.1038/ng1254; Debinski W, 2005, MOL CANCER RES, V3, P237; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dong ZG, 1996, J BIOL CHEM, V271, P9942, DOI 10.1074/jbc.271.17.9942; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Ishizuka T, 2001, MOL ENDOCRINOL, V15, P1329, DOI 10.1210/me.15.8.1329; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kakumoto K, 2006, P NATL ACAD SCI USA, V103, P5490, DOI 10.1073/pnas.0601222103; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Luo YP, 2010, ONCOGENE, V29, P662, DOI 10.1038/onc.2009.308; Park BW, 1999, P NATL ACAD SCI USA, V96, P6434, DOI 10.1073/pnas.96.11.6434; Pollice A, 2007, ONCOGENE, V26, P5154, DOI 10.1038/sj.onc.1210313; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Ramos-Nino ME, 2003, CANCER RES, V63, P3539; SAKSELA K, 1993, MOL CELL BIOL, V13, P3698, DOI 10.1128/MCB.13.6.3698; Satoh T, 2009, ENDOCRINOLOGY, V150, P3283, DOI 10.1210/en.2008-1122; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Talotta F, 2010, ONCOGENE, V29, P4732, DOI 10.1038/onc.2010.211; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001; Young MR, 2002, MOL CELL BIOL, V22, P587, DOI 10.1128/MCB.22.2.587-598.2002; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	50	19	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	14					1817	1824		10.1038/onc.2011.375	http://dx.doi.org/10.1038/onc.2011.375			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21874050	Green Submitted			2022-12-25	WOS:000302785200007
J	Balghi, H; Robert, R; Rappaz, B; Zhang, XX; Wohlhuter-Haddad, A; Evagelidis, A; Luo, YS; Goepp, J; Ferraro, P; Romeo, P; Trebak, M; Wiseman, PW; Thomas, DY; Hanrahan, JW				Balghi, Haouaria; Robert, Renaud; Rappaz, Benjamin; Zhang, Xuexin; Wohlhuter-Haddad, Adeline; Evagelidis, Alexandra; Luo, Yishan; Goepp, Julie; Ferraro, Pasquale; Romeo, Philippe; Trebak, Mohamed; Wiseman, Paul W.; Thomas, David Y.; Hanrahan, John W.			Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways	FASEB JOURNAL			English	Article						calcium influx; calcium channels; cystic fibrosis transmembrane conductance regulator; CFTR; cytokine	TRANSMEMBRANE CONDUCTANCE REGULATOR; NF-KAPPA-B; EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; CHANNEL FUNCTION; T-CELL; I-CRAC; FLUORESCENCE PROPERTIES; INFLAMMATORY RESPONSES; CFTR TRAFFICKING	Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR). The most common mutation, Delta F508, causes retention of CFTR in the endoplasmic reticulum (ER). Some CF abnormalities can be explained by altered Ca2+ homeostasis, although it remains unknown how CFTR influences calcium signaling. This study examined the novel hypothesis that store-operated calcium entry (SOCE) through Orai1 is abnormal in CF. The significance of Orai1-mediated SOCE for increased interleukin-8 (IL-8) expression in CF was also investigated. CF and non-CF human airway epithelial cell line and primary cells (obtained at lung transplantation) were used in Ca2+ imaging, electrophysiology, and fluorescence imaging experiments to explore differences in Orai1 function in CF vs. non-CF cells. Protein expression and localization was assessed by Western blots, cell surface biotinylation, ELISA, and image correlation spectroscopy (ICS). We show here that store-operated Ca2+ entry (SOCE) is elevated in CF human airway epithelial cells (hAECs; similar to 1.8- and similar to 2.5-fold for total Ca-i(2+) increase and Ca2+ influx rate, respectively, and similar to 2-fold increase in the I-CRAC current) and is caused by increased exocytotic insertion (similar to 2-fold) of Orai1 channels into the plasma membrane, which is normalized by rescue of Delta F508-CFTR trafficking to the cell surface. Augmented SOCE in CF cells is a major factor leading to increased IL-8 secretion (similar to 2-fold). CFTR normally down-regulates the Orai1/stromal interaction molecule 1 (STIM1) complex, and loss of this inhibition due to the absence of CFTR at the plasma membrane helps to explain the potentiated inflammatory response in CF cells.-Balghi, H., Robert, R., Rappaz, B., Zhang, X., Wohlhuter-Haddad, A., Evagelidis, A., Luo, Y., Goepp, J., Ferraro, P., Romeo, P., Trebak, M., Wiseman, P. W., Thomas, D. Y., Hanrahan, J. W. Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways. FASEB J. 25, 4274-4291 (2011). www.fasebj.org	[Balghi, Haouaria; Robert, Renaud; Wohlhuter-Haddad, Adeline; Evagelidis, Alexandra; Luo, Yishan; Goepp, Julie; Hanrahan, John W.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Rappaz, Benjamin; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Thomas, David Y.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Hanrahan, John W.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Zhang, Xuexin; Trebak, Mohamed] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Ferraro, Pasquale] Ctr Hosp Univ Montrel, Div Thorac Surg, Montreal, PQ, Canada; [Romeo, Philippe] Univ Montreal, Montreal Heart Inst, Dept Pathol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; Albany Medical College; Universite de Montreal	Balghi, H (corresponding author), 3655 Promenade Sir William Osler,McIntyre Med Bld, Montreal, PQ H3G 1Y6, Canada.	haouaria.balghi@mail.mcgill.ca	Rappaz, Benjamin/C-1881-2014; Zhang, Xuexin/I-7600-2013; Hanrahan, John/AGG-1926-2022; Trebak, Mohamed/E-7405-2014; 张学新, XUEXIN ZHANG/AAD-7645-2019; Thomas, David/M-7661-2017	Rappaz, Benjamin/0000-0002-8744-600X; Hanrahan, John/0000-0001-9080-2039; 张学新, XUEXIN ZHANG/0000-0001-8276-3885; Wohlhuter-Haddad, Adeline/0000-0002-2323-8092; Thomas, David/0000-0002-8854-762X	Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR); U.S. National Institutes of Health [1R01HL097111, 5K22ES014729]; CFC; Swiss National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES014729] Funding Source: NIH RePORTER	Cystic Fibrosis Canada (CFC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFC; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors are grateful to Richard S. Lewis (Stanford University School of Medicine, Stanford, CA, USA) for generously providing the STIM1-GFP and Orai1-mCherry plasmids. The authors thank the staff of the McGill University Life Sciences Complex Imaging Facility for excellent technical help and discussion and also the McGill University electron microscopy facility for the technical assistance. This work was supported by Cystic Fibrosis Canada (CFC) and Canadian Institutes of Health Research (CIHR). Part of this work was supported by U.S. National Institutes of Health grants 1R01HL097111 and 5K22ES014729 to M.T. H.B. is supported by a CFC fellowship and B.R. by a Swiss National Science Foundation fellowship. The authors have declared no conflicts of interest.	Antigny F, 2008, CELL CALCIUM, V43, P175, DOI 10.1016/j.ceca.2007.05.002; Antigny F, 2011, AM J RESP CELL MOL, V44, P83, DOI 10.1165/rcmb.2009-0347OC; Antigny F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-70; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; Di Sabatino A, 2009, J IMMUNOL, V183, P3454, DOI 10.4049/jimmunol.0802887; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galan C, 2009, ARCH BIOCHEM BIOPHYS, V490, P137, DOI 10.1016/j.abb.2009.08.007; Gallagher AM, 2001, AM J PHYSIOL-GASTR L, V281, pG681, DOI 10.1152/ajpgi.2001.281.3.G681; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hanrahan John W, 2004, Proc Am Thorac Soc, V1, P17, DOI 10.1513/pats.2306009; Hong JH, 2011, TRAFFIC, V12, P232, DOI 10.1111/j.1600-0854.2010.01138.x; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; KNOWLES MR, 1986, CLIN CHEST MED, V7, P285; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; LARSEN EH, 1990, J PHYSIOL-LONDON, V424, P109, DOI 10.1113/jphysiol.1990.sp018058; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; LLOYDSTILL JD, 1994, DIGEST DIS SCI, V39, P880, DOI 10.1007/BF02087437; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; McCarl CA, 2010, J IMMUNOL, V185, P5845, DOI 10.4049/jimmunol.1001796; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Michoud MC, 2009, AM J RESP CELL MOL, V40, P217, DOI 10.1165/rcmb.2006-0444OC; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peters KW, 2001, PFLUG ARCH EUR J PHY, V443, pS65, DOI 10.1007/s004240100647; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Randell SH, 2001, IN VITRO CELL DEV-AN, V37, P480; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Ribeiro Carla Maria Pedrosa, 2006, Drugs R D, V7, P17, DOI 10.2165/00126839-200607010-00002; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Roussel L., BIOCH BIOPHYS RES CO, V391, P505; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voynow JA, 2005, AM J RESP CRIT CARE, V172, P1013, DOI 10.1164/rccm.200410-1398OC; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; Woodard GE, 2008, AM J PHYSIOL-CELL PH, V294, pC1323, DOI 10.1152/ajpcell.00071.2008; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	67	47	48	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4274	4291		10.1096/fj.11-187682	http://dx.doi.org/10.1096/fj.11-187682			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21873556	Green Published			2022-12-25	WOS:000298138100020
J	Andrikopoulos, P; Baba, A; Matsuda, T; Djamgoz, MBA; Yaqoob, MM; Eccles, SA				Andrikopoulos, Petros; Baba, Akemichi; Matsuda, Toshio; Djamgoz, Mustafa B. A.; Yaqoob, Muhammad M.; Eccles, Suzanne A.			Ca2+ Influx through Reverse Mode Na+/Ca2+ Exchange Is Critical for Vascular Endothelial Growth Factor-mediated Extracellular Signal-regulated Kinase (ERK) 1/2 Activation and Angiogenic Functions of Human Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA+-CA2+ EXCHANGE; IN-VITRO; INTRACELLULAR NA+; PHOSPHOLIPASE-C; DNA-SYNTHESIS; ENTRY; INHIBITION; PATHWAY; STOICHIOMETRY	VEGF is a key angiogenic cytokine and a major target in antiangiogenic therapeutic strategies. In endothelial cells (ECs), VEGF binds VEGF receptors and activates ERK1/2 through the phospholipase gamma (PLC gamma)-PKC alpha-B-Raf pathway. Our previous work suggested that influx of extracellular Ca2+ is required for VEGF-induced ERK1/2 activation, and we hypothesized that this could occur through reverse mode (Ca2+ in and Na+ out) Na+-Ca2+ exchange (NCX). However, the role of NCX activity in VEGF signaling and angiogenic functions of ECs had not previously been described. Here, using human umbilical vein ECs (HUVECs), we report that extracellular Ca2+ is required for VEGF-induced ERK1/2 activation and that release of Ca2+ from intracellular stores alone, in the absence of extracellular Ca2+, is not sufficient to activate ERK1/2. Furthermore, inhibitors of reverse mode NCX suppressed the VEGF-induced activation of ERK1/2 in a time-and dose-dependent manner and attenuated VEGF-induced Ca2+ transients. Knockdown of NCX1 (the main NCX isoform in HUVECs) by siRNA confirmed the pharmacological data. A panel of NCX inhibitors also significantly reduced VEGF-induced B-Raf activity and inhibited PKC alpha translocation to the plasma membrane and total PKC activity in situ. Finally, NCX inhibitors reduced VEGF-induced HUVEC proliferation, migration, and tubular differentiation in surrogate angiogenesis functional assays in vitro. We propose that Ca2+ influx through reverse mode NCX is required for the activation and the targeting of PKC alpha to the plasma membrane, an essential step for VEGF-induced ERK1/2 phosphorylation and downstream EC functions in angiogenesis.	[Andrikopoulos, Petros; Eccles, Suzanne A.] Inst Canc Res, Canc Res UK Canc Therapeut Unit, McElwain Labs, Sutton SM2 5NG, Surrey, England; [Andrikopoulos, Petros; Djamgoz, Mustafa B. A.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Neurosci Solut Canc Res Grp, London SW7 2AZ, England; [Andrikopoulos, Petros; Yaqoob, Muhammad M.] Queen Marys Univ London, William Harvey Res Inst, Barts & London Sch Med, London EC1M 6BQ, England; [Baba, Akemichi; Matsuda, Toshio] Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan	Cancer Research UK; University of London; Institute of Cancer Research - UK; Imperial College London; University of London; Queen Mary University London; Osaka University	Andrikopoulos, P (corresponding author), Inst Canc Res, Canc Res UK Canc Therapeut Unit, McElwain Labs, Cotswold Rd, Sutton SM2 5NG, Surrey, England.	p.andrikopoulos@qmul.ac.uk; sue.eccles@icr.ac.uk	Andrikopoulos, Petros/N-7724-2019; Andrikopoulos, Petros/G-2519-2011	Andrikopoulos, Petros/0000-0002-1555-3498; 	British Heart Foundation [FS/06/22]; National Health Service; Cancer Research UK [C309/A8274]; Institute of Cancer Research; Cancer Research UK [11566] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Health Service; Cancer Research UK(Cancer Research UK); Institute of Cancer Research; Cancer Research UK(Cancer Research UK)	This work was supported by British Heart Foundation Studentship FS/06/22 (to P. A.) and by National Health Service funding to the National Institute for Health Research Biomedical Research Centre.; Supported by Cancer Research UK Grant C309/A8274 and the Institute of Cancer Research. To whom correspondence may be addressed. Tel.: 44-20-8722-4210; Fax: 44-20-8722-4134; E-mail: sue.eccles@icr.ac.uk.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Cook SJ, 1997, J BIOL CHEM, V272, P13309, DOI 10.1074/jbc.272.20.13309; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Dawson NS, 2006, FASEB J, V20, P991, DOI 10.1096/fj.05-3923fje; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; Eder P, 2007, CARDIOVASC RES, V73, P111, DOI 10.1016/j.cardiores.2006.10.016; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; FLEMING I, 1995, CIRC RES, V76, P522, DOI 10.1161/01.RES.76.4.522; Fujioka Y, 2000, J PHYSIOL-LONDON, V523, P339, DOI 10.1111/j.1469-7793.2000.t01-2-00339.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; JUHASZOVA M, 1994, AM J PHYSIOL, V266, pC234, DOI 10.1152/ajpcell.1994.266.1.C234; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KLEYMAN TR, 1990, METHOD ENZYMOL, V191, P739; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; LI L, 1995, CIRC RES, V76, P396, DOI 10.1161/01.RES.76.3.396; Liang GH, 2008, PFLUG ARCH EUR J PHY, V457, P67, DOI 10.1007/s00424-008-0490-9; Liu J, 2000, J BIOL CHEM, V275, P27838; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; MATSUOKA S, 1992, J GEN PHYSIOL, V100, P963, DOI 10.1085/jgp.100.6.963; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Platel JC, 2005, P NATL ACAD SCI USA, V102, P19174, DOI 10.1073/pnas.0504540102; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Poburko D, 2007, CIRC RES, V101, P1030, DOI 10.1161/CIRCRESAHA.107.155531; Putney J W Jr, 2001, Mol Interv, V1, P84; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Reuter H, 2002, CIRC RES, V91, P90, DOI 10.1161/01.RES.0000027529.37429.38; SAGE SO, 1991, J PHYSIOL-LONDON, V440, P569, DOI 10.1113/jphysiol.1991.sp018725; Sedova M, 1999, CELL CALCIUM, V25, P333, DOI 10.1054/ceca.1999.0036; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200	63	60	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37919	37931		10.1074/jbc.M111.251777	http://dx.doi.org/10.1074/jbc.M111.251777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21873429	Green Published, hybrid			2022-12-25	WOS:000296594200005
J	Agarwal, AK; Sukumaran, S; Cortes, VA; Tunison, K; Mizrachi, D; Sankella, S; Gerard, RD; Horton, JD; Garg, A				Agarwal, Anil K.; Sukumaran, Suja; Cortes, Victor A.; Tunison, Katie; Mizrachi, Dario; Sankella, Shireesha; Gerard, Robert D.; Horton, Jay D.; Garg, Abhimanyu			Human 1-Acylglycerol-3-phosphate O-Acyltransferase Isoforms 1 and 2 BIOCHEMICAL CHARACTERIZATION AND INABILITY TO RESCUE HEPATIC STEATOSIS IN Agpat2(-/-) GENE LIPODYSTROPHIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; CONGENITAL GENERALIZED LIPODYSTROPHY; INSULIN-RESISTANCE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; ENZYMATIC-ACTIVITY; DIABETES-MELLITUS; NUCLEAR SREBP-1C; ADIPOSE-TISSUE; CDNA CLONING	Loss-of-function mutations in 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) 2 in humans and mice result in loss of both the white and brown adipose tissues from birth. AGPAT2 generates precursors for the synthesis of glycerophospholipids and triacylglycerols. Loss of adipose tissue, or lipodystrophy, results in hyperinsulinemia, diabetes mellitus, and severe hepatic steatosis. Here, we analyzed biochemical properties of human AGPAT2 and its close homolog, AGPAT1, and we studied their role in liver by transducing their expression via recombinant adenoviruses in Agpat2(-/-) mice. The in vitro substrate specificities of AGPAT1 and AGPAT2 are quite similar for lysophosphatidic acid and acyl-CoA. Protein homology modeling of both the AGPATs with glycerol-3-phosphate acyltransferase 1 (GPAT1) revealed that they have similar tertiary protein structure, which is consistent with their similar substrate specificities. When co-expressed, both isoforms co-localize to the endoplasmic reticulum. Despite such similarities, restoring AGPAT activity in liver by overexpression of either AGPAT1 or AGPAT2 in Agpat2(-/-) mice failed to ameliorate the hepatic steatosis. From these studies, we suggest that the role of AGPAT1 or AGPAT2 in liver lipogenesis is minimal and that accumulation of liver fat is primarily a consequence of insulin resistance and loss of adipose tissue in Agpat2(-/-) mice.	[Agarwal, Anil K.] Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Div Gastroenterol, Dallas, TX 75390 USA; [Cortes, Victor A.; Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agarwal, AK (corresponding author), Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Ctr Human Nutr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Anil.Agarwal@UTSouthwestern.edu		Cortes, Victor/0000-0002-1658-0965	National Institutes of Health [R01-DK54387, DK081182, UL1DE019584]; Southwestern Medical Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182, R01DK054387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southwestern Medical Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK54387, DK081182, and UL1DE019584. This work was also supported by the Southwestern Medical Foundation.	Agarwal AK, 2006, ANNU REV MED, V57, P297, DOI 10.1146/annurev.med.57.022605.114424; Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2007, J ENDOCRINOL, V193, P445, DOI 10.1677/JOe-07-0027; Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; Agarwal AK, 2010, J LIPID RES, V51, P2143, DOI 10.1194/jlr.M004762; Aguado B, 1998, J BIOL CHEM, V273, P4096, DOI 10.1074/jbc.273.7.4096; Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Eberhardt C, 1999, ADV EXP MED BIOL, V469, P351; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Green M, 1979, Methods Enzymol, V58, P425; Haque W, 2005, BIOCHEM BIOPH RES CO, V327, P446, DOI 10.1016/j.bbrc.2004.12.024; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Leung DW, 2001, FRONT BIOSCI, V6, pD944, DOI 10.2741/Leung; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; McMaster CR, 2004, TOP CURR GENET, V6, P5; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prasad SS, 2011, J LIPID RES, V52, P451, DOI 10.1194/jlr.M007575; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sukumaran S, 2009, J MOL ENDOCRINOL, V42, P469, DOI 10.1677/JME-09-0010; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Turnbull AP, 2001, ACTA CRYSTALLOGR D, V57, P451, DOI 10.1107/S0907444901000257; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Ye GM, 2005, DNA SEQUENCE, V16, P386, DOI 10.1080/10425170500213712	55	56	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37676	37691		10.1074/jbc.M111.250449	http://dx.doi.org/10.1074/jbc.M111.250449			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21873652	hybrid, Green Published			2022-12-25	WOS:000296542400064
J	Khurana, A; Shao, ES; Kim, RY; Vilin, YY; Huang, XY; Yang, RY; Kurata, HT				Khurana, Anu; Shao, Evan S.; Kim, Robin Y.; Vilin, Yury Y.; Huang, Xinyang; Yang, Runying; Kurata, Harley T.			Forced Gating Motions by a Substituted Titratable Side Chain at the Bundle Crossing of a Potassium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; CRYSTAL-STRUCTURE; SULFONYLUREA RECEPTOR; SUBUNIT STOICHIOMETRY; FUNCTIONAL EXPRESSION; SELECTIVITY FILTER; MOLECULAR-BASIS; KIR6.2; PORE; BINDING	Voltage-gated sodium channels underlie the upstroke of action potentials and are fundamental to neuronal excitability. Small changes in the behavior of these channels are sufficient to change neuronal firing and trigger seizures. These channels are subject to highly conserved alternative splicing, affecting the short linker between the third transmembrane segment (S3) and the voltage sensor (S4) in their first domain. The biophysical consequences of this alternative splicing are incompletely understood. Here we focus on type 1 sodium channels (Nav1.1) that are implicated in human epilepsy. We show that the functional consequences of alternative splicing are highly sensitive to recording conditions, including the identity of the major intracellular anion and the recording temperature. In particular, the inactivation kinetics of channels containing the alternate exon 5N are more sensitive to intracellular fluoride ions and to changing temperature than channels containing exon 5A. Moreover, Nav1.1 channels containing exon 5N recover from inactivation more rapidly at physiological temperatures. Three amino acids differ between exons 5A and 5N. However, the changes in sensitivity and stability of inactivation were reproduced by a single conserved change from aspartate to asparagine in channels containing exon 5A, which was sufficient to make them behave like channels containing the complete exon 5N sequence. These data suggest that splicing at this site can modify the inactivation of sodium channels and reveal a possible interaction between splicing and anti-epileptic drugs that stabilize sodium channel inactivation.	[Khurana, Anu; Shao, Evan S.; Kim, Robin Y.; Vilin, Yury Y.; Huang, Xinyang; Yang, Runying; Kurata, Harley T.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Kurata, HT (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, 2176 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	harley.kurata@ubc.ca		Kurata, Harley/0000-0003-4357-4189	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by a Canadian Institutes of Health Research operating grant and New Investigator Awards from the Heart and Stroke Foundation of Canada and the Michael Smith Foundation for Health Research (to H. T. K.).	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Berneche S, 2002, BIOPHYS J, V82, P772, DOI 10.1016/S0006-3495(02)75439-8; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Claydon TW, 2003, J BIOL CHEM, V278, P50654, DOI 10.1074/jbc.M308183200; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Craig TJ, 2008, J GEN PHYSIOL, V132, P131, DOI 10.1085/jgp.200709874; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000315; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lindman S, 2007, BIOPHYS J, V92, P257, DOI 10.1529/biophysj.106.088682; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 2005, EMBO REP, V6, P470, DOI 10.1038/sj.embor.7400393; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Wang RP, 2006, J MEMBRANE BIOL, V213, P155, DOI 10.1007/s00232-006-0038-x; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Xu HX, 2001, J BIOL CHEM, V276, P38690, DOI 10.1074/jbc.M106595200; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	44	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36686	36693		10.1074/jbc.M111.249110	http://dx.doi.org/10.1074/jbc.M111.249110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878633	hybrid, Green Published			2022-12-25	WOS:000296538300051
J	Sipes, NS; Feng, YX; Guo, FK; Lee, HO; Chou, FS; Cheng, J; Mulloy, J; Zheng, Y				Sipes, Nisha S.; Feng, Yuxin; Guo, Fukun; Lee, Hyung-Ok; Chou, Fu-Sheng; Cheng, Jonathan; Mulloy, James; Zheng, Yi			Cdc42 Regulates Extracellular Matrix Remodeling in Three Dimensions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL COLLAGEN MATRICES; GEL CONTRACTION; RHO-GTPASES; IN-VIVO; FIBROBLASTS; CULTURE; KERATINOCYTES; ACTIVATION; EXPRESSION; INDUCTION	Extracellular matrix (ECM) actively participates in normal cell regulation and in the process of tumor progression. The Rho GTPase Cdc42 has been shown to regulate cell-ECM interaction in conventional two-dimensional culture conditions by using dominant mutants of Cdc42 in immortalized cell lines that may introduce nonspecific effects. Here, we employ three-dimensional culture systems for conditional gene targeted primary mouse embryonic fibroblasts that better simulate the reciprocal and adaptive interactions between cells and surrounding matrix to define the role of Cdc42 signaling pathways in ECM organization. Cdc42 deficiency leads to a defect in global cell-matrix interactions reflected by a decrease in collagen gel contraction. The defect is associated with an altered cell-matrix interaction that is evident by morphologic changes and reduced focal adhesion complex formation. The matrix defect is also associated with a reduction in synthesis and activation of matrix metalloproteinase 9 (MMP9) and altered fibronectin deposition patterning. A Cdc42 mutant rescue experiment found that downstream of Cdc42, p21-activated kinase (PAK), but not Par6 or WASP, may be involved in regulating collagen gel contraction and fibronectin organization. Thus, in addition to the previously implicated roles in intracellular regulation of actin organization, proliferation, and vesicle trafficking, Cdc42 is essential in ECM remodeling in three dimensions.	[Sipes, Nisha S.; Feng, Yuxin; Guo, Fukun; Chou, Fu-Sheng; Mulloy, James; Zheng, Yi] Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Sipes, Nisha S.; Chou, Fu-Sheng; Mulloy, James; Zheng, Yi] Univ Cincinnati, Dept Cell & Canc Biol, Cincinnati, OH 45229 USA; [Lee, Hyung-Ok; Cheng, Jonathan] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Fox Chase Cancer Center	Zheng, Y (corresponding author), Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, 333 Burnet Ave, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Chou, Fu-Sheng/0000-0002-5770-0580	National Institutes of Health [T32 HD046387, R01 CA150547, R01 HL085362]; Robert and EmmaLou Cardell Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046387] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA150547, T32CA117846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and EmmaLou Cardell Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 HD046387 (to N.S.S.) and by National Institutes of Health Grants R01 CA150547 and R01 HL085362 (to Y.Z.). This work was also supported by the Robert and EmmaLou Cardell Fellowship (to N.S.S.).	Beacham D. A., 2007, CURR PROTOC CELL BIO, V10, P9; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dahlmann-Noor AH, 2007, EXP CELL RES, V313, P4158, DOI 10.1016/j.yexcr.2007.07.040; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; Defawe OD, 2005, CARDIOVASC RES, V66, P402, DOI 10.1016/j.cardiores.2004.11.025; Deroanne CF, 2005, J CELL SCI, V118, P1173, DOI 10.1242/jcs.01707; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Harunaga JS, 2011, MATRIX BIOL; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ilina O, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015010; Ishii I, 2001, ATHEROSCLEROSIS, V158, P377, DOI 10.1016/S0021-9150(01)00461-0; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Lakshman N, 2007, CELL MOTIL CYTOSKEL, V64, P434, DOI 10.1002/cm.20194; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126; Phillips JA, 2003, BIOCHEM BIOPH RES CO, V312, P725, DOI 10.1016/j.bbrc.2003.10.179; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Rhee S, 2006, J CELL BIOL, V172, P423, DOI 10.1083/jcb.200505175; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Turchi L, 2003, J INVEST DERMATOL, V121, P1291, DOI 10.1111/j.1523-1747.2003.12627.x; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Wu XW, 2006, MATRIX BIOL, V25, P466, DOI 10.1016/j.matbio.2006.09.001; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	44	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36469	36477		10.1074/jbc.M111.283176	http://dx.doi.org/10.1074/jbc.M111.283176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880728	Green Published, hybrid			2022-12-25	WOS:000296538300032
J	Barbarini, N; Tiengo, A; Bellazzi, R				Barbarini, Nicola; Tiengo, Alessandra; Bellazzi, Riccardo			Prediction of Peptide Reactivity with Human IVIg through a Knowledge-Based Approach	PLOS ONE			English	Article							B-CELL EPITOPES; ANTIGENIC DETERMINANTS; NEUTRALIZING ANTIBODY; AMINO-ACIDS; BINDING; IDENTIFICATION; SELECTION; RESIDUES; MODEL; CHAIN	The prediction of antibody-protein (antigen) interactions is very difficult due to the huge variability that characterizes the structure of the antibodies. The region of the antigen bound to the antibodies is called epitope. Experimental data indicate that many antibodies react with a panel of distinct epitopes (positive reaction). The Challenge 1 of DREAM5 aims at understanding whether there exists rules for predicting the reactivity of a peptide/epitope, i.e., its capability to bind to human antibodies. DREAM 5 provided a training set of peptides with experimentally identified high and low reactivities to human antibodies. On the basis of this training set, the participants to the challenge were asked to develop a predictive model of reactivity. A test set was then provided to evaluate the performance of the model implemented so far. We developed a logistic regression model to predict the peptide reactivity, by facing the challenge as a machine learning problem. The initial features have been generated on the basis of the available knowledge and the information reported in the dataset. Our predictive model had the second best performance of the challenge. We also developed a method, based on a clustering approach, able to "in-silico'' generate a list of positive and negative new peptide sequences, as requested by the DREAM5 "bonus round" additional challenge. The paper describes the developed model and its results in terms of reactivity prediction, and highlights some open issues concerning the propensity of a peptide to react with human antibodies.	[Barbarini, Nicola; Tiengo, Alessandra; Bellazzi, Riccardo] Univ Pavia, Dept Comp Engn & Syst Sci, Lab Biomed Informat Mario Stefanelli, I-27100 Pavia, Italy	University of Pavia	Barbarini, N (corresponding author), Univ Pavia, Dept Comp Engn & Syst Sci, Lab Biomed Informat Mario Stefanelli, Via Palestro 3, I-27100 Pavia, Italy.	nicola.barbarini@unipv.it	Bellazzi, Riccardo/J-6432-2018	Bellazzi, Riccardo/0000-0002-6974-9808	Italian "Ministero dell'Universita edella Ricerca"; Innovative Medicines Initiative (IMI)	Italian "Ministero dell'Universita edella Ricerca"(Ministry of Education, Universities and Research (MIUR)); Innovative Medicines Initiative (IMI)	This project was partially funded by the Italian "Ministero dell'Universita edella Ricerca" through FIRB ITALBIONET project and by Innovative Medicines Initiative (IMI) through SUMMIT European research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Bellazzi R, 2008, INT J MED INFORM, V77, P81, DOI 10.1016/j.ijmedinf.2006.11.006; BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Carugo O, 1997, PROTEIN ENG, V10, P777, DOI 10.1093/protein/10.7.777; Castelletti D, 2004, CLIN EXP IMMUNOL, V136, P365, DOI 10.1111/j.1365-2249.2004.02442.x; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DIBRINO M, 1993, J IMMUNOL, V151, P5930; Dimitrov I, 2010, BIOINFORMATICS, V26, P2066, DOI 10.1093/bioinformatics/btq324; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; Janeway C.A., 1999, IMMUNOBIOLOGY IMMUNE; JANIN J, 1979, NATURE, V277, P491, DOI 10.1038/277491a0; John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338; Jorgensen KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015877; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Liu L, 2008, IFMBE PROC, V19, P167, DOI 10.1007/978-3-540-79039-6_43; Lorenz P, 2009, METHODS MOL BIOL, V524, P247, DOI 10.1007/978-1-59745-450-6_18; Lundegaard C, 2007, BIOINFORMATICS, V23, P3265, DOI 10.1093/bioinformatics/btm471; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; NOVOTNY J, 1986, BIOCHEMISTRY-US, V25, P6748, DOI 10.1021/bi00370a004; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; Ponomarenko JV, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-64; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Quinlan R., 1993, C4 5 PROGRAMS MACHIN, P302; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sollner J, 2006, J MOL RECOGNIT, V19, P209, DOI 10.1002/jmr.770; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tiengo A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S11; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004	52	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23616	10.1371/journal.pone.0023616	http://dx.doi.org/10.1371/journal.pone.0023616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887285	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000039
J	Merica, H; Fortune, RD				Merica, Helli; Fortune, Ronald D.			The Neuronal Transition Probability (NTP) Model for the Dynamic Progression of Non-REM Sleep EEG: The Role of the Suprachiasmatic Nucleus	PLOS ONE			English	Article							VENTROLATERAL PREOPTIC NUCLEUS; ASCENDING AROUSAL SYSTEM; BRAIN-STEM; CIRCADIAN REGULATION; MATHEMATICAL-MODEL; SPINDLE ACTIVITY; DELTA-WAVES; SLOW; OSCILLATIONS; MECHANISMS	Little attention has gone into linking to its neuronal substrates the dynamic structure of non-rapid-eye-movement (NREM) sleep, defined as the pattern of time-course power in all frequency bands across an entire episode. Using the spectral power time-courses in the sleep electroencephalogram (EEG), we showed in the typical first episode, several moves towards-and-away from deep sleep, each having an identical pattern linking the major frequency bands beta, sigma and delta. The neuronal transition probability model (NTP) - in fitting the data well - successfully explained the pattern as resulting from stochastic transitions of the firing-rates of the thalamically-projecting brainstem-activating neurons, alternating between two steady dynamic-states (towards-and-away from deep sleep) each initiated by a so-far unidentified flip-flop. The aims here are to identify this flip-flop and to demonstrate that the model fits well all NREM episodes, not just the first. Using published data on suprachiasmatic nucleus (SCN) activity we show that the SCN has the information required to provide a threshold-triggered flip-flop for TIMING the towards-and-away alternations, information provided by sleep-relevant feedback to the SCN. NTP then determines the PATTERN of spectral power within each dynamic-state. NTP was fitted to individual NREM episodes 1-4, using data from 30 healthy subjects aged 20-30 years, and the quality of fit for each NREM measured. We show that the model fits well all NREM episodes and the best-fit probability-set is found to be effectively the same in fitting all subject data. The significant model-data agreement, the constant probability parameter and the proposed role of the SCN add considerable strength to the model. With it we link for the first time findings at cellular level and detailed time-course data at EEG level, to give a coherent picture of NREM dynamics over the entire night and over hierarchic brain levels all the way from the SCN to the EEG.	[Merica, Helli] Hop Univ Geneve, Lab Sommeil & Neurophysiol, Geneva, Switzerland; [Fortune, Ronald D.] CERN European Org Nucl Res, Geneva, Switzerland	University of Geneva; European Organization for Nuclear Research (CERN)	Merica, H (corresponding author), Hop Univ Geneve, Lab Sommeil & Neurophysiol, Geneva, Switzerland.	helli.merica@hcuge.ch			Swiss National Science Foundation [3100A0-112500]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funded by The Swiss National Science Foundation (www.snf.ch) Grant# 3100A0-112500 to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Behn CGD, 2007, J NEUROPHYSIOL, V97, P3828, DOI 10.1152/jn.01184.2006; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Borbely A A, 1982, Hum Neurobiol, V1, P195; CHOU TC, 2003, THESIS HARVARD U CAM; Contreras D, 1997, J NEUROSCI, V17, P1179; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Deurveilher S, 2002, EUR J NEUROSCI, V16, P1195, DOI 10.1046/j.1460-9568.2002.02196.x; DIJK DJ, 1995, J NEUROSCI, V15, P3526; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; FERMI E, 1950, NUCL PHYS, P24; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Gooley J, 2011, PRINCIPLES PRACTICE, V5, P376; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; JONES BE, 1991, NEUROSCIENCE, V40, P637, DOI 10.1016/0306-4522(91)90002-6; JONES BE, 1994, PRINCIPLES PRACTICE, P145; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; LIN KH, 1973, CHEM ENG HDB, P4; Lu J, 1999, NEUROSCIENCE, V93, P209, DOI 10.1016/S0306-4522(99)00094-9; MCCARLEY RW, 1992, J SLEEP RES, V1, P132, DOI 10.1111/j.1365-2869.1992.tb00026.x; MCCARLEY RW, 1986, AM J PHYSIOL, V251, pR1011, DOI 10.1152/ajpregu.1986.251.6.R1011; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McGinty D, 2001, SLEEP MED REV, V5, P323, DOI 10.1053/smrv.2001.0170; Merica H, 2000, Sleep Res Online, V3, P53; Merica H, 2005, CEREB CORTEX, V15, P877, DOI 10.1093/cercor/bhh192; Merica H, 2003, CEREB CORTEX, V13, P1044, DOI 10.1093/cercor/13.10.1044; MERICA H, 1991, PHYSIOL BEHAV, V50, P1153, DOI 10.1016/0031-9384(91)90576-A; Merica H, 1997, PHYSIOL BEHAV, V62, P585, DOI 10.1016/S0031-9384(97)00165-0; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Molle M, 2002, J NEUROSCI, V22, P10941; MOORE RY, 1978, J COMP NEUROL, V180, P417, DOI 10.1002/cne.901800302; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; NAUTA WJH, 1946, J NEUROPHYSIOL, V9, P285, DOI 10.1152/jn.1946.9.4.285; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Phillips AJK, 2007, J BIOL RHYTHM, V22, P167, DOI 10.1177/0748730406297512; Phillips AJK, 2008, J THEOR BIOL, V255, P413, DOI 10.1016/j.jtbi.2008.08.022; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Saint-Mleux B, 2007, J NEUROSCI, V27, P6412, DOI 10.1523/JNEUROSCI.1432-07.2007; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Steriade M, 1998, Sleep Res Online, V1, P1; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1991, J NEUROSCI, V11, P3200; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STERIADE M, 1984, DYNAMIC ASPECTS NEOC, P107; Steriade M, 1997, THALAMUS, VI; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3; Tamakawa Y, 2006, J NEUROPHYSIOL, V95, P2055, DOI 10.1152/jn.00575.2005; von EC0N0M0 C., 1930, JOUR NERV & MENT DIS, V71, P249; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wurts SW, 2000, J NEUROSCI, V20, P4300	65	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23593	10.1371/journal.pone.0023593	http://dx.doi.org/10.1371/journal.pone.0023593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886801	gold, Green Submitted, Green Published			2022-12-25	WOS:000294128100021
J	Crispino, G; Di Pasquale, G; Scimemi, P; Rodriguez, L; Ramirez, FG; De Siati, RD; Santarelli, RM; Arslan, E; Bortolozzi, M; Chiorini, JA; Mammano, F				Crispino, Giulia; Di Pasquale, Giovanni; Scimemi, Pietro; Rodriguez, Laura; Ramirez, Fabian Galindo; De Siati, Romolo Daniele; Santarelli, Rosa Maria; Arslan, Edoardo; Bortolozzi, Mario; Chiorini, John A.; Mammano, Fabio			BAAV Mediated GJB2 Gene Transfer Restores Gap Junction Coupling in Cochlear Organotypic Cultures from Deaf Cx26Sox10Cre Mice	PLOS ONE			English	Article							BOVINE ADENOASSOCIATED VIRUS; CONNEXIN 26; INNER-EAR; HEARING IMPAIRMENT; ATP RELEASE; EXPRESSION; COMMUNICATION; PERMEABILITY; DEGENERATION; HEMICHANNELS	The deafness locus DFNB1 contains GJB2, the gene encoding connexin26 and GJB6, encoding connexin30, which appear to be coordinately regulated in the inner ear. In this work, we investigated the expression and function of connexin26 and connexin30 from postnatal day 5 to adult age in double transgenic Cx26(Sox10Cre) mice, which we obtained by crossing connexin26 floxed mice with a deleter Sox10-Cre line. Cx26(Sox10Cre) mice presented with complete connexin26 ablation in the epithelial gap junction network of the cochlea, whereas connexin30 expression was developmentally delayed; immunolabeling patterns for both connexins were normal in the cochlear lateral wall. In vivo electrophysiological measurements in Cx26(Sox10Cre) mice revealed profound hearing loss accompanied by reduction of endocochlear potential, and functional experiments performed in postnatal cochlear organotypic cultures showed impaired gap junction coupling. Transduction of these cultures with a bovine adeno associated virus vector restored connexin26 protein expression and rescued gap junction coupling. These results suggest that restoration of normal connexin levels by gene delivery via recombinant adeno associated virus could be a way to rescue hearing function in DFNB1 mouse models and, in future, lead to the development of therapeutic interventions in humans.	[Crispino, Giulia; Rodriguez, Laura; Ramirez, Fabian Galindo; Bortolozzi, Mario; Mammano, Fabio] Ist Veneto Med Mol, Fdn Ric Biomed Avanzata, Padua, Italy; [Crispino, Giulia; Rodriguez, Laura; Bortolozzi, Mario; Mammano, Fabio] Univ Padua, Dipartimento Fis G Galilei, Padua, Italy; [Di Pasquale, Giovanni; Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Scimemi, Pietro; De Siati, Romolo Daniele; Santarelli, Rosa Maria; Arslan, Edoardo] Univ Padua, Dipartimento Specialita Med Chirurg, Padua, Italy; [Scimemi, Pietro; De Siati, Romolo Daniele; Santarelli, Rosa Maria; Arslan, Edoardo] Univ Padua, Serv Audiol, Padua, Italy; [Bortolozzi, Mario; Mammano, Fabio] Ist CNR Neurosci, Padua, Italy	Veneto Institute Molecular Medicine; University of Padua; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Padua; University of Padua	Crispino, G (corresponding author), Ist Veneto Med Mol, Fdn Ric Biomed Avanzata, Padua, Italy.	fabio.mammano@unipd.it	Mammano, Fabio/I-5064-2012; Scimemi, Pietro/T-5390-2017; Bortolozzi, Mario/H-6872-2015; Mammano, Fabio/AAM-3902-2020	Mammano, Fabio/0000-0003-3751-1691; Scimemi, Pietro/0000-0001-5273-1938; Bortolozzi, Mario/0000-0001-7198-9838; Mammano, Fabio/0000-0003-3751-1691; Galindo Ramirez, Fabian/0000-0001-5536-458X	European Commission [LSHGCT20054512063]; Fondazione Cariparo; Telethon Italy [GGP09137]; Italian Ministry of Research [2007BZ4RX3_003]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Cariparo(Fondazione Cariparo); Telethon Italy(Fondazione Telethon); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by grants to FM from: The European Commission [FP6 Integrated Project EuroHear, grant number LSHGCT20054512063]; Fondazione Cariparo [Progetti di Eccellenza 2006-2007], Telethon Italy [grant number GGP09137], Italian Ministry of Research [PRIN 2007, grant number 2007BZ4RX3_003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Bry C, 2004, DEV BIOL, V267, P418, DOI 10.1016/j.ydbio.2003.11.022; Chang Q, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004088; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Denoyelle F, 1998, NATURE, V393, P319, DOI 10.1038/30639; Di Pasquale G, 2005, MOL THER, V11, P849, DOI 10.1016/j.ymthe.2005.02.004; Di Pasquale G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009336; DIVIRGILIO F, 1989, METHOD CELL BIOL, V31, P453; EGGSTON AA, 1947, EMBRYOLOGY EAR HISTO, P37; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Gasparini P, 1997, EUR J HUM GENET, V5, P83; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kelly JJ, 2011, NEUROSCIENCE, V180, P360, DOI 10.1016/j.neuroscience.2011.02.011; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Levin M, 2007, PROG BIOPHYS MOL BIO, V94, P186, DOI 10.1016/j.pbiomolbio.2007.03.005; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAGUCHI S, 1991, Auris Nasus Larynx, V18, P1; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Martinez AD, 2009, ANTIOXID REDOX SIGN, V11, P309, DOI 10.1089/ars.2008.2138; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Rozental R, 2001, METH MOL B, V154, P447; SADANAGA M, 1995, HEARING RES, V89, P155, DOI 10.1016/0378-5955(95)00133-X; Santarelli R, 2003, ACTA OTO-LARYNGOL, V123, P176, DOI 10.1080/0036554021000028108; SANTI PA, 1994, J HISTOCHEM CYTOCHEM, V42, P705, DOI 10.1177/42.6.8189033; Schmidt M, 2004, J VIROL, V78, P6509, DOI 10.1128/JVI.78.12.6509-6516.2004; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; Schutz M, 2010, HUM MOL GENET, V19, P4759, DOI 10.1093/hmg/ddq402; SHEFFIELD AM, 2011, HEAR RES; Shibata SB, 2009, GENE THER, V16, P990, DOI 10.1038/gt.2009.57; STEEL KP, 1989, DEVELOPMENT, V107, P453; Sun Y, 2009, J COMP NEUROL, V516, P569, DOI 10.1002/cne.22117; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; Watanabe K, 2000, MOL BRAIN RES, V84, P141, DOI 10.1016/S0169-328X(00)00236-9; Yoshikawa M, 2009, P NATL ACAD SCI USA, V106, P9483, DOI 10.1073/pnas.0903279106; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	50	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23279	10.1371/journal.pone.0023279	http://dx.doi.org/10.1371/journal.pone.0023279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876744	Green Published, Green Submitted, gold			2022-12-25	WOS:000294126900016
J	Boroughs, LK; Antonyak, MA; Johnson, JL; Cerione, RA				Boroughs, Lindsey K.; Antonyak, Marc A.; Johnson, Jared L.; Cerione, Richard A.			A Unique Role for Heat Shock Protein 70 and Its Binding Partner Tissue Transglutaminase in Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASION; LOCALIZATION; PROTRUSION; EXPRESSION; PROTEINS; ADHESION; BREAST; ACTIN	Cell migration is essential for several important biological outcomes and is involved in various developmental disorders and disease states including cancer cell invasiveness and metastasis. A fundamental step in cell migration is the development of a leading edge. By using HeLa carcinoma cells as an initial model system, we uncovered a surprising role for the heat shock protein 70 (Hsp70) and its ability to bind the protein cross-linking enzyme, tissue transglutaminase (tTG), in cancer cell migration. Treatment of HeLa cells with EGF results in the activation of a plasma membrane-associated pool of tTG and its redistribution to the leading edges of these cells, which are essential events for EGF-stimulated HeLa cell migration. However, we then found that the ability of tTG to be localized to the leading edge is dependent on Hsp70. Similarly, the localization of tTG to the leading edges of MDAMB231 breast carcinoma cells, where it also plays an essential role in their migration, has a strict requirement for Hsp70. Treatment of these different cell lines with inhibitors against the ATP hydrolytic activity of Hsp70 prevented tTG from localizing to their leading edges and thereby blocked EGF-stimulated HeLa cell migration, as well as the constitutive migration normally exhibited by MDAMB231 cells. These findings highlight a new and unconventional role for the chaperonin activity of Hsp70 in the localization of a key regulatory protein (tTG) at the leading edges of cancer cells and the important consequences that this holds for their ability to migrate.	[Boroughs, Lindsey K.; Antonyak, Marc A.; Johnson, Jared L.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Johnson, Jared/0000-0003-1802-6527	National Institutes of Health [GM061762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM061762.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Arispe N, 2004, FASEB J, V18, P1636, DOI 10.1096/fj.04-2088com; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dafik L, 2011, CHEM BIOL, V18, P58, DOI 10.1016/j.chembiol.2010.11.004; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Jego G., 2010, CANC LETT IN PRESS; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Raja, 2007, Front Biosci, V12, P2849; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Singer CF, 2006, CLIN EXP METASTAS, V23, P33, DOI 10.1007/s10585-006-9015-0; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298	33	35	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37094	37107		10.1074/jbc.M111.242438	http://dx.doi.org/10.1074/jbc.M111.242438			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896482	Green Published, hybrid			2022-12-25	WOS:000296542400010
J	Huang, YC; Cohen, JC; Hobbs, HH				Huang, Yongcheng; Cohen, Jonathan C.; Hobbs, Helen H.			Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; CHANARIN-DORFMAN-SYNDROME; PATATIN; GENE; SUSCEPTIBILITY; CGI-58; FAMILY; ESTERS	A genetic variant of PNPLA3 (patatin-like phospholipase domain-containing 3; PNPLA3-I148M), a serine protease of unknown function, is associated with accumulation of triacylglycerol (TAG) in the liver. To determine the biological substrates of PNPLA3 and the effect of the I148M substitution on enzymatic activity and substrate specificity, we purified and characterized recombinant human PNPLA3 and PNPLA3-I148M. Maximal hydrolytic activity of PNPLA3 was observed against the three major glycerolipids, TAG, diacylglycerol, and monoacylglycerol, with a strong preference for oleic acid as the acyl moiety. Substitution of methionine for isoleucine at position 148 markedly decreased the V-max of the enzyme for glycerolipids but had only a modest effect on the K-m. Purified PNPLA3 also catalyzed the hydrolysis of oleoyl-CoA, but the V-max was 100-fold lower for oleoyl-CoA than for triolein. The thioesterase activity required the catalytic serine but was only modestly decreased by the I148M substitution. The enzyme had little or no hydrolytic activity against the other lipid substrates tested, including phospholipids, cholesteryl ester, and retinyl esters. Neither the wild-type nor mutant enzyme catalyzed transfer of oleic acid from oleoyl-CoA to glycerophosphate, lysophosphatidic acid, or diacylglycerol, suggesting that the enzyme does not promote de novo TAG synthesis. Taken together, our results are consistent with the notion that PNPLA3 plays a role in the hydrolysis of glycerolipids and that the I148M substitution causes a loss of function, although we cannot exclude the possibility that the enzyme has additional substrates or activities.	[Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Huang, Yongcheng; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Huang, Yongcheng; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu			National Institutes of Health from NHLBI [P01HL20948, 1RLHL090550, R01DK090066]; NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL20948, 1RLHL090550, and R01DK090066 from NHLBI and NIDDK.	BAGINSKY ML, 1977, J LIPID RES, V18, P423; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Falleti E., 2011, LIVER INT IN PRESS; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; MORRISON WR, 1964, J LIPID RES, V5, P600; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; PARK WD, 1983, PLANT PHYSIOL, V71, P156, DOI 10.1104/pp.71.1.156; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, J HEPATOL, V53, P335, DOI 10.1016/j.jhep.2010.02.034; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	24	205	207	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37085	37093		10.1074/jbc.M111.290114	http://dx.doi.org/10.1074/jbc.M111.290114			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878620	Green Published, hybrid			2022-12-25	WOS:000296542400009
J	Thiele, S; Steen, A; Jensen, PC; Mokrosinski, J; Frimurer, TM; Rosenkilde, MM				Thiele, Stefanie; Steen, Anne; Jensen, Pia C.; Mokrosinski, Jacek; Frimurer, Thomas M.; Rosenkilde, Mette M.			Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOTACTIC PROTEIN-1; BRADYKININ B2 RECEPTOR; SMALL-MOLECULE; CRYSTAL-STRUCTURE; BINDING-SITE; INTRACELLULAR FACE; COUPLED RECEPTORS; MULTIPLE DOMAINS; LIGAND-BINDING; MCP-1 RECEPTOR	Chemokine receptors play a major role in immune system regulation and have consequently been targets for drug development leading to the discovery of several small molecule antagonists. Given the large size and predominantly extracellular receptor interaction of endogenous chemokines, small molecules often act more deeply in an allosteric mode. However, opposed to the well described molecular interaction of allosteric modulators in class C7-transmembrane helix (7TM) receptors, the interaction in class A, to which the chemokine receptors belong, is more sparsely described. Using the CCR5 chemokine receptor as a model system, we studied the molecular interaction and conformational interchange required for proper action of various orthosteric chemokines and allosteric small molecules, including the well known CCR5 antagonists TAK-779, SCH-C, and aplaviroc, and four novel CCR5 ago-allosteric molecules. A chimera was successfully constructed between CCR5 and the closely related CCR2 by transferring all extracellular regions of CCR2 to CCR5, i.e. a Trojan horse that resembles CCR2 extracellularly but signals through a CCR5 transmembrane unit. The chimera bound CCR2 (CCL2 and CCL7), but not CCR5 chemokines (CCL3 and CCL5), with CCR2-like high affinities and potencies throughout the CCR5 signaling unit. Concomitantly, high affinity binding of small molecule CCR5 agonists and antagonists was retained in the transmembrane region. Importantly, whereas the agonistic and antagonistic properties were preserved, the allosteric enhancement of chemokine binding was disrupted. In summary, the Trojan horse chimera revealed that orthosteric and allosteric sites could be structurally separated and still act together with transmission of agonism and antagonism across the different receptor units.	[Thiele, Stefanie; Steen, Anne; Jensen, Pia C.; Mokrosinski, Jacek; Rosenkilde, Mette M.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Frimurer, Thomas M.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Rosenkilde, MM (corresponding author), Blegdamsvej 3,Bldg 18-5, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Mokrosinski, Jacek/J-9506-2012; Mokrosinski, Jacek/M-1963-2019	Mokrosinski, Jacek/0000-0003-1710-1679; Mokrosinski, Jacek/0000-0001-5008-0457; Rosenkilde, Mette Marie/0000-0001-9600-3254; Karlshoj, Stefanie/0000-0001-6505-0883; Frimruer, Thomas/0000-0002-9682-8245	Danish Council for Independent Research, Medical Sciences; NovoNordisk Foundation; Lundbeck Foundation; European Community [LSHB-CT-2005-518167]; AP-Moller Foundation; Aase and Einar Danielsen Foundation	Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); NovoNordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); European Community(European Commission); AP-Moller Foundation; Aase and Einar Danielsen Foundation	This work was supported by The Danish Council for Independent Research, Medical Sciences, The NovoNordisk Foundation, The Lundbeck Foundation, European Community's Sixth Framework Program INNOCHEM, LSHB-CT-2005-518167, The AP-Moller Foundation, and The Aase and Einar Danielsen Foundation.	Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; Alkhatib G, 1997, J BIOL CHEM, V272, P20420, DOI 10.1074/jbc.272.33.20420; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Blanpain C, 2001, J LEUKOCYTE BIOL, V69, P977; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Gupte J, 2004, P NATL ACAD SCI USA, V101, P1508, DOI 10.1073/pnas.0308250100; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Holst B, 2000, MOL PHARMACOL, V58, P263, DOI 10.1124/mol.58.2.263; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Jensen PC, 2009, METHOD ENZYMOL, V461, P171, DOI 10.1016/S0076-6879(09)05408-1; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Monteclaro FS, 1996, J BIOL CHEM, V271, P19084, DOI 10.1074/jbc.271.32.19084; Murphy PM, 2000, PHARMACOL REV, V52, P145; Pal-Ghosh R, 2003, ARCH BIOCHEM BIOPHYS, V415, P54, DOI 10.1016/S0003-9861(03)00217-0; Palani A, 2001, J MED CHEM, V44, P3339, DOI 10.1021/jm015526o; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pease JE, 1998, J BIOL CHEM, V273, P19972, DOI 10.1074/jbc.273.32.19972; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Shields DC, 2000, GENE, V246, P239, DOI 10.1016/S0378-1119(00)00072-X; Shiraishi M, 2000, J MED CHEM, V43, P2049, DOI 10.1021/jm9906264; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wise EL, 2007, J BIOL CHEM, V282, P27935, DOI 10.1074/jbc.M703255200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Yu J, 2002, J CELL BIOCHEM, V85, P809, DOI 10.1002/jcb.10171	56	39	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37543	37554		10.1074/jbc.M111.243808	http://dx.doi.org/10.1074/jbc.M111.243808			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878623	Green Published, hybrid			2022-12-25	WOS:000296542400053
J	Antolikova, E; Zakova, L; Turkenburg, JP; Watson, CJ; Hanclova, I; Sanda, M; Cooper, A; Kraus, T; Brzozowski, AM; Jiracek, J				Antolikova, Emilia; Zakova, Lenka; Turkenburg, Johan P.; Watson, Christopher J.; Hanclova, Ivona; Sanda, Miloslav; Cooper, Alan; Kraus, Tomas; Brzozowski, A. Marek; Jiracek, Jiri			Non-equivalent Role of Inter- and Intramolecular Hydrogen Bonds in the Insulin Dimer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; NEGATIVE COOPERATIVITY; ASSOCIATION PROPERTIES; STRUCTURAL SWITCH; SELF-ASSOCIATION; PEPTIDE-BONDS; HEXAMER; PROTEIN; MUTANT; DISSOCIATION	Apart from its role in insulin receptor (IR) activation, the C terminus of the B-chain of insulin is also responsible for the formation of insulin dimers. The dimerization of insulin plays an important role in the endogenous delivery of the hormone and in the administration of insulin to patients. Here, we investigated insulin analogues with selective N-methylations of peptide bond amides at positions B24, B25, or B26 to delineate their structural and functional contribution to the dimer interface. All N-methylated analogues showed impaired binding affinities to IR, which suggests a direct IR-interacting role for the respective amide hydrogens. The dimerization capabilities of analogues were investigated by isothermal microcalorimetry. Selective N-methylations of B24, B25, or B26 amides resulted in reduced dimerization abilities compared with native insulin (K-d = 8.8 mu M). Interestingly, although the N-methylation in [NMeTyrB26]-insulin or [NMePheB24]-insulin resulted in K-d values of 142 and 587 mu M, respectively, the [NMePheB25]-insulin did not form dimers even at high concentrations. This effect may be attributed to the loss of intramolecular hydrogen bonding between NHB25 and COA19, which connects the B-chain beta-strand to the core of the molecule. The release of the B-chain beta-strand from this hydrogen bond lock may result in its higher mobility, thereby shifting solution equilibrium toward the monomeric state of the hormone. The study was complemented by analyses of two novel analogue crystal structures. All examined analogues crystallized only in the most stable R-6 form of insulin oligomers (even if the dimer interface was totally disrupted), confirming the role of R-6-specific intra/intermolecular interactions for hexamer stability.	[Turkenburg, Johan P.; Watson, Christopher J.; Brzozowski, A. Marek] Univ York, Dept Chem, York Struct Biol Lab, Heslington YO10 5YW, York, England; [Antolikova, Emilia; Zakova, Lenka; Hanclova, Ivona; Sanda, Miloslav; Kraus, Tomas; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Prague 16610 6, Czech Republic; [Cooper, Alan] Univ Glasgow, Sch Chem, Coll Sci & Engn, Glasgow G12 8QQ, Lanark, Scotland	University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Glasgow	Brzozowski, AM (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, Heslington YO10 5YW, York, England.	marek@ysbl.york.ac.uk; jiracek@uochb.cas.cz	Zakova, Lenka/A-7119-2008; Sanda, Miloslav/P-1631-2017; Cooper, Alan/F-7813-2011; Jiracek, Jiri/A-7124-2008; Kraus, Tomas/I-4687-2012; Jiracek, Jiri/Y-6703-2019; Zakova, Lenka/Y-6234-2019	Sanda, Miloslav/0000-0002-7735-3635; Cooper, Alan/0000-0001-6709-7343; Jiracek, Jiri/0000-0003-3848-2773; Kraus, Tomas/0000-0002-0055-5853; Jiracek, Jiri/0000-0003-3848-2773; Zakova, Lenka/0000-0001-6439-2574; Turkenburg, Johan/0000-0001-6992-6838	Ministry of Education, Youth, and Sports of the Czech Republic (Research Centre for Chemical Genetics) [LC060777]; Academy of Sciences of the Czech Republic [Z40550506]; Diamond Light Source (Didcot, United Kingdom); European Synchrotron Radiation Facility (Grenoble, France)	Ministry of Education, Youth, and Sports of the Czech Republic (Research Centre for Chemical Genetics)(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Diamond Light Source (Didcot, United Kingdom); European Synchrotron Radiation Facility (Grenoble, France)	This work was supported by Ministry of Education, Youth, and Sports of the Czech Republic Grant LC060777 (Research Centre for Chemical Genetics, to J. J.), Research Project of the Academy of Sciences of the Czech Republic Grant Z40550506 (to J. J.). This work was also supported by the Diamond Light Source (Didcot, United Kingdom) and European Synchrotron Radiation Facility (Grenoble, France).	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BLOOM CR, 1995, J MOL BIOL, V245, P324, DOI 10.1006/jmbi.1994.0027; BRADER ML, 1991, BIOCHEMISTRY-US, V30, P6636, DOI 10.1021/bi00241a002; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; BROMER WM, 1967, BIOCHIM BIOPHYS ACTA, V133, P219, DOI 10.1016/0005-2795(67)90061-X; BRZOVIC PS, 1994, BIOCHEMISTRY-US, V33, P13057, DOI 10.1021/bi00248a015; CHOI WE, 1993, BIOCHEMISTRY-US, V32, P11638, DOI 10.1021/bi00094a021; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DEMEYTS P, 1978, NATURE, V273, P504; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DIMARCHI RD, 1994, HORM RES, V41, P93, DOI 10.1159/000183967; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganim Z, 2010, PHYS CHEM CHEM PHYS, V12, P3579, DOI 10.1039/b923515a; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; Hassiepen U, 1999, BIOPHYS J, V77, P1638, DOI 10.1016/S0006-3495(99)77012-8; Hedman CA, 2001, DIABETES CARE, V24, P1120, DOI 10.2337/diacare.24.6.1120; Homko C, 2003, DIABETES CARE, V26, P2027, DOI 10.2337/diacare.26.7.2027; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huus K, 2006, BIOCHEMISTRY-US, V45, P4014, DOI 10.1021/bi0524520; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; KAARSHOLM NC, 1995, RECEPTOR, V5, P1; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; Keller D, 2001, BIOCHEMISTRY-US, V40, P10732, DOI 10.1021/bi0108150; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lovatt A, 1996, EUR BIOPHYS J BIOPHY, V24, P354; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; LUDVIGSEN S, 1994, BIOCHEMISTRY-US, V33, P7998, DOI 10.1021/bi00192a003; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McPhail D, 1997, J CHEM SOC FARADAY T, V93, P2283, DOI 10.1039/a701327b; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAGAWA SH, 1993, INT J PEPT PROT RES, V42, P578; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PITTMAN I, 1995, BIOCHEMISTRY-US, V34, P10578, DOI 10.1021/bi00033a033; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; ROY M, 1989, J BIOL CHEM, V264, P19081; SEYDOUX F, 1974, Critical Reviews in Biochemistry, V2, P227, DOI 10.3109/10409237409105448; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; STRAZZA S, 1985, ARCH BIOCHEM BIOPHYS, V238, P30, DOI 10.1016/0003-9861(85)90137-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; WOLLMER A, 1994, BIOL CHEM H-S, V375, P219; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zakova L, 2004, BIOCHEMISTRY-US, V43, P16293, DOI 10.1021/bi048856u; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2007, J PEPT SCI, V13, P334, DOI 10.1002/psc.847; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	60	29	29	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36968	36977		10.1074/jbc.M111.265249	http://dx.doi.org/10.1074/jbc.M111.265249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880708	Green Published, hybrid			2022-12-25	WOS:000296538300075
J	Terragni, J; Nayak, G; Banerjee, S; Medrano, JL; Graham, JR; Brennan, JF; Sepulveda, S; Cooper, GM				Terragni, Jolyon; Nayak, Gauri; Banerjee, Swati; Medrano, Jose-Luis; Graham, Julie R.; Brennan, James F.; Sepulveda, Sean; Cooper, Geoffrey M.			The E-box Binding Factors Max/Mnt, MITF, and USF1 Act Coordinately with FoxO to Regulate Expression of Proapoptotic and Cell Cycle Control Genes by Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR USF; HELIX-LOOP-HELIX; NF-KAPPA-B; C-MYC; MELANOCYTE DEVELOPMENT; MICROPHTHALMIA LOCUS; 3-KINASE PATHWAY; PROTEIN; PHOSPHORYLATION; FORKHEAD	Phosphatidylinositol (PI) 3-kinase/Akt signaling plays a critical role in cell proliferation and survival, partly by regulation of FoxO transcription factors. Previous work using global expression profiling indicated that inhibition of PI 3-kinase in proliferating cells led to induction of genes that promote cell cycle arrest and apoptosis. The upstream regulatory regions of these genes had binding sites not only for FoxO, but also for Myc/Max transcription factors. In the present study, we have addressed the role of Myc family members and related E-box-binding proteins in the regulation of these genes. Chromatin immunoprecipitations and RNA interference indicated that transcription was repressed by Max-Mnt-Sin3a-histone deacetylase complexes in proliferating cells. Inhibition of PI 3-kinase led to a loss of Max/Mnt binding and transcriptional induction by MITF and USF1, as well as FoxO. Both MITF and USF1 were activated by glycogen synthase kinase (GSK) 3, with GSK3 phosphorylation sites on USF1 identified as the previously described activating site threonine 153 as well as serine 186. siRNA against MITF as well as against FoxO3a protected cells from apoptosis following PI 3-kinase inhibition. These results define a novel E-box-regulated network that functions coordinately with FoxO to regulate transcription of apoptotic and cell cycle regulatory genes downstream of PI 3-kinase/Akt/GSK3 signaling.	[Terragni, Jolyon; Nayak, Gauri; Banerjee, Swati; Medrano, Jose-Luis; Graham, Julie R.; Brennan, James F.; Sepulveda, Sean; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Cooper, GM (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [RO1 CA18689]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA18689.	Aperlo C, 1996, EUR J BIOCHEM, V241, P249, DOI 10.1111/j.1432-1033.1996.0249t.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Chandramohan V, 2004, J IMMUNOL, V172, P5522, DOI 10.4049/jimmunol.172.9.5522; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fuse N, 1999, J BIOCHEM-TOKYO, V126, P1043, DOI 10.1093/oxfordjournals.jbchem.a022548; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hooker CW, 2006, J CELL SCI, V119, P208, DOI 10.1242/jcs.02815; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Khaled M, 2003, J INVEST DERMATOL, V121, P831, DOI 10.1046/j.1523-1747.2003.12420.x; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Martinez-Gac L, 2004, BIOCHEM SOC T, V32, P360, DOI 10.1042/BST0320360; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Popov N, 2005, ONCOGENE, V24, P8326, DOI 10.1038/sj.onc.1208961; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scholtz B, 1996, J BIOL CHEM, V271, P32375, DOI 10.1074/jbc.271.50.32375; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takahashi Y, 2000, GENE DEV, V14, P804; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Viney TJ, 2004, J BIOL CHEM, V279, P49948, DOI 10.1074/jbc.M406659200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yao R, 1996, ONCOGENE, V13, P343	56	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36215	36227		10.1074/jbc.M111.246116	http://dx.doi.org/10.1074/jbc.M111.246116			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21873430	Green Published, hybrid			2022-12-25	WOS:000296538300006
J	Liu, XS; Song, B; Elzey, BD; Ratliff, TL; Konieczny, SF; Cheng, L; Ahmad, N; Liu, XQ				Liu, X. Shawn; Song, Bing; Elzey, Bennett D.; Ratliff, Timothy L.; Konieczny, Stephen F.; Cheng, Liang; Ahmad, Nihal; Liu, Xiaoqi			Polo-like Kinase 1 Facilitates Loss of Pten Tumor Suppressor-induced Prostate Cancer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; MAMMALIAN-CELLS; NUCLEAR PTEN; BI 2536; INHIBITOR; POLO-LIKE-KINASE-1; PTEN/MMAC1; RECOVERY; SURVIVAL; THERAPY	Background: Loss of Pten is thought to mediate the majority of prostate cancers. Results: Polo-like kinase 1 confers the tumorigenic competence of Pten-deleted prostate cancer cells. Conclusion: Polo-like kinase 1 facilitates loss of Pten-induced prostate cancer formation. Significance: These results provide a mechanism explaining how cancer cells overcome oncogenesis-associated cellular stress.	[Liu, X. Shawn; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Song, Bing; Konieczny, Stephen F.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Liu, X. Shawn; Song, Bing; Elzey, Bennett D.; Ratliff, Timothy L.; Konieczny, Stephen F.; Liu, Xiaoqi] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Elzey, Bennett D.; Ratliff, Timothy L.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Cheng, Liang] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; University of Wisconsin System; University of Wisconsin Madison	Liu, XQ (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	liu8@purdue.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887	NCI, National Institutes of Health [K01 CA114401]; NATIONAL CANCER INSTITUTE [R01CA124586, R01CA157429, K01CA114401] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A recipient of the Howard Temin Award from the NCI, National Institutes of Health (K01 CA114401). To whom correspondence should be addressed: Dept. of Biochemistry and the Purdue Center for Cancer Research, Purdue University, 175 S. University St., West Lafayette, IN 47907. Tel.: 765-496-3764; Fax: 765-494-7897; E-mail: liu8@purdue.edu.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haverkamp JM, 2011, PROSTATE, V71, P1139, DOI 10.1002/pros.21327; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Jimeno A, 2010, MOL CANCER THER, V9, P311, DOI 10.1158/1535-7163.MCT-09-0693; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Syljuasen RG, 2006, CANCER RES, V66, P10253, DOI 10.1158/0008-5472.CAN-06-2144; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050	27	48	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35795	35800		10.1074/jbc.C111.269050	http://dx.doi.org/10.1074/jbc.C111.269050			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21890624	Green Published, hybrid			2022-12-25	WOS:000295927100052
J	Bao, WK; Aravindhan, K; Alsaid, H; Chendrimada, T; Szapacs, M; Citerone, DR; Harpel, MR; Willette, RN; Lepore, JJ; Jucker, BM				Bao, Weike; Aravindhan, Karpagam; Alsaid, Hasan; Chendrimada, Thimmaiah; Szapacs, Matthew; Citerone, David R.; Harpel, Mark R.; Willette, Robert N.; Lepore, John J.; Jucker, Beat M.			Albiglutide, a Long Lasting Glucagon-Like Peptide-1 Analog, Protects the Rat Heart against Ischemia/Reperfusion Injury: Evidence for Improving Cardiac Metabolic Efficiency	PLOS ONE			English	Article							INTRAMUSCULAR GLUCOSE-METABOLISM; LEFT-VENTRICULAR PERFORMANCE; DILATED CARDIOMYOPATHY; INFARCT SIZE; MYOCARDIAL-INFARCTION; INDIVIDUAL TISSUES; CONSCIOUS DOGS; REPERFUSION; RECEPTOR; FAILURE	Background: The cardioprotective effects of glucagon-like peptide-1 (GLP-1) and analogs have been previously reported. We tested the hypothesis that albiglutide, a novel long half-life analog of GLP-1, may protect the heart against I/R injury by increasing carbohydrate utilization and improving cardiac energetic efficiency. Methods/Principal Findings: Sprague-Dawley rats were treated with albiglutide and subjected to 30 min myocardial ischemia followed by 24 h reperfusion. Left ventricle infarct size, hemodynamics, function and energetics were determined. In addition, cardiac glucose disposal, carbohydrate metabolism and metabolic gene expression were assessed. Albiglutide significantly reduced infarct size and concomitantly improved post-ischemic hemodynamics, cardiac function and energetic parameters. Albiglutide markedly increased both in vivo and ex vivo cardiac glucose uptake while reducing lactate efflux. Analysis of metabolic substrate utilization directly in the heart showed that albiglutide increased the relative carbohydrate versus fat oxidation which in part was due to an increase in both glucose and lactate oxidation. Metabolic gene expression analysis indicated upregulation of key glucose metabolism genes in the non-ischemic myocardium by albiglutide. Conclusion/Significance: Albiglutide reduced myocardial infarct size and improved cardiac function and energetics following myocardial I/R injury. The observed benefits were associated with enhanced myocardial glucose uptake and a shift toward a more energetically favorable substrate metabolism by increasing both glucose and lactate oxidation. These findings suggest that albiglutide may have direct therapeutic potential for improving cardiac energetics and function.	[Bao, Weike; Aravindhan, Karpagam; Harpel, Mark R.; Willette, Robert N.; Lepore, John J.; Jucker, Beat M.] GlaxoSmithKline Inc, Heart Failure Discovery Performance Unit, Metab Pathways & Cardiovasc Therapy Area Unit, King Of Prussia, PA 19406 USA; [Alsaid, Hasan; Chendrimada, Thimmaiah] GlaxoSmithKline Inc, Clin Imaging Ctr, King Of Prussia, PA USA; [Szapacs, Matthew; Citerone, David R.] GlaxoSmithKline Inc, Platform Technol & Sci, King Of Prussia, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bao, WK (corresponding author), GlaxoSmithKline Inc, Heart Failure Discovery Performance Unit, Metab Pathways & Cardiovasc Therapy Area Unit, King Of Prussia, PA 19406 USA.	Beat.M.Jucker@gsk.com		Alsaid, Hasan/0000-0001-6600-2146	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The studies were funded by GlaxoSmithKline. GlaxoSmithKline was responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Aguilar David, 2008, Curr Treat Options Cardiovasc Med, V10, P465, DOI 10.1007/s11936-008-0039-4; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Barnett AH, 2009, CLIN ENDOCRINOL, V70, P343, DOI 10.1111/j.1365-2265.2008.03396.x; BLOCH G, 1993, MAGNET RESON MED, V30, P347, DOI 10.1002/mrm.1910300311; Bose AK, 2005, CARDIOVASC DRUG THER, V19, P9, DOI 10.1007/s10557-005-6892-4; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Bradley DP, 2010, NUTRITION, V26, P243, DOI 10.1016/j.nut.2009.07.008; Bush MA, 2009, DIABETES OBES METAB, V11, P498, DOI 10.1111/j.1463-1326.2008.00992.x; Grieve DJ, 2009, BRIT J PHARMACOL, V157, P1340, DOI 10.1111/j.1476-5381.2009.00376.x; Gropler RJ, 2010, J NUCL MED, V51, p88S, DOI 10.2967/jnumed.109.068197; Jucker BM, 1997, J BIOL CHEM, V272, P10464, DOI 10.1074/jbc.272.16.10464; Jucker BM, 1997, AM J PHYSIOL-ENDOC M, V273, pE139, DOI 10.1152/ajpendo.1997.273.1.E139; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Kristensen J, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-31; Luptak I, 2007, CIRCULATION, V116, P901, DOI 10.1161/CIRCULATIONAHA.107.691253; Makinde AO, 1998, MOL CELL BIOCHEM, V188, P49, DOI 10.1023/A:1006860104840; Matthews JE, 2008, J CLIN ENDOCR METAB, V93, P4810, DOI 10.1210/jc.2008-1518; NEUBAUER S, 1992, CIRCULATION, V86, P1810, DOI 10.1161/01.CIR.86.6.1810; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Nikolaidis LA, 2004, CIRCULATION, V110, P955, DOI 10.1161/01.CIR.0000139339.85840.DD; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; POOLEWILSON PA, 1989, MOL CELL BIOCHEM, V89, P151; Poornima I, 2008, CIRC-HEART FAIL, V1, P153, DOI 10.1161/CIRCHEARTFAILURE.108.766402; Pratley Richard E, 2008, Medscape J Med, V10, P171; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V282, pH766, DOI 10.1152/ajpheart.00767.2001; Schwarz ER, 2000, J THROMB THROMBOLYS, V10, P181, DOI 10.1023/A:1018770711705; St Onge EL, 2010, EXPERT OPIN BIOL TH, V10, P801, DOI 10.1517/14712598.2010.481281; TAYLOR DJ, 1986, MAGNET RESON MED, V3, P44, DOI 10.1002/mrm.1910030107; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	38	75	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23570	10.1371/journal.pone.0023570	http://dx.doi.org/10.1371/journal.pone.0023570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887274	gold, Green Submitted, Green Published			2022-12-25	WOS:000294298800016
J	Martino, CF; Castello, PR				Martino, Carlos F.; Castello, Pablo R.			Modulation of Hydrogen Peroxide Production in Cellular Systems by Low Level Magnetic Fields	PLOS ONE			English	Article							RADICAL RECOMBINATION REACTIONS; OXYGEN; SUPEROXIDE; MECHANISMS; ROS; MAGNETORECEPTION; CELLS; BIRDS; MODEL	Increased generation of reactive oxygen species (ROS) and an altered redox status have long been observed in cancer cells, suggesting that ROS might be involved in the development of these cells. However, recent studies suggest that inducing an excess of ROS in cancer cells can be exploited for therapeutic benefits. Cancer cells in advanced stage tumors frequently exhibit multiple genetic alterations and high oxidative stress, suggesting that it might be possible to preferentially modulate the development of these cells by controlling their ROS production. Low levels of ROS are also important for the development and survival of normal cells. In this manuscript, we present data on the influence of the suppression of the Earth's magnetic field (low level magnetic fields or LLF) which magnitudes range from 0.2 mu T to 2 mu T on the modulation of hydrogen peroxide (H(2)O(2)) in human fibrosarcoma cancer cell line HT1080, pancreatic AsPC-1 cancer cell line, and bovine pulmonary artery endothelial cells (PAEC) exposed to geomagnetic field (control; 45 mu T-60 mu T). Reduction of the Earth's magnetic field suppressed H(2)O(2) production in cancer cells and PAEC. The addition of catalase and superoxide dismutase (SOD) mimetic MnTBAP inhibited the magnetic field effect. Modulating ROS production by magnetic fields may open new venues of biomedical research and therapeutic strategies.	[Martino, Carlos F.] Univ Colorado, Elect Comp & Energy Dept, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Martino, CF (corresponding author), Univ Nevada, Reno, NV 89557 USA.	martino@colorado.edu	Martino, Carlos F/C-6597-2016; Castello, Pablo R/AAL-7069-2021	Martino, Carlos F/0000-0002-0560-2604; 	Gordon Prize	Gordon Prize	Funding was provided by The Gordon Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKLEHURST B, 1976, J CHEM SOC FARAD T 2, V72, P1869, DOI 10.1039/f29767201869; Brocklehurst B, 1996, INT J RADIAT BIOL, V69, P3, DOI 10.1080/095530096146147; Castello PR, 2008, J PHARMACOL EXP THER, V324, P970, DOI 10.1124/jpet.107.132134; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Eveson RW, 2000, INT J RADIAT BIOL, V76, P1509, DOI 10.1080/09553000050176270; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628; KELLOGG EW, 1975, J BIOL CHEM, V250, P8812; KELLOGG EW, 1977, J BIOL CHEM, V252, P6721; MANNERLING AC, 2010, RAD ENV BIOPHYS; Martino CF, 2010, BIOELECTROMAGNETICS, V31, P296, DOI 10.1002/bem.20565; MARTINO CF, 2010, BIOELECTROM IN PRESS; Na AR, 2008, BIOCHEM BIOPH RES CO, V369, P672, DOI 10.1016/j.bbrc.2008.02.098; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; SALIKHOV KM, 1983, CHEM PHYS, V82, P163, DOI 10.1016/0301-0104(83)85354-3; Sheng KC, 2010, J IMMUNOL, V184, P2863, DOI 10.4049/jimmunol.0903458; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134; Timmel CR, 2004, PHILOS T ROY SOC A, V362, P2573, DOI 10.1098/rsta.2004.1459; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783	28	43	53	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e22753	10.1371/journal.pone.0022753	http://dx.doi.org/10.1371/journal.pone.0022753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887222	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298800001
J	van Helden, MJG; de Graaf, N; Bekker, CPJ; Boog, CJP; Zaiss, DMW; Sijts, AJAM				van Helden, Mary J. G.; de Graaf, Natascha; Bekker, Cornelis P. J.; Boog, Claire J. P.; Zaiss, Dietmar M. W.; Sijts, Alice J. A. M.			Immunoproteasome-Deficiency Has No Effects on NK Cell Education, but Confers Lymphocytes into Targets for NK Cells in Infected Wild-Type Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MHC CLASS-I; CD8(+) T-CELLS; INHIBITORY RECEPTORS; IMMUNE-RESPONSES; RESPONSIVENESS; REPERTOIRE; MOLECULES; SELF; TOLERANCE	Natural killer (NK) cells are part of the innate immune system and contribute to the eradication of virus infected cells and tumors. NK cells express inhibitory and activating receptors and their decision to kill a target cell is based on the balance of signals received through these receptors. MHC class I molecules are recognized by inhibitory receptors, and their presence during NK cell education influences the responsiveness of peripheral NK cells. We here demonstrate that mice with reduced MHC class I cell surface expression, due to deficiency of immunoproteasomes, have responsive NK cells in the periphery, indicating that the lower MHC class I levels do not alter NK cell education. Following adoptive transfer into wild-type (wt) recipients, immunoproteasome-deficient splenocytes are tolerated in naive but rejected in virus-infected recipients, in an NK cell dependent fashion. These results indicate that the relatively low MHC class I levels are sufficient to protect these cells from rejection by wt NK cells, but that this tolerance is broken in infection, inducing an NK cell-dependent rejection of immunoproteasome-deficient cells.	[van Helden, Mary J. G.; de Graaf, Natascha; Bekker, Cornelis P. J.; Zaiss, Dietmar M. W.; Sijts, Alice J. A. M.] Univ Utrecht, Fac Vet Med, Div Immunol, Utrecht, Netherlands; [Boog, Claire J. P.] Natl Inst Publ Hlth & Environm RIVM, Dept Vaccinol, Ctr Infect Dis Control, Bilthoven, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment	van Helden, MJG (corresponding author), Univ Utrecht, Fac Vet Med, Div Immunol, Utrecht, Netherlands.	d.zaiss@uu.nl; e.j.a.m.sijts@uu.nl		Sijts, Alice/0000-0003-3815-4788; Zaiss, Dietmar M.W./0000-0003-3596-7062	Top Institute Pharma [T4-214]; Wellcome Trust [WT085733MA]; National Institutes of Health [AI064576]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064576] Funding Source: NIH RePORTER	Top Institute Pharma; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Top Institute Pharma grant T4-214 (http://www.tipharma.com/), Wellcome Trust grant WT085733MA (http://www.wellcome.ac.uk), and National Institutes of Health grant AI064576 (http://grants.nih.gov/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Brodin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013174; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; de Graaf N, 2011, EUR J IMMUNOL, V41, P926, DOI 10.1002/eji.201041040; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; HOGLUND P, 1991, P NATL ACAD SCI USA, V88, P10332, DOI 10.1073/pnas.88.22.10332; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; LJUNGGREN HG, 1994, P NATL ACAD SCI USA, V91, P6520, DOI 10.1073/pnas.91.14.6520; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; Yokoyama WM, 2010, BIOL BLOOD MARROW TR, V16, pS97, DOI 10.1016/j.bbmt.2009.10.009; Zaiss DMW, 2008, INFECT IMMUN, V76, P1207, DOI 10.1128/IAI.01134-07	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23769	10.1371/journal.pone.0023769	http://dx.doi.org/10.1371/journal.pone.0023769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887316	Green Submitted, gold, Green Published			2022-12-25	WOS:000295832000057
J	Wang, YG; Kheir, MM; Chai, YS; Hu, J; Xing, DM; Lei, F; Du, LJ				Wang, Yugang; Kheir, Michael M.; Chai, Yushuang; Hu, Jun; Xing, Dongming; Lei, Fan; Du, Lijun			Comprehensive Study in the Inhibitory Effect of Berberine on Gene Transcription, Including TATA Box	PLOS ONE			English	Article							COPTIDIS-RHIZOMA EXTRACT; UP-REGULATION; IN-VITRO; BINDING PROTEIN; DNA; EXPRESSION; MECHANISM; TOXICITY	Berberine (BBR) is an established natural DNA intercalator with numerous pharmacological functions. However, currently there are neither detailed reports concerning the distribution of this alkaloid in living cells nor reports concerning the relationship between BBR's association with DNA and the function of DNA. Here we report that the distribution of BBR within the nucleus can be observed 30 minutes after drug administration, and that the content of berberine in the nucleus peaks at around 4 mu mol, which is twelve hours after drug administration. The spatial conformation of DNA and chromatin was altered immediately after their association with BBR. Moreover, this association can effectively suppress the transcription of DNA in living cell systems and cell-free systems. Electrophoretic mobility shift assays (EMSA) demonstrated further that BBR can inhibit the association between the TATA binding protein (TBP) and the TATA box in the promoter, and this finding was also attained in living cells by chromatin immunoprecipitation (ChIP). Based on results from this study, we hypothesize that berberine can suppress the transcription of DNA in living cell systems, especially suppressing the association between TBP and the TATA box by binding with DNA and, thus, inhibiting TATA box-dependent gene expression in a non-specific way. This novel study has significantly expanded the sphere of knowledge concerning berberine's pharmacological effects, beginning at its paramount initial interaction with the TATA box.	[Wang, Yugang; Kheir, Michael M.; Chai, Yushuang; Hu, Jun; Xing, Dongming; Lei, Fan; Du, Lijun] Tsinghua Univ, Prot Sci Lab, Minist Educ, Lab Pharmaceut Sci,Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Yugang; Kheir, Michael M.; Chai, Yushuang; Hu, Jun; Xing, Dongming; Lei, Fan; Du, Lijun] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Kheir, Michael M.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Tsinghua University; Tsinghua University; University of Michigan System; University of Michigan	Wang, YG (corresponding author), Tsinghua Univ, Prot Sci Lab, Minist Educ, Lab Pharmaceut Sci,Sch Life Sci, Beijing 100084, Peoples R China.	leifan@mail.tsinghua.edu.cn; lijundu@mail.tsinghua.edu.cn	Kheir, Michael/ABA-5760-2021; Wang, Yijun/F-3547-2012; Wang, Yijun/GXW-1763-2022	Kheir, Michael/0000-0001-6469-6746	National Natural Science Foundation of China [90713043, 30973896, 81073092]; National S&T Major Special Project for New Drug RD of China [2009ZX09103-301, 2009ZX09502, 2011ZX09101-002-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National S&T Major Special Project for New Drug RD of China	This study was supported by the National Natural Science Foundation of China (90713043, 30973896, and 81073092) and the National S&T Major Special Project for New Drug R&D of China (2009ZX09103-301, 2009ZX09502, and 2011ZX09101-002-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIHIKO T, 2001, BIOPHYS J, V81, P501; Bhadra K, 2008, BBA-GEN SUBJECTS, V1780, P1054, DOI 10.1016/j.bbagen.2008.05.005; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bonner J, 1968, METHODS ENZYMOL, V12, P3; BOVA S, 1992, J PHARMACOL EXP THER, V261, P318; Chen WH, 2005, BIOORGAN MED CHEM, V13, P1859, DOI 10.1016/j.bmc.2004.10.049; Chen YY, 2008, BIOMED CHROMATOGR, V22, P28, DOI 10.1002/bmc.889; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; CHIOU WF, 1991, EUR J PHARMACOL, V204, P35; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; KREY AK, 1969, SCIENCE, V166, P755, DOI 10.1126/science.166.3906.755; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; KUO CL, 1995, CANCER LETT, V93, P193, DOI 10.1016/0304-3835(95)03809-B; Lee S, 2007, BIOCHEM BIOPH RES CO, V362, P853, DOI 10.1016/j.bbrc.2007.08.060; Li HY, 2010, EUR J PHARMACOL, V649, P92, DOI 10.1016/j.ejphar.2010.09.023; Li WY, 1998, MICROCHEM J, V60, P84, DOI 10.1006/mchj.1998.1633; Lin CC, 2006, ANTICANCER RES, V26, P1097; Mazzini S, 2003, BIOORGAN MED CHEM, V11, P505, DOI 10.1016/S0968-0896(02)00466-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; STEPHEN KB, 1996, CURR OPIN STRUC BIOL, V6, P69; STEPHEN N, 2001, ROYAL SOC CHEM, V18, P291; STOCKERT JC, 1985, CHROMOSOMA, V93, P21, DOI 10.1007/BF01259441; Wang XL, 2005, NEUROSCI LETT, V379, P132, DOI 10.1016/j.neulet.2004.12.050; Wang Yugang, 2010, Zhongguo Zhong Yao Za Zhi, V35, P76; Wang Yugang, 2009, Zhongguo Zhong Yao Za Zhi, V34, P2261; Xu LH, 2005, CELL MOL IMMUNOL, V2, P295; Yin J, 2008, METABOLISM, V57, P712, DOI 10.1016/j.metabol.2008.01.013; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; [张小辉 ZHANG Xiaohui], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P1380; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064	34	365	379	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23495	10.1371/journal.pone.0023495	http://dx.doi.org/10.1371/journal.pone.0023495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887260	gold, Green Submitted, Green Published			2022-12-25	WOS:000294251800013
J	Oda, GA; Friesen, WO				Oda, Gisele A.; Friesen, W. Otto			Modeling Two-Oscillator Circadian Systems Entrained by Two Environmental Cycles	PLOS ONE			English	Article							FOOD-ANTICIPATORY ACTIVITY; SUPRACHIASMATIC NUCLEUS; MATHEMATICAL-MODEL; CLOCK NEURONS; LIGHT-DARK; TEMPERATURE; RHYTHMS; OSCILLATORS; PACEMAKER; ORGANIZATION	Several experimental studies have altered the phase relationship between photic and non-photic environmental, 24 h cycles (zeitgebers) in order to assess their role in the synchronization of circadian rhythms. To assist in the interpretation of the complex activity patterns that emerge from these "conflicting zeitgeber'' protocols, we present computer simulations of coupled circadian oscillators forced by two independent zeitgebers. This circadian system configuration was first employed by Pittendrigh and Bruce (1959), to model their studies of the light and temperature entrainment of the eclosion oscillator in Drosophila. Whereas most of the recent experiments have restricted conflicting zeitgeber experiments to two experimental conditions, by comparing circadian oscillator phases under two distinct phase relationships between zeitgebers (usually 0 and 12 h), Pittendrigh and Bruce compared eclosion phase under 12 distinct phase relationships, spanning the 24 h interval. Our simulations using non-linear differential equations replicated complex non-linear phenomena, such as "phase jumps'' and sudden switches in zeitgeber preferences, which had previously been difficult to interpret. Our simulations reveal that these phenomena generally arise when inter-oscillator coupling is high in relation to the zeitgeber strength. Manipulations in the structural symmetry of the model indicated that these results can be expected to apply to a wide range of system configurations. Finally, our studies recommend the use of the complete protocol employed by Pittendrigh and Bruce, because different system configurations can generate similar results when a "conflicting zeitgeber experiment'' incorporates only two phase relationships between zeitgebers.	[Oda, Gisele A.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Friesen, W. Otto] Univ Virginia, Dept Biol, Charlottesville, VA USA	Universidade de Sao Paulo; University of Virginia	Oda, GA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	gaoda@ib.usp.br	oda, gisele a/F-4283-2012	oda, gisele a/0000-0001-7776-5368	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [06/61276-0]; USA National Science Foundation [IOB-061563]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); USA National Science Foundation(National Science Foundation (NSF))	This work was supported by grant (06/61276-0; GAO) from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), and grant (IOB-061563; WOF) from USA National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; BRUCE VG, 1960, COLD SPRING HARB SYM, V25, P29, DOI 10.1101/SQB.1960.025.01.005; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; CHALLET E, 1998, AM J PHYSIOL, V274, P1751; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; FRIESEN WO, 2009, NEURODYNAMIX, V2; Glass L., 1988, CLOCKS CHAOS RHYTHMS; GWINNER E, 1966, EXPERIENTIA, V22, P765, DOI 10.1007/BF01901370; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Huang GC, 2006, EMBO J, V25, P5349, DOI 10.1038/sj.emboj.7601397; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; KRONAUER RE, 1982, AM J PHYSIOL, V242, pR3, DOI 10.1152/ajpregu.1982.242.1.R3; Lague M, 2000, PHYSIOL BEHAV, V70, P55, DOI 10.1016/S0031-9384(00)00246-8; Menaker M, 2006, P NATL ACAD SCI USA, V103, P3015, DOI 10.1073/pnas.0600360103; MENAKER M, 1966, SCIENCE, V154, P1579, DOI 10.1126/science.154.3756.1579; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; MROSOVSKY N, 1988, J COMP PHYSIOL A, V162, P35, DOI 10.1007/BF01342701; Nagano M, 2003, J NEUROSCI, V23, P6141; NEUMANN D, 1985, J INSECT PHYSIOL, V31, P549, DOI 10.1016/0022-1910(85)90111-8; Oda GA, 2002, J BIOL RHYTHM, V17, P76, DOI 10.1177/074873002129002357; Oda GA, 2000, J BIOL RHYTHM, V15, P246, DOI 10.1177/074873040001500306; PAGE TL, 1985, COMPREHENSIVE INSECT, V6, P632; PAVLIDIS T, 1967, B MATH BIOPHYS, V29, P291, DOI 10.1007/BF02476901; PITTENDRIGH C, 1958, P NATL ACAD SCI USA, V44, P965, DOI 10.1073/pnas.44.9.965; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Pittendrigh CS, 1959, PHOTOPERIODISM RELAT, P475, DOI DOI 10.1177/0748730413516309; Refinetti R, 2010, J BIOL RHYTHM, V25, P247, DOI 10.1177/0748730410372074; Reierth E, 1998, J BIOL RHYTHM, V13, P393, DOI 10.1177/074873098129000219; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Roces F, 1996, PHYSIOL ENTOMOL, V21, P138, DOI 10.1111/j.1365-3032.1996.tb00846.x; SANCHEZVAZQUEZ FJ, 1995, PHYSIOL BEHAV, V58, P705, DOI 10.1016/0031-9384(95)00116-Z; Schwartz MD, 2009, P NATL ACAD SCI USA, V106, P17540, DOI 10.1073/pnas.0906382106; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; SWEENEY BM, 1960, COLD SPRING HARB SYM, V25, P87, DOI 10.1101/SQB.1960.025.01.009; TAKAHASHI JS, 1982, J COMP PHYSIOL, V146, P245, DOI 10.1007/BF00610244; Tanaka K, 2003, NATURWISSENSCHAFTEN, V90, P76, DOI 10.1007/s00114-002-0390-3; van der Veen DR, 2006, P NATL ACAD SCI USA, V103, P3393, DOI 10.1073/pnas.0507825103; Watari Y, 2010, J INSECT PHYSIOL, V56, P1192, DOI 10.1016/j.jinsphys.2010.03.022; WEVER R, 1972, J THEOR BIOL, V36, P119, DOI 10.1016/0022-5193(72)90181-6; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Yoshii T, 2010, J BIOL RHYTHM, V25, P387, DOI 10.1177/0748730410381962; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	50	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23895	10.1371/journal.pone.0023895	http://dx.doi.org/10.1371/journal.pone.0023895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886835	Green Published, gold, Green Submitted			2022-12-25	WOS:000294128100039
J	Lai, KK; Stogios, PJ; Vu, C; Xu, X; Cui, H; Molloy, S; Savchenko, A; Yakunin, A; Gonzalez, CF				Lai, Kin-Kwan; Stogios, Peter J.; Vu, Clara; Xu, Xiaohui; Cui, Hong; Molloy, Sara; Savchenko, Alexei; Yakunin, Alexander; Gonzalez, Claudio F.			An Inserted alpha/beta Subdomain Shapes the Catalytic Pocket of Lactobacillus johnsonii Cinnamoyl Esterase	PLOS ONE			English	Article							FERULOYL ESTERASE; SUBSTRATE-SPECIFICITY; HUMAN VALACYCLOVIRASE; MAXIMUM-LIKELIHOOD; MOLECULAR-BASIS; PROTEIN; ACID; HYDROLASE; CRYSTALLIZATION; IDENTIFICATION	Background: Microbial enzymes produced in the gastrointestinal tract are primarily responsible for the release and biochemical transformation of absorbable bioactive monophenols. In the present work we described the crystal structure of LJ0536, a serine cinnamoyl esterase produced by the probiotic bacterium Lactobacillus johnsonii N6.2. Methodology/Principal Findings: We crystallized LJ0536 in the apo form and in three substrate-bound complexes. The structure showed a canonical alpha/beta fold characteristic of esterases, and the enzyme is dimeric. Two classical serine esterase motifs (GlyXSerXGly) can be recognized from the amino acid sequence, and the structure revealed that the catalytic triad of the enzyme is formed by Ser(106), His(225), and Asp(197), while the other motif is non-functional. In all substrate-bound complexes, the aromatic acyl group of the ester compound was bound in the deepest part of the catalytic pocket. The binding pocket also contained an unoccupied area that could accommodate larger ligands. The structure revealed a prominent inserted alpha/beta subdomain of 54 amino acids, from which multiple contacts to the aromatic acyl groups of the substrates are made. Inserts of this size are seen in other esterases, but the secondary structure topology of this subdomain of LJ0536 is unique to this enzyme and its closest homolog (Est1E) in the Protein Databank. Conclusions: The binding mechanism characterized (involving the inserted alpha/beta subdomain) clearly differentiates LJ0536 from enzymes with similar activity of a fungal origin. The structural features herein described together with the activity profile of LJ0536 suggest that this enzyme should be clustered in a new group of bacterial cinnamoyl esterases.	[Lai, Kin-Kwan; Vu, Clara; Molloy, Sara; Gonzalez, Claudio F.] Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA; [Stogios, Peter J.; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Vu, Clara; Molloy, Sara] Univ Florida, Dept Microbiol & Cell Sci, UF Undergrad Res Program MCB4905, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of Toronto; State University System of Florida; University of Florida	Lai, KK (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Genet Inst, Gainesville, FL 32611 USA.	cfgonzalez@ufl.edu	Yakunin, Alexander/J-1519-2014	Stogios, Peter/0000-0001-8663-1425; Yakunin, Alexander/0000-0003-0813-6490	Institute of Food and Agricultural Sciences, University of Florida; University of Florida	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); University of Florida(University of Florida)	This work was supported by the Research Innovation Award, Institute of Food and Agricultural Sciences, University of Florida. Publication of this article was also funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreasen MF, 2001, J AGR FOOD CHEM, V49, P5679, DOI 10.1021/jf010668c; Benoit I, 2007, APPL ENVIRON MICROB, V73, P5624, DOI 10.1128/AEM.00374-07; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; Choo WS, 2009, LIPIDS, V44, P145, DOI 10.1007/s11745-008-3242-x; Clifford MN, 2000, J SCI FOOD AGR, V80, P1118, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1118::AID-JSFA570&gt;3.0.CO;2-9, 10.1002/(SICI)1097-0010(20000515)80:7<1118::AID-JSFA570>3.0.CO;2-9]; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Dalrymple BP, 1996, FEMS MICROBIOL LETT, V143, P115, DOI 10.1016/0378-1097(96)00306-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faulds CB, 2005, FEBS J, V272, P4362, DOI 10.1111/j.1742-4658.2005.04849.x; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Hermoso JA, 2004, J MOL BIOL, V338, P495, DOI 10.1016/j.jmb.2004.03.003; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; Jemai H, 2009, J AGR FOOD CHEM, V57, P8798, DOI 10.1021/jf901280r; Karlsson PC, 2005, J NUTR, V135, P2343; Kim I, 2003, J BIOL CHEM, V278, P25348, DOI 10.1074/jbc.M302055200; Kimber MS, 2003, PROTEINS, V51, P562, DOI 10.1002/prot.10340; Konishi Y, 2005, J AGR FOOD CHEM, V53, P4740, DOI 10.1021/jf0478307; Konishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P583, DOI 10.1271/bbb.69.583; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroon PA, 1997, J AGR FOOD CHEM, V45, P661, DOI 10.1021/jf9604403; Lai KK, 2009, APPL ENVIRON MICROB, V75, P5018, DOI 10.1128/AEM.02837-08; Lai LS, 2008, J BIOL CHEM, V283, P9318, DOI 10.1074/jbc.M709530200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lorca GL, 2007, J BIOL CHEM, V282, P16476, DOI 10.1074/jbc.M610838200; Mastihuba V, 2002, ANAL BIOCHEM, V309, P96, DOI 10.1016/S0003-2697(02)00241-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Schubot FD, 2001, BIOCHEMISTRY-US, V40, P12524, DOI 10.1021/bi011391c; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Udatha DBRKG, 2011, BIOTECHNOL ADV, V29, P94, DOI 10.1016/j.biotechadv.2010.09.003; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Yin DL, 2010, BIOCHEMISTRY-US, V49, P1931, DOI 10.1021/bi9021268	53	41	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23269	10.1371/journal.pone.0023269	http://dx.doi.org/10.1371/journal.pone.0023269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876742	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900014
J	Marchal, M; Briandet, R; Halter, D; Koechler, S; Dubow, MS; Lett, MC; Bertin, PN				Marchal, Marie; Briandet, Romain; Halter, David; Koechler, Sandrine; DuBow, Michael S.; Lett, Marie-Claire; Bertin, Philippe N.			Subinhibitory Arsenite Concentrations Lead to Population Dispersal in Thiomonas sp.	PLOS ONE			English	Article							BIOFILMS; BIOREMEDIATION; METABOLISM; TOLERANCE; VIABILITY; OXIDATION; STRAINS; STRESS; CELLS	Biofilms represent the most common microbial lifestyle, allowing the survival of microbial populations exposed to harsh environmental conditions. Here, we show that the biofilm development of a bacterial species belonging to the Thiomonas genus, frequently found in arsenic polluted sites and playing a key role in arsenic natural remediation, is markedly modified when exposed to subinhibitory doses of this toxic element. Indeed, arsenite [As(III)] exposure led to a considerable impact on biofilm maturation by strongly increasing the extracellular matrix synthesis and by promoting significant cell death and lysis within microcolonies. These events were followed by the development of complex 3D-biofilm structures and subsequently by the dispersal of remobilized cells observed inside the previously formed hollow voids. Our results demonstrate that this biofilm community responds to arsenite stress in a multimodal way, enhancing both survival and dispersal. Addressing this complex bacterial response to As(III) stress, which might be used by other microorganisms under various adverse conditions, may be essential to understand how Thiomonas strains persist in extreme environments.	[Marchal, Marie; Halter, David; Koechler, Sandrine; Lett, Marie-Claire; Bertin, Philippe N.] CNRS, UMR7156, Strasbourg, France; [Marchal, Marie; Halter, David; Koechler, Sandrine; Lett, Marie-Claire; Bertin, Philippe N.] Univ Strasbourg, Strasbourg, France; [Briandet, Romain] INRA, MICALIS UMR1319, Jouy En Josas, France; [Briandet, Romain] AgroParisTech, UMR MICALIS, Massy, France; [DuBow, Michael S.] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR 8621, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Marchal, M (corresponding author), CNRS, UMR7156, Strasbourg, France.	philippe.bertin@unistra.fr	Briandet, Romain/AAD-2102-2020	Briandet, Romain/0000-0002-8123-3492; Philippe, Bertin/0000-0003-1158-6396	ANR; French Ministry of Education	ANR(French National Research Agency (ANR)); French Ministry of Education	MM was supported by a studentship from the ANR COBIAS project (PRECODD 2007}, and by Agence Nationale de la Recherche (http://cobias.brgm.fr/). DH was supported by a grant from the French Ministry of Education. This work was performed as part of the program of the "Groupement de Recherche Metabolisme de l'Arsenic chez les Microorganismes (GDR2909-CNRS)" (http://gdr2909.alsace.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Arsene-Ploetze F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000859; Barreto M, 2005, APPL ENVIRON MICROB, V71, P2902, DOI 10.1128/AEM.71.6.2902-2909.2005; Battaglia-Brunet F, 2006, ANTON LEEUW INT J G, V89, P99, DOI 10.1007/s10482-005-9013-2; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BERTIN PN, ISME J IN PRESS; Biggerstaff JP, 2006, MOL CELL PROBE, V20, P141, DOI 10.1016/j.mcp.2005.11.006; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Bruneel O, 2003, J APPL MICROBIOL, V95, P492, DOI 10.1046/j.1365-2672.2003.02004.x; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Cleiss-Arnold J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-709; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Kuehn M, 1998, APPL ENVIRON MICROB, V64, P4115; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; Mai-Prochnow A, 2006, APPL ENVIRON MICROB, V72, P5414, DOI 10.1128/AEM.00546-06; Michel C, 2007, APPL MICROBIOL BIOT, V77, P457, DOI 10.1007/s00253-007-1169-4; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053	26	35	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23181	10.1371/journal.pone.0023181	http://dx.doi.org/10.1371/journal.pone.0023181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876737	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900009
J	Davalos, V; Moutinho, C; Villanueva, A; Boque, R; Silva, P; Carneiro, F; Esteller, M				Davalos, V.; Moutinho, C.; Villanueva, A.; Boque, R.; Silva, P.; Carneiro, F.; Esteller, M.			Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis	ONCOGENE			English	Article						miR-200; cancer; EMT; epigenetic; CpG methylation	MIR-200 FAMILY; DNA METHYLATION; TGF-BETA; TUMOR PROGRESSION; REPRESSORS ZEB1; CELL POLARITY; CANCER; EXPRESSION; METASTASIS; EMT	Epithelial-mesenchymal (EMT) and mesenchymal-epithelial (MET) transitions occur in the development of human tumorigenesis and are part of the natural history of the process to adapt to the changing microenvironment. In this setting, the miR-200 family is recognized as a master regulator of the epithelial phenotype by targeting ZEB1 and ZEB2, two important transcriptional repressors of the cell adherence (E-cadherin) and polarity (CRB3 and LGL2) genes. Recently, the putative DNA methylation associated inactivation of various miR-200 members has been described in cancer. Herein, we show that the miR-200ba429 and miR-200c141 transcripts undergo a dynamic epigenetic regulation linked to EMT or MET phenotypes in tumor progression. The 5'-CpG islands of both miR-200 loci were found unmethylated and coupled to the expression of the corresponding miRNAs in human cancer cell lines with epithelial features, such as low levels of ZEB1/ZEB2 and high expression of E-cadherin, CRB3 and LGL2, while CpG island hypermethylation-associated silencing was observed in transformed cells with mesenchymal characteristics. The recovery of miR-200ba429 and miR-200c141 expression by stable transfection in the hypermethylated cells restored the epithelial markers and inhibited migration in cell culture and tumoral growth and metastasis formation in nude mice. We also discovered, using both cell culture and animal models, that the miR-200 epigenetic silencing is not an static and fixed process but it can be shifted to hypermethylated or unmethylated 5'-CpG island status corresponding to the EMT and MET phenotypes, respectively. In fact, careful laser microdissection in human primary colorectal tumorigenesis unveiled that in normal colon mucosa crypts (epithelia) and stroma (mesenchyma) already are unmethylated and methylated at these loci, respectively; and that the colorectal tumors undergo selective miR-200 hypermethylation of their epithelial component. These findings indicate that the epigenetic silencing plasticity of the miR-200 family contributes to the evolving and adapting phenotypes of human tumors. Oncogene (2012) 31, 2062-2074; doi:10.1038/onc.2011.383; published online 29 August 2011	[Davalos, V.; Moutinho, C.; Boque, R.; Esteller, M.] Hosp Duran i Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Villanueva, A.] IDIBELL Inst Catala Oncol, Translat Res Lab, Barcelona, Spain; [Silva, P.; Carneiro, F.] Univ Porto IPATIMUP, Inst Pathol & Mol Immunol, Oporto, Portugal; [Silva, P.; Carneiro, F.] Fac Med, Oporto, Portugal; [Esteller, M.] Univ Barcelona, Sch Med, Dept Ciencies Fisiol 2, Barcelona, Spain; [Esteller, M.] ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universidade do Porto; Universidade do Porto; University of Barcelona; ICREA	Esteller, M (corresponding author), Hosp Duran i Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, 3rd Floor,Av Gran Via 199-203, Barcelona 08908, Catalonia, Spain.	mesteller@idibell.cat	Davalos, Veronica/AAR-8547-2020; Carneiro, Fatima/AAV-8677-2021; Xie, Huangming/B-2260-2012; Carneiro, Fatima/J-6432-2013; Boque-Sastre, Raquel/AAA-6548-2020; Esteller, Manel/L-5956-2014; Davalos, Veronica/S-1668-2016	Carneiro, Fatima/0000-0002-1964-1006; Carneiro, Fatima/0000-0002-1964-1006; Esteller, Manel/0000-0003-4490-6093; Davalos, Veronica/0000-0003-4077-5137; , Raquel Boque-Sastre/0000-0002-0214-8848	Fondo de Investigaciones Sanitarias [PI08-1345]; Olga Torres Foundation; Consolider Grant [MEC09-05]; Dr Josef Steiner Cancer Research Foundation; Lilly Foundation; European Research Council; Health Department of the Catalan Government (Generalitat de Catalunya); Instituto de Salud Carlos III; ICREA Funding Source: Custom	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Olga Torres Foundation; Consolider Grant(Spanish Government); Dr Josef Steiner Cancer Research Foundation; Lilly Foundation; European Research Council(European Research Council (ERC)European Commission); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ICREA(ICREA)	We thank Dr Balazs Balint for bioinformatic support. This study was supported by Fondo de Investigaciones Sanitarias Grant PI08-1345, Olga Torres Foundation Grant, Consolider Grant MEC09-05, Dr Josef Steiner Cancer Research Foundation Award, Lilly Foundation Biomedical Research Award, European Research Council Advanced Grant EPINORC and the Health Department of the Catalan Government (Generalitat de Catalunya). VD is supported by Instituto de Salud Carlos III, Sara Borrell postdoctoral contract. ME is an Institucio Catalana de Recerca i Estudis Avancats (ICREA) Research Professor.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Agami R, 2010, EUR J CLIN INVEST, V40, P370, DOI 10.1111/j.1365-2362.2010.02279.x; Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Aokage K, 2011, INT J CANCER, V128, P1585, DOI 10.1002/ijc.25500; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chou JL, 2010, EXPERT OPIN THER TAR, V14, P1213, DOI 10.1517/14728222.2010.525353; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Fujimoto K, 2002, GASTROENTEROLOGY, V123, P1941, DOI 10.1053/gast.2002.37065; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2006, CELL CYCLE, V5, P1951, DOI 10.4161/cc.5.17.3133; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kaiser J, 2010, SCIENCE, V330, P576, DOI 10.1126/science.330.6004.577; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	63	258	270	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	16					2062	2074		10.1038/onc.2011.383	http://dx.doi.org/10.1038/onc.2011.383			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21874049	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000303008600007
J	Saito, M; Kurokawa, M; Oda, M; Oshima, M; Tsutsui, K; Kosaka, K; Nakao, K; Ogawa, M; Manabe, R; Suda, N; Ganjargal, G; Hada, Y; Noguchi, T; Teranaka, T; Sekiguchi, K; Yoneda, T; Tsuji, T				Saito, Masahiro; Kurokawa, Misaki; Oda, Masahito; Oshima, Masamitsu; Tsutsui, Ko; Kosaka, Kazutaka; Nakao, Kazuhisa; Ogawa, Miho; Manabe, Ri-ichiroh; Suda, Naoto; Ganjargal, Ganburged; Hada, Yasunobu; Noguchi, Toshihide; Teranaka, Toshio; Sekiguchi, Kiyotoshi; Yoneda, Toshiyuki; Tsuji, Takashi			ADAMTSL6 beta Protein Rescues Fibrillin-1 Microfibril Disorder in a Marfan Syndrome Mouse Model through the Promotion of Fibrillin-1 Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTAL FOLLICLE CELLS; EXTRACELLULAR-MATRIX; PERIODONTAL-LIGAMENT; MUSCLE REGENERATION; IN-VIVO; PATHOGENESIS; EXPRESSION; DISEASE; MUTATIONS; PHENOTYPE	Marfan syndrome (MFS) is a systemic disorder of the connective tissues caused by insufficient fibrillin-1 microfibril formation and can cause cardiac complications, emphysema, ocular lens dislocation, and severe periodontal disease. ADAMTSL6 beta (A disintegrin-like metalloprotease domain with thrombospondin type I motifs-like 6 beta) is a microfibril-associated extracellular matrix protein expressed in various connective tissues that has been implicated in fibrillin-1 microfibril assembly. We here report that ADAMTSL6 beta plays an essential role in the development and regeneration of connective tissues. ADAMTSL6 beta expression rescues microfibril disorder after periodontal ligament injury in an MFS mouse model through the promotion of fibrillin-1 microfibril assembly. In addition, improved fibrillin-1 assembly in MFS mice following the administration of ADAMTSL6 beta attenuates the overactivation of TGF-beta signals associated with the increased release of active TGF-beta from disrupted fibrillin-1 microfibrils within periodontal ligaments. Our current data thus demonstrate the essential contribution of ADAMTSL6 beta to fibrillin-1 microfibril formation. These findings also suggest a new therapeutic strategy for the treatment of MFS through ADAMTSL6 beta-mediated fibrillin-1 microfibril assembly.	[Saito, Masahiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Res Inst Sci & Technol, Chiba 2788510, Japan; [Saito, Masahiro; Kurokawa, Misaki; Oda, Masahito; Hada, Yasunobu; Tsuji, Takashi] Tokyo Univ Sci, Fac Ind Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Ogawa, Miho; Tsuji, Takashi] Organ Technol Inc, Tokyo, Japan; [Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan; [Tsutsui, Ko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Kosaka, Kazutaka; Teranaka, Toshio] Kanagawa Dent Coll, Dept Oral Med, Div Restorat Dent, Yokosuka Kanagawa 2388580, Japan; [Noguchi, Toshihide] Aichi Gakuin Univ, Sch Dent, Dept Periodontol, Nisshin 4700195, Japan; [Suda, Naoto; Ganjargal, Ganburged; Hada, Yasunobu] Tokyo Med & Dent Univ, Grad Sch, Tokyo 1130034, Japan; [Manabe, Ri-ichiroh] RIKEN Yokohama Inst, RIKEN Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Tokyo University of Science; Tokyo University of Science; Osaka University; Osaka University; Kanagawa Dental College; Aichi Gakuin University; Tokyo Medical & Dental University (TMDU); RIKEN	Saito, M (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Res Inst Sci & Technol, Chiba 2788510, Japan.	mssaito@rs.noda.tus.ac.jp	Tsuji, Takashi/N-6086-2015		Ministry of Health, Labour, and Welfare [23164001]; MEXT;  [23659980]; Grants-in-Aid for Scientific Research [21390509] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare (No. 23164001) (to M. S.), a Grant-in-aid for Scientific Research (B) (No. 23659980) (to M. S.), and Program for Development of Strategic Research Center in Private Universities supported by MEXT(2010) (to M. S.).	Ahram D, 2009, AM J HUM GENET, V84, P274, DOI 10.1016/j.ajhg.2009.01.007; Baldock C, 2006, P NATL ACAD SCI USA, V103, P11922, DOI 10.1073/pnas.0601609103; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Handa K, 2002, BONE, V31, P606, DOI 10.1016/S8756-3282(02)00868-2; Hasegawa T, 2007, CELL TISSUE RES, V329, P259, DOI 10.1007/s00441-007-0424-4; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Hutchinson S, 2003, HUM MOL GENET, V12, P2269, DOI 10.1093/hmg/ddg241; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; KAWAMOTO T, 1990, J HISTOCHEM CYTOCHEM, V38, P1805, DOI 10.1177/38.12.2254645; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nanci A, 2006, PERIODONTOL 2000, V40, P11, DOI 10.1111/j.1600-0757.2005.00141.x; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Nishida E, 2007, GENE, V404, P70, DOI 10.1016/j.gene.2007.09.009; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sawada T, 2006, J HISTOCHEM CYTOCHEM, V54, P1095, DOI 10.1369/jhc.5A6905.2006; Shiga M, 2008, CELL TISSUE RES, V331, P461, DOI 10.1007/s00441-007-0528-x; Staszyk C, 2004, ANAT HISTOL EMBRYOL, V33, P17, DOI 10.1111/j.1439-0264.2004.00503.x; Straub AM, 2002, J PERIODONTOL, V73, P823, DOI 10.1902/jop.2002.73.7.823; Tsuruga E, 2002, J DENT RES, V81, P771, DOI 10.1177/154405910208101110; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Yamamoto T, 2006, BLOOD, V108, P3305, DOI 10.1182/blood-2006-04-014829; Yokoi T, 2007, CELL TISSUE RES, V327, P301, DOI 10.1007/s00441-006-0257-6	51	32	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38602	38613		10.1074/jbc.M111.243451	http://dx.doi.org/10.1074/jbc.M111.243451			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880733	Green Published, hybrid			2022-12-25	WOS:000296594200073
J	Ghosh, A; Sakaguchi, R; Liu, CP; Vishveshwara, S; Hou, YM				Ghosh, Amit; Sakaguchi, Reiko; Liu, Cuiping; Vishveshwara, Saraswathi; Hou, Ya-Ming			Allosteric Communication in Cysteinyl tRNA Synthetase A NETWORK OF DIRECT AND INDIRECT READOUT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DISCRIMINATION; PROTEIN STRUCTURES; ESSENTIAL DYNAMICS; RECOGNITION; PATHWAYS; TRANSITIONS; DOMAIN; GROEL	Protein structure networks are constructed for the identification of long-range signaling pathways in cysteinyl tRNA synthetase (CysRS). Molecular dynamics simulation trajectory of CysRS-ligand complexes were used to determine conformational ensembles in order to gain insight into the allosteric signaling paths. Communication paths between the anticodon binding region and the aminoacylation region have been identified. Extensive interaction between the helix bundle domain and the anticodon binding domain, resulting in structural rigidity in the presence of tRNA, has been detected. Based on the predicted model, six residues along the communication paths have been examined by mutations (single and double) and shown to mediate a coordinated coupling between anticodon recognition and activation of amino acid at the active site. This study on CysRS clearly shows that specific key residues, which are involved in communication between distal sites in allosteric proteins but may be elusive in direct structure analysis, can be identified from dynamics of protein structure networks.	[Ghosh, Amit; Vishveshwara, Saraswathi] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Sakaguchi, Reiko; Liu, Cuiping; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA USA; [Ghosh, Amit] Univ Illinois, Dept Chem & Biomol Engn, Inst Genom Biol, Urbana, IL 61801 USA	Indian Institute of Science (IISC) - Bangalore; Jefferson University; University of Illinois System; University of Illinois Urbana-Champaign	Vishveshwara, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	sv@mbu.iisc.ernet.in; Ya-Ming.Hou@jefferson.edu	Ghosh, Amit/AAB-3140-2019; Ghosh, Amit/AAA-3490-2021	Ghosh, Amit/0000-0003-3514-885X; Hou, Ya-Ming/0000-0001-6546-2597	National Institutes of Health [GM56662]; Department of Science and Technology (DST), Government of India [DSTO773]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56662 (to Y.-M. H.).; We acknowledge the Computational grants for the Indian Institute of Science from the Department of Science and Technology (DST) ( support for Mathematical Biology, DSTO773), Government of India, and the computational facilities at the Supercomputer Education and Research Centre, Indian Institute of Science, Bangalore. We thank Moitrayee Bhattacharyya for readings of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Alexander RW, 1999, BIOCHEMISTRY-US, V38, P16359, DOI 10.1021/bi991948c; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Atilgan C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000544; Bhattacharyya M, 2010, PROTEINS, V78, P506, DOI 10.1002/prot.22573; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Case D, 2006, AMBER 9; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Christian T, 2000, J MOL BIOL, V303, P503, DOI 10.1006/jmbi.2000.4169; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Crepin T, 2003, J MOL BIOL, V332, P59, DOI 10.1016/S0022-2836(03)00917-3; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Ghosh A, 2008, BIOCHEMISTRY-US, V47, P11398, DOI 10.1021/bi8007559; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Ghosh A, 2007, BIOPHYS J, V92, P2523, DOI 10.1529/biophysj.106.099903; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hansia P, 2009, MOL BIOSYST, V5, P1860, DOI 10.1039/b903807h; Hauenstein S, 2004, NAT STRUCT MOL BIOL, V11, P1134, DOI 10.1038/nsmb849; HOU YM, 1991, P NATL ACAD SCI USA, V88, P976, DOI 10.1073/pnas.88.3.976; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KOMATSOULIS GA, 1993, BIOCHEMISTRY-US, V32, P7435, DOI 10.1021/bi00080a014; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Liu CP, 2007, J MOL BIOL, V367, P1063, DOI 10.1016/j.jmb.2007.01.050; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Newberry KJ, 2002, EMBO J, V21, P2778, DOI 10.1093/emboj/21.11.2778; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423; Zhang CM, 2003, BIOCHEMISTRY-US, V42, P10931, DOI 10.1021/bi034812u; Zhang CM, 2003, J MOL BIOL, V327, P911, DOI 10.1016/S0022-2836(03)00241-9; Zheng W, 2007, BIOPHYS J, V93, P2289, DOI 10.1529/biophysj.107.105270	44	61	62	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37721	37731		10.1074/jbc.M111.246702	http://dx.doi.org/10.1074/jbc.M111.246702			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890630	Green Published, hybrid			2022-12-25	WOS:000296542400068
J	Jansen, C; Hofheinz, K; Vogel, R; Roffeis, J; Anton, M; Reddanna, P; Kuhn, H; Walther, M				Jansen, Christian; Hofheinz, Katharina; Vogel, Robert; Roffeis, Jana; Anton, Monika; Reddanna, Pallu; Kuhn, Hartmut; Walther, Matthias			Stereocontrol of Arachidonic Acid Oxygenation by Vertebrate Lipoxygenases NEWLY CLONED ZEBRAFISH LIPOXYGENASE 1 DOES NOT FOLLOW THE ALA-VERSUS-GLY CONCEPT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; POSITIONAL SPECIFICITY; ACTIVE-SITE; PRODUCT STEREOCHEMISTRY; SEQUENCE DETERMINANTS; PEROXYL RADICALS; STRUCTURAL BASIS; SP PCC-7120; 15-LIPOXYGENASE; MODEL	Background: R-LOX carries a Gly at a critical position, but S-LOX contains an Ala there. Results: Zebrafish LOX1 carries a Gly at this position but catalyzed 12S-lipoxygenation. Conclusion: The Ala-versus-Gly concept is not applicable to zebrafish LOX1. Significance: Prediction of LOX specificity on the basis of primary structure is not always accurate; functional studies are always required.	[Jansen, Christian; Hofheinz, Katharina; Vogel, Robert; Roffeis, Jana; Anton, Monika; Kuhn, Hartmut; Walther, Matthias] Charite, Inst Biochem, D-10117 Berlin, Germany; [Reddanna, Pallu] Univ Hyderabad, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hyderabad	Kuhn, H (corresponding author), Charite, Inst Biochem, Oudenarderstr 16, D-13347 Berlin, Germany.	hartmut.kuehn@charite.de			European Commission [LSHM-CT-2004-0050333]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by European Commission FP6 Grant LSHM-CT-2004-0050333 (to H. K.).	Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Bhattacharya S, 2009, TUMOR BIOL, V30, P185, DOI 10.1159/000236864; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Borngraber S, 1999, J BIOL CHEM, V274, P37345, DOI 10.1074/jbc.274.52.37345; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Burger F, 2000, BIOCHEM J, V348, P329, DOI 10.1042/bj3480329; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Coffa G, 2005, J BIOL CHEM, V280, P38756, DOI 10.1074/jbc.M504870200; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; FEUSSNER I, 1995, P NATL ACAD SCI USA, V92, P11849, DOI 10.1073/pnas.92.25.11849; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Hersberger M, 2010, CLIN CHEM LAB MED, V48, P1063, DOI 10.1515/CCLM.2010.212; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Johannesson M, 2010, PROSTAG LEUKOTR ESS, V82, P121, DOI 10.1016/j.plefa.2009.11.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitaguchi H, 2005, J AM CHEM SOC, V127, P6605, DOI 10.1021/ja044345j; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Moreno JJ, 2009, BIOCHEM PHARMACOL, V77, P1, DOI 10.1016/j.bcp.2008.07.033; NELSON MJ, 1994, BIOCHEMISTRY-US, V33, P4966, DOI 10.1021/bi00182a027; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; SUZUKI H, 1994, BBA-LIPID LIPID MET, V1210, P308, DOI 10.1016/0005-2760(94)90234-8; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Vascotto SG, 1997, BIOCHEM CELL BIOL, V75, P479, DOI 10.1139/bcb-75-5-479; Vogel R, 2010, J BIOL CHEM, V285, P5369, DOI 10.1074/jbc.M109.057802; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374	43	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37804	37812		10.1074/jbc.M111.259242	http://dx.doi.org/10.1074/jbc.M111.259242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880725	hybrid, Green Published			2022-12-25	WOS:000296542400075
J	Lam, KKW; Chiu, PCN; Lee, CL; Pang, RTK; Leung, CON; Koistinen, H; Seppala, M; Ho, PC; Yeung, WSB				Lam, Kevin K. W.; Chiu, Philip C. N.; Lee, Cheuk-Lun; Pang, Ronald T. K.; Leung, Carmen O. N.; Koistinen, Hannu; Seppala, Markku; Ho, Pak-Chung; Yeung, William S. B.			Glycodelin-A Protein Interacts with Siglec-6 Protein to Suppress Trophoblast Invasiveness by Down-regulating Extracellular Signal-regulated Kinase (ERK)/c-Jun Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATERNAL-FETAL INTERFACE; C-JUN; MATRIX METALLOPROTEINASE-2; INFLAMMATORY CYTOKINES; NEGATIVE REGULATION; IMMUNE-SYSTEM; MAP KINASES; IN-VITRO; ACTIVATION; EXPRESSION	During placentation, the cytotrophoblast differentiates into the villous cytotrophoblast and the extravillous cytotrophoblast. The latter invades the decidualized endometrium. Glycodelin-A (GdA) is abundantly synthesized by the decidua but not the trophoblast. Previous data indicate that GdA suppresses the invasion of trophoblast cell lines by down-regulating proteinase expression and activities. This study addresses the signaling pathway involved in the above phenomenon. GdA was found to suppress phosphorylation of ERKs and expression of their downstream effector c-Jun, a component of the transcription factor activator protein-1 (AP-1). The involvement of ERKs and c-Jun in suppressing trophoblast invasion and biosynthesis of proteinases was confirmed by using siRNA knockdown and pharmacological inhibitors. Desialylation reduced binding affinity of GdA toward and invasion suppressive activities on the trophoblast. Co-immunoprecipitation showed that Siglec-6 on the trophoblast was the binding protein of GdA. The binding of GdA to Siglec-6 was sialic acid-dependent. Treatment with anti-Siglec-6 antibody abolished the invasion suppressive activities of GdA. These results show that GdA interacts with Siglec-6 to suppress trophoblast invasiveness by down-regulating the ERK/c-Jun signaling pathway.	[Lam, Kevin K. W.; Chiu, Philip C. N.; Lee, Cheuk-Lun; Pang, Ronald T. K.; Leung, Carmen O. N.; Ho, Pak-Chung; Yeung, William S. B.] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Chiu, Philip C. N.; Lee, Cheuk-Lun; Pang, Ronald T. K.; Ho, Pak-Chung; Yeung, William S. B.] Univ Hong Kong, Queen Mary Hosp, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, Dept Clin Chem, Helsinki 00029, Finland; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland	University of Hong Kong; University of Hong Kong; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Yeung, WSB (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	wsbyeung@hkucc.hku.hk	Koistinen, Hannu/AGU-1279-2022; Chiu, Chi Ngong/C-4245-2009; Seppala, Markku/AAT-6618-2021; Lee, Cheuk Lun/AGX-5720-2022; /B-8039-2013	Koistinen, Hannu/0000-0003-0926-3109; Chiu, Chi Ngong/0000-0001-6217-1970; Lee, Cheuk Lun/0000-0003-1553-3478; /0000-0001-5464-4125	Research Grant Council of Hong Kong [HKU7635/08M]; Academy of Finland; Helsinki University Central Hospital	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Academy of Finland(Academy of Finland); Helsinki University Central Hospital	This work was supported in part by the Research Grant Council of Hong Kong (Grant HKU7635/08M) and by the Academy of Finland and Helsinki University Central Hospital Research Funds.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Assi K, 2006, IMMUNOLOGY, V118, P112, DOI 10.1111/j.1365-2567.2006.02349.x; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; Byrne B, 2007, DRUG DISCOV TODAY, V12, P319, DOI 10.1016/j.drudis.2007.02.010; Chez R A, 1976, Perspect Nephrol Hypertens, V5, P421; Chiu PCN, 2003, BIOL REPROD, V69, P365, DOI 10.1095/biolreprod.102.012658; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Chiu PCN, 2010, HUM REPROD, V25, P2721, DOI 10.1093/humrep/deq243; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; DECESARE D, 1995, ONCOGENE, V11, P365; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Feng Hui Chen, 2005, J Soc Gynecol Investig, V12, pe21, DOI 10.1016/j.jsgi.2005.02.008; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Guccione M, 2002, AM J PHYSIOL-RENAL, V282, pF164, DOI 10.1152/ajprenal.0318.2000; HOWELL RJS, 1989, ACTA OBSTET GYN SCAN, V68, P237, DOI 10.3109/00016348909020995; Irwin JC, 2001, J CLIN ENDOCR METAB, V86, P2060, DOI 10.1210/jc.86.5.2060; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Jeschke U, 2005, VIRCHOWS ARCH, V446, P360, DOI 10.1007/s00428-004-1201-3; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Kita N, 2003, PLACENTA, V24, P164, DOI 10.1053/plac.2002.0880; Lam KKW, 2009, HUM REPROD, V24, P2093, DOI 10.1093/humrep/dep205; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lee CL, 2011, HUM REPROD, V26, P517, DOI 10.1093/humrep/deq381; Lee CL, 2010, FERTIL STERIL, V94, P769, DOI 10.1016/j.fertnstert.2009.10.009; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Linden ECMBVD, 2007, GLYCOBIOLOGY, V17, P922, DOI 10.1093/glyco/cwm065; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Milstone DS, 2000, DEV DYNAM, V219, P63, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1035>3.0.CO;2-D; Moon KC, 2008, PLACENTA, V29, P391, DOI 10.1016/j.placenta.2008.02.001; Morris HR, 1996, J BIOL CHEM, V271, P32159, DOI 10.1074/jbc.271.50.32159; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nagamine Y, 2005, THROMB HAEMOSTASIS, V93, P661, DOI 10.1160/TH04-12-0814; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Poornima BL, 2007, FEBS LETT, V581, P4366, DOI 10.1016/j.febslet.2007.07.078; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Rohrschneider LR, 2000, GENE DEV, V14, P505; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shiverick KT, 2001, PLACENTA, V22, pS104, DOI 10.1053/plac.2001.0647; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Takai N, 2006, GYNECOL OBSTET INVES, V61, P15, DOI 10.1159/000087855; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Varki A., 2009, ESSENTIALS GLYCOBIOL; VERDE P, 1988, NUCLEIC ACIDS RES, V16, P10699, DOI 10.1093/nar/16.22.10699; von Gunten S, 2006, FASEB J, V20, P601, DOI 10.1096/fj.05-5401hyp; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Yeung WSB, 2006, MOL CELL ENDOCRINOL, V250, P149, DOI 10.1016/j.mce.2005.12.038; Yeung WSB, 2009, J REPROD IMMUNOL, V83, P26, DOI 10.1016/j.jri.2009.04.012	65	36	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37118	37127		10.1074/jbc.M111.233841	http://dx.doi.org/10.1074/jbc.M111.233841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880722	hybrid, Green Published			2022-12-25	WOS:000296542400012
J	Osabe, M; Negishi, M				Osabe, Makoto; Negishi, Masahiko			Active ERK1/2 Protein Interacts with the Phosphorylated Nuclear Constitutive Active/Androstane Receptor (CAR; NR1I3), Repressing Dephosphorylation and Sequestering CAR in the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-LIVER; CYP2B GENE; INDUCTION; KINASE; TRANSLOCATION; ACTIVATION; ENZYMES; PXR	The nuclear constitutive active/androstane receptor (CAR) is inactivated and sequestered in the cytoplasm when Thr-38 is phosphorylated. Here, we have demonstrated that activated ERK1/2 interacts with phosphorylated CAR to repress dephosphorylation of Thr-38. The phosphorylation-dependent interaction between CAR and ERK1/2 was examined by co-immunoprecipitation experiments of ectopically expressed FLAG-tagged CAR T38A and CAR T38D mutants with endogenous phospho-ERK1/2 in Huh-7 cells. Phospho-ERK1/2 coprecipitated only the phosphorylation-mimicking CAR T38D mutant; this coprecipitation was mediated by the interaction with the xenochemical response signal peptide near the C terminus of CAR. This interaction increased after EGF treatment and decreased after treatment with the MEK inhibitor U0126 as well as after knockdown of MEK1/2 by shRNA in Huh-7 cells. The phosphorylation levels of Thr-38 of CAR decreased in U0126-treated Huh-7 cells. Thus, activated ERK1/2 interacts with CAR and represses dephosphorylation of Thr-38, providing a cell signal-regulated mechanism for CAR activation.	[Osabe, Makoto; Negishi, Masahiko] NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	National Institutes of Health; National Institutes of Health, NIEHS [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and National Institutes of Health Grant Z01ES1005-01 from NIEHS.	Bauer D, 2004, MOL PHARMACOL, V65, P172, DOI 10.1124/mol.65.1.172; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Kamino H, 2012, MOL CARCINOGEN, V51, P206, DOI 10.1002/mc.20783; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Osabe M, 2008, BIOCHEM BIOPH RES CO, V369, P1027, DOI 10.1016/j.bbrc.2008.02.140; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Ueda A, 2002, MOL PHARMACOL, V61, P1284, DOI 10.1124/mol.61.6.1284; Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamamoto Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010121; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	19	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35763	35769		10.1074/jbc.M111.284596	http://dx.doi.org/10.1074/jbc.M111.284596			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21873423	hybrid, Green Published			2022-12-25	WOS:000295927100049
J	Fontaneto, D; Westberg, M; Hortal, J				Fontaneto, Diego; Westberg, Martin; Hortal, Joaquin			Evidence of Weak Habitat Specialisation in Microscopic Animals	PLOS ONE			English	Article							GENERAL-PURPOSE GENOTYPE; HOST-SPECIFICITY; SPECIES RICHNESS; DIVERSITY; BIOGEOGRAPHY; ROTIFERS; PATTERNS; MICROORGANISMS; DISTRIBUTIONS; DISPERSAL	Macroecology and biogeography of microscopic organisms (any living organism smaller than 2 mm) are quickly developing into fruitful research areas. Microscopic organisms also offer the potential for testing predictions and models derived from observations on larger organisms due to the feasibility of performing lab and mesocosm experiments. However, more empirical knowledge on the similarities and differences between micro- and macro-organisms is needed to ascertain how much of the results obtained from the former can be generalised to the latter. One potential misconception, based mostly on anedoctal evidence rather than explicit tests, is that microscopic organisms may have wider ecological tolerance and a lower degree of habitat specialisation than large organisms. Here we explicitly test this hypothesis within the framework of metacommunity theory, by studying host specificify in the assemblages of bdelloid rotifers (animals about 350 mm in body length) living in different species of lichens in Sweden. Using several regression-based and ANOVA analyses and controlling for both spatial structure and the kind of substrate the lichen grow over (bark vs rock), we found evidence of significant but weak species-specific associations between bdelloids and lichens, a wide overlap in species composition between lichens, and wide ecological tolerance for most bdelloid species. This confirms that microscopic organisms such as bdelloids have a lower degree of habitat specialisation than larger organisms, although this happens in a complex scenario of ecological processes, where source-sink dynamics and geographic distances seem to have no effect on species composition at the analysed scale.	[Fontaneto, Diego] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [Fontaneto, Diego] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; [Westberg, Martin] Swedish Museum Nat Hist, Dept Cryptogam Bot, S-10405 Stockholm, Sweden; [Hortal, Joaquin] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain; [Hortal, Joaquin] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil	Imperial College London; Swedish Museum of Natural History; Swedish Museum of Natural History; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidade Federal de Goias	Fontaneto, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, Ascot, Berks, England.	d.fontaneto@imperial.ac.uk	Hortal, Joaquín/A-1531-2008; Fontaneto, Diego/B-9710-2008	Hortal, Joaquín/0000-0002-8370-8877; Fontaneto, Diego/0000-0002-5770-0353	Swedish Taxonomy Initiative; Natural Environmental Research Council (United Kingdom); Lars Hiertas Minne (Sweden); Spanish Ministerio de Ciencia e Innovacion; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [400130/2010-6]; NERC [NE/G013179/1] Funding Source: UKRI; Natural Environment Research Council [NE/G013179/1] Funding Source: researchfish	Swedish Taxonomy Initiative; Natural Environmental Research Council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Lars Hiertas Minne (Sweden); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has received financial support from the Swedish Taxonomy Initiative to DF and MW, from Natural Environmental Research Council (United Kingdom) and Lars Hiertas Minne (Sweden) to DF, and from the Spanish Ministerio de Ciencia e Innovacion and Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to JH through a Ramon y Cajal grant and the Visiting Researcher grant 400130/2010-6, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Bass D, 2011, BIOGEOGRAPHY MICROSC, P88; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; BURGER ANDRE, 1948, TRANS AMER MICROSC SOC, V67, P111, DOI 10.2307/3223491; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Culberson C.F., 1969, CHEM BOT GUIDE LICHE; Culberson C. F, 1977, CHEM BOT GUIDE LICHE; DONNER J, 1965, ORDNUNG BDELLOIDEA; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Elix JA, 2008, LICHEN BIOLOGY, 2ND EDITION, P104, DOI 10.1017/CBO9780511790478.008; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Fontaneto D, 2006, GLOBAL ECOL BIOGEOGR, V15, P153, DOI 10.1111/j.1466-822X.2006.00193.x; FONTANETO D, BIOGEOGRAPHY MICROSC; Fontaneto D, 2008, MOL ECOL, V17, P3136, DOI 10.1111/j.1365-294X.2008.03806.x; Fontaneto D, 2006, J MAR BIOL ASSOC UK, V86, P623, DOI 10.1017/S0025315406013531; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2010, LIMNOL OCEANOGR, V55, P1327, DOI 10.4319/lo.2010.55.3.1327; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Francez A.J., 1981, Revue des Sciences Naturelles d'Auvergne, V46, P21; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Guil N, 2009, SYST BIODIVERS, V7, P259, DOI 10.1017/S1477200009003016; Hortal J., 2011, MICROBIAL BIOGEOGRAP, P335; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; JENKINS DG, 2011, BIOGEOGRAPHY MICROSC, P309; Kawakita A, 2010, P ROY SOC B-BIOL SCI, V277, P2765, DOI 10.1098/rspb.2010.0355; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Maestre FT, 2004, DIVERS DISTRIB, V10, P21, DOI 10.1111/j.1472-4642.2004.00057.x; Marchant R, 2008, APPL MICROBIOL BIOT, V78, P841, DOI 10.1007/s00253-008-1372-y; MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Nesteruk T, 1996, HYDROBIOLOGIA, V339, P141, DOI 10.1007/BF00008922; Obertegger U, 2010, GLOBAL ECOL BIOGEOGR, V19, P895, DOI 10.1111/j.1466-8238.2010.00556.x; Oksanen J, 2010, R PACKAGE VERSION 1; Pagano A, 2008, J ZOOL SYST EVOL RES, V46, P162, DOI 10.1111/j.1439-0469.2007.00439.x; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; RICCI CN, 1987, HYDROBIOLOGIA, V147, P117, DOI 10.1007/BF00025734; Segers Hendrik, 2007, Zootaxa, V1564, P1; Tobias R. D., 2003, INTRO PARTIAL LEAST; Van Doninck K, 2002, OECOLOGIA, V132, P205, DOI 10.1007/s00442-002-0939-z; Vorburger C, 2003, ECOL LETT, V6, P1091, DOI 10.1046/j.1461-0248.2003.00536.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zuur Alain F., 2009, P1	49	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23969	10.1371/journal.pone.0023969	http://dx.doi.org/10.1371/journal.pone.0023969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887355	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000080
J	Liu, YD; Shen, H; Zhou, ZT; Hu, DW				Liu, Yadong; Shen, Hui; Zhou, Zongtan; Hu, Dewen			Sustained Negative BOLD Response in Human fMRI Finger Tapping Task	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; PRIMARY MOTOR CORTEX; HUMAN VISUAL-CORTEX; SIGNAL DECREASES; CEREBRAL-CORTEX; DEACTIVATION; ORIGIN; BRAIN; SUPPRESSION; INHIBITION	In this work, we investigated the sustained negative blood oxygen level-dependent (BOLD) response (sNBR) using functional magnetic resonance imaging during a finger tapping task. We observed that the sNBR for this task was more extensive than has previously been reported. The cortical regions involved in sNBR are divided into the following three groups: frontal, somatosensory and occipital. By investigating the spatial structure, area, amplitude, and dynamics of the sNBR in comparison with those of its positive BOLD response (PBR) counterpart, we made the following observations. First, among the three groups, the somatosensory group contained the greatest number of activated voxels and the fewest deactivated voxels. In addition, the amplitude of the sNBR in this group was the smallest among the three groups. Second, the onset and peak time of the sNBR are both larger than those of the PBR, whereas the falling edge time of the sNBR is less than that of the PBR. Third, the long distance between most sNBR foci and their corresponding PBR foci makes it unlikely that they share the same blood supply artery. Fourth, the couplings between the sNBR and its PBR counterpart are distinct among different regions and thus should be investigated separately. These findings imply that the origin of most sNBR foci in the finger-tapping task is much more likely to be neuronal activity suppression rather than "blood steal."	[Liu, Yadong; Shen, Hui; Zhou, Zongtan; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Liu, YD (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/AAN-8511-2020; Hu, Dewen/D-1978-2015		National Basic Research Program of China [2011CB707802, 2007CB311001]; Natural Science Foundation of China [60835005, 61005083, 90820304, 61003202]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB707802, 2007CB311001) and the Natural Science Foundation of China (60835005, 61005083, 90820304, 61003202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; Boorman L, 2010, J NEUROSCI, V30, P4285, DOI 10.1523/JNEUROSCI.6063-09.2010; Bressler D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000410; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Hamzei F, 2002, NEUROIMAGE, V17, P490, DOI 10.1006/nimg.2002.1077; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hyvarinen A., INDEPENDENT COMPONEN, V46; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Newton JM, 2005, NEUROIMAGE, V24, P1080, DOI 10.1016/j.neuroimage.2004.10.003; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Pouratian N., 2002, BRAIN MAPPING METHOD, V2nd, P97; Rodriguez-Baeza A, 1998, ANAT RECORD, V252, P176, DOI 10.1002/(SICI)1097-0185(199810)252:2<176::AID-AR3>3.0.CO;2-1; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; SHMUEL A, 2003, NEUROIMAGE S, V19, P309; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Woolsey TA, 1996, CEREB CORTEX, V6, P647, DOI 10.1093/cercor/6.5.647; YEVHEN H, 2006, J NEUROSCI, V26, P5819; Yin HB, 2011, BRAIN RES BULL, V84, P157, DOI 10.1016/j.brainresbull.2010.12.004	29	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23839	10.1371/journal.pone.0023839	http://dx.doi.org/10.1371/journal.pone.0023839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887329	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000065
J	MacDonald, BT; Semenov, MV; Huang, H; He, X				MacDonald, Bryan T.; Semenov, Mikhail V.; Huang, He; He, Xi			Dissecting Molecular Differences between Wnt Coreceptors LRP5 and LRP6	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; HIGH-BONE-MASS; SIGNAL-TRANSDUCTION; PPPSP MOTIFS; BETA-CATENIN; DENSITY; MICE; INHIBITION; MUTATION; DISEASE	Low-density lipoprotein receptor-related proteins 5 and 6 (LRP5 and LRP6) serve as Wnt co-receptors for the canonical beta-catenin pathway. While LRP6 is essential for embryogenesis, both LRP5 and LRP6 play critical roles for skeletal remodeling, osteoporosis pathogenesis and cancer formation, making LRP5 and LRP6 key therapeutic targets for cancer and disease treatment. LRP5 and LRP6 each contain in the cytoplasmic domain five conserved PPPSPxS motifs that are pivotal for signaling and serve collectively as phosphorylation-dependent docking sites for the scaffolding protein Axin. However existing data suggest that LRP6 is more effective than LRP5 in transducing the Wnt signal. To understand the molecular basis that accounts for the different signaling activity of LRP5 and LRP6, we generated a series of chimeric receptors via swapping LRP5 and LRP6 cytoplasmic domains, LRP5C and LRP6C, and studied their Wnt signaling activity using biochemical and functional assays. We demonstrate that LRP6C exhibits strong signaling activity while LRP5C is much less active in cells. Recombinant LRP5C and LRP6C upon in vitro phosphorylation exhibit similar Axin-binding capability, suggesting that LRP5 and LRP6 differ in vivo at a step prior to Axin-binding, likely at receiving phosphorylation. We identified between the two most carboxyl PPPSPxS motifs an intervening "gap4" region that appears to account for much of the difference between LRP5C and LRP6C, and showed that alterations in this region are sufficient to enhance LRP5 PPPSPxS phosphorylation and signaling to levels comparable to LRP6 in cells. In addition we provide evidence that binding of phosphorylated LRP5 or LRP6 to Axin is likely direct and does not require the GSK3 kinase as a bridging intermediate as has been proposed. Our studies therefore uncover a new and important molecular tuning mechanism for differential regulation of LRP5 and LRP6 phosphorylation and signaling activity.	[MacDonald, Bryan T.; Semenov, Mikhail V.; Huang, He; He, Xi] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	MacDonald, BT (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu			National Institutes of Health [RO1 GM74241]; Ruth L. Kirschstein National Research Service; Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health grant (RO1 GM74241) to XH, who was a Leukemia and Lymphoma Society Scholar. BTM and HH were supported by a Ruth L. Kirschstein National Research Service Award and Institutes of Health Research postdoctoral fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Balemans W, 2007, ENDOCRINOLOGY, V148, P2622, DOI 10.1210/en.2006-1352; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Houston DW, 2002, MECH DEVELOP, V117, P337, DOI 10.1016/S0925-4773(02)00205-8; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu WZ, 2008, CIRC RES, V103, P1280, DOI 10.1161/CIRCRESAHA.108.183863; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yum S, 2009, BIOCHEM BIOPH RES CO, V381, P345, DOI 10.1016/j.bbrc.2009.02.044; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	42	41	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23537	10.1371/journal.pone.0023537	http://dx.doi.org/10.1371/journal.pone.0023537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887268	gold, Green Submitted, Green Published			2022-12-25	WOS:000295832000025
J	Peckys, DB; Kleinhans, FW; Mazur, P				Peckys, Diana B.; Kleinhans, F. W.; Mazur, Peter			Rectification of the Water Permeability in COS-7 Cells at 22, 10 and 0 degrees C	PLOS ONE			English	Article							INTRACELLULAR ICE FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; HYDRAULIC CONDUCTIVITY; SUBZERO TEMPERATURES; XENOPUS OOCYTES; MOUSE; MEMBRANES; KINETICS; EMBRYOS; VOLUME	The osmotic and permeability parameters of a cell membrane are essential physico-chemical properties of a cell and particularly important with respect to cell volume changes and the regulation thereof. Here, we report the hydraulic conductivity, L-p, the non-osmotic volume, V-b, and the Arrhenius activation energy, E-a, of mammalian COS-7 cells. The ratio of V-b to the isotonic cell volume, V-c (iso), was 0.29. E-a, the activation energy required for the permeation of water through the cell membrane, was 10,700, and 12,000 cal/mol under hyper- and hypotonic conditions, respectively. Average values for L-p were calculated from swell/shrink curves by using an integrated equation for L-p. The curves represented the volume changes of 358 individually measured cells, placed into solutions of nonpermeating solutes of 157 or 602 mOsm/kg (at 0, 10 or 22 degrees C) and imaged over time. L-p estimates for all six combinations of osmolality and temperature were calculated, resulting in values of 0.11, 0.21, and 0.10 mu m/min/atm for exosmotic flow and 0.79, 1.73 and 1.87 mu m/min/atm for endosmotic flow (at 0, 10 and 22 degrees C, respectively). The unexpected finding of several fold higher L-p values for endosmotic flow indicates highly asymmetric membrane permeability for water in COS-7. This phenomenon is known as rectification and has mainly been reported for plant cell, but only rarely for animal cells. Although the mechanism underlying the strong rectification found in COS-7 cells is yet unknown, it is a phenomenon of biological interest and has important practical consequences, for instance, in the development of optimal cryopreservation.	[Peckys, Diana B.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Kleinhans, F. W.] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46205 USA; [Peckys, Diana B.; Kleinhans, F. W.; Mazur, Peter] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA	Vanderbilt University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Tennessee System; University of Tennessee Knoxville	Peckys, DB (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	diana.peckys@vanderbilt.edu	Peckys, Diana B./B-4642-2015	Peckys, Diana/0000-0002-2972-9714	National Institutes of Health [R01-RR018470]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018470] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research supported by National Institutes of Health grant R01-RR018470, P. Mazur, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE WJ, 1986, J PHYSIOL-LONDON, V374, P375, DOI 10.1113/jphysiol.1986.sp016085; Chara O, 2005, J MEMBRANE BIOL, V207, P143, DOI 10.1007/s00232-005-0809-9; CLEMO HF, 1995, CIRC RES, V77, P741, DOI 10.1161/01.RES.77.4.741; DAINTY J, 1964, BIOCHIM BIOPHYS ACTA, V79, P129, DOI 10.1016/0926-6577(64)90046-4; DAINTY J, 1964, BIOCHIM BIOPHYS ACTA, V79, P102, DOI 10.1016/0926-6577(64)90043-9; Dick DAT, 1996, CELL WATER; Guenther JF, 2006, CRYOBIOLOGY, V52, P401, DOI 10.1016/j.cryobiol.2006.02.002; Hagedorn M, 2002, BIOL REPROD, V67, P961, DOI 10.1095/biolreprod.101.002915; Heymann JB, 1998, J STRUCT BIOL, V121, P191, DOI 10.1006/jsbi.1997.3951; House C.R., 1974, WATER TRANSPORT CELL; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jessner W, 2008, WIEN MED WOCHENSCHR, V158, P565, DOI 10.1007/s10354-008-0597-9; Katkov II, 2011, CRYOBIOLOGY IN PRESS, V2; Kleinhans FW, 2006, CRYOBIOLOGY, V52, P128, DOI 10.1016/j.cryobiol.2005.10.008; LEIBO SP, 1980, J MEMBRANE BIOL, V53, P179, DOI 10.1007/BF01868823; Lucke B., 1940, Cold Spring Harbor Symposia on Quantitative Biology, V8, P123; MAZUR P, 1986, CELL BIOPHYS, V8, P259, DOI 10.1007/BF02788516; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; Mazur P, 2005, CRYOBIOLOGY, V51, P29, DOI 10.1016/j.cryobiol.2005.04.008; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Muldrew K, 2001, CRYOLETTERS, V22, P329; Muldrew K, 2009, CRYOBIOLOGY, V58, P62, DOI 10.1016/j.cryobiol.2008.10.129; Ozu M, 2005, J BIOCHEM BIOPH METH, V63, P187, DOI 10.1016/j.jbbm.2005.04.007; PAPPIUS HM, 1964, CAN J BIOCHEM PHYS, V42, P945, DOI 10.1139/o64-106; Peckys D, 2010, VB CRYOBIOLOGY, V61, P374; Seki S, 2010, BIOL REPROD, V82, P1198, DOI 10.1095/biolreprod.109.083063; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; TOUPIN CJ, 1989, CRYOBIOLOGY, V26, P431, DOI 10.1016/0011-2240(89)90068-0; Wang X, 2005, SCI CHINA SER E, V48, P530, DOI 10.1360/04ye0156; Yoshimori T, 2009, CRYOBIOLOGY, V58, P52, DOI 10.1016/j.cryobiol.2008.10.128	30	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23643	10.1371/journal.pone.0023643	http://dx.doi.org/10.1371/journal.pone.0023643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887290	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000042
J	Wang, H; Gottfries, J; Barrenas, F; Benson, M				Wang, Hui; Gottfries, Johan; Barrenas, Fredrik; Benson, Mikael			Identification of Novel Biomarkers in Seasonal Allergic Rhinitis by Combining Proteomic, Multivariate and Pathway Analysis	PLOS ONE			English	Article							GLUCOCORTICOID RESISTANCE; ALPHA(1)-ACID GLYCOPROTEIN; INDUCIBLE EXPRESSION; ASTHMA; NEUTROPHILS; PROTEIN; GENES; RAT	Background: Glucocorticoids (GCs) play a key role in the treatment of seasonal allergic rhinitis (SAR). However, some patients show a low response to GC treatment. We hypothesized that proteins that correlated to discrimination between symptomatic high and low responders (HR and LR) to GC treatment might be regulated by GCs and therefore suitable as biomarkers for GC treatment. Methodology/Principal Findings: We identified 953 nasal fluid proteins in symptomatic HR and LR with a LC MS/MS based-quantitative proteomics analysis and performed multivariate analysis to identify a combination of proteins that best separated symptomatic HR and LR. Pathway analysis showed that those proteins were most enriched in the acute phase response pathway. We prioritized candidate biomarkers for GC treatment based on the multivariate and pathway analysis. Next, we tested if those candidate biomarkers differed before and after GC treatment in nasal fluids from 40 patients with SAR using ELISA. Several proteins including ORM (P<0.0001), APOH (P<0.0001), FGA (P<0.01), CTSD (P<0.05) and SERPINB3 (P<0.05) differed significantly before and after GC treatment. Particularly, ORM (P<0.01), FGA (P<0.05) and APOH (P<0.01) that belonged to the acute phase response pathway decreased significantly in HR but not LR before and after GC treatment. Conclusions/Significance: We identified several novel biomarkers for GC treatment response in SAR with combined proteomics, multivariate and pathway analysis. The analytical principles may be generally applicable to identify biomarkers in clinical studies of complex diseases.	[Wang, Hui] Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden; [Gottfries, Johan] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Wang, Hui; Barrenas, Fredrik; Benson, Mikael] Linkoping Univ, Ctr Individualized Medicat, Linkoping, Sweden; [Benson, Mikael] Linkoping Univ Hosp, Dept Pediat, S-58185 Linkoping, Sweden	University of Gothenburg; University of Gothenburg; Linkoping University; Linkoping University	Wang, H (corresponding author), Univ Gothenburg, Unit Clin Syst Biol, Gothenburg, Sweden.	hui.wang@gu.se	Gottfries, Johan/M-3445-2016	Gottfries, Johan/0000-0001-7135-4664	European Commission [223367]; MultiMod; Swedish Medical Research Council	European Commission(European CommissionEuropean Commission Joint Research Centre); MultiMod; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This research has been supported by the European Commission under the Seventh Framework Programme, grant agreement number 223367, MultiMod, the Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BARNES PJ, 1995, AM J RESP CRIT CARE, V152, pS125, DOI 10.1164/ajrccm/152.6_Pt_2.S125; Benson LM, 2009, J SEP SCI, V32, P44, DOI 10.1002/jssc.200800474; Benson M, 2004, J ALLERGY CLIN IMMUN, V113, P1137, DOI 10.1016/j.jaci.2004.02.028; Benson M, 2000, J ALLERGY CLIN IMMUN, V106, P307, DOI 10.1067/mai.2000.108111; Boot JD, 2008, J INVEST ALLERG CLIN, V18, P433; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2010, ALLERGY, V65, P1212, DOI [10.1111/j.1398-9995.2010.02439.x, 10.1111/j.1398-9995.2010.02480.x]; Crestani B, 1998, J IMMUNOL, V160, P4596; de Jong EP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011148; Diamant Z, 2010, PULM PHARMACOL THER, V23, P468, DOI 10.1016/j.pupt.2010.06.006; Fournier T, 1999, J IMMUNOL, V163, P2883; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Gunnarsson P, 2007, FASEB J, V21, P4059, DOI 10.1096/fj.07-8534com; Kirwan JR, 2007, SCAND J RHEUMATOL, V36, P165, DOI 10.1080/03009740701340263; Meyer P, 2003, PEDIAT ALLERG IMM-UK, V14, P60, DOI 10.1034/j.1399-3038.2003.02102.x; Moazzami AA, 2010, NMR BIOMED; NORBACK D, 2000, INDOOR AIR, V55, P163; Okano M, 2009, CLIN EXP IMMUNOL, V158, P164, DOI 10.1111/j.1365-2249.2009.04010.x; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Sousa AR, 2000, J ALLERGY CLIN IMMUN, V105, P943, DOI 10.1067/mai.2000.106486; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175; VINAY P, 1980, KIDNEY INT, V17, P312, DOI 10.1038/ki.1980.37; Wang H, 2011, ALLERGY, V66, P132, DOI 10.1111/j.1398-9995.2010.02444.x; Wang H, 2009, J ALLERGY CLIN IMMUN, V124, P1360, DOI 10.1016/j.jaci.2009.09.037; Wang WY, 2009, ALLERGY, V64, P1102, DOI 10.1111/j.1398-9995.2009.01996.x; Whelehan OP, 2006, CHEMOMETR INTELL LAB, V84, P82, DOI 10.1016/j.chemolab.2006.03.008; Woodfolk JA, 2007, J ALLERGY CLIN IMMUN, V119, P280, DOI 10.1016/j.jaci.2006.11.008; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972	30	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23563	10.1371/journal.pone.0023563	http://dx.doi.org/10.1371/journal.pone.0023563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887273	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000029
J	Waddell, J; Kim, J; Alger, BE; McCarthy, MM				Waddell, Jaylyn; Kim, Jimok; Alger, Bradley E.; McCarthy, Margaret M.			The Depolarizing Action of GABA in Cultured Hippocampal Neurons Is Not Due to the Absence of Ketone Bodies	PLOS ONE			English	Article							IMMATURE NEOCORTICAL NEURONS; POSTSYNAPTIC ACTIVITY; MEDIATED EXCITATION; RAT; COTRANSPORTER; PROMOTES; CL; DIFFERENTIATION; AVAILABILITY; EXPRESSION	Two recent reports propose that the depolarizing action of GABA in the immature brain is an artifact of in vitro preparations in which glucose is the only energy source. The authors argue that this does not mimic the physiological environment because the suckling rats use ketone bodies and pyruvate as major sources of metabolic energy. Here, we show that availability of physiologically relevant levels of ketone bodies has no impact on the excitatory action of GABA in immature cultured hippocampal neurons. Addition of beta-hydroxybutyrate (BHB), the primary ketone body in the neonate rat, affected neither intracellular calcium elevation nor membrane depolarizations induced by the GABA-A receptor agonist muscimol, when assessed with calcium imaging or perforated patch-clamp recording, respectively. These results confirm that the addition of ketone bodies to the extracellular environment to mimic conditions in the neonatal brain does not reverse the chloride gradient and therefore render GABA hyperpolarizing. Our data are consistent with the existence of a genuine "developmental switch'' mechanism in which GABA goes from having a predominantly excitatory role in immature cells to a predominantly inhibitory one in adults.	[Waddell, Jaylyn; Kim, Jimok; Alger, Bradley E.; McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Waddell, J (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	jaylyn.waddell@gmail.com	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726	National Institute of Neurological Disorders and Stroke at the National Institutes of Health [R01 NS050525]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050525] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01 NS050525 awarded to MMM by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger AP, 2001, P NATL ACAD SCI USA, V98, P8059, DOI 10.1073/pnas.131016298; Balena T, 2008, EUR J NEUROSCI, V27, P2402, DOI 10.1111/j.1460-9568.2008.06194.x; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Galanopoulou AS, 2003, EXP NEUROL, V184, P1003, DOI 10.1016/S0014-4886(03)00387-X; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Holmgren CD, 2010, J NEUROCHEM, V112, P900, DOI 10.1111/j.1471-4159.2009.06506.x; Kandler K, 2002, PHYSIOL BEHAV, V77, P583, DOI 10.1016/S0031-9384(02)00905-8; Kirmse K, 2010, J NEUROSCI, V30, P16002, DOI 10.1523/JNEUROSCI.2534-10.2010; Lagostena L, 2010, J NEUROSCI, V30, P885, DOI 10.1523/JNEUROSCI.3326-09.2010; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Lust WD, 2003, METAB BRAIN DIS, V18, P195, DOI 10.1023/A:1025503115837; Nehlig A, 1996, DEV NEUROSCI-BASEL, V18, P426, DOI 10.1159/000111437; Nunez JL, 2005, EUR J NEUROSCI, V21, P3251, DOI 10.1111/j.1460-9568.2005.04175.x; Nunez JL, 2007, DEV NEUROBIOL, V67, P1879, DOI 10.1002/dneu.20567; Owens DF, 1996, J NEUROSCI, V16, P6414; Perrot-Sinal TS, 2001, ENDOCRINOLOGY, V142, P2238, DOI 10.1210/en.142.6.2238; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Prins M, 2008, EPILEPSIA, V49, P111, DOI 10.1111/j.1528-1167.2008.01852.x; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rheims S, 2009, J NEUROCHEM, V110, P1330, DOI 10.1111/j.1471-4159.2009.06230.x; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Ruusuvuori E, 2010, J NEUROSCI, V30, P15638, DOI 10.1523/JNEUROSCI.3355-10.2010; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Sipila ST, 2006, J PHYSIOL-LONDON, V573, P765, DOI 10.1113/jphysiol.2006.107086; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tyzio R, 2011, J NEUROSCI, V31, P34, DOI 10.1523/JNEUROSCI.3314-10.2011; Wasterlain CG, 2010, NEUROCHEM RES, V35, P2193, DOI 10.1007/s11064-010-0339-4; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23020	10.1371/journal.pone.0023020	http://dx.doi.org/10.1371/journal.pone.0023020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886776	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100005
J	Zhang, QC; Zhang, Y; Feng, HH; Guo, R; Jin, L; Wan, R; Wang, LN; Chen, C; Li, SN				Zhang, Qichun; Zhang, Yun; Feng, Haihua; Guo, Rui; Jin, Lai; Wan, Rong; Wang, Lina; Chen, Cheng; Li, Shengnan			High Density Lipoprotein (HDL) Promotes Glucose Uptake in Adipocytes and Glycogen Synthesis in Muscle Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN SKELETAL-MUSCLE; APOLIPOPROTEIN-A-I; SELECTIVE LIPID UPTAKE; SCAVENGER RECEPTOR-BI; SR-BI; SIGNALING PATHWAYS; INSULIN-RESISTANCE; TRANSPORTER GLUT4; 3T3-L1 ADIPOCYTES	Background: High density lipoprotein (HDL) was reported to decrease plasma glucose and promote insulin secretion in type 2 diabetes patients. This investigation was designed to determine the effects and mechanisms of HDL on glucose uptake in adipocytes and glycogen synthesis in muscle cells. Methods and Results: Actions of HDL on glucose uptake and GLUT4 translocation were assessed with 1-[(3)H]-2-deoxyglucose and plasma membrane lawn, respectively, in 3T3-L1 adipocytes. Glycogen analysis was performed with amyloglucosidase and glucose oxidase-peroxidase methods in normal and palmitate-treated L6 cells. Small interfering RNA was used to observe role of scavenger receptor type I (SR-BI) in glucose uptake of HDL. Corresponding signaling molecules were detected by immunoblotting. HDL stimulated glucose uptake in a time-and concentration-dependent manner in 3T3-L1 adipocytes. GLUT4 translocation was significantly increased by HDL. Glycogen deposition got enhanced in L6 muscle cells paralleling with elevated glycogen synthase kinase3 (GSK3) phosphorylation. Meanwhile, increased phosphorylations of Akt-Ser473 and AMP activated protein kinase (AMPK) alpha were detected in 3T3-L1 adipocytes. Glucose uptake and Akt-Ser473 activation but not AMPK-a were diminished in SR-BI knock-down 3T3-L1 cells. Conclusions: HDL stimulates glucose uptake in 3T3-L1 adipocytes through enhancing GLUT4 translocation by mechanisms involving PI3K/Akt via SR-BI and AMPK signaling pathways, and increases glycogen deposition in L6 muscle cells through promoting GSK3 phosphorylation.	[Zhang, Qichun; Zhang, Yun; Feng, Haihua; Guo, Rui; Jin, Lai; Wan, Rong; Wang, Lina; Chen, Cheng; Li, Shengnan] Nanjing Med Univ, Dept Pharmacol, Jiangsu Prov Key Lab Cardiovasc Dis & Mol Interve, Nanjing, Peoples R China; [Zhang, Qichun] Nanjing Univ Chinese Med, Sch Pharm, Nanjing, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine	Zhang, QC (corresponding author), Nanjing Med Univ, Dept Pharmacol, Jiangsu Prov Key Lab Cardiovasc Dis & Mol Interve, Nanjing, Peoples R China.	snli@njmu.edu.cn	Feng, Haihua/ABE-2440-2021		National Foundation of Science of China [81072668]; Natural Science Foundation of Jiangsu Province [BK2010078]	National Foundation of Science of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	National Foundation of Science of China (No. 81072668), http://www.nsfc.gov.cn/Portal0/default124.htm, Natural Science Foundation of Jiangsu Province (No. BK2010078), http://www.jsnsf.gov.cn/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; Al-Jarallah A, 2010, BBA-MOL CELL BIOL L, V1801, P1239, DOI 10.1016/j.bbalip.2010.08.006; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Baldan A, 2006, CURR OPIN LIPIDOL, V17, P227, DOI 10.1097/01.mol.0000226113.89812.bb; BORTHWICK AC, 1995, BIOCHEM BIOPH RES CO, V210, P738, DOI 10.1006/bbrc.1995.1721; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Chen GL, 2006, MOL ENDOCRINOL, V20, P857, DOI 10.1210/me.2005-0255; Drew BG, 2004, P NATL ACAD SCI USA, V101, P6999, DOI 10.1073/pnas.0306266101; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Gantman A, 2010, BIOCHEM BIOPH RES CO, V391, P523, DOI 10.1016/j.bbrc.2009.11.091; Guan F, 2008, ARCH MED RES, V39, P52, DOI 10.1016/j.arcmed.2007.06.022; Han R, 2007, DIABETOLOGIA, V50, P1960, DOI 10.1007/s00125-007-0752-7; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Koneru S, 2007, AM J PHYSIOL-HEART C, V292, pH2060, DOI 10.1152/ajpheart.01169.2006; Kuvin JT, 2002, AM HEART J, V144, P165, DOI 10.1067/mhj.2002.123145; Lamarche B, 1999, J CLIN INVEST, V103, P1191, DOI 10.1172/JCI5286; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Li XA, 2002, J BIOL CHEM, V277, P11058, DOI 10.1074/jbc.M110985200; Link JJ, 2007, CURR PROB CARDIOLOGY, V32, P268, DOI 10.1016/j.cpcardiol.2007.01.004; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Nakhjavani M, 2008, DIABETES RES CLIN PR, V81, P38, DOI 10.1016/j.diabres.2008.01.018; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Rodriguez C, 2009, THROMB HAEMOSTASIS, V101, P665, DOI 10.1160/TH08-10-0675; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Storey SM, 2007, BIOCHEMISTRY-US, V46, P13891, DOI 10.1021/bi700690s; von Eckardstein A, 2011, CURR OPIN LIPIDOL, V22, P26, DOI 10.1097/MOL.0b013e3283412279; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Westendorf T, 2005, MOL CELL BIOCHEM, V277, P143, DOI 10.1007/s11010-005-5873-z; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zhang Y, 2007, J LIPID RES, V48, P405, DOI 10.1194/jlr.M600326-JLR200	41	41	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23556	10.1371/journal.pone.0023556	http://dx.doi.org/10.1371/journal.pone.0023556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886796	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100018
J	Jongsma, MLA; Postma, SAE; Souren, P; Arns, M; Gordon, E; Vissers, K; Wilder-Smith, O; van Rijn, CM; van Goor, H				Jongsma, Marijtje L. A.; Postma, Simone A. E.; Souren, Pierre; Arns, Martijn; Gordon, Evian; Vissers, Kris; Wilder-Smith, Oliver; van Rijn, Clementina M.; van Goor, Harry			Neurodegenerative Properties of Chronic Pain: Cognitive Decline in Patients with Chronic Pancreatitis	PLOS ONE			English	Article							CHRONIC BACK-PAIN; QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL PERFORMANCE; GRAY-MATTER; ATTENTIONAL CONTROL; MAJOR DEPRESSION; ALCOHOLIC WOMEN; PERSISTENT PAIN; MEMORY; FIBROMYALGIA	Chronic pain has been associated with impaired cognitive function. We examined cognitive performance in patients with severe chronic pancreatitis pain. We explored the following factors for their contribution to observed cognitive deficits: pain duration, comorbidity (depression, sleep disturbance), use of opioids, and premorbid alcohol abuse. The cognitive profiles of 16 patients with severe pain due to chronic pancreatitis were determined using an extensive neuropsychological test battery. Data from three cognitive domains (psychomotor performance, memory, executive functions) were compared to data from healthy controls matched for age, gender and education. Multivariate multilevel analysis of the data showed decreased test scores in patients with chronic pancreatitis pain in different cognitive domains. Psychomotor performance and executive functions showed the most prominent decline. Interestingly, pain duration appeared to be the strongest predictor for observed cognitive decline. Depressive symptoms, sleep disturbance, opioid use and history of alcohol abuse provided additional explanations for the observed cognitive decline in some of the tests, but to a lesser extent than pain duration. The negative effect of pain duration on cognitive performance is compatible with the theory of neurodegenerative properties of chronic pain. Therefore, early and effective therapeutic interventions might reduce or prevent decline in cognitive performance, thereby improving outcomes and quality of life in these patients.	[Jongsma, Marijtje L. A.; Postma, Simone A. E.; van Rijn, Clementina M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands; [Jongsma, Marijtje L. A.] Radboud Univ Nijmegen, Inst Behav Sci, Dept Learning & Dev, NL-6525 ED Nijmegen, Netherlands; [Souren, Pierre] Radboud Univ Nijmegen, Dept Social Psychol, Res Tech Support Grp RTOG, NL-6525 ED Nijmegen, Netherlands; [Arns, Martijn] Res Inst Brainclin, Nijmegen, Netherlands; [Gordon, Evian] Brain Resource Int Database, Ultimo, Australia; [Gordon, Evian] Brain Resource Co, Ultimo, Australia; [Vissers, Kris; Wilder-Smith, Oliver] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Med, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands; [van Goor, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Pain & Nocicept Neurosci Res Grp, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Total Brain; Radboud University Nijmegen; Radboud University Nijmegen	Jongsma, MLA (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Donders Ctr Cognit, NL-6525 ED Nijmegen, Netherlands.	t.vanrijn@donders.ru.nl	Vissers, Kris C.P./D-3569-2009; Vissers, Kris/H-8110-2014; van Goor, H./H-8035-2014; Wilder-Smith, Oliver H.G./E-7541-2012; Souren, Pierre/E-9003-2012; Postma, Simone/D-5051-2016; van Rijn, Clementina/D-5828-2012	Vissers, Kris C.P./0000-0002-2919-6356; Vissers, Kris/0000-0002-2919-6356; van Goor, H./0000-0003-0323-4876; Wilder-Smith, Oliver H.G./0000-0003-4390-2381; van Rijn, Clementina/0000-0002-1103-6338; Arns, Martijn/0000-0002-0610-7613				Andren-Sandberg A, 2002, EUR J GASTROEN HEPAT, V14, P957, DOI 10.1097/00042737-200209000-00006; Apkarian A.V., 2006, DRUG DISCOV TODAY DI, V3, P319, DOI DOI 10.1016/J.DDRNEC.2006.09.006; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Attree EA, 2003, APPL NEUROPSYCHOL, V10, P96, DOI 10.1207/S15324826AN1002_05; Bartsch AJ, 2007, BRAIN, V130, P36, DOI 10.1093/brain/awl303; BROWNE W, 2004, MULTILEVEL MODELLING; Buscher HCJL, 2008, SURGERY, V143, P715, DOI 10.1016/j.surg.2008.03.001; Buscher HG, 2006, EUR J PAIN, V10, P363, DOI 10.1016/j.ejpain.2005.06.006; Clark CR, 2006, ARCH CLIN NEUROPSYCH, V21, P449, DOI 10.1016/j.acn.2006.06.005; Demir IE, 2011, LANGENBECK ARCH SURG, V396, P151, DOI 10.1007/s00423-010-0731-1; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Drewes AM, 2008, WORLD J GASTROENTERO, V14, P4020, DOI 10.3748/wjg.14.4020; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; ECCLESTON C, 1995, PAIN, V63, P3, DOI 10.1016/0304-3959(95)00093-8; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Ende G, 2005, BIOL PSYCHIAT, V58, P974, DOI 10.1016/j.biopsych.2005.05.038; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Fein G, 2006, ALCOHOL CLIN EXP RES, V30, P1538, DOI 10.1111/j.1530-0277.2006.00185.x; Gallassi R, 2006, J AFFECT DISORDERS, V91, P243, DOI 10.1016/j.jad.2006.01.018; Gallassi R, 2001, ARCH GERONTOL GERIAT, P163; Gardner TB, 2010, PANCREAS, V39, P498, DOI 10.1097/MPA.0b013e3181c5c693; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Glass JM, 2009, RHEUM DIS CLIN N AM, V35, P299, DOI 10.1016/j.rdc.2009.06.002; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gomez RG, 2006, BIOL PSYCHIAT, V60, P472, DOI 10.1016/j.biopsych.2005.11.010; Grisart JM, 2001, PAIN, V94, P305, DOI 10.1016/S0304-3959(01)00366-9; Grossi ML, 2001, J OROFAC PAIN, V15, P329; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Harman K, 2005, CLIN J PAIN, V21, P216, DOI 10.1097/00002508-200505000-00004; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; LEEUW JD, HDB MULTILEVEL ANAL; Majer M, 2008, PSYCHOSOM MED, V70, P829, DOI 10.1097/PSY.0b013e31817b9793; Mergener L, 1997, LANCET, V350, P1379, DOI 10.1016/S0140-6736(97)07332-7; Oosterman JM, 2011, CLIN J PAIN, V27, P70, DOI 10.1097/AJP.0b013e3181f15cf5; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Park DC, 2001, ARTHRITIS RHEUM, V44, P2125, DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1; Pezzilli R, 2006, WORLD J GASTROENTERO, V12, P6249, DOI 10.3748/wjg.v12.i39.6249; Pfeffermann D, 1998, J ROY STAT SOC B, V60, P23, DOI 10.1111/1467-9868.00106; Riley JL, 2001, J PAIN, V2, P354, DOI 10.1054/jpai.2001.27000; Rosenbloom MJ, 2004, NEUROPSYCHOLOGY, V18, P589, DOI 10.1037/0894-4105.18.3.589; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Sjogren P, 2005, EUR J PAIN, V9, P453, DOI 10.1016/j.ejpain.2004.10.005; Sjogren P, 2000, PAIN, V86, P237, DOI 10.1016/S0304-3959(00)00248-7; Sjogren P, 2000, J PAIN SYMPTOM MANAG, V19, P100, DOI 10.1016/S0885-3924(99)00143-8; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Sullivan EV, 2002, NEUROPSYCHOLOGY, V16, P74, DOI 10.1037//0894-4105.16.1.74; van Esch AAJ, 2006, DIGEST LIVER DIS, V38, P518, DOI 10.1016/j.dld.2006.02.002; van Loo ES, 2010, BRIT J SURG, V97, P1079, DOI 10.1002/bjs.7103; Wehler M, 2004, AM J GASTROENTEROL, V99, P138, DOI 10.1111/j.1572-0241.2004.04005.x; Weiner DK, 2006, PAIN MED, V7, P60, DOI 10.1111/j.1526-4637.2006.00091.x; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	60	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23363	10.1371/journal.pone.0023363	http://dx.doi.org/10.1371/journal.pone.0023363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	810LN	21876748	gold, Green Published, Green Submitted			2022-12-25	WOS:000294126900020
J	Song, ZF; Jin, R; Yu, SY; Rivet, JJ; Smyth, SS; Nanda, A; Granger, DN; Li, GH				Song, Zifang; Jin, Rong; Yu, Shiyong; Rivet, Joshua J.; Smyth, Susan S.; Nanda, Anil; Granger, D. Neil; Li, Guohong			CD40 Is Essential in the Upregulation of TRAF Proteins and NF-KappaB-Dependent Proinflammatory Gene Expression after Arterial Injury	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; REDUCES NEOINTIMAL FORMATION; RECEPTOR-ASSOCIATED FACTOR-6; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; VASCULAR INJURY; CAROTID-ARTERY; BALLOON INJURY; B PATHWAY; ATHEROSCLEROSIS	Despite extensive investigations, restenosis, which is characterized primarily by neointima formation, remains an unsolved clinical problem after vascular interventions. A recent study has shown that CD40 signaling through TNF receptor associated factor 6 (TRAF6) plays a key role in neointima formation after carotid artery injury; however, underlying mechanisms are not clearly elucidated. Because neointima formation may vary significantly depending on the type of injury, we first assessed the effect of CD40 deficiency on neointima formation in 2 injury models, carotid artery ligation and femoral artery denudation injury. Compared with wild-type mice, CD40 deficiency significantly reduced neointima formation and lumen stenosis in two different models. Further, we investigated the mechanism by which CD40 signaling affects neointima formation after arterial injury. In wild-type mice, the expression levels of CD40, several TRAF proteins, including TRAF1, TRAF2, TRAF3, TRAF5, and TRAF6, as well as total NF-kB p65 and phospho-NF-kB p65, in the carotid artery were markedly upregulated within 3-7 days after carotid ligation. Deficiency of CD40 abolished the injury-induced upregulation of TRAFs including TRAF6 and NF-kB-p65 in the injured vessel wall. Further, CD40-/- mice showed a significant decrease in the recruitment of neutrophils (at 3, 7d) and macrophages (at 7, 21d) into injured artery; this effect was most likely attributed to inhibition of NF-kB activation and marked downregulation of NF-kB-related gene expression, including cytokines (TNF alpha, IL-1 beta, IL-6), chemokines (MCP-1), and adhesion molecules (ICAM-1, VCAM-1). Moreover, neutrophil recruitment in a model of thioglycollate-induced peritonitis is impaired in CD40-deficient mice. In vitro data revealed that CD40 deficiency blocked CD40L-induced NF-kB p65 nuclear translocation in leukocytes. Altogether, our data identified for the first time that CD40 is essential in the upregulation of TRAF6, NF-kB activation, and NF-kB-dependent proinflammatory genes in vivo. Our findings firmly established the role for CD40 in neointima formation in 2 distinct injury models.	[Song, Zifang; Jin, Rong; Yu, Shiyong; Rivet, Joshua J.; Nanda, Anil; Li, Guohong] LSU Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA USA; [Granger, D. Neil; Li, Guohong] LSU Hlth Sci Ctr Shreveport, Dept Physiol, Shreveport, LA USA; [Smyth, Susan S.] Univ Kentucky, Dept Med, Lexington, KY 40506 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Kentucky	Song, ZF (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Neurosurg, Vasc Biol & Stroke Res Lab, Shreveport, LA USA.	gli@lsuhsc.edu	Song, Zifang/AAA-8467-2022		National Institutes of Health [HL087990]; American Heart Association [0530166N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL087990 (GL) and by a scientist development grant (0530166N, GL) from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker T, 2002, J CELL BIOL, V158, P1277, DOI 10.1083/jcb.200208083; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Bu DX, 2005, FASEB J, V19, P1293, DOI 10.1096/fj.04-2645fje; Cercek B, 1997, ATHEROSCLEROSIS, V131, P59, DOI 10.1016/S0021-9150(96)06767-6; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Chung JY, 2002, J CELL SCI, V115, P679; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Engel D, 2009, SEMIN IMMUNOL, V21, P308, DOI 10.1016/j.smim.2009.06.004; Evans DJW, 2009, CIRCULATION, V119, P116, DOI 10.1161/CIRCULATIONAHA.107.762690; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Ialenti A, 2001, N-S ARCH PHARMACOL, V364, P343, DOI 10.1007/s002100100467; Iwata H, 2010, CIRCULATION, V122, P2048, DOI 10.1161/CIRCULATIONAHA.110.965202; Koga J, 2009, ARTERIOSCL THROM VAS, V29, P458, DOI 10.1161/ATVBAHA.109.183772; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Landry DB, 1997, AM J PATHOL, V151, P1085; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Li GH, 2007, ARTERIOSCL THROM VAS, V27, P1850, DOI 10.1161/ATVBAHA.107.144576; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Lutgens E, 1999, NAT MED, V5, P1313, DOI 10.1038/15271; Lutgens E, 2007, TRENDS CARDIOVAS MED, V17, P118, DOI 10.1016/j.tcm.2007.02.004; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Missiou A, 2010, CIRC RES, V107, P757, DOI 10.1161/CIRCRESAHA.110.219295; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Mistry P, 2004, J BIOL CHEM, V279, P1482, DOI 10.1074/jbc.M310413200; Miyahara T, 2006, J VASC SURG, V43, P592, DOI 10.1016/j.jvs.2005.11.010; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Qu YM, 2009, J VASC SURG, V50, P1452, DOI 10.1016/j.jvs.2009.08.050; Remskar M, 2001, CIRC RES, V88, P390; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stachon P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011589; Su CH, 2007, INT J RADIAT BIOL, V83, P707, DOI 10.1080/09553000701596126; Takada Y, 2004, J BIOL CHEM, V279, P4750, DOI 10.1074/jbc.M304546200; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Xia M, 2007, ARTERIOSCL THROM VAS, V27, P519, DOI 10.1161/01.ATV.0000254672.04573.2d; Yamasaki K, 2003, GENE THER, V10, P356, DOI 10.1038/sj.gt.3301875; Zapata JM, 2003, EXPERT OPIN THER TAR, V7, P411, DOI 10.1517/14728222.7.3.411; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	49	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23239	10.1371/journal.pone.0023239	http://dx.doi.org/10.1371/journal.pone.0023239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876738	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900010
J	Wong, LSM; Huzen, J; de Boer, RA; van Gilst, WH; van Veldhuisen, DJ; van der Harst, P				Wong, Liza S. M.; Huzen, Jardi; de Boer, Rudolf A.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.; van der Harst, Pim			Telomere Length of Circulating Leukocyte Subpopulations and Buccal Cells in Patients with Ischemic Heart Failure and Their Offspring	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; CD34(+) CELLS; HUMAN-DISEASE; ATHEROSCLEROSIS; RISK; SHORTER; TISSUES	Background: We aimed to find support for the hypothesis that telomere length (TL) is causally involved in the pathogenesis of ischemic heart failure (IHF). We measured TL in IHF patients and their high-risk offspring and determined whether mean leukocyte TL reflects TL in CD34+ progenitor. We additionally measured TL of offspring of patients and controls to examine heritability throughout different cell types. Methods and Results: TL was measured by qPCR in overall leukocytes, CD34+ progenitor cells, mononuclear cells (MNCs), and buccal cells in 27 IHF patients, 24 healthy controls and 60 offspring. TL in IHF patients was shorter than healthy controls in leukocytes (p = 0.002), but not in CD34+ cells (p = 0.39), MNCs (p = 0.31) or buccal cells (p = 0.19). Offspring of IHF patients had shorter TL in leukocytes than offspring of healthy subjects (p = 0.04) but not in other cell types. Controls and offspring showed a good within person correlation between leukocytes and CD34+ cells (r 0.562; p = 0.004 and r 0.602; p = 0.001, respectively). In IHF patients and offspring the correlation among cell types was blunted. Finally, we found strong correlations between parent and offspring TL in all four cell types. Conclusions: Reduced leukocyte TL in offspring of IHF subjects suggests a potential causal link of TL in ischemic heart disease. However, this causality is unlikely to originate from exhaustion of TL in CD34+ progenitor or MNC cells as their lengths are not well captured by overall leukocyte TL. Additionally, we found strong correlations between parent and offspring TL in all examined cell types, suggesting high heritability of TL among cell types.	[Wong, Liza S. M.; Huzen, Jardi; de Boer, Rudolf A.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Wong, Liza S. M.] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Huzen, Jardi] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen	Wong, LSM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.harst@thorax.umcg.nl	de Boer, Rudolf/ABE-9879-2020; van Veldhuisen, Dirk Jan/E-8967-2014; van Gilst, Wiek/R-1806-2019	van Gilst, Wiek/0000-0003-2968-8585	Netherlands Organisation for Scientific Research [NWO] [916.76.170]; Netherlands Heart Foundation [2008T028, 2006T003, 2004T046, D97-017]; Interuniversitair Cardiologisch Instituut Nederland (ICIN)	Netherlands Organisation for Scientific Research [NWO](Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); Interuniversitair Cardiologisch Instituut Nederland (ICIN)	This work was supported by the Innovational Research Incentives Scheme program of the Netherlands Organisation for Scientific Research [NWO VENI, grant number 916.76.170 to P. van der Harst] and the Netherlands Heart Foundation [E. Dekker grant, grant number 2008T028 to L.S.M. Wong]. P. van der Harst and R.A. de Boer are research fellows of the Netherlands Heart Foundation [grant numbers 2006T003 and 2004T046, respectively] and the Interuniversitair Cardiologisch Instituut Nederland (ICIN). D.J. van Veldhuisen is an Established Investigators of the Netherlands Heart Foundation [grant numbers D97-017]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2006, NEW ENGL J MED, V355, P1195, DOI 10.1056/NEJMp068187; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2008, HEART, V94, P422, DOI 10.1136/hrt.2007.139675; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Ogami M, 2004, ARTERIOSCL THROM VAS, V24, P546, DOI 10.1161/01.ATV.0000117200.46938.e7; Pasquet S, 2009, CYTOTHERAPY, V11, P1002, DOI 10.3109/14653240903164963; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sebastian C, 2009, J IMMUNOL, V183, P2356, DOI 10.4049/jimmunol.0901131; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Spyridopoulos I, 2009, CIRCULATION, V120, P1364, DOI 10.1161/CIRCULATIONAHA.109.854299; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; van der Harst P, 2010, ANN MED, V42, P36, DOI 10.3109/07853890903321567; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wong LSM, 2010, EUR J HEART FAIL, V12, P348, DOI 10.1093/eurjhf/hfq007; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228	26	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23118	10.1371/journal.pone.0023118	http://dx.doi.org/10.1371/journal.pone.0023118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876736	Green Published, Green Submitted, gold			2022-12-25	WOS:000294126900008
J	Foulds, PG; Mitchell, JD; Parker, A; Turner, R; Green, G; Diggle, P; Hasegawa, M; Taylor, M; Mann, D; Allsop, D				Foulds, Penelope G.; Mitchell, J. Douglas; Parker, Angela; Turner, Roisin; Green, Gerwyn; Diggle, Peter; Hasegawa, Masato; Taylor, Mark; Mann, David; Allsop, David			Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease	FASEB JOURNAL			English	Article						Lewy body; oligomer; immunoassay; immunoblot	LEWY BODY; NEURODEGENERATIVE DISORDERS; CLINICAL-DIAGNOSIS; DEMENTIA; SER-129; BODIES; OLIGOMERS; MUTATION; MODEL; CSF	Parkinson's disease (PD) is characterized by the presence of Lewy bodies containing phosphorylated and aggregated alpha-synuclein (alpha-syn). alpha-Syn is present in human body fluids, including blood plasma, and is a potential biomarker for PD. Immunoassays for total and oligomeric forms of both normal and phosphorylated (at Ser-129) alpha-syn have been used to assay plasma samples from a longitudinal cohort of 32 patients with PD (sampled at mo 0, 1, 2, 3), as well as single plasma samples from a group of 30 healthy control participants. The levels of alpha-syn in plasma varied greatly between individuals, but were remarkably consistent over time within the same individual with PD. The mean level of phospho-alpha-syn was found to be higher (P=0.053) in the PD samples than the controls, whereas this was not the case for total alpha-syn (P=0.244), oligo-alpha-syn (P=0.221), or oligo-phospho-alpha-syn (P=0.181). Immunoblots of plasma revealed bands (at 21, 24, and 50-60 kDa) corresponding to phosphorylated alpha-syn. Thus, phosphorylated alpha-syn can be detected in blood plasma and shows more promise as a diagnostic marker than the nonphosphorylated protein. Longitudinal studies undertaken over a more extended time period will be required to determine whether alpha-syn can act as a marker of disease progression.-Foulds, P. G., Mitchell, J. D., Parker, A., Turner, R., Green, G., Diggle, P., Hasegawa, M., Taylor, M., Mann, D., Allsop, D. Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease. FASEB J. 25, 4127-4137 (2011). www.fasebj.org	[Foulds, Penelope G.; Taylor, Mark; Allsop, David] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4AY, England; [Green, Gerwyn; Diggle, Peter] Univ Lancaster, Sch Hlth & Med, Div Hlth Res, Lancaster LA1 4AY, England; [Mitchell, J. Douglas; Parker, Angela; Turner, Roisin] Royal Preston Hosp, Preston, Lancs, England; [Hasegawa, Masato] Tokyo Inst Psychiat, Dept Mol Neurobiol, Tokyo, Japan; [Mann, David] Univ Manchester, Hope Hosp, Sch Community Based Med, Neurodegenerat & Mental Hlth Res Grp, Salford M6 8HD, Lancs, England	Lancaster University; Lancaster University; Royal Preston Hospital; Tokyo Institute of Psychiatry; University of Manchester	Allsop, D (corresponding author), Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4AY, England.	d.allsop@lancaster.ac.uk	Allsop, David/B-9725-2008	Allsop, David/0000-0002-0513-5575; Diggle, Peter/0000-0003-3521-5020	UK Medical Research Council [G0601364]; MRC [G0601364] Funding Source: UKRI; Medical Research Council [G0601364] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors dedicate this paper to the memory of Prof. John Douglas Mitchell. The authors are grateful to the UK Medical Research Council for financial support (grant award G0601364). The authors thank all of the medical, nursing, and administrative staff of Dementias and Neurodegenerative Diseases Research Network North West, who assisted with the recruitment of patients and the collection and preparation of samples. We also wish to acknowledge and thank all the Consultant Neurologists and their staff within the North West Region of Great Britain who took part in this study, particularly Prof. J. Barrett (Arrowe Park Hospital, Wirral) and Drs. M. Kellett (Salford Royal Hospitals National Health Service Foundation Trust), S. N. H. Naqvi (Chorley and South Ribble District General Hospital), J. Raw (Fairfield General Hospital, Bury), M. J. Steiger (The Walton Centre, Liverpool), P. Tidswell (Royal Blackburn Hospital), C. J. Turnbull (Arrowe Park Hospital, Wirral), and J. Vassallo (Royal Oldham Hospital), for their enthusiasm for, and commitment to, the project. The authors thank students H. Sheldon, S. Macari, E. Mooney, and H. Kennedy from Lancaster Girls Grammar School for their help with the immunoblotting, and Mrs K. Lamb for her assistance in preparing the recombinant proteins.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Angot E, 2009, PARKINSONISM RELAT D, V15, pS143, DOI 10.1016/S1353-8020(09)70802-8; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; de Lau LML, 2006, ARCH NEUROL-CHICAGO, V63, P362, DOI 10.1001/archneur.63.3.noc50312; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2003, LANCET NEUROL, V2, P461, DOI 10.1016/S1474-4422(03)00481-2; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eller M, 2009, NAT REV NEUROL, V5, P561, DOI 10.1038/nrneurol.2009.135; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Foulds P, 2010, NAT REV NEUROL, V6, P359, DOI 10.1038/nrneurol.2010.78; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuda N, 2010, J ALZHEIMERS DIS, V19, P1, DOI 10.3233/JAD-2010-1231; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Parkkinen L, 2008, ACTA NEUROPATHOL, V115, P399, DOI 10.1007/s00401-008-0346-6; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qing H, 2009, BIOCHEM BIOPH RES CO, V387, P149, DOI 10.1016/j.bbrc.2009.06.142; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Schapira AHV, 1999, BRIT MED J, V318, P311, DOI 10.1136/bmj.318.7179.311; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Suchowersky O, 2006, NEUROLOGY, V66, P968, DOI 10.1212/01.wnl.0000215437.80053.d0; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wider C, 2010, MOVEMENT DISORD, V25, pS15, DOI 10.1002/mds.22723; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	54	143	152	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4127	4137		10.1096/fj.10-179192	http://dx.doi.org/10.1096/fj.10-179192			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21865317				2022-12-25	WOS:000298138100007
J	Huang, T; Xie, ZH; Wang, JY; Li, M; Jing, NH; Li, L				Huang, Tao; Xie, Zhihui; Wang, Jiyong; Li, Meng; Jing, Naihe; Li, Lin			Nuclear Factor of Activated T Cells (NFAT) Proteins Repress Canonical Wnt Signaling via Its Interaction with Dishevelled (Dvl) Protein and Participate in Regulating Neural Progenitor Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTION FACTORS; CANCER CELLS; C-JUN; PATHWAY; CALCINEURIN; CALCIUM; DISEASE; FAMILY; SUMOYLATION	The Ca2+ signaling pathway appears to regulate the processes of the early development through its antagonism of canonical Wnt/beta-catenin signaling pathway. However, the underlying mechanism is still poorly understood. Here, we show that nuclear factor of activated T cells (NFAT), a component of Ca2+ signaling, interacts directly with Dishevelled (Dvl) in a Ca2+-dependent manner. A dominant negative form of NFAT rescued the inhibition of the Wnt/beta-catenin pathway triggered by the Ca2+ signal. NFAT functioned downstream of beta-catenin without interfering with its stability, but influencing the interaction of beta-catenin with Dvl by its competitively binding to Dvl. Furthermore, we demonstrate that NFAT is a regulator in the proliferation and differentiation of neural progenitor cells by modulating canonical Wnt/beta-catenin signaling pathway in the neural tube of chick embryo. Our findings suggest that NFAT negatively regulates canonical Wnt/beta-catenin signaling by binding to Dvl, thereby participating in vertebrate neurogenesis.	[Huang, Tao; Wang, Jiyong; Li, Meng; Li, Lin] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xie, Zhihui; Jing, Naihe] Chinese Acad Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	LI, LI/GVS-5344-2022; li, li/HII-4157-2022; Li, Li/AEM-3636-2022		Ministry of Science and Technology of China [2010CB912100, 2007CB914500]; National Natural Science Foundation of China [30821065, 30930052, 90813024]; Science and Technology Commission of Shanghai Municipality	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by Ministry of Science and Technology of China Grants 2010CB912100 and 2007CB914500, National Natural Science Foundation of China Grants 30821065, 30930052, and 90813024, and the Science and Technology Commission of Shanghai Municipality.	Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Chow CW, 1999, MOL CELL BIOL, V19, P2300; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li M, 2010, J BIOL CHEM, V285, P13397, DOI 10.1074/jbc.M109.083246; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Santoro IM, 1997, CANCER RES, V57, P488; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Wan YY, 2009, J MOL CELL BIOL, V1, P20, DOI 10.1093/jmcb/mjp001; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102	44	34	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37399	37405		10.1074/jbc.M111.251165	http://dx.doi.org/10.1074/jbc.M111.251165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880741	Green Published, hybrid			2022-12-25	WOS:000296542400040
J	Fletcher, EV; Kullmann, DM; Schorge, S				Fletcher, Emily V.; Kullmann, Dimitri M.; Schorge, Stephanie			Alternative Splicing Modulates Inactivation of Type 1 Voltage-gated Sodium Channels by Toggling an Amino Acid in the First S3-S4 Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ANTIEPILEPTIC DRUGS; FEBRILE SEIZURES; MESSENGER-RNAS; STATUS-EPILEPTICUS; RAT HIPPOCAMPUS; NA+ CHANNELS; MOUSE MODEL; HUMAN BRAIN; SCN1A GENE	Voltage-gated sodium channels underlie the upstroke of action potentials and are fundamental to neuronal excitability. Small changes in the behavior of these channels are sufficient to change neuronal firing and trigger seizures. These channels are subject to highly conserved alternative splicing, affecting the short linker between the third transmembrane segment (S3) and the voltage sensor (S4) in their first domain. The biophysical consequences of this alternative splicing are incompletely understood. Here we focus on type 1 sodium channels (Nav1.1) that are implicated in human epilepsy. We show that the functional consequences of alternative splicing are highly sensitive to recording conditions, including the identity of the major intracellular anion and the recording temperature. In particular, the inactivation kinetics of channels containing the alternate exon 5N are more sensitive to intracellular fluoride ions and to changing temperature than channels containing exon 5A. Moreover, Nav1.1 channels containing exon 5N recover from inactivation more rapidly at physiological temperatures. Three amino acids differ between exons 5A and 5N. However, the changes in sensitivity and stability of inactivation were reproduced by a single conserved change from aspartate to asparagine in channels containing exon 5A, which was sufficient to make them behave like channels containing the complete exon 5N sequence. These data suggest that splicing at this site can modify the inactivation of sodium channels and reveal a possible interaction between splicing and anti-epileptic drugs that stabilize sodium channel inactivation.	[Fletcher, Emily V.; Kullmann, Dimitri M.; Schorge, Stephanie] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England	University of London; University College London	Schorge, S (corresponding author), UCL Inst Neurol Queen Sq, DCEE 8th Floor QSH, London WC1N 3BG, England.	s.schorge@ion.ucl.ac.uk	Schorge, Stephanie/C-8515-2009; Kullmann, Dimitri M/A-3162-2009; Fletcher, Emily V/AAN-9916-2020	Schorge, Stephanie/0000-0003-1541-5148; Kullmann, Dimitri M/0000-0001-6696-3545; Fletcher, Emily V/0000-0002-9786-4221	Medical Research Council [G0601440]; European Union (Epicure) [LSH 037315]; Brain Research Trust; Worshipful Company of Pewterers; Medical Research Council [G0601943, G0802158, G0801316] Funding Source: researchfish; Action Medical Research [1725] Funding Source: researchfish; MRC [G116/147, G0400136, G0400627, G0801316, G0900613, G0802158, G0600368, G9805989, G0200373, G0601440, G0601943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (Epicure)(European Commission); Brain Research Trust; Worshipful Company of Pewterers; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0601440 and by the European Union (Epicure, Grant LSH 037315).; Supported by a Brain Research Trust studentship.; Funded by a fellowship by the Worshipful Company of Pewterers. To whom correspondence should be addressed: DCEE 8th floor QSH, UCL-Institute of Neurology Queen Square, London WC1N 3BG. E-mail: s.schorge@ion.ucl. ac.uk.	Abe T, 2008, BRIT J CLIN PHARMACO, V66, P304, DOI 10.1111/j.1365-2125.2008.03203.x; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Aronica E, 2001, EUR J NEUROSCI, V13, P1261, DOI 10.1046/j.0953-816x.2001.01502.x; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BIGAY J, 1985, FEBS LETT, V191, P181, DOI 10.1016/0014-5793(85)80004-1; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chatelier A, 2008, J NEUROPHYSIOL, V99, P2241, DOI 10.1152/jn.01350.2007; Chioni AM, 2005, J NEUROSCI METH, V147, P88, DOI 10.1016/j.jneumeth.2005.03.010; Choi JS, 2010, BRAIN, V133, P1823, DOI 10.1093/brain/awq114; Copley RR, 2004, TRENDS GENET, V20, P171, DOI 10.1016/j.tig.2004.02.001; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Czapinski P, 2005, CURR TOP MED CHEM, V5, P3, DOI 10.2174/1568026053386962; DibHajj SD, 1997, FEBS LETT, V416, P11, DOI 10.1016/S0014-5793(97)01154-X; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Gastaldi M, 1997, MOL BRAIN RES, V44, P179, DOI 10.1016/S0169-328X(96)00199-4; Gazina EV, 2010, NEUROSCIENCE, V166, P195, DOI 10.1016/j.neuroscience.2009.12.011; Heinzen EL, 2007, AM J HUM GENET, V80, P876, DOI 10.1086/516650; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Jarecki BW, 2009, CHANNELS, V3, P259; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; Mantegazza M, 2005, J NEUROSCI, V25, P3341, DOI 10.1523/JNEUROSCI.0104-05.2005; Mantegazza M, 2010, EPILEPSY RES, V92, P1, DOI 10.1016/j.eplepsyres.2010.08.003; Martin MS, 2010, J BIOL CHEM, V285, P9823, DOI 10.1074/jbc.M109.078568; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Onkal R, 2008, J CELL PHYSIOL, V216, P716, DOI 10.1002/jcp.21451; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Petrovski S, 2009, NEUROLOGY, V73, P1928, DOI 10.1212/WNL.0b013e3181c3fd6f; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; SCHALLER KL, 1992, J NEUROSCI, V12, P1370; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; Schlachter K, 2009, NEUROLOGY, V72, P974, DOI 10.1212/01.wnl.0000344401.02915.00; Schorge S, 2006, NEUROLOGY, V67, P1538, DOI 10.1212/01.wnl.0000242618.60344.8c; Strunecka A, 2002, PHYSIOL RES, V51, P557; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tate SK, 2006, PHARMACOGENET GENOM, V16, P721, DOI 10.1097/01.fpc.0000230114.41828.73; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; The YK, 2006, BIOPHYS J, V90, P3511, DOI 10.1529/biophysj.105.073072; Xu R, 2007, MOL CELL NEUROSCI, V35, P292, DOI 10.1016/j.mcn.2007.03.003; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zimprich F, 2008, EPILEPSIA, V49, P1108, DOI 10.1111/j.1528-1167.2008.01549_4.x	47	31	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36700	36708		10.1074/jbc.M111.250225	http://dx.doi.org/10.1074/jbc.M111.250225			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890636	hybrid, Green Published			2022-12-25	WOS:000296538300053
J	Vojnov, L; Martins, MA; Almeida, JR; Ende, Z; Rakasz, EG; Reynolds, MR; Leon, EJ; Weisgrau, KL; Burwitz, BJ; Folkvord, JM; de Santana, MGV; Neves, PCC; Connick, E; Skinner, PJ; Gostick, E; O'Connor, DH; Wilson, NA; Bonaldo, MC; Galler, R; Price, DA; Douek, DC; Watkins, DI				Vojnov, Lara; Martins, Mauricio A.; Almeida, Jorge R.; Ende, Zachary; Rakasz, Eva G.; Reynolds, Matthew R.; Leon, Enrique J.; Weisgrau, Kim L.; Burwitz, Benjamin J.; Folkvord, Joy M.; Veloso de Santana, Marlon G.; Costa Neves, Patricia C.; Connick, Elizabeth; Skinner, Pamela J.; Gostick, Emma; O'Connor, David H.; Wilson, Nancy A.; Bonaldo, Myrna C.; Galler, Ricardo; Price, David A.; Douek, Danny C.; Watkins, David I.			GagCM9-Specific CD8(+) T Cells Expressing Limited Public TCR Clonotypes Do Not Suppress SIV Replication In Vivo	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CELLULAR IMMUNE-RESPONSES; RHESUS-MONKEYS; LYMPHOCYTE RESPONSE; HIV-1 INFECTION; MAMU-B-ASTERISK-08-POSITIVE MACAQUES; GASTROINTESTINAL-TRACT; SIVMAC239 REPLICATION; VIRAL REPLICATION; ESCAPE MUTATIONS	Several lines of evidence suggest that HIV/SIV-specific CD8(+) T cells play a critical role in the control of viral replication. Recently we observed high levels of viremia in Indian rhesus macaques vaccinated with a segment of SIVmac239 Gag (Gag(45-269)) that were subsequently infected with SIVsmE660. These seven Mamu-A*01(+) animals developed CD8(+) T cell responses against an immunodominant epitope in Gag, GagCM9, yet failed to control virus replication. We carried out a series of immunological and virological assays to understand why these Gag-specific CD8(+) T cells could not control virus replication in vivo. GagCM9-specific CD8(+) T cells from all of the animals were multifunctional and were found in the colonic mucosa. Additionally, GagCM9-specific CD8(+) T cells accessed B cell follicles, the primary residence of SIV-infected cells in lymph nodes, with effector to target ratios between 20-250 GagCM9-specific CD8(+) T cells per SIV-producing cell. Interestingly, vaccinated animals had few public TCR clonotypes within the GagCM9-specific CD8(+) T cell population pre- and post-infection. The number of public TCR clonotypes expressed by GagCM9-specific CD8(+) T cells post-infection significantly inversely correlated with chronic phase viral load. It is possible that these seven animals failed to control viral replication because of the narrow TCR repertoire expressed by the GagCM9-specific CD8(+) T cell population elicited by vaccination and infection.	[Vojnov, Lara; Martins, Mauricio A.; Rakasz, Eva G.; Reynolds, Matthew R.; Burwitz, Benjamin J.; O'Connor, David H.; Wilson, Nancy A.; Watkins, David I.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Almeida, Jorge R.; Ende, Zachary; Douek, Danny C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Rakasz, Eva G.; Leon, Enrique J.; Weisgrau, Kim L.; Watkins, David I.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Folkvord, Joy M.; Connick, Elizabeth] Univ Colorado, Sch Med, Denver, CO USA; [Veloso de Santana, Marlon G.; Costa Neves, Patricia C.; Bonaldo, Myrna C.] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil; [Skinner, Pamela J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Galler, Ricardo] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Rio De Janeiro, Brazil; [Gostick, Emma; Price, David A.] Cardiff Univ, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales	University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Fundacao Oswaldo Cruz; University of Minnesota System; University of Minnesota Twin Cities; Fundacao Oswaldo Cruz; Cardiff University	Vojnov, L (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	Watkins@primate.wisc.edu	Bonaldo, Myrna C/D-9494-2013; Bonaldo, Myrna/AAE-2799-2021; Martins, Mauricio/AAU-9226-2020; Price, David A/C-7876-2013; Ende, Zachary/AAD-3800-2019; Galler, Ricardo/B-3280-2014; Rakasz, Eva G/H-9197-2019; Veloso de Santana, Marlon Gilsepp/H-8146-2017	Martins, Mauricio/0000-0001-8336-216X; Price, David A/0000-0001-9416-2737; Ramos de Almeida, Jorge/0000-0002-5009-8478; Wilson, Nancy/0000-0002-9472-6026; Veloso de Santana, Marlon Gilsepp/0000-0002-3427-841X; Vojnov, Lara/0000-0003-0488-1012; Skinner, Pamela/0000-0003-3388-1687; o'connor, david/0000-0003-2139-470X	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease [R01 AI076114, R01 AI049120, R24 RR015371, R24 RR016038]; National Center for Research Resources (NCRR) [R51 RR000167]; Medical Research Council [G0501963] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016038, P51RR000167, R24RR015371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049120, R01AI076114] Funding Source: NIH RePORTER; MRC [G0501963] Funding Source: UKRI	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Disease grants R01 AI076114, R01 AI049120, R24 RR015371, and R24 RR016038 and in part by grant R51 RR000167 from the National Center for Research Resources (NCRR) awarded to the WNPRC, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2002, J VIROL, V76, P10507, DOI 10.1128/JVI.76.20.10507-10511.2002; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Cline AN, 2005, J MED PRIMATOL, V34, P303; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; Folkvord JM, 2003, JAIDS-J ACQ IMM DEF, V32, P469, DOI 10.1097/00126334-200304150-00001; Friedrich TC, 2004, J VIROL, V78, P10064, DOI 10.1128/JVI.78.18.10064-10073.2004; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaizu M, 2007, IMMUNOGENETICS, V59, P693, DOI 10.1007/s00251-007-0233-7; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Liang XP, 2005, J VIROL, V79, P12321, DOI 10.1128/JVI.79.19.12321-12331.2005; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venturi V, 2008, J IMMUNOL, V181, P2597, DOI 10.4049/jimmunol.181.4.2597; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23515	10.1371/journal.pone.0023515	http://dx.doi.org/10.1371/journal.pone.0023515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887264	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000294298800011
J	Kaplan, GB; Leite-Morris, KA; Fan, WY; Young, AJ; Guy, MD				Kaplan, Gary B.; Leite-Morris, Kimberly A.; Fan, WenYing; Young, Angela J.; Guy, Marsha D.			Opiate Sensitization Induces FosB/Delta FosB Expression in Prefrontal Cortical, Striatal and Amygdala Brain Regions	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE RELEASE; VENTRAL TEGMENTAL AREA; DELTA-FOSB; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; LOCOMOTOR-ACTIVITY; DISTINCT PATTERNS; CHRONIC COCAINE; C-FOS; MORPHINE	Sensitization to the effects of drugs of abuse and associated stimuli contributes to drug craving, compulsive drug use, and relapse in addiction. Repeated opiate exposure produces behavioral sensitization that is hypothesized to result from neural plasticity in specific limbic, striatal and cortical systems. Delta FosB and FosB are members of the Fos family of transcription factors that are implicated in neural plasticity in addiction. This study examined the effects of intermittent morphine treatment, associated with motor sensitization, on FosB/Delta FosB levels using quantitative immunohistochemistry. Motor sensitization was tested in C57BL/6 mice that received six intermittent pre-treatments (on days 1, 3, 5, 8, 10, 12) with either subcutaneous morphine (10 mg/kg) or saline followed by a challenge injection of morphine or saline on day 16. Mice receiving repeated morphine injections demonstrated significant increases in locomotor activity on days 8, 10, and 12 of treatment (vs. day 1), consistent with development of locomotor sensitization. A morphine challenge on day 16 significantly increased locomotor activity of saline pre-treated mice and produced even larger increases in motor activity in the morphine pre-treated mice, consistent with the expression of opiate sensitization. Intermittent morphine pre-treatment on these six pre-treatment days produced a significant induction of FosB/Delta FosB, measured on day 16, in multiple brain regions including prelimbic (PL) and infralimbic (IL) cortex, nucleus accumbens (NAc) core, dorsomedial caudate-putamen (CPU), basolateral amygdala (BLA) and central nucleus of the amygdala (CNA) but not in a motor cortex control region. Opiate induced sensitization may develop via Fos/Delta FosB plasticity in motivational pathways (NAc), motor outputs (CPU), and associative learning (PL, IL, BLA) and stress pathways (CNA).	[Kaplan, Gary B.] VA Boston Healthcare Syst, Mental Hlth Serv, Boston, MA USA; [Kaplan, Gary B.; Leite-Morris, Kimberly A.; Fan, WenYing; Young, Angela J.; Guy, Marsha D.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Leite-Morris, Kimberly A.; Fan, WenYing] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Leite-Morris, Kimberly A.; Fan, WenYing] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University	Kaplan, GB (corresponding author), VA Boston Healthcare Syst, Mental Hlth Serv, Boston, MA USA.	Gary.Kaplan@va.gov; kleitemo@bu.edu	Kaplan, Gary B./AAJ-5099-2020	Leite-Morris, Kimberly/0000-0003-3407-7375; Kaplan, M.D., Gary B./0000-0003-1316-2749	Department of Veterans Affairs; Department of Defense	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense(United States Department of Defense)	This work was supported by a Merit Review Grant from the Department of Veterans Affairs and from the Department of Defense to G.B.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bjijou Y, 2002, NEUROSCIENCE, V109, P499, DOI 10.1016/S0306-4522(01)00508-5; Brenhouse HC, 2006, NEUROSCIENCE, V137, P773, DOI 10.1016/j.neuroscience.2005.09.039; Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Eitan S, 2003, J NEUROSCI, V23, P8360; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Ghasemzadeh MB, 1999, J NEUROCHEM, V72, P157, DOI 10.1046/j.1471-4159.1999.0720157.x; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; KALIVAS PW, 1987, J PHARMACOL EXP THER, V241, P204; Kaste K, 2009, PHARMACOL BIOCHEM BE, V92, P655, DOI 10.1016/j.pbb.2009.03.004; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Leite-Morris KA, 2004, J PHARMACOL EXP THER, V308, P667, DOI 10.1124/jpet.103.058412; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Martiila K, 2006, NEUROPHARMACOLOGY, V51, P44, DOI 10.1016/j.neuropharm.2006.02.014; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McDaid J, 2006, NEUROPSYCHOPHARMACOL, V31, P1212, DOI 10.1038/sj.npp.1300854; Mickiewicz AL, 2009, NEUROPSYCHOPHARMACOL, V34, P874, DOI 10.1038/npp.2008.111; Muller DL, 2005, J PHARMACOL EXP THER, V314, P148, DOI 10.1124/jpet.105.083410; Murphy NP, 2001, J NEUROCHEM, V79, P626, DOI 10.1046/j.1471-4159.2001.00599.x; Narita M, 2005, J NEUROCHEM, V93, P1463, DOI 10.1111/j.1471-4159.2005.03136.x; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Nye HE, 1996, MOL PHARMACOL, V49, P636; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2005, EUR J NEUROSCI, V21, P2817, DOI 10.1111/j.1460-9568.2005.04110.x; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Powell KR, 2001, DRUG ALCOHOL DEPEN, V62, P83, DOI 10.1016/S0376-8716(00)00167-8; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Shippenberg TS, 1996, EUR J PHARMACOL, V299, P33, DOI 10.1016/0014-2999(95)00852-7; SPANAGEL R, 1993, SYNAPSE, V14, P243, DOI 10.1002/syn.890140307; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 1997, PSYCHOPHARMACOLOGY, V131, P115, DOI 10.1007/s002130050273; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zar JH, 1984, BIOSTAT ANAL, P83	48	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23574	10.1371/journal.pone.0023574	http://dx.doi.org/10.1371/journal.pone.0023574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886798	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500016
J	Cronin, NJ; Carty, CP; Barrett, RS				Cronin, Neil J.; Carty, Christopher P.; Barrett, Rod S.			Triceps Surae Short Latency Stretch Reflexes Contribute to Ankle Stiffness Regulation during Human Running	PLOS ONE			English	Article							MUSCLE TENDON VIBRATION; HUMAN LOCOMOTION; SOLEUS MUSCLE; AFFERENT FEEDBACK; GROUP IA; RESPONSES; WALKING; STANCE; CAT; LEG	During human running, short latency stretch reflexes (SLRs) are elicited in the triceps surae muscles, but the function of these responses is still a matter of controversy. As the SLR is primarily mediated by Ia afferent nerve fibres, various methods have been used to examine SLR function by selectively blocking the Ia pathway in seated, standing and walking paradigms, but stretch reflex function has not been examined in detail during running. The purpose of this study was to examine triceps surae SLR function at different running speeds using Achilles tendon vibration to modify SLR size. Ten healthy participants ran on an instrumented treadmill at speeds between 7 and 15 km/h under 2 Achilles tendon vibration conditions: no vibration and 90 Hz vibration. Surface EMG from the triceps surae and tibialis anterior muscles, and 3D lower limb kinematics and ground reaction forces were simultaneously collected. In response to vibration, the SLR was depressed in the triceps surae muscles at all speeds. This coincided with short-lasting yielding at the ankle joint at speeds between 7 and 12 km/h, suggesting that the SLR contributes to muscle stiffness regulation by minimising ankle yielding during the early contact phase of running. Furthermore, at the fastest speed of 15 km/h, the SLR was still depressed by vibration in all muscles but yielding was no longer evident. This finding suggests that the SLR has greater functional importance at slow to intermediate running speeds than at faster speeds.	[Cronin, Neil J.; Carty, Christopher P.; Barrett, Rod S.] Griffith Univ, Sch Physiotherapy & Exercise Sci, Musculoskeletal Res Program, Nathan, Qld 4111, Australia	Griffith University	Cronin, NJ (corresponding author), Griffith Univ, Sch Physiotherapy & Exercise Sci, Musculoskeletal Res Program, Nathan, Qld 4111, Australia.	n.cronin@griffith.edu.au	Barrett, Rod/B-4419-2009; Cronin, Neil/AAA-8815-2022; Cronin, Neil/B-3860-2011	Cronin, Neil/0000-0002-5332-1188; Barrett, Rod/0000-0002-1784-1629; Carty, Christopher/0000-0002-8969-5181	Griffith University	Griffith University(Griffith University)	NC was supported by a New Researcher Grant from Griffith University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLUM JHJ, 1982, EXP BRAIN RES, V48, P153; ALLUM JHJ, 1982, BRAIN RES, V234, P159, DOI 10.1016/0006-8993(82)90481-4; Bove M, 2003, J PHYSIOL-LONDON, V550, P617, DOI 10.1113/jphysiol.2003.043331; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; BURKE D, 1983, J PHYSIOL-LONDON, V339, P535, DOI 10.1113/jphysiol.1983.sp014732; CORDO P, 1993, ELECTROEN CLIN NEURO, V89, P45, DOI 10.1016/0168-5597(93)90084-3; Courtine G, 2007, J NEUROPHYSIOL, V97, P772, DOI 10.1152/jn.00764.2006; Cronin NJ, 2008, J APPL PHYSIOL, V105, P226, DOI 10.1152/japplphysiol.90432.2008; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DIETZ V, 1979, J NEUROPHYSIOL, V42, P1212, DOI 10.1152/jn.1979.42.5.1212; DIETZ V, 1978, J NEUROL SCI, V37, P187, DOI 10.1016/0022-510X(78)90202-2; Duysens J, 2008, NEUROPHYSIOL CLIN, V38, P399, DOI 10.1016/j.neucli.2008.09.010; Fallon JB, 2007, MUSCLE NERVE, V36, P21, DOI 10.1002/mus.20796; Gottschall JS, 2007, EXP BRAIN RES, V182, P131, DOI 10.1007/s00221-007-1084-z; Grey MJ, 2004, CAN J PHYSIOL PHARM, V82, P610, DOI 10.1139/y04-077; Grey MJ, 2001, J PHYSIOL-LONDON, V534, P925, DOI 10.1111/j.1469-7793.2001.00925.x; HOFFER JA, 1981, J NEUROPHYSIOL, V45, P267, DOI 10.1152/jn.1981.45.2.267; Ishikawa M, 2007, J APPL PHYSIOL, V103, P1030, DOI 10.1152/japplphysiol.00277.2007; Kennedy PM, 2004, CAN J PHYSIOL PHARM, V82, P675, DOI 10.1139/Y04-080; LANCE JW, 1965, J NEUROL NEUROSUR PS, V28, P328, DOI 10.1136/jnnp.28.4.328; Leukel C, 2009, J APPL PHYSIOL, V107, P1051, DOI 10.1152/japplphysiol.00301.2009; Mazzaro N, 2005, J NEUROPHYSIOL, V93, P167, DOI 10.1152/jn.00283.2004; Nardone A, 2005, CLIN NEUROPHYSIOL, V116, P1370, DOI 10.1016/j.clinph.2005.01.015; Nardone A, 1996, NEUROSCI LETT, V206, P89, DOI 10.1016/S0304-3940(96)12430-7; NICHOLS TR, 1973, SCIENCE, V181, P182, DOI 10.1126/science.181.4095.182; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; Pearson KG, 2003, EXP BRAIN RES, V150, P50, DOI 10.1007/s00221-003-1445-1; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Schillings AM, 1999, BRAIN RES, V816, P480, DOI 10.1016/S0006-8993(98)01198-6; SINKJAER T, 1988, J NEUROPHYSIOL, V60, P1110, DOI 10.1152/jn.1988.60.3.1110; STEIN RB, 1976, J NEUROPHYSIOL, V39, P1105, DOI 10.1152/jn.1976.39.5.1105; Verschueren SMP, 2002, EXP BRAIN RES, V143, P231, DOI 10.1007/s00221-001-0987-3; Whelan PJ, 1997, J NEUROPHYSIOL, V78, P1643, DOI 10.1152/jn.1997.78.3.1643; Zuur AT, 2010, J PHYSIOL-LONDON, V588, P799, DOI 10.1113/jphysiol.2009.182709	37	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23917	10.1371/journal.pone.0023917	http://dx.doi.org/10.1371/journal.pone.0023917			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887345	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800039
J	Huang, CW; Jha, A; Sweany, R; DeRobertis, C; Damann, KE				Huang, Changwei; Jha, Archana; Sweany, Rebecca; DeRobertis, Catherine; Damann, Kenneth E., Jr.			Intraspecific Aflatoxin Inhibition in Aspergillus flavus Is Thigmoregulated, Independent of Vegetative Compatibility Group and Is Strain Dependent	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; ATOXIGENIC STRAINS; ASSOCIATION; COMPETITION; RESISTANCE; MYCOTOXIN	Biological control of preharvest aflatoxin contamination by atoxigenic stains of Aspergillus flavus has been demonstrated in several crops. The assumption is that some form of competition suppresses the fungus's ability to infect or produce aflatoxin when challenged. Intraspecific aflatoxin inhibition was demonstrated by others. This work investigates the mechanistic basis of that phenomenon. A toxigenic and atoxigenic isolate of A. flavus which exhibited intraspecific aflatoxin inhibition when grown together in suspended disc culture were not inhibited when grown in a filter insert-plate well system separated by a .4 or 3 mu m membrane. Toxigenic and atoxigenic conidial mixtures (50: 50) placed on both sides of these filters restored inhibition. There was similar to 50% inhibition when a 12 mu m pore size filter was used. Conidial and mycelial diameters were in the 3.5-7.0 mu m range and could pass through the 12 mu m filter. Larger pore sizes in the initially separated system restored aflatoxin inhibition. This suggests isolates must come into physical contact with one another. This negates a role for nutrient competition or for soluble diffusible signals or antibiotics in aflatoxin inhibition. The toxigenic isolate was maximally sensitive to inhibition during the first 24 hrs of growth while the atoxigenic isolate was always inhibition competent. The atoxigenic isolate when grown with a green fluorescent protein (GFP) toxigenic isolate failed to inhibit aflatoxin indicating that there is specificity in the touch inhibiton. Several atoxigenic isolates were found which inhibited the GFP isolate. These results suggest that an unknown signaling pathway is initiated in the toxigenic isolate by physical interaction with an appropriate atoxigenic isolate in the first 24 hrs which prevents or down-regulates normal expression of aflatoxin after 3-5 days growth. We suspect thigmo-downregulation of aflatoxin synthesis is the mechanistic basis of intraspecific aflatoxin inhibition and the major contributor to biological control of aflatoxin contamination.	[Huang, Changwei; Jha, Archana; Sweany, Rebecca; DeRobertis, Catherine; Damann, Kenneth E., Jr.] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Huang, CW (corresponding author), Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA.	kdamann@agcenter.lsu.edu		Sweany, Rebecca/0000-0002-5275-8943	Louisiana Soybean and Grain Research and Promotion Board	Louisiana Soybean and Grain Research and Promotion Board	The Louisiana Soybean and Grain Research and Promotion Board provided the funding in support of this research under the grant entitled "Managing Mycotoxin Contamination of Louisiana Corn: Biological Control''. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjaiah V, 1998, MOL PLANT MICROBE IN, V11, P847, DOI 10.1094/MPMI.1998.11.9.847; BANDYOPADHYAY R, 2004, BIOL CONTROL INTEGRA, P193; BOTHAST RJ, 1974, MYCOLOGIA, V66, P365, DOI 10.2307/3758375; BROWN RL, 1991, J FOOD PROTECT, V54, P623, DOI 10.4315/0362-028X-54.8.623; *CAST, 1989, MYCOTOXINS EC HLTH R; Chang PK, 2007, INT J FOOD MICROBIOL, V114, P275, DOI 10.1016/j.ijfoodmicro.2006.09.017; COTTY PJ, 1994, PHYTOPATHOLOGY, V84, P1270, DOI 10.1094/Phyto-84-1270; COTTY PJ, 1993, PHYTOPATHOLOGY, V83, P1283, DOI 10.1094/Phyto-83-1283; COTTY PJ, 1990, PLANT DIS, V74, P233, DOI 10.1094/PD-74-0233; COVE DJ, 1976, HEREDITY, V36, P191, DOI 10.1038/hdy.1976.24; ELLIS JG, 1979, PHYSIOL PLANT PATHOL, V15, P311, DOI 10.1016/0048-4059(79)90082-1; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Geiser DM, 2000, FUNGAL GENET BIOL, V31, P169, DOI 10.1006/fgbi.2000.1215; Horn BW, 1996, MYCOLOGIA, V88, P574, DOI 10.2307/3761151; Horn BW, 2002, MYCOLOGIA, V94, P741, DOI 10.2307/3761688; Jaime-Garcia R, 2003, PHYTOPATHOLOGY, V93, P1190, DOI 10.1094/PHYTO.2003.93.9.1190; Janisiewicz WJ, 2000, PHYTOPATHOLOGY, V90, P1196, DOI 10.1094/PHYTO.2000.90.11.1196; JOSHUA H, 1993, J CHROMATOGR A, V654, P247, DOI 10.1016/0021-9673(93)83367-2; KERR A, 1980, PLANT DIS, V64, P25; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Pal KK, 2006, PLANT HLTH INSTRUCTO, V2, P1117, DOI [DOI 10.1094/PHI-A-2006-1117-02, 10.1094/PHI-A-2006-1117-02]; PAPA KE, 1986, MYCOLOGIA, V78, P98, DOI 10.2307/3793383; PITT JI, 1983, J APPL BACTERIOL, V54, P109, DOI 10.1111/j.1365-2672.1983.tb01307.x; Rajasekaran K, 2008, MYCOPATHOLOGIA, V165, P89, DOI 10.1007/s11046-007-9085-9; Sobolev VS, 2002, J AOAC INT, V85, P642; van Loon LC, 1998, ANNU REV PHYTOPATHOL, V36, P453, DOI 10.1146/annurev.phyto.36.1.453; Wicklow Donald T., 2007, Mycoscience, V48, P267, DOI 10.1007/s10267-007-0363-7; Wicklow DT, 2003, MYCOL RES, V107, P617, DOI 10.1017/S0953756203007792; ZUMMO N, 1991, PLANT DIS, V75, P910, DOI 10.1094/PD-75-0910	29	33	33	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23470	10.1371/journal.pone.0023470	http://dx.doi.org/10.1371/journal.pone.0023470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886793	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100015
J	Brouwer, MSM; Warburton, PJ; Roberts, AP; Mullany, P; Allan, E				Brouwer, Michael S. M.; Warburton, Philip J.; Roberts, Adam P.; Mullany, Peter; Allan, Elaine			Genetic Organisation, Mobility and Predicted Functions of Genes on Integrated, Mobile Genetic Elements in Sequenced Strains of Clostridium difficile	PLOS ONE			English	Article							CONJUGATIVE TRANSPOSON TN916; AUREUS COLLAGEN ADHESIN; ENTEROCOCCUS-FAECALIS; RESISTANCE; PROTEIN; IDENTIFICATION; PERFRINGENS; INFECTION; GENOME; TOXIN	Background: Clostridium difficile is the leading cause of hospital-associated diarrhoea in the US and Europe. Recently the incidence of C. difficile-associated disease has risen dramatically and concomitantly with the emergence of 'hypervirulent' strains associated with more severe disease and increased mortality. C. difficile contains numerous mobile genetic elements, resulting in the potential for a highly plastic genome. In the first sequenced strain, 630, there is one proven conjugative transposon (CTn), Tn5397, and six putative CTns (CTn1, CTn2 and CTn4-7), of which, CTn4 and CTn5 were capable of excision. In the second sequenced strain, R20291, two further CTns were described. Results: CTn1, CTn2 CTn4, CTn5 and CTn7 were shown to excise from the genome of strain 630 and transfer to strain CD37. A putative CTn from R20291, misleadingly termed a phage island previously, was shown to excise and to contain three putative mobilisable transposons, one of which was capable of excision. In silico probing of C. difficile genome sequences with recombinase gene fragments identified new putative conjugative and mobilisable transposons related to the elements in strains 630 and R20291. CTn5-like elements were described occupying different insertion sites in different strains, CTn1-like elements that have lost the ability to excise in some ribotype 027 strains were described and one strain was shown to contain CTn5-like and CTn7-like elements arranged in tandem. Additionally, using bioinformatics, we updated previous gene annotations and predicted novel functions for the accessory gene products on these new elements. Conclusions: The genomes of the C. difficile strains examined contain highly related CTns suggesting recent horizontal gene transfer. Several elements were capable of excision and conjugative transfer. The presence of antibiotic resistance genes and genes predicted to promote adaptation to the intestinal environment suggests that CTns play a role in the interaction of C. difficile with its human host.	[Brouwer, Michael S. M.; Warburton, Philip J.; Roberts, Adam P.; Mullany, Peter; Allan, Elaine] UCL, UCL Eastman Dent Inst, Dept Microbial Dis, London, England	University of London; University College London	Brouwer, MSM (corresponding author), UCL, UCL Eastman Dent Inst, Dept Microbial Dis, London, England.	e.allan@ucl.ac.uk	Brouwer, Mike/Z-1653-2019; Roberts, Adam P/C-1787-2008; Warburton, Philip/AAV-1606-2021; Roberts, Adam/AAU-5493-2021	Roberts, Adam P/0000-0002-0760-3088; Roberts, Adam/0000-0002-0760-3088; Warburton, Philip/0000-0002-5810-0296	European Community [223585]; Medical Research Council [G0601176]; Wellcome Trust [WT078131AIA]; MRC [G0601176] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 223585, the Medical Research Council (grant no. G0601176) and the Wellcome Trust (grant no. WT078131AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM LJ, 1987, J BACTERIOL, V169, P1579, DOI 10.1128/jb.169.4.1579-1584.1987; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], [No title captured]; BANNAM TL, 1995, MOL MICROBIOL, V16, P535, DOI 10.1111/j.1365-2958.1995.tb02417.x; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Bauer MP, 2009, CLIN MICROBIOL INFEC, V15, P1087, DOI 10.1111/j.1469-0691.2009.02853.x; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; COLEMAN JP, 1995, APPL ENVIRON MICROB, V61, P2514, DOI 10.1128/AEM.61.7.2514-2520.1995; FLANNAGAN SE, 1994, PLASMID, V32, P350, DOI 10.1006/plas.1994.1077; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gal M, 2005, J HOSP INFECT, V61, P231, DOI 10.1016/j.jhin.2005.01.017; Gomez A, 2008, PROTEIN J, V27, P130, DOI 10.1007/s10930-007-9116-x; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METHODS; Hernandez S, 2009, CURR MICROBIOL, V59, P451, DOI 10.1007/s00284-009-9459-y; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lyras D, 2004, MOL MICROBIOL, V51, P1787, DOI 10.1111/j.1365-2958.2003.03950.x; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Marsden GL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-389; McBride SM, 2011, INFECT IMMUN, V79, P167, DOI 10.1128/IAI.00731-10; MULLANY P, 1995, J ANTIMICROB CHEMOTH, V35, P305, DOI 10.1093/jac/35.2.305; MULLANY P, 1990, J GEN MICROBIOL, V136, P1343, DOI 10.1099/00221287-136-7-1343; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OLSSON A, 1986, GENE, V45, P175, DOI 10.1016/0378-1119(86)90252-0; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Rich RL, 1998, BIOCHEMISTRY-US, V37, P15423, DOI 10.1021/bi981773r; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Rupnik M, 1998, J CLIN MICROBIOL, V36, P2240, DOI 10.1128/JCM.36.8.2240-2247.1998; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCOTT JR, 1988, P NATL ACAD SCI USA, V85, P4809, DOI 10.1073/pnas.85.13.4809; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; UNDERWOOD A, DOUBLEACT V2; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; WUST J, 1983, ANTIMICROB AGENTS CH, V23, P784, DOI 10.1128/AAC.23.5.784; Zafar MA, 2011, J MOL BIOL, V407, P333, DOI 10.1016/j.jmb.2010.12.037	47	70	73	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23014	10.1371/journal.pone.0023014	http://dx.doi.org/10.1371/journal.pone.0023014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876735	Green Published, gold			2022-12-25	WOS:000294126900007
J	Erban, T				Erban, Tomas			Purification of Tropomyosin, Paramyosin, Actin, Tubulin, Troponin and Kinases for Chemiproteomics and Its Application to Different Scientific Fields	PLOS ONE			English	Article							AFFINITY-CHROMATOGRAPHY; PARA-AMINOBENZAMIDINE; SERINE PROTEASES; IDENTIFICATION; ENTEROKINASE; PROTEINS	Background: p-aminobenzamidine (p-ABA) is used as a ligand in the purification of many serine proteases and in their removal from heterogeneous samples. Moreover, p-ABA has a potent ability to bind Ca(2+)-binding proteins. The binding ability and use of p-ABA in purification processes is still not fully understood. Methodology/Principal Findings: A p-Aminobenzamidine (p-ABA) ligand enabled the purification of the panallergenic proteins tropomyosin and paramyosin, as well as actin, tubulin, troponin and several kinases and annexins, with variable specificity depending on the tissue source and slight modifications to the purification process. The high affinity of p-ABA to tropomyosin, paramyosin, actin, troponin and myosin is calcium-dependent, since calcium regulates the function of these proteins. In addition, p-ABA probably simulates phosphorylated serine and therefore purified appropriate kinases. Because p-ABA binds to calcium-dependent proteins, and probably those with binding sites containing serine, it is not a suitable inhibitor of proteolysis during the purification of such proteins. p-ABA is widely used to inhibit proteases during protein purification processes, but it is used in columns here to purify non-protease proteins. Two strategies were applied; the first was the inactivation of proteases that were not of interest using protease inhibitors. The second strategy employed was the use of a Ca(2+) wash solution to remove calcium-dependent proteins. The removal of calcium-dependent proteins from rabbit hind muscle pointed out even more selective purification. It is possible to obtain two purified samples: a) calcium dependent proteins and b) calcium independent proteins. Moreover, p-ABA may be useful as a model to study processes involving the phosphorylation of serine. Conclusion: A p-Aminobenzamidine (p-ABA) ligand enabled the purification of non-protease proteins, with variable specificity depending on the tissue source and slight modifications to the purification process. The method is applicable to various scientific branches, but is especially practical for medicinal applications.	Crop Res Inst, Dept Stored Prod Pest Control & Food Safety, Lab Prote, Prague, Czech Republic	Czech Crop Research Institute (CRI)	Erban, T (corresponding author), Crop Res Inst, Dept Stored Prod Pest Control & Food Safety, Lab Prote, Prague, Czech Republic.	arachnid@centrum.cz	Erban, Tomas/F-9615-2011	Erban, Tomas/0000-0003-1730-779X	Grant Agency of the Ministry of Agriculture of the Czech Republic [MZE0002700604]; Ministry of Education, Youth and Sports of the Czech Republic [OC10019]	Grant Agency of the Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by grants from the Grant Agency of the Ministry of Agriculture of the Czech Republic (http://eagri.cz/public/web/mze/), Grant No: MZE0002700604 and the Ministry of Education, Youth and Sports (http://www.msmt.cz/) of the Czech Republic, Grant No: OC10019 (COST CM0804 action; Chemical Biology with Natural Products). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian L, 2009, EXP APPL ACAROL, V47, P159, DOI 10.1007/s10493-008-9199-x; BROSCHAT KO, 1986, J BIOL CHEM, V261, P3350; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Brushia R. J., 1999, FRONT BIOSCI, V4, pD618; COTE GP, 1981, J BIOL CHEM, V256, P1004; De-Simone SG, 2005, J CHROMATOGR B, V822, P1, DOI 10.1016/j.jchromb.2005.04.018; ELFVIN M, 1976, J CELL BIOL, V71, P261, DOI 10.1083/jcb.71.1.261; EVANS SA, 1982, J BIOL CHEM, V257, P3014; GRANT DAW, 1984, CLIN CHIM ACTA, V142, P39, DOI 10.1016/0009-8981(84)90099-8; GRANT DAW, 1978, EUR J BIOCHEM, V88, P183, DOI 10.1111/j.1432-1033.1978.tb12436.x; Hu LH, 2009, EXPERT REV PROTEOMIC, V6, P433, DOI [10.1586/epr.09.55, 10.1586/EPR.09.55]; Jeong KY, 2006, PROTEIN PEPTIDE LETT, V13, P835; Jiz M, 2008, INFECT IMMUN, V76, P3164, DOI 10.1128/IAI.00409-08; LIU HP, 1989, P NATL ACAD SCI USA, V86, P90, DOI 10.1073/pnas.86.1.90; Nakamura K, 2003, J CHROMATOGR A, V1009, P133, DOI 10.1016/S0021-9673(03)00569-7; Panzani RC, 2001, ALLERGY, V56, P1, DOI 10.1111/j.1398-9995.2001.tb04419.x; Preetha S, 1997, WORLD J MICROB BIOT, V13, P573, DOI 10.1023/A:1018525711573; Ramos JDA, 2003, ALLERGY, V58, P412, DOI 10.1034/j.1398-9995.2003.00106.x; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Tian RJ, 2006, J CHROMATOGR A, V1134, P134, DOI 10.1016/j.chroma.2006.08.097; Vazquez-Talavera J, 2001, INFECT IMMUN, V69, P5412, DOI 10.1128/IAI.69.9.5412-5416.2001; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	25	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22860	10.1371/journal.pone.0022860	http://dx.doi.org/10.1371/journal.pone.0022860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876731	gold, Green Published, Green Submitted			2022-12-25	WOS:000294126900003
J	Fidler, JA; Treleaven, CM; Frakes, A; Tamsett, TJ; McCrate, M; Cheng, SH; Shihabuddin, LS; Kaspar, BK; Dodge, JC				Fidler, Jonathan A.; Treleaven, Christopher M.; Frakes, Ashley; Tamsett, Thomas J.; McCrate, Mary; Cheng, Seng H.; Shihabuddin, Lamya S.; Kaspar, Brian K.; Dodge, James C.			Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone	FASEB JOURNAL			English	Article						ALS; motor neuron disease; MND; glucocorticoid; allostasis; cacostasis	MOTOR-NEURON DEGENERATION; BLOOD-BRAIN-BARRIER; SALIVARY CORTISOL; ALS PATIENTS; SPINAL-CORD; SURVIVAL; MICE; HOMEOSTASIS; DEPRESSION; EXERCISE	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by motor neuron cell loss, muscular atrophy, and a shortened life span. Survival is highly variable, as some patients die within months, while others live for many years. Exposure to stress or the development of a nonoptimal stress response to disease might account for some of this variability. We show in the SOD1(G93A) mouse model of ALS that recurrent exposure to restraint stress led to an earlier onset of astrogliosis and microglial activation within the spinal cord, accelerated muscular weakness, and a significant decrease in median survival (105 vs. 122 d) when compared to non-stressed animals. Moreover, during normal disease course, ALS mice display a cacostatic stress response by developing an aberrant serum corticosterone circadian rhythm. Interestingly, we also found that higher corticosterone levels were significantly correlated with both an earlier onset of paralysis (males: r(2)=0.746; females: r(2)=0.707) and shorter survival times (males: r(2)=0.680; females: r(2)=0.552) in ALS mice. These results suggest that stress is capable of accelerating disease progression and that strategies that modulate glucocorticoid metabolism might be a viable treatment approach for ALS.-Fidler, J. A., Treleaven, C. M., Frakes, A., Tamsett, T. J., McCrate, M., Cheng, S. H., Shihabuddin, L. S., Kaspar, B. K., Dodge, J. C. Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB J. 25, 4369-4377 (2011). www.fasebj.org	[Fidler, Jonathan A.; Treleaven, Christopher M.; Tamsett, Thomas J.; Cheng, Seng H.; Shihabuddin, Lamya S.; Dodge, James C.] Genzyme Corp, Framingham, MA 01701 USA; [Frakes, Ashley; McCrate, Mary; Kaspar, Brian K.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Frakes, Ashley; McCrate, Mary; Kaspar, Brian K.] Ohio State Univ, Coll Med, Integrated Biomed Grad Program, Columbus, OH 43210 USA	Sanofi-Aventis; Genzyme Corporation; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Dodge, JC (corresponding author), Genzyme Corp, 49 New York Ave, Framingham, MA 01701 USA.	jim.dodge@genzyme.com	Kaspar, Brian/E-3349-2011; Cheng, Seng H/AAC-6564-2022		U.S. National Institutes of Health [R01NS064492, RC2NS069476-01]; ALS; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064492, T32NS077984, RC2NS069476] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Ms. Amy Eagle for her technical assistance. This work was funded, in part, by grants from the U.S. National Institutes of Health (R01NS064492 and RC2NS069476-01), Project ALS, and the Muscular Dystrophy Association to B. K. K.	BERTEL O, 1991, BRAIN RES, V566, P54, DOI 10.1016/0006-8993(91)91680-Y; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Czaplinski A, 2006, ARCH NEUROL-CHICAGO, V63, P1139, DOI 10.1001/archneur.63.8.1139; Deniselle MCG, 1997, J STEROID BIOCHEM, V60, P205, DOI 10.1016/S0960-0760(96)00193-8; Dodge JC, 2008, MOL THER, V16, P1056, DOI 10.1038/mt.2008.60; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Dumas TC, 2010, J NEUROSCI, V30, P1712, DOI 10.1523/JNEUROSCI.4402-09.2010; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Garbuzova-Davis S, 2007, BRAIN RES, V1157, P126, DOI 10.1016/j.brainres.2007.04.044; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; Hunter M D, 1993, Disabil Rehabil, V15, P119; Iellamo F, 2003, J SPORT MED PHYS FIT, V43, P539; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kimura K, 1999, J NEUROL SCI, V164, P37, DOI 10.1016/S0022-510X(99)00044-1; KRAEMER WJ, 1992, INT J SPORTS MED, V13, P103, DOI 10.1055/s-2007-1021240; KRAEMER WJ, 1995, J APPL PHYSIOL, V78, P976, DOI 10.1152/jappl.1995.78.3.976; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; Mastorakos George, 2005, Hormones (Athens), V4, P73; MCDONALD ER, 1994, ARCH NEUROL-CHICAGO, V51, P17, DOI 10.1001/archneur.1994.00540130027010; McElhiney MC, 2009, J NEUROL NEUROSUR PS, V80, P1146, DOI 10.1136/jnnp.2008.163246; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Morgan CA, 2000, BIOL PSYCHIAT, V47, P891, DOI 10.1016/S0006-3223(99)00307-8; Morselli LL, 2006, CLIN ENDOCRINOL, V65, P385, DOI 10.1111/j.1365-2265.2006.02609.x; Nagao M, 1998, J NEUROPATH EXP NEUR, V57, P329, DOI 10.1097/00005072-199804000-00004; NELSON JF, 1995, NEUROBIOL AGING, V16, P837, DOI 10.1016/0197-4580(95)00072-M; OCONNOR PJ, 1989, PSYCHONEUROENDOCRINO, V14, P303, DOI 10.1016/0306-4530(89)90032-2; Ohno T, 2001, AUTON NEUROSCI-BASIC, V88, P94, DOI 10.1016/S1566-0702(01)00217-X; Paccotti P, 2005, INT J SPORTS MED, V26, P747, DOI 10.1055/s-2004-830449; Patacchioli FR, 2003, J ENDOCRINOL INVEST, V26, pRC23, DOI 10.1007/BF03349149; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; PERNA FM, 1995, INT J BEHAV MED, V2, P13, DOI 10.1207/s15327558ijbm0201_2; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; RAPS D, 1971, EXPERIENTIA, V27, P339, DOI 10.1007/BF02138184; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sapolsky RM, 2000, NEUROBIOL DIS, V7, P540, DOI 10.1006/nbdi.2000.0350; Sato Y, 1997, EUR NEUROL, V37, P225, DOI 10.1159/000117447; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Tanskanen MM, 2011, J STRENGTH COND RES, V25, P787, DOI 10.1519/JSC.0b013e3181c1fa5d; Tateno M, 2009, HUM MOL GENET, V18, P942, DOI 10.1093/hmg/ddn422; Toepfer M, 1999, AMYOTROPH LATERAL SC, V1, P15; Vignola A, 2008, EUR J NEUROL, V15, P1231, DOI 10.1111/j.1468-1331.2008.02303.x; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Wheaton MW, 2007, NEUROLOGY, V69, P1411, DOI 10.1212/01.wnl.0000277422.11236.2c; Wilczak N, 2003, LANCET, V361, P1007, DOI 10.1016/S0140-6736(03)12828-0; Yang WW, 2011, EXP NEUROL, V227, P287, DOI 10.1016/j.expneurol.2010.11.019; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; ZIEGLER MG, 1980, NEUROLOGY, V30, P98, DOI 10.1212/WNL.30.1.98	56	23	25	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4369	4377		10.1096/fj.11-190819	http://dx.doi.org/10.1096/fj.11-190819			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21876068	Green Published			2022-12-25	WOS:000298138100028
J	Logue, JS; Whiting, JL; Tunquist, B; Sacks, DB; Langeberg, LK; Wordeman, L; Scott, JD				Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Sacks, David B.; Langeberg, Lorene K.; Wordeman, Linda; Scott, John D.			AKAP220 Protein Organizes Signaling Elements That Impact Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE ANCHORING PROTEIN; DYNAMIC INSTABILITY; EPITHELIAL-CELLS; IN-VIVO; MICROTUBULE; IQGAP1; ASSOCIATION; ADHESION; GROWTH; PHOSPHORYLATION	Cell movement requires the coordinated reception, integration, and processing of intracellular signals. We have discovered that the protein kinase A anchoring protein AKAP220 interacts with the cytoskeletal scaffolding protein IQGAP1 to influence cell motility. AKAP220/IQGAP1 networks receive and integrate calcium and cAMP second messenger signals and position signaling enzymes near their intended substrates at leading edges of migrating cells. IQGAP1 supports calcium/calmodulin-dependent association of factors that modulate microtubule dynamics. AKAP220 suppresses GSK-3 beta and positions this kinase to allow recruitment of the plus-end microtubule tracking protein CLASP2. Gene silencing of AKAP220 alters the rate of microtubule polymerization and the lateral tracking of growing microtubules and retards cell migration in metastatic human cancer cells. This reveals an unappreciated role for this anchored kinase/microtubule effector protein network in the propagation of cell motility.	[Logue, Jeremy S.; Whiting, Jennifer L.; Tunquist, Brian; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Whiting, Jennifer L.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Logue, Jeremy S.] Univ Washington, Sch Med, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Wordeman, Linda] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA	Scott, JD (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, 1959 Pacific Ave NE,Box 357750, Seattle, WA 98195 USA.	scottjdw@u.washington.edu		Sacks, David/0000-0003-3100-0735; Wordeman, Linda/0000-0002-9444-0650	National Institutes of Health [DK54441, GM69429, CA93645]; NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069429] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health Grants DK54441 (to J. D. S.), GM69429 (to L. W.), and CA93645 (to D. B. S.).	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; CARR DW, 1991, J BIOL CHEM, V266, P14188; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Graves LM, 1996, J BIOL CHEM, V271, P505, DOI 10.1074/jbc.271.1.505; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lester LB, 1996, J BIOL CHEM, V271, P9460, DOI 10.1074/jbc.271.16.9460; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Schillace RV, 1999, CURR BIOL, V9, P321, DOI 10.1016/S0960-9822(99)80141-9; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe T, 2009, J CELL SCI, V122, P2969, DOI 10.1242/jcs.046649; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	42	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39269	39281		10.1074/jbc.M111.277756	http://dx.doi.org/10.1074/jbc.M111.277756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21890631	Green Published, hybrid			2022-12-25	WOS:000296759800045
J	Kalita, MK; Sargsyan, K; Tian, B; Paulucci-Holthauzen, A; Najm, HN; Debusschere, BJ; Brasier, AR				Kalita, Mridul K.; Sargsyan, Khachik; Tian, Bing; Paulucci-Holthauzen, Adriana; Najm, Habib N.; Debusschere, Bert J.; Brasier, Allan R.			Sources of Cell-to-cell Variability in Canonical Nuclear Factor-kappa B (NF-kappa B) Signaling Pathway Inferred from Single Cell Dynamic Images	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ALPHA; OSCILLATIONS; ACTIVATION; MODEL; IKK; UBIQUITINATION; IDENTIFICATION; PROTEINS; KINASES	The canonical nuclear factor-kappa B (NF-kappa B) signaling pathway controls a gene network important in the cellular inflammatory response. Upon activation, NF-kappa B/RelA is released from cytoplasmic inhibitors, from where it translocates into the nucleus, subsequently activating negative feedback loops producing either monophasic or damped oscillatory nucleo-cytoplasmic dynamics. Although the population behavior of the NF-kappa B pathway has been extensively modeled, the sources of cell-to-cell variability are not well understood. We describe an integrated experimental-computational analysis of NF-kappa B/RelA translocation in a validated cell model exhibiting monophasic dynamics. Quantitative measures of cellular geometry and total cytoplasmic concentration and translocated RelA amounts were used as priors in Bayesian inference to estimate biophysically realistic parameter values based on dynamic live cell imaging studies of enhanced GFP-tagged RelA in stable transfectants. Bayesian inference was performed on multiple cells simultaneously, assuming identical reaction rate parameters, whereas cellular geometry and initial and total NF-kappa B concentration-related parameters were cell-specific. A subpopulation of cells exhibiting distinct kinetic profiles was identified that corresponded to differences in the I kappa B alpha translation rate. We conclude that cellular geometry, initial and total NF-kappa B concentration, I kappa B alpha translation, and I kappa B alpha degradation rates account for distinct cell-to-cell differences in canonical NF-kappa B translocation dynamics.	[Kalita, Mridul K.; Tian, Bing; Brasier, Allan R.] Univ Texas Med Branch, Dept Med, Galveston, TX 77555 USA; [Paulucci-Holthauzen, Adriana] Univ Texas Med Branch, Opt Imaging Lab, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Sargsyan, Khachik; Najm, Habib N.; Debusschere, Bert J.] Sandia Natl Labs, Livermore, CA 94551 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Sandia National Laboratories	Brasier, AR (corresponding author), Univ Texas Med Branch, Dept Med, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu		Brasier, Allan/0000-0002-5012-4090; Debusschere, Bert/0000-0001-7253-7059	National Institutes of Health (NIH) [AI062885]; NIH, NHLBI [BAA-HL-02-04]; NIH [RO1 GM086885]; University of Texas-Sandia National Laboratories; Sandia Laboratory; United States Department of Energy Office of Science through Office of Advanced Scientific Computing Research [07-012783]; Sandia Corp. [DE-AC04-94AL85000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas-Sandia National Laboratories; Sandia Laboratory(United States Department of Energy (DOE)); United States Department of Energy Office of Science through Office of Advanced Scientific Computing Research; Sandia Corp.(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant AI062885 (to A. R. B.), NIH, NHLBI, Contract BAA-HL-02-04 (to A. R. B.) and NIH Grant RO1 GM086885 (to M. Kimmel, Rice University). This work was supported in part by a University of Texas-Sandia National Laboratories joint postdoctoral program (to M. K. K.).; Supported by the Sandia Laboratory Directed Research and Development program as well as the United States Department of Energy Office of Science through the Applied Mathematics program in the Office of Advanced Scientific Computing Research under Contract 07-012783 with Sandia National Laboratories. Sandia National Laboratories is a multiprogram laboratory managed and operated by Sandia Corp., a wholly owned subsidiary of Lockheed Martin Corporation, for the United States Department of Energy National Nuclear Security Administration under Contract DE-AC04-94AL85000.	BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P1; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gelman A., 1996, BAYESIAN STAT, V5, P599; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Han YQ, 1997, J BIOL CHEM, V272, P9825; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; Jamaluddin M, 2010, J VIROL, V84, P9533, DOI 10.1128/JVI.01005-10; Joo J, 2007, ANN NY ACAD SCI, V1115, P221, DOI 10.1196/annals.1407.014; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lipniacki T, 2006, BIOPHYS J, V90, P725, DOI 10.1529/biophysj.104.056754; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008079; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Reagan MT, 2003, COMBUST FLAME, V132, P545, DOI 10.1016/S0010-2180(02)00503-5; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Sivia D, 1996, BAYESIAN ANAL TUTORI; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Wang YJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-23; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhao YX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008771	40	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37741	37757		10.1074/jbc.M111.280925	http://dx.doi.org/10.1074/jbc.M111.280925			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21868381	hybrid, Green Published			2022-12-25	WOS:000296542400070
J	Saeed, M; Suzuki, R; Watanabe, N; Masaki, T; Tomonaga, M; Muhammad, A; Kato, T; Matsuura, Y; Watanabe, H; Wakita, T; Suzuki, T				Saeed, Mohsan; Suzuki, Ryosuke; Watanabe, Noriyuki; Masaki, Takahiro; Tomonaga, Mitsunori; Muhammad, Amir; Kato, Takanobu; Matsuura, Yoshiharu; Watanabe, Haruo; Wakita, Takaji; Suzuki, Tetsuro			Role of the Endoplasmic Reticulum-associated Degradation (ERAD) Pathway in Degradation of Hepatitis C Virus Envelope Proteins and Production of Virus Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAPANESE-ENCEPHALITIS-VIRUS; INFECTION; STRESS; INDUCTION; GENOME; REPLICATION; INVOLVEMENT; APOPTOSIS; HOMOLOG; CHOP	Viral infections frequently cause endoplasmic reticulum (ER) stress in host cells leading to stimulation of the ER-associated degradation (ERAD) pathway, which subsequently targets unassembled glycoproteins for ubiquitylation and proteasomal degradation. However, the role of the ERAD pathway in the viral life cycle is poorly defined. In this paper, we demonstrate that hepatitis C virus (HCV) infection activates the ERAD pathway, which in turn controls the fate of viral glycoproteins and modulates virus production. ERAD proteins, such as EDEM1 and EDEM3, were found to increase ubiquitylation of HCV envelope proteins via direct physical interaction. Knocking down of EDEM1 and EDEM3 increased the half-life of HCV E2, as well as virus production, whereas exogenous expression of these proteins reduced the production of infectious virus particles. Further investigation revealed that only EDEM1 and EDEM3 bind with SEL1L, an ER membrane adaptor protein involved in translocation of ERAD substrates from the ER to the cytoplasm. When HCV-infected cells were treated with kifunensine, a potent inhibitor of the ERAD pathway, the half-life of HCV E2 increased and so did virus production. Kifunensine inhibited the binding of EDEM1 and EDEM3 with SEL1L, thus blocking the ubiquitylation of HCV E2 protein. Chemical inhibition of the ERAD pathway neither affected production of the Japanese encephalitis virus (JEV) nor stability of the JEV envelope protein. A co-immunoprecipitation assay showed that EDEM orthologs do not bind with JEV envelope protein. These findings highlight the crucial role of the ERAD pathway in the life cycle of specific viruses.	[Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Ryosuke; Watanabe, Noriyuki; Masaki, Takahiro; Tomonaga, Mitsunori; Kato, Takanobu; Wakita, Takaji; Suzuki, Tetsuro] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan; [Saeed, Mohsan; Watanabe, Haruo] Univ Tokyo, Dept Infect & Pathol, Grad Sch Med, Tokyo 1130033, Japan; [Muhammad, Amir] Khyber Girls Med Coll, Dept Pathol, Peshawar 25000, Pakistan; [Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Hamamatsu University School of Medicine; National Institute of Infectious Diseases (NIID); University of Tokyo; Osaka University	Suzuki, T (corresponding author), Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan.	tesuzuki@hama-med.ac.jp	Saeed, Mohsan/AAM-8375-2021		Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare, and from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Eriksson KK, 2004, J BIOL CHEM, V279, P44600, DOI 10.1074/jbc.M407972200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005; Lim CK, 2008, VIROLOGY, V374, P60, DOI 10.1016/j.virol.2007.12.021; Masaki T, 2010, J VIROL, V84, P5824, DOI 10.1128/JVI.02397-09; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	29	67	69	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37264	37273		10.1074/jbc.M111.259085	http://dx.doi.org/10.1074/jbc.M111.259085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878646	Green Published, hybrid			2022-12-25	WOS:000296542400026
J	Amosova, O; Kumar, V; Deutsch, A; Fresco, JR				Amosova, Olga; Kumar, Veena; Deutsch, Aaron; Fresco, Jacques R.			Self-catalyzed Site-specific Depurination of G Residues Mediated by Cruciform Extrusion in Closed Circular DNA Plasmids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; STRUCTURAL TRANSITION; SECONDARY STRUCTURES; BINDING PROTEIN; ABASIC SITES; STRANDED-DNA; IN-VIVO; CELLS; GENE; REPAIR	A major variety of "spontaneous" genomic damage is endogenous generation of apurinic sites. Depurination rates vary widely across genomes, occurring with higher frequency at "depurination hot spots." Recently, we discovered a site-specific self-catalyzed depurinating activity in short (14-18 nucleotides) DNA stem-loop-forming sequences with a 5'-G(T/A)GG-3' loop and T.A or G.C as the first base pair at the base of the loop; the 5'-G residue of the loop self-depurinates at least 10(5)-fold faster than random "spontaneous" depurination at pH 5. Formation of the catalytic intermediate for self-depurination in double-stranded DNA requires a stem-loop to extrude as part of a cruciform. In this study, evidence is presented for self-catalyzed depurination mediated by cruciform formation in plasmid DNA in vitro. Cruciform extrusion was confirmed, and its extent was quantitated by digestion of the plasmid with single strand-specific mung bean endonuclease, followed by restriction digestion and sequencing of resulting mung bean-generated fragments. Appearance of the apurinic site in the self-depurinating stem-loop was confirmed by digestion of plasmid DNA with apurinic endonuclease IV, followed by primer extension and/or PCR amplification to detect the endonuclease-generated strand break and identify its location. Self-catalyzed depurination was contingent on the plasmid being supercoiled and was not observed in linearized plasmids, consistent with the presence of the extruded cruciform in the supercoiled plasmid and not in the linear one. These results indicate that self-catalyzed depurination is not unique to single-stranded DNA; rather, it can occur in stem-loop structures extruding from double-stranded DNA and therefore could, in principle, occur in vivo.	[Amosova, Olga; Kumar, Veena; Deutsch, Aaron; Fresco, Jacques R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Fresco, JR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jrfresco@princeton.edu		Deutsch, Aaron/0000-0001-6750-5335; Kumar, Veena/0000-0002-7001-0277	United States Army Research Office [W911NF-07-1-0152]; Higgins Trust	United States Army Research Office; Higgins Trust	This work was supported by United States Army Research Office Grant W911NF-07-1-0152 and the Higgins Trust. The previous paper in this series is Ref. 10.	Alvarez D, 2002, J CELL BIOCHEM, V87, P194, DOI 10.1002/jcb.10294; Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36316, DOI 10.1074/jbc.M111.272047; ASAKURA Y, 1985, J BIOCHEM-TOKYO, V98, P41, DOI 10.1093/oxfordjournals.jbchem.a135270; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Chakravarti D, 2000, MUTAT RES-FUND MOL M, V456, P17, DOI 10.1016/S0027-5107(00)00102-0; Chen ZD, 1996, BIOTECHNIQUES, V21, P820; Cunningham LA, 2003, MOL CELL BIOL, V23, P8740, DOI 10.1128/MCB.23.23.8740-8750.2003; Dai X, 1998, J MOL BIOL, V283, P43, DOI 10.1006/jmbi.1998.2096; Dai X, 1997, P NATL ACAD SCI USA, V94, P2174, DOI 10.1073/pnas.94.6.2174; DAYN A, 1991, J BACTERIOL, V173, P2658, DOI 10.1128/jb.173.8.2658-2664.1991; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Fresco JR, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P3, DOI 10.1007/978-3-642-20763-1_1; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Inagaki H, 2005, HUM MUTAT, V26, P332, DOI 10.1002/humu.20228; Inagaki H, 2009, GENOME RES, V19, P191, DOI 10.1101/gr.079244.108; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kolb J, 2009, CHROMOSOME RES, V17, P469, DOI 10.1007/s10577-009-9039-9; Krasilnikov AS, 1999, J MOL BIOL, V292, P1149, DOI 10.1006/jmbi.1999.3117; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; PANYUTIN I, 1985, J BIOMOL STRUCT DYN, V2, P1221, DOI 10.1080/07391102.1985.10507634; PEARSON CE, 1994, BIOCHEMISTRY-US, V33, P14185, DOI 10.1021/bi00251a030; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Potaman VN, 2005, J MOL BIOL, V348, P609, DOI 10.1016/j.jmb.2005.03.010; Sambrook J., 1989, MOL CLONING, pA1; SHEFLIN LG, 1985, NUCLEIC ACIDS RES, V13, P6137, DOI 10.1093/nar/13.17.6137; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; Simonelli V, 2005, NUCLEIC ACIDS RES, V33, P4404, DOI 10.1093/nar/gki749; Svoboda P., 2009, COLD SPRING HARB PRO, ptop56; Tornaletti S, 2006, CHEM RES TOXICOL, V19, P1215, DOI 10.1021/tx060103g; Viswanathan VK, 1999, BIOTECHNIQUES, V27, P508, DOI 10.2144/99273st04; Wright B. E., 2011, CARCINOGENE IN PRESS; Wright BE, 2008, MOL IMMUNOL, V45, P3589, DOI 10.1016/j.molimm.2008.02.030; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x; Wright BE, 2002, CANCER RES, V62, P5641; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zheng KW, 2010, NUCLEIC ACIDS RES, V38, P327, DOI 10.1093/nar/gkp898	43	8	9	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36322	36330		10.1074/jbc.M111.272112	http://dx.doi.org/10.1074/jbc.M111.272112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868375	Green Published, hybrid			2022-12-25	WOS:000296538300017
J	Huang, GZ; Fang, JM; Sant'Anna, C; Li, ZH; Wellems, DL; Rohloff, P; Docampo, R				Huang, Guozhong; Fang, Jianmin; Sant'Anna, Celso; Li, Zhu-Hong; Wellems, Dianne L.; Rohloff, Peter; Docampo, Roberto			Adaptor Protein-3 (AP-3) Complex Mediates the Biogenesis of Acidocalcisomes and Is Essential for Growth and Virulence of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE-PROTEINS; YEAST SACCHAROMYCES-CEREVISIAE; UNICELLULAR EUKARYOTES; POLYPHOSPHATE STORAGE; H+-PYROPHOSPHATASE; VACUOLE FUSION; CLATHRIN; TRAFFICKING; TRANSPORT; LEISHMANIA	Acidocalcisomes are acidic calcium and polyphosphate storage organelles found in a diverse range of organisms. Here we present evidence that the biogenesis of acidocalcisomes in Trypanosoma brucei is linked to the expression of adaptor protein-3 (AP-3) complex. Localization studies in cell lines expressing beta 3 and delta subunits of AP-3 fused to epitope tags revealed their partial co-localization with the vacuolar proton pyrophosphatase, a marker of acidocalcisomes, with the Golgi marker Golgi reassembly and stacking protein, and with antibodies against the small GTPase Rab11. Ablation of the beta 3 subunit by RNA interference (RNAi) resulted in disappearance of acidocalcisomes from both procyclic and bloodstream form trypanosomes, as revealed by immmunofluorescence and electron microscopy assays, with no alterations in trafficking of different markers to lysosomes. Knockdown of the beta 3 subunit resulted in lower acidic calcium, pyrophosphate, and polyphosphate content as well as defects in growth in culture, resistance to osmotic stress, and virulence in mice. Similar results were obtained by knocking down the expression of the delta subunit of AP-3. These results indicate that AP-3 is essential for the biogenesis of acidocalcisomes and for growth and virulence of T. brucei.	[Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, 350B Paul D Coverdell Ctr, Athens, GA 30602 USA.	rdocampo@uga.edu	Rohloff, Peter/P-8722-2017	Rohloff, Peter/0000-0001-7274-8315	National Institutes of Health [AI-077538]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-077538 (to R.D.).; Supported by a training grant from the Ellison Medical Foundation to the Center for Tropical and Emerging Global Diseases. Present address: Diretoria de Programas, Instituto Nacional de Metrologia, Normalizacao e Qualidade Industrial-INMETRO. Av. Nossa Senhora das Gracas, 50, Xerem, Duque de Caxias-Rio de Janeiro 25250-020, Brazil.	Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Allen CL, 2007, MOL BIOCHEM PARASIT, V156, P175, DOI 10.1016/j.molbiopara.2007.07.020; Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; Anitei M, 2010, MOL MEMBR BIOL, V27, P443, DOI 10.3109/09687688.2010.522601; Ault-Riche D, 1999, Prog Mol Subcell Biol, V23, P241; Babes V., 1895, Z HYG INFEKTIONSKR, V20, P412, DOI DOI 10.1007/BF02216664; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; BENAIM G, 1993, BIOCHEM J, V296, P759, DOI 10.1042/bj2960759; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2008, J CELL SCI, V121, P561, DOI 10.1242/jcs.022574; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; COPPENS I, 1993, MOL BIOCHEM PARASIT, V58, P223, DOI 10.1016/0166-6851(93)90044-X; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Cutler DF, 2002, SEMIN CELL DEV BIOL, V13, P261, DOI 10.1016/S108495210200054X; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Docampo R, 2010, PHILOS T R SOC B, V365, P775, DOI 10.1098/rstb.2009.0179; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Grimme A., 1902, ZENTRALBL BAKTERIO 1, V32, P161; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Jeffries TR, 2001, J CELL SCI, V114, P2617; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lu S, 2007, PARASITOLOGY, V134, P1639, DOI 10.1017/S0031182007003046; Luo SH, 2005, MOL MICROBIOL, V55, P1034, DOI 10.1111/j.1365-2958.2004.04464.x; Meyer A., 1904, BOT Z, V62, P113; Morgan GW, 2001, J CELL SCI, V114, P2605; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Ramos IB, 2010, BIOL CELL, V102, P421, DOI 10.1042/BC20100011; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Seufferheld M, 2004, J BIOL CHEM, V279, P51193, DOI 10.1074/jbc.M406099200; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; SHATTON JB, 1983, ANAL BIOCHEM, V130, P114, DOI 10.1016/0003-2697(83)90657-7; Tazeh NN, 2009, EUKARYOT CELL, V8, P1352, DOI 10.1128/EC.00156-09; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Vannier-Santos MA, 1999, MICROBIOL-UK, V145, P3213, DOI 10.1099/00221287-145-11-3213; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Vowels JJ, 1998, EMBO J, V17, P2482, DOI 10.1093/emboj/17.9.2482; WIAME JM, 1947, BIOCHIM BIOPHYS ACTA, V1, P234, DOI 10.1016/0006-3002(47)90137-6; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yang W, 2000, J CELL SCI, V113, P4077; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x	70	37	37	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36619	36630		10.1074/jbc.M111.284661	http://dx.doi.org/10.1074/jbc.M111.284661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880705	hybrid, Green Published			2022-12-25	WOS:000296538300045
J	Gizard, F; Zhao, Y; Findeisen, HM; Qing, H; Cohn, D; Heywood, EB; Jones, KL; Nomiyama, T; Bruemmer, D				Gizard, Florence; Zhao, Yue; Findeisen, Hannes M.; Qing, Hua; Cohn, Dianne; Heywood, Elizabeth B.; Jones, Karrie L.; Nomiyama, Takashi; Bruemmer, Dennis			Transcriptional Regulation of S Phase Kinase-associated Protein 2 by NR4A Orphan Nuclear Receptor NOR1 in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEOINTIMA FORMATION; PROLIFERATION; ATHEROSCLEROSIS; P27(KIP1); SKP2; DEGRADATION; PROGRESSION; INHIBITORS; CYCLE; DEFICIENCY	Members of the NR4A subgroup of the nuclear hormone receptor superfamily have emerged as key transcriptional regulators of proliferation and inflammation. NOR1 constitutes a ligand-independent transcription factor of this subgroup and induces cell proliferation; however, the transcriptional mechanisms underlying this mitogenic role remain to be defined. Here, we demonstrate that the F-box protein SKP2 (S phase kinase-associated protein 2), the substrate-specific receptor of the ubiquitin ligase responsible for the degradation of p27(KIP1) through the proteasome pathway, constitutes a direct transcriptional target for NOR1. Mitogen-induced Skp2 expression is silenced in vascular smooth muscle cells (VSMC) isolated from Nor1-deficient mice or transfected with Nor1 siRNA. Conversely, adenovirus-mediated overexpression of NOR1 induces Skp2 expression in VSMC and decreases protein abundance of its target p27. Transient transfection experiments establish that NOR1 transactivates the Skp2 promoter through a nerve growth factor-induced clone B response element (NBRE). Electrophoretic mobility shift and chromatin immunoprecipitation assays further revealed that NOR1 is recruited to this NBRE site in the Skp2 promoter in response to mitogenic stimulation. In vivo Skp2 expression is increased during the proliferative response underlying neointima formation, and this transcriptional induction depends on the expression of NOR1. Finally, we demonstrate that overexpression of Skp2 rescues the proliferative arrest of Nor1-deficient VSMC. Collectively, these results characterize Skp2 as a novel NOR1-regulated target gene and detail a previously unrecognized transcriptional cascade regulating mitogen-induced VSMC proliferation.	[Gizard, Florence; Zhao, Yue; Findeisen, Hannes M.; Qing, Hua; Cohn, Dianne; Heywood, Elizabeth B.; Jones, Karrie L.; Bruemmer, Dennis] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Zhao, Yue; Bruemmer, Dennis] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Nomiyama, Takashi] Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Fukuoka 8140180, Japan	University of Kentucky; University of Kentucky; Fukuoka University	Bruemmer, D (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Wethington Hlth Sci Bldg,Room 575,900 S Limestone, Lexington, KY 40536 USA.	Dennis.Bruemmer@uky.edu			National Institutes of Health [R01HL084611]; American Recovery and Reinvestment Act [R01HL084611-04S1]; American Heart Association [0815514D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL084611 and the American Recovery and Reinvestment Act of 2009 Grant R01HL084611-04S1 (to D. B.).; Supported by Fellowship Grant 0815514D from the American Heart Association.	Arkenbout EK, 2002, CIRCULATION, V106, P1530, DOI 10.1161/01.CIR.0000028811.03056.BF; Bond M, 2004, J BIOL CHEM, V279, P37304, DOI 10.1074/jbc.M404307200; Bonta PI, 2007, TRENDS CARDIOVAS MED, V17, P105, DOI 10.1016/j.tcm.2007.02.001; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Diez-Juan A, 2004, BLOOD, V103, P158, DOI 10.1182/blood-2003-07-2319; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Gallo R, 1999, CIRCULATION, V99, P2164, DOI 10.1161/01.CIR.99.16.2164; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Imaki H, 2003, CANCER RES, V63, P4607; Laufs U, 1999, J BIOL CHEM, V274, P21926, DOI 10.1074/jbc.274.31.21926; Majesky Mark W, 2003, Curr Atheroscler Rep, V5, P208, DOI 10.1007/s11883-003-0026-x; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286; Zhao Y, 2010, CIRC RES, V107, P501, DOI 10.1161/CIRCRESAHA.110.222083; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	31	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35485	35493		10.1074/jbc.M111.295840	http://dx.doi.org/10.1074/jbc.M111.295840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868379	Green Published, hybrid			2022-12-25	WOS:000295927100020
J	Qi, XM; Hou, SW; Lepp, A; Li, RS; Basir, Z; Lou, ZK; Chen, G				Qi, Xiaomei; Hou, Songwang; Lepp, Adrienne; Li, Rongshan; Basir, Zainab; Lou, Zhenkun; Chen, Guan			Phosphorylation and Stabilization of Topoisomerase II alpha Protein by p38 gamma Mitogen-activated Protein Kinase Sensitize Breast Cancer Cells to Its Poisons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECATENATION CHECKPOINT; RAS TRANSFORMATION; CYCLE ARREST; MAP KINASES; DNA-DAMAGE; APOPTOSIS; EXPRESSION; PATHWAY; DRUG; CHEMOTHERAPY	Cancer drugs suppress tumor cell growth by inhibiting specific cellular targets. However, most drugs also activate several cellular nonspecific stress pathways, and the implications of these off-target effects are mostly unknown. Here, we report that p38 gamma, but not p38 alpha, MAPK is specifically activated by treatment of breast cancer cells with topoisomerase II (Topo II) drugs, whereas paclitaxel (Taxol) does not have this effect. The activated p38 gamma in turn phosphorylates and stabilizes Topo II alpha protein, and this enhances the growth inhibition by Topo II drugs. Moreover, p38 gamma activity was shown to be necessary and sufficient for Topo II alpha expression, the drug-p38 gamma-Topo II alpha axis is only detected in intrinsically sensitive but not resistant cells, and p38 gamma is co-overexpressed with Topo II alpha protein in primary breast cancers. These results reveal a new paradigm in which p38 gamma actively regulates the drug-Topo II alpha signal transduction, and this may be exploited to increase the therapeutic activity of Topo II drugs.	[Qi, Xiaomei; Hou, Songwang; Lepp, Adrienne; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Li, Rongshan; Basir, Zainab] Med Coll Wisconsin, Dept Pathol, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Chen, Guan] Med Coll Wisconsin, Dept Res Serv, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA; [Lou, Zhenkun] Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Mayo Clinic	Chen, G (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	gchen@mcw.edu			National Institutes of Health [2R01 91576]; Veterans Affairs Merit Review, a Cancer Center Breast Cancer Show-House; Medical College of Wisconsin; NATIONAL CANCER INSTITUTE [R01CA129344, R01CA130996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review, a Cancer Center Breast Cancer Show-House(US Department of Veterans Affairs); Medical College of Wisconsin(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 91576. This work was also supported by a Veterans Affairs Merit Review, a Cancer Center Breast Cancer Show-House, and the Medical College of Wisconsin.	Antony S, 2005, MOL PHARMACOL, V67, P523, DOI 10.1124/mol.104.003889; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bandele OJ, 2008, BIOCHEMISTRY-US, V47, P11900, DOI 10.1021/bi800981j; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen G, 1997, ONCOGENE, V15, P1643, DOI 10.1038/sj.onc.1201347; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Chen G, 1999, ONCOGENE, V18, P7149, DOI 10.1038/sj.onc.1203149; CHEN GA, 1995, BIOCHEM PHARMACOL, V49, P1691, DOI 10.1016/0006-2952(95)00079-F; Chen L, 2009, CANCER RES, V69, P8853, DOI 10.1158/0008-5472.CAN-09-1636; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; HELLEMANS P, 1995, J CLIN PATHOL, V48, P147, DOI 10.1136/jcp.48.2.147; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; LIPPMAN ME, 1978, NEW ENGL J MED, V298, P1223, DOI 10.1056/NEJM197806012982203; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; MacGrogan G, 2003, BRIT J CANCER, V89, P666, DOI 10.1038/sj.bjc.6601185; McPherson JP, 1998, CANCER RES, V58, P4519; Mensah-Osman EJ, 2002, MOL CANCER THER, V1, P1321; MIRSKI SEL, 1993, CANCER RES, V53, P4866; Munro AF, 2010, ONCOGENE, V29, P5231, DOI 10.1038/onc.2010.286; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pillaire MJ, 2000, BIOCHEM BIOPH RES CO, V278, P724, DOI 10.1006/bbrc.2000.3877; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Stacey DW, 2000, MOL CELL BIOL, V20, P9127, DOI 10.1128/MCB.20.24.9127-9137.2000; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; WOESSNER RD, 1990, CANCER RES, V50, P2901; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	49	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35883	35890		10.1074/jbc.M111.229260	http://dx.doi.org/10.1074/jbc.M111.229260			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878638	Green Published, hybrid			2022-12-25	WOS:000295927100061
J	Soong, G; Martin, FJ; Chun, JR; Cohen, TS; Ahn, DS; Prince, A				Soong, Grace; Martin, Francis J.; Chun, Jarin; Cohen, Taylor S.; Ahn, Danielle S.; Prince, Alice			Staphylococcus aureus Protein A Mediates Invasion across Airway Epithelial Cells through Activation of RhoA GTPase Signaling and Proteolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTON-VALENTINE LEUKOCIDIN; ENDOTHELIAL-CELLS; BARRIER FUNCTION; ALPHA-HEMOLYSIN; TNF-ALPHA; IN-VIVO; BINDING-PROTEIN; PNEUMONIA; RECEPTOR; KINASE	Background: S. aureus is an important cause of severe pneumonia acquired following upper airway colonization. Results: S. aureus-expressing SpA induces RhoA, EGFR, and calpain activity resulting in disruption of tight junctions. Conclusion: SpA is necessary but not sufficient to mediate invasive infection across the airway epithelium. Significance: S. aureus activates multiple epithelial signaling cascades to initiate invasive pulmonary infection.	[Martin, Francis J.; Chun, Jarin; Prince, Alice] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Soong, Grace; Cohen, Taylor S.; Ahn, Danielle S.; Prince, Alice] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA	Columbia University; Columbia University	Prince, A (corresponding author), 650 W 168th St,BB 416, New York, NY 10032 USA.	asp7@columbia.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	National Institutes of Health [R01 HL079395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL079395 (to A. P.).	Bekeredjian-Ding I, 2007, J IMMUNOL, V178, P2803, DOI 10.4049/jimmunol.178.5.2803; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Cheung AL, 1997, INFECT IMMUN, V65, P2243, DOI 10.1128/IAI.65.6.2243-2249.1997; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Clarke SR, 2010, CELL HOST MICROBE, V7, P423, DOI 10.1016/j.chom.2010.05.015; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Gomez MI, 2007, EMBO J, V26, P701, DOI 10.1038/sj.emboj.7601554; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Harari PM, 2007, J CLIN ONCOL, V25, P4057, DOI 10.1200/JCO.2007.11.8984; Hartleib J, 2000, BLOOD, V96, P2149; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Kakiashvili E, 2011, J BIOL CHEM, V286, P9268, DOI 10.1074/jbc.M110.179903; Kedinger V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003518; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin FJ, 2009, J CLIN INVEST, V119, P1931, DOI 10.1172/JCI35879; Mateus AR, 2007, HUM MOL GENET, V16, P1639, DOI 10.1093/hmg/ddm113; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Otto M, 2011, NAT MED, V17, P169, DOI 10.1038/nm0211-169; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Sax JK, 2003, J BIOL CHEM, V278, P36435, DOI 10.1074/jbc.M303191200; Schmidt KA, 2001, INFECT IMMUN, V69, P4749, DOI 10.1128/IAI.69.8.4749-4758.2001; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; Usatyuk PV, 2004, J BIOL CHEM, V279, P11789, DOI 10.1074/jbc.M311184200; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B	43	47	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35891	35898		10.1074/jbc.M111.295386	http://dx.doi.org/10.1074/jbc.M111.295386			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878647	hybrid, Green Published			2022-12-25	WOS:000295927100062
J	Suzuki, T; Miyauchi, K; Suzuki, T; Yokobori, S; Shigi, N; Kondow, A; Takeuchi, N; Yamagishi, A; Watanabe, K				Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu; Yokobori, Shin-ichi; Shigi, Naoki; Kondow, Akiko; Takeuchi, Nono; Yamagishi, Akihiko; Watanabe, Kimitsuna			Taurine-containing Uridine Modifications in tRNA Anticodons Are Required to Decipher Non-universal Genetic Codes in Ascidian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST POSITION; NUCLEOTIDE-SEQUENCE; MODIFYING ENZYMES; BOVINE LIVER; CODONS AGA; GENOME; ORGANIZATION; TRNA(MET); DISEASES; DNA	Variations in the genetic code are found frequently in mitochondrial decoding systems. Four non-universal genetic codes are employed in ascidian mitochondria: AUA for Met, UGA for Trp, and AGA/AGG(AGR) for Gly. To clarify the decoding mechanism for the non-universal genetic codes, we isolated and analyzed mitochondrial tRNAs for Trp, Met, and Gly from an ascidian, Halocynthia roretzi. Mass spectrometric analysis identified 5-taurinomethyluridine (tau m(5)U) at the anticodon wobble positions of tRNA(Met)(AUR), tRNA(Trp)(UGR), and tRNA(Gly)(AGR), suggesting that tau m(5)U plays a critical role in the accurate deciphering of all four non-universal codes by preventing the misreading of pyrimidine-ending near-cognate codons (NNY) in their respective family boxes. Acquisition of the wobble modification appears to be a prerequisite for the genetic code alteration.	[Suzuki, Takeo; Miyauchi, Kenjyo; Suzuki, Tsutomu] Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Yokobori, Shin-ichi; Yamagishi, Akihiko; Watanabe, Kimitsuna] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Biol, Tokyo 1920392, Japan; [Shigi, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Kondow, Akiko] Fujita Hlth Univ, Inst Comprehens Med Sci, Aichi 4701192, Japan; [Takeuchi, Nono] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome, Chiba 2778652, Japan; [Watanabe, Kimitsuna] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; Tokyo University of Pharmacy & Life Sciences; National Institute of Advanced Industrial Science & Technology (AIST); Fujita Health University; University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp; kim-wata@toyaku.ac.jp	Yokobori, Shin-ichi/K-9537-2017; Suzuki, Tsutomu/J-1776-2015; Shigi, Naoki/L-7135-2018	Yokobori, Shin-ichi/0000-0002-7356-3299; Suzuki, Tsutomu/0000-0002-9731-1731; Shigi, Naoki/0000-0003-4452-8264; Yamagishi, Akihiko/0000-0001-5162-3927	Japan Society for the Promotion of Science; Ministry of Education, Science, Sports, and Culture of Japan; Grants-in-Aid for Scientific Research [21570242, 21570101, 23770202] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research (C) from The Japan Society for the Promotion of Science (to K. W.) and by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to Takeo Suzuki and Tsutomu Suzuki).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BARRELL BG, 1979, NATURE, V282, P189, DOI 10.1038/282189a0; BESSHO Y, 1992, J MOL EVOL, V34, P331, DOI 10.1007/BF00160240; Bilbille Y, 2011, J MOL BIOL, V406, P257, DOI 10.1016/j.jmb.2010.11.042; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; HIMENO H, 1987, GENE, V56, P219; HOFFMANN RJ, 1992, GENETICS, V131, P397; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Kiryu H, 2011, BIOINFORMATICS, V27, P1788, DOI 10.1093/bioinformatics/btr276; Kondow A, 1999, NUCLEIC ACIDS RES, V27, P2554, DOI 10.1093/nar/27.12.2554; Kondow A, 1998, NUCLEOS NUCLEOT NUCL, V17, P531, DOI 10.1080/07328319808005196; KONDOW A, 1998, THESIS U TOKYO; KUCHINO Y, 1987, METHOD ENZYMOL, V155, P379; Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; LIAO HX, 1991, J BIOL CHEM, V266, P20714; Lusic H, 2008, NUCLEIC ACIDS RES, V36, P6548, DOI 10.1093/nar/gkn703; MARTIN RP, 1990, BIOCHEMISTRY-US, V29, P956, DOI 10.1021/bi00456a016; MCLUCKEY SA, 1992, J AM SOC MASS SPECTR, V3, P60, DOI 10.1016/1044-0305(92)85019-G; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; Sakurai M, 2005, FEBS LETT, V579, P2767, DOI 10.1016/j.febslet.2005.04.009; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; SUZUKI T, 2011, ANN REV GEN IN PRESS; SUZUKI T, 2005, FINE TUNING RNA FUNC, P23; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; UEDA T, 1985, J BIOCHEM-TOKYO, V98, P1275, DOI 10.1093/oxfordjournals.jbchem.a135394; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; WATANABE K, 1995, TRNA STRUCTURE SBIOS; WATANABE K, 2011, J NUCL ACID IN PRESS; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; Yassin AS, 2011, P NATL ACAD SCI USA, V108, P3918, DOI 10.1073/pnas.1017425108; YOKOBORI S, 1993, J MOL EVOL, V36, P1, DOI 10.1007/BF02407301; Yokobori S, 2001, J MOL EVOL, V53, P314, DOI 10.1007/s002390010221; Yokobori S, 1999, GENETICS, V153, P1851; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905	47	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35494	35498		10.1074/jbc.M111.279810	http://dx.doi.org/10.1074/jbc.M111.279810			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21873425	hybrid, Green Published			2022-12-25	WOS:000295927100021
J	Cheung, CHA; Lin, WH; Hsu, JTA; Hour, TC; Yeh, TK; Ko, SK; Lien, TW; Coumar, MS; Liu, JF; Lai, WY; Shiao, HY; Lee, TR; Hsieh, HP; Chang, JY				Cheung, Chun Hei Antonio; Lin, Wen-Hsing; Hsu, John Tsu-An; Hour, Tzyh-Chyuan; Yeh, Teng-Kuang; Ko, Shengkai; Lien, Tzu-Wen; Coumar, Mohane Selvaraj; Liu, Jin-Fen; Lai, Wen-Yang; Shiao, Hui-Yi; Lee, Tian-Ren; Hsieh, Hsing-Pang; Chang, Jang-Yang			BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; B-KINASE; DRUG-RESISTANCE; FREQUENT OVEREXPRESSION; SELECTIVE INHIBITOR; ANTITUMOR-ACTIVITY; LUNG-CARCINOMA; IN-VITRO; GENE; EXPRESSION	Background: Over-expression of Aurora kinases promotes the tumorigenesis of cells. The aim of this study was to determine the preclinical profile of a novel pan-Aurora kinase inhibitor, BPR1K653, as a candidate for anti-cancer therapy. Since expression of the drug efflux pump, MDR1, reduces the effectiveness of various chemotherapeutic compounds in human cancers, this study also aimed to determine whether the potency of BPR1K653 could be affected by the expression of MDR1 in cancer cells. Principal Findings: BPR1K653 specifically inhibited the activity of Aurora-A and Aurora-B kinase at low nano-molar concentrations in vitro. Anti-proliferative activity of BPR1K653 was evaluated in various human cancer cell lines. Results of the clonogenic assay showed that BPR1K653 was potent in targeting a variety of cancer cell lines regardless of the tissue origin, p53 status, or expression of MDR1. At the cellular level, BPR1K653 induced endo-replication and subsequent apoptosis in both MDR1-negative and MDR1-positive cancer cells. Importantly, it showed potent activity against the growth of xenograft tumors of the human cervical carcinoma KB and KB-derived MDR1-positive KB-VIN10 cells in nude mice. Finally, BPR1K653 also exhibited favorable pharmacokinetic properties in rats. Conclusions and Significance: BPR1K653 is a novel potent anti-cancer compound, and its potency is not affected by the expression of the multiple drug resistant protein, MDR1, in cancer cells. Therefore, BPR1K653 is a promising anti-cancer compound that has potential for the management of various malignancies, particularly for patients with MDR1-related drug resistance after prolonged chemotherapeutic treatments.	[Cheung, Chun Hei Antonio; Liu, Jin-Fen; Lai, Wen-Yang; Lee, Tian-Ren; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Lin, Wen-Hsing; Hsu, John Tsu-An; Yeh, Teng-Kuang; Ko, Shengkai; Lien, Tzu-Wen; Shiao, Hui-Yi; Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Miaoli County, Taiwan; [Hour, Tzyh-Chyuan] Kaohsiung Med Univ, Inst Biochem, Kaohsiung, Taiwan; [Coumar, Mohane Selvaraj] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Kalapet, Puducherry, India; [Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Tainan 70428, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Pondicherry University; National Cheng Kung University; National Cheng Kung University Hospital	Cheung, CHA (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	hphsieh@nhri.org.tw; jychang@nhri.org.tw	Lin, Wen-Hsing/K-8580-2013; Selvaraj, Mohane C/M-5095-2015; Hsieh, Hsing-Pang/B-2649-2010; Coumar, Mohane/C-3393-2008; Hsu, John Tsu-An/C-1199-2010; Chang, Jang-Yang/D-2099-2010; Chang, Jang-Yang/M-3656-2014	Lin, Wen-Hsing/0000-0001-5023-310X; Selvaraj, Mohane C/0000-0002-0505-568X; Hsieh, Hsing-Pang/0000-0002-1332-005X; Cheung, Chun Hei Antonio/0000-0003-4181-1435	National Science Council [NSC99-2323-B-400-006, NSC99-2323-B-400-007, NSC99-2120-M-006-005]; Department of Health [DOH99-TD-C-111-004]; National Health Research Institutes, Taiwan R.O.C. [CA-099-PP-02]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; National Health Research Institutes, Taiwan R.O.C.(National Health Research Institutes - Taiwan)	The study was supported by grants from the National Science Council (NSC99-2323-B-400-006, NSC99-2323-B-400-007, NSC99-2120-M-006-005), Department of Health (DOH99-TD-C-111-004), and National Health Research Institutes (CA-099-PP-02), Taiwan R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2009, BIOCHEM J, V420, P259, DOI 10.1042/BJ20090121; Arbitrario JP, 2010, CANCER CHEMOTH PHARM, V65, P707, DOI 10.1007/s00280-009-1076-8; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Cheung CH, 2010, EXPERT OPIN INV DRUG, V19, P1; Cheung CHA, 2011, EXPERT OPIN THER PAT, V21, P857, DOI 10.1517/13543776.2011.574614; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Coumar MS, 2010, CHEMMEDCHEM, V5, P255, DOI 10.1002/cmdc.200900339; Coumar MS, 2009, EXPERT OPIN THER PAT, V19, P321, DOI 10.1517/13543770802646949; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; FERGUSON PJ, 1988, CANCER RES, V48, P5956; Gaj CL, 1998, BIOCHEM PHARMACOL, V55, P1199, DOI 10.1016/S0006-2952(97)00614-X; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; Gully CP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-42; Guo J, 2009, PHARMACOGENOMICS J, V9, P90, DOI 10.1038/tpj.2008.20; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hsieh CC, 2010, BIOCHEM PHARMACOL, V79, P1261, DOI 10.1016/j.bcp.2009.12.017; Huang GC, 2004, JPN J CLIN ONCOL, V34, P499, DOI 10.1093/jjco/hyh091; KANAMARU H, 1989, J NATL CANCER I, V81, P844, DOI 10.1093/jnci/81.11.844; Keshelava N, 2001, CANCER RES, V61, P6185; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Liou JP, 2007, J PHARMACOL EXP THER, V323, P398, DOI 10.1124/jpet.107.126680; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Lukasiewicz KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021291; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; PARK JG, 1994, J NATL CANCER I, V86, P700, DOI 10.1093/jnci/86.9.700; Payton MN, 2010, CANCER RES, V70; PELLATDECEUNYNK C, 1995, BLOOD, V86, P4001, DOI 10.1182/blood.V86.10.4001.bloodjournal86104001; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Sabatino MA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-259; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Susa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010764; Tsuno T, 2007, J NEURO-ONCOL, V83, P249, DOI 10.1007/s11060-007-9335-1; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Warmann S, 2003, ANTICANCER RES, V23, P4607; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806	51	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23485	10.1371/journal.pone.0023485	http://dx.doi.org/10.1371/journal.pone.0023485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887256	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000020
J	Dixit, SS; Jadot, M; Sohar, I; Sleat, DE; Stock, AM; Lobel, P				Dixit, Sayali S.; Jadot, Michel; Sohar, Istvan; Sleat, David E.; Stock, Ann M.; Lobel, Peter			Loss of Niemann-Pick C1 or C2 Protein Results in Similar Biochemical Changes Suggesting That These Proteins Function in a Common Lysosomal Pathway	PLOS ONE			English	Article							MAJOR SECRETORY PROTEIN; LIPID STORAGE DISORDER; PURIFIED NPC1 PROTEIN; STEROL-SENSING DOMAIN; NCTR-BALB/C MICE; CHOLESTEROL HOMEOSTASIS; RETROGRADE TRANSPORT; HUMAN EPIDIDYMIS; MEMBRANE-LIPIDS; LATE ENDOSOMES	Niemann-Pick Type C (NPC) disease is a lysosomal storage disorder characterized by accumulation of unesterified cholesterol and other lipids in the endolysosomal system. NPC disease results from a defect in either of two distinct cholesterol-binding proteins: a transmembrane protein, NPC1, and a small soluble protein, NPC2. NPC1 and NPC2 are thought to function closely in the export of lysosomal cholesterol with both proteins binding cholesterol in vitro but they may have unrelated lysosomal roles. To investigate this possibility, we compared biochemical consequences of the loss of either protein. Analyses of lysosome-enriched subcellular fractions from brain and liver revealed similar decreases in buoyant densities of lysosomes from NPC1 or NPC2 deficient mice compared to controls. The subcellular distribution of both proteins was similar and paralleled a lysosomal marker. In liver, absence of either NPC1 or NPC2 resulted in similar alterations in the carbohydrate processing of the lysosomal protease, tripeptidyl peptidase I. These results highlight biochemical alterations in the lysosomal system of the NPC-mutant mice that appear secondary to lipid storage. In addition, the similarity in biochemical phenotypes resulting from either NPC1 or NPC2 deficiency supports models in which the function of these two proteins within lysosomes are linked closely.	[Dixit, Sayali S.; Sohar, Istvan; Sleat, David E.; Stock, Ann M.; Lobel, Peter] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Dixit, Sayali S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Grad Sch Biomed Sci, Piscataway, NJ 08854 USA; [Dixit, Sayali S.; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Jadot, Michel] Namur Res Inst Life Sci, Chim Physiol Lab, Namur, Belgium; [Jadot, Michel] Fac Univ Notre Dame Paix, B-5000 Namur, Belgium; [Sleat, David E.; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Namur; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dixit, SS (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu		Stock, Ann/0000-0002-0446-8079	Ara Parseghian Medical Research Foundation (Tucson, AZ); Fonds de la Recherche Fondamentale Collective (FRFC) [2.4543.08]	Ara Parseghian Medical Research Foundation (Tucson, AZ); Fonds de la Recherche Fondamentale Collective (FRFC)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Ara Parseghian Medical Research Foundation (Tucson, AZ) (PL and AMS) and by the Fonds de la Recherche Fondamentale Collective (FRFC 2.4543.08) (MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Baker CS, 1993, BIOL REPROD S1, V48, P86; BEAUFAY H, 1964, BIOCHEM J, V92, P184, DOI 10.1042/bj0920184; BHUVANESWARAN C, 1982, AM J PATHOL, V108, P160; Bhuvaneswaran C, 2000, MOL CELL BIOCHEM, V214, P15, DOI 10.1023/A:1007180800941; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; Damme M, 2011, J NEUROPATH EXP NEUR, V70, P83, DOI 10.1097/NEN.0b013e31820428fa; Damme M, 2010, MOL CELL BIOL, V30, P273, DOI 10.1128/MCB.01143-09; de Duve C, 1971, J Cell Biol, V50, P20; Della Valle MC, 2006, J BIOL CHEM, V281, P35436, DOI 10.1074/jbc.M606208200; Dixit SS, 2007, BIOCHEM J, V408, P1, DOI 10.1042/BJ20071167; DRAYE JP, 1987, EUR J BIOCHEM, V170, P405, DOI 10.1111/j.1432-1033.1987.tb13714.x; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Gallala HD, 2011, J NEUROCHEM, V116, P702, DOI 10.1111/j.1471-4159.2010.07014.x; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Larsen LB, 1997, EUR J BIOCHEM, V243, P437, DOI 10.1111/j.1432-1033.1997.0437a.x; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P1, DOI 10.1016/j.bbalip.2004.08.004; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; PENTCHEV PG, 1980, BIOCHIM BIOPHYS ACTA, V619, P669, DOI 10.1016/0005-2760(80)90116-2; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Scott C, 2004, J BIOL CHEM, V279, P48214, DOI 10.1074/jbc.M406090200; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Towatari T, 1998, EUR J BIOCHEM, V256, P163, DOI 10.1046/j.1432-1327.1998.2560163.x; Vance JE, 2010, CELL METAB, V12, P105, DOI 10.1016/j.cmet.2010.07.004; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	47	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23677	10.1371/journal.pone.0023677	http://dx.doi.org/10.1371/journal.pone.0023677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887293	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000045
J	Galiano, M; Agapow, PM; Thompson, C; Platt, S; Underwood, A; Ellis, J; Myers, R; Green, J; Zambon, M				Galiano, Monica; Agapow, Paul-Michael; Thompson, Catherine; Platt, Steven; Underwood, Anthony; Ellis, Joanna; Myers, Richard; Green, Jonathan; Zambon, Maria			Evolutionary Pathways of the Pandemic Influenza A (H1N1) 2009 in the UK	PLOS ONE			English	Article							HEMAGGLUTININ; NEURAMINIDASE; D222G; SUBSTITUTION; INFECTION; REVEALS	The emergence of the influenza (H1N1) 2009 virus provided a unique opportunity to study the evolution of a pandemic virus following its introduction into the human population. Virological and clinical surveillance in the UK were comprehensive during the first and second waves of the pandemic in 2009, with extensive laboratory confirmation of infection allowing a detailed sampling of representative circulating viruses. We sequenced the complete coding region of the haemagglutinin (HA) segment of 685 H1N1 pandemic viruses selected without bias during two waves of pandemic in the UK (April-December 2009). Phylogenetic analysis showed that although temporal accumulation of amino acid changes was observed in the HA sequences, the overall diversity was less than that typically seen for seasonal influenza A H1N1 or H3N2. There was co-circulation of multiple variants as characterised by signature amino acid changes in the HA. A specific substitution (S203T) became predominant both in UK and global isolates. No antigenic drift occurred during 2009 as viruses with greater than four-fold reduction in their haemagglutination inhibition (HI) titre ("low reactors") were detected in a low proportion (3%) and occurred sporadically. Although some limited antigenic divergence in viruses with four-fold reduction in HI titre might be related to the presence of 203T, additional studies are needed to test this hypothesis.	[Galiano, Monica; Agapow, Paul-Michael; Thompson, Catherine; Platt, Steven; Underwood, Anthony; Ellis, Joanna; Myers, Richard; Green, Jonathan; Zambon, Maria] Hlth Protect Agcy, Ctr Infect, London, England	Health Protection Agency	Galiano, M (corresponding author), Hlth Protect Agcy, Ctr Infect, London, England.	Monica.Galiano@hpa.org.uk		Underwood, Anthony/0000-0002-8547-4277	Health Protection Agency	Health Protection Agency	This work was supported by the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-77; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P222; Applied-Maths, BIONUMERICS 5 10; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Beer M, 2009, EURO SURVEILL, V14, P19409; Bhoumik P, 2010, EMERG INFECT DIS, V16, P1748, DOI 10.3201/eid1611.100361; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chan M., 2009, COMMUNICATION   0429; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Curran MD, 2007, J MED MICROBIOL, V56, P1263, DOI 10.1099/jmm.0.47336-0; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ellis J, 2009, EUROSURVEILLANCE, V14; Ellis J, 2011, EURO SURVEILL, V16, P19760; ELLIS J, DIAGNOSTIC IN PRESS; European Centre for Disease Prevention and Control, 2009, WEEKL EL B WEEK 32 0; Evans B, 2011, INFLUENZA OTHER RESP; Flasche S, 2011, EPIDEMICS-NETH, V3, P125, DOI 10.1016/j.epidem.2011.03.005; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Furuse Y, 2010, BIOINFORMATION, V5, P7, DOI 10.6026/97320630005007; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GeneCodes Corporation, SEQ 4 8; Gupta R, 2004, PREDICTION N GLYCOSY; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Health Protection Agency, 2010, EP REP PAND H1N1 200; Health Protection Agency, 2009, PAND H1N1 2009 ENGL; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kilander A, EURO SURVEILL, V15, P19498; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller RR, EURO SURVEILL, V15, P19546; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2009, PLOS CURR INFLUENZA, V1, DOI [10.1371/currents.RRN1003, DOI 10.1371/CURRENTS.RRN1003]; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schrodinger L., PYMOL MOL GRAPHICS S; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Valli MB, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1149; World Health Organization, 2009, 24 WHO; World Health Organization (WHO), 2011, REC COMP INFL VIR VA; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; [No title captured]	61	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23779	10.1371/journal.pone.0023779	http://dx.doi.org/10.1371/journal.pone.0023779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887318	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000059
J	Thornton, JK; Taylor, KM; Ford, D; Valentine, RA				Thornton, Jared K.; Taylor, Kathryn M.; Ford, Dianne; Valentine, Ruth A.			Differential Subcellular Localization of the Splice Variants of the Zinc Transporter ZnT5 Is Dictated by the Different C-Terminal Regions	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CELLS; HOMEOSTASIS; MEMBRANE; PROTEINS	Background: Zinc is emerging as an important intracellular signaling molecule, as well as fulfilling essential structural and catalytic functions through incorporation in a myriad of zinc metalloproteins so it is important to elucidate the molecular mechanisms of zinc homeostasis, including the subcellular localizations of zinc transporters. Principal Findings: Two splice variants of the human SLC30A5 Zn transporter gene (ZnT5) have been reported in the literature. These variants differ at their N- and C-terminal regions, corresponding with the use of different 5' and 3' exons. We demonstrate that full length human ZnT5 variant B is a genuine transcript in human intestinal cells and confirm expression of both variant A and variant B in a range of untreated human tissues by splice variant-specific RT-PCR. Using N- or C-terminal GFP or FLAG fusions of both isoforms of ZnT5 we identify that the differential subcellular localization to the Golgi apparatus and ER respectively is a function of their alternative C-terminal sequences. These different C-terminal regions result from the incorporation into the mature transcript of either the whole of exon 14 (variant B) or only the 5' region of exon 14 plus exons 15-17 (variant A). Conclusions: We thus propose that exons 15 to 17 include a signal that results in trafficking of ZnT5 to the Golgi apparatus and that the 39 end of exon 14 includes a signal that leads to retention in the ER.	[Thornton, Jared K.; Ford, Dianne; Valentine, Ruth A.] Newcastle Univ, Inst Cell & Mol Biosci, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thornton, Jared K.; Valentine, Ruth A.] Newcastle Univ, Inst Cell & Mol Biosci, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Taylor, Kathryn M.] Cardiff Univ, Welsh Sch Pharm, Tenovus Canc Res Ctr, Cardiff, S Glam, Wales	Newcastle University - UK; Newcastle University - UK; Cardiff University	Thornton, JK (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	r.a.valentine@ncl.ac.uk	Taylor, Kathryn M/O-3401-2014	Taylor, Kathryn M/0000-0002-9576-9490	UK Biotechnology and Biological Sciences Research Council [BBD01669X/2, BB/F019637/1]; Biotechnology and Biological Sciences Research Council [BB/F019637/1, BB/D01669X/1] Funding Source: researchfish; BBSRC [BB/F019637/1, BB/D01669X/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biotechnology and Biological Sciences Research Council Grants BBD01669X/2 (to RAV) and BB/F019637/1 (to DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Greenfield JJA, 1999, J CELL SCI, V112, P1477; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081	22	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23878	10.1371/journal.pone.0023878	http://dx.doi.org/10.1371/journal.pone.0023878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887337	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295832000069
J	Gandapu, U; Chaitanya, RK; Kishore, G; Reddy, RC; Kondapi, AK				Gandapu, Upendhar; Chaitanya, R. K.; Kishore, Golla; Reddy, Raju C.; Kondapi, Anand K.			Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TARGETED DRUG-DELIVERY; LONG TERMINAL REPEAT; ENCAPSULATED CURCUMIN; RECEIVING ZIDOVUDINE; DIFERULOYL METHANE; GENE-EXPRESSION; RATS; INTEGRASE; CELLS	Background: Curcumin (diferuloylmethane) shows significant activity across a wide spectrum of conditions, but its usefulness is rather limited because of its low bioavailability. Use of nanoparticle formulations to enhance curcumin bioavailability is an emerging area of research. Methodology/Principal Findings: In the present study, curcumin-loaded apotransferrin nanoparticles (nano-curcumin) prepared by sol-oil chemistry and were characterized by electron and atomic force microscopy. Confocal studies and fluorimetric analysis revealed that these particles enter T cells through transferrin-mediated endocytosis. Nano-curcumin releases significant quantities of drug gradually over a fairly long period, similar to 50% of curcumin still remaining at 6 h of time. In contrast, intracellular soluble curcumin (sol-curcumin) reaches a maximum at 2 h followed by its complete elimination by 4 h. While sol-curcumin (GI(50) = 15.6 mu M) is twice more toxic than nano-curcumin (GI(50) = 32.5 mu M), nano-curcumin (IC50 < 1.75 mu M) shows a higher anti-HIV activity compared to sol-curcumin (IC50 = 5.1 mu M). Studies in vitro showed that nano-curcumin prominently inhibited the HIV-1 induced expression of Topo II alpha, IL-1 beta and COX-2, an effect not seen with sol-curcumin. Nano-curcumin did not affect the expression of Topoisomerase II beta and TNF alpha. This point out that nano-curcumin affects the HIV-1 induced inflammatory responses through pathways downstream or independent of TNF alpha. Furthermore, nano-curcumin completely blocks the synthesis of viral cDNA in the gag region suggesting that the nano-curcumin mediated inhibition of HIV-1 replication is targeted to viral cDNA synthesis. Conclusion: Curcumin-loaded apotransferrin nanoparticles are highly efficacious inhibitors of HIV-1 replication in vitro and promise a high potential for clinical usefulness.	[Gandapu, Upendhar; Chaitanya, R. K.; Kondapi, Anand K.] Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Kishore, Golla; Kondapi, Anand K.] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Kishore, Golla; Kondapi, Anand K.] Univ Hyderabad, Ctr Nanotechnol, Hyderabad 500134, Andhra Pradesh, India; [Reddy, Raju C.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA	University of Hyderabad; University of Hyderabad; University of Hyderabad; Emory University	Gandapu, U (corresponding author), Univ Hyderabad, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	akksl@uohyd.ernet.in	Reddy, Raju C/GLR-5338-2022	Reddy, Raju C/0000-0001-7079-1520	National Institutes of Health [AI079539]; Indian Council of Medical Research [Indo-US/67/2007-ECD-II]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI079539 and Indian Council of Medical Research grant Indo-US/67/2007-ECD-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; Barthelemy S, 1998, RES VIROLOGY, V149, P43, DOI 10.1016/S0923-2516(97)86899-9; Bisht Savita, 2007, Journal of Nanobiotechnology, V5, P3, DOI 10.1186/1477-3155-5-3; Bouille P, 1999, J MOL BIOL, V285, P945, DOI 10.1006/jmbi.1998.2360; Cheng AL, 2001, ANTICANCER RES, V21, P2895; DEODHAR SD, 1980, INDIAN J MED RES, V71, P632; Deveaud C, 2005, BIOCHEM PHARMACOL, V70, P90, DOI 10.1016/j.bcp.2005.04.015; Garcea G, 2004, BRIT J CANCER, V90, P1011, DOI 10.1038/sj.bjc.6601623; KISO Y, 1983, PLANTA MED, V49, P185, DOI 10.1055/s-2007-969845; Kondapi AK, 2006, ARCH BIOCHEM BIOPHYS, V450, P123, DOI 10.1016/j.abb.2006.04.003; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; KUMAR DR, 2010, NANOMED-NANOTECHNOL, V6, P153; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; LI CJ, 1993, P NATL ACAD SCI USA, V90, P1839, DOI 10.1073/pnas.90.5.1839; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Mahady GB, 2002, ANTICANCER RES, V22, P4179; Mandraju RK, 2007, ARCH BIOCHEM BIOPHYS, V461, P40, DOI 10.1016/j.abb.2007.01.026; Martin-Cordero C, 2003, J ENZYM INHIB MED CH, V18, P505, DOI 10.1080/14756360310001613085; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; MHIRI C, 1991, ANN NEUROL, V29, P606, DOI 10.1002/ana.410290607; Moh R, 2005, ANTIVIR THER, V10, P615; Nirmala C, 1996, MOL CELL BIOCHEM, V159, P85, DOI 10.1007/BF00420910; OLANO JP, 1995, CLIN INFECT DIS, V21, P973, DOI 10.1093/clinids/21.4.973; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; PRUSS D, 1994, J BIOL CHEM, V269, P25031; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Savarino A, 1999, CELL BIOCHEM FUNCT, V17, P47, DOI 10.1002/(SICI)1099-0844(199903)17:1<47::AID-CBF810>3.0.CO;2-V; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; SINNWELL TM, 1995, J CLIN INVEST, V96, P126, DOI 10.1172/JCI118012; SMITH SD, 1984, CANCER RES, V44, P5657; SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x; SRIVASTAVA R, 1985, THROMB RES, V40, P413, DOI 10.1016/0049-3848(85)90276-2; Sui Z, 1993, Bioorg Med Chem, V1, P415, DOI 10.1016/S0968-0896(00)82152-5; Sun AM, 2006, J MED CHEM, V49, P3153, DOI 10.1021/jm051141k; Taher MM, 2003, MOL CELL BIOCHEM, V254, P289, DOI 10.1023/A:1027393719610; THORSTENSEN K, 1993, SCAND J CLIN LAB INV, V53, P113, DOI 10.3109/00365519309090703; Venkatesan N, 2000, BRIT J PHARMACOL, V129, P231, DOI 10.1038/sj.bjp.0703067	41	48	51	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23388	10.1371/journal.pone.0023388	http://dx.doi.org/10.1371/journal.pone.0023388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887247	gold, Green Submitted, Green Published			2022-12-25	WOS:000294251800010
J	Zhu, JF; Li, ZJ; sen Zhang, G; Meng, K; Kuang, WY; Li, J; Zhou, XF; Li, RJ; Peng, HL; Dai, CW; Shen, JK; Gong, FJ; Xu, YX; Liu, SF				Zhu, Jian Feng; Li, Zi Jian; sen Zhang, Guang; Meng, Kun; Kuang, Wen Yong; Li, Jin; Zhou, Xin Fu; Li, Rui Juan; Peng, Hong Ling; Dai, Chong Wen; Shen, Jian Kai; Gong, Fan Jie; Xu, Yun Xiao; Liu, Su Fang			Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3/AKT Signalings	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE-ACTIVITY; APOPTOTIC CELL-DEATH; EMBRYONIC STEM-CELLS; BCR-ABL; CYTOGENETIC RESPONSES; TRANSCRIPTION FACTORS; BLAST CRISIS; K562 CELLS; DIFFERENTIATION	Purpose: To explore the effects of Icaritin on chronic myeloid leukemia (CML) cells and underlying mechanisms. Method: CML cells were incubated with various concentration of Icaritin for 48 hours, the cell proliferation was analyzed by MTT and the apoptosis was assessed with Annexin V and Hoechst 33258 staining. Cell hemoglobinization was determined. Western blotting was used to evaluate the expressions of MAPK/ERK/JNK signal pathway and Jak-2/Phorpho-Stat3/Phorsph-Akt network-related protein. NOD-SCID nude mice were applied to demonstrate the anti-leukemia effect of Icaritin in vivo. Results: Icaritin potently inhibited proliferation of K562 cells (IC50 was 8 mu M) and primary CML cells (IC50 was 13.4 mu M for CML-CP and 18 mu M for CML-BC), induced CML cells apoptosis and promoted the erythroid differentiation of K562 cells with time-dependent manner. Furthermore, Icaritin was able to suppress the growth of primary CD34+ leukemia cells (CML) and Imatinib-resistant cells, and to induce apoptosis. In mouse leukemia model, Icaritin could prolong lifespan of NOD-SCID nude mice inoculated with K562 cells as effective as Imatinib without suppression of bone marrow. Icaritin could up-regulate phospho-JNK or phospho-C-Jun and down-regulate phospho-ERK, phospho-P-38, Jak-2, phospho-Stat3 and phospho-Akt expression with dose-or time-dependent manner. Icaritin had no influence both on c-Abl and phospho-c-Abl protein expression and mRNA levels of Bcr/Abl. Conclusion: Icaritin from Chinese herb medicine may be a potential anti-CML agent with low adverse effect. The mechanism of anti-leukemia for Icaritin is involved in the regulation of Bcr/Abl downstream signaling. Icaritin may be useful for an alternative therapeutic choice of Imatinib-resistant forms of CML.	[Zhu, Jian Feng; Li, Zi Jian; sen Zhang, Guang; Kuang, Wen Yong; Zhou, Xin Fu; Li, Rui Juan; Peng, Hong Ling; Dai, Chong Wen; Shen, Jian Kai; Gong, Fan Jie; Xu, Yun Xiao; Liu, Su Fang] Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China; [Meng, Kun; Li, Jin] Shenogen Biomed Co Ltd, Beijing, Peoples R China	Central South University	Zhu, JF (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China.	zgsllzy@163.com; kunm88@yahoo.com	Li, Zi-Jian/O-7703-2019	Li, Zi-Jian/0000-0002-6796-4176	Ministry of Education, P.R. of China; Department of Science & Technology of Hunan Province, P.R. of China [2007JT3016]	Ministry of Education, P.R. of China; Department of Science & Technology of Hunan Province, P.R. of China	This work is supported partly by the grant specializing in doctor training program from Ministry of Education, P.R. of China (2010-2012). This work is also supported by the grant specializing in Leukemia study from Department of Science & Technology of Hunan Province, P.R. of China (No. 2007JT3016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani AS, 2002, LEUKEMIA RES, V26, P713, DOI 10.1016/S0145-2126(01)00197-7; ANDERSSON LC, 1979, INT J CANCER, V24, P717, DOI 10.1002/ijc.2910240603; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Belhacene N, 1998, FASEB J, V12, P531; Buchdunger E, 1996, CANCER RES, V56, P100; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burgess GS, 1998, BLOOD, V92, P2450, DOI 10.1182/blood.V92.7.2450.2450_2450_2460; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coppo P, 2003, ONCOGENE, V22, P4102, DOI 10.1038/sj.onc.1206607; Davidson SM, 2000, DEV BIOL, V218, P146, DOI 10.1006/dbio.1999.9596; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Ding L, 2008, STEM CELLS DEV, V17, P751, DOI 10.1089/scd.2007.0206; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Ferrao PT, 2003, BLOOD, V102, P4499, DOI 10.1182/blood-2003-01-0083; HE W, 1995, ARZNEIMITTELFORSCH, V45-2, P910; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; LIU H, 2006, CHINESE PHARMACOL B, P1509; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MCGAHON A, 1994, BLOOD, V83, P1179, DOI 10.1182/blood.V83.5.1179.bloodjournal8351179; Mensink E, 1998, BRIT J HAEMATOL, V102, P768; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Park JI, 2001, CELL GROWTH DIFFER, V12, P481; Peng HL, 2008, ANN HEMATOL, V87, P121, DOI 10.1007/s00277-007-0385-4; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Spiekermann K, 2002, EXP HEMATOL, V30, P262, DOI 10.1016/S0301-472X(01)00787-1; Talpaz M, 2002, BLOOD, V99, P1928, DOI 10.1182/blood.V99.6.1928; Uddin S, 2004, P NATL ACAD SCI USA, V101, P147, DOI 10.1073/pnas.0307075101; Wang ZQ, 2004, EUR J PHARMACOL, V504, P147, DOI 10.1016/j.ejphar.2004.10.002; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; YI Z, 1997, ZHONG HUA ZHONG LIU, V19, P53; Yu CR, 2002, CANCER RES, V62, P188; Zhang GS, 2000, LEUKEMIA RES, V24, P385, DOI 10.1016/S0145-2126(99)00198-8; [张京伟 ZHANG Jingwei], 2006, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V23, P1213; ZHANG ZH, 2006, PRACTICAL CLIN MED, V7, P1; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318; 李贵新, 2002, [中华血液学杂志, Chinese Journal of Hematology], V23, P322	45	75	85	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23720	10.1371/journal.pone.0023720	http://dx.doi.org/10.1371/journal.pone.0023720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887305	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800026
J	Chapman, JA; Ho, I; Sunkara, S; Luo, SJ; Schroth, GP; Rokhsar, DS				Chapman, Jarrod A.; Ho, Isaac; Sunkara, Sirisha; Luo, Shujun; Schroth, Gary P.; Rokhsar, Daniel S.			Meraculous: De Novo Genome Assembly with Short Paired-End Reads	PLOS ONE			English	Article							SEQUENCE; CHALLENGES; ALIGNMENT; ALLPATHS; MILLIONS; VELVET	We describe a new algorithm, meraculous, for whole genome assembly of deep paired-end short reads, and apply it to the assembly of a dataset of paired 75-bp Illumina reads derived from the 15.4 megabase genome of the haploid yeast Pichia stipitis. More than 95% of the genome is recovered, with no errors; half the assembled sequence is in contigs longer than 101 kilobases and in scaffolds longer than 269 kilobases. Incorporating fosmid ends recovers entire chromosomes. Meraculous relies on an efficient and conservative traversal of the subgraph of the k-mer (deBruijn) graph of oligonucleotides with unique high quality extensions in the dataset, avoiding an explicit error correction step as used in other short-read assemblers. A novel memory-efficient hashing scheme is introduced. The resulting contigs are ordered and oriented using paired reads separated by similar to 280 bp or similar to 3.2 kbp, and many gaps between contigs can be closed using paired-end placements. Practical issues with the dataset are described, and prospects for assembling larger genomes are discussed.	[Chapman, Jarrod A.; Ho, Isaac; Sunkara, Sirisha; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Luo, Shujun] Illumina Inc, Hayward, CA USA; [Schroth, Gary P.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Illumina; University of California System; University of California Berkeley	Chapman, JA (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	jchapman@lbl.gov		Rokhsar, Daniel/0000-0002-8704-2224	U.S. Department of Energy's Office of Science; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Center for Integrative Genomics at UC Berkeley; Gordon and Betty Moore Foundation	U.S. Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Center for Integrative Genomics at UC Berkeley; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was performed under the auspices of the U.S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, and at the Center for Integrative Genomics at UC Berkeley supported by a grant from the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors G. P. S. and S. L. are employees of Illumina and are also shareholders in the company. Illumina Inc. funded data collection and their contributions to this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson M, 2004, BIOINFORMATICS, V20, P2067, DOI 10.1093/bioinformatics/bth205; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; EDWARDS A, 1991, Methods (Orlando), V3, P41, DOI 10.1016/S1046-2023(05)80162-8; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Idury R M, 1995, J Comput Biol, V2, P291, DOI 10.1089/cmb.1995.2.291; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jeffries TW, 2004, APPL MICROBIOL BIOT, V63, P495, DOI 10.1007/s00253-003-1450-0; LANDER E S, 1988, Genomics, V2, P231; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; Myers EW, 2005, BIOINFORMATICS, V21, P79, DOI 10.1093/bioinformatics/bti1114; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008407	38	118	129	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23501	10.1371/journal.pone.0023501	http://dx.doi.org/10.1371/journal.pone.0023501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876754	Green Submitted, gold, Green Published			2022-12-25	WOS:000294126900026
J	Erlwein, O; Robinson, MJ; Dustan, S; Weber, J; Kaye, S; McClure, MO				Erlwein, Otto; Robinson, Mark J.; Dustan, Simon; Weber, Jonathan; Kaye, Steve; McClure, Myra O.			DNA Extraction Columns Contaminated with Murine Sequences	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; RETROVIRUS XMRV; MOUSE DNA; ABSENCE; PREVALENCE; FAILURE; SAMPLES; TUMORS	Sequences of the novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV) have been described in human prostate cancer tissue, although the amounts of DNA are low. Furthermore, XMRV sequences and polytropic (p) murine leukemia viruses (MLVs) have been reported in patients with chronic fatigue syndrome (CFS). In assessing the prevalence of XMRV in prostate cancer tissue samples we discovered that eluates from naive DNA purification columns, when subjected to PCR with primers designed to detect genomic mouse DNA contamination, occasionally gave rise to amplification products. Further PCR analysis, using primers to detect XMRV, revealed sequences derived from XMRV and pMLVs from mouse and human DNA and DNA of unspecified origin. Thus, DNA purification columns can present problems when used to detect minute amounts of DNA targets by highly sensitive amplification techniques.	[Erlwein, Otto; Robinson, Mark J.; Dustan, Simon; Weber, Jonathan; Kaye, Steve; McClure, Myra O.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Jefferiss Res Trust Labs, London, England	Imperial College London	Erlwein, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Jefferiss Res Trust Labs, London, England.	m.mcclure@imperial.ac.uk		McClure, Myra/0000-0002-5494-407X	NIHR Biomedical Research Centre; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are grateful for support of this work from the NIHR Biomedical Research Centre funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Dupressoir A, 1997, ONCOGENE, V14, P2951, DOI 10.1038/sj.onc.1201148; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schutzer SE, 2011, ANN NEUROL, V69, P735, DOI 10.1002/ana.22389; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018	24	59	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23484	10.1371/journal.pone.0023484	http://dx.doi.org/10.1371/journal.pone.0023484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876752	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900024
J	Liu, JF; Obi, IR; Thanikkal, EJ; Kieselbach, T; Francis, MS				Liu, Junfa; Obi, Ikenna R.; Thanikkal, Edvin J.; Kieselbach, Thomas; Francis, Matthew S.			Phosphorylated CpxR Restricts Production of the RovA Global Regulator in Yersinia pseudotuberculosis	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; ASSISTED-LASER-DESORPTION/IONIZATION; HIGHLY SELECTIVE ENRICHMENT; ESCHERICHIA-COLI; RESPONSE REGULATOR; OUTER-MEMBRANE; DNA-BINDING; ACETYL PHOSPHATE; RNA-POLYMERASE; TRANSCRIPTIONAL ACTIVATION	Background: RovA is a global transcriptional regulator of gene expression in pathogenic Yersinia. RovA levels are kept in check by a sophisticated layering of distinct transcriptional and post-transcriptional regulatory mechanisms. In the enteropathogen Y. pseudotuberculosis, we have previously reported that the extracytoplasmic stress sensing CpxA-CpxR two-component regulatory system modulates rovA expression. Methodology/Principal Findings: In this study, we characterized CpxR phosphorylation (CpxR similar to P) in vitro, and determined that phosphorylation was necessary for CpxR to efficiently bind to the PCR-amplified upstream regulatory region of rovA. The precise CpxR similar to P binding site was mapped by a nuclease protection assay and directed mutagenesis confirmed that in vivo binding to the rovA promoter inhibits transcription. Reduced RovA production was most pronounced following CpxR, P accumulation in the Yersinia cytoplasm during chronic Cpx pathway activation and by the indiscriminate phosphodonor action of acetyl phosphate. Conclusions/Significance: Cpx pathway activation restricts levels of the RovA global regulator. The regulatory influence of CpxR similar to P must therefore extend well beyond periplasmic quality control in the Yersinia envelope, to include genes involved in environmental survival and pathogenicity.	[Liu, Junfa; Obi, Ikenna R.; Thanikkal, Edvin J.; Francis, Matthew S.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Liu, Junfa; Obi, Ikenna R.; Thanikkal, Edvin J.; Francis, Matthew S.] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Kieselbach, Thomas] Umea Univ, Dept Chem, Umea, Sweden; [Liu, Junfa] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China	Umea University; Umea University; Umea University; Huazhong Agricultural University	Liu, JF (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	matthew.francis@molbiol.umu.se	Kieselbach, Thomas/O-6023-2015	Kieselbach, Thomas/0000-0001-5577-2938; Obi, Ikenna/0000-0003-0364-8964; Francis, Matthew/0000-0001-6817-9535	Swedish Research Council [2006-3869, 2009-3660]; Carl Tryggers Foundation for Scientific Research [04:110, 06:141]; Medical Research Foundation at Umea University; Carl Tryggers Post-doctoral fellowship; Umea Centre for Microbial Research (UCMR); Wallenberg foundation; Kempe foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation for Scientific Research; Medical Research Foundation at Umea University; Carl Tryggers Post-doctoral fellowship; Umea Centre for Microbial Research (UCMR); Wallenberg foundation(European Commission); Kempe foundation	This work was principally supported by grants 2006-3869 and 2009-3660 from the Swedish Research Council (http://www.vr.se/) and 04:110 and 06:141 from Carl Tryggers Foundation for Scientific Research (http://www.carltryggersstiftelse.se). Partial funding was also received from the Medical Research Foundation at Umea University. JL was sponsored in part by a Carl Tryggers Post-doctoral fellowship and IRO is a Post-doctoral fellow supported by Umea Centre for Microbial Research (UCMR) Linnaeus Program (LP) (http://www.ucmr.umu.se/). The authors also thank the Wallenberg foundation (http://www.wallenberg.com/) and Kempe foundation (http://www.kempe.com/index_start.html) for their support of the instruments and bioinformatics infrastructure at the Umea Protein Analysis Facility. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; BOLIN I, 1984, INFECT IMMUN, V43, P72; Brzostek K, 2007, MICROBIOL-SGM, V153, P2416, DOI 10.1099/mic.0.2006/003202-0; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Carlsson KE, 2007, INFECT IMMUN, V75, P4386, DOI 10.1128/IAI.01450-06; Carlsson KE, 2007, INFECT IMMUN, V75, P3913, DOI 10.1128/IAI.01346-06; Cathelyn JS, 2007, MOL MICROBIOL, V66, P189, DOI 10.1111/j.1365-2958.2007.05907.x; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; COSMA CL, 1995, MOL MICROBIOL, V18, P491, DOI 10.1111/j.1365-2958.1995.mmi_18030491.x; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; DANESE PN, 1995, J BACTERIOL, V177, P4969, DOI 10.1128/jb.177.17.4969-4973.1995; De Wulf P, 1999, J BACTERIOL, V181, P6772, DOI 10.1128/JB.181.21.6772-6778.1999; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; De Wulf P, 2000, J BACTERIOL, V182, P1423, DOI 10.1128/JB.182.5.1423-1426.2000; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Ellison DW, 2006, J BACTERIOL, V188, P5101, DOI 10.1128/JB.00862-05; Ellison DW, 2003, J BACTERIOL, V185, P7153, DOI 10.1128/JB.185.24.7153-7159.2003; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Heroven AK, 2008, MOL MICROBIOL, V68, P1179, DOI 10.1111/j.1365-2958.2008.06218.x; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Hirano Y, 2007, STRUCTURE, V15, P963, DOI 10.1016/j.str.2007.06.014; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Jubelin G, 2005, J BACTERIOL, V187, P2038, DOI 10.1128/JB.187.6.2038-2049.2005; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kussmann M, 1997, J MASS SPECTROM, V32, P483; Labandeira-Rey M, 2010, INFECT IMMUN, V78, P4779, DOI 10.1128/IAI.00678-10; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lau-Wong IC, 2008, MOL MICROBIOL, V67, P516, DOI 10.1111/j.1365-2958.2007.06055.x; Lawrenz MB, 2007, J BACTERIOL, V189, P5963, DOI 10.1128/JB.00528-07; Li L, 2008, MOL MICROBIOL, V68, P286, DOI 10.1111/j.1365-2958.2008.06151.x; MACRITCHIE DM, 2009, ECOSAL ESCHERICHIA C; MAKINO K, 1993, GENE DEV, V7, P149, DOI 10.1101/gad.7.1.149; Makino K, 1996, J MOL BIOL, V259, P15, DOI 10.1006/jmbi.1996.0298; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Miyadai H, 2004, J BIOL CHEM, V279, P39807, DOI 10.1074/jbc.M406390200; Mizrahi I, 2009, RES MICROBIOL, V160, P80, DOI 10.1016/j.resmic.2008.10.007; Mizrahi I, 2006, MOL MICROBIOL, V62, P201, DOI 10.1111/j.1365-2958.2006.05360.x; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Naktin J, 1999, CLIN LAB MED, V19, P523; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Perron-Savard P, 2005, MICROBIOL-SGM, V151, P3979, DOI 10.1099/mic.0.28236-0; Pogliano J, 1998, J BACTERIOL, V180, P3486, DOI 10.1128/JB.180.13.3486-3490.1998; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Purich DL, 2002, METHOD ENZYMOL, V354, P168; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RAMANI N, 1992, MOL GEN GENET, V231, P248, DOI 10.1007/BF00279798; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; Suntharalingam P, 2003, J BACTERIOL, V185, P432, DOI 10.1128/JB.185.2.432-443.2003; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wolfe AJ, 2003, MOL MICROBIOL, V48, P977, DOI 10.1046/j.1365-2958.2003.03457.x; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Yang FK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012840; Yang YX, 1997, MOL MICROBIOL, V24, P499, DOI 10.1046/j.1365-2958.1997.3511719.x; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200	78	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23314	10.1371/journal.pone.0023314	http://dx.doi.org/10.1371/journal.pone.0023314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876746	Green Published, Green Submitted, gold			2022-12-25	WOS:000294126900018
J	VanSchouwen, B; Selvaratnam, R; Fogolari, F; Melacini, G				VanSchouwen, Bryan; Selvaratnam, Rajeevan; Fogolari, Federico; Melacini, Giuseppe			Role of Dynamics in the Autoinhibition and Activation of the Exchange Protein Directly Activated by Cyclic AMP (EPAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL SELECTION; MOLECULAR-DYNAMICS; NMR-SPECTROSCOPY; BINDING DOMAINS; CELL-ADHESION; INDUCED FIT; KINASE-A; CAMP; MECHANISM; RECEPTOR	The exchange protein directly activated by cAMP (EPAC) is a key receptor of cAMP in eukaryotes and controls critical signaling pathways. Currently, no residue resolution information is available on the full-length EPAC dynamics, which are known to be pivotal determinants of allostery. In addition, no information is presently available on the intermediates for the classical induced fit and conformational selection activation pathways. Here these questions are addressed through molecular dynamics simulations on five key states along the thermodynamic cycle for the cAMP-dependent activation of a fully functional construct of EPAC2, which includes the cAMP-binding domain and the integral catalytic region. The simulations are not only validated by the agreement with the experimental trends in cAMP-binding domain dynamics determined by NMR, but they also reveal unanticipated dynamic attributes, rationalizing previously unexplained aspects of EPAC activation and autoinhibition. Specifically, the simulations show that cAMP binding causes an extensive perturbation of dynamics in the distal catalytic region, assisting the recognition of the Rap1b substrate. In addition, analysis of the activation intermediates points to a possible hybrid mechanism of EPAC allostery incorporating elements of both the induced fit and conformational selection models. In this mechanism an entropy compensation strategy results in a low free-energy pathway of activation. Furthermore, the simulations indicate that the autoinhibitory interactions of EPAC are more dynamic than previously anticipated, leading to a revised model of autoinhibition in which dynamics fine tune the stability of the autoinhibited state, optimally sensitizing it to cAMP while avoiding constitutive activation.	[VanSchouwen, Bryan; Selvaratnam, Rajeevan; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Fogolari, Federico] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy	McMaster University; McMaster University; University of Udine	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca		Fogolari, Federico/0000-0001-9862-250X; Selvaratnam, Rajeevan/0000-0003-4457-616X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada (NSERC) (to G. M.), and a Heart and Stroke Foundation of Canada M. Andrew New Investigator Award (to G. M.).	Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cho JH, 2011, NAT STRUCT MOL BIOL, V18, P550, DOI 10.1038/nsmb.2039; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; McCammon MG, 2004, CURR OPIN CHEM BIOL, V8, P60, DOI 10.1016/j.cbpa.2003.11.005; Nicholson LK, 2002, BIOPHYS J, V82, p3A; Patel N, 2011, J PHYS CHEM B, V115, P4856, DOI 10.1021/jp2012792; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Robert S, 2005, FEBS LETT, V579, P1136, DOI 10.1016/j.febslet.2005.01.010; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Schmidt M, 2007, CURR OPIN PHARMACOL, V7, P193, DOI 10.1016/j.coph.2006.10.004; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Wong CF, 2003, ANNU REV PHARMACOL, V43, P31, DOI 10.1146/annurev.pharmtox.43.100901.140216	42	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42655	42669		10.1074/jbc.M111.277723	http://dx.doi.org/10.1074/jbc.M111.277723			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21873431	hybrid, Green Published			2022-12-25	WOS:000298180900073
J	Kilger, E; Buehler, A; Woelfing, H; Kumar, S; Kaeser, SA; Nagarathinam, A; Walter, J; Jucker, M; Coomaraswamy, J				Kilger, Ellen; Buehler, Anika; Woelfing, Heidrun; Kumar, Sathish; Kaeser, Stephan A.; Nagarathinam, Amudha; Walter, Jochen; Jucker, Mathias; Coomaraswamy, Janaky			BRI2 Protein Regulates beta-Amyloid Degradation by Increasing Levels of Secreted Insulin-degrading Enzyme (IDE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL BRITISH DEMENTIA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; A-BETA; INTRACELLULAR DOMAIN; IN-VIVO; EXTRACELLULAR LEVELS; MEMORY DEFICITS; DANISH DEMENTIA; RECEPTOR	The amyloid precursor protein (APP) is one of the major proteins involved in Alzheimer disease (AD). Proteolytic cleavage of APP gives rise to amyloid-beta (A beta) peptides that aggregate and deposit extensively in the brain of AD patients. Although the increase in levels of aberrantly folded A beta peptide is considered to be important to disease pathogenesis, the regulation of APP processing and A beta metabolism is not fully understood. Recently, the British precursor protein (BRI2, ITM2B) has been implicated in influencing APP processing in cells and A beta deposition in vivo. Here, we show that the wild type BRI2 protein reduces plaque load in an AD mouse model, similar to its disease-associated mutant form, ADan precursor protein (ADanPP), and analyze in more detail the mechanism of how BRI2 and ADanPP influence APP processing and A beta metabolism. We find that overexpression of either BRI2 or ADanPP reduces extracellular A beta by increasing levels of secreted insulin-degrading enzyme (IDE), a major A beta-degrading protease. This effect is also observed with BRI2 lacking its C-terminal 23-amino acid peptide sequence. Our results suggest that BRI2 might act as a receptor protein that regulates IDE levels that in turn influences APP metabolism in a previously unrecognized way. Targeting the regulation of IDE may be a promising therapeutic approach to sporadic AD.	[Kilger, Ellen; Buehler, Anika; Woelfing, Heidrun; Kaeser, Stephan A.; Nagarathinam, Amudha; Jucker, Mathias; Coomaraswamy, Janaky] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; [Kilger, Ellen; Buehler, Anika; Woelfing, Heidrun; Kaeser, Stephan A.; Nagarathinam, Amudha; Jucker, Mathias; Coomaraswamy, Janaky] German Ctr Neurodegenerat Dis, DZNE, D-72076 Tubingen, Germany; [Nagarathinam, Amudha] Grad Sch Cellular & Mol Neurosci, D-72074 Tubingen, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn	Kilger, E (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Otfried Muller Str 27, D-72076 Tubingen, Germany.	ellen.kilger@uni-tuebingen.de; janaky.coomaraswamy@uni-tuebingen.de	Wang, Caihong/T-5837-2019; Kumar, Sathish/L-1367-2019; Walter, Jochen/B-3677-2014	Wang, Caihong/0000-0002-6808-3709; Kumar, Sathish/0000-0002-2792-7047; Walter, Jochen/0000-0002-4678-2912	German Research Foundation [Ju 655/3-1]; Carl-Zeiss Foundation	German Research Foundation(German Research Foundation (DFG)); Carl-Zeiss Foundation	This work was supported in part by German Research Foundation Grant Ju 655/3-1 and a stipend from the Carl-Zeiss Foundation.	Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Du J, 2010, PHARMAZIE, V65, P231, DOI 10.1691/ph.2010.9607; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Espuny-Camacho I, 2010, J ALZHEIMERS DIS, V20, P1119, DOI 10.3233/JAD-2010-091633; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Franklin K, 2004, MOUSE BRAIN STEREOTA; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Mathews PM, 2000, MOL MED, V6, P878, DOI 10.1007/BF03401825; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Morelli L, 2005, BIOCHEM BIOPH RES CO, V332, P808, DOI 10.1016/j.bbrc.2005.05.020; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Pittois K, 1998, GENE, V217, P141, DOI 10.1016/S0378-1119(98)00354-0; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tsachaki M, 2010, NEUROBIOL AGING, V31, P88, DOI 10.1016/j.neurobiolaging.2008.03.004; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4; Zhao LQ, 2011, NEUROBIOL AGING, V32, P1949, DOI 10.1016/j.neurobiolaging.2009.12.010; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	51	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37446	37457		10.1074/jbc.M111.288373	http://dx.doi.org/10.1074/jbc.M111.288373			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21873424	Green Published, hybrid			2022-12-25	WOS:000296542400044
J	Veillard, F; Saidi, A; Burden, RE; Scott, CJ; Gillet, L; Lecaille, F; Lalmanach, G				Veillard, Florian; Saidi, Ahlame; Burden, Roberta E.; Scott, Christopher J.; Gillet, Ludovic; Lecaille, Fabien; Lalmanach, Gilles			Cysteine Cathepsins S and L Modulate Anti-angiogenic Activities of Human Endostatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; TUMOR-GROWTH; AMINOPEPTIDASE-N; COLLAGEN-XVIII; EMERGING ROLES; INHIBITORS; DEGRADATION; GENERATION; FRAGMENTS	Human endostatin, a potent anti-angiogenic protein, is generated by release of the C terminus of collagen XVIII. Here, we propose that cysteine cathepsins are involved in both the liberation and activation of bioactive endostatin fragments, thus regulating their anti-angiogenic properties. Cathepsins B, S, and L efficiently cleaved in vitro FRET peptides that encompass the hinge region corresponding to the N terminus of endostatin. However, in human umbilical vein endothelial cell-based assays, silencing of cathepsins S and L, but not cathepsin B, impaired the generation of the similar to 22-kDa endostatin species. Moreover, cathepsins L and S released two peptides from endostatin with increased angiostatic properties and both encompassing the NGR sequence, a vasculature homing motif. The G10T peptide (residues 1455-1464: collagen XVIII numbering) displayed compelling anti-proliferative (EC50 = 0.23 nM) and proapoptotic properties. G10T inhibited aminopeptidase N (APN/CD13) and reduced tube formation of endothelial cells in a manner similar to bestatin. Combination of G10T with bestatin resulted in no further increase in anti-angiogenic activity. Taken together, these data suggest that endostatin-derived peptides may represent novel molecular links between cathepsins and APN/CD13 in the regulation of angiogenesis.	[Lalmanach, Gilles] Univ Tours, Fac Med, Equipe Proteases & Pathol Pulm, INSERM,U618 Proteases & Vectorisat Pulm, F-37032 Tours, France; [Burden, Roberta E.; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Gillet, Ludovic] Univ Tours, INSERM, Nutr Croissance & Canc U921, F-37000 Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Queens University Belfast; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Lalmanach, G (corresponding author), Univ Tours, Fac Med, Equipe Proteases & Pathol Pulm, INSERM,U618 Proteases & Vectorisat Pulm, 10 Blvd Tonnelle, F-37032 Tours, France.	gilles.lalmanach@univ-tours.fr	Lecaille, Fabien/GRY-5313-2022	Lalmanach, Gilles/0000-0001-8562-4821; Gillet, Ludovic/0000-0002-4990-6212; Veillard, Florian/0000-0003-1248-2396; Saidi, Ahlame/0000-0002-0282-2476; Lecaille, Fabien/0000-0003-1060-4222	Institut National de la Sante et de la Recherche Medicale (INSERM); l'Institut Federatif de Recherche "Imagerie Fonctionnelle", Tours, France [IFR 135]; Ministere de l'Education Nationale, de la Recherche et de la Technologie (France)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); l'Institut Federatif de Recherche "Imagerie Fonctionnelle", Tours, France; Ministere de l'Education Nationale, de la Recherche et de la Technologie (France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) and a grant from l'Institut Federatif de Recherche "Imagerie Fonctionnelle" (IFR 135, Tours, France).; Recipient of a doctoral fellowship from Ministere de l'Education Nationale, de la Recherche et de la Technologie (France).	Arap Wadih, 1998, Current Opinion in Oncology, V10, P560, DOI 10.1097/00001622-199811000-00014; Bauvois B, 2006, MED RES REV, V26, P88, DOI 10.1002/med.20044; Burden RE, 2009, CLIN CANCER RES, V15, P6042, DOI 10.1158/1078-0432.CCR-09-1262; Chang SH, 2009, CANCER RES, V69, P4537, DOI 10.1158/0008-5472.CAN-08-4539; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Dhanabal M, 1999, BIOCHEM BIOPH RES CO, V258, P345, DOI 10.1006/bbrc.1999.0595; Dixelius J, 2002, CANCER RES, V62, P1944; Farias SL, 2006, BIOL CHEM, V387, P611, DOI 10.1515/BC.2006.078; Faye C, 2010, BIOCHEM J, V427, P467, DOI 10.1042/BJ20091594; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015; Fukasawa K, 2006, CANCER LETT, V243, P135, DOI 10.1016/j.canlet.2005.11.051; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Godat E, 2004, BIOCHEM J, V383, P501, DOI 10.1042/BJ20040864; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; John H, 1999, BIOCHEMISTRY-US, V38, P10217, DOI 10.1021/bi990787+; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mucha A, 2010, BIOCHIMIE, V92, P1509, DOI 10.1016/j.biochi.2010.04.026; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pasqualini R, 2000, CANCER RES, V60, P722; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Serveau C, 1996, BIOCHEM J, V313, P951, DOI 10.1042/bj3130951; Serveau-Avesque C, 2006, BIOL CELL, V98, P15, DOI 10.1042/BC20040512; Standker L, 1997, FEBS LETT, V420, P129, DOI 10.1016/S0014-5793(97)01503-2; Suhr F, 2009, CURR PHARM DESIGN, V15, P389, DOI 10.2174/138161209787315756; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Veillard F, 2009, THESIS U FRANCOIS RA; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wen W, 1999, CANCER RES, V59, P6052; Xu HL, 2008, CURR PROTEIN PEPT SC, V9, P275, DOI 10.2174/138920308784534050; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Yokoyama Y, 2004, BRIT J CANCER, V90, P1627, DOI 10.1038/sj.bjc.6601745; YONEDA J, 1992, CLIN EXP METASTAS, V10, P49, DOI 10.1007/BF00163576	44	48	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37158	37167		10.1074/jbc.M111.284869	http://dx.doi.org/10.1074/jbc.M111.284869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896479	Green Published, hybrid			2022-12-25	WOS:000296542400016
J	Liu, T; Deng, M; Li, JH; Tong, XM; Wei, Q; Ye, X				Liu, Ting; Deng, Min; Li, Junhui; Tong, Xiaomei; Wei, Qian; Ye, Xin			Phosphorylation of Right Open Reading Frame 2 (Rio2) Protein Kinase by Polo-like Kinase 1 Regulates Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; SCF-BETA-TRCP; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; CYTOPLASMIC MATURATION; DNA-DAMAGE; YEAST; SUBUNIT; SPINDLE	Polo-like kinase 1 (Plk1) plays essential roles during multiple stages of mitosis by phosphorylating a number of substrates. Here, we report that the atypical protein kinase Rio2 is a novel substrate of Plk1 and can be phosphorylated by Plk1 at Ser-335, Ser-380, and Ser-548. Overexpression of Rio2 causes a prolonged mitotic exit whereas knockdown of Rio2 accelerates mitotic progression, suggesting that Rio2 is required for the proper mitotic progression. Overexpression of phospho-mimicking mutant Rio2 S3D but not the nonphosphorylatable mutant Rio2 S3A displays a profile similar to that of wild-type Rio2. These results indicate that the phosphorylation status of Rio2 correlates with its function in mitosis. Furthermore, time-lapse imaging data show that overexpression of Rio2 but not Rio2 S3A results in a slowed metaphase-anaphase transition. Collectively, these findings strongly indicate that the Plk1-mediated phosphorylation of Rio2 regulates metaphase-anaphase transition during mitotic progression.	[Liu, Ting; Deng, Min; Li, Junhui; Tong, Xiaomei; Wei, Qian; Ye, Xin] Chinese Acad Sci, Ctr Mol Immunol, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China; [Liu, Ting; Deng, Min; Li, Junhui; Wei, Qian] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Ctr Mol Immunol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, 1 Beichen W Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [30871238]; Ministry of Science and Technology of China [2009ZX10004-101, 2008ZX10002-009, 2011CB504705, 2012CB519003]; Chinese Academy of Sciences [KSCX2-YW-R-198, KSCX2-EW-J-6];  [81021003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); 	This work was supported by National Natural Science Foundation of China Grant 30871238, Ministry of Science and Technology of China Grants 2009ZX10004-101, 2008ZX10002-009, 2011CB504705, and 2012CB519003, and Chinese Academy of Sciences Innovation Projects KSCX2-YW-R-198 and KSCX2-EW-J-6.; Principal investigator of the Innovative Research Group of the National Natural Science Foundation of China and recipient of Foundation Grant 81021003. To whom correspondence should be addressed: Center for Molecular Immunology, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, 1 Beichen West Rd., Chaoyang District, Beijing 100101, China. Tel.: 86-1064807508; Fax: 86-10-64807513; E-mail: yex@im.ac.cn.	Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Angermayr M, 2007, FEBS J, V274, P4654, DOI 10.1111/j.1742-4658.2007.05993.x; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; Eckerdt F, 2006, CANCER RES, V66, P6895, DOI 10.1158/0008-5472.CAN-06-0358; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fry AM, 2006, DEV CELL, V11, P431, DOI 10.1016/j.devcel.2006.09.012; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Oeffinger M, 2007, NUCLEIC ACIDS RES, V35, P1354, DOI 10.1093/nar/gkl824; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Yuan K, 2007, J BIOL CHEM, V282, P27414, DOI 10.1074/jbc.M703555200; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	36	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36352	36360		10.1074/jbc.M111.250175	http://dx.doi.org/10.1074/jbc.M111.250175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880710	hybrid, Green Published			2022-12-25	WOS:000296538300020
J	Liang, ZJ; Li, LC; Wang, YY; Chen, LM; Kong, XQ; Hong, Y; Lan, LF; Zheng, MY; Cai, GY; Liu, H; Shen, X; Luo, C; Li, KK; Chen, KX; Jiang, HL				Liang, Zhongjie; Li, Lianchun; Wang, Yuanyuan; Chen, Limin; Kong, Xiangqian; Hong, Yao; Lan, Lefu; Zheng, Mingyue; Cai Guang-Yang; Liu, Hong; Shen, Xu; Luo, Cheng; Li, Keqin Kathy; Chen, Kaixian; Jiang, Hualiang			Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; 3-DIMENSIONAL STRUCTURE; BACTEROIDES-FRAGILIS; MECHANISM; INHIBITION; CATALYSIS	The New Delhi Metallo-beta-lactamase (NDM-1) was first reported in 2009 in a Swedish patient. A recent study reported that Klebsiella pneumonia NDM-1 positive strain or Escherichia coli NDM-1 positive strain was highly resistant to all antibiotics tested except tigecycline and colistin. These can no longer be relied on to treat infections and therefore, NDM-1 now becomes potentially a major global health threat. In this study, we performed modeling studies to obtain its 3D structure and NDM-1/antibiotics complex. It revealed that the hydrolytic mechanisms are highly conserved. In addition, the detailed analysis indicates that the more flexible and hydrophobic loop1, together with the evolution of more positive-charged loop2 leads to NDM-1 positive strain more potent and extensive in antibiotics resistance compared with other MBLs. Furthermore, through biological experiments, we revealed the molecular basis for antibiotics catalysis of NDM-1 on the enzymatic level. We found that NDM-1 enzyme was highly potent to degrade carbapenem antibiotics, while mostly susceptible to tigecycline, which had the ability to slow down the hydrolysis velocity of meropenem by NDM-1. Meanwhile, the mutagenesis experiments, including D124A, C208A, K211A and K211E, which displayed down-regulation on meropenem catalysis, proved the accuracy of our model. At present, there are no effective antibiotics against NDM-1 positive pathogen. Our study will provide clues to investigate the molecular basis of extended antibiotics resistance of NDM-1 and then accelerate the search for new antibiotics against NDM-1 positive strain in clinical studies.	[Liang, Zhongjie; Li, Lianchun; Wang, Yuanyuan; Chen, Limin; Kong, Xiangqian; Lan, Lefu; Zheng, Mingyue; Cai Guang-Yang; Liu, Hong; Shen, Xu; Luo, Cheng; Chen, Kaixian; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Li, Lianchun; Hong, Yao; Li, Keqin Kathy] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Shanghai Inst Hematol, Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Luo, Cheng] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Jiang, Hualiang] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Soochow University - China; East China University of Science & Technology	Liang, ZJ (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	cluo@mail.shcnc.ac.cn; kli@epigenetic.us; hljiang@mail.shcnc.ac.cn	Liang, Zhongjie/F-2108-2019; Kong, Xiangqian/J-4500-2017; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/Z-3582-2019; Wang, Yuanyuan/K-1154-2016; Zheng, Mingyue/HHZ-4062-2022	Liang, Zhongjie/0000-0003-0763-5407; Kong, Xiangqian/0000-0002-9596-7825; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092	State Key Program of Basic Research of China [2009CB918502, 2011CB510102]; National Natural Science Foundation of China [20972174, 20720102040, 21021063, 91029704]; Shanghai Committee of Science and Technology [10410703900, 11ZR1444500, 11XD1406100, 09PJ1411600]; Chinese Academy of Sciences [XDA01040305, KSCX2-YW-R-143]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors gratefully acknowledge financial support from the State Key Program of Basic Research of China grant (2009CB918502 and 2011CB510102), the National Natural Science Foundation of China grants (20972174, 20720102040, 21021063 and 91029704), Shanghai Committee of Science and Technology grants (10410703900, 11ZR1444500, 11XD1406100, and 09PJ1411600), Special grant from the Chinese Academy of Sciences (XDA01040305) and the 100 Talents Program of the Chinese Academy of Sciences (KSCX2-YW-R-143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bounaga S, 1998, BIOCHEM J, V331, P703, DOI 10.1042/bj3310703; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garcia-Saez I, 2003, J MOL BIOL, V325, P651, DOI 10.1016/S0022-2836(02)01271-8; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lassaux P, 2011, ANTIMICROB AGENTS CH, V55, P1248, DOI 10.1128/AAC.01486-09; Lassaux P, 2010, J MED CHEM, V53, P4862, DOI 10.1021/jm100213c; Moali C, 2003, CHEM BIOL, V10, P319, DOI 10.1016/S1074-5521(03)00070-X; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Yamaguchi Y, 2007, J MED CHEM, V50, P6647, DOI 10.1021/jm701031n; YONG D, 2009, CHEMOTHERAPY, V53, P5046; Yu KQ, 2009, CELL RES, V19, P1221, DOI 10.1038/cr.2009.111; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	20	50	52	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23606	10.1371/journal.pone.0023606	http://dx.doi.org/10.1371/journal.pone.0023606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887283	Green Submitted, gold, Green Published			2022-12-25	WOS:000295832000037
J	Poschmann, J; Drouin, S; Jacques, PE; El Fadili, K; Newmarch, M; Robert, F; Ramotar, D				Poschmann, Jeremie; Drouin, Simon; Jacques, Pierre-Etienne; El Fadili, Karima; Newmarch, Michael; Robert, Francois; Ramotar, Dindial			The Peptidyl Prolyl Isomerase Rrd1 Regulates the Elongation of RNA Polymerase II during Transcriptional Stresses	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; GENOME-WIDE LOCATION; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; TERMINAL DOMAIN; IN-VIVO; YEAST; TOR; ACTIVATOR; 6-AZAURACIL	Rapamycin is an anticancer agent and immunosuppressant that acts by inhibiting the TOR signaling pathway. In yeast, rapamycin mediates a profound transcriptional response for which the RRD1 gene is required. To further investigate this connection, we performed genome-wide location analysis of RNA polymerase II (RNAPII) and Rrd1 in response to rapamycin and found that Rrd1 colocalizes with RNAPII on actively transcribed genes and that both are recruited to rapamycin responsive genes. Strikingly, when Rrd1 is lacking, RNAPII remains inappropriately associated to ribosomal genes and fails to be recruited to rapamycin responsive genes. This occurs independently of TATA box binding protein recruitment but involves the modulation of the phosphorylation status of RNAPII CTD by Rrd1. Further, we demonstrate that Rrd1 is also involved in various other transcriptional stress responses besides rapamycin. We propose that Rrd1 is a novel transcription elongation factor that fine-tunes the transcriptional stress response of RNAPII.	[Poschmann, Jeremie; El Fadili, Karima; Newmarch, Michael; Ramotar, Dindial] Univ Montreal, Dept Med, Res Ctr, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada; [Drouin, Simon; Jacques, Pierre-Etienne; Robert, Francois] Inst Rech Clin Montreal, Montreal, PQ, Canada; [Robert, Francois] Univ Montreal, Dept Med, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Poschmann, J (corresponding author), Univ Montreal, Dept Med, Res Ctr, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada.	francois.robert@ircm.qc.ca; dramotar.hmr@ssss.gouv.qc.ca	Robert, Francois/D-2316-2012		Canadian Institutes of Health Research [CIHR-82891, MOP-13152]; Canadian foundation for Innovation [202432-01]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian foundation for Innovation(Canada Foundation for Innovation)	This work was supported by the grants CIHR-82891 and MOP-13152 from the Canadian Institutes of Health Research. The authors also thank the Canadian foundation for Innovation for the leader funding opportunity grant (202432-01) to D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Aureliano M, 2009, J INORG BIOCHEM, V103, P536, DOI 10.1016/j.jinorgbio.2008.11.010; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; CAYLA X, 1990, BIOCHEMISTRY-US, V29, P658, DOI 10.1021/bi00455a010; CAYLA X, 1994, J BIOL CHEM, V269, P15668; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheung AC, NATURE; Cho EJ, 2007, EXP MOL MED, V39, P247, DOI 10.1038/emm.2007.28; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Douville J, 2006, GENETICS, V172, P1369, DOI 10.1534/genetics.105.046110; Dowling RJO, 2009, BIODRUGS, V23, P77, DOI 10.2165/00063030-200923020-00002; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch AP, 2007, YEAST, V24, P961, DOI 10.1002/yea.1512; Ghavi-Helm Y, 2008, GENE DEV, V22, P1934, DOI 10.1101/gad.471908; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Jouvet N, BMC MOL BIOL, V11, P92; Kops O, 2002, FEBS LETT, V513, P305, DOI 10.1016/S0014-5793(02)02288-3; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Lloyd A, 2009, EUKARYOT CELL, V8, P257, DOI 10.1128/EC.00348-08; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Ralser M, 2005, BIOTECHNIQUES, V39, P165, DOI 10.2144/05392BM01; Ramotar D, 1998, J BIOL CHEM, V273, P21489, DOI 10.1074/jbc.273.34.21489; Rempola B, 2000, MOL GEN GENET, V262, P1081, DOI 10.1007/PL00008651; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Riles L, 2004, YEAST, V21, P241, DOI 10.1002/yea.1068; Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013; Ronald TKN, 2008, P NATL ACAD SCI USA, V105, P15166, DOI 10.1073/pnas.0807712105; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Uffenbeck SR, 2006, BIOCHEM CELL BIOL, V84, P477, DOI 10.1139/O06-079; Vance JR, 2001, MOL CELL BIOL, V21, P7191, DOI 10.1128/MCB.21.21.7191-7198.2001; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Wu XY, 2003, GENETICS, V165, P1687; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wysocki R, 2004, MOL BIOL CELL, V15, P2049, DOI 10.1091/mbc.E03-04-0236; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Zheng Y, 2005, MOL BIOL CELL, V16, P2119, DOI 10.1091/mbc.e04-09-0797	60	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23159	10.1371/journal.pone.0023159	http://dx.doi.org/10.1371/journal.pone.0023159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887235	Green Published, gold			2022-12-25	WOS:000295832000009
J	Teixido, N; Garrabou, J; Harmelin, JG				Teixido, Nuria; Garrabou, Joaquim; Harmelin, Jean-George			Low Dynamics, High Longevity and Persistence of Sessile Structural Species Dwelling on Mediterranean Coralligenous Outcrops	PLOS ONE			English	Article							ROCKY BENTHIC COMMUNITIES; MASS-MORTALITY; LIFE-HISTORY; LONG-TERM; MULTIVARIATE-ANALYSIS; CORAL; BIODIVERSITY; DISTURBANCE; REPRODUCTION; POPULATIONS	There is still limited understanding of the processes underlying benthic species dynamics in marine coastal habitats, which are of disproportionate importance in terms of productivity and biodiversity. The life-history traits of long-lived benthic species in these habitats are particularly poorly documented. In this study, we assessed decadal patterns of population dynamics for ten sponge and anthozoan species that play key structural roles in coralligenous outcrops (similar to 25 m depth) in two areas of the NW Mediterranean Sea. This study was based on examination of a unique long-term photographic series, which allowed analysis of population dynamics over extensive spatial and time spans for the very first time. Specifically, 671 individuals were censused annually over periods of 25-, 15-, and 5-years. This long-term study quantitatively revealed a common life-history pattern among the ten studied species, despite the fact they present different growth forms. Low mortality rates (3.4% yr(-1) for all species combined) and infrequent recruitment events (mean value of 3.1 +/- 0.5 SE recruits yr(-1)) provided only a very small fraction of the new colonies required to maintain population sizes. Overall, annual mortality and recruitment rates did not differ significantly among years; however, some species displayed important mortality events and recruitment pulses, indicating variability among species. Based on the growth rates of these 10 species, we projected their longevity and, obtained a mean estimated age of 25-200 years. Finally, the low to moderate turnover rates (mean value 0.80% yr(-1)) observed among the coralligenous species were in agreement with their low dynamics and persistence. These results offer solid baseline data and reveal that these habitats are among the most vulnerable to the current increases of anthropogenic disturbances.	[Teixido, Nuria] Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain; [Teixido, Nuria; Garrabou, Joaquim] Inst Marine Sci ICM CSIC, Barcelona, Spain; [Harmelin, Jean-George] Univ Mediterranee, CNRS UMR DIMAR 6540, Ctr Oceanol Marseille, Marseille, France	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Aix-Marseille Universite	Teixido, N (corresponding author), Univ Barcelona, Dept Ecol, Fac Biol, E-08028 Barcelona, Spain.	nteixido@icm.csic.es		Teixido, Nuria/0000-0001-9286-2852	Direccio General de Pesca Maritima (Generalitat de Catalunya) [PCC68003/9]; Direccio de Medi Natural (Generalitat de Catalunya) [10.05.227.07/5]; Agence National de la Recherche [207632]; Total Foundation; Beatriu de Pinos [2009-BP-263];  [I3P-CSIC]	Direccio General de Pesca Maritima (Generalitat de Catalunya)(Generalitat de Catalunya); Direccio de Medi Natural (Generalitat de Catalunya)(Generalitat de Catalunya); Agence National de la Recherche(French National Research Agency (ANR)); Total Foundation(Total SA); Beatriu de Pinos; 	This study has been funded by the Direccio General de Pesca Maritima (Generalitat de Catalunya, PCC68003/9), the Direccio de Medi Natural (Generalitat de Catalunya, 10.05.227.07/5), the Agence National de la Recherche (Medchange project), Marie Curie Reintegration Grant Mechanisms (FP7- No 207632), and Total Foundation (medDIVERSA project, http://meddiversa.medrecover.org). N. Teixido was partially funded by I3P-CSIC and Beatriu de Pinos (2009-BP-263) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; *ASS ME, 2005, EC HUM WELL BEING; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; Coma R, 2004, ECOL APPL, V14, P1466, DOI 10.1890/03-5176; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONNELL J, DISTURBANCE PATCH DY; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DONE TJ, 1988, MAR BIOL, V100, P51, DOI 10.1007/BF00392954; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; GRIGG RW, 1993, MAR FISH REV, V55, P50; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; HARMELIN JG, 1970, TETHYS, V2, P329; Harper J. L, 1977, POPULATION BIOL PLAN; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Huston M. A., 1994, BIOL DIVERSITY; JACKSON J, 1979, MORPHOLOGICAL STRATE, P499; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Linares C, 2010, MAR ECOL PROG SER, V402, P69, DOI 10.3354/meps08436; Lytle DA, 2001, AM NAT, V157, P525, DOI 10.1086/319930; MAC ARTHUR ROBERT H., 1967; MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286; Marschal C, 2004, CORAL REEFS, V23, P423, DOI 10.1007/s00338-004-0398-6; MCFADDEN CS, 1991, ECOLOGY, V72, P1849, DOI 10.2307/1940983; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Miriti MN, 2007, ECOLOGY, V88, P1177, DOI 10.1890/06-1006; Odum EP, 1974, READINGS ENV IMPACT, V164, P224; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SHEIL D, 1995, J ECOL, P331; SOUSA W, NATURAL DISTURBANCE; STEARNS S, 1992, EVOLUTIONARY BIOL, V21, P127; STEPHENSON NL, 1992, LONG TERM DYNAMICS G, P23; SWAINE MD, 1987, J TROP ECOL, V3, P359, DOI 10.1017/S0266467400002339; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tanner JE, 1996, ECOLOGY, V77, P108, DOI 10.2307/2265660; Tanner JE, 2001, ECOLOGY, V82, P1971, DOI 10.2307/2680062; Teixido N, 2009, MAR ECOL PROG SER, V375, P113, DOI 10.3354/meps07757; Torrents O, 2011, MAR BIOL, V158, P1019, DOI 10.1007/s00227-011-1627-5; TORRENTS O, 2007, BIOL POPULATIONS COR; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	73	50	50	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23744	10.1371/journal.pone.0023744	http://dx.doi.org/10.1371/journal.pone.0023744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887308	gold, Green Published			2022-12-25	WOS:000295832000052
J	Velisek, L; Shang, EY; Veliskova, J; Chachua, T; Macchiarulo, S; Maglakelidze, G; Wolgemuth, DJ; Greenberg, DA				Velisek, Libor; Shang, Enyuan; Veliskova, Jana; Chachua, Tamar; Macchiarulo, Stephania; Maglakelidze, Giorgi; Wolgemuth, Debra J.; Greenberg, David A.			GABAergic Neuron Deficit As An Idiopathic Generalized Epilepsy Mechanism: The Role Of BRD2 Haploinsufficiency In Juvenile Myoclonic Epilepsy	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC ACID; TONIC-CLONIC SEIZURES; SUBSTANTIA-NIGRA; ABSENCE EPILEPSY; WAVE DISCHARGES; BASAL GANGLIA; SUSCEPTIBILITY GENE; SEX-DIFFERENCES; GABA RECEPTORS; RAT	Idiopathic generalized epilepsy (IGE) syndromes represent about 30% of all epilepsies. They have strong, but elusive, genetic components and sex-specific seizure expression. Multiple linkage and population association studies have connected the bromodomain-containing gene BRD2 to forms of IGE. In mice, a null mutation at the homologous Brd2 locus results in embryonic lethality while heterozygous Brd2+/- mice are viable and overtly normal. However, using the flurothyl model, we now show, that compared to the Brd2+/+ littermates, Brd2+/- males have a decreased clonic, and females a decreased tonic-clonic, seizure threshold. Additionally, long-term EEG/video recordings captured spontaneous seizures in three out of five recorded Brd2+/- female mice. Anatomical analysis of specific regions of the brain further revealed significant differences in Brd2+/- vs+/+ mice. Specifically, there were decreases in the numbers of GABAergic (parvalbuminor GAD67-immunopositive) neurons along the basal ganglia pathway, i.e., in the neocortex and striatum of Brd2+/- mice, compared to Brd2+/+ mice. There were also fewer GABAergic neurons in the substantia nigra reticulata (SNR), yet there was a minor, possibly compensatory increase in the GABA producing enzyme GAD67 in these SNR cells. Further, GAD67 expression in the superior colliculus and ventral medial thalamic nucleus, the main SNR outputs, was significantly decreased in Brd2+/- mice, further supporting GABA downregulation. Our data show that the non-channel-encoding, developmentally critical Brd2 gene is associated with i) sex-specific increases in seizure susceptibility, ii) the development of spontaneous seizures, and iii) seizure-related anatomical changes in the GABA system, supporting BRD2's involvement in human IGE.	[Velisek, Libor; Veliskova, Jana; Chachua, Tamar] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Velisek, Libor] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA; [Veliskova, Jana] New York Med Coll, Dept Obstet & Gynecol, Valhalla, NY 10595 USA; [Velisek, Libor; Veliskova, Jana; Macchiarulo, Stephania] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Shang, Enyuan; Maglakelidze, Giorgi; Greenberg, David A.] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, Div Stat Genet,Dept Biostat, New York, NY USA; [Maglakelidze, Giorgi; Greenberg, David A.] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Wolgemuth, Debra J.] Columbia Univ, Med Ctr, Dept Genet & Dev & Obstet & Gynecol, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Wolgemuth, Debra J.] Columbia Univ, Inst Human Nutr, Med Ctr, New York, NY 10032 USA; [Velisek, Libor; Veliskova, Jana; Chachua, Tamar] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY 10467 USA	New York Medical College; New York Medical College; New York Medical College; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University; Columbia University; Columbia University; Yeshiva University; Albert Einstein College of Medicine	Velisek, L (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA.	libor_velisek@nymc.edu	Velisek, Libor/AAA-1151-2020	Velisek, Libor/0000-0003-2805-349X	NIH [NS059504, NS072966, NS056093, GM081767, NS027941, NS61829, MH48858, NS070323]; March of Dimes; New York Psychiatric Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070323, R01NS061829, R01NS027941, R01NS056093, RC4NS072966, R21NS059504] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); New York Psychiatric Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH; www.nih.gov, NS059504; NS072966; NS056093; GM081767; NS027941; NS61829; MH48858; NS070323, March of Dimes; www.marchofdimes.com, New York Psychiatric Institute; www.nyspi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; ANNEGERS JF, 1994, NEUROL CLIN, V12, P15, DOI 10.1016/S0733-8619(18)30108-7; BARTOS L, 1977, Laboratory Animals (London), V11, P53, DOI 10.1258/002367777780959148; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Cavalleri GL, 2007, EPILEPSIA, V48, P706, DOI 10.1111/j.1528-1167.2007.00977.x; de Kovel CGF, 2010, EPILEPSY RES, V89, P286, DOI 10.1016/j.eplepsyres.2010.01.013; de Kovel CGF, 2007, EPILEPSIA, V48, P2191, DOI 10.1111/j.1528-1167.2007.01306.x; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; DEPAULIS A, 1988, BRAIN RES, V448, P20, DOI 10.1016/0006-8993(88)91097-9; DEPAULIS A, 1990, NEUROSCIENCE, V39, P339, DOI 10.1016/0306-4522(90)90272-6; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Deransart C, 1998, EPILEPSY RES, V32, P213, DOI 10.1016/S0920-1211(98)00053-9; Deransart C, 1996, NEUROSCIENCE, V71, P721, DOI 10.1016/0306-4522(95)00471-8; Deransart C, 1999, NEUROSCI LETT, V265, P131, DOI 10.1016/S0304-3940(99)00113-5; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DiBenedetto AJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-39; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Fong GCY, 1998, AM J HUM GENET, V63, P1117, DOI 10.1086/302066; GALE K, 1985, FED PROC, V44, P2414; GALE K, 1993, BRAIN RES, V603, P279, DOI 10.1016/0006-8993(93)91248-Q; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; Goya RL, 2010, NEUROREPORT, V21, P349, DOI 10.1097/WNR.0b013e3283377463; Greenberg DA, 2000, AM J HUM GENET, V66, P508, DOI 10.1086/302763; GREENBERG DA, 1988, GENET EPIDEMIOL, V5, P81, DOI 10.1002/gepi.1370050204; GREENBERG DA, 1992, NEUROLOGY, V42, P56; GREENBERG DA, 1995, NEUROLOGY, V45, P942, DOI 10.1212/WNL.45.5.942; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Gyuris A, 2009, BBA-GENE REGUL MECH, V1789, P413, DOI 10.1016/j.bbagrm.2009.03.005; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; Joo EY, 2006, ARCH NEUROL-CHICAGO, V63, P1282, DOI 10.1001/archneur.63.9.1282; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Lansky P, 1997, B MATH BIOL, V59, P569, DOI 10.1016/S0092-8240(96)00108-5; Layouni S, 2010, NEUROL SCI, V31, P53, DOI 10.1007/s10072-009-0190-z; LIU AW, 1995, AM J HUM GENET, V57, P368; Lorenz S, 2006, NEUROSCI LETT, V400, P135, DOI 10.1016/j.neulet.2006.02.026; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Mory SB, 2003, EPILEPSIA, V44, P1402, DOI 10.1046/j.1528-1157.2003.67702.x; O'Muircheartaigh J, 2011, NEUROLOGY, V76, P34, DOI 10.1212/WNL.0b013e318203e93d; OVTSCHAROFF W, 1992, J COMP NEUROL, V323, P299, DOI 10.1002/cne.903230212; Pal DK, 2006, BRAIN DEV-JPN, V28, P92, DOI 10.1016/j.braindev.2005.05.009; Pal DK, 2003, AM J HUM GENET, V73, P261, DOI 10.1086/377006; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Pulsipher DT, 2009, EPILEPSIA, V50, P1210, DOI 10.1111/j.1528-1167.2008.01952.x; Ramos SD, 2001, J APPL PHYSIOL, V91, P667, DOI 10.1152/jappl.2001.91.2.667; Ravizza T, 2002, NEUROSCIENCE, V115, P685, DOI 10.1016/S0306-4522(02)00491-8; REDGRAVE P, 1992, NEUROSCIENCE, V46, P379, DOI 10.1016/0306-4522(92)90059-B; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; SANDER T, 1995, ANN NEUROL, V38, P210, DOI 10.1002/ana.410380213; Sander T, 1997, NEUROLOGY, V49, P842, DOI 10.1212/WNL.49.3.842; Seeck M, 2005, EPILEPSIA, V46, P1642, DOI 10.1111/j.1528-1167.2005.00259.x; Shang E, 2011, J CELL BIOCH; Shang EY, 2009, DEV DYNAM, V238, P908, DOI 10.1002/dvdy.21911; Shebab S, 1993, NEUROSCIENCE, V65, P671; Silva J, 2010, J NEUROSCI RES, V88, P3328, DOI 10.1002/jnr.22496; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Strug LJ, 2009, EUR J HUM GENET, V17, P1171, DOI 10.1038/ejhg.2008.267; Taradach C, 1982, Arch Toxicol Suppl, V5, P184; Tauer U, 2005, ANN NEUROL, V57, P866, DOI 10.1002/ana.20500; Velisek L, 2006, MODELS OF SEIZURES AND EPILEPSY, P127, DOI 10.1016/B978-012088554-1/50013-X; Velisek L, 2006, EXP NEUROL, V201, P203, DOI 10.1016/j.expneurol.2006.04.005; Veliskova J, 2001, ANN NEUROL, V50, P596, DOI 10.1002/ana.1248; Veliskova J, 2007, J NEUROSCI, V27, P6054, DOI 10.1523/JNEUROSCI.0366-07.2007; Veliskova J, 2007, NEUROSCIENTIST, V13, P77, DOI 10.1177/1073858406295827; Weber YG, 2008, DEV MED CHILD NEUROL, V50, P648, DOI 10.1111/j.1469-8749.2008.03058.x; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101	71	54	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23656	10.1371/journal.pone.0023656	http://dx.doi.org/10.1371/journal.pone.0023656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887291	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000043
J	Basu, A; Banerjee, P; Contreras, AG; Flynn, E; Pal, S				Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro			Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; KINASE C-ZETA; PROTEIN-KINASE; POSTTRANSPLANT MALIGNANCY; CYCLOSPORINE-A; KIDNEY-TRANSPLANTATION; ORGAN-TRANSPLANTATION; MAMMALIAN TARGET; ONCOGENIC RAS; RAPAMYCIN	Malignancy is a major problem in patients treated with immunosuppressive agents. We have demonstrated that treatment with calcineurin inhibitors (CNIs) can induce the activation of proto-oncogenic Ras, and may promote a rapid progression of human renal cancer through the overexpression of vascular endothelial growth factor (VEGF). Interestingly, we found that CNI-induced VEGF overexpression and cancer cell proliferation was inhibited by rapamycin treatment, indicating potential involvement of the mammalian target of rapamycin (mTOR) pathway in this tumorigenic process. Here, we examined the role of mTOR pathway in mediating CNI- and Ras-induced overexpression of VEGF in human renal cancer cells (786-0 and Caki-1). We found that the knockdown of raptor (using siRNA) significantly decreased CNI-induced VEGF promoter activity as observed by promoter-luciferase assay, suggesting the role of mTOR complex1 (mTORC1) in CNI-induced VEGF transcription. It is known that mTOR becomes activated following phosphorylation of its negative regulator PRAS40, which is a part of mTORC1. We observed that CNI treatment and activation of H-Ras (through transfection of an active H-Ras plasmid) markedly increased the phosphorylation of PRAS40, and the transfection of cells using a dominant-negative plasmid of Ras, significantly decreased PRAS40 phosphorylation. Protein kinase C (PKC)-zeta and PKC-delta, which are critical intermediary signaling molecules for CNI-induced tumorigenic pathway, formed complex with PRAS40; and we found that the CNI treatment increased the complex formation between PRAS40 and PKC, particularly (PKC)-zeta. Inhibition of PKC activity using pharmacological inhibitor markedly decreased H-Ras-induced phosphorylation of PRAS40. The overexpression of PRAS40 in renal cancer cells significantly down-regulated CNI- and H-Ras-induced VEGF transcriptional activation. Finally, it was observed that CNI treatment increased the expression of phosho-PRAS40 in renal tumor tissues in vivo. Together, the phosphorylation of PRAS40 is critical for the activation of mTOR in CNI-induced VEGF overexpression and renal cancer progression.	[Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro] Childrens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Basu, Aninda; Banerjee, Pallavi; Contreras, Alan G.; Flynn, Evelyn; Pal, Soumitro] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Basu, A (corresponding author), Childrens Hosp, Div Nephrol, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu		CONTRERAS, AlAN/0000-0003-4960-2240	National Institutes of Health [R01 CA131145]; John-Merrill Grant ASN-AST; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John-Merrill Grant ASN-AST; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by the following: 1) National Institutes of Health Grant R01 CA131145 (to S. P.); 2) John-Merrill Grant ASN-AST (to S. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2008, CANCER RES, V68, P5689, DOI 10.1158/0008-5472.CAN-07-6603; Basu A, 2010, J BIOL CHEM, V285, P25196, DOI 10.1074/jbc.M110.119446; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bustami RT, 2004, AM J TRANSPLANT, V4, P87, DOI 10.1046/j.1600-6135.2003.00274.x; Campistol Josep M, 2010, G Ital Nefrol, V27 Suppl 50, pS81; Campistol JM, 2009, TRANSPLANTATION, V87, pS19, DOI 10.1097/TP.0b013e3181a07a57; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chen CG, 2009, J SURG RES, V153, P156, DOI 10.1016/j.jss.2008.03.017; Cho CS, 2003, CELL SIGNAL, V15, P85, DOI 10.1016/S0898-6568(02)00046-3; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; Durrbach A, 2010, NAT REV NEPHROL, V6, P160, DOI 10.1038/nrneph.2009.233; DVORAK HF, 1995, AM J PATHOL, V146, P1029; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Garcia JA, 2008, MOL CANCER THER, V7, P1347, DOI 10.1158/1535-7163.MCT-07-2408; Geissler EK, 2010, KIDNEY INT, V78, P1075, DOI 10.1038/ki.2010.324; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Han WN, 2010, J BIOL CHEM, V285, P11369, DOI 10.1074/jbc.M109.028142; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jamil B, 1999, TRANSPLANTATION, V68, P1597, DOI 10.1097/00007890-199911270-00027; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Koehl GE, 2004, TRANSPLANTATION, V77, P1319, DOI 10.1097/00007890-200405150-00002; Kumar V, 2000, EMBO J, V19, P1087, DOI 10.1093/emboj/19.5.1087; Leseux L, 2008, BLOOD, V111, P285, DOI 10.1182/blood-2007-04-085092; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200; Mireuta M, 2010, GROWTH FACTORS, V28, P243, DOI 10.3109/08977191003745472; Monaco AP, 2009, TRANSPLANTATION, V87, P157, DOI 10.1097/TP.0b013e318193886e; Morath C, 2004, J AM SOC NEPHROL, V15, P1582, DOI 10.1097/01.ASN.0000126194.77004.9B; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Pal S, 2001, J BIOL CHEM, V276, P2395, DOI 10.1074/jbc.M007818200; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Peddi VR, 2001, SEMIN DIALYSIS, V14, P218, DOI 10.1046/j.1525-139X.2001.00054.x; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Webster AC, 2007, AM J TRANSPLANT, V7, P2140, DOI 10.1111/j.1600-6143.2007.01908.x; Wimmer CD, 2007, KIDNEY INT, V71, P1271, DOI 10.1038/sj.ki.5002154; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23919	10.1371/journal.pone.0023919	http://dx.doi.org/10.1371/journal.pone.0023919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886838	Green Submitted, Green Published, gold			2022-12-25	WOS:000294253500038
J	Dang, UJ; Bauch, CT				Dang, Utkarsh J.; Bauch, Chris T.			Can Interactions between Timing of Vaccine-Altered Influenza Pandemic Waves and Seasonality in Influenza Complications Lead to More Severe Outcomes?	PLOS ONE			English	Article							UNITED-STATES; TRANSMISSION; MORTALITY; MORBIDITY; IMPACT; VIRUS; STRATEGIES; PNEUMONIA; INFECTION; RADIATION	Vaccination can delay the peak of a pandemic influenza wave by reducing the number of individuals initially susceptible to influenza infection. Emerging evidence indicates that susceptibility to severe secondary bacterial infections following a primary influenza infection may vary seasonally, with peak susceptibility occurring in winter. Taken together, these two observations suggest that vaccinating to prevent a fall pandemic wave might delay it long enough to inadvertently increase influenza infections in winter, when primary influenza infection is more likely to cause severe outcomes. This could potentially cause a net increase in severe outcomes. Most pandemic models implicitly assume that the probability of severe outcomes does not vary seasonally and hence cannot capture this effect. Here we show that the probability of intensive care unit (ICU) admission per influenza infection in the 2009 H1N1 pandemic followed a seasonal pattern. We combine this with an influenza transmission model to investigate conditions under which a vaccination program could inadvertently shift influenza susceptibility to months where the risk of ICU admission due to influenza is higher. We find that vaccination in advance of a fall pandemic wave can actually increase the number of ICU admissions in situations where antigenic drift is sufficiently rapid or where importation of a cross-reactive strain is possible. Moreover, this effect is stronger for vaccination programs that prevent more primary influenza infections. Sensitivity analysis indicates several mechanisms that may cause this effect. We also find that the predicted number of ICU admissions changes dramatically depending on whether the probability of ICU admission varies seasonally, or whether it is held constant. These results suggest that pandemic planning should explore the potential interactions between seasonally varying susceptibility to severe influenza outcomes and the timing of vaccine-altered pandemic influenza waves.	[Dang, Utkarsh J.; Bauch, Chris T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Bauch, Chris T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Guelph; Princeton University	Dang, UJ (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada.	cbauch@uoguelph.ca		Dang, Utkarsh/0000-0003-4120-2015	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; BARKER WH, 1981, AM J PUBLIC HEALTH, V71, P643, DOI 10.2105/AJPH.71.6.643; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; *CDCP, 2009, PREV PNEUM INF SEC S; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Dimitrov NB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016094; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; FEIGIN RD, 2004, TXB PEDIAT INFECTIOU, V2, pCH181; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; FISMAN DN, 2009, CANADIAN MED ASS J, V171, P181; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Handel A, 2009, EPIDEMICS-NETH, V1, P185, DOI 10.1016/j.epidem.2009.09.001; HE D, 2011, THEORETICAL ECOLOGY; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; *MATHW INC, 2007, MATHL VERS 7 5 NAT; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Neuzil KM, 1999, JAMA-J AM MED ASSOC, V281, P901, DOI 10.1001/jama.281.10.901; Nichol KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009548; *ONT PUBL HLTH AG, 2010, SER STUD PAND H1N1 I; *PUBL HLTH AG CAN, 2010, WEEKL REP 2009 2010; *PUBL HLTH AG CAN, 2010, ANN INT INFL SURV RE; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rios-Doria D, 2009, J THEOR BIOL, V261, P584, DOI 10.1016/j.jtbi.2009.08.020; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Sagripanti JL, 2007, PHOTOCHEM PHOTOBIOL, V83, P1278, DOI 10.1111/j.1751-1097.2007.00177.x; Sertsou G, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-38; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; White ANJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-196	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23580	10.1371/journal.pone.0023580	http://dx.doi.org/10.1371/journal.pone.0023580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886799	Green Submitted, Green Published, gold			2022-12-25	WOS:000294253500017
J	Henriksen, R; Groothuis, TG; Rettenbacher, S				Henriksen, Rie; Groothuis, Ton G.; Rettenbacher, Sophie			Elevated Plasma Corticosterone Decreases Yolk Testosterone and Progesterone in Chickens: Linking Maternal Stress and Hormone-Mediated Maternal Effects	PLOS ONE			English	Article							GALLUS-GALLUS-DOMESTICUS; AVIAN GRANULOSA-CELLS; OFFSPRING PHENOTYPE; STEROID-HORMONES; LAYING HENS; OVARIAN-FUNCTION; SEX-DIFFERENCES; EGG-YOLK; BIRDS; GLUCOCORTICOIDS	Despite considerable research on hormone-mediated maternal effects in birds, the underlying physiology remains poorly understood. This study investigated a potential regulation mechanism for differential accumulation of gonadal hormones in bird eggs. Across vertebrates, glucocorticoids can suppress reproduction by downregulating gonadal hormones. Using the chicken as a model species, we therefore tested whether elevated levels of plasma corticosterone in female birds influence the production of gonadal steroids by the ovarian follicles and thus the amount of reproductive hormones in the egg yolk. Adult laying hens of two different strains (ISA brown and white Leghorn) were implanted subcutaneously with corticosterone pellets that elevated plasma corticosterone concentrations over a period of nine days. Steroid hormones were subsequently quantified in plasma and yolk. Corticosterone-implanted hens of both strains had lower plasma progesterone and testosterone levels and their yolks contained less progesterone and testosterone. The treatment also reduced egg and yolk mass. Plasma estrogen concentrations decreased in white Leghorns only whereas in both strains yolk estrogens were unaffected. Our results demonstrate for the first time that maternal plasma corticosterone levels influence reproductive hormone concentrations in the yolk. Maternal corticosterone could therefore mediate environmentally induced changes in yolk gonadal hormone concentrations. In addition, stressful situations experienced by the bird mother might affect the offspring via reduced amounts of reproductive hormones present in the egg as well as available nutrients for the embryo.	[Henriksen, Rie; Groothuis, Ton G.] Univ Groningen, Inst Behav Neurosci, Groningen, Netherlands; [Henriksen, Rie; Rettenbacher, Sophie] Univ Vet Med Vienna, Vienna, Austria	University of Groningen; University of Veterinary Medicine Vienna	Henriksen, R (corresponding author), Univ Groningen, Inst Behav Neurosci, Groningen, Netherlands.	Sophie.Rettenbacher@vetmeduni.ac.at			Austrian Science Foundation (FWF) [19169]	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (FWF Proj. No. 19169 to SR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DG, 1984, J ENDOCRINOL, V100, P81, DOI 10.1677/joe.0.1000081; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bonier F, 2007, BEHAV ECOL, V18, P1045, DOI 10.1093/beheco/arm075; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Deviche PJ, 2010, GEN COMP ENDOCR, V169, P82, DOI 10.1016/j.ygcen.2010.07.009; Dong H, 2007, COMP BIOCHEM PHYS A, V147, P189, DOI 10.1016/j.cbpa.2006.12.034; Downing JA, 2008, PHYSIOL BEHAV, V95, P381, DOI 10.1016/j.physbeh.2008.07.001; DOWNING JA, 2002, RIRDC PUBLICATION, V1143; ETCHES RJ, 1984, J REPROD FERTIL, V70, P121, DOI 10.1530/jrf.0.0700121; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2003, ARDEOLA, V50, P281; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GILBERT AB, 1983, J REPROD FERTIL, V69, P221, DOI 10.1530/jrf.0.0690221; Goutte A, 2010, GEN COMP ENDOCR, V169, P108, DOI 10.1016/j.ygcen.2010.07.016; GRAU CR, 1976, POULTRY SCI, V55, P1418, DOI 10.3382/ps.0551418; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hartmann S, 1998, FOOD CHEM, V62, P7, DOI 10.1016/S0308-8146(97)00150-7; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Johnson A.L., 2002, STURKIES AVIAN PHYSL, P569; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Michael AE, 2003, REPRODUCTION, V126, P425, DOI 10.1530/rep.0.1260425; Millet S, 2006, BRIT POULTRY SCI, V47, P294, DOI 10.1080/00071660600741818; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller C, 2009, GEN COMP ENDOCR, V160, P59, DOI 10.1016/j.ygcen.2008.10.018; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Okuliarova M, 2011, AM NAT, V177, P824, DOI 10.1086/659996; Okuliarova M, 2010, GEN COMP ENDOCR, V165, P91, DOI 10.1016/j.ygcen.2009.06.007; Okuliarova M, 2009, COMP BIOCHEM PHYS A, V154, P530, DOI 10.1016/j.cbpa.2009.08.012; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 1997, Z SAUGETIERKD, V62, P192; PORTER TE, 1989, ENDOCRINOLOGY, V125, P109, DOI 10.1210/endo-125-1-109; RASBASH J, 2000, MULTILEVEL MODELS PR; Rettenbacher S, 2005, ANN NY ACAD SCI, V1046, P193, DOI 10.1196/annals.1343.016; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Rozenboim I, 2007, POULTRY SCI, V86, P1760, DOI 10.1093/ps/86.8.1760; SAKETOS M, 1993, BIOL REPROD, V49, P1270, DOI 10.1095/biolreprod49.6.1270; Salvante KG, 2003, GEN COMP ENDOCR, V130, P205, DOI 10.1016/S0016-6480(02)00637-8; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHAR B, 1967, EXPERIENTIA, V23, P716, DOI 10.1007/BF02154131; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwarzenberger F, 1996, ZOO BIOL, V15, P159, DOI 10.1002/(SICI)1098-2361(1996)15:2<159::AID-ZOO6>3.0.CO;2-A; Tetsuka M, 2007, ANIM SCI J, V78, P112, DOI 10.1111/j.1740-0929.2007.00414.x; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/revreprod/5.2.105; TILLY JL, 1991, BIOL REPROD, V44, P305, DOI 10.1095/biolreprod44.2.305; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; Wagner CK, 2008, ENDOCRINOLOGY, V149, P2743, DOI 10.1210/en.2008-0049; Warren DC, 1934, SCIENCE, V80, P461, DOI 10.1126/science.80.2081.461; WIEBE JP, 1990, J STEROID BIOCHEM, V37, P113, DOI 10.1016/0960-0760(90)90379-Y; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010	55	49	51	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23824	10.1371/journal.pone.0023824	http://dx.doi.org/10.1371/journal.pone.0023824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886826	Green Submitted, Green Published, gold			2022-12-25	WOS:000294253500031
J	Li, L; Qiao, D; Fu, XY; Lao, SH; Zhang, XL; Wu, CY				Li, Li; Qiao, Dan; Fu, Xiaoying; Lao, Suihua; Zhang, Xianlan; Wu, Changyou			Identification of M. tuberculosis-Specific Th1 Cells Expressing CD69 Generated in vivo in Pleural Fluid Cells from Patients with Tuberculous Pleurisy	PLOS ONE			English	Article							REGULATORY T-CELLS; GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; PULMONARY TUBERCULOSIS; POLYFUNCTIONAL CD4(+); ADENOSINE-DEAMINASE; IMMUNE-RESPONSE; DIAGNOSIS; DISEASE	Th1 cell-mediated immune responses at the site of active infection are important to restrict the growth of M. tuberculosis (MTB) and for the spontaneous resolution of patients with tuberculous pleurisy (TBP). In the present study, we found that without any stimulation, CD4(+) T cells in pleural fluid cells (PFCs) from patients with TBP expressed significantly higher levels of CD69 than PBMCs from patients with tuberculosis (TB) or healthy donors. CD4(+) CD69(+) T cells expressed T-bet and IL-12R beta 2. After stimulation with MTB-specific antigens, CD4(+)CD69(+) T cells expressed significantly higher levels of IFN-gamma, IL-2 and TNF-alpha than CD4(+)CD69(-) T cells, demonstrating that CD4(+)CD69(+) T cells were MTB-specific Th1 cells. In addition, CD4(+)CD69(+) T cells were mostly polyfunctional Th1 cells that simultaneously produced IFN-gamma, IL-2, TNF-alpha and displayed an effector or effector memory phenotype (CD45RA(-)CCR7(-)CD62L(-)CD27(-)). Moreover, the percentages of CD4(+)CD69(+) T cells were significantly and positively correlated with polyfunctional T cells. Interestingly, sorted CD4(+)CD69(+) but not CD4(+)CD69(-) fractions by flow cytometry produced IFN-gamma, IL-2 and TNF-alpha that were significantly regulated by CD4(+)CD25(+) Treg cells. Taken together, based on the expression of CD69, we found a direct quantitative and qualitative method to detect and evaluate the in vivo generated MTB-specific polyfunctional CD4(+) T cells in PFCs from patients with TBP. This method can be used for the potential diagnosis and enrichment or isolation of MTB-specific Th1 cells in the investigations.	[Li, Li; Qiao, Dan; Fu, Xiaoying; Wu, Changyou] Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Lao, Suihua; Zhang, Xianlan] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, L (corresponding author), Sun Yat Sen Univ, Inst Immunol, Zhongshan Sch Med, Key Lab Trop Dis Control Res,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			Fundamental Research Funds for the Central Universities [09YKPY76]; National Nature Science Foundation of China [30872300]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (No. 09YKPY76) and National Nature Science Foundation of China (No. 30872300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Avgustin B, 2005, CLIN DIAGN LAB IMMUN, V12, P101, DOI 10.1128/CDLI.12.1.101-106.2005; Baba K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002788; BARNES PF, 1993, INFECT IMMUN, V61, P3482, DOI 10.1128/IAI.61.8.3482-3489.1993; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Delgado JC, 2006, J IMMUNOL, V176, P1090, DOI 10.4049/jimmunol.176.2.1090; DEVERGNE O, 1994, J EXP MED, V179, P1689, DOI 10.1084/jem.179.5.1689; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Hoheisel G, 1998, RESP MED, V92, P14, DOI 10.1016/S0954-6111(98)90025-7; Hooper CE, 2009, CURR OPIN PULM MED, V15, P358, DOI 10.1097/MCP.0b013e32832bcc4e; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Hsieh SM, 2000, J ACQ IMMUN DEF SYND, V25, P212, DOI 10.1097/00126334-200011010-00002; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Joshi R, 2008, RESPIRATION, V76, P128, DOI 10.1159/000135933; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Li L, 2008, BLOOD, V111, P5629, DOI 10.1182/blood-2008-02-139899; Li L, 2007, TUBERCULOSIS, V87, P526, DOI 10.1016/j.tube.2007.07.004; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2010, RESPIROLOGY, V15, P451, DOI 10.1111/j.1440-1843.2010.01723.x; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Mustafa AS, 2003, SCAND J IMMUNOL, V57, P125, DOI 10.1046/j.1365-3083.2003.01204.x; Mustafa AS, 2002, MOL IMMUNOL, V39, P113, DOI 10.1016/S0161-5890(02)00048-2; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Raju B, 2001, INFECT IMMUN, V69, P4790, DOI 10.1128/IAI.69.8.4790-4798.2001; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Santucci MB, 2004, EUR RESPIR J, V24, P638, DOI 10.1183/09031936.04.000105403; Schierloh P, 2005, J IMMUNOL, V175, P6852, DOI 10.4049/jimmunol.175.10.6852; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Shams H, 2004, J IMMUNOL, V173, P1966, DOI 10.4049/jimmunol.173.3.1966; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886; Shimokata K, 1995, Kekkaku, V70, P595; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; Udwadia ZF, 2010, CURR OPIN PULM MED, V16, P399, DOI 10.1097/MCP.0b013e328339cf6e; Ulrichs T, 1998, EUR J IMMUNOL, V28, P3949, DOI 10.1002/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4; Yamada Y, 2001, RESP MED, V95, P577, DOI 10.1053/rmed.2001.1103; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013	48	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23700	10.1371/journal.pone.0023700	http://dx.doi.org/10.1371/journal.pone.0023700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887301	Green Submitted, Green Published, gold			2022-12-25	WOS:000294251800023
J	Wagar, LE; Gentleman, B; Pircher, H; McElhaney, JE; Watts, TH				Wagar, Lisa E.; Gentleman, Beth; Pircher, Hanspeter; McElhaney, Janet E.; Watts, Tania H.			Influenza-Specific T Cells from Older People Are Enriched in the Late Effector Subset and Their Presence Inversely Correlates with Vaccine Response	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; REPLICATIVE SENESCENCE; LYMPHOCYTE SUBPOPULATIONS; ANTIGEN STIMULATION; HUMAN IMMUNOLOGY; PD-1 EXPRESSION; RECEPTOR KLRG1; A VIRUS; AGE; MEMORY	T cells specific for persistent pathogens accumulate with age and express markers of immune senescence. In contrast, much less is known about the state of T cell memory for acutely infecting pathogens. Here we examined T cell responses to influenza in human peripheral blood mononuclear cells from older (>64) and younger (<40) donors using whole virus restimulation with influenza A (A/PR8/34) ex vivo. Although most donors had pre-existing influenza reactive T cells as measured by IFN gamma production, older donors had smaller populations of influenza-responsive T cells than young controls and had lost a significant proportion of their CD45RA-negative functional memory population. Despite this apparent dysfunction in a proportion of the older T cells, both old and young donors' T cells from 2008 could respond to A/California/07/2009 ex vivo. For HLA-A2+ donors, MHC tetramer staining showed that a higher proportion of influenza-specific memory CD8 T cells from the 65+ group co-express the markers killer cell lectin-like receptor G1 (KLRG1) and CD57 compared to their younger counterparts. These markers have previously been associated with a late differentiation state or immune senescence. Thus, memory CD8 T cells to an acutely infecting pathogen show signs of advanced differentiation and functional deterioration with age. There was a significant negative correlation between the frequency of KLRG1(+)CD57(+) influenza M1-specific CD8 T cells pre-vaccination and the ability to make antibodies in response to vaccination with seasonal trivalent inactivated vaccine, whereas no such trend was observed when the total CD8(+)KLRG1(+)CD57(+) population was analyzed. These results suggest that the state of the influenza-specific memory CD8 T cells may be a predictive indicator of a vaccine responsive healthy immune system in old age.	[Wagar, Lisa E.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Gentleman, Beth; McElhaney, Janet E.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Pircher, Hanspeter] Inst Med Microbiol & Hyg, Dept Immunol, Freiburg, Germany; [McElhaney, Janet E.] Univ Connecticut, Sch Med, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT USA	University of Toronto; University of British Columbia; University of Connecticut	Wagar, LE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	tania.watts@utoronto.ca		Wagar, Lisa/0000-0001-5980-3586; Tripp, Ralph/0000-0002-2924-9956	Canadian Institutes of Health Research (CIHR) [TPA-90194, MOP-74492]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by grants TPA-90194 from the Canadian Institutes of Health Research (CIHR) to T. H. W. and J.E.M. and by CIHR grant MOP-74492 to T. H. W. T. H. W. holds the Sanofi Pasteur Chair in Human Immunology at the University of Toronto. L. E. W. was funded by a CIHR studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; AZUMA M, 1993, J IMMUNOL, V150, P1147; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; *CDCP, 2010, JAMA MORBIDITY MORTA, V304, P1778; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Co MDT, 2008, VACCINE, V26, P1990, DOI 10.1016/j.vaccine.2008.02.024; Co MDT, 2009, VACCINE, V27, P319, DOI 10.1016/j.vaccine.2008.09.092; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DENIS F, 1984, J INFECT DIS, V149, P1019, DOI 10.1093/infdis/149.6.1019; Doherty PC, 2008, J CLIN INVEST, V118, P3273, DOI 10.1172/JCI37232; Duraiswamy J, 2011, J IMMUNOL, V186, P4200, DOI 10.4049/jimmunol.1001783; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Effros RB, 2004, EXP GERONTOL, V39, P517, DOI 10.1016/j.exger.2003.09.024; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamann D, 1999, INT IMMUNOL, V11, P1027, DOI 10.1093/intimm/11.7.1027; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hayday AC, 2008, NAT IMMUNOL, V9, P575, DOI 10.1038/ni0608-575; Herndler-Brandstetter D, 2006, CLIN APPL IMMUNOL RE, V6, P131; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kuijpers TW, 2003, J IMMUNOL, V170, P4342, DOI 10.4049/jimmunol.170.8.4342; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Marcolino I, 2004, EUR J IMMUNOL, V34, P2672, DOI 10.1002/eji.200425282; McElhaney JE, 2009, VACCINE, V27, P2418, DOI 10.1016/j.vaccine.2009.01.136; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Monteiro J, 1996, J IMMUNOL, V156, P3587; Moraes TJ, 2011, VACCINE, V29, P6301, DOI 10.1016/j.vaccine.2011.06.022; *NAT ADV COMM IMM, 1999, ACS22 NAT ADV COMM I; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Olsson J, 2000, MECH AGEING DEV, V121, P187; Ouyang Qin, 2003, Experimental Gerontology, V38, P911, DOI 10.1016/S0531-5565(03)00134-7; Pawelec G, 2006, REJUV RES, V9, P111, DOI 10.1089/rej.2006.9.111; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Plunkett FJ, 2007, J IMMUNOL, V178, P7710, DOI 10.4049/jimmunol.178.12.7710; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Shahid Z, 2010, VACCINE, V28, P6145, DOI 10.1016/j.vaccine.2010.07.036; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Tan LC, 1999, J IMMUNOL, V162, P1827; Tan PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008754; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; TREANOR J, 1994, J INFECT DIS, V169, P402, DOI 10.1093/infdis/169.2.402; Uhrlaub JL, 2011, J IMMUNOL, V186, P3882, DOI 10.4049/jimmunol.1002799; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8; Vescovini R, 2004, EXP GERONTOL, V39, P1233, DOI 10.1016/j.exger.2004.04.004; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Wang C, 2007, J IMMUNOL, V179, P8252, DOI 10.4049/jimmunol.179.12.8252; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhou X, 2011, VACCINE, V29, P2169, DOI 10.1016/j.vaccine.2010.12.029	79	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23698	10.1371/journal.pone.0023698	http://dx.doi.org/10.1371/journal.pone.0023698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887299	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800021
J	Yuan, ZW; Liu, DC; Zhang, LQ; Zhang, L; Chen, WJ; Yan, ZH; Zheng, YL; Zhang, HG; Yen, Y				Yuan, Zhongwei; Liu, Dengcai; Zhang, Lianquan; Zhang, Li; Chen, Wenjie; Yan, Zehong; Zheng, Youliang; Zhang, Huaigang; Yen, Yang			Mitotic Illegitimate Recombination Is a Mechanism for Novel Changes in High-Molecular-Weight Glutenin Subunits in Wheat-Rye Hybrids	PLOS ONE			English	Article							GENE-EXPRESSION; BRASSICA-NAPUS; GENOME; EVOLUTION; ALLOPOLYPLOIDIZATION; TRANSCRIPTOME; DIVERGENCE; RESISTANCE; RESPONSES; ALTERS	Wide hybrids can have novel traits or changed expression of a quantitative trait that their parents do not have. These phenomena have long been noticed, yet the mechanisms are poorly understood. High-molecular-weight glutenin subunits (HMW-GS) are seed storage proteins encoded by Glu-1 genes that only express in endosperm in wheat and its related species. Novel HMW-GS compositions have been observed in their hybrids. This research elucidated the molecular mechanisms by investigating the causative factors of novel HMW-GS changes in wheat-rye hybrids. HMW-GS compositions in the endosperm and their coding sequences in the leaves of F-1 and F-2 hybrids between wheat landrace Shinchunaga and rye landrace Qinling were investigated. Missing and/or additional novel HMW-GSs were observed in the endosperm of 0.5% of the 2078 F-1 and 22% of 36 F-2 hybrid seeds. The wildtype Glu-1Ax null allele was found to have 42 types of short repeat sequences of 3-60 bp long that appeared 2 to 100 times. It also has an in-frame stop codon in the central repetitive region. Analyzing cloned allele sequences of HMW-GS coding gene Glu-1 revealed that deletions involving the in-frame stop codon had happened, resulting in novel similar to 1.8-kb Glu-1Ax alleles in some F-1 and F-2 plants. The cloned mutant Glu-1Ax alleles were expressed in Escherichia coli, and the HMW-GSs produced matched the novel HMW-GSs found in the hybrids. The differential changes between the endosperm and the plant of the same hybrids and the data of E. coli expression of the cloned deletion alleles both suggested that mitotic illegitimate recombination between two copies of a short repeat sequence had resulted in the deletions and thus the changed HMW-GS compositions. Our experiments have provided the first direct evidence to show that mitotic illegitimate recombination is a mechanism that produces novel phenotypes in wide hybrids.	[Yuan, Zhongwei; Liu, Dengcai; Zhang, Lianquan; Zhang, Li; Chen, Wenjie; Yan, Zehong; Zheng, Youliang] Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang, Sichuan, Peoples R China; [Liu, Dengcai; Zhang, Huaigang] Chinese Acad Sci, Key Lab Adaptat & Evolut Plateau Biota, NW Inst Plateau Biol, Xining, Peoples R China; [Yen, Yang] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA	Chinese Academy of Sciences; South Dakota State University	Yuan, ZW (corresponding author), Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang, Sichuan, Peoples R China.	dcliu7@yahoo.com; yang.yen@sdstate.edu	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; Liu, Dengcai/0000-0001-5508-1125	973 Program [2009CB118300, 2010CB134402]; Chinese Academy of Sciences; National Natural Science Foundation of China [31071418, 31071420]; South Dakota Agricultural Experiment Station	973 Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); South Dakota Agricultural Experiment Station	This research was supported by the 973 Program (2009CB118300, 2010CB134402), the 100-Talent Program of the Chinese Academy of Sciences, the National Natural Science Foundation of China (31071418, 31071420), and the South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Anderson O. D., 2003, Functional & Integrative Genomics, V3, P56; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Gu YQ, 2003, GENOME, V46, P1084, DOI [10.1139/g03-071, 10.1139/G03-071]; He P, 2003, PLANT MOL BIOL, V52, P401, DOI 10.1023/A:1023965400532; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hegarty MJ, 2006, CURR BIOL, V16, P1652, DOI 10.1016/j.cub.2006.06.071; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Johnson RC, 2008, STRUCTURE, V16, P653, DOI 10.1016/j.str.2008.04.005; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Khasdan V, 2010, GENETICS, V185, P387, DOI 10.1534/genetics.110.116178; Kong XY, 2004, PLANT MOL BIOL, V54, P55, DOI 10.1023/B:PLAN.0000028768.21587.dc; LAFIANDRA D, 1993, J CEREAL SCI, V18, P197, DOI 10.1006/jcrs.1993.1046; Liu DC, 1999, EUPHYTICA, V108, P79, DOI 10.1023/A:1003691925501; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Ma XF, 2008, ANN BOT-LONDON, V101, P825, DOI 10.1093/aob/mcm331; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nakamura H, 2001, EUPHYTICA, V120, P227, DOI 10.1023/A:1017514423061; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Schranz ME, 2004, AM J BOT, V91, P174, DOI 10.3732/ajb.91.2.174; UDELL JA, 2006, CROP SCI S, V46, pS1; Wan Y, 2000, THEOR APPL GENET, V101, P879, DOI 10.1007/s001220051556; Wan Y, 2002, THEOR APPL GENET, V104, P828, DOI 10.1007/s00122-001-0793-0; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, PLANT J, V51, P631, DOI 10.1111/j.1365-313X.2007.03164.x; Xie RL, 2001, CHINESE SCI BULL, V46, P309, DOI 10.1007/BF03187192; Yan ZH, 2002, CHINESE SCI BULL, V47, P220, DOI 10.1360/02tb9053; Zhang LQ, 2007, SEX PLANT REPROD, V20, P159, DOI 10.1007/s00497-007-0052-x; Zhao JW, 2006, THEOR APPL GENET, V112, P509, DOI 10.1007/s00122-005-0154-5	39	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23511	10.1371/journal.pone.0023511	http://dx.doi.org/10.1371/journal.pone.0023511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887262	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800014
J	Mead, RJ; Bennett, EJ; Kennerley, AJ; Sharp, P; Sunyach, C; Kasher, P; Berwick, J; Pettmann, B; Battaglia, G; Azzouz, M; Grierson, A; Shaw, PJ				Mead, Richard J.; Bennett, Ellen J.; Kennerley, Aneurin J.; Sharp, Paul; Sunyach, Claire; Kasher, Paul; Berwick, Jason; Pettmann, Brigitte; Battaglia, Guiseppe; Azzouz, Mimoun; Grierson, Andrew; Shaw, Pamela J.			Optimised and Rapid Pre-clinical Screening in the SOD1(G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS)	PLOS ONE			English	Article							CU,ZN SUPEROXIDE-DISMUTASE; LINKED SOD1 MUTANTS; SPINAL-CORD; MOTOR-NEURONS; FALS MICE; AXONAL-TRANSPORT; OXIDATIVE DAMAGE; GAIT ANALYSIS; RAT MODEL; DEGENERATION	The human SOD1(G93A) transgenic mouse has been used extensively since its development in 1994 as a model for amyotrophic lateral sclerosis (ALS). In that time, a great many insights into the toxicity of mutant SOD1 have been gained using this and other mutant SOD transgenic mouse models. They all demonstrate a selective toxicity towards motor neurons and in some cases features of the pathology seen in the human disease. These models have two major drawbacks. Firstly the generation of robust preclinical data in these models has been highlighted as an area for concern. Secondly, the amount of time required for a single preclinical experiment in these models (3-4 months) is a hurdle to the development of new therapies. We have developed an inbred C57BL/6 mouse line from the original mixed background (SJLxC57BL/6) SOD1(G93A) transgenic line and show here that the disease course is remarkably consistent and much less prone to background noise, enabling reduced numbers of mice for testing of therapeutics. Secondly we have identified very early readouts showing a large decline in motor function compared to normal mice. This loss of motor function has allowed us to develop an early, sensitive and rapid screening protocol for the initial phases of denervation of muscle fibers, observed in this model. We describe multiple, quantitative readouts of motor function that can be used to interrogate this early mechanism. Such an approach will increase throughput for reduced costs, whilst reducing the severity of the experimental procedures involved.	[Mead, Richard J.; Bennett, Ellen J.; Sharp, Paul; Kasher, Paul; Azzouz, Mimoun; Grierson, Andrew; Shaw, Pamela J.] Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England; [Kennerley, Aneurin J.; Berwick, Jason] Univ Sheffield, Dept Psychol, Fac Sci, Sheffield S10 2TN, S Yorkshire, England; [Sunyach, Claire; Pettmann, Brigitte] Mediterranean Inst Neurobiol, Inserm Avenir Team, Marseille, France; [Sunyach, Claire; Pettmann, Brigitte] Aix Marseille Univ, Fac Sci, Marseille, France; [Sharp, Paul; Battaglia, Guiseppe] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Sheffield	Mead, RJ (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Dept Neurosci, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England.	Pamela.Shaw@sheffield.ac.uk	Grierson, Andy/A-5067-2009; Mead, Richard J/B-4779-2009; Battaglia, Giuseppe/I-2142-2013; Battaglia, Giuseppe/A-2253-2012; Berwick, Jason/P-6950-2017; Azzouz, Mimoun/B-3979-2009	Grierson, Andy/0000-0001-7039-6731; Mead, Richard J/0000-0002-3207-0068; Battaglia, Giuseppe/0000-0003-3349-6770; Kennerley, Aneurin James/0000-0002-7599-7461; Berwick, Jason/0000-0003-4026-0088; Kasher, Paul/0000-0002-9213-502X; Azzouz, Mimoun/0000-0001-6564-5967; Shaw, Pamela/0000-0002-8925-2567; Bennett, Ellen/0000-0002-9818-827X	Wellcome Trust; EPSRC/BBSRC [EP/G062137/1]; European Union [HEALTH-F2-2008-223388]; EPSRC [EP/G062137/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G062137/1] Funding Source: researchfish; National Centre for the Replacement [G0700628/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC/BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement	This work was funded by a program grant to Dr. Shaw from the Wellcome Trust (http://www.wellcome.ac.uk/), an NC3Rs project grant (http://www.nc3rs.org.uk/) to Dr. Grierson, Dr. Mead, Dr. Azzouz and Dr. Sharp, an EPSRC/BBSRC collaborative project grant (EP/G062137/1, http://www.epsrc.ac.uk/) to Dr. Battaglia, Dr. Mead, Dr. Azzouz and Dr. Shaw, and by the European Union under the 7th Framework Program for RTD (http://cordis.europa.eu/fp7/home_en.html) -Project MitoTarget - Grant Agreement HEALTH-F2-2008-223388 awarded to Dr. Shaw, Dr. Grierson, Dr. Sunyach and Dr. Pettmann and the Moody Trust (Dr. Kasher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; Amendola J, 2004, EUR J NEUROSCI, V20, P2822, DOI 10.1111/j.1460-9568.2004.03745.x; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bendotti C, 2001, J NEUROCHEM, V79, P737, DOI 10.1046/j.1471-4159.2001.00572.x; Bendotti C, 2001, J NEUROL SCI, V191, P25, DOI 10.1016/S0022-510X(01)00627-X; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bories C, 2007, EUR J NEUROSCI, V25, P451, DOI 10.1111/j.1460-9568.2007.05306.x; Brooks KJ, 2004, NMR BIOMED, V17, P28, DOI 10.1002/nbm.861; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Dupuis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005390; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrante RJ, 1997, ANN NEUROL, V42, P326, DOI 10.1002/ana.410420309; Festing M.F.W., 2002, DESIGN ANIMAL EXPT R; Festing MFW, 2010, METHODS MOL BIOL, V602, P1, DOI 10.1007/978-1-60761-058-8_1; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; GOODRICK CL, 1975, J GERONTOL, V30, P257, DOI 10.1093/geronj/30.3.257; Graber DJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-8; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Kennel PF, 1996, NEUROREPORT, V7, P1427, DOI 10.1097/00001756-199605310-00021; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim K, 2006, EUR J PHARMACOL, V542, P100, DOI 10.1016/j.ejphar.2006.05.025; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Kong JM, 1998, J NEUROSCI, V18, P3241; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Miana-Mena FJ, 2005, AMYOTROPH LATERAL SC, V6, P55, DOI 10.1080/14660820510026162; Morrison BM, 1996, J COMP NEUROL, V373, P619, DOI 10.1002/(SICI)1096-9861(19960930)373:4<619::AID-CNE9>3.0.CO;2-4; Mourelatos Z, 1996, P NATL ACAD SCI USA, V93, P5472, DOI 10.1073/pnas.93.11.5472; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Reinholz MM, 1999, EXP NEUROL, V159, P204, DOI 10.1006/exnr.1999.7142; Russell WMS., 1959, MED J AUSTRALIA; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Taft RA, 2006, TRENDS GENET, V22, P649, DOI 10.1016/j.tig.2006.09.010; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; van Zundert B, 2008, J NEUROSCI, V28, P10864, DOI 10.1523/JNEUROSCI.1340-08.2008; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	53	58	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23244	10.1371/journal.pone.0023244	http://dx.doi.org/10.1371/journal.pone.0023244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876739	Green Published, Green Accepted, gold			2022-12-25	WOS:000294126900011
J	Storoni, M; Petzold, A; Plant, GT				Storoni, Mithu; Petzold, Axel; Plant, Gordon T.			The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis	PLOS ONE			English	Article							ASTROCYTIC DAMAGE; NEUROPATHY; CRITERIA; NMO	Background: Glial fibrillary acidic protein (GFAP) is a specific intermediate filament of the cytoskeleton of the astrocyte and may be used as a specific marker for astrocytic damage. It is detectable in the cerebrospinal fluid following a relapse caused by Multiple Sclerosis (MS) and Neuromyelitis Optica (NMO) spectrum disease. Higher levels are found following an NMO-related relapse. It is not known if GFAP is also detectable in the serum following such relapses. In particular, it is not known if lesions limited to the optic nerve release GFAP in sufficient quantities to be detectable within the serum. The aim of this study was to ascertain the extent to which serum GFAP levels can distinguish between an episode of optic neuritis (ON) related to NMO spectrum disease and ON from other causes. Methodology/Principal Findings: Out of 150 patients consecutively presenting to our eye hospital over the period March 2009 until July 2010, we were able to collect a serum sample from 12 patients who had presented with MS-related ON and from 10 patients who had presented with NMO spectrum disease-related ON. We also identified 8 patients with recurrent isolated ON and 8 patients with a corticosteroid-dependent optic neuropathy in the absence of any identified aetiology. GFAP was detectable in the serum of all but three patients (two patients with MS-related ON and one with recurrent optic neuritis). The median serum GFAP level in the patient group with NMO spectrum disease was 4.63 pg/mL whereas in all other cases combined together, this was 2.14 pg/mL. The difference was statistically significant (P = 0.01). A similar statistically significant difference was found when cases with pathology limited to the optic nerve were compared (P = 0.03). Conclusions: Glial pathology in NMO related optic neuritis is reflected in elevated serum GFAP levels independently of whether or not there is extra-optic nerve disease.	[Storoni, Mithu; Petzold, Axel; Plant, Gordon T.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Storoni, Mithu; Plant, Gordon T.] Moorfields Eye Hosp, London, England; [Petzold, Axel] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Storoni, M (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	m.storoni@doctors.net.uk	Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749	UCLH/UCL Comprehensive Biomedical Research Centre; Fight for Sight; Stichting MS Research, The Netherlands [09-687 MS]	UCLH/UCL Comprehensive Biomedical Research Centre; Fight for Sight; Stichting MS Research, The Netherlands(Netherlands Government)	This research reported in this article is supported by the UCLH/UCL Comprehensive Biomedical Research Centre. Mithu Storoni was supported by a Fight for Sight Clinical Research Fellowship Grant. Axel Petzold received funding from Stichting MS Research, The Netherlands (grant 09-687 MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt C, 2008, J FR OPHTALMOL, V31, P363, DOI 10.1016/S0181-5512(08)71430-X; AXELSSON M, 2011, J NEUROL        0101; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck RW, 2008, ARCH OPHTHALMOL-CHIC, V126, P994, DOI 10.1001/archopht.126.7.994; Burman J, 2011, ACTA NEUROL SCAND, V123, P207, DOI 10.1111/j.1600-0404.2010.01388.x; FUJIHARA K, 2011, J NEUROL SCI    0309; Kidd D, 2003, BRAIN, V126, P276, DOI 10.1093/brain/awg045; KUPERSMITH MJ, 1988, J NEUROL NEUROSUR PS, V51, P1381, DOI 10.1136/jnnp.51.11.1381; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Misu T, 2009, J NEUROL NEUROSUR PS, V80, P575, DOI 10.1136/jnnp.2008.150698; Nakamura M, 2010, GRAEF ARCH CLIN EXP, V248, P1777, DOI 10.1007/s00417-010-1344-7; Petzold A, 2004, J NEUROL NEUROSUR PS, V75, P1178, DOI 10.1136/jnnp.2003.017236; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	20	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23489	10.1371/journal.pone.0023489	http://dx.doi.org/10.1371/journal.pone.0023489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876753	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900025
J	Lopez-Vales, R; Ghasemlou, N; Redensek, A; Kerr, BJ; Barbayianni, E; Antonopoulou, G; Baskakis, C; Rathore, KI; Constantinou-Kokotou, V; Stephens, D; Shimizu, T; Dennis, EA; Kokotos, G; David, S				Lopez-Vales, Ruben; Ghasemlou, Nader; Redensek, Adriana; Kerr, Bradley J.; Barbayianni, Efrosini; Antonopoulou, Georgia; Baskakis, Constantinos; Rathore, Khizr I.; Constantinou-Kokotou, Violetta; Stephens, Daren; Shimizu, Takao; Dennis, Edward A.; Kokotos, George; David, Samuel			Phospholipase A(2) superfamily members play divergent roles after spinal cord injury	FASEB JOURNAL			English	Article						CNS injury; secondary damage; lipid metabolismw; prostaglandin receptors	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GROUP-IVA; ADULT-MOUSE; 2-OXOAMIDE INHIBITORS; REGULATORY FUNCTIONS; CONTUSION INJURY; MICE DEFICIENT; IN-VIVO; LYSOPHOSPHATIDYLCHOLINE; RECOVERY	Spinal cord injury (SCI) results in permanent loss of motor functions. A significant aspect of the tissue damage and functional loss may be preventable as it occurs, secondary to the trauma. We show that the phospholipase A(2) (PLA(2)) superfamily plays important roles in SCI. PLA(2) enzymes hydrolyze membrane glycerophospholipids to yield a free fatty acid and lysophospholipid. Some free fatty acids (arachidonic acid) give rise to eicosanoids that promote inflammation, while some lysophospholipids (lysophosphatidylcholine) cause demyelination. We show in a mouse model of SCI that two cytosolic forms [calcium-dependent PLA(2) group IVA (cPLA(2) GIVA) and calcium-independent PLA(2) group VIA (iPLA(2) GVIA)], and a secreted form [secreted PLA(2) group IIA (sPLA(2) GIIA)] are up-regulated. Using selective inhibitors and null mice, we show that these PLA(2)s play differing roles. cPLA(2) GIVA mediates protection, whereas sPLA(2) GIIA and, to a lesser extent, iPLA(2) GVIA are detrimental. Furthermore, completely blocking all three PLA(2)s worsens outcome, while the most beneficial effects are seen by partial inhibition of all three. The partial inhibitor enhances expression of cPLA(2) and mediates its beneficial effects via the prostaglandin EP1 receptor. These findings indicate that drugs that inhibit detrimental forms of PLA(2) (sPLA(2) and iPLA(2)) and up-regulate the protective form (cPLA(2)) may be useful for the treatment of SCI.-Lopez-Vales, R., Ghasemlou, N., Redensek, A., Kerr, B. J., Barbayianni, E., Antonopoulou, G., Baskakis, C., Rathore, K. I., Constantinou-Kokotou, V., Stephens, D., Shimizu, T., Dennis, E. A., Kokotos, G., David, S. Phospholipase A2 superfamily members play divergent roles after spinal cord injury. FASEB J. 25, 4240-4252 (2011). www.fasebj.org	[Lopez-Vales, Ruben; Ghasemlou, Nader; Redensek, Adriana; Kerr, Bradley J.; Rathore, Khizr I.; David, Samuel] McGill Univ, Ctr Hlth, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada; [Lopez-Vales, Ruben] Univ Autonoma Barcelona, Ctr Inves Biomed Red Enfermedades Neurodegenerat, Inst Neurociencies, Dept Biol Cellular Fisiol & Immunol, Bellaterra, Spain; [Barbayianni, Efrosini; Antonopoulou, Georgia; Baskakis, Constantinos; Kokotos, George] Univ Athens, Dept Chem, GR-10680 Athens, Greece; [Constantinou-Kokotou, Violetta] Agr Univ Athens, Chem Labs, Athens, Greece; [Stephens, Daren; Dennis, Edward A.] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Shimizu, Takao] Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Tokyo 113, Japan	McGill University; Autonomous University of Barcelona; National & Kapodistrian University of Athens; Agricultural University of Athens; University of California System; University of California San Diego; University of Tokyo	David, S (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Ctr Res Neurosci, Livingston Hall,Rm L7-210,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	sam.david@mcgill.ca	Dennis, Edward A./M-5554-2019; Baskakis, Constantinos/F-3350-2011; Lopez-Vales, Ruben/E-2150-2011; Ghasemlou, Nader/AAB-5673-2022; Shimizu, Takao/AAV-7052-2021	Dennis, Edward A./0000-0003-3738-3140; Lopez-Vales, Ruben/0000-0001-7615-9550; Ghasemlou, Nader/0000-0002-1696-7342; 	Canadian Institutes of Health Research (CIHR); Wings for Life (Austria); European Social Fund and National Resources (EPEAEK); U.S. National Institutes of Health [RO1 GM20508, R01 GM64611]; CIHR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM064611] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Wings for Life (Austria); European Social Fund and National Resources (EPEAEK); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Hiba Kazak and Eva Santos-Nogueira for technical assistance and Margaret Attiwell for help with preparing the illustrations. This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Wings for Life (Austria) to S.D.; from the European Social Fund and National Resources (EPEAEK program) to G.K.; and from the U.S. National Institutes of Health (RO1 GM20508 and R01 GM64611) to E.A.D. R.L.V. was the recipient of a CIHR postdoctoral fellowship.	Antonopoulou G, 2008, BIOORGAN MED CHEM, V16, P10257, DOI 10.1016/j.bmc.2008.10.046; Arai K, 2001, EUR J NEUROSCI, V13, P2319, DOI 10.1046/j.0953-816x.2001.01623.x; Baskakis C, 2008, J MED CHEM, V51, P8027, DOI 10.1021/jm800649q; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Casas J, 2006, J BIOL CHEM, V281, P6106, DOI 10.1074/jbc.M505230200; Forlenza OV, 2007, PROSTAG LEUKOTR ESS, V76, P47, DOI 10.1016/j.plefa.2006.10.002; Genovese T, 2005, J NEUROIMMUNOL, V166, P55, DOI 10.1016/j.jneuroim.2005.05.009; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Ghomashchi F, 1999, BBA-BIOMEMBRANES, V1420, P45, DOI 10.1016/S0005-2736(99)00056-5; Hains BC, 2001, J NEUROTRAUM, V18, P409, DOI 10.1089/089771501750170994; HALL SM, 1971, J CELL SCI, V9, P769; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Huang WL, 2009, J NEUROTRAUM, V26, P1429, DOI [10.1089/neu.2008.0835, 10.1089/neu.2008-0835]; Ikeda-Matsuo Y, 2006, P NATL ACAD SCI USA, V103, P11790, DOI 10.1073/pnas.0604400103; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kalyvas A, 2009, BRAIN, V132, P1221, DOI 10.1093/brain/awp002; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kokotos G, 2004, J MED CHEM, V47, P3615, DOI 10.1021/jm030485c; Kokotos G, 2002, J MED CHEM, V45, P2891, DOI 10.1021/jm025538p; Kwon BK, 2005, SPINE, V30, pS3, DOI 10.1097/01.brs.0000175186.17923.87; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Lopez-Vales R, 2006, SPINE, V31, P1100; Lopez-Vales R, 2008, BRAIN, V131, P2620, DOI 10.1093/brain/awn188; Marusic S, 2005, J EXP MED, V202, P841, DOI 10.1084/jem.20050665; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Offer S, 2005, AM J PHYSIOL-LUNG C, V288, pL523, DOI 10.1152/ajplung.00199.2004; Oikawa Y, 2005, FEBS LETT, V579, P3975, DOI 10.1016/j.febslet.2005.06.024; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Rocha PN, 2003, SPRINGER SEMIN IMMUN, V25, P215, DOI 10.1007/s00281-003-0132-4; RYBORG AK, 1994, ARCH DERMATOL RES, V286, P462, DOI 10.1007/BF00371572; Ryborg AK, 2000, ACTA DERM-VENEREOL, V80, P242; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Six DA, 2007, J MED CHEM, V50, P4222, DOI 10.1021/jm0613673; Stephens D, 2006, J MED CHEM, V49, P2821, DOI 10.1021/jm050993h; Tabuchi S, 2003, ACT NEUR S, V86, P169; Titsworth WL, 2007, EXP NEUROL, V207, P150, DOI 10.1016/j.expneurol.2007.06.010; Titsworth WL, 2009, GLIA, V57, P1521, DOI 10.1002/glia.20867; Trigueros SDA, 2003, MOL CELL NEUROSCI, V24, P753, DOI 10.1016/S1044-7431(03)00241-0; Yaksh TL, 2006, J PHARMACOL EXP THER, V316, P466, DOI 10.1124/jpet.105.091686	47	41	44	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4240	4252		10.1096/fj.11-183186	http://dx.doi.org/10.1096/fj.11-183186			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21868473	Green Published, Green Submitted			2022-12-25	WOS:000298138100017
J	Zhu, N; Feng, XC; He, CY; Gao, HW; Yang, LF; Ma, QJ; Guo, L; Qiao, Y; Yang, H; Ma, TH				Zhu, Na; Feng, Xuechao; He, Chengyan; Gao, Hongwen; Yang, Longfei; Ma, Qingjie; Guo, Lei; Qiao, Ying; Yang, Hong; Ma, Tonghui			Defective macrophage function in aquaporin-3 deficiency	FASEB JOURNAL			English	Article						aquaglyceroporin; water transport; phagocytosis; migration; innate immunity	WATER PERMEABILITY; DENDRITIC CELLS; GENE DISRUPTION; PHAGOCYTIC CUP; GLYCEROL; MICE; MIGRATION; CHANNELS; AQUAGLYCEROPORINS; INVOLVEMENT	Macrophages play an essential role in innate immunity. We found that mouse resident peritoneal macrophages (mRPMs) express the aquaglyceroporin aquaporin-3 (AQP3) in a plasma membrane pattern. AQP3-deficient (AQP3(-/-)) mice showed significantly greater mortality than wild-type (AQP3(+/+)) mice in a model of bacterial peritonitis. To establish the cellular mechanism of the peritonitis phenotype, measurements were made of mRPM phagocytosis, migration, and water/glycerol permeability. We found significantly impaired engulfment of Escherichia coli and chicken erythrocytes in AQP3(-/-) vs. AQP3(+/+) mRPMs, as well as impaired migration of AQP3(-/-) mRPMs in response to a chemotactic stimulus. In AQP3(+/+) mRPMs, AQP3 was polarized to pseudopodia at the leading edge during migration and around the phagocytic cup during engulfment. Water and glycerol permeabilities in mRPMs from AQP3(-/-) mice were reduced compared to mRPMs from AQP3(+/+) mice. Cellular glycerol and ATP content were remarkably lower in AQP3(-/-) vs. AQP3(+/+) mRPMs, and glycerol supplementation partially rescued the reduced ATP content and impaired function of AQP3(-/-) mRPMs. These data implicate AQP3 as a novel determinant in macrophage immune function by a cellular mechanism involving facilitated water and glycerol transport, and consequent phagocytic and migration activity. This is the first study demonstrating involvement of an aquaporin in innate immunity. Our results suggest AQP3 as a novel therapeutic target in modulating the immune response in various infectious and inflammatory conditions.-Zhu, N., Feng, X., He, C., Gao, H., Yang, L., Ma, Q., Guo, L., Qiao, Y., Yang, Y., Ma, T. Defective macrophage function in aquaporin-3 deficiency. FASEB J. 25, 4233-4239 (2011). www.fasebj.org	[Zhu, Na; Feng, Xuechao; Gao, Hongwen; Yang, Longfei; Guo, Lei; Qiao, Ying; Yang, Hong; Ma, Tonghui] Jilin Univ, Bethune Hosp 2, Cent Res Lab, Changchun 130041, Peoples R China; [He, Chengyan; Ma, Qingjie] Jilin Univ, China Japan Union Hosp, Changchun 130041, Peoples R China; [Zhu, Na] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Biotech Ctr Viral Dis Emergency, Beijing, Peoples R China; [Yang, Hong] Liaoning Normal Univ, Sch Life Sci, Dalian, Peoples R China	Jilin University; Jilin University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Liaoning Normal University	Ma, TH (corresponding author), Jilin Univ, Bethune Hosp 2, Cent Res Lab, Changchun 130041, Peoples R China.	math108@gmail.com	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670; Ma, Tonghui/0000-0001-9338-1030; feng, xuechao/0000-0003-2444-3757	National Natural Science Fund for Distinguished Young Scholars [30325011]; National Natural Science Fund [30670477, 30770493]; National Basic Research Program of China (973) [2009CB521908]	National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China)	The authors are grateful to Prof. Alan Verkman (University of California, San Francisco, CA, USA) for critical reading of the manuscript and helpful suggestions. The authors thank Mr. Qingyan Li and Ms. Lianhui Dou for mouse breeding. This work was supported by the National Natural Science Fund for Distinguished Young Scholars (grant 30325011), the National Natural Science Fund (grants 30670477 and 30770493), and the National Basic Research Program of China (973; grant 2009CB521908). The authors paid to use the animal facility of Northeast Normal University (NENU; Changchun, China) for breeding and maintenance of the transgenic mice and performing the animal procedures used in this study. The authors and grant support in this project have no other relations with NENU.	BABA H, 1995, NUTRITION, V11, P149; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Chen ZH, 2011, RESP PHYSIOL NEUROBI, V176, P110, DOI 10.1016/j.resp.2011.02.001; Chi Y, 2011, AGING CELL, V10, P368, DOI 10.1111/j.1474-9726.2011.00677.x; Clarke M, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-154; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Kida H, 2005, J MEMBRANE BIOL, V208, P55, DOI 10.1007/s00232-005-0819-7; Lee WL, 2007, MOL BIOL CELL, V18, P2883, DOI 10.1091/mbc.E06-05-0450; Li YH, 2009, INT J BIOCHEM CELL B, V41, P2466, DOI 10.1016/j.biocel.2009.07.017; Lignot JH, 2002, J EXP BIOL, V205, P2653; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Liu YJ, 2009, BIOL CELL, V101, P133, DOI 10.1042/BC20080083; Loitto VM, 2009, CELL MOTIL CYTOSKEL, V66, P237, DOI 10.1002/cm.20357; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Maeda N, 2008, NAT CLIN PRACT ENDOC, V4, P627, DOI 10.1038/ncpendmet0980; Maeda Norikazu, 2009, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-540-79885-9_12; Mao JW, 2005, CELL RES, V15, P371, DOI 10.1038/sj.cr.7290304; Maree AFM, 2005, J THEOR BIOL, V233, P533, DOI 10.1016/j.jtbi.2004.10.030; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; PILKIS SJ, 1976, J BIOL CHEM, V251, P7841; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Tollis S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-149; Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690; Wang GF, 2008, CLIN EXP IMMUNOL, V153, P410, DOI 10.1111/j.1365-2249.2008.03702.x; Yeung CH, 2009, BIOL REPROD, V80, P350, DOI 10.1095/biolreprod.108.071928; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	42	44	47	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4233	4239		10.1096/fj.11-182808	http://dx.doi.org/10.1096/fj.11-182808			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21865318				2022-12-25	WOS:000298138100016
J	Sanford, MR; Tomberlin, JK				Sanford, Michelle R.; Tomberlin, Jeffery K.			Conditioning Individual Mosquitoes to an Odor: Sex, Source, and Time	PLOS ONE			English	Article							HUMAN SWEAT COMPONENTS; MICROPLITIS-CROCEIPES; CONSOLIDATED MEMORY; DIPTERA; RESPONSES; BEHAVIOR; VECTORS; DISCRIMINATION; CULICIDAE; EVOLUTION	Olfactory conditioning of mosquitoes may have important implications for vector-pathogen-host dynamics. If mosquitoes learn about specific host attributes associated with pathogen infection, it may help to explain the heterogeneity of biting and disease patterns observed in the field. Sugar-feeding is a requirement for survival in both male and female mosquitoes. It provides a starting point for learning research in mosquitoes that avoids the confounding factors associated with the observer being a potential blood-host and has the capability to address certain areas of close-range mosquito learning behavior that have not previously been described. This study was designed to investigate the ability of the southern house mosquito, Culex quinquefasciatus Say to associate odor with a sugar-meal with emphasis on important experimental considerations of mosquito age (1.2 d old and 3-5 d old), sex (male and female), source (laboratory and wild), and the time between conditioning and testing (<5 min, 1 hr, 2.5 hr, 5 hr, 10 hr, and 24 hr). Mosquitoes were individually conditioned to an odor across these different experimental conditions. Details of the conditioning protocol are presented as well as the use of binary logistic regression to analyze the complex dataset generated from this experimental design. The results suggest that each of the experimental factors may be important in different ways. Both the source of the mosquitoes and sex of the mosquitoes had significant effects on conditioned responses. The largest effect on conditioning was observed in the lack of positive response following conditioning for females aged 3-5 d derived from a long established colony. Overall, this study provides a method for conditioning experiments involving individual mosquitoes at close range and provides for future discussion of the relevance and broader questions that can be asked of olfactory conditioning in mosquitoes.	[Sanford, Michelle R.; Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Sanford, MR (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	uranotaenia@gmail.com	Sanford, Michelle/C-9575-2011	Sanford, Michelle/0000-0001-6212-4023	Department of Entomology, Texas AM University; Texas A&M University Agrilife Research; Department of Parasitology at Chiang Mai University, Chiang Mai, Thailand	Department of Entomology, Texas AM University; Texas A&M University Agrilife Research; Department of Parasitology at Chiang Mai University, Chiang Mai, Thailand	The Department of Entomology, Texas A&M University and Texas A&M University Agrilife Research contributed financial support to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge Jimmy Olson of the Department of Entomology, Texas A&M University for advice and useful suggestions. Also to acknowledge Thoris Greene and Glen Rains of the Department of Biological and Agricultural Engineering, University of Georgia, Tifton Campus, GA, USA for their technical assistance. Videos S6 and S7 were obtained while MRS was supported by a US Student Fulbright Fellowship to Thailand in the Department of Parasitology at Chiang Mai University, Chiang Mai, Thailand and the authors wish to acknowledge the assistance of Pradya Somboon, the US State Department and Fulbright Thailand. The authors also acknowledge the comments of two anonymous reviewers, which greatly improved the manuscript. This work was completed in partial fulfillment of a doctoral degree to MRS.	Alonso WJ, 2006, MED VET ENTOMOL, V20, P157, DOI 10.1111/j.1365-2915.2006.00623.x; Alonso WJ, 2003, MEM I OSWALDO CRUZ, V98, P665, DOI 10.1590/S0074-02762003000500014; [Anonymous], 1989, JMP VERS 7; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BOWEN MF, 1992, J INSECT PHYSIOL, V38, P759, DOI 10.1016/0022-1910(92)90028-C; CARDE RT, 2007, ODOUR PLUMES ODOUR M, P54; CHARLWOOD JD, 1988, MED VET ENTOMOL, V2, P101, DOI 10.1111/j.1365-2915.1988.tb00059.x; CHRISTENSEN TA, 1989, CHEM SENSES, V14, P463, DOI 10.1093/chemse/14.3.463; Coates CJ, 2000, NATURE, V405, P900, DOI 10.1038/35016192; Daly KC, 2000, J EXP BIOL, V203, P2025; DeMaris A, 1995, J MARRIAGE FAM, V57, P956, DOI 10.2307/353415; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; FRIEND WG, 1989, PHYSIOL ENTOMOL, V14, P137, DOI 10.1111/j.1365-3032.1989.tb00945.x; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Gould James L., 1993, P18; HAEGER J. S., 1955, MOSQUITO NEWS, V15, P21; Hartz S.M., 2001, ANIM COGN, V3, P185, DOI [10.1007/s100710000075, DOI 10.1007/S100710000075]; HII JLK, 1991, J MED ENTOMOL, V28, P675, DOI 10.1093/jmedent/28.5.675; Jhumur US, 2006, J MED ENTOMOL, V43, P1164, DOI 10.1603/0022-2585(2006)43[1164:NACROC]2.0.CO;2; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111; LEWIS WJ, 1988, NATURE, V331, P257, DOI 10.1038/331257a0; LUDLAM KW, 1970, J AM VET MED ASSOC, V157, P1354; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; McCall PJ, 2001, T ROY SOC TROP MED H, V95, P587, DOI 10.1016/S0035-9203(01)90087-2; McCall PJ, 2002, TRENDS PARASITOL, V18, P429, DOI 10.1016/S1471-4922(02)02370-X; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Meiners T, 2002, CHEM SENSES, V27, P811, DOI 10.1093/chemse/27.9.811; Meller VH, 1996, INSECT BIOCHEM MOLEC, V26, P327, DOI 10.1016/0965-1748(95)00100-X; Mery F, 2002, P NATL ACAD SCI USA, V99, P14274, DOI 10.1073/pnas.222371199; Mery F, 2007, EXP GERONTOL, V42, P99, DOI 10.1016/j.exger.2006.06.004; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Monath TP, 1988, ARBOVIRUSES EPIDEMIO; Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; Mwandawiro C, 2000, T ROY SOC TROP MED H, V94, P238, DOI 10.1016/S0035-9203(00)90303-1; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Papaj DR, 2007, P NATL ACAD SCI USA, V104, P13539, DOI 10.1073/pnas.0706165104; PHELAN PL, 1987, SCIENCE, V235, P205, DOI 10.1126/science.235.4785.205; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; Rains GC, 2006, BIOTECHNOL PROGR, V22, P2, DOI 10.1021/bp050164p; Reisen W.K., 1990, P254; REITER P, 1986, J AM MOSQUITO CONTR, V2, P219; RIBBANDS CR, 1949, B ENTOMOL RES, V40, P227, DOI 10.1017/S0007485300024524; SANFORD MR, 2010, ASS LEARNING CAPABIL; Schlein Y, 2008, J MED ENTOMOL, V45, P384, DOI 10.1603/0022-2585(2008)45[384:AATMCU]2.0.CO;2; SKINNER WA, 1968, EXPERIENTIA, V24, P679, DOI 10.1007/BF02138308; SKINNER WA, 1965, NATURE, V207, P661, DOI 10.1038/207661a0; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SPATZ HC, 1974, NATURE, V248, P359, DOI 10.1038/248359a0; *SPSS I, 2007, SPSS GRAD PACK 16 0; Stephens David W., 1993, P195; Takasu K, 1996, J INSECT BEHAV, V9, P265, DOI 10.1007/BF02213870; Tamura T, 2003, NEURON, V40, P1003, DOI 10.1016/S0896-6273(03)00732-3; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Tertuliano M, 2004, ENTOMOL EXP APPL, V110, P165, DOI 10.1111/j.0013-8703.2004.00132.x; Tomberlin JK, 2008, ENTOMOL EXP APPL, V128, P249, DOI 10.1111/j.1570-7458.2008.00743.x; Tomberlin JK, 2006, NATURWISSENSCHAFTEN, V93, P551, DOI 10.1007/s00114-006-0143-9; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; TULLY T, 1984, BEHAV GENET, V14, P527, DOI 10.1007/BF01065446; Turlings Ted C. J., 1993, P51; Vet Louise E.M., 1995, P65; Wackers F, 2006, ANIM BIOL, V56, P193, DOI 10.1163/157075606777304230; Wackers FL, 2002, ENTOMOL EXP APPL, V103, P135, DOI 10.1023/A:1020330021587; WHITE GB, 1989, LYMPHATIC FILARIASIS, P23; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; YUVAL B, 1992, B SOC VECTOR ECOL, V12, P150	72	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24218	10.1371/journal.pone.0024218	http://dx.doi.org/10.1371/journal.pone.0024218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887384	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298800037
J	Smith, DR; Burki, F; Yamada, T; Grimwood, J; Grigoriev, IV; Van Etten, JL; Keeling, PJ				Smith, David Roy; Burki, Fabien; Yamada, Takashi; Grimwood, Jane; Grigoriev, Igor V.; Van Etten, James L.; Keeling, Patrick J.			The GC-Rich Mitochondrial and Plastid Genomes of the Green Alga Coccomyxa Give Insight into the Evolution of Organelle DNA Nucleotide Landscape	PLOS ONE			English	Article							BIASED GENE CONVERSION; CHLOROPLAST GENOME; PEDINOMONAS-MINOR; COMPLETE SEQUENCE; CHLOROPHYTA; ULVOPHYCEAE; TREBOUXIOPHYCEAE; HELICOSPORIDIUM; RECOMBINATION; CHROMOSOMES	Most of the available mitochondrial and plastid genome sequences are biased towards adenine and thymine (AT) over guanine and cytosine (GC). Examples of GC-rich organelle DNAs are limited to a small but eclectic list of species, including certain green algae. Here, to gain insight in the evolution of organelle nucleotide landscape, we present the GC-rich mitochondrial and plastid DNAs from the trebouxiophyte green alga Coccomyxa sp. C-169. We compare these sequences with other GC-rich organelle DNAs and argue that the forces biasing them towards G and C are nonadaptive and linked to the metabolic and/or life history features of this species. The Coccomyxa organelle genomes are also used for phylogenetic analyses, which highlight the complexities in trying to resolve the interrelationships among the core chlorophyte green algae, but ultimately favour a sister relationship between the Ulvophyceae and Chlorophyceae, with the Trebouxiophyceae branching at the base of the chlorophyte crown.	[Smith, David Roy; Burki, Fabien; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada; [Yamada, Takashi] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 724, Japan; [Grimwood, Jane] HudsonAlpha Genome Sequencing Ctr, HudsonAlpha JGI, Huntsville, AL USA; [Grigoriev, Igor V.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Hiroshima University; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Smith, DR (corresponding author), Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada.	smithdr@dal.ca	Burki, Fabien/F-4818-2010; Grimwood, Jane/ABD-5737-2021; Smith, David Roy/AAR-1529-2020; Smith, David/L-7910-2015	Smith, David Roy/0000-0001-9560-5210; Smith, David/0000-0001-9560-5210; Burki, Fabien/0000-0002-8248-8462; Grigoriev, Igor/0000-0002-3136-8903; Keeling, Patrick/0000-0002-7644-0745	Natural Sciences and Engineering Research Council (NSERC) of Canada; Swiss National Science Foundation; Tula Foundation; National Center for Research Resources [P20-RR15635]; NSERC [227301]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Grants-in-Aid for Scientific Research [23657039] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Tula Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	DRS is supported by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council (NSERC) of Canada. FB is supported by a prospective researcher postdoctoral fellowship from the Swiss National Science Foundation, and by a grant to the Centre for Microbial Diversity and Evolution from the Tula Foundation. JLVE was partially supported by grant P20-RR15635 from the COBRE program of the National Center for Research Resources (no additional external funding received for this study). PJK is funded by a grant from NSERC (227301). PJK is a Fellow of the Canadian Institute for Advanced Research and a Senior Scholar of the Michael Smith Foundation for Health Research. The work conducted by the DOE JGI is supported by the Office of Science of the U.S. Department of Energy under Contract Number DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendich AJ, 2004, PLANT CELL, V16, P1661, DOI 10.1105/tpc.160771; Bendich AJ, 2007, BIOESSAYS, V29, P474, DOI 10.1002/bies.20576; Borza T, 2009, J PHYCOL, V45, P1323, DOI 10.1111/j.1529-8817.2009.00753.x; Burger G, 2003, IUBMB LIFE, V55, P205, DOI 10.1080/1521654031000137380; Carrie C, 2009, FEBS J, V276, P1187, DOI 10.1111/j.1742-4658.2009.06876.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; de Cambiaire JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-213; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; De Wever A, 2009, P R SOC B, V276, P3591, DOI 10.1098/rspb.2009.0994; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Fricova D, 2010, MICROBIOL-SGM, V156, P2153, DOI 10.1099/mic.0.038646-0; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; HOLM-HANSEN O., 1964, PHYCOLOGIA, V4, P43, DOI DOI 10.2216/I0031-8884-4-1-43.1; Kang D, 2002, CURR GENET, V41, P311, DOI 10.1007/s00294-002-0312-0; Karsten U, 2005, J PHYCOL, V41, P557, DOI 10.1111/j.1529-8817.2005.00081.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kroymann J, 1998, J MOL EVOL, V47, P431, DOI 10.1007/PL00006400; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Kusumi J, 2005, J MOL EVOL, V60, P417, DOI 10.1007/s00239-004-0086-8; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lockhorst GM, 1994, CRYPTOGAMIC BOT, V4, P394; Lu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014663; Lynch, 2007, ORIGINS GENOME ARCHI; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Mattox K.R., 1984, SYSTEMATICS GREEN AL, V27, P29, DOI DOI 10.1017/S0024282985000482; Melkonian M., 1990, P649; Millar AH, 2006, CURR OPIN PLANT BIOL, V9, P610, DOI 10.1016/j.pbi.2006.09.002; MOESTRUP O, 1991, J PHYCOL, V27, P119, DOI 10.1111/j.0022-3646.1991.00119.x; O'Kelly Charles J., 2007, P287; Pombert JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008954; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Proschold Thomas, 2007, Systematics Association Special Volume Series, V75, P123; Smith DR, 2008, MOL BIOL EVOL, V25, P487, DOI 10.1093/molbev/msm245; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr068, 10.1093/gbe/evr001]; Smith DR, 2010, MOL BIOL EVOL, V27, P2244, DOI 10.1093/molbev/msq110; Smith DR, 2009, PLANT MOL BIOL, V71, P627, DOI 10.1007/s11103-009-9545-3; Spencer CCA, 2006, BIOCHEM SOC T, V34, P535, DOI 10.1042/BST0340535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; Turmel M, 1999, PLANT CELL, V11, P1717, DOI 10.1105/tpc.11.9.1717; Turmel M, 2009, MOL BIOL EVOL, V26, P2317, DOI 10.1093/molbev/msp138; Watanabe S, 2007, PHYCOL RES, V55, P1, DOI 10.1111/j.1440-1835.2006.00439.x; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210	52	41	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23624	10.1371/journal.pone.0023624	http://dx.doi.org/10.1371/journal.pone.0023624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887287	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298800017
J	Aguilar-Hernandez, V; Aguilar-Henonin, L; Guzman, P				Aguilar-Hernandez, Victor; Aguilar-Henonin, Laura; Guzman, Plinio			Diversity in the Architecture of ATLs, a Family of Plant Ubiquitin-Ligases, Leads to Recognition and Targeting of Substrates in Different Cellular Environments	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RING-H2 FINGER PROTEIN; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; GENE DUPLICATION; E3; EXPRESSION; EVOLUTION; DOMAIN; IDENTIFICATION	Ubiquitin-ligases or E3s are components of the ubiquitin proteasome system (UPS) that coordinate the transfer of ubiquitin to the target protein. A major class of ubiquitin-ligases consists of RING-finger domain proteins that include the substrate recognition sequences in the same polypeptide; these are known as single-subunit RING finger E3s. We are studying a particular family of RING finger E3s, named ATL, that contain a transmembrane domain and the RING-H2 finger domain; none of the member of the family contains any other previously described domain. Although the study of a few members in A. thaliana and O. sativa has been reported, the role of this family in the life cycle of a plant is still vague. To provide tools to advance on the functional analysis of this family we have undertaken a phylogenetic analysis of ATLs in twenty-four plant genomes. ATLs were found in all the 24 plant species analyzed, in numbers ranging from 20-28 in two basal species to 162 in soybean. Analysis of ATLs arrayed in tandem indicates that sets of genes are expanding in a species-specific manner. To get insights into the domain architecture of ATLs we generated 75 pHMM LOGOs from 1815 ATLs, and unraveled potential protein-protein interaction regions by means of yeast two-hybrid assays. Several ATLs were found to interact with DSK2a/ubiquilin through a region at the amino-terminal end, suggesting that this is a widespread interaction that may assist in the mode of action of ATLs; the region was traced to a distinct sequence LOGO. Our analysis provides significant observations on the evolution and expansion of the ATL family in addition to information on the domain structure of this class of ubiquitin-ligases that may be involved in plant adaptation to environmental stress.	[Aguilar-Hernandez, Victor; Aguilar-Henonin, Laura; Guzman, Plinio] Unidad Irapuato, Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Irapuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Aguilar-Hernandez, V (corresponding author), Unidad Irapuato, Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Irapuato, Mexico.	pguzman@ira.cinvestav.mx	Guzman, Plinio/A-3073-2012; Aguilar-Hernández, Victor/Q-9860-2019	Aguilar-Hernández, Victor/0000-0001-7308-4047	Consejo Nacional de Ciencia y Tecnologia Mexico [78777]	Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Grant 78777 from Consejo Nacional de Ciencia y Tecnologia Mexico (http://www.conacyt.mx/Paginas/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguilar-Henonin L, 2006, CURR GENET, V50, P257, DOI 10.1007/s00294-006-0093-y; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Azevedo J, 2008, P NATL ACAD SCI USA, V105, P9123, DOI 10.1073/pnas.0800909105; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Bopopi JM, 2010, J EXP BOT, V61, P297, DOI 10.1093/jxb/erp305; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Ficklin MB, 2005, J BIOL CHEM, V280, P34088, DOI 10.1074/jbc.M506781200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; Hondo D, 2007, MOL PLANT MICROBE IN, V20, P72, DOI 10.1094/MPMI-20-0072; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Karlowski WM, 2003, PLANT MOL BIOL, V52, P121, DOI 10.1023/A:1023916701669; Katoh S, 2005, J BIOL CHEM, V280, P41015, DOI 10.1074/jbc.M411127200; Katoh S, 2003, J BIOL CHEM, V278, P15341, DOI 10.1074/jbc.M210531200; Kawasaki T, 2005, PLANT J, V44, P258, DOI 10.1111/j.1365-313X.2005.02525.x; Koiwai H, 2007, PLANT J, V51, P92, DOI 10.1111/j.1365-313X.2007.03120.x; Kong QH, 2010, BIOCHEM BIOPH RES CO, V393, P708, DOI 10.1016/j.bbrc.2010.02.066; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu HZ, 2008, PLANT MOL BIOL, V68, P17, DOI 10.1007/s11103-008-9349-x; Liu Q, 1998, CURR BIOL, V8, pS1301; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Livnat-Levanon N, 2010, BIOCH BIOPHYSICA ACT; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; MartinezGarcia M, 1996, MOL GEN GENET, V252, P587, DOI 10.1007/s004380050266; Mehnert M, 2010, BIOESSAYS; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morris K, 2010, PLANT CELL, V22, P1118, DOI 10.1105/tpc.109.066605; Mudge J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-15; Ni XM, 2010, J PLANT PHYSIOL, V167, P488, DOI 10.1016/j.jplph.2009.10.019; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Peng Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-41; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; Sato T, 2009, PLANT J, V60, P852, DOI 10.1111/j.1365-313X.2009.04006.x; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Woznik M, 2010, J GEN VIROL, V91, P2773, DOI 10.1099/vir.0.024638-0; Yoshida K, 2009, BIOCHEM BIOPH RES CO, V389, P506, DOI 10.1016/j.bbrc.2009.09.011; Yu FR, 2008, NEUROSCI LETT, V440, P4, DOI 10.1016/j.neulet.2008.05.052; Zhang L, 2003, PROG NAT SCI, V13, P13, DOI 10.1080/10020070312331343060; Zou C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000581	76	37	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23934	10.1371/journal.pone.0023934	http://dx.doi.org/10.1371/journal.pone.0023934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887349	Green Submitted, gold, Green Published			2022-12-25	WOS:000295832000075
J	Garcia, MA; Carrasco, E; Aguilera, M; Alvarez, P; Rivas, C; Campos, JM; Prados, JC; Calleja, MA; Esteban, M; Marchal, JA; Aranega, A				Angel Garcia, Maria; Carrasco, Esther; Aguilera, Margarita; Alvarez, Pablo; Rivas, Carmen; Maria Campos, Joaquin; Carlos Prados, Jose; Angel Calleja, Miguel; Esteban, Mariano; Antonio Marchal, Juan; Aranega, Antonia			The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53-Independent Manner in Colon and Breast Cancer Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; INTERFERON-ALPHA; EIF2-ALPHA PHOSPHORYLATION; TRANSLATIONAL CONTROL; ACTIVATION; P53; MECHANISM	The chemotherapeutic drug 5-FU is widely used in the treatment of a range of cancers, but resistance to the drug remains a major clinical problem. Since defects in the mediators of apoptosis may account for chemo-resistance, the identification of new targets involved in 5-FU-induced apoptosis is of main clinical interest. We have identified the ds-RNA-dependent protein kinase (PKR) as a key molecular target of 5-FU involved in apoptosis induction in human colon and breast cancer cell lines. PKR distribution and activation, apoptosis induction and cytotoxic effects were analyzed during 5-FU and 5-FU/IFN alpha treatment in several colon and breast cancer cell lines with different p53 status. PKR protein was activated by 5-FU treatment in a p53-independent manner, inducing phosphorylation of the protein synthesis translation initiation factor eIF-2 alpha and cell death by apoptosis. Furthermore, PKR interference promoted a decreased response to 5-FU treatment and those cells were not affected by the synergistic antitumor activity of 5-FU/IFN alpha combination. These results, taken together, provide evidence that PKR is a key molecular target of 5-FU with potential relevance in the clinical use of this drug.	[Angel Garcia, Maria] Hosp Univ Virgen de las Nieves, Unidad Invest, Granada, Spain; [Angel Garcia, Maria; Carrasco, Esther; Alvarez, Pablo; Carlos Prados, Jose; Antonio Marchal, Juan; Aranega, Antonia] Univ Granada, Inst Biopatol & Med Regenerat IBIMER, Granada, Spain; [Aguilera, Margarita; Angel Calleja, Miguel] Hosp Univ Virgen de las Nieves, Unidad Farmacogenet, Granada, Spain; [Rivas, Carmen; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain; [Maria Campos, Joaquin] Univ Granada, Fac Farm, Dept Quim Farmaceut & Organ, Granada, Spain	Hospital Universitario Virgen de las Nieves; University of Granada; Hospital Universitario Virgen de las Nieves; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Granada	Garcia, MA (corresponding author), Hosp Univ Virgen de las Nieves, Unidad Invest, Granada, Spain.	mangelgarcia@ugr.es; jmarchal@ugr.es	Garcia, Maria Angel MA/I-5116-2016; Rosa, Joaquín/L-8436-2014; Marchal, Juan Antonio/M-4305-2014; Aguilera, Margarita/M-8238-2013; Esteban, Mariano/ABG-5375-2020; Rivas, Carmen/L-3162-2017; BOULAIZ, HOURIA TASSI/H-4253-2015; Rivas, Carmen/AAB-6278-2019; Prados, Jose/J-7116-2017	Garcia, Maria Angel MA/0000-0003-2003-3769; Rosa, Joaquín/0000-0002-9035-8123; Marchal, Juan Antonio/0000-0002-4996-8261; Aguilera, Margarita/0000-0002-3204-9787; Esteban, Mariano/0000-0003-0846-2827; Rivas, Carmen/0000-0002-0518-7199; BOULAIZ, HOURIA TASSI/0000-0003-4433-7556; Rivas, Carmen/0000-0002-0518-7199; Aranega, Antonia/0000-0001-5981-5675; Prados, Jose/0000-0003-4303-7746	Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria) [CP08/0063, PI07/0527, PI10/02295]	Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III)	This work was supported in part by grants from the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria projects no. CP08/0063, PI07/0527 and PI10/02295). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani J, 2006, CANCER-AM CANCER SOC, V107, P221, DOI 10.1002/cncr.21986; Backus HHJ, 2003, EUR J CANCER, V39, P1310, DOI 10.1016/S0959-8049(03)00204-1; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Borden EC, 2005, J INTERF CYTOK RES, V25, P511, DOI 10.1089/jir.2005.25.511; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brown JM, 1999, CANCER RES, V59, P1391; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Dagon Y, 2001, ONCOGENE, V20, P8045, DOI 10.1038/sj.onc.1204945; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Donze O, 2004, EMBO J, V23, P564, DOI 10.1038/sj.emboj.7600078; Eguchi H, 2000, CLIN CANCER RES, V6, P2881; ELIAS L, 1989, BIOCHEM BIOPH RES CO, V163, P867, DOI 10.1016/0006-291X(89)92302-4; Ershler WB, 2006, CRIT REV ONCOL HEMAT, V58, P68, DOI 10.1016/j.critrevonc.2005.08.006; ESTEBAN M, 1974, EUR J BIOCHEM, V45, P567, DOI 10.1111/j.1432-1033.1974.tb03583.x; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gil J, 2000, ONCOGENE, V19, P1369, DOI 10.1038/sj.onc.1203448; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2002, FEBS LETT, V529, P249, DOI 10.1016/S0014-5793(02)03348-3; Guerra S, 2006, J BIOL CHEM, V281, P18734, DOI 10.1074/jbc.M511983200; Haug K, 2008, ANTICANCER RES, V28, P583; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HOVANESSIAN AG, 1987, EUR J BIOCHEM, V167, P467, DOI 10.1111/j.1432-1033.1987.tb13360.x; Ju J, 2007, CLIN CANCER RES, V13, P4245, DOI 10.1158/1078-0432.CCR-06-2890; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Ke ZJ, 2009, ALCOHOL CLIN EXP RES, V33, P1097, DOI 10.1111/j.1530-0277.2009.00931.x; Kudo K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq024; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Li SY, 2001, J BIOL CHEM, V276, P13881, DOI 10.1074/jbc.M008140200; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Masci P, 2007, CLIN PHARMACOL THER, V81, P354, DOI 10.1038/sj.clpt.6100081; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Pap M, 2008, CELL MOL NEUROBIOL, V28, P443, DOI 10.1007/s10571-007-9245-y; Pataer A, 2010, CLIN CANCER RES, V16, P5522, DOI 10.1158/1078-0432.CCR-10-0753; Patel RC, 2002, ARTERIOSCL THROM VAS, V22, P1439, DOI 10.1161/01.ATV.0000028817.20351.FE; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peel AL, 2004, J NEUROPATH EXP NEUR, V63, P97, DOI 10.1093/jnen/63.2.97; Peidis P, 2011, CELL DEATH DIFFER, V18, P145, DOI 10.1038/cdd.2010.76; PEIDIS P, 2011, CELL DEATH DIFFER; Petak I, 2000, CLIN CANCER RES, V6, P4432; Presant CA, 2000, J CLIN ONCOL, V18, P255, DOI 10.1200/JCO.2000.18.2.255; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Ruvolo PP, 2001, J BIOL CHEM, V276, P11754, DOI 10.1074/jbc.M011400200; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schmitz JC, 2001, CANCER METAST REV, V20, P33, DOI 10.1023/A:1013100306315; SENGC, 1978, J BIOL CHEM, V253, P5915; Shimada A, 1998, CANCER RES, V58, P4434; Sorensen HT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c703; SPARANO JA, 1993, INT J CLIN PHARM RES, V13, P1; Tan SL, 2002, J BIOL CHEM, V277, P36109, DOI 10.1074/jbc.M205109200; Tejpar S, 2010, ONCOLOGIST, V15, P390, DOI 10.1634/theoncologist.2009-0233; VILLALOBOS C, 1995, PFLUG ARCH EUR J PHY, V430, P923, DOI 10.1007/BF01837406; WADLER S, 1990, CANCER RES, V50, P3473; WADLER S, 1990, CANCER RES, V50, P2056; WADLER S, 1992, CANCER INVEST, V10, P323, DOI 10.3109/07357909209032757; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Yamamoto T, 2004, CLIN CANCER RES, V10, P7884, DOI 10.1158/1078-0432.CCR-04-0794; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yeung MC, 1996, P NATL ACAD SCI USA, V93, P12451, DOI 10.1073/pnas.93.22.12451; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Zamanian-Daryoush M, 1999, ONCOGENE, V18, P315, DOI 10.1038/sj.onc.1202293; Zhang P, 2009, J VIROL, V83, P5718, DOI 10.1128/JVI.00224-09	68	41	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23887	10.1371/journal.pone.0023887	http://dx.doi.org/10.1371/journal.pone.0023887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887339	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000070
J	Dama, MS				Dama, Madhukar Shivajirao			Sex Ratio at Birth and Mortality Rates Are Negatively Related in Humans	PLOS ONE			English	Article							LIFE EXPECTANCY; TRIVERS-WILLARD; OFFSPRING SEX; COITAL RATE; MATERNAL WEIGHT; INVESTMENT; UNDERNUTRITION; HYPOTHESIS; FERTILITY; SUPPORT	Evolutionary theory posits that resource availability and parental investment ability could signal offspring sex selection, in order to maximize reproductive returns. Non-human studies have provided evidence for this phenomenon, and maternal condition around the time of conception has been identified as most important factor that influence offspring sex selection. However, studies on humans have reported inconsistent results, mostly due to use of disparate measures as indicators of maternal condition. In the present study, the cross-cultural differences in human natal sex ratio were analyzed with respect to indirect measures of condition namely, life expectancy and mortality rate. Multiple regression modeling suggested that mortality rates have distinct predictive power independent of cross-cultural differences in fertility, wealth and latitude that were earlier shown to predict sex ratio at birth. These findings suggest that sex ratio variation in humans may relate to differences in parental and environmental conditions.	Rural Vet Dispensary, Rajola, Bidar, India		Dama, MS (corresponding author), Rural Vet Dispensary, Rajola, Bidar, India.	madhukar262@gmail.com	Dama, Madhukar/H-9945-2012	Dama, Madhukar/0000-0002-8361-1530				Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Barber N, 2004, SOC BIOL, V51, P71; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Braza F, 2004, HUM ECOL, V32, P163, DOI 10.1023/B:HUEC.0000019761.98723.af; Cagnacci A, 2005, FERTIL STERIL, V84, P246, DOI 10.1016/j.fertnstert.2004.12.054; Cagnacci A, 2004, HUM REPROD, V19, P442, DOI 10.1093/humrep/deh071; Cagnacci A, 2003, HUM REPROD, V18, P885, DOI 10.1093/humrep/deg185; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Catalano RA, 2003, HUM REPROD, V18, P1972, DOI 10.1093/humrep/deg370; Central Intelligence Agency, 2010, WORLD FACTB; Coall DA, 2010, AM J HUM BIOL, V22, P143, DOI 10.1002/ajhb.20965; CRIMMINS EM, 1994, DEMOGRAPHY, V31, P159, DOI 10.2307/2061913; Crognier E, 2006, AM J HUM BIOL, V18, P325, DOI 10.1002/ajhb.20499; Cronk L, 2007, REPROD BIOMED ONLINE, V15, P23, DOI 10.1016/S1472-6483(10)60546-9; Fox J., 1991, SAGE U PAPER SERIES; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Gibson MA, 2003, P ROY SOC B-BIOL SCI, V270, pS108, DOI 10.1098/rsbl.2003.0031; Godoy R, 2006, HUM NATURE-INT BIOS, V17, P169, DOI 10.1007/s12110-006-1016-9; Graffelman J, 2000, HUM BIOL, V72, P433; Gray PB, 2006, AM J HUM BIOL, V18, P123, DOI 10.1002/ajhb.20471; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Halford C, 2010, UPSALA J MED SCI, V115, P266, DOI 10.3109/03009734.2010.496910; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hill E.M., 2008, J SOCIO-ECON, V37, P1381, DOI [10.1016/j.socec.2006.12.081, DOI 10.1016/J.SOCEC.2006.12.081]; Hurd MD, 2002, ECON J, V112, P966, DOI 10.1111/1468-0297.00065; Jacobsen R, 1999, HUM REPROD, V14, P1127, DOI 10.1093/humrep/14.4.1127; James WH, 2007, LUPUS, V16, P65, DOI 10.1177/0961203306073365; James WH, 2006, DIABETIC MED, V23, P1043, DOI 10.1111/j.1464-5491.2006.01807.x; JAMES WH, 1986, J THEOR BIOL, V118, P427, DOI 10.1016/S0022-5193(86)80163-1; JAMES WH, 1971, LANCET, V2, P159; James WH, 2005, J EPIDEMIOL COMMUN H, V59, P810; James WH, 1997, ANN HUM BIOL, V24, P403, DOI 10.1080/03014469700005162; JAMES WH, 1971, LANCET, V1, P1294; James WH, 2011, J BIOSOC SCI, V43, P167, DOI 10.1017/S0021932010000660; Johns SE, 2004, P ROY SOC B-BIOL SCI, V271, pS474, DOI 10.1098/rsbl.2004.0220; Kemkes A, 2006, AM J HUM BIOL, V18, P806, DOI 10.1002/ajhb.20562; MACKEY WC, 1993, HUM NATURE-INT BIOS, V4, P175, DOI 10.1007/BF02734115; Mathews F, 2008, P ROY SOC B-BIOL SCI, V275, P1661, DOI 10.1098/rspb.2008.0105; Mathews T J, 2005, Natl Vital Stat Rep, V53, P1; Mills JL, 2003, FERTIL STERIL, V79, P1243, DOI 10.1016/S0015-0282(03)00156-0; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; Nicolich MJ, 2000, FERTIL STERIL, V73, P487, DOI 10.1016/S0015-0282(99)00576-2; Parazzini F, 1998, HUM REPROD, V13, P1394, DOI 10.1093/humrep/13.5.1394; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Pollet T, 2010, J EVOLUTIONARY PSYCH, V8, P57; Pollet TV, 2009, BIOL LETTERS, V5, P765, DOI 10.1098/rsbl.2009.0394; PRICE B, 1977, PSYCHOL BULL, V84, P759, DOI 10.1037/0033-2909.84.4.759; ROBINE JM, 1991, BMJ-BRIT MED J, V302, P457, DOI 10.1136/bmj.302.6774.457; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Ross CE, 2002, J HEALTH SOC BEHAV, V43, P469, DOI 10.2307/3090238; Saadat M, 2004, HUM REPROD, V19, P465, DOI 10.1093/humrep/deh086; Siegel M, 2003, GERONTOLOGY, V49, P265, DOI 10.1159/000070409; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS138, DOI 10.1098/rsbl.2003.0123; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS37, DOI 10.1098/rsbl.2003.0086; Tamimi RM, 2003, BRIT MED J, V326, P1245, DOI 10.1136/bmj.326.7401.1245; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vartiainen T, 1999, ENVIRON HEALTH PERSP, V107, P813, DOI 10.2307/3454578; World Bank, 2010, WORLD GLANC KEY DEV; World Health Organization, 2010, STAT INF SYST WHOSIS; Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173	62	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23792	10.1371/journal.pone.0023792	http://dx.doi.org/10.1371/journal.pone.0023792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887320	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000061
J	Ghosn, J; Galimand, J; Raymond, S; Meyer, L; Deveau, C; Goujard, C; Izopet, J; Rouzioux, C; Chaix, ML				Ghosn, Jade; Galimand, Julie; Raymond, Stephanie; Meyer, Laurence; Deveau, Christiane; Goujard, Cecile; Izopet, Jacques; Rouzioux, Christine; Chaix, Marie-Laure		ANRS CO 06 PRIMO Cohort	X4 Tropic Multi-Drug Resistant Quasi-Species Detected at the Time of Primary HIV-1 Infection Remain Exclusive or at Least Dominant Far from PHI	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; GENOTYPIC PREDICTION; DISEASE PROGRESSION; CORECEPTOR USAGE; TYPE-1 INFECTION; TRANSMISSION; VIRUS; PERSISTENCE; COHORT	Our objective was to analyze the evolution of resistance mutations (RM) and viral tropism of multi-drug-resistant (MDR) strains detected at primary HIV-1 infection (PHI). MDR HIV strain was defined as the presence of genotypic resistance to at least 1 antiretroviral of the 3 classes. Tropism determinations (CCR5 or CXCR4) were performed on baseline plasma HIV-RNA and/or PBMC-HIV-DNA samples, then during follow-up using population-based sequencing of V3 loop and phenotypic tests. Clonal analysis was performed at baseline for env, RT and protease genes, and for HIV-DNA env gene during follow-up. Five patients were eligible. At baseline, RT, protease and env clones from HIV-RNA and HIV-DNA were highly homogenous for each patient; genotypic tropism was R5 in 3 (A, B, C) and X4 in 2 patients (D, E). MDR strains persisted in HIV-DNA throughout follow-up in all patients. For patient A, tropism remained R5 with concordance between phenotypic and genotypic tests. Clonal analysis on Month (M) 78 HIV-DNA evidenced exclusively R5 (21/21) variants. In patient B, clonal analysis at M36 showed exclusively R5 variants (19/19) using both genotypic and phenotypic tests. In patient C, baseline tropism was R5 by genotypic test and R5/X4 by phenotypic test. An expansion of these X4 clones was evidenced by clonal analysis on M72 HIV-DNA (12/14 X4 and 2/14 R5 variants). In patient D, baseline tropism was X4 with concordance between both techniques and HIV-RNA and HIV-DNA remained X4-tropic up to M72, confirmed by the clonal analysis. Patient E harboured highly homogenous X4-using population at baseline; tropism was unchanged at M1 and M18. In all patients, the initial MDR population was highly homogenous initially, supporting the early expansion of a monoclonal population and its long-term persistence. X4-tropic variants present at baseline were still exclusive (patients D and E) or dominant (at least one time point, patient C) far from PHI.	[Ghosn, Jade; Galimand, Julie; Rouzioux, Christine; Chaix, Marie-Laure] Univ Paris 05, CHU Necker Enfants Malad, EA 3620, Paris, France; [Ghosn, Jade; Goujard, Cecile] CHU Bicetre, AP HP, Serv Med Interne & Malad Infect, Le Kremlin Bicetre, France; [Galimand, Julie; Rouzioux, Christine; Chaix, Marie-Laure] CHU Necker Enfants Malad, AP HP, Virol Lab, Paris, France; [Raymond, Stephanie; Izopet, Jacques] Hop Purpan, INSERM U563, Virol Lab, Toulouse, France; [Meyer, Laurence; Deveau, Christiane; Goujard, Cecile] Univ Paris 11, Fac Med Paris Sud, Hop Bicetre, AP HP,INSERM U1018,Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Ghosn, J (corresponding author), Univ Paris 05, CHU Necker Enfants Malad, EA 3620, Paris, France.	jade.ghosn@bct.aphp.fr	Raymond, Stephanie/L-8401-2019; IZOPET, Jacques/L-5756-2014; Raymond, Stephanie/K-4507-2014; Boucherit, Soraya/I-1704-2017; Bergmann, Jean-Francois/L-6044-2017	Raymond, Stephanie/0000-0002-3780-5844; Boucherit, Soraya/0000-0002-8819-7594; Bergmann, Jean-Francois/0000-0001-6861-9748; ABEL, Sylvie/0000-0002-3351-0547; Cabie, Andre/0000-0003-0117-3061	French National Agency for Research on AIDS (ANRS)	French National Agency for Research on AIDS (ANRS)(ANRS)	This work was supported by the French National Agency for Research on AIDS (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Balandya E, 2010, J IMMUNOL, V185, P7596, DOI 10.4049/jimmunol.1002846; Bhaskaran K, 2004, AIDS, V18, P1471, DOI 10.1097/01.aids.0000131341.45795.33; Bomsel M, 2002, NAT MED, V8, P114, DOI 10.1038/nm0202-114; Briggs DR, 2000, AIDS, V14, P2937, DOI 10.1097/00002030-200012220-00016; Chaix ML, 2007, ANTIVIR THER, V12, P1305; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Dalmau J, 2009, CLIN INFECT DIS, V48, P229, DOI 10.1086/595704; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; de Mendoza C, 2007, J ANTIMICROB CHEMOTH, V59, P698, DOI 10.1093/jac/dkm012; DEJONG JJ, 1992, J VIROL, V66, P757, DOI 10.1128/JVI.66.2.757-765.1992; Delaugerre C, 2004, ANTIVIR THER, V9, P415; Delaugerre C, 2007, AIDS, V21, P1365, DOI 10.1097/QAD.0b013e3280d6edf1; Desquilbet L, 2004, AIDS, V18, P2361; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Frange P, 2009, J ANTIMICROB CHEMOTH, V64, P135, DOI 10.1093/jac/dkp151; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Ghosn J, 2005, AIDS, V19, P1643, DOI 10.1097/01.aids.0000181322.17679.b2; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2009, CLIN INFECT DIS, V49, P982, DOI 10.1086/605504; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moyle GJ, 2005, J INFECT DIS, V191, P866, DOI 10.1086/428096; Nischalke HD, 2004, AIDS RES HUM RETROV, V20, P750, DOI 10.1089/0889222041524634; Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2010, AIDS, V24, P2305, DOI 10.1097/QAD.0b013e32833e50bb; Raymond S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/j.jcv.2009.11.018; Raymond S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0b013e3181c8413b; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Schiffer V, 2004, HIV MED, V5, P326, DOI 10.1111/j.1468-1293.2004.00231.x; Shepherd JC, 2008, J INFECT DIS, V198, P1104, DOI 10.1086/591623; Smith DM, 2007, J INFECT DIS, V196, P356, DOI 10.1086/519164; Soulie C, 2007, AIDS, V21, P2243, DOI 10.1097/QAD.0b013e3282f0e3d0; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Sucupira MCA, 2010, ANTIVIR THER, V15, pA163; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wagner TA, 2010, ANTIVIR THER, V15, pA45; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Wei X, 2003, VIROLOGY, V311, P202, DOI 10.1016/S0042-6822(03)00173-9; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Yeni P, 2010, PRISE CHARGE MED PER; Yerly S, 2004, ANTIVIR THER, V9, P375; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	51	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23301	10.1371/journal.pone.0023301	http://dx.doi.org/10.1371/journal.pone.0023301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887243	Green Submitted, gold, Green Published			2022-12-25	WOS:000295832000013
J	Kurdikova, V; Smolinsky, R; Gvozdik, L				Kurdikova, Vendula; Smolinsky, Radovan; Gvozdik, Lumir			Mothers Matter Too: Benefits of Temperature Oviposition Preferences in Newts	PLOS ONE			English	Article							SITE SELECTION; MATERNAL MANIPULATION; REPTILIAN VIVIPARITY; SWIMMING PERFORMANCE; PREDATION; SIZE; BEHAVIOR; VULNERABILITY; CHOICE; EGGS	The maternal manipulation hypothesis states that ectothermic females modify thermal conditions during embryonic development to benefit their offspring (anticipatory maternal effect). However, the recent theory suggests that the ultimate currency of an adaptive maternal effect is female fitness that can be maximized also by decreasing mean fitness of individual offspring. We evaluated benefits of temperature oviposition preferences in Alpine newts (Ichthyosaura [formerly Triturus] alpestris) by comparing the thermal sensitivity of maternal and offspring traits across a range of preferred oviposition temperatures (12, 17, and 22 degrees C) and by manipulating the egg-predation risk during oviposition in a laboratory thermal gradient (12-22 degrees C). All traits showed varying responses to oviposition temperatures. Embryonic developmental rates increased with oviposition temperature, whereas hatchling size and swimming capacity showed the opposite pattern. Maternal oviposition and egg-predation rates were highest at the intermediate temperature. In the thermal gradient, females oviposited at the same temperature despite the presence of caged egg-predators, water beetles (Agabus bipustulatus). We conclude that female newts prefer a particular temperature for egg-deposition to maximize their oviposition performance rather than offspring fitness. The evolution of advanced reproductive modes, such as prolonged egg-retention and viviparity, may require, among others, the transition from selfish temperature preferences for ovipositon to the anticipatory maternal effect.	[Kurdikova, Vendula; Smolinsky, Radovan; Gvozdik, Lumir] Acad Sci Czech Republ, Inst Vertebrate Biol, Dept Populat Biol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Kurdikova, V (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Dept Populat Biol, Brno, Czech Republic.	gvozdik@brno.cas.cz	Gvoždík, Lumír/G-1178-2014; Smolinsky, Radovan/F-9730-2014	Gvoždík, Lumír/0000-0002-6495-2233; 	Czech Science Foundation [P506/10/2170]; Czech Ministry of Education [LC06073]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	This work was funded by a grant from the Czech Science Foundation (P506/10/2170) and the Czech Ministry of Education (LC06073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, ECOLOGY, V90, P2933, DOI 10.1890/08-2224.1; BAUWENS D, 1981, J ANIM ECOL, V50, P733, DOI 10.2307/4133; Binckley CA, 2008, BEHAV ECOL, V19, P552, DOI 10.1093/beheco/arm164; Blackburn DG, 2000, COMP BIOCHEM PHYS A, V127, P391, DOI 10.1016/S1095-6433(00)00272-5; Blaustein L, 2004, OECOLOGIA, V138, P300, DOI 10.1007/s00442-003-1398-x; Carriere Y, 1997, EVOLUTION, V51, P2028, DOI 10.1111/j.1558-5646.1997.tb05125.x; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; Doak P, 2006, ECOLOGY, V87, P395, DOI 10.1890/05-0647; Dvorak J, 2010, EVOL ECOL, V24, P1115, DOI 10.1007/s10682-010-9355-8; Dvorak J, 2009, ETHOLOGY, V115, P533, DOI 10.1111/j.1439-0310.2009.01633.x; Einum S, 2004, EVOL ECOL RES, V6, P443; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Feder ME, 1997, ANIM BEHAV, V53, P585, DOI 10.1006/anbe.1996.0333; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Garner TWJ, 2003, P ROY SOC B-BIOL SCI, V270, P619, DOI 10.1098/rspb.2002.2284; Gotthard K, 2007, AM NAT, V169, P768, DOI 10.1086/516651; Griffiths RA, 1996, NEWTS SALAMANDERS EU; HOPEY ME, 1994, COPEIA, P1023; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; KINGSOLVER JG, 1979, ECOL MONOGR, V49, P357, DOI 10.2307/1942468; Kingsolver JG, 2003, INTEGR COMP BIOL, V43, P470, DOI 10.1093/icb/43.3.470; MANGEL M, 1987, J MATH BIOL, V25, P1, DOI 10.1007/BF00275885; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Merakova E, 2009, FUNCT ECOL, V23, P989, DOI 10.1111/j.1365-2435.2009.01588.x; MIAUD C, 1993, J ZOOL, V231, P575, DOI 10.1111/j.1469-7998.1993.tb01939.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Orizaola G, 2003, HERPETOL J, V13, P121; PACKARD GC, 1989, LIFE SCI R, V45, P281; PIVNICK KA, 1986, ECOLOGY, V67, P1024, DOI 10.2307/1939825; Plaut I, 2002, FUNCT ECOL, V16, P290, DOI 10.1046/j.1365-2435.2002.00638.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; RESETARITS WJ, 1989, ECOLOGY, V70, P220, DOI 10.2307/1938428; Rieger JF, 2004, ECOLOGY, V85, P2094, DOI 10.1890/04-0156; SEIGEL RA, 1987, OECOLOGIA, V73, P481, DOI 10.1007/BF00379404; Shine R, 1996, ECOLOGY, V77, P1808, DOI 10.2307/2265785; Webb JK, 2006, EVOLUTION, V60, P115, DOI 10.1554/05-460.1; Wolf J. B., 2004, PHENOTYPIC PLASTICIT, P173; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]	40	20	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23842	10.1371/journal.pone.0023842	http://dx.doi.org/10.1371/journal.pone.0023842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887330	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000066
J	Ojeda, L; Gao, JL; Hooten, KG; Wang, EY; Thonhoff, JR; Dunn, TJ; Gao, TY; Wu, P				Ojeda, Luis; Gao, Junling; Hooten, Kristopher G.; Wang, Enyin; Thonhoff, Jason R.; Dunn, Tiffany J.; Gao, Tianyan; Wu, Ping			Critical Role of PI3K/Akt/GSK3 beta in Motoneuron Specification from Human Neural Stem Cells in Response to FGF2 and EGF	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; PROTEIN-KINASE-C; SPINAL MOTOR-NEURONS; PHOSPHOINOSITIDE 3-KINASE; ADULT-RAT; CHOLINE-ACETYLTRANSFERASE; DIFFERENTIATION; CORD; PROLIFERATION; ACTIVATION	Fibroblast growth factor (FGF) and epidermal growth factor (EGF) are critical for the development of the nervous system. We previously discovered that FGF2 and EGF had opposite effects on motor neuron differentiation from human fetal neural stem cells (hNSCs), but the underlying mechanisms remain unclear. Here, we show that FGF2 and EGF differentially affect the temporal patterns of Akt and glycogen synthase kinase 3 beta (GSK3 beta) activation. High levels of phosphatidylinositol 3-kinase (PI3K)/Akt activation accompanied with GSK3b inactivation result in reduction of the motor neuron transcription factor HB9. Inhibition of PI3K/Akt by chemical inhibitors or RNA interference or overexpression of a constitutively active form of GSK3b enhances HB9 expression. Consequently, PI3K inhibition increases hNSCs differentiation into HB9(+)/microtubule-associated protein 2 (MAP2)(+) motor neurons in vitro. More importantly, blocking PI3K not only enhances motor neuron differentiation from hNSCs grafted into the ventral horn of adult rat spinal cords, but also permits ectopic generation of motor neurons in the dorsal horn by overriding environmental influences. Our data suggest that FGF2 and EGF affect the motor neuron fate decision in hNSCs differently through a fine tuning of the PI3K/AKT/GSK3 beta pathway, and that manipulation of this pathway can enhance motor neuron generation.	[Ojeda, Luis; Gao, Junling; Wang, Enyin; Thonhoff, Jason R.; Dunn, Tiffany J.; Wu, Ping] Univ Texas Med Branch Galveston, Dept Neurosci & Cell Biol, Galveston, TX USA; [Hooten, Kristopher G.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Wang, Enyin] Sichuan Univ, W China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China; [Gao, Tianyan] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY USA; [Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA	University of Texas System; University of Texas Medical Branch Galveston; State University System of Florida; University of Florida; Sichuan University; University of Kentucky; University of Kentucky	Ojeda, L (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	piwu@utmb.edu			John S. Dunn Research Foundation; Cullen Foundation; TIRR Foundation; Gillson Longenbaugh Foundation; Moody Foundation; NIH [F30NS060387, R01 CA133429]; NATIONAL CANCER INSTITUTE [R01CA133429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS060387] Funding Source: NIH RePORTER	John S. Dunn Research Foundation; Cullen Foundation; TIRR Foundation; Gillson Longenbaugh Foundation; Moody Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the John S. Dunn Research Foundation, the Cullen Foundation, the TIRR Foundation, the Gillson Longenbaugh Foundation, the Moody Foundation, and the NIH (F30NS060387 to J.R.T. and R01 CA133429 to T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER RP, 1984, J COMP NEUROL, V229, P329, DOI 10.1002/cne.902290305; BORGES LF, 1986, BRAIN RES, V362, P140, DOI 10.1016/0006-8993(86)91407-1; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Bruno L, 2008, CELL CYCLE, V7, P2296, DOI 10.4161/cc.6444; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Coffer PJ, 1998, BIOCHEM J, V335, P1; Corti S, 2010, BRAIN, V133, P465, DOI 10.1093/brain/awp318; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gao J, 2005, NEUROSCIENCE, V131, P257, DOI 10.1016/j.neuroscience.2004.10.033; Gao JL, 2007, NEUROREPORT, V18, P565, DOI 10.1097/WNR.0b013e3280b10c2c; Gremo F, 2000, INT J DEV NEUROSCI, V18, P271, DOI 10.1016/S0736-5748(99)00095-7; Hedlund E, 2007, EUR J NEUROSCI, V26, P1721, DOI 10.1111/j.1460-9568.2007.05780.x; Ho WC, 2005, MOL CELL BIOCHEM, V271, P29, DOI 10.1007/s11010-005-3458-5; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Ma YC, 2008, NEURON, V58, P65, DOI 10.1016/j.neuron.2008.01.037; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin LJ, 2007, J NEUROPATH EXP NEUR, V66, P1002, DOI 10.1097/nen.0b013e318158822b; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nayak MS, 2006, BBA-MOL BASIS DIS, V1762, P1128, DOI 10.1016/j.bbadis.2006.06.004; Oliva JL, 2005, GROWTH FACTORS, V23, P245, DOI 10.1080/08977190500366043; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Raballo R, 2000, J NEUROSCI, V20, P5012; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Thonhoff JR, 2009, CURR STEM CELL RES T, V4, P178, DOI 10.2174/157488809789057392; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Wada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006722; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Weiss S, 1996, J NEUROSCI, V16, P7599; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	46	57	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23414	10.1371/journal.pone.0023414	http://dx.doi.org/10.1371/journal.pone.0023414			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887250	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000018
J	Yetukuri, L; Huopaniemi, I; Koivuniemi, A; Maranghi, M; Hiukka, A; Nygren, H; Kaski, S; Taskinen, MR; Vattulainen, I; Jauhiainen, M; Oresic, M				Yetukuri, Laxman; Huopaniemi, Ilkka; Koivuniemi, Artturi; Maranghi, Marianna; Hiukka, Anne; Nygren, Heli; Kaski, Samuel; Taskinen, Marja-Riitta; Vattulainen, Ilpo; Jauhiainen, Matti; Oresic, Matej			High Density Lipoprotein Structural Changes and Drug Response in Lipidomic Profiles following the Long-Term Fenofibrate Therapy in the FIELD Substudy	PLOS ONE			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-A-II; TYPE-2 DIABETES-MELLITUS; CHOLESTEROL ACYLTRANSFERASE REACTION; HDL INTERCONVERSION; MOLECULAR-DYNAMICS; METABOLIC SYNDROME; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; HEPATIC LIPASE	In a recent FIELD study the fenofibrate therapy surprisingly failed to achieve significant benefit over placebo in the primary endpoint of coronary heart disease events. Increased levels of atherogenic homocysteine were observed in some patients assigned to fenofibrate therapy but the molecular mechanisms behind this are poorly understood. Herein we investigated HDL lipidomic profiles associated with fenofibrate treatment and the drug-induced Hcy levels in the FIELD substudy. We found that fenofibrate leads to complex HDL compositional changes including increased apoA-II, diminishment of lysophosphatidylcholines and increase of sphingomyelins. Ethanolamine plasmalogens were diminished only in a subgroup of fenofibrate-treated patients with elevated homocysteine levels. Finally we performed molecular dynamics simulations to qualitatively reconstitute HDL particles in silico. We found that increased number of apoA-II excludes neutral lipids from HDL surface and apoA-II is more deeply buried in the lipid matrix than apoA-I. In conclusion, a detailed molecular characterization of HDL may provide surrogates for predictors of drug response and thus help identify the patients who might benefit from fenofibrate treatment.	[Yetukuri, Laxman; Koivuniemi, Artturi; Nygren, Heli; Oresic, Matej] Tech Res Ctr Finland, FIN-02150 Espoo, Finland; [Huopaniemi, Ilkka; Kaski, Samuel] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Helsinki Inst Informat Technol, Espoo, Finland; [Maranghi, Marianna] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy; [Maranghi, Marianna; Hiukka, Anne; Taskinen, Marja-Riitta] Univ Helsinki, Dept Med, Div Cardiol, Helsinki, Finland; [Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Vattulainen, Ilpo] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Espoo, Finland; [Vattulainen, Ilpo] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Jauhiainen, Matti] Natl Inst Hlth & Welf, Helsinki, Finland; [Jauhiainen, Matti; Oresic, Matej] Inst Mol Med Finland, Helsinki, Finland	VTT Technical Research Center Finland; Aalto University; University of Helsinki; Sapienza University Rome; University of Helsinki; Tampere University; Aalto University; University of Southern Denmark; Finland National Institute for Health & Welfare	Yetukuri, L (corresponding author), Tech Res Ctr Finland, FIN-02150 Espoo, Finland.	matej.oresic@vtt.fi	Vattulainen, Ilpo T/G-4224-2014; Kaski, Samuel/B-6684-2008; Taskinen, Marja-Riitta/AAN-5432-2020; Oresic, Matej/AAV-3978-2020; Oresic, Matej/K-7673-2016	Kaski, Samuel/0000-0003-1925-9154; Taskinen, Marja-Riitta/0000-0002-6229-3588; Oresic, Matej/0000-0002-2856-9165; MARANGHI, MARIANNA/0000-0002-3117-7488; Nygren, Heli/0000-0002-6498-7567; Koivuniemi, Artturi/0000-0002-3979-7809	Academy of Finland	Academy of Finland(Academy of Finland)	This work was supported by financial assistance from Academy of Finland (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Arsenault BJ, 2009, ATHEROSCLEROSIS, V206, P276, DOI 10.1016/j.atherosclerosis.2009.01.044; Barter PJ, 2008, ARTERIOSCL THROM VAS, V28, P39, DOI 10.1161/ATVBAHA.107.148817; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bertsch T, 2001, CLIN CHEM LAB MED, V39, P721, DOI 10.1515/CCLM.2001.120; Bolin DJ, 1996, J BIOL CHEM, V271, P19152, DOI 10.1074/jbc.271.32.19152; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; CHAPMAN J, 2011, EUR HEART J, DOI DOI 10.1093/EURHEARTJ/EHR1112; Collet X, 1999, J LIPID RES, V40, P1185; Connelly PW, 1999, CLIN CHIM ACTA, V286, P243, DOI 10.1016/S0009-8981(99)00105-9; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Dierkes J, 1999, LANCET, V354, P219, DOI 10.1016/S0140-6736(99)02153-4; Fournier N, 2001, ATHEROSCLEROSIS, V157, P315, DOI 10.1016/S0021-9150(00)00730-9; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hiukka A, 2007, DIABETOLOGIA, V50, P2067, DOI 10.1007/s00125-007-0751-8; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huopaniemi I, 2010, BIOINFORMATICS, V26, pi391, DOI 10.1093/bioinformatics/btq174; Huopaniemi I, 2009, DATA MIN KNOWL DISC, V19, P261, DOI 10.1007/s10618-009-0142-5; IBDAH JA, 1989, BIOCHIM BIOPHYS ACTA, V1004, P300, DOI 10.1016/0005-2760(89)90077-5; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keating GM, 2007, DRUGS, V67, P121, DOI 10.2165/00003495-200767010-00013; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kotronen A, 2009, DIABETOLOGIA, V52, P684, DOI 10.1007/s00125-009-1282-2; LAGOCKI PA, 1980, J BIOL CHEM, V255, P3701; LAGROST L, 1995, J BIOL CHEM, V270, P13004, DOI 10.1074/jbc.270.22.13004; Li M, 2011, ANAL BIOANAL CHEM, V399, P243, DOI 10.1007/s00216-010-4327-y; Maeba R, 2003, J LIPID RES, V44, P164, DOI 10.1194/jlr.M200340-JLR200; MARANGHI M, 2011, ATHEROSCLEROSIS; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mitsche MA, 2010, J PHYS CHEM B, V114, P3276, DOI 10.1021/jp908730t; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; NAVASIGLESIAS N, 2009, TRAC-TREND ANAL CHEM, V28; Oresic M, 2008, TRENDS BIOTECHNOL, V26, P647, DOI 10.1016/j.tibtech.2008.09.001; Perusse M, 2001, J LIPID RES, V42, P1331; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; PUSSINEN P, 1995, J LIPID RES, V36, P975; Pussinen PJ, 1997, J LIPID RES, V38, P12; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Remick J, 2008, CARDIOL REV, V16, P129, DOI 10.1097/CRD.0b013e31816b43d3; ROSSENEU M, 1981, EUR J BIOCHEM, V117, P347, DOI 10.1111/j.1432-1033.1981.tb06344.x; Rye KA, 1998, J LIPID RES, V39, P613; Sasaki J, 2002, CLIN THER, V24, P1614, DOI 10.1016/S0149-2918(02)80064-9; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; SUBBAIAH PV, 1993, J BIOL CHEM, V268, P20156; Taskinen MR, 2009, ARTERIOSCL THROM VAS, V29, P950, DOI 10.1161/ATVBAHA.108.178228; TASKINEN MR, 1988, ARTERIOSCLEROSIS, V8, P168, DOI 10.1161/01.ATV.8.2.168; VADIVELOO PK, 1990, BIOCHIM BIOPHYS ACTA, V1045, P135, DOI 10.1016/0005-2760(90)90142-K; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vance DE, 2008, N COMP BIOC, P1; VANTORNOUT P, 1981, BIOCHIM BIOPHYS ACTA, V663, P630, DOI 10.1016/0005-2760(81)90073-4; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Wierzbicki Anthony S, 2007, Diab Vasc Dis Res, V4, P143; Yetukuri L, 2010, J LIPID RES, V51, P2341, DOI 10.1194/jlr.M006494	59	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23589	10.1371/journal.pone.0023589	http://dx.doi.org/10.1371/journal.pone.0023589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887280	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000035
J	Appia-Ayme, C; Patrick, E; Sullivan, MJ; Alston, MJ; Field, SJ; AbuOun, M; Anjum, MF; Rowley, G				Appia-Ayme, Corinne; Patrick, Elaine; Sullivan, Matthew J.; Alston, Mark J.; Field, Sarah J.; AbuOun, Manal; Anjum, Muna F.; Rowley, Gary			Novel Inducers of the Envelope Stress Response BaeSR in Salmonella Typhimurium: BaeR Is Critically Required for Tungstate Waste Disposal	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; ALTERNATIVE SIGMA-FACTOR; SHOCK PROTEIN OPERON; ESCHERICHIA-COLI; GENE-EXPRESSION; RPOE GENE; CHROMOSOMAL GENES; RESISTANCE; VIRULENCE; TRANSPORT	The RpoE and CpxR regulated envelope stress responses are extremely important for SalmonellaTyphimurium to cause infection in a range of hosts. Until now the role for BaeSR in both the Salmonella Typhimurium response to stress and its contribution to infection have not been fully elucidated. Here we demonstrate stationary phase growth, iron and sodium tungstate as novel inducers of the BaeRregulon, with BaeR critically required for Salmonella resistance to sodium tungstate. We show that functional overlap between the resistance nodulation-cell division (RND) multidrug transporters, MdtA, AcrD and AcrB exists for the waste disposal of tungstate from the cell. We also point to a role for enterobactinsiderophores in the protection of enteric organisms from tungstate, akin to the scenario in nitrogen fixing bacteria. Surprisingly, BaeR is the first envelope stress response pathway investigated in S. Typhimurium that is not required for murine typhoid in either ity(S) or ity(R) mouse backgrounds. BaeR is therefore either required for survival in larger mammals such as pigs or calves, an avian host such as chickens, or survival out with the host altogether where Salmonella and related enterics must survive in soil and water.	[Appia-Ayme, Corinne; Patrick, Elaine; Sullivan, Matthew J.; Field, Sarah J.; Rowley, Gary] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [AbuOun, Manal; Anjum, Muna F.] Anim Hlth & Vet Labs Agcy Weybridge, Surrey, England; [Alston, Mark J.] Genome Anal Ctr, Norwich, Norfolk, England	University of East Anglia; Veterinary Laboratories Agency; The Genome Analysis Centre (TGAC)	Appia-Ayme, C (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	c.appia-ayme@uea.ac.uk; g.rowley@uea.ac.uk	Sullivan, Matthew J/C-3857-2009; anjum, muna/C-5213-2011; ABUOUN, MANAL/D-8456-2011; Rowley, Gary/F-7869-2011	Sullivan, Matthew J/0000-0003-2276-3132; Alston, Mark/0000-0002-1645-3982	Biotechnology and Biological Sciences Research Council (United Kingdom) [BB/G020582/1]; BBSRC [BB/G020582/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020582/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (United Kingdom), grant ref BB/G020582/1, http://www.bbsrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston MJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-73; Andreesen JR, 2008, ANN NY ACAD SCI, V1125, P215, DOI 10.1196/annals.1419.003; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Becker LA, 2005, MOL MICROBIOL, V56, P1004, DOI 10.1111/j.1365-2958.2005.04604.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Braun V, 2002, FEBS LETT, V529, P78, DOI 10.1016/S0014-5793(02)03185-X; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; BRISSETTE JL, 1991, J MOL BIOL, V220, P35, DOI 10.1016/0022-2836(91)90379-K; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cornish AS, 2000, APPL ENVIRON MICROB, V66, P1580, DOI 10.1128/AEM.66.4.1580-1586.2000; Craig JE, 2002, INFECT IMMUN, V70, P708, DOI 10.1128/IAI.70.2.708-715.2002; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DONG JM, 1993, GENE, V136, P227; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GEMSKI P, 1967, J BACTERIOL, V93, P1588, DOI 10.1128/JB.93.5.1588-1597.1967; Helling RB, 2002, J BACTERIOL, V184, P3699, DOI 10.1128/JB.184.13.3699-3703.2002; Hirakawa H, 2003, J ANTIMICROB CHEMOTH, V52, P576, DOI 10.1093/jac/dkg406; HIRATSU K, 1995, J BACTERIOL, V177, P2918, DOI 10.1128/jb.177.10.2918-2922.1995; Humphreys S, 1999, INFECT IMMUN, V67, P1560; Imperial J, 1998, BBA-BIOMEMBRANES, V1370, P337, DOI 10.1016/S0005-2736(98)00003-0; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x; Kenyon WJ, 2002, MICROBIOL-SGM, V148, P113, DOI 10.1099/00221287-148-1-113; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; LEBLANC SK, 2011, J BACTERIOL; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Miticka H, 2003, FEMS MICROBIOL LETT, V226, P307, DOI 10.1016/S0378-1097(03)00600-1; Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x; NAGASAWA S, 1993, J BIOCHEM-TOKYO, V114, P350, DOI 10.1093/oxfordjournals.jbchem.a124180; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Pullinger GD, 2010, MICROBIOL-SGM, V156, P3108, DOI 10.1099/mic.0.041830-0; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Skovierova H, 2006, MICROBIOL-SGM, V152, P1347, DOI 10.1099/mic.0.28744-0; Smart JP, 2009, MOL MICROBIOL, V74, P742, DOI 10.1111/j.1365-2958.2009.06902.x; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; TAKAHASHI H, 1957, BIOCHIM BIOPHYS ACTA, V23, P433, DOI 10.1016/0006-3002(57)90351-7; Tedin K, 1996, J BIOL CHEM, V271, P17675, DOI 10.1074/jbc.271.30.17675; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191; Wichard T, 2008, ENVIRON SCI TECHNOL, V42, P2408, DOI 10.1021/es702651f; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yamamoto K, 2008, J BIOTECHNOL, V133, P196, DOI 10.1016/j.jbiotec.2007.08.002; Ygberg SE, 2006, INFECT IMMUN, V74, P1243, DOI 10.1128/IAI.74.2.1243-1254.2006; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zoetendal EG, 2008, APPL ENVIRON MICROB, V74, P535, DOI 10.1128/AEM.02271-07	62	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23713	10.1371/journal.pone.0023713	http://dx.doi.org/10.1371/journal.pone.0023713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886814	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500026
J	Cui, P; Lin, Q; Zhang, LF; Ding, F; Xin, CQ; Zhang, DY; Sun, FL; Hu, SN; Yu, J				Cui, Peng; Lin, Qiang; Zhang, Lingfang; Ding, Feng; Xin, Chengqi; Zhang, Daoyong; Sun, Fanglin; Hu, Songnian; Yu, Jun			The Disequilibrium of Nucleosomes Distribution along Chromosomes Plays a Functional and Evolutionarily Role in Regulating Gene Expression	PLOS ONE			English	Article							HIGH-RESOLUTION; ORGANIZATION; OCCUPANCY; SEQUENCE; TRANSPORT; REVEALS; REGIONS	To further understand the relationship between nucleosome-space occupancy (NO) and global transcriptional activity in mammals, we acquired a set of genome-wide nucleosome distribution and transcriptome data from the mouse cerebrum and testis based on ChIP (H3)-seq and RNA-seq, respectively. We identified a nearly consistent NO patterns among three mouse tissues-cerebrum, testis, and ESCs- and found, through clustering analysis for transcriptional activation, that the NO variations among chromosomes are closely associated with distinct expression levels between house-keeping (HK) genes and tissue-specific (TS) genes. Both TS and HK genes form clusters albeit the obvious majority. This feature implies that NO patterns, i.e. nucleosome binding and clustering, are coupled with gene clustering that may be functionally and evolutionarily conserved in regulating gene expression among different cell types.	[Cui, Peng; Lin, Qiang; Zhang, Lingfang; Ding, Feng; Xin, Chengqi; Hu, Songnian; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Zhang, Daoyong; Sun, Fanglin] Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China; [Cui, Peng; Ding, Feng] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Lin, Qiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Tsinghua University; King Abdullah University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, P (corresponding author), Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	husn@big.ac.cn; junyu@big.ac.cn	郑, 征/C-8514-2011; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111; Ding, Feng/0000-0001-8237-4062	National Basic Research Program (973 Program) [2011CB944100, 2011CB944101]; National Natural Science Foundation of China [90919024]; Chinese Academy of Sciences [KSCX2-EW-R-01-04]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program (973 Program; 2011CB944100 and 2011CB944101), National Natural Science Foundation of China (90919024), and Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-01-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi AS, 2003, WASTE MANAGE RES, V21, P474, DOI 10.1177/0734242X0302100510; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Chung HR, 2009, J MOL BIOL, V386, P1411, DOI 10.1016/j.jmb.2008.11.049; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cui P, 2010, BIOCHEM BIOPH RES CO, V391, P884, DOI 10.1016/j.bbrc.2009.11.157; Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nili EL, 2010, GENOME RES, V20, P1361, DOI 10.1101/gr.103945.109; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Shimizu M, 1993, Tanpakushitsu Kakusan Koso, V38, P971; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Westenberger SJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-610; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	38	12	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23219	10.1371/journal.pone.0023219	http://dx.doi.org/10.1371/journal.pone.0023219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886783	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100008
J	Koyanagi, M; Asahara, S; Matsuda, T; Hashimoto, N; Shigeyama, Y; Shibutani, Y; Kanno, A; Fuchita, M; Mikami, T; Hosooka, T; Inoue, H; Matsumoto, M; Koike, M; Uchiyama, Y; Noda, T; Seino, S; Kasuga, M; Kido, Y				Koyanagi, Maki; Asahara, Shun-ichiro; Matsuda, Tomokazu; Hashimoto, Naoko; Shigeyama, Yutaka; Shibutani, Yuki; Kanno, Ayumi; Fuchita, Megumi; Mikami, Tomoko; Hosooka, Tetsutya; Inoue, Hiroshi; Matsumoto, Michihiro; Koike, Masato; Uchiyama, Yasuo; Noda, Tetsuo; Seino, Susumu; Kasuga, Masato; Kido, Yoshiaki			Ablation of TSC2 Enhances Insulin Secretion by Increasing the Number of Mitochondria through Activation of mTORC1	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TUBEROUS SCLEROSIS GENE; PROTEIN-KINASE; RENAL CARCINOGENESIS; NATURAL-HISTORY; SKELETAL-MUSCLE; PKC-LAMBDA; MICE; BIOGENESIS; RESISTANCE	Aim: We previously found that chronic tuberous sclerosis protein 2 (TSC2) deletion induces activation of mammalian target of rapamycin Complex 1 (mTORC1) and leads to hypertrophy of pancreatic beta cells from pancreatic beta cell-specific TSC2 knockout (beta TSC2(-/-)) mice. The present study examines the effects of TSC2 ablation on insulin secretion from pancreatic beta cells. Methods: Isolated islets from beta TSC2(-/-) mice and TSC2 knockdown insulin 1 (INS-1) insulinoma cells treated with small interfering ribonucleic acid were used to investigate insulin secretion, ATP content and the expression of mitochondrial genes. Results: Activation of mTORC1 increased mitochondrial DNA expression, mitochondrial density and ATP production in pancreatic beta cells of beta TSC2(-/-) mice. In TSC2 knockdown INS-1 cells, mitochondrial DNA expression, mitochondrial density and ATP production were increased compared with those in control INS-1 cells, consistent with the phenotype of beta TSC2(-/-) mice. TSC2 knockdown INS-1 cells also exhibited augmented insulin secretory response to glucose. Rapamycin inhibited mitochondrial DNA expression and ATP production as well as insulin secretion in response to glucose. Thus, beta TSC2(-/-) mice exhibit hyperinsulinemia due to an increase in the number of mitochondria as well as enlargement of individual beta cells via activation of mTORC1 Conclusion: Activation of mTORC1 by TSC2 ablation increases mitochondrial biogenesis and enhances insulin secretion from pancreatic beta cells.	[Koyanagi, Maki; Asahara, Shun-ichiro; Matsuda, Tomokazu; Hashimoto, Naoko; Shigeyama, Yutaka; Shibutani, Yuki; Kanno, Ayumi; Hosooka, Tetsutya; Seino, Susumu; Kido, Yoshiaki] Kobe Univ, Div Diabet & Endocrinol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 657, Japan; [Fuchita, Megumi; Mikami, Tomoko; Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 657, Japan; [Inoue, Hiroshi] Kanazawa Univ, Frontier Sci Org, Kanazawa, Ishikawa, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan; [Matsumoto, Michihiro; Kasuga, Masato] Natl Ctr Global Hlth & Med, Res Inst, Tokyo, Japan	Kobe University; Kobe University; Kobe University; Kanazawa University; Juntendo University; Japanese Foundation for Cancer Research; National Center for Global Health & Medicine - Japan	Koyanagi, M (corresponding author), Kobe Univ, Div Diabet & Endocrinol, Grad Sch Med, Kobe, Hyogo 657, Japan.	kido@med.kobe-u.ac.jp	Noda, Tetsuo/B-1667-2016; Asahara, Shun-ichiro/I-6645-2019; Koike, Masato/F-9584-2010	Asahara, Shun-ichiro/0000-0001-6661-9402; Koike, Masato/0000-0002-3174-5684; Inoue, Hiroshi/0000-0002-7724-6637	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT [18GS0317, 22590981]; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Scientific Research [22790863, 22790861, 21249057, 23300274] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for the Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, to M. Kasuga; a Grant-in-Aid for Creative Scientific Research from MEXT to M. Kasuga (18GS0317), a Grant-in-Aid for Scientific Research from MEXT to Y. Kido (22590981) and the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN) to H. Inoue. The funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Asahara S, 2009, BIOCHEM BIOPH RES CO, V381, P367, DOI 10.1016/j.bbrc.2009.02.047; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hino O, 2003, GENE CHROMOSOME CANC, V38, P357, DOI 10.1002/gcc.10265; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwabu M., NATURE, V464; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kobayashi T, 1999, CANCER RES, V59, P1206; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; LEAHY JL, 1990, DIABETES CARE, V13, P992, DOI 10.2337/diacare.13.9.992; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; NELLIST M, 1993, CELL, V75, P1305; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rutter GA, 2009, MOL CELL ENDOCRINOL, V297, P41, DOI 10.1016/j.mce.2008.05.020; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soejima A, 1996, J BIOL CHEM, V271, P26194, DOI 10.1074/jbc.271.42.26194; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	48	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23238	10.1371/journal.pone.0023238	http://dx.doi.org/10.1371/journal.pone.0023238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886784	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100009
J	Xu, ZS; Du, X; Li, TT; Gan, F; Tang, B; Tang, XF				Xu, Zhisheng; Du, Xin; Li, Tingting; Gan, Fei; Tang, Bing; Tang, Xiao-Feng			Functional Insight into the C-Terminal Extension of Halolysin SptA from Haloarchaeon Natrinema sp J7	PLOS ONE			English	Article							ALKALINE SERINE-PROTEASE; COLLAGEN-BINDING DOMAIN; CRYSTAL-STRUCTURE; GENE CLONING; EXTRACELLULAR PROTEASE; DISULFIDE BOND; SUBTILISIN; EXPRESSION; STABILIZATION; REQUIREMENT	Halolysin SptA from haloarchaeon Natrinema sp. J7 consists of a subtilisin-like catalytic domain and a C-terminal extension (CTE) containing two cysteine residues. In this report, we have investigated the function of the CTE using recombinant enzymes expressed in Haloferax volcanii WFD11. Deletion of the CTE greatly reduced but did not abolish protease activity, which suggests that the CTE is not essential for enzyme folding. Mutational analysis suggests that residues Cys303 and Cys338 within the CTE form a disulfide bond that make this domain resistant to autocleavage and proteolysis under hypotonic conditions. Characterization of full-length and CTE-truncation enzymes indicates the CTE not only confers extra stability to the enzyme but also assists enzyme activity on protein substrates by facilitating binding at high salinities. Interestingly, homology modeling of the CTE yields a beta-jelly roll-like structure similar to those seen in Claudin-binding domain of Clostridium perfringens enterotoxin (clostridial C-CPE) and collagen binding domain (CBD), and the CTE also possesses collagen-binding activity, making it a potential candidate as an anchoring unit in drug delivery systems.	[Xu, Zhisheng; Du, Xin; Li, Tingting; Gan, Fei; Tang, Bing; Tang, Xiao-Feng] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Xu, ZS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	tangxf@whu.edu.cn	Gan, Fei/I-8599-2017		National Natural Science Foundation of China [30870063, 30970071]; Natural Science Foundation of Hubei Province [2007ABB022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported in part by the National Natural Science Foundation of China (30870063 and 30970071) and the Natural Science Foundation of Hubei Province for Distinguished Young Scientists (2007ABB022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian Y, 2006, FEBS LETT, V580, P6007, DOI 10.1016/j.febslet.2006.09.068; Brown CK, 2005, P NATL ACAD SCI USA, V102, P18391, DOI 10.1073/pnas.0504954102; Capiralla H, 2002, PROCESS BIOCHEM, V38, P571, DOI 10.1016/S0032-9592(02)00180-2; Cheng GY, 2009, MICROBIOL-SGM, V155, P3661, DOI 10.1099/mic.0.031336-0; CLINE SW, 1989, CAN J MICROBIOL, V35, P148, DOI 10.1139/m89-022; De Castro RE, 2006, FEMS MICROBIOL REV, V30, P17, DOI 10.1111/j.1574-6976.2005.00003.x; De Castro RE, 2008, EXTREMOPHILES, V12, P677, DOI 10.1007/s00792-008-0174-6; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Foophow T, 2010, J MOL BIOL, V400, P865, DOI 10.1016/j.jmb.2010.05.064; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GRIFFIN HL, 1992, CURR MICROBIOL, V24, P111, DOI 10.1007/BF01570907; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Kagawa TF, 2009, J MOL BIOL, V386, P754, DOI 10.1016/j.jmb.2008.12.074; KAMEKURA M, 1992, J BACTERIOL, V174, P736, DOI 10.1128/jb.174.3.736-742.1992; Kamekura M, 1996, BBA-PROTEIN STRUCT M, V1294, P159, DOI 10.1016/0167-4838(96)00016-7; Kim DW, 2000, BIOCHEM BIOPH RES CO, V277, P216, DOI 10.1006/bbrc.2000.3657; Kim JS, 2004, J MOL BIOL, V335, P787, DOI 10.1016/j.jmb.2003.11.006; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P17223, DOI 10.1073/pnas.0907587106; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; RYU KG, 1994, ENZYME MICROB TECH, V16, P266, DOI 10.1016/0141-0229(94)90165-1; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shi WL, 2006, EXTREMOPHILES, V10, P599, DOI 10.1007/s00792-006-0003-8; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Wang CC, 2009, J BIOL CHEM, V284, P10957, DOI 10.1074/jbc.M807624200; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107	36	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23562	10.1371/journal.pone.0023562	http://dx.doi.org/10.1371/journal.pone.0023562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886797	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100019
J	Yu, SL; Wong, CK; Wong, PTY; Chen, DP; Szeto, CC; Li, EK; Tam, LS				Yu, Shui-Lian; Wong, Chun-Kwok; Wong, Purple Tsz-Yan; Chen, Da-Peng; Szeto, Cheuk-Chun; Li, Edmund K.; Tam, Lai-Shan			Down-Regulated NOD2 by Immunosuppressants in Peripheral Blood Cells in Patients with SLE Reduces the Muramyl Dipeptide-Induced IL-10 Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; HUMAN B-LYMPHOCYTES; EPSTEIN-BARR-VIRUS; T-HELPER-CELL; DISEASE-ACTIVITY; CYTOKINE PRODUCTION; AUTOIMMUNE-DISEASE; CROHNS-DISEASE; MYCOBACTERIUM-TUBERCULOSIS	Background: Pattern recognition receptors (PRRs) such as Toll-like receptors are aberrantly expressed of peripheral blood mononuclear cells (PBMCs) in systemic lupus erythematosus (SLE) patients, for playing immunopathological roles. Methodology/Principal Findings: We investigated the expression and function of the PRR nucleotide-binding oligomerization domain (NOD2) in SLE. NOD2 expression in T, B lymphocytes, monocytes, myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) was assessed in SLE patients and healthy controls (HCs) using flow cytometric analysis. Ex vivo production of cytokines from PBMCs upon NOD2 agonist muramyl dipeptide (MDP) stimulation was assessed using Cytometric Bead Array. Over-expression of NOD2 in monocytes was observed in immunosuppressant naive SLE patients, and was positively associated with longer disease duration. Immunosuppressive therapy was an independent explanatory variable for downregulating NOD2 expression in CD8+ T, monocytes, mDCs and pDCs. Ex vivo basal productions of cytokines (IL-6, IL-8 and IL-10) were significantly increased in immunosuppressant naive patients and patients with active disease despite immunosuppressants compared with HCs. Upon MDP stimulaiton, relative induction (%) of cytokines (IL-1 beta) from PBMC was significantly increased in immunosuppressant naive patients with inactive disease, and patients with active disease despite immunosuppressant treatment compared with HCs. Immunosuppressant usage was associated with a decreased basal production and MDP induced relative induction (%) of IL-10 in patients with inactive disease compared with immunosuppressant naive patients and HCs. Conclusions/Significance: Bacterial exposure may increase the NOD2 expression in monocytes in immunosuppressant naive SLE patients which can subsequently lead to aberrant activation of PBMCs to produce proinflammatory cytokines, implicating the innate immune response for extracellular pathogens in the immunopathological mechanisms in SLE. Immunosuppressant therapy may downregulate NOD2 expression in CD8+ T lymphocytes, monocytes, and DCs in SLE patients which subsequently IL-10 reduction, contributing towards the regulation of immunopathological mechanisms of SLE, at the expense of increasing risk of bacterial infection.	[Yu, Shui-Lian; Szeto, Cheuk-Chun; Li, Edmund K.; Tam, Lai-Shan] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Wong, Chun-Kwok; Wong, Purple Tsz-Yan; Chen, Da-Peng] Chinese Univ Hong Kong, Dept Chem Pathol, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Chen, Da-Peng] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab, Chongqing, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chongqing Medical University	Yu, SL (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China.	lstam@cuhk.edu.hk	Wong, CK/H-3256-2016; Szeto, Cheuk Chun/N-4954-2015; Tam, Lai-Shan/U-7044-2019; Tam, Lai-Shan/K-4980-2014	Wong, CK/0000-0002-5637-8331; Szeto, Cheuk Chun/0000-0002-8898-8505; Tam, Lai-Shan/0000-0001-6410-8852; Tam, Lai-Shan/0000-0001-6410-8852; Yu, Shui Lian/0000-0002-0739-1441	The Chinese University of Hong Kong	The Chinese University of Hong Kong(Chinese University of Hong Kong)	This study is supported by research grant from The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Al-Mutairi S, 2007, RHEUMATOL INT, V27, P621, DOI 10.1007/s00296-006-0268-3; Beebe AM, 2002, CYTOKINE GROWTH F R, V13, P403, DOI 10.1016/S1359-6101(02)00025-4; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brennan FM, 1996, CURR OPIN IMMUNOL, V8, P872, DOI 10.1016/S0952-7915(96)80018-5; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dean GS, 2000, ANN RHEUM DIS, V59, P243, DOI 10.1136/ard.59.4.243; DING L, 1993, J IMMUNOL, V151, P1224; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Doria A, 2004, ARTHRIT RHEUM-ARTHR, V51, P989, DOI 10.1002/art.20837; Ferreiros-Vidal I, 2003, RHEUMATOLOGY, V42, P570, DOI 10.1093/rheumatology/keg192; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; HANDWERGER BS, 1994, SPRINGER SEMIN IMMUN, V16, P153, DOI 10.1007/BF00197515; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; HEDL M, 2011, J BIOL CHEM; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Joosten LAB, 2008, P NATL ACAD SCI USA, V105, P9017, DOI 10.1073/pnas.0710445105; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Khan N, 2010, HUM IMMUNOL, V71, P372, DOI 10.1016/j.humimm.2010.01.018; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Koval'chuk L. V., 2011, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P93; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Lacki JK, 1997, CLIN RHEUMATOL, V16, P275, DOI 10.1007/BF02238963; Lecat A, 2010, BIOCHEM PHARMACOL, V80, P2021, DOI 10.1016/j.bcp.2010.07.016; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lun SWM, 2009, J CLIN IMMUNOL, V29, P330, DOI 10.1007/s10875-008-9269-1; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; MALEFYT RD, 1991, J EXP MED, V174, P915; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Means TK, 1999, J IMMUNOL, V163, P3920; Miyazaki M, 2008, J MED VIROL, V80, P980, DOI 10.1002/jmv.21174; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ospelt C, 2009, ARTHRITIS RHEUM, V60, P355, DOI 10.1002/art.24226; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Ribeiro FM, 2010, CLIN REV ALLERG IMMU, V38, P163, DOI 10.1007/s12016-009-8149-7; Rosenzweig HL, 2008, J LEUKOCYTE BIOL, V84, P529, DOI 10.1189/jlb.0108015; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Sabry A, 2006, CYTOKINE, V35, P148, DOI 10.1016/j.cyto.2006.07.023; Schiffenbauer J, 2004, LUPUS, V13, P398, DOI 10.1191/0961203303lu1033oa; Segal R, 1997, J IMMUNOL, V158, P3009; Shin JN, 2010, IMMUNOL CELL BIOL, V88, P343, DOI 10.1038/icb.2010.19; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; Tam LS, 2004, ARTHRITIS RHEUM-US, V50, P3619, DOI 10.1002/art.20616; Tam LS, 2002, SCAND J RHEUMATOL, V31, P296, DOI 10.1080/030097402760375205; Tomita H, 2003, CLIN EXP RHEUMATOL, V21, P497; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; Van Beek MJ, 2001, DERMATOL CLIN, V19, P147, DOI 10.1016/S0733-8635(05)70236-9; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; Verdolini R, 2002, BRIT J DERMATOL, V146, P877, DOI 10.1046/j.1365-2133.2002.04627.x; Voronov E, 2006, EUR CYTOKINE NETW, V17, P109; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Zandman-Goddard G, 2003, CLIN REV ALLERG IMMU, V25, P29, DOI 10.1385/CRIAI:25:1:29; Zandman-Goddard G, 2005, AUTOIMMUNITY, V38, P473, DOI 10.1080/08916930500285352	71	16	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23855	10.1371/journal.pone.0023855	http://dx.doi.org/10.1371/journal.pone.0023855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886831	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100037
J	Marquez-Villavicencio, MD; Weber, B; Witherell, RA; Willis, DK; Charkowski, AO				Marquez-Villavicencio, Maria del Pilar; Weber, Brooke; Witherell, R. Andrews; Willis, David K.; Charkowski, Amy O.			The 3-Hydroxy-2-Butanone Pathway Is Required for Pectobacterium carotovorum Pathogenesis	PLOS ONE			English	Article							BACTERIAL SOFT-ROT; SEED-CORN MAGGOT; ERWINIA-CAROTOVORA; VAR ATROSEPTICA; INSECT TRANSMISSION; BACILLUS-SUBTILIS; SUBSP CAROTOVORA; MATE CHOICE; GENES; ACETOIN	Pectobacterium species are necrotrophic bacterial pathogens that cause soft rot diseases in potatoes and several other crops worldwide. Gene expression data identified Pectobacterium carotovorum subsp. carotovorum budB, which encodes the alpha-acetolactate synthase enzyme in the 2,3-butanediol pathway, as more highly expressed in potato tubers than potato stems. This pathway is of interest because volatiles produced by the 2,3-butanediol pathway have been shown to act as plant growth promoting molecules, insect attractants, and, in other bacterial species, affect virulence and fitness. Disruption of the 2,3-butanediol pathway reduced virulence of P. c. subsp. carotovorum WPP14 on potato tubers and impaired alkalinization of growth medium and potato tubers under anaerobic conditions. Alkalinization of the milieu via this pathway may aid in plant cell maceration since Pectobacterium pectate lyases are most active at alkaline pH.	[Marquez-Villavicencio, Maria del Pilar; Weber, Brooke; Witherell, R. Andrews; Willis, David K.; Charkowski, Amy O.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Willis, David K.] USDA, Agr Res Serv, Vegetable Crops Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Marquez-Villavicencio, MD (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	acharkowski@plantpath.wisc.edu		Charkowski, Amy/0000-0002-8913-2071	National Science Foundation [0412599]; United States Department of Agriculture [2006-398 35319-17396]; Wisconsin Potato and Vegetable Growers Association	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Wisconsin Potato and Vegetable Growers Association	This work was funded by the National Science Foundation Genomics in the Environment Program award number 0412599, the United States Department of Agriculture NRI program grant 2006-398 35319-17396, and the Wisconsin Potato and Vegetable Growers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Bengtsson JM, 2009, J CHEM ECOL, V35, P1063, DOI 10.1007/s10886-009-9684-7; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128/AEM.01073-08; BRENNER DJ, 2004, PROTEOBACTERIA; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUTTERY RG, 1984, J AGR FOOD CHEM, V32, P254, DOI 10.1021/jf00122a019; Byers JT, 2002, J BACTERIOL, V184, P1163, DOI 10.1128/jb.184.4.1163-1171.2002; Cho SM, 2008, MOL PLANT MICROBE IN, V21, P1067, DOI 10.1094/MPMI-21-8-1067; Dalmacio SC, 2007, PLANT DIS, V91, P346, DOI 10.1094/PDIS-91-4-0346; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DINDONIS LL, 1980, ENVIRON ENTOMOL, V9, P467, DOI 10.1093/ee/9.4.467; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; FRUND C, 1989, J BACTERIOL, V171, P6539; Geraats BPJ, 2003, PHYTOPATHOLOGY, V93, P813, DOI 10.1094/PHYTO.2003.93.7.813; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; Glasner JD, 2003, NUCLEIC ACIDS RES, V31, P147, DOI 10.1093/nar/gkg125; Glasner JD, 2006, NUCLEIC ACIDS RES, V34, pD41, DOI 10.1093/nar/gkj164; Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; GRUNDY FJ, 1993, MOL MICROBIOL, V10, P259, DOI 10.1111/j.1365-2958.1993.tb01952.x; HABERLACH GT, 1985, PLANT SCI, V39, P67, DOI 10.1016/0168-9452(85)90194-3; HARRISON M D, 1977, Potato Research, V20, P37, DOI 10.1007/BF02362299; HOWARD CM, 1963, PHYTOPATHOLOGY, V53, P1190; Hsieh SC, 2007, MICROBES INFECT, V9, P1402, DOI 10.1016/j.micinf.2007.07.004; Huang M, 1999, J BACTERIOL, V181, P3837, DOI 10.1128/JB.181.12.3837-3841.1999; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; JOHANSEN L, 1975, J BACTERIOL, V123, P1124, DOI 10.1128/JB.123.3.1124-1130.1975; KLOEPPER JW, 1979, AM POTATO J, V56, P351, DOI 10.1007/BF02853850; KLOEPPER JW, 1981, AM POTATO J, V58, P585, DOI 10.1007/BF02853468; KLOEPPER JW, 1981, AM POTATO J, V58, P165, DOI 10.1007/BF02854416; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2010, J BACTERIOL, V192, P4181, DOI 10.1128/JB.00193-10; Kramer-Haimovich H, 2006, APPL ENVIRON MICROB, V72, P1034, DOI 10.1128/AEM.72.2.1034-1039.2006; LEACH J. G., 1933, ZEITSCHR ANGEW ENT, V20, P150; Leach JG, 1931, PHYTOPATHOLOGY, V21, P387; Leach JG, 1926, PHYTOPATHOLOGY, V16, P149; LEI SP, 1988, GENE, V62, P159, DOI 10.1016/0378-1119(88)90590-2; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Levine M, 1916, J BACTERIOL, V1, P153, DOI 10.1128/JB.1.2.153-164.1916; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Llama-Palacios A, 2002, APPL ENVIRON MICROB, V68, P1624, DOI 10.1128/AEM.68.4.1624-1630.2002; LOPEZ JM, 1975, EUR J BIOCHEM, V57, P425, DOI 10.1111/j.1432-1033.1975.tb02317.x; Lui LH, 2005, AM J POTATO RES, V82, P1, DOI 10.1007/BF02894914; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; MOLINA JJ, 1974, AM POTATO J, V51, P245, DOI 10.1007/BF02851435; MOONS P, 2011, APPL ENV MICROBIOL; Moore AJ, 2001, P ROY SOC B-BIOL SCI, V268, P517, DOI 10.1098/rspb.2000.1399; Moore AJ, 2003, J EVOLUTION BIOL, V16, P523, DOI 10.1046/j.1420-9101.2003.00527.x; Moore AJ, 2002, AM NAT, V160, pS186, DOI 10.1086/342899; Moore AJ, 1999, P ROY SOC B-BIOL SCI, V266, P711, DOI 10.1098/rspb.1999.0694; Nachin L, 2000, MOL PLANT MICROBE IN, V13, P882, DOI 10.1094/MPMI.2000.13.8.882; Noel JT, 2010, MOL PLANT MICROBE IN, V23, P273, DOI 10.1094/MPMI-23-3-0273; Nout MJR, 1998, J CHEM ECOL, V24, P1217, DOI 10.1023/A:1022451020013; PEROMBELON MCM, 1979, PHYTOPATHOLOGY, V69, P167, DOI 10.1094/Phyto-69-167; PHILLIPS JA, 1982, PHYTOPATHOLOGY, V72, P898, DOI 10.1094/Phyto-72-898; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; RENNA MC, 1993, J BACTERIOL, V175, P3863, DOI 10.1128/JB.175.12.3863-3875.1993; RIED JL, 1986, APPL ENVIRON MICROB, V52, P305, DOI 10.1128/AEM.52.2.305-310.1986; Robacker DC, 2002, J CHEM ECOL, V28, P1549, DOI 10.1023/A:1019920328062; Rochat D, 2002, J CHEM ECOL, V28, P479, DOI 10.1023/A:1014531810037; ROTENBERG DT, 2006, VIROLOGICAL METHODS, P1; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Sambrook J, 2001, MOL CLONING LAB MANU; THIND BS, 1976, CURR SCI INDIA, V45, P117; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; van Rooy FGBGJ, 2007, AM J RESP CRIT CARE, V176, P498, DOI 10.1164/rccm.200611-1620OC; Vikram A, 2006, ANN APPL BIOL, V148, P17, DOI 10.1111/j.1744-7348.2005.00036.x; Wells JM, 1997, PLANT DIS, V81, P867, DOI 10.1094/PDIS.1997.81.8.867; Wevers E, 2009, INT J FOOD MICROBIOL, V134, P63, DOI 10.1016/j.ijfoodmicro.2008.12.017; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Yap MN, 2004, APPL ENVIRON MICROB, V70, P3013, DOI 10.1128/AEM.70.5.3013-3023.2004; Yoon SS, 2006, INFECT IMMUN, V74, P6547, DOI 10.1128/IAI.00695-06	78	45	45	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22974	10.1371/journal.pone.0022974	http://dx.doi.org/10.1371/journal.pone.0022974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876734	Green Submitted, gold, Green Published			2022-12-25	WOS:000294126900006
J	Xu, X; Gupta, S; Hu, WL; McGrath, BC; Cavener, DR				Xu, Xu; Gupta, Sounak; Hu, Wenli; McGrath, Barbara C.; Cavener, Douglas R.			Hyperthermia Induces the ER Stress Pathway	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; HEAT-SHOCK RESPONSE; GLUCOSE-REGULATED PROTEIN; PERK EIF2-ALPHA KINASE; ENDOPLASMIC-RETICULUM; TRANSLATION INITIATION; EXPRESSION; MICE; PHOSPHORYLATION; RECOVERY	Background: The ER chaperone GRP78/BiP is a homolog of the Hsp70 family of heat shock proteins, yet GRP78/BiP is not induced by heat shock but instead by ER stress. However, previous studies had not considered more physiologically relevant temperature elevation associated with febrile hyperthermia. In this report we examine the response of GRP78/BiP and other components of the ER stress pathway in cells exposed to 40 degrees C. Methodology: AD293 cells were exposed to 43 degrees C heat shock to confirm inhibition of the ER stress response genes. Five mammalian cell types, including AD293 cells, were then exposed to 40 degrees C hyperthermia for various time periods and induction of the ER stress pathway was assessed. Principal Findings: The inhibition of the ER stress pathway by heat shock (43 degrees C) was confirmed. In contrast cells subjected to more mild temperature elevation (40 degrees C) showed either a partial or full ER stress pathway induction as determined by downstream targets of the three arms of the ER stress pathway as well as a heat shock response. Cells deficient for Perk or Gcn2 exhibit great sensitivity to ER stress induction by hyperthermia. Conclusions: The ER stress pathway is induced partially or fully as a consequence of hyperthermia in parallel with induction of Hsp70. These findings suggest that the ER and cytoplasm of cells contain parallel pathways to coordinately regulate adaptation to febrile hyperthermia associated with disease or infection.	[Xu, Xu; Gupta, Sounak; Hu, Wenli; McGrath, Barbara C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Xu, X (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu			National Institutes of Health [R01-GM56957]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Institutes of Health (R01-GM56957) to D. R. C. and from the American Heart Association fellowship to S. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; CHANG SC, 1987, P NATL ACAD SCI USA, V84, P680, DOI 10.1073/pnas.84.3.680; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; DIDOMENICO BJ, 1982, CELL, V31, P593, DOI 10.1016/0092-8674(82)90315-4; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; DUNCAN RF, 1995, BIOCHEMISTRY-US, V34, P2985, DOI 10.1021/bi00009a030; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; IKEGUCHI M, 1991, DNA CELL BIOL, V10, P639, DOI 10.1089/dna.1991.10.639; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LINDQUIST S, 1975, P NATL ACAD SCI USA, V72, P1117, DOI 10.1073/pnas.72.3.1117; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; MURTHARIEL P, 1993, J BIOL CHEM, V268, P12946; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; SITIA R, 2004, SCI STKE, pPE27; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	40	43	44	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23740	10.1371/journal.pone.0023740	http://dx.doi.org/10.1371/journal.pone.0023740			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876766	Green Submitted, Green Published, gold			2022-12-25	WOS:000294126900038
J	Shapiro, MD; Bagley, J; Latz, J; Godwin, JG; Ge, XP; Tullius, SG; Iacomini, J				Shapiro, Michael D.; Bagley, Jessamyn; Latz, Jeff; Godwin, Jonathan G.; Ge, Xupeng; Tullius, Stefan G.; Iacomini, John			MicroRNA Expression Data Reveals a Signature of Kidney Damage following Ischemia Reperfusion Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; EPITHELIAL-CELLS	Ischemia reperfusion injury (IRI) is a leading cause of acute kidney injury, a common problem worldwide associated with significant morbidity and mortality. We have recently examined the role of microRNAs (miRs) in renal IRI using expression profiling. Here we conducted mathematical analyses to determine if differential expression of miRs can be used to define a biomarker of renal IRI. Principal component analysis (PCA) was combined with spherical geometry to determine whether samples that underwent renal injury as a result of IRI can be distinguished from controls based on alterations in miR expression using our data set consisting of time series measuring 571 miRs. Using PCA, we examined whether changes in miR expression in the kidney following IRI have a distinct direction when compared to controls based on the trajectory of the first three principal components (PCs) for our time series. We then used Monte Carlo methods and spherical geometry to assess the statistical significance of these directions. We hypothesized that if IRI and control samples exhibit distinct directions, then miR expression can be used as a biomarker of injury. Our data reveal that the pattern of miR expression in the kidney following IRI has a distinct direction based on the trajectory of the first three PCs and can be distinguished from changes observed in sham controls. Analyses of samples from immunodeficient mice indicated that the changes in miR expression observed following IRI were lymphocyte independent, and therefore represent a kidney intrinsic response to injury. Together, these data strongly support the notion that IRI results in distinct changes in miR expression that can be used as a biomarker of injury.	[Shapiro, Michael D.; Latz, Jeff] Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Pathol, Boston, MA 02111 USA; [Bagley, Jessamyn; Iacomini, John] Tufts Med Ctr, Translat Immunol Sci Ctr, Mol Cardiol Res Ctr, Boston, MA USA; [Godwin, Jonathan G.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Godwin, Jonathan G.] Childrens Hosp, Boston, MA 02115 USA; [Ge, Xupeng; Tullius, Stefan G.] Harvard Univ, Sch Med, Div Transplant Surg, Boston, MA USA; [Ge, Xupeng; Tullius, Stefan G.] Harvard Univ, Sch Med, Transplant Surg Res Lab, Boston, MA USA; [Iacomini, John] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Iacomini, John] Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Program Immunol, Boston, MA 02111 USA; [Iacomini, John] Tufts Univ, Sackler Sch Grad Biomed Sci, Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Shapiro, MD (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Dept Pathol, Boston, MA 02111 USA.	john.iacomini@tufts.edu		Shapiro, Michael/0000-0002-2769-9320	Roche Organ Transplantation Research Foundation; Instituto Carlos Slim de la Salud; American Heart Association; National Institutes of Health (NIH) [K25AI079404-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI079404] Funding Source: NIH RePORTER	Roche Organ Transplantation Research Foundation; Instituto Carlos Slim de la Salud; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the Roche Organ Transplantation Research Foundation to Dr. Tullius and Dr. Iacomini, a grant by the Instituto Carlos Slim de la Salud to Dr. Tullius, an American Heart Association Scientist Development Grant to Dr. Bagley, and a National Institutes of Health (NIH) grant K25AI079404-02 to Dr. Shapiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; FISHER NI, STAT ANAL SPHERICAL; Godwin JG, 2010, P NATL ACAD SCI USA, V107, P14339, DOI 10.1073/pnas.0912701107; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Kim VN, 2005, MOL CELLS, V19, P1; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214	15	44	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2011	6	8							e23011	10.1371/journal.pone.0023011	http://dx.doi.org/10.1371/journal.pone.0023011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CV	21887224	Green Published, gold			2022-12-25	WOS:000293953700003
J	Delgado-Martin, C; Escribano, C; Pablos, JL; Riol-Blanco, L; Rodriguez-Fernandez, JL				Delgado-Martin, Cristina; Escribano, Cristina; Luis Pablos, Jose; Riol-Blanco, Lorena; Luis Rodriguez-Fernandez, Jose			Chemokine CXCL12 Uses CXCR4 and a Signaling Core Formed by Bifunctional Akt, Extracellular Signal-regulated Kinase (ERK) 1/2, and Mammalian Target of Rapamycin Complex 1 (mTORC1) Proteins to Control Chemotaxis and Survival Simultaneously in Mature Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN RECEPTOR RDC1; T-LYMPHOCYTES; PHOSPHOINOSITIDE 3-KINASE; RHEUMATOID-ARTHRITIS; MIGRATION; ACTIVATION; CCR7; TRANSDUCTION; MATURATION; APOPTOSIS	Chemokines control several cell functions in addition to chemotaxis. Although much information is available on the involvement of specific signaling molecules in the control of single functions controlled by chemokines, especially chemotaxis, the mechanisms used by these ligands to regulate several cell functions simultaneously are completely unknown. Mature dendritic cells (maDCs) migrate through the afferent lymphatic vessels to the lymph nodes, where they regulate the initiation of the immune response. As maDCs are exposed to chemokine CXCL12 ( receptors CXCR4 and CXCR7) during their migration, its functions are amenable to be regulated by this ligand. We have used maDCs as a model system to analyze the mechanisms whereby CXCL12 simultaneously controls chemotaxis and survival in maDCs. We show that CXCL12 uses CXCR4, but not CXCR7, and the components of a signaling core that includes Gi/G beta gamma, PI3K-alpha/-beta/-gamma, Akt, ERK1/2 and mammalian target of rapamycin complex 1 (mTORC1), which organize hierarchically to control both functions. Downstream of Akt, Fork-head box class O (FOXO) regulates CXCL12-dependent survival, but not chemotaxis, suggesting that downstream of the aforementioned signaling core, additional signaling molecules may control more selectively CXCL12-dependent chemotaxis or survival. Finally, the data obtained also show that CXCR4 uses a signaling signature that is different from that used by CCR7 to control similar functions.	[Delgado-Martin, Cristina; Escribano, Cristina; Riol-Blanco, Lorena; Luis Rodriguez-Fernandez, Jose] Consejo Super Invest Cient, Ctr Invest Biol, Madrid 28040, Spain; [Luis Pablos, Jose] Inst Invest Hosp, Serv Reumatol, Madrid 28041, Spain; [Luis Pablos, Jose] Inst Invest Hosp, Unidad Invest, Madrid 28041, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Rodriguez-Fernandez, JL (corresponding author), Consejo Super Invest Cient, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	rodrifer@cib.csic.es	Rodriguez-Fernandez, Jose Luis/Q-5021-2019	Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425	Redes Tematicas de Investigacion Cooperativas (RETICS) Program/Instituto de Salud Carlos III [RD08/0075]; Ministerio de Educacion y Ciencia [SAF2005-00801]; Proyectos Intramurales de Incorporacion, Consejo Superior de Investigaciones Cientificas [200620I167]; Genoma Espana; Formacion de Personal Investigador (FPI); RETICS Program/Instituto de Salud Carlos III [RD08/0075]; I3P scholarship from the Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo; Ministerio de Sanidad (Spain) [PI021058]	Redes Tematicas de Investigacion Cooperativas (RETICS) Program/Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia(Spanish Government); Proyectos Intramurales de Incorporacion, Consejo Superior de Investigaciones Cientificas; Genoma Espana; Formacion de Personal Investigador (FPI)(Spanish Government); RETICS Program/Instituto de Salud Carlos III(Instituto de Salud Carlos III); I3P scholarship from the Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo; Ministerio de Sanidad (Spain)(Spanish Government)	This work was supported by Redes Tematicas de Investigacion Cooperativas (RETICS) Program/Instituto de Salud Carlos III Grant RD08/0075 (to J. L. R.-F. and J. L. P.), Ministerio de Educacion y Ciencia Grant SAF2005-00801 (to J. L. R.-F.), Proyectos Intramurales de Incorporacion, Consejo Superior de Investigaciones Cientificas Grant 200620I167, and by Genoma Espana.; Supported by fellowship Formacion de Personal Investigador (FPI), conferred by the Ministerio de Educacion y Ciencia (Spain) and by a contract associated with RETICS Program/Instituto de Salud Carlos III Grant RD08/0075.; Recipient of an I3P scholarship from the Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo.; Supported by a scholarship associated with Grant PI021058 awarded by the Ministerio de Sanidad (Spain).	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Delgado E, 1998, IMMUNOBIOLOGY, V198, P490, DOI 10.1016/S0171-2985(98)80073-9; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gonzalez N, 2010, J VIROL, V84, P4341, DOI 10.1128/JVI.02449-09; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hernandez-Lopez C, 2008, IMMUNOL LETT, V120, P72, DOI 10.1016/j.imlet.2008.07.006; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Huttenlocher A, 2008, TRENDS CELL BIOL, V18, P298, DOI 10.1016/j.tcb.2008.04.001; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lin CL, 1998, EUR J IMMUNOL, V28, P4114, DOI 10.1002/(SICI)1521-4141(199812)28:12<4114::AID-IMMU4114>3.0.CO;2-C; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Ouwehand K, 2008, EUR J IMMUNOL, V38, P3050, DOI 10.1002/eji.200838384; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Procko E, 2005, BIOESSAYS, V27, P153, DOI 10.1002/bies.20157; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Rodriguez-Fernandez JL, 1999, MOL BIOL CELL, V10, P1891, DOI 10.1091/mbc.10.6.1891; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Sozzani S, 1998, J IMMUNOL, V161, P1083; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200	59	63	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37222	37236		10.1074/jbc.M111.294116	http://dx.doi.org/10.1074/jbc.M111.294116			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878648	Green Published, hybrid			2022-12-25	WOS:000296542400023
J	Hsu, YL; Huang, MS; Yang, CJ; Hung, JY; Wu, LY; Kuo, PL				Hsu, Ya-Ling; Huang, Ming-Shyan; Yang, Chih-Jen; Hung, Jen-Yu; Wu, Ling-Yu; Kuo, Po-Lin			Lung Tumor-associated Osteoblast-derived Bone Morphogenetic Protein-2 Increased Epithelial-to-Mesenchymal Transition of Cancer by Runx2/Snail Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVATION; TGF-BETA; RUNX2; CELLS; METASTASIS; EXPRESSION; KINASE; ACETYLATION; GROWTH	Bone is a frequent target of lung cancer metastasis and is associated with significant morbidity and a dismal prognosis. Interaction between cancer cells and the bone microenvironment causes a vicious cycle of tumor progression and bone destruction. This study analyzed the soluble factors secreted by lung tumor-associated osteoblast (TAOB), which are responsible for increasing cancer progression. The addition of bone morphogenetic protein-2 (BMP-2), present in large amounts in TAOB conditioned medium (TAOB-CM) and lung cancer patient sera, mimicked the inductive effect of TAOB-CM on lung cancer migration, invasion, and epithelial-to-mesenchymal transition. In contrast, inhibition of BMP by noggin decreases the inductive properties of TAOB-CM and lung cancer patient sera on cancer progression. Induction of lung cancer migration by BMP-2 is associated with increased ERK and p38 activation and the up-regulation of Runx2 and Snail. Blocking ERK and p38 by a specific inhibitor significantly decreases cancer cell migration by inhibiting Runx2 up-regulation and subsequently attenuating the expression of Snail. Enhancement of Runx2 facilitates Rux2 to recruit p300, which in turn enhances histone acetylation, increases Snail expression, and decreases E-cadherin. Furthermore, inhibiting Runx2 by siRNA also suppresses BMP-2-induced Snail up-regulation and cell migration. Our findings provide novel evidence that inhibition of BMP-2 or BMP-2-mediated MAPK/Runx2/Snail signaling is an attractive therapeutic target for osteolytic bone metastases in lung cancer patients.	[Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung 807, Taiwan; [Hsu, Ya-Ling; Yang, Chih-Jen; Hung, Jen-Yu; Wu, Ling-Yu] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Huang, Ming-Shyan; Yang, Chih-Jen; Hung, Jen-Yu] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Ming-Shyan; Yang, Chih-Jen; Hung, Jen-Yu; Kuo, Po-Lin] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung 807, Taiwan; [Kuo, Po-Lin] Kaohsiung Med Univ Kaohsiung, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, PL (corresponding author), Kaohsiung Med Univ, Inst Clin Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	kuopolin@seed.net.tw			National Science Council of Taiwan [NSC 98-2320-B-037-007-MY3]; Department of Health, Executive Yuan, Taipei, Taiwan [DOH100-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taipei, Taiwan	This work is supported by National Science Council of Taiwan Grant NSC 98-2320-B-037-007-MY3) and Excellence for Cancer Research Center Grant DOH100-TD-C-111-002 from the Department of Health, Executive Yuan, Taipei, Taiwan.	Akech J, 2010, ONCOGENE, V29, P811, DOI 10.1038/onc.2009.389; Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Bunyaratavej P, 2000, EXP CELL RES, V260, P324, DOI 10.1006/excr.2000.5019; Chen HW, 2008, CANCER RES, V68, P7428, DOI 10.1158/0008-5472.CAN-07-6734; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Galvan JA, 2010, LUNG CANCER, V69, P289, DOI 10.1016/j.lungcan.2009.12.010; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Georges S, 2009, CYTOKINE GROWTH F R, V20, P29, DOI 10.1016/j.cytogfr.2008.11.005; Gordon KJ, 2009, CARCINOGENESIS, V30, P238, DOI 10.1093/carcin/bgn274; Graham TR, 2009, PROSTATE, V69, P168, DOI 10.1002/pros.20870; Graves EE, 2010, SEMIN RADIAT ONCOL, V20, P156, DOI 10.1016/j.semradonc.2010.01.003; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Juarez P, 2011, BONE, V48, P23, DOI 10.1016/j.bone.2010.08.004; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Knerr K, 2004, INT J CANCER, V111, P152, DOI 10.1002/ijc.20223; Kuo PL, 2005, J PHARMACOL EXP THER, V314, P1290, DOI 10.1124/jpet.105.085092; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Kvale PA, 2003, CHEST, V123, p284S, DOI 10.1378/chest.123.1_suppl.284S; Lai TH, 2008, PROSTATE, V68, P1341, DOI 10.1002/pros.20799; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Lee M, 2010, J BIOL CHEM, V285, P38014, DOI 10.1074/jbc.M110.142141; Lin QA, 2010, JPN J CLIN ONCOL, V40, P670, DOI 10.1093/jjco/hyq041; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nannuru Kalyan C, 2010, Curr Osteoporos Rep, V8, P105, DOI 10.1007/s11914-010-0011-6; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Onodera Y, 2010, CANCER SCI, V101, P2670, DOI 10.1111/j.1349-7006.2010.01742.x; Ooi LL, 2011, BONE, V48, P66, DOI 10.1016/j.bone.2010.05.007; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Paredes R, 2004, J STEROID BIOCHEM, V89-90, P269, DOI 10.1016/j.jsbmb.2004.03.076; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Park Y, 2010, MED ONCOL, V27, P1192, DOI 10.1007/s12032-009-9358-x; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Scherberich A, 2005, ONCOGENE, V24, P1525, DOI 10.1038/sj.onc.1208342; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yanagawa J, 2009, CLIN CANCER RES, V15, P6820, DOI 10.1158/1078-0432.CCR-09-1558	44	58	61	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37335	37346		10.1074/jbc.M111.256156	http://dx.doi.org/10.1074/jbc.M111.256156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21885439	Green Published, hybrid			2022-12-25	WOS:000296542400034
J	Lee, SYC; De la Mota-Peynado, A; Roelofs, J				Lee, Stella Yu-Chien; De la Mota-Peynado, Alina; Roelofs, Jeroen			Loss of Rpt5 Protein Interactions with the Core Particle and Nas2 Protein Causes the Formation of Faulty Proteasomes That Are Inhibited by Ecm29 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; REGULATORY PARTICLE; C-TERMINI; ASSEMBLY PATHWAY; 20S PROTEASOME; ATPASES; COMPLEX; ROLES; YEAST; ACTIVATION	The proteasome is a large and complex protease formed by 66 polypeptides. The assembly of the proteasome is assisted by at least nine chaperones. One of these chaperones, Nas2/p27, binds to the C-terminal region of the AAA-ATPase Rpt5. We report here that the tail of Rpt5 provides two functions. First, it facilitates the previously reported interaction with the proteasome core particle (CP). Second, it is essential for the interaction with Nas2. Deletion of the C-terminal amino acid of Rpt5 disrupts the CP interaction, but not the binding to Nas2. The latter is surprising considering Nas2 contains a PDZ domain, which is often involved in binding to C termini. Interestingly, deletion of the last three amino acids interferes with both functions. The disruption of the Rpt5-CP interactions gave distinct phenotypes different from disruption of the Nas2-Rpt5 interaction. Additionally, proteasomes purified from a Saccharomyces cerevisiae rpt5-Delta 3 strain show a strong enrichment of Ecm29. The function of Ecm29, a proteasome-associated protein, is not well understood. Our data show that Ecm29 can inhibit proteasomes, because our Ecm29-containing proteasomes have reduced suc-LLVY-AMC hydrolytic activity. Consistent with this apparent role as negative regulator, the deletion of ECM29 rescues the phenotypes of rpt5-Delta 3 and nas2 Delta in an hsm3 Delta background. In sum, the interactions facilitated by the tail of Rpt5 act synergistically to minimize the formation of faulty proteasomes, thereby preventing recognition and inhibition by Ecm29.	[Lee, Stella Yu-Chien; De la Mota-Peynado, Alina; Roelofs, Jeroen] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, 338 Ackert Hall, Manhattan, KS 66506 USA.	jroelofs@ksu.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465	National Institutes of Health [P20 RR017708, P20 RR016475]; Terry Johnson Center for basic cancer research at Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR017708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Johnson Center for basic cancer research at Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR017708 and P20 RR016475. This work was also supported by a grant from the Terry Johnson Center for basic cancer research at Kansas State University.	Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Iwanczyk J, 2006, J MOL BIOL, V363, P648, DOI 10.1016/j.jmb.2006.08.010; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; Lopez AD, 2011, MOL BIOL CELL, V22, P528, DOI 10.1091/mbc.E10-04-0352; Marques AJ, 2007, J BIOL CHEM, V282, P34869, DOI 10.1074/jbc.M705836200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ortega J, 2005, J MOL BIOL, V346, P1221, DOI 10.1016/j.jmb.2004.12.049; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sakata E, 2011, MOL CELL, V42, P637, DOI 10.1016/j.molcel.2011.04.021; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	47	45	46	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36641	36651		10.1074/jbc.M111.280875	http://dx.doi.org/10.1074/jbc.M111.280875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878651	Green Published, hybrid			2022-12-25	WOS:000296538300047
J	Tang, FQ; Zou, FY; Peng, ZK; Huang, DM; Wu, Y; Chen, Y; Duan, CJ; Cao, Y; Mei, WH; Tang, XW; Dong, ZG				Tang, Faqing; Zou, Feiyan; Peng, Zhengke; Huang, Damao; Wu, Yuan; Chen, Yu; Duan, Chaojun; Cao, Ya; Mei, Wenhua; Tang, Xiaowei; Dong, Zigang			N,N '-Dinitrosopiperazine-mediated Ezrin Protein Phosphorylation via Activation of Rho Kinase and Protein Kinase C Is Involved in Metastasis of Nasopharyngeal Carcinoma 6-10B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE SALTED FISH; NITROSO-COMPOUNDS; ORGANIZER EZRIN; LINKER EZRIN; ERM PROTEINS; HUMAN CANCER; CYTOSKELETON; MECHANISMS; INDUCTION; FILOPODIA	N,N'-Dinitrosopiperazine (DNP) is a carcinogen for nasopharyngeal carcinoma (NPC), which shows organ specificity to nasopharyngeal epithelium. Herein, we demonstrate that DNP induces fiber formation of NPC cells (6-10B) and also increases invasion and motility of 6-10B cells. DNP-mediated NPC metastasis also was confirmed in nude mice. Importantly, DNP induced the expression of phosphorylated ezrin (phos-ezrin) at threonine 567 (Thr-567) dose-and time-dependently but had no effect on the total ezrin expression at these concentrations. Furthermore, DNP-induced phos-ezrin expression was dependent on increased Rho kinase and protein kinase C (PKC) activity. DNP may activate Rho kinase through binding to its pleckstrin homology and may activate PKC through promoting its translocation to the plasma membrane in vivo. DNP-induced phos-ezrin was associated with induction of fiber growth in 6-10B cells. However, DNP could not induce motility and invasion of NPC cells containing ezrin mutated at Thr-567. Similarly, DNP could not induce motility and invasion of the cells containing siRNAs against Rho or PKC. These results indicate that DNP induces ezrin phosphorylation at Thr-567, increases motility and invasion of cells, and promotes tumor metastasis. DNP may be involved in NPC metastasis through regulation of ezrin phosphorylation at Thr-567.	[Tang, Faqing; Mei, Wenhua] Jinan Univ, Med Res Ctr, Zhuhai Hosp, Guangzhou 510000, Guangdong, Peoples R China; [Zou, Feiyan] Jinan Univ, Coll Life Sci, Guangzhou 510000, Guangdong, Peoples R China; [Peng, Zhengke; Huang, Damao; Wu, Yuan; Chen, Yu; Duan, Chaojun; Tang, Xiaowei] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Cao, Ya] Cent S Univ, Canc Res Inst, Changsha 410008, Hunan, Peoples R China; [Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Jinan University; Jinan University; Central South University; Central South University; University of Minnesota System	Tang, FQ (corresponding author), Jinan Univ, Zhuhai Hosp, Zhuhai 519000, Guangdong, Peoples R China.	tangfaqing33@hotmail.com			National Natural Science Foundation of China [81071718, 81000881, 30973400, 30572455]; Program for New Century Excellent Talents in University [NCET-06-0685]; Technology Foundation of Hunan [08FJ3176]; Science Foundation of Central South University [08SDF07]; Department of Pathology of Xiangya Hospital, Central South University; Youping Sun of BEST Inc.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Technology Foundation of Hunan; Science Foundation of Central South University; Department of Pathology of Xiangya Hospital, Central South University; Youping Sun of BEST Inc.	This work was supported in part by National Natural Science Foundation of China Grants 81071718, 81000881, 30973400, and 30572455; Program for New Century Excellent Talents in University Grant NCET-06-0685; Technology Foundation of Hunan Grant 08FJ3176; and Science Foundation of Central South University Grant 08SDF07.; We thank Director Tieyong Li at the Cancer Research Institute of Central South University for providing DNP and Prof. Haiying Jian and Deyun Feng at the Department of Pathology of Xiangya Hospital, Central South University and Youping Sun of BEST Inc. for support.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Attiga FA, 2000, CANCER RES, V60, P4629; BARTSCH H, 1992, PHARMACOGENETICS, V2, P272, DOI 10.1097/00008571-199212000-00005; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Cant SH, 2005, MOL BIOL CELL, V16, P3088, DOI 10.1091/mbc.E04-10-0877; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009187; CHEN J, 1995, P NATL ACAD SCI USA, V92, P7495, DOI 10.1073/pnas.92.16.7495; Chen Z C, 1991, IARC Sci Publ, P434; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Deng XY, 2007, CLIN EXP METASTAS, V24, P107, DOI 10.1007/s10585-007-9059-9; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Gallo G, 2008, DEV NEUROBIOL, V68, P926, DOI 10.1002/dneu.20631; Henderson B E, 1978, IARC Sci Publ, P251; Howlett AC, 2000, J NEUROCHEM, V74, P2174, DOI 10.1046/j.1471-4159.2000.0742174.x; Huang D P, 1978, IARC Sci Publ, P315; HUANG SC, 1985, INT J RADIAT ONCOL, V11, P1789, DOI 10.1016/0360-3016(85)90033-1; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jimenez-Sainz MC, 2006, MOL BIOL CELL, V17, P25, DOI 10.1091/mbc.e05-05-0399; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Meschler JP, 1999, PHARMACOL BIOCHEM BE, V62, P473, DOI 10.1016/S0091-3057(98)00195-6; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Poirier S, 1987, IARC Sci Publ, P415; PRESTONMARTIN S, 1989, CANCER SURV, V8, P459; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Tang FQ, 2009, CANCER SCI, V100, P216, DOI 10.1111/j.1349-7006.2008.01028.x; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Yang XY, 2005, CELL ONCOL, V27, P215; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yonemura S, 2002, J CELL SCI, V115, P2569; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1989, BRIT J CANCER, V60, P198, DOI 10.1038/bjc.1989.250; YU MC, 1986, CANCER RES, V46, P956; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhang Y, 2006, J CANCER RES CLIN, V132, P685, DOI 10.1007/s00432-006-0117-5; ZHENG X, 1994, ACTA OTO-LARYNGOL, V114, P98, DOI 10.3109/00016489409126024; Zou J, 2000, J Radiat Res, V41 Suppl, P53; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202; 1987, IARC SCI PUBL, V88, P1	55	24	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36956	36967		10.1074/jbc.M111.259234	http://dx.doi.org/10.1074/jbc.M111.259234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878630	Green Published, hybrid			2022-12-25	WOS:000296538300074
J	Clemencon, B; Rey, M; Trezeguet, V; Forest, E; Pelosi, L				Clemencon, Benjamin; Rey, Martial; Trezeguet, Veronique; Forest, Eric; Pelosi, Ludovic			Yeast ADP/ATP Carrier Isoform 2 CONFORMATIONAL DYNAMICS AND ROLE OF THE RRRMMM SIGNATURE SEQUENCE METHIONINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP TRANSLOCATOR; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; TERMINAL REGION; MATRIX LOOP; WILD-TYPE; PROTEIN; PURIFICATION; MITOCHONDRIA	The mitochondrial ADP/ATPcarrier, or Ancp, is a member of the mitochondrial carrier family responsible for exchanging ADP and ATP across the mitochondrial inner membrane. ADP/ATP transport involves Ancp switching between two conformational states. These can be analyzed using specific inhibitors, carboxyatractyloside (CATR) and bongkrekic acid (BA). The high resolution three-dimensional structure of bovine Anc1p (bAnc1p), as a CATR-carrier complex, has been solved. However, because the structure of the BA-carrier complex has not yet been determined, the detailed mechanism of transport remains unknown. Recently, sample processing for hydrogen/deuterium exchange experiments coupled to mass spectrometry was improved, providing novel insights into bAnc1p conformational transitions due to inhibitor binding. In this work we performed both hydrogen/deuterium exchange-mass spectrometry experiments and genetic manipulations. Because these are very difficult to apply with bovine Anc1p, we used Saccharomyces cerevisiae Anc isoform 2 (ScAnc2p). Significant differences in solvent accessibility were observed throughout the amino acid sequence for ScAnc2p complexed to either CATR or BA. Interestingly, in detergent solution, the conformational dynamics of ScAnc2p were dissimilar to those of bAnc1p, in particular for the upper half of the cavity, toward the intermembrane space, and the m2 loop, which is thought to be easily accessible to the solvent from the matrix in bAnc1p. Our study then focused on the methionyl residues of the Ancp signature sequence, RRRMMM. All our results indicate that the methionine cluster is involved in the ADP/ATP transport mechanism and confirm that the Ancp cavity is a highly dynamic structure.	[Forest, Eric] UJF, CEA, CNRS UMR 5075, Inst Biol Struct,Lab Spectrometrie Masse Prot, F-38027 Grenoble, France; [Clemencon, Benjamin; Rey, Martial; Pelosi, Ludovic] CEA, DSV, Inst Rech Technol & Sci Vivant, Lab Biol Grande Echelle, F-38054 Grenoble, France; [Clemencon, Benjamin; Rey, Martial; Forest, Eric; Pelosi, Ludovic] Univ Grenoble 1, F-38000 Grenoble, France; [Clemencon, Benjamin; Rey, Martial] INSERM, U1038, F-38054 Grenoble, France; [Trezeguet, Veronique] CNRS, Inst Biochim & Genet Cellulaires, Lab Physiol Mol & Cellulaire, UMR 5095, F-33077 Bordeaux, France; [Trezeguet, Veronique] Univ Victor Segalen, F-33076 Bordeaux, France; [Forest, Eric] CEA, DSV, Inst Biol Struct, F-38054 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Forest, E (corresponding author), UJF, CEA, CNRS UMR 5075, Inst Biol Struct,Lab Spectrometrie Masse Prot, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	eric.forest@ibs.fr; ludovic.pelosi@cea.fr	Forest, Eric/E-9042-2012; Pelosi, Ludovic/AAB-9832-2020; Pelosi, Ludovic/M-6406-2014	Pelosi, Ludovic/0000-0002-4198-5681; Rey, Martial/0000-0002-7378-1106; Trezeguet, Veronique/0000-0003-2487-7571	Universite Joseph Fourier; French CNRS; Commissariat a l'Energie Atomique; Region Rhone-Alpes	Universite Joseph Fourier; French CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by grants from the Universite Joseph Fourier, the French CNRS, and the Commissariat a l'Energie Atomique.; Supported by a fellowship from the Region Rhone-Alpes.	BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; BRANDOLIN G, 1974, FEBS LETT, V46, P149, DOI 10.1016/0014-5793(74)80356-X; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; BRANDOLIN G, 1993, J BIOENERG BIOMEMBR, V25, P459, DOI 10.1007/BF01108403; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Dahout-Gonzalez C, 2005, BIOCHEMISTRY-US, V44, P16310, DOI 10.1021/bi0514820; Dassa EP, 2005, PROTEIN EXPRES PURIF, V40, P358, DOI 10.1016/j.pep.2004.12.019; Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004; Dianoux AC, 2000, BIOCHEMISTRY-US, V39, P11477, DOI 10.1021/bi000618l; DRGON T, 1991, FEBS LETT, V289, P159, DOI 10.1016/0014-5793(91)81059-H; Fiore C, 2000, PROTEIN EXPRES PURIF, V19, P57, DOI 10.1006/prep.2000.1213; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Iwahashi A, 2006, MITOCHONDRION, V6, P245, DOI 10.1016/j.mito.2006.07.007; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kihira Y, 2005, BIOCHEMISTRY-US, V44, P184, DOI 10.1021/bi0488653; Kihira Y, 2007, BIOL PHARM BULL, V30, P885, DOI 10.1248/bpb.30.885; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KNIRSCH M, 1989, FEBS LETT, V244, P427, DOI 10.1016/0014-5793(89)80577-0; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; LeSaux A, 1996, BIOCHEMISTRY-US, V35, P16116, DOI 10.1021/bi961714i; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; MARTY I, 1992, BIOCHEMISTRY-US, V31, P4058, DOI 10.1021/bi00131a023; NELSON DR, 1993, J MOL BIOL, V230, P1171, DOI 10.1006/jmbi.1993.1234; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; Rey M, 2009, RAPID COMMUN MASS SP, V23, P3431, DOI 10.1002/rcm.4260; Thomas A, 2011, BIOCHIMIE, V93, P1415, DOI 10.1016/j.biochi.2011.04.015; Trezeguet V, 2008, J BIOENERG BIOMEMBR, V40, P435, DOI 10.1007/s10863-008-9178-2; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	36	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36119	36131		10.1074/jbc.M111.277376	http://dx.doi.org/10.1074/jbc.M111.277376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868387	Green Published, hybrid			2022-12-25	WOS:000295927100084
J	Aasa-Chapman, MMI; Cheney, KM; Hue, S; Forsman, A; O'Farrell, S; Pellegrino, P; Williams, I; McKnight, A				Aasa-Chapman, Marlen M. I.; Cheney, Kelly M.; Hue, Stephane; Forsman, Anna; O'Farrell, Stephen; Pellegrino, Pierre; Williams, Ian; McKnight, Aine			In Vivo Emergence of HIV-1 Highly Sensitive to Neutralizing Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; ENVELOPE GLYCOPROTEINS; ENV CLONES; ESCAPE; GP120; EVOLUTION; EPITOPE; IDENTIFICATION; DETERMINANTS	Background: The rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infection. Here we report in vivo emergence of viruses with heightened sensitivity to neutralizing antibodies, sometimes paralleling the development of neutralization escape. Methodology/Principal Findings: Sequential viral envs were amplified from seven HIV-1 infected men monitored from seroconversion up to 5 years after infection. Env-recombinant infectious molecular clones were generated and tested for coreceptor use, macrophage tropism and neutralization sensitivity to homologous and heterologous serum, soluble CD4 and monoclonal antibodies IgG1b12, 2G12 and 17b. We found that HIV-1 evolves sensitivity to contemporaneous neutralizing antibodies during infection. Neutralization sensitive viruses grow out even when potent autologous neutralizing antibodies are present in patient serum. Increased sensitivity to neutralization was associated with susceptibility of the CD4 binding site or epitopes induced after CD4 binding, and mediated by complex envelope determinants including V3 and V4 residues. The development of neutralization sensitive viruses occurred without clinical progression, coreceptor switch or change in tropism for primary macrophages. Conclusions: We propose that an interplay of selective forces for greater virus replication efficiency without the need to resist neutralizing antibodies in a compartment protected from immune surveillance may explain the temporal course described here for the in vivo emergence of HIV-1 isolates with high sensitivity to neutralizing antibodies.	[Aasa-Chapman, Marlen M. I.; Hue, Stephane; Forsman, Anna; McKnight, Aine] UCL, Div Infect & Immun, MRC UCL Ctr Med Mol Virol, London, England; [Cheney, Kelly M.; McKnight, Aine] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London, England; [O'Farrell, Stephen; Pellegrino, Pierre; Williams, Ian] UCL, Ctr Sexual Hlth & HIV Res, London, England	University of London; University College London; University of London; Queen Mary University London; University of London; University College London	Aasa-Chapman, MMI (corresponding author), UCL, Div Infect & Immun, MRC UCL Ctr Med Mol Virol, London, England.	m.aasa-chapman@ucl.ac.uk		McKnight, Aine/0000-0002-8113-817X; Hue, Stephane/0000-0002-8580-6905	Wellcome Trust; MRC-UK; Edward Jenner Institute for Vaccine Research; Medical Research Council [G117/547] Funding Source: researchfish; MRC [G117/547] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Edward Jenner Institute for Vaccine Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, the MRC-UK and core funding from the Edward Jenner Institute for Vaccine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2006, VIROLOGY, V351, P489, DOI 10.1016/j.virol.2006.04.002; Aasa-Chapman MMI, 2006, J VIROL, V80, P10884, DOI 10.1128/JVI.01030-06; Aasa-Chapman MMI, 2005, J VIROL, V79, P2823, DOI 10.1128/JVI.79.5.2823-2830.2005; Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; ALBERT J, 1990, AIDS, V4, P107, DOI 10.1097/00002030-199002000-00002; Bosch KA, 2010, VIROLOGY, V398, P115, DOI 10.1016/j.virol.2009.11.032; Brew BJ, 1996, J NEUROVIROL, V2, P152, DOI 10.3109/13550289609146877; Bunnik EM, 2007, J VIROL, V81, P525, DOI 10.1128/JVI.01983-06; Bunnik EM, 2010, VIROLOGY, V397, P224, DOI 10.1016/j.virol.2009.11.009; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; DITZEL HJ, 1995, J IMMUNOL, V154, P893; Duenas-Decamp MJ, 2009, J VIROL, V83, P2575, DOI 10.1128/JVI.02133-08; Ferguson TA, 2006, IMMUNOL REV, V213, P228, DOI 10.1111/j.1600-065X.2006.00430.x; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gorry PR, 2005, CURR HIV RES, V3, P53, DOI 10.2174/1570162052772951; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kelly Halonna R., 2005, Human Antibodies, V14, P89; Krachmarov CP, 2001, AIDS RES HUM RETROV, V17, P1737, DOI 10.1089/08892220152741432; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Mahalanabis M, 2009, J VIROL, V83, P662, DOI 10.1128/JVI.01328-08; Marchant D, 2006, J GEN VIROL, V87, P411, DOI 10.1099/vir.0.81391-0; MCKEATING JA, 1989, AIDS, V3, P777, DOI 10.1097/00002030-198912000-00001; McKeating JA, 1996, VIROLOGY, V220, P450, DOI 10.1006/viro.1996.0332; MCKNIGHT A, 1992, AIDS, V6, P799, DOI 10.1097/00002030-199208000-00005; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Rambaut A, 1996, COMPUT APPL BIOSCI, V12, P469; Richards KH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-48; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23961	10.1371/journal.pone.0023961	http://dx.doi.org/10.1371/journal.pone.0023961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887353	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000295832000078
J	Banci, L; Barbieri, L; Bertini, I; Cantini, F; Luchinat, E				Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Cantini, Francesca; Luchinat, Enrico			In-cell NMR in E. coli to Monitor Maturation Steps of hSOD1	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MITOCHONDRIAL INTERMEMBRANE SPACE; ESCHERICHIA-COLI; REDUCED FORM; COPPER; SOD1; DISMUTASE; METAL; SPECTROSCOPY; APO	In-cell NMR allows characterizing the folding state of a protein as well as posttranslational events at molecular level, in the cellular context. Here, the initial maturation steps of human copper, zinc superoxide dismutase 1 are characterized in the E. coli cytoplasm by in-cell NMR: from the apo protein, which is partially unfolded, to the zinc binding which causes its final quaternary structure. The protein selectively binds only one zinc ion, whereas in vitro also the copper site binds a non-physiological zinc ion. However, no intramolecular disulfide bridge formation occurs, nor copper uptake, suggesting the need of a specific chaperone for those purposes.	[Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Cantini, Francesca; Luchinat, Enrico] Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy; [Banci, Lucia; Barbieri, Letizia; Bertini, Ivano; Cantini, Francesca; Luchinat, Enrico] Univ Florence, Dept Chem, Sesto Fiorentino, Italy	University of Florence; University of Florence	Banci, L (corresponding author), Univ Florence, Magnet Resonance Ctr, Sesto Fiorentino, Italy.	banci@cerm.unifi.it; bertini@cerm.unifi.it	Cantini, Francesca/O-1220-2015; Luchinat, Enrico/O-1776-2014	Cantini, Francesca/0000-0003-0526-6732; Luchinat, Enrico/0000-0003-4183-4311; BANCI, LUCIA/0000-0003-0562-5774; Barbieri, Letizia/0000-0002-7457-490X	Italian FIRB PROTEOMICA MIUR [RBRN07BMCT]; European Commission [261863]	Italian FIRB PROTEOMICA MIUR(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Italian FIRB PROTEOMICA MIUR contract RBRN07BMCT, and is part of the JRA2 of the Bio-Nuclear Magnetic Resonance project (European Commission's FP7, project number 261863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kawamata H, 2010, ANTIOXID REDOX SIGN, V13, P1375, DOI 10.1089/ars.2010.3212; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Reckel S, 2007, PROG NUCL MAG RES SP, V51, P91, DOI 10.1016/j.pnmrs.2007.02.002; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	27	51	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23561	10.1371/journal.pone.0023561	http://dx.doi.org/10.1371/journal.pone.0023561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887272	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000028
J	Bellet, MM; Vawter, MP; Bunney, BG; Bunney, WE; Sassone-Corsi, P				Bellet, Marina M.; Vawter, Marquis P.; Bunney, Blynn G.; Bunney, William E.; Sassone-Corsi, Paolo			Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NMDA RECEPTOR ANTAGONISTS; MOLECULAR CLOCK GENES; SUPRACHIASMATIC NUCLEUS; GLUTAMATE-RECEPTOR; DEPRESSED-PATIENTS; SIGNALING PATHWAY; MOOD DISORDERS; MESSENGER-RNA; IN-VITRO	Major mood disorders have been linked to abnormalities in circadian rhythms, leading to disturbances in sleep, mood, temperature, and hormonal levels. We provide evidence that ketamine, a drug with rapid antidepressant effects, influences the function of the circadian molecular machinery. Ketamine modulates CLOCK:BMAL1-mediated transcriptional activation when these regulators are ectopically expressed in NG108-15 neuronal cells. Inhibition occurs in a dose-dependent manner and is attenuated after treatment with the GSK3 beta antagonist SB21673. We analyzed the effect of ketamine on circadian gene expression and observed a dose-dependent reduction in the amplitude of circadian transcription of the Bmal1, Per2, and Cry1 genes. Finally, chromatin-immunoprecipitation analyses revealed that ketamine altered the recruitment of the CLOCK:BMAL1 complex on circadian promoters in a time-dependent manner. Our results reveal a yet unsuspected molecular mode of action of ketamine and thereby may suggest possible pharmacological antidepressant strategies.	[Bellet, Marina M.; Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA; [Vawter, Marquis P.; Bunney, Blynn G.; Bunney, William E.] Univ Calif Irvine, Sch Med, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Bellet, MM (corresponding author), Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92717 USA.	webunney@hs.uci.edu; psc@uci.edu	Bellet, Marina Maria/K-7794-2016	Bellet, Marina Maria/0000-0001-7604-0189	Della Martin Foundation; National Institutes of Health [R01-GM081634, R21-AG033888]; National Institute of Mental Health [5R01MH085801-03]; William Lion Penzner Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033888] Funding Source: NIH RePORTER	Della Martin Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); William Lion Penzner Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MMB was partially supported by a postdoctoral fellowship from the Della Martin Foundation. This work was supported by the National Institutes of Health (R01-GM081634 and R21-AG033888) to PSC, by the National Institute of Mental Health (5R01MH085801-03) to MPV, and by the William Lion Penzner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aan het Rot M, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038; ABE H, 1992, BRAIN RES BULL, V28, P831, DOI 10.1016/0361-9230(92)90269-4; Abe M, 2000, NEUROREPORT, V11, P3261, DOI 10.1097/00001756-200009280-00042; Asai M, 2001, CURR BIOL, V11, P1524, DOI 10.1016/S0960-9822(01)00445-6; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; BEUREL E, 2011, MOL PSYCHIATR, V19, P1; Bunney BG, 2011, INT J NEUROPSYCHOPH, P1; Bunney JN, 2008, BRIT MED BULL, V86, P23, DOI 10.1093/bmb/ldn019; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005; Cao RF, 2010, J NEUROSCI, V30, P6302, DOI 10.1523/JNEUROSCI.5482-09.2010; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; CARPENTER WT, 1971, AM J PSYCHIAT, V128, P31, DOI 10.1176/ajp.128.1.31; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chambille I, 1999, BRAIN RES, V833, P27, DOI 10.1016/S0006-8993(99)01460-2; CHAN PH, 1990, ACT NEUR S, V51, P7; Chang Y, 2004, J BIOMED SCI, V11, P764, DOI 10.1159/000081823; Chang Y, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/705379; Chassard D, 2007, CURR OPIN ANESTHESIO, V20, P186, DOI 10.1097/ACO.0b013e328136c55e; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doi M, 2006, NAT NEUROSCI, V9, P732, DOI 10.1038/nn1711; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241; Duncan WC, 1996, PHARMACOL THERAPEUT, V71, P253, DOI 10.1016/S0163-7258(96)00092-7; Eckel-Mahan K, 2010, AGING-US, V2, P320, DOI 10.18632/aging.100154; Gachon F, 2010, AGING-US, V2, P101, DOI 10.18632/aging.100123; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gelenberg AJ, 2000, J CLIN PSYCHIAT, V61, P712, DOI 10.4088/JCP.v61n1002; Genever PG, 1999, J INVEST DERMATOL, V112, P337, DOI 10.1046/j.1523-1747.1999.00509.x; Genever PG, 1999, BLOOD, V93, P2876; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; ISHIDA N, 1994, NEUROSCI LETT, V166, P211, DOI 10.1016/0304-3940(94)90488-X; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kondratova AA, 2010, AGING-US, V2, P285; Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103; Lam RW, 2006, INT CLIN PSYCHOPHARM, V21, pS25, DOI 10.1097/01.yic.0000195658.91524.61; Li CY, 1997, CAN J ANAESTH, V44, P989, DOI 10.1007/BF03011971; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Machado-Vieira R, 2010, THESCIENTIFICWORLDJO, V10, P713, DOI 10.1100/tsw.2010.65; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Morris DW, 2009, DEPRESS ANXIETY, V26, P851, DOI 10.1002/da.20557; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; NEMEROFF CB, 2004, INT CLIN PSYCHOPH S1, V38, P14; NIMH, 2011, AN MOOD DIS AD; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Paul KN, 2005, MOL BRAIN RES, V139, P129, DOI 10.1016/j.molbrainres.2005.05.017; Paul KN, 2003, NEUROSCIENCE, V119, P137, DOI 10.1016/S0306-4522(03)00098-8; Peet NM, 1999, FASEB J, V13, P2179, DOI 10.1096/fasebj.13.15.2179; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; Rausch JL, 2003, NEUROPSYCHOBIOLOGY, V47, P120, DOI 10.1159/000070579; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Rush AJ, 2003, AM J PSYCHIAT, V160, P237, DOI 10.1176/appi.ajp.160.2.237; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Sato Y, 2004, BRIT J ANAESTH, V92, P859, DOI 10.1093/bja/aeh144; Shang LH, 2010, NITRIC OXIDE-BIOL CH, V23, P327, DOI 10.1016/j.niox.2010.09.004; Skerry TM, 2001, TRENDS PHARMACOL SCI, V22, P174, DOI 10.1016/S0165-6147(00)01642-4; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Tamanini Filippo, 2007, Methods Mol Biol, V362, P443; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Vinogradova IA, 2010, AGING-US, V2, P82, DOI 10.18632/aging.100120; Warden Diane, 2007, Curr Psychiatry Rep, V9, P449, DOI 10.1007/s11920-007-0061-3; WEISS J, 1986, BRAIN RES, V380, P186, DOI 10.1016/0006-8993(86)91447-2; Wirz-Justice Anna, 2008, Dialogues Clin Neurosci, V10, P337; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zarate C, 2010, HARVARD REV PSYCHIAT, V18, P293, DOI 10.3109/10673229.2010.511059	75	45	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23982	10.1371/journal.pone.0023982	http://dx.doi.org/10.1371/journal.pone.0023982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887357	Green Published, gold			2022-12-25	WOS:000295832000082
J	Corfield, J; Kubke, MF; Parsons, S; Wild, JM; Koppl, C				Corfield, Jeremy; Kubke, M. Fabiana; Parsons, Stuart; Wild, J. Martin; Koeppl, Christine			Evidence for an Auditory Fovea in the New Zealand Kiwi (Apteryx mantelli)	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCES; BRAIN-STEM; BASILAR PAPILLA; BARN OWL; NUCLEUS-LAMINARIS; HAIR-CELL; COINCIDENCE DETECTION; EYE SIZE; CHICKEN; ORGANIZATION	Kiwi are rare and strictly protected birds of iconic status in New Zealand. Yet, perhaps due to their unusual, nocturnal lifestyle, surprisingly little is known about their behaviour or physiology. In the present study, we exploited known correlations between morphology and physiology in the avian inner ear and brainstem to predict the frequency range of best hearing in the North Island brown kiwi. The mechanosensitive hair bundles of the sensory hair cells in the basilar papilla showed the typical change from tall bundles with few stereovilli to short bundles with many stereovilli along the apical-to-basal tonotopic axis. In contrast to most birds, however, the change was considerably less in the basal half of the epithelium. Dendritic lengths in the brainstem nucleus laminaris also showed the typical change along the tonotopic axis. However, as in the basilar papilla, the change was much less pronounced in the presumed high-frequency regions. Together, these morphological data suggest a fovea-like overrepresentation of a narrow high-frequency band in kiwi. Based on known correlations of hair-cell microanatomy and physiological responses in other birds, a specific prediction for the frequency representation along the basilar papilla of the kiwi was derived. The predicted overrepresentation of approximately 4-6 kHz matches potentially salient frequency bands of kiwi vocalisations and may thus be an adaptation to a nocturnal lifestyle in which auditory communication plays a dominant role.	[Corfield, Jeremy; Kubke, M. Fabiana; Wild, J. Martin] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand; [Corfield, Jeremy; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Koeppl, Christine] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Oldenburg, Germany; [Koeppl, Christine] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany	University of Auckland; University of Auckland; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Corfield, J (corresponding author), Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand.	Christine.Koeppl@uni-oldenburg.de	Kubke, M Fabiana/H-3320-2012	Kubke, Maria Fabiana/0000-0002-3351-5225; Koppl, Christine/0000-0003-0729-709X; Parsons, Stuart/0000-0003-1025-5616	University of Auckland; Royal Society of New Zealand [3606430, 3603426, UOA0503]; Sydney Medical School	University of Auckland; Royal Society of New Zealand(Royal Society of New Zealand); Sydney Medical School	This project was partially funded by the University of Auckland Graduate Research Fund (http://www.auckland.ac.nz/uoa/), the Royal Society of New Zealand (Grants 3606430 and 3603426 to MFK and JMW; http://www.royalsociety.org.nz/), the Royal Society of New Zealand Marsden Fund (grant UOA0503 to MFK; http://www.royalsociety.org.nz/programmes/funds/marsden/) and a Sydney Medical School Strategic Research Grant to CK (http://sydney.edu.au/medicine/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Art JJ, 2006, SPR HDB AUD, V27, P204; BANG BG, 1968, AUK, V85, P55; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; Buller WL., 1888, HIST BIRDS NZ, V2; Carr C. E., 1998, PSYCHOPHYSICAL PHYSL, P344; CARR CE, 1993, J COMP NEUROL, V334, P337, DOI 10.1002/cne.903340302; CARR CE, 1993, BRAIN RES, V628, P330, DOI 10.1016/0006-8993(93)90975-S; CARR CE, 1990, J NEUROSCI, V10, P3227; CHEN L, 1994, HEARING RES, V81, P130, DOI 10.1016/0378-5955(94)90160-0; COBB S, 1960, EPILEPSIA, V1, P394; COLBOURNE R, 1984, NOTORNIS, V31, P191; Corfield J, 2008, AUK, V125, P326, DOI 10.1525/auk.2008.06234; CORFIELD JR, 2005, DESCRIPTION DUETING; COUNTER SA, 1986, ACTA OTO-LARYNGOL, V101, P34, DOI 10.3109/00016488609108605; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Cunningham S, 2007, J ANAT, V211, P493, DOI 10.1111/j.1469-7580.2007.00786.x; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Dyson ML, 1998, J COMP PHYSIOL A, V182, P695, DOI 10.1007/s003590050214; Field L.H., 2001, BIOL WETAS KING CRIC; FISCHER FP, 1994, HEARING RES, V73, P1, DOI 10.1016/0378-5955(94)90277-1; FISCHER FP, 1988, HEARING RES, V34, P87, DOI 10.1016/0378-5955(88)90053-6; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gleich O, 2004, SPR HDB AUD, V22, P224; GLEICH O, 1994, J MORPHOL, V221, P1, DOI 10.1002/jmor.1052210102; GLEICH O, 1989, HEARING RES, V37, P255, DOI 10.1016/0378-5955(89)90026-9; GLEICH O, 1988, HEARING RES, V34, P69, DOI 10.1016/0378-5955(88)90052-4; Gleich O, 2000, SPR HDB AUD, V13, P70; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Husband S., 2001, AVIAN VISUAL COGNITI; Hyson RL, 2005, PHYSIOL BEHAV, V86, P297, DOI 10.1016/j.physbeh.2005.08.003; HYSON RL, 1989, J NEUROSCI, V9, P2835; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; JORGENSEN JM, 1989, BRAIN BEHAV EVOLUT, V34, P273, DOI 10.1159/000116512; KONISHI M, 1973, AM SCI, V61, P414; Konishi M, 2003, ANNU REV NEUROSCI, V26, P31, DOI 10.1146/annurev.neuro.26.041002.131123; KONISHI M, 1973, AM NAT, V107, P775, DOI 10.1086/282875; KOPPL C, 1988, HEARING RES, V35, P209, DOI 10.1016/0378-5955(88)90119-0; Koppl C, 1997, J ACOUST SOC AM, V101, P1574, DOI 10.1121/1.418145; KOPPL C, 1993, J COMP PHYSIOL A, V171, P695, DOI 10.1007/BF00213066; Koppl C, 1998, HEARING RES, V126, P99, DOI 10.1016/S0378-5955(98)00156-7; Kuba H, 2005, J NEUROSCI, V25, P1924, DOI 10.1523/JnEUROSCI.4428-04.2005; Kubke MF, 2000, HEARING RES, V147, P1, DOI 10.1016/S0378-5955(00)00116-7; Kubke MF, 2006, INT J COMP PSYCHOL, V19, P83; MacLeod KM, 2006, J COMP NEUROL, V495, P185, DOI 10.1002/cne.20862; Manley GA, 1996, J MORPHOL, V227, P197, DOI 10.1002/(SICI)1097-4687(199602)227:2<197::AID-JMOR6>3.0.CO;2-6; MANLEY GA, 1993, J MORPHOL, V218, P153, DOI 10.1002/jmor.1052180205; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; PETTIGREW JD, 1979, PROC R SOC SER B-BIO, V204, P435, DOI 10.1098/rspb.1979.0038; REID B, 1982, NEW ZEAL J ECOL, V5, P76; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; SHIMIZU T, 1993, VISION BRAIN BEHAV B; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; SMITH ZDJ, 1981, J COMP NEUROL, V203, P309, DOI 10.1002/cne.902030302; SULLIVAN WE, 1986, BRAIN BEHAV EVOLUT, V28, P109, DOI 10.1159/000118696; TILNEY LG, 1983, J CELL BIOL, V96, P807, DOI 10.1083/jcb.96.3.807; TILNEY MS, 1987, HEARING RES, V25, P141, DOI 10.1016/0378-5955(87)90087-6; Van Dijk T., 1973, Netherlands J Zool, V23, P131; WATT J C, 1971, New Zealand Entomologist, V5, P25; WENZEL BM, 1971, ANN NY ACAD SCI, V188, P183, DOI 10.1111/j.1749-6632.1971.tb13097.x; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0	65	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23771	10.1371/journal.pone.0023771	http://dx.doi.org/10.1371/journal.pone.0023771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887317	gold, Green Submitted, Green Published			2022-12-25	WOS:000295832000058
J	Sun, WN; Hoffman, KM; Holley, DC; Kavanaugh, MP				Sun, Weinan; Hoffman, Katie M.; Holley, David C.; Kavanaugh, Michael P.			Specificity and Actions of an Arylaspartate Inhibitor of Glutamate Transport at the Schaffer Collateral-CA1 Pyramidal Cell Synapse	PLOS ONE			English	Article							SUBSTRATE INTERACTIONS; HIPPOCAMPUS; ACTIVATION; SPILLOVER; TRANSMISSION; EXCITATION; RECEPTORS; BLOCKER	In this study we characterized the pharmacological selectivity and physiological actions of a new arylaspartate glutamate transporter blocker, L-threo-beta-benzylaspartate (L-TBA). At concentrations up to 100 mu M, L-TBA did not act as an AMPA receptor (AMPAR) or NMDA receptor (NMDAR) agonist or antagonist when applied to outside-out patches from mouse hippocampal CA1 pyramidal neurons. L-TBA had no effect on the amplitude of field excitatory postsynaptic potentials (fEPSPs) recorded at the Schaffer collateral-CA1 pyramidal cell synapse. Excitatory postsynaptic currents (EPSCs) in CA1 pyramidal neurons were unaffected by L-TBA in the presence of physiological extracellular Mg(2+) concentrations, but in Mg(2+)-free solution, EPSCs were significantly prolonged as a consequence of increased NMDAR activity. Although L-TBA exhibited approximately four-fold selectivity for neuronal EAAT3 over glial EAAT1/EAAT2 transporter subtypes expressed in Xenopus oocytes, the L-TBA concentration-dependence of the EPSC charge transfer increase in the absence of Mg(2+) was the same in hippocampal slices from EAAT3 +/+ and EAAT3 -/- mice, suggesting that TBA effects were primarily due to block of glial transporters. Consistent with this, L-TBA blocked synaptically evoked transporter currents in CA1 astrocytes with a potency in accord with its block of heterologously expressed glial transporters. Extracellular recording in the presence of physiological Mg(2+) revealed that L-TBA prolonged fEPSPs in a frequency-dependent manner by selectively increasing the NMDAR-mediated component of the fEPSP during short bursts of activity. The data indicate that glial glutamate transporters play a dominant role in limiting extrasynaptic transmitter diffusion and binding to NMDARs. Furthermore, NMDAR signaling is primarily limited by voltage-dependent Mg(2+) block during low-frequency activity, while the relative contribution of transport increases during short bursts of higher frequency signaling.	[Sun, Weinan; Hoffman, Katie M.; Holley, David C.; Kavanaugh, Michael P.] Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Sun, WN (corresponding author), Univ Montana, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA.	michael.kavanaugh@umontana.edu		Sun, Weinan/0000-0002-6723-7964	National Institutes of Health (NIH NINDS) [NS33270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033270] Funding Source: NIH RePORTER	National Institutes of Health (NIH NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH NINDS grant NS33270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Esslinger CS, 2005, NEUROPHARMACOLOGY, V49, P850, DOI 10.1016/j.neuropharm.2005.08.009; Furuta A, 1997, J NEUROSCI, V17, P8363; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P2187, DOI 10.1152/jn.1993.70.5.2187; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Lozovaya NA, 1999, NEUROSCIENCE, V91, P1321, DOI 10.1016/S0306-4522(98)00638-1; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Shimamoto K, 2000, BIOORG MED CHEM LETT, V10, P2407, DOI 10.1016/S0960-894X(00)00487-X; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Tsukada S, 2005, NEUROPHARMACOLOGY, V48, P479, DOI 10.1016/j.neuropharm.2004.11.006; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23765	10.1371/journal.pone.0023765	http://dx.doi.org/10.1371/journal.pone.0023765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887314	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000055
J	Valdivia, N; Scrosati, RA; Molis, M; Knox, AS				Valdivia, Nelson; Scrosati, Ricardo A.; Molis, Markus; Knox, Amanda S.			Variation in Community Structure across Vertical Intertidal Stress Gradients: How Does It Compare with Horizontal Variation at Different Scales?	PLOS ONE			English	Article							ENVIRONMENTAL-STRESS; SPATIAL SCALES; RECRUITMENT LIMITATION; SESSILE ASSEMBLAGES; SPECIES RICHNESS; MARINE-ALGAE; MID-SHORE; ROCKY; HELGOLAND; PATTERNS	In rocky intertidal habitats, the pronounced increase in environmental stress from low to high elevations greatly affects community structure, that is, the combined measure of species identity and their relative abundance. Recent studies have shown that ecological variation also occurs along the coastline at a variety of spatial scales. Little is known, however, on how vertical variation compares with horizontal variation measured at increasing spatial scales (in terms of sampling interval). Because broad-scale processes can generate geographical patterns in community structure, we tested the hypothesis that vertical ecological variation is higher than fine-scale horizontal variation but lower than broad-scale horizontal variation. To test this prediction, we compared the variation in community structure across intertidal elevations on rocky shores of Helgoland Island with independent estimates of horizontal variation measured at the scale of patches (quadrats separated by 10s of cm), sites (quadrats separated by a few m), and shores (quadrats separated by 100s to 1000s of m). The multivariate analyses done on community structure supported our prediction. Specifically, vertical variation was significantly higher than patch-and site-scale horizontal variation but lower than shore-scale horizontal variation. Similar patterns were found for the variation in abundance of foundation taxa such as Fucus spp. and Mastocarpus stellatus, suggesting that the effects of these canopy-forming algae, known to function as ecosystem engineers, may explain part of the observed variability in community structure. Our findings suggest that broad-scale processes affecting species performance increase ecological variability relative to the pervasive fine-scale patchiness already described for marine coasts and the well known variation caused by vertical stress gradients. Our results also indicate that experimental research aiming to understand community structure on marine shores should benefit from applying a multi-scale approach.	[Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Valdivia, Nelson] Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile; [Scrosati, Ricardo A.; Knox, Amanda S.] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada; [Molis, Markus] Alfred Wegener Inst Polar & Marine Res, Sect Funct Ecol, Biol Anstalt Helgoland, Helgoland, Germany	Universidad Austral de Chile; Universidad Catolica del Norte; Saint Francis Xavier University - Canada; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson A/C-3613-2009; Scrosati, Ricardo A/K-6172-2016	Valdivia, Nelson A/0000-0002-5394-2072; Scrosati, Ricardo A/0000-0002-3050-132X	Canada Research Chairs (CRC) program; Canada Foundation for Innovation (CFI); Natural Sciences and Engineering Research Council of Canada (NSERC); Biologische Anstalt Helgoland; Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [3100014]	Canada Research Chairs (CRC) program(Canada Research Chairs); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Biologische Anstalt Helgoland; Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Research was supported by grants from the Canada Research Chairs (CRC) program, the Canada Foundation for Innovation (CFI), and the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant) to RAS, by funds from Biologische Anstalt Helgoland to NV and MM, and by a grant from the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT, grant #3100014) to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arenas F, 2006, ECOLOGY, V87, P2851, DOI 10.1890/0012-9658(2006)87[2851:TIOMAA]2.0.CO;2; Bartsch I, 2004, HELGOLAND MAR RES, V58, P289, DOI 10.1007/s10152-004-0194-2; Benedetti-Cecchi L, 1999, MAR ECOL PROG SER, V181, P13, DOI 10.3354/meps181013; Benedetti-Cecchi L, 2000, OECOLOGIA, V123, P406, DOI 10.1007/s004420051028; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V215, P79, DOI 10.3354/meps215079; Benedetti-Cecchi L, 2006, ECOLOGY, V87, P2489, DOI 10.1890/0012-9658(2006)87[2489:TVRTIO]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Bertocci I, 2010, MAR ECOL PROG SER, V414, P107, DOI 10.3354/meps08729; Blanchette CA, 2009, PROG OCEANOGR, V83, P107, DOI 10.1016/j.pocean.2009.07.038; Broitman BR, 2006, MAR ECOL PROG SER, V327, P15, DOI 10.3354/meps327015; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burnaford JL, 2004, ECOLOGY, V85, P2837, DOI 10.1890/03-0113; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Diaz ER, 2011, J ECOL, V99, P416, DOI 10.1111/j.1365-2745.2010.01779.x; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gimenez L, 2007, MAR ECOL PROG SER, V338, P159, DOI 10.3354/meps338159; Hahn A, 2007, EFFEKTE INVASIVEN SP, P91; Heaven CS, 2008, MAR ECOL PROG SER, V369, P13, DOI 10.3354/meps07655; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; JANKE K, 1990, HELGOLANDER MEERESUN, V44, P219, DOI 10.1007/BF02365466; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Jenkins SR, 2008, ECOLOGY, V89, pS3, DOI 10.1890/07-1155.1; Johnson MP, 2008, J EXP MAR BIOL ECOL, V365, P136, DOI 10.1016/j.jembe.2008.08.006; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; KORNMANN P, 1994, HELGOLANDER MEERESUN, V48, P365, DOI 10.1007/BF02366253; KORNMANN P, 1977, HELGOLAND WISS MEER, V29, P1, DOI 10.1007/BF01611137; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; LUTHER G, 1987, HELGOLANDER MEERESUN, V41, P1, DOI 10.1007/BF02365098; Maggs CA, 1993, SEAWEEDS BRIT ISLE 3; Martins GM, 2008, MAR ECOL PROG SER, V356, P15, DOI 10.3354/meps07247; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Menge BA, 2001, MARINE COMMUNITY ECOLOGY, P221; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Methratta ET, 2008, ECOLOGY, V89, P3128, DOI 10.1890/07-0849.1; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Noda T, 2009, POPUL ECOL, V51, P41, DOI 10.1007/s10144-008-0117-1; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; Piazzi L, 2004, AQUAT BOT, V79, P345, DOI 10.1016/j.aquabot.2004.05.006; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ryland JS, 1995, HDB MARINE FAUNA N W; Sarr DA, 2005, Q REV BIOL, V80, P187, DOI 10.1086/433058; Scrosati R, 2005, PHYCOL RES, V53, P224; Scrosati R, 2007, MAR ECOL PROG SER, V342, P1, DOI 10.3354/meps342001; Scrosati RA, 2011, HELGOLAND MAR RES, V65, P91, DOI 10.1007/s10152-010-0205-4; Scrosati RA, 2011, ECOGRAPHY, V34, P151, DOI 10.1111/j.1600-0587.2010.06119.x; Smale DA, 2010, DIVERS DISTRIB, V16, P985, DOI 10.1111/j.1472-4642.2010.00709.x; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; STEPHENSON TA, 1949, J ECOL, V37, P289, DOI 10.2307/2256610; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Underwood AJ, 2004, MAR ECOL PROG SER, V268, P173, DOI 10.3354/meps268173; Underwood AJ, 1998, OECOLOGIA, V117, P570, DOI 10.1007/s004420050694; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Worm B, 1998, J EXP MAR BIOL ECOL, V220, P247, DOI 10.1016/S0022-0981(97)00108-1; Ysebaert T, 2002, MAR ECOL PROG SER, V244, P105, DOI 10.3354/meps244105	69	40	42	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24062	10.1371/journal.pone.0024062	http://dx.doi.org/10.1371/journal.pone.0024062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887371	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000090
J	Espinoza, LJ; Takami, A; Nakata, K; Yamada, K; Onizuka, M; Kawase, T; Sao, H; Akiyama, H; Miyamura, K; Okamoto, S; Inoue, M; Fukuda, T; Morishima, Y; Kodera, Y; Nakao, S				Espinoza, Luis J.; Takami, Akiyoshi; Nakata, Katsuya; Yamada, Kayoko; Onizuka, Makoto; Kawase, Takakazu; Sao, Hiroshi; Akiyama, Hideki; Miyamura, Koichi; Okamoto, Shinichiro; Inoue, Masami; Fukuda, Takahiro; Morishima, Yasuo; Kodera, Yoshihisa; Nakao, Shinji		Japan Marrow Donor Program	Genetic Variants of Human Granzyme B Predict Transplant Outcomes after HLA Matched Unrelated Bone Marrow Transplantation for Myeloid Malignancies	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; CHRONIC GRAFT; ACUTE GVHD; RISK; POLYMORPHISM; PERFORIN; ALLELE; INHIBITOR; MECHANISM	Serine protease granzyme B plays important roles in infections, autoimmunity, transplant rejection, and antitumor immunity. A triple-mutated granzyme B variant that encodes three amino substitutions (Q48R, P88A, and Y245H) has been reported to have altered biological functions. In the polymorphism rs8192917 (2364A>G), the A and G alleles represent wild type QPY and RAH mutant variants, respectively. In this study, we analyzed the impact of granzyme B polymorphisms on transplant outcomes in recipients undergoing unrelated HLA-fully matched T-cell-replete bone marrow transplantation (BMT) through the Japan Donor Marrow Program. The granzyme B genotypes were retrospectively analyzed in a cohort of 613 pairs of recipients with hematological malignancies and their unrelated donors. In patients with myeloid malignancies consisting of acute myeloid leukemia and myelodysplastic syndrome, the donor G/G or A/G genotype was associated with improved overall survival (OS; adjusted hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.41-0.89; P = 0.01) as well as transplant related mortality (TRM; adjusted HR, 0.48; 95% CI, 0.27-0.86, P = 0.01). The recipient G/G or A/G genotype was associated with a better OS (adjusted HR, 0.68; 95% CI, 0.47-0.99; P = 0.05) and a trend toward a reduced TRM (adjusted HR, 0.61; 95% CI, 0.35-1.06; P = 0.08). Granzyme B polymorphism did not have any effect on the transplant outcomes in patients with lymphoid malignancies consisting of acute lymphoid leukemia and malignant lymphoma. These data suggest that there is an association between the granzyme B genotype and better clinical outcomes in patients with myeloid malignancies after unrelated BMT.	[Espinoza, Luis J.; Takami, Akiyoshi; Nakata, Katsuya; Yamada, Kayoko; Nakao, Shinji] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Onizuka, Makoto] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kawase, Takakazu] Aichi Canc Ctr Hosp, Div Epidemiol, Nagoya, Aichi 464, Japan; [Morishima, Yasuo] Aichi Canc Ctr Hosp, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Sao, Hiroshi] Meitetsu Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Akiyama, Hideki] Ebara Hosp, Dept Internal Med, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Okamoto, Shinichiro] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 160, Japan; [Inoue, Masami] Osaka Med Ctr, Dept Hematol & Oncol, Osaka, Japan; [Inoue, Masami] Res Inst Maternal & Child Hlth, Osaka, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Nagoya, Aichi, Japan	Kanazawa University; Tokai University; Aichi Cancer Center; Aichi Cancer Center; Red Cross Nagoya Daiichi Hospital; Keio University; Osaka Medical Center for Cancer & Cardiovascular Diseases; National Cancer Center - Japan; Aichi Medical University	Espinoza, LJ (corresponding author), Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan.	takami@med3.m.kanazawa-u.ac.jp	Espinoza, Luis/L-1586-2013; Takami, Akiyoshi/O-5677-2019	Espinoza, Luis/0000-0002-1794-6666; Takami, Akiyoshi/0000-0002-1822-9976; ONIZUKA, MAKOTO/0000-0003-3864-0823	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports and Technology; Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan)	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan)	This study was supported by grants from the Ministry of Health, Labor and Welfare, and the Ministry of Education, Culture, Sports and Technology, and funds from the Mitani Research and Development Assistance Organization (Kanazawa, Japan) and by the Japan Leukemia Research Fund (Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; Classen CF, 2004, HAEMATOLOGICA, V89, P1314; de Boer MGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018403; Dickinson AM, 2004, BRIT J HAEMATOL, V127, P479, DOI 10.1111/j.1365-2141.2004.05216.x; Elmaagacli AH, 2008, BONE MARROW TRANSPL, V41, P821, DOI 10.1038/sj.bmt.1705980; Espinoza JL, 2009, HAEMATOL-HEMATOL J, V94, P1427, DOI 10.3324/haematol.2009.008318; ESPINOZA JL, 2011, BONE MARROW TRANSPLA; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Gaafar A, 2009, EXP HEMATOL, V37, P838, DOI 10.1016/j.exphem.2009.04.003; Gerbitz A, 2008, BIOL BLOOD MARROW TR, V14, P1180, DOI 10.1016/j.bbmt.2008.08.002; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Gratwohl A, 2005, BONE MARROW TRANSPL, V36, P757, DOI 10.1038/sj.bmt.1705140; Graubert TA, 1997, J CLIN INVEST, V100, P904, DOI 10.1172/JCI119606; Hernandez-Pigeon H, 2006, J BIOL CHEM, V281, P13525, DOI 10.1074/jbc.M512694200; Higaki Y, 2001, DERMATOLOGY, V202, P94, DOI 10.1159/000051606; Jahrsdorfer B, 2010, BLOOD, V115, P1156, DOI 10.1182/blood-2009-07-235382; KANDA Y, 2011, EZR ON R COMMANDER; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Kim DH, 2007, TRANSPLANTATION, V84, P917, DOI 10.1097/01.tp.0000284583.15810.6e; Kircher B, 2009, BONE MARROW TRANSPL, V43, P787, DOI 10.1038/bmt.2008.395; Krupnick AS, 2002, TRANSPLANTATION, V74, P871, DOI 10.1097/00007890-200209270-00022; Lauw FN, 2000, J INFECT DIS, V182, P206, DOI 10.1086/315642; McDermott DH, 2010, BLOOD, V115, P2311, DOI 10.1182/blood-2009-08-237768; McIlroy D, 2003, P NATL ACAD SCI USA, V100, P2562, DOI 10.1073/pnas.0437935100; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Morishima Y, 2007, BIOL BLOOD MARROW TR, V13, P315, DOI 10.1016/j.bbmt.2006.10.027; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Noori-Daloill MR, 2007, ANN TRANSPL, V12, P5; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Pascoe MD, 2000, TRANSPLANTATION, V69, P2547, DOI 10.1097/00007890-200006270-00013; Prakash MD, 2009, IMMUNOL CELL BIOL, V87, P249, DOI 10.1038/icb.2008.98; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rousalova I, 2010, INT J ONCOL, V37, P1361, DOI 10.3892/ijo_00000788; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Strik MCM, 2007, MOL IMMUNOL, V44, P3462, DOI 10.1016/j.molimm.2007.03.024; Sugimoto K, 2008, INT J HEMATOL, V87, P451, DOI 10.1007/s12185-008-0061-z; Sun JR, 2004, J BIOL CHEM, V279, P16907, DOI 10.1074/jbc.M400563200; Sutton VR, 1997, J IMMUNOL, V158, P5783; TAK PP, 1994, ARTHRITIS RHEUM, V37, P1735, DOI 10.1002/art.1780371205; TAKAMI A, 2010, BONE MARROW TRANSPLA; Viel DO, 2007, SCAND J IMMUNOL, V66, P703, DOI 10.1111/j.1365-3083.2007.02021.x; Wagner C, 2004, BLOOD, V103, P1099, DOI 10.1182/blood-2003-04-1069; Zaitsu M, 2004, TISSUE ANTIGENS, V64, P611, DOI 10.1111/j.1399-0039.2004.00325.x	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23827	10.1371/journal.pone.0023827	http://dx.doi.org/10.1371/journal.pone.0023827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886827	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500032
J	Pesonen, AK; Sjosten, NM; Matthews, KA; Heinonen, K; Martikainen, S; Kajantie, E; Tammelin, T; Eriksson, JG; Strandberg, T; Raikkonen, KR				Pesonen, Anu-Katriina; Sjosten, Noora M.; Matthews, Karen A.; Heinonen, Kati; Martikainen, Silja; Kajantie, Eero; Tammelin, Tuija; Eriksson, Johan G.; Strandberg, Timo; Raikkonen, Katri			Temporal Associations between Daytime Physical Activity and Sleep in Children	PLOS ONE			English	Article							LICORICE CONSUMPTION; SALIVARY CORTISOL; RISK-FACTORS; DURATION; EXERCISE; ACTIGRAPHY; INFANCY; TEMPERAMENT; PREVALENCE; CONTINUITY	Objectives: We examined temporal associations between objectively-measured physical activity (PA) during the day and in the evening, and sleep quantity and quality. Study Design: PA and sleep were measured by actigraphs for an average of one week in an epidemiological cohort study of 275 eight-year-old children. Results: For each one standard deviation (SD) unit of increased PA during the day, sleep duration was decreased by 0.30, sleep efficiency by 0.16, and sleep fragmentation increased by 0.08 SD units that night. For each one SD unit increase in sleep duration and efficiency the preceding night, PA the following day decreased by 0.09 and 0.16 SD units, respectively. When we contrasted days with a high amount of moderate to vigorous activity during the day or in the evening to days with a more sedentary profile, the results were essentially similar. However, moderate to vigorous PA in the evening shortened sleep latency. Conclusions: The relationship between a higher level of PA and poorer sleep is bidirectional. These within-person findings challenge epidemiological findings showing that more active people report better sleep. Since only a few studies using objective measurements of both PA and sleep have been conducted in children, further studies are needed to confirm/refute these results.	[Pesonen, Anu-Katriina; Sjosten, Noora M.; Heinonen, Kati; Martikainen, Silja; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Fac Behav Sci, Helsinki, Finland; [Sjosten, Noora M.] Ctr Expertise Work Org, Finnish Inst Occupat Hlth, Turku, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Inst Clin Med, Clin Children & Adolescent, Helsinki, Finland; [Matthews, Karen A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Helsinki, Finland; [Tammelin, Tuija] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Strandberg, Timo] Univ Oulu, Unit Gen Practice, Dept Hlth Sci Geriatr, Oulu, Finland	University of Helsinki; Finnish Institute of Occupational Health; University of Helsinki; Helsinki University Central Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; University of Oulu	Pesonen, AK (corresponding author), Univ Helsinki, Inst Behav Sci, Fac Behav Sci, Helsinki, Finland.	Anukatriina.pesonen@helsinki.fi		strandberg, timo/0000-0001-6299-925X; Pesonen, Anu-Katriina/0000-0002-0662-6261; Heinonen, Kati/0000-0002-1262-5599; Eriksson, Johan/0000-0002-2516-2060; Raikkonen, Katri/0000-0003-3124-3470; Martikainen, Silja/0000-0001-7986-1580	John D. and Catherine T. MacArthur Foundation; European Science Foundation (EuroSTRESS); Finnish Academy; Ministry fo Culture and Education in Finland	John D. and Catherine T. MacArthur Foundation; European Science Foundation (EuroSTRESS)(European Science Foundation (ESF)); Finnish Academy(Academy of Finland); Ministry fo Culture and Education in Finland	The study was sponsored by grants from the John D. and Catherine T. MacArthur Foundation, the European Science Foundation (EuroSTRESS), the Finnish Academy, and the Ministry fo Culture and Education in Finland. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chen Kong Y, 2003, Diabetes Technol Ther, V5, P1023, DOI 10.1089/152091503322641088; Committee PAGA, 2008, PHYS ACT GUID ADV CO; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Danielsen YS, 2010, INT J PEDIATR OBES, V5, P214, DOI 10.3109/17477160903473739; DELCORRAL P, 1994, MED SCI SPORT EXER, V26, P1297; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; Fillipas S, 2010, J ASSOC NURSE AIDS C, V21, P173, DOI 10.1016/j.jana.2009.11.003; Fricke-Oerkermann L, 2007, SLEEP, V30, P1371, DOI 10.1093/sleep/30.10.1371; Heil DP, 2006, RES Q EXERCISE SPORT, V77, P64, DOI 10.5641/027013606X13080769703920; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Hyde M, 2007, J SLEEP RES, V16, P213, DOI 10.1111/j.1365-2869.2007.00588.x; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Kim K, 2000, SLEEP, V23, P41; Komsi N, 2008, INFANT BEHAV DEV, V31, P239, DOI 10.1016/j.infbeh.2007.10.002; Komsi N, 2006, INFANT BEHAV DEV, V29, P494, DOI 10.1016/j.infbeh.2006.05.002; Kos D, 2007, CHRONOBIOL INT, V24, P345, DOI 10.1080/07420520701282364; Kumahara H, 2004, INT J OBESITY, V28, P1105, DOI 10.1038/sj.ijo.0802712; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Liu XC, 2000, SLEEP, V23, P27; Morgan K, 2003, J SLEEP RES, V12, P231, DOI 10.1046/j.1365-2869.2003.00355.x; Nixon GM, 2009, ARCH DIS CHILD, V94, P686, DOI 10.1136/adc.2009.157453; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Paccotti P, 2005, INT J SPORTS MED, V26, P747, DOI 10.1055/s-2004-830449; Pesonen AK, 2009, SLEEP, V32, P1086, DOI 10.1093/sleep/32.8.1086; Raikkonen K, 2010, J CLIN ENDOCR METAB, V95, P2254, DOI 10.1210/jc.2009-0943; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P1137, DOI 10.1093/aje/kwp272; Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894; Singh GK, 2008, J COMMUN HEALTH, V33, P206, DOI 10.1007/s10900-008-9094-8; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Strandberg TE, 2001, AM J EPIDEMIOL, V153, P1085, DOI 10.1093/aje/153.11.1085; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; URPONEN H, 1988, SOC SCI MED, V26, P443, DOI 10.1016/0277-9536(88)90313-9; Westerterp KR, 1999, INT J OBESITY, V23, pS45, DOI 10.1038/sj.ijo.0800883; Wood AC, 2008, BEHAV GENET, V38, P266, DOI 10.1007/s10519-008-9196-1; Yen CF, 2010, PSYCHIAT RES, V179, P69, DOI 10.1016/j.psychres.2009.02.016; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203; [No title captured]; [No title captured]; [No title captured]	45	88	88	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22958	10.1371/journal.pone.0022958	http://dx.doi.org/10.1371/journal.pone.0022958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811YA	21886770	Green Published, Green Accepted, gold			2022-12-25	WOS:000294253500004
J	Eliyahu, E; Wolfson, T; Ge, Y; Jepsen, KJ; Schuchman, EH; Simonaro, CM				Eliyahu, Efrat; Wolfson, Theodore; Ge, Yi; Jepsen, Karl J.; Schuchman, Edward H.; Simonaro, Calogera M.			Anti-TNF-Alpha Therapy Enhances the Effects of Enzyme Replacement Therapy in Rats with Mucopolysaccharidosis Type VI	PLOS ONE			English	Article							ARYLSULFATASE-B; JOINT DISEASE; MECHANISM; BONE; IDENTIFICATION; GENE	Background: Although enzyme replacement therapy (ERT) is available for several lysosomal storage disorders, the benefit of this treatment to the skeletal system is very limited. Our previous work has shown the importance of the Toll-like receptor 4/TNF-alpha inflammatory pathway in the skeletal pathology of the mucopolysaccharidoses (MPS), and we therefore undertook a study to examine the additive benefit of combining anti-TNF-alpha therapy with ERT in a rat model of MPS type VI. Methodology/Principal Findings: MPS VI rats were treated for 8 months with Naglazyme(R) (recombinant human N-acetyl-galactosamine-4-sulfatase), or by a combined protocol using Naglazyme(R) and the rat-specific anti-TNF-alpha drug, CNTO1081. Both protocols led to markedly reduced serum levels of TNF-alpha and RANKL, although only the combined treatment reduced TNF-alpha in the articular cartilage. Analysis of cultured articular chondrocytes showed that the combination therapy also restored collagen IIA1 expression, and reduced expression of the apoptotic marker, PARP. Motor activity and mobility were improved by ERT, and these were significantly enhanced by combination treatment. Tracheal deformities in the MPS VI animals were only improved by combination therapy, and there was a modest improvement in bone length. Ceramide levels in the trachea also were markedly reduced. MicroCT analysis did not demonstrate any significant positive effects on bone microarchitecture from either treatment, nor was there histological improvement in the bone growth plates. Conclusions/Significance: The results demonstrate that combining ERT with anti-TNF-alpha therapy improved the treatment outcome and led to significant clinical benefit. They also further validate the usefulness of TNF-alpha, RANKL and other inflammatory molecules as biomarkers for the MPS disorders. Further evaluation of this combination approach in other MPS animal models and patients is warranted.	[Eliyahu, Efrat; Ge, Yi; Schuchman, Edward H.; Simonaro, Calogera M.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Wolfson, Theodore; Jepsen, Karl J.] Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Eliyahu, E (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	calogera.simonaro@mssm.edu	Wolfson, Theodore/ABB-2629-2020	Wolfson, Theodore/0000-0002-2593-1755	National Institutes of Health [1R01DK087185, AR44927]; National Mucopolysaccharidosis Society; Isaac Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044927, R56AR044927, R29AR044927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Mucopolysaccharidosis Society; Isaac Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by grants from the National Institutes of Health ((http://grants.nih.gov/grants/oer.htm) 1R01DK087185 and AR44927), The National Mucopolysaccharidosis Society (http://www.mpssociety.org/), and The Isaac Foundation (www.theisaacfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair D, 2007, MOL GENET METAB, V91, P352, DOI 10.1016/j.ymgme.2007.04.009; Becker KA, 2010, BIOCHEM BIOPH RES CO, V403, P368, DOI 10.1016/j.bbrc.2010.11.038; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; Connor V, 2011, RHEUMATOL INT, V31, P327, DOI 10.1007/s00296-009-1292-x; Coppa GV, 2010, GLYCOBIOLOGY, V20, P1259, DOI 10.1093/glycob/cwq088; Cotugno G, 2010, HUM GENE THER, V21, P555, DOI 10.1089/hum.2009.189; Cox-Brinkman J, 2010, ULTRASTRUCT PATHOL, V34, P126, DOI 10.3109/01913121003648485; Decker C, 2010, J PEDIATR REHAB MED, V3, P89, DOI 10.3233/PRM-2010-0113; GLAMUZINA E, 2011, J INHERIT METAB 0216; Herati RS, 2008, MOL GENET METAB, V95, P142, DOI 10.1016/j.ymgme.2008.07.003; Klaasen R, 2011, ARTHRITIS RHEUM-US, V63, P359, DOI 10.1002/art.30136; KUNIEDA T, 1995, GENOMICS, V29, P582, DOI 10.1006/geno.1995.9962; LU JZ, 2011, BIOTECHNOL BIOE 0223; McGill JJ, 2010, CLIN GENET, V77, P492, DOI 10.1111/j.1399-0004.2009.01324.x; Metcalf JA, 2009, MOL GENET METAB, V97, P202, DOI 10.1016/j.ymgme.2009.03.005; Miebach E, 2005, ACTA PAEDIATR, V94, P58, DOI 10.1080/08035320510028120; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249; Rodgers M, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI [10.3310/hta15100, 10.3310/hta15suppl1/01]; RUTELLA S, 2011, AM J GASTROENTE 0301; SEMENZA GL, 1988, MEDICINE, V67, P209, DOI 10.1097/00005792-198807000-00002; Shinhar SY, 2004, ARCH OTOLARYNGOL, V130, P233, DOI 10.1001/archotol.130.2.233; Simonardo CM, 1997, TRANSPLANTATION, V63, P1386, DOI 10.1097/00007890-199705270-00003; Simonaro CM, 2008, AM J PATHOL, V172, P112, DOI 10.2353/ajpath.2008.070564; Simonaro CM, 2010, P NATL ACAD SCI USA, V107, P222, DOI 10.1073/pnas.0912937107; Simonaro CM, 2005, PEDIATR RES, V57, P701, DOI 10.1203/01.PDR.0000156510.96253.5A; Simonaro CM, 2001, LAB INVEST, V81, P1319, DOI 10.1038/labinvest.3780345; Valayannopoulos V, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-5; Weaver Arthur L, 2004, Mod Rheumatol, V14, P101; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; YOSHIDA M, 1993, J CLIN INVEST, V91, P1099, DOI 10.1172/JCI116268	31	56	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e22447	10.1371/journal.pone.0022447	http://dx.doi.org/10.1371/journal.pone.0022447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887218	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800005
J	Berleman, JE; Vicente, JJ; Davis, AE; Jiang, SY; Seo, YE; Zusman, DR				Berleman, James E.; Vicente, Juan J.; Davis, Annie E.; Jiang, Sharon Y.; Seo, Young-Eun; Zusman, David R.			FrzS Regulates Social Motility in Myxococcus xanthus by Controlling Exopolysaccharide Production	PLOS ONE			English	Article							GLIDING MOTILITY; CELL-INTERACTIONS; IV PILUS; GENES; LOCALIZATION; MYXOBACTERIA; EVOLUTION; MOVEMENT; SYSTEMS; PATHWAY	Myxococcus xanthus Social (S) motility occurs at high cell densities and is powered by the extension and retraction of Type IV pili which bind ligands normally found in matrix exopolysaccharides (EPS). Previous studies showed that FrzS, a protein required for S-motility, is organized in polar clusters that show pole-to-pole translocation as cells reverse their direction of movement. Since the leading cell pole is the site of both the major FrzS cluster and type IV pilus extension/retraction, it was suggested that FrzS might regulate S-motility by activating pili at the leading cell pole. Here, we show that FrzS regulates EPS production, rather than type IV pilus function. We found that the frzS phenotype is distinct from that of Type IV pilus mutants such as pilA and pilT, but indistinguishable from EPS mutants, such as epsZ. Indeed, frzS mutants can be rescued by the addition of purified EPS, 1% methylcellulose, or co-culturing with wildtype cells. Our data also indicate that the cell density requirement in S-motility is likely a function of the ability of cells to construct functional multicellular clusters surrounding an EPS core.	[Berleman, James E.; Vicente, Juan J.; Davis, Annie E.; Jiang, Sharon Y.; Seo, Young-Eun; Zusman, David R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berleman, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	zusman@berkeley.edu		Vicente, Juan Jesus/0000-0002-3402-3046	National Institutes of Health [GM020509, GM020509-36S1, GM020509-37S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants GM020509, GM020509-36S1 and GM020509-37S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD JW, 1988, J BACTERIOL, V170, P5765, DOI 10.1128/jb.170.12.5765-5770.1988; Berleman JE, 2007, J BACTERIOL, V189, P5675, DOI 10.1128/JB.00544-07; Berleman JE, 2009, FEMS MICROBIOL REV, V33, P942, DOI 10.1111/j.1574-6976.2009.00185.x; Black WP, 2006, MOL MICROBIOL, V61, P447, DOI 10.1111/j.1365-2958.2006.05230.x; Black WP, 2010, J BACTERIOL, V192, P4267, DOI 10.1128/JB.00403-10; Black WP, 2009, MICROBIOL-SGM, V155, P3599, DOI 10.1099/mic.0.031070-0; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Bustamante VH, 2004, MOL MICROBIOL, V53, P1501, DOI 10.1111/j.1365-2958.2004.04221.x; CAMPOS JM, 1975, P NATL ACAD SCI USA, V72, P518, DOI 10.1073/pnas.72.2.518; Cole JL, 2003, MOL MICROBIOL, V49, P1671, DOI 10.1046/j.1365-2958.2003.03664.x; DANA JR, 1993, J BACTERIOL, V175, P3636, DOI 10.1128/jb.175.11.3636-3647.1993; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Fraser JS, 2007, MOL MICROBIOL, V65, P319, DOI 10.1111/j.1365-2958.2007.05785.x; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7033, DOI 10.1128/jb.175.21.7033-7044.1993; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Guo YZ, 2010, INFECT IMMUN, V78, P1390, DOI 10.1128/IAI.01188-09; Hillesland KL, 2005, MICROBIAL ECOL, V49, P558, DOI 10.1007/s00248-004-0069-8; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; Hu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016102; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; KAISER D, 1983, CELL MOTILITY, P227; Kim SH, 1999, J BACTERIOL, V181, P1496, DOI 10.1128/JB.181.5.1496-1507.1999; Lancero H, 2002, J BACTERIOL, V184, P1462, DOI 10.1128/JB.184.5.1462-1465.2002; Lu A, 2005, MOL MICROBIOL, V55, P206, DOI 10.1111/j.1365-2958.2004.04369.x; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Mignot T, 2007, MOL MICROBIOL, V65, P363, DOI 10.1111/j.1365-2958.2007.05789.x; Nan BY, 2011, P NATL ACAD SCI USA, V108, P2498, DOI 10.1073/pnas.1018556108; Palsdottir H, 2009, J BACTERIOL, V191, P2077, DOI 10.1128/JB.01333-08; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; SHI WY, 1993, P NATL ACAD SCI USA, V90, P3378, DOI 10.1073/pnas.90.8.3378; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; SHIMKETS LJ, 1986, J BACTERIOL, V166, P837, DOI 10.1128/jb.166.3.837-841.1986; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; Vlamakis HC, 2004, MOL MICROBIOL, V52, P1799, DOI 10.1111/j.1365-2958.2004.04098.x; Ward MJ, 2000, MOL MICROBIOL, V37, P1357, DOI 10.1046/j.1365-2958.2000.02079.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Xu Q, 2005, J BACTERIOL, V187, P6410, DOI 10.1128/JB.187.18.6410-6418.2005; Yang Z, 2010, MOL MICROBIOL, V76, P1500, DOI 10.1111/j.1365-2958.2010.07180.x; Yang ZM, 1998, MOL MICROBIOL, V30, P1123, DOI 10.1046/j.1365-2958.1998.01160.x; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x	52	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23920	10.1371/journal.pone.0023920	http://dx.doi.org/10.1371/journal.pone.0023920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886839	Green Submitted, Green Published, gold			2022-12-25	WOS:000294128100040
J	Feng, JX; Yang, JX; Zheng, SY; Qiu, YR; Chai, CW				Feng, Jiexiong; Yang, Jixin; Zheng, Shuaiyu; Qiu, Yinrong; Chai, Chengwei			Silencing of the Rotavirus NSP4 Protein Decreases the Incidence of Biliary Atresia in Murine Model	PLOS ONE			English	Article							EPITHELIAL-CELLS; PATHOGENESIS; OBSTRUCTION; CHILDREN; DISEASE; MICE; RNA	Biliary atresia is a common disease in neonates which causes obstructive jaundice and progressive hepatic fibrosis. Our previous studies indicate that rotavirus infection is an initiator in the pathogenesis of experimental biliary atresia (BA) through the induction of increased nuclear factor-kappaB and abnormal activation of the osteopontin inflammation pathway. In the setting of rotavirus infection, rotavirus nonstructural protein 4 (NSP4) serves as an important immunogen, viral protein 7 (VP7) is necessary in rotavirus maturity and viral protein 4 (VP4) is a virulence determiner. The purpose of the current study is to clarify the roles of NSP4, VP7 and VP4 in the pathogenesis of experimental BA. Primary cultured extrahepatic biliary epithelia were infected with Rotavirus (mmu18006). Small interfering RNA targeting NSP4, VP7 or VP4 was transfected before rotavirus infection both in vitro and in vivo. We analyzed the incidence of BA, morphological change, morphogenesis of viral particles and viral mRNA and protein expression. The in vitro experiments showed NSP4 silencing decreased the levels of VP7 and VP4, reduced viral particles and decreased cytopathic effect. NSP4-positive cells had strongly positive expression of integrin subunit alpha 2. Silencing of VP7 or VP4 partially decreased epithelial injury. Animal experiments indicated after NSP4 silencing, mouse pups had lower incidence of BA than after VP7 or VP4 silencing. However, 33.3% of VP4-silenced pups (N = 6) suffered BA and 50% of pups (N = 6) suffered biliary injury after VP7 silencing. Hepatic injury was decreased after NSP4 or VP4 silencing. Neither VP4 nor VP7 were detected in the biliary ducts after NSP4. All together, NSP4 silencing down-regulates VP7 and VP4, resulting in decreased incidence of BA.	[Feng, Jiexiong; Yang, Jixin; Zheng, Shuaiyu; Qiu, Yinrong; Chai, Chengwei] Huazhong Univ Sci & Technol, Dept Pediat Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Feng, JX (corresponding author), Huazhong Univ Sci & Technol, Dept Pediat Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	fengjiexiong@126.com		Feng, Jiexiong/0000-0001-9596-2330	National Natural Science Foundation of China [81070284, 30672195]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81070284 and No. 30672195; http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANGARU B, 1980, LAB INVEST, V43, P456; Chai CW, 2010, IN VITRO CELL DEV-AN, V46, P820, DOI 10.1007/s11626-010-9346-7; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Dector MA, 2002, EMBO REP, V3, P1175, DOI 10.1093/embo-reports/kvf234; Enouf V, 2003, J VIROL, V77, P7041, DOI 10.1128/JVI.77.12.7041-7047.2003; ESPARZA J, 1980, J GEN VIROL, V47, P461, DOI 10.1099/0022-1317-47-2-461; Feng JX, 2008, CURR PEDIATR REV, V4, P164, DOI 10.2174/157339608785856054; Feng JX, 2005, J PEDIATR SURG, V40, P630, DOI 10.1016/j.jpedsurg.2004.12.004; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Harada K, 2007, HEPATOLOGY, V46, P1146, DOI 10.1002/hep.21797; Huang L, 2008, EUR J PEDIATR SURG, V18, P224, DOI 10.1055/s-2008-1038483; Jafri M, 2007, SURGERY, V142, P192, DOI 10.1016/j.surg.2007.03.008; LANDAU SM, 1982, ARCH VIROL, V73, P79, DOI 10.1007/BF01341731; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Mack CL, 2007, SEMIN LIVER DIS, V27, P233, DOI 10.1055/s-2007-985068; MARIA GC, 2009, GASTROENTEROLOGY S, V136, pA808; Mohanty SK, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-14; Petersen C, 1997, J PEDIATR SURG, V32, P1190, DOI 10.1016/S0022-3468(97)90680-1; Petersen C, 2007, PEDIATR SURG INT, V23, P521, DOI 10.1007/s00383-007-1922-x; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; Zarnbrano JL, 2008, J VIROL, V82, P5815, DOI 10.1128/JVI.02719-07	23	70	73	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23655	10.1371/journal.pone.0023655	http://dx.doi.org/10.1371/journal.pone.0023655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876759	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900031
J	Berezov, A; Cai, Z; Freudenberg, JA; Zhang, H; Cheng, X; Thompson, T; Murali, R; Greene, MI; Wang, Q				Berezov, A.; Cai, Z.; Freudenberg, J. A.; Zhang, H.; Cheng, X.; Thompson, T.; Murali, R.; Greene, M. I.; Wang, Q.			Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin	ONCOGENE			English	Article						mitosis; cancer; therapeutic; survivin	KINETOCHORE FIBERS CONTRIBUTES; THERAPEUTIC TARGET; SIGNALING PATHWAY; INNER CENTROMERE; MOTOR PROTEINS; CELL-DIVISION; BINDING-SITE; AURORA B; APOPTOSIS; MITOSIS	Survivin is a member of the inhibitor of apoptosis protein family and has an essential role in mitosis. Survivin is overexpressed in a large variety of human cancers and represents an attractive target for cancer therapy. Epidermal growth factor receptor and Her/neu-transformed human tumors in particular exhibit high levels of survivin. The survivin protein forms dimers through a conserved region that is critical for subcellular localization and biological functions of the protein. We identified small molecules that target a specific cavity adjacent to the survivin dimerization surfaces. S12, a lead compound identified in the screen, can bind to the survivin protein at the intended target site. Moreover, S12 alters spindle formation, causing mitotic arrest and cell death, and inhibits tumor growth in vitro and in vivo. Cell death occurs in premetaphase stage following mitotic arrest and is not a consequence of general toxicity. Thus, the study validates a novel therapeutic target site in the survivin protein and provides a promising strategy to develop a new class of therapeutic small molecules for the treatment of human cancers. Oncogene (2012) 31, 1938-1948; doi:10.1038/onc.2011.377; published online 5 September 2011	[Berezov, A.; Cai, Z.; Freudenberg, J. A.; Zhang, H.; Cheng, X.; Thompson, T.; Murali, R.; Greene, M. I.; Wang, Q.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Greene, MI (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	greene@reo.med.upenn.edu; Qiang.Wang@cshs.org	Wang, Qiang/N-7310-2015	Wang, Qiang/0000-0001-9409-0251; Zhang, Hongtao/0000-0001-9173-0049; Neely, Jaclyn/0000-0001-7137-3953; Murali, Ramachandran/0000-0002-8384-2793	Abramson Family Cancer Research Institute of the University of Pennsylvania; The National Cancer Institute; Breast Cancer Research Foundation; Nidus Laboratories, Inc.; NATIONAL CANCER INSTITUTE [R01CA055306, R01CA089481] Funding Source: NIH RePORTER	Abramson Family Cancer Research Institute of the University of Pennsylvania; The National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Nidus Laboratories, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Robert L Margolis (the Sanford-Burnham Medical Research Institute, La Jolla, CA, USA) for providing the pGEX-survivin plasmid. This work was supported by grants from the Abramson Family Cancer Research Institute of the University of Pennsylvania, The National Cancer Institute, the Breast Cancer Research Foundation and the Nidus Laboratories, Inc.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; DESJARLAIS RL, 1988, J MED CHEM, V31, P722, DOI 10.1021/jm00399a006; Giodini A, 2002, CANCER RES, V62, P2462; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kappler M, 2004, CANCER GENE THER, V11, P186, DOI 10.1038/sj.cgt.7700677; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Khodjakov A, 2003, J CELL BIOL, V160, P671, DOI 10.1083/jcb.200208143; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; Maiato H, 2004, CHROMOSOME RES, V12, P585, DOI 10.1023/B:CHRO.0000036587.26566.81; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; Rodel F, 2005, CANCER RES, V65, P4881, DOI 10.1158/0008-5472.CAN-04-3028; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Rosenthal DS, 1997, EXP CELL RES, V232, P313, DOI 10.1006/excr.1997.3536; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Tamm I, 1998, CANCER RES, V58, P5315; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang Q, 2005, EXP MOL PATHOL, V79, P100, DOI 10.1016/j.yexmp.2005.05.002; Wendt MD, 2007, BIOORG MED CHEM LETT, V17, P3122, DOI 10.1016/j.bmcl.2007.03.042; Xia WL, 2006, CANCER RES, V66, P1640, DOI 10.1158/0008-5472.CAN-05-2000; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498	38	29	32	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	15					1938	1948		10.1038/onc.2011.377	http://dx.doi.org/10.1038/onc.2011.377			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21892210	Green Accepted			2022-12-25	WOS:000302809900006
J	Llarrull, LI; Toth, M; Champion, MM; Mobashery, S				Llarrull, Leticia I.; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar			Activation of BlaR1 Protein of Methicillin-resistant Staphylococcus aureus, Its Proteolytic Processing, and Recovery from Induction of Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM ANTIBIOTICS; N-ZETA-DECARBOXYLATION; SIGNALING PATHWAY; ESCHERICHIA-COLI; SENSOR DOMAIN; MEMBRANE; BINDING; TRANSDUCER; OPERON	The fates of BlaI, the gene repressor protein for the bla operon, BlaR1, the beta-lactam sensor/signal transducer, and PC1 beta-lactamase in four strains of Staphylococcus aureus upon exposure to four different beta-lactam antibiotics were investigated as a function of time. The genes for the three proteins are encoded by the bla operon, the functions of which afford inducible resistance to beta-lactam antibiotics in S. aureus. BlaR1 protein is expressed at low copy number. Acylation of the sensor domain of BlaR1 by beta-lactam antibiotics initiates signal transduction to the cytoplasmic domain, a zinc protease, which is activated and degrades BlaI. This proteolytic degradation derepresses transcription of all three genes, resulting in inducible resistance. These processes take place within minutes of exposure to the antibiotics. The BlaR1 protein was shown to undergo fragmentation in three S. aureus strains within the time frame relevant for manifestation of resistance and was below the detection threshold in the fourth. Two specific sites of fragmentation were identified, one cytoplasmic and the other in the sensor domain. This is proposed as a means for turnover, a process required for recovery from induction of resistance in S. aureus in the absence of the antibiotic challenge. In S. aureus not exposed to beta-lactam antibiotics (i.e. not acylated by antibiotic) the same fragmentation of BlaR1 is still observed, including the shedding of the sensor domain, an observation that leads to the conclusion that the sites of proteolysis might have evolved to predispose the protein to degradation within a set period of time.	[Llarrull, Leticia I.; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Mobashery, S (corresponding author), 423 Nieuwland Sci Ctr, Notre Dame, IN 46556 USA.	mobashery@nd.edu		Champion, Matthew M./0000-0001-5927-5277; Llarrull, Leticia/0000-0002-5679-4343	National Institutes of Health [AI 33170]; Pew Charitable Trusts; NIAID, National Institutes of Health [HHSN272200700055C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 33170.; A Pew Latin American Fellow in the Biomedical Sciences, supported by The Pew Charitable Trusts.; S. aureus isolates NRS128, NRS123, NRS70, and NRS144 were obtained through the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) program, supported under NIAID, National Institutes of Health, Contract HHSN272200700055C. We acknowledge Dr. Maxim Suvorov for construction of the vector pET-24a(+)_BlaRHis<INF>6</INF>.	Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Antunes NT, 2011, BIOCHEMISTRY-US, V50, P6387, DOI 10.1021/bi200403e; Bernsel A, 2009, TRENDS MICROBIOL, V17, P444, DOI 10.1016/j.tim.2009.07.005; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Carrasco-Lopez C, 2011, J BIOL CHEM, V286, P31714, DOI 10.1074/jbc.M111.264366; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; Clarke SR, 2001, J ANTIMICROB CHEMOTH, V47, P377, DOI 10.1093/jac/47.4.377; Collins J. F., 1979, BETA LACTAMASES, P351; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guo FS, 1999, BBA-PROTEIN STRUCT M, V1431, P132, DOI 10.1016/S0167-4838(99)00048-5; Hanique S, 2004, J BIOL CHEM, V279, P14264, DOI 10.1074/jbc.M313488200; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Jones AR, 2008, MOL CELL PROTEOMICS, V7, P2067, DOI 10.1074/mcp.H800010-MCP200; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; KOZAK M, 1983, MICROBIOL REV, V47, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Llarrull LI, 2010, BIOCHEMISTRY-US, V49, P7975, DOI 10.1021/bi101177a; Powers ME, 2011, J BACTERIOL, V193, P340, DOI 10.1128/JB.01052-10; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; SUGINO Y, 1980, J BIOCHEM-TOKYO, V87, P351, DOI 10.1093/oxfordjournals.jbchem.a132746; Tang JZ, 2004, PROTEIN EXPRES PURIF, V36, P100, DOI 10.1016/j.pep.2004.03.007; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Wikler M., 2006, METHODS DILUTION ANT; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; ZHU YF, 1992, J BACTERIOL, V174, P6171, DOI 10.1128/JB.174.19.6171-6178.1992	34	47	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38148	38158		10.1074/jbc.M111.288985	http://dx.doi.org/10.1074/jbc.M111.288985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896485	Green Published, hybrid			2022-12-25	WOS:000296594200028
J	Garcia-Saez, AJ; Buschhorn, SB; Keller, H; Anderluh, G; Simons, K; Schwille, P				Garcia-Saez, Ana J.; Buschhorn, Sabine B.; Keller, Heiko; Anderluh, Gregor; Simons, Kai; Schwille, Petra			Oligomerization and Pore Formation by Equinatoxin II Inhibit Endocytosis and Lead to Plasma Membrane Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SEA-ANEMONE; FORMING TOXIN; LIPID RAFTS; PHASE COEXISTENCE; STICHOLYSIN-II; RECEPTOR; PROTEINS; SPHINGOMYELIN; ORGANIZATION	Pore-forming toxins have evolved to induce membrane injury by formation of pores in the target cell that alter ion homeostasis and lead to cell death. Many pore-forming toxins use cholesterol, sphingolipids, or other raft components as receptors. However, the role of plasma membrane organization for toxin action is not well understood. In this study, we have investigated cellular dynamics during the attack of equinatoxin II, a pore-forming toxin from the sea anemone Actinia equina, by combining time lapse three-dimensional live cell imaging, fluorescence recovery after photobleaching, FRET, and fluorescence cross-correlation spectroscopy. Our results show that membrane binding by equinatoxin II is accompanied by extensive plasma membrane reorganization into microscopic domains that resemble coalesced lipid rafts. Pore formation by the toxin induces Ca2+ entry into the cytosol, which is accompanied by hydrolysis of phosphatidylinositol 4,5-bisphosphate, plasma membrane blebbing, actin cytoskeleton reorganization, and inhibition of endocytosis. We propose that plasma membrane reorganization into stabilized raft domains is part of the killing strategy of equinatoxin II.	[Garcia-Saez, Ana J.; Keller, Heiko; Schwille, Petra] Tech Univ Dresden, BIOTEC, D-01307 Dresden, Germany; [Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-69120 Heidelberg, Germany; [Garcia-Saez, Ana J.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Buschhorn, Sabine B.; Simons, Kai] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia	Technische Universitat Dresden; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; University of Ljubljana	Garcia-Saez, AJ (corresponding author), Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	ana.garcia@mf.mpg.de; petra.schwille@biotec.tu-dresden.de	Schwille, Petra/A-4983-2010; Anderluh, Gregor/C-6905-2014; Saez, Ana J. Garcia/U-1611-2019	Anderluh, Gregor/0000-0002-9916-8465; Simons, Kai/0000-0002-9231-9996	German Cancer Research Center; Max Planck Society	German Cancer Research Center(Helmholtz Association); Max Planck Society(Max Planck Society)	This work was supported by funds from the German Cancer Research Center (to A. J. G.-S.) and the Max Planck Society.	Abe Y, 2008, J BIOCHEM, V143, P269, DOI 10.1093/jb/mvm220; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderluh G, 2000, J MEMBRANE BIOL, V173, P47, DOI 10.1007/s002320001006; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Bakrac B, 2010, ADV EXP MED BIOL, V677, P106; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Garcia-Saez AJ, 2010, METHODS MOL BIOL, V606, P493, DOI 10.1007/978-1-60761-447-0_33; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Gekara NO, 2004, BIOCHEM SOC T, V32, P712, DOI 10.1042/BST0320712; Goehring NW, 2010, BIOPHYS J, V99, P2443, DOI 10.1016/j.bpj.2010.08.033; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Gonzalez MR, 2011, CELL MICROBIOL, V13, P1026, DOI 10.1111/j.1462-5822.2011.01600.x; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Keller H, 2009, CHEMPHYSCHEM, V10, P2805, DOI 10.1002/cphc.200900598; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kitada S, 2009, TOXICOLOGY, V264, P80, DOI 10.1016/j.tox.2009.07.016; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Malovrh P, 2003, J BIOL CHEM, V278, P22678, DOI 10.1074/jbc.M300622200; Mancheno JA, 2006, BIOPHYS CHEM, V119, P219, DOI 10.1016/j.bpc.2005.09.021; Martin-Benito J, 2000, BIOPHYS J, V78, P3186, DOI 10.1016/S0006-3495(00)76855-X; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ries J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113009; Saxena R, 2011, J NEUROCHEM, V116, P726, DOI 10.1111/j.1471-4159.2010.07037.x; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Tejuca M, 2001, J MEMBRANE BIOL, V183, P125, DOI 10.1007/s00232-001-0060-y; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; ZOREC R, 1990, J MEMBRANE BIOL, V118, P243, DOI 10.1007/BF01868608	54	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37768	37777		10.1074/jbc.M111.281592	http://dx.doi.org/10.1074/jbc.M111.281592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21885440	hybrid, Green Published			2022-12-25	WOS:000296542400072
J	Karasawa, A; Erkens, GB; Berntsson, RPA; Otten, R; Schuurman-Wolters, GK; Mulder, FAA; Poolman, B				Karasawa, Akira; Erkens, Guus B.; Berntsson, Ronnie P. -A.; Otten, Renee; Schuurman-Wolters, Gea K.; Mulder, Frans A. A.; Poolman, Bert			Cystathionine beta-Synthase (CBS) Domains 1 and 2 Fulfill Different Roles in Ionic Strength Sensing of the ATP-binding Cassette (ABC) Transporter OpuA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHLORIDE CHANNELS; CARRIER BETP; CORYNEBACTERIUM-GLUTAMICUM; LACTOCOCCUS-LACTIS; OSMOTIC ACTIVATION; COILED-COIL; PROTEIN	The cystathionine beta-synthase module of OpuA in conjunction with an anionic membrane surface acts as a sensor of internal ionic strength, which allows the protein to respond to osmotic stress. We now show by chemical modification and cross-linking studies that CBS2-CBS2 interface residues are critical for transport activity and/or ionic regulation of transport, whereas CBS1 serves no functional role. We establish that Cys residues in CBS1, CBS2, and the nucleotide-binding domain are more accessible for cross-linking at high than low ionic strength, indicating that these domains undergo conformational changes when transiting between the active and inactive state. Structural analyses suggest that the cystathionine beta-synthase module is largely unstructured. Moreover, we could substitute CBS1 by a linker and preserve ionic regulation of transport. These data suggest that CBS1 serves as a linker and the structured CBS2-CBS2 interface forms a hinge point for ionic strength-dependent rearrangements that are transmitted to the nucleotide-binding domain and thereby affect translocation activity.	Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Poolman, B (corresponding author), Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Mulder, Frans AA/C-7158-2017; Karasawa, Akira/ABC-9782-2021; Poolman, Bert/D-1882-2012; Karasawa, Akira/ABF-4128-2021; Institute, Zernike/W-7033-2019; Berntsson, Ronnie/J-3535-2019	Mulder, Frans AA/0000-0001-9427-8406; Berntsson, Ronnie/0000-0001-6848-322X; Otten, Renee/0000-0001-7342-6131	Netherlands Organization for Scientific Research Top Subsidy [700.56.302]; European Union	Netherlands Organization for Scientific Research Top Subsidy; European Union(European Commission)	This work was supported by Netherlands Organization for Scientific Research Top Subsidy Grant 700.56.302 (to B.P.) and the European Union EDICT Program.	Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Bolen D W, 2001, Methods Mol Biol, V168, P17; Checroun C, 2004, FEMS MICROBIOL LETT, V236, P221, DOI 10.1016/j.femsle.2004.05.046; Chen CL, 2007, J BACTERIOL, V189, P6901, DOI 10.1128/JB.00763-07; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; DeLano WL., 2020, PYMOL MOL GRAPHICS S; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Gomez-Garcia I, 2010, J MOL BIOL, V399, P53, DOI 10.1016/j.jmb.2010.03.045; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hillar A, 2005, BIOCHEMISTRY-US, V44, P10170, DOI 10.1021/bi050774y; Horn C, 2003, J MOL BIOL, V334, P403, DOI 10.1016/j.jmb.2003.09.079; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Keates RAB, 2010, BIOCHEMISTRY-US, V49, P8847, DOI 10.1021/bi101281f; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Mahmood NABN, 2009, J BIOL CHEM, V284, P14368, DOI 10.1074/jbc.M901238200; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Mulder F. A., 2010, NUCL MAGNETIC RESONA, P59; Ozcan N, 2007, J BACTERIOL, V189, P7485, DOI 10.1128/JB.00986-07; Ott V, 2008, BIOCHEMISTRY-US, V47, P12208, DOI 10.1021/bi801325r; Poolman B, 2005, METHOD ENZYMOL, V400, P429, DOI 10.1016/S0076-6879(05)00025-X; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Ragunathan P, 2008, BIOCHEM BIOPH RES CO, V375, P124, DOI 10.1016/j.bbrc.2008.07.140; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schiller D, 2004, BIOCHEMISTRY-US, V43, P5583, DOI 10.1021/bi0359628; Schiller D, 2004, FEBS LETT, V563, P108, DOI 10.1016/S0014-5793(04)00279-0; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sharpe ML, 2008, J MOL BIOL, V383, P822, DOI 10.1016/j.jmb.2008.07.001; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tan L, 2006, MOL MICROBIOL, V61, P861, DOI 10.1111/j.1365-2958.2006.05265.x; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; Tuominen H, 2010, J MOL BIOL, V398, P400, DOI 10.1016/j.jmb.2010.03.019; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Viana R, 2007, J BIOL CHEM, V282, P16117, DOI 10.1074/jbc.M611804200; Wolters JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010361; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou RB, 2009, P NATL ACAD SCI USA, V106, P16174, DOI 10.1073/pnas.0901455106; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	70	11	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37280	37291		10.1074/jbc.M111.284059	http://dx.doi.org/10.1074/jbc.M111.284059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878634	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000296542400028
J	Robichaud, TK; Steffensen, B; Fields, GB				Robichaud, Trista K.; Steffensen, Bjorn; Fields, Gregg B.			Exosite Interactions Impact Matrix Metalloproteinase Collagen Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SUBSTRATE-SPECIFICITY; I COLLAGEN; FLUOROGENIC SUBSTRATE; TISSUE INHIBITOR; PEPTIDE MODELS; GELATINASE-A; DESIGN; CANCER; ACTIVATION	Members of the matrix metalloproteinase (MMP) family selectively cleave collagens in vivo. However, the substrate structural determinants that facilitate interaction with specific MMPs are not well defined. We hypothesized that type I-III collagen sequences located N- or C-terminal to the physiological cleavage site mediate substrate selectivity among MMP-1, MMP-2, MMP-8, MMP-13, and MMP-14/membrane-type 1 (MT1)-MMP. The enzyme kinetics for hydrolysis of three fluorogenic triple-helical peptides (fTHPs) was evaluated herein. The first fTHP contained consensus residues 769-783 from type I-III collagens, the second inserted alpha 1(II) collagen residues 763-768 N-terminal to the consensus sequence, and the third inserted alpha 1(II) collagen residues 784-792 C-terminal to the consensus sequence. Our analyses showed that insertion of the C-terminal residues significantly increased k(cat)/K-m and k(cat) for MMP-1. MMP-13 showed the opposite behavior with a decreased k(cat)/K-m and k(cat) and a greatly improved K-m in response to the C-terminal residues. Insertion of the N-terminal residues enhanced k(cat)/K-m and k(cat) for MMP-8 and MT1-MMP. For MMP-2, the C-terminal residues enhanced K-m and dramatically decreased k(cat), resulting in a decrease in the overall activity. These changes in activities and kinetic parameters represented the collagen preferences of MMP-8, MMP-13, and MT1-MMP well. Thus, interactions with secondary binding sites (exosites) helped direct the specificity of these enzymes. However, MMP-1 collagen preferences were not recapitulated by the fTHP studies. The preference of MMP-1 for type III collagen appears to be primarily based on the flexibility of the hydrolysis site of type III collagen compared with types I and II. Further characterization of exosite determinants that govern interactions of MMPs with collagenous substrates should aid the development of pharmacotherapeutics that target individual MMPs.	[Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Robichaud, Trista K.; Steffensen, Bjorn] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Robichaud, Trista K.; Steffensen, Bjorn; Fields, Gregg B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	Torrey Pines Institute for Molecular Studies, Florida; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org			National Institutes of Health [HL07446, DE017139, CA098799]; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants HL07446 (T32 training grant to T.K.R.), DE017139 (to B.S.), and CA098799 (to G.B.F.).	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; AMES RT, 1994, BIOCHEM J, V300, P729, DOI 10.1042/bj3000729; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Fisher JF, 2006, CANCER METAST REV, V25, P115, DOI 10.1007/s10555-006-7894-9; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; HASTY KA, 1987, J BIOL CHEM, V262, P10048; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Jacobsen JA, 2010, BBA-MOL CELL RES, V1803, P72, DOI 10.1016/j.bbamcr.2009.08.006; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Muller JCD, 2000, BIOCHEMISTRY-US, V39, P5111, DOI 10.1021/bi992724x; MURPHY G, 1992, J BIOL CHEM, V267, P9612; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Piez K.A., 1984, EXTRACELLULAR MATRIX; Rao BG, 2005, CURR PHARM DESIGN, V11, P295, DOI 10.2174/1381612053382115; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Song FY, 2006, FRONT BIOSCI-LANDMRK, V11, P3100, DOI 10.2741/2036; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Uttamchandani M, 2007, J AM CHEM SOC, V129, P7848, DOI 10.1021/ja070870h; WELGUS HG, 1981, J BIOL CHEM, V256, P9511; WELGUS HG, 1985, J BIOL CHEM, V260, P1052; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009; Woessner J.F., 2000, PROTEIN PROFILE SER	57	31	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37535	37542		10.1074/jbc.M111.273391	http://dx.doi.org/10.1074/jbc.M111.273391			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896477	Green Published, hybrid			2022-12-25	WOS:000296542400052
J	Mizutani, K; Kawano, S; Minami, A; Waseda, M; Ikeda, W; Takai, Y				Mizutani, Kiyohito; Kawano, Satoshi; Minami, Akihiro; Waseda, Masazumi; Ikeda, Wataru; Takai, Yoshimi			Interaction of Nectin-like Molecule 2 with Integrin alpha(6)beta(4) and Inhibition of Disassembly of Integrin alpha(6)beta(4) from Hemidesmosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; CELL-CELL ADHESION; TUMOR-SUPPRESSOR TSLC1; MOVING NIH3T3 CELLS; IMMUNOGLOBULIN SUPERFAMILY; NECL-5/POLIOVIRUS RECEPTOR; ALPHA-6-BETA-4 INTEGRIN; LUNG-CANCER; MDCK CELLS; GENE	In normal epithelial cells, integrin alpha(6)beta(4) is abundantly expressed and forms hemidesmosomes, which is a cellular structure that mediates cell-extracellular matrix binding. In many types of cancer cells, integrin alpha(6)beta(4) is up-regulated, laminin is cleaved, and hemidesmosomes are disrupted, eventually causing an enhancement of cancer cell movement and facilitation of their invasion. We previously showed that the immunoglobulin-like cell adhesion molecule Necl-2 (Nectin-like molecule 2), known as a tumor suppressor, inhibits cancer cell movement by suppressing the ErbB3/ErbB2 signaling. We show here that Necl-2 interacts in cis with integrin alpha(6)beta(4). The binding of Necl-2 with integrin beta(4) was mediated by its extracellular region. In human colorectal adenocarcinoma Caco-2 cells, integrin alpha(6)beta(4) was localized at hemidesmosomes. Small interfering RNA-mediated suppression of Necl-2 expression enhanced the phorbol ester-induced disruption of the integrin alpha(6)beta(4) complex at hemidesmosomes, whereas expression of Necl-2 suppressed the disruption of this structure. These results indicate that tumor-suppressive functions of Necl-2 are mediated by the stabilization of the hemidesmosome structure in addition to the inhibition of the ErbB3/ErbB2 signaling.	[Mizutani, Kiyohito; Kawano, Satoshi; Minami, Akihiro; Waseda, Masazumi; Ikeda, Wataru; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ikeda, Wataru/V-8531-2019; Mizutani, Kiyohito/L-8474-2019	Ikeda, Wataru/0000-0002-6907-9058; Waseda, Masazumi/0000-0001-7179-5945	Ministry of Education, Culture, Sports, Science, and Technology in Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Global COE Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology in Japan and by grants-in-aid from the Japan Society for the Promotion of Science.	Amano H, 2008, GENES CELLS, V13, P269, DOI 10.1111/j.1365-2443.2008.01167.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fukami T, 2002, GENE, V295, P7, DOI 10.1016/S0378-1119(02)00835-1; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Honore S, 2000, HISTOCHEM CELL BIOL, V114, P323; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kawano S, 2010, GENES CELLS, V15, P995, DOI 10.1111/j.1365-2443.2010.01438.x; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kim DY, 2002, J BIOL CHEM, V277, P49976, DOI 10.1074/jbc.M210179200; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Minami A, 2010, GENES CELLS, V15, P1123, DOI 10.1111/j.1365-2443.2010.01450.x; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tanabe Y, 2008, NEUROSCI LETT, V444, P16, DOI 10.1016/j.neulet.2008.08.023; Tanaka Y, 2002, BIOCHEM BIOPH RES CO, V299, P472, DOI 10.1016/S0006-291X(02)02681-5; Underwood RA, 2009, J HISTOCHEM CYTOCHEM, V57, P123, DOI 10.1369/jhc.2008.952176; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yageta M, 2002, CANCER RES, V62, P5129	46	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36667	36676		10.1074/jbc.M110.200535	http://dx.doi.org/10.1074/jbc.M110.200535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880726	Green Published, hybrid			2022-12-25	WOS:000296538300049
J	Seok, HY; Tatsuguchi, M; Callis, TE; He, AB; Pu, WT; Wang, DZ				Seok, Hee Young; Tatsuguchi, Mariko; Callis, Thomas E.; He, Aibin; Pu, William T.; Wang, Da-Zhi			miR-155 Inhibits Expression of the MEF2A Protein to Repress Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; REGULATORY NETWORKS; GENE-EXPRESSION; MICE LACKING; MICRORNAS; MYOD; CELLS; HEART; PROLIFERATION; DEACETYLASES	microRNAs (miRNAs) are 21-23-nucleotide non-coding RNAs. It has become more and more evident that this class of small RNAs plays critical roles in the regulation of gene expression at the post-transcriptional level. MEF2A is a member of the MEF2 (myogenic enhancer factor 2) family of transcription factors. Prior report showed that the 3'-untranslated region (3'-UTR) of the Mef2A gene mediated its repression; however, the molecular mechanism underlying this intriguing observation was unknown. Here, we report that MEF2A is repressed by miRNAs. We identify miR-155 as one of the primary miRNAs that significantly represses the expression of MEF2A. We show that knockdown of the Mef2A gene by siRNA impairs myoblast differentiation. Similarly, overexpression of miR-155 leads to the repression of endogenous MEF2A expression and the inhibition of myoblast differentiation. Most importantly, reintroduction of MEF2A in miR-155 overexpressed myoblasts was able to partially rescue the miR-155-induced myoblast differentiation defect. Our data therefore establish miR-155 as an important regulator of MEF2A expression and uncover its function in muscle gene expression and myogenic differentiation.	[Seok, Hee Young; Tatsuguchi, Mariko; He, Aibin; Pu, William T.; Wang, Da-Zhi] Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA 02115 USA; [Seok, Hee Young; Callis, Thomas E.; Wang, Da-Zhi] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	seok, heeyoung/ABC-3957-2020; He, Aibin/AAI-1639-2019; Pu, William/AAJ-8301-2020	He, Aibin/0000-0002-3489-2305; Pu, William/0000-0002-4551-8079	National Institutes of Health; March of Dimes Foundation; Muscular Dystrophy Association; Wang laboratory	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Muscular Dystrophy Association(Muscular Dystrophy Association); Wang laboratory	This work was supported, in whole or in part, by National Institutes of Health. This work was also supported by the March of Dimes Foundation and Muscular Dystrophy Association.; We thank members of the Wang laboratory for discussion and support. We are grateful to Dr. John McDermott (York University) for generous gift of anti-MEF2A antibody and to Dr. Isidore Rigoutsos (Thomas Jefferson University) for the initial analyses of miRNAs that target MEF2A. We thank Dr. Francisco Naya (Boston University) for sharing unpublished results and reagents.	Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1997, MOL CELL BIOL, V17, P2756, DOI 10.1128/MCB.17.5.2756; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Chen JF, 2009, J CELL SCI, V122, P13, DOI 10.1242/jcs.041723; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	39	73	86	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35339	35346		10.1074/jbc.M111.273276	http://dx.doi.org/10.1074/jbc.M111.273276			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868385	Green Published, hybrid			2022-12-25	WOS:000295927100005
J	Daegling, DJ; McGraw, WS; Ungar, PS; Pampush, JD; Vick, AE; Bitty, EA				Daegling, David J.; McGraw, W. Scott; Ungar, Peter S.; Pampush, James D.; Vick, Anna E.; Bitty, E. Anderson			Hard-Object Feeding in Sooty Mangabeys (Cercocebus atys) and Interpretation of Early Hominin Feeding Ecology	PLOS ONE			English	Article							MICROWEAR TEXTURE ANALYSIS; MOLAR ENAMEL THICKNESS; DENTAL MICROWEAR; CRANIAL MORPHOLOGY; DIPHYLETIC ORIGIN; FALLBACK FOODS; TOOTH USE; DIET; AUSTRALOPITHECUS; EVOLUTION	Morphology of the dentofacial complex of early hominins has figured prominently in the inference of their dietary adaptations. Recent theoretical analysis of craniofacial morphology of Australopithecus africanus proposes that skull form in this taxon represents adaptation to feeding on large, hard objects. A modern analog for this specific dietary specialization is provided by the West African sooty mangabey, Cercocebus atys. This species habitually feeds on the large, exceptionally hard nuts of Sacoglottis gabonensis, stereotypically crushing the seed casings using their premolars and molars. This type of behavior has been inferred for A. africanus based on mathematical stress analysis and aspects of dental wear and morphology. While postcanine megadontia, premolar enlargement and thick molar enamel characterize both A. africanus and C. atys, these features are not universally associated with durophagy among living anthropoids. Occlusal microwear analysis reveals complex microwear textures in C. atys unlike those observed in A. africanus, but more closely resembling textures observed in Paranthropus robustus. Since sooty mangabeys process hard objects in a manner similar to that proposed for A. africanus, yet do so without the craniofacial buttressing characteristic of this hominin, it follows that derived features of the australopith skull are sufficient but not necessary for the consumption of large, hard objects. The adaptive significance of australopith craniofacial morphology may instead be related to the toughness, rather than the hardness, of ingested foods.	[Daegling, David J.; Pampush, James D.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [McGraw, W. Scott] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Vick, Anna E.] Santa Fe Coll, Dept Social & Behav Sci, Gainesville, FL USA; [Bitty, E. Anderson] Univ Abidjan Cocody, Lab Zool, Abidjan, Cote Ivoire	State University System of Florida; University of Florida; University System of Ohio; Ohio State University; University of Arkansas System; University of Arkansas Fayetteville	Daegling, DJ (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	daegling@ufl.edu			NSF BCS [0840110, 0921770, 0922429, 0315157]	NSF BCS(National Science Foundation (NSF))	Supported by NSF BCS 0840110, 0921770, 0922429, 0315157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; Caldecott J. O., 1996, P73; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; Cooke C, 2010, AM J PRIMATOL, V72, P38; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; DAEGLING DJ, 1992, INT J PRIMATOL, V13, P545, DOI 10.1007/BF02547832; Daegling DJ, 1999, PRIMATES, V40, P559, DOI 10.1007/BF02574831; DECHOW PC, 1990, AM J PHYS ANTHROPOL, V83, P219, DOI 10.1002/ajpa.1330830211; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; DEMES B, 1988, J HUM EVOL, V17, P657, DOI 10.1016/0047-2484(88)90023-1; DUBRUL EL, 1977, AM J PHYS ANTHROPOL, V47, P305, DOI 10.1002/ajpa.1330470211; DUMONT ER, 1995, J MAMMAL, V76, P1127, DOI 10.2307/1382604; Fleagle JG, 1999, P NATL ACAD SCI USA, V96, P1157, DOI 10.1073/pnas.96.3.1157; FORD S M, 1980, Primates, V21, P31, DOI 10.1007/BF02383822; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Gilbert CC, 2007, J HUM EVOL, V53, P69, DOI 10.1016/j.jhevol.2007.03.004; Grine F.E., 1988, P3; GRINE FE, 1981, S AFR J SCI, V77, P203; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Grine FE, 2010, J HUM EVOL, V58, P293, DOI 10.1016/j.jhevol.2009.12.001; HAPPEL R, 1988, AM J PHYS ANTHROPOL, V75, P303, DOI 10.1002/ajpa.1330750303; HOSHINO J, 1985, Primates, V26, P248, DOI 10.1007/BF02382401; Hylander W.L., 1988, P55; Hylander WL, 2006, AM J PHYS ANTHROPOL, P107; HYLANDER WL, 1979, J MORPHOL, V160, P223, DOI 10.1002/jmor.1051600208; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; KAY RF, 1985, ANNU REV ANTHROPOL, V14, P315, DOI 10.1146/annurev.an.14.100185.001531; KAY RF, 1977, J HUM EVOL, V6, P19, DOI 10.1016/S0047-2484(77)80040-7; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; LUCAS PW, 1985, J HUM EVOL, V14, P187, DOI 10.1016/S0047-2484(85)80006-3; LUCAS PW, 1994, AM J PHYS ANTHROPOL, V94, P365, DOI 10.1002/ajpa.1330940306; Martin LB, 2003, J HUM EVOL, V45, P351, DOI 10.1016/j.jhevol.2003.08.005; McGraw WS, 2011, AM J PHYS ANTHROPOL, V144, P140, DOI 10.1002/ajpa.21402; MCHENRY HM, 1984, AM J PHYS ANTHROPOL, V64, P297, DOI 10.1002/ajpa.1330640312; MOLNAR S, 1977, AM J PHYS ANTHROPOL, V46, P447, DOI 10.1002/ajpa.1330460310; Norconk Marilyn A., 2009, P279, DOI 10.1007/978-0-387-78705-3_11; OBrien TG, 1997, INT J PRIMATOL, V18, P321, DOI 10.1023/A:1026330332061; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; PETERS CR, 1987, AM J PHYS ANTHROPOL, V73, P333, DOI 10.1002/ajpa.1330730306; Prinz JF, 2001, J ORAL REHABIL, V28, P614, DOI 10.1046/j.1365-2842.2001.00732.x; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Ravosa MJ, 1996, INT J PRIMATOL, V17, P909, DOI 10.1007/BF02735294; RAVOSA MJ, 1990, AM J PHYS ANTHROPOL, V82, P199, DOI 10.1002/ajpa.1330820209; Rosenberger A.L., 1984, PRIMATOLOGIA BRASIL, P159, DOI DOI 10.1002/AR.A.20248; Rubin C. T., 1991, CRANIOFACIAL GROWTH, P75; RUBIN CT, 1990, J BIOMECH, V23, P43, DOI 10.1016/0021-9290(90)90040-A; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Shellis RP, 1998, J HUM EVOL, V35, P507, DOI 10.1006/jhev.1998.0238; Singleton M, 2004, J ANTHROPOL SCI, V82, P27; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Spencer MA, 1999, AM J PHYS ANTHROPOL, V108, P483, DOI 10.1002/(SICI)1096-8644(199904)108:4<483::AID-AJPA7>3.0.CO;2-L; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; STRUHSAKER TT, 1977, BIOTROPICA, V9, P124, DOI 10.2307/2387666; SUSSMAN RW, 1984, AM J PHYS ANTHROPOL, V64, P419, DOI 10.1002/ajpa.1330640407; Swindler D.R., 2002, PRIMATE DENTITION; Szalay F.S., 1979, EVOLUTIONARY HIST PR; SZALAY FS, 1975, MAN, V10, P420, DOI 10.2307/2799811; Taylor AB, 2006, J HUM EVOL, V50, P377, DOI 10.1016/j.jhevol.2005.10.006; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; UNGAR PS, 1994, AM J PHYS ANTHROPOL, V94, P339, DOI 10.1002/ajpa.1330940305; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; WHITE TD, 1981, S AFR J SCI, V77, P445; Wieczkowski J, 2009, AM J PHYS ANTHROPOL, V140, P572, DOI 10.1002/ajpa.21132; Williams SH, 2005, AM J PRIMATOL, V67, P329, DOI 10.1002/ajp.20189; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Yamashita N, 2003, AM J PHYS ANTHROPOL, V121, P125, DOI 10.1002/ajpa.10206; Yamashita N, 1996, INT J PRIMATOL, V17, P355, DOI 10.1007/BF02736627	81	91	93	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23095	10.1371/journal.pone.0023095	http://dx.doi.org/10.1371/journal.pone.0023095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887229	Green Submitted, gold, Green Published			2022-12-25	WOS:000294298800004
J	Pinho, BR; Sousa, C; Valentao, P; Andrade, PB				Pinho, Brigida R.; Sousa, Carla; Valentao, Patricia; Andrade, Paula B.			Is Nitric Oxide Decrease Observed with Naphthoquinones in LPS Stimulated RAW 264.7 Macrophages a Beneficial Property?	PLOS ONE			English	Article							KAPPA-B ACTIVATION; TYROSINE NITRATION; CELL-LINES; IN-VITRO; DIOSPYROS; DERIVATIVES; PEROXYNITRITE; INHIBITION; PLUMBAGIN; APOPTOSIS	The search of new anti-inflammatory drugs has been a current preoccupation, due to the need of effective drugs, with less adverse reactions than those used nowadays. Several naphthoquinones (plumbagin, naphthazarin, juglone, menadione, diosquinone and 1,4-naphthoquinone), plus p-hydroquinone and p-benzoquinone were evaluated for their ability to cause a reduction of nitric oxide (NO) production, when RAW 264.7 macrophages were stimulated with lipopolysaccharide (LPS). Dexamethasone was used as positive control. Among the tested compounds, diosquinone was the only one that caused a NO reduction with statistical importance and without cytotoxicity: an IC(25) of 1.09 +/- 0.24 mu M was found, with 38.25 +/- 6.50% (p<0.001) NO reduction at 1.5 mu M. In order to elucidate if this NO decrease resulted from the interference of diosquinone with cellular defence mechanisms against LPS or to its conversion into peroxynitrite, by reaction with superoxide radical formed by naphthoquinones redox cycling, 3-nitrotyrosine and superoxide determination was also performed. None of these parameters showed significant changes relative to control. Furthermore, diosquinone caused a decrease in the pro-inflammatory cytokines: tumour necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6). Therefore, according to the results obtained, diosquinone, studied for its anti-inflammatory potential for the first time herein, has beneficial effects in inflammation control. This study enlightens the mechanisms of action of naphthoquinones in inflammatory models, by checking for the first time the contribution of oxidative stress generated by naphthoquinones to NO reduction.	[Pinho, Brigida R.; Sousa, Carla; Valentao, Patricia; Andrade, Paula B.] Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, P-4100 Oporto, Portugal	Universidade do Porto	Pinho, BR (corresponding author), Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	pandrade@ff.up.pt	Andrade, Paula B/A-5900-2008; Valentão, Patrícia/D-4818-2013; Sousa, Carla/D-4989-2013; REQUIMTE, PHYTO/M-4633-2013; Pinho, Brígida/L-1504-2016	Andrade, Paula B/0000-0002-9764-3920; Valentão, Patrícia/0000-0002-0740-4396; Sousa, Carla/0000-0003-2734-7461; Pinho, Brígida/0000-0002-1627-6795	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/63852/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	B.R. Pinho is grateful to Fundacao para a Ciencia e a Tecnologia (FCT) for the grant (SFRH/BD/63852/2009). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Adeniyi BA, 2000, PHYTOTHER RES, V14, P112, DOI 10.1002/(SICI)1099-1573(200003)14:2&lt;112::AID-PTR488&gt;3.0.CO;2-T; ALVES AC, 1983, PLANTA MED, V47, P121, DOI 10.1055/s-2007-969969; Andreakos ET, 2002, CYTOKINE GROWTH F R, V13, P299, DOI 10.1016/S1359-6101(02)00018-7; Babula P, 2009, CURR PHARM ANAL, V5, P47, DOI 10.2174/157341209787314936; Chakrabarty S, 2002, CANCER LETT, V188, P85, DOI 10.1016/S0304-3835(02)00494-9; Checker R, 2009, INT IMMUNOPHARMACOL, V9, P949, DOI 10.1016/j.intimp.2009.03.022; Cheng YW, 2008, J ETHNOPHARMACOL, V120, P264, DOI 10.1016/j.jep.2008.09.002; CHIA JKS, 1989, J INFECT DIS, V159, P872, DOI 10.1093/infdis/159.5.872; Costa MAC, 1998, PLANTA MED, V64, P391, DOI 10.1055/s-2006-957464; De Vera ME, 1997, AM J PHYSIOL-GASTR L, V273, pG1290, DOI 10.1152/ajpgi.1997.273.6.G1290; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Han AR, 2008, CHEM PHARM BULL, V56, P1314, DOI 10.1248/cpb.56.1314; HernandezPerez M, 1995, PLANTA MED, V61, P505, DOI 10.1055/s-2006-959358; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Kuke C, 1998, PHYTOTHER RES, V12, P155, DOI 10.1002/(SICI)1099-1573(199805)12:3&lt;155::AID-PTR214&gt;3.0.CO;2-1; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Liu Xiangli, 2005, J Med Invest, V52 Suppl, P293, DOI 10.2152/jmi.52.293; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Mallavadhani UV, 1998, PHYTOCHEMISTRY, V49, P901, DOI 10.1016/S0031-9422(97)01020-0; Mallozzi C, 1997, FASEB J, V11, P1281, DOI 10.1096/fasebj.11.14.9409547; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moreira-Goncalves D, 2011, AM J PHYSIOL-HEART C, V300, pH1044, DOI 10.1152/ajpheart.01008.2010; Murakami K, 2010, TOXICOL IN VITRO, V24, P905, DOI 10.1016/j.tiv.2009.11.018; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; OBRIEN PJ, 1991, CHEM-BIOL INTERACT, V80, P1, DOI 10.1016/0009-2797(91)90029-7; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Pfeiffer S, 1998, J BIOL CHEM, V273, P27280, DOI 10.1074/jbc.273.42.27280; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sousa C, 2009, TOXICOL IN VITRO, V23, P1131, DOI 10.1016/j.tiv.2009.05.012; Stein B, 1998, DRUG DISCOV TODAY, V3, P202, DOI 10.1016/S1359-6446(97)01164-1; Subbaramaiah K, 2001, J BIOMOL SCREEN, V6, P101; Sun ZW, 2002, SHOCK, V18, P99, DOI 10.1097/00024382-200208000-00001; SWETT MJ, 1996, J LEUKOCYTE BIOL, V60, P8; Theerachayanan T., 2007, CMU J NAT SCI, V6, P253; WANG JP, 1995, EUR J PHARMACOL, V272, P87, DOI 10.1016/0014-2999(94)00627-J	40	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24098	10.1371/journal.pone.0024098	http://dx.doi.org/10.1371/journal.pone.0024098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887376	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298800031
J	Braun, F; Bertin-Ciftci, J; Gallouet, AS; Millour, J; Juin, P				Braun, Frederique; Bertin-Ciftci, Josephine; Gallouet, Anne-Sophie; Millour, Julie; Juin, Philippe			Serum-Nutrient Starvation Induces Cell Death Mediated by Bax and Puma That Is Counteracted by p21 and Unmasked by Bcl-x(L) Inhibition	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; BREAST-CANCER; BCL-XL; SUBCELLULAR-LOCALIZATION; INDUCED APOPTOSIS; CARCINOMA-CELLS; DNA-DAMAGE; PHOSPHORYLATION; P21(WAF1/CIP1); ACTIVATION	The cyclin-dependent kinase inhibitor p21 (p21WAF1/Cip1) is a multifunctional protein known to promote cell cycle arrest and survival in response to p53-dependent and p53 independent stimuli. We herein investigated whether and how it might contribute to the survival of cancer cells that are in low-nutrient conditions during tumour growth, by culturing isogenic human colorectal cancer cell lines (HCT116) and breast cancer cell lines in a medium deprived in amino acids and serum. We show that such starvation enhances, independently from p53, the expression of p21 and that of the pro-apoptotic BH3-only protein Puma. Under these conditions, p21 prevents Puma and its downstream effector Bax from triggering the mitochondrial apoptotic pathway. This anti-apoptotic effect is exerted from the cytosol but it is unrelated to the ability of p21 to interfere with the effector caspase 3. The survival function of p21 is, however, overcome by RNA interference mediated Bcl-x(L) depletion, or by the pharmacological inhibitor ABT-737. Thus, an insufficient supply in nutrients may not have an overt effect on cancer cell viability due to p21 induction, but it primes these cells to die, and sensitizes them to the deleterious effects of Bcl-x(L) inhibitors regardless of their p53 status.	[Braun, Frederique; Bertin-Ciftci, Josephine; Gallouet, Anne-Sophie; Millour, Julie; Juin, Philippe] Univ Nantes, Inst Rech Therapeut, INSERM, Ctr Rech Cancerol Nantes Angers,UMR 892, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Braun, F (corresponding author), Univ Nantes, Inst Rech Therapeut, INSERM, Ctr Rech Cancerol Nantes Angers,UMR 892, Nantes, France.	frederique.braun@univ-nantes.fr; philippe.juin@univ-nantes.fr	JUIN, Philippe/Q-1338-2019; JUIN, Philippe P/H-3636-2014	JUIN, Philippe/0000-0002-4997-3888; JUIN, Philippe P/0000-0002-4997-3888; BRAUN, Frederique/0000-0001-5871-6042	Ministere de la Recherche et de l'Enseignement Superieur; ARC [SFI20101201568]; Fondation de France (Tumor committee); Region Pays de Loire; Canceropole Grand Ouest [2010-12798]	Ministere de la Recherche et de l'Enseignement Superieur; ARC(Australian Research Council); Fondation de France (Tumor committee)(Fondation de France); Region Pays de Loire(Region Pays de la Loire); Canceropole Grand Ouest	JB-C was supported by grants from the Ministere de la Recherche et de l'Enseignement Superieur. PJ was supported by ARC (no SFI20101201568), Fondation de France (Tumor committee), Region Pays de Loire (CIMATH2) and Canceropole Grand Ouest (2010-12798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Chu R, 2009, BIOCHEM PHARMACOL, V78, P241, DOI 10.1016/j.bcp.2009.04.005; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan YP, 2003, MOL CANCER THER, V2, P773; Fan YM, 2007, BIOCHEM BIOPH RES CO, V355, P263, DOI 10.1016/j.bbrc.2007.01.146; Ferrandiz N, 2009, DNA REPAIR, V8, P390, DOI 10.1016/j.dnarep.2008.12.001; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gautier F, 2011, MOL CELL BIOL, V31, P832, DOI 10.1128/MCB.00161-10; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Janicke RU, 2007, CELL CYCLE, V6, P407; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lin Pei-Yin, 2007, Mol Cancer, V6, P16, DOI 10.1186/1476-4598-6-16; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Priault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008755; Schmidt M, 2000, ONCOGENE, V19, P2423, DOI 10.1038/sj.onc.1203546; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; Tian H, 2000, CANCER RES, V60, P679; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Van Le H, 2005, J BIOL CHEM, V280, P32018, DOI 10.1074/jbc.M504689200; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wendt J, 2006, ONCOGENE, V25, P972, DOI 10.1038/sj.onc.1209031; Winters ZE, 2001, EUR J CANCER, V37, P2405, DOI 10.1016/S0959-8049(01)00327-6; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06	37	53	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23577	10.1371/journal.pone.0023577	http://dx.doi.org/10.1371/journal.pone.0023577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887277	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000032
J	de Voer, RM; van der Klis, FRM; Schepp, RM; Rijkers, GT; Sanders, EAM; Berbers, GAM				de Voer, Richarda M.; van der Klis, Fiona R. M.; Schepp, Rutger M.; Rijkers, Ger T.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.			Age-Related Immunity to Meningococcal Serogroup C Vaccination: An Increase in the Persistence of IgG2 Correlates with a Decrease in the Avidity of IgG	PLOS ONE			English	Article							MEMORY B-CELLS; CONJUGATE VACCINE; IMMUNOLOGICAL MEMORY; SUBCLASS RESPONSE; UNITED-KINGDOM; ANTIGEN-DRIVEN; IMMUNIZATION; ANTIBODIES; POLYSACCHARIDE; SEROPREVALENCE	Background: All children and adolescents between 1 and 19 years of age in The Netherlands received a single meningococcal serogroup C conjugate (MenCC) vaccine in 2002. During follow-up 4-5 years later, the persistence of MenC polysaccharide-specific IgG was found to be dependent on age of vaccination with higher IgG levels in the oldest immunized age categories. Methods and Findings: Two cross-sectional population-based serum banks, collected in 1995/1996 and in 2006/2007, were used for this study. We measured MenC polysaccharide-specific IgM, the IgG1 and IgG2 subclasses and determined the avidity of the IgG antibodies. We report that the age-related persistence of IgG after immunization with the MenCC vaccine seemed to result from an increase of IgG2 levels with age, while IgG1 levels remained stable throughout the different age-cohorts. Furthermore, an age-related increase in IgM levels was observed, correlating with the persistence of IgG antibodies with age. It is noteworthy that the increase in IgG2 correlated with a reduced IgG-avidity with age. Conclusion: These date indicate that the classical characteristics of a T-cell-dependent antibody response as elicited by protein based vaccines might not be completely applicable when conjugate vaccines are administered to older children and adolescents up to 18 years of age. The response elicited by the MenCC vaccine seemed to be more a mixture of both T cell dependent and T cell independent responses in terms of humoral immunological characteristics.	[de Voer, Richarda M.; van der Klis, Fiona R. M.; Schepp, Rutger M.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Perinatal Screening, NL-3720 BA Bilthoven, Netherlands; [de Voer, Richarda M.] Univ Med Ctr, Dept Immunol, Utrecht, Netherlands; [Rijkers, Ger T.] St Antonius Hosp, Lab Med Microbiol & Immunol, Nieuwegein, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	de Voer, RM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands.	Guy.Berbers@rivm.nl	Rijkers, Ger/R-7236-2019; de Voer, Richarda M/GSD-6097-2022; de Voer, Richarda/P-5728-2015; Rijkers, Ger/AAW-6143-2020; de Voer, Richarda M/ABD-1525-2021	Rijkers, Ger/0000-0001-6948-6123; de Voer, Richarda M/0000-0002-8222-0343; 	Ministry of Health, Welfare and Sport, The Hague, The Netherlands; Wyeth; Baxter; GlaxoSmithKline	Ministry of Health, Welfare and Sport, The Hague, The Netherlands; Wyeth(Wyeth); Baxter; GlaxoSmithKline(GlaxoSmithKline)	This study was supported by the Ministry of Health, Welfare and Sport, The Hague, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Sanders reports receiving unrestricted grants from Wyeth and Baxter for research, consulting fees from Wyeth and GlaxoSmithKline, lecturing fees from Wyeth and grant support from Wyeth and GlaxoSmithKline for vaccine studies. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have no conflicts to declare.	Ada G, 2003, CLIN MICROBIOL INFEC, V9, P79, DOI 10.1046/j.1469-0691.2003.00530.x; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Borrow R, 2002, J INFECT DIS, V186, P1353, DOI 10.1086/344324; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; CAPPEL R, 1981, J MED VIROL, V8, P201, DOI 10.1002/jmv.1890080307; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Voer RM, 2008, CLIN VACCINE IMMUNOL, V15, P1188, DOI 10.1128/CVI.00478-07; de Voer RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012144; de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082; Findlow H, 2006, CLIN VACCINE IMMUNOL, V13, P507, DOI 10.1128/CVI.13.4.507-510.2006; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Goldblatt D, 2002, J INFECT DIS, V185, P397, DOI 10.1086/338474; GRANOFF DM, 1988, PEDIATR RES, V24, P180, DOI 10.1203/00006450-198808000-00008; Kamboj KK, 2001, J INFECT DIS, V184, P931, DOI 10.1086/323342; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Laher G, 2006, FEMS IMMUNOL MED MIC, V48, P34, DOI 10.1111/j.1574-695X.2006.00121.x; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Neppelenbroek SE, 2002, GOED GEDAAN WOORDVER; Neves AR, 2003, CLIN DIAGN LAB IMMUN, V10, P802, DOI 10.1128/CDLI.10.5.802-807.2003; Ochsenbein AF, 2000, P NATL ACAD SCI USA, V97, P13263, DOI 10.1073/pnas.230417497; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; ROBBINS JB, 1972, INFECT IMMUN, V6, P651, DOI 10.1128/IAI.6.5.651-656.1972; Sakou II, 2009, VACCINE, V27, P4408, DOI 10.1016/j.vaccine.2009.05.047; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Sterla S, 1999, PARASITE IMMUNOL, V21, P27, DOI 10.1046/j.1365-3024.1999.00197.x; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; TEW JG, 1980, IMMUNOL REV, V53, P175; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; van der Klis FRM, 2009, NETH J MED, V67, P301; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; Vinuesa CG, 2003, EUR J IMMUNOL, V33, P297, DOI 10.1002/immu.200310003; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Wuorimaa T, 2001, J INFECT DIS, V184, P1211, DOI 10.1086/323648	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23497	10.1371/journal.pone.0023497	http://dx.doi.org/10.1371/journal.pone.0023497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887261	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000023
J	Kang, S; Tang, JJ; Schaeffer, SW; Bader, DA				Kang, Seunghwa; Tang, Jijun; Schaeffer, Stephen W.; Bader, David A.			Rec-DCM-Eigen: Reconstructing a Less Parsimonious but More Accurate Tree in Shorter Time	PLOS ONE			English	Article							GENOME REARRANGEMENT; EVOLUTION; PERFORMANCE; REVERSALS; ALGORITHM	Maximum parsimony (MP) methods aim to reconstruct the phylogeny of extant species by finding the most parsimonious evolutionary scenario using the species' genome data. MP methods are considered to be accurate, but they are also computationally expensive especially for a large number of species. Several disk-covering methods (DCMs), which decompose the input species to multiple overlapping subgroups (or disks), have been proposed to solve the problem in a divide-and-conquer way. We design a new DCM based on the spectral method and also develop the COGNAC (Comparing Orders of Genes using Novel Algorithms and high-performance Computers) software package. COGNAC uses the new DCM to reduce the phylogenetic tree search space and selects an output tree from the reduced search space based on the MP principle. We test the new DCM using gene order data and inversion distance. The new DCM not only reduces the number of candidate tree topologies but also excludes erroneous tree topologies which can be selected by original MP methods. Initial labeling of internal genomes affects the accuracy of MP methods using gene order data, and the new DCM enables more accurate initial labeling as well. COGNAC demonstrates superior accuracy as a consequence. We compare COGNAC with FastME and the combination of the state of the art DCM (Rec-I-DCM3) and GRAPPA. COGNAC clearly outperforms FastME in accuracy. COGNAC -using the new DCM- also reconstructs a much more accurate tree in significantly shorter time than GRAPPA with Rec-I-DCM3.	[Kang, Seunghwa] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Tang, Jijun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Schaeffer, Stephen W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Bader, David A.] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; Georgia Institute of Technology	Kang, S (corresponding author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	bader@cc.gatech.edu	Bader, David/AAI-4029-2021; Tang, Jijun/ABH-6528-2020; Schaeffer, Stephen/AAA-2303-2021	Bader, David/0000-0002-7380-5876; Schaeffer, Stephen/0000-0003-2070-5342	National Science Foundation (NSF) [NSF OCI-0904461, OCI-0904179, OCI-0904166]; Direct For Computer & Info Scie & Enginr [0904179] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [0904461] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation (NSF) PetaApps project (grant numbers: NSF OCI-0904461, OCI-0904179 and OCI-0904166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt W, 2007, LECT N BIOINFORMAT, V4751, P30; Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Bader DA, 2001, J COMPUT BIOL, V8, P483, DOI 10.1089/106652701753216503; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bernt M, 2006, IEEE ACM T COMPUT BI, V3, P275, DOI 10.1109/TCBB.2006.38; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Blanchette M, 1996, GENE, V172, pGC11, DOI 10.1016/0378-1119(95)00878-0; Bourque G, 2002, GENOME RES, V12, P26; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Fertin G, 2009, COMBINATORICS GENOME; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; HARTIGAN JA, 1973, BIOMETRICS, V29, P53, DOI 10.2307/2529676; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; Huson DH, 1999, J COMPUT BIOL, V6, P369, DOI 10.1089/106652799318337; Huson DH, 1999, P INT C INT SYST MOL; Li GL, 2007, LECT N BIOINFORMAT, V4751, P110; Lin Y, 2010, P RECOMB SAT WORKSH; Lin Y, 2008, BIOINFORMATICS, V24, pI114, DOI 10.1093/bioinformatics/btn148; Mohar B., 1991, GRAPH THEORY COMBINA, P12; Moret BME, 2002, LECT NOTES COMPUT SC, V2452, P521; Moret BME, 2002, J COMPUT SYST SCI, V65, P508, DOI 10.1016/S0022-0000(02)00007-7; Moret BME, 2002, J SUPERCOMPUT, V22, P99, DOI 10.1023/A:1014362705613; Moret BME, 2001, P PAC S BIOC PSB BIG; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pattengale ND, 2010, LECT N BIOINFORMAT, V6053, P128, DOI 10.1007/978-3-642-13078-6_16; POTHEN A, 1990, SIAM J MATRIX ANAL A, V11, P430, DOI 10.1137/0611030; Roshan UW, 2004, P COMP SYST BIOINF C; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson M, R8S SOFTWARE PACKAGE; Sankoff D, 2002, CURRENT TOPICS COMPU, P135; Stewart CA, 2010, CYBERINFRASTRUCTURE; Swenson KM, 2009, BMC BIOINFORMATICS; Tang JJ, 2003, BIOINFORMATICS, V19, pi305, DOI 10.1093/bioinformatics/btg1042; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Xu AW, 2009, J COMPUT BIOL, V16, P1369, DOI 10.1089/cmb.2009.0087	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e22483	10.1371/journal.pone.0022483	http://dx.doi.org/10.1371/journal.pone.0022483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887219	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000002
J	Paintain, LS; Antwi, GD; Jones, C; Amoako, E; Adjei, RO; Afrah, NA; Greenwood, B; Chandramohan, D; Tagbor, H; Webster, J				Paintain, Lucy Smith; Antwi, Gifty D.; Jones, Caroline; Amoako, Esther; Adjei, Rose O.; Afrah, Nana A.; Greenwood, Brian; Chandramohan, Daniel; Tagbor, Harry; Webster, Jayne			Intermittent Screening and Treatment versus Intermittent Preventive Treatment of Malaria in Pregnancy: Provider Knowledge and Acceptability	PLOS ONE			English	Article							OUTPATIENT HEALTH FACILITIES; WORKER PERFORMANCE; TANZANIA; CHILDREN; POLICY; CHALLENGES; PREDICTORS; EFFICACY; DISTRICT; THERAPY	Malaria in pregnancy (MiP) is associated with increased risks of maternal and foetal complications. The WHO recommends a package of interventions including intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine (SP), insecticide-treated nets and effective case management. However, with increasing SP resistance, the effectiveness of SP-IPT has been questioned. Intermittent screening and treatment (IST) has recently been shown in Ghana to be as efficacious as SP-IPT. This study investigates two important requirements for effective delivery of IST and SP-IPT: antenatal care (ANC) provider knowledge, and acceptance of the different strategies. Structured interviews with 134 ANC providers at 67 public health facilities in Ashanti Region, Ghana collected information on knowledge of the risks and preventative and curative interventions against MiP. Composite indicators of knowledge of SP-IPT, and case management of MiP were developed. Log binomial regression of predictors of provider knowledge was explored. Qualitative data were collected through in-depth interviews with fourteen ANC providers with some knowledge of IST to gain an indication of the factors influencing acceptance of the IST approach. 88.1% of providers knew all elements of the SP-IPT policy, compared to 20.1% and 41.8% who knew the treatment policy for malaria in the first or second/third trimesters, respectively. Workshop attendance was a univariate predictor of each knowledge indicator. Qualitative findings suggest preference for prevention over cure, and increased workload may be barriers to IST implementation. However, a change in strategy in the face of SP resistance is likely to be supported; health of pregnant women is a strong motivation for ANC provider practice. If IST was to be introduced as part of routine ANC activities, attention would need to be given to improving the knowledge and practices of ANC staff in relation to appropriate treatment of MiP. Health worker support for any MiP intervention delivered through ANC clinics is critical.	[Paintain, Lucy Smith; Jones, Caroline; Greenwood, Brian; Chandramohan, Daniel; Tagbor, Harry; Webster, Jayne] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England; [Antwi, Gifty D.; Amoako, Esther; Adjei, Rose O.; Afrah, Nana A.; Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana	University of London; London School of Hygiene & Tropical Medicine; Kwame Nkrumah University Science & Technology	Paintain, LS (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London WC1, England.	Lucy.Paintain@lshtm.ac.uk	Tagbor, Harry/B-9312-2018	Tagbor, Harry/0000-0002-9300-665X; Webster, Jayne/0000-0002-0498-8883	DFiD; London School of Hygiene & Tropical Medicine	DFiD; London School of Hygiene & Tropical Medicine	Funding for this study was provided by the DFiD-funded TARGETS Research Consortium and Gates Malaria Partnership at the London School of Hygiene & Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwara PA, 2005, IN DEPTH ANAL HIV PR; Anders K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-79; Bernard HR, 2006, RES METHODS ANTHR QU, V4th; BRABIN BJ, 1991, WHO APPL FIELD RES M, V1, P1; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Ghana Statistical Service and ICF Macro, 2009, GHAN DEM HLTH SURV 2; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Maestad O, 2010, J HEALTH ECON, V29, P686, DOI 10.1016/j.jhealeco.2010.05.006; Marchant T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-260; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Mubyazi G, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-31; Newman RD, 2003, TROP MED INT HEALTH, V8, P488, DOI 10.1046/j.1365-3156.2003.01066.x; Osterholt DM, 2006, TROP MED INT HEALTH, V11, P1147, DOI 10.1111/j.1365-3156.2006.01666.x; QSR International Pty Ltd, 2020, NVIVO; Rowe AK, 2000, AM J EPIDEMIOL, V151, P1029, DOI 10.1093/oxfordjournals.aje.a010131; Rowe AK, 2003, INT J EPIDEMIOL, V32, P296, DOI 10.1093/ije/dyg063; Sayang C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-174; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; StataCorp, 2009, STAT STAT SOFTW REL; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; UNAIDS, 2010, REP GLOB AIDS EP 201; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2004, AFRMAL0401 WHO REG O	27	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24035	10.1371/journal.pone.0024035	http://dx.doi.org/10.1371/journal.pone.0024035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887367	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000295832000087
J	Palmer, CV; Traylor-Knowles, NG; Willis, BL; Bythell, JC				Palmer, Caroline V.; Traylor-Knowles, Nikki G.; Willis, Bette L.; Bythell, John C.			Corals Use Similar Immune Cells and Wound-Healing Processes as Those of Higher Organisms	PLOS ONE			English	Article							REEF-BUILDING CORAL; GRANULATION-TISSUE; HURRICANE HUGO; REGENERATION; REPAIR; COAGULATION; HEMOCYTES; INJURY; TEMPERATURE; MECHANISMS	Sessile animals, like corals, frequently suffer physical injury from a variety of sources, thus wound-healing mechanisms that restore tissue integrity and prevent infection are vitally important for defence. Despite the ecological importance of reef-building corals, little is known about the cells and processes involved in wound healing in this group or in phylogenetically basal metazoans in general. A histological investigation into wound healing of the scleractinian coral Porites cylindrica at 0 h, 6 h, 24 h and 48 h after injury revealed differences in cellular components between injured and healthy tissues. Cell counts of the obligate endosymbiont, Symbiodinium, and melanin volume fraction analysis revealed rapid declines in both Symbiodinium abundance and tissue cross-sectional area occupied by melanin-containing granular cells after injury. Four phases of wound healing were identified, which are similar to phases described for both vertebrates and invertebrates. The four phases included (i) plug formation via the degranulation of melanin-containing granular cells; (ii) immune cell infiltration (inflammation); (iii) granular tissue formation (proliferation); and (iv) maturation. This study provides detailed documentation of the processes involved in scleractinian wound healing for the first time and further elucidates the roles of previously-described immune cells, such as fibroblasts. These results demonstrate the conservation of wound healing processes from anthozoans to humans.	[Palmer, Caroline V.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Palmer, Caroline V.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Palmer, Caroline V.; Bythell, John C.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Traylor-Knowles, Nikki G.] Boston Univ, Dept Biol, Boston, MA 02215 USA	James Cook University; James Cook University; Newcastle University - UK; Boston University	Palmer, CV (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	caroline.palmer@jcu.edu.au	Bythell, John/ABE-6138-2021; Bythell, John C/E-7962-2010; Traylor-Knowles, Nikki G/D-4354-2012; Palmer, Caroline/B-6498-2011	Bythell, John/0000-0003-2416-9786; Bythell, John C/0000-0003-2416-9786; Palmer, Caroline/0000-0002-5903-995X	Natural Environmental Research Council (NERC) United Kingdom; Australian Research Council (ARC); NERC [NE/E006949/1] Funding Source: UKRI; Natural Environment Research Council [NE/E006949/1] Funding Source: researchfish	Natural Environmental Research Council (NERC) United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council (ARC)(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Research funding was provided by a Natural Environmental Research Council (NERC) United Kingdom grant to J. Bythell, and an Australian Research Council (ARC) Discovery Project grant to B. Willis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladaileh S, 2007, J INVERTEBR PATHOL, V96, P48, DOI 10.1016/j.jip.2007.02.011; Alvarado E, 2009, REV BIOL TROP, V57, P939; Ancona Lunetta G.D., 2005, ISJ, V2, P124; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Biressi A, 2010, ZOOMORPHOLOGY, V129, P1, DOI 10.1007/s00435-009-0095-7; Bolitho C, 2010, WOUND REPAIR REGEN, V18, P211, DOI 10.1111/j.1524-475X.2010.00572.x; BURKE JM, 1974, J EXP ZOOL, V188, P49, DOI 10.1002/jez.1401880106; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; BYTHELL JC, 1993, J EXP MAR BIOL ECOL, V172, P171, DOI 10.1016/0022-0981(93)90096-7; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; EDMUNDS PJ, 1991, MAR ECOL PROG SER, V78, P201, DOI 10.3354/meps078201; FANG LS, 1988, MAR BIOL, V97, P349, DOI 10.1007/BF00397765; Fine M, 2002, MAR ECOL PROG SER, V234, P119, DOI 10.3354/meps234119; FOLEY DA, 1977, J INVERTEBR PATHOL, V29, P321, DOI 10.1016/S0022-2011(77)80037-2; FONTAINE CT, 1973, J INVERTEBR PATHOL, V22, P23, DOI 10.1016/0022-2011(73)90005-0; Franchini A, 2000, TISSUE CELL, V32, P312, DOI 10.1054/tice.2000.0118; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; GROTENDORST GR, 1985, J CLIN INVEST, V76, P2323, DOI 10.1172/JCI112243; HENNERE EP, 1992, CELL TISSUE RES, V269, P167; Henry LA, 2005, INT REV HYDROBIOL, V90, P125, DOI 10.1002/iroh.200410759; Herrick EH, 1932, BIOL BULL-US, V63, P271, DOI 10.2307/1537244; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Lirman D, 2000, MAR ECOL PROG SER, V197, P209, DOI 10.3354/meps197209; Mackintosh JA, 2001, J THEOR BIOL, V211, P101, DOI 10.1006/jtbi.2001.2331; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; MEESTERS EH, 1994, MAR ECOL PROG SER, V112, P119, DOI 10.3354/meps112119; Meesters EH, 1997, MAR ECOL PROG SER, V146, P91, DOI 10.3354/meps146091; MENTON DN, 1973, J MORPHOL, V141, P185, DOI 10.1002/jmor.1051410206; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Miguel-Ruiz JES, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-115; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; PALMER CV, 2010, FEDERATION AM SOC EX, V12, P1; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; PATTERSON MJ, 1979, J INVERTEBR PATHOL, V33, P189, DOI 10.1016/0022-2011(79)90152-6; Pech LL, 1996, J CELL SCI, V109, P2053; Perazzolo LM, 1997, DEV COMP IMMUNOL, V21, P385, DOI 10.1016/S0145-305X(97)00022-0; Pipe RK, 1997, CELL TISSUE RES, V289, P537, DOI 10.1007/s004410050899; Robson MC, 2001, CURR PROB SURG, V38, P65; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Rowley AF, 1996, MEDIAT INFLAMM, V5, P3, DOI 10.1155/S0962935196000014; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Soderhall K., 1986, P251; Sparks AK., 1972, INVERTEBRATE PATHOLO, V1; Tettamanti G, 2005, BIOL CELL, V97, P557, DOI 10.1042/BC20040085; Tettamanti G, 2004, BIOL CELL, V96, P443, DOI 10.1016/j.biolcel.2004.04.008; Tettamanti G, 2008, CURR PHARM DESIGN, V14, P116, DOI 10.2174/138161208783378716; Theopold U, 2002, CELL MOL LIFE SCI, V59, P363, DOI 10.1007/s00018-002-8428-4; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; VACCA LL, 1983, BIOL BULL, V165, P758, DOI 10.2307/1541477; VAFOPOULOU X, 2009, INVERTEBRATE SURVIVA, P125; Vargas-Angel B, 2007, J INVERTEBR PATHOL, V95, P140, DOI 10.1016/j.jip.2007.01.003; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; Wilkinson C, 2008, STATUS CORAL REEFS W; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X; Work TM, 2010, J INVERTEBR PATHOL, V105, P116, DOI 10.1016/j.jip.2010.05.009; YOUNG JAC, 1974, J MAR BIOL ASSOC UK, V54, P599, DOI 10.1017/S0025315400022773	63	68	68	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23992	10.1371/journal.pone.0023992	http://dx.doi.org/10.1371/journal.pone.0023992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887359	Green Published, Green Accepted, gold			2022-12-25	WOS:000295832000084
J	Wu, HY; Quintana, FJ; da Cunha, AP; Dake, BT; Koeglsperger, T; Starossom, SC; Weiner, HL				Wu, Henry Yim; Quintana, Francisco J.; da Cunha, Andre Pires; Dake, Benjamin T.; Koeglsperger, Thomas; Starossom, Sarah C.; Weiner, Howard L.			In Vivo Induction of Tr1 Cells via Mucosal Dendritic Cells and AHR Signaling	PLOS ONE			English	Article							REGULATORY T-CELLS; RETINOIC-ACID; C-MAF; LAMINA PROPRIA; INTERLEUKIN-10; RECEPTOR; IL-10; DIFFERENTIATION; GENERATION; FOXP3(+)	Background: Type 1 regulatory T (Tr1) cells, characterized by the secretion of high levels of the anti-inflammatory cytokine interleukin-10 (IL-10), play an important role in the regulation of autoimmune diseases and transplantation. However, effective strategies that specifically induce Tr1 cells in vivo are limited. Furthermore, the pathways controlling the induction of these cells in vivo are not well understood. Methodology/Principal Findings: Here we report that nasal administration of anti-CD3 antibody induces suppressive Tr1 cells in mice. The in vivo induction of Tr1 cells by nasal anti-CD3 is dependent on IL-27 produced by upper airway resident dendritic cells (DCs), and is controlled by the transcription factors aryl hydrocarbon receptor (AHR) and c-Maf. Subsequently, IL-21 acts in an autocrine fashion to expand and maintain the Tr1 cells induced in vivo by nasally administered anti-CD3. Conclusions/Significance: Our findings identify a unique approach to generate Tr1 cells in vivo and provide insights into the mechanisms by which these cells are induced.	[Wu, Henry Yim; Quintana, Francisco J.; da Cunha, Andre Pires; Dake, Benjamin T.; Koeglsperger, Thomas; Starossom, Sarah C.; Weiner, Howard L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wu, HY (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020	Starossom, Sarah/0000-0001-7935-9910	NIH [R01 AI43458, R00 AI75285-02]; Susan Furbacher Conroy Fellowship; National Multiple Sclerosis Society [RG4111A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043458, R56AI093903, R00AI075285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Furbacher Conroy Fellowship; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (R01 AI43458 to HLW), Susan Furbacher Conroy Fellowship to HYW, and R00 AI75285-02 from the National Institutes of Health and RG4111A1 from the National Multiple Sclerosis Society to FJQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Wu HY, 2008, J IMMUNOL, V181, P6038, DOI 10.4049/jimmunol.181.9.6038; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123	31	76	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23618	10.1371/journal.pone.0023618	http://dx.doi.org/10.1371/journal.pone.0023618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886804	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500020
J	Buranapraditkun, S; Hempel, U; Pitakpolrat, P; Allgaier, RL; Thantivorasit, P; Lorenzen, SI; Sirivichayakul, S; Hildebrand, WH; Altfeld, M; Brander, C; Walker, BD; Phanuphak, P; Hansasuta, P; Rowland-Jones, SL; Allen, TM; Ruxrungtham, K				Buranapraditkun, Supranee; Hempel, Ursula; Pitakpolrat, Patrawadee; Allgaier, Rachel L.; Thantivorasit, Pattarawat; Lorenzen, Sven-Iver; Sirivichayakul, Sunee; Hildebrand, William H.; Altfeld, Marcus; Brander, Christian; Walker, Bruce D.; Phanuphak, Praphan; Hansasuta, Pokrath; Rowland-Jones, Sarah L.; Allen, Todd M.; Ruxrungtham, Kiat			A Novel Immunodominant CD8+T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; MAJOR DETERMINANTS; GENETIC-VARIATION; TYPE-1 INFECTION; ESCAPE VARIANTS; DOUBLE-BLIND; VACCINE; EPITOPES; SELECTION	Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversity of HIV-1 represents a critical hurdle to developing an effective HIV-1 vaccine, and it is likely that regional-specific vaccine strains will be required to overcome the diversity of the different HIV-1 clades distributed world-wide. Unfortunately, little is known about the CD8+ T cell responses against CRF01_AE, which is responsible for the majority of infections in Southeast Asia. Methodology/Principal Findings: To identify dominant CD8+ T cell responses recognized in HIV-1 clade CRF01_AE infected subjects we drew upon data from an immunological screen of 100 HIV-1 clade CRF01_AE infected subjects using IFNgamma ELISpot to characterize a novel immunodominant CD8+ T cell response in HIV-1 Gag restricted by HLA-Cw*0102 (p24, (277)YSPVSILDI(285), YI9). Over 75% of Cw*0102+ve subjects targeted this epitope, representing the strongest response in more than a third of these individuals. This novel CD8 epitope was located in a highly conserved region of HIV-1 Gag known to contain immunodominant CD8 epitopes, which are restricted by HLA-B*57 and -B*27 in clade B infection. Nonetheless, viral escape in this epitope was frequently observed in Cw*0102+ve subjects, suggestive of strong selection pressure being exerted by this common CD8+ T cell response. Conclusions/Significance: As HLA-Cw*0102 is frequently expressed in the Thai population (allelic frequency of 16.8%), this immunodominant Cw*0102-restricted Gag epitope may represent an attractive candidate for vaccines specific to CRF01_AE and may help facilitate further studies of immunopathogenesis in this understudied HIV-1 clade.	[Buranapraditkun, Supranee; Pitakpolrat, Patrawadee; Thantivorasit, Pattarawat; Lorenzen, Sven-Iver; Sirivichayakul, Sunee; Phanuphak, Praphan; Ruxrungtham, Kiat] Chulalongkorn Univ, Chulalongkorn Med Res Ctr ChulaMRC, Vaccine & Cellular Immunol Lab, Bangkok, Thailand; [Buranapraditkun, Supranee; Pitakpolrat, Patrawadee; Thantivorasit, Pattarawat; Lorenzen, Sven-Iver; Sirivichayakul, Sunee; Phanuphak, Praphan; Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Hempel, Ursula; Allgaier, Rachel L.; Altfeld, Marcus; Walker, Bruce D.; Allen, Todd M.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Brander, Christian] Hosp Badalona Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Badalona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [Phanuphak, Praphan; Ruxrungtham, Kiat] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Hansasuta, Pokrath] Chulalongkorn Univ, Fac Med, Dept Microbiol, Bangkok 10330, Thailand; [Rowland-Jones, Sarah L.] John Radcliffe Hosp, MRC, Human Immunol Unit, Weather All Inst Mol Med, Oxford OX3 9DU, England; [Buranapraditkun, Supranee] Chulalongkorn Univ, Interdisciplinary Program Med Microbiol, Grad Sch, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA; Thai Red Cross Society; Chulalongkorn University; University of Oxford; Chulalongkorn University	Buranapraditkun, S (corresponding author), Chulalongkorn Univ, Chulalongkorn Med Res Ctr ChulaMRC, Vaccine & Cellular Immunol Lab, Bangkok, Thailand.	kiat.r@chula.ac.th	Allen, Todd/F-5473-2011; Altfeld, Marcus/AAE-7306-2019	Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; Ruxrungtham, Kiat/0000-0001-7348-2352; Brander, Christian/0000-0002-0548-5778	National Institutes of Health: NIH [N01-A1-30024]; National Center for Genetic Engineering and Biotechnology (BIOTEC) Thailand; Office of the Commission of Higher Education (CHE) in Thailand; Royal Golden Jubilee Ph.D. Program [Ph.D.0243/2549]; Higher Education Research Promotion and National Research University Project of Thailand; Office of Higher Education Commission; Ratchadaphiseksomphot Endowment Fund [HR1161A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Genetic Engineering and Biotechnology (BIOTEC) Thailand; Office of the Commission of Higher Education (CHE) in Thailand; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Higher Education Research Promotion and National Research University Project of Thailand; Office of Higher Education Commission(Office of Higher Education Commission (OHEC)); Ratchadaphiseksomphot Endowment Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	This study is mainly supported by National Institutes of Health: NIH grant N01-A1-30024; the Research-team Strengthening Grant, National Center for Genetic Engineering and Biotechnology (BIOTEC) Thailand, The AIDS Prevention and Care Research grant from Office of the Commission of Higher Education (CHE) in Thailand. SB and KR are also supported by the Royal Golden Jubilee Ph.D. Program (Ph.D.0243/2549); KR, SB, and SS are partly supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of Higher Education Commission, and the Ratchadaphiseksomphot Endowment Fund (HR1161A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2002, AIDS, V16, P1071, DOI 10.1097/00002030-200205030-00015; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Bond KB, 2001, AIDS RES HUM RETROV, V17, P703, DOI 10.1089/088922201750236988; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fukada K, 2002, AIDS, V16, P701, DOI 10.1097/00002030-200203290-00005; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kantakamalakul W, 2006, AIDS RES HUM RETROV, V22, P1271, DOI 10.1089/aid.2006.22.1271; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Larder B, 2001, AIDS, V15, pS27, DOI 10.1097/00002030-200100005-00005; Lau KA, 2007, AIDS REV, V9, P218; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Ljungberg K, 2007, EXPERT REV VACCINES, V6, P879, DOI 10.1586/14760584.6.6.879; Matucci A, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-68; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Nelson KE, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000299410.37152.17; Ojikutu B, 2007, J INFECT DIS, V196, pS445, DOI 10.1086/521123; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Sanchez-Merino V, 2008, J INFECT DIS, V197, P300, DOI 10.1086/524845; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Specht A, 2010, J VIROL, V84, P7300, DOI 10.1128/JVI.00619-10; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wirachsilp Piyanot, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P814; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	47	16	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23603	10.1371/journal.pone.0023603	http://dx.doi.org/10.1371/journal.pone.0023603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887282	gold, Green Published, Green Submitted			2022-12-25	WOS:000294251800016
J	Goldman, A; Chen, H; Khan, MR; Roesly, H; Hill, KA; Shahidullah, M; Mandal, A; Delamere, NA; Dvorak, K				Goldman, Aaron; Chen, HwuDauRw; Khan, Mohammad R.; Roesly, Heather; Hill, Kimberly A.; Shahidullah, Mohammad; Mandal, Amritlal; Delamere, Nicholas A.; Dvorak, Katerina			The Na+/H+ Exchanger Controls Deoxycholic Acid-Induced Apoptosis by a H+-Activated, Na+-Dependent Ionic Shift in Esophageal Cells	PLOS ONE			English	Article							MULTIPLE STRESS-INDUCER; NITRIC-OXIDE SYNTHASE; SODIUM-HYDROGEN EXCHANGE; EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; BARRETTS-ESOPHAGUS; BILE-ACIDS; OXIDATIVE STRESS; MITOCHONDRIAL PERTURBATION; CYTOSOLIC ACIDIFICATION	Apoptosis resistance is a hallmark of cancer cells. Typically, bile acids induce apoptosis. However during gastrointestinal (GI) tumorigenesis the cancer cells develop resistance to bile acid-induced cell death. To understand how bile acids induce apoptosis resistance we first need to identify the molecular pathways that initiate apoptosis in response to bile acid exposure. In this study we examined the mechanism of deoxycholic acid (DCA)-induced apoptosis, specifically the role of Na+/H+ exchanger (NHE) and Na+ influx in esophageal cells. In vitro studies revealed that the exposure of esophageal cells (JH-EsoAd1, CP-A) to DCA (0.2 mM -0.5 mM) caused lysosomal membrane perturbation and transient cytoplasmic acidification. Fluorescence microscopy in conjunction with atomic absorption spectrophotometry demonstrated that this effect on lysosomes correlated with influx of Na+, subsequent loss of intracellular K+, an increase of Ca2+ and apoptosis. However, ethylisopropyl-amiloride (EIPA), a selective inhibitor of NHE, prevented Na+, K+ and Ca2+ changes and caspase 3/7 activation induced by DCA. Ouabain and amphotericin B, two drugs that increase intracellular Na+ levels, induced similar changes as DCA (ion imbalance, caspase3/7 activation). On the contrary, DCA-induced cell death was inhibited by medium with low a Na+ concentrations. In the same experiments, we exposed rat ileum ex-vivo to DCA with or without EIPA. Severe tissue damage and caspase-3 activation was observed after DCA treatment, but EIPA almost fully prevented this response. In summary, NHE-mediated Na+ influx is a critical step leading to DCA-induced apoptosis. Cells tolerate acidification but evade DCA-induced apoptosis if NHE is inhibited. Our data suggests that suppression of NHE by endogenous or exogenous inhibitors may lead to apoptosis resistance during GI tumorigenesis.	[Goldman, Aaron; Chen, HwuDauRw; Khan, Mohammad R.; Roesly, Heather; Hill, Kimberly A.; Dvorak, Katerina] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Shahidullah, Mohammad; Mandal, Amritlal; Delamere, Nicholas A.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Goldman, Aaron; Dvorak, Katerina] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona	Goldman, A (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.	kdvorak@email.arizona.edu	Shahidullah, Mohammad/AAA-1359-2022; Mandal, Amritlal/G-7946-2018	Mandal, Amritlal/0000-0001-9401-5649; Delamere, Nicholas/0000-0002-3018-1645; Shahidullah, Mohammad/0000-0002-1142-4242	National Institutes of Health (NIH) [CA95060, T-32 CA009213, RO1 EY06915]; NATIONAL CANCER INSTITUTE [P30CA023074, T32CA009213, P50CA095060] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006915] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the National Institutes of Health (NIH) GI SPORE grant CA95060, T-32 CA009213 and RO1 EY06915 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez H, 2008, CANCER BIOL THER, V7, P1753; Bae JD, 2005, J KOREAN MED SCI, V20, P56, DOI 10.3346/jkms.2005.20.1.56; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CENGIZ P, ANTIOXID REDOX SIGNA; Crowley CL, 2000, CELL DEATH DIFFER, V7, P314, DOI 10.1038/sj.cdd.4400658; Crowley-Weber CL, 2002, CARCINOGENESIS, V23, P2063, DOI 10.1093/carcin/23.12.2063; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; DONOWITZ M, 1986, ANNU REV PHYSIOL, V48, P135, DOI 10.1146/annurev.ph.48.030186.001031; Dvorak K, 2007, CLIN CANCER RES, V13, P5305, DOI 10.1158/1078-0432.CCR-07-0483; Dvorakova K, 2001, BLOOD, V97, P3544, DOI 10.1182/blood.V97.11.3544; Dvorakova K, 2005, AM J GASTROENTEROL, V100, P424, DOI 10.1111/j.1572-0241.2005.40932.x; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Fujiwara Y, 2006, AM J PHYSIOL-GASTR L, V290, pG665, DOI 10.1152/ajpgi.00238.2005; Gerbino A, 2009, GASTROENTEROLOGY, V137, P955, DOI 10.1053/j.gastro.2009.03.038; GOLDMAN A, 2009, DIS ESOPHAGUS; Goldman A, 2010, GUT, V59, P1606, DOI 10.1136/gut.2010.213686; Gumpricht E, 2002, J BIOL CHEM, V277, P25823, DOI 10.1074/jbc.M112305200; Gupta A, 2001, CANCER LETT, V173, P115, DOI 10.1016/S0304-3835(01)00656-5; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Hirpara JL, 2001, J BIOL CHEM, V276, P514, DOI 10.1074/jbc.M004687200; Hou Y, 2001, J MEMBRANE BIOL, V182, P81, DOI 10.1007/s00232-001-0028-y; Jones BA, 1997, AM J PHYSIOL-GASTR L, V272, pG1109, DOI 10.1152/ajpgi.1997.272.5.G1109; Karpinets TV, 2005, CARCINOGENESIS, V26, P1323, DOI 10.1093/carcin/bgi079; Karwatowska-Prokopczuk E, 1998, CIRC RES, V82, P1139, DOI 10.1161/01.RES.82.11.1139; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Lang KS, 2003, N-S ARCH PHARMACOL, V367, P391, DOI 10.1007/s00210-003-0701-z; Liu Y, 2009, CELL ADHES MIGR, V3, P94, DOI 10.4161/cam.3.1.7516; Mandal A, 2008, AM J PHYSIOL-CELL PH, V295, pC100, DOI 10.1152/ajpcell.90636.2007; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Nehra D, 1999, GUT, V44, P598, DOI 10.1136/gut.44.5.598; Nilsson C, 2006, APOPTOSIS, V11, P1149, DOI 10.1007/s10495-006-7108-5; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Panayiotidis MI, 2010, APOPTOSIS, V15, P834, DOI 10.1007/s10495-010-0494-8; Payne CM, 2005, CELL BIOL TOXICOL, V21, P215, DOI 10.1007/s10565-005-0166-6; Payne CM, 2003, CELL BIOL TOXICOL, V19, P373, DOI 10.1023/B:CBTO.0000013331.70391.0e; PAYNE CM, 1995, ULTRASTRUCT PATHOL, V19, P221, DOI 10.3109/01913129509064227; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Roussi S, 2007, APOPTOSIS, V12, P87, DOI 10.1007/s10495-006-0485-y; Shahidullah M, 2009, INVEST OPHTH VIS SCI, V50, P5851, DOI 10.1167/iovs.09-3453; Society AC, 2010, CANC FACTS FIG 2010; Stein H J, 1998, J Gastrointest Surg, V2, P333, DOI 10.1016/S1091-255X(98)80072-3; STUBBS M, 1995, ADV ENZYME REGUL, V35, P101, DOI 10.1016/0065-2571(94)00016-V; Tarshis M, 2004, CURR MICROBIOL, V49, P136, DOI 10.1007/s00284-004-4298-3; Teshima Y, 2003, CIRCULATION, V108, P2275, DOI 10.1161/01.CIR.0000093277.20968.C7; Tsuchiya S, 2006, TOXICOL LETT, V166, P140, DOI 10.1016/j.toxlet.2006.06.006; Vaninetti NM, 2008, MOL CARCINOGEN, V47, P275, DOI 10.1002/mc.20382; Waibel M, 2007, APOPTOSIS, V12, P623, DOI 10.1007/s10495-006-0006-z; Wang L, 2009, BIOL TRACE ELEM RES, V127, P53, DOI 10.1007/s12011-008-8223-7; Wilson KT, 1998, CANCER RES, V58, P2929; Wu JT, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-333; Yurinskaya VE, 2005, CELL PHYSIOL BIOCHEM, V16, P155, DOI 10.1159/000089841; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	57	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23835	10.1371/journal.pone.0023835	http://dx.doi.org/10.1371/journal.pone.0023835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887327	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800034
J	Kozina, V; Cappallo-Obermann, H; Gromoll, J; Spiess, AN				Kozina, Viviana; Cappallo-Obermann, Heike; Gromoll, Joerg; Spiess, Andrej-Nikolai			A One-Step Real-Time Multiplex PCR for Screening Y-Chromosomal Microdeletions without Downstream Amplicon Size Analysis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MELTING CURVE ANALYSIS; SYBR-GREEN-I; MALE-INFERTILITY; SEVERE OLIGOZOOSPERMIA; AZOOSPERMIC MEN; AZFC REGIONS; DELETIONS; IDENTIFICATION; GENE	Backgound: Y-chromosomal microdeletions (YCMD) are one of the major genetic causes for non-obstructive azoospermia. Genetic testing for YCMD by multiplex polymerase chain reaction (PCR) is an established method for quick and robust screening of deletions in the AZF regions of the Y-chromosome. Multiplex PCRs have the advantage of including a control gene in every reaction and significantly reducing the number of reactions needed to screen the relevant genomic markers. Principal Findings: The widely established "EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions (2004)" were used as a basis for designing a real-time multiplex PCR system, in which the YCMD can simply be identified by their melting points. For this reason, some AZF primers were substituted by primers for regions in their genomic proximity, and the ZFX/ZFY control primer was exchanged by the AMELX/AMELY control primer. Furthermore, we substituted the classical SybrGreen I dye by the novel and high-performing DNA-binding dye EvaGreen(TM) and put substantial effort in titrating the primer combinations in respect to optimal melting peak separation and peak size. Significance: With these changes, we were able to develop a platform-independent and robust real-time based multiplex PCR, which makes the need for amplicon identification by electrophoretic sizing expendable. By using an open-source system for real-time PCR analysis, we further demonstrate the applicability of automated melting point and YCMD detection.	[Kozina, Viviana] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Cappallo-Obermann, Heike; Spiess, Andrej-Nikolai] Univ Hosp Hamburg Eppendorf, Dept Androl, Hamburg, Germany; [Gromoll, Joerg] Univ Hosp Munster, Ctr Reprod Med & Androl, Munster, Germany	University of Zagreb; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster	Kozina, V (corresponding author), Univ Zagreb, Sch Med, Zagreb 41001, Croatia.	a.spiess@uke.de	Spiess, Andrej-Nikolai/A-2941-2015; Gromoll, Joerg/AAB-2146-2019	Spiess, Andrej-Nikolai/0000-0002-9630-4724; Gromoll, Joerg/0000-0002-7788-8138	DAAD; Ministry of Science, Croatia [108-1080399-0383]; German Research Foundation [Sp721/1-3]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Science, Croatia; German Research Foundation(German Research Foundation (DFG))	Financial support for this work was paid in part by the DAAD stability pack/special program for South East Europe and by grant 108-1080399-0383 of the Ministry of Science, Croatia, to Dr. Kozina. Financial support from grant Sp721/1-3 of the German Research Foundation, awarded to Dr. Spiess and Dr. Cappallo-Obermann, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknin-Seifer IE, 2003, HUM REPROD, V18, P257, DOI 10.1093/humrep/deg067; Bor P, 2003, J ASSIST REPROD GEN, V20, P46, DOI 10.1023/A:1021215006775; Bor P, 2001, J ASSIST REPROD GEN, V18, P291, DOI 10.1023/A:1016618418319; Brandell RA, 1998, HUM REPROD, V13, P2812, DOI 10.1093/humrep/13.10.2812; Buch B, 2003, FERTIL STERIL, V80, P907, DOI 10.1016/S0015-0282(03)01155-5; Charpenel C, 2002, GENET TEST, V6, P207, DOI 10.1089/109065702761403379; Costa P, 2008, MOL HUM REPROD, V14, P251, DOI 10.1093/molehr/gan014; Cram DS, 2006, MED J AUSTRALIA, V185, P433, DOI 10.5694/j.1326-5377.2006.tb00641.x; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Feig C, 2007, MOL HUM REPROD, V13, P33, DOI 10.1093/molehr/gal097; Fodor F, 2007, GENET TEST, V11, P139, DOI 10.1089/gte.2006.0506; Foresta C, 2000, J ENDOCRINOL INVEST, V23, P646, DOI 10.1007/BF03343788; Foresta C, 2005, J CLIN ENDOCR METAB, V90, P152, DOI 10.1210/jc.2004-1469; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Fujisawa M, 2001, FERTIL STERIL, V76, P491, DOI 10.1016/S0015-0282(01)01955-0; Giglio S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng135; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; HENEGARIU O, 1994, ANDROLOGIA, V26, P97; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; Hopps CV, 2003, HUM REPROD, V18, P1660, DOI 10.1093/humrep/deg348; Jabasini M, 2005, J CHROMATOGR SCI, V43, P221, DOI 10.1093/chromsci/43.5.221; Jobling MA, 2007, HUM MOL GENET, V16, P307, DOI 10.1093/hmg/ddl465; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kent-First M, 1999, MOL REPROD DEV, V53, P27, DOI 10.1002/(SICI)1098-2795(199905)53:1<27::AID-MRD4>3.0.CO;2-W; Kent-First MG, 1996, MOL HUM REPROD, V2, P943, DOI 10.1093/molehr/2.12.943; Kim SW, 1999, FERTIL STERIL, V72, P349, DOI 10.1016/S0015-0282(99)00255-1; Kleiman SE, 2007, HUM REPROD, V22, P151, DOI 10.1093/humrep/del341; Krausz C, 2001, HUM MOL GENET, V10, P1873, DOI 10.1093/hmg/10.18.1873; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lin YW, 2006, MOL HUM REPROD, V12, P347, DOI 10.1093/molehr/gal038; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Martinez MC, 2000, J ANDROL, V21, P651; Mitra A, 2008, INDIAN J MED RES, V127, P124; Moro E, 2000, J CLIN ENDOCR METAB, V85, P4069, DOI 10.1210/jc.85.11.4069; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; Plaseski T, 2008, GENET TEST, V12, P595, DOI 10.1089/gte.2008.0068; Rajender S, 2006, MOL HUM REPROD, V12, P341, DOI 10.1093/molehr/gal030; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Simoni M, 1997, FERTIL STERIL, V67, P542, DOI 10.1016/S0015-0282(97)80083-0; Simoni M, 2008, REPROD BIOMED ONLINE, V16, P289, DOI 10.1016/S1472-6483(10)60588-3; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; Thornhill AR, 2002, INT J ANDROL, V25, P352, DOI 10.1046/j.1365-2605.2002.00377.x; Umeno M, 2006, J MED INVESTIG, V53, P147, DOI 10.2152/jmi.53.147; Varga A, 2006, J VIROL METHODS, V132, P146, DOI 10.1016/j.jviromet.2005.10.004; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Zhang J, 2008, MOL HUM REPROD, V14, P371, DOI 10.1093/molehr/gan022	52	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23174	10.1371/journal.pone.0023174	http://dx.doi.org/10.1371/journal.pone.0023174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887237	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800008
J	Lang, JS; Yang, N; Deng, JJ; Liu, KT; Yang, P; Zhang, GG; Jiang, CY				Lang, Jianshe; Yang, Ning; Deng, Jiejie; Liu, Kangtai; Yang, Peng; Zhang, Guigen; Jiang, Chengyu			Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; RESPIRATORY-SYNDROME-CORONAVIRUS; VESICULAR STOMATITIS-VIRUS; BOVINE LACTOFERRIN; HUMAN-PAPILLOMAVIRUS; ANTIVIRAL ACTIVITY; VIRAL ENTRY; EARLY STEPS; HOST-CELLS; PROTEIN	It has been reported that lactoferrin (LF) participates in the host immune response against Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) invasion by enhancing NK cell activity and stimulating neutrophil aggregation and adhesion. We further investigated the role of LF in the entry of SARS pseudovirus into HEK293E/ACE2-Myc cells. Our results reveal that LF inhibits SARS pseudovirus infection in a dose-dependent manner. Further analysis suggested that LF was able to block the binding of spike protein to host cells at 4 degrees C, indicating that LF exerted its inhibitory function at the viral attachment stage. However, LF did not disrupt the interaction of spike protein with angiotensin-converting enzyme 2 (ACE2), the functional receptor of SARS-CoV. Previous studies have shown that LF colocalizes with the widely distributed cell-surface heparan sulfate proteoglycans (HSPGs). Our experiments have also confirmed this conclusion. Treatment of the cells with heparinase or exogenous heparin prevented binding of spike protein to host cells and inhibited SARS pseudovirus infection, demonstrating that HSPGs provide the binding sites for SARS-CoV invasion at the early attachment phase. Taken together, our results suggest that, in addition to ACE2, HSPGs are essential cell-surface molecules involved in SARS-CoV cell entry. LF may play a protective role in host defense against SARS-CoV infection through binding to HSPGs and blocking the preliminary interaction between SARS-CoV and host cells. Our findings may provide further understanding of SARS-CoV pathogenesis and aid in treatment of this deadly disease.	[Lang, Jianshe; Yang, Ning; Deng, Jiejie; Liu, Kangtai; Yang, Peng; Zhang, Guigen; Jiang, Chengyu] Tsinghua Univ, State Key Lab Med Mol Biol, Inst Basic Med Sci, Chinese Acad Med Sci,Peking Union Med Coll, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Lang, JS (corresponding author), Tsinghua Univ, State Key Lab Med Mol Biol, Inst Basic Med Sci, Chinese Acad Med Sci,Peking Union Med Coll, Beijing 100084, Peoples R China.	jiang@pumc.edu.cn		Zhang, Guigen/0000-0002-3336-6768	National Natural Science Foundation of China [30625013, 30623009]; Ministry of Science and Technology of China [2009CB522105]; Ministry of Health [2009ZX10004-308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Health	This work was supported by the National Natural Science Foundation of China (30625013 and 30623009), the Ministry of Science and Technology of China (2009CB522105), and the Ministry of Health (2009ZX10004-308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Ammendolia MG, 2007, ANTIVIR RES, V73, P151, DOI 10.1016/j.antiviral.2006.09.002; Andersen JH, 2001, ANTIVIR RES, V51, P141, DOI 10.1016/S0166-3542(01)00146-2; Arai T, 1998, J VIROL, V72, P1115, DOI 10.1128/JVI.72.2.1115-1121.1998; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Baker EN, 2009, BIOCHIMIE, V91, P3, DOI 10.1016/j.biochi.2008.05.006; Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Bartlam M, 2005, CURR OPIN STRUC BIOL, V15, P664, DOI 10.1016/j.sbi.2005.10.004; Beljaars L, 2004, ANTIVIR RES, V63, P197, DOI 10.1016/j.antiviral.2004.05.002; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; Burckhardt CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000621; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; CONTI C, 1991, RES VIROLOGY, V142, P17, DOI 10.1016/0923-2516(91)90023-V; Copreni E, 2008, J GENE MED, V10, P1294, DOI 10.1002/jgm.1248; Drobni P, 2004, ANTIVIR RES, V64, P63, DOI [10.1016/j.antiviral.2004.05.005, 10.1016/S0166-3542(04)00123-8]; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020; Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; HAAN CA, 2005, J VIROL, V79, P14451; Han DP, 2007, J VIROL, V81, P12029, DOI 10.1128/JVI.00315-07; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Jenssen H, 2005, CELL MOL LIFE SCI, V62, P3002, DOI 10.1007/s00018-005-5228-7; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Krahling V, 2009, J VIROL, V83, P2298, DOI 10.1128/JVI.01245-08; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Longhi G, 2006, ANTIVIR RES, V72, P145, DOI 10.1016/j.antiviral.2006.05.008; Marchetti M, 2004, VIROLOGY, V318, P405, DOI 10.1016/j.virol.2003.09.029; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Puddu P, 1998, INT J BIOCHEM CELL B, V30, P1055, DOI 10.1016/S1357-2725(98)00066-1; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Sapp M, 2009, FEBS J, V276, P7206, DOI 10.1111/j.1742-4658.2009.07400.x; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Selinka HC, 2007, J VIROL, V81, P10970, DOI 10.1128/JVI.00998-07; Selinka HC, 2002, VIROLOGY, V299, P279, DOI 10.1006/viro.2001.1493; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Superti F, 2001, BBA-GEN SUBJECTS, V1528, P107, DOI 10.1016/S0304-4165(01)00178-7; Thorne RG, 2008, P NATL ACAD SCI USA, V105, P8416, DOI 10.1073/pnas.0711345105; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Vicenzi E, 2004, EMERG INFECT DIS, V10, P413, DOI 10.3201/eid1003.030683; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565; Waarts BL, 2005, VIROLOGY, V333, P284, DOI 10.1016/j.virol.2005.01.010; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Watanabe R, 2008, J VIROL, V82, P11985, DOI 10.1128/JVI.01412-08; Yamauchi K, 2006, BIOCHEM CELL BIOL, V84, P291, DOI 10.1139/O06-054; Yeung KS, 2006, MED RES REV, V26, P414, DOI 10.1002/med.20055; Zautner AE, 2003, J VIROL, V77, P10071, DOI 10.1128/JVI.77.18.10071-10077.2003	57	274	289	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23710	10.1371/journal.pone.0023710	http://dx.doi.org/10.1371/journal.pone.0023710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887302	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800024
J	Abe, M; Tsai, SY; Jin, SG; Pfeifer, GP; Szabo, PE				Abe, Masanobu; Tsai, Shirley Y.; Jin, Seung-Gi; Pfeifer, Gerd P.; Szabo, Piroska E.			Sex-Specific Dynamics of Global Chromatin Changes in Fetal Mouse Germ Cells	PLOS ONE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; IMPRINTED GENES; MAMMALIAN DEVELOPMENT; OOCYTE GROWTH; MICE; EXPRESSION; HETEROCHROMATIN; GENOME; ESTABLISHMENT	Mammalian germ cells undergo global reprogramming of DNA methylation during their development. Global DNA demethylation occurs around the time when the primordial germ cells colonize the embryonic gonads and this coincides with dynamic changes in chromatin composition. Global de novo DNA methylation takes place with remarkably different dynamics between the two sexes, prospermatogonia attaining methylation during fetal stages and oocytes attaining methylation postnatally. Our hypothesis was that dynamic changes in chromatin composition may precede or accompany the wave of global DNA de novo methylation as well. We used immunocytochemistry to measure global DNA methylation and chromatin components in male and female mouse fetal germ cells compared to control somatic cells of the gonad. We found that global DNA methylation levels sharply increased in male germ cells at 17.5 days post coitum, but remained low in female germ cells at all fetal stages. Global changes in chromatin composition: i, preceded global DNA methylation in fetal germ cells; ii, sex specifically occurred in male but not in female germ cells; iii, affected active and repressive histone marks and iv, included histone tail and histone globular domain modifications. Our data suggest that dynamic changes of chromatin composition may provide a framework for the pattern of male-specific de novo DNA methylation in prospermatogonia.	[Abe, Masanobu; Tsai, Shirley Y.; Szabo, Piroska E.] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Abe, Masanobu; Tsai, Shirley Y.; Jin, Seung-Gi; Pfeifer, Gerd P.; Szabo, Piroska E.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Jin, Seung-Gi; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope	Abe, M (corresponding author), Tokyo Univ Hosp, Dept Oral & Maxillofacial Surg, Tokyo 113, Japan.	pszabo@coh.org		Szabo, Piroska/0000-0001-9314-7009; Jin, Seung-Gi/0000-0001-5041-0559	National Institutes of Health [RO1GM064378, RO1ES015185]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants RO1GM064378 and RO1ES015185 to PES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cheng X., BIOCHEMISTRY, V49, P2999; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Ferguson-Smith A, 2003, SEMIN CELL DEV BIOL, V14, P43, DOI 10.1016/S1084-9521(02)00171-4; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Lee DH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001224; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; MONK M, 1987, DEVELOPMENT, V99, P371; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Singh P, 2011, MOL CELL BIOL, V31, P1757, DOI 10.1128/MCB.00961-10; Singh P, 2010, MOL CELL BIOL, V30, P2693, DOI 10.1128/MCB.01537-09; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Thorvaldsen JL, 2000, SCIENCE, V288, P2145, DOI 10.1126/science.288.5474.2145; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795; Yoshioka H, 2009, BIOL REPROD, V80, P804, DOI 10.1095/biolreprod.108.072603	40	28	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23848	10.1371/journal.pone.0023848	http://dx.doi.org/10.1371/journal.pone.0023848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886830	Green Published, gold, Green Submitted			2022-12-25	WOS:000294128100036
J	Zhu, ZJ; Fu, CL; Li, XX; Song, YM; Li, CH; Zou, MH; Guan, YF; Zhu, Y				Zhu, Zhenjiu; Fu, Chenglai; Li, Xiaoxia; Song, Yimeng; Li, Chenghong; Zou, Minghui; Guan, Youfei; Zhu, Yi			Prostaglandin E2 Promotes Endothelial Differentiation from Bone Marrow-Derived Cells through AMPK Activation	PLOS ONE			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; TRANSPLANTED HUMAN HEART; PROTEIN-KINASE; PROGENITOR CELLS; CANCER CELLS; CYCLOOXYGENASE-2 EXPRESSION; MYOCARDIAL-INFARCTION; COX-2 EXPRESSION; RECEPTOR SUBTYPE; IN-VIVO	Prostaglandin E2 (PGE2) has been reported to modulate angiogenesis, the process of new blood vessel formation, by promoting proliferation, migration and tube formation of endothelial cells. Endothelial progenitor cells are known as a subset of circulating bone marrow mononuclear cells that have the capacity to differentiate into endothelial cells. However, the mechanism underlying the stimulatory effects of PGE2 and its specific receptors on bone marrow-derived cells (BMCs) in angiogenesis has not been fully characterized. Treatment with PGE2 significantly increased the differentiation and migration of BMCs. Also, the markers of differentiation to endothelial cells, CD31 and von Willebrand factor, and the genes associated with migration, matrix metalloproteinases 2 and 9, were significantly upregulated. This upregulation was abolished by dominant-negative AMP-activated protein kinase (AMPK) and AMPK inhibitor but not protein kinase, a inhibitor. As a functional consequence of differentiation and migration, the tube formation of BMCs was reinforced. Along with altered BMCs functions, phosphorylation and activation of AMPK and endothelial nitric oxide synthase, the target of activated AMPK, were both increased which could be blocked by EP4 blocking peptide and simulated by the agonist of EP4 but not EP1, EP2 or EP3. The pro-angiogenic role of PGE2 could be repressed by EP4 blocking peptide and retarded in EP4(+/-) mice. Therefore, by promoting the differentiation and migration of BMCs, PGE2 reinforced their neovascularization by binding to the receptor of EP4 in an AMPK-dependent manner. PGE2 may have clinical value in ischemic heart disease.	[Zhu, Zhenjiu; Fu, Chenglai; Li, Xiaoxia; Song, Yimeng; Li, Chenghong; Guan, Youfei; Zhu, Yi] Peking Univ, Key Lab Mol Cardiovasc Sci, Educ Minist, Dept Physiol & Pathophysiol,Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zou, Minghui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK USA	Peking University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, ZJ (corresponding author), Peking Univ, Key Lab Mol Cardiovasc Sci, Educ Minist, Dept Physiol & Pathophysiol,Hlth Sci Ctr, Beijing 100871, Peoples R China.	youfeiguan@hsc.pku.edu.cn; zhuyi@hsc.pku.edu.cn	Fu, Chenglai/H-5330-2018	Fu, Chenglai/0000-0003-4300-9948; guan, youfei/0000-0002-5231-0209	Major National Basic Research Grant of China [2010CB912504]; National Natural Science Foundation of China [308201001, 810701113, 81028002]; "111" plan of China	Major National Basic Research Grant of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "111" plan of China(Ministry of Education, China - 111 Project)	This work was supported in part by grants from the Major National Basic Research Grant of China (2010CB912504) (http://www.973.gov.cn/); the National Natural Science Foundation of China (308201001, 810701113, 81028002) (http://www.nsfc.gov.cn/Portal0/default124.htm) and the "111" plan of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no additional external funding received for this study.	Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Cui X, 2007, STEM CELLS, V25, P2777, DOI 10.1634/stemcells.2007-0169; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Fukuda R, 2003, CANCER RES, V63, P2330; Funahashi K, 2009, PROSTAG OTH LIPID M, V88, P31, DOI 10.1016/j.prostaglandins.2008.09.002; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Jin F, 2008, BONE MARROW TRANSPL, V42, P581, DOI 10.1038/bmt.2008.222; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Kaye DM, 2006, CIRCULATION, V113, pE844, DOI 10.1161/CIRCULATIONAHA.105.601989; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Ogawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P720, DOI 10.1016/j.bbrc.2009.03.094; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Pino MS, 2005, CANCER BIOL THER, V4, P1263, DOI 10.4161/cbt.4.11.2138; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Stahmann N, 2010, J BIOL CHEM, V285, P10638, DOI 10.1074/jbc.M110.108688; Steinert D, 2009, AM J PHYSIOL-CELL PH, V296, pC75, DOI 10.1152/ajpcell.00024.2008; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tsuji T, 2009, PROSTAG OTH LIPID M, V90, P85, DOI 10.1016/j.prostaglandins.2009.09.002; Uefuji K, 2000, CLIN CANCER RES, V6, P135; Ueno T, 2010, BIOMED PHARMACOTHER, V64, P93, DOI 10.1016/j.biopha.2009.04.034; Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Xie C, 2009, AM J PATHOL, V175, P772, DOI 10.2353/ajpath.2009.081099; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Yanni SE, 2009, INVEST OPHTH VIS SCI, V50, P5479, DOI 10.1167/iovs.09-3652; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98	46	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23554	10.1371/journal.pone.0023554	http://dx.doi.org/10.1371/journal.pone.0023554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876756	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900028
J	Pasha, Z; Haider, HK; Ashraf, M				Pasha, Zeeshan; Haider, Husnain Kh; Ashraf, Muhammad			Efficient Non-Viral Reprogramming of Myoblasts to Stemness with a Single Small Molecule to Generate Cardiac Progenitor Cells	PLOS ONE			English	Article							INDUCTION; MOUSE; OCT4; PLURIPOTENCY; FIBROBLASTS; MYC	The current protocols for generation of induced pluripotent stem (iPS) cells involve genome integrating viral vectors which may induce tumorgenesis. The aim of this study was to develop and optimize a non-viral method without genetic manipulation for reprogramming of skeletal myoblasts (SMs) using small molecules. Methods and Results: SMs from young male Oct3/4-GFP(+) transgenic mouse were treated with DNA methyltransferase (DNMT) inhibitor, RG108. Two weeks later, GFP(+) colonies of SM derived iPS cells (SiPS) expressing GFP and with morphological similarity of mouse embryonic stem (ESCs) were formed and propagated in vitro. SiPS were positive for alkaline phosphatase activity, expressed SSEA1, displayed ES cell specific pluripotency markers and formed teratoma in nude mice. Optimization of culture conditions for embryoid body (EBs) formation yielded spontaneously contracting EBs having morphological, molecular, and ultra-structural similarities with cardiomyocytes and expressed early and late cardiac markers. miR profiling showed abrogation of let-7 family and upregulation of ESCs specific miR-290-295 cluster thus indicating that SiPS were similar to ESCs in miR profile. Four weeks after transplantation into the immunocompetent mice model of acute myocardial infarction (n = 12 per group), extensive myogenesis was observed in SiPS transplanted hearts as compared to DMEM controls (n = 6 per group). A significant reduction in fibrosis and improvement in global heart function in the hearts transplanted with SiPS derived cardiac progenitor cells were observed. Conclusions: Reprogramming of SMs by DNMT inhibitor is a simple, reproducible and efficient technique more likely to generate transgene integration-free iPS cells. Cardiac progenitors derived from iPS cells propagated extensively in the infarcted myocardium without tumorgenesis and improved cardiac function.	[Pasha, Zeeshan; Haider, Husnain Kh; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Pasha, Z (corresponding author), Univ Cincinnati, Dept Pathol, Cincinnati, OH 45221 USA.	ashrafm@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health (NIH) [R37-HL074272, HL-080686, HL-087246, HL 107957, HL-087288, HL-089535, HL106190-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL074272, R01HL107957, R01HL089535, R01HL087288, R01HL080686, R01HL106190, R01HL087246] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants R37-HL074272; HL-080686; HL-087246; HL 107957 (M.A.) and HL-087288; HL-089535; HL106190-01 (H.K.H.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RPH, 2011, CIRC RES, V109, P60, DOI 10.1161/CIRCRESAHA.110.240010; Ahmed RPH, 2011, REGEN MED, V6, P171, DOI 10.2217/RME.10.103; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Haider HK, 2004, J MOL MED, V82, P539, DOI 10.1007/s00109-004-0546-z; Han JW, 2011, ANTIOXID REDOX SIGN, V15, P1799, DOI 10.1089/ars.2010.3814; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jain M, 2001, CIRCULATION, V103, P1920; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stefani G, 2006, COLD SPRING HARB SYM, V71, P129, DOI 10.1101/sqb.2006.71.032; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang YG, 2006, J MOL CELL CARDIOL, V40, P736, DOI 10.1016/j.yjmcc.2006.02.004; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863	28	44	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2011	6	8							e23667	10.1371/journal.pone.0023667	http://dx.doi.org/10.1371/journal.pone.0023667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810JJ	21886809	gold, Green Published, Green Submitted			2022-12-25	WOS:000294121300077
J	Thylur, RP; Senthivinayagam, S; Campbell, EM; Rangasamy, V; Thorenoor, N; Sondarva, G; Mehrotra, S; Mishra, P; Zook, E; Le, PT; Rana, A; Rana, B				Thylur, Ramesh P.; Senthivinayagam, Subramanian; Campbell, Edward M.; Rangasamy, Velusamy; Thorenoor, Nithyananda; Sondarva, Gautam; Mehrotra, Suneet; Mishra, Prajna; Zook, Erin; Le, Phong T.; Rana, Ajay; Rana, Basabi			Mixed Lineage Kinase 3 Modulates beta-Catenin Signaling in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE GROWTH; ACTIVATION; WNT; APOPTOSIS; POLYPOSIS; APC; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION; REQUIREMENT	Expression of beta-catenin is strictly regulated in normal cells via the glycogen synthase kinase 3 beta (GSK3 beta)-adenomatous polyposis coli-axin-mediated degradation pathway. Mechanisms leading to inactivation of this pathway (example: activation of Wnt/beta-catenin signaling or mutations of members of the degradation complex) can result in beta-catenin stabilization and activation of beta-catenin/T-cell factor (TCF) signaling. beta-Catenin-mediated cellular events are diverse and complex. A better understanding of the cellular signaling networks that control beta-catenin pathway is important for designing effective therapeutic strategies targeting this axis. To gain more insight, we focused on determining any possible cross-talk between beta-catenin and mixed lineage kinase 3 (MLK3), a MAPK kinase kinase member. Our studies indicated that MLK3 can induce beta-catenin expression via post-translational stabilization in various cancer cells, including prostate cancer. This function of MLK3 was dependent on its kinase activity. MLK3 can interact with beta-catenin and phosphorylate it in vitro. Overexpression of GSK3 beta-WT or the S9A mutant was unable to antagonize MLK3-induced stabilization, suggesting this to be independent of GSK3 beta pathway. Surprisingly, despite stabilizing beta-catenin, MLK3 inhibited TCF transcriptional activity in the presence of both WT and S37A beta-catenin. These resulted in reduced expression of beta-catenin/TCF downstream targets Survivin and myc. Immunoprecipitation studies indicated that MLK3 did not decrease beta-catenin/TCF interaction but promoted interaction between beta-catenin and KLF4, a known repressor of beta-catenin/TCF transcriptional activity. In addition, co-expression of MLK3 and beta-catenin resulted in significant G(2)/M arrest. These studies provide a novel insight toward the regulation of beta-catenin pathway, which can be targeted to control cancer cell proliferation, particularly those with aberrant activation of beta-catenin signaling.	[Thylur, Ramesh P.; Senthivinayagam, Subramanian; Thorenoor, Nithyananda; Mishra, Prajna; Rana, Basabi] Loyola Univ Chicago, Dept Med, Div Gastroenterol Hepatol & Nutr, Maywood, IL 60153 USA; [Rangasamy, Velusamy; Sondarva, Gautam; Mehrotra, Suneet; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Campbell, Edward M.; Zook, Erin; Le, Phong T.] Loyola Univ Chicago, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Rana, Basabi] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Rana, Ajay; Rana, Basabi] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Rana, B (corresponding author), Loyola Univ Chicago, Dept Med, Div Gastroenterol Hepatol & Nutr, Bldg 101,Rm 2729,2160 S 1st Ave, Maywood, IL 60153 USA.	brana@lumc.edu	MEHROTRA, SUNEET/A-5673-2012; Thorenoor, Nithyananda/X-5746-2019; Rana, Ajay/ABE-3739-2020; Senthivinayagam, Subramanian/E-3141-2012; Puttalingaiah, Ramesh Thylur/AAH-9087-2020	Rana, Ajay/0000-0003-0951-2566; Senthivinayagam, Subramanian/0000-0001-8796-3640; Thorenoor, Nithyananda/0000-0003-2958-4065; Mishra, Prajna/0000-0002-1906-0244	National Institutes of Health [CA121221, K22 AI078757, RO1 AI093258, GM55835]; Veterans Affairs Merit awards [BX000571-01, BX000312-01]; NATIONAL CANCER INSTITUTE [R21CA121221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093258, K22AI078757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000571, I01BX000312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit awards(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants CA121221 (to B. R.), K22 AI078757 and RO1 AI093258 (to E. M. C.), and GM55835 (to A. R.). This work was also supported by Veterans Affairs Merit awards BX000571-01 (to B. R.) and BX000312-01 (to A. R.).	Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bierie B, 2003, ONCOGENE, V22, P3875, DOI 10.1038/sj.onc.1206426; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cadoret A, 2001, CANCER RES, V61, P3245; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gounari F, 2002, ONCOGENE, V21, P4099, DOI 10.1038/sj.onc.1205562; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mishra Prajna, 2010, J Mol Signal, V5, P9, DOI 10.1186/1750-2187-5-9; Mishra P, 2010, MOL ENDOCRINOL, V24, P598, DOI 10.1210/me.2009-0387; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rangasamy V, 2010, CANCER RES, V70, P1731, DOI 10.1158/0008-5472.CAN-09-3492; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Sondarva G, 2010, CELL RES, V20, P89, DOI 10.1038/cr.2009.125; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Truica CI, 2000, CANCER RES, V60, P4709; Voeller HJ, 1998, CANCER RES, V58, P2520; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006	50	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37470	37482		10.1074/jbc.M111.298943	http://dx.doi.org/10.1074/jbc.M111.298943			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880738	Green Published, hybrid			2022-12-25	WOS:000296542400046
J	Yadav, S; Pandey, A; Shukla, A; Talwelkar, SS; Kumar, A; Pant, AB; Parmar, D				Yadav, Sanjay; Pandey, Ankita; Shukla, Aruna; Talwelkar, Sarang S.; Kumar, Ashutosh; Pant, Aditya B.; Parmar, Devendra			miR-497 and miR-302b Regulate Ethanol-induced Neuronal Cell Death through BCL2 Protein and Cyclin D2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ADULT NEUROGENESIS; POSTTRANSCRIPTIONAL REGULATION; MOUSE-BRAIN; RAT-BRAIN; EXPRESSION; APOPTOSIS; ROLES; NEURODEGENERATION; MICRORNAS	In chronic alcoholism, brain shrinkage and cognitive defects because of neuronal death are well established, although the sequence of molecular events has not been fully explored yet. We explored the role of microRNAs (miRNAs) in ethanol-induced apoptosis of neuronal cells. Ethanol-sensitive miRNAs in SH-SY5Y, a human neuroblastoma cell line, were identified using real-time PCR-based TaqMan low-density arrays. Longterm exposure to ethanol (0.5% v/v for 72 h) produced a maximum increase in expression of miR-497 (474-fold) and miR-302b (322-fold). Similar to SH-SY5Y, long-term exposure to ethanol induced miR-497 and miR-302b in IMR-32, another human neuroblastoma cell line. Using in silico approaches, BCL2 and cyclin D2 (CCND2) were identified as probable target genes of these miRNAs. Cotransfection studies with 3'-UTR of these genes and miRNA mimics have demonstrated that BCL2 is a direct target of miR-497 and that CCND2 is regulated negatively by either miR-302b or miR-497. Overexpression of either miR-497 or miR-302b reduced expression of their identified target genes and increased caspase 3-mediated apoptosis of SH-SY5Y cells. However, overexpression of only miR-497 increased reactive oxygen species formation, disrupted mitochondrial membrane potential, and induced cytochrome c release (mitochondria-related events of apoptosis). Moreover, ethanol induced changes in miRNAs, and their target genes were substantially prevented by pre-exposure to GSK-3B inhibitors. In conclusion, our studies have shown that ethanol-induced neuronal apoptosis follows both the mitochondria-mediated (miR-497- and BCL2-mediated) and non-mitochondria-mediated (miR-302b- and CCND2-mediated) pathway.	[Yadav, Sanjay; Pandey, Ankita; Shukla, Aruna; Talwelkar, Sarang S.; Kumar, Ashutosh; Pant, Aditya B.; Parmar, Devendra] Indian Inst Toxicol Res, Div Dev Toxicol, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Yadav, S (corresponding author), Indian Inst Toxicol Res, Div Dev Toxicol, CSIR, MG Marg 80, Lucknow 226001, Uttar Pradesh, India.	sanjay@iitr.res.in	Yadav, Sanjay/E-2902-2010; Kumar, Ashutosh/V-8563-2019; Talwelkar, Sarang/C-8925-2015	Kumar, Ashutosh/0000-0002-6856-3980; 	CSIR, New Delhi [SIP08, NWP34]; ICMR, New Delhi	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); ICMR, New Delhi(Indian Council of Medical Research (ICMR))	This work was supported by the SIP08 and NWP34 projects of CSIR, New Delhi.; Recipient of a Senior Research Fellowship from ICMR, New Delhi.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Baroukh NN, 2009, FEBS J, V276, P6509, DOI 10.1111/j.1742-4658.2009.07353.x; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen G, 2009, NEUROTOX RES, V15, P321, DOI 10.1007/s12640-009-9036-y; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chin VS, 2010, ALCOHOL, V44, P3, DOI 10.1016/j.alcohol.2009.10.015; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Elibol-Can B., 2011, ALCOHOL CLIN EXP RES; Freyberg Z, 2010, AM J PSYCHIAT, V167, P388, DOI 10.1176/appi.ajp.2009.08121873; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Heaton MB, 1999, BRAIN RES, V817, P13, DOI 10.1016/S0006-8993(98)01173-1; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Luo J, 2009, MOL NEUROBIOL, V40, P108, DOI 10.1007/s12035-009-8075-y; Mitchell JJ, 1998, ALCOHOL, V15, P137, DOI 10.1016/S0741-8329(97)00124-9; Nixon K, 2006, HIPPOCAMPUS, V16, P287, DOI 10.1002/hipo.20162; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Siddiqui MA, 2008, TOXICOL IN VITRO, V22, P1681, DOI 10.1016/j.tiv.2008.07.001; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Susaki E, 2007, MOL CELL BIOL, V27, P4626, DOI 10.1128/MCB.00862-06; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Wang XY, 2009, BRAIN RES BULL, V80, P268, DOI 10.1016/j.brainresbull.2009.08.006; Yadav S, 2006, TOXICOL APPL PHARM, V217, P15, DOI 10.1016/j.taap.2006.07.008; Yadav S, 2006, MOL CELL BIOCHEM, V286, P171, DOI 10.1007/s11010-005-9109-z; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Young C, 2003, CELL DEATH DIFFER, V10, P1148, DOI 10.1038/sj.cdd.4401277; Zhang BH, 2009, ENVIRON HEALTH PERSP, V117, P231, DOI 10.1289/ehp.11841; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	43	114	129	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37347	37357		10.1074/jbc.M111.235531	http://dx.doi.org/10.1074/jbc.M111.235531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878650	Green Published, hybrid			2022-12-25	WOS:000296542400035
J	Yuen, S; Ogut, O; Brozovich, FV				Yuen, Samantha; Ogut, Ozgur; Brozovich, Frank V.			MYPT1 Protein Isoforms Are Differentially Phosphorylated by Protein Kinase G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; MUSCLE MYOSIN PHOSPHATASE; SMOOTH-MUSCLE; LEUCINE-ZIPPER; INCREASED SENSITIVITY; TARGETING SUBUNIT; BINDING SUBUNIT; NITRIC-OXIDE; I-ALPHA; RELAXATION	Smooth muscle relaxation in response to NO signaling is due, in part, to a Ca2+-independent activation of myosin light chain (MLC) phosphatase by protein kinase GI alpha (PKGI alpha). MLC phosphatase is a trimeric complex of a 20-kDa subunit, a 38-kDa catalytic subunit, and a 110-133-kDa myosin-targeting subunit (MYPT1). Alternative mRNA splicing produces four MYPT1 isoforms, differing by the presence or absence of a central insert and leucine zipper (LZ). The LZ domain of MYPT1 has been shown to be important for PKGI alpha-mediated activation of MLC phosphatase activity, and changes in LZ+ MYPT1 isoform expression result in changes in the sensitivity of smooth muscle to NO-mediated relaxation. Furthermore, PKGI alpha has been demonstrated to phosphorylate Ser-694 of MYPT1, but phosphorylation at this site does not always accompany cGMP-mediated smooth muscle relaxation. This study was designed to determine whether MYPT1 isoforms are differentially phosphorylated by PKGI alpha. The results demonstrate that purified LZ+ MYPT1 fragments are rapidly phosphorylated by PKGI alpha at Ser-667 and Ser-694, whereas fragments lacking the LZ domain are poor PKGI alpha substrates. Mutation of Ser-667 and Ser-694 to Ala and/or Asp showed that Ser-667 phosphorylation is more rapid than Ser-694 phosphorylation, suggesting that Ser-667 may play an important role in the activation of MLC phosphatase. These results demonstrate that MYPT1 isoform expression is important for determining the heterogeneous response of vascular beds to NO and NO-based vasodilators, thereby playing a central role in the regulation of vascular tone in health and disease.	[Yuen, Samantha; Ogut, Ozgur; Brozovich, Frank V.] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Brozovich, FV (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	brozovich.frank@mayo.edu			Mayo Clinic	Mayo Clinic	This work was supported by the Mayo Clinic.	Alioua A, 1998, J BIOL CHEM, V273, P32950, DOI 10.1074/jbc.273.49.32950; Chen FC, 2006, J MOL CELL CARDIOL, V41, P488, DOI 10.1016/j.yjmcc.2006.05.018; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choudhury N, 2004, J MUSCLE RES CELL M, V25, P657, DOI 10.1007/s10974-004-7807-x; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; El-Toukhy A, 2006, FEBS LETT, V580, P5779, DOI 10.1016/j.febslet.2006.09.035; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; GONG MC, 1992, J BIOL CHEM, V267, P14662; Hartshorne D. J, 1987, PHYSL GASTROINTESTIN; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Nakamura K, 2007, CIRC RES, V101, P712, DOI 10.1161/CIRCRESAHA.107.153981; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Ogut O, 2000, AM J PHYSIOL-CELL PH, V279, pC1722, DOI 10.1152/ajpcell.2000.279.6.C1722; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	30	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37274	37279		10.1074/jbc.M111.282905	http://dx.doi.org/10.1074/jbc.M111.282905			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21890627	Green Published, hybrid			2022-12-25	WOS:000296542400027
J	Tulloch, LB; Howie, J; Wypijewski, KJ; Wilson, CR; Bernard, WG; Shattock, MJ; Fuller, W				Tulloch, Lindsay B.; Howie, Jacqueline; Wypijewski, Krzysztof J.; Wilson, Catherine R.; Bernard, William G.; Shattock, Michael J.; Fuller, William			The Inhibitory Effect of Phospholemman on the Sodium Pump Requires Its Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CARDIAC NA/K ATPASE; NA+-K+-ATPASE; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; POTASSIUM PUMP; FXYD PROTEINS; PHOSPHORYLATION; MYOCYTES; SITES	Background: Phospholemman regulates the plasmalemmal sodium pump in excitable tissues such as the heart. Results: Phospholemman is palmitoylated at two intracellular cysteines, and this reduces ion transport by the sodium pump. Conclusion: Phospholemman must be palmitoylated to inhibit the sodium pump. Significance: This is a potentially new way to regulate the sodium pump, an enzyme expressed in most eukaryotic cells.	[Tulloch, Lindsay B.; Howie, Jacqueline; Wypijewski, Krzysztof J.; Wilson, Catherine R.; Bernard, William G.; Fuller, William] Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland; [Shattock, Michael J.] Kings Coll London, St Thomas Hosp, Div Cardiovasc, Rayne Inst, London SE1 7EH, England	University of Dundee; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Fuller, W (corresponding author), Ninewells Hosp, Ctr Cardiovasc & Lung Biol, Mailbox 1, Dundee DD1 9SY, Scotland.	w.fuller@dundee.ac.uk		Shattock, Michael/0000-0001-6242-7585; Fuller, William/0000-0002-5883-4433; Tulloch, Lindsay/0000-0001-7223-5106; Bernard, William/0000-0002-2622-5115	British Heart Foundation [RG/07/001]; Medical Research Council [G0700903]; Tenovus Scotland [T07/26]; British Heart Foundation [RG/07/001/22628, PG/10/93/28650] Funding Source: researchfish; MRC [G0700903] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tenovus Scotland; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the British Heart Foundation (RG/07/001 to W. F. and M. J. S.), the Medical Research Council (G0700903 to W. F.), and Tenovus Scotland (T07/26 to W. F.).	Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Fuller W, 2006, CIRC RES, V99, P1290, DOI 10.1161/01.RES.0000253090.54488.81; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Han F, 2009, AM J PHYSIOL-CELL PH, V297, pC699, DOI 10.1152/ajpcell.00063.2009; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kostiuk MA, 2008, FASEB J, V22, P721, DOI 10.1096/fj.07-9199com; Lansbery KL, 2006, AM J PHYSIOL-CELL PH, V290, pC1275, DOI 10.1152/ajpcell.00110.2005; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Song JL, 2008, AM J PHYSIOL-HEART C, V295, pH1615, DOI 10.1152/ajpheart.00287.2008; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Zhang XQ, 2006, J BIOL CHEM, V281, P7784, DOI 10.1074/jbc.M512092200	48	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36020	36031		10.1074/jbc.M111.282145	http://dx.doi.org/10.1074/jbc.M111.282145			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21868384	Green Published, hybrid			2022-12-25	WOS:000295927100075
J	McCracken, KG; Wilson, RE				McCracken, Kevin G.; Wilson, Robert E.			Gene Flow and Hybridization between Numerically Imbalanced Populations of Two Duck Species in the Falkland Islands	PLOS ONE			English	Article							MALLARDS ANAS-PLATYRHYNCHOS; MITOCHONDRIAL-DNA; REPRODUCTIVE ISOLATION; CONTROL REGION; HALDANES RULE; SEX-RATIO; INTROGRESSION; COMPLEX; PHYLOGEOGRAPHY; EXTINCTION	Interspecific hybridization is common in plants and animals, particularly in waterfowl (Anatidae). One factor shown to contribute to hybridization is restricted mate choice, which can occur when two species occur in sympatry but one is rare. The Hubbs principle, or "desperation hypothesis," states that under such circumstances the rarer species is more likely to mate with heterospecifics. Here we report interspecific hybridization between two waterfowl species that coexist in broad sympatry and mixed flocks throughout southern South America. Speckled teal (Anas flavirostris) and yellow-billed pintails (Anas georgica) are abundant in continental South America, but in the Falkland Islands speckled teal outnumber yellow-billed pintails approximately ten to one. Using eight genetic loci (mtDNA and 7 nuclear introns) coupled with Bayesian assignment tests and relatedness analysis, we identified a speckled teal x yellow-billed pintail F(1) hybrid female and her duckling sired by a male speckled teal. Although our sample in the Falkland Islands was small, we failed to identify unequivocal evidence of hybridization or introgression in a much larger sample from Argentina using a three-population "isolation with migration" coalescent analysis. While additional data are needed to determine if this event in the Falkland Islands was a rare singular occurrence, our results provide further support for the "desperation hypothesis," which states that scarcity in one population and abundance of another will often lead to hybridization.	[McCracken, Kevin G.] Univ Alaska Museum, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	McCracken, KG (corresponding author), Univ Alaska Museum, Inst Arctic Biol, Fairbanks, AK 99775 USA.	kmccrack@iab.alaska.edu			Institute of Arctic Biology at the University of Alaska, Fairbanks; National Science Foundation [NSF] [EPS-0092040, EPS-0346770]; Delta Waterfowl Foundation; American Museum of Natural History; NSF [DEB-0444748, DEB-0746365, IOS-0949439]	Institute of Arctic Biology at the University of Alaska, Fairbanks; National Science Foundation [NSF](National Science Foundation (NSF)); Delta Waterfowl Foundation; American Museum of Natural History; NSF(National Science Foundation (NSF))	Funding was provided by the Institute of Arctic Biology at the University of Alaska, Fairbanks, Experimental Program to Stimulate Competitive Research (National Science Foundation [NSF] EPS-0092040 and EPS-0346770), grants from the Delta Waterfowl Foundation and Frank M. Chapman Fund at the American Museum of Natural History to REW, and NSF grants DEB-0444748, DEB-0746365, and IOS-0949439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Balakrishnan CN, 2009, P ROY SOC B-BIOL SCI, V276, P219, DOI 10.1098/rspb.2008.0733; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BOTTEMA CDK, 1993, METHOD ENZYMOL, V218, P388; CALKELL EM, 1961, IBIS, V103, P1; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fowler AC, 2009, CONSERV GENET, V10, P1747, DOI 10.1007/s10592-008-9778-8; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 2005, AM NAT, V166, P56, DOI 10.1086/430331; Grant V., 1981, PLANT SPECIATION, Vsecond; GRAY AP, 1958, BRID HYBRIDS CHECK L; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; HUDSON RR, 1985, GENETICS, V111, P147; JOHNSGARD PAUL A., 1960, CONDOR, V62, P25, DOI 10.2307/1365656; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Kirby RE, 2004, CAN J ZOOL, V82, P1827, DOI 10.1139/Z04-169; Kirby RE, 2000, USGSBRDBSR20000002; Kulikova IV, 2010, RUSS J GENET+, V46, P976, DOI 10.1134/S1022795410080090; Kulikova IV, 2005, AUK, V122, P949, DOI 10.1642/0004-8038(2005)122[0949:POTMAP]2.0.CO;2; Kulikova IV, 2004, AUK, V121, P930, DOI 10.1642/0004-8038(2004)121[0930:AHASGF]2.0.CO;2; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MAC ARTHUR ROBERT H., 1967; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Masta SE, 2002, MOL PHYLOGENET EVOL, V24, P302, DOI 10.1016/S1055-7903(02)00216-6; McCarthy EM, 2006, HDB AVIAN HYBRIDS WO; McCracken KG, 2009, AM NAT, V174, P631, DOI 10.1086/606020; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; Morando M, 2004, EVOLUTION, V58, P842, DOI 10.1111/j.0014-3820.2004.tb00416.x; Munoz-Fuentes V, 2007, MOL ECOL, V16, P629, DOI 10.1111/j.1365-294X.2006.03170.x; Panov, 1989, NATURAL HYBRIDIZATIO; Pearce JM, 2009, AUK, V126, P784, DOI 10.1525/auk.2009.08182; Peters JL, 2007, EVOLUTION, V61, P1992, DOI 10.1111/j.1558-5646.2007.00149.x; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; Phillips JC, 1914, J EXP ZOOL, V16, P131, DOI 10.1002/jez.1400160105; POSADA D, 2006, COLL DESCR HAPL SEQ; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2005, MOL ECOL, V14, P1421, DOI 10.1111/j.1365-294X.2005.02493.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Randler C, 2002, ANIM BEHAV, V63, P103, DOI 10.1006/anbe.2001.1884; Randler C, 2008, WATERBIRDS, V31, P143, DOI 10.1675/1524-4695(2008)31[143:HWICEA]2.0.CO;2; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RHYMER JM, 1994, AUK, V111, P970, DOI 10.2307/4088829; Rohwer FC, 1988, CURRENT ORNITHOLOGY, V5, P187; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schwacke L, 2005, RE RAT RELATEDNESS E; Sefc KM, 2005, MOL ECOL, V14, P1407, DOI 10.1111/j.1365-294X.2005.02492.x; Simpson G.G., 1934, ATTENDING MARVELS; Sonsthagen SA, 2010, MOL ECOL, V19, P647, DOI 10.1111/j.1365-294X.2009.04495.x; Steeves TE, 2010, MOL ECOL, V19, P5090, DOI 10.1111/j.1365-294X.2010.04895.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tubaro PL, 2002, BIOL J LINN SOC, V77, P193, DOI 10.1046/j.1095-8312.2002.00096.x; WELLER M W, 1972, Wildfowl, V23, P25; Weller M.W., 1980, ISLAND WATERFOWL; Wetlands International, 2006, WAT POP EST; Williams CL, 2005, CONSERV GENET, V6, P445, DOI 10.1007/s10592-005-4978-y; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Woods RW, 1997, ATLAS BREEDING BIRDS	69	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23173	10.1371/journal.pone.0023173	http://dx.doi.org/10.1371/journal.pone.0023173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887236	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298800006
J	Poustchi, H; Esmaili, S; Mohamadkhani, A; Nikmahzar, A; Pourshams, A; Sepanlou, SG; Merat, S; Malekzadeh, R				Poustchi, Hossein; Esmaili, Saeed; Mohamadkhani, Ashraf; Nikmahzar, Aghbibi; Pourshams, Akram; Sepanlou, Sadaf G.; Merat, Shahin; Malekzadeh, Reza			The Impact of Illicit Drug Use on Spontaneous Hepatitis C Clearance: Experience from a Large Cohort Population Study	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; SPONTANEOUS HCV CLEARANCE; VIRUS-INFECTION; NATURAL COURSE; GENERAL-POPULATION; FOLLOW-UP; IRAN; REINFECTION; PREVALENCE; HIV	Background and Aims: Acute hepatitis C infection usually ends in chronic infection, while in a minority of patients it is spontaneously cleared. The current population-based study is performed on a large cohort in Golestan province of Iran to examine the demographic correlates of Spontaneous Hepatitis C Clearance. Methods: Serum samples used in this study had been stored in biorepository of Golestan Cohort Study. These samples were evaluated for anti hepatitis C Virus by third generation Enzyme-linked immunosorbent assay (ELISA). Subjects who tested positive were then invited and tested by Recombinant Immunoblot Assay (RIBA) and Ribonucleic Acid Polymerase Chain Reaction test (PCR). If tested positive for RIBA, subjects were recalled and the two tests were re-done after 6 months. Those subjects who again tested positive for RIBA but negative for PCR were marked as cases of spontaneous clearance. Results: 49,338 serum samples were evaluated. The prevalence of Chronic Hepatitis C Virus (CHCV) infection based on PCR results was 0.31%. Among those who had acquired hepatitis C, the rate of SC was 38%. In multivariate analysis, illicit drug use both Injecting Use (OR = 3.271, 95% CI: 1.784-6.000, p-value<0.001) and Non-Injecting Use (OR = 1.901, 95% CI: 1.068-3.386, p-value = 0.029) were significant correlates of CHCV infection versus SC. Conclusions: Illicit drug use whether intravenous or non-intravenous is the only significant correlate of CHCV, for which several underlying mechanisms can be postulated including repeated contacts with hepatitis C antigen.	[Poustchi, Hossein; Esmaili, Saeed; Mohamadkhani, Ashraf; Nikmahzar, Aghbibi; Pourshams, Akram; Sepanlou, Sadaf G.; Merat, Shahin; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran	Tehran University of Medical Sciences	Poustchi, H (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran.	malek@ams.ac.ir	Merat, Shahin/A-5478-2009; Nikmahzar, Aghbibi/AAF-2044-2019; Malekzadeh, Reza/U-1382-2017; Sepanlou, Sadaf G/H-9343-2016	Malekzadeh, Reza/0000-0002-9820-6335; Sepanlou, Sadaf G/0000-0002-3669-5129; Esmaili, Saeed/0000-0002-2843-7277; Malekzadeh, Reza/0000-0003-1043-3814; Pourshams, Akram/0000-0002-7950-3983	Tehran University of Medical Sciences	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was funded by Tehran University of Medical Sciences. The study was not supported by any other internal or external resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aborsangaya KB, 2007, HEPATOLOGY, V45, P623, DOI 10.1002/hep.21511; Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Alavian S. M., 2005, Archives of Iranian Medicine, V8, P84; Alavian SM, 2009, HEPAT MON, V9, P211; Alric L, 2000, TISSUE ANTIGENS, V56, P154, DOI 10.1034/j.1399-0039.2000.560207.x; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Bakr I, 2006, GUT, V55, P1183, DOI [10.1136/gut.2005.078147, 10.1136/gut.2006.078147]; Barrett S, 2001, GUT, V49, P423, DOI 10.1136/gut.49.3.423; Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902; Chung RT, 2005, CLIN INFECT DIS, V41, pS14, DOI 10.1086/429490; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Grebely J, 2007, CAN J GASTROENTEROL, V21, P447, DOI 10.1155/2007/796325; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Hayashi J, 1998, ARCH INTERN MED, V158, P177, DOI 10.1001/archinte.158.2.177; Inoue G, 2000, J GASTROEN HEPATOL, V15, P1054, DOI 10.1046/j.1440-1746.2000.02276.x; Jabbari A, 2008, HEPAT MON, V8, P61; Javadzadeh-Shahshahani H, 2007, SCI J IRANIAN BLOOD, V4, P51; Kafi-Abad SA, 2009, TRANSFUSION, V49, P2214, DOI 10.1111/j.1537-2995.2009.02245.x; Kamal SM, 2008, AM J GASTROENTEROL, V103, P1283, DOI 10.1111/j.1572-0241.2008.01825.x; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kondili LA, 2002, GUT, V50, P693, DOI 10.1136/gut.50.5.693; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lewis-Ximenez LL, 2010, CLIN INFECT DIS, V50, P1222, DOI 10.1086/651599; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Mazzeo C, 2003, GUT, V52, P1030, DOI 10.1136/gut.52.7.1030; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Merat S, 2010, INT J INFECT DIS, V14, pE113, DOI 10.1016/j.ijid.2009.11.032; Merat S, 2009, ARCH IRAN MED, V12, P225; Messick K, 2001, HAEMOPHILIA, V7, P568, DOI 10.1046/j.1365-2516.2001.00559.x; Mirmomen Shahram, 2006, Arch Iran Med, V9, P319; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Piasecki BA, 2004, HEPATOLOGY, V40, P892, DOI [10.1002/hep.20384, 10.1002/hep.1840400419]; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rodriguez OES, 1998, EUR J EPIDEMIOL, V14, P555, DOI 10.1023/A:1007410707801; Santantonio T, 2006, CLIN INFECT DIS, V43, P1154, DOI 10.1086/507640; Santantonio T, 2003, DIGEST LIVER DIS, V35, P104, DOI 10.1016/S1590-8658(03)00007-0; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shores NJ, 2008, J HEPATOL, V49, P323, DOI 10.1016/j.jhep.2008.04.010; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Vahdani Parviz, 2006, Arch Iran Med, V9, P153; Vahdani P, 2009, ARCH IRAN MED, V12, P483; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Wietzke-Braun P, 2007, WORLD J GASTROENTERO, V13, P4224, DOI 10.3748/wjg.v13.i31.4224; Yamakawa Y, 1996, J VIRAL HEPATITIS, V3, P317, DOI 10.1111/j.1365-2893.1996.tb00104.x; Zakizad M, 2009, Pak J Biol Sci, V12, P1012, DOI 10.3923/pjbs.2009.1012.1018	52	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23830	10.1371/journal.pone.0023830	http://dx.doi.org/10.1371/journal.pone.0023830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887326	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000064
J	Goel, M; Sienkiewicz, AE; Picciani, R; Lee, RK; Bhattacharya, SK				Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Lee, Richard K.; Bhattacharya, Sanjoy K.			Cochlin Induced TREK-1 Co-Expression and Annexin A2 Secretion: Role in Trabecular Meshwork Cell Elongation and Motility	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; CHANNEL TREK-1; OPTIC ATROPHY; PROFILIN-I; PROTEIN; OUTFLOW; GENE; PHOSPHORYLATION; TRANSDUCTION; CYTOSKELETON	Fluid flow through large interstitial spaces is sensed at the cellular level, and mechanistic responses to flow changes enables expansion or contraction of the cells modulating the surrounding area and brings about changes in fluid flow. In the anterior eye chamber, aqueous humor, a clear fluid, flows through trabecular meshwork (TM), a filter like region. Cochlin, a secreted protein in the extracellular matrix, was identified in the TM of glaucomatous patients but not controls by mass spectrometry. Cochlin undergoes shear induced multimerization and plays a role in mechanosensing of fluid shear. Cytoskeletal changes in response to mechanosensing in the ECM by cochlin will necessitate transduction of mechanosensing. TREK-1, a stretch activated outward rectifying potassium channel protein known to act as mechanotransducer was found to be expressed in TM. Cochlin expression results in co-expression of TREK-1 and filopodia formation. Prolonged cochlin expression results in expression and subsequent secretion of annexin A2, a protein known to play a role in cytoskeletal remodeling. Cochlin interacts with TREK-1 and annexin A2. Cochlin-TREK-1 interaction has functional consequences and results in changes in cell shape and motility. Annexin A2 expression and secretion follows cochlin-TREK-1 syn-expression and correlates with cell elongation. Thus cytoskeleton changes in response to fluid shear sensed by cochlin are further mediated by TREK-1 and annexin A2.	[Goel, Manik; Sienkiewicz, Adam E.; Picciani, Renata; Lee, Richard K.; Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	Bascom Palmer Eye Institute; University of Miami	Goel, M (corresponding author), Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA.	Sbhattacharya@med.miami.edu			National Institutes of Health [EY016112, EY016112S1, EY015266, EY016775, EY014801]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY014801, R03EY015266, R01EY016112, K08EY016775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health Grants EY016112, EY016112S1, EY015266, EY016775, and EY014801; a career development and an unrestricted grant to the University of Miami from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Douglas R, 2003, Curr Opin Ophthalmol, V14, P86; Asrani S, 2000, J GLAUCOMA, V9, P134; Bhattacharya SK, 2009, INVEST OPHTH VIS SCI, V50, P551, DOI 10.1167/iovs.08-2632; Bhattacharya SK, 2005, J BIOL CHEM, V280, P6080, DOI 10.1074/jbc.M411233200; Chan ME, 2009, CELL MOL BIOENG, V2, P405, DOI 10.1007/s12195-009-0075-5; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Ilagan RM, 2010, BIOTECHNIQUES, V48, P153, DOI 10.2144/000113349; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Kalapesi FB, 2005, CLIN EXP OPHTHALMOL, V33, P210, DOI 10.1111/j.1442-9071.2005.00981.x; Katoh M, 2004, INT J ONCOL, V24, P757; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Lambrechts A, 2006, J CELL SCI, V119, P1570, DOI 10.1242/jcs.02884; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Lee ES, 2010, INVEST OPHTH VIS SCI, V51, P2060, DOI 10.1167/iovs.09-4521; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Morales M, 2007, EUR J PHARMACOL, V567, P145, DOI 10.1016/j.ejphar.2007.04.020; Nawrot M, 2004, INVEST OPHTH VIS SCI, V45, P393, DOI 10.1167/iovs.03-0989; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Patel AJ, 2001, CURR OPIN CELL BIOL, V13, P422, DOI 10.1016/S0955-0674(00)00231-3; Picciani R, 2007, PROG RETIN EYE RES, V26, P453, DOI 10.1016/j.preteyeres.2007.06.002; Rao VP, 2007, BIODRUGS, V21, P167, DOI 10.2165/00063030-200721030-00004; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Syriani E, 2008, FASEB J, V22, P1581, DOI 10.1096/fj.06-7654com; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; WuDunn D, 2009, EXP EYE RES, V88, P718, DOI 10.1016/j.exer.2008.11.008	40	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23070	10.1371/journal.pone.0023070	http://dx.doi.org/10.1371/journal.pone.0023070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886777	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500008
J	Benabdellah, K; Cobo, M; Munoz, P; Toscano, MG; Martin, F				Benabdellah, Karim; Cobo, Marien; Munoz, Pilar; Toscano, Miguel G.; Martin, Francisco			Development of an All-in-One Lentiviral Vector System Based on the Original TetR for the Easy Generation of Tet-ON Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; TETRACYCLINE; TRANSACTIVATOR; LEVEL; TRANSDUCTION; PERFORMANCE; INHIBITION; THERAPY; VITRO	Lentiviral vectors (LVs) are considered one of the most promising vehicles to efficiently deliver genetic information for basic research and gene therapy approaches. Combining LVs with drug-inducible expression systems should allow tight control of transgene expression with minimal side effect on relevant target cells. A new doxycycline-regulated system based on the original TetR repressor was developed in 1998 as an alternative to the TetR-VP16 chimeras (tTA and rtTA) to avoid secondary effects due to the expression of transactivator domains. However, previously described TetR-based systems required cell cloning and/or antibiotic selection of tetracycline-responsive cells in order to achieve good regulation. In the present manuscript we have constructed a dual Tet-ON system based on two lentiviral vectors, one expressing the TetR through the spleen focus forming virus (SFFV) promoter (STetR) and a second expressing eGFP through the regulatable CMV-TetO promoter (CTetOE). Using these vectors we have demonstrated that the TetR repressor, contrary to the reverse transactivator (rtTA), can be expressed in excess to bind and modulate a high number of TetO operons. We have also showed that this dual vector system can generate regulatable bulk cell lines (expressing high levels of TetR) that are able to modulate transgene expression either by varying doxycycline concentration and/or by varying the amount of CTetOE vector genomes per cell. Based on these results we have developed a new all-in-one lentiviral vector (CEST) driving the expression of TetR through the SFFV promoter and the expression of eGFP through the doxycycline-responsive CMV-TetO operon. This vector efficiently produced Tet-ON regulatable immortalized (293T) and primary (human mesenchymal stem cells and human primary fibroblasts) cells. Bulk doxycycline-responsive cell lines express high levels of the transgene with low amount of doxycycline and are phenotypically indistinct from its parental cells.	[Benabdellah, Karim; Cobo, Marien; Munoz, Pilar; Toscano, Miguel G.; Martin, Francisco] Univ Granada, Andalusian Stem Cell Bank, Ctr Invest Biomed, Granada, Spain	University of Granada	Benabdellah, K (corresponding author), Pfizer Univ Granada Andalusian Govt Ctr Genom & O, GENYO, Parque Tecnol Ciencias Salud, Granada, Spain.	francisco.martin.molina@juntadeandalucia.es	Benabdellah, karim/L-4569-2014; Martin, Francisco/K-8763-2014; Toscano, Miguel G. G/I-1053-2015; Munoz, Pilar/N-2277-2016; Benabdellah, karim/F-4209-2016	Benabdellah, karim/0000-0003-4673-2111; Martin, Francisco/0000-0003-1961-8612; Toscano, Miguel G. G/0000-0002-6384-3123; Munoz, Pilar/0000-0002-7985-9859; Benabdellah, karim/0000-0003-2790-562X	Fondo de Investigaciones Sanitarias (FIS) [PS09/00340]; Junta de Andalucia [P09-CTS-04532, PI0001/2009]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia)	Fondo de Investigaciones Sanitarias (FIS) grant: PS09/00340. Junta de Andalucia grants: P09-CTS-04532 and PI0001/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; BARDE I, 2005, MOL THER; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Haack K, 2004, MOL THER, V10, P585, DOI 10.1016/j.ymthe.2004.06.109; Judelson HS, 2007, CURR GENET, V51, P297, DOI 10.1007/s00294-007-0125-2; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Licursi M, 2011, GENE THER, V18, P631, DOI 10.1038/gt.2011.11; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Ogueta SB, 2001, MOL MED, V7, P569, DOI 10.1007/BF03401863; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Sisson TH, 2006, AM J RESP CELL MOL, V34, P552, DOI 10.1165/rcmb.2005-0378OC; Toniatti C, 2004, GENE THER, V11, P649, DOI 10.1038/sj.gt.3302251; Toscano MG, 2004, GENE THER, V11, P956, DOI 10.1038/sj.gt.3302259; Toscano MG, 2009, HUM GENE THER, V20, P1279, DOI 10.1089/hum.2009.118; Trapani JG, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-15; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vieyra DS, 2007, STEM CELLS, V25, P2559, DOI 10.1634/stemcells.2007-0248; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939; Yao F, 2006, MOL THER, V13, P1133, DOI 10.1016/j.ymthe.2006.01.009	29	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23734	10.1371/journal.pone.0023734	http://dx.doi.org/10.1371/journal.pone.0023734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876765	Green Submitted, Green Published, gold			2022-12-25	WOS:000294126900037
J	Tabata, J; De Moraes, CM; Mescher, MC				Tabata, Jun; De Moraes, Consuelo M.; Mescher, Mark C.			Olfactory Cues from Plants Infected by Powdery Mildew Guide Foraging by a Mycophagous Ladybird Beetle	PLOS ONE			English	Article							ATTRACT INSECT VECTORS; COLEOPTERA-COCCINELLIDAE; PLEUROTUS-PULMONARIUS; BIOLOGICAL-CONTROL; VIRUS ATTRACT; LINOLEIC-ACID; VOLATILES; HOST; FUNGI; BIOSYNTHESIS	Powdery mildews (Erysiphales) are economically important plant pathogens that attack many agricultural crops. Conventional management strategies involving fungicide application face challenges, including the evolution of resistance and concerns over impacts on non-target organisms, that call for investigation of more sustainable alternatives. Mycophagous ladybird beetles (Coleoptera: Coccinellidae) feed on powdery mildew and have considerable potential as biological control agents; however, the foraging ecology and behavior of these beetles is not well understood. Here we document the olfactory cues presented by squash plants (Cucurbita moschata) infected by powdery mildew (Podosphaera sp.) and the behavioral responses of twenty-spotted ladybird beetles (Psyllobora vigintimaculata) to these cues. Volatile analyses through gas chromatography revealed a number of volatile compounds characteristic of infected plants, including 3-octanol and its analogues 1-octen-3-ol and 3-octanone. These compounds are typical "moldy'' odorants previously reported in volatiles collected from other fungi. In addition, infected plants exhibited elevated emissions of several compounds also observed in collections from healthy leaves, including linalool and benzyl alcohol, which are reported to have anti-fungal properties. In Y-tube choice assays, P. vigintimaculata beetles displayed a significant preference for the odors of infected plants compared to those of healthy plants. Moreover, beetles exhibited strong attraction to one individual compound, 1-octen-3-ol, which was the most abundant of the characteristic fungal compounds identified. These results enhance our understanding of the olfactory cues that guide foraging by mycophagous insects and may facilitate the development of integrated disease-management strategies informed by an understanding of underlying ecological mechanisms.	[Tabata, Jun; De Moraes, Consuelo M.; Mescher, Mark C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Tabata, Jun] Natl Inst Agroenvironm Sci, Biodivers Div, Tsukuba, Ibaraki 305, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute for Agro-Environmental Sciences (NIAES) Japan	Tabata, J (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	mcmescher@psu.edu		Tabata, Jun/0000-0001-9095-2694	Japan Society for the Promotion of Science (JSPS) [21-7080]; U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative [2008-35302-04577]; David and Lucile Packard Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This research was supported by the Excellent Young Researchers Overseas Visit Program (No. 21-7080) of the Japan Society for the Promotion of Science (JSPS). Additional support was provided by Grant 2008-35302-04577 from the U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative and by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 1986, HOST RANGE GEOGRAPHI; ASSAF S, 1995, J AGR FOOD CHEM, V43, P2173, DOI 10.1021/jf00056a040; Assaf S, 1997, ENZYME MICROB TECH, V21, P484, DOI 10.1016/S0141-0229(97)00019-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Combet Emilie, 2006, Mycoscience, V47, P317, DOI 10.1007/s10267-006-0318-4; D'Auria FD, 2005, MED MYCOL, V43, P391, DOI 10.1080/13693780400004810; Darriet P, 2002, J AGR FOOD CHEM, V50, P3277, DOI 10.1021/jf011527d; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dik AJ, 1998, EUR J PLANT PATHOL, V104, P413, DOI 10.1023/A:1008025416672; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Eilenberg J, 2006, ECOLOGICAL AND SOCIETAL APPROACH TO BIOLOGICAL CONTROL, P1; English-Loeb G, 1999, BIOL CONTROL, V14, P97, DOI 10.1006/bcon.1998.0681; English-Loeb G, 2005, ECOL APPL, V15, P1679, DOI 10.1890/04-1939; English-Loeb G, 2007, PLANT DIS, V91, P421, DOI 10.1094/PDIS-91-4-0421; Faldt J, 1999, J CHEM ECOL, V25, P567, DOI 10.1023/A:1020958005023; Francis F, 2004, J CHEM ECOL, V30, P741, DOI 10.1023/B:JOEC.0000028429.13413.a2; Giorgi JA, 2009, BIOL CONTROL, V51, P215, DOI 10.1016/j.biocontrol.2009.05.019; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; GORDON RD, 1985, J NEW YORK ENTOMOL S, V93, P1; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; GROVE JF, 1983, J SCI FOOD AGR, V34, P181, DOI 10.1002/jsfa.2740340211; Guevara R, 2000, PHYSIOL ENTOMOL, V25, P288, DOI 10.1046/j.1365-3032.2000.00194.x; HIJWEGEN T, 1992, EUR J PLANT PATHOL, V98, P221; Ichiki RT, 2008, J CHEM ECOL, V34, P614, DOI 10.1007/s10886-008-9459-6; ITO T, 1995, BIOSCI BIOTECH BIOCH, V59, P1944, DOI 10.1271/bbb.59.1944; Jamal E, 2001, ENVIRON ENTOMOL, V30, P1012, DOI 10.1603/0046-225X-30.6.1012; Jimenez-Martinez ES, 2004, ENVIRON ENTOMOL, V33, P1207, DOI 10.1603/0046-225X-33.5.1207; Koitabashi Motoo, 2002, Journal of General Plant Pathology, V68, P183, DOI 10.1007/PL00013074; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McLeod G, 2005, P ROY SOC B-BIOL SCI, V272, P2499, DOI 10.1098/rspb.2005.3202; Morawicki RO, 2005, PROCESS BIOCHEM, V40, P131, DOI 10.1016/j.procbio.2003.11.037; Naef A, 2002, NEW PHYTOL, V154, P717, DOI 10.1046/j.1469-8137.2002.00406.x; NAKAMUTA K, 1991, APPL ENTOMOL ZOOL, V26, P1; Ngugi HK, 2006, FEMS MICROBIOL LETT, V257, P171, DOI 10.1111/j.1574-6968.2006.00168.x; Ninkovic V, 2001, BIOL CONTROL, V21, P191, DOI 10.1006/bcon.2001.0935; Norton AP, 2000, ECOLOGY, V81, P490, DOI 10.1890/0012-9658(2000)081[0490:MMAFPL]2.0.CO;2; Parrella AM, 2006, CAL C BIOL CONTR RIV, V5, P188; Pettersson J, 2008, APPL ENTOMOL ZOOL, V43, P315, DOI 10.1303/aez.2008.315; Pickett JA, 2006, WAG UR FRON, V16, P161; Price P.W., 1981, P251; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; Razdan V. K., 2009, P369, DOI 10.1007/978-1-4020-8992-3_15; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Sasaji H, 1998, NATURAL HIST LADYBIR; Sutherland AM, 2009, BIOL CONTROL, V51, P284, DOI 10.1016/j.biocontrol.2009.05.012; Sutherland AM, 2009, ANN ENTOMOL SOC AM, V102, P484, DOI 10.1603/008.102.0319; Takeuchi M, 2000, JPN J APPL ENTOMOL Z, V44, P89, DOI 10.1303/jjaez.2000.89; URQUHART EJ, 1994, PHYTOPATHOLOGY, V84, P342; Verhaar MA, 1996, BIOL CONTROL, V6, P353, DOI 10.1006/bcon.1996.0045; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028	51	30	33	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23799	10.1371/journal.pone.0023799	http://dx.doi.org/10.1371/journal.pone.0023799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876772	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900044
J	Lanthier, N; Molendi-Coste, O; Cani, PD; van Rooijen, N; Horsmans, Y; Leclercq, IA				Lanthier, Nicolas; Molendi-Coste, Olivier; Cani, Patrice D.; van Rooijen, Nico; Horsmans, Yves; Leclercq, Isabelle A.			Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet	FASEB JOURNAL			English	Article						macrophage; insulin resistance; steatosis; NAFLD; clodronate	HEPATIC INSULIN-RESISTANCE; ADIPOSE-TISSUE MACROPHAGES; PHOSPHATIDYLINOSITOL 3-KINASE; NONALCOHOLIC STEATOHEPATITIS; INDUCED OBESITY; LIVER-CELLS; FED RATS; STEATOSIS; ACTIVATION; EXPRESSION	We aimed to evaluate activation of macrophages in insulin-sensitive tissues (liver, adipose tissue, and muscles) under high-fat diet (HFD) and elucidate the role of Kupffer cells (KC) in HFD-induced insulin resistance. Tissue macrophage populations, insulin signaling, and sensitivity were evaluated in mice fed a HFD for 4 or 16 wk. Selective KC depletion was obtained by intravenous injections of liposome-encapsulated clodronate. Mice fed a HFD for 4 to 16 wk have hepatic and peripheral insulin resistance together with macrophage recruitment in the adipose tissue but not in the liver. Depletion of KC for the last 10 d of the 16 wk experiment fails to improve insulin sensitivity compared to PBS-treated animals. In contrast, preventive KC depletion prior to and during the 4 wk HFD attenuates the development of obesity, adiposity, adipose tissue inflammation (P<0.01 vs. PBS group), and insulin resistance (P<0.01). Interestingly, in mice fed a normal diet, prolonged KC depletion ameliorates insulin sensitivity and decreases adiposity without altering physiological body weight gain or food intake. Preventive and prolonged KC depletion ameliorates insulin sensitivity and prevents adipose tissue inflammation, suggesting a communication between the liver and the adipose tissue in the development of HFD-induced metabolic alterations.-Lanthier, N., Molendi-Coste, O., Cani, P. D., van Rooijen, N., Horsmans, Y., Leclercq, I. A. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J. 25, 4301-4311 (2011). www.fasebj.org	[Lanthier, Nicolas; Molendi-Coste, Olivier; Horsmans, Yves; Leclercq, Isabelle A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Gastroenterol, B-1200 Brussels, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [van Rooijen, Nico] Vrije Univ Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands	Universite Catholique Louvain; Universite Catholique Louvain; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Leclercq, IA (corresponding author), Catholic Univ Louvain, Inst Rech Expt & Clin, Lab Hepatogastroenterol, UCL GAEN 5379, Ave E Mounier 53, B-1200 Brussels, Belgium.	isabelle.leclercq@uclouvain.be	D., Cani Patrice/M-8055-2016; Lanthier, Nicolas/AAT-2930-2021; Van Rooijen, Nico/Z-1578-2019	D., Cani Patrice/0000-0003-2040-2448; Lanthier, Nicolas/0000-0002-7651-9314; Molendi-Coste, Olivier/0000-0002-0498-9456	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) [3.4520.10, 3.4578.07, M.I.S.F.45.08.08]; University FSR; Fondation St Luc; Astra Zeneca; Roche	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); University FSR; Fondation St Luc; Astra Zeneca(AstraZeneca); Roche(Roche Holding)	The authors are grateful to Martine Petit, Valerie Lebrun, and Jorge Abarca-Quinones for expert technical assistance. This work was supported by Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) grants (3.4520.10, 3.4578.07, and M.I.S.F.45.08.08); University FSR grants to I.L.; and a Liver, Virus, and Diabetes research grant from the Fondation St Luc, Astra Zeneca, and Roche to I.L. and Y.H. I.L. and P.D.C. are FRS-FNRS research associates. The authors declare no conflicts of interest in relation to this work. The foundation Clodronate Liposomes (NVR) is a nonprofit foundation related to the Department of Molecular Cell Biology of Vrije Universiteit (Amsterdam, The Netherlands).	Anai M, 1999, DIABETES, V48, P158, DOI 10.2337/diabetes.48.1.158; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; BIEWENGA J, 1995, CELL TISSUE RES, V280, P189, DOI 10.1007/BF00304524; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; FOLLI F, 1993, J CLIN INVEST, V92, P1787, DOI 10.1172/JCI116768; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lanthier N, 2010, HEPATOLOGY, V51, P721, DOI 10.1002/hep.23455; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Neyrinck AM, 2009, BIOCHEM BIOPH RES CO, V385, P351, DOI 10.1016/j.bbrc.2009.05.070; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wu J, 2010, IMMUNOLOGY, V129, P363, DOI 10.1111/j.1365-2567.2009.03179.x; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	46	84	86	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4301	4311		10.1096/fj.11-189472	http://dx.doi.org/10.1096/fj.11-189472			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21873555	Bronze			2022-12-25	WOS:000298138100022
J	Liu, Z; Turan, S; Wehbi, VL; Vilardaga, JP; Bastepe, M				Liu, Zun; Turan, Serap; Wehbi, Vanessa L.; Vilardaga, Jean-Pierre; Bastepe, Murat			Extra-long G alpha s Variant XL alpha s Protein Escapes Activation-induced Subcellular Redistribution and Is Able to Provide Sustained Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATORY G-PROTEIN; MCCUNE-ALBRIGHT-SYNDROME; GNAS1 T393C POLYMORPHISM; PARATHYROID-HORMONE RECEPTOR; COUPLED RECEPTORS; ADENYLYL-CYCLASE; CELL CARCINOMA; FREE SURVIVAL; GENE VARIANT; SUBUNIT	Murine models indicate that G alpha s and its extra-long variant XL alpha s, both of which are derived from GNAS, markedly differ regarding their cellular actions, but these differences are unknown. Here we investigated activation-induced trafficking of G alpha s and XL alpha s, using immunofluorescence microscopy, cell fractionation, and total internal reflection fluorescence microscopy. In transfected cells, XL alpha s remained localized to the plasma membrane, whereas G alpha s redistributed to the cytosol after activation by GTPase-inhibiting mutations, cholera toxin treatment, or G protein-coupled receptor agonists (isoproterenol or parathyroid hormone (PTH)(1-34)). Cholera toxin treatment or agonist (isoproterenol or pituitary adenylate cyclase activating peptide-27) stimulation of PC12 cells expressing G alpha s and XL alpha s endogenously led to an increased abundance of G alpha s, but not XL alpha s, in the soluble fraction. Mutational analyses revealed two conserved cysteines and the highly charged domain as being critically involved in the plasma membrane anchoring of XL alpha s. The cAMP response induced by M-PTH(1-14), a parathyroid hormone analog, terminated quickly in HEK293 cells stably expressing the type 1 PTH/PTH-related peptide receptor, whereas the response remained maximal for at least 6 min in cells that co-expressed the PTH receptor and XL alpha s. Although isoproterenol-induced cAMP response was not prolonged by XL alpha s expression, a GTPase-deficient XL alpha s mutant found in certain tumors and patients with fibrous dysplasia of bone and McCune-Albright syndrome generated more basal cAMP accumulation in HEK293 cells and caused more severe impairment of osteoblastic differentiation of MC3T3-E1 cells than the cognate G alpha s mutant (gsp oncogene). Thus, activated XL alpha s and G alpha s traffic differently, and this may form the basis for the differences in their cellular actions.	[Liu, Zun; Turan, Serap; Vilardaga, Jean-Pierre; Bastepe, Murat] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; [Liu, Zun; Turan, Serap; Vilardaga, Jean-Pierre; Bastepe, Murat] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Turan, Serap] Marmara Univ, Sch Med Hosp, TR-34662 Istanbul, Turkey; [Wehbi, Vanessa L.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab Protein Coupled Receptor Biol G, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Marmara University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bastepe, M (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Dept Med, 50 Blossom St Thier 10, Boston, MA 02114 USA.	bastepe@helix.mgh.harvard.edu	Turan, Serap/U-7195-2018; Bastepe, Murat/GQQ-3389-2022	Turan, Serap/0000-0002-5172-5402; Vilardaga, Jean-Pierre/0000-0002-1217-1435; Bastepe, Murat/0000-0002-2643-3504	National Institutes of Health from NIDDK [R01DK073911, R01DK087688]; March of Dimes Foundation [6-FY10-336]; European Society for Paediatric Endocrinology through Lilly, LLC.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688, R01DK073911] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; March of Dimes Foundation(March of Dimes); European Society for Paediatric Endocrinology through Lilly, LLC.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK073911 (to M. B.) and R01DK087688 (to J.-P. V.) from NIDDK. This work was also supported in part by March of Dimes Foundation Research Grant 6-FY10-336 (to M. B.).; Supported by a grant of the Sabbatical Leave Programme from the European Society for Paediatric Endocrinology through an educational grant from Lilly, LLC.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Aydin C, 2009, ENDOCRINOLOGY, V150, P3567, DOI 10.1210/en.2009-0318; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bastepe M, 2002, MOL ENDOCRINOL, V16, P1912, DOI 10.1210/me.2002-0054; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen YS, 2003, HYPERTENS RES, V26, P439, DOI 10.1291/hypres.26.439; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Frey UH, 2006, CLIN CANCER RES, V12, P759, DOI 10.1158/1078-0432.CCR-05-1722; Frey UH, 2005, CLIN CANCER RES, V11, P5071, DOI 10.1158/1078-0432.CCR-05-0472; Frey UH, 2005, CANCER EPIDEM BIOMAR, V14, P871, DOI 10.1158/1055-9965.EPI-04-0720; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Hahn S, 2006, EUR J ENDOCRINOL, V155, P763, DOI 10.1530/eje.1.02275; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaya AI, 2009, J PHARMACOL EXP THER, V329, P350, DOI 10.1124/jpet.108.149989; KEHLENBACH RH, 1994, NATURE, V372, P804; Klemke M, 2000, J BIOL CHEM, V275, P33633, DOI 10.1074/jbc.M006594200; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Lehnerdt GF, 2008, CLIN CANCER RES, V14, P1753, DOI 10.1158/1078-0432.CCR-07-1605; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Linglart AS, 2006, ENDOCRINOLOGY, V147, P2253, DOI 10.1210/en.2005-1487; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Mantovani G, 2004, J CLIN ENDOCR METAB, V89, P3007, DOI 10.1210/jc.2004-0194; Mariot V, 2011, BONE, V48, P312, DOI 10.1016/j.bone.2010.09.032; Michienzi S, 2007, HUM MOL GENET, V16, P1921, DOI 10.1093/hmg/ddm139; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Otterbach F, 2007, BREAST CANCER RES TR, V105, P311, DOI 10.1007/s10549-006-9462-y; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; Pasolli HA, 2000, J BIOL CHEM, V275, P33622, DOI 10.1074/jbc.M001335200; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Peters J, 2008, ADV EXP MED BIOL, V626, P16; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Reik W, 2000, INT J DEV BIOL, V44, P145; Sandgren J, 2010, EXP MOL MED, V42, P484, DOI 10.3858/emm.2010.42.7.050; Schmitz KJ, 2007, NEOPLASIA, V9, P159, DOI 10.1593/neo.06796; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Shimizu N, 2005, J BIOL CHEM, V280, P1797, DOI 10.1074/jbc.M408270200; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Tominaga E, 2010, GYNECOL ONCOL, V118, P160, DOI 10.1016/j.ygyno.2010.03.010; Ugur O, 2000, MOL BIOL CELL, V11, P1421, DOI 10.1091/mbc.11.4.1421; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Xie T, 2006, J BIOL CHEM, V281, P18989, DOI 10.1074/jbc.M511752200; Yamamoto M, 2004, HYPERTENS RES, V27, P919, DOI 10.1291/hypres.27.919; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	69	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38558	38569		10.1074/jbc.M111.240150	http://dx.doi.org/10.1074/jbc.M111.240150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21890629	Green Published, hybrid			2022-12-25	WOS:000296594200069
J	Dun, MD; Smith, ND; Baker, MA; Lin, MJ; Aitken, RJ; Nixon, B				Dun, Matthew D.; Smith, Nathan D.; Baker, Mark A.; Lin, Minjie; Aitken, R. John; Nixon, Brett			The Chaperonin Containing TCP1 Complex (CCT/TRiC) Is Involved in Mediating Sperm-Oocyte Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA BINDING; BLUE-NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; O-LINKED OLIGOSACCHARIDES; MOUSE SPERM; TYROSINE PHOSPHORYLATION; CYTOPLASMIC CHAPERONIN; T-COMPLEX; MOLECULAR CHAPERONE; RECEPTOR-ACTIVITY	Sperm-oocyte interactions are among the most remarkable processes in cell biology. These cellular recognition events are initiated by an exquisitely specific adhesion of free-swimming spermatozoa to the zona pellucida, an acellular matrix that surrounds the ovulated oocyte. Decades of research focusing on this interaction have led to the establishment of a widely held paradigm that the zona pellucida receptor is a single molecular entity that is constitutively expressed on the sperm cell surface. In contrast, we have employed the techniques of blue native-polyacrylamide gel electrophoresis, far Western blotting, and proximity ligation to secure the first direct evidence in support of a novel hypothesis that zona binding is mediated by multimeric sperm receptor complex(es). Furthermore, we show that one such multimeric association, comprising the chaperonin-containing TCP1 complex (CCT/TRiC) and a zona-binding protein, zona pellucida-binding protein 2, is present on the surface of capacitated spermatozoa and could account for the zona binding activity of these cells. Collectively, these data provide an important biochemical insight into the molecular basis of sperm-zona pellucida interaction and a plausible explanation for how spermatozoa gain their ability to fertilize.	[Dun, Matthew D.; Smith, Nathan D.; Baker, Mark A.; Lin, Minjie; Aitken, R. John; Nixon, Brett] Univ Newcastle, Reprod Sci Grp, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; [Dun, Matthew D.; Baker, Mark A.; Aitken, R. John] Univ Newcastle, ARC Ctr Excellence Biotechnol & Dev, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle	Nixon, B (corresponding author), Univ Newcastle, Reprod Sci Grp, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia.	Brett.Nixon@newcastle.edu.au	Aitken, Robert John/AAY-8238-2020; Dun, Matthew D./I-3399-2012; Nixon, Brett/B-5121-2012	Aitken, Robert John/0000-0002-9152-156X; Nixon, Brett/0000-0003-2745-8188; Dun, Matthew/0000-0002-9063-5370				Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Adham IM, 1997, MOL REPROD DEV, V46, P370, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;370::AID-MRD16&gt;3.0.CO;2-2; Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Aivaliotis M, 2006, PHOTOSYNTH RES, V88, P143, DOI 10.1007/s11120-006-9046-z; ARTZT K, 1979, GENET RES, V33, P279, DOI 10.1017/S0016672300018425; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baker MA, 2010, J PROTEOME RES, V9, P718, DOI 10.1021/pr900513d; BENNETT D, 1975, NATURE, V257, P236, DOI 10.1038/257236a0; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; BLEIL JD, 1983, DEV BIOL, V95, P317, DOI 10.1016/0012-1606(83)90032-5; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CHENG CC, 1980, CELL, V19, P537, DOI 10.1016/0092-8674(80)90528-0; Clark GF, 2006, J BIOL CHEM, V281, P13853, DOI 10.1074/jbc.R600001200; Cooper T., 1998, ENCY REPROD, V2, P1; Couldrey C, 1999, HUM MOL GENET, V8, P2489, DOI 10.1093/hmg/8.13.2489; Dean J, 2004, BIOESSAYS, V26, P29, DOI 10.1002/bies.10412; Dean J, 2005, ANDROLOGIA, V37, P198, DOI 10.1111/j.1439-0272.2005.00686.x; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FRANKEN DR, 1989, J IN VITRO FERTIL EM, V6, P44, DOI 10.1007/BF01134581; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GINSBERG L, 1975, J EMBRYOL EXP MORPH, V33, P715; Harrison RAP, 2005, THERIOGENOLOGY, V63, P342, DOI 10.1016/j.theriogenology.2004.09.016; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049; KUBOTA H, 1994, CURR BIOL, V4, P89, DOI 10.1016/S0960-9822(94)00024-2; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; LITSCHER ES, 1995, BIOCHEMISTRY-US, V34, P4662, DOI 10.1021/bi00014a020; Lu QX, 1997, DEVELOPMENT, V124, P4121; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Lyng R, 2009, J CELL SCI, V122, P3894, DOI 10.1242/jcs.058776; MARCO S, 1994, BIOPHYS J, V67, P364, DOI 10.1016/S0006-3495(94)80489-8; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; MORI E, 1993, BIOCHEM BIOPH RES CO, V196, P196, DOI 10.1006/bbrc.1993.2234; Neff D, 1999, BIOCHEM BIOPH RES CO, V259, P569, DOI 10.1006/bbrc.1999.0820; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nixon B, 2007, CELL MOL LIFE SCI, V64, P1805, DOI 10.1007/s00018-007-6552-x; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rivenzon-Segal D, 2005, NAT STRUCT MOL BIOL, V12, P233, DOI 10.1038/nsmb901; Rodeheffer C, 2004, DEVELOPMENT, V131, P503, DOI 10.1242/dev.00937; Rossato Marco, 2005, Purinergic Signal, V1, P369, DOI 10.1007/s11302-005-1172-0; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHUR BD, 1981, GENET RES, V38, P225, DOI 10.1017/S0016672300020577; SILVER LM, 1985, ANNU REV GENET, V19, P179, DOI 10.1146/annurev.ge.19.120185.001143; SILVER LM, 1979, CELL, V17, P275, DOI 10.1016/0092-8674(79)90153-3; Soues S, 2003, EXP CELL RES, V288, P363, DOI 10.1016/S0014-4827(03)00248-9; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Wassarman PM, 2009, BIOESSAYS, V31, P153, DOI 10.1002/bies.200800152; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193; WUDL LR, 1978, J EMBRYOL EXP MORPH, V48, P127; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yu Y, 2006, DEV BIOL, V290, P32, DOI 10.1016/j.ydbio.2005.11.003; Yu Y, 2009, MICROSC RES TECHNIQ, V72, P558, DOI 10.1002/jemt.20696	76	81	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36875	36887		10.1074/jbc.M110.188888	http://dx.doi.org/10.1074/jbc.M110.188888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880732	Green Published, hybrid			2022-12-25	WOS:000296538300067
J	Shen, WW; Frieden, M; Demaurex, N				Shen, Wei-Wei; Frieden, Maud; Demaurex, Nicolas			Local Cytosolic Ca2+ Elevations Are Required for Stromal Interaction Molecule 1 (STIM1) De-oligomerization and Termination of Store-operated Ca2+ Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; INITIATION MECHANISM; ORAI1; DEPLETION; PROTEIN; DOMAIN; SENSOR; DEFICIENCY; REVEALS; BINDING	The Ca2+ depletion of the endoplasmic reticulum (ER) activates the ubiquitous store-operated Ca2+ entry (SOCE) pathway that sustains long-term Ca2+ signals critical for cellular functions. ER Ca2+ depletion initiates the oligomerization of stromal interaction molecules (STIM) that control SOCE activation, but whether ER Ca2+ refilling controls STIM de-oligomerization and SOCE termination is not known. Here, we correlate the changes in free luminal ER Ca2+ concentrations ([Ca2+](ER)) and in STIM1 oligomerization, using fluorescence resonance energy transfer (FRET) between CFP-STIM1 and YFP-STIM1. We observed that STIM1 de-oligomerized at much lower [Ca2+](ER) levels during store refilling than it oligomerized during store depletion. We then refilled ER stores without adding exogenous Ca2+ using a membrane-permeable Ca2+ chelator to provide a large reservoir of buffered Ca2+. This procedure rapidly restored pre-stimulatory [Ca2+](ER) levels but did not trigger STIM1 de-oligomerization, the FRET signals remaining elevated as long as the external [Ca2+] remained low. STIM1 dissociation evoked by Ca2+ readmission was prevented by SOC channel inhibition and was associated with cytosolic Ca2+ elevations restricted to STIM1 puncta, indicating that Ca2+ acts on a cytosolic target close to STIM1 clusters. These data indicate that the refilling of ER Ca2+ stores is not sufficient to induce STIM1 de-oligomerization and that localized Ca2+ elevations in the vicinity of assembled SOCE complexes are required for the termination of SOCE.	[Shen, Wei-Wei; Frieden, Maud; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@unige.ch		Demaurex, Nicolas/0000-0002-9933-6772; Frieden, Maud/0000-0001-7135-0874	Swiss National Foundation [310030B-133126]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 310030B-133126 (to N.D.).	Bauer MC, 2008, BIOCHEMISTRY-US, V47, P6089, DOI 10.1021/bi800496a; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Demaurex N, 2003, CELL CALCIUM, V34, P109, DOI 10.1016/S0143-4160(03)00081-2; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Larson L, 2005, P NATL ACAD SCI USA, V102, P1921, DOI 10.1073/pnas.0409062102; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sampieri A, 2009, CELL CALCIUM, V45, P439, DOI 10.1016/j.ceca.2009.02.010; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2010, BIOCHEM CELL BIOL, V88, P175, DOI [10.1139/o09-125, 10.1139/O09-125]; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang YJ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3148pe42; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	44	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36448	36459		10.1074/jbc.M111.269415	http://dx.doi.org/10.1074/jbc.M111.269415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880734	Green Published, hybrid			2022-12-25	WOS:000296538300030
J	Ghose, J; Sinha, M; Das, E; Jana, NR; Bhattacharyya, NP				Ghose, Jayeeta; Sinha, Mithun; Das, Eashita; Jana, Nihar R.; Bhattacharyya, Nitai P.			Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) Cells, a Cell Model of Huntington's Disease	PLOS ONE			English	Article							NF-KAPPA-B; CREB-BINDING PROTEIN; MUTANT-HUNTINGTIN; RNA EXTRACTION; CAG REPEAT; MICRORNA; EXPRESSION; GENE; ACTIVATION; CONTRIBUTES	Huntington's disease (HD) is caused by the expansion of N-terminal polymorphic poly Q stretch of the protein huntingtin (HTT). Deregulated microRNAs and loss of function of transcription factors recruited to mutant HTT aggregates could cause characteristic transcriptional deregulation associated with HD. We observed earlier that expressions of miR-125b, miR-146a and miR-150 are decreased in STHdh(Q111)/Hdh(Q111) cells, a model for HD in comparison to those of wild type STHdh(Q7)/Hdh(Q7) cells. In the present manuscript, we show by luciferase reporter assays and real time PCR that decreased miR-146a expression in STHdh(Q111)/Hdh(Q111) cells is due to decreased expression and activity of p65 subunit of NFkB (RelA/NFkB). By reporter luciferase assay, RT-PCR and western blot analysis, we also show that both miR-150 and miR-125b target p53. This partially explains the up regulation of p53 observed in HD. Elevated p53 interacts with RelA/NFkB, reduces its expression and activity and decreases the expression of miR-146a, while knocking down p53 increases RelA/NFkB and miR-146a expressions. We also demonstrate that expression of p53 is increased and levels of RelA/NFkB, miR-146a, miR-150 and miR-125b are decreased in striatum of R6/2 mice, a mouse model of HD and in cell models of HD. In a cell model, this effect could be reversed by exogenous expression of chaperone like proteins HYPK and Hsp70. We conclude that (i) miR-125b and miR-150 target p53, which in turn regulates RelA/NFkB and miR-146a expressions; (ii) reduced miR-125b and miR-150 expressions, increased p53 level and decreased RelA/NFkB and miR-146a expressions originate from mutant HTT (iii) p53 directly or indirectly regulates the expression of miR-146a. Our observation of interplay between transcription factors and miRNAs using HD cell model provides an important platform upon which further work is to be done to establish if such regulation plays any role in HD pathogenesis.	[Ghose, Jayeeta; Das, Eashita; Bhattacharyya, Nitai P.] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India; [Sinha, Mithun] Saha Inst Nucl Phys, Struct Genom Div, Kolkata, W Bengal, India; [Jana, Nihar R.] Natl Brain Res Ctr, Div Cellular & Mol Neurosci, Manesar, Haryana, India	Saha Institute of Nuclear Physics; Saha Institute of Nuclear Physics; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Ghose, J (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, W Bengal, India.	nitaipada.bhattacharya@saha.ac.in	Xie, Huangming/B-2260-2012; Sinha, Mithun/N-8172-2019	Jana, Nihar/0000-0002-6549-4211; Sinha, Mithun/0000-0002-9222-1921	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was supported by the Institutional Grant to Saha Institute of Nuclear Physics for the Project 'Structural Proteomics and Genomics of Human Genetic Diseases' by the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Bertrand F, 1998, J BIOL CHEM, V273, P2931, DOI 10.1074/jbc.273.5.2931; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chakravorty M, 2009, INT J BIOCHEM CELL B, V41, P1502, DOI 10.1016/j.biocel.2008.12.017; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Godavarthi SK, 2009, J NEUROCHEM, V108, P787, DOI 10.1111/j.1471-4159.2008.05823.x; Goswami A, 2006, BIOCHEM BIOPH RES CO, V342, P184, DOI 10.1016/j.bbrc.2006.01.136; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Huang CC, 1998, SOMAT CELL MOLEC GEN, V24, P217, DOI 10.1023/B:SCAM.0000007124.19463.e5; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Kawauchi K, 2008, BIOCHEM BIOPH RES CO, V372, P137, DOI 10.1016/j.bbrc.2008.05.021; Kaznacheeva AV, 2009, BIOL MEMBRANY, V26, P314; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kim H, 2005, GASTROENTEROLOGY, V129, P1875, DOI 10.1053/j.gastro.2005.09.011; Kong PJ, 2009, NEUROL RES, V31, P77, DOI 10.1179/174313208X331572; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Korbler T, 2003, EXP MOL PATHOL, V74, P336, DOI 10.1016/S0014-4800(03)00024-8; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2007, BMC BIOTECHNOL, V29, P7; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Raychaudhuri S, 2008, HUM MOL GENET, V17, P240, DOI 10.1093/hmg/ddm301; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Royds JA, 1998, J CLIN PATHOL-MOL PA, V51, P55; Ryan AB, 2006, NEUROBIOL DIS, V24, P419, DOI 10.1016/j.nbd.2006.08.002; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Sinha M, 2010, BIOCHEM BIOPH RES CO, V396, P742, DOI 10.1016/j.bbrc.2010.05.007; Stanta G, 1998, METH MOL B, V86, P23; STANTA G, 1991, BIOTECHNIQUES, V11, P304; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takano H, 2002, BMC NEUROSCI, V14, P3; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Xifro X, 2008, J NEUROCHEM, V105, P1596, DOI 10.1111/j.1471-4159.2008.05252.x	72	74	76	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23837	10.1371/journal.pone.0023837	http://dx.doi.org/10.1371/journal.pone.0023837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887328	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298800019
J	Kohler, S; Schaller, V; Bausch, AR				Koehler, Simone; Schaller, Volker; Bausch, Andreas R.			Collective Dynamics of Active Cytoskeletal Networks	PLOS ONE			English	Article							SKELETAL-MUSCLE MYOSIN; CONTRACTION; FORCES; GELS	Self organization mechanisms are essential for the cytoskeleton to adapt to the requirements of living cells. They rely on the intricate interplay of cytoskeletal filaments, crosslinking proteins and molecular motors. Here we present an in vitro minimal model system consisting of actin filaments, fascin and myosin-II filaments exhibiting pulsatile collective dynamics and superdiffusive transport properties. Both phenomena rely on the complex competition of crosslinking molecules and motor filaments in the network. They are only observed if the relative strength of the binding of myosin-II filaments to the actin network allows exerting high enough forces to unbind actin/fascin crosslinks. This is shown by varying the binding strength of the acto-myosin bond and by combining the experiments with phenomenological simulations based on simple interaction rules.	[Koehler, Simone; Schaller, Volker; Bausch, Andreas R.] Tech Univ Munich, D-8046 Garching, Germany	Technical University of Munich	Kohler, S (corresponding author), Tech Univ Munich, E27 Cellular Biophys, D-8046 Garching, Germany.	abausch@ph.tum.de		Kohler, Simone/0000-0002-1119-8855	DFG [SFB 863]; German Excellence Initiative; Elite Network of Bavaria by the graduate programme CompInt; National Science Foundation [NSF PHY05-51164]	DFG(German Research Foundation (DFG)); German Excellence Initiative; Elite Network of Bavaria by the graduate programme CompInt; National Science Foundation(National Science Foundation (NSF))	The authors thank the DFG in the framework of the SFB 863, the German Excellence Initiative 'International Graduate School for Science and Engineering' and 'Nanosystems Initiative Munich' for financial support. V.S. acknowledges support from the Elite Network of Bavaria by the graduate programme CompInt. For the writing of the final manuscript, A.R.B. acknowledges the generous support and hospitality of the KITP through the National Science Foundation under Grant No. NSF PHY05-51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; COOKE R, 1979, BIOPHYS J, V28, P241, DOI 10.1016/S0006-3495(79)85174-7; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Debold EP, 2005, BIOPHYS J, V89, pL34, DOI 10.1529/biophysj.105.072967; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; JANSON LW, 1991, J CELL BIOL, V114, P1005, DOI 10.1083/jcb.114.5.1005; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; KANE RE, 1983, J CELL BIOL, V97, P1745, DOI 10.1083/jcb.97.6.1745; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; KATSURA I, 1971, J BIOCHEM-TOKYO, V69, P219, DOI 10.1093/oxfordjournals.jbchem.a129449; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Liverpool TB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.138102; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Metzler R, 2000, EUROPHYS LETT, V51, P492, DOI 10.1209/epl/i2000-00364-5; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TAKIGUCHI K, 1990, J BIOCHEM-TOKYO, V107, P671, DOI 10.1093/oxfordjournals.jbchem.a123106; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059	29	36	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23798	10.1371/journal.pone.0023798	http://dx.doi.org/10.1371/journal.pone.0023798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887321	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298800018
J	Lin, JS; Nazarenus, TJ; Frey, JL; Liang, XW; Wilson, MA; Stone, JM				Lin, Jiusheng; Nazarenus, Tara J.; Frey, Jeanine L.; Liang, Xinwen; Wilson, Mark A.; Stone, Julie M.			A Plant DJ-1 Homolog Is Essential for Arabidopsis thaliana Chloroplast Development	PLOS ONE			English	Article							PARKINSONISM PROTEIN DJ-1; SQUAMOUS-CELL CARCINOMA; CYSTEINE-SULFINIC ACID; OXIDATIVE DAMAGE; ALPHA-SYNUCLEIN; INTRACELLULAR PROTEASE; MITOCHONDRIAL-FUNCTION; ANTIOXIDATIVE STRESS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE	Protein superfamilies can exhibit considerable diversification of function among their members in various organisms. The DJ-1 superfamily is composed of proteins that are principally involved in stress response and are widely distributed in all kingdoms of life. The model flowering plant Arabidopsis thaliana contains three close homologs of animal DJ-1, all of which are tandem duplications of the DJ-1 domain. Consequently, the plant DJ-1 homologs are likely pseudo-dimeric proteins composed of a single polypeptide chain. We report that one A. thaliana DJ-1 homolog (AtDJ1C) is the first DJ-1 homolog in any organism that is required for viability. Homozygous disruption of the AtDJ1C gene results in non-viable, albino seedlings that can be complemented by expression of wild-type or epitope-tagged AtDJ1C. The plastids from these dj1c plants lack thylakoid membranes and granal stacks, indicating that AtDJ1C is required for proper chloroplast development. AtDJ1C is expressed early in leaf development when chloroplasts mature, but is downregulated in older tissue, consistent with a proposed role in plastid development. In addition to its plant-specific function, AtDJ1C is an atypical member of the DJ-1 superfamily that lacks a conserved cysteine residue that is required for the functions of most other superfamily members. The essential role for AtDJ1C in chloroplast maturation expands the known functional diversity of the DJ-1 superfamily and provides the first evidence of a role for specialized DJ-1-like proteins in eukaryotic development.	[Lin, Jiusheng; Nazarenus, Tara J.; Frey, Jeanine L.; Liang, Xinwen; Wilson, Mark A.; Stone, Julie M.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Wilson, Mark A.; Stone, Julie M.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA; [Stone, Julie M.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Lin, JS (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	jstone2@unl.edu		Van Nostrand, Jeanine/0000-0003-1363-9527	National Institutes of Health (NIH) [P20 RR017675, R01 GM092999]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092999] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) grants P20 RR017675 (Nebraska Redox Biology Center) and R01 GM092999 to MAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Cahoon AB, 2008, PLANT MOL BIOL, V66, P33, DOI 10.1007/s11103-007-9250-z; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Emanuelsson O, 2001, BBA-MOL CELL RES, V1541, P114, DOI 10.1016/S0167-4889(01)00145-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gadjev I, 2008, INT REV CEL MOL BIO, V270, P87, DOI 10.1016/S1937-6448(08)01403-2; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Goda M, 2001, J BIOL CHEM, V276, P23480, DOI 10.1074/jbc.M007856200; Halio SB, 1997, APPL ENVIRON MICROB, V63, P289, DOI 10.1128/AEM.63.1.289-295.1997; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kthiri F, 2010, J BIOL CHEM, V285, P10328, DOI 10.1074/jbc.M109.077529; Lakshminarasimhan M, 2010, J BIOL CHEM, V285, P29651, DOI 10.1074/jbc.M110.147934; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Oh KJ, 2004, J BIOCHEM MOL BIOL, V37, P343; Polanska L, 2007, J EXP BOT, V58, P637, DOI 10.1093/jxb/erl235; Ramsey CP, 2010, J NEUROSCI RES, V88, P3111, DOI 10.1002/jnr.22477; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Stern DB, 2004, TRENDS PLANT SCI, V9, P293, DOI 10.1016/j.tplants.2004.04.001; Sun Q, 2004, PLANT PHYSIOL, V135, P723, DOI 10.1104/pp.104.040717; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yabe T, 2008, J MOL BIOL, V381, P160, DOI 10.1016/j.jmb.2008.05.072; Yamaguchi H, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-10; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yuen HF, 2008, CANCER EPIDEM BIOMAR, V17, P3593, DOI 10.1158/1055-9965.EPI-08-0214; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhu XL, 2010, CANCER SCI, V101, P1320, DOI 10.1111/j.1349-7006.2010.01531.x	59	22	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23731	10.1371/journal.pone.0023731	http://dx.doi.org/10.1371/journal.pone.0023731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886817	Green Published, gold			2022-12-25	WOS:000294253500027
J	Andersen, S; Donnem, T; Stenvold, H; Al-Saad, S; Al-Shibli, K; Busund, LT; Bremnes, RM				Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Al-Saad, Samer; Al-Shibli, Khalid; Busund, Lill-Tove; Bremnes, Roy M.			Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival	PLOS ONE			English	Article							CELL LUNG-CANCER; HYPOXIA-INDUCIBLE FACTOR; PROLYL-HYDROXYLASES; TUMOR-GROWTH; STROMAL CELLS; E-CADHERIN; EXPRESSION; ANGIOGENESIS; IMPACT; AGGRESSIVENESS	Introduction: Hypoxia induced factors (HIFs) are at the heart of the adaptive mechanisms cancer cells must implement for survival. HIFs are regulated by four hydroxylases; Prolyl hydroxylase (PHD)-1,-2,-3 and factor inhibiting HIF (FIH). We aimed to investigate the prognostic impact of these oxygen sensors in NSCLC. Methods: Tumor tissue samples from 335 resected stages I to IIIA NSCLC patients was obtained and tissue microarrays (TMAs) were constructed. Hydroxylase expression was evaluated by immunohistochemistry. Principal Findings: There was scorable expression for all HIF hydroxylases in tumor cells, but not in stroma. In univariate analyses, high tumor cell expression of all the HIF hydroxylases were unfavorable prognosticators for disease-specific survival (DSS); PHD1 (P = 0.023), PHD2 (P = 0.013), PHD3 (P = 0.018) and FIH (P = 0.033). In the multivariate analyses we found high tumor cell expression of PHD2 (HR = 2.03, CI 95% 1.20-3.42, P = 0.008) and PHD1 (HR = 1.45, CI 95% 1.01-2.10, P = 0.047) to be significant independent prognosticators for DSS. Besides, there was an additive prognostic effect by the increasing number of highly expressed HIF hydroxylases. Provided none high expression HIF hydroxylases, the 5-year survival was 80% vs. 23% if all four were highly expressed (HR = 6.48, CI 95% 2.23-18.8, P = 0.001). Conclusions: HIF hydroxylases are, in general, poor prognosticators for NSCLC survival. PHD1 and PHD2 are independent negative prognostic factors in NSCLC. Moreover, there is an additive poor prognostic impact by an increasing number of highly expressed HIF hydroxylases.	[Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Stenvold, Helge; Bremnes, Roy M.] Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Al-Saad, Samer; Al-Shibli, Khalid; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp N Norway, Dept Pathol, Tromso, Norway; [Al-Shibli, Khalid] Nordland Cent Hosp, Dept Pathol, Bodo, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Andersen, S (corresponding author), Univ Tromso, Inst Clin Med, Tromso, Norway.	sigve.andersen@uit.no		Al-Saad, Samer/0000-0003-3707-9667	Northern Norway Regional Health Authority (Helse Nord RHF)	Northern Norway Regional Health Authority (Helse Nord RHF)	The study was solely funded by the Northern Norway Regional Health Authority (Helse Nord RHF) which is responsible for the public hospitals in northern Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Andersen S, 2011, LUNG CANCER, V72, P294, DOI 10.1016/j.lungcan.2010.10.006; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Boddy JL, 2005, CLIN CANCER RES, V11, P7658, DOI 10.1158/1078-0432.CCR-05-0460; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Chan DA, 2010, BRIT J CANCER, V103, P1, DOI 10.1038/sj.bjc.6605682; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; DONNEM T, 2010, CANCER; Donnem T, 2008, J THORAC ONCOL, V3, P963, DOI 10.1097/JTO.0b013e3181834f52; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erez N, 2003, CANCER RES, V63, P8777; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Giatromanolaki A, 2008, CANCER LETT, V262, P87, DOI 10.1016/j.canlet.2007.11.041; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gossage L, 2010, HISTOPATHOLOGY, V56, P908, DOI 10.1111/j.1365-2559.2010.03566.x; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Nagel S, 2010, ANTIOXID REDOX SIGN, V12, P481, DOI 10.1089/ars.2009.2711; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Sangha R, 2010, ONCOLOGIST, V15, P862, DOI 10.1634/theoncologist.2009-0186; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844	36	43	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23847	10.1371/journal.pone.0023847	http://dx.doi.org/10.1371/journal.pone.0023847			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887331	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800035
J	Deng, YM; Caldwell, N; Barr, IG				Deng, Yi-Mo; Caldwell, Natalie; Barr, Ian G.			Rapid Detection and Subtyping of Human Influenza A Viruses and Reassortants by Pyrosequencing	PLOS ONE			English	Article							SWINE; RESISTANCE; SEASON; H1N1	Background: Given the continuing co-circulation of the 2009 H1N1 pandemic influenza A viruses with seasonal H3N2 viruses, rapid and reliable detection of newly emerging influenza reassortant viruses is important to enhance our influenza surveillance. Methodology/Principal Findings: A novel pyrosequencing assay was developed for the rapid identification and subtyping of potential human influenza A virus reassortants based on all eight gene segments of the virus. Except for HA and NA genes, one universal set of primers was used to amplify and subtype each of the six internal genes. With this method, all eight gene segments of 57 laboratory isolates and 17 original specimens of seasonal H1N1, H3N2 and 2009 H1N1 pandemic viruses were correctly matched with their corresponding subtypes. In addition, this method was shown to be capable of detecting reassortant viruses by correctly identifying the source of all 8 gene segments from three vaccine production reassortant viruses and three H1N2 viruses. Conclusions/Significance: In summary, this pyrosequencing assay is a sensitive and specific procedure for screening large numbers of viruses for reassortment events amongst the commonly circulating human influenza A viruses, which is more rapid and cheaper than using conventional sequencing approaches.	[Deng, Yi-Mo; Caldwell, Natalie; Barr, Ian G.] WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia; [Barr, Ian G.] Monash Univ, Sch Appl Sci, Churchill, Vic, Australia	Victorian Infectious Diseases Reference Laboratory; World Health Organization; Monash University	Deng, YM (corresponding author), WHO Collaborating Ctr Reference & Res Influenza, VIDRL, Melbourne, Vic, Australia.	yi-mo.deng@influenzacentre.org		Deng, Yi-Mo/0000-0003-2177-8308; Barr, Ian/0000-0002-7351-418X	Australian Government Department of Health and Ageing	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Faress S, 2008, VIRUS RES, V132, P33, DOI 10.1016/j.virusres.2007.10.007; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DENG YM, 2009, ANTIVIR RES, V90, P87; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Diggle MA, 2004, MOL BIOTECHNOL, V28, P129, DOI 10.1385/MB:28:2:129; Ducatez MF, 2010, J VIROL METHODS, V168, P78, DOI 10.1016/j.jviromet.2010.04.020; Duwe S, 2008, J VIROL METHODS, V153, P134, DOI 10.1016/j.jviromet.2008.07.017; Ellis JS, 2003, EMERG INFECT DIS, V9, P304; Fourment M, 2010, J CLIN MICROBIOL, V48, P295, DOI 10.1128/JCM.01687-09; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Komadina N, 2007, VIRUS GENES, V35, P161, DOI 10.1007/s11262-007-0097-9; Lackenby A, 2008, ANTIVIR THER, V13, P809; Mak PWY, 2011, EMERG INFECT DIS, V17, P691, DOI 10.3201/eid1704.101726; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Paget W J, 2002, Euro Surveill, V7, P147; Palese P., 2007, FIELDS VIROLOGY, P1647; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; STARICK E, 2011, J GEN VIROL; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132	21	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23400	10.1371/journal.pone.0023400	http://dx.doi.org/10.1371/journal.pone.0023400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886790	gold, Green Published			2022-12-25	WOS:000294128100013
J	Hall, GL; Logie, KM; Parsons, F; Schulzke, SM; Nolan, G; Murray, C; Ranganathan, S; Robinson, P; Sly, PD; Stick, SM				Hall, Graham L.; Logie, Karla M.; Parsons, Faith; Schulzke, Sven M.; Nolan, Gary; Murray, Conor; Ranganathan, Sarath; Robinson, Phil; Sly, Peter D.; Stick, Stephen M.		AREST CF	Air Trapping on Chest CT Is Associated with Worse Ventilation Distribution in Infants with Cystic Fibrosis Diagnosed following Newborn Screening	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; MULTIPLE-BREATH WASHOUT; ULTRASONIC FLOW METER; INERT-GAS WASHOUT; LUNG-DISEASE; HEALTHY INFANTS; CHILDREN; VOLUME	Background: In school-aged children with cystic fibrosis (CF) structural lung damage assessed using chest CT is associated with abnormal ventilation distribution. The primary objective of this analysis was to determine the relationships between ventilation distribution outcomes and the presence and extent of structural damage as assessed by chest CT in infants and young children with CF. Methods: Data of infants and young children with CF diagnosed following newborn screening consecutively reviewed between August 2005 and December 2009 were analysed. Ventilation distribution (lung clearance index and the first and second moment ratios [LCI, M-1/M-0 and M-2/M-0, respectively]), chest CT and airway pathology from bronchoalveolar lavage were determined at diagnosis and then annually. The chest CT scans were evaluated for the presence or absence of bronchiectasis and air trapping. Results: Matched lung function, chest CT and pathology outcomes were available in 49 infants (31 male) with bronchiectasis and air trapping present in 13 (27%) and 24 (49%) infants, respectively. The presence of bronchiectasis or air trapping was associated with increased M-2/M-0 but not LCI or M-1/M-0. There was a weak, but statistically significant association between the extent of air trapping and all ventilation distribution outcomes. Conclusion: These findings suggest that in early CF lung disease there are weak associations between ventilation distribution and lung damage from chest CT. These finding are in contrast to those reported in older children. These findings suggest that assessments of LCI could not be used to replace a chest CT scan for the assessment of structural lung disease in the first two years of life. Further research in which both MBW and chest CT outcomes are obtained is required to assess the role of ventilation distribution in tracking the progression of lung damage in infants with CF.	[Hall, Graham L.; Nolan, Gary; Murray, Conor; Sly, Peter D.; Stick, Stephen M.] Princess Margaret Hosp Children, Perth, WA, Australia; [Hall, Graham L.; Logie, Karla M.; Stick, Stephen M.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Hall, Graham L.; Logie, Karla M.; Parsons, Faith; Nolan, Gary; Sly, Peter D.; Stick, Stephen M.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Hall, Graham L.; Logie, Karla M.; Parsons, Faith; Nolan, Gary; Sly, Peter D.; Stick, Stephen M.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Schulzke, Sven M.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Ranganathan, Sarath; Robinson, Phil] Royal Childrens Hosp, Melbourne, Vic, Australia; [Ranganathan, Sarath; AREST CF] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ranganathan, Sarath; Robinson, Phil] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Schulzke, Sven M.] Univ Childrens Hosp Basel, Basel, Switzerland	University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Queensland; University of Basel	Hall, GL (corresponding author), Princess Margaret Hosp Children, Perth, WA, Australia.	grahamh@ichr.uwa.edu.au	Sly, Peter D/F-1486-2010; Garratt, Luke Wisely/N-2371-2013; Hall, Graham/C-4775-2008; Stick, Stephen/AAA-5945-2021; Hall, Graham/AAB-6418-2019; Stick, Stephen/O-5683-2014; Schulzke, Sven/ABA-2339-2020; Stick, Stephen/GZG-7584-2022; Simpson, Shannon/C-4651-2013	Sly, Peter D/0000-0001-6305-2201; Garratt, Luke Wisely/0000-0001-9381-326X; Stick, Stephen/0000-0002-5386-8482; Hall, Graham/0000-0002-6217-9494; Simpson, Shannon/0000-0002-4895-0975; Logie, Karla/0000-0001-7671-098X; Schulzke, Sven/0000-0002-5475-6239; Ranganathan, Sarath/0000-0002-6975-0307	Cystic Fibrosis Foundation, Australia; Cystic Fibrosis Foundation Therapeutics [SLY04A0, STICK09A0]; National Health and Medical Research Council [513730]	Cystic Fibrosis Foundation, Australia; Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The AREST CF would like to thank the contributions of Princess Margaret Hospital for Children, The Telethon Institute for Child Health Research, Royal Children's Hospital Melbourne and Murdoch Children's Research Institute. We would also like to thank the participants and their families who contribute to the AREST CF program. We also acknowledge the support of the Cystic Fibrosis Foundation, Australia to the AREST CF program.; This study was funded by the Cystic Fibrosis Foundation Therapeutics (SLY04A0, STICK09A0) and the National Health and Medical Research Council (513730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2010, EUR RESP J; Amin R, 2010, THORAX, V65, P379, DOI 10.1136/thx.2009.125831; Aurora P, 2004, THORAX, V59, P1068, DOI 10.1136/thx.2004.022590; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; AURORA P, 2010, AM J RESP CRIT CARE; BELESSIS Y, 2010, ASSESSMENT NONINVASI; Cooper P, 2006, PAEDIATR RESPIR REV, V7, P197, DOI 10.1016/j.prrv.2006.04.005; Davis SD, 2007, AM J RESP CRIT CARE, V175, P943, DOI 10.1164/rccm.200603-343OC; de Jong PA, 2006, PEDIATR RADIOL, V36, P50, DOI 10.1007/s00247-005-0006-0; ELLEMUNTER H, 2010, RESP MED; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; HOO AF, IS LUNG FUNCTION DIM; Huelskamp G, 2009, THORAX, V64, P240, DOI 10.1136/thx.2008.101758; Kraemer R, 2005, AM J RESP CRIT CARE, V171, P371, DOI 10.1164/rccm.200407-948OC; Latzin P, 2007, PEDIATR PULM, V42, P888, DOI 10.1002/ppul.20674; Latzin P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004635; Linnane B, 2008, PAEDIATR RESPIR REV, V9; Linnane B, 2008, PAEDIATR RESPIR REV, V9, P168, DOI 10.1016/j.prrv.2008.05.009; Lum S, 2007, THORAX, V62, P341, DOI 10.1136/thx.2006.068262; Martinez TM, 2005, AM J RESP CRIT CARE, V172, P1133, DOI 10.1164/rccm.200412-1665OC; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; Pillow JJ, 2004, EUR RESPIR J, V23, P763, DOI 10.1183/09031936.04.00091504; Robinson PD, 2009, PEDIATR PULM, V44, P733, DOI 10.1002/ppul.20956; SAIDEL GM, 1975, J APPL PHYSIOL, V38, P328, DOI 10.1152/jappl.1975.38.2.328; Schibler A, 2002, EUR RESPIR J, V20, P912, DOI 10.1183/09031936.02.00226002; Schulzke SM, 2010, J PEDIATR-US, V156, P542, DOI 10.1016/j.jpeds.2009.10.017; Sinhal S, 2010, PEDIATR PULM, V45, P62, DOI 10.1002/ppul.21113; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; SONNAPPA S, 2010, J ALLERGY CLIN IMMUN; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Tiddens HAWM, 2006, PAEDIATR RESPIR REV, V7, P202, DOI 10.1016/j.prrv.2006.04.002	32	92	92	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23932	10.1371/journal.pone.0023932	http://dx.doi.org/10.1371/journal.pone.0023932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886842	Green Published, gold			2022-12-25	WOS:000294128100042
J	Kuhn, T; Ihalainen, TO; Hyvaluoma, J; Dross, N; Willman, SF; Langowski, J; Vihinen-Ranta, M; Timonen, J				Kuhn, Thomas; Ihalainen, Teemu O.; Hyvaluoma, Jari; Dross, Nicolas; Willman, Sami F.; Langowski, Jorg; Vihinen-Ranta, Maija; Timonen, Jussi			Protein Diffusion in Mammalian Cell Cytoplasm	PLOS ONE			English	Article							FLUORESCENCE RECOVERY; ANOMALOUS DIFFUSION; MOBILITY; RESOLUTION; DYNAMICS	We introduce a new method for mesoscopic modeling of protein diffusion in an entire cell. This method is based on the construction of a three-dimensional digital model cell from confocal microscopy data. The model cell is segmented into the cytoplasm, nucleus, plasma membrane, and nuclear envelope, in which environment protein motion is modeled by fully numerical mesoscopic methods. Finer cellular structures that cannot be resolved with the imaging technique, which significantly affect protein motion, are accounted for in this method by assigning an effective, position-dependent porosity to the cell. This porosity can also be determined by confocal microscopy using the equilibrium distribution of a non-binding fluorescent protein. Distinction can now be made within this method between diffusion in the liquid phase of the cell (cytosol/nucleosol) and the cytoplasm/nucleoplasm. Here we applied the method to analyze fluorescence recovery after photobleach (FRAP) experiments in which the diffusion coefficient of a freely-diffusing model protein was determined for two different cell lines, and to explain the clear difference typically observed between conventional FRAP results and those of fluorescence correlation spectroscopy (FCS). A large difference was found in the FRAP experiments between diffusion in the cytoplasm/nucleoplasm and in the cytosol/nucleosol, for all of which the diffusion coefficients were determined. The cytosol results were found to be in very good agreement with those by FCS.	[Kuhn, Thomas; Hyvaluoma, Jari; Timonen, Jussi] Univ Jyvaskyla, Dept Phys, NanoSci Ctr, Jyvaskyla, Finland; [Ihalainen, Teemu O.; Willman, Sami F.; Vihinen-Ranta, Maija] Univ Jyvaskyla, Dept Biol, NanoSci Ctr, Jyvaskyla, Finland; [Hyvaluoma, Jari] MTT Agrifood Res Finland, Jokioinen, Finland; [Dross, Nicolas; Langowski, Jorg] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany	University of Jyvaskyla; University of Jyvaskyla; Natural Resources Institute Finland (Luke); Helmholtz Association; German Cancer Research Center (DKFZ)	Kuhn, T (corresponding author), Univ Jyvaskyla, Dept Phys, NanoSci Ctr, Jyvaskyla, Finland.	thomas.h.kuehn@jyu.fi	Kühn, Thomas/AAZ-6834-2020; Langowski, Jörg/A-1843-2011; Ihalainen, Teemu/C-9500-2016; Kühn, Thomas/AAS-1949-2021	Kühn, Thomas/0000-0001-5978-0601; Langowski, Jörg/0000-0001-8600-0666; Vihinen-Ranta, Maija/0000-0003-0959-1153; Ihalainen, Teemu/0000-0003-4351-8697	Emil Aaltonen Foundation; Academy of Finland [107311]; National Graduate School in NanoScience	Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); National Graduate School in NanoScience	The contribution of the Department of Physics, University of Jyvaskylaw was supported by the Emil Aaltonen Foundation. The contribution of the Department of Biology, University of Jyvaskyla was supported by grants from the Academy of Finland (Contract No. 107311) and National Graduate School in NanoScience. The group at the DKFZ received no external funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; BRAECKMANS K, 2007, BIOPHSY J, V92, P1482; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Burov S, 2011, PHYS CHEM CHEM PHYS, V13, P1800, DOI 10.1039/c0cp01879a; Dross N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005041; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hinde E, 2010, P NATL ACAD SCI USA, V107, P16560, DOI 10.1073/pnas.1006731107; Ihalainen TO, 2007, CELL MICROBIOL, V9, P1946, DOI 10.1111/j.1462-5822.2007.00926.x; Jeon JH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048103; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Kaviany M., 2002, PRINCIPLES HEAT TRAN; KUBITSCHECK U, 1994, BIOPHYS J, V67, P948, DOI 10.1016/S0006-3495(94)80596-X; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Meyvis TKL, 1999, PHARM RES-DORDR, V16, P1153, DOI 10.1023/A:1011924909138; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; PARRISH CR, 1988, VIROLOGY, V163, P230, DOI 10.1016/0042-6822(88)90255-3; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Rojo M, 2000, J CELL SCI, V113, P1043; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; Schaff J, 1997, BIOPHYS J, V73, P1135, DOI 10.1016/S0006-3495(97)78146-3; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, DOI [10.1038/nrm2989, 10.1038/nrm2983]; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Succi S, 2001, LATTICE BOLTZMANN EQ, P290; TEWES M, 2001, Patent No. 0941470; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; WACHSMUTH M, 2001, THESIS R KARLS U HEI; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; WOLFGLADROW D, 1995, J STAT PHYS, V79, P1023, DOI 10.1007/BF02181215; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053	39	124	125	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e22962	10.1371/journal.pone.0022962	http://dx.doi.org/10.1371/journal.pone.0022962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886771	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100003
J	Zhao, RM; Cui, SJ; Guo, L; Wu, C; Gonzalez, R; Paranhos-Baccala, G; Vernet, G; Wang, JW; Hung, T				Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Paranhos-Baccala, Glaucia; Vernet, Guy; Wang, Jianwei; Hung, Tao			Identification of a Highly Conserved H1 Subtype-Specific Epitope with Diagnostic Potential in the Hemagglutinin Protein of Influenza A Virus	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; UNIVERSAL ANTIBODIES; ANTIGENIC STRUCTURE; SYNTHETIC PEPTIDE; BLOCKING ELISA; FUSION; LESSONS; BINDING; ENTRY	Subtype specificity of influenza A virus (IAV) is determined by its two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA). For HA, 16 distinct subtypes (H1-H16) exist, while nine exist for NA. The epidemic strains of H1N1 IAV change frequently and cause annual seasonal epidemics as well as occasional pandemics, such as the notorious 1918 influenza pandemic. The recent introduction of pandemic A/H1N1 IAV (H1N1pdm virus) into humans re-emphasizes the public health concern about H1N1 IAV. Several studies have identified conserved epitopes within specific HA subtypes that can be used for diagnostics. However, immune specific epitopes in H1N1 IAV have not been completely assessed. In this study, linear epitopes on the H1N1pdm viral HA protein were identified by peptide scanning using libraries of overlapping peptides against convalescent sera from H1N1pdm patients. One epitope, P5 (aa 58-72) was found to be immunodominant in patients and to evoke high titer antibodies in mice. Multiple sequence alignments and in silico coverage analysis showed that this epitope is highly conserved in influenza H1 HA [with a coverage of 91.6% (9,860/10,767)] and almost completely absent in other subtypes [with a coverage of 3.3% (792/23,895)]. This previously unidentified linear epitope is located outside the five well-recognized antigenic sites in HA. A peptide ELISA method based on this epitope was developed and showed high correlation (chi(2) = 51.81, P < 0.01, Pearson correlation coefficient R = 0.741) with a hemagglutination inhibition test. The highly conserved H1 subtype-specific immunodominant epitope may form the basis for developing novel assays for sero-diagnosis and active surveillance against H1N1 IAVs.	[Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, State Key Lab Mol Virol & Genet Engn, Beijing 100021, Peoples R China; [Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, Christophe Merieux Lab, Beijing 100021, Peoples R China; [Zhao, Rongmao; Cui, Shujuan; Guo, Li; Wu, Chao; Gonzalez, Richard; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Gonzalez, Richard; Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhao, RM (corresponding author), Peking Union Med Coll, State Key Lab Mol Virol & Genet Engn, Beijing 100021, Peoples R China.	wangjw28@163.com	Wang, Jianwei/AAW-9499-2020; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; 	International Science and Technology Cooperation Program of China [2010DFB33270]; National Basic Research Program (973 Program) of China [2010CB534003]	International Science and Technology Cooperation Program of China; National Basic Research Program (973 Program) of China(National Basic Research Program of China)	This study is supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn/) and by the National Basic Research Program (973 Program) of China (2010CB534003) (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2010, CLIN VACCINE IMMUNOL, V17, P1481, DOI 10.1128/CVI.00223-10; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; BROWN LE, 1988, J VIROL, V62, P1746, DOI 10.1128/JVI.62.5.1746-1752.1988; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carter, 2004, CARTOGR PERSPECT, V49, P4, DOI [10.14714/CP49.437, DOI 10.14714/CP49.437]; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; COLIGAN JE, 2001, CURR PROTOC NEUROSCI, P5; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; DEL RC, 2010, T AM CLIN CLIMAT ASS, V121; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guo Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-39; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; He YX, 2005, J CLIN MICROBIOL, V43, P3718, DOI 10.1128/JCM.43.8.3718-3726.2005; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; Li OTW, 2009, EXPERT REV ANTI-INFE, V7, P687, DOI [10.1586/eri.09.48, 10.1586/ERI.09.48]; Liu DB, 2011, J VIROL METHODS, V172, P16, DOI 10.1016/j.jviromet.2010.12.007; LIVINGSTON PO, 1995, IMMUNOL REV, V145, P147, DOI 10.1111/j.1600-065X.1995.tb00080.x; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; MASSICOT J, 1977, J INFECT DIS, V136, pS472, DOI 10.1093/infdis/136.Supplement_3.S472; Mueller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009097; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; *OIE, 2010, MAN DIAGN TEST VACC, V1; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; PALESE P, 2007, FIELDS VIROLOGY ORTH; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Shahsavandi S, 2011, J VIROL METHODS, V171, P260, DOI 10.1016/j.jviromet.2010.11.012; Shien JH, 2008, J MICROBIOL IMMUNOL, V41, P369; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; TANG XL, 1988, J VIROL, V62, P4745, DOI 10.1128/JVI.62.12.4745-4751.1988; Tsuchiya E, 2001, J GEN VIROL, V82, P2475, DOI 10.1099/0022-1317-82-10-2475; Vareckova E, 2002, J CLIN MICROBIOL, V40, P2220, DOI 10.1128/JCM.40.6.2220-2223.2002; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018016; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	51	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23374	10.1371/journal.pone.0023374	http://dx.doi.org/10.1371/journal.pone.0023374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886787	Green Submitted, gold, Green Published			2022-12-25	WOS:000294128100011
J	Mitra, A; Kalayarasan, S; Gupta, V; Radha, V				Mitra, Aninda; Kalayarasan, Srinivasan; Gupta, Vijay; Radha, Vegesna			TC-PTP Dephosphorylates the Guanine Nucleotide Exchange Factor C3G (RapGEF1) and Negatively Regulates Differentiation of Human Neuroblastoma Cells	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; NEURITE OUTGROWTH; ACTIVATION; RECEPTOR; GROWTH; RAP1; CRK; INSULIN; BINDING; IDENTIFICATION	The guanine nucleotide exchange factor, C3G (RapGEF1), functions in multiple signaling pathways involved in cell adhesion, proliferation, apoptosis and actin reorganization. C3G is regulated by tyrosine phosphorylation on Y504, known to be mediated by c-Abl and Src family kinases. In the present study we explored the possibility of cellular phospho-C3G (pC3G) being a substrate of the intracellular T-cell protein tyrosine phosphatase TC-PTP (PTPN2) using the human neuroblastoma cell line, IMR-32. In vivo and in vitro binding assays demonstrated interaction between C3G and TC-PTP. Interaction is mediated through the Crk-binding region of C3G and C-terminal noncatalytic residues of TC-PTP. C3G interacted better with a substrate trap mutant of TC48 and this complex formation was inhibited by vanadate. Endogenous pC3G colocalized with catalytically inactive mutant TC48 in the Golgi. Expression of TC48 abrogated pervanadate and c-Src induced phosphorylation of C3G without affecting total cellular phospho-tyrosine. Insulin-like growth factor treatment of c-Src expressing cells resulted in dephosphorylation of C3G dependent on the activity of endogenous TC48. TC48 expression inhibited forskolin induced tyrosine phosphorylation of C3G and neurite outgrowth in IMR-32 cells. Our results identify a novel Golgi localized substrate of TC48 and delineate a role for TC48 in dephosphorylation of substrates required during differentiation of human neuroblastoma cells.	[Mitra, Aninda; Kalayarasan, Srinivasan; Gupta, Vijay; Radha, Vegesna] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Mitra, A (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	vradha@ccmb.res.in		Gupta, Dr. Vijay/0000-0002-3613-6378	Department of Biotechnology, Govt. of India [BT/PR11921/BRB/10/698/2009]; DBT	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	This work was supported in part by a grant awarded to VR by the Department of Biotechnology, Govt. of India (BT/PR11921/BRB/10/698/2009). SK was a recipient of a postdoctoral fellowship from DBT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Gupta V, 2006, J CELL SCI, V119, P1703, DOI 10.1242/jcs.02885; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Ichiba T, 1997, J BIOL CHEM, V272, P22215, DOI 10.1074/jbc.272.35.22215; Ichiba T, 1999, J BIOL CHEM, V274, P14376, DOI 10.1074/jbc.274.20.14376; Kamatkar S, 1996, J BIOL CHEM, V271, P26755, DOI 10.1074/jbc.271.43.26755; KENNER KA, 1993, J BIOL CHEM, V268, P25455; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Konstantopoulos N, 1996, BIOCHEM J, V314, P387, DOI 10.1042/bj3140387; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Martin-Encabo S, 2007, EXP CELL RES, V313, P3881, DOI 10.1016/j.yexcr.2007.07.036; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mitra A, 2010, ONCOGENE, V29, P4528, DOI 10.1038/onc.2010.113; Mitra SK, 2001, EXP CELL RES, V270, P32, DOI 10.1006/excr.2001.5313; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; Ohba Y, 2000, MOL CELL BIOL, V20, P6074, DOI 10.1128/MCB.20.16.6074-6083.2000; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Pasquali C, 2003, MOL ENDOCRINOL, V17, P2228, DOI 10.1210/me.2003-0011; Paul S, 2003, CELL MOL LIFE SCI, V60, P2465, DOI 10.1007/s00018-003-3123-7; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; RADHA V, 1994, BIOCHEM J, V299, P41, DOI 10.1042/bj2990041; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Radha V, 2011, BIOSCIENCE REP, V31, P231, DOI 10.1042/BSR20100094; Radha V, 2008, J NEUROCHEM, V107, P1424, DOI 10.1111/j.1471-4159.2008.05710.x; Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200; Savchenko A, 2001, P NATL ACAD SCI USA, V98, P5880, DOI 10.1073/pnas.101524998; Schonherr C, 2010, ONCOGENE, V29, P2817, DOI 10.1038/onc.2010.27; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Shintani T, 2001, DEV NEUROSCI-BASEL, V23, P55, DOI 10.1159/000048696; Shivakrupa R, 2003, J BIOL CHEM, V278, P52188, DOI 10.1074/jbc.M310656200; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; TILLMANN U, 1994, MOL CELL BIOL, V14, P3030, DOI 10.1128/MCB.14.5.3030; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Voss AK, 2003, DEVELOPMENT, V130, P355, DOI 10.1242/dev.00217; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Wang SF, 2008, BLOOD, V111, P2878, DOI 10.1182/blood-2007-07-103119; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	56	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23681	10.1371/journal.pone.0023681	http://dx.doi.org/10.1371/journal.pone.0023681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876762	Green Submitted, Green Published, gold			2022-12-25	WOS:000294126900034
J	Taniguchi, N; Carames, B; Hsu, E; Cherqui, S; Kawakami, Y; Lotz, M				Taniguchi, Noboru; Carames, Beatriz; Hsu, Emily; Cherqui, Stephanie; Kawakami, Yasuhiko; Lotz, Martin			Expression Patterns and Function of Chromatin Protein HMGB2 during Mesenchymal Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTICULAR-CARTILAGE; TRANSCRIPTION FACTOR-2; PROGENITOR CELLS; GENE-REGULATION; DNA-BINDING; IN-VITRO; IDENTIFICATION; CHONDROGENESIS; PROMOTER; SURFACE	The superficial zone (SZ) of articular cartilage is critical in maintaining tissue function and homeostasis and represents the site of the earliest changes in osteoarthritis (OA). The expression of chromatin protein HMGB2 is restricted to the SZ, which contains cells expressing mesenchymal stein cell (MSC) markers. Age-related loss of HMGB2 and gene deletion are associated with reduced SL cellularity and early onset OA. This study addressed HMGB2 expression patterns in MSC and its role during differentiation. HMGB2 was detected at higher levels in human MSC as compared with human articular chondrocytes, and its expression declined during chondrogenic differentiation of MSC. Lentiviral HMGB2 transduction of MSC suppressed chondrogenesis as reflected by an inhibition of Col2a1 and Col10al expression. Conversely, in bone marrow MSC from Hmgb2(-/-) mice, Col10a1 was more strongly expressed than in wild-type MSC. This is consistent with in vivo results from mouse growth plates showing that Hmgb2 is expressed in proliferating and prehypertrophic zones but not in hypertrophic cartilage where Col10a1 is strongly expressed. Osteogenesis was also accelerated in Hmgb2(-/-) MSC. The expression of Runx2, which plays a major role in late stage chondrocyte differentiation, was enhanced in Hmgb2(-/-) MSC, and HMGB2 negatively regulated the stimulatory effect of Wnt/beta-catenin signaling on the Runx2 proximal promoter. These results demonstrate that HMGB2 expression is inversely correlated with the differentiation status of MSC and that HMGB2 suppresses chondrogenic differentiation. The age-related loss of HMGB2 in articular cartilage may represent a mechanism responsible for the decline in adult cartilage stem cell populations.	[Taniguchi, Noboru; Carames, Beatriz; Hsu, Emily; Cherqui, Stephanie; Lotz, Martin] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kawakami, Yasuhiko] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kawakami, Yasuhiko] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA	Scripps Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lotz, M (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mlotz@scripps.edu		Cherqui, Stephanie/0000-0003-1240-5219; Carames, Beatriz/0000-0002-8353-6526; Kawakami, Yasuhiko/0000-0002-0043-9705	National Institutes of Health [AR056026, AG007996, RR027557]; Consortium for Functional Glycomics [GM62116]; Sam and Rose Stein Endowment Fund; Arthritis National Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Functional Glycomics; Sam and Rose Stein Endowment Fund; Arthritis National Research Foundation(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056026, AG007996, RR027557 and the Consortium for Functional Glycomics GM62116. This work was also supported by the Sam and Rose Stein Endowment Fund (to M. L) and the Arthritis National Research Foundation (to N. T.).	Akiyama H, 1999, J CELL PHYSIOL, V181, P169, DOI 10.1002/(SICI)1097-4652(199910)181:1<169::AID-JCP18>3.0.CO;2-5; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Collas P, 2007, J CELL MOL MED, V11, P602, DOI 10.1111/j.1582-4934.2007.00079.x; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hashimoto S, 1998, P NATL ACAD SCI USA, V95, P3094, DOI 10.1073/pnas.95.6.3094; Higashikawa A, 2009, ARTHRITIS RHEUM-US, V60, P166, DOI 10.1002/art.24243; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Husa M, 2010, NAT MED, V16, P641, DOI 10.1038/nm0610-641; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Itou J, 2011, DEV DYNAM, V240, P1151, DOI 10.1002/dvdy.22598; Kahler RA, 2003, J BIOL CHEM, V278, P11937, DOI 10.1074/jbc.M211443200; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kim CG, 2006, MOL CELLS, V21, P343; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lee HJ, 2009, ARTHRITIS RHEUM-US, V60, P2325, DOI 10.1002/art.24786; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Syres K, 2009, BLOOD, V114, P2542, DOI 10.1182/blood-2009-03-213934; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Taniguchi N, 2007, MOL CELL BIOL, V27, P5650, DOI 10.1128/MCB.00130-07; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P16817, DOI 10.1073/pnas.0904414106; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Tetsunaga T, 2011, OSTEOARTHR CARTILAGE, V19, P222, DOI 10.1016/j.joca.2010.11.004; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	52	41	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41489	41498		10.1074/jbc.M111.236984	http://dx.doi.org/10.1074/jbc.M111.236984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21890638	Green Published, hybrid			2022-12-25	WOS:000298057500035
J	Hibino, N; Yi, T; Duncan, DR; Rathore, A; Dean, E; Naito, Y; Dardik, A; Kyriakides, T; Madri, J; Pober, JS; Shinoka, T; Breuer, CK				Hibino, Narutoshi; Yi, Tai; Duncan, Daniel R.; Rathore, Animesh; Dean, Ethan; Naito, Yuji; Dardik, Alan; Kyriakides, Themis; Madri, Joseph; Pober, Jordan S.; Shinoka, Toshiharu; Breuer, Christopher K.			A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts	FASEB JOURNAL			English	Article						monocytes; clodronate liposomes	ULTRASMALL SUPERPARAMAGNETIC PARTICLES; BONE-MARROW-CELLS; IN-VIVO; NEOINTIMAL FORMATION; PULMONARY-ARTERY; BLOOD-VESSELS; ANIMAL-MODEL; MOUSE MODEL; IRON-OXIDE; AUTOGRAFTS	The primary graft-related complication during the first clinical trial evaluating the use of tissue-engineered vascular grafts (TEVGs) was stenosis. We investigated the role of macrophages in the formation of TEVG stenosis in a murine model. We analyzed the natural history of TEVG macrophage infiltration at critical time points and evaluated the role of cell seeding on neovessel formation. To assess the function of infiltrating macrophages, we implanted TEVGs into mice that had been macrophage depleted using clodronate liposomes. To confirm this, we used a CD11b-diphtheria toxin-receptor (DTR) transgenic mouse model. Monocytes infiltrated the scaffold within the first few days and initially transformed into M1 macrophages. As the scaffold degraded, the macrophage infiltrate disappeared. Cell seeding decreased the incidence of stenosis (32% seeded, 64% unseeded, P=0.024) and the degree of macrophage infiltration at 2 wk. Unseeded TEVGs demonstrated conversion from M1 to M2 phenotype, whereas seeded grafts did not. Clodronate and DTR inhibited macrophage infiltration and decreased stenosis but blocked formation of vascular neotissue, evidenced by the absence of endothelial and smooth muscle cells and collagen. These findings suggest that macrophage infiltration is critical for neovessel formation and provides a strategy for predicting, detecting, and inhibiting stenosis in TEVGs.-Hibino, N., Yi, T., Duncan, D. R., Rathore, A., Dean, E., Naito, Y., Dardik, A., Kyriakides, T., Madri, J., Pober, J. S., Shinoka, T., Breuer, C. K. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 25, 4253-4263 (2011). www.fasebj.org	[Hibino, Narutoshi; Yi, Tai; Duncan, Daniel R.; Rathore, Animesh; Dean, Ethan; Naito, Yuji; Dardik, Alan; Kyriakides, Themis; Madri, Joseph; Pober, Jordan S.; Shinoka, Toshiharu; Breuer, Christopher K.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT USA	Yale University	Breuer, CK (corresponding author), 10 Amistad St,Amistad Bldg,Rm 301 C, New Haven, CT 06510 USA.	christopher.breuer@yale.edu		Breuer, Christopher/0000-0003-0987-3898; Duncan, Daniel/0000-0003-4771-8901	U.S. National Institutes of Health (NIH) [K08HL083980, NIH R01HL098228, NIH UL1RR024139, NIH P30DK072442, NIH P01HL070295]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; Gunze Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL083980, R01HL095498, P01HL070295, R01HL098228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Gunze Ltd.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research support was provided through the following grants: U.S. National Institutes of Health (NIH) K08HL083980, NIH R01HL098228, NIH UL1RR024139, NIH P30DK072442, and NIH P01HL070295; Howard Hughes Medical Institute; and the Doris Duke Charitable Foundation Clinical Scientist Development Award. Histological processing was done by the Yale Core Center for Musculoskeletal Disorders (NIH AR46032). Gunze Ltd. has provided research support for the clinical trial evaluating the use of tissue-engineered vascular grafts. None of the funding for the work done in this manuscript was provided by Gunze Ltd.	Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Brennan MP, 2008, ANN SURG, V248, P370, DOI 10.1097/SLA.0b013e318184dcbd; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030; Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Hyafil F, 2006, ARTERIOSCL THROM VAS, V26, P176, DOI 10.1161/01.ATV.0000194098.82677.57; Isomatsu Y, 2003, J THORAC CARDIOV SUR, V126, P1958, DOI 10.1016/S0022-5223(03)01042-0; Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61; Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7; Matsumura G, 2006, TISSUE ENG, V12, P3075, DOI 10.1089/ten.2006.12.3075; Mirensky TL, 2008, PEDIATR RES, V63, P559, DOI 10.1203/01.pdr.0000305938.92695.b9; Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102; Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035; Mosser D. M., 2010, NAT REV IMMUNOL, V18, P958; Motwani JG, 1998, CIRCULATION, V97, P916, DOI 10.1161/01.CIR.97.9.916; Naito Y, 2003, J THORAC CARDIOV SUR, V125, P419, DOI 10.1067/mtc.2003.134; Nelson GN, 2008, ARCH SURG-CHICAGO, V143, P488, DOI 10.1001/archsurg.143.5.488; RATLIFF NB, 1989, ARCH PATHOL LAB MED, V113, P772; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; ROLL FJ, 1980, J CELL BIOL, V85, P597, DOI 10.1083/jcb.85.3.597; Ruehm SG, 2001, CIRCULATION, V103, P415; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0; Shinoka Toshiharu, 2008, Yale Journal of Biology and Medicine, V81, P161; Stark VK, 1997, ARTERIOSCL THROM VAS, V17, P1614, DOI 10.1161/01.ATV.17.8.1614; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Tatewaki H, 2007, J VASC SURG, V45, P1236, DOI 10.1016/j.jvs.2007.01.066; Trivedi RA, 2004, STROKE, V35, P1631, DOI 10.1161/01.STR.0000131268.50418.b7; Truijers M, 2009, AM J ROENTGENOL, V193, pW437, DOI 10.2214/AJR.09.2619; vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7; Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481	40	164	172	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4253	4263		10.1096/fj.11-186585	http://dx.doi.org/10.1096/fj.11-186585			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21865316	Green Published			2022-12-25	WOS:000298138100018
J	Bae, JY; Park, HH				Bae, Ju Young; Park, Hyun Ho			Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; RECRUITMENT DOMAIN; EFFECTOR-DOMAIN; INNATE-IMMUNITY; NMR STRUCTURE; DEATH; ACTIVATION; APOPTOSIS; ASC; MECHANISM	NALP3 inflammasome, composed of the three proteins NALP3, ASC, and Caspase-1, is a macromolecular complex responsible for the innate immune response against infection with bacterial and viral pathogens. Formation of the inflammasome can lead to the activation of inflammatory caspases, such as Caspase-1, which then activate pro-inflammatory cytokines by proteolytic cleavage. The assembly of the NALP3 inflammasome depends on the protein-interacting domain known as the death domain superfamily. NALP3 inflammasome is assembled via a pyrin domain (PYD)/PYD interaction between ASC and NALP3 and a caspase recruitment domain/caspase recruitment domain interaction between ASC and Caspase-1. As a first step toward elucidating the molecular mechanisms of inflammatory caspase activation by formation of inflammasome, we report the crystal structure of the PYD from NALP3 at 1.7-angstrom resolution. Although NALP3 PYD has the canonical six-helical bundle structural fold similar to other PYDs, the high resolution structure reveals the possible biologically important homodimeric interface and the dynamic properties of the fold. Comparison with other PYD structures shows both similarities and differences that may be functionally relevant. Structural and sequence analyses further implicate conserved surface residues in NALP3 PYD for ASC interaction and inflammasome assembly. The most interesting aspect of the structure was the unexpected disulfide bond between Cys-8 and Cys-108, which might be important for regulation of the activity of NALP3 by redox potential.	[Park, Hyun Ho] Yeungnam Univ, Grad Sch Biochem, Sch Biotechnol, Gyongsan, South Korea; Yeungnam Univ, Res Inst Prot Sensor, Gyongsan, South Korea	Yeungnam University; Yeungnam University	Park, HH (corresponding author), Yeungnam Univ, Grad Sch Biochem, Sch Biotechnol, Gyongsan, South Korea.	hyunho@ynu.ac.kr		park, hyun ho/0000-0001-9928-0847	National Research Foundation of Korea, Ministry of Education, Science, and Technology [2011-0003406, 2011-0025697]	National Research Foundation of Korea, Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by Grants 2011-0003406 and 2011-0025697 from the Basic Science Research Program through the National Research Foundation of Korea, Ministry of Education, Science, and Technology.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Damiano JS, 2004, CURR DRUG TARGETS, V5, P367, DOI 10.2174/1389450043345470; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jang TH, 2011, J BIOTECHNOL, V151, P335, DOI 10.1016/j.jbiotec.2011.01.003; Kolly L, 2010, IMMUNOLOGY, V129, P178, DOI 10.1111/j.1365-2567.2009.03174.x; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Liu-Bryan R, 2010, IMMUNOL CELL BIOL, V88, P20, DOI 10.1038/icb.2009.93; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park HH, 2011, APOPTOSIS, V16, P209, DOI 10.1007/s10495-010-0571-z; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023	45	142	146	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39528	39536		10.1074/jbc.M111.278812	http://dx.doi.org/10.1074/jbc.M111.278812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21880711	hybrid, Green Published			2022-12-25	WOS:000296759800070
J	Hug, I; Zheng, B; Reiz, B; Whittal, RM; Fentabil, MA; Klassen, JS; Feldman, MF				Hug, Isabelle; Zheng, Blake; Reiz, Bela; Whittal, Randy M.; Fentabil, Messele A.; Klassen, John S.; Feldman, Mario F.			Exploiting Bacterial Glycosylation Machineries for the Synthesis of a Lewis Antigen-containing Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; PROTEIN GLYCOSYLATION; SUBSTRATE-SPECIFICITY; MASS SPECTROMETRY; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; SEQUENCE	Glycoproteins constitute a class of compounds of increasing importance for pharmaceutical applications. The manipulation of bacterial protein glycosylation systems from Gram-negative bacteria for the synthesis of recombinant glycoproteins is a promising alternative to the current production methods. Proteins carrying Lewis antigens have been shown to have potential applications for the treatment of diverse autoimmune diseases. In this work, we developed a mixed approach consisting of in vivo and in vitro steps for the synthesis of glycoproteins containing the Lewis x antigen. Using glycosyltransferases from Haemophilus influenzae, we engineered Escherichia coli to assemble a tetrasaccharide on the lipid carrier undecaprenylphosphate. This glycan was transferred in vivo from the lipid to a carrier protein by the Campylobacter jejuni oligosaccharyltransferase PglB. The glycoprotein was then fucosylated in vitro by a truncated fucosyltransferase from Helicobacter pylori. Diverse mass spectrometry techniques were used to confirm the structure of the glycan. The strategy presented here could be adapted in the future for the synthesis of diverse glycoproteins. Our experiments demonstrate that bacterial enzymes can be exploited for the production of glycoproteins carrying glycans present in human cells for potential therapeutic applications.	[Hug, Isabelle; Feldman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Zheng, Blake; Reiz, Bela; Whittal, Randy M.; Fentabil, Messele A.; Klassen, John S.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Feldman, MF (corresponding author), Univ Alberta, Dept Biol Sci, 405 Biol Sci Bldg, Edmonton, AB T6G 2E9, Canada.	mfeldman@ualberta.ca	Feldman, Mario/A-2637-2014	Feldman, Mario/0000-0003-4497-0976; Hug, Isabelle/0000-0002-4524-9569; Klassen, John/0000-0002-3389-7112; Whittal, Randy/0000-0003-1174-8172	Alberta Innovates Health Solutions; Alberta Innovates Centre for Carbohydrate Science (AICCS)	Alberta Innovates Health Solutions; Alberta Innovates Centre for Carbohydrate Science (AICCS)	This work was supported in part by grants from Alberta Innovates Health Solutions and the Alberta Innovates Centre for Carbohydrate Science (AICCS) (to M. F. F.).	Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Antoine T, 2003, CHEMBIOCHEM, V4, P406, DOI 10.1002/cbic.200200540; Atochina O, 2006, EXP DERMATOL, V15, P461, DOI 10.1111/j.1600-0625.2006.00431.x; CHAN NWC, 1995, GLYCOBIOLOGY, V5, P683, DOI 10.1093/glycob/5.7.683; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Dumon C, 2006, CHEMBIOCHEM, V7, P359, DOI 10.1002/cbic.200500293; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; Faridmoayer A, 2008, J BIOL CHEM, V283, P34596, DOI 10.1074/jbc.M807113200; Feldman MF, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P903; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Harvey DJ, 2002, ANAL CHEM, V74, P734, DOI 10.1021/ac0109321; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Ielmini MV, 2011, GLYCOBIOLOGY, V21, P734, DOI 10.1093/glycob/cwq192; Jones C, 2005, AN ACAD BRAS CIENC, V77, P293, DOI 10.1590/S0001-37652005000200009; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Langdon RH, 2009, FUTURE MICROBIOL, V4, P401, DOI 10.2217/FMB.09.10; Liu X, 2006, ANAL CHEM, V78, P6081, DOI 10.1021/ac060516m; Ma B, 2006, J BIOL CHEM, V281, P6385, DOI 10.1074/jbc.M511320200; Ma B, 2003, J BIOL CHEM, V278, P21893, DOI 10.1074/jbc.M301704200; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; Phillips NJ, 2000, J BIOL CHEM, V275, P4747, DOI 10.1074/jbc.275.7.4747; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Schwarz F, 2010, NAT CHEM BIOL, V6, P264, DOI [10.1038/NCHEMBIO.314, 10.1038/nchembio.314]; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SRIVATSAN J, 1992, J BIOL CHEM, V267, P20196; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790	34	27	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37887	37894		10.1074/jbc.M111.287755	http://dx.doi.org/10.1074/jbc.M111.287755			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878645	hybrid, Green Published			2022-12-25	WOS:000296542400083
J	Tiwari, A; Jung, JJ; Inamdar, SM; Brown, CO; Goel, A; Choudhury, A				Tiwari, Ajit; Jung, Jae-Joon; Inamdar, Shivangi M.; Brown, Charles O.; Goel, Apollina; Choudhury, Amit			Endothelial Cell Migration on Fibronectin Is Regulated by Syntaxin 6-mediated alpha 5 beta 1 Integrin Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE-MEDIATED TRAFFICKING; MEMBRANE-FUSION; TRANS-GOLGI; EXTRACELLULAR-MATRIX; VASCULAR DEVELOPMENT; 3T3-L1 ADIPOCYTES; EARLY ENDOSOMES; CHO-CELLS; ADHESION; RAC	The alpha 5 beta 1 integrin heterodimer regulates many processes that contribute to embryonic development and angiogenesis, in both physiological and pathological contexts. As one of the major adhesion complexes on endothelial cells, it plays a vital role in adhesion and migration along the extracellular matrix. We recently showed that angiogenesis is modulated by syntaxin 6, a Golgi-and endosome-localized t-SNARE, and that it does so by regulating the post-Golgi trafficking of VEGFR2. Here we show that syntaxin 6 is also required for alpha 5 beta 1 integrin-mediated adhesion of endothelial cells to, and migration along, fibronectin. We demonstrate that syntaxin 6 and alpha 5 beta 1 integrin colocalize in EEA1-containing early endosomes, and that functional inhibition of syntaxin 6 leads to misrouting of beta 1 integrin to the degradation pathway (late endosomes and lysosomes) rather transport along recycling pathway from early endosomes; an increase in the pool of ubiquitinylated alpha 5 integrin and its lysosome-dependent degradation; reduced cell spreading on fibronectin; decreased Rac1 activation; and altered Rac1 localization. Collectively, our data show that functional syntaxin 6 is required for the regulation of alpha 5 beta 1-mediated endothelial cell movement on fibronectin. These syntaxin 6-regulated membrane trafficking events control outside-in signaling via haptotactic and chemotactic mechanisms.	[Tiwari, Ajit; Jung, Jae-Joon; Inamdar, Shivangi M.; Choudhury, Amit] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Brown, Charles O.; Goel, Apollina] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Choudhury, A (corresponding author), 51 Newton Rd, Iowa City, IA 52242 USA.	amit-choudhury@uiowa.edu	Jung, Jae-Joon/I-2186-2014		NHLBI, National Institutes of Health [HL089599]; NCI, National Institutes of Health [CA127958]; NATIONAL CANCER INSTITUTE [R01CA127958] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089599] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089599 from the NHLBI (to A. C.) and CA127958 from the NCI (to A. G.).	Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Banerjee ER, 2008, EXP HEMATOL, V36, P1004, DOI 10.1016/j.exphem.2008.03.008; Berrier AL, 2002, J CELL SCI, V115, P4285, DOI 10.1242/jcs.00109; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmona G, 2009, BLOOD, V113, P488, DOI 10.1182/blood-2008-02-138438; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Gonon EM, 2005, FEBS LETT, V579, P6169, DOI 10.1016/j.febslet.2005.09.090; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; Teckchandani A, 2009, J CELL BIOL, V186, P98, DOI 10.1083/jcb.200812160; Teng FYH, 2001, GENOME BIOL, V2; Wang Y, 2005, MOL MEMBR BIOL, V22, P313, DOI 10.1080/09687860500143829; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhang YH, 2008, J BIOL CHEM, V283, P30689, DOI 10.1074/jbc.M801711200	58	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36749	36761		10.1074/jbc.M111.260828	http://dx.doi.org/10.1074/jbc.M111.260828			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880737	Green Published, hybrid			2022-12-25	WOS:000296538300057
J	Yu, XJ; Liu, M; Matthews, S; Holden, DW				Yu, Xiu-Jun; Liu, Mei; Matthews, Steve; Holden, David W.			Tandem Translation Generates a Chaperone for the Salmonella Type III Secretion System Protein SsaQ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; PATHOGENICITY ISLAND-2; INITIATION SITES; CHROMOSOMAL GENES; C-RING; TYPHIMURIUM; VIRULENCE; CONSTRUCTION; EXPRESSION; LOCUS	Type III secretion systems (T3SSs) of bacterial pathogens involve the assembly of a surface-localized needle complex, through which translocon proteins are secreted to form a pore in the eukaryotic cell membrane. This enables the transfer of effector proteins from the bacterial cytoplasm to the host cell. A structure known as the C-ring is thought to have a crucial role in secretion by acting as a cytoplasmic sorting platform at the base of the T3SS. Here, we studied SsaQ, an FliN-like putative C-ring protein of the Salmonella pathogenicity island 2 (SPI-2)-encoded T3SS. ssaQ produces two proteins by tandem translation: a long form (SsaQ(L)) composed of 322 amino acids and a shorter protein (SsaQ(S)) comprising the C-terminal 106 residues of SsaQ(L). SsaQ(L) is essential for SPI-2 T3SS function. Loss of SsaQ(S) impairs the function of the T3SS both ex vivo and in vivo. SsaQ(S) binds to its corresponding region within SsaQ(L) and stabilizes the larger protein. Therefore, SsaQ(L) function is optimized by a novel chaperone-like protein, produced by tandem translation from its own mRNA species.	[Yu, Xiu-Jun; Liu, Mei; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Microbiol Sect, London SW7 2AZ, England; [Matthews, Steve] Univ London Imperial Coll Sci Technol & Med, Struct Biol Ctr, Div Mol Biosci, London SW7 2AZ, England	Imperial College London; Imperial College London	Holden, DW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Microbiol Sect, London SW7 2AZ, England.	d.holden@imperial.ac.uk		Liu, Mei/0000-0002-4319-3063; Matthews, Steve/0000-0003-0676-0927	Medical Research Council (United Kingdom); Wellcome Trust; Medical Research Council [G0800148] Funding Source: researchfish; MRC [G0800148] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council (United Kingdom) and the Wellcome Trust (to D. W. H.).	Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Beuzon CR, 2001, INFECT IMMUN, V69, P7254, DOI 10.1128/IAI.69.12.7254-7261.2001; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Mathews MAA, 1998, J BACTERIOL, V180, P5580, DOI 10.1128/JB.180.21.5580-5590.1998; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; MCCARTHY JEG, 1994, TRENDS GENET, V10, P402, DOI 10.1016/0168-9525(94)90057-4; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; PARK SK, 1993, J BIOL CHEM, V268, P20170; PLUMBRIDGE JA, 1985, EMBO J, V4, P223, DOI 10.1002/j.1460-2075.1985.tb02339.x; Poh J, 2008, CELL MICROBIOL, V10, P20, DOI 10.1111/j.1462-5822.2007.01010.x; ROSS TK, 1989, J BACTERIOL, V171, P1974, DOI 10.1128/jb.171.4.1974-1981.1989; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Sarkar MK, 2010, J BIOL CHEM, V285, P675, DOI 10.1074/jbc.M109.068676; Schoenhals GJ, 1998, J BACTERIOL, V180, P2936, DOI 10.1128/JB.180.11.2936-2942.1998; Schuch R, 2001, INFECT IMMUN, V69, P2180, DOI 10.1128/IAI.69.4.2180-2189.2001; SMITH RA, 1980, P NATL ACAD SCI-BIOL, V77, P5370, DOI 10.1073/pnas.77.9.5370; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Yu XJ, 2004, MOL MICROBIOL, V54, P604, DOI 10.1111/j.1365-2958.2004.04297.x; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452	45	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					36098	36107		10.1074/jbc.M111.278663	http://dx.doi.org/10.1074/jbc.M111.278663			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21878641	hybrid, Green Published			2022-12-25	WOS:000295927100082
J	Liu, XS; Chopp, M; Zhang, RL; Tao, T; Wang, XL; Kassis, H; Hozeska-Solgot, A; Zhang, L; Chen, C; Zhang, ZG				Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Tao, Tang; Wang, Xin Li; Kassis, Haifa; Hozeska-Solgot, Ann; Zhang, Li; Chen, Charles; Zhang, Zheng Gang			MicroRNA Profiling in Subventricular Zone after Stroke: MiR-124a Regulates Proliferation of Neural Progenitor Cells through Notch Signaling Pathway	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; GENE-EXPRESSION DATA; QUANTITATIVE PCR; DOWN-REGULATION; STEM-CELLS; BRAIN; DIFFERENTIATION; NEUROGENESIS; RAT; MOUSE	Background: The Notch signaling pathway regulates adult neurogenesis under physiological and pathophysiological conditions. MicroRNAs are small non-coding RNA molecules that regulate gene expression. The present study investigated the effect of miR-124a on the Notch signaling pathway in stroke-induced neurogenesis. Methodology and Principal Findings: We found that adult rats subjected to focal cerebral ischemia exhibited substantial reduction of miR-124a expression, a neuron specific miRNA, in the neural progenitor cells of the subventricular zone (SVZ) of the lateral ventricle, which was inversely associated with activation of Notch signals. In vitro, transfection of neural progenitor cells harvested from the SVZ of adult rat with miR-124a repressed Jagged-1 (JAG1), a ligand of Notch, in a luciferase construct containing the JAG1 target site. Introduction of miR-124a in neural progenitor cells significantly reduced JAG1 transcript and protein levels, leading to inactivation of Notch signals. Transfection of neural progenitor cells with miR-124a significantly reduced progenitor cell proliferation and promoted neuronal differentiation measured by an increase in the number of Doublecortin positive cells, a marker of neuroblasts. Furthermore, introduction of miR-124a significantly increased p27Kip1 mRNA and protein levels, a downstream target gene of the Notch signaling pathway. Conclusions: Collectively, our study demonstrated that in vivo, stroke alters miRNA expression in SVZ neural progenitor cells and that in vitro, miR-124a mediates stroke-induced neurogenesis by targeting the JAG-Notch signaling pathway.	[Liu, Xian Shuang; Chopp, Michael; Zhang, Rui Lan; Tao, Tang; Wang, Xin Li; Kassis, Haifa; Hozeska-Solgot, Ann; Zhang, Li; Chen, Charles; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, XS (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Kassis, Haifa/0000-0003-3546-2590	National Institutes of Health [PO1 NS23393, RO1 HL064766]; AHA [10SDG2790012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156, P01NS023393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants PO1 NS23393 (MC), RO1 HL064766 (ZGZ) and AHA Scientist Development Grant 10SDG2790012 (XL). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Crombez L, 2007, BIOCHEM SOC T, V35, P44, DOI 10.1042/BST0350044; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Goodsaid FM, 2004, ENVIRON HEALTH PERSP, V112, P456, DOI 10.1289/ehp.6695; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jones P, 1998, BLOOD, V92, P1505, DOI 10.1182/blood.V92.5.1505.417k42_1505_1511; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Liu XS, 2009, J CEREBR BLOOD F MET, V29, P297, DOI 10.1038/jcbfm.2008.119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Murata J, 2009, J NEUROSCI RES, V87, P3521, DOI 10.1002/jnr.22169; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; OZCELIK T, 1992, GENOMICS, V13, P1157, DOI 10.1016/0888-7543(92)90031-M; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Papagiannakopoulos T, 2009, CELL STEM CELL, V4, P375, DOI 10.1016/j.stem.2009.04.007; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Scott CE, 2010, NAT NEUROSCI, V13, P1181, DOI 10.1038/nn.2646; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Solomon A, 2008, DEV BIOL, V316, P191, DOI 10.1016/j.ydbio.2007.12.046; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vohradsky J, 2010, NUCLEIC ACIDS RES, V38, P4579, DOI 10.1093/nar/gkq220; Wang L, 2009, NEUROSCIENCE, V158, P1356, DOI 10.1016/j.neuroscience.2008.10.064; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	61	177	196	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23461	10.1371/journal.pone.0023461	http://dx.doi.org/10.1371/journal.pone.0023461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887253	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298800009
J	Petris, G; Vecchi, L; Bestagno, M; Burrone, OR				Petris, Gianluca; Vecchi, Lara; Bestagno, Marco; Burrone, Oscar R.			Efficient Detection of Proteins Retro-Translocated from the ER to the Cytosol by In Vivo Biotinylation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; BIOTIN HOLOENZYME SYNTHETASE; SECRETORY PATHWAY; MISFOLDED PROTEINS; HEAVY-CHAINS; DEGRADATION; PROTEASOME; COMPLEX; RETROTRANSLOCATION; DISLOCATION	Retro-translocation from the ER to the cytosol of proteins within the secretory pathway takes place on misfolded molecules that are targeted for degradation by the cytosolically located 26S proteasome complex. Retro-translocation occurs also for other proteins (such as calreticulin) that, despite being synthesized and transported to the ER, are in part dislocated to the cytosol. We have taken advantage of the E. coli derived biotin-ligase (BirA) expressed in the cytosol of mammalian cells to specifically biotin-label in vivo proteins within the secretory pathway that undergo retro-translocation. We validated the method using four different proteins that are known to undergo retro-translocation upon different conditions: the human trans-membrane protein MHC class-I alpha chain (MHC-I alpha), the Null Hong Kong mutant of the secretory alpha 1 anti-trypsin (NHK-alpha 1AT), the immunoglobulin heavy chain (HC) and the ER chaperone calreticulin (Crt). We observed specific mono-biotinylation of cytosolically dislocated molecules, resulting in a novel, reliable way of determining the extent of retrotranslocation.	[Petris, Gianluca; Vecchi, Lara; Bestagno, Marco; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Petris, G (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	burrone@icgeb.org	Vecchi, Lara/AAJ-8208-2021; Petris, Gianluca/N-9754-2018	Petris, Gianluca/0000-0002-2420-6359	ICGEB	ICGEB	This work was supported by ICGEB institutional funding. G.P. was supported by an ICGEB pre-doctoral fellowship. L.V. was supported by an ICGEB pre-doctoral fellowship for the Corso di Perfezionamento of the Scuola Normale Superiore di Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Arieh SVB, 2003, BLOOD, V101, P2858, DOI 10.1182/blood-2002-07-2158; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; BATISTA FD, 1995, J IMMUNOL, V154, P209; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chevalier MS, 2002, J VIROL, V76, P8265, DOI 10.1128/JVI.76.16.8265-8275.2002; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Ding WX, 2008, AUTOPHAGY, V4, P141, DOI 10.4161/auto.5190; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Lee SO, 2010, EMBO J, V29, P363, DOI 10.1038/emboj.2009.359; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Paquet ME, 2004, J IMMUNOL, V172, P7548, DOI 10.4049/jimmunol.172.12.7548; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; Wolf B, 2005, J NUTR BIOCHEM, V16, P441, DOI 10.1016/j.jnutbio.2005.03.024	40	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23712	10.1371/journal.pone.0023712	http://dx.doi.org/10.1371/journal.pone.0023712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887304	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000049
J	Osborne, BJW; Sheth, PM; Kovacs, C; Mazzulli, T; Kaul, R				Osborne, Brendan J. W.; Sheth, Prameet M.; Kovacs, Colin; Mazzulli, Tony; Kaul, Rupert			Impact of Collection Method on Assessment of Semen HIV RNA Viral Load	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; SEMINAL PLASMA; TRANSMISSION; MEN	Background: The blood HIV RNA viral load is the best-defined predictor of HIV transmission, in part due to ease of measurement and the correlation of blood and genital tract (semen or cervico-vaginal) viral load, although recent studies found semen HIV RNA concentration to be a stronger predictor of HIV transmission. There is currently no standardized method for semen collection when measuring HIV RNA concentration. Therefore, we compared two collection techniques in order to study of the impact of antiretroviral therapy on the semen viral load. Methodology/Principal Findings: Semen was collected by masturbation from HIV-infected, therapy-naive men who have sex with men (MSM) either undiluted (Visit 1) or directly into transport medium (Visit 2). Seminal plasma was then isolated, and the HIV RNA concentration obtained with each collection technique was measured and corrected for dilution if necessary. Collection of semen directly into transport medium resulted in a median HIV RNA viral load that was 0.4 log10 higher than undiluted samples. Conclusions/Significance: The method of semen collection is an important consideration when quantifying the HIV RNA viral load in this compartment.	[Osborne, Brendan J. W.; Sheth, Prameet M.; Mazzulli, Tony; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Kovacs, Colin] Maple Leaf Med Ctr, Toronto, ON, Canada; [Mazzulli, Tony] Mt Sinai Hosp, Dept Med Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Osborne, BJW (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	brendan.osborne@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093	Canadian Institutes of Health Research [HOP-81735]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The present study is supported by a grant from the Canadian Institutes of Health Research (R.K.: HOP-81735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Chan DJ, 2008, CURR HIV RES, V6, P138, DOI 10.2174/157016208783885074; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunne AL, 2003, J CLIN VIROL, V26, P239, DOI 10.1016/S1386-6532(02)00122-1; Dyer JR, 1996, J VIROL METHODS, V60, P161, DOI 10.1016/0166-0934(96)02063-0; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Politch JA, 2007, HUM REPROD, V22, P2928, DOI 10.1093/humrep/dem281; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RESNICK L, 1986, JAMA-J AM MED ASSOC, V255, P1887, DOI 10.1001/jama.255.14.1887; Sheth PM, 2005, J IMMUNOL, V175, P4789, DOI 10.4049/jimmunol.175.7.4789; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04	11	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23654	10.1371/journal.pone.0023654	http://dx.doi.org/10.1371/journal.pone.0023654			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886808	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100023
J	Foerder, P; Galloway, M; Barthel, T; Moore, DE; Reiss, D				Foerder, Preston; Galloway, Marie; Barthel, Tony; Moore, Donald E., III; Reiss, Diana			Insightful Problem Solving in an Asian Elephant	PLOS ONE			English	Article							SELF-RECOGNITION; MAXIMUS; INTELLIGENCE; EVOLUTION; BEHAVIOR; BRAIN; TRUNK	The "aha" moment or the sudden arrival of the solution to a problem is a common human experience. Spontaneous problem solving without evident trial and error behavior in humans and other animals has been referred to as insight. Surprisingly, elephants, thought to be highly intelligent, have failed to exhibit insightful problem solving in previous cognitive studies. We tested whether three Asian elephants (Elephas maximus) would use sticks or other objects to obtain food items placed out-of-reach and overhead. Without prior trial and error behavior, a 7-year-old male Asian elephant showed spontaneous problem solving by moving a large plastic cube, on which he then stood, to acquire the food. In further testing he showed behavioral flexibility, using this technique to reach other items and retrieving the cube from various locations to use as a tool to acquire food. In the cube's absence, he generalized this tool utilization technique to other objects and, when given smaller objects, stacked them in an attempt to reach the food. The elephant's overall behavior was consistent with the definition of insightful problem solving. Previous failures to demonstrate this ability in elephants may have resulted not from a lack of cognitive ability but from the presentation of tasks requiring trunk-held sticks as potential tools, thereby interfering with the trunk's use as a sensory organ to locate the targeted food.	[Foerder, Preston; Reiss, Diana] CUNY, Grad Ctr, Biopsychol & Behav Neurosci Program, New York, NY 10021 USA; [Galloway, Marie; Barthel, Tony; Moore, Donald E., III] Smithsonian Natl Zool Pk, Washington, DC USA; [Reiss, Diana] CUNY, Hunter Coll, Dept Psychol, New York, NY 10021 USA	City University of New York (CUNY) System; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; City University of New York (CUNY) System; Hunter College (CUNY)	Foerder, P (corresponding author), CUNY, Grad Ctr, Biopsychol & Behav Neurosci Program, New York, NY 10021 USA.	dlr28@columbia.edu			Graduate Center of the City University of New York	Graduate Center of the City University of New York	Funding was provided by a Graduate Center of the City University of New York Doctoral Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK B B, 1973, Science (Washington D C), V182, P594, DOI 10.1126/science.182.4112.594; Bird CD, 2009, P NATL ACAD SCI USA, V106, pE77, DOI 10.1073/pnas.0906351106; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Byrne RW, 2009, COMP COGN BEHAV REV, V4, P65, DOI 10.3819/ccbr.2009.40009; CHEVALIERSKOLNIKOFF S, 1993, ANIM BEHAV, V46, P209, DOI 10.1006/anbe.1993.1183; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Hart BL, 2001, ANIM BEHAV, V62, P839, DOI 10.1006/anbe.2001.1815; HAUG H, 1987, AM J ANAT, V180, P126, DOI 10.1002/aja.1001800203; Irie-Sugimoto N, 2008, ANIM COGN, V11, P359, DOI 10.1007/s10071-007-0126-z; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; Jacobs B, 2011, BRAIN STRUCT FUNCT, V215, P273, DOI 10.1007/s00429-010-0288-3; Kacelnik A, 2009, P NATL ACAD SCI USA, V106, P10071, DOI 10.1073/pnas.0904735106; Kohler W., 1925, MENTALITY APES; Nissani Moti, 2004, P227; Pettigrew JD, 2010, BRAIN BEHAV EVOLUT, V75, P251, DOI 10.1159/000314898; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Plotnik JM, 2011, P NATL ACAD SCI USA, V108, P5116, DOI 10.1073/pnas.1101765108; Plotnik JM, 2010, ZOO BIOL, V29, P179, DOI 10.1002/zoo.20257; Poole Joyce H., 2008, P69; Rasmussen L.E.L., 2006, P409, DOI 10.1002/9780470344484.ch32; Rasmussen LEL, 1996, ANAT REC, V246, P127; RENSCH B, 1957, SCI AM, V196, P44, DOI 10.1038/scientificamerican0257-44; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shoshani J, 2006, BRAIN RES BULL, V70, P124, DOI 10.1016/j.brainresbull.2006.03.016; Shumaker R.W., 2011, ANIMAL TOOL BEHAV US; SUKUMAR R, 1997, ILLUSTRATED ENCY ELE, P158; Thorpe, 1963, LEARNING INSTINCT AN; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; ZEDTWITZ FRANZ XAVER, 1930, ZOOL GARTEN [LEIPZIG], V3, P250	32	51	53	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23251	10.1371/journal.pone.0023251	http://dx.doi.org/10.1371/journal.pone.0023251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876741	Green Published, gold			2022-12-25	WOS:000294126900013
J	Kukar, TL; Ladd, TB; Robertson, P; Pintchovski, SA; Moore, B; Bann, MA; Ren, Z; Jansen-West, K; Malphrus, K; Eggert, S; Maruyama, H; Cottrell, BA; Das, P; Basi, GS; Koo, EH; Golde, TE				Kukar, Thomas L.; Ladd, Thomas B.; Robertson, Paul; Pintchovski, Sean A.; Moore, Brenda; Bann, Maralyssa A.; Ren, Zhao; Jansen-West, Karen; Malphrus, Kim; Eggert, Simone; Maruyama, Hiroko; Cottrell, Barbara A.; Das, Pritam; Basi, Guriqbal S.; Koo, Edward H.; Golde, Todd E.			Lysine 624 of the Amyloid Precursor Protein (APP) Is a Critical Determinant of Amyloid beta Peptide Length SUPPORT FOR A SEQUENTIAL MODEL OF gamma-SECRETASE INTRAMEMBRANE PROTEOLYSIS AND REGULATION BY THE AMYLOID beta PRECURSOR PROTEIN (APP) JUXTAMEMBRANE REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL FRAGMENT; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; CLEAVAGE SITE; ZETA-CLEAVAGE; GXXXG MOTIFS; SUBSTRATE; SPECIFICITY; MODULATION	gamma-Secretase is a multiprotein intramembrane cleaving aspartyl protease (I-CLiP) that catalyzes the final cleavage of the amyloid beta precursor protein (APP) to release the amyloid beta peptide (A beta). A beta is the primary component of senile plaques in Alzheimer's disease (AD), and its mechanism of production has been studied intensely. gamma-Secretase executes multiple cleavages within the transmembrane domain of APP, with cleavages producing A beta and the APP intracellular domain (AICD), referred to as gamma and epsilon, respectively. The heterogeneous nature of the gamma cleavage that produces various A beta peptides is highly relevant to AD, as increased production of A beta 1-42 is genetically and biochemically linked to the development of AD. We have identified an amino acid in the juxtamembrane region of APP, lysine 624, on the basis of APP695 numbering (position 28 relative to A beta) that plays a critical role in determining the final length of A beta peptides released by gamma-secretase. Mutation of this lysine to alanine (K28A) shifts the primary site of gamma-secretase cleavage from 1-40 to 1-33 without significant changes to epsilon cleavage. These results further support a model where epsilon cleavage occurs first, followed by sequential proteolysis of the remaining transmembrane fragment, but extend these observations by demonstrating that charged residues at the luminal boundary of the APP transmembrane domain limit processivity of gamma-secretase.	[Kukar, Thomas L.] Emory Univ, Sch Med, Dept Pharmacol, Ctr Neurodegenerat Dis,Dept Neurol, Atlanta, GA 30322 USA; [Ladd, Thomas B.; Moore, Brenda; Golde, Todd E.] Univ Florida, Gainesville, FL 32610 USA; [Robertson, Paul; Jansen-West, Karen; Malphrus, Kim; Das, Pritam] Mayo Clin, Jacksonville, FL 32224 USA; [Pintchovski, Sean A.; Ren, Zhao; Basi, Guriqbal S.] Elan Pharmaceut, San Francisco, CA 94080 USA; [Bann, Maralyssa A.] Univ Washington, Seattle, WA 98195 USA; [Eggert, Simone; Maruyama, Hiroko; Cottrell, Barbara A.; Koo, Edward H.] Univ Calif San Diego, San Diego, CA 92093 USA	Emory University; State University System of Florida; University of Florida; Mayo Clinic; University of Washington; University of Washington Seattle; University of California System; University of California San Diego	Kukar, TL (corresponding author), 1510 Clifton Rd,5123 Rollins Res Ctr, Atlanta, GA 30322 USA.	tkukar@emory.edu	Kukar, Thomas/AAW-2612-2021	Kukar, Thomas/0000-0002-3750-6262; Moore, Brenda/0000-0002-9685-6561; Bann, Maralyssa/0000-0002-5893-950X	National Institutes of Health [AG20206, AG29886, AG032362, NS069289]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG032362, R01AG029886, K99AG032362, P01AG020206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG20206 (to T. E. G.), AG29886 (to E. H. K.), AG032362 (to T. L. K.), and NS069289 (to T. L. K.).	Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brouwers N, 2008, ANN MED, V40, P562, DOI 10.1080/07853890802186905; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dillen K, 2006, INT REV CYTOL, V254, P215, DOI 10.1016/S0074-7696(06)54005-7; Ford MJ, 2008, J NEUROSCI METH, V168, P465, DOI 10.1016/j.jneumeth.2007.11.019; Fukumori A, 2010, J NEUROSCI, V30, P7853, DOI 10.1523/JNEUROSCI.1443-10.2010; Golde TE, 2009, SCIENCE, V324, P603, DOI 10.1126/science.1174267; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Holt A, 2010, EUR BIOPHYS J BIOPHY, V39, P609, DOI 10.1007/s00249-009-0567-1; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kawooya JK, 2003, ANAL BIOCHEM, V323, P103, DOI 10.1016/j.ab.2003.08.027; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Murphy MP, 1999, J BIOL CHEM, V274, P11914, DOI 10.1074/jbc.274.17.11914; Narlawar R, 2007, BIOORG MED CHEM LETT, V17, P5428, DOI 10.1016/j.bmcl.2007.07.044; Ohki Y., 2011, EMBO J IN PRESS; Okochi M, 2006, J BIOL CHEM, V281, P7890, DOI 10.1074/jbc.M513250200; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Rosen Rebecca F, 2010, J Vis Exp, DOI 10.3791/1916; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; USAMI M, 1993, J NEUROCHEM, V61, P239, DOI 10.1111/j.1471-4159.1993.tb03560.x; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	49	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39804	39812		10.1074/jbc.M111.274696	http://dx.doi.org/10.1074/jbc.M111.274696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21868378	Green Published, hybrid			2022-12-25	WOS:000296925700014
J	Vellano, CP; Maher, EM; Hepler, JR; Blumer, JB				Vellano, Christopher P.; Maher, Ellen M.; Hepler, John R.; Blumer, Joe B.			G Protein-coupled Receptors and Resistance to Inhibitors of Cholinesterase-8A (Ric-8A) Both Regulate the Regulator of G Protein Signaling 14 (RGS14).G alpha(i1) Complex in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEINS; GOLOCO MOTIF; BETA(2)-ADRENERGIC RECEPTOR; EXPRESSION ANALYSIS; PLASMA-MEMBRANE; POINT MUTATION; ALPHA; RGS14; ACTIVATION	Regulator of G protein Signaling 14 (RGS14) is a multifunctional scaffolding protein that integrates both conventional and unconventional G protein signaling pathways. Like other RGS (regulator of G protein signaling) proteins, RGS14 acts as a GTPase accelerating protein to terminate conventional G alpha(i/o) signaling. However, unlike other RGS proteins, RGS14 also contains a G protein regulatory/GoLoco motif that specifically binds G alpha(i1/3)-GDP in cells and in vitro. The non-receptor guanine nucleotide exchange factor Ric-8A can bind and act on the RGS14.G alpha(i1)-GDP complex to play a role in unconventional G protein signaling independent of G protein-coupled receptors (GPCRs). Here we demonstrate that RGS14 forms a G alpha(i/o)-dependent complex with a G(i)-linked GPCR and that this complex is regulated by receptor agonist and Ric-8A (resistance to inhibitors of cholinesterase-8A). Using live cell bioluminescence resonance energy transfer, we show that RGS14 functionally associates with the alpha(2A)-adrenergic receptor (alpha(2A)-AR) in a G alpha(i/o)-dependent manner. This interaction is markedly disrupted after receptor stimulation by the specific agonist UK14304, suggesting complex dissociation or rearrangement. Agonist-mediated dissociation of the RGS14.alpha(2A)-AR complex occurs in the presence of G alpha(i/o) but not G alpha(s) or G alpha(q). Unexpectedly, RGS14 does not dissociate from G alpha(i1) in the presence of stimulated alpha(2A)-AR, suggesting preservation of RGS14.G alpha(i1) complexes after receptor activation. However, Ric-8A facilitates dissociation of both the RGS14.G alpha(i1) complex and the G alpha(i1)-dependent RGS14.alpha(2A)-AR complex after receptor activation. Together, these findings indicate that RGS14 can form complexes with GPCRs in cells that are dependent on G alpha(i/o) and that these RGS14.G alpha(i1).GPCR complexes may be substrates for other signaling partners such as Ric-8A.	[Vellano, Christopher P.; Hepler, John R.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Maher, Ellen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Emory University; Medical University of South Carolina	Vellano, CP (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd,Rollins Res Ctr G205, Atlanta, GA 30322 USA.	cvellan@emory.edu; blumerjb@musc.edu		Blumer, Joe/0000-0002-0020-3815	National Institutes of Health [R01NS049195, R01NS037112, R01GM086510]; Pharmacological Sciences Training Grant [T32 GM008602]; PhRMA Foundation; Microscopy Core of the Emory Neuroscience NINDS Core Facilities [P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R01NS049195, P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; PhRMA Foundation; Microscopy Core of the Emory Neuroscience NINDS Core Facilities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049195 and R01NS037112 (to J. R. H.), R01GM086510 (to J. B. B.), and Pharmacological Sciences Training Grant T32 GM008602 (to C. P. V.). This work was also supported by a PhRMA Foundation Pre-doctoral Pharmacology/Toxicology Fellowship (to C. P. V.). This research was also supported in part by the Microscopy Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077.	Audet N, 2008, J BIOL CHEM, V283, P15078, DOI 10.1074/jbc.M707941200; Blumer J. B., 2011, ACTA PHYSL IN PRESS; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; DUZIC E, 1992, J BIOL CHEM, V267, P9844; Fenech C, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.011.2009; Gabay M., 2011, FASEB J, V25, p[804, 805]; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hepler JR, 2005, BIOCHEMISTRY-US, V44, P5495, DOI 10.1021/bi048359d; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hollinger S, 2001, J NEUROCHEM, V79, P941, DOI 10.1046/j.1471-4159.2001.00629.x; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Ingi T, 1998, J NEUROSCI, V18, P7178; Khafizov K, 2009, J MOL MODEL, V15, P1491, DOI 10.1007/s00894-009-0516-z; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lambert NA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.125re5; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Shu FJ, 2010, CELL SIGNAL, V22, P366, DOI 10.1016/j.cellsig.2009.10.005; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Snow BE, 1997, BIOCHEM BIOPH RES CO, V233, P770, DOI 10.1006/bbrc.1997.6537; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Traver S, 2000, BIOCHEM J, V350, P19, DOI 10.1042/0264-6021:3500019; Vellano CP, 2011, BIOCHEMISTRY-US, V50, P752, DOI 10.1021/bi101910n; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yoshikawa K, 2009, CHEM SENSES, V34, P15, DOI 10.1093/chemse/bjn047	61	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38659	38669		10.1074/jbc.M111.274928	http://dx.doi.org/10.1074/jbc.M111.274928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21880739	hybrid, Green Published			2022-12-25	WOS:000296594200078
J	Achuthan, S; Santhoshkumar, TR; Prabhakar, J; Nair, SA; Pillai, MR				Achuthan, Santhi; Santhoshkumar, Thankayyan R.; Prabhakar, Jem; Nair, S. Asha; Pillai, M. Radhakrishna			Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; OXIDATIVE STRESS; CD133 EXPRESSION; SIDE-POPULATION; IDENTIFICATION; RESISTANCE; LINES; DEGRADATION; ASSOCIATION; OCT-4	Tumor recurrence after chemotherapy or radiation remains a major obstacle to successful cancer treatment. A subset of cancer cells, termed cancer stem cells, can elude conventional treatments and eventually regenerate a tumor that is more aggressive. Despite the large number of studies, molecular events that govern the emergence of aggressive therapy-resistant cells with stem cell properties after chemotherapy are poorly defined. The present study provides evidence for the rare escape of tumor cells from drug-induced cell death, after an intermediate stay in a non-cycling senescent stage followed by unstable multiplication characterized by spontaneous cell death. However, some cells appear to escape and generate stable colonies with an aggressive tumor stem cell-like phenotype. These cells displayed higher CD133 and Oct-4 expression. Notably, the drug-selected cells that contained low levels of reactive oxygen species (ROS) also showed an increase in antioxidant enzymes. Consistent with this in vitro experimental data, we observed lower levels of ROSin breast tumors obtained after neoadjuvant chemotherapy compared with samples that did not receive preoperative chemotherapy. These latter tissues also expressed enhanced levels of ROS defenses with enhanced expression of superoxide dismutase. Higher levels of Oct-4 and CD133 were also observed in tumors obtained after neoadjuvant chemotherapy. Further studies provided evidence for the stabilization of Nrf2 due to reduced 26 S proteasome activity and increased p21 association as the driving signaling event that contributes to the transition from a high ROS quiescent state to a low ROS proliferating stage in drug-induced tumor stem cell enrichment.	[Achuthan, Santhi; Santhoshkumar, Thankayyan R.; Nair, S. Asha; Pillai, M. Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Prabhakar, Jem] Reg Canc Ctr, Div Surg Oncol, Thiruvananthapuram 695011, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Pillai, MR (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	mrpillai@rgcb.res.in			Department of Biotechnology, Government of India [BT/PR/7793/MED/14/1112/2006]; Innovative Young Biotechnologist Award [BT/B1/12/040/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Innovative Young Biotechnologist Award	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR/7793/MED/14/1112/2006 (to M. R. P.) and Innovative Young Biotechnologist Award Grant BT/B1/12/040/2005 (to T. R. S. K.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Guo Y, 2004, STEM CELLS, V22, P259, DOI 10.1634/stemcells.22-3-259; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Jiang XH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-116; Joseph J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020114; Karakas B, 2007, CANCER BIOL THER, V6, P1025, DOI 10.4161/cbt.6.7.4202; Karimi-Busheri F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2583; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liang Y, 2010, J BIOL CHEM, V285, P4931, DOI 10.1074/jbc.M109.048397; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Ong CW, 2010, MODERN PATHOL, V23, P450, DOI 10.1038/modpathol.2009.181; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Ramanathan B, 2005, CANCER RES, V65, P8455, DOI 10.1158/0008-5472.CAN-05-1162; Rao AK, 2008, MOL ENDOCRINOL, V22, P1113, DOI 10.1210/me.2007-0381; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; te Poele RH, 2002, CANCER RES, V62, P1876; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Zheng X, 2004, CANCER RES, V64, P1773, DOI 10.1158/0008-5472.CAN-03-0820; Zhong WX, 1997, ONCOGENE, V14, P481, DOI 10.1038/sj.onc.1200852	50	145	156	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37813	37829		10.1074/jbc.M110.200675	http://dx.doi.org/10.1074/jbc.M110.200675			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878644	hybrid, Green Published			2022-12-25	WOS:000296542400076
J	Jaspers, C; Moller, LF; Kiorboe, T				Jaspers, Cornelia; Moller, Lene Friis; Kiorboe, Thomas			Salinity Gradient of the Baltic Sea Limits the Reproduction and Population Expansion of the Newly Invaded Comb Jelly Mnemiopsis leidyi	PLOS ONE			English	Article							CTENOPHORE MNEMIOPSIS; KIEL FJORD; DYNAMICS; PREDATION; COMMUNITY; ECOSYSTEM; PATTERNS; COPEPODS; CLIMATE; IMPACT	The recent invasion of the comb jelly Mnemiopsis leidyi into northern European waters is of major public and scientific concern. One of the key features making M. leidyi a successful invader is its high fecundity combined with fast growth rates. However, little is known about physiological limitations to its reproduction and consequent possible abiotic restrictions to its dispersal. To evaluate the invasion potential of M. leidyi into the brackish Baltic Sea we studied in situ egg production rates in different regions and at different salinities in the laboratory, representing the salinity gradient of the Baltic Sea. During October 2009 M. leidyi actively reproduced over large areas of the Baltic Sea. Egg production rates scaled with animal size but decreased significantly with decreasing salinity, both in the field (7-29) and in laboratory experiments (6-33). Temperature and zooplankton, i.e. food abundance, could not explain the observed differences. Reproduction rates at conditions representing the Kattegat, south western and central Baltic Sea, respectively, were 2.8 fold higher at the highest salinities (33 and 25) than at intermediate salinities (10 and 15) and 21 times higher compared from intermediate to the lowest salinity tested (6). Higher salinity areas such as the Kattegat, and to a lower extent the south western Baltic, seem to act as source regions for the M. leidyi population in the central Baltic Sea where a self-sustaining population, due to the low salinity, cannot be maintained.	[Jaspers, Cornelia; Kiorboe, Thomas] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Moller, Lene Friis] Univ Gothenburg, Dept Marine Ecol Kristineberg, Fiskebackskil, Sweden	Technical University of Denmark; University of Gothenburg	Jaspers, C (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	coja@aqua.dtu.dk	Kiørboe, Thomas/ABI-4733-2020; Kiørboe, Thomas/G-3190-2011	Kiørboe, Thomas/0000-0002-3265-336X; Kiørboe, Thomas/0000-0002-3265-336X; Butts, Ian/0000-0001-8447-1392; Jaspers, Cornelia/0000-0003-2850-4131	Baltic Organisations Network for funding Science EEIG (BONUS); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [210-2008-1882]; Royal Swedish Academy of Science [FOA11SLC-009]; FORMAS [217-2008-917]	Baltic Organisations Network for funding Science EEIG (BONUS); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Royal Swedish Academy of Science; FORMAS(Swedish Research Council Formas)	This work is a contribution to Baltic Zooplankton Cascades (BAZOOCA) funded by Baltic Organisations Network for funding Science EEIG (BONUS) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) project 210-2008-1882 CJ, LFM, TK (www.bazooca.se). Additional funding by the Royal Swedish Academy of Science (FOA11SLC-009) to CJ and FORMAS (217-2008-917) to LFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamstedt U., 1986, P1; Barz K, 2006, J MARINE SYST, V60, P167, DOI 10.1016/j.jmarsys.2006.01.002; Boersma M, 2007, HELGOLAND MAR RES, V61, P153, DOI 10.1007/s10152-006-0055-2; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Costello JH, 2006, LIMNOL OCEANOGR, V51, P1819, DOI 10.4319/lo.2006.51.4.1819; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Finenko GA, 2006, MAR ECOL PROG SER, V314, P171, DOI 10.3354/meps314171; Grove M, 2005, MAR ECOL PROG SER, V301, P185, DOI 10.3354/meps301185; Hardie DC, 2010, ENVIRON REV, V18, P1, DOI 10.1139/A09-014; Haslob H, 2007, MAR ECOL PROG SER, V349, P303, DOI 10.3354/meps07283; Huwer Bastian, 2008, Aquatic Invasions, V3, P113, DOI 10.3391/ai.2008.3.2.1; Jaspers C, 2011, LIMNOL OCEANOGR, V56, P431, DOI 10.4319/lo.2011.56.2.0431; Jaspers C, 2009, LIMNOL OCEANOGR-METH, V7, P430, DOI 10.4319/lom.2009.7.430; Javidpour J, 2009, J PLANKTON RES, V31, P729, DOI 10.1093/plankt/fbp021; Javidpour J, 2009, BIOL INVASIONS, V11, P873, DOI 10.1007/s10530-008-9300-8; Kideys AE, 2002, SCIENCE, V297, P1482, DOI 10.1126/science.1073002; KIORBOE T, 1988, HYDROBIOLOGIA, V167, P219, DOI 10.1007/BF00026308; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; Krauss W., 2001, BALTIC SEA CIRCULATI, DOI DOI 10.1006/RWOS.2001.0381; KREMER P, 1994, ICES J MAR SCI, V51, P347, DOI 10.1006/jmsc.1994.1036; KREMER P, 1975, THESIS U RHODE ISLAN; Kremer P., 1976, ESTUAR PROCESSES, V1, P197, DOI [10.1016/b978-0-12-751801-5.50024-1, DOI 10.1016/B978-0-12-751801-5.50024-1]; Nielsen TG, 2002, MAR BIOL, V141, P707, DOI 10.1007/s00227-002-0868-8; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Oliveira OMP, 2007, AQUAT INVASIONS, V2, P185, DOI 10.3391/ai.2007.2.3.5; Prieto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013793; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Purcell JE, 2005, LIMNOL OCEANOGR, V50, P376, DOI 10.4319/lo.2005.50.1.0376; REEVE MR, 1989, J PLANKTON RES, V11, P535, DOI 10.1093/plankt/11.3.535; RIISGAARD HU, 2007, AQUAT INVASIONS, V4, P395; RIISGAARD HU, 2010, AQUAT INVASIONS, DOI DOI 10.3391/AI.2010.5.4; Schaber M, 2011, J PLANKTON RES, V33, P1053, DOI 10.1093/plankt/fbq167; Tendal Ole Secher, 2007, Aquatic Invasions, V2, P455, DOI 10.3391/ai.2007.2.4.19	33	47	48	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24065	10.1371/journal.pone.0024065	http://dx.doi.org/10.1371/journal.pone.0024065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887373	Green Published, Green Accepted, gold			2022-12-25	WOS:000294298800030
J	Nasi, T; Maki, H; Kotilahti, K; Nissila, I; Haapalahti, P; Ilmoniemi, RJ				Nasi, Tiina; Maki, Hanna; Kotilahti, Kalle; Nissila, Ilkka; Haapalahti, Petri; Ilmoniemi, Risto J.			Magnetic-Stimulation-Related Physiological Artifacts in Hemodynamic Near-Infrared Spectroscopy Signals	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; HEMOGLOBIN-CONCENTRATION CHANGES; LEFT FRONTAL-LOBE; STIMULUS-INTENSITY; BRAIN ACTIVATION; FUNCTIONAL MRI; TMS; CORTEX; EXCITABILITY	Hemodynamic responses evoked by transcranial magnetic stimulation (TMS) can be measured with near-infrared spectroscopy (NIRS). This study demonstrates that cerebral neuronal activity is not their sole contributor. We compared bilateral NIRS responses following brain stimulation to those from the shoulders evoked by shoulder stimulation and contrasted them with changes in circulatory parameters. The left primary motor cortex of ten subjects was stimulated with 8-s repetitive TMS trains at 0.5, 1, and 2 Hz at an intensity of 75% of the resting motor threshold. Hemoglobin concentration changes were measured with NIRS on the stimulated and contralateral hemispheres. The photoplethysmograph (PPG) amplitude and heart rate were recorded as well. The left shoulder of ten other subjects was stimulated with the same protocol while the hemoglobin concentration changes in both shoulders were measured. In addition to PPG amplitude and heart rate, the pulse transit time was recorded. The brain stimulation reduced the total hemoglobin concentration (HbT) on the stimulated and contralateral hemispheres. The shoulder stimulation reduced HbT on the stimulated shoulder but increased it contralaterally. The waveforms of the HbT responses on the stimulated hemisphere and shoulder correlated strongly with each other (r = 0.65-0.87). All circulatory parameters were also affected. The results suggest that the TMS-evoked NIRS signal includes components that do not result directly from cerebral neuronal activity. These components arise from local effects of TMS on the vasculature. Also global circulatory effects due to arousal may affect the responses. Thus, studies involving TMS-evoked NIRS responses should be carefully controlled for physiological artifacts and effective artifact removal methods are needed to draw inferences about TMS-evoked brain activity.	[Nasi, Tiina; Maki, Hanna; Kotilahti, Kalle; Nissila, Ilkka; Ilmoniemi, Risto J.] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland; [Nasi, Tiina; Maki, Hanna; Kotilahti, Kalle; Ilmoniemi, Risto J.] Univ Helsinki, Cent Hosp, BioMag Lab, HUSLAB, Helsinki, Finland; [Haapalahti, Petri] Univ Helsinki, Cent Hosp, Div Clin Physiol & Nucl Med, HUSLAB, Helsinki, Finland	Aalto University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Nasi, T (corresponding author), Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci BECS, Espoo, Finland.	tiina.nasi@tkk.fi	Kotilahti, Kalle/G-7042-2012; Näsi, Tiina/E-7314-2012; Nissilä, Ilkka T/G-6879-2012; Ilmoniemi, Risto/E-9704-2012; Kotilahti, Kalle/O-1537-2019	Näsi, Tiina/0000-0002-5311-3530; Nissilä, Ilkka T/0000-0001-6534-8436; Ilmoniemi, Risto/0000-0002-3340-2618; 	Instrumentarium Science Foundation; Finnish Cultural Foundation; International Graduate School in Biomedical Engineering and Medical Physics; Academy of Finland [120946, 121167]	Instrumentarium Science Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); International Graduate School in Biomedical Engineering and Medical Physics; Academy of Finland(Academy of Finland)	This study was supported by the Instrumentarium Science Foundation, the Finnish Cultural Foundation, the International Graduate School in Biomedical Engineering and Medical Physics, and the Academy of Finland (projects 120946 and 121167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Y, 2009, NEUROSCI RES, V63, P47, DOI 10.1016/j.neures.2008.10.003; BARKER AT, 1985, LANCET, V1, P1106; Baudewig J, 2001, NEUROREPORT, V12, P3543, DOI 10.1097/00001756-200111160-00034; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bestmann S, 2005, NEUROIMAGE, V28, P22, DOI 10.1016/j.neuroimage.2005.05.027; Bestmann S, 2004, EUR J NEUROSCI, V19, P1950, DOI 10.1111/j.1460-9568.2004.03277.x; Bestmann S, 2008, EXP BRAIN RES, V191, P383, DOI 10.1007/s00221-008-1601-8; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Boden S, 2007, NEUROIMAGE, V36, P100, DOI 10.1016/j.neuroimage.2007.01.045; Bohning DE, 1999, BIOL PSYCHIAT, V45, P385, DOI 10.1016/S0006-3223(98)00368-0; Bohning DE, 1998, INVEST RADIOL, V33, P336, DOI 10.1097/00004424-199806000-00004; Firbank M, 1998, NEUROIMAGE, V8, P69, DOI 10.1006/nimg.1998.0348; Foerster A, 1997, EVOKED POTENTIAL, V104, P207, DOI 10.1016/S0168-5597(97)00016-6; Fox PT, 2006, HUM BRAIN MAPP, V27, P478, DOI 10.1002/hbm.20192; Franceschini MA, 2003, PSYCHOPHYSIOLOGY, V40, P548, DOI 10.1111/1469-8986.00057; Gregg Nicholas M, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00014; Guyton AC., 2006, TXB MED PHYSL; Hada Y, 2006, NEUROIMAGE, V32, P1226, DOI 10.1016/j.neuroimage.2006.04.200; Hanaoka N, 2007, NEUROSCI LETT, V414, P99, DOI 10.1016/j.neulet.2006.10.002; Heiskala J, 2009, PHYS MED BIOL, V54, P535, DOI 10.1088/0031-9155/54/3/005; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Kicic D, 2008, NEUROSCIENCE, V152, P1119, DOI 10.1016/j.neuroscience.2008.01.043; Koch Stefan P, 2010, Front Neuroenergetics, V2, P12, DOI 10.3389/fnene.2010.00012; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; Kozel FA, 2009, NEUROIMAGE, V47, P1177, DOI 10.1016/j.neuroimage.2009.05.016; Macefield VG, 1998, J AUTONOM NERV SYST, V68, P49, DOI 10.1016/S0165-1838(97)00117-3; Maki H, 2011, NEUROIMAGE, V54, P2706, DOI 10.1016/j.neuroimage.2010.11.041; Mochizuki H, 2006, EXP BRAIN RES, V169, P302, DOI 10.1007/s00221-005-0149-0; Mochizuki H, 2007, EXP BRAIN RES, V180, P667, DOI 10.1007/s00221-007-0884-5; Naschitz Jochanan E, 2004, J Clin Monit Comput, V18, P333, DOI 10.1007/s10877-005-4300-z; Nissila I, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1884193; Nissila I, 2005, ADV ELECTROMAG FIELD, V4, P77, DOI 10.1007/0-387-24024-1_3; Noguchi Y, 2003, NEUROIMAGE, V19, P156, DOI 10.1016/S1053-8119(03)00054-5; O'Shea J, 2008, CORTEX, V44, P598, DOI 10.1016/j.cortex.2007.08.012; Oliviero A, 1999, J NEUROL, V246, P1164, DOI 10.1007/s004150050536; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Saager R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940587; SANDER D, 1995, ELECTROMYOGR MOTOR C, V97, P43, DOI 10.1016/0924-980X(94)00247-5; Shelley KH, 2007, ANESTH ANALG, V105, pS31, DOI 10.1213/01.ane.0000269512.82836.c9; Shibasaki H, 2008, CLIN NEUROPHYSIOL, V119, P731, DOI 10.1016/j.clinph.2007.10.026; Siebner HR, 2001, NEUROIMAGE, V14, P883, DOI 10.1006/nimg.2001.0889; Speer AM, 2003, BIOL PSYCHIAT, V54, P826, DOI 10.1016/S0006-3223(03)00324-X; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P307, DOI 10.1007/978-0-387-85998-9_46; Thomson RH, 2011, CLIN NEUROPHYSIOL, V122, P378, DOI 10.1016/j.clinph.2010.08.003; Virtanen J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253323; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552	49	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24002	10.1371/journal.pone.0024002	http://dx.doi.org/10.1371/journal.pone.0024002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887362	gold, Green Published, Green Submitted			2022-12-25	WOS:000294298800025
J	Chung, S; Sundar, IK; Hwang, JW; Yull, FE; Blackwell, TS; Kinnula, VL; Bulger, M; Yao, HW; Rahman, I				Chung, Sangwoon; Sundar, Isaac K.; Hwang, Jae-Woong; Yull, Fiona E.; Blackwell, Timothy S.; Kinnula, Vuokko L.; Bulger, Michael; Yao, Hongwei; Rahman, Irfan			NF-kappa B Inducing Kinase, NIK Mediates Cigarette Smoke/TNF alpha-Induced Histone Acetylation and Inflammation through Differential Activation of IKKs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ALVEOLAR EPITHELIAL-CELLS; PROINFLAMMATORY CYTOKINE RELEASE; INDUCED LUNG INFLAMMATION; GENE-EXPRESSION; OXIDATIVE STRESS; CHROMATIN MODIFICATION; DEACETYLASE ACTIVITY; PHOSPHORYLATION; PATHWAY	Background: Nuclear factor (NF)-kappa B inducing kinase (NIK) is a central player in the non-canonical NF kappa B pathway, which phosphorylates I kappa B kinase alpha (IKK alpha) resulting in enhancement of target gene expression. We have recently shown that IKK alpha responds to a variety of stimuli including oxidants and cigarette smoke (CS) regulating the histone modification in addition to its role in NF-kappa B activation. However, the primary signaling mechanism linking CS-mediated oxidative stress and TNF alpha with histone acetylation and pro-inflammatory gene transcription is not well understood. We hypothesized that CS and TNF alpha increase NIK levels causing phosphorylation of IKKa, which leads to histone acetylation. Methodology: To test this hypothesis, we investigated whether NIK mediates effects of CS and TNF alpha on histone acetylation in human lung epithelial cells in vitro and in lungs of mouse exposed to CS in vivo. CS increased the phosphorylation levels of IKK alpha/NIK in lung epithelial cells and mouse lungs. NIK is accumulated in the nuclear compartment, and is recruited to the promoters of pro-inflammatory genes, to induce posttranslational acetylation of histones in response to CS and TNF alpha. Cells in which NIK is knocked down using siRNA showed partial attenuation of CSE- and TNF alpha-induced acetylation of histone H3 on pro-inflammatory gene promoters. Additional study to determine the role of IKK beta/NF-kappa B pathway in CS-induced histone acetylation suggests that the canonical pathway does not play a role in histone acetylation particularly in response to CS in mouse lungs. Conclusions: Overall, our findings provide a novel role for NIK in CS- and TNF alpha-induced histone acetylation, especially on histone H3K9.	[Chung, Sangwoon; Sundar, Isaac K.; Hwang, Jae-Woong; Yao, Hongwei; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Yull, Fiona E.; Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Kinnula, Vuokko L.] Univ Helsinki, Div Pulm, Dept Med, Helsinki, Finland; [Kinnula, Vuokko L.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Bulger, Michael] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA	University of Rochester; Vanderbilt University; Vanderbilt University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Rochester	Chung, S (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Lung Biol & Dis Program, Rochester, NY 14642 USA.	Irfan_Rahman@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; Sundar, Isaac K/F-8764-2012	Sundar, Isaac K/0000-0001-6742-3460	National Institutes of Health - National Heart, Lung, and Blood Institute [R01-HL085613]; National Institute of Environmental Health Sciences Center [NIEHS P30-ES01247]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health - National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health - National Heart, Lung, and Blood Institute Grant R01-HL085613, and the National Institute of Environmental Health Sciences Center Grant NIEHS P30-ES01247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Adcock IM, 2011, RESPIRATION, V81, P265, DOI 10.1159/000324601; Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Azim AC, 2007, J IMMUNOL, V179, P7868, DOI 10.4049/jimmunol.179.11.7868; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Chung S, 2010, AM J PHYSIOL-LUNG C, V299, pL192, DOI 10.1152/ajplung.00426.2009; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hirata Y, 2006, INFECT IMMUN, V74, P1452, DOI 10.1128/IAI.74.3.1452-1461.2006; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jiang X, 2003, BIOCHEM BIOPH RES CO, V301, P583, DOI 10.1016/S0006-291X(03)00011-1; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Li Q, 2006, J BIOL CHEM, V281, P1495, DOI 10.1074/jbc.M511153200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Marwick JA, 2004, AM J RESP CELL MOL, V31, P633, DOI 10.1165/rcmb.2004-0006OC; Millington GWM, 2008, PHARMACOGENOMICS, V9, P1835, DOI 10.2217/14622416.9.12.1835; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Park GY, 2006, J BIOL CHEM, V281, P18684, DOI 10.1074/jbc.M600733200; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rajendrasozhan S, 2008, ANTIOXID REDOX SIGN, V10, P799, DOI 10.1089/ars.2007.1938; Rajendrasozhan S, 2010, PULM PHARMACOL THER, V23, P172, DOI 10.1016/j.pupt.2010.01.002; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; RODKEY FL, 1979, CLIN CHEM, V25, P1388; Sanjo H, 2010, J BIOL CHEM, V285, P17148, DOI 10.1074/jbc.M110.105874; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Song YS, 2010, J CEREBR BLOOD F MET, V30, P1265, DOI 10.1038/jcbfm.2010.6; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; Szulakowski P, 2006, AM J RESP CRIT CARE, V174, P41, DOI 10.1164/rccm.200505-725OC; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Tuder RM, 2006, AM J RESP CRIT CARE, V174, P490, DOI 10.1164/rccm.200607-924ED; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang SR, 2008, AM J RESP CELL MOL, V38, P689, DOI 10.1165/rcmb.2007-0379OC; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2011, TOXICOL APPL PHARM, V254, P72, DOI 10.1016/j.taap.2009.10.022; Yao HW, 2010, J BIOL CHEM, V285, P5405, DOI 10.1074/jbc.M109.041418; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105	65	36	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23488	10.1371/journal.pone.0023488	http://dx.doi.org/10.1371/journal.pone.0023488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887257	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000021
J	Mahlokozera, T; Kang, HH; Goonetilleke, N; Stacey, AR; Lovingood, RV; Denny, TN; Kalilani, L; Bunn, JEG; Meshnick, SR; Borrow, P; Letvin, NL; Permar, SR				Mahlokozera, Tatenda; Kang, Helen H.; Goonetilleke, Nilu; Stacey, Andrea R.; Lovingood, Rachel V.; Denny, Thomas N.; Kalilani, Linda; Bunn, James E. G.; Meshnick, Steve R.; Borrow, Persephone; Letvin, Norman L.; Permar, Sallie R.		Ctr HIV AIDS Vaccine Immunology	The Magnitude and Kinetics of the Mucosal HIV-Specific CD8+T Lymphocyte Response and Virus RNA Load in Breast Milk	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; SUBCLINICAL MASTITIS; CELL RESPONSES; TYPE-1 RNA; CHILD TRANSMISSION; VIRAL LOAD; CLASS-I; RISK; INFECTION	Background: The risk of postnatal HIV transmission is associated with the magnitude of the milk virus load. While HIV-specific cellular immune responses control systemic virus load and are detectable in milk, the contribution of these responses to the control of virus load in milk is unknown. Methods: We assessed the magnitude of the immunodominant GagRY11 and subdominant EnvKY9-specific CD8+ T lymphocyte response in blood and milk of 10 A*3002+, HIV-infected Malawian women throughout the period of lactation and correlated this response to milk virus RNA load and markers of breast inflammation. Results: The magnitude and kinetics of the HIV-specific CD8+ T lymphocyte responses were discordant in blood and milk of the right and left breast, indicating independent regulation of these responses in each breast. However, there was no correlation between the magnitude of the HIV-specific CD8+ T lymphocyte response and the milk virus RNA load. Further, there was no correlation between the magnitude of this response and markers of breast inflammation. Conclusions: The magnitude of the HIV-specific CD8+ T lymphocyte response in milk does not appear to be solely determined by the milk virus RNA load and is likely only one of the factors contributing to maintenance of low virus load in milk.	[Mahlokozera, Tatenda; Kang, Helen H.; Letvin, Norman L.; Permar, Sallie R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA; [Goonetilleke, Nilu] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford, England; [Stacey, Andrea R.; Borrow, Persephone] Univ Oxford, Jenner Inst, Nuffield Dept Clin Med, Newbury, Berks, England; [Lovingood, Rachel V.; Denny, Thomas N.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Kalilani, Linda; Bunn, James E. G.] Univ Malawi, Coll Med, Blantyre, Malawi; [Bunn, James E. G.] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Meshnick, Steve R.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Permar, Sallie R.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Oxford; University of Oxford; Jenner Institute; Duke University; University of Malawi; Alder Hey Children's NHS Foundation Trust; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard Medical School	Mahlokozera, T (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA.	sallie.permar@childrens.harvard.edu		Denny, Thomas/0000-0002-7364-8276; Borrow, Persephone/0000-0002-3877-9780	Center for HIV/AIDS Vaccine Immunology [AI067854]; National Institutes of Health (NIH) [K08AI087992]; Pediatric Infectious Disease Society/St. Jude Children's Hospital; Doris Duke Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, P30AI060354, K08AI087992, U01AI067854] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Infectious Disease Society/St. Jude Children's Hospital; Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for HIV/AIDS Vaccine Immunology (AI067854), the National Institutes of Health (NIH) grant K08AI087992 (S. R. P.), the Pediatric Infectious Disease Society/St. Jude Children's Hospital Basic Science Research Award (S. R. P.), and the Doris Duke Foundation Clinical Scientist Development Award (S. R. P.). P. B. is a Jenner Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosire R, 2007, BREASTFEED MED, V2, P129, DOI 10.1089/bfm.2007.0009; Bunce Mike, 2003, Methods Mol Biol, V210, P143; Cromwell MA, 2011, AM J REPROD IMMUNOL, V65, P242, DOI 10.1111/j.1600-0897.2010.00966.x; Embree JE, 2000, AIDS, V14, P2535, DOI 10.1097/00002030-200011100-00016; Farquhar C, 2005, CURR HIV RES, V3, P361, DOI 10.2174/157016205774370393; FUJIWARA S, 1986, J IMMUNOL METHODS, V90, P265; Gantt S, 2010, J VIROL, V84, P10812, DOI 10.1128/JVI.00543-10; Gomo E, 2003, T ROY SOC TROP MED H, V97, P212, DOI 10.1016/S0035-9203(03)90124-6; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Goulder PJR, 2001, J VIROL, V75, P1339, DOI 10.1128/JVI.75.3.1339-1347.2001; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; HALE ML, 1976, NATURE, V260, P44, DOI 10.1038/260044a0; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HEAD JR, 1977, SEMIN PERINATOL, V1, P195; Heath L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010213; Hel Z, 2001, J VIROL, V75, P11483, DOI 10.1128/JVI.75.23.11483-11495.2001; Hoffman IF, 2003, J INFECT DIS, V188, P1209, DOI 10.1086/378414; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; John G C, 2001, East Afr Med J, V78, P75; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KELLER MA, 1987, PEDIATR RES, V22, P277, DOI 10.1203/00006450-198709000-00008; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Lunney KM, 2010, CLIN INFECT DIS, V50, P762, DOI 10.1086/650535; MOHR JA, 1973, J PEDIATR-US, V82, P1062, DOI 10.1016/S0022-3476(73)80448-2; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; OGRA SS, 1977, J IMMUNOL, V119, P245; Permar SR, 2008, J IMMUNOL, V181, P3643, DOI 10.4049/jimmunol.181.5.3643; Permar SR, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-7; Pillay K, 2000, J ACQ IMMUN DEF SYND, V24, P330, DOI 10.1097/00126334-200008010-00006; Read JS, 2003, PEDIATRICS, V112, P1196, DOI 10.1542/peds.112.5.1196; Roehr Bob, 2008, BMJ, V337, pa1099, DOI 10.1136/bmj.a1099; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Salazar-Gonzalez JF, 2011, J VIROL, V85, P2751, DOI 10.1128/JVI.02316-10; SCHLESINGER JJ, 1977, LANCET, V2, P529; Schmitz JE, 2001, BLOOD, V98, P3757, DOI 10.1182/blood.V98.13.3757; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; Semba R D, 1999, J Hum Lact, V15, P301, DOI 10.1177/089033449901500407; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Shacklett BL, 2000, AIDS, V14, P1911, DOI 10.1097/00002030-200009080-00005; Shacklett BL, 2000, AIDS RES HUM RETROV, V16, P1157, DOI 10.1089/088922200415009; Shepard RN, 2000, J CLIN MICROBIOL, V38, P1414, DOI 10.1128/JCM.38.4.1414-1418.2000; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; Veazey RS, 2003, J MED PRIMATOL, V32, P194, DOI 10.1034/j.1600-0684.2003.00025.x; VENKATARAMAN M, 1986, CRYOBIOLOGY, V23, P199, DOI 10.1016/0011-2240(86)90045-3; Walter J, 2007, JAIDS-J ACQ IMM DEF, V46, P200, DOI 10.1097/QAI.0b013e318141f942; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; Willumsen JF, 2003, AIDS, V17, P407, DOI 10.1097/00002030-200302140-00015; Willumsen JF, 2001, AIDS, V15, P1896, DOI 10.1097/00002030-200109280-00026; Willumsen JF, 2000, ADV EXP MED BIOL, V478, P211	57	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23735	10.1371/journal.pone.0023735	http://dx.doi.org/10.1371/journal.pone.0023735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886819	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500029
J	Yuan, J; Wei, BY; Shi, MM; Gao, HC				Yuan, Jie; Wei, Buyun; Shi, Miaomiao; Gao, Haichun			Functional Assessment of EnvZ/OmpR Two-Component System in Shewanella oneidensis	PLOS ONE			English	Article							GLOBAL TRANSCRIPTOME ANALYSIS; ENTERICA SEROVAR TYPHIMURIUM; ACID TOLERANCE RESPONSE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; REGULATORY SYSTEM; ACETYL PHOSPHATE; SHOCK RESPONSE; SP-NOV.; OMPR	EnvZ and OmpR constitute the bacterial two-component signal transduction system known to mediate osmotic stress response in a number of Gram-negative bacteria. In an effort to understand the mechanism through which Shewanella oneidensis senses and responds to environmental osmolarity changes, structure of the ompR-envZ operon was determined with Northern blotting assay and roles of the EnvZ/OmpR two-component system in response to various stresses were investigated with mutational analysis, quantitative reverse transcriptase PCR (qRT-PCR), and phenotype microarrays. Results from the mutational analysis and qRT-PCR suggested that the EnvZ/OmpR system contributed to osmotic stress response of S. oneidensis and very likely engaged a similar strategy employed by E. coli, which involved reciprocal regulation of two major porin coding genes. Additionally, the ompR-envZ system was also found related to cell motility. We further showed that the ompR-envZ dependent regulation of porin genes and motility resided almost completely on ompR and only partially on envZ, indicating additional mechanisms for OmpR phosphorylation. In contrast to E. coli lacking ompR-envZ, however, growth of S. oneidensis did not show a significant dependence on ompR-envZ even under osmotic stress. Further analysis with phenotype microarrays revealed that the S. oneidensis strains lacking a complete ompR-envZ system displayed hypersensitivities to a number of agents, especially in alkaline environment. Taken together, our results suggest that the function of the ompR-envZ system in S. oneidensis, although still connected with osmoregulation, has diverged considerably from that of E. coli. Additional mechanism must exist to support growth of S. oneidensis under osmotic stress.	[Yuan, Jie; Wei, Buyun; Shi, Miaomiao; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yuan, J (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Science and Technology Department of Zhejiang [2009C12061]; Fundamental Research Funds for the Central Universities; Major State Basic Research Development Program (973 Program) [2010CB833803]; Zhejiang RD program [2009R50G2010001]; Department of education of Zhejiang Province [Z200909658]	Science and Technology Department of Zhejiang; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); Zhejiang RD program; Department of education of Zhejiang Province	This study was financially supported by Major Program of Science and Technology Department of Zhejiang (2009C12061), by the Fundamental Research Funds for the Central Universities, and by Major State Basic Research Development Program (973 Program: 2010CB833803) to HG; and by Zhejiang R&D program (2009R50G2010001) and Department of education of Zhejiang Province (Z200909658) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1990, FEBS LETT, V261, P19, DOI 10.1016/0014-5793(90)80626-T; Arricau N, 1998, MOL MICROBIOL, V29, P835, DOI 10.1046/j.1365-2958.1998.00976.x; Bang IS, 2000, J BACTERIOL, V182, P2245, DOI 10.1128/JB.182.8.2245-2252.2000; Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x; BERNARDINI ML, 1990, J BACTERIOL, V172, P6274, DOI 10.1128/jb.172.11.6274-6281.1990; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; BRETTAR I, 1993, MAR ECOL PROG SER, V94, P253, DOI 10.3354/meps094253; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Csonka L. N., 1996, ESCHERICHIA COLI SAL, P1210; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gao WM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-76; Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Heyde M, 2000, J BACTERIOL, V182, P198, DOI 10.1128/JB.182.1.198-202.2000; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Matsubara M, 2000, GENES CELLS, V5, P555, DOI 10.1046/j.1365-2443.2000.00347.x; Matsubara M, 1999, BIOSCI BIOTECH BIOCH, V63, P408, DOI 10.1271/bbb.63.408; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; Mills SD, 1998, INFECT IMMUN, V66, P1806, DOI 10.1128/IAI.66.4.1806-1811.1998; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; MIZUNO T, 1988, J BIOL CHEM, V263, P1008; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Pagani L, 2003, J CLIN MICROBIOL, V41, P2240, DOI 10.1128/JCM.41.5.2240-2241.2003; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Rodriguez-Morales O, 2006, INFECT IMMUN, V74, P1398, DOI 10.1128/IAI.74.2.1398-1402.2006; Rychlik I, 2005, FEMS MICROBIOL REV, V29, P1021, DOI 10.1016/j.femsre.2005.03.005; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; SEMPLE KM, 1987, CAN J MICROBIOL, V33, P366, DOI 10.1139/m87-064; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Skerratt JH, 2002, INT J SYST EVOL MICR, V52, P2101, DOI [10.1099/ijs.0.02351-0, 10.1099/00207713-52-6-2101]; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yamada M, 2000, J BACTERIOL, V182, P2945, DOI 10.1128/JB.182.10.2945-2952.2000; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	51	49	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23701	10.1371/journal.pone.0023701	http://dx.doi.org/10.1371/journal.pone.0023701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886811	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500024
J	Kwei, KA; Shain, AH; Bair, R; Montgomery, K; Karikari, CA; van de Rijn, M; Hidalgo, M; Maitra, A; Bashyam, MD; Pollack, JR				Kwei, Kevin A.; Shain, A. Hunter; Bair, Ryan; Montgomery, Kelli; Karikari, Collins A.; van de Rijn, Matt; Hidalgo, Manuel; Maitra, Anirban; Bashyam, Murali D.; Pollack, Jonathan R.			SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN BREAST-TUMORS; TGF-BETA; HOMOZYGOUS DELETIONS; UBIQUITIN LIGASES; CELL-MIGRATION; REVEALS; ADENOCARCINOMA; IDENTIFICATION; DEGRADATION	Pancreatic cancer is a deadly disease, and new therapeutic targets are urgently needed. We previously identified DNA amplification at 7q21-q22 in pancreatic cancer cell lines. Now, by high-resolution genomic profiling of human pancreatic cancer cell lines and human tumors (engrafted in immunodeficient mice to enrich the cancer epithelial fraction), we define a 325 Kb minimal amplicon spanning SMURF1, an E3 ubiquitin ligase and known negative regulator of transforming growth factor beta (TGF beta) growth inhibitory signaling. SMURF1 amplification was confirmed in primary human pancreatic cancers by fluorescence in situ hybridization (FISH), where 4 of 95 cases (4.2%) exhibited amplification. By RNA interference (RNAi), knockdown of SMURF1 in a human pancreatic cancer line with focal amplification (AsPC-1) did not alter cell growth, but led to reduced cell invasion and anchorage-independent growth. Interestingly, this effect was not mediated through altered TGFb signaling, assayed by transcriptional reporter. Finally, overexpression of SMURF1 (but not a catalytic mutant) led to loss of contact inhibition in NIH-3T3 mouse embryo fibroblast cells. Together, these findings identify SMURF1 as an amplified oncogene driving multiple tumorigenic phenotypes in pancreatic cancer, and provide a new druggable target for molecularly directed therapy.	[Kwei, Kevin A.; Shain, A. Hunter; Bair, Ryan; Montgomery, Kelli; van de Rijn, Matt; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Karikari, Collins A.; Maitra, Anirban] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Hidalgo, Manuel] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Hidalgo, Manuel] Ctr Nacl Invest Oncol, Clin Res Program, Madrid, Spain; [Bashyam, Murali D.] Ctr DNA Fingerprinting & Diagnost, Mol Oncol Lab, Hyderabad, Andhra Pradesh, India	Stanford University; Johns Hopkins University; Johns Hopkins University; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Kwei, KA (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	pollack1@stanford.edu	HIDALGO, MANUEL/I-4995-2015	HIDALGO, MANUEL/0000-0002-3765-3318; van de Rijn, Matt/0000-0002-1909-9739	NIH [CA112016, CA09151, CA62924]; NIH/NCRR [UL1 RR025744]; Lustgarten Foundation; Department of Biotechnology, Ministry of Science and Technology, Government of India; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA112016, T32CA009151] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Lustgarten Foundation; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the NIH: CA112016 (J.R.P.), CA09151 (K.A.K.), GI Cancer SPORE CA62924 (A.M.); NIH/NCRR CTSA grant UL1 RR025744 to Stanford Spectrum; and the Lustgarten Foundation (J.R.P.). M.D.B. was supported in part by a Biotechnology overseas associateship from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The authors also thank the family of Margaret Lee and the Sol Goldman Pancreatic Cancer Research Center for supporting the xenografting efforts at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; CHEN S, 2008, CANC BIOL THER, V7; Dai JL, 1998, CANCER RES, V58, P4592; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HAHN SA, 1995, CANCER RES, V55, P4670; Heidenblad M, 2004, CANCER RES, V64, P3052, DOI 10.1158/0008-5472.CAN-03-3159; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Hruban Ralph H, 2008, Gastrointest Cancer Res, V2, pS10; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kwei KA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000081; Laurila E, 2009, GENE CHROMOSOME CANC, V48, P330, DOI 10.1002/gcc.20643; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Mahlamaki EH, 2004, NEOPLASIA, V6, P432, DOI 10.1593/neo.04130; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Schutte M, 1996, CANCER RES, V56, P2527; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Suzuki A, 2008, CANCER SCI, V99, P986, DOI 10.1111/j.1349-7006.2008.00779.x; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Wan M, 2005, AM J PATHOL, V166, P1379, DOI 10.1016/S0002-9440(10)62356-5; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S	35	45	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23924	10.1371/journal.pone.0023924	http://dx.doi.org/10.1371/journal.pone.0023924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887346	gold, Green Published, Green Submitted			2022-12-25	WOS:000294251800040
J	Rubio, M; Villain, H; Docagne, F; Roussel, BD; Ramos, JA; Vivien, D; Fernandez-Ruiz, J; Ali, C				Rubio, Marina; Villain, Helene; Docagne, Fabian; Roussel, Benoit D.; Ramos, Jose Antonio; Vivien, Denis; Fernandez-Ruiz, Javier; Ali, Carine			Pharmacological Activation/Inhibition of the Cannabinoid System Affects Alcohol Withdrawal-Induced Neuronal Hypersensitivity to Excitotoxic Insults	PLOS ONE			English	Article							BRAIN-DAMAGE; ENDOCANNABINOID CONTENTS; PRECLINICAL EVIDENCE; HIPPOCAMPAL-NEURONS; RECEPTOR AGONISTS; CORTICAL-NEURONS; PRIMARY CULTURES; CB1 RECEPTORS; ETHANOL; ANANDAMIDE	Cessation of chronic ethanol consumption can increase the sensitivity of the brain to excitotoxic damages. Cannabinoids have been proposed as neuroprotectants in different models of neuronal injury, but their effect have never been investigated in a context of excitotoxicity after alcohol cessation. Here we examined the effects of the pharmacological activation/inhibition of the endocannabinoid system in an in vitro model of chronic ethanol exposure and withdrawal followed by an excitotoxic challenge. Ethanol withdrawal increased N-methyl-D-aspartate (NMDA)-evoked neuronal death, probably by altering the ratio between GluN2A and GluN2B NMDA receptor subunits. The stimulation of the endocannabinoid system with the cannabinoid agonist HU-210 decreased NMDA-induced neuronal death exclusively in ethanol-withdrawn neurons. This neuroprotection could be explained by a decrease in NMDA-stimulated calcium influx after the administration of HU-210, found exclusively in ethanol-withdrawn neurons. By contrast, the inhibition of the cannabinoid system with the CB1 receptor antagonist rimonabant (SR141716) during ethanol withdrawal increased death of ethanol-withdrawn neurons without any modification of NMDA-stimulated calcium influx. Moreover, chronic administration of rimonabant increased NMDA-stimulated toxicity not only in withdrawn neurons, but also in control neurons. In summary, we show for the first time that the stimulation of the endocannabinoid system is protective against the hyperexcitability developed during alcohol withdrawal. By contrast, the blockade of the endocannabinoid system is highly counterproductive during alcohol withdrawal.	[Rubio, Marina; Villain, Helene; Docagne, Fabian; Roussel, Benoit D.; Vivien, Denis; Ali, Carine] UMR CNRS 6232 CINAPS, INSERM U919, Serine Protease & Pathophysiol Neurovasc Unit, Caen, France; [Rubio, Marina; Ramos, Jose Antonio; Fernandez-Ruiz, Javier] Univ Complutense, Dept Bioquim & Biol Mol, Inst Univ Invest Neuroquim, E-28040 Madrid, Spain; [Ramos, Jose Antonio; Fernandez-Ruiz, Javier] Univ Complutense, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-28040 Madrid, Spain; [Ramos, Jose Antonio; Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, IRYCIS, E-28040 Madrid, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Complutense University of Madrid	Rubio, M (corresponding author), UMR CNRS 6232 CINAPS, INSERM U919, Serine Protease & Pathophysiol Neurovasc Unit, Caen, France.	rubio@cyceron.fr	Docagne, Fabian/S-8308-2018; Roussel, Benoit/L-9520-2018; Roussel, Benoit/P-9309-2019; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	Roussel, Benoit/0000-0003-0575-8112; Rubio, Marina/0000-0002-6120-4053; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Ali, Carine/0000-0001-8007-7910; VIVIEN, DENIS/0000-0002-7636-2185; Docagne, Fabian/0000-0003-1745-0625	INSERM; French Ministry of Research and Technology; Regional Council of Lower Normandy; University of Caen Basse-Normandie; Spanish Ministry of Education and Science [AP2003-1262]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministry of Research and Technology; Regional Council of Lower Normandy(Region Normandie); University of Caen Basse-Normandie(Region Normandie); Spanish Ministry of Education and Science(Spanish Government)	This work was supported by grants from the INSERM, the French Ministry of Research and Technology, the Regional Council of Lower Normandy, the University of Caen Basse-Normandie. MR had a grant from the Spanish Ministry of Education and Science (AP2003-1262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basavarajappa BS, 1999, J NEUROCHEM, V72, P522, DOI 10.1046/j.1471-4159.1999.0720522.x; Basavarajappa BS, 2003, EUR J PHARMACOL, V466, P73, DOI 10.1016/S0014-2999(03)01557-7; Basavarajappa BS, 2002, PROSTAG LEUKOTR ESS, V66, P287, DOI 10.1054/plef.2001.0352; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Colombo G, 2007, MOL NEUROBIOL, V36, P102, DOI 10.1007/s12035-007-0017-y; De Witte P, 2003, NEUROSCI BIOBEHAV R, V27, P189, DOI 10.1016/S0149-7634(03)00030-7; Docagne F, 2007, MOL CELL NEUROSCI, V34, P551, DOI 10.1016/j.mcn.2006.12.005; Fernandez-Lopez D, 2006, PEDIATR RES, V60, P169, DOI 10.1203/01.pdr.0000228839.00122.6c; Fernandez-Ruiz J, 2009, BRIT J PHARMACOL, V156, P1029, DOI 10.1111/j.1476-5381.2008.00088.x; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; George DT, 2010, PSYCHOPHARMACOLOGY, V208, P37, DOI 10.1007/s00213-009-1704-3; Gilbert GL, 2007, BRAIN RES, V1128, P61, DOI 10.1016/j.brainres.2006.03.011; Gonzalez S, 2004, BRIT J PHARMACOL, V143, P455, DOI 10.1038/sj.bjp.0705963; Gonzalez S, 2002, BRAIN RES, V954, P73, DOI 10.1016/S0006-8993(02)03344-9; Hampson AJ, 1998, J NEUROCHEM, V70, P671; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Liu Q, 2009, J PHARMACOL EXP THER, V331, P1062, DOI 10.1124/jpet.109.156216; Maccioni P, 2010, CNS NEUROL DISORD-DR, V9, P55, DOI 10.2174/187152710790966623; McKeon A, 2008, J NEUROL NEUROSUR PS, V79, P854, DOI 10.1136/jnnp.2007.128322; Nagy J, 2002, NEUROCHEM INT, V40, P585, DOI 10.1016/S0197-0186(01)00131-0; Nagy J, 2001, DRUG ALCOHOL DEPEN, V61, P155, DOI 10.1016/S0376-8716(00)00132-0; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Rivers Jack Rocky-Jay, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P47; Rubio M, 2007, NEUROSCI LETT, V421, P270, DOI 10.1016/j.neulet.2007.05.052; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Soyka M, 2008, J CLIN PSYCHOPHARM, V28, P317, DOI 10.1097/JCP.0b013e318172b8bc; Vinod KY, 2012, ADDICT BIOL, V17, P62, DOI 10.1111/j.1369-1600.2010.00299.x; Vinod KY, 2010, J PSYCHIATR RES, V44, P591, DOI 10.1016/j.jpsychires.2009.11.013; Ward RJ, 2009, ALCOHOL ALCOHOLISM, V44, P128, DOI 10.1093/alcalc/agn100; Warnault V, 2007, J NEUROCHEM, V102, P741, DOI 10.1111/j.1471-4159.2007.04577.x; Zhuang SY, 2005, NEUROPHARMACOLOGY, V48, P1086, DOI 10.1016/j.neuropharm.2005.01.005	32	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23690	10.1371/journal.pone.0023690	http://dx.doi.org/10.1371/journal.pone.0023690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886913	Green Published, gold, Green Submitted			2022-12-25	WOS:000294128100025
J	Shibata, K; Sugawara, T; Fujishita, K; Shinozaki, Y; Matsukawa, T; Suzuki, T; Koizumi, S				Shibata, Keisuke; Sugawara, Takeshi; Fujishita, Kayoko; Shinozaki, Youichi; Matsukawa, Takashi; Suzuki, Tsutomu; Koizumi, Schuichi			The Astrocyte-Targeted Therapy by Bushi for the Neuropathic Pain in Mice	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; NERVE INJURY; MECHANICAL ALLODYNIA; PATHOLOGICAL PAIN; SPINAL ASTROCYTES; MICROGLIA; GLIA; IMMUNE; CELLS; INTERLEUKIN-1-BETA	Background: There is accumulating evidence that the activation of spinal glial cells, especially microglia, is a key event in the pathogenesis of neuropathic pain. However, the inhibition of microglial activation is often ineffective, especially for long-lasting persistent neuropathic pain. So far, neuropathic pain remains largely intractable and a new therapeutic strategy for the pain is still required. Methods/Principal Findings: Using Seltzer model mice, we investigated the temporal aspect of two types of neuropathic pain behaviors, i.e., thermal hyperalgesia and mechanical allodynia, as well as that of morphological changes in spinal microglia and astrocytes by immunohistochemical studies. Firstly, we analyzed the pattern of progression in the pain behaviors, and found that the pain consisted of an "early induction phase'' and subsequent "late maintenance phase''. We next analyzed the temporal changes in spinal glial cells, and found that the induction and the maintenance phase of pain were associated with the activation of microglia and astrocytes, respectively. When Bushi, a Japanese herbal medicine often used for several types of persistent pain, was administered chronically, it inhibited the maintenance phase of pain without affecting the induction phase, which was in accordance with the inhibition of astrocytic activation in the spinal cord. These analgesic effects and the inhibition of astrocytic activation by Bushi were mimicked by the intrathecal injection of fluorocitrate, an inhibitor of astrocytic activation. Finally, we tested the direct effect of Bushi on astrocytic activation, and found that Bushi suppressed the IL-1b- or IL-18-evoked ERK1/2-phosphorylation in cultured astrocytes but not the ATP-evoked p38- and ERK1/2-phosphorylation in microglia in vitro. Conclusions: Our results indicated that the activation of spinal astrocytes was responsible for the late maintenance phase of neuropathic pain in the Seltzer model mice and, therefore, the inhibition of astrocytic activation by Bushi could be a useful therapeutic strategy for treating neuropathic pain.	[Shibata, Keisuke; Fujishita, Kayoko; Shinozaki, Youichi; Koizumi, Schuichi] Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Sugawara, Takeshi] Kenyudo Clin, Yamanashi, Japan; [Sugawara, Takeshi; Matsukawa, Takashi] Univ Yamanashi, Dept Anesthesiol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan; [Suzuki, Tsutomu] Hoshi Univ, Dept Toxicol, Sch Pharm & Pharmaceut Sci, Tokyo 142, Japan	University of Yamanashi; University of Yamanashi; Hoshi University	Shibata, K (corresponding author), Univ Yamanashi, Dept Neuropharmacol, Interdisciplinary Grad Sch Med & Engn, Yamanashi, Japan.	skoizumi@yamanashi.ac.jp	Shinozaki, Youichi/AAC-9431-2019; Shinozaki, Youichi/E-8594-2010; Koizumi, Schuichi/E-8568-2010	Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106	Ministry of Education, Culture, Sports, Science and Technology; JSPS; University of Yamanashi; Takeda Science Foundation; Sumitomo Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Yamanashi(University of Yamanashi); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This study was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for Scientific Research (A) from JSPS (S. K.); Grants-in-Aid for a Scientific Base-Forming program (S. K.) and for an Encouragement of Young Investigators (K. S) from University of Yamanashi; and by grants from Takeda Science Foundation, Sumitomo Foundation and Uehara Memorial Foundation (S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; AFTANAS LI, 2002, NIPPON SEIRIGAKU ZAS, V64, P143; Araque A, 2008, NEURON GLIA BIOL, V4, P3, DOI 10.1017/S1740925X09000064; Bardia A, 2006, J CLIN ONCOL, V24, P5457, DOI 10.1200/JCO.2006.08.3725; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Benarroch EE, 2010, NEUROLOGY, V75, P273, DOI 10.1212/WNL.0b013e3181e8e984; Brunelli B, 2004, J NEUROL SCI, V218, P59, DOI 10.1016/j.jns.2003.10.013; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; de Leo JA, 2006, PAIN, V122, P17, DOI 10.1016/j.pain.2006.02.034; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Gao YJ, 2010, NEUROTHERAPEUTICS, V7, P482, DOI 10.1016/j.nurt.2010.05.016; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Goncharov NV, 2006, J APPL TOXICOL, V26, P148, DOI 10.1002/jat.1118; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Inoue K, 2009, GLIA, V57, P1469, DOI 10.1002/glia.20871; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; MURAYAMA M, 1991, J ETHNOPHARMACOL, V35, P159, DOI 10.1016/0378-8741(91)90068-O; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Proudfoot Alex T, 2006, Toxicol Rev, V25, P213, DOI 10.2165/00139709-200625040-00002; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Suter MR, 2007, NEURON GLIA BIOL, V3, P255, DOI 10.1017/S1740925X08000100; Suzuki Y, 1999, JPN J PHARMACOL, V79, P169, DOI 10.1254/jjp.79.169; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Takasaki I, 2000, PAIN, V86, P95, DOI 10.1016/S0304-3959(00)00240-2; TAWATA M, 1994, DIABETES RES CLIN PR, V26, P121, DOI 10.1016/0168-8227(94)90149-X; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; VANDAM AM, 1995, NEUROSCIENCE, V65, P815, DOI 10.1016/0306-4522(94)00549-K; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Wegert S, 1997, PAIN, V71, P57, DOI 10.1016/S0304-3959(97)03337-X; Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yamamoto Tomoya, 2009, Gan To Kagaku Ryoho, V36, P89; Yang S, 2005, BRAIN RES, V1034, P172, DOI 10.1016/j.brainres.2004.11.018; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	54	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23510	10.1371/journal.pone.0023510	http://dx.doi.org/10.1371/journal.pone.0023510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876755	Green Published, Green Submitted, gold			2022-12-25	WOS:000294126900027
J	Swei, A; Rowley, JJL; Rodder, D; Diesmos, MLL; Diesmos, AC; Briggs, CJ; Brown, R; Cao, TT; Cheng, TL; Chong, RA; Han, B; Hero, JM; Hoang, HD; Kusrini, MD; Duong, TTL; McGuire, JA; Meegaskumbura, M; Min, MS; Mulcahy, DG; Neang, T; Phimmachak, S; Rao, DQ; Reeder, NM; Schoville, SD; Sivongxay, N; Srei, N; Stock, M; Stuart, BL; Torres, LS; Dao, TAT; Tunstall, TS; Vieites, D; Vredenburg, VT				Swei, Andrea; Rowley, Jodi J. L.; Roedder, Dennis; Diesmos, Mae L. L.; Diesmos, Arvin C.; Briggs, Cheryl J.; Brown, Rafe; Trung Tien Cao; Cheng, Tina L.; Chong, Rebecca A.; Han, Ben; Hero, Jean-Marc; Huy Duc Hoang; Kusrini, Mirza D.; Duong Thi Thuy Le; McGuire, Jimmy A.; Meegaskumbura, Madhava; Min, Mi-Sook; Mulcahy, Daniel G.; Thy Neang; Phimmachak, Somphouthone; Rao, Ding-Qi; Reeder, Natalie M.; Schoville, Sean D.; Sivongxay, Niane; Srei, Narin; Stoeck, Matthias; Stuart, Bryan L.; Torres, Lilia S.; Dao Thi Anh Tran; Tunstall, Tate S.; Vieites, David; Vredenburg, Vance T.			Is Chytridiomycosis an Emerging Infectious Disease in Asia?	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; PREVALENCE; DECLINES; FROGS; HAPLOTYPES; INTENSITY; DYNAMICS; TIME	The disease chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis (Bd), has caused dramatic amphibian population declines and extinctions in Australia, Central and North America, and Europe. Bd is associated with >200 species extinctions of amphibians, but not all species that become infected are susceptible to the disease. Specifically, Bd has rapidly emerged in some areas of the world, such as in Australia, USA, and throughout Central and South America, causing population and species collapse. The mechanism behind the rapid global emergence of the disease is poorly understood, in part due to an incomplete picture of the global distribution of Bd. At present, there is a considerable amount of geographic bias in survey effort for Bd, with Asia being the most neglected continent. To date, Bd surveys have been published for few Asian countries, and infected amphibians have been reported only from Indonesia, South Korea, China and Japan. Thus far, there have been no substantiated reports of enigmatic or suspected disease-caused population declines of the kind that has been attributed to Bd in other areas. In order to gain a more detailed picture of the distribution of Bd in Asia, we undertook a widespread, opportunistic survey of over 3,000 amphibians for Bd throughout Asia and adjoining Papua New Guinea. Survey sites spanned 15 countries, approximately 36 degrees latitude, 111 degrees longitude, and over 2000 m in elevation. Bd prevalence was very low throughout our survey area (2.35% overall) and infected animals were not clumped as would be expected in epizootic events. This suggests that Bd is either newly emerging in Asia, endemic at low prevalence, or that some other ecological factor is preventing Bd from fully invading Asian amphibians. The current observed pattern in Asia differs from that in many other parts of the world.	[Swei, Andrea] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Rowley, Jodi J. L.] Australian Museum, Dept Herpetol, Sydney, NSW 2000, Australia; [Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Bonn, N Rhine Westpha, Germany; [Diesmos, Mae L. L.] Univ Santo Tomas, Dept Biol Sci, Manila, Philippines; [Diesmos, Arvin C.] Natl Museum Philippines, Manila, Philippines; [Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Brown, Rafe] Univ Kansas, KU Biodivers Inst, Lawrence, KS 66045 USA; [Trung Tien Cao] Vinh Univ, Fac Biol, Vinh City, Nghe An, Vietnam; [Cheng, Tina L.; Reeder, Natalie M.; Torres, Lilia S.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Chong, Rebecca A.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Han, Ben] SW Forestry Univ, Fac Life Sci, Kunming, Yunnan, Peoples R China; [Hero, Jean-Marc] Griffith Univ Gold Coast Campus, Sch Environm, Gold Coast, Qld, Australia; [Huy Duc Hoang; Duong Thi Thuy Le; Dao Thi Anh Tran] Univ Sci Ho Chi Minh City, Fac Biol, Ho Chi Minh City, Vietnam; [Kusrini, Mirza D.] Bogor Agr Univ Darmaga Campus, Fac Forestry, Dept Forest Resources Conservat & Ecotourism, Bogor, W Java, Indonesia; [McGuire, Jimmy A.; Tunstall, Tate S.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Meegaskumbura, Madhava] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Min, Mi-Sook] Seoul Natl Univ, Res Inst Vet Sci Vet Med, Seoul, South Korea; [Mulcahy, Daniel G.] Smithsonian Inst, Suitland, MD USA; [Thy Neang] Minist Environm, Dept Natl Pk, Phnom Penh, Cambodia; [Phimmachak, Somphouthone; Sivongxay, Niane] Natl Univ Laos, Fac Sci, Dept Biol, Viangchan, Laos; [Rao, Ding-Qi] Chinese Acad Sci, Kunming Inst Zool, Kunming, Peoples R China; [Schoville, Sean D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Srei, Narin] Royal Univ Phnom Penh, Dept Biol, Phnom Penh, Cambodia; [Srei, Narin] Royal Univ Phnom Penh, Ctr Biodivers Conservat, Phnom Penh, Cambodia; [Stoeck, Matthias] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Vaud, Switzerland; [Stuart, Bryan L.] N Carolina Museum Nat Sci, Raleigh, NC USA; [Vieites, David] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Cary Institute of Ecosystem Studies; Australian Museum; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Santo Tomas; National Museum of the Philippines; University of California System; University of California Santa Barbara; University of Kansas; Vinh University; California State University System; San Francisco State University; Colorado State University; Griffith University; Bogor Agricultural University; University of California System; University of California Berkeley; Harvard University; Seoul National University (SNU); Smithsonian Institution; Chinese Academy of Sciences; Kunming Institute of Zoology; University of California System; University of California Berkeley; University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Swei, A (corresponding author), Cary Inst Ecosyst Studies, Millbrook, NY USA.	swei@berkeley.edu	Schoville, Sean D./AAY-5324-2020; Kusrini, Mirza Dikari/GQB-2150-2022; Rödder, Dennis/AAT-8644-2021; Swei, Andrea/AAD-9649-2021; Schoville, Sean D./J-8061-2012; Diesmos, Arvin C./AGG-8542-2022; Diesmos, Mae Lowe/AGG-8517-2022; Stöck, Matthias/E-7245-2014; Meegaskumbura, Madhava/F-8782-2013; McGuire, Jimmy/N-7357-2019; Briggs, Cheryl/F-7456-2013; Rowley, Jodi J. L./F-2466-2012; Vieites, David/B-4481-2009	Schoville, Sean D./0000-0001-7364-434X; Rödder, Dennis/0000-0002-6108-1639; Schoville, Sean D./0000-0001-7364-434X; Stöck, Matthias/0000-0003-4888-8371; Meegaskumbura, Madhava/0000-0002-4599-6724; Vieites, David/0000-0001-5551-7419; Vredenburg, Vance/0000-0002-9682-1190; Mulcahy, Daniel G./0000-0001-6614-2405; Rowley, Jodi/0000-0002-2011-9143; Tien Trung, Cao/0000-0002-4256-8951	National Science Foundation-National Institutes of Health Ecology of Infectious Diseases [EF-0723563]; California Academy of Sciences; Direct For Biological Sciences [0743491] Funding Source: National Science Foundation	National Science Foundation-National Institutes of Health Ecology of Infectious Diseases(National Science Foundation (NSF)); California Academy of Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the joint National Science Foundation-National Institutes of Health Ecology of Infectious Diseases (EF-0723563, http://www.nsf.gov). Additional funding was secured by David A. Neeley through the California Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CM, 2010, ECOHEALTH, V7, P127, DOI 10.1007/s10393-010-0307-0; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bolker B, 2008, ECOLOGICAL MODELS DA; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Clough HE, 2003, PREV VET MED, V58, P145, DOI 10.1016/S0167-5877(03)00050-3; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher MC, 2009, MOL ECOL, V18, P4731, DOI 10.1111/j.1365-294X.2009.04385.x; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; IUCN, 2008, AN AMPH 2008 IUCN RE; Jimenez-Valverde A, 2011, BIOL INVASIONS; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Kusrini MD, 2008, DIS AQUAT ORGAN, V82, P187, DOI 10.3354/dao01981; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; MURRAY KA, J APPL ECOL IN PRESS; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, J WILDLIFE DIS, V42, P301, DOI 10.7589/0090-3558-42.2.301; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rodder D, 2008, ANIM CONSERV, V11, P513, DOI 10.1111/j.1469-1795.2008.00210.x; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rota CT, 2011, ECOGRAPHY; Rowley JJL, 2007, DIS AQUAT ORGAN, V78, P87, DOI 10.3354/dao01861; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; SCHMIDT B. R., 2009, METHODEN FELDHERPETO, P229; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Une Y, 2008, DIS AQUAT ORGAN, V82, P157, DOI 10.3354/dao02006; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wei Y, 2010, DIS AQUAT ORGAN, V92, P241, DOI 10.3354/dao02172; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Yang H, 2009, DIS AQUAT ORGAN, V86, P9, DOI 10.3354/dao02098	51	73	74	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2011	6	8							e23179	10.1371/journal.pone.0023179	http://dx.doi.org/10.1371/journal.pone.0023179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810KZ	21887238	gold, Green Published			2022-12-25	WOS:000294125500018
J	Paranjape, AN; Mandal, T; Mukherjee, G; Kumar, MV; Sengupta, K; Rangarajan, A				Paranjape, A. N.; Mandal, T.; Mukherjee, G.; Kumar, M. V.; Sengupta, K.; Rangarajan, A.			Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties	ONCOGENE			English	Article						adenocarcinoma; breast cancer stem cells; EMT; mammospheres; SV40ER; telomerase	MAMMARY STEM/PROGENITOR CELLS; LARGE T-ANTIGEN; EPITHELIAL-CELLS; SELF-RENEWAL; TRANSFORMATION; EXPRESSION; CULTURE; NOTCH; P53; IMMORTALIZATION	Emerging evidence suggests that cancers arise in stem/progenitor cells. Yet, the requirements for transformation of these primitive cells remains poorly understood. In this study, we have exploited the 'mammosphere' system that selects for primitive mammary stem/progenitor cells to explore their potential and requirements for transformation. Introduction of Simian Virus 40 Early Region and hTERT into mammosphere-derived cells led to the generation of NBLE, an immortalized mammary epithelial cell line. The NBLEs largely comprised of bi-potent progenitors with long-term self-renewal and multi-lineage differentiation potential. Clonal and karyotype analyses revealed the existence of heterogeneous population within NBLEs with varied proliferation, differentiation and sphere-forming potential. Significantly, injection of NBLEs into immunocompromised mice resulted in the generation of invasive ductal adenocarcinomas. Further, these cells harbored a sub-population of CD44(+)/CD24(-) fraction that alone had sphere- and tumor-initiating potential and resembled the breast cancer stem cell gene signature. Interestingly, prolonged in vitro culturing led to their further enrichment. The NBLE cells also showed increased expression of stemness and epithelial to mesenchymal transition markers, deregulated self-renewal pathways, activated DNA-damage response and cancer-associated chromosomal aberrations-all of which are likely to have contributed to their tumorigenic transformation. Thus, unlike previous in vitro transformation studies that used adherent, more differentiated human mammary epithelial cells our study demonstrates that the mammosphere-derived, less-differentiated cells undergo tumorigenic conversion with only two genetic elements, without requiring oncogenic Ras. Moreover, the striking phenotypic and molecular resemblance of the NBLE-generated tumors with naturally arising breast adenocarcinomas supports the notion of a primitive breast cell as the origin for this subtype of breast cancer. Finally, the NBLEs represent a heterogeneous population of cells with striking plasticity, capable of differentiation, self-renewal and tumorigenicity, thus offering a unique model system to study the molecular mechanisms involved with these processes. Oncogene (2012) 31, 1896-1909; doi:10.1038/onc.2011.378; published online 29 August 2011	[Paranjape, A. N.; Mandal, T.; Rangarajan, A.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Paranjape, A. N.; Mukherjee, G.; Kumar, M. V.] Kidwai Mem Inst Oncol, Dept Pathol, Bangalore, Karnataka, India; [Sengupta, K.] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India	Indian Institute of Science (IISC) - Bangalore; Kidwai Memorial Institute of Oncology; Indian Institute of Science Education & Research (IISER) Pune	Rangarajan, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, CV Raman Ave, Bangalore 560012, Karnataka, India.	anu@mrdg.iisc.ernet.in	Paranjape, Anurag N./P-1255-2018; Mandal, Tamoghna/AAX-3710-2021	Paranjape, Anurag N./0000-0001-6119-0766; Mandal, Tamoghna/0000-0003-4372-6760; M, Vijayakumar/0000-0002-0711-1737; Mukherjee, Geetashree/0000-0003-4954-0035	DBT; UGC	DBT(Department of Biotechnology (DBT) India); UGC(University Grants Commission, India)	We thank Dr Robert A Weinberg (Whitehead Institute) for hTERT cDNA, HMLE and HMLER cells and Dr Inder M Verma (Salk Institute) for pCSCG lentiviral vector. We acknowledge Swati Maiti for insightful discussions, and thank D Alaguraj, Drs Omana Joy, William Surin (IISc) and H Krishnamurthy (NCBS) for help with flow cytometry. We also thank Dr Paturu Kondaiah and Imran Khan (IISc), and Mohammed Aiyaz (Genotypic India Pvt. Ltd) for help with microarray experiments and data analysis. This work was largely supported by research grants from DBT to AR for equipment and consumables. We acknowledge the confocal, IRIS, FACS and animal facilities at IISc, and grants from UGC to the Department of MRDG, IISc.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; Ali-Seyed M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-54; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Bissell MJ, 1999, CANCER RES, V59, p1757S; Charafe-Jauffret E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-202; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jerry DJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2133; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muschler J, 1999, MOL BIOL CELL, V10, P2817, DOI 10.1091/mbc.10.9.2817; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Phesse TJ, 2009, BRIT J CANCER, V100, P221, DOI 10.1038/sj.bjc.6604850; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; ROCHLITZ CF, 1989, CANCER RES, V49, P357; Salas NR, 2010, CLIN TRANSL ONCOL, V12, P395, DOI 10.1007/s12094-010-0526-4; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Shackleton M, 2010, SEMIN CANCER BIOL, V20, P85, DOI 10.1016/j.semcancer.2010.04.002; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Uchino M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-414; WAZER DE, 1995, P NATL ACAD SCI USA, V92, P3687, DOI 10.1073/pnas.92.9.3687; WOODS C, 1994, ONCOGENE, V9, P2943; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	41	25	25	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1896	1909		10.1038/onc.2011.378	http://dx.doi.org/10.1038/onc.2011.378			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21874052				2022-12-25	WOS:000302809900003
J	Sinan, S; Yuan, XY; Russell, R				Sinan, Selma; Yuan, Xiaoyan; Russell, Rick			The Azoarcus Group I Intron Ribozyme Misfolds and Is Accelerated for Refolding by ATP-dependent RNA Chaperone Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEINS; TETRAHYMENA RIBOZYME; FOLDING LANDSCAPE; STRUCTURED RNA; CATALYTIC CORE; UNWINDING RNA; GENERAL RNA; PATHWAYS; BINDING; MECHANISMS	Structured RNAs traverse complex energy landscapes that include valleys representing misfolded intermediates. In Neurospora crassa and Saccharomyces cerevisiae, efficient splicing of mitochondrial group I and II introns requires the DEAD box proteins CYT-19 and Mss116p, respectively, which promote folding transitions and function as general RNA chaperones. To test the generality of RNA misfolding and the activities of DEAD box proteins in vitro, here we measure native folding of a small group I intron ribozyme from the bacterium Azoarcus by monitoring its catalytic activity. To develop this assay, we first measure cleavage of an oligonucleotide substrate by the prefolded ribozyme. Substrate cleavage is rate-limited by binding and is readily reversible, with an internal equilibrium near unity, such that the amount of product observed is less than the amount of native ribozyme. We use this assay to show that approximately half of the ribozyme folds readily to the native state, whereas the other half forms an intermediate that transitions slowly to the native state. This folding transition is accelerated by urea and increased temperature and slowed by increased Mg2+ concentration, suggesting that the intermediate is misfolded and must undergo transient unfolding during refolding to the native state. CYT-19 and Mss116p accelerate refolding in an ATP-dependent manner, presumably by disrupting structure in the intermediate. These results highlight the tendency of RNAs to misfold, underscore the roles of CYT-19 and Mss116p as general RNA chaperones, and identify a refolding transition for further dissection of the roles of DEAD box proteins in RNA folding.	[Sinan, Selma; Yuan, Xiaoyan; Russell, Rick] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Sinan, Selma] Balikesir Univ, Sci & Art Fac, Dept Biol, TR-10000 Balikesir, Turkey	University of Texas System; University of Texas Austin; Balikesir University	Russell, R (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, 1 Univ Stn,A4800, Austin, TX 78712 USA.	rick_russell@mail.utexas.edu	Russell, Rick/A-9256-2012		National Institutes of Health [GM70456]; Welch Foundation [F-1563]; Scientific and Technological Research Council of Turkey; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM70456 (to R. R.). This work was also supported by Welch Foundation Grant F-1563 (to R. R.).; Supported by a fellowship from the Scientific and Technological Research Council of Turkey.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; Bifano AL, 2010, J MOL BIOL, V398, P429, DOI 10.1016/j.jmb.2010.03.025; Chauhan S, 2005, J MOL BIOL, V353, P1199, DOI 10.1016/j.jmb.2005.09.015; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Chauhan S, 2009, J MOL BIOL, V386, P1167, DOI 10.1016/j.jmb.2008.12.075; Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028; Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fedorova O, 2010, J MOL BIOL, V397, P799, DOI 10.1016/j.jmb.2010.02.001; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Golden BL, 1996, BIOCHEMISTRY-US, V35, P3754, DOI 10.1021/bi952599z; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jiang YF, 2006, RNA, V12, P561, DOI 10.1261/rna.2188306; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; Karbstein K, 2002, BIOCHEMISTRY-US, V41, P11171, DOI 10.1021/bi0202631; Karunatilaka KS, 2010, NATURE, V467, P935, DOI 10.1038/nature09422; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Kwok LW, 2006, J MOL BIOL, V355, P282, DOI 10.1016/j.jmb.2005.10.070; Laederach A, 2007, P NATL ACAD SCI USA, V104, P7045, DOI 10.1073/pnas.0608765104; MCCONNELL TS, 1993, P NATL ACAD SCI USA, V90, P8362, DOI 10.1073/pnas.90.18.8362; Mei R, 1996, BIOCHEMISTRY-US, V35, P5796, DOI 10.1021/bi9527653; Mitra S, 2011, RNA, V17, P1589, DOI 10.1261/rna.2694811; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Narlikar GJ, 1996, NAT STRUCT BIOL, V3, P701, DOI 10.1038/nsb0896-701; Pan C, 2010, RNA BIOL, V7, P667, DOI 10.4161/rna.7.6.13571; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; Potratz JP, 2011, J MOL BIOL, V411, P661, DOI 10.1016/j.jmb.2011.05.047; Rangan P, 2004, J MOL BIOL, V339, P41, DOI 10.1016/j.jmb.2004.03.059; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Roh JH, 2010, J AM CHEM SOC, V132, P10148, DOI 10.1021/ja103867p; Russell R, 2000, NAT STRUCT BIOL, V7, P367; Russell R, 1999, J MOL BIOL, V291, P1155, DOI 10.1006/jmbi.1999.3026; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Russell R, 2008, FRONT BIOSCI-LANDMRK, V13, P1, DOI 10.2741/2557; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; Serra MJ, 1995, METHOD ENZYMOL, V259, P242; Shcherbakova I, 2008, CURR OPIN CHEM BIOL, V12, P655, DOI 10.1016/j.cbpa.2008.09.017; Shelton VM, 1999, BIOCHEMISTRY-US, V38, P16831, DOI 10.1021/bi991699s; Solem A, 2006, MOL CELL, V24, P611, DOI 10.1016/j.molcel.2006.10.032; Strauss-Soukup JK, 2000, J MOL BIOL, V302, P339, DOI 10.1006/jmbi.2000.4056; Tanner MA, 1996, RNA, V2, P74; Testa SM, 1997, BIOCHEMISTRY-US, V36, P15303, DOI 10.1021/bi9713097; Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Wan YQ, 2010, J MOL BIOL, V400, P1067, DOI 10.1016/j.jmb.2010.06.010; Wan YQ, 2009, METHOD ENZYMOL, V468, P195, DOI 10.1016/S0076-6879(09)68010-1; Woodson SA, 2010, ANNU REV BIOPHYS, V39, P61, DOI 10.1146/annurev.biophys.093008.131334; Yang Q, 2007, MOL CELL, V28, P253, DOI 10.1016/j.molcel.2007.08.016; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; Zhang LB, 2005, RNA, V11, P59, DOI 10.1261/rna.7145105; Zingler N, 2010, NUCLEIC ACIDS RES, V38, P6602, DOI 10.1093/nar/gkq530	64	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37304	37312		10.1074/jbc.M111.287706	http://dx.doi.org/10.1074/jbc.M111.287706			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21878649	hybrid, Green Published			2022-12-25	WOS:000296542400030
J	Dhindwal, S; Patil, DN; Mohammadi, M; Sylvestre, M; Tomar, S; Kumar, P				Dhindwal, Sonali; Patil, Dipak N.; Mohammadi, Mahmood; Sylvestre, Michel; Tomar, Shailly; Kumar, Pravindra			Biochemical Studies and Ligand-bound Structures of Biphenyl Dehydrogenase from Pandoraea pnomenusa Strain B-356 Reveal a Basis for Broad Specificity of the Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMAMONAS-TESTOSTERONI B-356; CIS-2,3-DIHYDRO-2,3-DIHYDROXYBIPHENYL DEHYDROGENASE; D-3-HYDROXYBUTYRATE DEHYDROGENASE; POLYCHLORINATED-BIPHENYLS; CRYSTAL-STRUCTURES; ACTIVE-SITE; DEGRADATION; PURIFICATION; DIOXYGENASE; STRATEGIES	Biphenyl dehydrogenase, a member of short-chain dehydrogenase/reductase enzymes, catalyzes the second step of the biphenyl/polychlorinated biphenyls catabolic pathway in bacteria. To understand the molecular basis for the broad substrate specificity of Pandoraea pnomenusa strain B-356 biphenyl dehydrogenase (BphB(B-356)), the crystal structures of the apoenzyme, the binary complex with NAD(+), and the ternary complexes with NAD(+)-2,3-dihydroxybiphenyl and NAD(+)-4,4'-dihydroxybiphenyl were determined at 2.2-, 2.5-, 2.4-, and 2.1-angstrom resolutions, respectively. A crystal structure representing an intermediate state of the enzyme was also obtained in which the substrate binding loop was ordered as compared with the apo and binary forms but it was displaced significantly with respect to the ternary structures. These five structures reveal that the substrate binding loop is highly mobile and that its conformation changes during ligand binding, starting from a disorganized loop in the apo state to a well organized loop structure in the ligand-bound form. Conformational changes are induced during ligand binding; forming a well defined cavity to accommodate a wide variety of substrates. This explains the biochemical data that shows BphB(B-356) converts the dihydrodiol metabolites of 3,3'-dichlorobiphenyl, 2,4,4'-trichlorobiphenyl, and 2,6-dichlorobiphenyl to their respective dihydroxy metabolites. For the first time, a combination of structural, biochemical, and molecular docking studies of BphB(B-356) elucidate the unique ability of the enzyme to transform the cis-dihydrodiols of double meta-, para-, and ortho-substituted chlorobiphenyls.	[Dhindwal, Sonali; Patil, Dipak N.; Tomar, Shailly; Kumar, Pravindra] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India; [Mohammadi, Mahmood; Sylvestre, Michel] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of Quebec; Institut national de la recherche scientifique (INRS)	Kumar, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttarakhand, India.	pravshai@gmail.com	Patil, Dipak N./X-9567-2019; KUMAR, PRAVINDRA/AAF-2859-2020	Patil, Dipak N./0000-0003-1112-5557; KUMAR, PRAVINDRA/0000-0003-2128-7736; Sylvestre, Michel/0000-0002-6942-3373	Council of Scientific and Industrial Research (CSIR), New Delhi, India; Ministry of Human Resource Development, India; Department of Biotechnology (DBT), India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Human Resource Development, India(Ministry of Higher Education & Scientific Research (MHESR)); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR), New Delhi, India, and the Ministry of Human Resource Development, India (to S. D. and D. N. P.).; We thank the Macromolecular Crystallographic Facility (MCU) at the Indian Institute of Technology, IIT Roorkee. We also thank the Department of Biotechnology (DBT), India, for providing financial assistance and the allocation and provision of synchrotron beamtime at the BM14, ESRF (Grenoble, France). We thank Hassan Belrhali and Babu Manjasetty for help during data collection at the synchrotron. We are grateful to Dr. David Neau for carefully reading the manuscript and Dr. Ashwani Kumar Sharma for helpful discussions.	Andersson A, 1997, FEBS LETT, V400, P173, DOI 10.1016/S0014-5793(96)01382-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barriault D, 1999, BIOCHEM BIOPH RES CO, V260, P181, DOI 10.1006/bbrc.1999.0706; Barriault D, 2002, J BACTERIOL, V184, P3794, DOI 10.1128/JB.184.14.3794-3800.2002; Benach-Andreu J., 1999, XRAY STRUCTURE ANAL; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Borja J, 2005, PROCESS BIOCHEM, V40, P1999, DOI 10.1016/j.procbio.2004.08.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; FUKUDA M, 1994, BIOCHEM BIOPH RES CO, V202, P850, DOI 10.1006/bbrc.1994.2008; Furukawa K, 2003, TRENDS BIOTECHNOL, V21, P187, DOI 10.1016/S0167-7799(03)00054-4; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Gomez-Gil L, 2007, J BACTERIOL, V189, P5705, DOI 10.1128/JB.01476-06; HADDOCK JD, 1993, J BACTERIOL, V175, P395, DOI 10.1128/JB.175.2.395-400.1993; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hosfield DJ, 2005, J BIOL CHEM, V280, P4639, DOI 10.1074/jbc.M411104200; Hulsmeyer M, 1998, PROTEIN SCI, V7, P1286; HURTUBISE Y, 1995, J BACTERIOL, V177, P6610, DOI 10.1128/jb.177.22.6610-6618.1995; Ito K, 2006, J MOL BIOL, V355, P722, DOI 10.1016/j.jmb.2005.10.072; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jouanneau Y, 2006, APPL ENVIRON MICROB, V72, P4726, DOI 10.1128/AEM.00395-06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsubo Y, 2004, APPL MICROBIOL BIOT, V65, P250, DOI 10.1007/s00253-004-1654-y; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paithankar KS, 2007, FEBS J, V274, P5767, DOI 10.1111/j.1742-4658.2007.06102.x; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; Pieper DH, 2000, CURR OPIN BIOTECH, V11, P262, DOI 10.1016/S0958-1669(00)00094-X; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Sakshi, 2010, ACTA CRYSTALLOGR F, V66, P1517, DOI 10.1107/S1744309110036894; Smilda T, 1998, BIOCHEM GENET, V36, P37, DOI 10.1023/A:1018748118901; Strand S. E., 2004, CEWA ESC MICRO, V518, P1; Sylvestre M, 1996, APPL ENVIRON MICROB, V62, P2710, DOI 10.1128/AEM.62.8.2710-2715.1996; TAIRA K, 1992, J BIOL CHEM, V267, P4844; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 2001, CURR ORG CHEM, V5, P89, DOI 10.2174/1385272013375751; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vedadi M, 2000, BIOCHEMISTRY-US, V39, P5028, DOI 10.1021/bi992232k; Yamazawa R, 2011, J BIOCHEM, V149, P701, DOI 10.1093/jb/mvr024	43	23	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					37011	37022		10.1074/jbc.M111.291013	http://dx.doi.org/10.1074/jbc.M111.291013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880718	Green Published, hybrid			2022-12-25	WOS:000296538300079
J	Melo, SP; Barbour, KW; Berger, FG				Melo, Sandra P.; Barbour, Karen W.; Berger, Franklin G.			Cooperation between an Intrinsically Disordered Region and a Helical Segment Is Required for Ubiquitin-independent Degradation by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYMIDYLATE SYNTHASE; KAPPA-B-ALPHA; ORNITHINE-DECARBOXYLASE; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURE; GAMMA-PROTEASOME; C-FOS; PROTEIN; PATHWAY; SITE	The 26 S proteasomal complex, which is responsible for the bulk of protein degradation within the cell, recognizes its target substrates via covalently linked polyubiquitin moieties. However, a small but growing number of proteasomal substrates are degraded without a requirement for ubiquitinylation. One such substrate is the pyrimidine biosynthetic enzyme thymidylate synthase (EC 2.1.1.45), which catalyzes the synthesis of TMP and is the sole de novo source of TTP for DNA replication and repair. Previous work showed that intracellular proteolysis of human thymidylate synthase is directed by a degron at the polypeptide's N-terminal end, composed of an intrinsically disordered region (IDR) followed by a highly conserved amphipathic alpha-helix (hA). In the present report, we show that the hA helix does not function simply as an extension or scaffold for the IDR; rather, it provides a specific structural component that is necessary for degradation. Furthermore, its helical conformation is required for this function. We demonstrate that small domains from heterologous proteins can substitute for the IDR and the hA helix of human thymidylate synthase, indicating that the degradation-promoting function of these regions is not sequence-specific. The results, in general, indicate that cooperation between intrinsically disordered domains and alpha-helical segments is required for ubiquitin-independent degradation by the proteasome. There appears to be little sequence constraint on the ability of these regions to function as degron constituents. Rather, it is the overall conformation (or lack thereof) that is critical.	[Berger, Franklin G.] Univ S Carolina, Jones Phys Sci Ctr, Ctr Colon Canc Res, Columbia, SC 29208 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Berger, FG (corresponding author), Univ S Carolina, Jones Phys Sci Ctr, Ctr Colon Canc Res, Rm 614, Columbia, SC 29208 USA.	fgberger@mailbox.sc.edu			National Institutes of Health [CA44013]; NATIONAL CANCER INSTITUTE [R01CA044013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA44013.	Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Berger FG, 2006, CANCER BIOL THER, V5, P1238, DOI 10.4161/cbt.5.9.3414; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burns KE, 2010, SUBCELL BIOCHEM, V54, P149, DOI 10.1007/978-1-4419-6676-6_12; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Cheng YF, 2009, CURR OPIN STRUC BIOL, V19, P203, DOI 10.1016/j.sbi.2009.02.004; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; MAHALINGAM S, 1995, P NATL ACAD SCI USA, V92, P3794, DOI 10.1073/pnas.92.9.3794; Mathes E, 2008, EMBO J, V27, P1357, DOI 10.1038/emboj.2008.73; Melo SP, 2010, BIOCHEM J, V432, P217, DOI 10.1042/BJ20101027; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; NUSSBAUM RL, 1985, AM J HUM GENET, V37, P1192; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Pena MMO, 2009, J BIOL CHEM, V284, P31597, DOI 10.1074/jbc.M109.038455; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Phan J, 2001, J BIOL CHEM, V276, P14170, DOI 10.1074/jbc.M009493200; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Slijper M, 1996, J MOL BIOL, V259, P761, DOI 10.1006/jmbi.1996.0356; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	53	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36559	36567		10.1074/jbc.M111.274258	http://dx.doi.org/10.1074/jbc.M111.274258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878626	Green Published, hybrid			2022-12-25	WOS:000296538300040
J	Moffat, LD; Brown, SBA; Grassie, ME; Ulke-Lemee, A; Williamson, LM; Walsh, MP; MacDonald, JA				Moffat, Lori D.; Brown, Shannon B. A.; Grassie, Michael E.; Ulke-Lemee, Annegret; Williamson, Laura M.; Walsh, Michael P.; MacDonald, Justin A.			Chemical Genetics of Zipper-interacting Protein Kinase Reveal Myosin Light Chain as a Bona Fide Substrate in Permeabilized Arterial Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; PHOSPHATASE-ASSOCIATED KINASE; UNNATURAL NUCLEOTIDE SPECIFICITY; CA2+ SENSITIZATION; TARGET SUBUNIT; PSEUDOSUBSTRATE PEPTIDE; PHOSPHORYLATION; IDENTIFICATION; CONTRACTION; CPI-17	Zipper-interacting protein kinase (ZIPK) has been implicated in Ca2+-independent smooth muscle contraction, although its specific role is unknown. The addition of ZIPK to demembranated rat caudal arterial strips induced an increase in force, which correlated with increases in LC20 and MYPT1 phosphorylation. However, because of the number of kinases capable of phosphorylating LC20 and MYPT1, it has proven difficult to identify the mechanism underlying ZIPK action. Therefore, we set out to identify bona fide ZIPK substrates using a chemical genetics method that takes advantage of ATP analogs with bulky substituents at the N-6 position and an engineered ZIPK capable of utilizing such substrates. P-32-Labeled 6-phenyl-ATP and ZIPK-L93G mutant protein were added to permeabilized rat caudal arterial strips, and substrate proteins were detected by autoradiography following SDS-PAGE. Mass spectrometry identified LC20 as a direct target of ZIPK in situ for the first time. Tissues were also exposed to 6-phenyl-ATP and ZIPK-L93G in the absence of endogenous ATP, and putative ZIPK substrates were identified by Western blotting. LC20 was thereby confirmed as a direct target of ZIPK; however, no phosphorylation of MYPT1 was detected. We conclude that ZIPK is involved in the regulation of smooth muscle contraction through direct phosphorylation of LC20.	[MacDonald, Justin A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4Z6, Canada; Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4Z6, Canada	University of Calgary; University of Calgary	MacDonald, JA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	jmacdo@ucalgary.ca		MacDonald, Justin/0000-0002-9238-8473	Canadian Institutes of Health Research (CIHR) [MOP-72720, MT-13101]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Research Grants MOP-72720 (to J. A. M.) and MT-13101 (to M. P. W.) from the Canadian Institutes of Health Research (CIHR).	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Blethrow J., 2004, CURR PROTOC MOL MAY; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Borman MA, 2002, J BIOL CHEM, V277, P23441, DOI 10.1074/jbc.M201597200; Borman MA, 2007, BIOCHEM CELL BIOL, V85, P111, DOI 10.1139/O06-209; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Deng JT, 2002, BIOCHEM J, V367, P517, DOI 10.1042/BJ20020522; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Eblen ST, 2003, J BIOL CHEM, V278, P14926, DOI 10.1074/jbc.M300485200; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Hindley AD, 2004, FEBS LETT, V556, P26, DOI 10.1016/S0014-5793(03)01352-8; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2007, AM J PHYSIOL-CELL PH, V292, pC1951, DOI 10.1152/ajpcell.00434.2006; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Ihara E, 2009, AM J PHYSIOL-GASTR L, V297, pG361, DOI 10.1152/ajpgi.00112.2009; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim N, 2004, AM J PHYSIOL-CELL PH, V287, pC384, DOI 10.1152/ajpcell.00390.2003; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; MacDonald JA, 2001, FEBS LETT, V493, P91, DOI 10.1016/S0014-5793(01)02277-3; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; McNamara LK, 2009, ACTA CRYSTALLOGR D, V65, P241, DOI 10.1107/S0907444908043679; Morrison DL, 1996, BIOCHEM CELL BIOL, V74, P549, DOI 10.1139/o96-459; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Muranyi A, 2002, BIOCHEM J, V366, P211, DOI 10.1042/BJ20020401; Murata-Hori M, 1999, FEBS LETT, V451, P81, DOI 10.1016/S0014-5793(99)00550-5; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Okuzumi T, 2010, MOL BIOSYST, V6, P1389, DOI 10.1039/c003917a; Patel CA, 2006, AM J PHYSIOL-GASTR L, V291, pG830, DOI 10.1152/ajpgi.00130.2006; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; SHIBATA S, 1982, J PHARMACOL EXP THER, V223, P135; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Somlyo A P, 1999, Rev Physiol Biochem Pharmacol, V134, P201; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ulke-Lemee A, 2010, PHARMACEUTICALS, V3, P1739, DOI 10.3390/ph3061739; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Vetterkind S, 2010, MOL BIOL CELL, V21, P1214, DOI 10.1091/mbc.E09-08-0711; Vetterkind S, 2009, J CELL MOL MED, V13, P887, DOI 10.1111/j.1582-4934.2008.00374.x; Walsh Michael P., 2007, V365, P209; Weber LP, 1999, J PHYSIOL-LONDON, V516, P805, DOI 10.1111/j.1469-7793.1999.0805u.x; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173	56	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36978	36991		10.1074/jbc.M111.257949	http://dx.doi.org/10.1074/jbc.M111.257949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880706	Green Published, hybrid			2022-12-25	WOS:000296538300076
J	Shiraki, N; Yamazoe, T; Qin, Z; Ohgomori, K; Mochitate, K; Kume, K; Kume, S				Shiraki, Nobuaki; Yamazoe, Taiji; Qin, Zeng; Ohgomori, Keiko; Mochitate, Katsumi; Kume, Kazuhiko; Kume, Shoen			Efficient Differentiation of Embryonic Stem Cells into Hepatic Cells In Vitro Using a Feeder-Free Basement Membrane Substratum	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; LIVER DEVELOPMENT; GROWTH-FACTORS; DEFINITIVE ENDODERM; PROGENITOR CELLS; MOUSE; HEPATOCYTES; EXPRESSION; GENERATION; CULTURE	The endoderm-inducing effect of the mesoderm-derived supportive cell line M15 on embryonic stem (ES) cells is partly mediated through the extracellular matrix, of which laminin alpha 5 is a crucial component. Mouse ES or induced pluripotent stem cells cultured on a synthesized basement membrane (sBM) substratum, using an HEK293 cell line (rLN10-293 cell) stably expressing laminin-511, could differentiate into definitive endoderm and subsequently into pancreatic lineages. In this study, we investigated the differentiation on sBM of mouse and human ES cells into hepatic lineages. The results indicated that the BM components played an important role in supporting the regional-specific differentiation of ES cells into hepatic endoderm. We show here that knockdown of integrin beta 1 (Itgb1) in ES cells reduced their differentiation into hepatic lineages and that this is mediated through Akt signaling activation. Moreover, under optimal conditions, human ES cells differentiated to express mature hepatocyte markers and secreted high levels of albumin. This novel procedure for inducing hepatic differentiation will be useful for elucidating the molecular mechanisms controlling lineage-specific fates during gut regionalization. It could also represent an attractive approach to providing a surrogate cell source, not only for regenerative medicine, but also for pharmaceutical and toxicologic studies.	[Shiraki, Nobuaki; Yamazoe, Taiji; Kume, Kazuhiko; Kume, Shoen] Kumamoto Univ, Dept Stem Cell Biol, Inst Mol Embryol & Genet, Kumamoto, Japan; [Shiraki, Nobuaki; Yamazoe, Taiji; Kume, Kazuhiko; Kume, Shoen] Kumamoto Univ, Global Ctr Excellence Program, Kumamoto, Japan; [Qin, Zeng; Ohgomori, Keiko; Mochitate, Katsumi] Natl Inst Environm Studies, BM Matrix Lab, Environm Hlth Sci Div, Ibaraki, Japan	Kumamoto University; Kumamoto University; National Institute for Environmental Studies - Japan	Shiraki, N (corresponding author), Kumamoto Univ, Dept Stem Cell Biol, Inst Mol Embryol & Genet, Kumamoto, Japan.	skume@kumamoto-u.ac.jp		shiraki, nobuaki/0000-0001-6708-9976; Kume, Kazuhiko/0000-0003-4232-1657	New Energy and Industrial Technology Development Organization (NEDO); National Institute of Biomedical Innovation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University	This work was supported by a grant from the New Energy and Industrial Technology Development Organization (NEDO) (to SK and KM), a grant from National Institute of Biomedical Innovation (to NS), and in part by a global COE grant (Cell Fate Regulation Research and Education Unit) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan (to SK), and by a collaborative program of Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University (to KM and SK). SK is a member of the Global COE Program (Cell Fate Regulation Research and Education Unit), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2004, GENES CELLS, V9, P1297, DOI 10.1111/j.1365-2443.2004.00809.x; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Berger TM, 2003, ANAT EMBRYOL, V207, P283, DOI 10.1007/s00429-003-0354-1; Bi YA, 2006, DRUG METAB DISPOS, V34, P1658, DOI 10.1124/dmd.105.009118; Biname F, 2008, MOL BIOL CELL, V19, P945, DOI 10.1091/mbc.E07-09-0967; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Einstein M, 2001, MOL CELL BIOL, V21, P5122, DOI 10.1128/MCB.21.15.5122-5131.2001; ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Heo J, 2006, HEPATOLOGY, V44, P1478, DOI 10.1002/hep.21441; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Ishii T, 2005, EXP CELL RES, V309, P68, DOI 10.1016/j.yexcr.2005.05.028; Ishii T, 2008, AM J PHYSIOL-GASTR L, V295, pG313, DOI 10.1152/ajpgi.00072.2008; Katsumoto K, 2010, DEV GROWTH DIFFER, V52, P115, DOI 10.1111/j.1440-169X.2009.01160.x; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Liu T, 2010, TISSUE ENG PT A, V16, P1115, DOI [10.1089/ten.tea.2009.0391, 10.1089/ten.TEA.2009.0391]; Matsumoto K, 2008, J BIOSCI BIOENG, V105, P350, DOI 10.1263/jbb.105.350; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Pinkse GGM, 2004, LIVER INT, V24, P218, DOI 10.1111/j.1478-3231.2004.0914.x; Roediger M, 2010, J MOL HISTOL, V41, P177, DOI 10.1007/s10735-010-9275-5; Saito K, 2006, WORLD J GASTROENTERO, V12, P6818, DOI 10.3748/wjg.v12.i42.6818; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shiojiri N, 2004, HEPATOLOGY, V40, P346, DOI 10.1002/hep.20303; Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Suzuki A, 2008, DEVELOPMENT, V135, P1589, DOI 10.1242/dev.016634; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Teratani T, 2005, HEPATOLOGY, V41, P836, DOI 10.1002/hep.20629; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Vellon L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-81; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	44	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24228	10.1371/journal.pone.0024228	http://dx.doi.org/10.1371/journal.pone.0024228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887386	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298800039
J	da Silva, ICD; Carneiro, VC; Maciel, RD; da Costa, RFM; Furtado, DR; de Oliveira, FMB; da Silva-Neto, MAC; Rumjanek, FD; Fantappie, MR				de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Maciel, Renata de Moraes; Madeiro da Costa, Rodrigo Furtado; Furtado, Daniel Rodrigues; Bastos de Oliveira, Francisco Meirelles; Cardoso da Silva-Neto, Mario Alberto; Rumjanek, Franklin David; Fantappie, Marcelo Rosado			CK2 Phosphorylation of Schistosoma mansoni HMGB1 Protein Regulates Its Cellular Traffic and Secretion but Not Its DNA Transactions	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; TNF-ALPHA; CHROMATIN PROTEIN; CYTOKINE ACTIVITY; IMMUNE-RESPONSES; KINASE CK2; SCID MICE; CELLS; INFECTION; HIGH-MOBILITY-GROUP-BOX-1	Background: The helminth Schistosoma mansoni parasite resides in mesenteric veins where fecundated female worms lay hundred of eggs daily. Some of the egg antigens are trapped in the liver and induce a vigorous granulomatous response. High Mobility Group Box 1 (HMGB1), a nuclear factor, can also be secreted and act as a cytokine. Schistosome HMGB1 (SmHMGB1) is secreted by the eggs and stimulate the production of key cytokines involved in the pathology of schistosomiasis. Thus, understanding the mechanism of SmHMGB1 release becomes mandatory. Here, we addressed the question of how the nuclear SmHMGB1 can reach the extracellular space. Principal Findings: We showed in vitro and in vivo that CK2 phosphorylation was involved in the nucleocytoplasmic shuttling of SmHMGB1. By site-directed mutagenesis we mapped the two serine residues of SmHMGB1 that were phosphorylated by CK2. By DNA bending and supercoiling assays we showed that CK2 phosphorylation of SmHMGB1 had no effect in the DNA binding activities of the protein. We showed by electron microscopy, as well as by cell transfection and fluorescence microscopy that SmHMGB1 was present in the nucleus and cytoplasm of adult schistosomes and mammalian cells. In addition, we showed that treatments of the cells with either a phosphatase or a CK2 inhibitor were able to enhance or block, respectively, the cellular traffic of SmHMGB1. Importantly, we showed by confocal microscopy and biochemically that SmHMGB1 is significantly secreted by S. mansoni eggs of infected animals and that SmHMGB1 that were localized in the periovular schistosomotic granuloma were phosphorylated. Conclusions: We showed that secretion of SmHMGB1 is regulated by phosphorylation. Moreover, our results suggest that egg-secreted SmHMGB1 may represent a new egg antigen. Therefore, the identification of drugs that specifically target phosphorylation of SmHMGB1 might block its secretion and interfere with the pathogenesis of schistosomiasis.	[de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Maciel, Renata de Moraes; Madeiro da Costa, Rodrigo Furtado; Furtado, Daniel Rodrigues; Bastos de Oliveira, Francisco Meirelles; Cardoso da Silva-Neto, Mario Alberto; Rumjanek, Franklin David; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	da Silva, ICD (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.	fantappie@bioqmed.ufrj.br	Bastos de Oliveira, Francisco/C-2349-2008; Madeiro, Rodrigo/M-6433-2017; de Oliveira, Francisco Bastos/I-3540-2013; Silva-Neto, Mario A C/C-1211-2013; Furtado, Daniel/B-8697-2008; de Moraes Maciel, Renata/E-1426-2014	Madeiro, Rodrigo/0000-0001-5646-8858; de Oliveira, Francisco Bastos/0000-0003-3314-3940; Silva-Neto, Mario A C/0000-0003-2273-194X; Furtado, Daniel/0000-0001-7072-7879; Carneiro, Vitor/0000-0003-1518-7667; Rumjanek, Franklin/0000-0002-6618-7096	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRI P, 1992, NATURE, V356, P604, DOI 10.1038/356604a0; de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; BOROS DL, 1986, ANN NY ACAD SCI, V465, P313, DOI 10.1111/j.1749-6632.1986.tb18507.x; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129; Cheever AW, 1999, INFECT IMMUN, V67, P2201, DOI 10.1128/IAI.67.5.2201-2208.1999; CHEEVER AW, 1967, T ROY SOC TROP MED H, V61, P626, DOI 10.1016/0035-9203(67)90125-3; Choi YR, 2003, CANCER RES, V63, P2188; Davies SJ, 2004, INT J PARASITOL, V34, P27, DOI 10.1016/j.ijpara.2003.10.010; Ditsworth D, 2007, J BIOL CHEM, V282, P17845, DOI 10.1074/jbc.M701465200; Duraes FV, 2009, IMMUNOL LETT, V125, P72, DOI 10.1016/j.imlet.2009.06.004; Gnanasekar M, 2006, MOL BIOCHEM PARASIT, V145, P137, DOI 10.1016/j.molbiopara.2005.09.013; Haseeb MA, 2001, CYTOKINE, V15, P266, DOI 10.1006/cyto.2001.0925; Henri S, 2002, J IMMUNOL, V169, P929, DOI 10.4049/jimmunol.169.2.929; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; JOSEPH AL, 1993, J IMMUNOL, V151, P5461; Kang HJ, 2009, LAB INVEST, V89, P948, DOI 10.1038/labinvest.2009.47; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kokkola R, 2003, ARTHRITIS RHEUM, V48, P2052, DOI 10.1002/art.11161; Leptak CL, 1997, J IMMUNOL, V158, P301; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; LUND T, 1987, EUR J BIOCHEM, V166, P21, DOI 10.1111/j.1432-1033.1987.tb13477.x; Marguerite M, 1999, TROP MED INT HEALTH, V4, P530, DOI 10.1046/j.1365-3156.1999.00443.x; Marshall AJ, 1999, J IMMUNOL, V163, P2089; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Oliveira VR, 2000, MICROBES INFECT, V2, P1817, DOI 10.1016/S1286-4579(00)01341-1; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pelovsky P, 2009, BIOCHEM BIOPH RES CO, V380, P138, DOI 10.1016/j.bbrc.2009.01.056; Quack T, 2010, INT J PARASITOL, V40, P991, DOI 10.1016/j.ijpara.2010.04.013; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; Sapojnikova N, 2005, BBA-GENE STRUCT EXPR, V1729, P57, DOI 10.1016/j.bbaexp.2005.03.002; Stemmer C, 2003, BIOCHEMISTRY-US, V42, P3503, DOI 10.1021/bi027350d; Stemmer C, 2002, J BIOL CHEM, V277, P1092, DOI 10.1074/jbc.M109503200; Street M, 1999, J IMMUNOL, V163, P4489; Stros M, 2002, J BIOL CHEM, V277, P7157, DOI 10.1074/jbc.M110233200; Stros M, 2001, BIOCHEMISTRY-US, V40, P4769, DOI 10.1021/bi002741i; Stros M, 2000, EUR J BIOCHEM, V267, P4088, DOI 10.1046/j.1432-1327.2000.01450.x; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Susa Y, 2009, CRIT CARE MED, V37, P2619, DOI 10.1097/CCM.0b013e3181a930f7; Tang YT, 2008, INT IMMUNOPHARMACOL, V8, P1646, DOI 10.1016/j.intimp.2008.07.014; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WELLS KE, 1991, EXP PARASITOL, V73, P295, DOI 10.1016/0014-4894(91)90101-2; WISNIEWSKI JR, 1994, EUR J BIOCHEM, V225, P687, DOI 10.1111/j.1432-1033.1994.00687.x; World Health Organization (WHO), 2002, TDR STRAT DIR RES SC; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zien P, 2005, BBA-PROTEINS PROTEOM, V1754, P271, DOI 10.1016/j.bbapap.2005.07.039	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23572	10.1371/journal.pone.0023572	http://dx.doi.org/10.1371/journal.pone.0023572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887276	Green Submitted, gold, Green Published			2022-12-25	WOS:000295832000031
J	Koutsoudakis, G; Perez-del-Pulgar, S; Coto-Llerena, M; Gonzalez, P; Dragun, J; Mensa, L; Crespo, G; Navasa, M; Forns, X				Koutsoudakis, George; Perez-del-Pulgar, Sofia; Coto-Llerena, Mairene; Gonzalez, Patricia; Dragun, Jakub; Mensa, Laura; Crespo, Gonzalo; Navasa, Miguel; Forns, Xavier			Cell Culture Replication of a Genotype 1b Hepatitis C Virus Isolate Cloned from a Patient Who Underwent Liver Transplantation	PLOS ONE			English	Article							ENVELOPE PROTEIN; CDNA-CLONE; MUTATIONS; TRANSMISSION; SYSTEMS; ENTRY; CD81	The introduction of the genotype 2a isolate JFH1 was a major breakthrough in the field of hepatitis C virus (HCV), allowing researchers to study the complete life cycle of the virus in cell culture. However, fully competent culture systems encompassing the most therapeutically relevant HCV genotypes are still lacking, especially for the highly drug-resistant genotype 1b. For most isolated HCV clones, efficient replication in cultured hepatoma cells requires the introduction of replication-enhancing mutations. However, such mutations may interfere with viral assembly, as occurs in the case of the genotype 1b isolate Con1. In this study, we show that a clinical serum carrying a genotype 1b virus with an exceptionally high viral load was able to infect Huh7.5 cells. Similar to previous reports, inoculation of Huh7.5 cells by natural virus is very inefficient compared to infection by cell culture HCV. A consensus sequence of a new genotype 1b HCV isolate was cloned from the clinical serum (designated Barcelona HCV1), and then subjected to replication studies. This virus replicated poorly in a transient fashion in Huh7.5 cells after electroporation with in vitro transcribed RNA. Nonetheless, approximately 3 weeks post electroporation and thereafter, core protein-positive cells were detected by immunofluorescence. Surprisingly, small amounts of core protein were also measurable in the supernatant of electroporated cells, suggesting that HCV particles might be assembled and released. Our findings not only enhance the current method of cloning in vitro HCV replication-competent isolates, but also offer valuable insights for the realization of fully competent culture systems for HCV.	[Koutsoudakis, George; Perez-del-Pulgar, Sofia; Coto-Llerena, Mairene; Gonzalez, Patricia; Dragun, Jakub; Mensa, Laura; Crespo, Gonzalo; Navasa, Miguel; Forns, Xavier] Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi i Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Koutsoudakis, G (corresponding author), Hosp Clin Barcelona, Liver Unit, Inst Invest Biomed August Pi i Sunyer, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	gkoutsou@clinic.ub.es	Mensa, Laura/ABC-3124-2021; Navasa, Miquel/G-7958-2016	Navasa, Miquel/0000-0002-3130-9604; Mensa, Laura/0000-0003-2009-3550; Crespo, Gonzalo/0000-0002-1178-4897; Forns, Xavier/0000-0002-8188-1764; Perez-del-Pulgar, Sofia/0000-0002-9890-300X	Instituto de Salud Carlos III [PI080239]; European Regional Development Fund (ERDF); EIHCV Marie Curie Research Training Network [MRTN-CT-2006-035599]; Hospital Clinic (Ajut a la Recerca Josep Font); Fundacion BBVA; Ministerio de Ciencia e Innovacion; Ministerio de Asuntos Exteriores y Cooperacion (Agencia Espanola de Cooperacion Internacional)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); EIHCV Marie Curie Research Training Network; Hospital Clinic (Ajut a la Recerca Josep Font); Fundacion BBVA(BBVA Foundation); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Asuntos Exteriores y Cooperacion (Agencia Espanola de Cooperacion Internacional)	X. Forns received support in part by grants from the Instituto de Salud Carlos III (PI080239), co-funded by the European Regional Development Fund (ERDF), and the EIHCV Marie Curie Research Training Network (MRTN-CT-2006-035599). The other authors were supported by grants from the following institutions: G. Koutsoudakis and J. Dragun from the EIHCV Marie Curie Research Training Network (MRTN-CT-2006-035599), G. Crespo from Hospital Clinic (Ajut a la Recerca Josep Font) and the Fundacion BBVA, L. Mensa from the Ministerio de Ciencia e Innovacion, and M. Coto-Llerena from the Ministerio de Asuntos Exteriores y Cooperacion (Agencia Espanola de Cooperacion Internacional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; KATO N, 1992, BIOCHEM BIOPH RES CO, V189, P119, DOI 10.1016/0006-291X(92)91533-V; Kato N, 2000, CURR TOP MICROBIOL, V242, P261; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; LopezLabrador FX, 1997, J HEPATOL, V27, P959, DOI 10.1016/S0168-8278(97)80137-7; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pietschmann T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000475; Revie D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-37; Rosen HR, 2008, GASTROENTEROLOGY, V134, P1789, DOI 10.1053/j.gastro.2008.02.062; Silberstein E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000910; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomson M, 2001, GASTROENTEROLOGY, V121, P1226, DOI 10.1053/gast.2001.28669; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	41	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23587	10.1371/journal.pone.0023587	http://dx.doi.org/10.1371/journal.pone.0023587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887279	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000034
J	Nielsen, HL; Nielsen, H; Ejlertsen, T; Engberg, J; Gunzel, D; Zeitz, M; Hering, NA; Fromm, M; Schulzke, JD; Bucker, R				Nielsen, Hans Linde; Nielsen, Henrik; Ejlertsen, Tove; Engberg, Jorgen; Guenzel, Dorothee; Zeitz, Martin; Hering, Nina A.; Fromm, Michael; Schulzke, Joerg-Dieter; Buecker, Roland			Oral and Fecal Campylobacter concisus Strains Perturb Barrier Function by Apoptosis Induction in HT-29/B6 Intestinal Epithelial Cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TIME QUANTITATIVE PCR; COLONIC EPITHELIUM; TIGHT JUNCTIONS; STIMULATION; PREVALENCE; ARCOBACTER; MONOLAYERS; SECRETION; MECHANISM	Campylobacter concisus infections of the gastrointestinal tract can be accompanied by diarrhea and inflammation, whereas colonization of the human oral cavity might have a commensal nature. We focus on the pathophysiology of C. concisus and the effects of different clinical oral and fecal C. concisus strains on human HT-29/B6 colon cells. Six oral and eight fecal strains of C. concisus were isolated. Mucus-producing HT-29/B6 epithelial monolayers were infected with the C. concisus strains. Transepithelial electrical resistance (R-t) and tracer fluxes of different molecule size were measured in Ussing chambers. Tight junction (TJ) protein expression was determined by Western blotting, and subcellular TJ distribution was analyzed by confocal laser-scanning microscopy. Apoptosis induction was examined by TUNEL-staining and Western blot of caspase-3 activation. All strains invaded confluent HT-29/B6 cells and impaired epithelial barrier function, characterized by a time- and dose-dependent decrease in R-t either after infection from the apical side but even more from the basolateral compartment. TJ protein expression changes were sparse, only in apoptotic areas of infected monolayers TJ proteins were redistributed. Solely the barrier-forming TJ protein claudin-5 showed a reduced expression level to 66 +/- 8% (P<0.05), by expression regulation from the gene. Concomitantly, Lactate dehydrogenase release was elevated to 3.1 +/- 0.3% versus 0.7 +/- 0.1% in control (P<0.001), suggesting cytotoxic effects. Furthermore, oral and fecal C. concisus strains elevated apoptotic events to 5-fold. C. concisus-infected monolayers revealed an increased permeability for 332 Da fluorescein (1.74 +/- 0.13 vs. 0.56 +/- 0.17 10(-6) cm/s in control, P<0.05) but showed no difference in permeability for 4 kDa FITC-dextran (FD-4). The same was true in camptothecin-exposed monolayers, where camptothecin was used for apoptosis induction. In conclusion, epithelial barrier dysfunction by oral and fecal C. concisus strains could mainly be assigned to apoptotic leaks together with moderate TJ changes, demonstrating a leak-flux mechanism that parallels the clinical manifestation of diarrhea.	[Nielsen, Hans Linde; Nielsen, Henrik] Aarhus Univ Hosp, Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark; [Ejlertsen, Tove] Aarhus Univ Hosp, Aalborg Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Engberg, Jorgen] Slagelse Hosp, Dept Clin Microbiol, Slagelse, Denmark; [Guenzel, Dorothee; Fromm, Michael] Charite, Inst Clin Physiol, D-13353 Berlin, Germany; [Zeitz, Martin; Hering, Nina A.; Schulzke, Joerg-Dieter; Buecker, Roland] Charite, Div Gen Med & Nutr, Dept Gastroenterol Infect Dis & Rheumatol, D-13353 Berlin, Germany	Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Nielsen, HL (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Dept Infect Dis, Aalborg, Denmark.	joerg.schulzke@charite.de	Bücker, Roland/O-2233-2015; Fromm, Michael/K-6203-2013	Bücker, Roland/0000-0002-1345-4146; Fromm, Michael/0000-0003-4497-7983; Hering, Nina Alexandra/0000-0001-9751-6967; Engberg, Jorgen/0000-0001-9042-1631; Gunzel, Dorothee/0000-0002-7998-7164	Deutsche Forschungsgemeinschaft [DFG] [Schu 559/11-1]	Deutsche Forschungsgemeinschaft [DFG](German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [DFG Schu 559/11-1 to MZ, JDS, RB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Aabenhus R, 2008, WORLD J GASTROENTERO, V14, P6954, DOI 10.3748/wjg.14.6954; Amasheh S, 2005, CELL TISSUE RES, V321, P89, DOI 10.1007/s00441-005-1101-0; Bojarski C, 2001, J PHYSIOL-LONDON, V535, P541, DOI 10.1111/j.1469-7793.2001.00541.x; Bucker R, 2011, J INFECT DI IN PRESS; Bucker R, 2009, J INFECT DIS, V200, P756, DOI 10.1086/600868; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Epple HJ, 1997, PFLUG ARCH EUR J PHY, V433, P638, DOI 10.1007/s004240050325; Florian P, 2002, J PHYSIOL-LONDON, V545, P485, DOI 10.1113/jphysiol.2002.031161; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Istivan TS, 2004, J MED MICROBIOL, V53, P483, DOI 10.1099/jmm.0.45554-0; Kaakoush NO, 2010, FEBS J, V277, P1606, DOI 10.1111/j.1742-4658.2010.07587.x; Kalischuk LD, 2007, MICROBIOL-SGM, V153, P2952, DOI 10.1099/mic.0.2006/003962-0; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Lastovica AJ, 2009, J CLIN MICROBIOL, V47, P2360, DOI 10.1128/JCM.00568-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Newell DG, 2005, EUR J GASTROEN HEPAT, V17, P1013, DOI 10.1097/00042737-200510000-00001; SCHULZKE JD, 1992, GASTROENTEROLOGY, V102, P497, DOI 10.1016/0016-5085(92)90096-H; Soderholm JD, 2004, GUT, V53, P1817, DOI 10.1136/gut.2004.041426; Troeger H, 2007, CELL MICROBIOL, V9, P2530, DOI 10.1111/j.1462-5822.2007.00978.x; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09	27	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23858	10.1371/journal.pone.0023858	http://dx.doi.org/10.1371/journal.pone.0023858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887334	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000068
J	Rodrigues, CO; Shehadeh, LA; Hoosien, M; Otero, V; Chopra, I; Tsinoremas, NF; Bishopric, NH				Rodrigues, Claudia O.; Shehadeh, Lina A.; Hoosien, Michael; Otero, Valerie; Chopra, Ines; Tsinoremas, Nicholas F.; Bishopric, Nanette H.			Heterogeneity in SDF-1 Expression Defines the Vasculogenic Potential of Adult Cardiac Progenitor Cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC-HEART FAILURE; SIDE POPULATION CELLS; STEM-CELLS; FACTOR-I; GROWTH-FACTOR; CARDIOVASCULAR REGENERATION; INTRAMYOCARDIAL INJECTION; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS	Rationale: The adult myocardium has been reported to harbor several classes of multipotent progenitor cells (CPCs) with tri-lineage differentiation potential. It is not clear whether c-kit+CPCs represent a uniform precursor population or a more complex mixture of cell types. Objective: To characterize and understand vasculogenic heterogeneity within c-kit+presumptive cardiac progenitor cell populations. Methods and Results: c-kit+, sca-1+CPCs obtained from adult mouse left ventricle expressed stem cell-associated genes, including Oct-4 and Myc, and were self-renewing, pluripotent and clonogenic. Detailed single cell clonal analysis of 17 clones revealed that most (14/17) exhibited trilineage differentiation potential. However, striking morphological differences were observed among clones that were heritable and stable in long-term culture. 3 major groups were identified: round (7/17), flat or spindle-shaped (5/17) and stellate (5/17). Stellate morphology was predictive of vasculogenic differentiation in Matrigel. Genome-wide expression studies and bioinformatic analysis revealed clonally stable, heritable differences in stromal cell-derived factor-1 (SDF-1) expression that correlated strongly with stellate morphology and vasculogenic capacity. Endogenous SDF-1 production contributed directly to vasculogenic differentiation: both shRNA-mediated knockdown of SDF-1 and AMD3100, an antagonist of the SDF-1 receptor CXC chemokine Receptor-4 (CXCR4), reduced tube-forming capacity, while exogenous SDF-1 induced tube formation by 2 non-vasculogenic clones. CPCs producing SDF-1 were able to vascularize Matrigel dermal implants in vivo, while CPCs with low SDF-1 production were not. Conclusions: Clonogenic c-kit+, sca-1+ CPCs are heterogeneous in morphology, gene expression patterns and differentiation potential. Clone-specific levels of SDF-1 expression both predict and promote development of a vasculogenic phenotype via a previously unreported autocrine mechanism.	[Rodrigues, Claudia O.; Chopra, Ines; Bishopric, Nanette H.] Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL USA; [Shehadeh, Lina A.; Hoosien, Michael; Otero, Valerie; Bishopric, Nanette H.] Univ Miami, Dept Med, Leonard M Miller Sch Med, Div Cardiol, Miami, FL USA; [Tsinoremas, Nicholas F.] Univ Miami, Ctr Computat Sci, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University of Miami; University of Miami	Rodrigues, CO (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL USA.	n.bishopric@miami.edu			National Institutes of Health [R01-HL71094]; Fondation Leducq [05-CVD-02]; Florida Heart Research Institute; American Heart Association (National) [0735311N];  [T32-HL007188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071094, T32HL007188, F32HL083673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Florida Heart Research Institute; American Heart Association (National)(American Heart Association); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health R01-HL71094 (to NHB), the Fondation Leducq (05-CVD-02, to NHB), T32-HL007188 to the Department of Molecular and Cellular Pharmacology and the Florida Heart Research Institute (to NHB). Dr. Rodrigues is the recipient of a Scientist Development Grant from the American Heart Association (National) (0735311N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Angert David, 2009, Curr Treat Options Cardiovasc Med, V11, P316; Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1; Anversa P, 2007, STEM CELLS, V25, P589, DOI 10.1634/stemcells.2006-0623; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; D'Alessandro David A, 2010, Curr Treat Options Cardiovasc Med, V12, P614, DOI 10.1007/s11936-010-0099-0; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Diederichsen ACP, 2010, SCAND CARDIOVASC J, V44, P139, DOI 10.3109/14017430903556294; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Flores-Ramirez R, 2010, CARDIOVASC REVASCULA, V11, P72, DOI 10.1016/j.carrev.2009.04.001; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]; Franco D, 2007, CELL MOL LIFE SCI, V64, P683, DOI 10.1007/s00018-007-6521-4; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Garry DJ, 2005, AM J MED SCI, V329, P190, DOI 10.1097/00000441-200504000-00005; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Heidenreich PA, 2010, J AM COLL CARDIOL, V56, P362, DOI 10.1016/j.jacc.2010.02.053; JAMES TN, 1994, CIRCULATION, V90, P556, DOI 10.1161/01.CIR.90.1.556; Karystinou A, 2009, RHEUMATOLOGY, V48, P1057, DOI 10.1093/rheumatology/kep192; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Kovacic JC, 2008, TRENDS CARDIOVAS MED, V18, P45, DOI 10.1016/j.tcm.2007.12.002; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Leri A, 2001, Ital Heart J, V2 Suppl 3, p12S; Leri A, 2008, CURR PROB CARDIOLOGY, V33, P91, DOI 10.1016/j.cpcardiol.2007.11.002; Li MZ, 2009, SEMIN CANCER BIOL, V19, P111, DOI 10.1016/j.semcancer.2008.11.001; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Lyngbaek S, 2007, BASIC RES CARDIOL, V102, P101, DOI 10.1007/s00395-007-0638-3; Lyon A, 2007, CURR OPIN PHARMACOL, V7, P164, DOI 10.1016/j.coph.2006.10.003; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; McManus DD, 2011, AM J CARDIOL, V107, P353, DOI 10.1016/j.amjcard.2010.09.026; Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Patel AN, 2005, J THORAC CARDIOV SUR, V130, P1631, DOI 10.1016/j.jtcvs.2005.07.056; Penn MS, 2009, CIRC RES, V104, P1133, DOI 10.1161/CIRCRESAHA.109.198929; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pi XC, 2009, P NATL ACAD SCI USA, V106, P5675, DOI 10.1073/pnas.0809568106; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rodrigues CO, 2007, PROG PEDIATR CARDIOL, V23, P49, DOI 10.1016/j.ppedcard.2007.05.001; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Steinhauser ML, 2009, CELL STEM CELL, V4, P277, DOI 10.1016/j.stem.2009.03.008; Strauer BE, 2010, EUR J HEART FAIL, V12, P721, DOI 10.1093/eurjhf/hfq095; Surder D, 2010, AM HEART J, V160, P58, DOI 10.1016/j.ahj.2010.03.039; Tateishi K, 2007, J CELL SCI, V120, P1791, DOI 10.1242/jcs.006122; Tillmanns J, 2008, P NATL ACAD SCI USA, V105, P1668, DOI 10.1073/pnas.0706315105; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella D, 2007, CELL MOL LIFE SCI, V64, P661, DOI 10.1007/s00018-007-6519-y; Torella D, 2005, TRENDS CARDIOVAS MED, V15, P229, DOI 10.1016/j.tcm.2005.06.006; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vrijsen KR, 2009, CURR OPIN ORGAN TRAN, V14, P560, DOI 10.1097/MOT.0b013e328330389e; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Weidt Corinna, 2007, Curr Stem Cell Res Ther, V2, P89, DOI 10.2174/157488807779317008; Willerson JT, 2010, AM HEART J, V160, P215, DOI 10.1016/j.ahj.2010.03.029; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yeo C, 2009, REGEN MED, V4, P119, DOI 10.2217/17460751.4.1.119; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350	89	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24013	10.1371/journal.pone.0024013	http://dx.doi.org/10.1371/journal.pone.0024013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887363	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000086
J	Sarmento, RA; Lemos, F; Dias, CR; Kikuchi, WT; Rodrigues, JCP; Pallini, A; Sabelis, MW; Janssen, A				Sarmento, Renato A.; Lemos, Felipe; Dias, Cleide R.; Kikuchi, Wagner T.; Rodrigues, Jean C. P.; Pallini, Angelo; Sabelis, Maurice W.; Janssen, Arne			A Herbivorous Mite Down-Regulates Plant Defence and Produces Web to Exclude Competitors	PLOS ONE			English	Article							TETRANYCHUS-EVANSI; SPIDER-MITES; RESPONSES; PREY; INHIBITORS; MECHANISM; ACID	Herbivores may interact with each other through resource competition, but also through their impact on plant defence. We recently found that the spider mite Tetranychus evansi down-regulates plant defences in tomato plants, resulting in higher rates of oviposition and population growth on previously attacked than on unattacked leaves. The danger of such down-regulation is that attacked plants could become a more profitable resource for heterospecific competitors, such as the two-spotted spider mite Tetranychus urticae. Indeed, T. urticae had an almost 2-fold higher rate of oviposition on leaf discs on which T. evansi had fed previously. In contrast, induction of direct plant defences by T. urticae resulted in decreased oviposition by T. evansi. Hence, both herbivores affect each other through induced plant responses. However, when populations of T. evansi and T. urticae competed on the same plants, populations of the latter invariably went extinct, whereas T. evansi was not significantly affected by the presence of its competitor. This suggests that T. evansi can somehow prevent its competitor from benefiting from the down-regulated plant defence, perhaps by covering it with a profuse web. Indeed, we found that T. urticae had difficulties reaching the leaf surface to feed when the leaf was covered with web produced by T. evansi. Furthermore, T. evansi produced more web when exposed to damage or other cues associated with T. urticae. We suggest that the silken web produced by T. evansi serves to prevent competitors from profiting from down-regulated plant defences.	[Sarmento, Renato A.; Kikuchi, Wagner T.; Rodrigues, Jean C. P.] Fed Univ Tocantins UFT, Grad Programme Plant Sci, Gurupi, Tocantins, Brazil; [Sarmento, Renato A.; Sabelis, Maurice W.; Janssen, Arne] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, Amsterdam, Netherlands; [Lemos, Felipe; Dias, Cleide R.; Pallini, Angelo] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal do Tocantins (UFT); University of Amsterdam; Universidade Federal de Vicosa	Sarmento, RA (corresponding author), Fed Univ Tocantins UFT, Grad Programme Plant Sci, Gurupi, Tocantins, Brazil.	arne.janssen@uva.nl	Pallini, Angelo/F-7791-2012; Janssen, Arne/B-2657-2009; Lemos, Felipe/F-9902-2014	Pallini, Angelo/0000-0003-3752-3545; Janssen, Arne/0000-0001-5075-5303; Lemos, Felipe/0000-0001-7157-216X; Sarmento, Renato/0000-0002-5379-9595	CNPq-Brazil; WOTRO-NWO [W82-281]; FAPEMIG, Brazil (PVE)	CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); WOTRO-NWO(Netherlands Organization for Scientific Research (NWO)); FAPEMIG, Brazil (PVE)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported in part by CNPq-Brazil. RAS received a scholarship from WOTRO-NWO (project W82-281), AJ received a scholarship from FAPEMIG, Brazil (PVE), AP from CNPq, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; Alba JM, 2011, J PLANT INTERACT, V6, P221, DOI 10.1080/17429145.2010.551670; Ament K, 2004, PLANT PHYSIOL, V135, P2025, DOI 10.1104/pp.104.048694; [Anonymous], 2010, R LANG ENV STAT COMP; Baldwin IT, 1999, PLANTA, V208, P137, DOI 10.1007/s004250050543; Begon M., 1996, ECOLOGY; BROADWAY RM, 1986, J INSECT PHYSIOL, V32, P827, DOI 10.1016/0022-1910(86)90097-1; Crawley MJ., 2007, R BOOK; DEMORAES GJ, 1987, ACAROLOGIA, V28, P333; Gerson U, 1985, SPIDER MITES THEIR A, P223; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; HAZAN A, 1975, COMP BIOCHEM PHYS B, V51, P457, DOI 10.1016/0305-0491(75)90038-3; Janssen A, 1997, J ANIM ECOL, V66, P223, DOI 10.2307/6024; JANSSEN A, 1992, EXP APPL ACAROL, V14, P233, DOI 10.1007/BF01200566; Jeppson I. R., 1975, MITES INJURIOUS EC P; Kant MR, 2008, P R SOC B, V275, P443, DOI 10.1098/rspb.2007.1277; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; KARBAN R, 1984, SCIENCE, V225, P53, DOI 10.1126/science.225.4657.53; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Lemos F, 2010, EXP APPL ACAROL, V52, P1, DOI 10.1007/s10493-010-9344-1; Morimoto K, 2006, J ECON ENTOMOL, V99, P678, DOI 10.1603/0022-0493-99.3.678; de Vasconcelos GJN, 2008, EXP APPL ACAROL, V44, P27, DOI 10.1007/s10493-007-9124-8; Pallini A, 1998, ECOL LETT, V1, P171; Ricklefs RE., 1990, ECOLOGY; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sabelis M.W., 1991, P23; Sabelis M.W, 1981, 910 ENT AGR PUBL ANF; SABELIS MW, 1992, EXP APPL ACAROL, V16, P203, DOI 10.1007/BF01193804; SAITO Y, 1979, JPN J APPL ENTOMOL Z, V23, P82, DOI 10.1303/jjaez.23.82; SAITO Y, 1983, ACAROLOGIA, V24, P377; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; THURLING DJ, 1980, OECOLOGIA, V46, P391, DOI 10.1007/BF00346269; Van Zandt PA, 2004, ECOLOGY, V85, P2616, DOI 10.1890/03-0622; Van Zandt PA, 2004, OIKOS, V104, P401, DOI 10.1111/j.0030-1299.2004.12964.x; [No title captured]	38	47	48	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23757	10.1371/journal.pone.0023757	http://dx.doi.org/10.1371/journal.pone.0023757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887311	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000053
J	Zhang, CY; Elkahloun, AG; Robertson, M; Gills, JJ; Tsurutani, J; Shih, JH; Fukuoka, J; Hollander, MC; Harris, CC; Travis, WD; Jen, J; Dennis, PA				Zhang, Chunyu; Elkahloun, Abdel G.; Robertson, Matthew; Gills, Joell J.; Tsurutani, Junji; Shih, Joanna H.; Fukuoka, Junya; Hollander, M. Christine; Harris, Curtis C.; Travis, William D.; Jen, Jin; Dennis, Phillip A.			Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; GENE-EXPRESSION; EPIGENETIC INACTIVATION; MAMMARY TUMORIGENESIS; AKT ACTIVATION; APOPTOSIS; PHOSPHORYLATION; TRANSFORMATION; LOCALIZATION	The dismal lethality of lung cancer is due to late stage at diagnosis and inherent therapeutic resistance. The incorporation of targeted therapies has modestly improved clinical outcomes, but the identification of new targets could further improve clinical outcomes by guiding stratification of poor-risk early stage patients and individualizing therapeutic choices. We hypothesized that a sequential, combined microarray approach would be valuable to identify and validate new targets in lung cancer. We profiled gene expression signatures during lung epithelial cell immortalization and transformation, and showed that genes involved in mitosis were progressively enhanced in carcinogenesis. 28 genes were validated by immunoblotting and 4 genes were further evaluated in non-small cell lung cancer tissue microarrays. Although CDK1 was highly expressed in tumor tissues, its loss from the cytoplasm unexpectedly predicted poor survival and conferred resistance to chemotherapy in multiple cell lines, especially microtubule-directed agents. An analysis of expression of CDK1 and CDK1-associated genes in the NCI60 cell line database confirmed the broad association of these genes with chemotherapeutic responsiveness. These results have implications for personalizing lung cancer therapy and highlight the potential of combined approaches for biomarker discovery.	[Zhang, Chunyu; Robertson, Matthew; Gills, Joell J.; Tsurutani, Junji; Hollander, M. Christine; Dennis, Phillip A.] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Tsurutani, Junji] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan; [Shih, Joanna H.] NCI, Biometr Res Branch, NIH, Bethesda, MD 20892 USA; [Fukuoka, Junya; Jen, Jin] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Fukuoka, Junya] Toyama Univ Hosp, Dept Surg Pathol, Toyama, Japan; [Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Jen, Jin] Mayo Clin, Dept Pulm & Crit Care Med, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Kindai University (Kinki University); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toyama; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Mayo Clinic	Zhang, CY (corresponding author), Lovelace Resp Res Inst, COPD program, Albuquerque, NM USA.	dennisp@mail.nih.gov	Zhang, Chun-yu/HDP-5776-2022; Fukuoka, Junya/AAT-2924-2021	Fukuoka, Junya/0000-0002-2496-3050	NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010748, ZIASC010292, ZIABC010450] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander SV, 2001, CANCER RES, V61, P8624; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Braybrooke JP, 2003, CLIN CANCER RES, V9, P4682; Brognard J, 2001, CANCER RES, V61, P3986; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; DeRisi J, 1996, NAT GENET, V14, P457; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Falleni M, 2003, J PATHOL, V200, P620, DOI 10.1002/path.1388; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; Gupta PC, 1996, CRIT REV TOXICOL, V26, P183, DOI 10.3109/10408449609017930; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; HANASH SM, 1988, J BIOL CHEM, V263, P12813; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Honda S, 2003, ANTICANCER RES, V23, P3775; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kallstrom H, 2005, EXP CELL RES, V303, P89, DOI 10.1016/j.yexcr.2004.09.012; Kim SJ, 2008, ANN ONCOL, V19, P68, DOI 10.1093/annonc/mdm358; KLEINSZANTO AJP, 1992, P NATL ACAD SCI USA, V89, P6693, DOI 10.1073/pnas.89.15.6693; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Leisser C, 2004, CELL DEATH DIFFER, V11, P80, DOI 10.1038/sj.cdd.4401318; Linares JF, 2011, MOL CELL BIOL, V31, P105, DOI 10.1128/MCB.00620-10; Liu DG, 2002, CANCER, V94, P2239, DOI 10.1002/cncr.10450; Lodygin D, 2005, CELL RES, V15, P237, DOI 10.1038/sj.cr.7290292; Lu B, 2004, BRIT J CANCER, V91, P537, DOI 10.1038/sj.bjc.6602027; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manchado E, 2010, CANCER CELL, V18, P641, DOI 10.1016/j.ccr.2010.10.028; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; NIEDERLE N, 1991, CANCER CHEMOTH PHARM, V28, P59, DOI 10.1007/BF00684958; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Ray D, 2007, CANCER RES, V67, P984, DOI 10.1158/0008-5472.CAN-06-3927; REDDEL RR, 1988, CANCER RES, V48, P1904; RODENHUIS S, 1988, CANCER RES, V48, P5738; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schang LM, 2004, BBA-PROTEINS PROTEOM, V1697, P197, DOI 10.1016/j.bbapap.2003.11.024; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; Singhal S, 2003, CANCER BIOL THER, V2, P291, DOI 10.4161/cbt.2.3.399; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Vischioni B, 2004, ANN ONCOL, V15, P1654, DOI 10.1093/annonc/mdh436; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	56	43	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23849	10.1371/journal.pone.0023849	http://dx.doi.org/10.1371/journal.pone.0023849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887332	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000067
J	Cheng, ZX; Sun, B; Wang, SJ; Gao, Y; Zhang, YM; Zhou, HX; Jia, G; Wang, YW; Kong, R; Pan, SH; Xue, DB; Jiang, HC; Bai, XW				Cheng, Zhuo-Xin; Sun, Bei; Wang, Shuang-Jia; Gao, Yue; Zhang, Ying-Mei; Zhou, Hao-Xin; Jia, Guang; Wang, Yong-Wei; Kong, Rui; Pan, Shang-Ha; Xue, Dong-Bo; Jiang, Hong-Chi; Bai, Xue-Wei			Nuclear Factor-kappa B-Dependent Epithelial to Mesenchymal Transition Induced by HIF-1 alpha Activation in Pancreatic Cancer Cells under Hypoxic Conditions	PLOS ONE			English	Article							GEMCITABINE; EXPRESSION; RESISTANCE; PATHWAY; GROWTH; MULTICENTER; PROGRESSION; METASTASIS; ALPHA; SNAIL	Background: Epithelial to mesenchymal transition (EMT) induced by hypoxia is one of the critical causes of treatment failure in different types of human cancers. NF-kappa B is closely involved in the progression of EMT. Compared with HIF-1 alpha, the correlation between NF-kappa B and EMT during hypoxia has been less studied, and although the phenomenon was observed in the past, the molecular mechanisms involved remained unclear. Methodology/Principal Findings: Here, we report that hypoxia or overexpression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) promotes EMT in pancreatic cancer cells. On molecular or pharmacologic inhibition of NF-kappa B, hypoxic cells regained expression of E-cadherin, lost expression of N-cadherin, and attenuated their highly invasive and drug-resistant phenotype. Introducing a pcDNA3.0/HIF-1 alpha into pancreatic cancer cells under normoxic conditions heightened NF-kappa B activity, phenocopying EMT effects produced by hypoxia. Conversely, inhibiting the heightened NF-kappa B activity in this setting attenuated the EMT phenotype. Conclusions/Significance: These results suggest that hypoxia or overexpression of HIF-1 alpha induces the EMT that is largely dependent on NF-kappa B in pancreatic cancer cells.	[Cheng, Zhuo-Xin; Sun, Bei; Wang, Shuang-Jia; Zhou, Hao-Xin; Jia, Guang; Wang, Yong-Wei; Kong, Rui; Pan, Shang-Ha; Xue, Dong-Bo; Jiang, Hong-Chi; Bai, Xue-Wei] Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China; [Gao, Yue] Case Western Reserve Univ, Dept Surg, Univ Hosp, Cleveland, OH 44106 USA; [Zhang, Ying-Mei] Harbin Med Univ, Affiliated Hosp 1, Cent Lab, Harbin, Peoples R China	Harbin Medical University; Case Western Reserve University; University Hospitals of Cleveland; Harbin Medical University	Cheng, ZX (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Harbin, Peoples R China.	sunbei70@tom.com	shuangjia, wang/AFX-8272-2022; Jiang, HongChi/M-5031-2018	Jiang, HongChi/0000-0001-8215-8984	New Century Support Foundation for Elitist of Chinese Ministry of Education [NCET-07-0248]; Scientific Foundation for Prominent Youth of Heilongjiang Province, China [JC200717]; Scientific and Technological Project of Heilongjiang Province, China [GC09C407-2]; National Natural Scientific Foundation of China [30571808, 30872987]	New Century Support Foundation for Elitist of Chinese Ministry of Education; Scientific Foundation for Prominent Youth of Heilongjiang Province, China; Scientific and Technological Project of Heilongjiang Province, China; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the New Century Support Foundation for Elitist of Chinese Ministry of Education (NCET-07-0248), the Scientific Foundation for Prominent Youth of Heilongjiang Province, China (JC200717), the Scientific and Technological Project of Heilongjiang Province, China (GC09C407-2), and the National Natural Scientific Foundation of China (30571808, 30872987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algul H, 2002, J GASTROINTEST CANC, V31, P71, DOI 10.1385/IJGC:31:1-3:71; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Beger HG, 2003, WORLD J SURG, V27, P1075, DOI 10.1007/s00268-003-7165-7; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chandler NM, 2004, J SURG RES, V118, P9, DOI 10.1016/S0022-4804(03)00354-8; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Herrmann R, 2007, J CLIN ONCOL, V25, P2212, DOI 10.1200/JCO.2006.09.0886; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; KOONG AC, 1994, CANCER RES, V54, P1425; Kullmann F, 2009, BRIT J CANCER, V100, P1032, DOI 10.1038/sj.bjc.6604983; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; SEMENZA GL, 2003, NAT REV CANCER, P3721; SHIELDS MA, 2011, J BIOL CHEM IN PRESS, V2; Shin SR, 2006, CANCER RES, V66, P2570, DOI 10.1158/0008-5472.CAN-05-3056; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488	32	75	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23752	10.1371/journal.pone.0023752	http://dx.doi.org/10.1371/journal.pone.0023752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887310	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800028
J	Takahashi, H; Ohuchi, A; Miya, S; Izawa, Y; Kimura, B				Takahashi, Hajime; Ohuchi, Ayumi; Miya, Satoko; Izawa, Yukino; Kimura, Bon			Effect of Food Residues on Norovirus Survival on Stainless Steel Surfaces	PLOS ONE			English	Article							FELINE CALICIVIRUS; MURINE NOROVIRUS; INACTIVATION; SURROGATE; GASTROENTERITIS; DISINFECTANTS; OUTBREAK; VIRUS; CONSUMPTION; INFECTION	Background: In households and food processing plants, minute food residues left behind from improper cleaning may influence the survivability of human norovirus on surfaces. In this study, the survivability of norovirus on desiccated food residue-attached stainless steel coupons was investigated. Methodology/Principal Findings: Using murine norovirus-1 (MNV-1) as a surrogate of human norovirus, the survivability of norovirus was investigated on lettuce, cabbage, or ground pork-attached stainless steel coupons. A 6.2 log MPN/ml of MNV-1 infectivity was completely lost at day 30 in residue-free coupons, whereas only a 1.4 log MPN/ml reduction was observed in coupons with residues. Moreover, the disinfective effect of sodium hypochlorite was reduced when residues were present on the coupons. Conclusions/Significance: This study revealed that the food residues increased the survivability and the resistance to chemicals of norovirus, indicating the need of thorough cleaning in food processing plants and household settings.	[Takahashi, Hajime; Ohuchi, Ayumi; Miya, Satoko; Izawa, Yukino; Kimura, Bon] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Fac Marine Sci, Tokyo, Japan	Tokyo University of Marine Science & Technology	Takahashi, H (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Fac Marine Sci, Tokyo, Japan.	kimubo@kaiyodai.ac.jp	Kimbo, Bon/O-1879-2014	Kimbo, Bon/0000-0002-3071-1343	Tokyo University of Marine Science and Technology	Tokyo University of Marine Science and Technology	This study was supported by Tokyo University of Marine Science and Technology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Belliot G, 2008, APPL ENVIRON MICROB, V74, P3315, DOI 10.1128/AEM.02148-07; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Centers for Disease Control and Prevention, 2010, NOR TECHN FACT SHEET; Doultree JC, 1999, J HOSP INFECT, V41, P51, DOI 10.1016/S0195-6701(99)90037-3; Duizer E, 2004, APPL ENVIRON MICROB, V70, P4538, DOI 10.1128/AEM.70.8.4538-4543.2004; ENTIS P, 2002, FOOD MICROBIOLOGY LA, P18; Friedman DS, 2005, EPIDEMIOL INFECT, V133, P1057, DOI 10.1017/S0950268805004760; GARTHRIGHT WE, 1995, FDA BACTERIOLOGICAL; Girard M, 2010, J FOOD PROTECT, V73, P400, DOI 10.4315/0362-028X-73.2.400; GRAHAM DY, 1994, J INFECT DIS, V170, P34, DOI 10.1093/infdis/170.1.34; Gulati BR, 2001, J FOOD PROTECT, V64, P1430, DOI 10.4315/0362-028X-64.9.1430; HOOVER EA, 1975, J AM VET MED ASSOC, V166, P463; Jimenez L, 2006, AM J INFECT CONTROL, V34, P269, DOI 10.1016/j.ajic.2005.11.009; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029; KURITSKY JN, 1984, ANN INTERN MED, V100, P519, DOI 10.7326/0003-4819-100-4-519; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; Mattison K, 2007, J FOOD PROTECT, V70, P500, DOI 10.4315/0362-028X-70.2.500; *MIN HLTH LAB WELF, 2009, FOOD POIS SURV REP; Moe C., 1999, 1 INT WORKSH HUM CAL; Parashar UD, 1998, EPIDEMIOL INFECT, V121, P615, DOI 10.1017/S0950268898001150; Park GW, 2007, APPL ENVIRON MICROB, V73, P4463, DOI 10.1128/AEM.02839-06; Patterson W, 1997, Commun Dis Rep CDR Rev, V7, pR101; Stals A, 2009, J VIROL METHODS, V161, P247, DOI 10.1016/j.jviromet.2009.06.019; Urakami H, 2007, APPL ENVIRON MICROB, V73, P5679, DOI 10.1128/AEM.00083-07; Whitehead K, 2010, AM J INFECT CONTROL, V38, P26, DOI 10.1016/j.ajic.2009.03.015; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; [No title captured]	31	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e21951	10.1371/journal.pone.0021951	http://dx.doi.org/10.1371/journal.pone.0021951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887215	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800003
J	Talbot, AL; Bullock, GC; Delehanty, LL; Sattler, M; Zhao, ZJ; Goldfarb, AN				Talbot, Anne-Laure; Bullock, Grant C.; Delehanty, Lorrie L.; Sattler, Martin; Zhao, Zhizhuang Joe; Goldfarb, Adam N.			Aconitase Regulation of Erythropoiesis Correlates with a Novel Licensing Function in Erythropoietin-Induced ERK Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IRON-SULFUR CLUSTER; MYELOPROLIFERATIVE NEOPLASMS; ERYTHROID-DIFFERENTIATION; POLYCYTHEMIA-VERA; MITOCHONDRIAL-DNA; EXPRESSION; CELLS; MICE; PHOSPHORYLATION	Background: Erythroid development requires the action of erythropoietin (EPO) on committed progenitors to match red cell output to demand. In this process, iron acts as a critical cofactor, with iron deficiency blunting EPO-responsiveness of erythroid progenitors. Aconitase enzymes have recently been identified as possible signal integration elements that couple erythropoiesis with iron availability. In the current study, a regulatory role for aconitase during erythropoiesis was ascertained using a direct inhibitory strategy. Methodology/Principal Findings: In C57BL/6 mice, infusion of an aconitase active-site inhibitor caused a hypoplastic anemia and suppressed responsiveness to hemolytic challenge. In a murine model of polycythemia vera, aconitase inhibition rapidly normalized red cell counts, but did not perturb other lineages. In primary erythroid progenitor cultures, aconitase inhibition impaired proliferation and maturation but had no effect on viability or ATP levels. This inhibition correlated with a blockade in EPO signal transmission specifically via ERK, with preservation of JAK2-STAT5 and Akt activation. Correspondingly, a physical interaction between ERK and mitochondrial aconitase was identified and found to be sensitive to aconitase inhibition. Conclusions/Significance: Direct aconitase inhibition interferes with erythropoiesis in vivo and in vitro, confirming a lineage-selective regulatory role involving its enzymatic activity. This inhibition spares metabolic function but impedes EPO-induced ERK signaling and disturbs a newly identified ERK-aconitase physical interaction. We propose a model in which aconitase functions as a licensing factor in ERK-dependent proliferation and differentiation, thereby providing a regulatory input for iron in EPO-dependent erythropoiesis. Directly targeting aconitase may provide an alternative to phlebotomy in the treatment of polycythemia vera.	[Talbot, Anne-Laure; Bullock, Grant C.; Delehanty, Lorrie L.; Goldfarb, Adam N.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; [Sattler, Martin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhao, Zhizhuang Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA	University of Virginia; Harvard University; Dana-Farber Cancer Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center	Talbot, AL (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	ang3x@virginia.edu			NIH [2T32GM007267-32, CA134660]; Ruth L. Kirschstein National Research Service Award [F32 HL0860046]; University of Virginia; NIDDK [R01 DK079924]; Roche Foundation for Anemia Research; NATIONAL CANCER INSTITUTE [R01CA134660] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Roche Foundation for Anemia Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a NIH MSTP grant (grant 2T32GM007267-32, A.-L. T.), by a Ruth L. Kirschstein National Research Service Award (grant F32 HL0860046, G.C.B.), by a University of Virginia K12 Clinical Translational Career Development Award (G.C.B.), by the NIDDK (grant R01 DK079924, A.N.G.), and by the Roche Foundation for Anemia Research (A.N.G). Dr. Martin Sattler is supported by NIH grant CA134660. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutin RM, 2009, EXP HEMATOL, V37, P151, DOI 10.1016/j.exphem.2008.10.008; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; ANDREAS SE, 2006, BRIT J HAEMATOL, V135, P117; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arcasoy MO, 2005, BRIT J HAEMATOL, V130, P121, DOI 10.1111/j.1365-2141.2005.05580.x; Bullock GC, 2010, BLOOD, V116, P97, DOI 10.1182/blood-2009-10-251496; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Choi YJ, 2006, CANCER RES, V66, P2990, DOI 10.1158/0008-5472.CAN-05-2944; Deck KM, 2009, J BIOL CHEM, V284, P12701, DOI 10.1074/jbc.M807717200; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; Elliott MA, 2005, BRIT J HAEMATOL, V128, P275, DOI 10.1111/j.1365-2141.2004.05277.x; FINCH CA, 1982, BLOOD, V60, P1241; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Goncharov NV, 2006, J APPL TOXICOL, V26, P148, DOI 10.1002/jat.1118; Goodnough LT, 2000, BLOOD, V96, P823, DOI 10.1182/blood.V96.3.823.015k49_823_833; Greer JP, 2008, WINTROBES CLIN HEMAT; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; Halupa A, 2005, EXP CELL RES, V309, P1, DOI 10.1016/j.yexcr.2005.04.030; Haq R, 2002, J BIOL CHEM, V277, P17359, DOI 10.1074/jbc.M201842200; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Inoue SI, 2007, FEBS LETT, V581, P1910, DOI 10.1016/j.febslet.2007.03.092; ISKEN F, 2006, HORMONE METABOLIC RE, P543; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; KIMURA H, 1986, J CELL PHYSIOL, V126, P298, DOI 10.1002/jcp.1041260221; Klingmuller U, 1997, EUR J BIOCHEM, V249, P637, DOI 10.1111/j.1432-1033.1997.t01-1-00637.x; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Leiter LM, 1999, J CELL PHYSIOL, V180, P334, DOI 10.1002/(SICI)1097-4652(199909)180:3<334::AID-JCP4>3.3.CO;2-H; Liao HJ, 2002, J BIOL CHEM, V277, P9335, DOI 10.1074/jbc.M109955200; Lin G, 2009, CELL MOL LIFE SCI, V66, P919, DOI 10.1007/s00018-009-8696-3; Lyoumi S, 2007, BLOOD, V109, P811, DOI 10.1182/blood-2006-04-014142; Magocsi M, 1999, IMMUNOL LETT, V68, P187, DOI 10.1016/S0165-2478(99)00048-6; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; NOBES PR, 1990, J CLIN PATHOL, V43, P675, DOI 10.1136/jcp.43.8.675; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; SAVARIE PJ, 1984, P 11 VERT PEST C, P132; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; SEGER R, 2010, ANAL ERKS DIMERIZATI, P335; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spivak JL, 2005, NAT REV CANCER, V5, P543, DOI 10.1038/nrc1648; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Stark Chris, NUCL ACIDS RES, V34, pD535; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1154, DOI 10.1152/ajpcell.00110.2007; Zou HY, 2011, FEBS LETT, V585, P1007, DOI 10.1016/j.febslet.2011.02.032	67	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23850	10.1371/journal.pone.0023850	http://dx.doi.org/10.1371/journal.pone.0023850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887333	Green Submitted, Green Published, gold			2022-12-25	WOS:000294251800036
J	Bohnsack, BL; Gallina, D; Kahana, A				Bohnsack, Brenda L.; Gallina, Donika; Kahana, Alon			Phenothiourea Sensitizes Zebrafish Cranial Neural Crest and Extraocular Muscle Development to Changes in Retinoic Acid and IGF Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EMBRYONIC-DEVELOPMENT; THYROID-HORMONE; GENE-EXPRESSION; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; TOXICITY; PHENYLTHIOUREA; MORPHOGENESIS; PIGMENTATION; MUTATIONS	1-phenyl 2-thiourea (PTU) is a tyrosinase inhibitor commonly used to block pigmentation and aid visualization of zebrafish development. At the standard concentration of 0.003% (200 mu M), PTU inhibits melanogenesis and reportedly has minimal other effects on zebrafish embryogenesis. We found that 0.003% PTU altered retinoic acid and insulin-like growth factor (IGF) regulation of neural crest and mesodermal components of craniofacial development. Reduction of retinoic acid synthesis by the pan-aldehyde dehydrogenase inhibitor diethylbenzaldehyde, only when combined with 0.003% PTU, resulted in extraocular muscle disorganization. PTU also decreased retinoic acid-induced teratogenic effects on pharyngeal arch and jaw cartilage despite morphologically normal appearing PTU-treated controls. Furthermore, 0.003% PTU in combination with inhibition of IGF signaling through either morpholino knockdown or pharmacologic inhibition of tyrosine kinase receptor phosphorylation, disrupted jaw development and extraocular muscle organization. PTU in and of itself inhibited neural crest development at higher concentrations (0.03%) and had the greatest inhibitory effect when added prior to 22 hours post fertilization (hpf). Addition of 0.003% PTU between 4 and 20 hpf decreased thyroxine (T4) in thyroid follicles in the nasopharynx of 96 hpf embryos. Treatment with exogenous triiodothyronine (T3) and T4 improved, but did not completely rescue, PTU-induced neural crest defects. Thus, PTU should be used with caution when studying zebrafish embryogenesis as it alters the threshold of different signaling pathways important during craniofacial development. The effects of PTU on neural crest development are partially caused by thyroid hormone signaling.	[Bohnsack, Brenda L.; Gallina, Donika; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bohnsack, BL (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	akahana@med.umich.edu		Bohnsack, Brenda/0000-0001-8961-6343; Kahana, Alon/0000-0002-5667-2274	National Eye Institute of the National Institutes of Health [T32 EY013934, K08 EY018689]; Fight for Sight Post-Doctoral Award; Knights Templar Eye Foundation; Research to Prevent Blindness; Vision Research Core Award [P30 EY007003]; NIHNCRR [P40 RR012546]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY013934, K08EY018689, P30EY007003] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Fight for Sight Post-Doctoral Award; Knights Templar Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Vision Research Core Award; NIHNCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by postdoctoral training grant T32 EY013934 from the National Eye Institute of the National Institutes of Health (BLB), Fight for Sight Post-Doctoral Award (BLB), Knights Templar Eye Foundation (BLB), a Research to Prevent Blindness Career Development Award (AK), grant K08 EY018689 (AK) from the National Eye Institute of the National Institutes of Health, and a Vision Research Core Award P30 EY007003 to the Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan. AK acknowledges the generous support of The Alliance for Vision Research, Southfield, Michigan. The Zebrafish International Resource Center is supported by grant P40 RR012546 from the NIHNCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt B, 2006, DEV DYNAM, V235, P1872, DOI 10.1002/dvdy.20831; BOHNSACK BL, 2011, ARCH OPHTHA IN PRESS; BOHNSACK BL, 2011, ZEBRAFISH MODE UNPUB; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Craig MP, 2006, LAB ANIMAL, V35, P41, DOI 10.1038/laban1006-41; Deltour L, 1996, FASEB J, V10, P1050, DOI 10.1096/fasebj.10.9.8801166; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Dutton K, 2001, GENESIS, V30, P188, DOI 10.1002/gene.1062; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; Gitton Y, 2010, SEMIN CELL DEV BIOL, V21, P301, DOI 10.1016/j.semcdb.2010.01.008; Hellawell GO, 2002, CANCER RES, V62, P2942; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hove Jay R, 2004, Birth Defects Res C Embryo Today, V72, P277, DOI 10.1002/bdrc.20019; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KISH PE, 2011, GENESIS; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kumar S, 2010, DEV BIOL, V340, P67, DOI 10.1016/j.ydbio.2010.01.027; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Langenberg T, 2008, DEV DYNAM, V237, P1645, DOI 10.1002/dvdy.21577; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MILLOT N, 1966, NATURE, V209, P99, DOI 10.1038/209099b0; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; ROSA FW, 1986, TERATOLOGY, V33, P355, DOI 10.1002/tera.1420330315; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SCHEVEN G, 2006, DEVELOPMENT, V133, P2731; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Smith TJ, 2008, THYROID, V18, P983, DOI 10.1089/thy.2007.0404; Teraoka H, 2002, TOXICOL SCI, V65, P192, DOI 10.1093/toxsci/65.2.192; Teraoka H, 2006, AQUAT TOXICOL, V78, P103, DOI 10.1016/j.aquatox.2006.02.009; Thisse B., 2001, EXPRESSION ZEBRAFISH; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Wang WD, 2004, BIOCHEM PHARMACOL, V68, P63, DOI 10.1016/j.bcp.2004.03.010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; WHITTAKE.JR, 1966, DEV BIOL, V14, P1, DOI 10.1016/0012-1606(66)90003-0; Zacharias AL, 2011, DEV BIOL, V349, P395, DOI 10.1016/j.ydbio.2010.10.028	43	44	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e22991	10.1371/journal.pone.0022991	http://dx.doi.org/10.1371/journal.pone.0022991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886774	Green Published, gold			2022-12-25	WOS:000294128100004
J	Wei, WH; Hemani, G; Hicks, AA; Vitart, V; Cabrera-Cardenas, C; Navarro, P; Huffman, J; Hayward, C; Knott, SA; Rudan, I; Pramstaller, PP; Wild, SH; Wilson, JF; Campbell, H; Dunlop, MG; Hastie, N; Wright, AF; Haley, CS				Wei, Wenhua; Hemani, Gibran; Hicks, Andrew A.; Vitart, Veronique; Cabrera-Cardenas, Claudia; Navarro, Pau; Huffman, Jennifer; Hayward, Caroline; Knott, Sara A.; Rudan, Igor; Pramstaller, Peter P.; Wild, Sarah H.; Wilson, James F.; Campbell, Harry; Dunlop, Malcolm G.; Hastie, Nicholas; Wright, Alan F.; Haley, Chris S.			Characterisation of Genome-Wide Association Epistasis Signals for Serum Uric Acid in Human Population Isolates	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRANSPORTER GENE SLC2A9; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; COMMON VARIANTS; GOUT; ISLAND; SUSCEPTIBILITY; EPIDEMIOLOGY; HERITABILITY	Genome-wide association (GWA) studies have identified a number of loci underlying variation in human serum uric acid (SUA) levels with the SLC2A9 gene having the largest effect identified so far. Gene-gene interactions (epistasis) are largely unexplored in these GWA studies. We performed a full pair-wise genome scan in the Italian MICROS population (n = 1201) to characterise epistasis signals in SUA levels. In the resultant epistasis profile, no SNP pairs reached the Bonferroni adjusted threshold for the pair-wise genome-wide significance. However, SLC2A9 was found interacting with multiple loci across the genome, with NFIA - SLC2A9 and SLC2A9 - ESRRAP2 being significant based on a threshold derived for interactions between GWA significant SNPs and the genome and jointly explaining 8.0% of the phenotypic variance in SUA levels (3.4% by interaction components). Epistasis signal replication in a CROATIAN population (n = 1772) was limited at the SNP level but improved dramatically at the gene ontology level. In addition, gene ontology terms enriched by the epistasis signals in each population support links between SUA levels and neurological disorders. We conclude that GWA epistasis analysis is useful despite relatively low power in small isolated populations.	[Wei, Wenhua; Vitart, Veronique; Cabrera-Cardenas, Claudia; Navarro, Pau; Huffman, Jennifer; Hayward, Caroline; Dunlop, Malcolm G.; Hastie, Nicholas; Wright, Alan F.; Haley, Chris S.] Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Hemani, Gibran; Haley, Chris S.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Hemani, Gibran; Haley, Chris S.] Univ Edinburgh, R D SVS, Roslin, Midlothian, Scotland; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Knott, Sara A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Rudan, Igor; Wild, Sarah H.; Wilson, James F.; Campbell, Harry] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Split, Croatia; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; European Academy of Bozen-Bolzano; University of Lubeck; University of Edinburgh; University of Edinburgh; University of Split; Krankenhaus Bozen; University of Lubeck	Wei, WH (corresponding author), Western Gen Hosp, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	wenhua.wei@hgu.mrc.ac.uk; chris.haley@hgu.mrc.ac.uk	Hicks, Andrew Anthony/E-9518-2017; Knott, Sara A/H-2466-2013; Campbell, Harry/E-2959-2010; Wei, Wenhua/A-6454-2012; Hayward, Caroline/M-8818-2016; Dunlop, Malcolm G/F-1973-2011; Rudan, Igor/I-1467-2012; Wilson, James F/A-5704-2009; Haley, Chris S/F-3110-2013; Pramstaller, Peter P/C-2357-2008; Navarro, Pau/AAJ-8091-2021	Hicks, Andrew Anthony/0000-0001-6320-0411; Knott, Sara A/0000-0002-4568-2928; Campbell, Harry/0000-0002-6169-6262; Wei, Wenhua/0000-0001-5774-5941; Hayward, Caroline/0000-0002-9405-9550; Dunlop, Malcolm G/0000-0002-3033-5851; Rudan, Igor/0000-0001-6993-6884; Wilson, James F/0000-0001-5751-9178; Navarro, Pau/0000-0001-5576-8584; Pramstaller, Peter P/0000-0002-9831-8302; Haley, Chris/0000-0002-9811-0210; Hemani, Gibran/0000-0003-0920-1055	MRC Core Fund; BBSRC [BB/H024484/1]; Ministry of Health; Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; BBSRC [BBS/E/R/00001604] Funding Source: UKRI; MRC [MC_U127592696, MC_PC_U127592696, MC_U127527198, MC_U127561128, MC_PC_U127527198, MC_PC_U127561128] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001604, BB/H024484/1] Funding Source: researchfish; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127592696, MC_U127527198, MC_U127561128, MC_PC_U127561128, MC_PC_U127592696, MC_PC_U127527198] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish	MRC Core Fund(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Health; Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The authors acknowledge the financial support provided by the MRC Core Fund. BBSRC funded WHW and CSH's time in part (grant reference: BB/H024484/1). The MICROS study was supported by the Ministry of Health and the Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annanmaki T, 2008, PARKINSONISM RELAT D, V14, P576, DOI 10.1016/j.parkreldis.2007.11.001; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Doherty M, 2009, RHEUMATOLOGY, V48, P2, DOI 10.1093/rheumatology/kep086; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Facheris MF, 2011, J MOL NEUROSCI, V43, P246, DOI 10.1007/s12031-010-9409-y; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Guan M, 2011, CLIN RHEUMATOL, V30, P29, DOI 10.1007/s10067-010-1597-x; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoffjan S, 2010, MOL CELL PROBE, V24, P237, DOI 10.1016/j.mcp.2010.04.006; Hollis-Moffatt JE, 2009, ARTHRITIS RHEUM-US, V60, P3485, DOI 10.1002/art.24938; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Houlihan LM, 2010, HUM MOL GENET, V19, P2321, DOI 10.1093/hmg/ddq097; Jannink JL, 2001, GENETICS, V157, P445; Jeroncic I, 2010, CROAT MED J, V51, P40, DOI 10.3325/cmj.2010.51.40; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kooperberg C, 2008, GENET EPIDEMIOL, V32, P255, DOI 10.1002/gepi.20300; Lam Alex C, 2009, BMC Proc, V3 Suppl 1, pS6; Lorentzen AR, 2010, J NEUROIMMUNOL, V226, P194, DOI 10.1016/j.jneuroim.2010.07.003; Lu WN, 2007, PLOS GENET, V3, P830, DOI 10.1371/journal.pgen.0030080; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Markowitz Alison J B, 2007, Cellscience, V4, P111; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mero IL, 2011, GENES IMMUN, V12, P191, DOI 10.1038/gene.2010.59; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Nischwitz S, 2011, ACTA NEUROL SCAND, V123, P400, DOI 10.1111/j.1600-0404.2010.01421.x; Pattaro C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-29; Polasek O, 2009, CROAT MED J, V50, P7, DOI 10.3325/cmj.2009.50.7; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Rule AD, 2011, RHEUMATOLOGY, V50, P871, DOI 10.1093/rheumatology/keq425; Schretlen DJ, 2007, NEUROLOGY, V69, P1418, DOI 10.1212/01.wnl.0000277468.10236.f1; Schupbach T, 2010, BIOINFORMATICS, V26, P1468, DOI 10.1093/bioinformatics/btq147; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Spitsin S, 2008, CURR TOP MICROBIOL, V318, P325; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Vannorsdall TD, 2008, STROKE, V39, P3418, DOI 10.1161/STROKEAHA.108.521591; Vitart V, 2006, EUR J HUM GENET, V14, P478, DOI 10.1038/sj.ejhg.5201589; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wei WH, 2010, HEREDITY, V104, P401, DOI 10.1038/hdy.2009.129; WHITFIELD JB, 1983, ACTA GENET MED GEMEL, V32, P117, DOI 10.1017/S0001566000006401; Wright AF, 2010, KIDNEY INT, V78, P446, DOI 10.1038/ki.2010.206; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131	56	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23836	10.1371/journal.pone.0023836	http://dx.doi.org/10.1371/journal.pone.0023836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886828	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100035
J	Jiang, JT; Zheng, X; Xu, X; Zhou, Q; Yan, HJ; Zhang, XG; Lu, BF; Wu, CP; Ju, JF				Jiang, Jingting; Zheng, Xiao; Xu, Xiao; Zhou, Qi; Yan, Haijiao; Zhang, Xueguang; Lu, Binfeng; Wu, Changping; Ju, Jingfang			Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin	PLOS ONE			English	Article							MICRORNA EXPRESSION; PATHOGENESIS; INHIBITION; SIGNATURE	Background: The goal of this study is to evaluate the effectiveness of S-1/Oxaliplatin vs. Doxifluridine/Oxaliplatin regimen and to identify miRNAs as potential prognostic biomarkers in gastric cancer patients. The expression of candidate miRNAs was quantified from fifty-five late stage gastric cancer FFPE specimens. Experimental Design: Gastric cancer patients with KPS>70 were recruited for the trial. The control group was treated with 400 mg/twice/day Doxifluridine plus i.v. with Oxaliplatin at 130 mg/m(2)/first day/4 week cycle. The testing group was treated with S-1 at 40 mg/twice/day/4 week cycle plus i.v. with Oxaliplatin at 130 mg/m(2)/first day/4 week cycle. Total RNAs were extracted from normal and gastric tumor specimens. The levels of miRNAs were quantified using real time qRT-PCR expression analysis. Results: The overall objective response rate (CR+PR) of patients treated with S-1/Oxaliplatin was 33.3% (CR+PR) vs. 17.6% (CR+PR) with Doxifluridine/Oxaliplatin for advanced stage gastric cancer patients. The average overall survival for patients treated with S-1/Oxaliplatin was 7.80 month vs. 7.30 month with patients treated with Doxifluridine/Oxaliplatin. The expression of miR-181b (P = 0.022) and miR-21 (P = 0.0029) was significantly overexpressed in gastric tumors compared to normal gastric tissues. Kaplan-Meier survival analysis revealed that low levels of miR-21 expression (Log rank test, hazard ratio: 0.17, CI = 0.06-0.45; P = 0.0004) and miR-181b (Log rank test, hazard ratio: 0.37, CI = 0.16-0.87; P = 0.018) are closely associated with better patient's overall survival for both S-1 and Doxifluridine based regimens. Conclusion: Patients treated with S-1/Oxaliplatin had a better response than those treated with Doxifluridine/Oxaliplatin. miR-21 and miR-181b hold great potential as prognostic biomarkers in late stage gastric cancer.	[Jiang, Jingting; Zheng, Xiao; Zhou, Qi; Yan, Haijiao; Wu, Changping] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Jiangsu Prov, Peoples R China; [Xu, Xiao; Ju, Jingfang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zhang, Xueguang] Soochow Univ, Key Lab Clin Immunol Jiangsu Prov, Key Lab Stem Cell Jiangsu Prov, Suzhou, Jiangsu Prov, Peoples R China; [Lu, Binfeng] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA	Soochow University - China; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jiang, JT (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Jiangsu Prov, Peoples R China.	newjjt@163.com; jiju@notes.cc.sunysb.edu		Ju, Jingfang/0000-0002-4821-7458	National Natural Science Foundation of China [30950022, 30972703]; Society Developing Plans, Department of Science and Technology Changzhou [BS20092019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Society Developing Plans, Department of Science and Technology Changzhou	This research project was supported by the National Natural Science Foundation of China (30950022 and 30972703) and Society Developing Plans, Department of Science and Technology Changzhou (BS20092019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COCHRANE DR, 2009, J ONCOL, V2010; DONY C, 1985, NATURE, V317, P636, DOI 10.1038/317636a0; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Nakajima Go, 2006, Cancer Genomics & Proteomics, V3, P317; Park DJ, 2006, CURR OPIN PHARMACOL, V6, P337, DOI 10.1016/j.coph.2006.05.002; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Ruvkun G, 2006, SCIENCE, V311, P36; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; SCHRAMEDEI K, 2011, ONCOGENE; Shang J, 2005, WORLD J GASTROENTERO, V11, P4131; SONG B, 2009, ONCOGENE; Song B, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001663; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Varadhachary Gauri, 2005, Clin Adv Hematol Oncol, V3, P118; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu JG, 2010, OPT EXPRESS, V18, P6661, DOI 10.1364/OE.18.006661; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260	26	63	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23271	10.1371/journal.pone.0023271	http://dx.doi.org/10.1371/journal.pone.0023271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876743	Green Published, gold			2022-12-25	WOS:000294126900015
J	Fischer, JM; Miller, AJ; Shibata, D; Liskay, RM				Fischer, J. M.; Miller, A. J.; Shibata, D.; Liskay, R. M.			Different phenotypic consequences of simultaneous versus stepwise Apc loss	ONCOGENE			English	Article						APC; cancer; simultaneous; stepwise intestine	FAMILIAL ADENOMATOUS POLYPOSIS; MULTIPLE INTESTINAL NEOPLASIA; SOMATIC MUTATIONS; MOUSE MODEL; STEM-CELLS; CANCER; SUPPRESSION; PROTEOME; SEQUENCE; CATALOG	APC is considered a gatekeeper for colorectal cancer (CRC). Cells with heterozygous APC mutations have altered expression profiles suggesting that the first APC hit may help set the stage for subsequent transformation. Therefore, we measured transformation efficiency following what we have designated as 'simultaneous' versus 'stepwise' Apc loss. We combined a conditional Apc allele (Apc(CKO)) with a Cre reporter gene and an out-of-frame Cre allele (Pms2(cre)) that stochastically becomes functional by a frameshift mutation in single cells. Loss of one Apc allele (Apc(CKO/+)) had little consequence, whereas simultaneous loss of both Apc alleles (Apc(CKO/CKO)) resulted in increased clonal expansion (crypt fission), consistent with the gatekeeper function of Apc. Interestingly, our analyses showed that most of the Apc-deficient crypts in Apc(CKO/CKO) mice appeared normal, with morphological transformation, including beta-catenin deregulation, occurring in only 17% of such crypts. To determine whether transformation efficiency was different following stepwise Apc loss, we combined Apc(CKO) with a germline mutant allele, either Apc(Min) or Apc(1638N). Transformation efficiency following stepwise Apc loss (Apc(Min/CKO) or Apc(1638N/CKO)) was increased five-fold and essentially all of the Apc-deficient cells were dysplastic. In summary, our data suggest that the gatekeeper function of Apc consists of two roles, clonal expansion and morphological transformation, because simultaneous Apc loss frequently leads to occult clonal expansion without morphological transformation, whereas stepwise Apc loss more often results in visible neoplasia. Finally, that Apc-deficient cells in certain scenarios can retain a normal phenotype is unexpected and may have clinical implications for surveillance strategies to prevent CRC. Oncogene (2012) 31, 2028-2038; doi: 10.1038/onc.2011.385; published online 5 September 2011	[Fischer, J. M.; Miller, A. J.; Liskay, R. M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Shibata, D.] Univ So Calif, Sch Med, Dept Pathol, Norris Canc Ctr, Los Angeles, CA 90033 USA	Oregon Health & Science University; University of Southern California	Liskay, RM (corresponding author), Oregon Hlth & Sci Univ, 3181 Sam Jackson Pk Rd, Portland, OR 97239 USA.	liskaym@ohsu.edu	Fischer, Jared/HCH-8013-2022	Fischer, Jared/0000-0002-0062-0870	NIH [2R01GM032741-28, 5T32HD046420-05]; ACS [PF-11-067-01-TBE]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs James Stringer and Melissa Wong for critical reading of the manuscript. We also thank Drs Raju Kucherlapati and Winfried Edelmann for the Apc<SUP>CKO</SUP> and Apc<SUP>1638N</SUP> mice, respectively; John Swain and Dr Melissa Wong for Apc<SUP>Min</SUP> mice and Apc<SUP>580S</SUP> intestinal material; and Dan Lioy and Drs Gail Mandel and Paul Brehm for assistance with confocal microscopy. RML and DS were funded by NIH Grant 2R01GM032741-28. JMF was funded by NIH training Grant 5T32HD046420-05 and ACS postdoctoral fellow PF-11-067-01-TBE.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816; Chan MF, 2001, MOL CELL BIOL, V21, P7587, DOI 10.1128/MCB.21.22.7587-7600.2001; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cruz-Correa M, 2002, GASTROENTEROLOGY, V122, P641, DOI 10.1053/gast.2002.31890; Eads CA, 2002, CANCER RES, V62, P1296; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Hung KE, 2010, P NATL ACAD SCI USA, V107, P1565, DOI 10.1073/pnas.0908682107; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Lynch PM, 2010, EXPERT OPIN PHARMACO, V11, P1101, DOI 10.1517/14656561003698123; Miller AJ, 2008, NAT METHODS, V5, P227, DOI 10.1038/NMETH.1183; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Patel BB, 2011, ONCOTARGET, V2, P197, DOI 10.18632/oncotarget.241; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sasai H, 2000, CARCINOGENESIS, V21, P953, DOI 10.1093/carcin/21.5.953; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang DH, 2010, CANCER RES, V70, P5348, DOI 10.1158/0008-5472.CAN-09-4593; Yeung AT, 2008, CANCER RES, V68, P7579, DOI 10.1158/0008-5472.CAN-08-0856	35	16	16	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	16					2028	2038		10.1038/onc.2011.385	http://dx.doi.org/10.1038/onc.2011.385			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21892206	Green Accepted			2022-12-25	WOS:000303008600004
J	Diercke, K; Kohl, A; Lux, CJ; Erber, R				Diercke, Katja; Kohl, Annette; Lux, Christopher J.; Erber, Ralf			Strain-dependent Up-regulation of Ephrin-B2 Protein in Periodontal Ligament Fibroblasts Contributes to Osteogenesis during Tooth Movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPH RECEPTORS; VASCULAR DEVELOPMENT; GENE-EXPRESSION; RHO GTPASES; ACTIVATION; CELLS; STRESS; KINASES; MECHANOTRANSDUCTION; PHOSPHORYLATION	During orthodontic tooth movement, the application of adequate orthodontic forces allows teeth to be moved through the alveolar bone. These forces are transmitted through the periodontal ligaments (PDL) to the supporting alveolar bone and lead to deposition or resorption of bone, depending on whether the tissues are exposed to a tensile or compressive mechanical strain. Fibroblasts within the PDL (PDLF) are considered to be mechanoresponsive. The transduction mechanisms from mechanical loading of the PDLF to the initiation of bone remodeling are not clearly understood. Recently, members of the ephrin/Eph family have been shown to be involved in the regulation of bone homeostasis. For the first time, we demonstrate that PDLF exposed to tensile strain induce the expression of ephrin-B2 via a FAK-, Ras-, ERK1/2-, and SP1-dependent pathway. Osteoblasts of the alveolar bone stimulated with ephrin-B2 increased their osteoblastogenic gene expression and showed functional signs of osteoblastic differentiation. In a physiological setting, ephrin-B2-EphB4 signaling between PDLF and osteoblasts of the alveolar bone might contribute to osteogenesis at tension sites during orthodontic tooth movement.	[Diercke, Katja; Kohl, Annette; Lux, Christopher J.; Erber, Ralf] Univ Heidelberg, Sch Dent, Dept Orthodont & Dentofacial Orthopaed, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Erber, R (corresponding author), Univ Heidelberg, Sch Dent, Dept Orthodont & Dentofacial Orthopaed, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	ralf.erber@med.uni-heidelberg.de	Erber, Ralf/AAF-3002-2020	Lux, Christopher J./0000-0002-6995-5572				Abumiya T, 2002, ARTERIOSCL THROM VAS, V22, P907, DOI 10.1161/01.ATV.0000018300.43492.83; Adams RH, 2000, TRENDS CARDIOVAS MED, V10, P183, DOI 10.1016/S1050-1738(00)00046-3; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; BASDRA EK, 1995, BBA-MOL CELL RES, V1268, P209, DOI 10.1016/0167-4889(95)00090-F; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416; de Oliveira MV, 2009, FEBS LETT, V583, P2975, DOI 10.1016/j.febslet.2009.08.022; Diercke K, 2011, J DENT RES, V90, P1108, DOI 10.1177/0022034511413926; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HASEGAWA S, 1985, CALCIFIED TISSUE INT, V37, P431, DOI 10.1007/BF02553714; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holder N, 2000, E SCHERING RES FDN W, V29, P123; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kawarizadeh A, 2005, J DENT RES, V84, P902, DOI 10.1177/154405910508401006; Kono SJ, 2007, BONE, V40, P68, DOI 10.1016/j.bone.2006.07.024; Kook SH, 2009, J CELL BIOCHEM, V106, P1060, DOI 10.1002/jcb.22085; Korff T, 2008, BLOOD, V112, P73, DOI 10.1182/blood-2007-12-128835; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Li BS, 1999, EUR J BIOCHEM, V262, P211, DOI 10.1046/j.1432-1327.1999.00372.x; Liedert A, 2006, BIOCHEM BIOPH RES CO, V342, P1070, DOI 10.1016/j.bbrc.2006.02.063; Martin TJ, 2010, ADV EXP MED BIOL, V658, P51, DOI 10.1007/978-1-4419-1050-9_6; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015; Myshkin E, 2003, J CHEM INF COMP SCI, V43, P1004, DOI 10.1021/ci0256586; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Sohl M, 2010, BIOCHEM BIOPH RES CO, V391, P24, DOI 10.1016/j.bbrc.2009.10.146; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Urbich C, 2003, FEBS LETT, V535, P87, DOI 10.1016/S0014-5793(02)03879-6; Wescott DC, 2007, J DENT RES, V86, P1212, DOI 10.1177/154405910708601214; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2057, DOI 10.1152/ajpcell.00493.2006; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	42	38	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37651	37664		10.1074/jbc.M110.166900	http://dx.doi.org/10.1074/jbc.M110.166900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880727	Green Published, hybrid			2022-12-25	WOS:000296542400062
J	Lin, LYC; Rakic, B; Chiu, CPC; Lameignere, E; Wakarchuk, WW; Withers, SG; Strynadka, NCJ				Lin, Leo Y. -C.; Rakic, Bojana; Chiu, Cecilia P. C.; Lameignere, Emilie; Wakarchuk, Warren W.; Withers, Stephen G.; Strynadka, Natalie C. J.			Structure and Mechanism of the Lipooligosaccharide Sialyltransferase from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PASTEURELLA-MULTOCIDA; CATALYTIC MECHANISM; BIOSYNTHETIC-PATHWAY; MOLECULAR MIMICRY; SERUM RESISTANCE; GLYCOSYLTRANSFERASES; ACCEPTOR; COMPLEX; BINDING	The first x-ray crystallographic structure of a CAZY family-52 glycosyltransferase, that of the membrane associated alpha 2,3/alpha 2,6 lipooligosaccharide sialyltransferase from Neisseria meningitidis serotype L1 (NST), has been solved to 1.95 angstrom resolution. The structure of NST adopts a GT-B-fold common with other glycosyltransferase (GT) families but exhibits a novel domain swap of the N-terminal 130 residues to create a functional homodimeric form not observed in any other class to date. The domain swap is mediated at the structural level by a loop-helix-loop extension between residues Leu-108 and Met-130 (we term the swapping module) and a unique lipid-binding domain. NST catalyzes the creation of alpha 2,3- or 2,6-linked oligosaccharide products from a CMP-sialic acid (Neu5Ac) donor and galactosyl-containing acceptor sugars. Our structures of NST bound to the non-hydrolyzable substrate analog CMP-3F((axial))-Neu5Ac show that the swapping module from one monomer of NST mediates the binding of the donor sugar in a composite active site formed at the dimeric interface. Kinetic analysis of designed point mutations observed in the CMP-3F((axial))-Neu5Ac binding site suggests potential roles of a requisite general base (Asp-258) and general acid (His-280) in the NST catalytic mechanism. A long hydrophobic tunnel adjacent to the dimer interface in each of the two monomers contains electron density for two extended linear molecules that likely belong to either the two fatty acyl chains of a diglyceride lipid or the two polyethylene glycol groups of the detergent Triton X-100. In this work, Triton X-100 maintains the activity and increases the solubility of NST during purification and is critical to the formation of ordered crystals. Together, the mechanistic implications of the NST structure provide insight into lipooligosaccharide sialylation with respect to the association of substrates and the essential membrane-anchored nature of NST on the bacterial surface.	[Lin, Leo Y. -C.; Chiu, Cecilia P. C.; Lameignere, Emilie; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lin, Leo Y. -C.; Chiu, Cecilia P. C.; Lameignere, Emilie; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Rakic, Bojana; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Rakic, Bojana/0000-0002-3460-6081	Canadian Institutes of Health Research [MOP84272]; Howard Hughes Medical Institute; Michael Smith Foundation for Health Research; NSERC; Canada Foundation for Innovation; British Columbia Knowledge Development Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund	This work was supported by Canadian Institutes of Health Research Operating Grant MOP84272 (to N. C. J. S., W. W. W., and S. G. W.), the Howard Hughes Medical Institute International Scholar Program (to N. C. J. S.), scholarship funding from the Michael Smith Foundation for Health Research (to L. Y.-C. L. and C. P. C. C.), postdoctoral fellowship from the NSERC (to B. R.), and infrastructure funding from the Canada Foundation for Innovation and the British Columbia Knowledge Development Fund.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cebo C, 2001, J BIOL CHEM, V276, P5685, DOI 10.1074/jbc.M008662200; Chen JQ, 2002, J MOL MICROB BIOTECH, V4, P519; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Gulati S, 2005, INFECT IMMUN, V73, P7390, DOI 10.1128/IAI.73.11.7390-7397.2005; Gunawan J, 2005, J BIOL CHEM, V280, P3555, DOI 10.1074/jbc.M411942200; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Houliston RS, 2007, BIOCHEMISTRY-US, V46, P8164, DOI 10.1021/bi700685s; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Izumi M, 2001, J AM CHEM SOC, V123, P10909, DOI 10.1021/ja011382r; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; Kahler CM, 1998, INFECT IMMUN, V66, P5939, DOI 10.1128/IAI.66.12.5939-5947.1998; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kaniuk NA, 2002, MOL MICROBIOL, V46, P1305, DOI 10.1046/j.1365-2958.2002.03243.x; Kim DU, 2008, BMB REP, V41, P48; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LASKY LA, 1995, ANNU REV BIOCHEM, V64, P113, DOI 10.1146/annurev.bi.64.070195.000553; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Liaw SH, 2004, J BIOL CHEM, V279, P35479, DOI 10.1074/jbc.M405304200; MANDRELL RE, 1993, MICROB PATHOGENESIS, V14, P307, DOI 10.1006/mpat.1993.1030; MANDRELL RE, 1993, IMMUNOBIOLOGY, V187, P382, DOI 10.1016/S0171-2985(11)80352-9; Mittler M, 2007, J MOL BIOL, V372, P67, DOI 10.1016/j.jmb.2007.06.005; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Mulichak AM, 2004, BIOCHEMISTRY-US, V43, P5170, DOI 10.1021/bi036130c; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3218; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Ni LS, 2006, BIOCHEMISTRY-US, V45, P2139, DOI 10.1021/bi0524013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preston A, 1996, CRIT REV MICROBIOL, V22, P139, DOI 10.3109/10408419609106458; Qu CX, 2000, STRUCTURE, V8, P1095, DOI 10.1016/S0969-2126(00)00508-6; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rest RF, 1995, MICROB PATHOGENESIS, V19, P379, DOI 10.1006/mpat.1995.0073; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Shell DM, 2002, INFECT IMMUN, V70, P3744, DOI 10.1128/IAI.70.7.3744-3751.2002; Sun W, 2006, J BIOL CHEM, V281, P12919, DOI 10.1074/jbc.M511986200; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wakarchuk WW, 2001, J BIOL CHEM, V276, P12785, DOI 10.1074/jbc.M011293200; Yu H, 2004, BIOORGAN MED CHEM, V12, P6427, DOI 10.1016/j.bmc.2004.09.030; Yuki N, 2000, CELL MOL LIFE SCI, V57, P527, DOI 10.1007/PL00000714	58	31	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37237	37248		10.1074/jbc.M111.249920	http://dx.doi.org/10.1074/jbc.M111.249920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880735	Green Published, hybrid			2022-12-25	WOS:000296542400024
J	Tiden, AK; Sjogren, T; Svensson, M; Bernlind, A; Senthilmohan, R; Auchere, F; Norman, H; Markgren, PO; Gustavsson, S; Schmidt, S; Lundquist, S; Forbes, LV; Magon, NJ; Paton, LN; Jameson, GNL; Eriksson, H; Kettle, AJ				Tiden, Anna-Karin; Sjogren, Tove; Svensson, Mats; Bernlind, Alexandra; Senthilmohan, Revathy; Auchere, Francoise; Norman, Henrietta; Markgren, Per-Olof; Gustavsson, Susanne; Schmidt, Staffan; Lundquist, Stefan; Forbes, Louisa V.; Magon, Nicholas J.; Paton, Louise N.; Jameson, Guy N. L.; Eriksson, Hakan; Kettle, Anthony J.			2-Thioxanthines Are Mechanism-based Inactivators of Myeloperoxidase That Block Oxidative Stress during Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; HYPOCHLOROUS ACID; REDOX PROPERTIES; SUPEROXIDE; KINETICS; ENZYME; 3-CHLOROTYROSINE; CHLORINATION; INHIBITION; CHLORIDE	Myeloperoxidase (MPO) is a prime candidate for promoting oxidative stress during inflammation. This abundant enzyme of neutrophils uses hydrogen peroxide to oxidize chloride to highly reactive and toxic chlorine bleach. We have identified 2-thioxanthines as potent mechanism-based inactivators of MPO. Mass spectrometry and x-ray crystal structures revealed that these inhibitors become covalently attached to the heme prosthetic groups of the enzyme. We propose a mechanism whereby 2-thioxanthines are oxidized, and their incipient free radicals react with the heme groups of the enzyme before they can exit the active site. 2-Thioxanthines inhibited MPO in plasma and decreased protein chlorination in a mouse model of peritonitis. They slowed but did not prevent neutrophils from killing bacteria and were poor inhibitors of thyroid peroxidase. Our study shows that MPO is susceptible to the free radicals it generates, and this Achilles' heel of the enzyme can be exploited to block oxidative stress during inflammation.	[Senthilmohan, Revathy; Auchere, Francoise; Forbes, Louisa V.; Magon, Nicholas J.; Paton, Louise N.; Kettle, Anthony J.] Univ Otago Christchurch, Free Rad Res Grp, Dept Pathol, Christchurch 8140, New Zealand; [Svensson, Mats; Bernlind, Alexandra; Norman, Henrietta; Markgren, Per-Olof; Gustavsson, Susanne; Schmidt, Staffan; Lundquist, Stefan; Eriksson, Hakan] AstraZeneca R&D, SE-15185 Sodertalje, Sweden; [Sjogren, Tove] AstraZeneca R&D, SE-43183 Molndal, Sweden; [Jameson, Guy N. L.] Univ Otago, Dept Chem, Dunedin 9054, New Zealand; [Tiden, Anna-Karin] AstraZeneca R&D, Leicester LE11, Leics, England	University of Otago; AstraZeneca; AstraZeneca; University of Otago; AstraZeneca	Kettle, AJ (corresponding author), Univ Otago Christchurch, Free Rad Res Grp, Dept Pathol, POB 4345, Christchurch 8140, New Zealand.	tony.kettle@otago.ac.nz	Kettle, Anthony J/A-8520-2008; Jameson, Guy N. L./J-3258-2015; Ashby, Louisa/GRN-9388-2022	Kettle, Anthony J/0000-0002-8218-7766; Jameson, Guy N. L./0000-0001-9416-699X; Ashby, Louisa/0000-0001-8247-096X; Paton, Louise N/0000-0002-7055-5170	AstraZeneca	AstraZeneca(AstraZeneca)	A.-K. T., T. S., M. S., A. B., H. N., P.-O. M., S. G., S. S., S. L., and H. E. were employed by AstraZeneca when involved in this study. The following authors own stocks or stock options of AstraZeneca plc.: H. E., A.-K. T., T. S., P.-O. M., H. N., A. B., M. S., S. S., S. G., and S. L. A. J. K. received financial support from AstraZeneca to conduct this research.	Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; ATOR MA, 1987, J BIOL CHEM, V262, P14954; ATOR MA, 1989, J BIOL CHEM, V264, P9250; ATOR MA, 1987, J BIOL CHEM, V262, P1542; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Burner U, 1999, J BIOL CHEM, V274, P9494, DOI 10.1074/jbc.274.14.9494; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; CHESNEY JA, 1991, ANAL BIOCHEM, V196, P262, DOI 10.1016/0003-2697(91)90463-4; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Erve JCL, 2004, CHEM RES TOXICOL, V17, P564, DOI 10.1021/tx034238n; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Green Jessie N., 2007, V412, P319, DOI 10.1007/978-1-59745-467-4_21; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; Jantschko W, 2005, BIOCHEM PHARMACOL, V69, P1149, DOI 10.1016/j.bcp.2005.02.006; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; KETTLE AJ, 1993, BIOCHEM PHARMACOL, V45, P2003, DOI 10.1016/0006-2952(93)90010-T; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Koelsch M, 2010, BIOCHEM PHARMACOL, V79, P1156, DOI 10.1016/j.bcp.2009.11.024; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MARQUEZ LA, 1994, J BIOL CHEM, V269, P7950; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nordvall G, 2003, Patent No. [WO/2003/089430, 2003089430, WO 2003089430 A1 20031030]; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; SUBRAHMANYAM VV, 1987, CHEM-BIOL INTERACT, V61, P45, DOI 10.1016/0009-2797(87)90018-4; TAYLOR KL, 1995, ARCH BIOCHEM BIOPHYS, V316, P635, DOI 10.1006/abbi.1995.1083; vanDalen CJ, 1997, BIOCHEM J, V327, P487; WALEY SG, 1985, BIOCHEM J, V227, P843, DOI 10.1042/bj2270843; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	53	124	127	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37578	37589		10.1074/jbc.M111.266981	http://dx.doi.org/10.1074/jbc.M111.266981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21880720	Green Published, hybrid			2022-12-25	WOS:000296542400056
J	Amosova, O; Smith, A; Fresco, JR				Amosova, Olga; Smith, Alexander; Fresco, Jacques R.			The Consensus Sequence for Self-catalyzed Site-specific G Residue Depurination in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGONUCLEOTIDES; CONFORMATION; DEPENDENCE; STABILITY	The sequence variation tolerated within the stem-loop-forming genomic consensus sequence for self-catalyzed site-specific depurination of G residues is explored. The variation in self-depurination kinetics with sequence changes in the loop residues and stem base pairs, as well as with pH, provides insights into the self-catalytic mechanism. The observations suggest that self-catalyzed depurination of the 5' G residue of the loop consensus sequence 5'-G(T/A)GG-3' probably involves formation of some intraloop hydrogen-bonded base pair with the 3'-terminal G residue; although the electronic structure of both these G residues is retained, their 2-amino substituents are not critical for that interaction. The strong dependence of the self-depurination kinetics on stem stability suggests that the lifetime of some strained form of the loop is controlled by the integrity of the stem. In addition to the effects of length and base pair sequence on stem stability, there is a base pair requirement at the base of the loop: self-depurination is suppressed by 5'-C.G-3', 5'-A.T-3', or a mismatch but is most favored by 5'T.A3' and less so by 5'-G.C-3'. The occurrence in T and G of a similarly located carbonyl capable of hydrogen-bonding to the water molecule required for glycosyl bond hydrolysis may explain this sequence requirement. In toto, the more complete definition of the consensus sequence provided by this investigation enables a more accurate estimation of their number in the human genome and their distribution among different genes.	[Amosova, Olga; Smith, Alexander; Fresco, Jacques R.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Fresco, JR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jrfresco@princeton.edu			National Institutes of Health [5R01HL63888, 4R33CA88547]; U. S. Army Research Office [W911NF-07-1-0152]; Higgins Trust; NATIONAL CANCER INSTITUTE [R33CA088547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Army Research Office; Higgins Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants 5R01HL63888 and 4R33CA88547, by U. S. Army Research Office Grant W911NF-07-1-0152, and by the Higgins Trust. The previous paper in this series is Ref. 1.	Amosova O, 2006, P NATL ACAD SCI USA, V103, P4392, DOI 10.1073/pnas.0508499103; Amosova O, 2011, J BIOL CHEM, V286, P36322, DOI 10.1074/jbc.M111.272112; BLAKE RD, 1973, BIOPOLYMERS, V12, P775, DOI 10.1002/bip.1973.360120407; BRAHMS J, 1967, J MOL BIOL, V25, P465, DOI 10.1016/0022-2836(67)90199-4; BROWN T, 1990, J MOL BIOL, V212, P437, DOI 10.1016/0022-2836(90)90320-L; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; DAYN A, 1992, NUCLEIC ACIDS RES, V20, P5991, DOI 10.1093/nar/20.22.5991; Dill K. A, 2002, MOL DRIVING FORCES S, V418; Fresco JR, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P3, DOI 10.1007/978-3-642-20763-1_1; FRESCO JR, 1960, NATURE, V188, P98, DOI 10.1038/188098a0; FRESCO JR, 1960, P NATL ACAD SCI USA, V46, P311, DOI 10.1073/pnas.46.3.311; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; LIPSETT MN, 1960, BIOCHIM BIOPHYS ACTA, V41, P175, DOI 10.1016/0006-3002(60)90394-2; Lomant A J, 1975, Prog Nucleic Acid Res Mol Biol, V15, P185, DOI 10.1016/S0079-6603(08)60120-8; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MARMUR J, 1959, NATURE, V183, P1427, DOI 10.1038/1831427a0; Marnett LJ, 2001, TRENDS GENET, V17, P214, DOI 10.1016/S0168-9525(01)02239-9; McEwan NR, 1997, BIOTECHNOL TECH, V11, P727, DOI 10.1023/A:1018436132644; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; ORNSTEIN RL, 1983, BIOPOLYMERS, V22, P1979, DOI 10.1002/bip.360220811; PURRELLO R, 1993, J AM CHEM SOC, V115, P760, DOI 10.1021/ja00055a056; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P4997, DOI 10.1093/nar/22.23.4997; TAMM C, 1952, J BIOL CHEM, V195, P49; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0	29	8	9	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36316	36321		10.1074/jbc.M111.272047	http://dx.doi.org/10.1074/jbc.M111.272047			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868376	Green Published, hybrid			2022-12-25	WOS:000296538300016
J	Boll, B; Taubitz, T; Heide, L				Boll, Bjoern; Taubitz, Tatjana; Heide, Lutz			Role of MbtH-like Proteins in the Adenylation of Tyrosine during Aminocoumarin and Vancomycin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR; PEPTIDE SYNTHETASES; GENE-CLUSTER; NONRIBOSOMAL BIOSYNTHESIS; CRYSTAL-STRUCTURE; ANTIBIOTICS; CLONING; DOMAIN; ACTIVATION; MECHANISM	MbtH-like proteins consist of similar to 70 amino acids and are encoded in the biosynthetic gene clusters of non-ribosomally formed peptides and other secondary metabolites derived from amino acids. Recently, several MbtH-like proteins have been shown to be required for the adenylation of amino acid in non-ribosomal peptide synthesis. We now investigated the role of MbtH-like proteins in the biosynthesis of the aminocoumarin antibiotics novobiocin, clorobiocin, and simocyclinone D8 and of the glycopeptide antibiotic vancomycin. The tyrosine-adenylating enzymes CloH, SimH, and Pcza361.18, involved in the biosynthesis of clorobiocin, simocyclinone D8, and vancomycin, respectively, required the presence of MbtH-like proteins in a 1: 1 molar ratio, forming heterotetrameric complexes. In contrast, NovH, involved in novobiocin biosynthesis, showed activity in the absence of MbtH-like proteins. Comparison of the active centers of CloH and NovH showed only one amino acid to be different, i.e. Leu-383 versus Met-383. Mutation of this amino acid in CloH (L383M) indeed led to MbtH-independent adenylating activity. All investigated tyrosine-adenylating enzymes exhibited remarkable promiscuity for MbtH-like proteins from different pathways and organisms. YbdZ, the MbtH-like protein from the expression host Escherichia coli, was found to bind to adenylating enzymes during expression and to influence their biochemical properties markedly. Therefore, the use of ybdZ-deficient expression hosts is important in biochemical studies of adenylating enzymes.	[Boll, Bjoern; Taubitz, Tatjana; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	heide@uni-tuebingen.de	Taubitz, Tatjana/AAA-2941-2021; Boll, Björn/AAJ-2892-2020	Taubitz, Tatjana/0000-0002-6747-4484; Heide, Lutz/0000-0001-7809-7453	Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 766.	Alt S, 2011, CHEM BIOL, V18, P304, DOI 10.1016/j.chembiol.2010.12.016; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Buchko GW, 2010, TUBERCULOSIS, V90, P245, DOI 10.1016/j.tube.2010.04.002; Chen HW, 2001, CHEM BIOL, V8, P301, DOI 10.1016/S1074-5521(01)00009-6; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; Dybkaer R, 2002, CLIN CHEM, V48, P586; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Heide L, 2009, BIOTECHNOL ADV, V27, P1006, DOI 10.1016/j.biotechadv.2009.05.017; Heide L, 2009, NAT PROD REP, V26, P1241, DOI 10.1039/b808333a; Hojati Z, 2002, CHEM BIOL, V9, P1175, DOI 10.1016/S1074-5521(02)00252-1; Imker HJ, 2010, CHEM BIOL, V17, P1077, DOI 10.1016/j.chembiol.2010.08.007; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Koglin A, 2009, NAT PROD REP, V26, P987, DOI 10.1039/b904543k; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Mulyani S, 2010, CHEMBIOCHEM, V11, P266, DOI 10.1002/cbic.200900600; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Recktenwald J, 2002, MICROBIOL-SGM, V148, P1105, DOI 10.1099/00221287-148-4-1105; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; STACHELHAUS T, 1995, J BIOL CHEM, V270, P6163, DOI 10.1074/jbc.270.11.6163; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Steffensky M, 2000, ANTIMICROB AGENTS CH, V44, P1214, DOI 10.1128/AAC.44.5.1214-1222.2000; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; Wu R, 2009, BIOCHEMISTRY-US, V48, P4115, DOI 10.1021/bi9002327; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	31	55	56	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36281	36290		10.1074/jbc.M111.288092	http://dx.doi.org/10.1074/jbc.M111.288092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21890635	Green Published, hybrid			2022-12-25	WOS:000296538300012
J	Jemel, I; Ii, H; Oslund, RC; Payre, C; Dabert-Gay, AS; Douguet, D; Chargui, K; Scarzello, S; Gelb, MH; Lambeau, G				Jemel, Ikram; Ii, Hiromi; Oslund, Rob C.; Payre, Christine; Dabert-Gay, Anne-Sophie; Douguet, Dominique; Chargui, Khaoula; Scarzello, Sabine; Gelb, Michael H.; Lambeau, Gerard			Group X Secreted Phospholipase A(2) Proenzyme Is Matured by a Furin-like Proprotein Convertase and Releases Arachidonic Acid inside of Human HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-V; MAMMALIAN-CELLS; COMPLETE SET; GROUP-II; EXPRESSION; BINDING; PROTEIN; ENZYMES; MICE; PROPHOSPHOLIPASE	Among mammalian secreted phospholipases A(2) (sPLA(2)s), group X sPLA(2) has the most potent hydrolyzing activity toward phosphatidylcholine and is involved in arachidonic acid (AA) release. Group X sPLA(2) is produced as a proenzyme and contains a short propeptide of 11 amino acids ending with a dibasic motif, suggesting cleavage by proprotein convertases. Although the removal of this propeptide is clearly required for enzymatic activity, the cellular location and the protease(s) involved in proenzyme conversion are unknown. Here we have analyzed the maturation of group X sPLA(2) in HEK293 cells, which have been extensively used to analyze sPLA(2)-induced AA release. Using recombinant mouse (PromGX) and human (ProhGX) proenzymes; HEK293 cells transfected with cDNAs coding for full-length ProhGX, PromGX, and propeptide mutants; and various permeable and non-permeable sPLA(2) inhibitors and protease inhibitors, we demonstrate that group X sPLA(2) is mainly converted intracellularly and releases AA before externalization from the cell. Most strikingly, the exogenous proenzyme does not elicit AA release, whereas the transfected proenzyme does elicit AA release in a way insensitive to non-permeable sPLA(2) inhibitors. In transfected cells, a permeable proprotein convertase inhibitor, but not a non-permeable one, prevents group X sPLA(2) maturation and partially blocks AA release. Mutations at the dibasic motif of the propeptide indicate that the last basic residue is required and sufficient for efficient maturation and AA release. All together, these results argue for the intracellular maturation of group X proenzyme in HEK293 cells by a furin-like proprotein convertase, leading to intracellular release of AA during secretion.	[Jemel, Ikram; Payre, Christine; Dabert-Gay, Anne-Sophie; Douguet, Dominique; Chargui, Khaoula; Scarzello, Sabine; Lambeau, Gerard] CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France; [Jemel, Ikram; Payre, Christine; Dabert-Gay, Anne-Sophie; Douguet, Dominique; Chargui, Khaoula; Scarzello, Sabine; Lambeau, Gerard] Univ Nice Sophia Antipolis, F-06560 Valbonne, France; [Ii, Hiromi; Oslund, Rob C.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Campus Box 351700,36 Bagley Hall, Seattle, WA 98195 USA.	gelb@chem.washington.edu; lambeau@ipmc.cnrs.fr	douguet, dominique/D-5644-2017; Lambeau, Gerard/GRJ-5624-2022	Lambeau, Gerard/0000-0002-9239-518X; gelb, michael/0000-0001-7000-5219; Payre, Christine/0000-0003-3640-5061	National Institutes of Health [R37HL36235]; CNRS; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37HL36235 (to M.H.G.). This work was also supported by CNRS (to G.L.), the Association pour la Recherche sur le Cancer (to G.L.), and the Agence Nationale de la Recherche (to G.L.).	ABITA JP, 1972, EUR J BIOCHEM, V30, P37, DOI 10.1111/j.1432-1033.1972.tb02069.x; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Epstein TM, 2001, BIOCHEMISTRY-US, V40, P11411, DOI 10.1021/bi011228h; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gorski JP, 2011, J BIOL CHEM, V286, P1836, DOI 10.1074/jbc.M110.151647; Gracy J, 2005, NUCLEIC ACIDS RES, V33, pW65, DOI 10.1093/nar/gki455; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Izidoro MA, 2009, ARCH BIOCHEM BIOPHYS, V487, P105, DOI 10.1016/j.abb.2009.05.013; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Masuda S, 2005, J BIOL CHEM, V280, P23203, DOI 10.1074/jbc.M500985200; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; NAKANO T, 1994, BIOCHEM BIOPH RES CO, V198, P10, DOI 10.1006/bbrc.1994.1002; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Rae D., 1996, SCAND J GASTROENTE S, V219, P24; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Seeds MC, 2000, AM J RESP CELL MOL, V23, P37, DOI 10.1165/ajrcmb.23.1.4034; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Singh DK, 2007, J LIPID RES, V48, P683, DOI 10.1194/jlr.M600421-JLR200; Surrel F, 2009, MOL PHARMACOL, V76, P778, DOI 10.1124/mol.108.053371; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Valentin E, 1999, J BIOL CHEM, V274, P19152, DOI 10.1074/jbc.274.27.19152; VERGER R, 1973, J BIOL CHEM, V248, P4023; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; Xu W, 2009, J BIOL CHEM, V284, P16659, DOI 10.1074/jbc.M808029200	55	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36509	36521		10.1074/jbc.M111.268540	http://dx.doi.org/10.1074/jbc.M111.268540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878635	hybrid, Green Published			2022-12-25	WOS:000296538300036
J	Li, W; Wang, XR; Li, Y				Li, Wei; Wang, Xiaoru; Li, Yue			Stability in and Correlation between Factors Influencing Genetic Quality of Seed Lots in Seed Orchard of Pinus tabuliformis Carr. over a 12-Year Span	PLOS ONE			English	Article							REPRODUCTIVE PHENOLOGY; DIVERSITY; GAIN; SUCCESS; IMPACT	Coniferous seed orchards require a long period from initial seed harvest to stable seed production. Differential reproductive success and asynchrony are among the main factors for orchard crops year-to-year variation in terms of parental gametic contribution and ultimately the genetic gain. It is fundamental in both making predictions about the genetic composition of the seed crop and decisions about orchard roguing and improved seed orchard establishment. In this paper, a primary Chinese pine seed orchard with 49 clones is investigated for stability, variation and correlation analysis of factors which influence genetic quality of the seed lots from initial seed harvest to the stable seed production over a 12 years span. Results indicated that the reproductive synchrony index of pollen shedding has shown to be higher than that of the strobili receptivity, and both can be drastically influenced by the ambient climate factors. Reproductive synchrony index of the clones has certain relative stability and it could be used as an indication of the seed orchard status during maturity stage; clones in the studied orchard have shown extreme differences in terms of the gametic and genetic contribution to the seed crop at the orchard's early production phase specifically when they severe as either female or male parents. Those differences are closely related to clonal sex tendency at the time of orchard's initial reproduction. Clonal gamete contribution as male and female parent often has a negative correlation. Clone utilization as pollen, seed or both pollen and seed donors should consider the role it would play in the seed crop; due to numerous factors influencing on the mating system in seed orchards, clonal genetic contribution as male parent is uncertain, and it has major influence on the genetic composition in the seed orchard during the initial reproductive and seed production phase.	[Li, Wei; Li, Yue] Beijing Forestry Univ, Natl Engn Lab Forest Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China; [Wang, Xiaoru] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Botany, CAS	Li, Y (corresponding author), Beijing Forestry Univ, Natl Engn Lab Forest Tree Breeding, Key Lab Genet & Breeding Forest Trees & Ornamenta, Minist Educ, Beijing, Peoples R China.	liyue@bjfu.edu.cn	Wang, Xiao-Ru/H-6811-2012	Wang, Xiao-Ru/0000-0002-6150-7046	Fundamental Research Funds for the Central Universities [JD2011-4]; Special Fund for Forestry Scientific Research in the Public Interest [201104022]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Forestry Scientific Research in the Public Interest	This work was supported by grants from The Fundamental Research Funds for the Central Universities (No.JD2011-4) and Special Fund for Forestry Scientific Research in the Public Interest (No. 201104022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKEW GR, 1988, SILVAE GENET, V37, P227; ASKEW GR, 1990, SILVAE GENET, V39, P168; Codesido V, 2005, SILVAE GENET, V54, P246, DOI 10.1515/sg-2005-0035; Codesido V, 2001, 3 C FOR ESP ACT C, VIII, P69; El-Kassaby YA, 2010, J HERED, V101, P164, DOI 10.1093/jhered/esp126; ELKASSABY YA, 1991, FOREST SCI, V37, P827; ELKASSABY YA, 1994, SILVAE GENET, V43, P243; Funda T, 2009, TREE GENET GENOMES, V5, P583, DOI 10.1007/s11295-009-0211-3; Gomory D., 1992, Journal of Genetics and Breeding, V46, P309; Gomory D., 2000, Forest Genetics, V7, P65; Gomory D, 2003, FOREST ECOL MANAG, V174, P117, DOI 10.1016/S0378-1127(02)00031-2; Hansen OK, 2008, FOREST ECOL MANAG, V256, P1167, DOI 10.1016/j.foreco.2008.06.032; Huang ZH, 1993, J BEIJING FOR U, V15, P39; Kang KS, 2001, THEOR APPL GENET, V103, P1099, DOI 10.1007/s001220100700; KOSKI V, 1980, Silva Fennica, V14, P136; Li Y, 2010, J BEIJING FORESTRY U, V32; Li Y., 1994, AS PAC S FOR GEN IMP; MATZIRIS DI, 1994, SILVAE GENET, V43, P321; SHEN X. H., 1985, J BEIJING FORESTRY U, V3, P1; Stoehr M, 2004, FORESTRY, V77, P297, DOI 10.1093/forestry/77.4.297; Torimaru T, 2009, SILVAE GENET, V58, P262, DOI 10.1515/sg-2009-0033; Wang SS, 1985, J BEIJING FORESTRY U, V4, P72; Zhang DongMei, 2004, Scientia Silvae Sinicae, V40, P70; ZHANG H. X., 1995, HEBEI J FOR ORCH RES, V10, P199	24	8	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23544	10.1371/journal.pone.0023544	http://dx.doi.org/10.1371/journal.pone.0023544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887269	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000026
J	Rowe, AH; Xiao, YC; Scales, J; Linse, KD; Rowe, MP; Cummins, TR; Zakon, HH				Rowe, Ashlee H.; Xiao, Yucheng; Scales, Joseph; Linse, Klaus D.; Rowe, Matthew P.; Cummins, Theodore R.; Zakon, Harold H.			Isolation and Characterization of CvIV4: A Pain Inducing alpha- Scorpion Toxin	PLOS ONE			English	Article							MICE ONYCHOMYS SPP.; SODIUM-CHANNELS; NA+ CHANNELS; BMK-I; PEPTIDES; MODULATION; EXPRESSION; NA(V)1.7; ENVENOMATION; MECHANISMS	Background: Among scorpion species, the Buthidae produce the most deadly and painful venoms. However, little is known regarding the venom components that cause pain and their mechanism of action. Using a paw-licking assay (Mus musculus), this study compared the pain-inducing capabilities of venoms from two species of New World scorpion (Centruroides vittatus, C. exilicauda) belonging to the neurotoxin-producing family Buthidae with one species of non-neurotoxin producing scorpion (Vaejovis spinigerus) in the family Vaejovidae. A pain-inducing alpha-toxin (CvIV4) was isolated from the venom of C. vittatus and tested on five Na+ channel isoforms. Principal Findings: C. vittatus and C. exilicauda venoms produced significantly more paw licking in Mus than V. spinigerus venom. CvIV4 produced paw licking in Mus equivalent to the effects of whole venom. CvIV4 slowed the fast inactivation of Na(v)1.7, a Na+ channel expressed in peripheral pain-pathway neurons (nociceptors), but did not affect the Na(v)1.8-based sodium currents of these neurons. CvIV4 also slowed the fast inactivation of Na(v)1.2, Na(v)1.3 and Na(v)1.4. The effects of CvIV4 are similar to Old World a-toxins that target Na(v)1.7 (AahII, BmK MI, LqhIII, OD1), however the primary structure of CvIV4 is not similar to these toxins. Mutant Na(v)1.7 channels (D1586A and E1589Q, DIV S3-S4 linker) reduced but did not abolish the effects of CvIV4. Conclusions: This study: 1) agrees with anecdotal evidence suggesting that buthid venom is significantly more painful than non-neurotoxic venom; 2) demonstrates that New World buthids inflict painful stings via toxins that modulate Na+ channels expressed in nociceptors; 3) reveals that Old and New World buthids employ similar mechanisms to produce pain. Old and New World alpha-toxins that target Na(v)1.7 have diverged in sequence, but the activity of these toxins is similar. Pain-inducing toxins may have evolved in a common ancestor. Alternatively, these toxins may be the product of convergent evolution.	[Rowe, Ashlee H.; Scales, Joseph; Zakon, Harold H.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Linse, Klaus D.] Univ Texas Austin, Inst Cell & Mol Biol, Prot & Mass Spect Facil, Austin, TX 78712 USA; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Stark Neurosci Res Inst, Indianapolis, IN USA; [Rowe, Matthew P.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Indiana University System; Indiana University Bloomington; Texas State University System; Sam Houston State University	Rowe, AH (corresponding author), Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA.	ahrowe@mail.utexas.edu	Xiao, Yucheng/H-3600-2012		Army Research Office (ARO) Life Sciences Division [W911NF-06-1-0213, W911NF-09-1-0355]; National Institute of General Medical Sciences (NIGMS); National Institute of Neurological Disorders and Stroke (NINDS) [NS053422]; University of Texas at Austin College of Natural Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422] Funding Source: NIH RePORTER	Army Research Office (ARO) Life Sciences Division; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Texas at Austin College of Natural Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in part or in whole, by Department of The Army Grants W911NF-06-1-0213 and W911NF-09-1-0355 from the Army Research Office (ARO) Life Sciences Division (to Dr. Rowe and Dr. Zakon) and by National Institutes of Health Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship from the National Institute of General Medical Sciences (NIGMS) (to Dr. Rowe). This research was also supported by National Institutes of Health Grant NS053422 from the National Institute of Neurological Disorders and Stroke (NINDS) (to Dr. Cummins), and by a University of Texas at Austin College of Natural Sciences Undergraduate Research Fellowship (to Dr. Scales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Asmari AK, 2004, SAUDI MED J, V25, P64; Bai ZT, 2010, EXP NEUROL, V226, P159, DOI 10.1016/j.expneurol.2010.08.018; Ben-Abraham R, 2000, HUM EXP TOXICOL, V19, P663, DOI 10.1191/096032700666836486; BOGOMOLSKIYAHALOM V, 1995, J TOXICOL-CLIN TOXIC, V33, P79, DOI 10.3109/15563659509020220; Bonhaus DW, 1996, NEUROPHARMACOLOGY, V35, P605, DOI 10.1016/0028-3908(96)84631-4; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Chen B, 2001, NEUROTOXICOL TERATOL, V23, P675, DOI 10.1016/S0892-0362(01)00174-X; Chen HJ, 2002, EUR J NEUROSCI, V16, P767, DOI 10.1046/j.1460-9568.2002.02142.x; Chen J, 2005, NEUROSCI LETT, V390, P66, DOI 10.1016/j.neulet.2005.08.003; Corona M, 2001, TOXICON, V39, P1893, DOI 10.1016/S0041-0101(01)00174-X; Couraud F., 1984, HDB NATURAL TOXINS E, V2, P659; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Fet V., 2000, CATALOG SCORPIONS WO, P54; Froy O, 2003, TOXICON, V42, P549, DOI 10.1016/S0041-0101(03)00236-8; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; O'Leary ME, 1998, CAN J PHYSIOL PHARM, V76, P1041, DOI 10.1139/y98-137; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Rowe AH, 2008, TOXICON, V52, P597, DOI 10.1016/j.toxicon.2008.07.004; Sadeghian H, 2003, NEUROLOGY, V60, P346, DOI 10.1212/01.WNL.0000044158.90246.9F; Simard J.M., 1992, NATURAL TOXINS TOXIC, P236; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Vandendriessche T, 2010, TOXICON, V56, P613, DOI 10.1016/j.toxicon.2010.06.008; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Wilson MJ, 2011, J PHARM EXPT THERAPE	38	21	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23520	10.1371/journal.pone.0023520	http://dx.doi.org/10.1371/journal.pone.0023520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887265	Green Published, gold			2022-12-25	WOS:000295832000024
J	Terry, C; Shepherd, A; Radford, DS; Moir, A; Bullough, PA				Terry, Cassandra; Shepherd, Andrew; Radford, David S.; Moir, Anne; Bullough, Per A.			YwdL in Bacillus cereus: Its Role in Germination and Exosporium Structure	PLOS ONE			English	Article							SUBTILIS SPORE COAT; ANTHRACIS EXOSPORIUM; PROTEIN; IDENTIFICATION; THURINGIENSIS; SURFACE; GERQ; LOCALIZATION; GLYCOPROTEIN; OPERON	In members of the Bacillus cereus group the outermost layer of the spore is the exosporium, which interacts with hosts and the environment. Efforts have been made to identify proteins of the exosporium but only a few have so far been characterised and their role in determining spore architecture and spore function is still poorly understood. We have characterised the exosporium protein, YwdL. Delta ywdL spores have a more fragile exosporium, subject to damage on repeated freeze-thawing, although there is no evidence of altered resistance properties, and coats appear intact. Immunogold labelling and Western blotting with anti-YwdL antibodies identified YwdL to be located exclusively on the inner surface of the exosporium of B. cereus and B. thuringiensis. We conclude that YwdL is important for formation of a robust exosporium but is not required to maintain the crystalline assembly within the basal layer or for attachment of the hairy nap structure. DywdL spores are unable to germinate in response to CaDPA, and have altered germination properties, a phenotype that confirms the expected defect in localization of the cortex lytic enzyme CwlJ in the coat.	[Terry, Cassandra; Shepherd, Andrew; Radford, David S.; Moir, Anne; Bullough, Per A.] Univ Sheffield, Krebs Inst Biomolec Res, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Terry, C (corresponding author), UCL Inst Neurol, MRC Prion Unit, London, England.	p.bullough@sheffield.ac.uk	Terry, Cassandra/AAP-1280-2021	Bullough, Per/0000-0001-8147-1127; Terry, Cassandra/0000-0002-8611-8821	BBSRC [BB/G004323/1]; Biotechnology and Biological Sciences Research Council [BB/G004323/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC (http://www.bbsrc.ac.uk, grant number BB/G004323/1). CT and AS were in receipt of BBSRC studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Bailey-Smith K, 2005, J BACTERIOL, V187, P3800, DOI 10.1128/JB.187.11.3800-3806.2005; Ball DA, 2008, MOL MICROBIOL, V68, P947, DOI 10.1111/j.1365-2958.2008.06206.x; Barlass PJ, 2002, MICROBIOL-SGM, V148, P2089, DOI 10.1099/00221287-148-7-2089; Boydston JA, 2006, J BACTERIOL, V188, P7440, DOI 10.1128/JB.00639-06; Clements MO, 1998, J BACTERIOL, V180, P6729, DOI 10.1128/JB.180.24.6729-6735.1998; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; CYBULSKI RJ, 2008, VACCINE, V26; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Gai YL, 2006, ANTON LEEUW INT J G, V89, P251, DOI 10.1007/s10482-005-9026-x; GERHARDT P, 1964, J BACTERIOL, V88, P1774, DOI 10.1128/JB.88.6.1774-1789.1964; Giorno R, 2007, J BACTERIOL, V189, P691, DOI 10.1128/JB.00921-06; Heffron JD, 2009, J BACTERIOL, V191, P2237, DOI 10.1128/JB.01598-08; Ishikawa S, 1998, J BACTERIOL, V180, P1375, DOI 10.1128/JB.180.6.1375-1380.1998; Johnson MJ, 2006, J BACTERIOL, V188, P7905, DOI 10.1128/JB.00997-06; KOSHIKAWA T, 1989, J GEN MICROBIOL, V135, P2717; Kuwana R, 2006, J BIOCHEM, V139, P887, DOI 10.1093/jb/mvj096; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; MATZ LL, 1970, J BACTERIOL, V101, P196, DOI 10.1128/JB.101.1.196-201.1970; Monroe A, 2006, J BACTERIOL, V188, P7609, DOI 10.1128/JB.01116-06; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; OHYE DF, 1973, J BACTERIOL, V115, P1179, DOI 10.1128/JB.115.3.1179-1190.1973; Ragkousi K, 2003, J BACTERIOL, V185, P2315, DOI 10.1128/JB.185.7.2315-2329.2003; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; SCHERRER PS, 1977, EUR J BIOCHEM, V72, P479, DOI 10.1111/j.1432-1033.1977.tb11271.x; Severson KM, 2009, J BACTERIOL, V191, P7587, DOI 10.1128/JB.01110-09; STAHLY DP, 1978, BIOCHEM BIOPH RES CO, V84, P581, DOI 10.1016/0006-291X(78)90745-3; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Steichen CT, 2005, J BACTERIOL, V187, P5868, DOI 10.1128/JB.187.17.5868-5876.2005; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Sylvestre P, 2005, J BACTERIOL, V187, P5122, DOI 10.1128/JB.187.15.5122-5128.2005; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Thompson BM, 2007, J BACTERIOL, V189, P6704, DOI 10.1128/JB.00762-07; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; WEHRLI E, 1980, EUR J CELL BIOL, V20, P283	35	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23801	10.1371/journal.pone.0023801	http://dx.doi.org/10.1371/journal.pone.0023801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887322	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000295832000062
J	Xi, LF; Jiang, MJ; Shen, ZP; Hulbert, A; Zhou, XH; Lin, YY; Kiviat, NB; Koutsky, LA				Xi, Long Fu; Jiang, Mingjun; Shen, Zhenping; Hulbert, Ayaka; Zhou, Xiao-Hua; Lin, Ying-Ying; Kiviat, Nancy B.; Koutsky, Laura A.			Inverse Association between Methylation of Human Papillomavirus Type 16 DNA and Risk of Cervical Intraepithelial Neoplasia Grades 2 or 3	PLOS ONE			English	Article							CPG METHYLATION; GENE-EXPRESSION; POSITIVE WOMEN; CANCER; SMOKING; PROGRESSION; INFECTION; AGE; CLEARANCE; E2	Background: The clinical relevance of human papillomavirus type 16 (HPV16) DNA methylation has not been well documented, although its role in modulation of viral transcription is recognized. Methods: Study subjects were 211 women attending Planned Parenthood clinics in Western Washington for routine Papanicolaou screening who were HPV16 positive at the screening and/or subsequent colposcopy visit. Methylation of 11 CpG dinucleotides in the 3' end of the long control region of the HPV16 genome was examined by sequencing the cloned polymerase chain reaction products. The association between risk of CIN2/3 and degree of CpG methylation was estimated using a logistic regression model. Results: CIN2/3 was histologically confirmed in 94 (44.5%) of 211 HPV16 positive women. The likelihood of being diagnosed as CIN2/3 increased significantly with decreasing numbers of methylated CpGs (meCpGs) in the 3' end of the long control region (P-for (trend) = 0.003). After adjusting for HPV16 variants, number of HPV16-positive visits, current smoking status and lifetime number of male sex partners, the odds ratio for the association of CIN2/3 with >= 4 meCpGs was 0.31 (95% confidence interval, 0.12-0.79). The proportion of >= 4 meCpGs decreased appreciably as the severity of the cervical lesion increased (P-for (trend) = 0.001). The inverse association remained similar when CIN3 was used as the clinical endpoint. Although not statistically significant, the >= 4 meCpGs-related risk reduction was more substantial among current, as compared to noncurrent, smokers. Conclusion: Results suggest that degree of the viral genome methylation is related to the outcome of an HPV16 cervical infection.	[Xi, Long Fu; Jiang, Mingjun; Shen, Zhenping; Hulbert, Ayaka; Lin, Ying-Ying; Kiviat, Nancy B.] Univ Washington, Sch Publ Hlth, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Xi, Long Fu; Koutsky, Laura A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Zhou, Xiao-Hua] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xi, LF (corresponding author), Univ Washington, Sch Publ Hlth, Sch Med, Dept Pathol, Seattle, WA 98195 USA.	longfu@u.washington.edu	MQ, Li/HGU-6545-2022	Zhou, Xiaohua/0000-0001-7935-1222	Public Health Service [CA120680, CA34493]; NATIONAL CANCER INSTITUTE [R01CA034493, R01CA120680] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grants CA120680 to L.F.X. and CA34493 to L.A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2008, J VIROL, V82, P1053, DOI 10.1128/JVI.01813-07; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Cox JT, 2003, ARCH PATHOL LAB MED, V127, P950; DANIEL B, 1995, J GEN VIROL, V76, P2589, DOI 10.1099/0022-1317-76-10-2589; Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; Doerfler W, 2001, Dev Biol (Basel), V106, P89; Doerfler W, 2001, DEV BIOL BASEL, V106, P143; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Hublarova P, 2009, INT J GYNECOL CANCER, V19, P321, DOI 10.1111/IGC.0b013e31819d8a5c; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2008, INT J CANCER, V123, P1832, DOI 10.1002/ijc.23707; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; LEMESHOW S, 1984, AM J EPIDEMIOL, V119, P147, DOI 10.1093/oxfordjournals.aje.a113732; Li LC, 2004, BIOCHEM BIOPH RES CO, V321, P455, DOI 10.1016/j.bbrc.2004.06.164; LIST HJ, 1994, J BIOL CHEM, V269, P11902; McIntyre-Seltman K, 2005, CANCER EPIDEM BIOMAR, V14, P1165, DOI 10.1158/1055-9965.EPI-04-0918; Nobbenhuis MAE, 2001, LANCET, V358, P1782, DOI 10.1016/S0140-6736(01)06809-X; Park IS, CANC PREV RES PHILA, V4, P207; Philibert RA, 2010, AM J MED GENET B, V153B, P619, DOI 10.1002/ajmg.b.31031; Piyathilake CJ, CANCER; Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e; Rajeevan MS, 2005, INT J CANCER, V115, P114, DOI 10.1002/ijc.20894; Remus R, 1999, J VIROL, V73, P1010, DOI 10.1128/JVI.73.2.1010-1022.1999; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; ROSL F, 1993, J GEN VIROL, V74, P791, DOI 10.1099/0022-1317-74-5-791; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Stunkel W, 1999, J VIROL, V73, P1918; Syrjanen S, 2005, EUR J OBSTET GYN R B, V119, P219, DOI 10.1016/j.ejogrb.2004.07.036; Szalmas A, 2009, SEMIN CANCER BIOL, V19, P144, DOI 10.1016/j.semcancer.2009.02.011; Thain A, 1996, J VIROL, V70, P7233, DOI 10.1128/JVI.70.10.7233-7235.1996; Tolstrup J, 2006, ACTA OBSTET GYN SCAN, V85, P1114, DOI 10.1080/00016340600677027; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Van Tine B. A., 2001, V106, P381; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Wiley DJ, 2005, JAIDS-J ACQ IMM DEF, V39, P143; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178; Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P3490, DOI 10.1158/1055-9965.EPI-09-0763; Ylitalo N, 1999, INT J CANCER, V81, P357, DOI 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.3.CO;2-T	49	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23897	10.1371/journal.pone.0023897	http://dx.doi.org/10.1371/journal.pone.0023897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887341	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000071
J	Chico, L; Ciudad, T; Hsu, M; Lue, NF; Larriba, G				Chico, Lidia; Ciudad, Toni; Hsu, Min; Lue, Neal F.; Larriba, German			The Candida albicans Ku70 Modulates Telomere Length and Structure by Regulating Both Telomerase and Recombination	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DNA-REPAIR; END; MAINTENANCE; YEAST; COMPONENTS; MUTANTS; CIRCLES; PROTEIN; CELLS	The heterodimeric Ku complex has been shown to participate in DNA repair and telomere regulation in a variety of organisms. Here we report a detailed characterization of the function of Ku70 in the diploid fungal pathogen Candida albicans. Both ku70 heterozygous and homozygous deletion mutants have a wild-type colony and cellular morphology, and are not sensitive to MMS or UV light. Interestingly, we observed complex effects of KU70 gene dosage on telomere lengths, with the KU70/ku70 heterozygotes exhibiting slightly shorter telomeres, and the ku70 null strain exhibiting long and heterogeneous telomeres. Analysis of combination mutants suggests that the telomere elongation in the ku70 null mutant is due mostly to unregulated telomerase action. In addition, elevated levels of extrachromosomal telomeric circles were detected in the null mutant, consistent with activation of aberrant telomeric recombination. Altogether, our observations point to multiple mechanisms of the Ku complex in telomerase regulation and telomere protection in C. albicans, and reveal interesting similarities and differences in the mechanisms of the Ku complex in disparate systems.	[Chico, Lidia; Ciudad, Toni; Larriba, German] Univ Extremadura, Fac Sci, Dept Biomed Sci, Badajoz, Spain; [Hsu, Min; Lue, Neal F.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, WR Hearst Microbiol Res Ctr, New York, NY 10021 USA	Universidad de Extremadura; Cornell University	Chico, L (corresponding author), Univ Extremadura, Fac Sci, Dept Biomed Sci, Badajoz, Spain.	glarriba@unex.es	Larriba, Germán/E-3563-2013; CIUDAD, TONI/H-5594-2015; Lue, Neal/AAO-6759-2020	CIUDAD, TONI/0000-0002-9303-1628; Lue, Neal/0000-0001-9700-6895	Ministerio de Educacion y Ciencia [SAF2007-60810]; Junta de Extremadura [PRI07A029]; National Institutes of Health (NIH) [GM069507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069507] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Junta de Extremadura; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by SAF2007-60810 from Ministerio de Educacion y Ciencia and PRI07A029 from Junta de Extremadura to G. L., and GM069507 from the National Institutes of Health (NIH) to N.F.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaluz E, 2011, MOL MICROBIOL, V79, P1462, DOI 10.1111/j.1365-2958.2011.07532.x; Andaluz E, 2001, INFECT IMMUN, V69, P137, DOI 10.1128/IAI.69.01.137-147.2001; Barnes G, 1997, P NATL ACAD SCI USA, V94, P867, DOI 10.1073/pnas.94.3.867; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Carter SD, 2007, GENETICS, V175, P1035, DOI 10.1534/genetics.106.067447; Ciudad T, 2004, MOL MICROBIOL, V53, P1177, DOI 10.1111/j.1365-2958.2004.04197.x; Cohen S, 1996, MOL CELL BIOL, V16, P2002; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; FONZI WA, 1993, GENETICS, V134, P717; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Grandin N, 2003, MOL CELL BIOL, V23, P3721, DOI 10.1128/MCB.23.11.3721-3734.2003; Grandin N, 2009, MOL CELL BIOL, V29, P965, DOI 10.1128/MCB.00817-08; Gravel S, 2002, MOL CELL BIOL, V22, P2182, DOI 10.1128/MCB.22.7.2182-2193.2002; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hsu M, 2007, P NATL ACAD SCI USA, V104, P11682, DOI 10.1073/pnas.0700327104; Hsu M, 2007, EUKARYOT CELL, V6, P1330, DOI 10.1128/EC.00069-07; Larriba G, 2004, PATHOGENIC FUNGI: HOST INTERACTIONS AND EMERGING STRATEGIES FOR CONTROL, P285; Legrand M, 2007, EUKARYOT CELL, V6, P2194, DOI 10.1128/EC.00299-07; Lephart PR, 2006, GENETICS, V174, P1737, DOI 10.1534/genetics.106.063271; Magee P. T., 2007, Candida: comparative and functional genomics, P7; Myung K, 2004, MOL CELL BIOL, V24, P5050, DOI 10.1128/MCB.24.11.5050-5059.2004; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; Rosas-Hernandez LL, 2008, EUKARYOT CELL, V7, P2168, DOI 10.1128/EC.00228-08; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Siede W, 1996, GENETICS, V142, P91; Singh SM, 2002, EUKARYOT CELL, V1, P967, DOI 10.1128/EC.1.6.967-977.2002; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Tomaska L, 2009, NAT STRUCT MOL BIOL, V16, P1010, DOI 10.1038/nsmb.1660; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Yu EY, 2010, MOL CELL BIOL, V30, P1254, DOI 10.1128/MCB.00986-09; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025	52	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23732	10.1371/journal.pone.0023732	http://dx.doi.org/10.1371/journal.pone.0023732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886818	Green Published, Green Submitted, gold			2022-12-25	WOS:000294253500028
J	Besson, P; Bourdin, C; Bringoux, L				Besson, Patricia; Bourdin, Christophe; Bringoux, Lionel			A Comprehensive Model of Audiovisual Perception: Both Percept and Temporal Dynamics	PLOS ONE			English	Article							MULTISENSORY ENHANCEMENT; INFERENCE; INTEGRATION; INFORMATION; CONFLICT; HUMANS	The sparse information captured by the sensory systems is used by the brain to apprehend the environment, for example, to spatially locate the source of audiovisual stimuli. This is an ill-posed inverse problem whose inherent uncertainty can be solved by jointly processing the information, as well as introducing constraints during this process, on the way this multisensory information is handled. This process and its result - the percept - depend on the contextual conditions perception takes place in. To date, perception has been investigated and modeled on the basis of either one of two of its dimensions: the percept or the temporal dynamics of the process. Here, we extend our previously proposed audiovisual perception model to predict both these dimensions to capture the phenomenon as a whole. Starting from a behavioral analysis, we use a data-driven approach to elicit a Bayesian network which infers the different percepts and dynamics of the process. Context-specific independence analyses enable us to use the model's structure to directly explore how different contexts affect the way subjects handle the same available information. Hence, we establish that, while the percepts yielded by a unisensory stimulus or by the non-fusion of multisensory stimuli may be similar, they result from different processes, as shown by their differing temporal dynamics. Moreover, our model predicts the impact of bottom-up (stimulus driven) factors as well as of top-down factors (induced by instruction manipulation) on both the perception process and the percept itself.	[Besson, Patricia; Bourdin, Christophe; Bringoux, Lionel] Univ Mediterranee, CNRS, Inst Movement Sci, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Besson, P (corresponding author), Univ Mediterranee, CNRS, Inst Movement Sci, Marseille, France.	patricia.besson@univmed.fr	Bourdin, Christophe/O-9395-2017	Bourdin, Christophe/0000-0003-4149-1347; Lauwereyns, Jan/0000-0003-0551-2550				Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; BERNSTEI.IH, 1969, J EXP PSYCHOL, V81, P405, DOI 10.1037/h0027750; BERNSTEIN IH, 1969, J EXP PSYCHOL, V80, P567, DOI 10.1037/h0027444; Besson P, 2010, BIOL CYBERN, V103, P213, DOI 10.1007/s00422-010-0392-8; BILMES J, 2000, P 16 C UNC ART INT U; Boutilier Craig, 1996, UAI; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; CANO A, 2005, ECSQARU, P932; Clark J.J., 1990, DATA FUSION SENSORY; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Geiger D, 1996, ARTIF INTELL, V82, P45, DOI 10.1016/0004-3702(95)00014-3; GEIGER D, 1991, UAI; Hecht D, 2008, EXP BRAIN RES, V189, P133, DOI 10.1007/s00221-008-1410-0; Hospedales T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004205; Hospedales TM, 2008, IEEE T PATTERN ANAL, V30, P2140, DOI 10.1109/TPAMI.2008.25; Jepma M, 2009, J COGNITIVE NEUROSCI, V21, P847, DOI 10.1162/jocn.2009.21063; Knill DC, 1996, PERCEPTION BAYESIAN; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Neapolitan R.E., 2003, LEARNING BAYESIAN NE; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Rowland BA, 2007, J NEUROSCI, V27, P5879, DOI 10.1523/JNEUROSCI.4986-06.2007; Sarlegna FR, 2010, NEUROPSYCHOLOGIA, V48, P60, DOI 10.1016/j.neuropsychologia.2009.08.011; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Theodoridis S, 2006, PATTERN RECOGNITION, 3RD EDITION, P1; VERMA T, 1992, UNCERTAINTY ARTIFICI, V8, P323; WARREN DH, 1979, PERCEPTION, V8, P323, DOI 10.1068/p080323; Wozny DR, 2008, J VISION, V8, DOI 10.1167/8.3.24; ZHANG NL, 1999, P 16 INT JOINT C ART, V2, P1288	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23811	10.1371/journal.pone.0023811	http://dx.doi.org/10.1371/journal.pone.0023811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811XK	21887324	Green Published, gold, Green Submitted			2022-12-25	WOS:000294251800033
J	Lee, SB; Doberstein, K; Baumgarten, P; Wieland, A; Ungerer, C; Burger, C; Hardt, K; Boehncke, WH; Pfeilschifter, J; Mihic-Probst, D; Mittelbronn, M; Gutwein, P				Lee, Sophia Boyoung; Doberstein, Kai; Baumgarten, Peter; Wieland, Anja; Ungerer, Christopher; Buerger, Claudia; Hardt, Katja; Boehncke, Wolf-Henning; Pfeilschifter, Josef; Mihic-Probst, Daniela; Mittelbronn, Michel; Gutwein, Paul			PAX2 Regulates ADAM10 Expression and Mediates Anchorage-Independent Cell Growth of Melanoma Cells	PLOS ONE			English	Article							CANCER; CARCINOMA; APOPTOSIS; GENES; OLIGONUCLEOTIDES; RESISTANCE; ONCOGENE; BINDING; TUMOR; P53	PAX transcription factors play an important role during development and carcinogenesis. In this study, we investigated PAX2 protein levels in melanocytes and melanoma cells by Western Blot and immunofluorescence analysis and characterized the role of PAX2 in the pathogenesis of melanoma. In vitro we found weak PAX2 protein expression in keratinocytes and melanocytes. Compared to melanocytes increased PAX2 protein levels were detectable in melanoma cell lines. Interestingly, in tissue sections of melanoma patients nuclear PAX2 expression strongly correlated with nuclear atypia and the degree of prominent nucleoli, indicating an association of PAX2 with a more atypical cellular phenotype. In addition, with chromatin immunoprecipitation assay, PAX2 overexpression and PAX2 siRNA we present compelling evidence that PAX2 can regulate ADAM10 expression, a metalloproteinase known to play important roles in melanoma metastasis. In human tissue samples we found co-expression of PAX2 and ADAM10 in melanocytes of benign nevi and in melanoma cells of patients with malignant melanoma. Importantly, the downregulation of PAX2 by specific siRNA inhibited the anchorage independent cell growth and decreased the migratory and invasive capacity of melanoma cells. Furthermore, the downregulation of PAX2 abrogated the chemoresistance of melanoma cells against cisplatin, indicating that PAX2 expression mediates cell survival and plays important roles during melanoma progression.	[Lee, Sophia Boyoung; Doberstein, Kai; Ungerer, Christopher; Pfeilschifter, Josef; Gutwein, Paul] Goethe Univ Frankfurt, Univ Hosp Goethe, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Baumgarten, Peter; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Wieland, Anja] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, Bonn, Germany; [Wieland, Anja] Hertie Fdn, Bonn, Germany; [Buerger, Claudia; Hardt, Katja; Boehncke, Wolf-Henning] Clin Goethe Univ, Dept Dermatol, Frankfurt, Germany; [Mihic-Probst, Daniela] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt; University of Bonn; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Zurich; University Zurich Hospital	Lee, SB (corresponding author), Goethe Univ Frankfurt, Univ Hosp Goethe, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	p.gutwein@med.uni-frankfurt.de	Baumgarten, Peter/AAE-1140-2021; Mihic-Probst, Daniela/AAB-6374-2021; Baumgarten, Peter/AAS-6061-2020	Baumgarten, Peter/0000-0002-2563-2691; Baumgarten, Peter/0000-0002-2563-2691; Doberstein, Kai/0000-0002-9114-9913; Mittelbronn, Michel/0000-0002-2998-052X; Buerger, Claudia/0000-0002-7838-197X				Buttiglieri S, 2004, J BIOL CHEM, V279, P4136, DOI 10.1074/jbc.M306824200; Cazzaniga G, 2001, CANCER RES, V61, P4666; Crawford HC, 2009, CURR PHARM DESIGN, V15, P2288, DOI 10.2174/138161209788682442; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; GNARRA JR, 1995, CANCER RES, V55, P4092; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Hewitt SM, 1997, ANTICANCER RES, V17, P3211; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kaufmann R, 1998, ACTA DERM-VENEREOL, V78, P136; Koyanagi K, 2005, J CLIN ONCOL, V23, P8057, DOI 10.1200/JCO.2005.02.0958; Kroll TG, 2000, SCIENCE, V289, P1357, DOI 10.1126/science.289.5483.1357; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Lee SB, 2010, J INVEST DERMATOL, V130, P763, DOI 10.1038/jid.2009.335; Luu VD, 2009, CLIN CANCER RES, V15, P3297, DOI 10.1158/1078-0432.CCR-08-2779; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Palmieri G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-86; Ries LAG, 2000, CANCER-AM CANCER SOC, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Scholl FA, 2001, CANCER RES, V61, P823; Silberstein GB, 2002, ONCOGENE, V21, P1009, DOI 10.1038/sj.onc.1205172; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Takeuchi H, 2004, J CLIN ONCOL, V22, P2671, DOI 10.1200/JCO.2004.12.009; Torban E, 2000, AM J PATHOL, V157, P833, DOI 10.1016/S0002-9440(10)64597-X; Wang Z, 2010, TRANSL ONCOL, V3, P1, DOI 10.1593/tlo.09250	32	80	80	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22312	10.1371/journal.pone.0022312	http://dx.doi.org/10.1371/journal.pone.0022312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876729	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000294126900001
J	Ganguly, SS; Fiore, LS; Sims, JT; Friend, JW; Srinivasan, D; Thacker, MA; Cibull, ML; Wang, C; Novak, M; Kaetzel, DM; Plattner, R				Ganguly, S. S.; Fiore, L. S.; Sims, J. T.; Friend, J. W.; Srinivasan, D.; Thacker, M. A.; Cibull, M. L.; Wang, C.; Novak, M.; Kaetzel, D. M.; Plattner, R.			c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression	ONCOGENE			English	Article						c-Abl; Arg; melanoma; invasion; STAT3; MMP	TYROSINE KINASE; BREAST-CANCER; MATRIX-METALLOPROTEINASE; CLINICAL-EFFICACY; FAMILY KINASES; GROWTH-FACTOR; IMATINIB; EXPRESSION; INHIBITION; THERAPY	Despite 35 years of clinical trials, there is little improvement in 1-year survival rates for patients with metastatic melanoma, and the disease is essentially untreatable if not cured surgically. The paucity of chemotherapeutic agents that are effective for treating metastatic melanoma indicates a dire need to develop new therapies. Here, we found a previously unrecognized role for c-Abl and Arg in melanoma progression. We demonstrate that the kinase activities of c-Abl and Arg are elevated in primary melanomas (60%), in a subset of benign nevi (33%) and in some human melanoma cell lines. Using siRNA and pharmacological approaches, we show that c-Abl/Arg activation is functionally relevant because it is required for melanoma cell proliferation, survival and invasion. Significantly, we identify the mechanism by which activated c-Abl promotes melanoma invasion by showing that it transcriptionally upregulates matrix metalloproteinase-1 (MMP-1), and using rescue approaches we demonstrate that c-Abl promotes invasion through a STAT3-MMP-1 pathway. Additionally, we show that c-Abl and Arg are not merely redundant, as active Arg drives invasion in a STAT3-independent manner, and upregulates MMP-3 and MT1-MMP, in addition to MMP-1. Most importantly, c-Abl and Arg not only promote in vitro processes important for melanoma progression, but also promote metastasis in vivo, as inhibition of c-Abl/Arg kinase activity with the c-Abl/Arg inhibitor, nilotinib, dramatically inhibits metastasis in a mouse model. Taken together, these data identify c-Abl and Arg as critical, novel, drug targets in metastatic melanoma, and indicate that nilotinib may be useful in preventing metastasis in patients with melanomas harboring active c-Abl and Arg. Oncogene (2012) 31, 1804-1816; doi: 10.1038/onc.2011.361; published online 5 September 2011	[Ganguly, S. S.; Fiore, L. S.; Sims, J. T.; Friend, J. W.; Srinivasan, D.; Thacker, M. A.; Novak, M.; Kaetzel, D. M.; Plattner, R.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Sch Med, Lexington, KY 40536 USA; [Cibull, M. L.] Univ Kentucky, Dept Pathol, Sch Med, Lexington, KY 40536 USA; [Wang, C.] Univ Kentucky, Dept Biostat, Sch Med, Lexington, KY 40536 USA; [Wang, C.] Univ Kentucky, Lucille P Markey Canc Ctr, Sch Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Plattner, R (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Sch Med, 800 Rose St,Combs Res Bldg,Room 209, Lexington, KY 40536 USA.	rplat2@uky.edu			NIH [CA116784, CA83237]; NIH/NCI [1R01CA116784]; NATIONAL CANCER INSTITUTE [R01CA116784, P30CA177558, R01CA083237, R01CA166499] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Plattner's and Dr Kaetzel's work are supported by NIH CA116784 and CA83237, respectively. All of the other authors declare no potential conflict of interest.; We thank Patty Cross, J Anthony Brandon, Holly Bennett and Jennifer Strange for assistance with IHC, IVIS imaging, isolation of GST-STAT3 and cell sorting, respectively; John D'Orazio for primary melanocytes; Meenhard Herlyn for WM melanoma cell lines and for genotyping WM cell lines; Suyan Huang for A375; Fernando deCastro for IHC advice and Paul Manley (Novartis, Switzerland) for STI571 and nilotinib, and advice regarding their use. This work was supported by NIH/NCI grant 1R01CA116784.	Allington TM, 2011, CELLS TISSUES ORGANS, V193, P98, DOI 10.1159/000320163; Allington TM, 2009, FASEB J, V23, P4231, DOI 10.1096/fj.09-138412; Bachmeier BE, 2005, EXP CELL RES, V305, P83, DOI 10.1016/j.yexcr.2004.12.019; Berwick M, 2009, DERMATOL CLIN, V27, P205, DOI 10.1016/j.det.2008.12.002; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Candelaria M, 2005, MED ONCOL, V22, P1, DOI 10.1385/MO:22:1:001; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; DeMatteo R, 2009, ANN SURG ONCOL, V16, P799, DOI 10.1245/s10434-009-0316-9; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Furlan A, 2011, CELL DEATH DIFFER; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hofmann UB, 2009, CLIN CANCER RES, V15, P324, DOI 10.1158/1078-0432.CCR-08-2243; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Kabbarah O, 2005, CANCER CELL, V8, P439, DOI 10.1016/j.ccr.2005.11.008; Kong YY, 2010, ARCH PATHOL LAB MED, V134, P1740, DOI 10.1043/2009-0418-RAR.1; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; le Coutre P, 2004, CANCER CHEMOTH PHARM, V53, P313, DOI 10.1007/s00280-003-0741-6; Li X, 2010, CELL DEATH DIFFER, V17, P1277, DOI 10.1038/cdd.2010.8; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lin Kimberly, 2010, Genes Cancer, V1, P409; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mayorga ME, 2006, MELANOMA RES, V16, P127, DOI 10.1097/01.cmr.0000215039.30812.9b; Mouawad R, 2010, CRIT REV ONCOL HEMAT, V74, P27, DOI 10.1016/j.critrevonc.2009.08.005; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Ogawa Y, 2008, J DERMATOL SCI, V51, P190, DOI 10.1016/j.jdermsci.2008.03.011; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; PENDERGAST AM, 2001, CHRONIC MYELOID LEUK, P19; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Raby BN, 2001, INT J CANCER, V93, P644, DOI 10.1002/ijc.1380; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Redondo P, 2004, J INVEST DERMATOL, V123, P1208, DOI 10.1111/j.0022-202X.2004.23496.x; Santos FPS, 2009, LEUKEMIA LYMPHOMA, V50, P16, DOI 10.3109/10428190903383427; Satzger I, 2010, DERMATOLOGY, V220, P77, DOI 10.1159/000265558; Shepherd C, 2010, CURR ONCOL REP, V12, P146, DOI 10.1007/s11912-010-0095-2; Singer CF, 2004, ENDOCR-RELAT CANCER, V11, P861, DOI 10.1677/erc.1.00801; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tsareva SA, 2007, NEOPLASIA, V9, P279, DOI 10.1593/neo.06820; Ugurel S, 2005, BRIT J CANCER, V92, P1398, DOI 10.1038/sj.bjc.6602529; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200	53	50	52	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	14					1804	1816		10.1038/onc.2011.361	http://dx.doi.org/10.1038/onc.2011.361			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21892207	Green Accepted			2022-12-25	WOS:000302785200006
J	Bae, HB; Zmijewski, JW; Deshane, JS; Tadie, JM; Chaplin, DD; Takashima, S; Abraham, E				Bae, Hong-Beom; Zmijewski, Jaroslaw W.; Deshane, Jessy S.; Tadie, Jean-Marc; Chaplin, David D.; Takashima, Seiji; Abraham, Edward			AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils	FASEB JOURNAL			English	Article						inflammation; phagocytosis; efferocytosis; cytoskeleton	ACUTE LUNG INJURY; RECEPTOR-MEDIATED PHAGOCYTOSIS; RESPIRATORY COMPLEX-I; HYDROGEN-PEROXIDE; MUSCLE-CELLS; RHO GTPASES; BINDING; CLIP-170; MICROTUBULES; MECHANISM	Although AMPK plays well-established roles in the modulation of energy balance, recent studies have shown that AMPK activation has potent anti-inflammatory effects. In the present experiments, we examined the role of AMPK in phagocytosis. We found that ingestion of Escherichia coli or apoptotic cells by macrophages increased AMPK activity. AMPK activation increased the ability of neutrophils or macrophages to ingest bacteria (by 46 +/- 7.8 or 85 +/- 26%, respectively, compared to control, P<0.05) and the ability of macrophages to ingest apoptotic cells (by 21 +/- 1.4%, P<0.05 compared to control). AMPK activation resulted in cytoskeletal reorganization, including enhanced formation of actin and microtubule networks. Activation of PAK1/2 and WAVE2, which are downstream effectors of Rac1, accompanied AMPK activation. AMPK activation also induced phosphorylation of CLIP-170, a protein that participates in microtubule synthesis. The increase in phagocytosis was reversible by the specific AMPK inhibitor compound C, siRNA to AMPK alpha 1, Rac1 inhibitors, or agents that disrupt actin or microtubule networks. In vivo, AMPK activation resulted in enhanced phagocytosis of bacteria in the lungs by 75 +/- 5% vs. control (P<0.05). These results demonstrate a novel function for AMPK in enhancing the phagocytic activity of neutrophils and macrophages.-Bae, H. -B., Zmijewski, J. W., Deshane, J. S., Tadie, J. -M., Chaplin, D. D., Takashima, S., Abraham, E. AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils. FASEB J. 25, 4358-4368 (2011). www.fasebj.org	[Zmijewski, Jaroslaw W.] Univ Alabama Birmingham, Dept Med, Sch Med, Birmingham, AL 35294 USA; [Zmijewski, Jaroslaw W.; Chaplin, David D.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Bae, Hong-Beom] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Kwangju, South Korea; [Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Chonnam National University; Osaka University	Abraham, E (corresponding author), Wake Forest Baptist Med Ctr, Wake Forest Sch Med, 10th Floor,Richard Janeway Clin Sci Tower,Med Ctr, Winston Salem, NC 27157 USA.	zmijewsk@uab.edu; eabraham@wakehealth.edu		Chaplin, David/0000-0002-1354-3069	U.S. National Institutes of Health [HL76206, GM87748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087748] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by U.S. National Institutes of Health grants HL76206 and GM87748 to E.A. The authors declare no conflicts of interest.	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Aoki C, 2010, J ATHEROSCLER THROMB, V17, P503, DOI 10.5551/jat.3392; Binker MG, 2007, J IMMUNOL, V179, P3780, DOI 10.4049/jimmunol.179.6.3780; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; Friggeri A, 2011, J IMMUNOL, V186, P6191, DOI 10.4049/jimmunol.1004134; Friggeri A, 2010, AM J PHYSIOL-CELL PH, V299, pC1267, DOI 10.1152/ajpcell.00152.2010; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Lorne E, 2008, AM J PHYSIOL-CELL PH, V294, pC985, DOI 10.1152/ajpcell.00454.2007; Machuy N, 2007, J MOL BIOL, V370, P620, DOI 10.1016/j.jmb.2007.04.080; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; McGee K, 2003, FEBS LETT, V533, P35, DOI 10.1016/S0014-5793(02)03745-6; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; NEWMAN SL, 1990, J CLIN INVEST, V85, P223, DOI 10.1172/JCI114416; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Steenport M, 2009, J IMMUNOL, V183, P8119, DOI 10.4049/jimmunol.0901925; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Sulahian TH, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-59; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsoyi K., 2010, BRIT J PHARMACOL, V162, P1498; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; WAN CP, 1993, J IMMUNOL METHODS, V162, P1, DOI 10.1016/0022-1759(93)90400-2; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zmijewski JW, 2008, AM J RESP CRIT CARE, V178, P168, DOI 10.1164/rccm.200710-1602OC; Zmijewski JW, 2007, AM J PHYSIOL-CELL PH, V293, pC255, DOI 10.1152/ajpcell.00618.2006; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	54	97	98	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4358	4368		10.1096/fj.11-190587	http://dx.doi.org/10.1096/fj.11-190587			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21885655	Green Published			2022-12-25	WOS:000298138100027
J	Russell, R; Gori, I; Pellegrini, C; Kumar, R; Achtari, C; Canny, GO				Russell, Ronan; Gori, Ilaria; Pellegrini, Chiara; Kumar, Rajesh; Achtari, Chahin; Canny, Geraldine O.			Lipoxin A(4) is a novel estrogen receptor modulator	FASEB JOURNAL			English	Article						endometrium; eicosanoids; hormones; estradiol	ARYL-HYDROCARBON RECEPTOR; ASPIRIN-TRIGGERED LIPOXIN; FORMYL PEPTIDE RECEPTORS; ALPHA-KNOCKOUT MOUSE; PROTEIN-KINASE-C; PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; CELL-PROLIFERATION; HUMAN NEUTROPHILS; STEROID-HORMONES	Inflammation is intimately linked with naturally occurring remodeling events in the endometrium. Lipoxins comprise a group of short-lived, non-classic eicosanoids possessing potent anti-inflammatory and proresolution properties. In the present study, we investigated the role of lipoxin A(4) (LXA(4)) in the endometrium and demonstrated that 15-LOX-2, an enzyme necessary for LX biosynthesis, is expressed in this tissue. Our results establish that LXA(4) possesses robust estrogenic activity through its capacity to alter ERE transcriptional activity, as well as expression of estrogen-regulated genes, alkaline phosphatase activity, and proliferation in human endometrial epithelial cells. Interestingly, LXA(4) also demonstrated antiestrogenic potential, significantly attenuating E2-induced activity. This estrogenic activity was directly mediated through estrogen receptors (ERs). Subsequent investigations determined that the actions of LXA(4) are exclusively mediated through ER alpha and closely mimic those of the potent estrogen 17 beta-estradiol (E2). In binding assays, LXA(4) competed with E2 for ER binding, with an IC50 of 46 nM. Furthermore, LXA(4) exhibited estrogenic activity in vivo, increasing uterine wet weight and modulating E2-regulated gene expression. These findings reveal a previously unappreciated facet of LXA(4) bioactions, implicating this lipid mediator in novel immunoendocrine crosstalk mechanisms.-Russell R., Gori, I., Pellegrini, C., Kumar, R., Achtari, C., Canny, G. O. Lipoxin A4 is a novel estrogen receptor modulator. FASEB J. 25, 4326-4337 (2011). www.fasebj.org	[Canny, Geraldine O.] Univ Hosp Ctr, Dept Gynecol Obstet & Med Genet, Mucosal Immun Lab, CH-1011 Lausanne, Switzerland; Univ Lausanne, CH-1011 Lausanne, Switzerland	University of Lausanne	Canny, GO (corresponding author), Univ Hosp Ctr, Dept Gynecol Obstet & Med Genet, Mucosal Immun Lab, Ave Pierre Decker 2, CH-1011 Lausanne, Switzerland.	geraldine.canny@chuv.ch	Kumar, Rajesh/F-6579-2014; Kumar, Rajesh/I-5668-2019; Russell, Ronan/AAD-8418-2019	Achtari, Chahin/0000-0001-9265-9395; Canny, Geraldine/0000-0003-0632-7365; Kumar, Rajesh/0000-0002-0211-7195	Swiss National Science Foundation; Roche Research Foundation; Department of Gynecology and Obstetrics, CHUV (Lausanne, Switzerland); Swiss Confederation scholarship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; Department of Gynecology and Obstetrics, CHUV (Lausanne, Switzerland); Swiss Confederation scholarship	The authors thank Dr. Dela Golshayan for kindly facilitating in vivo experiments, and Carile Steinacher for assistance with immunohistochemistry, as well as Charles Serhan, Donald McDonnell, Karsten Gronert, and Sean Colgan for helpful discussions. Thanks also to Patrick Hohlfeld, Alan Baird, Stephen Keely, and Jane Irwin for their support. This work was funded by grants to G.O.C. from the Swiss National Science Foundation, Roche Research Foundation, and funds from the Department of Gynecology and Obstetrics, CHUV (Lausanne, Switzerland). R.R. was the recipient of a Swiss Confederation scholarship. The authors declare no conflicts of interest.	Abdelrahim M, 2006, CANCER RES, V66, P2459, DOI 10.1158/0008-5472.CAN-05-3132; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Amita M, 2010, ENDOCRINOLOGY, V151, P394, DOI 10.1210/en.2009-0721; Baker N, 2009, J IMMUNOL, V182, P3819, DOI 10.4049/jimmunol.0803175; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Boonyaratanakornkit V, 2004, ESSAYS BIOCHEM, V40, P105, DOI 10.1042/bse0400105; Brannstrom M, 2002, J REPROD IMMUNOL, V57, P47, DOI 10.1016/S0165-0378(02)00009-8; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Cezar-De-Mello PFT, 2008, BRIT J PHARMACOL, V153, P956, DOI 10.1038/sj.bjp.0707650; Cezar-de-Mello PFT, 2006, ONCOGENE, V25, P122, DOI 10.1038/sj.onc.1209002; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Chungaon KO, 1996, BRIT J PHARMACOL, V117, P1334, DOI 10.1111/j.1476-5381.1996.tb16733.x; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; CLARK JH, 1984, J STEROID BIOCHEM, V20, P1005, DOI 10.1016/0022-4731(84)90011-6; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Diel P, 2002, J CHROMATOGR B, V777, P191, DOI 10.1016/S1570-0232(02)00494-4; EDWIN SS, 1994, J LIPID MEDIAT CELL, V9, P291; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; FIORE S, 1993, BLOOD, V81, P3395; FIORE S, 1994, J EXP MED, V180, P253, DOI 10.1084/jem.180.1.253; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; HANSSON A, 1986, BIOCHEM BIOPH RES CO, V134, P1215, DOI 10.1016/0006-291X(86)90380-3; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hernandez-Ochoa I, 2009, BIOCHEM PHARMACOL, V77, P547, DOI 10.1016/j.bcp.2008.09.037; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; HOLINKA CF, 1986, CANCER RES, V46, P2771; Jabbour HN, 2009, REPRODUCTION, V138, P903, DOI 10.1530/REP-09-0247; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Jefferson WN, 2002, J CHROMATOGR B, V777, P179, DOI 10.1016/S1570-0232(02)00493-2; JORDAN VC, 1985, ENVIRON HEALTH PERSP, V61, P97, DOI 10.2307/3430064; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kure I, 2010, J PHARMACOL EXP THER, V332, P541, DOI 10.1124/jpet.109.159046; Kurita T, 2001, BIOL REPROD, V64, P272, DOI 10.1095/biolreprod64.1.272; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; Lousse JC, 2010, HUM REPROD, V25, P734, DOI 10.1093/humrep/dep408; Macdonald LJ, 2011, REPRODUCTION, V142, P345, DOI 10.1530/REP-11-0021; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Maldonado-Perez D, 2011, FASEB J, V25, P569, DOI 10.1096/fj.10-170340; McMahon B, 2002, FASEB J, V16, P1817, DOI 10.1096/fj.02-0416fje; McMahon B, 2000, J BIOL CHEM, V275, P27566; MEDLOCK KL, 1991, J RECEPTOR RES, V11, P743, DOI 10.3109/10799899109064677; Melamed M, 1997, MOL ENDOCRINOL, V11, P1868, DOI 10.1210/me.11.12.1868; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mitchell D, 2007, J BIOL CHEM, V282, P15606, DOI 10.1074/jbc.M611004200; Motohashi E, 2005, BIOMED PHARMACOTHER, V59, P330, DOI 10.1016/j.biopha.2005.05.005; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; O'Malley BW, 2005, MOL ENDOCRINOL, V19, P1402, DOI 10.1210/me.2004-0480; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Pearce ST, 2004, CANCER RES, V64, P2889, DOI 10.1158/0008-5472.CAN-03-1770; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Preisler-Mashek MT, 2002, AM J PHYSIOL-ENDOC M, V282, pE891, DOI 10.1152/ajpendo.00353.2001; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Santagati S, 1997, MOL ENDOCRINOL, V11, P938, DOI 10.1210/me.11.7.938; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SERHAN CN, 1989, ADV PROSTAG THROMB L, V19, P116; SERHAN CN, 1986, J BIOL CHEM, V261, P6340; Shipley JM, 2006, TOXICOL APPL PHARM, V213, P87, DOI 10.1016/j.taap.2005.09.011; SIMCHOWITZ L, 1994, AM J PHYSIOL-CELL PH, V267, pC1525, DOI 10.1152/ajpcell.1994.267.6.C1525; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; STENKE L, 1991, BIOCHEM BIOPH RES CO, V180, P255, DOI 10.1016/S0006-291X(05)81285-9; WAKELING AE, 1991, CANCER RES, V51, P3867; Wallace AE, 2010, J ENDOCRINOL, V206, P141, DOI 10.1677/JOE-10-0072; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107	75	53	55	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4326	4337		10.1096/fj.11-187658	http://dx.doi.org/10.1096/fj.11-187658			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21885654				2022-12-25	WOS:000298138100024
J	Salanova, M; Bortoloso, E; Schiffl, G; Gutsmann, M; Belavy, DL; Felsenberg, D; Furlan, S; Volpe, P; Blottner, D				Salanova, Michele; Bortoloso, Elena; Schiffl, Gudrun; Gutsmann, Martina; Belavy, Daniel L.; Felsenberg, Dieter; Furlan, Sandra; Volpe, Pompeo; Blottner, Dieter			Expression and regulation of Homer in human skeletal muscle during neuromuscular junction adaptation to disuse and exercise	FASEB JOURNAL			English	Article						bedrest; countermeasure; postsynaptic signaling; NFAT	METABOTROPIC GLUTAMATE RECEPTORS; BED-REST; RYANODINE RECEPTOR-TYPE-1; DECEREBRATE CAT; SOLEUS MUSCLES; VIBRATION; PROTEINS; ACTIVATION; FIBERS; CELLS	Protein calcium sensors of the Homer family have been proposed to modulate the activity of various ion channels and nuclear factor of activated T cells (NFAT), the transcription factor modulating skeletal muscle differentiation. We monitored Homer expression and subcellular localization in human skeletal muscle biopsies following 60 d of bedrest [Second Berlin Bedrest Study (BBR2-2)]. Soleus (SOL) and vastus lateralis (VL) biopsies were taken at start (pre) and at end (end) of bedrest from healthy male volunteers of a control group without exercise (CTR; n=9), a resistive-only exercise group (RE; n=7), and a combined resistive/ vibration exercise group (RVE; n=7). Confocal analysis showed Homer immunoreactivity at the postsynaptic microdomain of the neuromuscular junction (NMJ) at bedrest start. After bedrest, Homer immunoreactivity decreased (CTR), remained unchanged (RE), or increased (RVE) at the NMJ. Homer2 mRNA and protein were differently regulated in a muscle-specific way. Activated NFATc1 translocates from cytoplasm to nucleus; increased amounts of NFATc1-immunopositive slow-type myonuclei were found in RVE myofibers of both muscles. Pulldown assays identified NFATc1 and Homer as molecular partners in skeletal muscle. A direct motor nerve control of Homer2 was confirmed in rat NMJs by in vivo denervation. Homer2 is localized at the NMJ and is part of the calcineurin-NFATc1 signaling pathway. RVE has additional benefit over RE as countermeasure preventing disuse-induced neuromuscular maladaptation during bedrest.-Salanova, M., Bortoloso, E., Schiffl, G., Gutsmann, M., Belavy, D. L., Felsenberg, D., Furlan, S., Volpe, P., Blottner, D. Expression and regulation of Homer in human skeletal muscle during neuromuscular junction adaptation to disuse and exercise. FASEB J. 25, 4312-4325 (2011). www.fasebj.org	[Salanova, Michele; Schiffl, Gudrun; Gutsmann, Martina; Blottner, Dieter] Charite, Neuromuscular Grp, Inst Anat, Ctr Space Med Berlin, D-10115 Berlin, Germany; [Belavy, Daniel L.; Felsenberg, Dieter] Charite, Ctr Muscle & Bone Res ZMK, D-10115 Berlin, Germany; [Bortoloso, Elena; Furlan, Sandra; Volpe, Pompeo] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy; [Furlan, Sandra; Volpe, Pompeo] CNR, Inst Neurosci, Padua, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Salanova, M (corresponding author), Charite, Neuromuscular Grp, Inst Anat, Ctr Space Med Berlin, Campus Charite Mitte,Philippstr 12, D-10115 Berlin, Germany.	michele.salanova@charite.de	Belavy, Daniel/P-4947-2016	Belavy, Daniel/0000-0002-9307-832X; Blottner, Dieter/0000-0003-0355-3340	European Space Agency (ESA) [14431/02/NL/SH2]; German Aerospace Center (DLR) [50WB0821, 50WB0720]; Novotec Medical; Charite Universitatsmedizin Berlin; Siemens; Osteomedical Group; Wyeth Pharma; Servier Deutschland; PG; Kubivent; Seca; Astra-Zeneka; General Electric; Italian Space Agency (ASI); Alexander von Humboldt Foundation, Germany	European Space Agency (ESA)(European Space AgencyEuropean Commission); German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Novotec Medical; Charite Universitatsmedizin Berlin; Siemens(Siemens AG); Osteomedical Group; Wyeth Pharma(Wyeth); Servier Deutschland; PG; Kubivent; Seca; Astra-Zeneka; General Electric(General Electric); Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI)); Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	The authors are indebted to Dr. Vincenzo Sorrentino (University of Siena, Siena, Italy) for the GST-Homer constructs and Dr. Paul Rosenberg (Duke University, Durham, NC, USA) for the Homer2-V5 construct. The Second Berlin Bedrest Study (BBR2-2) was supported by grant 14431/02/NL/SH2 from the European Space Agency (ESA) and German Aerospace Center (DLR), grant 50WB0821 (D.B.), and grant 50WB0720 (D.F.). The BBR2-2 was also sponsored by Novotec Medical, Charite Universitatsmedizin Berlin, Siemens, Osteomedical Group, Wyeth Pharma, Servier Deutschland, P&G, Kubivent, Seca, Astra-Zeneka and General Electric. This work was also supported by funds from Italian Space Agency (ASI; to P.V). D.L.B. was supported by a postdoctoral fellowship from the Alexander von Humboldt Foundation, Germany. Special thanks are due to the volunteers, the staff of the Radiology Department at the Charite Campus Benjamin Franklin (CBF) Hospital, Drs. S. Krasnici and J. Fakler (Traumatology Unit, Charite CBF, Berlin), and all participants in the BBR2-2 study.	Ajima R, 2007, BIOCHEM BIOPH RES CO, V356, P851, DOI 10.1016/j.bbrc.2007.03.060; Alkner BA, 2004, EUR J APPL PHYSIOL, V93, P294, DOI 10.1007/s00421-004-1172-8; Belavy DL, 2010, J MUSCULOSKEL NEURON, V10, P207; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Bortoloso E, 2006, AM J PHYSIOL-CELL PH, V290, pC711, DOI 10.1152/ajpcell.00217.2005; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BROWN MC, 1967, J PHYSIOL-LONDON, V192, P773, DOI 10.1113/jphysiol.1967.sp008330; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695, DOI 10.1113/jphysiol.1976.sp011581; Cochrane DJ, 2009, MUSCLE NERVE, V40, P420, DOI 10.1002/mus.21330; Convertino V A, 1991, Physiologist, V34, pS125; Costelli P, 2005, INT J BIOCHEM CELL B, V37, P2134, DOI 10.1016/j.biocel.2005.03.010; Deschenes MR, 2006, NEUROSCIENCE, V137, P1277, DOI 10.1016/j.neuroscience.2005.10.042; Deschenes MR, 2005, MUSCLE NERVE, V31, P468, DOI 10.1002/mus.20277; Deschenes MR, 2000, MUSCLE NERVE, V23, P1576, DOI 10.1002/1097-4598(200010)23:10<1576::AID-MUS15>3.3.CO;2-A; Edgerton V R, 1994, Adv Space Biol Med, V4, P33; Feng W, 2002, J BIOL CHEM, V277, P44722, DOI 10.1074/jbc.M207675200; Gallagher P, 2005, ACTA PHYSIOL SCAND, V185, P61, DOI 10.1111/j.1365-201X.2005.01457.x; Gasperini R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-29; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GRANIT R, 1956, ACTA PHYSIOL SCAND, V37, P114, DOI 10.1111/j.1748-1716.1956.tb01347.x; HOMMA S, 1971, JPN J PHYSIOL, V21, P405; Huang GN, 2008, SCIENCE, V319, P476, DOI 10.1126/science.1151227; Huang G, 2007, J BIOL CHEM, V282, P14283, DOI 10.1074/jbc.M611529200; Hwang SY, 2003, CELL CALCIUM, V34, P177, DOI 10.1016/S0143-4160(03)00082-4; Ingalls CP, 2001, AVIAT SPACE ENVIR MD, V72, P471; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kim Jeong-Hwan, 2006, Genomics & Informatics, V4, P1; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; MATTHEWS PB, 1966, NATURE, V209, P204, DOI 10.1038/209204b0; Max N, 2001, MELANOMA RES, V11, P371, DOI 10.1097/00008390-200108000-00007; MCGRATH GJ, 1973, J PHYSIOL-LONDON, V235, P371, DOI 10.1113/jphysiol.1973.sp010392; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Pouliquin P, 2009, EUR BIOPHYS J BIOPHY, V39, P91, DOI 10.1007/s00249-009-0494-1; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Rudnick J, 2004, FASEB J, V18, P1228, DOI 10.1096/fj.03-0792fje; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Salanova M, 2002, CELL CALCIUM, V32, P193, DOI 10.1016/S0143416002001549; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Salanova M, 2009, HISTOCHEM CELL BIOL, V132, P383, DOI 10.1007/s00418-009-0624-y; Sandona D, 2000, BIOCHEM BIOPH RES CO, V279, P348, DOI 10.1006/bbrc.2000.3948; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Soloviev MM, 2000, J MOL BIOL, V295, P1185; Stiber JA, 2005, DEV BIOL, V287, P213, DOI 10.1016/j.ydbio.2005.06.030; Stiber JA, 2008, MOL CELL BIOL, V28, P2637, DOI 10.1128/MCB.01601-07; Tothova J, 2006, J CELL SCI, V119, P1604, DOI 10.1242/jcs.02875; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Volpe P, 2004, BIOCHEM BIOPH RES CO, V316, P884, DOI 10.1016/j.bbrc.2004.02.132; Ward CW, 2004, J BIOL CHEM, V279, P5781, DOI 10.1074/jbc.M311422200; Westhoff JH, 2003, CELL CALCIUM, V34, P261, DOI 10.1016/S0143-4160(03)00112-X; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007	54	37	37	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2011	25	12					4312	4325		10.1096/fj.11-186049	http://dx.doi.org/10.1096/fj.11-186049			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21885651	Green Submitted			2022-12-25	WOS:000298138100023
J	Nickerson, NN; Tosi, T; Dessen, A; Baron, B; Raynal, B; England, P; Pugsley, AP				Nickerson, Nicholas N.; Tosi, Tommaso; Dessen, Andrea; Baron, Bruno; Raynal, Bertrand; England, Patrick; Pugsley, Anthony P.			Outer Membrane Targeting of Secretin PulD Protein Relies on Disordered Domain Recognition by a Dedicated Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; PILUS BIOGENESIS; INNER MEMBRANE; PULLULANASE; MULTIMERIZATION; LIPOPROTEINS; FLAGELLIN; PATHWAY; POLYMERIZATION	Interaction of bacterial outer membrane secretin PulD with its dedicated lipoprotein chaperone PulS relies on a disorder-to-order transition of the chaperone binding (S) domain near the PulD C terminus. PulS interacts with purified S domain to form a 1:1 complex. Circular dichroism, one-dimensional NMR, and hydrodynamic measurements indicate that the S domain is elongated and intrinsically disordered but gains secondary structure upon binding to PulS. Limited proteolysis and mass spectrometry identified the 28 C-terminal residues of the S domain as a minimal binding site with low nanomolar affinity for PulS in vitro that is sufficient for outer membrane targeting of PulD in vivo. The region upstream of this binding site is not required for targeting or multimerization and does not interact with PulS, but it is required for secretin function in type II secretion. Although other secretin chaperones differ substantially from PulS in sequence and secondary structure, they have all adopted at least superficially similar mechanisms of interaction with their cognate secretins, suggesting that intrinsically disordered regions facilitate rapid interaction between secretins and their chaperones.	[Nickerson, Nicholas N.; Pugsley, Anthony P.] Inst Pasteur, Mol Genet Unit, Dept Microbiol, F-75724 Paris 15, France; [Nickerson, Nicholas N.; Pugsley, Anthony P.] CNRS, URA2172, F-75015 Paris, France; [Tosi, Tommaso; Dessen, Andrea] Univ Grenoble 1, Inst Biol Struct, Bacterial Pathogenesis Grp, F-38027 Grenoble, France; [Tosi, Tommaso; Dessen, Andrea] CNRS, UMR 5075, F-38027 Grenoble, France; [Tosi, Tommaso; Dessen, Andrea] Commissariat Energie Atom, F-38027 Grenoble, France; [Baron, Bruno; Raynal, Bertrand; England, Patrick] Inst Pasteur, Proteopole & Struct Biol & Chem Dept, F-75015 Paris, France; [Baron, Bruno; Raynal, Bertrand; England, Patrick] CNRS, URA2185, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, Dept Microbiol, 28 Rue Dr Roux, F-75724 Paris 15, France.	max@pasteur.fr		raynal, Bertrand/0000-0001-5634-0408; ENGLAND, Patrick/0000-0001-6410-5918; Dessen, Andrea/0000-0001-6487-4020	French National Research Agency [ANR-05-0307-01, ANR-09-BLAN-0291]; Canadian Louis Pasteur Foundation	French National Research Agency(French National Research Agency (ANR)); Canadian Louis Pasteur Foundation	This work was supported in part by French National Research Agency Grants ANR-05-0307-01 and ANR-09-BLAN-0291.; Supported by a postdoctoral fellowship from the Canadian Louis Pasteur Foundation during part of this work.	AIZAWA SI, 1990, J MOL BIOL, V211, P673, DOI 10.1016/0022-2836(90)90064-S; Arts J., 2007, THESIS UTRECHT U UTR; Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buchko GW, 2010, MOL BIOSYST, V6, P2448, DOI 10.1039/c0mb00097c; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DENFERT C, 1989, J BIOL CHEM, V264, P17462; DENFERT C, 1987, MOL MICROBIOL, V1, P107, DOI 10.1111/j.1365-2958.1987.tb00534.x; DENFERT C, 1989, J BACTERIOL, V171, P3673, DOI 10.1128/jb.171.7.3673-3679.1989; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; Francetic O, 2005, J BACTERIOL, V187, P7045, DOI 10.1128/JB.187.20.7045-7055.2005; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006; Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; HARDING SE, 1995, BIOPHYS CHEM, V55, P69, DOI 10.1016/0301-4622(94)00143-8; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; KOSTYUKOVA AS, 1988, FEBS LETT, V241, P141, DOI 10.1016/0014-5793(88)81047-0; Lario PI, 2005, EMBO J, V24, P1111, DOI 10.1038/sj.emboj.7600610; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Login FH, 2010, MOL MICROBIOL, V76, P944, DOI 10.1111/j.1365-2958.2010.07149.x; Lu YL, 2006, BIOPHYS J, V91, P1688, DOI 10.1529/biophysj.106.083469; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Ruiz-Perez F, 2010, GUT MICROBES, V1, P339, DOI 10.4161/gmic.1.5.13436; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219; Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; TARTOF KD, 1987, FOCUS, V9, P12; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Trindade MB, 2008, J MOL BIOL, V378, P1031, DOI 10.1016/j.jmb.2008.03.028; Uversky V. N., 2010, INSTRUMENTAL ANAL IN; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	67	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38833	38843		10.1074/jbc.M111.279851	http://dx.doi.org/10.1074/jbc.M111.279851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21878629	Green Published, hybrid			2022-12-25	WOS:000296759800002
J	Stapf, C; Cartwright, E; Bycroft, M; Hofmann, K; Buchberger, A				Stapf, Christopher; Cartwright, Edward; Bycroft, Mark; Hofmann, Kay; Buchberger, Alexander			The General Definition of the p97/Valosin-containing Protein (VCP)-interacting Motif (VIM) Delineates a New Family of p97 Cofactors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; AAA ATPASE P97/VCP; ENDOPLASMIC-RETICULUM; UBIQUITIN LIGASES; FRONTOTEMPORAL DEMENTIA; STRUCTURAL INSIGHTS; PAGET-DISEASE; YEAST GENES; BINDING; COMPLEX	Cellular functions of the essential, ubiquitin-selective AAA ATPase p97/valosin-containing protein (VCP) are controlled by regulatory cofactors determining substrate specificity and fate. Most cofactors bind p97 through a ubiquitin regulatory X (UBX) or UBX-like domain or linear sequence motifs, including the hitherto ill defined p97/VCP-interacting motif (VIM). Here, we present the new, minimal consensus sequence RX(5)AAX(2)R as a general definition of the VIM that unites a novel family of known and putative p97 cofactors, among them UBXD1 and ZNF744/ANKZF1. We demonstrate that this minimal VIM consensus sequence is necessary and sufficient for p97 binding. Using NMR chemical shift mapping, we identified several residues of the p97 N-terminal domain (N domain) that are critical for VIM binding. Importantly, we show that cellular stress resistance conferred by the yeast VIM-containing cofactor Vms1 depends on the physical interaction between its VIM and the critical N domain residues of the yeast p97 homolog, Cdc48. Thus, the VIM-N domain interaction characterized in this study is required for the physiological function of Vms1 and most likely other members of the newly defined VIM family of cofactors.	[Stapf, Christopher; Buchberger, Alexander] Univ Wurzburg, Dept Biochem, Bioctr, D-97074 Wurzburg, Germany; [Cartwright, Edward; Bycroft, Mark] Med Res Council Ctr Prot Engn, Cambridge CB2 2QH, England; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany	University of Wurzburg; University of Cambridge; Miltenyi Biotec	Buchberger, A (corresponding author), Univ Wurzburg, Dept Biochem, Bioctr, D-97074 Wurzburg, Germany.	alexander.buchberger@biozentrum.uni-wuerzburg.de	Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019; Bycroft, Mark/D-9446-2017	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820; Bycroft, Mark/0000-0002-0673-2216	Deutsche Forschungsgemeinschaft [Bu 951/3-1, Bu 951/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Bu 951/3-1 and Bu 951/4-1 (to A. B.).	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Allen MD, 2006, J BIOL CHEM, V281, P25502, DOI 10.1074/jbc.M601173200; Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A., 2006, PROTEIN DEGRADATION, V3, P194; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Meyer H, 2008, BIOCHEM SOC T, V36, P126, DOI 10.1042/BST0360126; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nagahama M, 2003, MOL BIOL CELL, V14, P262, DOI 10.1091/mbc.02-07-0115; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	56	43	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38670	38678		10.1074/jbc.M111.274472	http://dx.doi.org/10.1074/jbc.M111.274472			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21896481	hybrid, Green Published			2022-12-25	WOS:000296594200079
J	Ebke, A; Luebbers, T; Fukumori, A; Shirotani, K; Haass, C; Baumann, K; Steiner, H				Ebke, Amelie; Luebbers, Thomas; Fukumori, Akio; Shirotani, Keiro; Haass, Christian; Baumann, Karlheinz; Steiner, Harald			Novel gamma-Secretase Enzyme Modulators Directly Target Presenilin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; A-BETA; SULINDAC; PEPTIDE; DISEASE; METABOLITES; GENERATION; A-BETA(42); INHIBITOR; MUTATIONS	gamma-Secretase is essential for the generation of the neurotoxic 42-amino acid amyloid beta-peptide (A beta(42)). The aggregation-prone hydrophobic peptide, which is deposited in Alzheimer disease (AD) patient brain, is generated from a C-terminal fragment of the beta-amyloid precursor protein by an intramembrane cleavage of gamma-secretase. Because A beta(42) is widely believed to trigger AD pathogenesis, gamma-secretase is a key AD drug target. Unlike inhibitors of the enzyme, gamma-secretase modulators (GSMs) selectively lower A beta(42) without interfering with the physiological function of gamma-secretase. The molecular target(s) of GSMs and hence the mechanism of GSM action are not established. Here we demonstrate by using a biotinylated photocross-linkable derivative of highly potent novel second generation GSMs that gamma-secretase is a direct target of GSMs. The GSM photoprobe specifically bound to the N-terminal fragment of presenilin, the catalytic subunit of gamma-secretase, but not to other gamma-secretase subunits. Binding was differentially competed by GSMs of diverse structural classes, indicating the existence of overlapping/multiple GSM binding sites or allosteric alteration of the photoprobe binding site. The beta-amyloid precursor protein C-terminal fragment previously implicated as the GSM binding site was not targeted by the compound. The identification of presenilin as the molecular target of GSMs directly establishes allosteric modulation of enzyme activity as a mechanism of GSM action and may contribute to the development of therapeutically active GSMs for the treatment of AD.	[Luebbers, Thomas; Baumann, Karlheinz] F Hoffmann La Roche Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland; [Ebke, Amelie; Fukumori, Akio; Haass, Christian; Steiner, Harald] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Ebke, Amelie; Fukumori, Akio; Haass, Christian; Steiner, Harald] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Shirotani, Keiro] Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan	Roche Holding; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Fukushima Medical University	Baumann, K (corresponding author), F Hoffmann La Roche Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland.	karlheinz.baumann@roche.com; harald.steiner@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB596]; Bundesministerium fur Bildung und Forschung (KNDD); Center for Integrated Protein Science Munich (CIPSM); Elitenetzwerk Bayern; LMU	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (KNDD)(Federal Ministry of Education & Research (BMBF)); Center for Integrated Protein Science Munich (CIPSM); Elitenetzwerk Bayern; LMU	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB596) (to H. S. and C. H.), the Bundesministerium fur Bildung und Forschung (KNDD) (to C. H. and H. S.), and the Center for Integrated Protein Science Munich (CIPSM).; Supported by the Elitenetzwerk Bayern.; Supported by a research professorship from the LMU excellent program.	Baumann K., 2009, PCT Int. Appl., Patent No. [WO 2009103652, 2009103652]; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Czech C, 2007, J NEUROCHEM, V101, P929, DOI 10.1111/j.1471-4159.2007.04467.x; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; FAN SS, 1981, J MED CHEM, V24, P1197, DOI 10.1021/jm00142a015; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Santos F, 2008, FREE RADICAL RES, V42, P639, DOI 10.1080/10715760802270326; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011	28	69	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37181	37186		10.1074/jbc.C111.276972	http://dx.doi.org/10.1074/jbc.C111.276972			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21896486	Green Published, hybrid			2022-12-25	WOS:000296542400018
J	Bhattacharjee, A; Pal, S; Feldman, GM; Cathcart, MK				Bhattacharjee, Ashish; Pal, Srabani; Feldman, Gerald M.; Cathcart, Martha K.			Hck Is a Key Regulator of Gene Expression in Alternatively Activated Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; KINASE-C-DELTA; HUMAN ATHEROSCLEROTIC PLAQUES; CENTRIFUGAL ELUTRIATION CCE; SIGNAL-TRANSDUCTION PATHWAY; PERIPHERAL-BLOOD MONOCYTES; POLAR STEROL ESTERS; SRC-FAMILY KINASES; NF-KAPPA-B; PROTEIN-KINASE	IL-13 is a Th2 cytokine that promotes alternative activation (M2 polarization) in primary human monocytes. Our studies have characterized the functional IL-13 receptor complex and the downstream signaling events in response to IL-13 stimulation in alternatively activated monocytes/macrophages. In this report, we present evidence that IL-13 induces the activation of a Src family tyrosine kinase, which is required for IL-13 induction of M2 gene expression, including 15-lipoxygenase (15-LO). Our data show that Src kinase activity regulates IL-13-induced p38 MAPK tyrosine phosphorylation via the upstream kinases MKK3or MKK6. Our findings also reveal that the IL-13 receptor-associated tyrosine kinase Jak2 is required for the activation of both Src kinase as well as p38 MAPK. Further, we found that Src tyrosine kinase-mediated activation of p38 MAPK is required for Stat1 and Stat3 serine 727 phosphorylation in alternatively activated monocytes/macrophages. Additional studies identify Hck as the specific Src family member, stimulated by IL-13 and involved in regulating both p38 MAPK activation and p38 MAPK-mediated 15-LO expression. Finally we show that the Hck regulates the expression of other alternative state (M2)-specific genes (Mannose receptor, MAO-A, and CD36) and therefore conclude that Hck acts as a key regulator controlling gene expression in alternatively activated monocytes/macrophages.	[Bhattacharjee, Ashish; Pal, Srabani; Cathcart, Martha K.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Bhattacharjee, Ashish; Pal, Srabani; Cathcart, Martha K.] Case Western Reserve Univ, Lerner Coll Med, Dept Mol Med, Cleveland Clin, Cleveland, OH 44195 USA; [Feldman, Gerald M.] US FDA, Div Monoclonal Antibodies, Off Therapeut Res & Review, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; US Food & Drug Administration (FDA)	Bhattacharjee, A (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bhattaa@ccf.org; cathcam@ccf.org			National Institutes of Health [HL051068, HL087018]; National Center for Research Resources [1UL1RR024989]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, R01HL051068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL051068 and HL087018 (to M. K. C.). This work was also supported by the National Center for Research Resources (Grant Center for Translational Science Activities 1UL1RR024989).	Abe JI, 2007, J MOL CELL CARDIOL, V43, P404, DOI 10.1016/j.yjmcc.2007.07.002; Alexander M, 2004, J CELL PHYSIOL, V201, P35, DOI 10.1002/jcp.20050; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharjee A, 2010, J IMMUNOL, V185, P5211, DOI 10.4049/jimmunol.1000514; Bhattacharya S, 2006, BIOCHEM J, V397, P437, DOI 10.1042/BJ20060256; Bosco MC, 2000, J IMMUNOL, V164, P4575, DOI 10.4049/jimmunol.164.9.4575; BOULET I, 1992, ONCOGENE, V7, P703; BROOKS CJW, 1971, ATHEROSCLEROSIS, V13, P223, DOI 10.1016/0021-9150(71)90025-6; Callera GE, 2005, HYPERTENSION, V45, P773, DOI 10.1161/01.HYP.0000154365.30593.d3; Cathcart MK, 2000, FREE RADICAL BIO MED, V28, P1726, DOI 10.1016/S0891-5849(00)00230-6; Chabaud-Riou M, 2004, AM J PATHOL, V164, P177, DOI 10.1016/S0002-9440(10)63108-2; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Chaitidis P, 2004, J IMMUNOL, V173, P4821, DOI 10.4049/jimmunol.173.8.4821; Chen XL, 2003, BURNS, V29, P533, DOI 10.1016/S0305-4179(03)00147-5; Cirri P, 1997, BIOCHEM BIOPH RES CO, V239, P493, DOI 10.1006/bbrc.1997.7493; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; ENGLISH BK, 1993, J EXP MED, V178, P1017, DOI 10.1084/jem.178.3.1017; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Gharavi NM, 2007, J BIOL CHEM, V282, P31460, DOI 10.1074/jbc.M704267200; GHAZIZADEH S, 1994, J IMMUNOL, V152, P30; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; HARLAND WA, 1971, ATHEROSCLEROSIS, V13, P239, DOI 10.1016/0021-9150(71)90026-8; Ishida M, 1998, CIRC RES, V82, P7; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Khadaroo RG, 2003, SURGERY, V134, P242, DOI 10.1067/msy.2003.228; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Lim MJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P197, DOI 10.1016/j.abb.2007.06.004; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maung AA, 2005, J LEUKOCYTE BIOL, V78, P565, DOI 10.1189/jlb.1204698; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Murr MM, 2003, J GASTROINTEST SURG, V7, P20, DOI 10.1016/S1091-255X(02)00053-7; MUSSO T, 1995, J EXP MED, V181, P1425, DOI 10.1084/jem.181.4.1425; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Norkina O, 2007, J LEUKOCYTE BIOL, V82, P752, DOI 10.1189/jlb.0207099; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Okutani Y, 2001, ONCOGENE, V20, P6643, DOI 10.1038/sj.onc.1204807; Poole DP, 2007, GASTROENTEROLOGY, V133, P1229, DOI 10.1053/j.gastro.2007.07.002; Proietti C, 2005, MOL CELL BIOL, V25, P4826, DOI 10.1128/MCB.25.12.4826-4840.2005; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Rosen RL, 1996, BLOOD, V88, P1206, DOI 10.1182/blood.V88.4.1206.bloodjournal8841206; Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Thobe BM, 2006, AM J PHYSIOL-CELL PH, V291, pC476, DOI 10.1152/ajpcell.00076.2006; Touyz RM, 2001, HYPERTENSION, V38, P56, DOI 10.1161/01.HYP.38.1.56; WAHL LM, 1984, CELL IMMUNOL, V85, P373, DOI 10.1016/0008-8749(84)90251-X; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746; ZIEGLER SF, 1988, J EXP MED, V168, P1801, DOI 10.1084/jem.168.5.1801	71	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36709	36723		10.1074/jbc.M111.291492	http://dx.doi.org/10.1074/jbc.M111.291492			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878628	Green Published, hybrid			2022-12-25	WOS:000296538300054
J	De Ceunynck, K; Rocha, S; Feys, HB; De Meyer, SF; Uji-i, H; Deckmyn, H; Hofkens, J; Vanhoorelbeke, K				De Ceunynck, Karen; Rocha, Susana; Feys, Hendrik B.; De Meyer, Simon F.; Uji-i, Hiroshi; Deckmyn, Hans; Hofkens, Johan; Vanhoorelbeke, Karen			Local Elongation of Endothelial Cell-anchored von Willebrand Factor Strings Precedes ADAMTS13 Protein-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; VONWILLEBRAND-FACTOR MULTIMERS; WEIBEL-PALADE BODIES; FLUID SHEAR-STRESS; SELF-ASSOCIATION; FACTOR-VIII; P-SELECTIN; ULTRALARGE; CLEAVAGE; FLOW	Platelet-decorated von Willebrand factor (VWF) strings anchored to the endothelial surface are rapidly cleaved by ADAMTS13. Individual VWF string characteristics such as number, location, and auxiliary features of the ADAMTS13 cleavage sites were explored here using imaging and computing software. By following changes in VWF string length, we demonstrated that VWF strings are cleaved multiple times, successively shortening string length in the function of time and generating fragments ranging in size from 5 to over 100 mu m. These are larger than generally observed in normal plasma, indicating that further proteolysis takes place in circulation. Interestingly, in 89% of all cleavage events, VWF strings elongate precisely at the cleavage site before ADAMTS13 proteolysis. These local elongations are a general characteristic of VWF strings, independent of the presence of ADAMTS13. Furthermore, large elongations, ranging in size from 1.4 to 40 mu m, occur at different sites in space and time. In conclusion, ADAMTS13-mediated proteolysis of VWF strings under flow is preceded by large elongations of the string at the cleavage site. These elongations may lead to the simultaneous exposure of many exosites, thereby facilitating ADAMTS13-mediated cleavage.	[Rocha, Susana; Uji-i, Hiroshi; Hofkens, Johan] Katholieke Univ Leuven, Div Mol & Nano Mat, Dept Chem, B-3001 Heverlee, Belgium; [De Ceunynck, Karen; Feys, Hendrik B.; De Meyer, Simon F.; Deckmyn, Hans; Vanhoorelbeke, Karen] Katholieke Univ Leuven, Lab Thrombosis Res, B-8500 Kortrijk, Belgium	KU Leuven; KU Leuven	Hofkens, J (corresponding author), Katholieke Univ Leuven, Div Mol & Nano Mat, Dept Chem, Celestijnenlaan 200F, B-3001 Heverlee, Belgium.	johan.hofkens@chem.kuleuven.be; karen.vanhoorelbeke@kuleuven-kortrijk.be	Deckmyn, Hans/L-9434-2015; Rocha, Susana/O-7622-2016; Uji-i, Hiroshi/AAK-5275-2020; Hofkens, Johan/AAP-9255-2020; Hofkens, Johan/AAL-4204-2020; Rocha, Susana/AAH-8343-2020; Deckmyn, Hans/N-8932-2019; Hofkens, Johan/D-4284-2017	Deckmyn, Hans/0000-0003-3952-5501; Rocha, Susana/0000-0003-1258-9396; Uji-i, Hiroshi/0000-0002-0463-9659; Rocha, Susana/0000-0003-1258-9396; Deckmyn, Hans/0000-0003-3952-5501; Vanhoorelbeke, Karen/0000-0003-2288-8277; De Meyer, Simon/0000-0002-1807-5882; Hofkens, Johan/0000-0002-9101-0567; Feys, Hendrik/0000-0003-0052-8852	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)) [G.0299.06, G.0607.09, G.0402.09, G0603.10]; Katholieke Universiteit Leuven (K.U.Leuven) [GOA/2004/09, GOA/2011/03]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) [83328]	Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO))(FWO); Katholieke Universiteit Leuven (K.U.Leuven)(KU Leuven); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Research Foundation Flanders (Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)) (Grants G.0299.06, G.0607.09, G.0402.09, and G0603.10) and the Katholieke Universiteit Leuven (K.U.Leuven) (Grants GOA/2004/09 and GOA/2011/03).; Supported by a Ph. D. grant Agentschap voor Innovatie door Wetenschap en Technologie (IWT number 83328) of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen).; A fellow of the Special Research Fund of the K.U. Leuven.	Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Chauhan AK, 2007, J THROMB HAEMOST, V5, P583, DOI 10.1111/j.1538-7836.2007.02361.x; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; De Meyer SF, 2009, BLOOD, V113, P5049, DOI 10.1182/blood-2008-10-165621; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Feys HB, 2010, BLOOD, V116, P2005, DOI 10.1182/blood-2010-04-280479; Feys HB, 2009, BLOOD, V114, P4749, DOI 10.1182/blood-2009-07-230615; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Huang RH, 2008, P NATL ACAD SCI USA, V105, P482, DOI 10.1073/pnas.0710079105; Jin SY, 2009, J THROMB HAEMOST, V7, P1749, DOI 10.1111/j.1538-7836.2009.03570.x; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Li Y, 2008, J THROMB HAEMOST, V6, P1135, DOI 10.1111/j.1538-7836.2008.02991.x; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 2002, P NATL ACAD SCI USA, V99, P425, DOI 10.1073/pnas.012459599; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Suzuki M, 2004, BIOCHEM BIOPH RES CO, V313, P212, DOI 10.1016/j.bbrc.2003.11.111; Tsai HM, 2007, HEMATOL ONCOL CLIN N, V21, P609, DOI 10.1016/j.hoc.2007.06.003; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Turner N, 2009, J THROMB HAEMOST, V7, P229, DOI 10.1111/j.1538-7836.2008.03209.x; Turner NA, 2009, BLOOD, V114, P5102, DOI 10.1182/blood-2009-07-231597; Ulrichts H, 2005, J THROMB HAEMOST, V3, P552, DOI 10.1111/j.1538-7836.2005.01209.x; van den Biggelaar M, 2009, HAEMATOL-HEMATOL J, V94, P670, DOI 10.3324/haematol.13427; Wang AY, 2010, THROMB RES, V126, pE260, DOI 10.1016/j.thromres.2010.07.009; Zannettino ACW, 2005, J CELL PHYSIOL, V204, P714, DOI 10.1002/jcp.20354; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	38	41	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36361	36367		10.1074/jbc.M111.271890	http://dx.doi.org/10.1074/jbc.M111.271890			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21896483	Green Published, hybrid			2022-12-25	WOS:000296538300021
J	Ohashi, K; Fujiwara, S; Watanabe, T; Kondo, H; Kiuchi, T; Sato, M; Mizuno, K				Ohashi, Kazumasa; Fujiwara, Sachiko; Watanabe, Takuya; Kondo, Hiroshi; Kiuchi, Tai; Sato, Masaaki; Mizuno, Kensaku			LIM Kinase Has a Dual Role in Regulating Lamellipodium Extension by Decelerating the Rate of Actin Retrograde Flow and the Rate of Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFILIN-PHOSPHATASE SLINGSHOT; DEPOLYMERIZING FACTOR; CYTOSKELETAL DYNAMICS; NONMUSCLE CELLS; PHOSPHORYLATION; ACTIVATION; MOTILITY; ADF/COFILIN; PROTRUSION; RHO	Lamellipodium extension is crucial for cell migration and spreading. The rate of lamellipodium extension is determined by the balance between the rate of actin polymerization and the rate of actin retrograde flow. LIM kinase 1 (LIMK1) regulates actin dynamics by phosphorylating and inactivating cofilin, an actin-depolymerizing protein. We examined the role of LIMK1 in lamellipodium extension by measuring the rates of actin polymerization, actin retrograde flow, and lamellipodium extension using time-lapse imaging of fluorescence recovery after photobleaching. In the non-extending lamellipodia of active Rac-expressing N1E-115 cells, LIMK1 expression decelerated and LIMK1 knockdown accelerated actin retrograde flow. In the extending lamellipodia of neuregulin-stimulated MCF-7 cells, LIMK1 knockdown accelerated both the rate of actin polymerization and the rate of actin retrograde flow, but the accelerating effect on retrograde flow was greater than the effect on polymerization, thus resulting in a decreased rate of lamellipodium extension. These results indicate that LIMK1 has a dual role in regulating lamellipodium extension by decelerating actin retrograde flow and polymerization, and in MCF-7 cells endogenous LIMK1 contributes to lamellipodium extension by decelerating actin retrograde flow more effectively than decelerating actin polymerization.	[Ohashi, Kazumasa; Fujiwara, Sachiko; Watanabe, Takuya; Kondo, Hiroshi; Kiuchi, Tai; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Sato, Masaaki] Tohoku Univ, Dept Biomed Engn, Grad Sch Biomed Engn, Sendai, Miyagi 9808578, Japan	Tohoku University; Tohoku University	Ohashi, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kohashi@biology.tohoku.ac.jp; kmizuno@biology.tohoku.ac.jp	Ohashi, Kazumasa/U-7028-2019; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; Fujiwara, Sachiko/0000-0002-5620-637X	Ministry of Education, Culture, Science, Sports, and Technology of Japan [20200057, 22616001, 20001007, 20013004, 22121501]; Center for Interdisciplinary Research, Tohoku University; Grants-in-Aid for Scientific Research [22616001] Funding Source: KAKEN	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Interdisciplinary Research, Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants for Scientific Research from the Ministry of Education, Culture, Science, Sports, and Technology of Japan 20200057 and 22616001 (to K. O.), 20001007 (to M. S.), and 20013004 and 22121501 (to K. M.) and by a grant from the Program Research in Center for Interdisciplinary Research, Tohoku University (to K. O.).	Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Cramer Louise P., 1997, Frontiers in Bioscience (online), V2, pD260; Danuser G, 2005, BIOCHEM SOC T, V33, P1250, DOI 10.1042/BST0331250; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kiuchi T, 2011, J CELL BIOL, V193, P365, DOI 10.1083/jcb.201101035; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	44	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36340	36351		10.1074/jbc.M111.259135	http://dx.doi.org/10.1074/jbc.M111.259135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21868383	Green Published, hybrid			2022-12-25	WOS:000296538300019
J	Fernando, C; Vasas, V; Szathmary, E; Husbands, P				Fernando, Chrisantha; Vasas, Vera; Szathmary, Eoers; Husbands, Phil			Evolvable Neuronal Paths: A Novel Basis for Information and Search in the Brain	PLOS ONE			English	Article							SELECTION; COMPUTATION; EVOLUTION; LINKAGE; ORIGIN; STDP	We propose a previously unrecognized kind of informational entity in the brain that is capable of acting as the basis for unlimited hereditary variation in neuronal networks. This unit is a path of activity through a network of neurons, analogous to a path taken through a hidden Markov model. To prove in principle the capabilities of this new kind of informational substrate, we show how a population of paths can be used as the hereditary material for a neuronally implemented genetic algorithm, (the swiss-army knife of black-box optimization techniques) which we have proposed elsewhere could operate at somatic timescales in the brain. We compare this to the same genetic algorithm that uses a standard 'genetic' informational substrate, i.e. non-overlapping discrete genotypes, on a range of optimization problems. A path evolution algorithm (PEA) is defined as any algorithm that implements natural selection of paths in a network substrate. A PEA is a previously unrecognized type of natural selection that is well suited for implementation by biological neuronal networks with structural plasticity. The important similarities and differences between a standard genetic algorithm and a PEA are considered. Whilst most experiments are conducted on an abstract network model, at the conclusion of the paper a slightly more realistic neuronal implementation of a PEA is outlined based on Izhikevich spiking neurons. Finally, experimental predictions are made for the identification of such informational paths in the brain.	[Fernando, Chrisantha; Husbands, Phil] Univ Sussex, Dept Informat, Brighton, E Sussex, England; [Fernando, Chrisantha] Natl Inst Med Res, MRC, London NW7 1AA, England; [Vasas, Vera] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain; [Szathmary, Eoers] Coll Budapest, Inst Adv Study, Budapest, Hungary; [Szathmary, Eoers] Parmenides Ctr Study Thinking, Pullach Munich, Germany; [Szathmary, Eoers] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary	University of Sussex; MRC National Institute for Medical Research; Autonomous University of Barcelona; Eotvos Lorand University	Fernando, C (corresponding author), Univ Sussex, Dept Informat, Brighton, E Sussex, England.	ctf20@sussex.ac.uk	Szathmary, Eors/AAS-1202-2021; Husbands, Philip/AAA-6052-2022	Szathmary, Eors/0000-0001-5227-2997; Husbands, Philip/0000-0002-5164-4004	FP7 E-FLUX (Evolutionary microfluidix); FET Open [225167]	FP7 E-FLUX (Evolutionary microfluidix); FET Open	Funding was provided by FP7 E-FLUX (Evolutionary microfluidix), FET Open Contract no, 225167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 1998, J THEOR BIOL, V195, P419, DOI 10.1006/jtbi.1997.0620; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chu PC, 1998, J HEURISTICS, V4, P63, DOI 10.1023/A:1009642405419; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Fernando C., 2009, THEORY THINKING, P291; Fernando C, 2010, GECCO 10 PORTL OR, P153; Fernando C, 2009, EXTENDED EVOLUTIONAR, P209; Fernando C, 2011, J THEOR BIOL, V275, P29, DOI 10.1016/j.jtbi.2011.01.009; Fernando C, 2010, NEURAL COMPUT, V22, P2809, DOI 10.1162/NECO_a_00031; Fernando C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003775; FONTANA W, 1994, P NATL ACAD SCI USA, V91, P757, DOI 10.1073/pnas.91.2.757; Frank SA, 1997, J THEOR BIOL, V184, P31, DOI 10.1006/jtbi.1996.0241; Frank SA, 1997, BIOSYSTEMS, V40, P237, DOI 10.1016/S0303-2647(96)01658-9; Harvey I., 2009, P EUR C ART LIF BERL, P126; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Holland J.H., 1992, ADAPTATION NATURAL A; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Izhikevich EM, 2009, INT J BIFURCAT CHAOS, V19, P1733, DOI 10.1142/S0218127409023809; IZQUIERDO EJ, 2008, ARTIF LIFE, V11, P265; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Khuri S., 1994, P ACM S APPL COMPUTI, P188, DOI DOI 10.1145/326619.326694.(HTTP://D0LACM.0RG/10.1145/326619.326694); Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; Masquelier T, 2009, NEURAL COMPUT, V21, P1259, DOI 10.1162/neco.2008.06-08-804; Maynard Smith J., 1988, EVOLUTIONARY PROGR, P219; Maynard Smith J., 1986, PROBLEMS BIOL; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Pelikan M, 2000, EVOL COMPUT, V8, P311, DOI 10.1162/106365600750078808; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Poli Riccardo, 2007, Swarm Intelligence, V1, P33, DOI 10.1007/s11721-007-0002-0; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Schmidhuber J, 2000, IEEE IND ELEC, P2992, DOI 10.1109/IECON.2000.972474; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Sutton Richard S., 1998, REINFORCEMENT LEARNI; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Thomsen R., 2002, Parallel Problem Solving from Nature - PPSN VII. 7th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2439), P861; Toussaint M, 2003, EVOLUTION GENETIC RE; Vasas V, 2010, P NATL ACAD SCI USA, V107, P1470, DOI 10.1073/pnas.0912628107; Watson R.A., 2009, EFFECT HEBBIAN LEARN; Watson RA, 1998, LECT NOTES COMPUT SC, V1498, P97, DOI 10.1007/BFb0056853; WATSON RA, 2006, COMPOSITIONAL EVOLUT	52	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23534	10.1371/journal.pone.0023534	http://dx.doi.org/10.1371/journal.pone.0023534			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887266	Green Submitted, Green Published, gold			2022-12-25	WOS:000294298800012
J	Barsov, EV; Trivett, MT; Minang, JT; Sun, HS; Ohlen, C; Ott, DE				Barsov, Eugene V.; Trivett, Matthew T.; Minang, Jacob T.; Sun, Haosi; Ohlen, Claes; Ott, David E.			Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECEPTOR GENES; VIRAL ESCAPE; RETROVIRAL TRANSFER; CANCER REGRESSION; ADOPTIVE IMMUNOTHERAPY; EFFECTOR FUNCTIONS; IMMUNE ESCAPE; LYMPHOCYTES; THERAPY	Background: The SIV/rhesus macaque model for HIV/AIDS is a powerful system for examining the contribution of T cells in the control of AIDS viruses. To better our understanding of CD8(+) T-cell control of SIV replication in CD4(+) T cells, we asked whether TCRs isolated from rhesus macaque CD8(+) T-cell clones that exhibited varying abilities to suppress SIV replication could convey their suppressive properties to CD8(+) T cells obtained from an uninfected/unvaccinated animal. Principal Findings: We transferred SIV-specific TCR genes isolated from rhesus macaque CD8(+) T-cell clones with varying abilities to suppress SIV replication in vitro into CD8(+) T cells obtained from an uninfected animal by retroviral transduction. After sorting and expansion, transduced CD8(+) T-cell lines were obtained that specifically bound their cognate SIV tetramer. These cell lines displayed appropriate effector function and specificity, expressing intracellular IFN gamma upon peptide stimulation. Importantly, the SIV suppression properties of the transduced cell lines mirrored those of the original TCR donor clones: cell lines expressing TCRs transferred from highly suppressive clones effectively reduced wild-type SIV replication, while expression of a non-suppressing TCR failed to reduce the spread of virus. However, all TCRs were able to suppress the replication of an SIV mutant that did not downregulate MHC-I, recapitulating the properties of their donor clones. Conclusions: Our results show that antigen-specific SIV suppression can be transferred between allogenic T cells simply by TCR gene transfer. This advance provides a platform for examining the contributions of TCRs versus the intrinsic effector characteristics of T-cell clones in virus suppression. Additionally, this approach can be applied to develop non-human primate models to evaluate adoptive T-cell transfer therapy for AIDS and other diseases.	[Barsov, Eugene V.; Trivett, Matthew T.; Minang, Jacob T.; Sun, Haosi; Ohlen, Claes; Ott, David E.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Barsov, EV (corresponding author), NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	ottde@mail.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organization imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen H, 2007, AIDS RES HUM RETROV, V23, P456, DOI 10.1089/aid.2006.0194; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berry LJ, 2009, TISSUE ANTIGENS, V74, P277, DOI 10.1111/j.1399-0039.2009.01336.x; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bollard CM, 2004, J EXP MED, V200, P1623, DOI 10.1084/jem.20040890; Bolton DL, 2010, J IMMUNOL, V184, P303, DOI 10.4049/jimmunol.0902413; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Calogero A, 2000, ANTICANCER RES, V20, P1793; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06; Clay TM, 2002, EXPERT OPIN BIOL TH, V2, P353; Cooper LJN, 2000, J VIROL, V74, P8207, DOI 10.1128/JVI.74.17.8207-8212.2000; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Engels B, 2005, HUM GENE THER, V16, P799, DOI 10.1089/hum.2005.16.799; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Frahm Nicole, 2007, Curr Infect Dis Rep, V9, P161, DOI 10.1007/s11908-007-0012-5; Fujio K, 2000, J IMMUNOL, V165, P528, DOI 10.4049/jimmunol.165.1.528; Fujita Y, 2008, BONE MARROW TRANSPL, V41, P193, DOI 10.1038/sj.bmt.1705906; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; Joseph A, 2008, J VIROL, V82, P3078, DOI 10.1128/JVI.01812-07; Kapp M, 2007, CYTOTHERAPY, V9, P699, DOI 10.1080/14653240701656046; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kollgaard T, 2009, CYTOTHERAPY, V11, P631, DOI 10.1080/14653240902923146; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152; Loffredo JT, 2007, J VIROL, V81, P2624, DOI 10.1128/JVI.01912-06; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Loh L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040012; Mandl JN, 2007, J VIROL, V81, P11982, DOI 10.1128/JVI.00946-07; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Marcu-Malina V, 2009, EXPERT OPIN BIOL TH, V9, P579, DOI [10.1517/14712590902887018 , 10.1517/14712590902887018]; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Minang JT, 2008, VIROLOGY, V372, P430, DOI 10.1016/j.virol.2007.11.013; Minang JT, 2010, J IMMUNOL, V184, P315, DOI 10.4049/jimmunol.0902410; Minang JT, 2009, VIROLOGY, V391, P130, DOI 10.1016/j.virol.2009.06.008; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Orentas RJ, 2003, SCAND J IMMUNOL, V58, P33, DOI 10.1046/j.1365-3083.2003.01277.x; Peggs KS, 2009, CLIN INFECT DIS, V49, P1851, DOI 10.1086/648422; Peggs KS, 2009, EXPERT OPIN BIOL TH, V9, P725, DOI 10.1517/14712590902967588; Pogulis RJ, 1998, HUM GENE THER, V9, P2299, DOI 10.1089/hum.1998.9.15-2299; Riddell Stanley R, 2007, Hematology Am Soc Hematol Educ Program, P250; Rooney CM, 1998, BLOOD, V92, P1549, DOI 10.1182/blood.V92.5.1549.417k32_1549_1555; Rosenberg SA, 2008, P NATL ACAD SCI USA, V105, P12643, DOI 10.1073/pnas.0806877105; Rosenberg SA, 2008, NEW ENGL J MED, V359, P1072, DOI 10.1056/NEJMc081511; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rubinstein MP, 2003, J IMMUNOL, V170, P1209, DOI 10.4049/jimmunol.170.3.1209; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Sadagopal S, 2008, J VIROL, V82, P4149, DOI 10.1128/JVI.02242-07; Schmitz JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000691; Schweighardt B, 2010, JAIDS-J ACQ IMM DEF, V53, P36, DOI 10.1097/QAI.0b013e3181c4b885; Shao HW, 2010, MOL BIOL REP, V37, P3951, DOI 10.1007/s11033-010-0053-y; Sommermeyer D, 2006, EUR J IMMUNOL, V36, P3052, DOI 10.1002/eji.200636539; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Ueno T, 2004, EUR J IMMUNOL, V34, P3379, DOI 10.1002/eji.200425568; Ueno T, 2007, J IMMUNOL, V178, P5513, DOI 10.4049/jimmunol.178.9.5513; van Loenen MM, 2010, P NATL ACAD SCI USA, V107, P10972, DOI 10.1073/pnas.1005802107; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Yang OO, 2003, J IMMUNOL, V171, P3718, DOI 10.4049/jimmunol.171.7.3718	72	16	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23703	10.1371/journal.pone.0023703	http://dx.doi.org/10.1371/journal.pone.0023703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886812	gold, Green Submitted, Green Published			2022-12-25	WOS:000294253500025
J	Takeuchi, H; Taki, Y; Sassa, Y; Hashizume, H; Sekiguchi, A; Fukushima, A; Kawashima, R				Takeuchi, Hikaru; Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta			Working Memory Training Using Mental Calculation Impacts Regional Gray Matter of the Frontal and Parietal Regions	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BRAIN STRUCTURE CHANGES; INDIVIDUAL-DIFFERENCES; CREATIVITY; CHILDREN; SCHIZOPHRENIA; ADHD; ACTIVATION; PLASTICITY; COGNITION	Training working memory (WM) improves performance on untrained cognitive tasks and alters functional activity. However, WM training's effects on gray matter morphology and a wide range of cognitive tasks are still unknown. We investigated this issue using voxel-based morphometry (VBM), various psychological measures, such as non-trained WM tasks and a creativity task, and intensive adaptive training of WM using mental calculations (IATWMMC), all of which are typical WM tasks. IATWMMC was associated with reduced regional gray matter volume in the bilateral fronto-parietal regions and the left superior temporal gyrus. It improved verbal letter span and complex arithmetic ability, but deteriorated creativity. These results confirm the training-induced plasticity in psychological mechanisms and the plasticity of gray matter structures in regions that have been assumed to be under strong genetic control.	[Takeuchi, Hikaru; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Sassa, Yuko; Hashizume, Hiroshi; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Fukushima, Ai; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Takeuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan.	takehi@idac.tohoku.ac.jp	Takeuchi, Hikaru/D-1057-2011	Takeuchi, Hikaru/0000-0002-8022-9694	Japan Science and Technology Agency (JST)/Research Institute of Science and Technology for Society; JST/Core Research for Evolutional Science and Technology	Japan Science and Technology Agency (JST)/Research Institute of Science and Technology for Society(Japan Science & Technology Agency (JST)); JST/Core Research for Evolutional Science and Technology(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by Japan Science and Technology Agency (JST)/Research Institute of Science and Technology for Society and JST/Core Research for Evolutional Science and Technology (no particular numbers exist). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova E, 2005, BIOL PSYCHIAT, V58, P457, DOI 10.1016/j.biopsych.2005.04.036; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; BEECH A, 1987, BRIT J PSYCHOL, V78, P349, DOI 10.1111/j.2044-8295.1987.tb02252.x; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Butterworth B., 1999, MATH BRAIN; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Colom R, 2004, INTELLIGENCE, V32, P277, DOI 10.1016/j.intell.2003.12.002; Court J., 1998, MANUAL RAVENS PROGRE; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; DYKES M, 1976, BRIT J PSYCHIAT, V128, P50, DOI 10.1192/bjp.128.1.50; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; GASER C, VBM TOOLBOX SPM2 VBM; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Hakoda Y., 1990, KYOIKUSHINRIGAKUKENK, V38, P389, DOI DOI 10.5926/JJEP1953.38.4_; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Healey D, 2006, CHILD NEUROPSYCHOL, V12, P421, DOI 10.1080/09297040600806086; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kawashima R, 2005, J GERONTOL A-BIOL, V60, P380, DOI 10.1093/gerona/60.3.380; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; KRISTOFFERSON MW, 1972, CAN J PSYCHOLOGY, V26, P54, DOI 10.1037/h0082415; Leff AP, 2009, BRAIN, V132, P3401, DOI 10.1093/brain/awp273; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; May A, 2006, CURR OPIN NEUROL, V19, P407, DOI 10.1097/01.wco.0000236622.91495.21; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mehta MA, 2004, J CHILD PSYCHOL PSYC, V45, P293, DOI 10.1111/j.1469-7610.2004.00221.x; Minds Society For Creative, 1969, MAN S A CREAT TEST; NECKA E, 1999, POLISH PSYCHOL B, V30, P85; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Osaka M, 2000, BRAIN WORKING MEMORY; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; RAWLINGS D, 1985, PERS INDIV DIFFER, V6, P737, DOI 10.1016/0191-8869(85)90084-4; SASAKI M, 1993, JPN J PSYCHOL, V64, P43, DOI 10.4992/jjpsy.64.43; SASAKI M, 1985, P JAP ED PSYH 27 ANN; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Silver M, 2011, NEUROIMAGE, V54, P992, DOI 10.1016/j.neuroimage.2010.08.049; Snow R. E., 1989, EDUC RES, V18, P8, DOI DOI 10.3102/0013189X018009008; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Stavridou A, 1996, PERS INDIV DIFFER, V21, P143, DOI 10.1016/0191-8869(96)00030-X; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; Swartwood MO, 2003, CREATIVITY RES J, V15, P417, DOI 10.1207/S15326934CRJ1504_9; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; TAKEUCHI H, REV NEUROSC IN PRESS; TAKEUCHI H, J NEUROSCIE IN PRESS; Takeuchi H, HUMAN BRAIN IN PRESS; Takeuchi H, 2011, NEUROIMAGE, V55, P681, DOI 10.1016/j.neuroimage.2010.11.052; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Testa C, 2004, J MAGN RESON IMAGING, V19, P274, DOI 10.1002/jmri.20001; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida S, 2008, AGE, V30, P21, DOI 10.1007/s11357-007-9044-x; WECHSLER D, 1997, WAIS 3 ADMINISTRATIO; Weinfurt K. P., 2002, READING UNDERSTANDIN, P317; White HA, 2006, PERS INDIV DIFFER, V40, P1121, DOI 10.1016/j.paid.2005.11.007	79	82	87	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e23175	10.1371/journal.pone.0023175	http://dx.doi.org/10.1371/journal.pone.0023175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	811YA	21886781	gold, Green Published, Green Submitted			2022-12-25	WOS:000294253500010
J	Elpek, KG; Bellemare-Pelletier, A; Malhotra, D; Reynoso, ED; Lukacs-Kornek, V; DeKruyff, RH; Turley, SJ				Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Reynoso, Erika D.; Lukacs-Kornek, Veronika; DeKruyff, Rosemarie H.; Turley, Shannon J.			Lymphoid Organ-Resident Dendritic Cells Exhibit Unique Transcriptional Fingerprints Based on Subset and Site	PLOS ONE			English	Article							IN-VIVO; RETINOIC ACID; CROSS-PRESENTATION; T-CELLS; REGULATORY FACTOR-4; ADAPTIVE IMMUNITY; GENE-EXPRESSION; SELF-ANTIGENS; DYING CELLS; MOUSE	Lymphoid organ-resident DC subsets are thought to play unique roles in determining the fate of T cell responses. Recent studies focusing on a single lymphoid organ identified molecular pathways that are differentially operative in each DC subset and led to the assumption that a given DC subset would more or less exhibit the same genomic and functional profiles throughout the body. Whether the local milieu in different anatomical sites can also influence the transcriptome of DC subsets has remained largely unexplored. Here, we interrogated the transcriptional relationships between lymphoid organ-resident DC subsets from spleen, gut-and skin-draining lymph nodes, and thymus of C57BL/6 mice. For this purpose, major resident DC subsets including CD4 and CD8 DCs were sorted at high purity and gene expression profiles were compared using microarray analysis. This investigation revealed that lymphoid organ-resident DC subsets exhibit divergent genomic programs across lymphoid organs. Interestingly, we also found that transcriptional and biochemical properties of a given DC subset can differ between lymphoid organs for lymphoid organ-resident DC subsets, but not plasmacytoid DCs, suggesting that determinants of the tissue milieu program resident DCs for essential site-specific functions.	[Elpek, Kutlu G.; Bellemare-Pelletier, Angelique; Malhotra, Deepali; Reynoso, Erika D.; Lukacs-Kornek, Veronika; Turley, Shannon J.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Malhotra, Deepali] Harvard Univ, Sch Med, Div Med Sci, Boston, MA USA; [DeKruyff, Rosemarie H.] Harvard Univ, Sch Med, Div Immunol, Childrens Hosp Boston, Boston, MA USA; [Turley, Shannon J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Elpek, KG (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	shannon_turley@dfci.harvard.edu		Malhotra, Deepali/0000-0002-8215-7639	AACR; Baruj Benacerraf Postdoctoral Fellowship; American Cancer Society; National Institutes of Health (NIH) [R01 DK074500, P01 AI045757, R24 AI072073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757, R01AI089955, R24AI072073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074500] Funding Source: NIH RePORTER	AACR; Baruj Benacerraf Postdoctoral Fellowship; American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by research funding from the AACR Centennial Postdoctoral Fellowship in Cancer Research to KGE, Baruj Benacerraf Postdoctoral Fellowship to VLK, American Cancer Society Research Scholar Award, National Institutes of Health (NIH) grants (R01 DK074500 and P01 AI045757) to SJT and NIH R24 AI072073 to the Immunological Genome Project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2002, J IMMUNOL, V168, P6066, DOI 10.4049/jimmunol.168.12.6066; Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hemmi H, 2009, J IMMUNOL, V182, P1278, DOI 10.4049/jimmunol.182.3.1278; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Park DJ, 2010, AM J PATHOL, V176, P2831, DOI 10.2353/ajpath.2010.090845; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104	50	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23921	10.1371/journal.pone.0023921	http://dx.doi.org/10.1371/journal.pone.0023921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886840	Green Published, Green Submitted, gold			2022-12-25	WOS:000294128100041
J	Fuchs, H; Mendler, MR; Scharnbeck, D; Ebsen, M; Hummler, HD				Fuchs, Hans; Mendler, Marc R.; Scharnbeck, Dominik; Ebsen, Michael; Hummler, Helmut D.			Very Low Tidal Volume Ventilation with Associated Hypercapnia - Effects on Lung Injury in a Model for Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							FACTOR-KAPPA-B; PERMISSIVE HYPERCAPNIA; CARBON-DIOXIDE; MECHANICAL VENTILATION; AIRWAY PRESSURES; NEONATAL-RATS; GAS-EXCHANGE; ACIDOSIS; ASSIST; PERMEABILITY	Background: Ventilation using low tidal volumes with permission of hypercapnia is recommended to protect the lung in acute respiratory distress syndrome. However, the most lung protective tidal volume in association with hypercapnia is unknown. The aim of this study was to assess the effects of different tidal volumes with associated hypercapnia on lung injury and gas exchange in a model for acute respiratory distress syndrome. Methodology/Principal Findings: In this randomized controlled experiment sixty-four surfactant-depleted rabbits were exposed to 6 hours of mechanical ventilation with the following targets: Group 1: tidal volume = 8-10 ml/kg/ PaCO(2) = 40 mm Hg; Group 2: tidal volume = 4-5 ml/kg/PaCO(2) = 80 mm Hg; Group 3: tidal volume = 3-4 ml/kg/ PaCO(2) = 120 mm Hg; Group 4: tidal volume = 2-3 ml/kg/PaCO(2) = 160 mm Hg. Decreased wet-dry weight ratios of the lungs, lower histological lung injury scores and higher PaO(2) were found in all low tidal volume/hypercapnia groups (group 2, 3, 4) as compared to the group with conventional tidal volume/normocapnia (group 1). The reduction of the tidal volume below 4-5 ml/kg did not enhance lung protection. However, oxygenation and lung protection were maintained at extremely low tidal volumes in association with very severe hypercapnia and no adverse hemodynamic effects were observed with this strategy. Conclusion: Ventilation with low tidal volumes and associated hypercapnia was lung protective. A tidal volume below 45 ml/kg/PaCO(2) 80 mm Hg with concomitant more severe hypercapnic acidosis did not increase lung protection in this surfactant deficiency model. However, even at extremely low tidal volumes in association with severe hypercapnia lung protection and oxygenation were maintained.	[Fuchs, Hans; Mendler, Marc R.; Scharnbeck, Dominik; Hummler, Helmut D.] Univ Ulm, Div Neonatol & Pediat Crit Care, Dept Pediat & Adolescent Med, Ulm, Germany; [Ebsen, Michael] Stadt Krankenhaus Kiel, Med Versorgungszentrum, Kiel, Germany	Ulm University	Fuchs, H (corresponding author), Univ Ulm, Div Neonatol & Pediat Crit Care, Dept Pediat & Adolescent Med, Ulm, Germany.	hans.fuchs@uniklinik-ulm.de	Hummler, Helmut/AAN-7297-2021					Bein T, 2009, ANAESTHESIA, V64, P195, DOI 10.1111/j.1365-2044.2008.05735.x; Broccard AF, 2001, AM J RESP CRIT CARE, V164, P802, DOI 10.1164/ajrccm.164.5.2007060; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carvalho CRR, 1997, AM J RESP CRIT CARE, V156, P1458, DOI 10.1164/ajrccm.156.5.9604081; Chonghaile MN, 2008, CRIT CARE MED, V36, P3135, DOI 10.1097/CCM.0b013e31818f0d13; COSTELLO J, 2009, CRIT CARE MED, V111, P1317; Dembinski R, 2007, CRIT CARE MED, V35, P2359, DOI 10.1097/01.CCM.0000281857.87354.A5; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Feihl F, 2000, AM J RESP CRIT CARE, V162, P209, DOI 10.1164/ajrccm.162.1.9907119; Galluccio Steven T, 2008, Crit Care Resusc, V10, P235; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Hummler HD, 2001, PEDIATR RES, V49, P572, DOI 10.1203/00006450-200104000-00021; Ketabchi F, 2009, AM J PHYSIOL-LUNG C, V297, pL977, DOI 10.1152/ajplung.00074.2009; Komori M, 2007, CRIT CARE MED, V35, P2171, DOI 10.1097/01.ccm.0000281445.77223.31; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; Lang JD, 2005, AM J RESP CRIT CARE, V171, P147, DOI 10.1164/rccm.200302-305OC; MacCarrick MJ, 2010, LUNG, V188, P235, DOI 10.1007/s00408-009-9211-1; Masood A, 2009, AM J PHYSIOL-LUNG C, V297, pL920, DOI 10.1152/ajplung.00139.2009; Muellenbach RM, 2008, EUR J ANAESTH, V25, P897, DOI 10.1017/S0265021508004870; Muellenbach RM, 2009, MED SCI MONITOR, V15, pBR213; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; PARKER JC, 1984, J APPL PHYSIOL, V57, P1809, DOI 10.1152/jappl.1984.57.6.1809; Pfeiffer B, 2002, CRIT CARE MED, V30, P285, DOI 10.1097/00003246-200202000-00003; Randolph AG, 2009, CRIT CARE MED, V37, P2448, DOI 10.1097/CCM.0b013e3181aee5dd; Ricard JD, 2003, AM J RESP CRIT CARE, V167, P1297, DOI 10.1164/rccm.2303003; Sinclair SE, 2002, AM J RESP CRIT CARE, V166, P403, DOI 10.1164/rccm.200112-117OC; SWENSON ER, 1994, AM J RESP CRIT CARE, V149, P1563, DOI 10.1164/ajrccm.149.6.8004314; Takeshita K, 2003, AM J RESP CELL MOL, V29, P124, DOI 10.1165/rcmb.2002-0126OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Wang Z, 2008, AM J RESP CRIT CARE, V177, P178, DOI 10.1164/rccm.200706-906OC; Yoshikawa S, 2004, J APPL PHYSIOL, V97, P2190, DOI 10.1152/japplphysiol.00324.2004; Zimmermann M, 2009, CRIT CARE, V13, DOI 10.1186/cc7703	36	19	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23816	10.1371/journal.pone.0023816	http://dx.doi.org/10.1371/journal.pone.0023816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886825	gold, Green Published, Green Submitted			2022-12-25	WOS:000294128100034
J	Uosaki, H; Fukushima, H; Takeuchi, A; Matsuoka, S; Nakatsuji, N; Yamanaka, S; Yamashita, JK				Uosaki, Hideki; Fukushima, Hiroyuki; Takeuchi, Ayako; Matsuoka, Satoshi; Nakatsuji, Norio; Yamanaka, Shinya; Yamashita, Jun K.			Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression	PLOS ONE			English	Article							DIFFERENTIATION; MOUSE; SELECTION; LINES	Rationale: Human embryonic and induced pluripotent stem cells (hESCs/hiPSCs) are promising cell sources for cardiac regenerative medicine. To realize hESC/hiPSC-based cardiac cell therapy, efficient induction, purification, and transplantation methods for cardiomyocytes are required. Though marker gene transduction or fluorescent-based purification methods have been reported, fast, efficient and scalable purification methods with no genetic modification are essential for clinical purpose but have not yet been established. In this study, we attempted to identify cell surface markers for cardiomyocytes derived from hESC/hiPSCs. Method and Result: We adopted a previously reported differentiation protocol for hESCs based on high density monolayer culture to hiPSCs with some modification. Cardiac troponin-T (TNNT2)-positive cardiomyocytes appeared robustly with 30-70% efficiency. Using this differentiation method, we screened 242 antibodies for human cell surface molecules to isolate cardiomyocytes derived from hiPSCs and identified anti-VCAM1 (Vascular cell adhesion molecule 1) antibody specifically marked cardiomyocytes. TNNT2-positive cells were detected at day 7-8 after induction and 80% of them became VCAM1-positive by day 11. Approximately 95-98% of VCAM1-positive cells at day 11 were positive for TNNT2. VCAM1 was exclusive with CD144 (endothelium), CD140b (pericytes) and TRA-1-60 (undifferentiated hESCs/hiPSCs). 95% of MACS-purified cells were positive for TNNT2. MACS purification yielded 5-10x10(5) VCAM1-positive cells from a single well of a six-well culture plate. Purified VCAM1-positive cells displayed molecular and functional features of cardiomyocytes. VCAM1 also specifically marked cardiomyocytes derived from other hESC or hiPSC lines. Conclusion: We succeeded in efficiently inducing cardiomyocytes from hESCs/hiPSCs and identifying VCAM1 as a potent cell surface marker for robust, efficient and scalable purification of cardiomyocytes from hESC/hiPSCs. These findings would offer a valuable technological basis for hESC/hiPSC-based cell therapy.	[Uosaki, Hideki; Fukushima, Hiroyuki; Yamashita, Jun K.] Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med Sci, Kyoto, Japan; [Uosaki, Hideki; Fukushima, Hiroyuki; Yamashita, Jun K.] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Takeuchi, Ayako] Kyoto Univ, Dept Physiol & Biophys, Grad Sch Med, Kyoto, Japan; [Matsuoka, Satoshi] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto, Japan; [Nakatsuji, Norio] Kyoto Univ, Dept Dev & Differentiat, Inst Frontier Med Sci, Kyoto, Japan; [Yamanaka, Shinya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Uosaki, H (corresponding author), Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med Sci, Kyoto, Japan.	juny@frontier.kyoto-u.ac.jp	matsuoka, satoshi/GWD-0440-2022; Uosaki, Hideki/AAQ-2619-2020	matsuoka, satoshi/0000-0003-3321-9749; Uosaki, Hideki/0000-0002-8964-8609	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare; Project for Realization of Regenerative Medicine; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23650258, 23122509, 23689011] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan, the Ministry of Health, Labour and Welfare, the Project for Realization of Regenerative Medicine, and Japan Science and Technology Agency. H.U. and H.F. are supported by the fellowship from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; KWEE L, 1995, DEVELOPMENT, V121, P489; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Murakami Y, 2007, MECH DEVELOP, V124, P830, DOI 10.1016/j.mod.2007.09.004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Rust W, 2009, REGEN MED, V4, P225, DOI 10.2217/17460751.4.2.225; SIMMONS PJ, 1992, BLOOD, V80, P388; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917	19	212	225	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e23657	10.1371/journal.pone.0023657	http://dx.doi.org/10.1371/journal.pone.0023657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876760	gold, Green Submitted, Green Published			2022-12-25	WOS:000294126900032
J	Papagiannakopoulos, T; Friedmann-Morvinski, D; Neveu, P; Dugas, JC; Gill, RM; Huillard, E; Liu, C; Zong, H; Rowitch, DH; Barres, BA; Verma, IM; Kosik, KS				Papagiannakopoulos, T.; Friedmann-Morvinski, D.; Neveu, P.; Dugas, J. C.; Gill, R. M.; Huillard, E.; Liu, C.; Zong, H.; Rowitch, D. H.; Barres, B. A.; Verma, I. M.; Kosik, K. S.			Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases	ONCOGENE			English	Article						microRNA; glioma stem cells; miR-128; EGFR; PDGFR alpha	GROWTH-FACTOR RECEPTOR; STEM-CELL; IN-VIVO; MICRORNAS; BRAIN; EGFR; MODULATION; MECHANISMS; RENEWAL; SET	MicroRNAs (miRNAs) carry out post-transcriptional control of a multitude of cellular processes. Aberrant expression of miRNA can lead to diseases, including cancer. Gliomas are aggressive brain tumors that are thought to arise from transformed glioma-initiating neural stem cells (giNSCs). With the use of giNSCs and human glioblastoma cells, we investigated the function of miRNAs in gliomas. We identified pro-neuronal miR-128 as a candidate glioma tumor suppressor miRNA. Decreased expression of miR-128 correlates with aggressive human glioma subtypes. With a combination of molecular, cellular and in vivo approaches, we characterize miR-128's tumor suppressive role. miR-128 represses giNSC growth by enhancing neuronal differentiation. miR-128 represses growth and mediates differentiation by targeting oncogenic receptor tyrosine kinases (RTKs) epithelial growth factor receptor and platelet-derived growth factor receptor-alpha. Using an autochthonous glioma mouse model, we demonstrated that miR-128 repressed gliomagenesis. We identified miR-128 as a glioma tumor suppressor that targets RTK signaling to repress giNSC self-renewal and enhance differentiation. Oncogene (2012) 31, 1884-1895; doi:10.1038/onc.2011.380; published online 29 August 2011	[Papagiannakopoulos, T.; Gill, R. M.; Kosik, K. S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Papagiannakopoulos, T.; Neveu, P.; Gill, R. M.; Kosik, K. S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Friedmann-Morvinski, D.; Verma, I. M.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Neveu, P.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Dugas, J. C.; Barres, B. A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Huillard, E.; Rowitch, D. H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Huillard, E.; Rowitch, D. H.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Liu, C.; Zong, H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Rowitch, D. H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Rowitch, D. H.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Salk Institute; University of California System; University of California Santa Barbara; Stanford University; University of California System; University of California San Francisco; University of Oregon; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Room 6139A, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Neveu, Pierre/C-1170-2009; Liu, Chong/J-4826-2014	Liu, Chong/0000-0001-6578-5919; Friedmann-Morvinski, Dinorah/0000-0002-6394-9876; Neveu, Pierre/0000-0003-4939-3418; Rowitch, David/0000-0002-0079-0060	WM Keck Foundation; Miriam and Sheldon Adelson Medical Foundation; National Science Foundation [PHY05-51164]; Myelin Repair Foundation; National Multiple Sclerosis Society; NIH [R55-CA136495, R01-CA136495]; The Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R01CA136495, R55CA136495] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053670] Funding Source: NIH RePORTER	WM Keck Foundation(W.M. Keck Foundation); Miriam and Sheldon Adelson Medical Foundation; National Science Foundation(National Science Foundation (NSF)); Myelin Repair Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Israel Hernandez, Diego Piedrahita and Yngo Garcia for providing assistance with animal experiments, and Na Xu, Min Jeong Kye and Cecilia Conaco for scientific conversations and suggestions. Judith Czerny assisted in constructing target 3'-UTR constructs. Support for the project was from the WM Keck Foundation (KSK), the Miriam and Sheldon Adelson Medical Foundation (KSK), the National Science Foundation under grant No. PHY05-51164 (PN), the Myelin Repair Foundation (JCD and BAB), and the National Multiple Sclerosis Society (JCD and BAB). HZ work is supported by NIH grants (R55-CA136495, R01-CA136495). HZ is a Pew Scholar in Biomedical Sciences, supported by The Pew Charitable Trusts. DHR is an HHMI investigator.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Boockvar JA, 2003, MOL CELL NEUROSCI, V24, P1116, DOI 10.1016/j.mcn.2003.09.011; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; Neveu P, 2010, CELL STEM CELL, V7, P671, DOI 10.1016/j.stem.2010.11.012; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014681; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	38	133	138	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	15					1884	1895		10.1038/onc.2011.380	http://dx.doi.org/10.1038/onc.2011.380			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	926CW	21874051	Green Accepted			2022-12-25	WOS:000302809900002
J	Casutt, MS; Nedielkov, R; Wendelspiess, S; Vossler, S; Gerken, U; Murai, M; Miyoshi, H; Moller, HM; Steuber, J				Casutt, Marco S.; Nedielkov, Ruslan; Wendelspiess, Severin; Vossler, Sara; Gerken, Uwe; Murai, Masatoshi; Miyoshi, Hideto; Moeller, Heiko M.; Steuber, Julia			Localization of Ubiquinone-8 in the Na+-pumping NADH: Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; SECONDARY STRUCTURE ANALYSES; ESCHERICHIA-COLI; NADHQUINONE OXIDOREDUCTASE; PROSTHETIC GROUPS; REDOX PROPERTIES; BINDING-SITE; SPECTROSCOPY; ALGINOLYTICUS; PURIFICATION	Na+ is the second major coupling ion at membranes after protons, and many pathogenic bacteria use the sodium-motive force to their advantage. A prominent example is Vibrio cholerae, which relies on the Na+-pumping NADH: quinone oxidoreductase (Na+-NQR) as the first complex in its respiratory chain. The Na+-NQR is a multisubunit, membrane-embedded NADH dehydrogenase that oxidizes NADH and reduces quinone to quinol. Existing models describing redox-driven Na+ translocation by the Na+-NQR are based on the assumption that the pump contains four flavins and one FeS cluster. Here we show that the large, peripheral NqrA subunit of the Na+-NQR binds one molecule of ubiquinone-8. Investigations of the dynamic interaction of NqrA with quinones by surface plasmon resonance and saturation transfer difference NMR reveal a high affinity, which is determined by the methoxy groups at the C-2 and C-3 positions of the quinone headgroup. Using photoactivatable quinone derivatives, it is demonstrated that ubiquinone-8 bound to NqrA occupies a functional site. A novel scheme of electron transfer in Na+-NQR is proposed that is initiated by NADH oxidation on subunit NqrF and leads to quinol formation on subunit NqrA.	[Nedielkov, Ruslan; Moeller, Heiko M.] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Casutt, Marco S.] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Wendelspiess, Severin; Vossler, Sara; Gerken, Uwe; Steuber, Julia] Univ Stuttgart Hohenheim, Inst Microbiol, D-70599 Stuttgart, Germany; [Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	University of Konstanz; University of Freiburg; University Hohenheim; Kyoto University	Moller, HM (corresponding author), Univ Konstanz, Dept Chem, D-78457 Constance, Germany.	heiko.moeller@uni-konstanz.de; julia.steuber@uni-hohenheim.de	Möller, Heiko/AAX-1075-2020; Möller, Heiko/N-1847-2013	Möller, Heiko/0000-0002-5795-1195; Murai, Masatoshi/0000-0001-6601-2854	Swiss National Science Foundation [PP0033-118994]; Baden-Wurttemberg Stiftung; Forschungsprogramm P-LS-Meth/4; Japan Society for the Promotion of Science [20380068]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baden-Wurttemberg Stiftung; Forschungsprogramm P-LS-Meth/4; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Swiss National Science Foundation (Grant PP0033-118994) (to J. S.), by contract research of the Baden-Wurttemberg Stiftung, Forschungsprogramm P-LS-Meth/4 (to J. S. and H. M. M.), and by Grant-in-Aid for Scientific Research 20380068 from the Japan Society for the Promotion of Science (to H. M.).	Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Johnson A. R, 1971, BIOCH METHODOLOGY LI, P131; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; Matsumoto Y, 2006, J BIOL CHEM, V281, P1905, DOI 10.1074/jbc.M508206200; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; Nakayama Y, 1998, FEBS LETT, V422, P240, DOI 10.1016/S0014-5793(98)00016-7; PENZER GR, 1967, Q REV CHEM SOC, V21, P43, DOI 10.1039/qr9672100043; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	27	36	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40075	40082		10.1074/jbc.M111.224980	http://dx.doi.org/10.1074/jbc.M111.224980			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21885438	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000296925700040
J	Markovics, JA; Araya, J; Cambier, S; Somanath, S; Gline, S; Jablons, D; Hill, A; Wolters, PJ; Nishimura, SL				Markovics, Jennifer A.; Araya, Jun; Cambier, Stephanie; Somanath, Sangeeta; Gline, Stephanie; Jablons, David; Hill, Arthur; Wolters, Paul J.; Nishimura, Stephen L.			Interleukin-1 beta Induces Increased Transcriptional Activation of the Transforming Growth Factor-beta-activating Integrin Subunit beta 8 through Altering Chromatin Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE; PULMONARY INFLAMMATION; HISTONE DEACETYLASE; GENE-EXPRESSION; LUNG; ALPHA-V-BETA-8; CELLS; P38; DIFFERENTIATION	The integrin alpha v beta 8 is a cell surface receptor for the latent domain (LAP) of the multifunctional cytokine TGF-beta. Through its association with LAP, TGF-beta is maintained in a latent form that must be activated to function. Binding to the integrin alpha v beta 8 with subsequent metalloproteolytic cleavage of LAP represents a major mechanism of TGF-beta activation in vivo. Altered expression of the integrin beta 8 subunit (ITGB8) is found in human chronic obstructive pulmonary disease, cancers, and brain vascular malformations. We have previously shown that the proinflammatory cytokine interleukin-1 beta (IL-1 beta) increases ITGB8 expression on lung fibroblasts, which increases alpha v beta 8-mediated TGF-beta activation in fibrosis and pathologic inflammation. Here we report the mechanism of increased ITGB8 expression by IL-1 beta. Our data support a model where the chromatin architecture of the ITGB8 core promoter is altered by nucleosomal repositioning that enhances the interaction of an AP1 complex (containing c-Jun and ATF2). This repositioning is caused by the dissociation of HDAC2 with the ITGB8 core promoter, leading to increased histone H4 acetylation and a loosening of nucleosomal-DNA interactions allowing "opening" of the chromatin structure and increased association of c-Jun and ATF-2. These changes are mediated through NF kappa B- and p38-dependent pathways. Ultimately, these events culminate in increasing ITGB8 transcription, alpha v beta 8 surface expression, and alpha v beta 8-mediated TGF beta activation.	[Markovics, Jennifer A.; Cambier, Stephanie; Somanath, Sangeeta; Nishimura, Stephen L.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94110 USA; [Gline, Stephanie; Jablons, David; Hill, Arthur] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94110 USA; [Wolters, Paul J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, Div Pulm, Lung Biol Ctr, San Francisco, CA 94110 USA; [Araya, Jun] Jikei Univ, Sch Med, Dept Internal Med, Div Resp Dis, Tokyo 1058461, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Jikei University	Nishimura, SL (corresponding author), UCSF SFGH, Bldg 3,Rm 211,1001 Potrero Ave, San Francisco, CA 94110 USA.	stephen.nishimura@ucsf.edu			National Institutes of Health [HL090662, ARRA HL63993, NS04415]; University of California; San Francisco Resource Allocation Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063993, R01HL090662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); San Francisco Resource Allocation Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL090662, ARRA HL63993, and NS04415 (to S. L. N.).; Supported by the University of California, San Francisco Resource Allocation Program.	Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Araya J, 2010, ANNU REV PATHOL-MECH, V5, P77, DOI 10.1146/annurev.pathol.4.110807.092217; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Cambier S, 2000, CANCER RES, V60, P7084; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Jarad G, 2002, J BIOL CHEM, V277, P47826, DOI 10.1074/jbc.M204901200; Kim H, 2009, CEREBROVASC DIS, V27, P176, DOI 10.1159/000185609; Kitamura H, 2011, J CLIN INVEST, V121, P2863, DOI 10.1172/JCI45589; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Long DL, 2010, OSTEOARTHR CARTILAGE, V18, P1203, DOI 10.1016/j.joca.2010.05.016; Markovics JA, 2010, J BIOL CHEM, V285, P24695, DOI 10.1074/jbc.M110.113977; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Ridley SH, 1997, J IMMUNOL, V158, P3165; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Singh B, 2010, Monaldi Arch Chest Dis, V73, P86; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Tomkinson A, 2001, J IMMUNOL, V166, P5792, DOI 10.4049/jimmunol.166.9.5792; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Ulivi V, 2008, J CELL BIOCHEM, V104, P1393, DOI 10.1002/jcb.21717; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Wilkinson TS, 2004, AM J RESP CELL MOL, V31, P92, DOI 10.1165/rcmb.2003-0380OC; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Zachlederova M, 2006, PHYSIOL RES, V55, P39, DOI 10.33549/physiolres.930703; Zhu JW, 2002, DEVELOPMENT, V129, P2891	54	28	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36864	36874		10.1074/jbc.M111.276790	http://dx.doi.org/10.1074/jbc.M111.276790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21878622	Green Published, hybrid			2022-12-25	WOS:000296538300066
J	Qin, S; Jin, L; Zhang, JH; Liu, L; Ji, P; Wu, MA; Wu, JH; Shi, YY				Qin, Su; Jin, Lei; Zhang, Jiahai; Liu, Lei; Ji, Peng; Wu, Mian; Wu, Jihui; Shi, Yunyu			Recognition of Unmodified Histone H3 by the First PHD Finger of Bromodomain-PHD Finger Protein 2 Provides Insights into the Regulation of Histone Acetyltransferases Monocytic Leukemic Zinc-finger Protein (MOZ) and MOZ-related factor (MORF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOX GENE-EXPRESSION; AUTOIMMUNE REGULATOR; MOLECULAR-BASIS; BINDING; METHYLATION; CHROMATIN; LYSINE-4; COMPLEX; DOMAIN; NMR	MOZ (monocytic leukemic zinc-finger protein) and MORF (MOZ-related factor) are histone acetyltransferases important for HOX gene expression as well as embryo and postnatal development. They form complexes with other regulatory subunits through the scaffold proteins BRPF1/2/3 (bromodomain-PHD (plant homeodomain) finger proteins 1, 2, or 3). BRPF proteins have multiple domains, including two PHD fingers, for potential interactions with histones. Here we show that the first PHD finger of BRPF2 specifically recognizes the N-terminal tail of unmodified histone H3 (unH3) and report the solution structures of this PHD finger both free and in complex with the unH3 peptide. Structural analysis revealed that the unH3 peptide forms a third antiparallel beta-strand that pairs with the PHD1 two-stranded antiparallel beta-sheet. The binding specificity was determined primarily through the recognition of arginine 2 and lysine 4 of the unH3 by conserved aspartic acids of PHD1 and of threonine 6 of the unH3 by a conserved asparagine. Isothermal titration calorimetry and NMR assays showed that post-translational modifications such as H3R2me2as, H3T3ph, H3K4me, H3K4ac, and H3T6ph antagonized the interaction between histone H3 and PHD1. Furthermore, histone binding by PHD1 was important for BRPF2 to localize to the HOXA9 locus in vivo. PHD1 is highly conserved in yeast NuA3 and other histone acetyltransferase complexes, so the results reported here also shed light on the function and regulation of these complexes.	[Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	QIN, SU/H-8735-2015; Qin, Su/Y-3750-2019; Shi, Yunyu/B-3240-2009; Jin, Lei/J-1896-2019; Qin, Su/N-7404-2015	Qin, Su/0000-0001-9437-6292; Shi, Yunyu/0000-0002-1348-4759; Jin, Lei/0000-0001-7187-9671; Qin, Su/0000-0001-9437-6292; Wu, Mian/0000-0002-2714-0500	Chinese National Natural Science Foundation [30830031]; National Basic Research Program of China (973 Program) [2011CB966302, 2011CB911104]; Chinese National High Technology RD Program [2006AA02A315]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National High Technology RD Program	This work was supported by Chinese National Natural Science Foundation Grant 30830031, National Basic Research Program of China (973 Program) Grants 2011CB966302 and 2011CB911104, and Chinese National High Technology R&D Program Grant 2006AA02A315.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Chignola F, 2009, NUCLEIC ACIDS RES, V37, P2951, DOI 10.1093/nar/gkp166; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Musselman CA, 2009, BIOCHEM J, V423, P179, DOI 10.1042/BJ20090870; Nebral K, 2009, LEUKEMIA, V23, P134, DOI 10.1038/leu.2008.306; O'Meara MM, 2010, GENETICS, V186, P1497, DOI 10.1534/genetics.110.123661; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Paggetti J, 2010, ONCOGENE, V29, P5019, DOI 10.1038/onc.2010.254; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Severinsen JE, 2006, MOL PSYCHIATR, V11, P1126, DOI 10.1038/sj.mp.4001885; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Simonson T, 2002, PROTEINS, V49, P37, DOI 10.1002/prot.10200; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Thomas T, 2004, FRONT BIOSCI, V9, P24, DOI 10.2741/1208; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Xie W, 2009, J CELL MOL MED, V13, P1719, DOI 10.1111/j.1582-4934.2008.00423.x; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zeng L, 2010, NATURE, V466, P258, DOI 10.1038/nature09139	53	50	53	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36944	36955		10.1074/jbc.M111.244400	http://dx.doi.org/10.1074/jbc.M111.244400			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21880731	Green Published, hybrid			2022-12-25	WOS:000296538300073
J	Ma, LJ; Mondal, AK; Murea, M; Sharma, NK; Tonjes, A; Langberg, KA; Das, SK; Franks, PW; Kovacs, P; Antinozzi, PA; Stumvoll, M; Parks, JS; Elbein, SC; Freedman, BI				Ma, Lijun; Mondal, Ashis K.; Murea, Mariana; Sharma, Neeraj K.; Toenjes, Anke; Langberg, Kurt A.; Das, Swapan K.; Franks, Paul W.; Kovacs, Peter; Antinozzi, Peter A.; Stumvoll, Michael; Parks, John S.; Elbein, Steven C.; Freedman, Barry I.			The Effect of ACACB cis-Variants on Gene Expression and Metabolic Traits	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE-2; FATTY-ACID OXIDATION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; BODY-WEIGHT; GLUCOSE; MICE; RESISTANCE; OBESITY	Background: Acetyl Coenzyme A carboxylase beta (ACACB) is the rate-limiting enzyme in fatty acid oxidation, and continuous fatty acid oxidation in Acacb knock-out mice increases insulin sensitivity. Systematic human studies have not been performed to evaluate whether ACACB variants regulate gene expression and insulin sensitivity in skeletal muscle and adipose tissues. We sought to determine whether ACACB transcribed variants were associated with ACACB gene expression and insulin sensitivity in non-diabetic African American (AA) and European American (EA) adults. Methods: ACACB transcribed single nucleotide polymorphisms (SNPs) were genotyped in 105 EAs and 46 AAs whose body mass index (BMI), lipid profiles and ACACB gene expression in subcutaneous adipose and skeletal muscle had been measured. Allelic expression imbalance (AEI) was assessed in lymphoblast cell lines from heterozygous subjects in an additional EA sample (n = 95). Selected SNPs were further examined for association with insulin sensitivity in a cohort of 417 EAs and 153 AAs. Results: ACACB transcribed SNP rs2075260 (A/G) was associated with adipose ACACB messenger RNA expression in EAs and AAs (p = 3.8x10(-5), dominant model in meta-analysis, Stouffer method), with the (A) allele representing lower gene expression in adipose and higher insulin sensitivity in EAs (p = 0.04). In EAs, adipose ACACB expression was negatively associated with age and sex-adjusted BMI (r = -0.35, p = 0.0002). Conclusions: Common variants within the ACACB locus appear to regulate adipose gene expression in humans. Body fat (represented by BMI) may further regulate adipose ACACB gene expression in the EA population.	[Ma, Lijun; Mondal, Ashis K.; Murea, Mariana; Sharma, Neeraj K.; Langberg, Kurt A.; Das, Swapan K.; Antinozzi, Peter A.; Parks, John S.; Elbein, Steven C.; Freedman, Barry I.] Wake Forest Sch Med, Winston Salem, NC 27157 USA; [Toenjes, Anke; Kovacs, Peter; Stumvoll, Michael] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Franks, Paul W.] Lund Univ, Malmo Gen Hosp, Clin Res Ctr, S-21401 Malmo, Sweden	Wake Forest University; Leipzig University; Lund University	Ma, LJ (corresponding author), Wake Forest Sch Med, Winston Salem, NC 27157 USA.	lima@wfubmc.edu	Stumvoll, Michael/ABE-1121-2021; Franks, Paul/AAA-3300-2020	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Franks, Paul/0000-0002-0520-7604; Das, Swapan/0000-0002-2197-8855	Wake Forest School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases (SCE) [DK039311]; National Institutes of Health; National Center for Research Resources, National Institutes of Health (SCE) [1UL1RR029889]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR029889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039311, R29DK039311] Funding Source: NIH RePORTER	Wake Forest School of Medicine; National Institute of Diabetes and Digestive and Kidney Diseases (SCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health (SCE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Wake Forest School of Medicine Development Fund and Translational Science Institute Synergy Fund (SCE, BIF), DK039311 from the National Institute of Diabetes and Digestive and Kidney Diseases (SCE), National Institutes of Health, and General Clinical Research Center grant 1UL1RR029889 from National Center for Research Resources, National Institutes of Health (SCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; *AM DIAB ASS, 2010, DIABETES CARE, V33, pS5; Balasubramanian S, 2007, J BIOL CHEM, V282, P6707, DOI 10.1074/jbc.M606003200; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boston Ray C, 2003, Diabetes Technol Ther, V5, P1003, DOI 10.1089/152091503322641060; Castle JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004369; Cho YS, 2010, BIOCHEM BIOPH RES CO, V391, P187, DOI 10.1016/j.bbrc.2009.11.029; Cox N., 2011, COMMUNICATION; Das SK, 2010, J LIPID RES, V51, P2121, DOI 10.1194/jlr.M004275; de Edelenyi FS, 2008, GENES NUTR, V3, P173, DOI 10.1007/s12263-008-0097-y; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Field FJ, 2002, BIOCHEM J, V368, P855, DOI 10.1042/BJ20020731; Fogarty MP, 2010, HUM MOL GENET, V19, P1921, DOI 10.1093/hmg/ddq067; Hansen A, 2010, GENE DEV, V24, P195, DOI 10.1101/gad.553410; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Huypens P, 2007, MED HYPOTHESES, V69, P161, DOI 10.1016/j.mehy.2006.10.053; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Kim SJ, 2008, BIOL PHARM BULL, V31, P1415, DOI 10.1248/bpb.31.1415; Maeda S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000842; Morse DL, 2005, ANAL BIOCHEM, V342, P69, DOI 10.1016/j.ab.2005.03.034; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schreurs M, 2009, DIABETES OBES METAB, V11, P987, DOI 10.1111/j.1463-1326.2009.01078.x; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; SHARMA NK, 2011, J CLIN ENDOCRIN META; Stouffer S. A., 1949, AM SOLDIER, V1; Tang SCW, 2010, NEPHROL DIAL TRANSPL, V25, P3931, DOI 10.1093/ndt/gfq303; Tonjes A, 2009, HUM MOL GENET, V18, P4662, DOI 10.1093/hmg/ddp423; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Wang Hua, 2007, V373, P157; Weyer C, 2000, J CLIN ENDOCR METAB, V85, P1087, DOI 10.1210/jc.85.3.1087; [No title captured]	40	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e23860	10.1371/journal.pone.0023860	http://dx.doi.org/10.1371/journal.pone.0023860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887335	Green Published, Green Submitted, gold			2022-12-25	WOS:000294298800020
J	Uehara, H; Senoh, Y; Yoneda, K; Kato, Y; Shiomi, K				Uehara, Hiroshi; Senoh, Yukiko; Yoneda, Kyohei; Kato, Yoshiomi; Shiomi, Kunihiro			An FXPRLamide Neuropeptide Induces Seasonal Reproductive Polyphenism Underlying a Life-History Tradeoff in the Tussock Moth	PLOS ONE			English	Article							BIOSYNTHESIS-ACTIVATING NEUROPEPTIDE; PROTEIN-COUPLED RECEPTOR; DIAPAUSE HORMONE; BOMBYX-MORI; SUBESOPHAGEAL GANGLION; PROTHORACICOTROPIC HORMONE; MOLECULAR CHARACTERIZATION; NEUROSECRETORY-CELLS; OVARIAN DEVELOPMENT; NONDIAPAUSE EGGS	The white spotted tussock moth, Orgyia thyellina, is a typical insect that exhibits seasonal polyphenisms in morphological, physiological, and behavioral traits, including a life-history tradeoff known as oogenesis-flight syndrome. However, the developmental processes and molecular mechanisms that mediate developmental plasticity, including life-history tradeoff, remain largely unknown. To analyze the molecular mechanisms involved in reproductive polyphenism, including the diapause induction, we first cloned and characterized the diapause hormone-pheromone biosynthesis activating neuropeptide (DH-PBAN) cDNA encoding the five Phe-X-Pro-Arg-Leu-NH2 (FXPRLa) neuropeptides: DH, PBAN, and alpha-, beta-, and gamma-SGNPs (subesophageal ganglion neuropeptides). This gene is expressed in neurosecretory cells within the subesophageal ganglion whose axonal projections reach the neurohemal organ, the corpus cardiacum, suggesting that the DH neuroendocrine system is conserved in Lepidoptera. By injection of chemically synthetic DH and anti-FXPRLa antibody into female pupae, we revealed that not only does the Orgyia DH induce embryonic diapause, but also that this neuropeptide induces seasonal polyphenism, participating in the hypertrophy of follicles and ovaries. In addition, the other four FXPRLa also induced embryonic diapause in O. thyellina, but not in Bombyx mori. This is the first study showing that a neuropeptide has a pleiotropic effect in seasonal reproductive polyphenism to accomplish seasonal adaptation. We also show that a novel factor (i.e., the DH neuropeptide) acts as an important inducer of seasonal polyphenism underlying a life-history tradeoff. Furthermore, we speculate that there must be evolutionary conservation and diversification in the neuroendocrine systems of two lepidopteran genera, Orgyia and Bombyx, in order to facilitate the evolution of coregulated life-history traits and tradeoffs.	[Uehara, Hiroshi; Senoh, Yukiko; Yoneda, Kyohei; Shiomi, Kunihiro] Shinshu Univ, Fac Text Sci & Technol, Nagano, Japan; [Kato, Yoshiomi] Int Christian Univ, Dept Life Sci, Tokyo, Japan	Shinshu University; International Christian University	Uehara, H (corresponding author), Shinshu Univ, Fac Text Sci & Technol, Nagano, Japan.	shiomi@shinshu-u.ac.jp			Japan Society for the Promotion of Science [20380033]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research (20380033) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATANI F, 1976, DEV GROWTH DIFFER, V18, P481; Choi MY, 2009, INSECT MOL BIOL, V18, P161, DOI 10.1111/j.1365-2583.2009.00867.x; Davis NT, 1996, MICROSC RES TECHNIQ, V35, P201, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;201::AID-JEMT3&gt;3.0.CO;2-Q; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; GATEHOUSE AG, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P193; GILBERT SF, 2009, ECOLOGICAL DEV BIOL, P38; GU SH, 1992, J INSECT PHYSIOL, V38, P1043, DOI 10.1016/0022-1910(92)90013-4; Hafez M., 1969, Bulletin de la Societe Entomologique d'Egypte, V53, P161; Hagino A, 2010, CELL TISSUE RES, V342, P459, DOI 10.1007/s00441-010-1083-4; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Heyland A, 2005, BIOESSAYS, V27, P64, DOI 10.1002/bies.20136; Hodin J., 2009, PHENOTYPIC PLASTICIT, P423, DOI DOI 10.1201/B10201-12; HOLMAN GM, 1986, COMP BIOCHEM PHYS C, V85, P219, DOI 10.1016/0742-8413(86)90077-0; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Ichikawa T, 1995, ZOOL SCI, V12, P703, DOI 10.2108/zsj.12.703; JURENKA R, 2010, INSECT MOL BIOL; KAWAGUCHI Y, 1989, JPN J APPL ENTOMOL Z, V33, P63, DOI 10.1303/jjaez.33.63; KIMURA T, 1977, Kontyu, V45, P97; MATSUMOTO S, 1990, J INSECT PHYSIOL, V36, P427, DOI 10.1016/0022-1910(90)90060-S; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; NARDI JB, 1991, J MORPHOL, V209, P121, DOI 10.1002/jmor.1052090110; Niitsu Shuhei, 2001, Entomological Science, V4, P1; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; NIJHOUT HF, 1994, INSECT HORMONES, P176; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Roff Derek A., 1992; SANTOS M, 1994, HEREDITY, V72, P515, DOI 10.1038/hdy.1994.69; SATO T, 1977, ODOKON, V21, P6; Sato Y, 1998, J INSECT PHYSIOL, V44, P333, DOI 10.1016/S0022-1910(97)00140-6; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; SATO Y, 1994, GEN COMP ENDOCR, V96, P27, DOI 10.1006/gcen.1994.1156; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Shiomi K, 2005, FEBS J, V272, P3853, DOI 10.1111/j.1742-4658.2005.04799.x; SHIOMI K, 1994, J INSECT PHYSIOL, V40, P693, DOI 10.1016/0022-1910(94)90096-5; Shiomi K, 2007, MOL CELL NEUROSCI, V34, P209, DOI 10.1016/j.mcn.2006.10.015; Stern DL, 1999, DEVELOPMENT, V126, P1091; SU ZH, 1994, BBA-GENE STRUCT EXPR, V1218, P366, DOI 10.1016/0167-4781(94)90190-2; Swevers L., 2005, P87; Swevers L, 2003, INSECT BIOCHEM MOLEC, V33, P1285, DOI 10.1016/j.ibmb.2003.06.012; THOMAS RH, 1993, ECOL ENTOMOL, V18, P84, DOI 10.1111/j.1365-2311.1993.tb01084.x; Umeya Y., 1946, B SERIC EXP STAT, V12, P393; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; West-Eberhard Mary Jane, 2003, pi; Xu WH, 2003, INSECT MOL BIOL, V12, P509, DOI 10.1046/j.1365-2583.2003.00437.x; YAGINUMA T, 1990, COMP BIOCHEM PHYS B, V97, P495, DOI 10.1016/0305-0491(90)90150-R; Yamashita O, 1996, J INSECT PHYSIOL, V42, P669, DOI 10.1016/0022-1910(96)00003-0; Yamashita O., 1991, P424; YAMASHITA O, 1980, NATURE, V283, P385, DOI 10.1038/283385a0; Yamashita O., 1985, P407; Zdarek J, 1997, ANN NY ACAD SCI, V814, P67, DOI 10.1111/j.1749-6632.1997.tb46145.x; Zera A. J., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P609; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhao ZW, 2002, P NATL ACAD SCI USA, V99, P16829, DOI 10.1073/pnas.262533999	55	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2011	6	8							e24213	10.1371/journal.pone.0024213	http://dx.doi.org/10.1371/journal.pone.0024213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	812MY	21887383	Green Published, gold, Green Submitted			2022-12-25	WOS:000294298800036
J	Briesemeister, BB; Kuchinke, L; Jacobs, AM				Briesemeister, Benny B.; Kuchinke, Lars; Jacobs, Arthur M.			Discrete Emotion Effects on Lexical Decision Response Times	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; VISUAL WORD RECOGNITION; AUTOMATIC VIGILANCE; NEGATIVE WORDS; CATEGORICAL PERCEPTION; FREQUENCY; ATTENTION; INFORMATION; AROUSAL; IMPACT	Our knowledge about affective processes, especially concerning effects on cognitive demands like word processing, is increasing steadily. Several studies consistently document valence and arousal effects, and although there is some debate on possible interactions and different notions of valence, broad agreement on a two dimensional model of affective space has been achieved. Alternative models like the discrete emotion theory have received little interest in word recognition research so far. Using backward elimination and multiple regression analyses, we show that five discrete emotions (i.e., happiness, disgust, fear, anger and sadness) explain as much variance as two published dimensional models assuming continuous or categorical valence, with the variables happiness, disgust and fear significantly contributing to this account. Moreover, these effects even persist in an experiment with discrete emotion conditions when the stimuli are controlled for emotional valence and arousal levels. We interpret this result as evidence for discrete emotion effects in visual word recognition that cannot be explained by the two dimensional affective space account.	[Briesemeister, Benny B.; Kuchinke, Lars; Jacobs, Arthur M.] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, D-1000 Berlin, Germany; [Kuchinke, Lars] Ruhr Univ Bochum, Dept Psychol, Bochum, Germany	Free University of Berlin; Ruhr University Bochum	Briesemeister, BB (corresponding author), Free Univ Berlin, Dahlem Inst Neuroimaging Emot, D-1000 Berlin, Germany.	benny.briesemeister@fu-berlin.de		Jacobs, Arthur/0000-0002-7910-3955				Agresti A, 1997, STAT METHODS SOCIAL; Andrews S, 1997, PSYCHON B REV, V4, P439, DOI 10.3758/BF03214334; Armstrong T, 2009, INT J COGN THER, V2, P37, DOI 10.1521/ijct.2009.2.1.37; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Bradley MM., 2000, SER AFFECTIVE SCI, P242; BRADLEY MM, 1999, C1 CITY U FLOR CTR R; Briesemeister BB, 2011, BEHAV RES METHODS, V43, P441, DOI 10.3758/s13428-011-0059-y; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P, 1972, EMOTION HUMAN FACE G; Estes Z, 2008, EMOTION, V8, P453, DOI 10.1037/a0012887; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Graf R, 2005, Z PSYCHOL, V213, P205, DOI 10.1026/0044-3409.213.4.205; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hofmann MJ, 2007, BEHAV RES METHODS, V39, P620, DOI 10.3758/BF03193034; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Holcomb PJ, 2002, J COGNITIVE NEUROSCI, V14, P938, DOI 10.1162/089892902760191153; Izard C.E., 1977, HUMAN EMOTIONS; Izard CE, 2007, PERSPECT PSYCHOL SCI, V2, P260, DOI [10.1111/j.1745-6916.2007.00044.x, 10.1111/j.1745-6916.2007.00053.x]; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kuchinke L, 2005, NEUROIMAGE, V28, P1022, DOI 10.1016/j.neuroimage.2005.06.050; Kuchinke L, 2007, INT J PSYCHOPHYSIOL, V65, P132, DOI 10.1016/j.ijpsycho.2007.04.004; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Larsen RJ, 2008, EMOTION, V8, P445, DOI 10.1037/1528-3542.8.4.445; Laukka P, 2005, EMOTION, V5, P277, DOI 10.1037/1528-3542.5.3.277; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Nakic M, 2006, NEUROIMAGE, V31, P1752, DOI 10.1016/j.neuroimage.2006.02.022; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2008, INTEGR PSYCHOL BEHAV, V42, P47, DOI 10.1007/s12124-007-9036-5; Parrott DJ, 2005, J GEN PSYCHOL, V132, P67, DOI 10.3200/GENP.132.1.67-80; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; REISENZEIN R, 1994, J PERS SOC PSYCHOL, V67, P525, DOI 10.1037/0022-3514.67.3.525; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Stevenson RA, 2007, MANUAL CATEGORIZATIO; Stevenson RA, 2007, BEHAV RES METHODS, V39, P1020, DOI 10.3758/BF03192999; Stevenson RA, 2011, ARCH SEX BEHAV, V40, P59, DOI 10.1007/s10508-010-9669-1; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Windmann S, 2002, BRAIN LANG, V80, P269, DOI 10.1006/brln.2001.2586; Wundt W, 1896, GRUNDRISS PSYCHOL; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	56	53	53	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23743	10.1371/journal.pone.0023743	http://dx.doi.org/10.1371/journal.pone.0023743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887307	Green Published, gold, Green Submitted			2022-12-25	WOS:000295832000051
J	Cantacessi, C; Young, ND; Nejsum, P; Jex, AR; Campbell, BE; Hall, RS; Thamsborg, SM; Scheerlinck, JP; Gasser, RB				Cantacessi, Cinzia; Young, Neil D.; Nejsum, Peter; Jex, Aaron R.; Campbell, Bronwyn E.; Hall, Ross S.; Thamsborg, Stig M.; Scheerlinck, Jean-Pierre; Gasser, Robin B.			The Transcriptome of Trichuris suis - First Molecular Insights into a Parasite with Curative Properties for Key Immune Diseases of Humans	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; AIRWAY INFLAMMATION; HELMINTH INFECTIONS; HYGIENE HYPOTHESIS; NEMATODE; RESPONSES; GENERATION; GENOME; DAF-16; TOOL	Background: Iatrogenic infection of humans with Trichuris suis (a parasitic nematode of swine) is being evaluated or promoted as a biological, curative treatment of immune diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, in humans. Although it is understood that short-term T. suis infection in people with such diseases usually induces a modified Th2-immune response, nothing is known about the molecules in the parasite that induce this response. Methodology/Principal Findings: As a first step toward filling the gaps in our knowledge of the molecular biology of T. suis, we characterised the transcriptome of the adult stage of this nematode employing next-generation sequencing and bioinformatic techniques. A total of similar to 65,000,000 reads were generated and assembled into similar to 20,000 contiguous sequences (=contigs); similar to 17,000 peptides were predicted and classified based on homology searches, protein motifs and gene ontology and biological pathway mapping. Conclusions: These analyses provided interesting insights into a number of molecular groups, particularly predicted excreted/secreted molecules (n = 1,288), likely to be involved in the parasite-host interactions, and also various molecules (n = 120) linked to chemokine, T-cell receptor and TGF-beta signalling as well as leukocyte transendothelial migration and natural killer cell-mediated cytotoxicity, which are likely to be immuno-regulatory or -modulatory in the infected host. This information provides a conceptual framework within which to test the immunobiological basis for the curative effect of T. suis infection in humans against some immune diseases. Importantly, the T. suis transcriptome characterised herein provides a curated resource for detailed studies of the immuno-molecular biology of this parasite, and will underpin future genomic and proteomic explorations.	[Cantacessi, Cinzia; Young, Neil D.; Jex, Aaron R.; Campbell, Bronwyn E.; Hall, Ross S.; Scheerlinck, Jean-Pierre; Gasser, Robin B.] Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia; [Nejsum, Peter; Thamsborg, Stig M.] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Nejsum, Peter; Thamsborg, Stig M.] Univ Copenhagen, Dept Basic Anim & Vet Sci, Frederiksberg, Denmark; [Scheerlinck, Jean-Pierre] Univ Melbourne, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia	University of Melbourne; University of Copenhagen; University of Copenhagen; University of Melbourne	Cantacessi, C (corresponding author), Univ Melbourne, Dept Vet Sci, Parkville, Vic 3052, Australia.	ccan@unimelb.edu.au; robinbg@unimelb.edu.au	Gasser, Robin/ABH-6185-2020; Jex, Aaron/AGZ-7897-2022; Cantacessi, Cinzia/B-7356-2014; Young, Neil David/AAU-4572-2020	Gasser, Robin/0000-0002-4423-1690; Jex, Aaron/0000-0002-1285-7947; Cantacessi, Cinzia/0000-0001-6863-2950; Young, Neil David/0000-0001-8756-229X; Campbell, Bronwyn/0000-0001-9090-764X; Scheerlinck, Jean-Pierre/0000-0002-8385-353X; Nejsum, Peter/0000-0002-6673-8505	Australian Research Council; Victorian Life Sciences Computation Initiative (VLSCI); IBM Collaboratory	Australian Research Council(Australian Research Council); Victorian Life Sciences Computation Initiative (VLSCI); IBM Collaboratory(International Business Machines (IBM))	This research was supported largely by the Australian Research Council (RBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support from the Victorian Life Sciences Computation Initiative (VLSCI) and IBM Collaboratory is gratefully acknowledged (RBG). The data reported here are available upon request (http://research.vet.unimelb.edu.au/gasserlab/contact.html).	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bager P, 2010, J ALLERGY CLIN IMMUN, V125, P123, DOI 10.1016/j.jaci.2009.08.006; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; BEER RJS, 1973, PARASITOLOGY, V67, P253, DOI 10.1017/S0031182000046497; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Bundy D. A. P., 1989, Advances in Parasitology, V28, P107, DOI 10.1016/S0065-308X(08)60332-2; Campbell BE, 2008, INT J PARASITOL, V38, P65, DOI 10.1016/j.ijpara.2007.07.001; Cantacessi C, 2009, MOL CELL PROBE, V23, P205, DOI 10.1016/j.mcp.2009.03.003; Cantacessi C, 2011, BIOTECHNOL ADV, V29, P261, DOI 10.1016/j.biotechadv.2010.11.005; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; CHANCO PP, 1978, DRUGS, V15, P87, DOI 10.2165/00003495-197800151-00017; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Choo KH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-249; COOPER ES, 1988, PARASITOL TODAY, V4, P301, DOI 10.1016/0169-4758(88)90110-X; COOPER ES, 1992, PARASITOLOGY, V104, pS91, DOI 10.1017/S0031182000075272; Coppede Fabio, 2010, Curr Aging Sci, V3, P3; Datu BJD, 2009, VET PARASITOL, V159, P139, DOI 10.1016/j.vetpar.2008.10.026; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; DRAKE L, 1994, P ROY SOC B-BIOL SCI, V257, P255, DOI 10.1098/rspb.1994.0123; DRAKE LJ, 1994, PARASITOLOGY, V109, P623, DOI 10.1017/S0031182000076502; EDER W, 2008, NEW ENGL J MED, V358, P1483; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; Elliott DE, 2000, FASEB J, V14, P1848, DOI 10.1096/fj.99-0885hyp; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Erb KJ, 2009, TRENDS IMMUNOL, V30, P75, DOI 10.1016/j.it.2008.11.005; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; Fakioglu E, 2008, J VIROL, V82, P9337, DOI 10.1128/JVI.00603-08; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; FLEMING JO, 2011, MULT SCLER IN PRESS; FRYKSMARK U, 1983, H-S Z PHYSIOL CHEM, V364, P793, DOI 10.1515/bchm2.1983.364.2.793; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012289; Grencis RK, 2004, CLIN REV ALLERG IMMU, V26, P51, DOI 10.1385/CRIAI:26:1:51; Harhay MO, 2010, EXPERT REV ANTI-INFE, V8, P219, DOI [10.1586/eri.09.119, 10.1586/ERI.09.119]; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Harris Todd W., 2006, V351, P31; Hepworth MR, 2010, J ALLERGY CLIN IMMUN, V125, P767, DOI 10.1016/j.jaci.2009.11.041; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; HILL DE, 1993, EXP PARASITOL, V77, P170, DOI 10.1006/expr.1993.1074; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Hunter MM, 2004, ALIMENT PHARM THER, V19, P167, DOI 10.1111/j.0269-2813.2004.01803.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Kringel H, 2006, INT J PARASITOL, V36, P915, DOI 10.1016/j.ijpara.2006.04.008; LEDER K, 2010, TROPICAL DIS TRAVELE, pCH31; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maizels RM, 2009, PARASITOLOGY, V136, P1549, DOI 10.1017/S0031182009006106; Marino R, 2011, J IMMUNOL, V186, P4433, DOI 10.4049/jimmunol.1001539; Massey HC, 2003, INT J PARASITOL, V33, P1537, DOI 10.1016/S0020-7519(03)00205-4; Mbeunkui F, 2010, J PROTEOME RES, V9, P5370, DOI 10.1021/pr1006069; McGeady SJ, 2004, PEDIATRICS, V113, P1107; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NIMMO-SMITH R. H., 1960, EXPTL PARASITOL, V10, P337, DOI 10.1016/0014-4894(60)90072-2; Odaka C, 2003, J IMMUNOL, V171, P1507, DOI 10.4049/jimmunol.171.3.1507; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; PANESAR TS, 1980, INT J PARASITOL, V10, P261, DOI 10.1016/0020-7519(80)90006-5; Parthasarathy G, 2005, VET PARASITOL, V131, P317, DOI 10.1016/j.vetpar.2005.03.043; Quarcoo D, 2004, CLIN EXP ALLERGY, V34, P1314, DOI 10.1111/j.1365-2222.2004.02023.x; RAMSEY FRANK C., 1962, WEST INDIAN MED JOUR, V11, P235; Reddy A, 2007, PARASITOL RES, V100, P921, DOI 10.1007/s00436-006-0416-4; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sagel SD, 2009, PEDIATR PULM, V44, P402, DOI 10.1002/ppul.21028; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Summers RW, 2005, INFLAMM BOWEL DIS, V11, P783, DOI 10.1097/01.MIB.0000179316.50002.f3; Summers RW, 2005, NAT CLIN PRACT GASTR, V2, P62, DOI 10.1038/ncpgasthep0087; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; Wright CD, 1999, J PHARMACOL EXP THER, V289, P1007; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Yang X, 2011, CELL MOL IMMUNOL, V8, P12, DOI 10.1038/cmi.2010.51; Yazdanbakhsh M, 2004, CLIN REV ALLERG IMMU, V26, P15, DOI 10.1385/CRIAI:26:1:15; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Young ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	99	38	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23590	10.1371/journal.pone.0023590	http://dx.doi.org/10.1371/journal.pone.0023590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887281	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295832000036
J	Lesku, JA; Meyer, LCR; Fuller, A; Maloney, SK; Dell'Omo, G; Vyssotski, AL; Rattenborg, NC				Lesku, John A.; Meyer, Leith C. R.; Fuller, Andrea; Maloney, Shane K.; Dell'Omo, Giacomo; Vyssotski, Alexei L.; Rattenborg, Niels C.			Ostriches Sleep like Platypuses	PLOS ONE			English	Article							PIGEON COLUMBA-LIVIA; EYE-MOVEMENT SLEEP; TACHYGLOSSUS-ACULEATUS; PHYLOGENETIC ANALYSIS; PARADOXICAL SLEEP; MAMMALIAN SLEEP; FIELD; BRAIN; BIRDS; EEG	Mammals and birds engage in two distinct states of sleep, slow wave sleep (SWS) and rapid eye movement (REM) sleep. SWS is characterized by slow, high amplitude brain waves, while REM sleep is characterized by fast, low amplitude waves, known as activation, occurring with rapid eye movements and reduced muscle tone. However, monotremes (platypuses and echidnas), the most basal (or 'ancient') group of living mammals, show only a single sleep state that combines elements of SWS and REM sleep, suggesting that these states became temporally segregated in the common ancestor to marsupial and eutherian mammals. Whether sleep in basal birds resembles that of monotremes or other mammals and birds is unknown. Here, we provide the first description of brain activity during sleep in ostriches (Struthio camelus), a member of the most basal group of living birds. We found that the brain activity of sleeping ostriches is unique. Episodes of REM sleep were delineated by rapid eye movements, reduced muscle tone, and head movements, similar to those observed in other birds and mammals engaged in REM sleep; however, during REM sleep in ostriches, forebrain activity would flip between REM sleep-like activation and SWS-like slow waves, the latter reminiscent of sleep in the platypus. Moreover, the amount of REM sleep in ostriches is greater than in any other bird, just as in platypuses, which have more REM sleep than other mammals. These findings reveal a recurring sequence of steps in the evolution of sleep in which SWS and REM sleep arose from a single heterogeneous state that became temporally segregated into two distinct states. This common trajectory suggests that forebrain activation during REM sleep is an evolutionarily new feature, presumably involved in performing new sleep functions not found in more basal animals.	[Lesku, John A.; Rattenborg, Niels C.] Max Planck Inst Ornithol, Seewiesen, Germany; [Meyer, Leith C. R.; Fuller, Andrea; Maloney, Shane K.] Univ Witwatersrand, Johannesburg, South Africa; [Maloney, Shane K.] Univ Western Australia, Crawley, WA, Australia; [Dell'Omo, Giacomo] Ornis Ital, Rome, Italy; [Vyssotski, Alexei L.] Univ Zurich, ETH Zurich, Zurich, Switzerland	Max Planck Society; University of Witwatersrand; University of Western Australia; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Lesku, JA (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	rattenborg@orn.mpg.de	Fuller, Andrea/P-3133-2016; maloney, shane k/AAU-5811-2021; /ABD-1334-2021; Meyer, Leith/AAN-4930-2020	Fuller, Andrea/0000-0001-6370-8151; maloney, shane k/0000-0002-5878-2266; Dell'Omo, Giacomo/0000-0002-9601-9675; Meyer, Leith/0000-0002-5122-2469; Vyssotski, Alexei/0000-0002-9021-1471; Lesku, John/0000-0001-5073-6954	Max Planck Society; Swiss National Science Foundation [31003A-122589]; Forschungskredit Universitat Zurich	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit Universitat Zurich	This study was supported by the Max Planck Society (JAL, NCR) and by grants from the Swiss National Science Foundation (31003A-122589) and Forschungskredit Universitat Zurich (ALV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON T, 1972, ARCH ITAL BIOL, V110, P145; Amlaner CJ, 2001, SLEEP, V24, pA202; [Anonymous], 1994, PRINCIPLES PRACTICE; Ayala-Guerrero F, 2003, PHYSIOL BEHAV, V78, P435, DOI 10.1016/S0031-9384(03)00032-5; AYALAGUERRERO F, 1989, PHYSIOL BEHAV, V46, P787, DOI 10.1016/0031-9384(89)90038-3; AYALAGUERRERO F, 1988, BEHAV NEURAL BIOL, V49, P133, DOI 10.1016/S0163-1047(88)90451-7; BERGER RJ, 1972, BEHAV BIOL, V7, P183, DOI 10.1016/S0091-6773(72)80198-6; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; BUCHET C, 1986, PHYSIOL BEHAV, V38, P331, DOI 10.1016/0031-9384(86)90103-4; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; Cooper RG, 2010, TROP ANIM HEALTH PRO, V42, P363, DOI 10.1007/s11250-009-9428-2; Daan S, 2011, SLEEP BIOL RHYTHMS, V9, P1, DOI 10.1111/j.1479-8425.2010.00482.x; Deeming DC, 1999, OSTRICH: BIOLOGY, PRODUCTION AND HEALTH, P83; DEWASMES G, 1985, PHYSIOL BEHAV, V35, P67, DOI 10.1016/0031-9384(85)90173-8; Eiland MM, 2001, ARCH ITAL BIOL, V139, P23; Fuller A, 2004, INT CONGR SER, V1275, P275, DOI 10.1016/j.ics.2004.08.092; Fuller A, 2003, J EXP BIOL, V206, P1171, DOI 10.1242/jeb.00230; Goldstein DL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P237, DOI 10.1086/499995; Gusel'nikova EA, 2007, J EVOL BIOCHEM PHYS+, V43, P442, DOI 10.1134/S0022093007040114; Hartse KM, 1994, PRINCIPLES PRACTICE, P95; IMMELMANN K, 1959, NATURWISSENSCHAFTEN, V46, P564, DOI 10.1007/BF00631301; JOUVET M, 1962, Arch Ital Biol, V100, P125; Komarova T G, 2008, Neurosci Behav Physiol, V38, P245, DOI 10.1007/s11055-008-0036-9; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Lesku JA, 2008, SLEEP MED REV, V12, P229, DOI 10.1016/j.smrv.2007.10.003; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Lesku JA, 2011, P ROY SOC B-BIOL SCI, V278, P2419, DOI 10.1098/rspb.2010.2316; Lesku JA, 2009, NEUROSCI BIOBEHAV R, V33, P1024, DOI 10.1016/j.neubiorev.2009.04.002; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Manger PR, 2002, BRAIN BEHAV EVOLUT, V60, P275, DOI 10.1159/000067195; Martinez-Gonzalez D, 2008, J SLEEP RES, V17, P140, DOI 10.1111/j.1365-2869.2008.00636.x; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; Nicol SC, 2000, NEUROSCI LETT, V283, P49, DOI 10.1016/S0304-3940(00)00922-8; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; OOKAWA T, 1982, J TOKYO SOC VET ZOOT, V30, P105; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Pigarev IN, 2011, EXP BRAIN RES, V210, P131, DOI 10.1007/s00221-011-2606-2; Rattenborg N. C., 2011, RAPID EYE MOVEMENT S, P58; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Rattenborg NC, 2001, BRAIN BEHAV EVOLUT, V58, P323, DOI 10.1159/000057573; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; Rattenborg NC, 2007, BRAIN RES BULL, V72, P187, DOI 10.1016/j.brainresbull.2007.02.010; ROJASRAM.JA, 1970, SCIENCE, V167, P1754, DOI 10.1126/science.167.3926.1754; Roth TC, 2006, J SLEEP RES, V15, P395, DOI 10.1111/j.1365-2869.2006.00559.x; RUCKEBUSCH Y, 1972, ANIM BEHAV, V20, P637, DOI 10.1016/S0003-3472(72)80136-2; Sauer E. G. F., 1966, Living Bird, V5, P45; SAUER EGF, 1967, AUK, V84, P571; Siegel JM, 1998, PHILOS T ROY SOC B, V353, P1147, DOI 10.1098/rstb.1998.0272; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Siegel JM, 1999, NEUROSCIENCE, V91, P391, DOI 10.1016/S0306-4522(98)00588-0; Siegel JM, 1996, J NEUROSCI, V16, P3500; Siegel JM, 2011, PRINCIPLES PRACTICE, P92; STAHEL CD, 1984, J COMP PHYSIOL, V154, P487, DOI 10.1007/BF02515153; SUSIC VT, 1973, PHYSIOL BEHAV, V11, P313, DOI 10.1016/0031-9384(73)90005-X; SZYMCZAK JT, 1993, PHYSIOL BEHAV, V53, P1201, DOI 10.1016/0031-9384(93)90380-X; SZYMCZAK JT, 1987, J COMP PHYSIOL A, V161, P321, DOI 10.1007/BF00615252; Szymusiak R, 2010, CURR OPIN PULM MED, V16, P530, DOI 10.1097/MCP.0b013e32833eec92; TOBLER I, 1988, J COMP PHYSIOL A, V163, P729, DOI 10.1007/BF00604050; TOMO AP, 1973, ANTARCT J US, V8, P202; VANTWYVER H, 1972, EXP NEUROL, V35, P138, DOI 10.1016/0014-4886(72)90065-9; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; WILLIAMS JB, 1993, ECOLOGY, V74, P390, DOI 10.2307/1939301	65	53	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23203	10.1371/journal.pone.0023203	http://dx.doi.org/10.1371/journal.pone.0023203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887239	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295832000010
J	Magnee, MJCM; de Gelder, B; van Engeland, H; Kemner, C				Magnee, Maurice J. C. M.; de Gelder, Beatrice; van Engeland, Herman; Kemner, Chantal			Multisensory Integration and Attention in Autism Spectrum Disorder: Evidence from Event-Related Potentials	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; AUDIOVISUAL SPEECH INTEGRATION; AUDITORY-VISUAL INTEGRATION; SELECTIVE ATTENTION; FACE; PERCEPTION; VOICE; SCHIZOPHRENIA; HUMANS; ERP	Successful integration of various simultaneously perceived perceptual signals is crucial for social behavior. Recent findings indicate that this multisensory integration (MSI) can be modulated by attention. Theories of Autism Spectrum Disorders (ASDs) suggest that MSI is affected in this population while it remains unclear to what extent this is related to impairments in attentional capacity. In the present study Event-related potentials (ERPs) following emotionally congruent and incongruent face-voice pairs were measured in 23 high-functioning, adult ASD individuals and 24 age-and IQ-matched controls. MSI was studied while the attention of the participants was manipulated. ERPs were measured at typical auditory and visual processing peaks, namely, P2 and N170. While controls showed MSI during divided attention and easy selective attention tasks, individuals with ASD showed MSI during easy selective attention tasks only. It was concluded that individuals with ASD are able to process multisensory emotional stimuli, but this is differently modulated by attention mechanisms in these participants, especially those associated with divided attention. This atypical interaction between attention and MSI is also relevant to treatment strategies, with training of multisensory attentional control possibly being more beneficial than conventional sensory integration therapy.	[Magnee, Maurice J. C. M.; van Engeland, Herman; Kemner, Chantal] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Utrecht, Netherlands; [Magnee, Maurice J. C. M.; de Gelder, Beatrice] Tilburg Univ, Lab Cognit & Affect Neurosci, NL-5000 LE Tilburg, Netherlands; [de Gelder, Beatrice] Harvard Univ, Sch Med, Charlestown, MA USA; [de Gelder, Beatrice] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Kemner, Chantal] Univ Utrecht, Dept Dev Psychol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Tilburg University; Harvard University; Harvard University; Massachusetts General Hospital; Utrecht University	Magnee, MJCM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child & Adolescent Psychiat, Utrecht, Netherlands.	M.J.C.M.Magnee@umcutrecht.nl			Netherlands Organization for Scientific Research (NWO) [402-01-094]; Utrecht University	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University	The work described was supported by an Innovational Research Incentives grant (VIDI-scheme, 402-01-094) of the Netherlands Organization for Scientific Research (NWO) and a Neuroscience and Cognition Utrecht (NCU) grant from Utrecht University to Chantal Kemner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; CIESIELSKI KT, 1995, NEUROPSYCHOLOGIA, V33, P225, DOI 10.1016/0028-3932(94)00094-6; COURCHESNE E, 1994, BEHAV NEUROSCI, V108, P848, DOI 10.1037/0735-7044.108.5.848; Dawson G, 2000, J AUTISM DEV DISORD, V30, P415, DOI 10.1023/A:1005547422749; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 1999, NEUROSCI LETT, V260, P133, DOI 10.1016/S0304-3940(98)00963-X; de Jong JJ, 2010, SCHIZOPHR RES, V122, P136, DOI 10.1016/j.schres.2010.04.010; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Fort A, 2002, COGNITIVE BRAIN RES, V14, P20, DOI 10.1016/S0926-6410(02)00058-7; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Hoeksma MR, 2004, J AUTISM DEV DISORD, V34, P341, DOI 10.1023/B:JADD.0000029555.98493.36; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lundqvist D., 1998, KAROLINSKA DIRECTED; Magnee MJCM, 2008, J CHILD PSYCHOL PSYC, V49, P995, DOI 10.1111/j.1469-7610.2008.01902.x; Magnee MJCM, 2008, CLIN NEUROPHYSIOL, V119, P2004, DOI 10.1016/j.clinph.2008.05.005; Magnee MJCM, 2009, NEUROPSYCHOLOGIA, V47, P1728, DOI 10.1016/j.neuropsychologia.2009.02.012; MAGNEE MJC, 2011, CLIN NEUROP IN PRESS; Pourtois G, 2002, COGNITIVE BRAIN RES, V14, P99, DOI 10.1016/S0926-6410(02)00064-2; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Smith EG, 2007, J CHILD PSYCHOL PSYC, V48, P813, DOI 10.1111/j.1469-7610.2007.01766.x; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; TALSMA D, 2010, TREND COGN SCI; Talsma D, 2007, CEREB CORTEX, V17, P679, DOI 10.1093/cercor/bhk016; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; van der Smagt MJ, 2007, J AUTISM DEV DISORD, V37, P2014, DOI 10.1007/s10803-006-0346-0	31	31	34	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e24196	10.1371/journal.pone.0024196	http://dx.doi.org/10.1371/journal.pone.0024196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832TW	21887382	Green Published, Green Submitted, gold			2022-12-25	WOS:000295832000095
J	Vezoli, J; Fifel, K; Leviel, V; Dehay, C; Kennedy, H; Cooper, HM; Gronfier, C; Procyk, E				Vezoli, Julien; Fifel, Karim; Leviel, Vincent; Dehay, Colette; Kennedy, Henry; Cooper, Howard M.; Gronfier, Claude; Procyk, Emmanuel			Early Presymptomatic and Long-Term Changes of Rest Activity Cycles and Cognitive Behavior in a MPTP-Monkey Model of Parkinson's Disease	PLOS ONE			English	Article							RHYTHM SLEEP DISORDERS; TREATED MONKEYS; DOPAMINE TRANSPORTER; RHESUS-MONKEYS; PRACTICE PARAMETERS; DAYTIME SLEEPINESS; STRIATAL DOPAMINE; NONHUMAN-PRIMATES; MOTOR DEFICITS; RECOVERY	Background: It is increasingly recognized that non-motor symptoms are a prominent feature of Parkinson's disease and in the case of cognitive deficits can precede onset of the characteristic motor symptoms. Here, we examine in 4 monkeys chronically treated with low doses of the neurotoxin MPTP the early and long-term alterations of rest-activity rhythms in relationship to the appearance of motor and cognitive symptoms. Methodology/Principal Findings: Behavioral activity recordings as well as motor and cognitive assessments were carried out continuously and in parallel before, during and for several months following MPTP-treatment (12-56 weeks). Cognitive abilities were assessed using a task that is dependent on the functional integrity of the fronto-striatal axis. Rest-activity cycles were monitored continuously using infrared movement detectors of locomotor activity. Motor impairment was evaluated using standardized scales for primates. Results show that MPTP treatment led to an immediate alteration (within one week) of rest-activity cycles and cognitive deficits. Parkinsonian motor deficits only became apparent 3 to 5 weeks after initiating chronic MPTP administration. In three of the four animals studied, clinical scores returned to control levels 5-7 weeks following cessation of MPTP treatment. In contrast, both cognitive deficits and chronobiological alterations persisted for many months. Levodopa treatment led to an improvement of cognitive performance but did not affect rest-activity rhythms in the two cases tested. Conclusions/Significance: Present results show that i) changes in the rest activity cycles constituted early detectable consequences of MPTP treatment and, along with cognitive alterations, characterize the presymptomatic stage; ii) following motor recovery there is a long-term persistence of non-motor symptoms that could reflect differential underlying compensatory mechanisms in these domains; iii) the progressive MPTP-monkey model of presymptomatic ongoing parkinsonism offers possibilities for in-depth studies of early non-motor symptoms including sleep alterations and cognitive deficits.	[Vezoli, Julien; Fifel, Karim; Leviel, Vincent; Dehay, Colette; Kennedy, Henry; Cooper, Howard M.; Gronfier, Claude; Procyk, Emmanuel] INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France; [Vezoli, Julien; Fifel, Karim; Leviel, Vincent; Dehay, Colette; Kennedy, Henry; Cooper, Howard M.; Gronfier, Claude; Procyk, Emmanuel] Univ Lyon, UMR S 846, Lyon, France; [Vezoli, Julien] Max Planck Gesell, ESI, Frankfurt, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm)	Vezoli, J (corresponding author), INSERM, U846, Stem Cell & Brain Res Inst, F-69500 Bron, France.	julien.vezoli@inserm.fr; howard.cooper@inserm.fr	fifel, karim/J-9262-2014; Gronfier, Claude/C-1243-2008; Kennedy, Henry/B-9636-2013; Vezoli, Julien/E-4267-2012; Vezoli, Julien/CAF-7700-2022; Dehay, Colette/H-4437-2014; COOPER, HOWARD/M-7304-2014; procyk, emmanuel/H-3037-2014	fifel, karim/0000-0001-6259-9336; Gronfier, Claude/0000-0002-6549-799X; Kennedy, Henry/0000-0002-2796-7663; Vezoli, Julien/0000-0001-8319-5429; Dehay, Colette/0000-0002-5196-1464; procyk, emmanuel/0000-0001-7486-4993	Fondation de France; Fondation CERA Lyon; EUCLOCK (EU) [018741]; Rhone-Alpes Cible; UNADEV; Cluster HVN;  [ANR-09-MNPS-040]	Fondation de France(Fondation de France); Fondation CERA Lyon; EUCLOCK (EU)(European Commission); Rhone-Alpes Cible(Region Auvergne-Rhone-Alpes); UNADEV; Cluster HVN(Region Auvergne-Rhone-Alpes); 	Funding was provided by Fondation de France, Fondation CERA Lyon, EUCLOCK (EU FP6 project 018741), Rhone-Alpes Cible, UNADEV, ANR-09-MNPS-040, Cluster HVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGID Y, 1991, LANCET, V337, P1321, DOI 10.1016/0140-6736(91)92989-F; Almirall H, 2001, NEUROPHYSIOL CLIN, V31, P161, DOI 10.1016/S0987-7053(01)00256-8; Arnulf I, 2005, SLEEP MED REV, V9, P185, DOI 10.1016/j.smrv.2005.01.001; Arnulf I, 2008, CURR OPIN NEUROL, V21, P472, DOI 10.1097/WCO.0b013e328305044d; Barcia C, 2003, NEUROENDOCRINOLOGY, V78, P118, DOI 10.1159/000071967; Barraud Q, 2009, EXP NEUROL, V219, P574, DOI 10.1016/j.expneurol.2009.07.019; BENAZZOUZ A, 1995, EUR J PHARMACOL, V284, P299, DOI 10.1016/0014-2999(95)00362-O; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Boulet S, 2008, J NEUROSCI, V28, P9575, DOI 10.1523/JNEUROSCI.3465-08.2008; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Decamp E, 2004, EUR J NEUROSCI, V20, P1371, DOI 10.1111/j.1460-9568.2004.03586.x; Diamond A, 1996, PHILOS T R SOC B, V351, P1483, DOI 10.1098/rstb.1996.0134; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Elsworth JD, 2000, NEUROSCIENCE, V95, P399; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; FernandezRuiz J, 1995, NEUROREPORT, V7, P102, DOI 10.1097/00001756-199512290-00024; Galvan A, 2008, CLIN NEUROPHYSIOL, V119, P1459, DOI 10.1016/j.clinph.2008.03.017; Happe S, 2007, J NEUROL, V254, P1037, DOI 10.1007/s00415-006-0483-6; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Jucaite A, 2006, EUR J NUCL MED MOL I, V33, P657, DOI 10.1007/s00259-005-0027-9; Marinus J, 2003, NEUROLOGY, V61, P1222, DOI 10.1212/01.WNL.0000091864.39702.1C; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; Mounayar S, 2007, BRAIN, V130, P2898, DOI 10.1093/brain/awm208; OBESO JA, 2010, NAT MED; OVADIA A, 1995, NEUROBIOL AGING, V16, P931, DOI 10.1016/0197-4580(95)02012-8; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; PEREZOTANO I, 1994, NEUROSCI LETT, V175, P121, DOI 10.1016/0304-3940(94)91094-4; Pessiglione M, 2004, EUR J NEUROSCI, V19, P426, DOI 10.1111/j.0953-816X.2003.03088.x; Pessiglione M, 2003, BRAIN, V126, P1392, DOI 10.1093/brain/awg139; Petzinger GM, 2006, J NEUROSCI RES, V83, P332, DOI 10.1002/jnr.20730; PIFL C, 1991, NEUROSCIENCE, V44, P591, DOI 10.1016/0306-4522(91)90080-8; Poyot T, 2001, J CEREBR BLOOD F MET, V21, P782, DOI 10.1097/00004647-200107000-00003; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; Sack RL, 2007, SLEEP, V30, P1484, DOI 10.1093/sleep/30.11.1484; Schneider JS, 1999, J PHARMACOL EXP THER, V290, P731; SCHNEIDER JS, 1990, BRAIN RES, V519, P122, DOI 10.1016/0006-8993(90)90069-N; SCHNEIDER JS, 1995, NEURODEGENERATION, V4, P245, DOI 10.1016/1055-8330(95)90014-4; Simuni T, 2008, ANN NEUROL, V64, pS65, DOI 10.1002/ana.21472; Slovin H, 1999, J NEUROPHYSIOL, V81, P858, DOI 10.1152/jn.1999.81.2.858; TAYLOR JR, 1990, BRAIN, V113, P617, DOI 10.1093/brain/113.3.617; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; VanSomeren EJW, 1997, BIOL PSYCHIAT, V41, P955, DOI 10.1016/S0006-3223(97)89928-3; Vezoli J, 2009, J NEUROSCI, V29, P15675, DOI 10.1523/JNEUROSCI.4943-09.2009; Yin DL, 2009, J NEUROSCI METH, V176, P200, DOI 10.1016/j.jneumeth.2008.08.027; Zhang ZM, 2000, J GERONTOL A-BIOL, V55, pB473, DOI 10.1093/gerona/55.10.B473	50	34	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23952	10.1371/journal.pone.0023952	http://dx.doi.org/10.1371/journal.pone.0023952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887350	Green Submitted, Green Published, gold			2022-12-25	WOS:000295832000076
J	Wyman, MT; Charlton, BD; Locatelli, Y; Reby, D				Wyman, Megan T.; Charlton, Benjamin D.; Locatelli, Yann; Reby, David			Variability of Female Responses to Conspecific vs. Heterospecific Male Mating Calls in Polygynous Deer: An Open Door to Hybridization?	PLOS ONE			English	Article							REPRODUCTIVE CHARACTER DISPLACEMENT; SIKA CERVUS-NIPPON; MATE CHOICE; RED DEER; SEXUAL SELECTION; HYBRID ZONE; PREFERENCE; EVOLUTION; BEHAVIOR; DISCRIMINATION	Males of all polygynous deer species (Cervinae) give conspicuous calls during the reproductive season. The extreme interspecific diversity that characterizes these vocalizations suggests that they play a strong role in species discrimination. However, interbreeding between several species of Cervinae indicates permeable interspecific reproductive barriers. This study examines the contribution of vocal behavior to female species discrimination and mating preferences in two closely related polygynous deer species known to hybridize in the wild after introductions. Specifically, we investigate the reaction of estrous female red deer (Cervus elaphus) to playbacks of red deer vs. sika deer (Cervus nippon) male mating calls, with the prediction that females will prefer conspecific calls. While on average female red deer preferred male red deer roars, two out of twenty females spent more time in close proximity to the speaker broadcasting male sika deer moans. We suggest that this absence of strict vocal preference for species-specific mating calls may contribute to the permeability of pre-zygotic reproductive barriers observed between these species. Our results also highlight the importance of examining inter-individual variation when studying the role of female preferences in species discrimination and intraspecific mate selection.	[Wyman, Megan T.; Reby, David] Univ Sussex, Sch Psychol, Falmer, England; [Charlton, Benjamin D.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Locatelli, Yann] Museum Natl Hist Nat, Obterre, France	University of Sussex; University of Vienna; Museum National d'Histoire Naturelle (MNHN)	Wyman, MT (corresponding author), Univ Sussex, Sch Psychol, Falmer, England.	wyman.mt@gmail.com	reby, david/A-4227-2013	Charlton, Benjamin/0000-0002-0218-7177; Locatelli, Yann/0000-0002-2657-9327; Reby, David/0000-0001-9261-1711	National Science Foundation [0908569]; Office Of The Director [0908569] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by a National Science Foundation grant to M. Wyman (International Research Fellowship, grant number 0908569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNATHY K, 1994, MOL ECOL, V3, P551, DOI 10.1111/j.1365-294X.1994.tb00086.x; Andersson Malte, 1994; [Anonymous], 1968, REPROD BEHAV UNGULAT; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; BAKER MC, 1990, EVOLUTION, V44, P332, DOI 10.1111/j.1558-5646.1990.tb05202.x; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; BARTOS L, 1982, ZOOL ANZ, V208, P30; Bartos Ludek, 2009, P573, DOI 10.1007/978-4-431-09429-6_39; BASOLO AL, 1990, SCIENCE, V250, P808, DOI 10.1126/science.250.4982.808; Basolo AL, 1998, P ROY SOC B-BIOL SCI, V265, P2223, DOI 10.1098/rspb.1998.0563; Bradbury Jack W., 1998, pi; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burley NT, 2006, ANIM BEHAV, V72, P713, DOI 10.1016/j.anbehav.2006.01.017; Buss DM, 1999, J PERS, V67, P209, DOI 10.1111/1467-6494.00053; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Deregnaucourt S, 2003, ETHOLOGY, V109, P107, DOI 10.1046/j.1439-0310.2003.00854.x; Diaz A, 2006, J ZOOL, V270, P227, DOI 10.1111/j.1469-7998.2006.00130.x; Doherty JA, 1996, ANIM BEHAV, V51, P981, DOI 10.1006/anbe.1996.0101; Doi M, 2001, P NATL ACAD SCI USA, V98, P6714, DOI 10.1073/pnas.091421598; Elias DO, 2006, BEHAV ECOL, V17, P765, DOI 10.1093/beheco/arl005; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Farrell ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018533; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Freed-Brown G, 2009, P ROY SOC B-BIOL SCI, V276, P3319, DOI 10.1098/rspb.2009.0580; Gee JM, 2009, BRAIN BEHAV EVOLUT, V74, P258, DOI 10.1159/000264661; Geist V., 1998, DEER WORLD THEIR EVO; GERHARDT HC, 1994, ANIM BEHAV, V47, P959, DOI 10.1006/anbe.1994.1127; Goodman SJ, 1999, GENETICS, V152, P355; HARRINGTON R, 1973, Irish Forestry, V30, P64; HARRINGTON R, 1982, T INT C GAME BIOL, V14, P559; HEDRICK AV, 1993, ANIM BEHAV, V46, P193, DOI 10.1006/anbe.1993.1176; HILL GE, 1994, BEHAV ECOL, V5, P64, DOI 10.1093/beheco/5.1.64; Hobel G, 2003, EVOLUTION, V57, P894; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Izzo AS, 2011, ANIM BEHAV, V81, P259, DOI 10.1016/j.anbehav.2010.10.015; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kidjo N, 2008, BIOACOUSTICS, V18, P159, DOI 10.1080/09524622.2008.9753598; LITTLEJOHN MJ, 1976, COPEIA, P76; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; Lynch KS, 2006, HORM BEHAV, V49, P450, DOI 10.1016/j.yhbeh.2005.10.001; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MCCOMB K, 1987, NATURE, V330, P648, DOI 10.1038/330648a0; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; McDevitt AD, 2009, MAMM BIOL, V74, P263, DOI 10.1016/j.mambio.2009.03.015; Minami Masato, 1992, Journal of the Mammalogical Society of Japan, V17, P71; MIURA S, 1984, Z TIERPSYCHOL, V64, P33; Nuechterlein GL, 1998, BEHAV ECOL, V9, P313, DOI 10.1093/beheco/9.3.313; PALOKANGAS P, 1992, ANIM BEHAV, V43, P659, DOI 10.1016/0003-3472(92)90087-P; Perez-Espona S, 2011, MAMM BIOL, V76, P640, DOI 10.1016/j.mambio.2010.10.001; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Phelps SM, 2006, AM NAT, V167, P28, DOI 10.1086/498538; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Ptacek MB, 1997, EVOLUTION, V51, P1217, DOI 10.1111/j.1558-5646.1997.tb03969.x; Ptacek MB, 2000, BEHAV PROCESS, V51, P111, DOI 10.1016/S0376-6357(00)00123-6; Putman R.J., 1993, Deer, V9, P104; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Ryan MJ, 1993, EVOLUTIONARY PATTERN, V14, P251; SEARCY WA, 1992, AM ZOOL, V32, P71; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Senn HV, 2010, J ANIM ECOL, V79, P414, DOI 10.1111/j.1365-2656.2009.01633.x; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Uetz GW, 2007, BEHAV ECOL SOCIOBIOL, V61, P631, DOI 10.1007/s00265-006-0293-y; van der Sluijs I, 2008, PHILOS T R SOC B, V363, P2871, DOI 10.1098/rstb.2008.0045; Van Oers K, 2008, ANIM BEHAV, V76, P555, DOI 10.1016/j.anbehav.2008.03.011; Van Opzeeland I, 2010, MAR ECOL PROG SER, V414, P267, DOI 10.3354/meps08683; Wagner WE, 1998, ANIM BEHAV, V55, P1029, DOI 10.1006/anbe.1997.0635; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6	82	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23296	10.1371/journal.pone.0023296	http://dx.doi.org/10.1371/journal.pone.0023296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887242	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295832000012
J	Smith, CR; Suarez, AV; Tsutsui, ND; Wittman, SE; Edmonds, B; Freauff, A; Tillberg, CV				Smith, Chris R.; Suarez, Andrew V.; Tsutsui, Neil D.; Wittman, Sarah E.; Edmonds, Benjamin; Freauff, Alex; Tillberg, Chadwick V.			Nutritional Asymmetries Are Related to Division of Labor in a Queenless Ant	PLOS ONE			English	Article							HARVESTER ANT; REPRODUCTION; SIZE; DOMINANCE; COLONIES; SOCIOGENESIS; SOCIOMETRY; WORKERS; HIERARCHY; INSECT	Eusocial species exhibit pronounced division of labor, most notably between reproductive and non-reproductive castes, but also within non-reproductive castes via morphological specialization and temporal polyethism. For species with distinct worker and queen castes, age-related differences in behavior among workers (e. g. within-nest tasks versus foraging) appear to result from physiological changes such as decreased lipid content. However, we know little about how labor is divided among individuals in species that lack a distinct queen caste. In this study, we investigated how fat storage varied among individuals in a species of ant (Dinoponera australis) that lacks a distinct queen caste and in which all individuals are morphologically similar and capable of reproduction (totipotent at birth). We distinguish between two hypotheses, 1) all individuals are physiologically similar, consistent with the possibility that any non-reproductive may eventually become reproductive, and 2) non-reproductive individuals vary in stored fat, similar to highly eusocial species, where depletion is associated with foraging and non-reproductives have lower lipid stores than reproducing individuals. Our data support the latter hypothesis. Location in the nest, the probability of foraging, and foraging effort, were all associated with decreased fat storage.	[Smith, Chris R.] Earlham Coll, Dept Biol, Richmond, IN 47374 USA; [Suarez, Andrew V.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Suarez, Andrew V.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Wittman, Sarah E.] La Trobe Univ, Dept Bot, Melbourne, Vic, Australia; [Edmonds, Benjamin; Freauff, Alex; Tillberg, Chadwick V.] Linfield Coll, Dept Biol, Mcminnville, OR USA	Earlham College; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; La Trobe University; Linfield University	Smith, CR (corresponding author), Earlham Coll, Dept Biol, Richmond, IN 47374 USA.	crsmith.ant@gmail.com	Edmonds, Benjamin/L-7944-2019	Smith, Chris/0000-0003-4667-9509	Linfield College; MJ Murdock Charitable Trust; NSF [DEB 07-16966]	Linfield College; MJ Murdock Charitable Trust; NSF(National Science Foundation (NSF))	This work was supported by Linfield College and the MJ Murdock Charitable Trust (CVT) and NSF DEB 07-16966 (AVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURKE AFG, 1988, BEHAV ECOL SOCIOBIOL, V23, P323, DOI 10.1007/BF00300579; Cuvillier-Hot V, 2004, ANIM BEHAV, V68, P1209, DOI 10.1016/j.anbehav.2003.11.026; Cuvillier-Hot V, 2002, P ROY SOC B-BIOL SCI, V269, P1295, DOI 10.1098/rspb.2002.1991; Gordon DM, 1999, BEHAV ECOL SOCIOBIOL, V45, P370, DOI 10.1007/s002650050573; Hayashi Y, 2007, SCIENCE, V318, P985, DOI 10.1126/science.1146711; Heinze J, 1999, ANIM BEHAV, V58, P751, DOI 10.1006/anbe.1999.1188; Holldobler B., 1990, pi; HUGHES CR, 1988, BEHAVIOUR, V107, P1, DOI 10.1163/156853988X00151; Julian GE, 2004, ANIM BEHAV, V68, P1, DOI 10.1016/j.anbehav.2003.06.023; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; KERR WE, 1950, GENETICS, V35, P143; Markiewicz DA, 2001, J COMP PHYSIOL A, V187, P327, DOI 10.1007/s003590100204; Monnin T, 2002, NATURE, V419, P61, DOI 10.1038/nature00932; Monnin T, 1999, BEHAV ECOL, V10, P323, DOI 10.1093/beheco/10.3.323; Monnin T, 1999, BEHAV ECOL SOCIOBIOL, V46, P413, DOI 10.1007/s002650050637; Monnin T, 1998, J CHEM ECOL, V24, P473, DOI 10.1023/A:1022360718870; Monnin T, 2008, NATURWISSENSCHAFTEN, V95, P109, DOI 10.1007/s00114-007-0297-0; Moron D, 2008, ANIM BEHAV, V75, P345, DOI 10.1016/j.anbehav.2007.06.005; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Oster G.F., 1978, Monographs in Population Biology, pi; Paiva RVS, 1995, ETHOL ECOL EVOL, V7, P297, DOI 10.1080/08927014.1995.9522938; Peeters C, 1999, P ROY SOC B-BIOL SCI, V266, P1323, DOI 10.1098/rspb.1999.0782; Peeters Christian, 1997, P372; Schwander T, 2005, BEHAV ECOL SOCIOBIOL, V59, P215, DOI 10.1007/s00265-005-0027-6; SIMPSON SJ, 1993, PHYSIOL ENTOMOL, V18, P395, DOI 10.1111/j.1365-3032.1993.tb00613.x; Smith CR, 2006, J INSECT SCI, V6, DOI 10.1673/2006_06_32.1; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Smith Chris R, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5243; STUART RJ, 1991, NATURWISSENSCHAFTEN, V78, P375, DOI 10.1007/BF01131615; SULLIVAN JD, 1984, BEHAV ECOL SOCIOBIOL, V15, P249, DOI 10.1007/BF00292986; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; Tilley CA, 1997, ANIM BEHAV, V54, P1483, DOI 10.1006/anbe.1997.0546; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; TSCHINKEL WR, 1987, INSECT SOC, V34, P143, DOI 10.1007/BF02224081; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Tschinkel WR, 1998, INSECT SOC, V45, P385, DOI 10.1007/s000400050097	38	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e24011	10.1371/journal.pone.0024011	http://dx.doi.org/10.1371/journal.pone.0024011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21886914	Green Published, gold, Green Submitted			2022-12-25	WOS:000294253500042
J	Hayton, SJ; Olmstead, MC; Dumont, EC				Hayton, Scott J.; Olmstead, Mary C.; Dumont, Eric C.			Shift in the Intrinsic Excitability of Medial Prefrontal Cortex Neurons following Training in Impulse Control and Cued-Responding Tasks	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS NEURONS; PYRAMIDAL NEURONS; BASOLATERAL AMYGDALA; MEMBRANE EXCITABILITY; ORBITOFRONTAL CORTEX; EXCITATORY SYNAPSES; COCAINE WITHDRAWAL; RAT; PLASTICITY; RECEPTORS	Impulse control is an executive process that allows animals to inhibit their actions until an appropriate time. Previously, we reported that learning a simple response inhibition task increases AMPA currents at excitatory synapses in the prelimbic region of the medial prefrontal cortex (mPFC). Here, we examined whether modifications to intrinsic excitability occurred alongside the synaptic changes. To that end, we trained rats to obtain a food reward in a response inhibition task by withhold responding on a lever until they were signaled to respond. We then measured excitability, using whole-cell patch clamp recordings in brain slices, by quantifying action potentials generated by the injection of depolarizing current steps. Training in this task depressed the excitability of layer V pyramidal neurons of the prelimbic, but not infralimbic, region of the mPFC relative to behavioral controls. This decrease in maximum spiking frequency was significantly correlated with performance on the final session of the task. This change in intrinsic excitability may represent a homeostatic mechanism counterbalancing increased excitatory synaptic inputs onto those neurons in trained rats. Interestingly, subjects trained with a cue that predicted imminent reward availability had increased excitability in infralimbic, but not the prelimbic, pyramidal neurons. This dissociation suggests that both prelimbic and infralimbic neurons are involved in directing action, but specialized for different types of information, inhibitory or anticipatory, respectively.	[Hayton, Scott J.; Olmstead, Mary C.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Olmstead, Mary C.; Dumont, Eric C.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Dumont, Eric C.] Queens Univ, Dept Anesthesiol & Perioperat Med, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Hayton, SJ (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	eric.dumont@queensu.ca			Natural Sciences and Engineering Research Council of Canada [MCO: 203707-2006, ECD: 327350-2008]; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (MCO: 203707-2006; ECD: 327350-2008). SJH held an NSERC post-graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten A.F., 2009, J PEDIAT, V154; Befort K, 2011, PSYCHOPHARMACOLOGY, V214, P967, DOI 10.1007/s00213-010-2108-0; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Carelli RM, 2003, J NEUROSCI, V23, P8204; Carli M, 2006, NEUROPSYCHOPHARMACOL, V31, P757, DOI 10.1038/sj.npp.1300893; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Dalley JW, 2007, NEUROPSYCHOPHARMACOL, V32, P1195, DOI 10.1038/sj.npp.1301220; Dong Y, 2005, J NEUROSCI, V25, P936, DOI 10.1523/JNEUROSCI.4715-04.2005; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hayton SJ, 2010, J NEUROSCI, V30, P11493, DOI 10.1523/JNEUROSCI.1550-10.2010; Ishikawa A, 2008, NEUROSCIENCE, V155, P573, DOI 10.1016/j.neuroscience.2008.06.037; Jones JL, 2010, BIOL PSYCHIAT, V67, P737, DOI 10.1016/j.biopsych.2009.11.006; Kasanetz F, 2009, J NEUROPHYSIOL, V101, P2516, DOI 10.1152/jn.91039.2008; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McLaughlin RJ, 2007, NEUROSCIENCE, V146, P1484, DOI 10.1016/j.neuroscience.2007.03.025; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Moyer JR, 1996, J NEUROSCI, V16, P5536; Mu P, 2010, J NEUROSCI, V30, P3689, DOI 10.1523/JNEUROSCI.4063-09.2010; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Nasif FJ, 2005, J PHARMACOL EXP THER, V312, P1305, DOI 10.1124/jpet.104.075184; Nasif FJ, 2005, J NEUROSCI, V25, P3674, DOI 10.1523/JNEUROSCI.0010-05.2005; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Olmstead M., 2009, ENDOPHENOTYPES PSYCH, P135; Olmstead MC, 2006, Q J EXP PSYCHOL, V59, P625, DOI 10.1080/17470210500356308; Paz JT, 2009, J PHYSIOL-LONDON, V587, P3189, DOI 10.1113/jphysiol.2009.169334; Peterson JD, 2003, BEHAV BRAIN RES, V143, P101, DOI 10.1016/S0166-4328(03)00035-4; Rogers RD, 2010, ALCOHOL CLIN EXP RES, V34, P1319, DOI 10.1111/j.1530-0277.2010.01216.x; Saar D, 2003, EUR J NEUROSCI, V17, P2727, DOI 10.1046/j.1460-9568.2003.02699.x; Saar D, 1998, EUR J NEUROSCI, V10, P1518, DOI 10.1046/j.1460-9568.1998.00149.x; Saar D, 2009, MOL NEUROBIOL, V39, P171, DOI 10.1007/s12035-009-8060-5; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Waxman SE, 2009, EUR EAT DISORD REV, V17, P408, DOI 10.1002/erv.952; Winstanley CA, 2009, CEREB CORTEX, V19, P435, DOI 10.1093/cercor/bhn094; Wolf ME, 2010, TRENDS NEUROSCI, V33, P391, DOI 10.1016/j.tins.2010.06.003; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248; Zhang XF, 1998, J NEUROSCI, V18, P488	46	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23885	10.1371/journal.pone.0023885	http://dx.doi.org/10.1371/journal.pone.0023885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21887338	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800037
J	Nevalainen, EM; Braun, A; Vartiainen, MK; Serlachius, M; Andersson, LC; Moser, M; Lappalainen, P				Nevalainen, Elisa M.; Braun, Attila; Vartiainen, Maria K.; Serlachius, Martina; Andersson, Leif C.; Moser, Markus; Lappalainen, Pekka			Twinfilin-2a Is Dispensable for Mouse Development	PLOS ONE			English	Article								Twinfilins are evolutionarily conserved regulators of cytoskeletal dynamics. They inhibit actin polymerization by binding both actin monomers and filament barbed ends. Inactivation of the single twinfilin gene from budding yeast and fruit fly results in defects in endocytosis, cell migration, and organization of the cortical actin filament structures. Mammals express three twinfilin isoforms, of which twinfilin-1 and twinfilin-2a display largely overlapping expression patterns in non-muscle tissues of developing and adult mice. The expression of twinfilin-2b, which is generated through alternative promoter usage of the twinfilin-2 gene, is restricted to heart and skeletal muscles. However, the physiological functions of mammalian twinfilins have not been reported. As a first step towards understanding the function of twinfilin in vertebrates, we generated twinfilin-2a deficient mice by deleting exon 1 of the twinfilin-2 gene. Twinfilin-2a knockout mice developed normally to adulthood, were fertile, and did not display obvious morphological or behavioural abnormalities. Tissue anatomy and morphology in twinfilin-2a deficient mice was similar to that of wild-type littermates. These data suggest that twinfilin-2a plays a redundant role in cytoskeletal dynamics with the biochemically similar twinfilin-1, which is typically co-expressed in same tissues with twinfilin-2a.	[Nevalainen, Elisa M.; Vartiainen, Maria K.; Serlachius, Martina; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Nevalainen, Elisa M.] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Braun, Attila; Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Andersson, Leif C.] Univ Helsinki, Dept Pathol, HUSLAB, Helsinki, Finland	University of Helsinki; University of Helsinki; Max Planck Society; University of Helsinki	Nevalainen, EM (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	pekka.lappalainen@helsinki.fi	Vartiainen, Maria/P-7043-2019; Vartiainen, Maria K/F-4767-2013	Vartiainen, Maria/0000-0002-2017-0475; Vartiainen, Maria K/0000-0002-2017-0475; Lappalainen, Pekka/0000-0001-6227-0354	Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from Academy of Finland and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszodi A, 1999, MOL CELL BIOL, V19, P7841; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Falck S, 2004, EMBO J, V23, P3010, DOI 10.1038/sj.emboj.7600310; FASSLER R, 1995, J CELL BIOL, V128, P979, DOI 10.1083/jcb.128.5.979; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Moseley JB, 2006, J CELL SCI, V119, P1547, DOI 10.1242/jcs.02860; NEVALAINEN EM, 2009, BIOCHEM J, V2, P593; Nicholson-Dykstra S, 2005, CURR BIOL, V15, pR346, DOI 10.1016/j.cub.2005.04.029; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Wang D, 2010, J CELL SCI, V123, P1546, DOI 10.1242/jcs.060251; Yamada S, 2007, BIOCHEM BIOPH RES CO, V363, P926, DOI 10.1016/j.bbrc.2007.09.069	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2011	6	8							e22894	10.1371/journal.pone.0022894	http://dx.doi.org/10.1371/journal.pone.0022894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LN	21876732	Green Published, gold, Green Submitted			2022-12-25	WOS:000294126900004
J	Huang, WT; Chen, WC; Teng, HJ; Huang, WI; Huang, YW; Hsu, CW; Chuang, JH				Huang, Wan-Ting; Chen, Wan-Chin; Teng, Hwa-Jen; Huang, Wei-I; Huang, Yu-Wen; Hsu, Chien-Wen; Chuang, Jen-Hsiang			Adverse Events Following Pandemic A (H1N1) 2009 Monovalent Vaccines in Pregnant Women - Taiwan, November 2009-August 2010	PLOS ONE			English	Article							INFLUENZA VACCINATION; CAPTURE-RECAPTURE; SAFETY; SURVEILLANCE; SYSTEMS	Background: During the 2009 H1N1 pandemic, pregnant women were prioritized to receive the unadjuvanted or MF59 (R)-adjuvanted pandemic A (H1N1) 2009 monovalent vaccines ("2009 H1N1 vaccines") in Taiwan regardless of stage of pregnancy. Monitoring adverse events following 2009 H1N1 vaccination in pregnant women was a priority for the mass immunization campaign beginning November 2009. Methods/Findings: We characterized reports to the national passive surveillance from November 2009 through August 2010 involving adverse events following 2009 H1N1 vaccines among pregnant women. Reports from the passive surveillance were matched to a large-linked database on a unique identifier, date of vaccination, and date of diagnosis in a capture-recapture analysis to estimate the true number of spontaneous abortion after 2009 H1N1 vaccination. We verified 16 spontaneous abortions, 11 stillbirths, 4 neonatal deaths, 4 nonpregnancy-specific adverse events, and 2 inadvertent immunizations in recipients who were unaware of pregnancy at time of vaccination. The Chapman capture-recapture estimator of true number of spontaneous abortion after 2009 H1N1 vaccination was 329 (95% confidence interval [CI] 196-553). Of the 14,474 pregnant women who received the 2009 H1N1 vaccines, the estimated risk of spontaneous abortion was 2.3 (95% CI, 1.4-3.8) per 100 pregnancies, compared with a local background rate of 12.8 (95% CI, 12.8-12.9) per 100 pregnancies. Conclusions: The passive surveillance provided rapid initial assessment of adverse events after 2009 H1N1 vaccination among pregnant women. Its findings were reassuring for the safety of 2009 H1N1 vaccines in pregnancy.	[Huang, Wan-Ting; Chen, Wan-Chin; Teng, Hwa-Jen; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Taipei, Taiwan; [Huang, Wei-I] Taiwan Drug Relief Fdn, Taipei, Taiwan; [Huang, Yu-Wen; Hsu, Chien-Wen] Taiwan Food & Drug Adm, Taipei, Taiwan; [Huang, Yu-Wen] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10764, Taiwan	National Taiwan University	Huang, WT (corresponding author), Taiwan Ctr Dis Control, Taipei, Taiwan.	muagi@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010; Huang, Wan-Ting/E-3497-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; Huang, Wan-Ting/0000-0002-4344-9567; Weninger, Tim/0000-0003-3164-2615; , Heli/0000-0002-2765-6582; Chen, Wan-Chin/0000-0002-2278-6193	Taiwan Centers for Disease Control; Taiwan Food and Drug Administration	Taiwan Centers for Disease Control; Taiwan Food and Drug Administration	This work is funded by Taiwan Centers for Disease Control and Taiwan Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Carvajal A, 2011, VACCINE, V29, P519, DOI 10.1016/j.vaccine.2010.10.067; Chapman D. G., 1951, U CALIFORNIA PUBLICA, V1, P131; *DEP HLTH, PHARM TAIW, P11601; European Medicines Agency, CHMP REC PHARM PLAN; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; HARRIS JW, 1919, JAMA-J AM MED ASSOC, V72, P970; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Huang WT, 2010, LANCET, V375, P1164, DOI 10.1016/S0140-6736(10)60515-6; HUANG WT, 2011, EMER INFECT IN PRESS, P11601; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lacroix I, 2011, VACCINE, V29, P1357, DOI 10.1016/j.vaccine.2010.12.011; Lim SH, 2010, VACCINE, V28, P7455, DOI 10.1016/j.vaccine.2010.08.087; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Moro PL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.050; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Reddy UM, 2009, OBSTET GYNECOL, V114, P901, DOI 10.1097/AOG.0b013e3181b8f6e4; Rosenthal S, 1995, AM J PUBLIC HEALTH, V85, P1706, DOI 10.2105/AJPH.85.12.1706; SEBER GAF, 1970, BIOMETRICS, V26, P13, DOI 10.2307/2529040; SIMPSON JL, 1990, AM J MED GENET, V35, P165, DOI 10.1002/ajmg.1320350205; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Verstraeten T, 2001, AM J EPIDEMIOL, V154, P1006, DOI 10.1093/aje/154.11.1006; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	30	63	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2011	6	8							e23049	10.1371/journal.pone.0023049	http://dx.doi.org/10.1371/journal.pone.0023049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	803EC	21887325	Green Published, gold			2022-12-25	WOS:000293563300035
J	Chang, YJ; Yeh, ML; Li, YC; Hsu, CY; Lin, CC; Hsu, MS; Chiu, WT				Chang, Ying-Jui; Yeh, Min-Li; Li, Yu-Chuan; Hsu, Chien-Yeh; Lin, Chao-Cheng; Hsu, Meng-Shiuan; Chiu, Wen-Ta			Predicting Hospital-Acquired Infections by Scoring System with Simple Parameters	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; BLOOD-STREAM INFECTIONS; ADMINISTRATIVE CODING DATA; TRAUMATIC BRAIN-INJURY; NOSOCOMIAL INFECTIONS; RISK-FACTORS; SURVEILLANCE; PREVENTION; MORTALITY; COSTS	Background: Hospital-acquired infections (HAI) are associated with increased attributable morbidity, mortality, prolonged hospitalization, and economic costs. A simple, reliable prediction model for HAI has great clinical relevance. The objective of this study is to develop a scoring system to predict HAI that was derived from Logistic Regression (LR) and validated by Artificial Neural Networks (ANN) simultaneously. Methodology/Principal Findings: A total of 476 patients from all the 806 HAI inpatients were included for the study between 2004 and 2005. A sample of 1,376 non-HAI inpatients was randomly drawn from all the admitted patients in the same period of time as the control group. External validation of 2,500 patients was abstracted from another academic teaching center. Sixteen variables were extracted from the Electronic Health Records (EHR) and fed into ANN and LR models. With stepwise selection, the following seven variables were identified by LR models as statistically significant: Foley catheterization, central venous catheterization, arterial line, nasogastric tube, hemodialysis, stress ulcer prophylaxes and systemic glucocorticosteroids. Both ANN and LR models displayed excellent discrimination (area under the receiver operating characteristic curve [AUC]: 0.964 versus 0.969, p = 0.507) to identify infection in internal validation. During external validation, high AUC was obtained from both models (AUC: 0.850 versus 0.870, p = 0.447). The scoring system also performed extremely well in the internal (AUC: 0.965) and external (AUC: 0.871) validations. Conclusions: We developed a scoring system to predict HAI with simple parameters validated with ANN and LR models. Armed with this scoring system, infectious disease specialists can more efficiently identify patients at high risk for HAI during hospitalization. Further, using parameters either by observation of medical devices used or data obtained from EHR also provided good prediction outcome that can be utilized in different clinical settings.	[Chang, Ying-Jui; Yeh, Min-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Ying-Jui] Far Eastern Mem Hosp, Dept Dermatol, New Taipei, Taiwan; [Yeh, Min-Li] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan; [Li, Yu-Chuan] Taipei Med Univ, Dept Dermatol, Wan Fang Hosp, Taipei, Taiwan; [Li, Yu-Chuan; Hsu, Chien-Yeh] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Hsu, Chien-Yeh] Taipei Med Univ, CECR, Taipei, Taiwan; [Lin, Chao-Cheng] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hsu, Meng-Shiuan] Far Eastern Mem Hosp, Infect Dis Sect, Dept Internal Med, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan	Taipei Medical University; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	jack@tmu.edu.tw; cyhsu@tmu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657				Archibald LK, 2007, BENNETT BRACHMANS HO, P483; Artigas AT, 2001, CRIT CARE MED, V29, P304, DOI 10.1097/00003246-200102000-00015; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Cevik MA, 2005, J HOSP INFECT, V59, P324, DOI 10.1016/j.jhin.2004.10.012; Chong Chee-Fah, 2003, AMIA Annu Symp Proc, P160; D'Agata EMC, 2000, AM J KIDNEY DIS, V35, P1083, DOI 10.1016/S0272-6386(00)70044-8; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Department of Health EY Taiwan, 2010, EL MED REC; DiGiovine B, 1999, AM J RESP CRIT CARE, V160, P976, DOI 10.1164/ajrccm.160.3.9808145; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Escolano S, 2000, STAT MED, V19, P3465, DOI 10.1002/1097-0258(20001230)19:24&lt;3465::AID-SIM658&gt;3.0.CO;2-6; Ferrer M, 1999, ANN INTERN MED, V130, P991, DOI 10.7326/0003-4819-130-12-199906150-00007; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Goldstein Melissa M, 2010, Perspect Health Inf Manag, V7; HALEY RW, 1985, AM J EPIDEMIOL, V121, P159, DOI 10.1093/oxfordjournals.aje.a113988; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kallen AJ, 2010, CLIN INFECT DIS, V51, P335, DOI 10.1086/653942; Kamp-Hopmans TEM, 2003, INFECT CONT HOSP EP, V24, P584, DOI 10.1086/502258; Kostadima E, 2006, EUR RESPIR J, V27, P437, DOI 10.1183/09031936.06.00127405; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Li YC, 2000, INT J MED INFORM, V57, P1, DOI 10.1016/S1386-5056(99)00054-4; Lin CC, 2008, COMPUT METH PROG BIO, V91, P91, DOI 10.1016/j.cmpb.2008.02.004; Mahieu LM, 2001, J HOSP INFECT, V47, P223, DOI 10.1053/jhin.2000.0852; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Saint S, 2009, ANN INTERN MED, V150, P877, DOI 10.7326/0003-4819-150-12-200906160-00013; Shang J S, 2000, Health Care Manag Sci, V3, P287, DOI 10.1023/A:1019018129822; Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Teramoto S, 2006, EUR RESPIR J, V27, P436, DOI 10.1183/09031936.06.00113405; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Wilson JS, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-47; Woeltje KF, 2010, CRIT CARE MED, V38, pS399, DOI 10.1097/CCM.0b013e3181e6d11d	42	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2011	6	8							e23137	10.1371/journal.pone.0023137	http://dx.doi.org/10.1371/journal.pone.0023137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832TW	21887234	gold, Green Published, Green Submitted			2022-12-25	WOS:000295832000008
J	Dalmasso, G; Hang, TTN; Yan, YT; Laroui, H; Charania, MA; Ayyadurai, S; Sitaraman, SV; Merlin, D				Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier			Microbiota Modulate Host Gene Expression via MicroRNAs	PLOS ONE			English	Article								Microbiota are known to modulate host gene expression, yet the underlying molecular mechanisms remain elusive. MicroRNAs (miRNAs) are importantly implicated in many cellular functions by post-transcriptionally regulating gene expression via binding to the 3'-untranslated regions (3'-UTRs) of the target mRNAs. However, a role for miRNAs in microbiota-host interactions remains unknown. Here we investigated if miRNAs are involved in microbiota-mediated regulation of host gene expression. Germ-free mice were colonized with the microbiota from pathogen-free mice. Comparative profiling of miRNA expression using miRNA arrays revealed one and eight miRNAs that were differently expressed in the ileum and the colon, respectively, of colonized mice relative to germ-free mice. A computational approach was then employed to predict genes that were potentially targeted by the dysregulated miRNAs during colonization. Overlapping the miRNA potential targets with the microbiota-induced dysregulated genes detected by a DNA microarray performed in parallel revealed several host genes that were regulated by miRNAs in response to colonization. Among them, Abcc3 was identified as a highly potential miRNA target during colonization. Using the murine macrophage RAW 264.7 cell line, we demonstrated that mmu-miR-665, which was dysregulated during colonization, down-regulated Abcc3 expression by directly targeting the Abcc3 3'-UTR. In conclusion, our study demonstrates that microbiota modulate host microRNA expression, which could in turn regulate host gene expression.	[Dalmasso, Guillaume; Hang Thi Thu Nguyen; Yan, Yutao; Laroui, Hamed; Charania, Moiz A.; Ayyadurai, Saravanan; Sitaraman, Shanthi V.; Merlin, Didier] Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA; [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Dalmasso, G (corresponding author), Emory Univ, Sch Med, Dept Med, Div Digest Dis, Atlanta, GA 30322 USA.	gdalmas@emory.edu	Dalmasso, Guillaume/N-2443-2018; Nguyen, Hang/N-2441-2018	Dalmasso, Guillaume/0000-0002-3433-870X; Nguyen, Hang/0000-0001-7431-5126	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399, RO1-DK-071594, RO1-DK-55850]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055850, R01DK071594, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R24-DK-064399 center grant, RO1-DK-071594 to D.M., RO1-DK-55850 to S.V.S.]; and a research fellowship award from the Crohn's and Colitis Foundation of America [to G.D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; WHITT DD, 1980, INFECT IMMUN, V29, P144, DOI 10.1128/IAI.29.1.144-151.1980; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	17	168	182	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2011	6	4							e19293	10.1371/journal.pone.0019293	http://dx.doi.org/10.1371/journal.pone.0019293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756OZ	21886824	Green Published, Green Submitted, gold			2022-12-25	WOS:000290024700127
J	Zhao, CJ; Wang, XF; Zhao, YW; Li, ZM; Lin, S; Wei, YQ; Yang, HS				Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo			A Novel Xenograft Model in Zebrafish for High-Resolution Investigating Dynamics of Neovascularization in Tumors	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; ANGIOGENESIS; GROWTH; RECRUITMENT; CELLS; METASTASIS; EXPRESSION; DISCOVERY; INVASION; CORNEA	Tumor neovascularization is a highly complex process including multiple steps. Understanding this process, especially the initial stage, has been limited by the difficulties of real-time visualizing the neovascularization embedded in tumor tissues in living animal models. In the present study, we have established a xenograft model in zebrafish by implanting mammalian tumor cells into the perivitelline space of 48 hours old Tg(Flk1:EGFP) transgenic zebrafish embryos. With this model, we dynamically visualized the process of tumor neovascularization, with unprecedented high-resolution, including new sprouts from the host vessels and the origination from VEGFR2(+) individual endothelial cells. Moreover, we quantified their contributions during the formation of vascular network in tumor. Real-time observations revealed that angiogenic sprouts in tumors preferred to connect each other to form endothelial loops, and more and more endothelial loops accumulated into the irregular and chaotic vascular network. The over-expression of VEGF165 in tumor cells significantly affected the vascularization in xenografts, not only the number and size of neo-vessels but the abnormalities of tumor vascular architecture. The specific inhibitor of VEGFR2, SU5416, significantly inhibited the vascularization and the growth of melanoma xenografts, but had little affects to normal vessels in zebrafish. Thus, this zebrafish/tumor xenograft model not only provides a unique window to investigate the earliest events of tumoral neoangiogenesis, but is sensitive to be used as an experimental platform to rapidly and visually evaluate functions of angiogenic-related genes. Finally, it also offers an efficient and cost-effective means for the rapid evaluation of anti-angiogenic chemicals.	[Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo] Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhao, Chengjian; Wang, Xiaofei; Zhao, Yuwei; Li, Zhimian; Lin, Shuo; Wei, Yuquan; Yang, Hanshuo] Sichuan Univ, W China Med Sch, Ctr Canc, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA	Sichuan University; Sichuan University; University of California System; University of California Los Angeles	Zhao, CJ (corresponding author), Sichuan Univ, W China Med Sch, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yhansh@scu.edu.cn		Dong, Jing/0000-0001-9856-5963; Wei, Yu-quan/0000-0002-6211-3217; chen, daozhen/0000-0003-4791-8065	National Key Basic Research Program of China [2010CB529900]	National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Key Basic Research Program of China (2010CB529900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dvorak HF, 2003, AM J PATHOL, V162, P1747, DOI 10.1016/S0002-9440(10)64309-X; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Hasan Jurjees, 2004, Angiogenesis, V7, P1, DOI 10.1023/B:AGEN.0000037338.51851.d1; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; KNIGHTON D, 1977, BRIT J CANCER, V35, P347, DOI 10.1038/bjc.1977.49; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Parng C, 2005, CURR OPIN DRUG DISC, V8, P100; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Phillips G D, 1994, In Vivo, V8, P961; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Vajkoczy P, 2002, J CLIN INVEST, V109, P777, DOI 10.1172/JCI200214105; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	31	214	220	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e21768	10.1371/journal.pone.0021768	http://dx.doi.org/10.1371/journal.pone.0021768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21765912	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500014
J	Huang, QD; Zhong, GX; Zhang, Y; Ren, J; Fu, Y; Zhang, J; Zhu, W; Yu, XQ				Huang, Qing-Dong; Zhong, Guo-Xing; Zhang, Yang; Ren, Jiang; Fu, Yun; Zhang, Ji; Zhu, Wen; Yu, Xiao-Qi			Cyclen-Based Cationic Lipids for Highly Efficient Gene Delivery towards Tumor Cells	PLOS ONE			English	Article							DNA COMPLEXES; TRANSFECTION; VECTORS; THERAPY; LINKER; GROWTH	Background: Gene therapy has tremendous potential for both inherited and acquired diseases. However, delivery problems limited their clinical application, and new gene delivery vehicles with low cytotoxicity and high transfection efficiency are greatly required. Methods: In this report, we designed and synthesized three amphiphilic molecules (L1-L3) with the structures involving 1, 4, 7, 10-tetraazacyclododecane (cyclen), imidazolium and a hydrophobic dodecyl chain. Their interactions with plasmid DNA were studied via electrophoretic gel retardation assays, fluorescent quenching experiments, dynamic light scattering and transmission electron microscopy. The in vitro gene transfection assay and cytotoxicity assay were conducted in four cell lines. Results: Results indicated that L1 and L3-formed liposomes could effectively bind to DNA to form well-shaped nanoparticles. Combining with neutral lipid DOPE, L3 was found with high efficiency in gene transfer in three tumor cell lines including A549, HepG2 and H460. The optimized gene transfection efficacy of L3 was nearly 5.5 times more efficient than that of the popular commercially available gene delivery agent Lipofectamine 2000 (TM) in human lung carcinoma cells A549. In addition, since L1 and L3 had nearly no gene transfection performance in normal cells HEK293, these cationic lipids showed tumor cell-targeting property to a certain extent. No significant cytotoxicity was found for the lipoplexes formed by L1-L3, and their cytotoxicities were similar to or slightly lower than the lipoplexes prepared from Lipofectamine 2000 (TM). Conclusion: Novel cyclen-based cationic lipids for effective in vitro gene transfection were founded, and these studies here may extend the application areas of macrocyclic polyamines, especially for cyclen.	[Huang, Qing-Dong] Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China; Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Huang, QD (corresponding author), Sichuan Univ, W China Hosp, Coll Chem, Key Lab Green Chem & Technol,Minist Educ, Chengdu 610064, Peoples R China.	jzhang@scu.edu.cn; zhuwen@scu.edu.cn; xqyu@scu.edu.cn	Yu, Xiao-Qi/AAF-2741-2020	YU, WEI/0000-0002-1777-5254	National Science Foundation of China [20972104, 20725206, 20732004, 20902062]; Program for Changjiang Scholars and Innovative Research Team in University; Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education in China; Scientific Fund of Sichuan Province	This work was financially supported by the National Science Foundation of China (Nos. 20972104, 20725206, 20732004 and 20902062), the Program for Changjiang Scholars and Innovative Research Team in University, the Key Project of Chinese Ministry of Education in China and the Scientific Fund of Sichuan Province for Outstanding Young Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J GENE MED, V7, P739, DOI 10.1002/jgm.717; Aissaoui A, 2004, J MED CHEM, V47, P5210, DOI 10.1021/jm0408159; Anderson WF, 1998, NATURE, V392, P25; Bajaj A, 2008, J MED CHEM, V51, P2533, DOI 10.1021/jm7010436; Bajaj A, 2007, BIOCONJUGATE CHEM, V18, P1537, DOI 10.1021/bc070010q; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Boktov J, 2007, J GENE MED, V9, P884, DOI 10.1002/jgm.1079; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cheung JL, 1997, J ORG CHEM, V62, P62, DOI 10.1021/jo961254z; Dobbs W, 2009, J AM CHEM SOC, V131, P13338, DOI 10.1021/ja903028f; Ewert K, 2002, J MED CHEM, V45, P5023, DOI 10.1021/jm020233w; Ewert KK, 2006, J AM CHEM SOC, V128, P3998, DOI 10.1021/ja055907h; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fujiwara T, 2000, BBA-BIOMEMBRANES, V1468, P396, DOI 10.1016/S0005-2736(00)00278-9; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Huang QD, 2008, CHEM BIOL DRUG DES, V71, P224, DOI 10.1111/j.1747-0285.2008.00631.x; Kimura E, 1999, CHEM-EUR J, V5, P3113, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3113::AID-CHEM3113>3.0.CO;2-L; Lam AMI, 2000, BBA-BIOMEMBRANES, V1463, P279, DOI 10.1016/S0005-2736(99)00219-9; Li QL, 2006, BIOORGAN MED CHEM, V14, P4151, DOI 10.1016/j.bmc.2006.01.069; Liberska A, 2009, ORG BIOMOL CHEM, V7, P61, DOI 10.1039/b815733b; Martin B, 2005, CURR PHARM DESIGN, V11, P375, DOI 10.2174/1381612053382133; Miller AD, 2003, CURR MED CHEM, V10, P1195, DOI 10.2174/0929867033457485; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Petukhov IA, 2010, RUSS CHEM B+, V59, P260, DOI 10.1007/s11172-010-0071-x; Rajesh M, 2007, J AM CHEM SOC, V129, P11408, DOI 10.1021/ja0704683; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Xia CQ, 2006, BIOORGAN MED CHEM, V14, P5756, DOI 10.1016/j.bmc.2006.04.048; Xiang YZ, 2010, ORG BIOMOL CHEM, V8, P640, DOI 10.1039/b914877a; Yang XB, 2008, BIOORGAN MED CHEM, V16, P3871, DOI 10.1016/j.bmc.2008.01.037; Yi WJ, 2011, ORG BIOMOL CHEM, V9, P2413, DOI 10.1039/c0ob00879f; Yla-Herttuala S, 2000, LANCET, V355, P213, DOI 10.1016/S0140-6736(99)04180-X; Zhang SB, 2007, J CONTROL RELEASE, V123, P1, DOI 10.1016/j.jconrel.2007.07.016; Zhou LH, 2009, CHEM BIOL DRUG DES, V73, P216, DOI 10.1111/j.1747-0285.2008.00765.x	35	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23134					11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	21887233				2022-12-25	WOS:000295454200045
J	Cook, S; Conrad, C; Fowlkes, AL; Mohebbi, MH				Cook, Samantha; Conrad, Corrie; Fowlkes, Ashley L.; Mohebbi, Matthew H.			Assessing Google Flu Trends Performance in the United States during the 2009 Influenza Virus A (H1N1) Pandemic	PLOS ONE			English	Article								Background: Google Flu Trends (GFT) uses anonymized, aggregated internet search activity to provide near-real time estimates of influenza activity. GFT estimates have shown a strong correlation with official influenza surveillance data. The 2009 influenza virus A (H1N1) pandemic [pH1N1] provided the first opportunity to evaluate GFT during a non-seasonal influenza outbreak. In September 2009, an updated United States GFT model was developed using data from the beginning of pH1N1. Methodology/Principal Findings: We evaluated the accuracy of each U. S. GFT model by comparing weekly estimates of ILI (influenza-like illness) activity with the U. S. Outpatient Influenza-like Illness Surveillance Network (ILINet). For each GFT model we calculated the correlation and RMSE (root mean square error) between model estimates and ILINet for four time periods: pre-H1N1, Summer H1N1, Winter H1N1, and H1N1 overall (Mar 2009-Dec 2009). We also compared the number of queries, query volume, and types of queries (e. g., influenza symptoms, influenza complications) in each model. Both models' estimates were highly correlated with ILINet pre-H1N1 and over the entire surveillance period, although the original model underestimated the magnitude of ILI activity during pH1N1. The updated model was more correlated with ILINet than the original model during Summer H1N1 (r = 0.95 and 0.29, respectively). The updated model included more search query terms than the original model, with more queries directly related to influenza infection, whereas the original model contained more queries related to influenza complications. Conclusions: Internet search behavior changed during pH1N1, particularly in the categories "influenza complications'' and "term for influenza.'' The complications associated with pH1N1, the fact that pH1N1 began in the summer rather than winter, and changes in health-seeking behavior each may have played a part. Both GFT models performed well prior to and during pH1N1, although the updated model performed better during pH1N1, especially during the summer months.	[Cook, Samantha; Mohebbi, Matthew H.] Google Inc, New York, NY USA; [Conrad, Corrie] Google Inc, London, England; [Fowlkes, Ashley L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Google Incorporated; Google Incorporated; Centers for Disease Control & Prevention - USA	Cook, S (corresponding author), Google Inc, New York, NY USA.	cconrad@google.com		Behmer, Spencer/0000-0002-5038-1046; Cook, Samantha/0000-0002-2173-4471	Google.org; Google Inc.	Google.org; Google Inc.(Google Incorporated)	This research was funded by Google.org, the non-profit arm of Google Inc. This funder played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Three of the authors (SC, CC, MM) are employees of one of the funders of the study (Google Inc.) and were involved with the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Yes, the authors have the following competing interest. This study was supported by funding from Google Inc., and three of the authors (SC, CC, MM) are employees of Google Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Brammer L, 2011, CLIN INFECT DIS, V52, pS27, DOI 10.1093/cid/ciq009; *CDC, 2007, MMWR-MORBID MORTAL W, V57, P692; *CDC, CDC SEAS INFL FLU FL; *CDCP CDC, INF 2009 H1N1 IMP RA; DEAN J, 2004, OSDI 60 S OP SYST DE; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google.org, 2009, GOOGL FLU TRENDS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed C, 2011, CLIN INFECT DIS, V52, pS90, DOI 10.1093/cid/ciq024; Wilson N, 2009, EUROSURVEILLANCE, V14; [No title captured]	13	225	237	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2011	6	8							e23610	10.1371/journal.pone.0023610	http://dx.doi.org/10.1371/journal.pone.0023610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	810LZ	21886802	gold, Green Submitted, Green Published			2022-12-25	WOS:000294128100022
J	Qiu, C; Tian, D; Wan, YM; Zhang, WJ; Qiu, CL; Zhu, ZQ; Ye, RQ; Song, ZG; Zhou, MZ; Yuan, SH; Shi, BS; Wu, M; Liu, Y; Gu, SM; Wei, J; Zhou, ZT; Zhang, XY; Zhang, ZY; Hu, YW; Yuan, ZH; Xu, JQ				Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Wei, Jun; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing			Early Adaptive Humoral Immune Responses and Virus Clearance in Humans Recently Infected with Pandemic 2009 H1N1 Influenza Virus	PLOS ONE			English	Article							ORIGIN; ANTIBODIES	Few studies on the humoral immune responses in human during natural influenza infection have been reported. Here, we used serum samples from pandemic 2009 H1N1 influenza infected patients to characterize the humoral immune responses to influenza during natural infection in humans. We observed for the first time that the pandemic 2009 H1N1 influenza induced influenza A-specific IgM within days after symptoms onset, whereas the unit of IgG did not changed. The magnitude of influenza A-specific IgM antibodies might have a value in predicting the rate of virus clearance to some degree. However, the newly developed IgM was not associated with hemagglutination inhibition (HI) activities in the same samples but correlated with HI activities of subsequently collected sera which were mediated by IgG antibodies, indicating that IgM was critical for influenza infection and influences subsequent IgG antibody responses. These findings provide new important insights on the human immunity to natural influenza infection.	[Qiu, Chao; Tian, Di; Wan, Yanmin; Zhang, Wanju; Qiu, Chenli; Zhu, Zhaoqin; Ye, Ruiqi; Song, Zhigang; Zhou, Mingzhe; Yuan, Songhua; Shi, Bisheng; Wu, Min; Liu, Yi; Gu, Shimin; Zhou, Zhitong; Zhang, Xiaoyan; Zhang, Zhiyong; Hu, Yunwen; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Yuan, Zhenghong; Xu, Jianqing] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ Hlth, Shanghai 200433, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wei, Jun] Yuncheng CDC, Yuncheng, Peoples R China	Fudan University; Fudan University; Chinese Center for Disease Control & Prevention	Qiu, C (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org; jianqingxu2008@gmail.com	Zhou, Mingzhe/AED-5236-2022; Qiu, Chao/M-6702-2014; , yanmin/GQH-2789-2022	Qiu, Chao/0000-0001-9401-5219; , yanmin/0000-0001-5027-9423; Zhang, Wanju/0000-0001-9913-8584; Zhou, Mingzhe/0000-0002-5518-7330; Zhou, Shi-Rong/0000-0003-2594-3198	National Grand Program on Key Infectious Disease Control [2008ZX10001-002, 2009ZX10602-11]; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program) [2005CB522903]; China Ministry of Science and Technology, China; Key Basic Research Project [10JC1413600]; Science and Technology Commission of Shanghai Municipality, Shanghai	National Grand Program on Key Infectious Disease Control; China Ministry of Health; China National Program on Key Basic Research Projects (973 Program)(National Basic Research Program of China); China Ministry of Science and Technology, China(Ministry of Science and Technology, China); Key Basic Research Project; Science and Technology Commission of Shanghai Municipality, Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by the National Grand Program on Key Infectious Disease Control (Grant #2008ZX10001-002 and 2009ZX10602-11), China Ministry of Health, and by the China National Program on Key Basic Research Projects (973 Program) (No. 2005CB522903), the China Ministry of Science and Technology, China, and by the Key Basic Research Project (10JC1413600), Science and Technology Commission of Shanghai Municipality, Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], MMWR MORB MORTAL WKL; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; McCracken J, 2009, LANCET, V373, P2107, DOI 10.1016/S0140-6736(09)61141-7; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Zhang H, 2009, LANCET INFECT DIS, V9, P456, DOI 10.1016/S1473-3099(09)70181-1	12	66	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2011	6	8							e22603	10.1371/journal.pone.0022603	http://dx.doi.org/10.1371/journal.pone.0022603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811YA	21966459	gold, Green Submitted, Green Published			2022-12-25	WOS:000294253500001
J	Chang, YT; Wu, CC; Shyr, YM; Chen, TC; Hwang, TL; Yeh, TS; Chang, KP; Liu, HP; Liu, YL; Tsai, MH; Chang, YS; Yu, JS				Chang, Ya-Ting; Wu, Chih-Ching; Shyr, Yi-Ming; Chen, Tse-Ching; Hwang, Tsann-Long; Yeh, Ta-Sen; Chang, Kai-Ping; Liu, Hao-Ping; Liu, Yu-Ling; Tsai, Ming-Hung; Chang, Yu-Sun; Yu, Jau-Song			Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CLINICAL-SIGNIFICANCE; PROTEOMIC ANALYSIS; NKG2D LIGANDS; CELL LINES; EXPRESSION; PROTEIN; BIOMARKERS; INDICATOR; DIAGNOSIS	Background: To discover novel markers for improving the efficacy of pancreatic cancer (PC) diagnosis, the secretome of two PC cell lines (BxPC-3 and MIA PaCa-2) was profiled. UL16 binding protein 2 (ULBP2), one of the proteins identified in the PC cell secretome, was selected for evaluation as a biomarker for PC detection because its mRNA level was also found to be significantly elevated in PC tissues. Methods: ULBP2 expression in PC tissues from 67 patients was studied by immunohistochemistry. ULBP2 serum levels in 154 PC patients and 142 healthy controls were measured by bead-based immunoassay, and the efficacy of serum ULBP2 for PC detection was compared with the widely used serological PC marker carbohydrate antigen 19-9 (CA 19-9). Results: Immunohistochemical analyses revealed an elevated expression of ULPB2 in PC tissues compared with adjacent non-cancerous tissues. Meanwhile, the serum levels of ULBP2 among all PC patients (n = 154) and in early-stage cancer patients were significantly higher than those in healthy controls (p < 0.0001). The combination of ULBP2 and CA 19-9 outperformed each marker alone in distinguishing PC patients from healthy individuals. Importantly, an analysis of the area under receiver operating characteristic curves showed that ULBP2 was superior to CA 19-9 in discriminating patients with early-stage PC from healthy controls. Conclusions: Collectively, our results indicate that ULBP2 may represent a novel and useful serum biomarker for pancreatic cancer primary screening.	[Chang, Ya-Ting; Tsai, Ming-Hung; Yu, Jau-Song] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Wu, Chih-Ching; Liu, Hao-Ping; Liu, Yu-Ling; Chang, Yu-Sun; Yu, Jau-Song] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan; [Wu, Chih-Ching] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Shyr, Yi-Ming] Taipei Vet Gen Hosp, Dept Surg, Div Gen & Transplantat Surg, Taipei, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Anat Pathol, Tao Yuan, Taiwan; [Hwang, Tsann-Long; Yeh, Ta-Sen] Chang Gung Mem Hosp, Dept Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol, Tao Yuan, Taiwan; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Head & Neck Surg, Tao Yuan, Taiwan; [Yu, Jau-Song] Chang Gung Univ, Dept Cell & Mol Biol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, YT (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	luckywu@mail.cgu.edu.tw; yusong@mail.cgu.edu.tw	li, JACK/HHC-6755-2022; Liu, Hao-Ping/AAJ-3038-2020	Liu, Hao-Ping/0000-0001-5915-5128; Yu, Jau-Song/0000-0002-4295-983X; Wu, Chih-Ching/0000-0002-7264-9672; Li, Yu-Chuan (Jack)/0000-0001-6497-4232; Hsu, Chien-Yeh/0000-0001-8233-6461; Chang, Yu-Sun/0000-0002-6457-3890; Chang, Ying-Jui/0000-0003-0294-4657	Taiwan National Science Council [NSC 96-2320-B-182-031-MY3]; Department of Health [DOH-99-TD-C-111-006]; Ministry of Education [EMRPD180241, EMRPD180091]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Ministry of Education	This study was supported by the grants from the Taiwan National Science Council (NSC 96-2320-B-182-031-MY3), Department of Health (DOH-99-TD-C-111-006), and Ministry of Education (EMRPD180241 and EMRPD180091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdogan M, 2001, TUMORI, V87, P337, DOI 10.1177/030089160108700513; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chang ST, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-105; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; *DEP HLTH, 2009, STAND DEATH RAT LEAD; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guo JH, 2009, CANCER SCI, V100, P2292, DOI 10.1111/j.1349-7006.2009.01324.x; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hoimes CJ, 2009, J PANCREAS, V10, P352; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Katz MH, 2005, PANCREATOLOGY, V5, P576, DOI 10.1159/000087500; Lee MX, 2009, J PANCREAS, V10, P104; Li K, 2009, CANCER IMMUNOL IMMUN, V58, P641, DOI 10.1007/s00262-008-0585-3; Maccalli C, 2007, CLIN CANCER RES, V13, P7459, DOI 10.1158/1078-0432.CCR-07-1166; MAGNANI JL, 1983, CANCER RES, V43, P5489; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Melle C, 2007, CLIN CHEM, V53, P629, DOI 10.1373/clinchem.2006.079194; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Oto A, 2006, CURR PROBL DIAGN RAD, V35, P199, DOI 10.1067/j.cpradiol.2006.06.001; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Pende D, 2002, CANCER RES, V62, P6178; Pliarchopoulou K, 2009, CANCER TREAT REV, V35, P431, DOI 10.1016/j.ctrv.2009.02.005; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; RAVN V, 1993, PATHOL RES PRACT, V189, P1015; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; TEMPERO MA, 1987, CANCER RES, V47, P5501; Tian M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-241; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Watson NFS, 2006, INT J CANCER, V118, P1445, DOI 10.1002/ijc.21510; Winter JM, 2006, J GASTROINTEST SURG, V10, P1199, DOI 10.1016/j.gassur.2006.08.018; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu CC, 2008, PROTEOM CLIN APPL, V2, P1586, DOI 10.1002/prca.200800080; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	41	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2011	6	5							e20029	10.1371/journal.pone.0020029	http://dx.doi.org/10.1371/journal.pone.0020029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766OI	21887234	Green Submitted, Green Published, gold			2022-12-25	WOS:000290793400031
